cid,cmpdname,cmpdsynonym,mw,mf,polararea,complexity,xlogp,heavycnt,hbonddonor,hbondacc,rotbonds,inchi,isosmiles,inchikey,iupacname,meshheadings,annothits,annothitcnt,aids,cidcdate,sidsrcname,depcatg,annotation
   121304016,Remdesivir,"1809249-37-3|3QKI37EEHE|GS 5734|GS 5734 [WHO-DD]|GS-5734|GS5734|Remdesivir|REMDESIVIR [INN]|Remdesivir [USAN]|REMDESIVIR [WHO-DD]|remdesivirum|UNII-3QKI37EEHE|Veklury|2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate|2-Ethylbutyl (2S)-2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate|2-ethylbutyl ",602.600,C27H35N6O8P,204.000,1010.000,1.900,42,4,13,14,"InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1",CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,RWWYLEGWBNMMLJ-YSOARWBDSA-N,"2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1409578|1409579|1409580|1409581|1409595|1409599|1409600|1409601|1409605|1409606|1440651|1440652|1440653|1440654|1440655|1440656|1440657|1440658|1440659|1440660|1440673|1440674|1440675|1440676|1440678|1440679|1440680|1440681|1440682|1440683|1440684|1440685|1440686|1440687|1440688|1440689|1440690|1440691|1440692|1440693|1440694|1440698|1467730|1467731|1467732|1467733|1467734|1467735|1467736|1467737|1467738|1467739|1467740|1508605|1508606,20160806,"AbaChemScene|Axon Medchem|BenchChem|BindingDB|BioChemPartner|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Comparative Toxicogenomics Database (CTD)|DAOGE BIOPHARMA|DrugBank|DTP/NCI|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|Hangzhou APIChem Technology|Hunan Huateng Pharmaceutical Co., Ltd.|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|Key Organics/BIONET|Lan Pharmatech|LKT Labs|MedChemexpress MCE|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextMo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2719,Chloroquine,chloroquine|54-05-7|Aralen|Chlorochin|Chloraquine|Artrichin|Chloroquinium|Chloroquina|Reumachlor|Capquin|Chemochin|Chlorquin|Clorochina|Malaquin|Arthrochin|Bemasulph|Benaquin|Bipiquin|Chingamin|Cidanchin|Cocartrit|Dichinalex|Gontochin|Heliopar|Iroquine|Klorokin|Lapaquin|Mesylith|Pfizerquine|Quinachlor|Quinercyl|Quinilon|Quinoscan|Sanoquin|Silbesan|Solprina|Sopaquin|Tresochin|Amokin|Bemaco|Elestol|Imagon|Malaren|Malarex|Neochin|Roquine|Siragan|Trochin|Nivaquine B|Bemaphate|Resoquine|Nivaquine|Chlorochine|Chl,319.900,C18H26ClN3,28.200,309.000,4.600,22,1,3,8,"InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)",CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,WHTVZRBIWZFKQO-UHFFFAOYSA-N,"4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine",Chloroquine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,179|248|256|1332|2660|2666|2667|2668|8665|17461|18982|18984|25339|26756|27167|27572|27587|28680|28681|28683|29338|29359|29811|40459|47338|47339|47340|47341|47342|47343|51933|59922|59925|60963|60965|68949|70548|71872|71879|72010|72011|72013|72016|72859|72861|72977|84652|85548|85552|88262|88264|88423|88424|91120|93345|93346|93347|93348|93349|93350|93351|93352|99681|99863|100892|104327|104328|104330|104331|105679|105682|105684|105687|105688|105690|105829|105830|105832|105835|105837|105839|105841|105843|105846|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alinda Chemical|Alsachim|Amadis Chemical|Ambeed",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
392622,Ritonavir,"ritonavir|155213-67-5|Norvir|ABT-538|Abbott 84538|A-84538|ABBOTT-84538|UNII-O3J8G9O825|RTV|CHEBI:45409|1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate|O3J8G9O825|MFCD00927142|NSC693184|Ritonavir, 98%|NSC-693184|thiazol-5-ylmethyl ((2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate|NCGC00159462",720.900,C37H48N6O5S2,202.000,1040.000,6.000,50,4,9,18,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,NCDNCNXCDXHOMX-XGKFQTDJSA-N,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate",Ritonavir,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,485|631|731|781|782|880|881|894|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1379|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1460|1461|1463|1465|1466|1467|1468|1469|1471|1476|1477|1478|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|1566|1578|1619|1621|162,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Aceschem Inc|Acesobio|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|Ambeed|AN PharmaTech|Angene Chemical|AOBIOUS INC|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BIDD|BindingDB|BioCrick|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Science",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
197020,N(4)-Hydroxycytidine,"N4-Hydroxycytidine|N(4)-Hydroxycytidine|Beta-D-N4-hydroxycytidine|3258-02-4|EIDD-1931|UNII-C3D11PV2O4|C3D11PV2O4|1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one|Uridine, 4-oxime|1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one|N-hydroxycytidine|4-N-Hydroxycytidine|N-4-Hydroxycytidine|Cytidine, N-hydroxy-|CCRIS 1074|SCHEMBL5190819|CHEMBL2178720|GTPL10735|DTXSID20186274|EX-A3655|MFCD01675695|HY-12",259.220,C9H13N3O6,135.000,398.000,-2.200,18,5,6,3,"InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)N=C1NO)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,XCUAIINAJCDIPM-XVFCMESISA-N,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active,10,707243|1259407|1259408,20050801,AbaChemScene|abcr GmbH|ABI Chem|Ambeed|AvaChem Scientific|BLD Pharm|Chem-Space.com Database|ChEMBL|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|CSNpharm|DAOGE BIOPHARMA|DiscoveryGate|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA/SPL Indexing Data|Genetic Toxicology Data Bank (GENE-TOX)|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|MedChemexpress MCE|Mol,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, Guide to PHARMACOLOGY]"
107970,Fingolimod,"Fingolimod|162359-55-9|2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol|2-Amino-2-(4-octylphenethyl)propane-1,3-diol|2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol|UNII-3QN8BYN5QF|2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol|Fingolimod [INN]|Gilenya (TN)|3QN8BYN5QF|1,3-Propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-|CHEMBL314854|CHEBI:63115|Fingolimod-d4|Fingolimod (INN)|1,3-Propanediol, 2-amino-2-(2-(4-octylphenyl)ethyl)-|C19H33NO2|2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol|2-amino-2-(2",307.500,C19H33NO2,66.500,258.000,4.200,22,3,3,12,"InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3",CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,KKGQTZUTZRNORY-UHFFFAOYSA-N,"2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol",Fingolimod Hydrochloride,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,132486|132505|173547|185363|185364|185365|185367|185368|185369|185370|185371|185372|185373|192200|240247|240248|240249|240250|240251|258414|258415|268317|268318|282267|282268|282269|282270|282271|282276|305218|305219|357390|362335|362336|362337|371965|473705|473706|473707|475242|588211|588212|588213|596404|596406|596407|596408|596409|596410|596411|596412|596413|596414|596415|596416|642403|642478|671363|671369|671380|672978|706333|706334|721980|743344|743345|743346|743347|777389|777390|777392|777393|777394|7,20050808,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
492405,Favipiravir,"Favipiravir|259793-96-9|6-FLUORO-3-HYDROXYPYRAZINE-2-CARBOXAMIDE|6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide|T-705|avigan|6-fluoro-3-hydroxy-2-pyrazinecarboxamide|Favipiravir (T-705)|T 705|5-fluoro-2-oxo-1H-pyrazine-3-carboxamide|UNII-EW5GL2X7E0|Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-|6-fluoro-3-hydroxy-pyrazine-2-carboxamide|Favipiravir; T-705|EW5GL2X7E0|T705|6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide|MFCD12032148|2-Pyrazinecarboxamide, 6-fluoro-3-hydroxy-|T-705 cpd|Fapilavir|Favilavir|",157.100,C5H4FN3O2,84.600,282.000,-0.600,11,2,4,1,"InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)",C1=C(N=C(C(=O)N1)C(=O)N)F,ZCGNOVWYSGBHAU-UHFFFAOYSA-N,5-fluoro-2-oxo-1H-pyrazine-3-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,13,283440|283441|283442|283443|283444|283445|283446|283447|283448|283449|283450|283451|283452|283453|283454|283456|283457|283458|283460|283461|283462|283464|283465|283466|283468|283469|283470|283472|283473|283474|283475|283476|283477|283478|283479|283480|283481|283482|283483|283484|283485|283486|283487|283488|283489|283490|283491|283492|283493|283494|283495|283496|283497|283498|283499|283500|283501|283502|283503|283504|283505|283506|283507|283508|283509|283510|283511|283512|283513|283514|283515|283516|283517|2,20050801,"001Chemical|A2Z Chemical|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Acemol|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Anward|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurora Fine Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
447043,Azithromycin,"azithromycin|Zithromax|83905-01-5|Sumamed|Zitromax|Zmax|Azithromycine|Azithromycinum|Hemomycin|Azasite|Azenil|Azithromycine [French]|Azithromycinum [Latin]|AZITHROMYCIN DIHYDRATE|CP-62993|Azitromax|Misultina|Tromix|CP 62993|C38H72N2O12|UNII-J2KLZ20U1M|Toraseptol|J2KLZ20U1M|CHEBI:2955|(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy",749.000,C38H72N2O12,180.000,1150.000,4.000,52,5,14,7,"InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,MQTOSJVFKKJCRP-BICOPXKESA-N,"(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one",Azithromycin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|940|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1376|1385|1422|1452|1457|1458|1465|1469|1471|1476|1477|1478|1479|1487|1490|1511|1529|1531|1532|1554|1580|1581|1582|1583|1584|1585|1586|,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|AmicBase - Antimicrobial Activities|ApexBio Technology|Aurora Fine Chemicals LLC|Axon Medchem|BIDD|BindingDB|BioCrick|BioCyc|Biosynth Carbosynth|BLD Pharm|Boerchem|B",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3113817,Triazavirin,"Riamilovir|Triazavirin|123606-06-4|UNII-F2HTG1MH2D|F2HTG1MH2D|4(1H)-one|[1,2,4]Triazolo[5,1-c][1,2,4]triazin-4(1H)-one, 7-(methylthio)-3-nitro-|7-(methylsulfanyl)-3-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-|7-(Methylthio)-3-nitro-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4(6H)-one|Riamilovir [INN]|ACMC-20mqnx|Riamilovir  [INN]|Triazavirin [WHO-DD]|Oprea1_193144|Oprea1_478576|C5H4N6O3S|CHEMBL1618116|SCHEMBL18199177|DTXSID40389402|STL363196|7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one|AK",228.190,C5H4N6O3S,141.000,435.000,0.400,15,1,6,1,"InChI=1S/C5H4N6O3S/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5/h1H3,(H,6,8,9)",CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-],IDVQGNMSSHPZSJ-UHFFFAOYSA-N,"7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one",NULL,Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity,8,NULL,20050809,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Achemica|AKos Consulting & Solutions|Ambeed|Ambinter|ASINEX|Aurora Fine Chemicals LLC|BioChemPartner|BLD Pharm|Chem-Space.com Database|ChemBank|ChEMBL|ChemDB|ChemFish Tokyo co.,ltd|ChemIDplus|ChemSpider|ChemTik|CSNpharm|DC Chemicals|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|Japan Chemical Substance Dictionary (Ni",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10445549,Galidesivir,"Galidesivir|IMMUCILLIN A|249503-25-1|Immucillin-A|BCX-4430|UNII-OLF97F86A7|BCX 4430 Free Base|BCX4430 freebase|BCX4430|(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol|OLF97F86A7|ImmA cpd|3,4-Pyrrolidinediol,2-(4-Amino-5h-Pyrrolo[3,2-D]pyrimidin-7-Yl)-5-(Hydroxymethyl)-2s,3s,4r,5r|BCX4430 (freebase)|UA2|CHEMBL1236524|SCHEMBL12468816|BDBM50513995|HY-18649A|ZINC13492903|CS-3779|DB11676|SB16942|NCGC00485882-01|BCX-4430 freebase;Immucillin-A;Galidesivir|(1S)-1-(9-C",265.270,C11H15N5O3,140.000,334.000,-2.100,19,6,7,2,"InChI=1S/C11H15N5O3/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15)/t5-,7+,9-,10+/m1/s1",C1=C(C2=C(N1)C(=NC=N2)N)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O,AMFDITJFBUXZQN-KUBHLMPHSA-N,"(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,1296008|1296009|1345084|1346986|1346987|1347055|1347149|1347156|1347158|1347159|1347160|1347161|1347163|1347164|1347167|1347168|1347169|1347170|1347171|1347172,20061025,"A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|BindingDB|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Comparative Toxicogenomics Database (CTD)|CSNpharm|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
44205240,Baricitinib,"Baricitinib|1187594-09-7|INCB028050|olumiant|LY3009104|2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile|INCB 028050|INCB-028050|1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile|LY-3009104|UNII-ISP4442I3Y|Baricitinib (LY3009104, INCB028050)|ISP4442I3Y|LY 3009104|LY3009104 (phosphate);INCB028050 (phosphate)|C16H17N7O2S|3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyraz",371.400,C16H17N7O2S,129.000,678.000,-0.500,26,1,7,5,"InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)",CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,XUZMWHLSFXCVMG-UHFFFAOYSA-N,"2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,743344|743345|743346|743347|1157422|1157423|1157424|1157425|1157426|1157427|1157428|1157429|1157430|1157431|1224824|1224825|1224857|1224859|1248155|1248156|1248157|1248158|1248159|1248160|1251058|1251059|1251060|1251061|1251062|1251063|1251064|1259252|1259253|1259255|1259256|1259398|1259399|1259416|1259421|1259423|1276684|1276685|1276686|1276687|1276691|1276699|1276700|1276701|1276702|1296008|1296009|1298804|1298805|1298806|1298813|1345084|1345714|1345757|1346986|1346987|1347053|1347055|1347060|1347061|1347,20090928,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acadechem|Acemol|Acesobio|Achemtek|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|Aurora ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank]"
92727,Lopinavir,"Lopinavir|192725-17-0|ABT-378|Aluviran|Kaletra|ABT 378|A 157378.0|A-157378.0|RS-346|UNII-2494G1JF75|CHEBI:31781|Lopinavir (ABT-378)|A-157378-0|(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide|(alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide|LPV|Koletra|A 157378|2494G1JF75|N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENO",628.800,C37H48N4O5,120.000,940.000,5.900,46,4,5,15,"InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1",CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,KJHKTHWMRKYKJE-SUGCFTRWSA-N,"(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",Lopinavir,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1471|1490|1688|1766|1768|1811|2528|2546|2551|2662|13678|21894|28092|104835|105346|105401|105589|106953|106958|160461|162683|162693|162704|163477|238043|238682|239809|239810|239819|242866|242868|242869|242932|242933|246160|246193|246194|246195|246225|246965|247984|248098|248545|248546|248600|249499|257269|257270|257271|257272|257273|263207|263208|263209|274379|274380|274381|274382|278953|278954|278955|278956|278957|278958|278959|278960|278961|278962|278963|278964|278965|278966|278967|278968|278969|278970|278,20050601,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acesobio|Achemtek|Adooq BioScience|AKos Consulting & Solutions|Alsachim|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|AvaChem Scientific|Axon Medchem|BePharm Ltd.|BIND|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|Broad Institute|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
213039,Darunavir,"Darunavir|206361-99-1|Prezista|TMC114|UIC-94017|TMC-114|Darunavirum|TMC 114|Darunavirum [INN-Latin]|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate|UNII-YO603Y8113|CHEMBL1323|(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE|CHEBI:367163|MFCD09260006|YO603Y8113|N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl",547.700,C27H37N3O7S,149.000,853.000,2.900,38,3,9,12,"InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1",CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CJBJHOAVZSMMDJ-HEXNFIEUSA-N,"[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate",Darunavir,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1471|1490|1688|1766|1768|1811|2528|2546|2551|2662|105016|160442|236641|236642|236937|236938|236972|236973|237560|237561|237954|237955|237956|238117|238198|242819|249503|249504|249505|249506|249507|249508|249509|260513|260514|260515|260516|260517|260518|263207|263208|263209|269303|269304|269310|269311|269312|269313|269314|269315|269316|269317|297694|297695|297696|297697|297698|311574|311575|311576|322096|322097|322098|322099|322100|322101|322102|322103|322104|322105|322106|322107|322108|322109|322110|322111|,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Active Biopharma|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BindingDB|BioChemPartner|BioCri",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5743,Dexamethasone,dexamethasone|50-02-2|Decadron|Maxidex|Dexamethazone|Dexasone|Hexadrol|Oradexon|Prednisolone F|Cortisumman|Decaspray|Desametasone|Hexadecadrol|Millicorten|Auxiron|Calonat|Dexacort|Dexason|Azium|Fluormethylprednisolone|Aeroseb-Dex|Deltafluorene|Desamethasone|Mediamethasone|Superprednol|Visumetazone|Aphtasolon|Decaderm|Decasone|Dectancyl|Dekacort|Dergramin|Desadrene|Desameton|Dexacortal|Dexacortin|Dexadeltone|Dexalona|Dexameth|Dexapolcort|Dextelan|Dinormon|Fortecortin|Gammacorten|Mymethasone|Turbinaire|Corson,392.500,C22H29FO5,94.800,805.000,1.900,28,3,6,2,"InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,UREBDLICKHMUKA-CXSFZGCWSA-N,"(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one",Dexamethasone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,1|3|5|9|13|15|17|19|21|23|25|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|63|65|67|69|71|73|75|79|81|99|101|103|105|107|109|113|115|119|121|123|125|131|137|139|141|143|145|155|157|161|165|167|175|179|180|190|192|196|200|206|208|212|220|248|256|264|268|296|328|330|342|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|,20050326,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alsachim|Apexmol|Aronis|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BIDD|BindingDB|BioCrick|BioCyc|Biosynth",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank, Guide to PHARMACOLOGY]"
131411,Arbidol,"Arbidol|umifenovir|131707-25-0|UNII-93M09WW4RU|Umifenovir [INN]|ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate|ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylsulfanyl)methyl]-1H-indole-3-carboxylate|MLS000777586|93M09WW4RU|Umifenovir (INN)|SMR000413980|1H-Indole-3-carboxylic acid, 6-bromo-4-((dimethylamino)methyl)-5-hydroxy-1-methyl-2-((phenylthio)methyl)-, ethyl ester|Arbidol base|1H-Indole-3-carboxylic acid, 6-bromo-4-[(dimethy",477.400,C22H25BrN2O3S,80.000,546.000,4.400,29,1,5,8,"InChI=1S/C22H25BrN2O3S/c1-5-28-22(27)20-18(13-29-14-9-7-6-8-10-14)25(4)17-11-16(23)21(26)15(19(17)20)12-24(2)3/h6-11,26H,5,12-13H2,1-4H3",CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,KCFYEAOKVJSACF-UHFFFAOYSA-N,ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,12,372|485|781|782|798|800|873|880|940|1021|1022|1046|1085|1230|1236|1242|1274|1304|1321|1359|1376|1377|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1467|1468|1469|1471|1477|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1533|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1662|1663|1665|1672|1688|1700|1706|1721|1722|1766|1775|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1865|1,20050709,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Amadis Chemical|Ambinter|AN PharmaTech|Anward|Ape",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6741,Methylprednisolone,methylprednisolone|83-43-2|Medrol|Medrone|Metilprednisolone|Urbason|6alpha-Methylprednisolone|Metilbetasone|Medrate|Dopomedrol|Promacortine|Besonia|Medesone|Mesopren|Metastab|Metrisone|Moderin|Noretona|Solomet|Urbasone|Wyacort|Methylprednisolon|Methyleneprednisolone|6-alpha-Methylprednisolone|Metilprednisolone [DCIT]|delta(1)-6alpha-Methylhydrocortisone|1-Dehydro-6alpha-methylhydrocortisone|Metilprednisolona|Methylprednisolonum|NSC-19987|Methylprednisolonum [INN-Latin]|Metilprednisolona [INN-Spanish]|Supram,374.500,C22H30O5,94.800,754.000,1.900,27,3,5,2,"InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,VHRSUDSXCMQTMA-PJHHCJLFSA-N,"(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",Methylprednisolone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|3|7|9|11|13|15|19|23|25|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|99|101|103|105|107|109|113|115|119|121|123|125|129|131|137|139|141|143|145|180|192|200|206|208|212|220|248|264|268|296|298|328|330|342|357|361|364|368|371|373|374|375|377|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|461|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|5,20050326,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|AvaChem Scientific|Axon Medchem|BePharm Ltd.|Bin",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
53361968,"(3r,3As,6ar)-Hexahydrofuro[2,3-B]furan-3-Yl {(2s,3r)-4-[({2-[(1-Cyclopentylpiperidin-4-Yl)amino]-1,3-Benzothiazol-6-Yl}sulfonyl)(2-Methylpropyl)amino]-3-Hydroxy-1-Phenylbutan-2-Yl}carbamate","TMC-310911|TMC310911|1000287-05-7|UNII-0151W500HP|0151W500HP|(3r,3as,6ar)-Hexahydrofuro[2,3-B]furan-3-Yl {(2s,3r)-4-[({2-[(1-Cyclopentylpiperidin-4-Yl)amino]-1,3-Benzothiazol-6-Yl}sulfonyl)(2-Methylpropyl)amino]-3-Hydroxy-1-Phenylbutan-2-Yl}carbamate|henylbutan-2-yl}carbamate|ASC09|ASC-09|SCHEMBL9976583|DB15623|SB17102|TMC 310911|HY-107123|CS-0027367|(3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl|Q27456657|((3aS,4R,6aR)-2,3,3a,4,5,6a-Hexahydrofuro(2,3-b)furan-4-yl) N-((1S,2R)-1-benzyl-3-((2-((1-cyclopentyl-4-p",756.000,C38H53N5O7S2,179.000,1250.000,6.300,52,3,12,15,"InChI=1S/C38H53N5O7S2/c1-25(2)22-43(23-33(44)32(20-26-8-4-3-5-9-26)41-38(45)50-34-24-49-36-30(34)16-19-48-36)52(46,47)29-12-13-31-35(21-29)51-37(40-31)39-27-14-17-42(18-15-27)28-10-6-7-11-28/h3-5,8-9,12-13,21,25,27-28,30,32-34,36,44H,6-7,10-11,14-20,22-24H2,1-2H3,(H,39,40)(H,41,45)/t30-,32-,33+,34-,36+/m0/s1",CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC5=C(C=C4)N=C(S5)NC6CCN(CC6)C7CCCC7,JQUNFHFWXCXPRK-AMMMHQJVSA-N,"[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20110921,"AbaChemScene|BLD Pharm|ChemIDplus|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|MedChemexpress MCE|MuseChem|NCBI Structure|NIAID ChemDB|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|Synblock Inc|THE BioTek|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank]"
71661251,Elbasvir,"Elbasvir|1370468-36-2|MK-8742|UNII-632L571YDK|MK 8742|632L571YDK|MK8742|Methyl ((1S)-1-(((2S)-2-(4-((6S)-10-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-6-phenyl-6H-indolo(1,2-c)(1,3)benzoxazin-3-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)carbonyl)-2-methylpropyl)carbamate|Dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-((S)-6-phenyl-6H-benzo[5,6][1,3]oxazino[3,4-a]indole-3,10-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))di",882.000,C49H55N9O7,189.000,1680.000,6.700,65,4,9,13,"InChI=1S/C49H55N9O7/c1-27(2)41(54-48(61)63-5)45(59)56-20-10-14-37(56)43-50-25-34(52-43)30-17-19-36-32(22-30)23-39-33-18-16-31(24-40(33)65-47(58(36)39)29-12-8-7-9-13-29)35-26-51-44(53-35)38-15-11-21-57(38)46(60)42(28(3)4)55-49(62)64-6/h7-9,12-13,16-19,22-28,37-38,41-42,47H,10-11,14-15,20-21H2,1-6H3,(H,50,52)(H,51,53)(H,54,61)(H,55,62)/t37-,38-,41-,42-,47-/m0/s1",CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC4=C(C=C3)N5[C@@H](OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)[C@@H]8CCCN8C(=O)[C@H](C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,BVAZQCUMNICBAQ-PZHYSIFUSA-N,"methyl N-[(2S)-1-[(2S)-2-[5-[(6S)-3-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,1303815|1303816|1303817|1303818|1303819|1313137|1313138|1313139|1313140|1313141|1313142|1313143|1313144|1323659|1323660|1323661|1323662|1323663|1323664|1338540|1338541|1338542|1338543|1338544|1338545|1338546|1338547|1338548|1338549|1338550|1338551|1338552|1338553|1370127|1370128|1370129|1370130|1370131|1370132|1370133|1370134|1409598|1409605|1479145|1479147|1479149|1479150,20130826,"A2B Chem|A2Z Chemical|AA BLOCKS|AbaChemScene|AbovChem LLC|Activate Scientific|Adooq BioScience|Alsachim|Ambeed|BindingDB|BLD Pharm|Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|CSNpharm|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA/SPL ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank]"
3652,Hydroxychloroquine,hydroxychloroquine|118-42-3|Plaquenil|Oxichloroquine|Hidroxicloroquina|Hydroxychloroquinum|oxichlorochine|WIN 1258|Quensyl|2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol|7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|Polirreumin|Oxychlorochin|CHEBI:5801|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|Oxichlorochinum|HYDROXY CHLOROQUINE|HCQ|2-((4-((7-Chloroquinolin-4-yl)amino,335.900,C18H26ClN3O,48.400,331.000,3.600,23,2,4,9,"InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)",CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,XXSMGPRMXLTPCZ-UHFFFAOYSA-N,2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol,Hydroxychloroquine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,880|881|894|1030|1195|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1688|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2528|2546|2549|2551|2662|318590|485281|485290|492961|492967|493162|504327|504332|504749|504832|504834|504847|504865|540209|540210|540211|540212|540213|557179|557180|557181|557182|557183|5571,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alinda Chemical|Alsachim|Ambeed|AN PharmaTech|Anward|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
25126798,Ruxolitinib,"Ruxolitinib|941678-49-5|INCB018424|Ruxolitinib (INCB018424)|(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile|INCB-018424|INCB 018424|UNII-82S8X8XX8H|(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile|82S8X8XX8H|INC424|INCB018424 (Ruxolitinib)|CHEBI:66919|(R)-ruxolitinib|C17H18N6|(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile|INCB18424|R-Ruxolitinib|(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d",306.400,C17H18N6,83.200,453.000,2.100,23,1,4,4,"InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1",C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,HFNKQEVNSGCOJV-OAHLLOKOSA-N,"(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,538223|538224|538225|538226|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|624767|6,20090119,"A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alsachim|Ambeed|Ambinter|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BePharm Ltd.|BerrChem|Bindin",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
44468216,"(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile","GS-441524|1191237-69-0|GS441524|(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile|EVO984|EVO-984|UNII-1BQK176DT6|1BQK176DT6|EVO 984|GS 441524|(2R,3R,4S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile|(2~{R},3~{R},4~{S},5~{R})-2-(4-azanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolane-2-carbonitrile|MFCD32666994|GS-441524 solution|CHEMBL2016757|SCHEMBL101",291.260,C12H13N5O4,150.000,456.000,-1.400,21,4,8,2,"InChI=1S/C12H13N5O4/c13-4-12(10(20)9(19)7(3-18)21-12)8-2-1-6-11(14)15-5-16-17(6)8/h1-2,5,7,9-10,18-20H,3H2,(H2,14,15,16)/t7-,9-,10-,12+/m1/s1",C1=C2C(=NC=NN2C(=C1)[C@]3([C@@H]([C@@H]([C@H](O3)CO)O)O)C#N)N,BRDWIEOJOWJCLU-LTGWCKQJSA-N,"(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbonitrile",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,656925|656926|656927|656928|656929|656930|656931|656932|656933|656934|656935|656936|656937|656938|656939|656941|1321300|1409605|1409606|1440651|1440652|1440653|1440654|1440655|1440656|1440657|1440658|1440673|1467731|1467732|1467733|1467734|1467735|1467736,20091130,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|Activate Scientific|AKos Consulting & Solutions|Ambeed|AvaChem Scientific|BioChemPartner|BLD Pharm|Changzhou Naide Chemical|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemShuttle|DAOGE BIOPHARMA|DC Chemicals|DiscoveryGate|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|Hangzhou APIChem Technology|Hunan Huateng Pharmaceutical Co., Ltd.|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|Key Org",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
145996610,EIDD-2801,"EIDD 2801|EIDD-2801|EIDD2801|molnupiravir|2349386-89-4|MK-4482|UNII-YA84KI1VEW|YA84KI1VEW|Molnupiravir [USAN]|WHO 11853|N4-Hydroxycytidine, 5'-isopropyl ester|((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyamino)-2-oxopyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate|((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate|[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate|Molnupir",329.310,C13H19N3O7,141.000,534.000,-0.800,23,4,7,6,"InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1",CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O,HTNPEHXGEKVIHG-QCNRFFRDSA-N,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,7,NULL,20200316,AbaChemScene|abcr GmbH|AbMole Bioscience|Ambeed|Axon Medchem|BindingDB|BioChemPartner|BLD Pharm|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|PATENTSCOPE (WIPO)|Selleck Chemicals|Smolecule|TargetMol (Target Molecule Corp.)|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
443363,MET-enkephalin,"MET-enkephalin|H-Tyr-Gly-Gly-Phe-Met-OH|Methionine enkephalin|METENKEFALIN|Tyr-Gly-Gly-Phe-Met-OH|58569-55-4|TYR-GLY-GLY-PHE-MET|[Met]enkephalin|[5-Methionine]Enkephalin|UNII-9JEZ9OD3AS|(Met5)-enkephalin|9JEZ9OD3AS|CHEMBL13786|CHEBI:6618|Lupex|[Met5]-ENKEPHALIN|[Met5]Enkephalin acetate salt hydrate|(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenyl-propanoyl]amino]-4-methylsulfanyl-butanoic acid|ENKEPHALIN, METHIONINE|Opioid growth factor|Metenkefal",573.700,C27H35N5O7S,225.000,847.000,-2.100,40,7,9,16,"InChI=1S/C27H35N5O7S/c1-40-12-11-21(27(38)39)32-26(37)22(14-17-5-3-2-4-6-17)31-24(35)16-29-23(34)15-30-25(36)20(28)13-18-7-9-19(33)10-8-18/h2-10,20-22,33H,11-16,28H2,1H3,(H,29,34)(H,30,36)(H,31,35)(H,32,37)(H,38,39)/t20-,21-,22-/m0/s1",CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N,YFGBQHOOROIVKG-FKBYEOEOSA-N,(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid,"Enkephalin, Methionine",Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,11,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1865|2101|2107|2112|2517|2549|76226|78684|132610|132839|141657|148653|149864|149938|150259|150264|150265|151897|197675|220515|223582|224584|229261|229264|231531|265378|265379|265380|265381|265382|265383|265384|265385|265386|265387|265388|265389|265390|265391|265392|265393|265394|265395|265396|265397|265398|265399|265400|265401|265402|265403|265404|265405|268677|268678|268679|268680|307013|307014|307015|307016|307017|307018|327874|424039|485281|48529,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Activate Scientific|AHH Chemical co.,ltd|Alichem|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BindingDB|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|CSNpharm|DiscoveryGate|DrugBan",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank]"
6918155,Ciclesonide,"Ciclesonide|Omnaris|Alvesco|Zetonna|126544-47-6|RPR251526|UNII-S59502J185|RPR-251526|S59502J185|141845-82-1|Osonase|Osonide|Omnair|RPR 251526|Alvesco HFA|Omnaris HFA|Alvesco (TN)|Omnaris (TN)|Ciclesonide [USAN:INN]|BTR-15K|Ciclesonide (JAN/USAN/INN)|BTR-15|TBN-15|(R)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclohexanecarboxaldehyde, 21-isobutyrate|NCGC00167484-01|(11?,16?)-16,17-[[(R)-Cyclohexylmethylene]bis(oxy)]-11-hydroxy-21-(2-methyl-1-oxopropoxy)-pregna-1,4",540.700,C32H44O7,99.100,1100.000,5.300,39,1,7,6,"InChI=1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1",CC(C)C(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)O[C@H](O2)C6CCCCC6,LUKZNWIVRBCLON-GXOBDPJESA-N,"[2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 2-methylpropanoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,588834|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|7,20060728,"A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|AN PharmaTech|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|BioCrick|BOC Sciences|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Comparative Toxicogenomics Database (CTD)|Crystallography Op",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16131138,Tridecactide,"Tridecactide|Des-acetyl MSH|DE-alpha-Msh|Msh, (desacetyl)alpha-|(Des-acetyl)-alpha-MSH|Adrenocorticotropin (1-13)NH2|Tridecactide [INN]|alpha1-13-Corticotropin|Desacetyl alpha-melanocyte-stimulating hormone|ACTH (1 - 13)-HUMAN|37213-49-3|alpha-1-13-corticotropin, humanL-seryl-L-tyrosyl-L-seryl-L-methionyl-L-glutamyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valine",1623.800,C75H106N20O19S,659.000,3240.000,-6.200,115,23,24,50,"InChI=1S/C75H106N20O19S/c1-41(2)62(74(113)114)94-72(111)59-19-12-29-95(59)73(112)53(17-9-10-27-76)85-60(99)37-83-64(103)56(33-44-35-82-49-16-8-7-15-47(44)49)91-65(104)50(18-11-28-81-75(78)79)86-68(107)55(31-42-13-5-4-6-14-42)90-70(109)57(34-45-36-80-40-84-45)92-66(105)51(24-25-61(100)101)87-67(106)52(26-30-115-3)88-71(110)58(39-97)93-69(108)54(89-63(102)48(77)38-96)32-43-20-22-46(98)23-21-43/h4-8,13-16,20-23,35-36,40-41,48,50-59,62,82,96-98H,9-12,17-19,24-34,37-39,76-77H2,1-3H3,(H,80,84)(H,83,103)(H,85,99)(",CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](CO)N,VGBVAARMQYYITG-DESRROFGSA-N,(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(1S)-1-carboxy-2-methylpropyl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-oxopentanoic,alpha-MSH,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20070703,"Ambinter|ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|eNovation Chemicals|Google Patents|LabNetwork, a WuXi AppTec Company|PATENTSCOPE (WIPO)|Smolecule|THE BioTek|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank]"
53472683,Zavegepant,"Zavegepant|BMS-742413|BHV-3500|UNII-ODU3ZAZ94J|ODU3ZAZ94J|CHEMBL2397415|BMS-742413-01|N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1H-quinolin-3-yl)piperidine-1-carboxamide|Zavegepant [USAN]|SCHEMBL107428|GTPL11513|BDBM50436107|BMS742413|WHO 11512|1-Piperidinecarboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-((1R)-1-((7-methyl-1H-indazol-5-yl)methyl)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxoethyl)-|1337918-83-8|4-(1,2-Dihydro-2-oxo-3-q",638.800,C36H46N8O3,117.000,1160.000,3.100,47,3,6,6,"InChI=1S/C36H46N8O3/c1-24-19-25(20-28-23-37-40-33(24)28)21-32(35(46)43-17-15-42(16-18-43)29-9-11-41(2)12-10-29)39-36(47)44-13-7-26(8-14-44)30-22-27-5-3-4-6-31(27)38-34(30)45/h3-6,19-20,22-23,26,29,32H,7-18,21H2,1-2H3,(H,37,40)(H,38,45)(H,39,47)/t32-/m1/s1",CC1=CC(=CC2=C1NN=C2)C[C@H](C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O,JJVAPHYEOZSKJZ-JGCGQSQUSA-N,N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1H-quinolin-3-yl)piperidine-1-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,10,754747|754748|754749|754750|754751|754752|754753|754754|754755|754756|754757|754758|754759|754760|754761|754762|754763|754764|754765|754766|754767|754768|754769|754770|754771|754772|754773|754774|754775|754776|754777|754778|754779|754780|754781|754782|754783|754784|754785|754787|754788|754789|754790|754791|754792|754793|754794|754795|754797,20111107,AbMole Bioscience|BindingDB|ChEMBL|ChemIDplus|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|MolPort|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.)|Thieme Chemistry|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3672,Ibuprofen,ibuprofen|15687-27-1|2-(4-Isobutylphenyl)propanoic acid|Motrin|Brufen|Advil|Nurofen|Dolgit|Liptan|Nuprin|Anflagen|Buburone|Butylenin|Ibumetin|Ibuprocin|Medipren|Ebufac|Lamidon|Mynosedin|Apsifen|Epobron|Haltran|Roidenin|Trendar|Adran|Andran|Bluton|Nobfen|Nobgen|PediaProfen|Rufen|2-[4-(2-methylpropyl)phenyl]propanoic acid|Nobfelon|Brufort|Inabrin|Pantrop|Rebugen|Suspren|Tabalon|(RS)-Ibuprofen|Anco|Urem|Ibu-slo|Brufanic|Ibuprohm|Napacetin|Ibufen|Ibren|4-Isobutylhydratropic acid|p-Isobutylhydratropic acid|Proar,206.280,C13H18O2,37.300,203.000,3.500,15,1,2,4,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,HEFNNWSXXWATRW-UHFFFAOYSA-N,2-[4-(2-methylpropyl)phenyl]propanoic acid,Ibuprofen,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|3|9|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|97|99|103|105|107|109|113|115|119|121|123|125|131|133|137|139|141|143|145|155|157|161|165|167|175|179|248|357|361|364|368|371|372|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alf",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank]"
2536,Camostat,"Camostat|59721-28-7|camostate|Camostat [INN]|UNII-0FD207WKDU|0FD207WKDU|4-(2-(2-(Dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate|Camostat (INN)|Foipan|[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate|Camostatum|Camostatum [INN-Latin]|CHEMBL85164|CCRIS 7219|NCGC00167526-01|camostat-mesilate|Dimethylcarbamoylmethyl 4-(4-guqnidinobenzoyloxy)phenylacetat|US9199927, camostat|SCHEMBL125269|CHEMBL590799|GTPL6432|DTXSID6044010|CHEBI:135632|BDBM193418|BCP",398.400,C20H22N4O5,137.000,602.000,1.100,29,2,6,9,"InChI=1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)",CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N,XASIMHXSUQUHLV-UHFFFAOYSA-N,[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,12,1471|1490|1688|1766|1768|2528|2546|2551|2662|456232|492961|504327|504332|504749|504832|504834|504847|504865|588579|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|721751|721752|721753|721754|743344|743345|743346|743347|1195360|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259409|1259416|1259421|1296008|1296009|1343455|1343456|1345994|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BindingDB|BioChemPar",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
37542,Ribavirin,"ribavirin|36791-04-5|Tribavirin|Rebetol|Virazole|Copegus|Vilona|Ribavirine|Viramid|Ribamide|Ribamidil|Ribasphere|Ribavirina|Ribavirinum|Ribavirine [INN-French]|Ribavirinum [INN-Latin]|ICN-1229|Ribavirina [INN-Spanish]|1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide|1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide|RTCA|RBV|SCH 18908|UNII-49717AWG6K|Ribamidyl|Ribavirin (Copegus)|1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide|1-((2R,3R,4S,5R)-3,4-dihydrox",244.200,C8H12N4O5,144.000,304.000,-1.800,17,4,7,3,"InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1",C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,IWUCXVSUMQZMFG-AFCXAGJDSA-N,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide",Ribavirin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,368|374|421|422|426|427|429|433|434|435|436|445|485|530|539|540|541|542|543|544|545|546|547|555|556|565|568|573|577|583|584|585|595|596|603|605|606|618|620|631|645|654|655|656|657|658|659|660|661|662|663|664|665|666|667|694|708|709|731|732|750|757|758|759|760|761|764|774|775|781|782|793|797|798|799|800|803|804|811|817|818|827|828|833|841|847|861|862|868|871|873|875|878|879|880|881|884|885|886|887|889|892|893|894|895|898|900|901|902|912|917|918|920|921|923|924|925|926|927|928|932|938|940|943|944|945|946|947|,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|BePh",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
5284616,Sirolimus,"(-)-Rapamycin|53123-88-9|AY 22989|AY-22989|I 2190A|I-2190A|I2190A|NSC 226080|RAPA|Rapammune|Rapamune|Rapamycin|SIIA 9268A|Sirolimus|Wy 090217|Rapamycin (Sirolimus)|Antibiotic AY 22989|UNII-W36ZG6FT64|CHEBI:9168|W36ZG6FT64|WY-090217|DE-109|MFCD00867594|NCGC00021305-05|DSSTox_CID_3582|sirolimusum|DSSTox_RID_77091|DSSTox_GSID_23582|SILA 9268A|Supralimus|C51H79NO13|(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-d",914.200,C51H79NO13,195.000,1760.000,6.000,65,3,13,6,"InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1",C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,QFJCIRLUMZQUOT-HPLJOQBZSA-N,"(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",Sirolimus,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1195|1471|1490|1688|1766|1768|1811|2528|2546|2551|2662|25399|37710|45154|45155|45156|45158|45159|45161|45162|45163|45165|45168|50151|50622|69092|69098|69106|69108|69113|69125|69247|69259|88934|90649|93824|106878|116769|132662|132664|137614|157079|178234|209808|209953|211471|230145|243422|254768|254831|257581|257582|257583|257584|257585|257586|257587|257588|257589|257590|257591|257592|276576|295405|311524|324364|324416|324468|324520|324572|324573|324574|324582|324583|324584|324585|324586|324595|324596|355286,20050624,"3B Scientific (Wuhan) Corp|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BIDD|BindingDB|BioCyc|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|CAPOT|CCSbase|Center for Chemical Genomics, University of Michigan|ChE",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918602,Relacatib,"Relacatib|SB-462795|362505-84-8|UNII-BL51M8CB8R|BL51M8CB8R|CHEMBL203665|N-[(2S)-4-methyl-1-[[(4S,7R)-7-methyl-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]-1-oxopentan-2-yl]-1-benzofuran-2-carboxamide|N-((S)-4-methyl-1-(((4S,7R)-7-methyl-3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-yl)amino)-1-oxopentan-2-yl)benzofuran-2-carboxamide.|Relacatib (USAN/INN)|Relacatib [USAN:INN]|Azepan-3-one compound 10|GSK-462795|GTPL7862|SCHEMBL1587331|BDBM19778|DTXSID30957639|AKOS025149082|DB06367|HY-10294|SB462795|CS-0002536|D06",540.600,C27H32N4O6S,147.000,967.000,3.900,38,2,8,8,"InChI=1S/C27H32N4O6S/c1-17(2)14-21(30-27(34)24-15-19-8-4-5-9-23(19)37-24)26(33)29-20-12-11-18(3)31(16-22(20)32)38(35,36)25-10-6-7-13-28-25/h4-10,13,15,17-18,20-21H,11-12,14,16H2,1-3H3,(H,29,33)(H,30,34)/t18-,20+,21+/m1/s1",C[C@@H]1CC[C@@H](C(=O)CN1S(=O)(=O)C2=CC=CC=N2)NC(=O)[C@H](CC(C)C)NC(=O)C3=CC4=CC=CC=C4O3,BWYBBMQLUKXECQ-GIVPXCGWSA-N,"N-[(2S)-4-methyl-1-[[(4S,7R)-7-methyl-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]-1-oxopentan-2-yl]-1-benzofuran-2-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,12,261373|261374|261375|261376|261377|261378|261379|261380|261381|261382|261383|261384|261385|261386|261387|261388|261389|261390|314219|314229|314230|314231|314232|314233|482421|482429|482430|482431|482432|482433|482434|482435|482436|482437|482438|482439|482440|482895|482898|482899|482900|1345903,20060728,"AbaChemScene|ABI Chem|Achemtek|AKos Consulting & Solutions|BindingDB|ChEMBL|ChemIDplus|ChemSpider|ChemTik|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|iChemical Technology USA Inc|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MedChemexpress MCE|MuseChem|NextBio|NextMove Software|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Prous Scienc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
25151504,Cobicistat,"Cobicistat|1004316-88-4|Cobicistat (GS-9350)|GS-9350|GS 9350|UNII-LW2E03M5PG|Cobicistat,GS-9350|CHEBI:72291|Tybost|LW2E03M5PG|1,3-thiazol-5-ylmethyl [(2R,5R)-5-{[(2S)-2-({[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}amino)-4-(morpholin-4-yl)butanoyl]amino}-1,6-diphenylhexan-2-yl]carbamate|thiazol-5-ylmethyl ((2R,5R)-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-4-morpholinobutanamido)-1,6-diphenylhexan-2-yl)carbamate|1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan",776.000,C40H53N7O5S2,195.000,1120.000,5.700,54,3,10,20,"InChI=1S/C40H53N7O5S2/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49)/t32-,33-,36+/m1/s1",CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,ZCIGNRJZKPOIKD-CQXVEOKZSA-N,"1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate",Cobicistat,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1069062|1069063|1069064|1069065|1069066|1069067|1069068|1069069|1259421|1409605|1409606|1479145|1479147|1479149|1479150,20090223,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Alsachim|Ambinter|Angene Chemical|AOBIOUS INC|ApexBio Technology|Assembly Blocks Pvt. Ltd.|BindingDB|BioChemPartner|BioCrick|BOC Sciences|Broad Institute|CEGChem|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Combi-Block",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
133081967,"3-(4,5-Dimethoxy-2-nitrophenyl)butan-2-yl 2-[[4-(3-azidopropoxy)-2,6-dimethylbenzoyl]amino]-3-[[2-[[3-(diaminomethylideneamino)benzoyl]amino]acetyl]amino]propanoate","GTPL9895|compound 1 [Vakkeel et al., 2018]",790.800,C37H46N10O10,266.000,1430.000,4.400,57,5,13,20,"InChI=1S/C37H46N10O10/c1-20-13-26(56-12-8-11-43-46-40)14-21(2)33(20)35(50)45-28(18-41-32(48)19-42-34(49)24-9-7-10-25(15-24)44-37(38)39)36(51)57-23(4)22(3)27-16-30(54-5)31(55-6)17-29(27)47(52)53/h7,9-10,13-17,22-23,28H,8,11-12,18-19H2,1-6H3,(H,41,48)(H,42,49)(H,45,50)(H4,38,39,44)",CC1=CC(=CC(=C1C(=O)NC(CNC(=O)CNC(=O)C2=CC(=CC=C2)N=C(N)N)C(=O)OC(C)C(C)C3=CC(=C(C=C3[N+](=O)[O-])OC)OC)C)OCCCN=[N+]=[N-],CCIKYPZLPYEMFX-UHFFFAOYSA-N,"3-(4,5-dimethoxy-2-nitrophenyl)butan-2-yl 2-[[4-(3-azidopropoxy)-2,6-dimethylbenzoyl]amino]-3-[[2-[[3-(diaminomethylideneamino)benzoyl]amino]acetyl]amino]propanoate",NULL,Literature,1,NULL,20180510,IUPHAR/BPS Guide to PHARMACOLOGY,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
772,Enoxaparin,enoxaparin|9005-49-6|Ardeparin|Bemiparin|SEMULOPARIN|Lovenox|LMWH|Nadroparin|Nadroparine|Clivarin|Liquaemin|Reviparin|Adomiparin|Multiparin|Novoheparin|Parnaparin|Parvoparin|Sandoparin|Sublingula|Tinzaparin|Heparina|Heparine|Heparinum|Hepathrom|Liquemin|Octaparin|Pabyrin|PK-10169|Pularin|Subeparin|Triofiban|Fluxum|Vetren|Hed-heparin|Depo-Heparin|Lipo-hepin|Fragmin A|Fragmin B|Vitrum AB|Eparina [DCIT]|Heparin [BAN]|Adomiparin [USAN]|CY 216|FR 860|Heparin CY 216|Heparine [INN-French]|Heparinum [INN-Latin]|Hep,1134.900,C26H42N2O37S5,652.000,2410.000,-10.800,70,15,38,21,"InChI=1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)",CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,HTTJABKRGRZYRN-UHFFFAOYSA-N,"6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,14,1159580|1259416|1259421|1346098,20050623,"AAA Chemistry|ABI Chem|AbovChem LLC|AKos Consulting & Solutions|Ambinter|Ark Pharm, Inc.|BioChemPartner|BOC Sciences|Broad Institute|Chembase.cn|chemical genetic matrix|ChemIDplus|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Drug Induced Liver Injury Rank (DILIrank) Dataset|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Glentham Life Sciences Ltd.|Google Patents|Human Metabolome Database (HMDB)|I",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2132,Ambroxol,"ambroxol|18683-91-5|107814-37-9|rac-cis-Ambroxol|36557-04-7|4-((2-amino-3,5-dibromobenzyl)amino)cyclohexan-1-ol|Bisolvon metabolite VIII|4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol|Bromhexine-metabolite VIII|NA-872|trans-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol|UNII-200168S0CL|Cyclohexanol, 4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-, trans-|UNII-QH6ZT6J071|cis-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol|trans-4-((2-Amino-3,5-dibromobencil)amino)ciclohexanol|trans-4-((2-Amino-3,5-dibromo",378.100,C13H18Br2N2O,58.300,259.000,2.600,18,3,3,3,"InChI=1S/C13H18Br2N2O/c14-9-5-8(13(16)12(15)6-9)7-17-10-1-3-11(18)4-2-10/h5-6,10-11,17-18H,1-4,7,16H2",C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,JBDGDEWWOUBZPM-UHFFFAOYSA-N,"4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol",Ambroxol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|995|1030|1195|1332|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1688|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|184,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consul",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
5426,Thalidomide,"thalidomide|50-35-1|Thalomid|2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione|Sedoval|(+/-)-THALIDOMIDE|Corronarobetin|Psycholiquid|Psychotablets|Theophilcholine|Algosediv|Asmadion|Bonbrain|Calmorex|Contergan|Distaval|Ectiluran|Enterosediv|Gastrinide|Glutanon|Hippuzon|Neosedyn|Neosydyn|Nerosedyn|Neufatin|Neurodyn|Neurosedin|Neurosedym|Nevrodyn|Noctosediv|Pantosediv|Polygripan|Profarmil|Quetimid|Quietoplex|Sandormin|Sedimide|Sedisperil|Shinnibrol|Softenil|Softenon|Talargan|Talismol|Telargean|Tensival|Thaline",258.230,C13H10N2O4,83.600,449.000,0.300,19,1,4,1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,UEJJHQNACJXSKW-UHFFFAOYSA-N,"2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione",Thalidomide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|5|7|9|13|15|19|21|23|25|29|31|33|35|37|41|43|45|47|53|55|59|67|71|73|77|79|81|83|85|87|89|91|93|95|97|101|103|105|107|109|113|115|119|121|123|131|133|137|139|143|145|179|180|192|216|224|246|248|250|282|290|306|314|318|328|330|332|336|338|377|422|429|436|485|547|631|694|731|732|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|878|880|881|894|920|932|940|950|951|952|999|1001|1004|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|Ambeed|AN PharmaTech|Anward|Ark Pharm, Inc.|Aronis|Assemb",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
70945511,"(3S)-N-Cyclopropyl-3-[[(2R)-3-(cyclopropylmethylsulfonyl)-2-[[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino]propanoyl]amino]-2-oxopentanamide","VBY-825|1310340-58-9|VBY825|VBY 825|(3S)-N-cyclopropyl-3-[[(2R)-3-(cyclopropylmethylsulfonyl)-2-[[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino]propanoyl]amino]-2-oxopentanamide|CHEMBL4303448|SCHEMBL13584968|GTPL10746|NSC782457|ZINC204927416|CS-3901|NSC-782457|SB17489|NCGC00485951-01|HY-15958|(3S)-N-Cyclopropyl-3-(((2R)-3-((cyclopropylmethyl)sulfonyl)-1-oxo-2-(((1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl)amino)propyl)amino)-2-oxopentanamide|(S)-N-cyclopropyl-3-((R)-3-((cyclopropylmethyl)sulfonyl)-2-((",535.600,C23H29F4N3O5S,130.000,908.000,2.700,36,3,10,13,"InChI=1S/C23H29F4N3O5S/c1-2-17(19(31)22(33)28-16-9-10-16)30-21(32)18(12-36(34,35)11-13-3-4-13)29-20(23(25,26)27)14-5-7-15(24)8-6-14/h5-8,13,16-18,20,29H,2-4,9-12H2,1H3,(H,28,33)(H,30,32)/t17-,18-,20-/m0/s1",CC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@H](CS(=O)(=O)CC2CC2)N[C@@H](C3=CC=C(C=C3)F)C(F)(F)F,PPUXXDKQNAHHON-BJLQDIEVSA-N,"(3S)-N-cyclopropyl-3-[[(2R)-3-(cyclopropylmethylsulfonyl)-2-[[(1S)-2,2,2-trifluoro-1-(4-fluorophenyl)ethyl]amino]propanoyl]amino]-2-oxopentanamide",NULL,Biological Test Results|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,7,1296008|1296009|1345084|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1409578|1508605|1508606,20130321,"A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|Broad Institute|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|CSNpharm|Davey Lab, Department of Microbiology, NEIDL, Boston University|DTP/NCI|eNovation Chemicals|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextMove Software|NIH/NCATS RNAi|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL|Synblock Inc|TargetMol (Target Molecule Corp.)|Thom",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
11582982,CID 11582982,"ONO-5334|868273-90-9|ONO 5334|N-((1s)-3-((2z)-2-((4r)-3,4-dimethyl-1,3-thiazolidin-2-ylidene) hydrazino)-2,3-dioxo-1-(tetrahydro-2h-pyran-4-yl)propyl)cycloheptane carboxamide|N-((1s)-3-{(2z)-2-((4r)-3,4-dimethyl-1,3-thiazolidin-2-ylidene) hydrazino}-2,3-dioxo-1-(tetrahydro-2h-pyran-4-yl)propyl)cycloheptane carboxamide|SCHEMBL3629499|CHEMBL4303672|CID 11582982|HY-108044|CS-0027222|2H-Pyran-4-propanoic acid, beta-((cycloheptylcarbonyl)amino)tetrahydro-alpha-oxo-, (2Z)-2-((4R)-3,4-dimethyl-2-thiazolidinylidene",438.600,C21H34N4O4S,125.000,657.000,3.100,30,2,6,6,"InChI=1S/C21H34N4O4S/c1-14-13-30-21(25(14)2)24-23-20(28)18(26)17(15-9-11-29-12-10-15)22-19(27)16-7-5-3-4-6-8-16/h14-17H,3-13H2,1-2H3,(H,22,27)(H,23,28)/b24-21-/t14-,17+/m1/s1",C[C@@H]1CS/C(=N\\NC(=O)C(=O)[C@H](C2CCOCC2)NC(=O)C3CCCCCC3)/N1C,BTZCSXIUAFVRTE-CHGLIHOBSA-N,"N-[(1S)-3-[(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazinyl]-1-(oxan-4-yl)-2,3-dioxopropyl]cycloheptanecarboxamide",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,1409578,20061026,AbaChemScene|ChEMBL|ChemIDplus|ChemSpider|CSNpharm|DiscoveryGate|eNovation Chemicals|Japan Chemical Substance Dictionary (Nikkaji)|Lan Pharmatech|MedChemexpress MCE|MolPort|NextBio|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
5291,Imatinib,Imatinib|152459-95-5|STI571|Glivec|sti-571|Imatinib free base|Imatinib (STI571)|Cgp 57148|N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide|STI 571|UNII-BKJ8M8G5HI|Imatinib Methansulfonate|CGP-57148|152459-95-5 (free base)|BKJ8M8G5HI|4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE|4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide|CHEMBL941|CHEBI:4,493.600,C29H31N7O,86.300,706.000,3.500,37,2,7,7,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,KTUFNOKKBVMGRW-UHFFFAOYSA-N,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,Imatinib Mesylate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,880|881|894|1030|1379|1433|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1811|1865|1948|2101|2107|2112|2314|2315|2451|2472|2528|2546|2549|2551|2662|24411|25605|69739|94799|94815|161243|161395|161421|161423|161424|163001|163515|164638|219648|227573|228823|228828|254662|254663|254706|254715|254803|255004|255976|255987|256551|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|2,20050325,"001Chemical|3A SpeedChemical Inc|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Acesobio|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKS",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
118253852,Brensocatib,"AZD7986|brensocatib|1802148-05-5|INS1007|AZD 7986|AZD-7986|(S)-N-((S)-1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide|UNII-25CG88L0BB|25CG88L0BB|CHEMBL3900409|INS-1007|GTPL9412|SCHEMBL16932317|EX-A1866|INS 1007|BDBM50195235|PZ1130|SB18722|HY-101056|CS-0020766|J3.556.230C|A17095|(2S)-N-[(1S)-1-cyano-2-[4-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide|(2S)-N-{(1S)-1-Cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)p",420.500,C23H24N4O4,104.000,699.000,2.000,31,2,6,5,"InChI=1S/C23H24N4O4/c1-27-19-12-17(7-8-20(19)31-23(27)29)16-5-3-15(4-6-16)11-18(13-24)26-22(28)21-14-25-9-2-10-30-21/h3-8,12,18,21,25H,2,9-11,14H2,1H3,(H,26,28)/t18-,21-/m0/s1",CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)C[C@@H](C#N)NC(=O)[C@@H]4CNCCCO4)OC1=O,AEXFXNFMSAAELR-RXVVDRJESA-N,"(2S)-N-[(1S)-1-cyano-2-[4-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,9,1320448|1320449|1320450|1320451|1320452|1320453|1320454|1320455|1320456|1320457|1320458|1320459|1320460|1320461|1320462|1320463|1320464|1320465|1320466|1320467|1320468|1320469|1320470|1320471|1320472|1320473|1320474|1320475|1320476|1320477|1320478|1320479|1320480|1320481|1320482|1320483|1320484|1320485|1320486|1320487|1320488|1320489|1320490|1320491|1320492|1320493|1320494|1320495|1320496|1320497|1320498|1320499|1320500|1320501|1320502|1320503|1320504|1320505|1320506|1320507|1320508|1320509|1320510|1320511|,20160223,"A2B Chem|AA BLOCKS|AbaChemScene|Adooq BioScience|Axon Medchem|BindingDB|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Davey Lab, Department of Microbiology, NEIDL, Boston University|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NextMove Software|Novartis Institutes for BioMedical Research|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL|Synblock Inc|T",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
71481097,Selinexor,"Selinexor|KPT-330|1393477-72-9|Xpovio|UNII-31TZ62FO8F|KPT 330|(Z)-3-(3-(3,5-Bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide|31TZ62FO8F|Selinexor (KPT-330)|2-Propenoic acid, 3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-, 2-(2-pyrazinyl)hydrazide, (2Z)-|2-Propenoic acid, 3-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]-, 2-(2-pyrazinyl)hydrazide, (2Z)-|Selinexor [USAN:INN]|Selinexor HCl|Selinexor free base|KPT330;Selinexor|Xpovio (TN)|Tube706|KPT",443.300,C17H11F6N7O,97.600,621.000,3.000,31,2,12,5,"InChI=1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1-",C1=CN=C(C=N1)NNC(=O)/C=C\\N2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,DEVSOMFAQLZNKR-RJRFIUFISA-N,"(Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1259398|1259399|1259416|1259421|1259423|1296008|1296009|1347060|1347064|1347065|1347067|1347068|1347411|1347412|1347414|1347415|1409598|1409605,20130610,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|Achemtek|Adooq BioScience|AK Scientific, Inc. (AKSCI)|ApexBio Technology|AvaChem Scientific|Axon Medchem|BindingDB|BioCrick|Biosynth Carbosynth|BLD Pharm|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
5496659,Otamixaban,"Otamixaban|193153-04-7|FXV-673|XRP0673|XRP-0673|CHEMBL46618|Methyl (2R,3R)-2-(3-carbamimidoylbenzyl)-3-((4-(1-oxidopyridin-4-yl)benzoyl)amino)butanoate|FXV673|UNII-S173RED00L|1ksn|SCHEMBL52983|S173RED00L|GTPL10732|DTXSID40172917|methyl (2R,3R)-2-[(3-carbamimidoylphenyl)methyl]-3-[[4-(1-oxidopyridin-1-ium-4-yl)benzoyl]amino]butanoate|ZINC1908051|3954AH|BDBM50114539|RPR130673|CS-0345|DB06635|RPR-130673|compound 9c [PMID: 12039587]|FXV 673;FXV-673;FXV673|NCGC00378763-01|HY-70035|A11517|W-5471|Q7108427|(2R,3R)-",446.500,C25H26N4O4,131.000,671.000,2.000,33,3,5,9,"InChI=1S/C25H26N4O4/c1-16(22(25(31)33-2)15-17-4-3-5-21(14-17)23(26)27)28-24(30)20-8-6-18(7-9-20)19-10-12-29(32)13-11-19/h3-14,16,22H,15H2,1-2H3,(H3,26,27)(H,28,30)/t16-,22-/m1/s1",C[C@H]([C@@H](CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-],PFGVNLZDWRZPJW-OPAMFIHVSA-N,"methyl (2R,3R)-2-[(3-carbamimidoylphenyl)methyl]-3-[[4-(1-oxidopyridin-1-ium-4-yl)benzoyl]amino]butanoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,1811|51168|52160|89354|170948|185189|185190|215540|229648|229649|229650|229651|229652|527394|527398|527399|977610|1259416|1259421|1296008|1296009|1342778|1342792|1342795|1342799|1342800|1342801|1342802|1342803|1342804|1342805|1342806|1342807|1342808|1342809|1342810|1345084|1346986|1346987|1347055|1347159|1347160|1409598,20050624,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbovChem LLC|Achemtek|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Aurum Pharmatech LLC|BindingDB|BioCrick|BLD Pharm|Broad Institute|Chem-Space.com Database|Chembase.cn|ChEMBL|CSNpharm|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|IUPHA",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
2833,"N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide","64-86-8|Colchine|(R/S)-Colchicine|CHEBI:23359|(S)-(-)-colchicine|N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide|209810-38-8|54192-66-4|Acetamide,N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]-|COLCHICINE, (+)-|Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)-|Colchicine-[d3]|CHEMBL87|(S)-Colchicine >95%|(+-)-COLCHICINE|Epitope ID:141498|Neuro_000002|MLS001181527|SCHEMBL675246|DTXSID20274387|HMS2875H17|HMS",399.400,C22H25NO6,83.100,740.000,1.000,29,1,6,5,"InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)",CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,IAKHMKGGTNLKSZ-UHFFFAOYSA-N,"N-(1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,351|811|833|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|995|1030|1044|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1511|1519|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1792|1800|1813|1814|1817|1822|1823|1825|1832|1834|1845|1850|1861|1863|1865|1875|1885|1899|1903|1905|1906|1907|1910|1933|1934|1935|1936|1947|1948|1950|1961|1962|1974|1979|1984|1986|1987|2006|2012|2013|201,20050325,"001Chemical|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|ABI Chem|AbMole Bioscience|Achemo Scientific Limited|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurum Pharmatech LLC|BenchChem|BioChemPartner|Biocore|BioCrick|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemBlock|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank]"
145996542,Chembl4585872,CHEMBL4585872|GTPL10706|BDBM50527131|compound 15 [PMID: 32045236]|2-Iodoadenosine-5'-O-[(phosphonomethyl)phosphonic Acid],551.130,C11H16IN5O9P2,223.000,672.000,-4.100,28,6,13,6,"InChI=1S/C11H16IN5O9P2/c12-11-15-8(13)5-9(16-11)17(2-14-5)10-7(19)6(18)4(26-10)1-25-28(23,24)3-27(20,21)22/h2,4,6-7,10,18-19H,1,3H2,(H,23,24)(H2,13,15,16)(H2,20,21,22)/t4-,6-,7-,10-/m1/s1",C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N,OJRUSAPKCPIVBY-KQYNXXCUSA-N,"[[(2R,3S,4R,5R)-5-(6-amino-2-iodopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid",NULL,Classification|Literature,2,NULL,20200314,BindingDB|ChEMBL|IUPHAR/BPS Guide to PHARMACOLOGY,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
4413,Nafamostat,"Nafamostat|81525-10-2|Nafamostat [INN]|FUT-175|UNII-Y25LQ0H97D|Nafamstat|CHEMBL273264|Y25LQ0H97D|p-Guanidinobenzoic acid ester with 6-hydroxy-2-naphthamidine|(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate|Nafamostat (INN)|Nafamostatum [Latin]|Nafamostatum|Nafamostat Mesylate(FUT-175)|NCGC00160398-01|6-Amidino2-naphthyl 4-guanidinobenzoate|6-(Aminoiminomethyl)-2-naphthalenyl 4-((aminoiminomethyl)amino)benzoate|Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalen",347.400,C19H17N5O2,141.000,552.000,2.000,26,4,4,5,"InChI=1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24)",C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,MQQNFDZXWVTQEH-UHFFFAOYSA-N,(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,12,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1487|1490|1688|1766|1768|1865|2101|2107|2112|2517|2528|2546|2549|2551|2658|2662|43030|43031|43032|43034|43035|43036|43042|43179|48013|50879|50880|51836|52486|95034|157798|203031|210643|211559|215021|215034|215374|225429|485281|485290|485393|492961|504327|504332|504749|504832|504834|504845|504847|504865|588579|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|686978|686979|720532|720533|720579|720580|743344|743345|743346|743347|1159524,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Ange",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
3082475,"D-Alanine, N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-","TRV-120027|UNII-J1J4P3PQZD|TRV120027|1234510-46-3|trv027|J1J4P3PQZD|TRV 120027|D-Alanine, N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-|GTPL6902|CHEMBL4297447|TRV-027|HY-P2141|DB12199|CS-0109050|Q27281029",926.100,C43H67N13O10,358.000,1690.000,-2.300,66,12,13,26,"InChI=1S/C43H67N13O10/c1-7-24(4)35(40(63)53-31(19-27-20-47-22-49-27)41(64)56-17-9-11-32(56)38(61)50-25(5)42(65)66)55-37(60)30(18-26-12-14-28(57)15-13-26)52-39(62)34(23(2)3)54-36(59)29(51-33(58)21-46-6)10-8-16-48-43(44)45/h12-15,20,22-25,29-32,34-35,46,57H,7-11,16-19,21H2,1-6H3,(H,47,49)(H,50,61)(H,51,58)(H,52,62)(H,53,63)(H,54,59)(H,55,60)(H,65,66)(H4,44,45,48)/t24-,25+,29-,30-,31-,32-,34-,35-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@H](C)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC,XIEWFECSPPTVQN-KMIMAYJXSA-N,"(2R)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active,7,1346995,20050809,"AbaChemScene|AbMole Bioscience|Chem-Space.com Database|ChEMBL|ChemIDplus|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|MolPort|MuseChem|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Smolecule|Springer Nature|TargetMol (Target Molecule Corp.)|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
15604015,Opaganib,"ABC294640|Opaganib|915385-81-8|ABC-294640|3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide|ABC 294640|CHEMBL2158685|UNII-DRG21OQ517|DRG21OQ517|Opaganib (ABC294640)|Yeliva|ABC294640Opaganib|GTPL6624|SCHEMBL1548333|(1s,3r,5R,7S)-3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide|CHEBI:124965|HMS3402P05|AMY42174|BCP08959|EX-A1962|BDBM50393642|NSC796101|AKOS027327311|CCG-268417|CS-0877|DB12764|NSC-796101|SB17167|AC-33116|AS-56117|HY-16015|S7174|BRD-A70814879-003-01-8|Q27074100|AB",380.900,C23H25ClN2O,42.000,551.000,4.700,27,1,2,4,"InChI=1S/C23H25ClN2O/c24-20-3-1-19(2-4-20)22-10-17-9-18(11-22)13-23(12-17,15-22)21(27)26-14-16-5-7-25-8-6-16/h1-8,17-18H,9-15H2,(H,26,27)",C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,CAOTVXGYTWCKQE-UHFFFAOYSA-N,3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,695247|762558|1077892|1151449|1199976|1252129|1277462|1277485|1306030|1345819|1347080|1409598|1478819|1478822|1478823|1482733,20070212,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|Acadechem|Achemtek|Activate Scientific|AKos Consulting & Solutions|Ambeed|Apexmol|Ark Pharma Scientific Limited|Axon Medchem|BindingDB|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Comparative Toxicogenomics Database (CTD)|CSNpharm|DC Chemicals|DiscoveryGate|DrugBa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
133083018,Zilucoplan,Zilucoplan|UNII-YG391PK0CC|YG391PK0CC|RA101495|Zilucoplan [INN]|Zilucoplan [USAN]|Zilucoplan [USAN:INN]|GTPL10404|WHO 10602|1841136-73-9,3562.000,C172H278N24O55,1070.000,6980.000,4.800,251,28,57,142,InChI=1S/C172H278N24O55/c1-9-10-11-12-13-14-15-16-17-18-19-20-27-44-146(202)182-136(170(226)227)53-56-144(200)177-64-67-229-69-71-231-73-75-233-77-79-235-81-83-237-85-87-239-89-91-241-93-95-243-97-99-245-101-103-247-105-107-249-109-111-251-113-112-250-110-108-248-106-104-246-102-100-244-98-96-242-94-92-240-90-88-238-86-84-236-82-80-234-78-76-232-74-72-230-70-68-228-66-59-145(201)175-60-31-29-41-135(169(224)225)186-165(220)152(126-37-25-22-26-38-126)193-162(217)142-43-34-65-196(142)168(223)140(116-125-47-51-,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](C1CCCCC1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC4=CNC5=C4C=CC=N5)NC(=O)[C@H](CC6=CC=C(C=C6)O)NC(=O)[C@H](C(C)(C)C)NC(=O)[C@H](CC(=O)O)N(C)C(=O)[C@@H]7CC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N7)CC8=CC=CC=C8)CCCNC(=N)N)CCC(=O)O)C(C)C)NC(=O)C)C(=O)O,JDXCOXKBIGBZSK-PSNKNOTQSA-N,"(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,5S,8S,11S,14S,22S)-22-acetamido-11-benzyl-8-(3-carbamimidamidopropyl)-5-(2-carboxyethyl)-3,6,9,12,16,23-hexaoxo-2-propan-2-yl-1,4,7,10,13,17-hexazacyclotricosane-14-carbonyl]-methylamino]-3-carboxypropanoyl]amino]-3,3-dimethylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-2-cyclohexylacet",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20180516,ChemIDplus|FDA/SPL Indexing Data|IUPHAR/BPS Guide to PHARMACOLOGY|PATENTSCOPE (WIPO)|Springer Nature,Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
6167,Colchicine,"colchicine|64-86-8|Colchicin|Colchisol|Colcin|Colchicina|Condylon|Colchineos|Colsaloid|Colchicinum|Colcrys|7alphaH-Colchicine|Kolkicin|Goutnil|(S)-colchicine|Mitigare|spindle poison|NSC 757|N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide|UNII-SML2Y3J35T|(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide|N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide|N-Acetyl trimethylcolchicinic acid methylether|NSC75",399.400,C22H25NO6,83.100,740.000,1.000,29,1,6,5,"InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1",CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,IAKHMKGGTNLKSZ-INIZCTEOSA-N,"N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide",Colchicine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|3|5|7|9|11|13|15|17|19|21|23|25|27|29|31|33|35|37|39|41|43|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|85|87|89|91|93|95|99|101|103|105|107|109|111|113|115|117|119|121|123|125|127|129|131|133|135|137|139|141|143|145|155|157|161|165|167|175|179|184|186|192|194|200|206|212|216|220|222|224|230|246|248|256|264|270|274|276|280|290|292|296|298|300|302|306|314|316|328|330|332|377|410|411|421|422|426|427|429|433|434|435|436|445|447|448|450|451|526|530|540|541|542|543|544|545|546|547|584|585|595|59,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|AN PharmaTech|ApexBio Technology|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
71226662,Acalabrutinib,"Acalabrutinib|1420477-60-6|ACP-196|Calquence|Acalabrutinib (ACP-196)|UNII-I42748ELQW|I42748ELQW|(S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide|Benzamide, 4-(8-amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinyl-|Acalabrutinib(ACP196)|Acalabrutinib [INN]|Acalabrutinib [USAN:INN]|acalabrutinibum|Calquence (TN)|4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide|Benz",465.500,C26H23N7O2,119.000,845.000,3.000,35,2,6,4,"InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1",CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,WDENQIQQYWYTPO-IBGZPJMESA-N,"4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1296008|1296009|1304232|1345084|1345502|1345572|1345597|1345617|1345653|1345664|1345682|1345705|1345717|1345744|1345860|1345861|1345882|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1357747|1409598|1409605|1468764|1468772|1468802|1468803|1468804|1468805|1468806|1468807|1468808|1468809|1468810|1468811|1468818|1468822|1468826|1508591|1508612,20130321,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Apexmol|AvaChem Scientific|BindingDB|Biosynth Carbosynth|Broad Institute|Cangzhou Enke Pharma Tech Co.,Ltd.|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Davey Lab, Department of ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
46215462,Bemcentinib,"Bemcentinib|R428|1037624-75-1|BGB-324|BGB324|R-428|UNII-0ICW2LX8AS|0ICW2LX8AS|(S)-1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine|CHEMBL3809489|SYN1131|CS-1046|HY-15150|QC-11751|R 428|W-5845|Bemcentinib [USAN]|Bemcentinib intermediate|Bemcentinib (USAN/INN)|BemcentinibR428BGB324)|SCHEMBL1639904|GTPL10478|BGB 324|DTXSID70673109|1-(6,7-dihydro-5H-benzo[2,3]cyclohepta[2,4-d]pyridazin-3-yl)-3-N-[(7S)-7",506.600,C30H34N8,97.800,775.000,5.500,38,2,7,4,"InChI=1S/C30H34N8/c31-29-33-30(32-24-13-10-20-11-14-25(15-12-22(20)18-24)37-16-3-4-17-37)36-38(29)27-19-23-8-5-7-21-6-1-2-9-26(21)28(23)35-34-27/h1-2,6,9-10,13,18-19,25H,3-5,7-8,11-12,14-17H2,(H3,31,32,33,36)/t25-/m0/s1",C1CCN(C1)[C@H]2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76,KXMZDGSRSGHMMK-VWLOTQADSA-N,"1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,1259416|1259421|1301416|1301417|1301428|1301429|1301430|1301431|1301432|1301437|1301438|1301439|1347060|1347064|1347065|1347067|1347068|1347411|1374803|1374804|1374805|1374806|1374807|1374808|1374809|1374810|1374811|1374812|1374813|1374814|1374815|1374816|1374817|1374818|1374819|1374820|1374821|1374831|1374832|1409598|1508605|1508606,20100706,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|ApexBio Technology|Apexmol|Ark Pharma Scientific Limited|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BenchChem|BindingDB|BioChemPartner|BioCrick|Boerchem|Broad Institute|CEGChem|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Compa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
11285792,Cenicriviroc,"Cenicriviroc|TBR-652|TAK-652|497223-25-3|TBR652|TBR 652|UNII-15C116UA4Y|15C116UA4Y|497223-25-3 (free base)|(S,E)-8-(4-(2-butoxyethoxy)phenyl)-1-isobutyl-N-(4-(((1-propyl-1H-imidazol-5-yl)methyl)sulfinyl)phenyl)-1,2,3,4-tetrahydrobenzo[b]azocine-5-carboxamide|TAK652|TAK 652|(5E)-8-[4-(2-butoxyethoxy)phenyl]-1-(2-methylpropyl)-N-[4-[(S)-(3-propylimidazol-4-yl)methylsulfinyl]phenyl]-3,4-dihydro-2H-1-benzazocine-5-carboxamide|CVC|cenicrivirocum|(-)-8-(4-(2-butoxyethoxy)phenyl)-1-isobutyl-n-(4-(((1-propyl-1H-imi",696.900,C41H52N4O4S,105.000,1060.000,7.500,50,1,7,17,"InChI=1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1",CCCCOCCOC1=CC=C(C=C1)C2=CC/3=C(C=C2)N(CCC/C(=C3)/C(=O)NC4=CC=C(C=C4)[S@@](=O)CC5=CN=CN5CCC)CC(C)C,PNDKCRDVVKJPKG-WHERJAGFSA-N,"(5E)-8-[4-(2-butoxyethoxy)phenyl]-1-(2-methylpropyl)-N-[4-[(S)-(3-propylimidazol-4-yl)methylsulfinyl]phenyl]-3,4-dihydro-2H-1-benzazocine-5-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,12,707899|707908|707914|707915|708110|1159829|1353545,20061026,"AbaChemScene|abcr GmbH|AbMole Bioscience|Achemtek|Activate Scientific|Apexmol|BindingDB|BioChemPartner|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|ChemSpider|Comparative Toxicogenomics Database (CTD)|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|Hangzhou APIChem Technology|iChemical Technol",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
11561674,Apremilast,"Apremilast|608141-41-9|OTEZLA|CC-10004|CC 10004|Apremilast (CC-10004)|CC10004|UNII-UP7QBP99PN|(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide|CHEBI:78540|UP7QBP99PN|CHEMBL514800|N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|C22H24N2O7S|N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|Apremilast [USAN:INN]|apremilastum|MFCD18782",460.500,C22H24N2O7S,128.000,825.000,1.800,32,1,7,8,"InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1",CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,IMOZEMNVLZVGJZ-QGZVFWFLSA-N,"N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,393494|393495|393496|393497|393498|393499|393500|393501|393502|393503|395573|395574|395575|395576|395577|395578|395579|395580|395581|395582|395583|395584|1222793|1259398|1259399|1259416|1259421|1259423|1345234|1345239|1345251|1345281|1409598|1409605|1455744,20061026,"A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|AOBIOUS INC|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BindingDB|BioChemPartner|BioCrick|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
22833565,Sodium heparin,"Sodium heparin|(2S,3S,4R,5R,6R)-6-{[(2S,3S,4S,5R,6S)-6-{[(2R,3S,4S,5R)-2-carboxy-4,6-dihydroxy-5-(sulfooxy)oxan-3-yl]oxy}-2-hydroxy-4-(sulfomethyl)-5-(sulfooxy)oxan-3-yl]oxy}-3-{[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}-4,5-dihydroxyoxane-2-carboxylic acid|HepFlush|CHEMBL526514|GTPL4214|S01XA14|BDBM50480251",1039.900,C26H41NO34S4,589.000,2140.000,-10.400,65,14,34,18,"InChI=1S/C26H41NO34S4/c1-4(28)27-7-9(30)8(29)6(2-52-63(43,44)45)53-24(7)56-15-10(31)11(32)25(58-19(15)21(36)37)55-13-5(3-62(40,41)42)14(60-64(46,47)48)26(59-22(13)38)57-16-12(33)17(61-65(49,50)51)23(39)54-18(16)20(34)35/h5-19,22-26,29-33,38-39H,2-3H2,1H3,(H,27,28)(H,34,35)(H,36,37)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)/t5-,6+,7+,8+,9+,10+,11+,12-,13-,14+,15-,16-,17+,18+,19-,22-,23?,24+,25+,26-/m0/s1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O[C@H]2[C@@H]([C@H]([C@@H](O[C@@H]2C(=O)O)O[C@H]3[C@@H]([C@H]([C@H](O[C@@H]3O)O[C@H]4[C@@H]([C@H](C(O[C@H]4C(=O)O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)CS(=O)(=O)O)O)O)COS(=O)(=O)O)O)O,ZFGMDIBRIDKWMY-PASTXAENSA-N,"(2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2S,3S,4S,5R,6S)-6-[(2R,3S,4S,5R)-2-carboxy-4,6-dihydroxy-5-sulfooxyoxan-3-yl]oxy-2-hydroxy-4-(sulfomethyl)-5-sulfooxyoxan-3-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid",Heparin,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,10,397122|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1346098,20071205,BindingDB|ChEMBL|ChemSpider|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|MetabolomicsWorkbench|NextMove Software|Therapeutic Target Database (TTD),Curation Efforts|Legacy Depositors|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
54752934,"Carbamic acid, N-[(1S)-1-[[[(1S)-1-formyl-2-(2-oxo-3-pyrrolidinyl)ethyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester","GC 373|GC-373|1333231-44-9|Carbamic acid, N-[(1S)-1-[[[(1S)-1-formyl-2-(2-oxo-3-pyrrolidinyl)ethyl]amino]carbonyl]-3-methylbutyl]-, phenylmethyl ester|CHEMBL1821850|SCHEMBL14838004|GTPL11635|BDBM476983|GC373|CS-B1606|EX-A4267|CS-16924|N-benzyloxycarbonyl-L-leucyl-3-(2-oxopyrrolidin-3-yl)-L-alaninal|Benzyl ((2S)-4-methyl-1-oxo-1-(((2S)-1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl)amino)pentan-2-yl)carbamate|benzyl N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl]amino]pentan-2-yl]carbam",403.500,C21H29N3O5,114.000,575.000,1.800,29,3,5,11,"InChI=1S/C21H29N3O5/c1-14(2)10-18(24-21(28)29-13-15-6-4-3-5-7-15)20(27)23-17(12-25)11-16-8-9-22-19(16)26/h3-7,12,14,16-18H,8-11,13H2,1-2H3,(H,22,26)(H,23,27)(H,24,28)/t16?,17-,18-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](CC1CCNC1=O)C=O)NC(=O)OCC2=CC=CC=C2,QYENXTYKACLCGO-FQECFTEESA-N,benzyl N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-(2-oxopyrrolidin-3-yl)propan-2-yl]amino]pentan-2-yl]carbamate,NULL,Biological Test Results|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,616241|616243|616244|616245|616246|722776|722778|722780|722781,20120102,A2B Chem|AA BLOCKS|AbaChemScene|BindingDB|BLD Pharm|Chem-Space.com Database|ChEMBL|Excenen Pharmatech|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank]"
3689,Ifenprodil,"Ifenprodil|23210-56-2|ifenprodil tartrate|Vadilex|Dilvax|IFENPRODIL HEMITARTRATE|4-(2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl)phenol|RC 61-91|UNII-R8OE3P6O5S|4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol|23210-58-4|R8OE3P6O5S|CHEMBL305187|(+/-)-Ifenprodil;RC 61-91|NP-120|NCGC00024643-03|Creocral|1-Piperidineethanol, alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-|DSSTox_CID_25656|DSSTox_RID_81034|DSSTox_GSID_45656|Ifenprodil tartrate salt|Ifenprodilum|Ifenprodil [INN:DCF]|Ifenprodilum [INN-Lat",325.400,C21H27NO2,43.700,353.000,3.900,24,2,3,5,"InChI=1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3",CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3,UYNVMODNBIQBMV-UHFFFAOYSA-N,4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,880|1030|1332|1457|1458|1460|1463|1468|1469|1471|1477|1479|1487|1490|1688|1766|1768|1865|2062|2101|2107|2112|2240|2241|2275|2313|2314|2315|2322|2330|2451|2472|2517|2528|2546|2549|2551|2660|2662|2666|2667|2668|4461|5131|36316|36843|61833|64128|87682|142907|144751|149325|204312|205913|229210|235213|256860|297869|332028|332029|332033|332034|348121|348122|348123|348124|348126|348127|348128|391045|392779|427337|434959|437518|463106|485281|485290|485295|485297|485298|485313|485342|485345|485366|485368|488772|4887,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|ABI Chem|AbovChem LLC|Achemtek|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alomone Labs|Ambeed|Ambinter|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|AvaChem Scientific|Axon Medchem|BePharm Ltd.|BindingDB|Biocore|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Scie",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9820008,Vidofludimus,"Vidofludimus|717824-30-1|4SC-101|2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic Acid|SC12267|UNII-8Y1PJ3VG81|SC 12267|8Y1PJ3VG81|CHEMBL197194|IMU-838|4sc-101;SC12267|Vidofludimus(4SC-101; SC12267)|SC-12267|2-((3-Fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)carbamoyl)cyclopent-1-enecarboxylic acid|2-[[2-fluoranyl-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid|2-{[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl}cyclopent-1-ene-1-carboxylic acid|Vidofludimus [INN]|SCHEMBL",355.400,C20H18FNO4,75.600,576.000,3.400,26,2,5,5,"InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25)",COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,XPRDUGXOWVXZLL-UHFFFAOYSA-N,2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,12,254980|255922|258048|743344|743345|743346|743347|1224824|1224825|1224852|1224853|1224854|1224855|1224856|1224857|1224858|1224859|1224860|1224861|1224862|1259252|1259253|1259255|1259256|1259421|1296008|1296009|1345084|1346089|1346121|1346140|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347081|1347082|1347083|1347084|1347085|1347086|1347087|1347088|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101,20061025,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Ambeed|Ambinter|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|Axon Medchem|BindingDB|BioChemPartner|BioCrick|BOC Sciences|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Clearsynth",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
71481120,Unii-O9H5KY11SV,"UNII-O9H5KY11SV|O9H5KY11SV|(2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonic acid|1417031-79-8|GC376|GC-376|GC-376 free acid|CHEMBL2365410|GTPL10883|compound 7a [PMID: 23218713]|3-Pyrrolidinepropanesulfonic acid, alpha-hydroxy-beta-(((2S)-4-methyl-1-oxo-2-(((phenylmethoxy)carbonyl)amino)pentyl)amino)-2-oxo-, (betaS)-",485.600,C21H31N3O8S,180.000,777.000,0.700,33,5,8,12,"InChI=1S/C21H31N3O8S/c1-13(2)10-16(24-21(28)32-12-14-6-4-3-5-7-14)19(26)23-17(20(27)33(29,30)31)11-15-8-9-22-18(15)25/h3-7,13,15-17,20,27H,8-12H2,1-2H3,(H,22,25)(H,23,26)(H,24,28)(H,29,30,31)/t15?,16-,17-,20?/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](CC1CCNC1=O)C(O)S(=O)(=O)O)NC(=O)OCC2=CC=CC=C2,BSPZFJDYQHDZNR-ASPXRTSYSA-N,(2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonic acid,NULL,Classification|Literature|Names and Identifiers|Patents,4,NULL,20130610,A2B Chem|AA BLOCKS|AbaChemScene|Ambeed|BindingDB|BioChemPartner|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemIDplus|CSNpharm|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|PATENTSCOPE (WIPO)|Selleck Chemicals|Smolecule|TargetMol (Target Molecule Corp.)|THE BioTek|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank]"
72734520,Abivertinib,"Avitinib|Abivertinib|1557267-42-1|AC0010|N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide|AC0010MA|EX-ACEA0010|ACEA100610|Abivertinib (USAN)|Abivertinib [USAN]|1557267-42-1 (free base)|AC-0010|A610|N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide|2-Propenamide, N-[3-[[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]-|Avitinib free bas",487.500,C26H26FN7O2,98.400,752.000,4.200,36,3,8,7,"InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)",CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F,UOFYSRZSLXWIQB-UHFFFAOYSA-N,"N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,1347060|1347064|1347065|1347067|1347068|1347411|1347412,20140218,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|Angel Pharmatech Ltd.|Ark Pharm, Inc.|Axon Medchem|BePharm Ltd.|BindingDB|BioChemPartner|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|Hangzh",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank]"
10077130,Vorapaxar,"Vorapaxar|618385-01-6|Zontivity|Sch 530348|SCH-530348|SCH530348|Vorapaxar free base|UNII-ZCE93644N2|MK-5348|CHEMBL493982|CHEBI:82702|ZCE93644N2|618385-01-6 (free base)|[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-carbamic acid ethyl ester|ethyl n-[(3r,3as,4s,4ar,7r,8ar,9ar)-4-[(e)-2-[5-(3-fluorophenyl)-2-pyridyl]vinyl]-3-methyl-1-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3h-benzo[f]isobenzofuran-7-yl]carbamate|Ethyl [(1r,3ar,4a",492.600,C29H33FN2O4,77.500,821.000,5.300,36,1,6,6,"InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1",CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C,ZBGXUVOIWDMMJE-QHNZEKIYSA-N,"ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,407981|407982|407983|407984|407985|407986|407993|407994|407995|407996|407997|407998|407999|408000|408001|408002|408003|408004|408005|408006|408007|408008|408009|408010|408011|408012|408013|408014|408015|408016|408017|408023|408024|408025|408026|408027|408028|527570|527581|527582|527583|527584|527585|1056257|1056258|1056259|1056260|1056261|1056262|1065173|1065174|1217220|1217221|1217222|1217223|1217224|1217225|1217226|1217227|1217228|1217229|1217252|1217253|1217254|1217255|1217258|1217259|1217260|1217261|121,20061025,"A1 BioChem Labs|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambinter|AN PharmaTech|Apexmol|Axon Medchem|BindingDB|BioCrick|Boerchem|Broad Institute|Cangzhou Enke Pharma Tech Co.,Ltd.|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
71364,Firazyr,"Icatibant|Firazyr|HOE140|HOE 140|JE049|GTPL667|SCHEMBL15992443|D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK|(2S)-2-[[(3aS,7aS)-1-[2-[(2S)-2-[[(2S)-2-[[2-[[(4R)-1-[1-[2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxy-pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-yl-propan|(2S)-2-{[(3aS,7aS)-1-({2-[(2S)-2-[(2S)-2-(2-{[(4R)-1-[(1-{2-[(2R)-2-amino-5-[(diaminomethylidene)amino]pentanamido]-5-[(diaminomethylidene)amino]pentanoyl}pyrrol",1304.500,C59H89N19O13S,552.000,2720.000,-6.400,92,15,18,30,"InChI=1S/C59H89N19O13S/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t33-,35+,37+,38?,39-,40-,41-,42-,43?,44?,45?",C1CC[C@H]2[C@@H](C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=CS5)NC(=O)CNC(=O)C6C[C@H](CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,QURWXBZNHXJZBE-MCDGZUPGSA-N,"(2S)-2-[[(3aS,7aS)-1-[2-[(2S)-2-[[(2S)-2-[[2-[[(4R)-1-[1-[2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid",NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,NULL,20050808,A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Chembase.cn|ChemSpider|ChemTik|Google Patents|Human Metabolome Database (HMDB)|IUPHAR/BPS Guide to PHARMACOLOGY|Kingston Chemistry|LeadScope|MolPort|NextBio|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Phion Ltd|Springer Nature|SureChEMBL|Therapeutic Target Database (TTD)|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
57030,Brequinar,"Brequinar|96187-53-0|6-Fluoro-2-(2'-fluoro-[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid|brequinarum|Biphenquinate|6-fluoro-2-(2'-fluorobiphenyl-4-yl)-3-methylquinoline-4-carboxylic acid|UNII-5XL19F49H6|6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid|NSC-368390|5XL19F49H6|NSC368390|6-FLUORO-2-(2'-FLUORO-1,1'-BIPHENYL-4-YL)-3-METHYLQUINOLINE-4-CARBOXYLIC ACID|brequinarum [Latin]|6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methyl-quinoline-4-carboxylic acid|Brequinar [INN]|Br",375.400,C23H15F2NO2,50.200,551.000,5.600,28,1,5,3,"InChI=1S/C23H15F2NO2/c1-13-21(23(27)28)18-12-16(24)10-11-20(18)26-22(13)15-8-6-14(7-9-15)17-4-2-3-5-19(17)25/h2-12H,1H3,(H,27,28)",CC1=C(C2=C(C=CC(=C2)F)N=C1C3=CC=C(C=C3)C4=CC=CC=C4F)C(=O)O,PHEZJEYUWHETKO-UHFFFAOYSA-N,6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,56916|90466|90645|179062|258048|463362|644163|729489|729490|729493|729494|748361|748362|748363|1196381|1196386|1233659|1233660|1233688|1233689|1234866|1259416|1259421|1307317|1326038|1326039|1326040|1326046|1326050|1347060|1347064|1347065|1347067|1347068|1347411|1392660|1392661|1392662|1392663|1392664|1392665|1392666|1392667|1392668|1392669|1392684|1392685|1392686|1392687|1392688|1392689|1392690|1392691|1392692|1392693|1392694|1392695|1392696|1392697|1392698|1416007|1439522|1439523|1439524|1439526|1439528|1,20050328,"001Chemical|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Acesobio|Achemo Scientific Limited|Achemtek|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY]"
139595263,Anakinra,"Anakinra|Raleukin;AMG-719|143090-92-0|7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",509.600,C20H23N5O7S2,227.000,961.000,1.100,34,3,12,10,"InChI=1S/C20H23N5O7S2/c1-5-9-6-33-16-12(15(27)25(16)13(9)17(28)29)23-14(26)11(10-7-34-19(21)22-10)24-32-8-31-18(30)20(2,3)4/h5,7,12,16H,1,6,8H2,2-4H3,(H2,21,22)(H,23,26)(H,28,29)",CC(C)(C)C(=O)OCON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C=C)C(=O)O,HMLGSIZOMSVISS-UHFFFAOYSA-N,"7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(2,2-dimethylpropanoyloxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",Interleukin 1 Receptor Antagonist Protein,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,8,NULL,20191122,001Chemical|AbMole Bioscience|Comparative Toxicogenomics Database (CTD)|Creative Biolabs|Drug Induced Liver Injury Rank (DILIrank) Dataset|iChemical Technology USA Inc|MolCore BioPharmatech|NORMAN Suspect List Exchange|Smolecule,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9960925,1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol,"EC-18|mosedipimod|1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol|221139-79-3|Plag, (+/-)|PLA-racglycerol|Mosedipimod [USAN]|EC-18 cpd|Mosedipimod (USAN/INN)|SCHEMBL974869|CHEMBL157366|(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate|WHO 10702|DB12592|1-palmitoyl-2-linoleoyl-3-acetylglycerol|1-palmitoyl-2-linoleoyl-3-acetyl-glycerol|1-palmitoyl-2-linoleoyl-3-acetyl-rac glycerol|D11668|Q27269906|Acetic acid 2-(linoleoyloxy)-3-(palmitoyloxy)propyl ester|9,12-Octadecadienoic acid (9Z,12",635.000,C39H70O6,78.900,744.000,14.100,45,0,6,36,"InChI=1S/C39H70O6/c1-4-6-8-10-12-14-16-18-19-21-23-25-27-29-31-33-39(42)45-37(34-43-36(3)40)35-44-38(41)32-30-28-26-24-22-20-17-15-13-11-9-7-5-2/h12,14,18-19,37H,4-11,13,15-17,20-35H2,1-3H3/b14-12-,19-18-",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)C)OC(=O)CCCCCCC/C=C\\C/C=C\\CCCCC,GAKUNXBDVGLOFS-DUZKARGPSA-N,"(1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,224780|224782,20061025,"ChEMBL|ChemIDplus|ChemSpider|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|NextBio|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|SureChEMBL|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank]"
118628567,Unii-XQ43H3V6M1,"TAK-981|1858276-04-6|UNII-XQ43H3V6M1|XQ43H3V6M1|1858276-04-6 (free)|[(1R,2S,4R)-4-[(5-[4-[(1R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl)amino]-2-hydroxycyclopentyl]methyl sulfamate|((1R,2S,4R)-4-((5-((4-((1R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl)-5-methylthien-2-yl)carbonyl)pyrimidin-4-yl)amino)-2-hydroxycyclopentyl)methyl sulfamate|[(1R,2S,4R)-4-[[5-[[4-((1R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl)-5-methylthien-2-yl]carbonyl]pyrimidin-4-yl]amino]",578.100,C25H28ClN5O5S2,193.000,942.000,3.500,38,4,11,8,"InChI=1S/C25H28ClN5O5S2/c1-13-18(23-19-7-16(26)3-2-14(19)4-5-29-23)9-22(37-13)24(33)20-10-28-12-30-25(20)31-17-6-15(21(32)8-17)11-36-38(27,34)35/h2-3,7,9-10,12,15,17,21,23,29,32H,4-6,8,11H2,1H3,(H2,27,34,35)(H,28,30,31)/t15-,17-,21+,23+/m1/s1",CC1=C(C=C(S1)C(=O)C2=CN=CN=C2N[C@@H]3C[C@@H]([C@H](C3)O)COS(=O)(=O)N)[C@H]4C5=C(CCN4)C=CC(=C5)Cl,LXRZVMYMQHNYJB-UNXOBOICSA-N,"[(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20160223,A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|AbMole Bioscience|BindingDB|BioChemPartner|BLD Pharm|Chem-Space.com Database|ChemIDplus|DTP/NCI|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|MolPort|NextMove Software|Smolecule|SureChEMBL|TargetMol (Target Molecule Corp.)|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, DrugBank]"
9595248,"3-[20-(2-Carboxyethyl)-22,22-dichloro-9,14-bis(ethenyl)-5,10,15,19-tetramethyl-21,23,24,25-tetraza-22-stannahexacyclo[9.9.3.13,6.113,16.08,23.018,21]pentacosa-1,3(25),4,6,8,10,12,14,16(24),17,19-undecaen-4-yl]propanoic acid",NULL,750.300,C34H32Cl2N4O4Sn,108.000,1760.000,NULL,45,2,7,8,"InChI=1S/C34H34N4O4.2ClH.Sn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;;;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);2*1H;/q;;;+4/p-4",CC1=C(C2=NC1=CC3=C(C(=C4N3[Sn](N5C(=CC6=NC(=C4)C(=C6C)C=C)C(=C(C5=C2)CCC(=O)O)C)(Cl)Cl)C)C=C)CCC(=O)O,HDGCWLZQBOZSGG-UHFFFAOYSA-J,"3-[20-(2-carboxyethyl)-22,22-dichloro-9,14-bis(ethenyl)-5,10,15,19-tetramethyl-21,23,24,25-tetraza-22-stannahexacyclo[9.9.3.13,6.113,16.08,23.018,21]pentacosa-1,3(25),4,6,8,10,12,14,16(24),17,19-undecaen-4-yl]propanoic acid",NULL,Patents,1,NULL,20061024,ChemDB|ChemSpider|NextBio|PATENTSCOPE (WIPO)|SCRIPDB,Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank]"
5283454,n-Oleoylethanolamine,n-oleoylethanolamine|oleoylethanolamide|N-(2-Hydroxyethyl)oleamide|111-58-0|Oleylethanolamide|N-oleoyl ethanolamine|Oleamide MEA|Oleoyl Ethanolamide|Oleoyl monoethanolamide|(Z)-N-(2-hydroxyethyl)octadec-9-enamide|N-(2-Hydroxyethyl)-9-octadecenamide|N-(Hydroxyethyl)oleamide|OLEIC MONOETHANOLAMIDE|UNII-1HI5J9N8E6|N-oleoyl ethanolamide|OEA|Oleic acid ethanolamide|N-(9Z-octadecenoyl)-ethanolamine|(9Z)-N-(2-hydroxyethyl)octadec-9-enamide|N-(cis-9-octadecenoyl) ethanolamine|N-(hydroxyethyl) oleamide|MLS002153155|,325.500,C20H39NO2,49.300,277.000,6.300,23,2,2,17,"InChI=1S/C20H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h9-10,22H,2-8,11-19H2,1H3,(H,21,23)/b10-9-",CCCCCCCC/C=C\\CCCCCCCC(=O)NCCO,BOWVQLFMWHZBEF-KTKRTIGZSA-N,(Z)-N-(2-hydroxyethyl)octadec-9-enamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1705|1707|1708|1766|1768|1815|1816|1828|1850|1851|1863|1865|1876|1877|1882|1883|1886|1899|,20060113,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AvaChem Scientific|BePharm Ltd.|BindingDB|BioCrick|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|C. David Weaver Laboratory, Vanderbilt University|Calbiochem|CCSbase|Center for ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank]"
10281,Thymoquinone,"Thymoquinone|490-91-5|Thymoquinon|p-Cymene-2,5-dione|2-Isopropyl-5-methyl-1,4-benzoquinone|2,5-CYCLOHEXADIENE-1,4-DIONE, 2-METHYL-5-(1-METHYLETHYL)-|2-Isopropyl-5-methyl-p-benzoquinone|2-Isopropyl-5-methylbenzoquinone|Polythymoquinone|2-Isopropyl-5-methylbenzo-1,4-quinone|5-Isopropyl-2-methyl-1,4-benzoquinone|p-Mentha-3,6-diene-2,5-dione|NSC 2228|2-Isopropyl-5-methylcyclohexa-2,5-diene-1,4-dione|2-Methyl-5-isopropyl-p-benzoquinone|2-methyl-5-propan-2-ylcyclohexa-2,5-diene-1,4-dione|NSC2228|2-methyl-5-(propa",164.200,C10H12O2,34.100,293.000,2.000,12,0,2,1,"InChI=1S/C10H12O2/c1-6(2)8-5-9(11)7(3)4-10(8)12/h4-6H,1-3H3",CC1=CC(=O)C(=CC1=O)C(C)C,KEQHJBNSCLWCAE-UHFFFAOYSA-N,"2-methyl-5-propan-2-ylcyclohexa-2,5-diene-1,4-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,155|157|161|165|167|175|256|328|330|576630|576631|576632|576633|576634|576635|697852|697853|977599|977602|977608|1067093|1079960|1079961|1079962|1091064|1091065|1091066|1091067|1091068|1091069|1091070|1091071|1091072|1091073|1091074|1091075|1091076|1091077|1091078|1091079|1091080|1091081|1091082|1091083|1091084|1091085|1091086|1091087|1091091|1091092|1091094|1091095|1091096|1091116|1091122|1091123|1091124|1091125|1091127|1091128|1091129|1091130|1091131|1159550|1159580|1159607|1181939|1190321|1190322|1190323,20050326,"001Chemical|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Angene Chemical|Anward|Ark Pharm, Inc.|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|BioChemPartner|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|Center for Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per DrugBank]"
10324367,Boceprevir,"Boceprevir|Victrelis|394730-60-0|SCH 503034|EBP 520|UNII-89BT58KELH|SCH503034|SCH-503034|89BT58KELH|CHEBI:68621|EBP-520|(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-((S)-2-(3-(tert-butyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide|3-{[(1R,2S,5S)-3-[(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide|(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[N-(tert-but",519.700,C27H45N5O5,151.000,959.000,3.100,37,4,5,10,"InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1",CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,LHHCSNFAOIFYRV-DOVBMPENSA-N,"(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,273218|273221|273222|273223|273224|273225|273226|273229|273230|273233|273234|273235|319955|319957|322946|322947|343552|343553|343554|346819|346820|346831|346832|346833|349816|349817|349819|350029|369085|369086|369087|375712|375713|375714|375729|375731|392938|392940|392942|392943|392944|410498|410499|410500|411320|411321|411322|417585|417586|417587|417588|417589|417590|429182|429183|429184|436457|436458|436459|453738|453740|456991|456992|456993|456994|456996|456997|466501|466502|466504|473868|473869|475494|4,20061025,"3WAY PHARM INC|A2B Chem|A2Z Chemical|AA BLOCKS|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|AKos Consulting & Solutions|Alsachim|Ambeed|AN PharmaTech|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Chem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per Guide to PHARMACOLOGY]"
5280352,Bilirubin,"bilirubin|635-65-4|Hematoidin|Hemetoidin|Principal bile pigment|Disodium bilirubinate IXalpha|UNII-RFM9X3LJ49|MFCD00005499|Bilirubin IXalpha|Bilirubin IX-alpha|RFM9X3LJ49|3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid|CHEBI:16990|Bilirubin, 99%|Biline-8,12-dipropionic acid, 1,10,19,22,23,24-hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-",584.700,C33H36N4O6,164.000,1340.000,2.900,43,6,6,12,"InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-",CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C\\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C\\4/C(=C(C(=O)N4)C=C)C,BPYKTIZUTYGOLE-IFADSCNNSA-N,3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid,Bilirubin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,392|398|510|516|608|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1033|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1476|1478|1479|1487|1490|1519|1549|1552|1637|1648|1766|1768|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|381952|381953|381955|381956|381957|485281|485290|504327|504847|504865|588208|588220|588579|588962|589068|602332|624263|624606|624608|624609|624612|624617|624619|680019|680209|680382|680553|680645|680734|681365|686978|686979|72,20040916,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alinda Chemical|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BenchChem|BindingDB|BioChemPartner|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosy",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5280453,Calcitriol,"calcitriol|Rocaltrol|Calcijex|32222-06-3|Topitriol|1alpha,25-Dihydroxyvitamin D3|Silkis|Soltriol|1alpha,25-Dihydroxycholecalciferol|1,25-DHCC|1,25-Dihydroxyvitamin D|Calcitriolum|1,25-DIHYDROXYCHOLECALCIFEROL|Vectical|1,25-Dihydroxyvitamin D3|1alpha,25(OH)2D3|Dihydroxyvitamin D3|Ro 21-5535|1-alpha,25-Dihydroxyvitamin D3|UNII-FXC9231JVH|DN-101|CHEMBL846|(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol|FXC9231JVH|1,25-(OH)2-D3|1a,25-Dihydroxycholecalciferol|CHEBI:17823|1-alpha-25-dihydroxyvitamin D3",416.600,C27H44O3,60.700,688.000,5.100,30,3,3,6,"InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](C[C@@H](C3=C)O)O)C,GMRQFYUYWCNGIN-NKMMMXOESA-N,"(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",Calcitriol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|880|894|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1048|1049|1051|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1379|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1469|1471|1476|1477|1478|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|1566|1578|1619|16,20040916,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|ACT Chemical|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BindingDB|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Boerchem|Boone Lab, Chemical Genomics, University of Toronto|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|Calbiochem|CAPOT|Center for Chemical Gen",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
5991,Ethinylestradiol,ethinyl estradiol|Ethynylestradiol|ETHINYLESTRADIOL|57-63-6|Ethynyl estradiol|Ethinyloestradiol|Ginestrene|Estinyl|17-Ethinylestradiol|17alpha-Ethynylestradiol|Progynon C|Ethinoral|Eticyclin|Eticyclol|Etinestrol|Etinestryl|Etinoestryl|Etistradiol|Follicoral|Novestrol|Orestralyn|Spanestrin|Amenoron|Dyloform|Ertonyl|Estigyn|Estoral|Estorals|Ethidol|Inestra|Linoral|Lynoral|Menolyn|Oradiol|Primogyn|Esteed|Neo-Estrone|Primogyn C|Primogyn M|Nogest-S|Eston-E|Feminone|Palonyl|Perovex|17-Ethynylestradiol|Diogyn E|Ch,296.400,C20H24O2,40.500,505.000,3.700,22,2,2,1,"InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,BFPYWIDHMRZLRN-SLHNCBLASA-N,"(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol",Ethinyl Estradiol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|3|5|7|11|13|15|17|19|21|23|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|99|101|103|107|109|115|119|123|125|129|131|133|137|139|141|143|145|180|192|206|210|220|226|248|256|260|264|268|270|276|296|328|334|342|368|374|421|426|427|433|434|435|445|485|530|539|540|541|542|543|544|545|546|555|556|565|568|573|577|583|584|585|595|596|603|605|606|618|620|631|645|654|655|656|657|658|659|660|661|662|663|664|665|666|667|708|709|731|750|757|758|759|760|761|764|774|775|781|782|793|797|79,20050326,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|AvaChem Scientific|BIDD|BindingDB|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Sc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21252250,"4E,15Z-Bilirubin IXa","4E,15Z-Bilirubin IXa|Bilirubin IX-alpha|(4E)2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo--21H-Biline-8,12-dipropanoic acid|(4E,15Z)-Bilirubin|NSC26685|NSC-26685|(Z,Z)-Bilirubin IXa|(4Z,15E)-Bilirubin|(4E,15Z)-Bilirubin Ixa|(4Z,15Z)-Bilirubin IXa|CHEBI:72719|2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-dipropanoic acid|69853-43-6|ZINC32785896|NCGC00095645-02|Q27140100|(4E)2,17-diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethy",584.700,C33H36N4O6,164.000,1340.000,2.900,43,6,6,12,"InChI=1S/C33H36N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-14,34-35H,1-2,9-12,15H2,3-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13+,27-14-",CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C\\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C/4\\C(=C(C(=O)N4)C=C)C,BPYKTIZUTYGOLE-KDUUSRDASA-N,3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(E)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,7,155|157|161|165|167|175,20071205,"AKos Consulting & Solutions|Ambinter|ChEBI|ChemSpider|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|MassBank of North America (MoNA)|MetabolomicsWorkbench|MolPort|National Center for Advancing Translational Sciences (NCATS)|Smolecule|THE BioTek|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9962735,Ubiquinol,"ubiquinol-10|ubiquinol|992-78-9|reduced coenzyme Q10|UNII-M9NL0C577Y|CoQ10H2|M9NL0C577Y|Dihydrocoenzyme Q10|1,4-Benzenediol, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl-|2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylbenzene-1,4-diol|2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39",865.400,C59H92O4,58.900,1600.000,20.200,63,2,4,31,"InChI=1S/C59H92O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42,60-61H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+",CC1=C(C(=C(C(=C1O)OC)OC)O)C/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CCC=C(C)C,QNTNKSLOFHEFPK-UPTCCGCDSA-N,"2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylbenzene-1,4-diol",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,NULL,20061025,"A2B Chem|AA BLOCKS|abcr GmbH|Alfa Chemistry|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|DrugBank|FDA/SPL Indexing Data|Google Patents|Hairui Chemical|Human Metabolome Database (HMDB)|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|MolPort|Nature Chemical Biology|NCBI Structure|NextBio|OChem|PATENTSCOPE (WIPO)|Smolecule|Springer Nature|SureChEMBL|SYNCHEM OHG|THE BioTek|Thoms",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5926222,Ubisemiquinone,"ubisemiquinone|Neuquinone|Ensorb|Bio-Quinon|Ubiquinone Q10|Coenzyme Q10 semiquinone|Q 10AA|unbiquinone|Kudesan|Liquid-Q|Unispheres Q 10|Bio-Quinone Q10|Li-Q-Sorb|Q-Gel|Kaneka Q10|PureSorb Q 40|Aqua Q10|Aqua Q 10L10|Q-Gel 100|2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone|(all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione|2-[(2E,6E,10E,14E,18",863.300,C59H90O4,52.600,1840.000,19.400,63,0,4,31,"InChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30-,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+",CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(/C)\\CC/C=C(\\C)/CC/C=C(\\C)/CCC=C(C)C,ACTIUHUUMQJHFO-NBZSDRGLSA-N,"2-[(2E,6E,10E,14E,18E,22E,26Z,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20050911,ABI Chem|ChemSpider|Human Metabolome Database (HMDB)|MetabolomicsWorkbench|The Natural Products Atlas,Chemical Vendors|Curation Efforts|Legacy Depositors|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5352425,Lead,"7439-92-1|Lead|Pb|Plumbum|Blei|Lead metal|Lead cation Pb4+|C.I. Pigment Metal 4|lead(0)|Lead ion (1 )|Lead, ion (Pb4+)|UNII-7Y62STE4M2|UNII-2P299V784P|C.I. 77575|Lead granules|7Y62STE4M2|Trimethyl Lead Ion|MFCD00134050|2P299V784P|plomo|Lead element|Lead flake|Lead, 99+%, powder|Lead, elemental|Lead, 99+%, granular|Lead powder, -200 mesh|Omaha & grant|Olow [Polish]|Rough lead bullion|CI pigment metal 4|Lead S2|plomb|Lead S 2|Olow|Lead, inorganic|Lead rod, 6.35mm (0.25in) dia|Plumbum metallicum|Lead and compo",207.000,Pb,0.000,0.000,NULL,1,0,0,0,InChI=1S/Pb,[Pb],WABPQHHGFIMREM-UHFFFAOYSA-N,lead,Lead,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,15,1259407|1259408,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Aronis|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|Biocore|BioCyc|Biosynth Ca",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45479374,Decaprenyl diphosphate,"decaprenyl pyrophosphate|omega,E, octa-Z-decaprenyl phosphate|decaprenyl diphosphate|(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-decaprenyl diphosphate|3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z, 34E,38-decaen-1-yl diphosphate|omega, mono-trans,poly-cis-decaprenyl diphosphate|Decaprenyldiphosphate|CHEBI:81671|trans,octacis-decaprenyl diphosphate|LMPR03030011|C18321|Q27155551|(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30",859.100,C50H84O7P2,113.000,1640.000,15.600,59,3,7,32,"InChI=1S/C50H84O7P2/c1-41(2)21-12-22-42(3)23-13-24-43(4)25-14-26-44(5)27-15-28-45(6)29-16-30-46(7)31-17-32-47(8)33-18-34-48(9)35-19-36-49(10)37-20-38-50(11)39-40-56-59(54,55)57-58(51,52)53/h21,23,25,27,29,31,33,35,37,39H,12-20,22,24,26,28,30,32,34,36,38,40H2,1-11H3,(H,54,55)(H2,51,52,53)/b42-23+,43-25-,44-27-,45-29-,46-31-,47-33-,48-35-,49-37-,50-39-",CC(=CCC/C(=C/CC/C(=C\\CC/C(=C\\CC/C(=C\\CC/C(=C\\CC/C(=C\\CC/C(=C\\CC/C(=C\\CC/C(=C\\COP(=O)(O)OP(=O)(O)O)/C)/C)/C)/C)/C)/C)/C)/C)/C)C,FSCYHDCTHRVSKN-DJNGBRKISA-N,"[(2Z,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl] phosphono hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20100526,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LIPID MAPS|MetabolomicsWorkbench|Wikidata",Curation Efforts|Governmental Organizations|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6253,Cytarabine,"cytarabine|147-94-4|Cytosine arabinoside|Ara-C|Arabinocytidine|Cytosar|Tarabine|Udicil|Cytosar-U|1-beta-D-Arabinofuranosylcytosine|Arabinofuranosylcytosine|DepoCyte|Cytarabin|Arabinosylcytosine|Aracytidine|Cytosine beta-D-arabinofuranoside|Cytosinearabinoside|Cytarabinoside|Citarabina|Cytarabinum|Alexan|Depocyt|beta-D-Arabinosylcytosine|Cytarabinum [INN-Latin]|Citarabina [INN-Spanish]|AraC|Cytosine beta-D-arabinoside|Spongocytidine|4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl",243.220,C9H13N3O5,129.000,383.000,-2.100,17,4,5,2,"InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1",C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,"4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",Cytarabine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|811|833|880|881|894|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1044|1048|1049|1051|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1379|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1460|1461|1463|1465|1466|1467|1468|1469|1471|1476|1477|1478|1479|1481|1486|1487|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|,20050624,"3A SpeedChemical Inc|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Ambinter|AN ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
11975273,"(E,E,E,E)-Squalene","(E,E,E,E)-Squalene|Spinacen|Squalen|Nikko Squalane EX|7683-64-9|(6Z,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene|hydrosqualene|ZINC6920409|111E024",410.700,C30H50,0.000,578.000,11.600,30,0,0,15,"InChI=1S/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23-,30-24+",CC(=CCC/C(=C/CC/C(=C/CC/C=C(\\C)/CC/C=C(/C)\\CCC=C(C)C)/C)/C)C,YYGNTYWPHWGJRM-FLHYQJCXSA-N,"(6Z,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene",NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20070103,"AHH Chemical co.,ltd|Alfa Chemistry|BOC Sciences|ChemMol|ChemSpider|DiscoveryGate|Google Patents|Human Metabolome Database (HMDB)|MassBank of North America (MoNA)|MolPort|NextBio|OChem|Parchem|PATENTSCOPE (WIPO)|Smolecule|Springer Nature|Thieme Chemistry|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477723,"(3S)-2,2-Dimethyl-3-[(3Z,7E,11Z,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane",NULL,426.700,C30H50O,12.500,677.000,10.300,31,0,1,15,"InChI=1S/C30H50O/c1-24(2)14-11-17-27(5)20-12-18-25(3)15-9-10-16-26(4)19-13-21-28(6)22-23-29-30(7,8)31-29/h14-16,20-21,29H,9-13,17-19,22-23H2,1-8H3/b25-15-,26-16+,27-20+,28-21-/t29-/m0/s1",CC(=CCC/C(=C/CC/C(=C\\CC/C=C(\\C)/CC/C=C(/C)\\CC[C@H]1C(O1)(C)C)/C)/C)C,QYIMSPSDBYKPPY-CBMIWKPVSA-N,"(3S)-2,2-dimethyl-3-[(3Z,7E,11Z,15E)-3,7,12,16,20-pentamethylhenicosa-3,7,11,15,19-pentaenyl]oxirane",NULL,Biomolecular Interactions and Pathways|Pharmacology and Biochemistry,2,NULL,20111109,Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
121893,Protoporphyrinogen,"protoporphyrinogen|protoporphyrinogen IX|7412-77-3|21H,23H-Porphine-2,18-dipropanoic acid, 7,12-diethenyl-5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-|7,12-diethenyl-3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,18-dipropanoic acid|Protoporphyrinogen IX (7CI,8CI)|protoporphyrinogen-IX|SCHEMBL52258|CHEBI:15435|DTXSID90225068|3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid|C01079|83398-EP2305655A2|83398-EP2371823A1",568.700,C34H40N4O4,138.000,1010.000,5.700,42,6,4,8,"InChI=1S/C34H40N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,35-38H,1-2,9-16H2,3-6H3,(H,39,40)(H,41,42)",CC1=C2CC3=C(C(=C(N3)CC4=C(C(=C(N4)CC5=C(C(=C(N5)CC(=C1CCC(=O)O)N2)CCC(=O)O)C)C=C)C)C=C)C,UHSGPDMIQQYNAX-UHFFFAOYSA-N,"3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050601,"AAA Chemistry|ABI Chem|BIND|BioCyc|ChEBI|ChemDB|ChemIDplus|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|NCBI Structure|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|SLING Consortium|Smolecule",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46931104,Preuroporphyrinogen(8-),"preuroporphyrinogen(8-)|hydroxymethylbilane|preuroporphyrinogen octaanion|CHEBI:57845|73023-76-4|Q27124997|3,8,13,18-tetrakis(carboxylatomethyl)-19-(hydroxymethyl)bilane-2,7,12,17-tetrapropanoate",846.700,C40H38N4O17-8,404.000,1550.000,4.300,61,5,17,19,"InChI=1S/C40H46N4O17/c45-17-32-25(12-40(60)61)21(4-8-36(52)53)29(44-32)15-31-24(11-39(58)59)20(3-7-35(50)51)28(43-31)14-30-23(10-38(56)57)19(2-6-34(48)49)27(42-30)13-26-22(9-37(54)55)18(16-41-26)1-5-33(46)47/h16,41-45H,1-15,17H2,(H,46,47)(H,48,49)(H,50,51)(H,52,53)(H,54,55)(H,56,57)(H,58,59)(H,60,61)/p-8",C1=C(C(=C(N1)CC2=C(C(=C(N2)CC3=C(C(=C(N3)CC4=C(C(=C(N4)CO)CC(=O)[O-])CCC(=O)[O-])CC(=O)[O-])CCC(=O)[O-])CC(=O)[O-])CCC(=O)[O-])CC(=O)[O-])CCC(=O)[O-],WDFJYRZCZIUBPR-UHFFFAOYSA-F,3-[5-[[3-(2-carboxylatoethyl)-5-[[3-(2-carboxylatoethyl)-5-[[3-(2-carboxylatoethyl)-4-(carboxylatomethyl)-5-(hydroxymethyl)-1H-pyrrol-2-yl]methyl]-4-(carboxylatomethyl)-1H-pyrrol-2-yl]methyl]-4-(carboxylatomethyl)-1H-pyrrol-2-yl]methyl]-4-(carboxylatomethyl)-1H-pyrrol-3-yl]propanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20101103,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
321,Coproporphyrinogen III,"coproporphyrinogen III|coproporphyrinogen|2624-63-7|coproporphyrinogen-III|CHEBI:15439|5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-21H,23H-porphine-2,7,12,18-tetrapropanoic acid|3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoic acid|3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropionic acid|21H,23H-Porphine-2,7,12,18-tetrapropanoic acid, 5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-|3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyr",660.800,C36H44N4O8,212.000,1170.000,3.600,48,8,8,12,"InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)",CC1=C2CC3=C(C(=C(N3)CC4=C(C(=C(N4)CC5=C(C(=C(N5)CC(=C1CCC(=O)O)N2)C)CCC(=O)O)C)CCC(=O)O)CCC(=O)O)C,NIUVHXTXUXOFEB-UHFFFAOYSA-N,"3-[8,12,17-tris(2-carboxyethyl)-3,7,13,18-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,574831,20050601,"AAA Chemistry|ABI Chem|BIND|BioCyc|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|iChemical Technology USA Inc|ISpharm|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|NextBio|NextMove Software|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Eu",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
323,Coumarin,"coumarin|91-64-5|2H-Chromen-2-one|2H-1-Benzopyran-2-one|1,2-Benzopyrone|cumarin|Rattex|Coumarinic anhydride|chromen-2-one|Tonka bean camphor|Coumarine|Benzo-alpha-pyrone|cis-o-Coumarinic acid lactone|o-Hydroxycinnamic acid lactone|o-Hydroxycinnamic lactone|2-Oxo-1,2-benzopyran|Coumarinic lactone|Kumarin|1-Benzopyran-2-one|Benzo-a-pyrone|Kumarin [Czech]|2H-1-Benzopyran, 2-oxo-|5,6-Benzo-2-pyrone|5,6-Benzo-alpha-pyrone|2H-Benzo(b)pyran-2-one|2H-Benzo[b]pyran-2-one|Caswell No. 259C|o-Coumaric acid lactone|o-Hy",146.140,C9H6O2,26.300,196.000,1.400,11,0,2,0,InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,C1=CC=C2C(=C1)C=CC(=O)O2,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,chromen-2-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1|3|7|9|11|13|15|17|19|21|23|25|27|29|31|33|35|39|45|47|49|51|53|55|57|59|63|65|67|69|71|73|75|77|79|81|99|101|103|105|107|109|113|119|121|123|125|129|133|135|137|139|141|143|145|179|192|200|212|220|222|226|248|256|268|270|302|316|328|330|421|426|427|433|434|435|445|485|530|540|541|542|543|544|545|546|584|585|595|596|603|605|608|631|654|655|656|657|658|659|660|661|662|663|664|665|666|667|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|875|878|880|8,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambin",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
1179,Uroporphyrinogen III,"Uroporphyrinogen III|Urogen III|uroporphyrinogen-III|1976-85-8|21H,23H-Porphine-2,7,12,18-tetrapropanoic acid, 3,8,13,17-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro-|Uroporphyrinogens|3,3',3'',3'''-[3,8,13,17-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrayl]tetrapropanoic acid|3,8,13,17-tetrakis(carboxymethyl)-5,10,15,20,22,24-hexahydro-21H,23H-porphine-2,7,12,18-tetrapropanoic acid|uroporphyrinogen|uro'gen III|SCHEMBL80064|CHEBI:15437|DTXSID40173444|Uroporphyrinogen III ",836.800,C40H44N4O16,362.000,1630.000,0.000,60,12,16,20,"InChI=1S/C40H44N4O16/c45-33(46)5-1-17-21(9-37(53)54)29-14-27-19(3-7-35(49)50)22(10-38(55)56)30(43-27)15-28-20(4-8-36(51)52)24(12-40(59)60)32(44-28)16-31-23(11-39(57)58)18(2-6-34(47)48)26(42-31)13-25(17)41-29/h41-44H,1-16H2,(H,45,46)(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)",C1C2=C(C(=C(N2)CC3=C(C(=C(N3)CC4=C(C(=C(N4)CC5=C(C(=C1N5)CCC(=O)O)CC(=O)O)CC(=O)O)CCC(=O)O)CC(=O)O)CCC(=O)O)CC(=O)O)CCC(=O)O,HUHWZXWWOFSFKF-UHFFFAOYSA-N,"3-[7,12,18-tris(2-carboxyethyl)-3,8,13,17-tetrakis(carboxymethyl)-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid",Uroporphyrinogens,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050608,"AAA Chemistry|ABI Chem|BIND|BioCyc|BOC Sciences|ChEBI|ChemDB|ChemIDplus|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|MuseChem|NCBI Structure|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Springer Nature|SureChEMBL|Thieme ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46173708,Vitamin B12s,cob(I)alamin|vitamin B12s|18534-66-2|Cbl|C00853,1330.400,C62H89CoN13O14P-,449.000,3160.000,NULL,91,10,19,26,"InChI=1S/C62H90N13O14P.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);/p-1/t31-,34-,35-,36-,37+,41-,52-,53-,56?,57+,59-,60+,61+,62+;/m1",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)(O)O[C@H](C)CNC(=O)CC[C@@]\\4([C@H](C5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co],FEZWOUWWJOYMLT-FSANSEACSA-M,"cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100701,KEGG|ToxPlanet,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
2244,Aspirin,aspirin|ACETYLSALICYLIC ACID|50-78-2|2-Acetoxybenzoic acid|2-(Acetyloxy)benzoic acid|O-Acetylsalicylic acid|o-Acetoxybenzoic acid|Acylpyrin|Easprin|Ecotrin|Acenterine|Acetophen|Polopiryna|Acetosal|Acetylsalicylate|Colfarit|Salicylic acid acetate|o-Carboxyphenyl acetate|Enterosarein|Aceticyl|Acetonyl|Acetosalin|Acetylin|Aspergum|Aspirdrops|Benaspir|Micristin|Pharmacin|Premaspin|Salcetogen|Temperal|Ecolen|Empirin|Endydol|Rhodine|Saletin|Rheumintabletten|Solprin acid|Acetisal|Acetylsal|Aspirine|Bialpirina|Bial,180.160,C9H8O4,63.600,212.000,1.200,13,1,4,3,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",CC(=O)OC1=CC=CC=C1C(=O)O,BSYNRYMUTXBXSQ-UHFFFAOYSA-N,2-acetyloxybenzoic acid,Aspirin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1|3|9|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|79|81|83|85|87|89|91|93|99|103|105|107|109|113|115|119|121|123|125|131|133|137|139|141|143|145|155|157|161|165|167|175|179|192|194|210|212|248|256|330|357|410|411|421|422|426|427|429|433|434|435|436|444|445|446|447|448|450|451|526|530|540|541|542|543|544|545|546|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|654|655|656|657|658|659|660|661|662|663|664|665|666|667|694|732|875|879|880|881|883|884|885|886|887|889|89,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambinter|AN PharmaTe",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
6029,Uridine,"uridine|58-96-8|Uridin|1-beta-D-Ribofuranosyluracil|Uracil riboside|Uracil, 1-beta-D-ribofuranosyl-|beta-Uridine|NSC 20256|d-uridine|CHEBI:16704|b-Uridine|UNII-WHI7HQ7H85|Urd|AI3-52690|WHI7HQ7H85|MLS000069625|1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione|1-.beta.-D-Ribofuranosyluracil|SMR000058222|uridine-1'-13C|MFCD00006526|1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione|1-((2R,3R,4S,5R)-tetrahydro-3,4-dihydroxy-5-(hydroxymethyl)furan-2-yl)pyrimidine-2,4",244.200,C9H12N2O6,119.000,371.000,-2.000,17,4,6,2,"InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,DRTQHJPVMGBUCF-XVFCMESISA-N,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Uridine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,485|568|583|598|602|606|618|620|629|630|631|633|639|648|687|701|719|731|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|875|878|880|881|884|885|887|889|892|893|894|898|900|901|902|920|923|924|932|940|950|951|952|995|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|13,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|Angene Chemical|Anward|Apexmol|Aurum Pharmatech LLC|AX Molecules Inc|BenchChem|BerrChem|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC S",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
446541,Mycophenolic acid,"mycophenolic acid|24280-93-1|Mycophenolate|Melbex|Myfortic|Mycophenolsaeure|Lilly-68618|6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid|Acido micofenolico|Micofenolico acido|483-60-3|NSC-129185|Acide mycophenolique|Acidum mycophenolicum|CCRIS 5565|(4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic acid|NSC 129185|UNII-HU9DX48N0T|Ly 68618|(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid|(E)-6-(4-Hy",320.300,C17H20O6,93.100,486.000,3.200,23,2,6,6,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\\C)/CCC(=O)O)O,HPNSFSBZBAHARI-RUDMXATFSA-N,(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid,Mycophenolic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1|3|5|7|9|11|13|15|17|19|21|23|25|27|29|31|33|35|37|39|41|43|45|47|49|53|55|59|61|63|65|67|69|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|179|192|198|226|248|272|276|328|330|357|377|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|608|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|910|912|914|915|923|924|925|926|927|930|938|940|,20050326,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaT",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
70678541,Adenosylcobalamin,"Cobamamide|Vitamin B12 coenzyme|coenzyme B-12|adenosylcobalamin|coenzyme B12|Cobamide coenzyme|Dibencozide|Calomide|Adenosylcob(III)alamin|Cobamamid|5'-Deoxy-5'-adenosylcobalamin|5'-Deoxyadenosylcobalamin|Cobalamin coenzyme|AdoCbl|Cobamamida|Cobamamidum|Funacomide|DBC coenzyme|(5,6-dimethylbenzimidazolyl)cobamide coenzyme|Deoxyadenosylcobalamin|5'-Deoxyadenosyl vitamin B12|(5'-Deoxy-5'-adenosyl)cobamide coenzyme|5'-Deoxy-5'-adenosyl vitamin B12|Vitamin B12 coenzymes|5'-Deoxyadenosyl-5,6-dimethylbenzimidazol",1579.600,C72H100CoN18O17P-3,571.000,3730.000,NULL,109,12,27,17,"InChI=1S/C62H90N13O14P.C10H12N5O3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);2-",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[CH2-][C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O.[Co],DFDCDQDATCDZSO-OUCXYWSSSA-L,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Toxicity,8,NULL,20121212,ChEBI|Comparative Toxicogenomics Database (CTD)|DrugBank|Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
249,Betaine aldehyde,"betaine aldehyde|glycine betaine aldehyde|7418-61-3|Trimethyl(formylmethyl)ammonium|trimethyl(2-oxoethyl)azanium|UNII-DEI7V5X7RB|DEI7V5X7RB|(Formylmethyl)trimethylammonium|Betaine aldehyde, chloride salt|CHEBI:15710|N,N,N-trimethyl-2-oxoethanaminium|BTL|Ethanaminium, N,N,N-trimethyl-2-oxo-|[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde|betaine-aldehyde|Lopac-B-3650|bmse000070|Lopac0_000182|SCHEMBL94563|(formylmethyl)trimethyl-Ammonium|CHEMBL1231491|DTXSID20225152|N,N,N-trimethyl-2-ox",102.150,C5H12NO+,17.100,63.000,-0.200,7,0,1,2,"InChI=1S/C5H12NO/c1-6(2,3)4-5-7/h5H,4H2,1-3H3/q+1",C[N+](C)(C)CC=O,SXKNCCSPZDCRFD-UHFFFAOYSA-N,trimethyl(2-oxoethyl)azanium,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Micromolar,9,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|881|883|884|885|886|887|889|891|892|893|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1452|1471|1851|2660|2666|2667|2668|463106|485295|485297|485298|485313|485342|485345|485366|485368|488772|488773|488816|488837|488949|488953|488978|488981|488982|488983|493106|493107|493153|493164|504327|504332|504536|504547|504548|50481,20040916,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|abcr GmbH|ABI Chem|Achemica|Achemtek|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Angel Pharmatech Ltd.|Aurora Fine Chemicals LLC|BIND|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|Chemhere|chemical genetic matrix|ChemIDplus|Chemi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
457,1-Methylnicotinamide,"1-methylnicotinamide|Trigonellinamide|N(1)-Methylnicotinamide|Trigonellamide|N1-Methylnicotinamide|3106-60-3|3-(Aminocarbonyl)-1-methylpyridinium|1-methylpyridin-1-ium-3-carboxamide|3-carbamoyl-1-methylpyridinium|Pyridinium, 3-carbamoyl-1-methyl-|UNII-UM47085BXC|3-carbamoyl-1-methylpyridin-1-ium|1-methylpyridine-3-carboxamide|UM47085BXC|CHEBI:16797|1-Methyl nicotinamide|6456-44-6|TRIA-662|CHEMBL1209652|N(sup 1)-Methylnicotinamide|BRN 3540351|1-methyl-3-carbamoylpyridinium|8GC|N'methylnicotinamide|1-mna|I-me",137.160,C7H9N2O+,47.000,136.000,-0.100,10,1,1,1,"InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1",C[N+]1=CC=CC(=C1)C(=O)N,LDHMAVIPBRSVRG-UHFFFAOYSA-O,1-methylpyridin-1-ium-3-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,10,61001|61002|1445037,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Aurora Fine Chemicals LLC|BindingDB|Biocore|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|CCSbase|Center for",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
937,Nicotinate,nicotinate|pyridine-3-carboxylate|3-pyridinecarboxylate|vitamin B3|nico-400-|CHEBI:32544|FT-0654944|9195-EP2269977A2|9195-EP2270004A1|9195-EP2270006A1|9195-EP2275412A1|9195-EP2277876A1|9195-EP2280010A2|9195-EP2281559A1|9195-EP2284172A1|9195-EP2289891A2|9195-EP2292227A2|9195-EP2292614A1|9195-EP2295412A1|9195-EP2295413A1|9195-EP2295426A1|9195-EP2295427A1|9195-EP2295437A1|9195-EP2295550A2|9195-EP2298734A2|9195-EP2298775A1|9195-EP2305666A1|9195-EP2308812A2|9195-EP2308844A2|9195-EP2308845A2|9195-EP2308846A2|9195,122.100,C6H4NO2-,53.000,108.000,0.900,9,0,3,0,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)/p-1",C1=CC(=CN=C1)C(=O)[O-],PVNIIMVLHYAWGP-UHFFFAOYSA-M,pyridine-3-carboxylate,Niacin,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,NULL,20040916,"A&J Pharmtech CO., LTD.|AAA Chemistry|ABI Chem|Aurora Fine Chemicals LLC|BioCyc|CCSbase|ChEBI|ChemDB|ChemMol|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Finetech Industry Limited|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|MuseChem|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|SLING Consortium|Specs|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
14985,Vitamin E,"alpha-Tocopherol|VITAMIN E|D-alpha-Tocopherol|59-02-9|5,7,8-Trimethyltocol|(+)-alpha-Tocopherol|alpha-Vitamin E|Aquasol E|(R,R,R)-alpha-Tocopherol|Phytogermine|Eprolin|a-Tocopherol|(2R,4'R,8'R)-alpha-Tocopherol|dl-a-Tocopherol|Denamone|Viteolin|Esorb|Tocopherol alpha|alpha Tocopherol|2074-53-5|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|Vitamin Ea|Mixed tocopherols|D-alpha tocopherol|Syntopherol|(R)-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol|Tocopherol",430.700,C29H50O2,29.500,503.000,10.700,31,1,2,12,"InChI=1S/C29H50O2/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8)19-17-26-25(7)27(30)23(5)24(6)28(26)31-29/h20-22,30H,9-19H2,1-8H3/t21-,22-,29-/m1/s1",CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C,GVJHHUAWPYXKBD-IEOSBIPESA-N,"(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol",Vitamin E,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,377|875|880|881|884|885|887|889|892|893|894|900|901|902|923|924|995|1030|1332|1376|1379|1385|1422|1452|1454|1457|1460|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1529|1530|1531|1532|1554|1576|1621|1626|1662|1663|1672|1688|1766|1768|1813|1814|1832|1850|1863|1865|1875|1885|1899|1903|1906|1910|1947|1948|1950|1956|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2107|2112|2129|2130|2147|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2314|2315,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BePharm Ltd.|BIDD|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|CCSbase|ChEBI|Chem-Space.com Database|ChemBank|Chembas",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
15993,2'-Deoxyadenosine 5'-triphosphate,"dATP|Deoxyadenosine triphosphate|2'-deoxyadenosine 5'-triphosphate|2'-deoxyadenosine triphosphate|deoxy-ATP|1927-31-7|Deoxyadenosine 5'-triphosphate|2'-Datp|UNII-K8KCC8SH6N|2'-Deoxyadenosine 5'-(tetrahydrogen triphosphate)|2'-deoxyadenosine-5'-triphosphate|CHEBI:16284|2'-Deoxy-ATP|2'-Deoxy-5'-ATP|K8KCC8SH6N|Adenosine 5'-(tetrahydrogen triphosphate), 2'-deoxy-|CHEMBL335538|ADENOSINE, 2'-DEOXY-, 5'-(TETRAHYDROGEN TRIPHOSPHATE)|(((2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl)triphos",491.180,C10H16N5O12P3,259.000,769.000,-4.400,30,6,16,8,"InChI=1S/C10H16N5O12P3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(25-7)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,SUYVUBYJARFZHO-RRKCRQDMSA-N,"[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,1811|18096|22610|24495|53665|107751|107761|107763|107766|107772|107904|107907|150470|150489|167233|167235|198921|229453|294600|294601|395722|395723|395724|395725|395726|395727|572770|572771|572772|618865|618875|618876|618877|670143|670145|670146|670147|670148|671283|711522|711538|711539|977611|1124515|1124517|1124518|1346335,20050608,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|Achemtek|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|AstaTech, Inc.|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Ph",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53241,1-(p-Methoxy-alpha-methylbenzyl)hydrazine,"1-(p-Methoxy-alpha-methylbenzyl)hydrazine|HYDRAZINE, (p-METHOXY-alpha-METHYLBENZYL)-, OXALATE",256.250,C11H16N2O5,126.000,200.000,NULL,18,3,6,3,"InChI=1S/C9H14N2O.C2H2O4/c1-7(11-10)8-3-5-9(12-2)6-4-8;3-1(4)2(5)6/h3-7,11H,10H2,1-2H3;(H,3,4)(H,5,6)",CC(C1=CC=C(C=C1)OC)N[NH3+].C(=O)(C(=O)[O-])O,QYRSBQTXGGKIJU-UHFFFAOYSA-N,2-hydroxy-2-oxoacetate;[1-(4-methoxyphenyl)ethylamino]azanium,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Toxicity,4,NULL,20050808,ABI Chem|ChemIDplus|ChemSpider|DiscoveryGate|LeadScope|NextBio|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
96009,4-Hydroxyphenyl acetate,"4-Acetoxyphenol|4-Hydroxyphenyl acetate|3233-32-7|hydroquinone monoacetate|(4-hydroxyphenyl) acetate|UNII-6GIM3882KV|1,4-Benzenediol, monoacetate|6GIM3882KV|CHEBI:31128|C8H8O3|4-acetoxy phenol|NSC 47899|Hydroquinone, acetate|Spectrum_000154|Spectrum2_001145|Spectrum3_001311|Spectrum4_001630|Spectrum5_000419|Acetic acid 4-hydroxyphenyl|BSPBio_003001|KBioGR_002039|KBioSS_000634|SCHEMBL203149|SPBio_001069|CHEMBL3039093|KBio2_000634|KBio2_003202|KBio2_005770|KBio3_002221|DTXSID70186062|acetic acid 4-hydroxy-phe",152.150,C8H8O3,46.500,136.000,0.800,11,1,3,2,"InChI=1S/C8H8O3/c1-6(9)11-8-4-2-7(10)3-5-8/h2-5,10H,1H3",CC(=O)OC1=CC=C(C=C1)O,HBMCQTHGYMTCOF-UHFFFAOYSA-N,(4-hydroxyphenyl) acetate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active,10,608|1033|1549|1552|1637|1648|2240|2241|2275|2313|2316|2322|2330|434959|624156|977599|977602|1159550|1159580|1159607|1345086|1346200,20050326,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Apexmol|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
119209,Thymidine-methyl-T,"Thymidine-methyl-T|1148-63-6|Tritiated methyl thymidine|THYMIDINE,[METHYL-3H]|1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(tritiomethyl)pyrimidine-2,4-dione|Thymidine-alpha-t|(methyl-(3)H1)thymidine|CHEBI:53527|DTXSID20921501|1-(2-Deoxypentofuranosyl)-4-hydroxy-5-(~3~H_1_)methylpyrimidin-2(1H)-one",244.240,C10H14N2O5,99.100,381.000,-1.200,17,3,5,2,"InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1/i1T",[3H]CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O,IQFYYKKMVGJFEH-ZEIUMXODSA-N,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(tritiomethyl)pyrimidine-2,4-dione",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20050808,"3B Scientific (Wuhan) Corp|ABI Chem|Alfa Chemistry|ChEBI|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|DiscoveryGate|Elsa Biotechnology|EPA DSSTox|Google Patents|MuseChem|NextBio|Smolecule|THE BioTek|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
150841,Imidazole-4-acetaldehyde,Imidazole-4-acetaldehyde|645-14-7|Imidazole acetaldehyde|1H-Imidazole-4-acetaldehyde|2-(1H-imidazol-5-yl)acetaldehyde|1H-Imidazole-5-acetaldehyde|(1H-IMIDAZOL-4-YL)-ACETALDEHYDE|4-Imidazolylacetaldehyde|1H-imidazol-4-ylacetaldehyde|SCHEMBL231455|(1h-imidazol-4-yl)acetaldehyde|Imidazole-4(or 5)-acetaldehyde|CHEBI:27398|DTXSID60214747|(3H-imidazol-4-yl)-acetaldehyde|2-(1H-imidazol-4-yl)acetaldehyde|ZINC12496212|AKOS006238362|C05130|Q27103107,110.110,C5H6N2O,45.800,84.500,-0.500,8,1,2,2,"InChI=1S/C5H6N2O/c8-2-1-5-3-6-4-7-5/h2-4H,1H2,(H,6,7)",C1=C(NC=N1)CC=O,MQSRGWNVEZRLDK-UHFFFAOYSA-N,2-(1H-imidazol-5-yl)acetaldehyde,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20040916,"3WAY PHARM INC|A2B Chem|AA BLOCKS|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BioCyc|BLD Pharm|BOC Sciences|ChEBI|ChemDB|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Day Biochem|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Meta",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439353,beta-D-Galactose,"beta-D-galactose|beta-D-galactopyranose|7296-64-2|beta-Galactose|beta-D-Gal|Gal-beta|UNII-RQ6K52J67A|beta-D-Galactoside|CHEBI:27667|CHEMBL300520|RQ6K52J67A|(2R,3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol|beta-Gal|Galactitol,1,5-anhydro-1-C-phenyl-|Galactopyranose, beta-D-|betaGal|delta-Galactose|b-Galactose|b-D-Galactose|1axz|1gca|1oko|1pum|1ugw|9abp|Beta D-Galactose|beta-D-galactosides|beta-delta-galactoside|I(2)-D-Galactose|beta-delta-galactosides|beta-aD-aGalactopyranose|6-(hydroxymethyl)tetrahydr",180.160,C6H12O6,110.000,151.000,-2.600,12,5,6,1,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6-/m1/s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O)O,WQZGKKKJIJFFOK-FPRJBGLDSA-N,"(2R,3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,1811|30427|35661|35662|38895|238137|305307|305308|452766|452767|452768|452769|452770|452771|977608|977611,20050624,"A2B Chem|AA BLOCKS|ABI Chem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|BindingDB|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|GlyTouCan Project|Google Patents|Human Metabolome Database (HMDB)|IBM|Immune Epitope Database (IEDB)|Japan Chemical Substance ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3674425,Phosphonatoenolpyruvate,phosphonatoenolpyruvate|phosphoenol pyruvate|Phosphoenol pyruvate(PEP)|phosphonatoenolpyruvate(3-)|2-(phosphooxy)- 2-propenoate|CHEBI:58702|2-(phosphonoatooxy)prop-2-enoate|2-(Dioxylatophosphinyloxy)acrylate|Q27125977,165.020,C3H2O6P-3,113.000,184.000,-0.600,10,0,6,1,"InChI=1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)/p-3",C=C(C(=O)[O-])OP(=O)([O-])[O-],DTBNBXWJWCWCIK-UHFFFAOYSA-K,2-phosphonatooxyprop-2-enoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050910,"ABI Chem|BioCyc|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|MassBank of North America (MoNA)|Nature Chemistry|NextBio|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3713609,Intropin,"dopaminium(1+)|dopaminium cation|intropin|3,4-Dihydroxyphenethylammonium|CHEBI:59905|(3,4-dihydroxyphenethyl)ammonium|2-(3,4-dihydroxyphenyl)ethanaminium|BDBM50049797|2-(3,4-dihydroxyphenyl)ethan-1-aminium|Q27126955",154.190,C8H12NO2+,68.100,119.000,-1.000,11,3,2,2,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2/p+1",C1=CC(=C(C=C1CC[NH3+])O)O,VYFYYTLLBUKUHU-UHFFFAOYSA-O,"2-(3,4-dihydroxyphenyl)ethylazanium",Dopamine,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20050910,"A&J Pharmtech CO., LTD.|ABI Chem|BindingDB|BioCyc|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NMRShiftDB|PATENTSCOPE (WIPO)|SCRIPDB|ToxPlanet|Wikidata|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
4592697,2-Oxo-3-phenylpropanoate,"keto-phenylpyruvate|2-oxo-3-phenylpropanoate|3-Phenylpyruvate|phenylpyruvate|2-oxidanylidene-3-phenyl-propanoate|benzylglyoxylate|CHEBI:18005|Phenylpyruvic acid, calcium salt|DTXSID30924063|BDBM50269985|P-5000|A804835|A809715|Q27102755",163.150,C9H7O3-,57.200,175.000,1.900,12,0,3,2,"InChI=1S/C9H8O3/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,11,12)/p-1",C1=CC=C(C=C1)CC(=O)C(=O)[O-],BTNMPGBKDVTSJY-UHFFFAOYSA-M,2-oxo-3-phenylpropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|AN PharmaTech|BindingDB|BioCyc|Biosynth Carbosynth|ChEBI|ChemDB|ChemMol|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5288393,D-Glucarate,"glucarate|D-glucarate(2-)|D-glucarate|D-saccharate|(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioate|(D)-glucarate|CHEBI:30612|Q27104135|(2R,3S,4S,5S)-2,3,4,5-tetrahydroxyhexanedioate (non-preferred name)",208.120,C6H8O8-2,161.000,191.000,-1.800,14,4,8,3,"InChI=1S/C6H10O8/c7-1(3(9)5(11)12)2(8)4(10)6(13)14/h1-4,7-10H,(H,11,12)(H,13,14)/p-2/t1-,2-,3-,4+/m0/s1",[C@H]([C@@H]([C@@H](C(=O)[O-])O)O)([C@H](C(=O)[O-])O)O,DSLZVSRJTYRBFB-LLEIAEIESA-L,"(2S,3S,4S,5R)-2,3,4,5-tetrahydroxyhexanedioate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SMID|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460697,Hydrogenselenate,"hydrogenselenate|Selenate, hydrogen|CHEBI:33490|(Selenic acid hydrogen)anion|HSeO4(-)|hydroxidotrioxidoselenate(1-)|[SeO3(OH)](-)|DTXSID90420112|14998-57-3|J3.560.162G|Q27115669",143.980,HO4Se-,77.400,76.000,NULL,5,1,4,0,"InChI=1S/H2O4Se/c1-5(2,3)4/h(H2,1,2,3,4)/p-1",O[Se](=O)(=O)[O-],QYHFIVBSNOWOCQ-UHFFFAOYSA-M,hydrogen selenate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20040916,"ABI Chem|ChEBI|ChemSpider|ChemTik|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460761,2-Aminoethanesulfonate,2-aminoethanesulfonate|CHEBI:32970|Q27115163,124.140,C2H6NO3S-,91.600,107.000,-4.200,7,1,4,1,"InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)/p-1",C(CS(=O)(=O)[O-])N,XOAAWQZATWQOTB-UHFFFAOYSA-M,2-aminoethanesulfonate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"ABI Chem|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NMRShiftDB|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Thieme Chemistry|Wikidata|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6857401,(S)-3-Methyl-2-oxovalerate,(S)-3-methyl-2-oxovalerate|(3S)-3-Methyl-2-oxopentanoate|(S)-3-methyl-2-oxopentanoate|2-keto-isoleucine|alpha-keto-methylvalerate|2-keto-3-methyl-valerate|(S)-2-oxo-3-methylpentanoate|alpha-keto-beta-methyl-valerate|CHEBI:35146|Q27104292,129.130,C6H9O3-,57.200,123.000,1.700,9,0,3,2,"InChI=1S/C6H10O3/c1-3-4(2)5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)/p-1/t4-/m0/s1",CC[C@H](C)C(=O)C(=O)[O-],JVQYSWDUAOAHFM-BYPYZUCNSA-M,(3S)-3-methyl-2-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060621,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NMRShiftDB|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7058169,Deoxycytidylate,"Deoxycytidylate|dCMP(2-)|deoxycytidine monophosphate (2-)|deoxycytidine-phosphate|dCMP dianion|2'-Deoxycytidine-5'-monophosphoricacid|2'-deoxycytidine 5'-phosphate|CHEBI:57566|2'-deoxy-5'-O-phosphonatocytidine|[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate|2'-deoxycytosine 5'-monophosphate(2-)|A800703|Q27124785|[(2R,3S,5R)-5-(4-amino-2-oxo-1-pyrimidinyl)-3-hydroxy-2-oxolanyl]methyl phosphate|[(2R,3S,5R)-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-oxolan-2-yl]met",305.180,C9H12N3O7P-2,161.000,490.000,-3.600,20,2,7,3,"InChI=1S/C9H14N3O7P/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(19-8)4-18-20(15,16)17/h1-2,5-6,8,13H,3-4H2,(H2,10,11,14)(H2,15,16,17)/p-2/t5-,6+,8+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)COP(=O)([O-])[O-])O,NCMVOABPESMRCP-SHYZEUOFSA-L,"[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060729,"3WAY PHARM INC|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Google Patents|NextBio|THE BioTek|Thieme Chemistry|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9870745,"[[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",ATP(3-)|CHEBI:57299|Q27124408,504.160,C10H13N5O13P3-3,288.000,781.000,-6.000,31,4,17,8,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O)O)N,ZKHQWZAMYRWXGA-KQYNXXCUSA-K,"[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20061025,"ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|NextBio|Springer Nature|Thomson Pharma|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16755641,"Hydrogen pyridine-2,3-dicarboxylate","quinolinate(1-)|Q60998691|CHEBI:46828|hydrogen pyridine-2,3-dicarboxylate",166.110,C7H4NO4-,93.200,193.000,NULL,12,1,5,0,"InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)/p-1",[H+].C1=CC(=C(N=C1)C(=O)[O-])C(=O)[O-],GJAWHXHKYYXBSV-UHFFFAOYSA-M,"hydron;pyridine-2,3-dicarboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20071102,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21125049,"D-Fructofuranose 1,6-bisphosphate(4-)","D-fructofuranose 1,6-bisphosphate(4-)|CHEBI:49299|1,6-di-O-phosphonato-D-fructofuranose|Q27121605",336.080,C6H10O12P2-4,215.000,405.000,-5.900,20,3,12,4,"InChI=1S/C6H14O12P2/c7-4-3(1-16-19(10,11)12)18-6(9,5(4)8)2-17-20(13,14)15/h3-5,7-9H,1-2H2,(H2,10,11,12)(H2,13,14,15)/p-4/t3-,4-,5+,6?/m1/s1",C([C@@H]1[C@H]([C@@H](C(O1)(COP(=O)([O-])[O-])O)O)O)OP(=O)([O-])[O-],RNBGYGVWRKECFJ-VRPWFDPXSA-J,"[(2R,3S,4S)-3,4,5-trihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20071205,"ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Thieme Chemistry|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
24771817,"3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate","a retinoate|a retinoic acid|CHEBI:15036|Q27109018|3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate",299.400,C20H27O2-,40.100,561.000,6.900,22,0,2,4,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/p-1",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)[O-])C)C,SHGAZHPCJJPHSC-UHFFFAOYSA-M,"3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20080501,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25113193,Lauroyl coenzyme A,"lauroyl-CoA(4-)|Lauroyl coenzyme A|dodecanoyl-CoA(4-)|lauroyl-CoA tetraanion|6244-92-4|lauroyl-coenzyme A(4-)|dodecanoyl-coenzyme A(4-)|CHEBI:57375|Dodecanoyl-CoA (n-C12:0CoA)|Q27124520|3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(dodecanoylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate)",945.800,C33H54N7O17P3S-4,400.000,1530.000,-0.800,61,5,22,29,"InChI=1S/C33H58N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-24(42)61-17-16-35-23(41)14-15-36-31(45)28(44)33(2,3)19-54-60(51,52)57-59(49,50)53-18-22-27(56-58(46,47)48)26(43)32(55-22)40-21-39-25-29(34)37-20-38-30(25)40/h20-22,26-28,32,43-44H,4-19H2,1-3H3,(H,35,41)(H,36,45)(H,49,50)(H,51,52)(H2,34,37,38)(H2,46,47,48)/p-4/t22-,26-,27-,28+,32-/m1/s1",CCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,YMCXGHLSVALICC-GMHMEAMDSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-(2-dodecanoylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090114,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245609,N-[(R)-4-Phosphonatopantothenoyl]-L-cysteinate(3-),"N-[(R)-4-phosphonatopantothenoyl]-L-cysteinate(3-)|4-P-N-pantothenoylcysteine|4'-P-N-pantothenoylcysteine|4'-phosphopantothenoylcysteine|4'-phospho-N-pantothenoylcysteine|(R)-4'-phospho-N-pantothenoyl-L-cysteine|CHEBI:59458|Q27104854|N-[(R)-4-phosphonatopantothenoyl]-L-cysteinate trianion|N-{N-[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonatooxybutanoyl]-beta-alanyl}-L-cysteinate",399.340,C12H20N2O9PS-3,192.000,520.000,-2.000,25,4,10,9,"InChI=1S/C12H23N2O9PS/c1-12(2,6-23-24(20,21)22)9(16)10(17)13-4-3-8(15)14-7(5-25)11(18)19/h7,9,16,25H,3-6H2,1-2H3,(H,13,17)(H,14,15)(H,18,19)(H2,20,21,22)/p-3/t7-,9-/m0/s1",CC(C)(COP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)N[C@@H](CS)C(=O)[O-])O,XQYALQVLCNHCFT-CBAPKCEASA-K,"(2R)-2-[3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonatooxybutanoyl]amino]propanoylamino]-3-sulfanylpropanoate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245769,"3-[(2Z,5Z)-2-[[3-(2-Carboxylatoethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoate","3-[(2Z,5Z)-2-[[3-(2-carboxylatoethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoate|biliverdin dianion|(Z,Z)-biliverdin-IX alpha|CHEBI:57991|3-[(2E,5Z)-2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid",580.600,C33H32N4O6-2,167.000,1520.000,3.800,43,3,7,9,"InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,34-35H,1-2,9-12H2,3-6H3,(H,37,42)(H,38,39)(H,40,41)/p-2/b24-13-,27-14-,28-15-",CC\\1=C(/C(=C/C2=C(C(=C(N2)/C=C\\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)[O-])/N/C1=C\\C4=NC(=O)C(=C4C)C=C)CCC(=O)[O-],RCNSAJSGRJSBKK-NSQVQWHSSA-L,"3-[(2Z,5Z)-2-[[3-(2-carboxylatoethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20090514,BenchChem|BioCyc|ChEBI|THE BioTek,Chemical Vendors|Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266553,(S)-3-Hydroxybutanoyl-CoA(4-),"(S)-3-hydroxybutanoyl-CoA(4-)|(S)-3-Hydroxybutyryl coenzyme A|L-3-hydroxybutyryl-CoA|CHEBI:57316|Q27124417|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(3S)-3-hydroxybutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] diphosphate}",849.600,C25H38N7O18P3S-4,421.000,1420.000,-6.300,54,6,23,21,"InChI=1S/C25H42N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-14,18-20,24,33,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14+,18+,19+,20-,24+/m0/s1",C[C@@H](CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O)O,QHHKKMYHDBRONY-VKBDFPRVSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-4-[[3-[2-[(3S)-3-hydroxybutanoyl]sulfanylethylamino]-3-oxopropyl]amino]-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266569,2-Methylbutanoyl-CoA(4-),"2-methylbutanoyl-CoA(4-)|2-methylbutyryl-CoA(4-)|2-methylbutanoyl-CoA tetraanion|CHEBI:57336|2-methylbutanoyl-coenzyme A(4-)|Q27124436|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-{[3-({2-[(2-methylbutanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl] diphosphate}",847.600,C26H40N7O17P3S-4,400.000,1420.000,-4.600,54,5,22,21,"InChI=1S/C26H44N7O17P3S/c1-5-14(2)25(38)54-9-8-28-16(34)6-7-29-23(37)20(36)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-19(49-51(39,40)41)18(35)24(48-15)33-13-32-17-21(27)30-12-31-22(17)33/h12-15,18-20,24,35-36H,5-11H2,1-4H3,(H,28,34)(H,29,37)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/t14?,15-,18-,19-,20+,24-/m1/s1",CCC(C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,LYNVNYDEQMMNMZ-XGXNYEOVSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-(2-methylbutanoylsulfanyl)ethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100507,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266761,(S)-1-Piperideine-6-carboxylate,"(S)-1-piperideine-6-carboxylate|2,3,4,5-tetrahydropyridine-2-carboxylate|Delta1-piperideine-6-carboxylate|Delta6-piperideine-2-carboxylate|1,6-didehydropiperidine-2-carboxylate|1-piperideine 6-carboxylate|L-1-piperideine-6-carboxylate|(S)-2,3,4,5-tetrahydropiperidine-2-carboxylate|CHEBI:58769|Delta(1)-piperideine-6-L-carboxylate|(2S)-2,3,4,5-tetrahydropyridine-2-carboxylate|Q27104844",126.130,C6H8NO2-,52.500,137.000,0.500,9,0,3,0,"InChI=1S/C6H9NO2/c8-6(9)5-3-1-2-4-7-5/h4-5H,1-3H2,(H,8,9)/p-1/t5-/m0/s1",C1CC=N[C@@H](C1)C(=O)[O-],CSDPVAKVEWETFG-YFKPBYRVSA-M,"(2S)-2,3,4,5-tetrahydropyridine-2-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata|WikiPathways",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878393,Orotidine 5'-phosphate(3-),"orotidine 5'-phosphate(3-)|orotidine 5'-phosphate trianion|CHEBI:57538|6-carboxylato-5'-O-phosphonatouridine|Q27124764|2,6-dioxo-3-(5-O-phosphonato-beta-D-ribofuranosyl)-1,2,3,6-tetrahydropyrimidine-4-carboxylate",365.170,C10H10N2O11P-3,212.000,626.000,-3.700,24,3,11,3,"InChI=1S/C10H13N2O11P/c13-5-1-3(9(16)17)12(10(18)11-5)8-7(15)6(14)4(23-8)2-22-24(19,20)21/h1,4,6-8,14-15H,2H2,(H,16,17)(H,11,13,18)(H2,19,20,21)/p-3/t4-,6-,7-,8-/m1/s1",C1=C(N(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O)C(=O)[O-],KYOBSHFOBAOFBF-XVFCMESISA-K,"3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878409,3-Phosphonato-D-glyceroyl phosphate(4-),"3-phosphonato-D-glyceroyl phosphate(4-)|P-glyceroyl-P|phosphoglyceroyl-P|3-P-glyceroyl-P|3-phosphoglyceroyl-P|glycerate 1,3-bisphosphate|3-phosphonato-D-glyceroyl phosphate tetraanion|CHEBI:57604|3-phosphonato-D-glyceroyl phosphate|(2R)-3-phospho-glyceroyl phosphate|Q27124807|(2R)-2-hydroxy-1-oxopropane-1,3-diyl bis(phosphate)",262.010,C3H4O10P2-4,182.000,288.000,-4.200,15,1,10,4,"InChI=1S/C3H8O10P2/c4-2(1-12-14(6,7)8)3(5)13-15(9,10)11/h2,4H,1H2,(H2,6,7,8)(H2,9,10,11)/p-4/t2-/m1/s1",C([C@H](C(=O)OP(=O)([O-])[O-])O)OP(=O)([O-])[O-],LJQLQCAXBUHEAZ-UWTATZPHSA-J,[(2R)-2-hydroxy-3-oxo-3-phosphonatooxypropyl] phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53262297,3-Oxodecanoyl-CoA(4-),"3-oxodecanoyl-CoA(4-)|CHEBI:62548|Q27132004|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-{[3-oxo-3-({2-[(3-oxodecanoyl)sulfanyl]ethyl}amino)propyl]amino}butyl] diphosphate}",931.700,C31H48N7O18P3S-4,417.000,1570.000,-3.100,60,5,23,27,"InChI=1S/C31H52N7O18P3S/c1-4-5-6-7-8-9-19(39)14-22(41)60-13-12-33-21(40)10-11-34-29(44)26(43)31(2,3)16-53-59(50,51)56-58(48,49)52-15-20-25(55-57(45,46)47)24(42)30(54-20)38-18-37-23-27(32)35-17-36-28(23)38/h17-18,20,24-26,30,42-43H,4-16H2,1-3H3,(H,33,40)(H,34,44)(H,48,49)(H,50,51)(H2,32,35,36)(H2,45,46,47)/p-4/t20-,24-,25-,26+,30-/m1/s1",CCCCCCCC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,AZCVXMAPLHSIKY-HSJNEKGZSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-(3-oxodecanoylsulfanyl)ethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20110801,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
54708745,4-Coumarate,trans-4-coumarate|4-coumarate|p-coumarate|(2E)-3-(4-hydroxyphenyl)acrylate|ZINC00039811|trans-p-coumarate|(E)-3-(4-hydroxyphenyl)prop-2-enoate|3-(4-hydroxyphenyl)acrylate|4-Oxylatocinnamate|(E)-4-coumarate|4-hydroxycinnamate anion|4-(2-Carboxyethenyl)phenolate|CHEBI:12876|CHEBI:32373|3-(4-hydroxyphenyl)prop-2-enoate|(E)-3-(4-hydroxyphenyl)-2-propenoate|(2E)-3-(4-hydroxyphenyl)prop-2-enoate|A828008|Q27104208|Q27108958,163.150,C9H7O3-,60.400,178.000,2.100,12,1,3,2,"InChI=1S/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/p-1/b6-3+",C1=CC(=CC=C1/C=C/C(=O)O)[O-],NGSWKAQJJWESNS-ZZXKWVIFSA-M,4-[(E)-2-carboxyethenyl]phenolate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20111226,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|Nature Chemical Biology|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|SMID|Springer Nature|Wikidata|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
86289401,"3-(4-Oxo-4,5-dihydro-1H-imidazol-3-ium-5-id-5-yl)propanoate","3-(4-oxo-4,5-dihydro-1H-imidazol-5-yl)propanoate(1-)|CHEBI:77893|3-(4-oxo-4,5-dihydro-1H-imidazol-3-ium-5-id-5-yl)propanoate",155.130,C6H7N2O3-,89.000,145.000,0.500,11,2,4,2,"InChI=1S/C6H8N2O3/c9-5(10)2-1-4-6(11)8-3-7-4/h3,11H,1-2H2,(H,7,8)(H,9,10)/p-1",C1=NC(=C(N1)CCC(=O)[O-])O,OWVUGOIAIJBQNX-UHFFFAOYSA-M,3-(4-hydroxy-1H-imidazol-5-yl)propanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20141218,ChEBI|Google Patents|Thieme Chemistry,Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
725,4-(Trimethylammonio)butanoate,"Actinine|Deoxycarnitine|4-(trimethylammonio)butanoate|gamma-butyrobetaine|4-Butyrobetaine|407-64-7|gamma-Butyrobetain|3-Dehydroxycarnitine|4-(N-Trimethylamino)butyrate|4-(trimethylazaniumyl)butanoate|4-TRIMETHYLAMMONIOBUTANOATE|UNII-HD7GI3HY9Q|HD7GI3HY9Q|4-(trimethylamino)butanoate|CHEBI:16244|gamma-Butyrobetaine;Deoxycarnitine|gamma-Butyrobetain [German]|3-carboxypropyl-trimethyl-ammonium|N-Trimethyl-gamma-aminobutyric acid|g-Butyrobetaine|2wsx|gamma Butyrobetaine|Ammonium, (3-carboxypropyl)trimethyl-, hyd",145.200,C7H15NO2,40.100,110.000,0.800,10,0,2,3,"InChI=1S/C7H15NO2/c1-8(2,3)6-4-5-7(9)10/h4-6H2,1-3H3",C[N+](C)(C)CCCC(=O)[O-],JHPNVNIEXXLNTR-UHFFFAOYSA-N,4-(trimethylazaniumyl)butanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active,10,680373|680966|687624|687625|687626|977611,20040916,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|AKos Consulting & Solutions|BioChemPartner|BioCrick|BioCyc|CCSbase|ChEBI|ChEMBL|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|Innovapharm|IUPHAR/BPS Guide to PHARMACOLOGY|LeadScope|MassBank Eur",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
800,Indole-3-acetaldehyde,indole-3-acetaldehyde|2-(1H-indol-3-yl)acetaldehyde|2591-98-2|Indoleacetaldehyde|1H-indole-3-acetaldehyde|indol-3-ylacetaldehyde|1H-Indol-3-ylacetaldehyde|2-(indol-3-yl)acetaldehyde|Tryptaldehyde|CCRIS 5808|indole acetaldehyde|Indol-3-acetaldehyde|(indol-3-yl)acetaldehyde|2-(3-Indolyl)acetaldehyde|1H-Indol-3-ylacetaldehyde #|SCHEMBL107104|CHEBI:18086|DTXSID90180582|ZINC895327|2170AB|ANW-69159|AKOS006237176|AB02302|ACN-049078|QC-9476|FT-0646077|C00637|3AA2B26B-6E90-473F-AE5E-CBF2BB1ACB49|Q27102813,159.180,C10H9NO,32.900,169.000,1.300,12,1,1,2,"InChI=1S/C10H9NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,6-7,11H,5H2",C1=CC=C2C(=C1)C(=CN2)CC=O,WHOOUMGHGSPMGR-UHFFFAOYSA-N,2-(1H-indol-3-yl)acetaldehyde,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,1259409,20040916,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Aurora Fine Chemicals LLC|BePharm Ltd.|BioCyc|BLD Pharm|BOC Sciences|CCSbase|CEGChem|ChEBI|Chem-Space.com Database|ChemDB|Chemenu Inc.|Chemhere|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplu",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
1669,4-(2-Aminoethyl)-2-methoxyphenol,"4-(2-Aminoethyl)-2-methoxyphenol|3-Methoxytyramine|554-52-9|4-(2-Amino-ethyl)-2-methoxy-phenol|3-O-methyldopamine|3-Methoxy-4-hydroxyphenethylamine|Methoxytyramine|UNII-JCH2767EDP|3-Methoxy-4-hydroxyphenylethyl amine|Phenol, 4-(2-aminoethyl)-2-methoxy-|Tyramine, 3-methoxy-|4-(2-aminoethyl)-2-methoxy-Phenol|5-(2-aminoethyl)guaiacol|JCH2767EDP|3-MT|CHEBI:1582|Lopac-M-4251|3-Methoxytyramine . HCl|bmse000929|bmse000958|EC 611-267-3|Lopac0_000796|SCHEMBL68386|GTPL6642|MT-3|CHEMBL1160785|BDBM85380|4-hydroxy-3-met",167.200,C9H13NO2,55.500,130.000,0.200,12,2,3,3,"InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3",COC1=C(C=CC(=C1)CCN)O,DIVQKHQLANKJQO-UHFFFAOYSA-N,4-(2-aminoethyl)-2-methoxyphenol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,11,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1030|1452|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1851|1865|2062|2101|2107|2112|2517|2549|64790|64917|64919|64925|485290|540276|588579|602332|686978|686979|720532|720533|720579|720580|1159524|1159607|1272365|1347131|134715,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|AN PharmaTech|Anward|Apexmol|Ark Pha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
4462,Ubiquinone-1,"Ubiquinone-1|Coenzyme Q1|Ubiquinone Q1|Ubiquinone 5|727-81-1|Coenzyme Q5|CoQ1|Ubiquinone 1|UNII-JR17826E4G|2,3-Dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-1,4-benzoquinone|CHEBI:46234|JR17826E4G|2,3-dimethoxy-5-methyl-6-(3-methylbut-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione|MFCD00274412|2,3-dimethoxy-5-methyl-6-(3-methylbut-2-enyl)cyclohexa-2,5-diene-1,4-dione|2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-methyl-6-(3-methyl-2-butenyl)-|mitoquinones|Ubichinon|a ubiquinone|Coenzymes Q|Ubiquionone 1|Coenzym Q|Koen",250.290,C14H18O4,52.600,474.000,2.800,18,0,4,4,"InChI=1S/C14H18O4/c1-8(2)6-7-10-9(3)11(15)13(17-4)14(18-5)12(10)16/h6H,7H2,1-5H3",CC1=C(C(=O)C(=C(C1=O)OC)OC)CC=C(C)C,SOECUQMRSRVZQQ-UHFFFAOYSA-N,"2,3-dimethoxy-5-methyl-6-(3-methylbut-2-enyl)cyclohexa-2,5-diene-1,4-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,330|610712|610713|610714|610718|610723|1091064|1091065|1091066|1091067|1091068|1091069|1091070|1091071|1091072|1091073|1091074|1091075|1091076|1091077|1091078|1091079|1091080|1091081|1091082|1091083|1091084|1091085|1091086|1091087|1091091|1091092|1091094|1091095|1091096|1091106|1091107|1091108|1091109|1091110|1091127|1091128|1091129|1091130|1091131,20040916,"001Chemical|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DrugBank|DTP/NCI|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Glenth",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5756,Estriol,"estriol|50-27-1|Oestriol|Trihydroxyestrin|Estratriol|Ovestin|Ovestrion|Destriol|Tridestrin|Theelol|Aacifemine|Oestratriol|Orestin|16alpha-Hydroxyestradiol|Ortho-Gynest|Deuslon-A|Hemostyptanon|Hormomed|Klimoral|Oestriolum|Orgastyptin|Overstin|Thulol|Triovex|Holin|16alpha,17beta-Estriol|Gynaesan|Hormonin|Stiptanon|Synapause|Triodurin|Estriel|Trihydroxyoestrin|Follicular hormone hydrate|16-alpha-Hydroxyestradiol|Estriolo [Italian]|16alpha-Hydroxyoestradiol|16alpha,17beta-Oestriol|16-alpha,17-beta-Estriol|16-al",288.400,C18H24O3,60.700,411.000,2.500,21,3,3,0,"InChI=1S/C18H24O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-17,19-21H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,17+,18+/m1/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,"(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol",Estriol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,155|157|161|165|167|175|192|248|268|272|328|330|485|631|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1204|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1332|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|143,20050326,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|AN PharmaTech|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|AvaChem Scientific|BIDD|BIND|BindingDB|BioChemPartner|B",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5870,Estrone,"estrone|53-16-7|folliculin|OESTRONE|Theelin|estrovarin|Estrugenone|follicular hormone|Hiestrone|Kestrone|Estron|Follicunodis|Disynformon|Folliculine|Glandubolin|Hormestrin|Oestroform|Oestronum|Oestroperos|Thelykinin|Femidyn|Folipex|Folisan|Kolpon|Menagen|Unden|Ketohydroxyestrin|Estrone-A|Ketohydroxyoestrin|3-Hydroxyestra-1,3,5(10)-trien-17-one|1,3,5(10)-Estratrien-3-ol-17-one|Estrona [Spanish]|Folliculine benzoate|Ovex (tablets)|Estronum [INN-Latin]|estrol|Estrona [INN-Spanish]|Aquacrine|Destrone|Oestrin|En",270.400,C18H22O2,37.300,418.000,3.100,20,1,2,0,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,"(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one",Estrone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|680|684|686|687|694|701|708|709|719|731|732|746|747|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|,20040916,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|AN PharmaTech|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BePharm Ltd.|BID",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6133,Uridine 5'-triphosphate,"uridine triphosphate|uridine 5'-triphosphate|63-39-8|Uridine 5'-(tetrahydrogen triphosphate)|Uteplex|UTP|5'-UTP|Uridine 5'-triphosphoric acid|INS316|uridine-5'-triphosphate|H4utp|UNII-UT0S826Z60|BRN 0071520|CHEMBL336296|CHEBI:15713|UT0S826Z60|(((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)triphosphoric acid|INS 316|EINECS 200-558-7|uridintriphosphat|Uridine5'-(tetrahydrogen triphosphate)|3h-uridine triphosphate|Spectrum_001697|Uridine 5_-triphosphate|Spe",484.140,C9H15N2O15P3,259.000,839.000,-5.800,29,7,15,8,"InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,PGAVKCOVUIYSFO-XVFCMESISA-N,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",Uridine Triphosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,11,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1865|2101|2107|2112|2517|2549|40281|40282|50022|89268|89269|89271|89273|150321|150331|150489|150627|150634|150636|221765|261436|261437|261438|261696|261697|261699|272716|272719|272722|278942|278943|278951|278952|280297|280298|280301|302989|304928|304929|304930|304931|305248|305249|305250|305251|310935|350665|350668|350669|350671|350672|350673|350674|350676|350677|350678|350679|350683|350684|350685|350686|350687|350688|350689|350690|350691|350692|350,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|AstaTech, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|Bin",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6912,Xylitol,"xylitol|ribitol|adonitol|87-99-0|Xylite|488-81-3|D-Xylitol|Adonite|Adonit|D-ribitol|Eutrit|Klinit|Xyliton|Xylit|Xylite (sugar)|Kannit|Newtol|1,2,3,4,5-pentanepentol|Xylisorb|L-ribitol|(2R,3R,4S)-Pentane-1,2,3,4,5-pentaol|meso-ribitol|meso-xylitol|L-xylitol|D-Adonitol|UNII-353ZQ9TVDA|UNII-VCQ006KQ1E|(2R,3s,4S)-pentane-1,2,3,4,5-pentol|NSC 25283|(2R,3S,4S)-Pentane-1,2,3,4,5-pentaol|BRN 1720523|CHEBI:15963|CHEBI:17151|(2S,4R)-pentane-1,2,3,4,5-pentol|1,2,3,4,5-Pentahydroxypentane|MFCD00064291|MFCD00064292|353Z",152.150,C5H12O5,101.000,76.100,-2.500,10,5,5,4,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5?",C([C@H](C([C@H](CO)O)O)O)O,HEBKCHPVOIAQTA-NGQZWQHPSA-N,"(2S,4R)-pentane-1,2,3,4,5-pentol",Xylitol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|219915|485281|485290|504327|504847|504884|540295|540308|540364|588335|588352|588354|588391|588405|588436|588458|588489|588492|588493|588497|588499|588501|588549|588579|588621|588664|588674|588692|588726|588814|588819|588850|588852|602123|602141|602162|602163|602229|602244|602247|602248|602250|602261|602274|602281|602329|602332|602340|602342|602346|602363|602393|602396|602399|602405|602429|602438|602440|602449|602481|62,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|Angene Chemical|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharm",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
8629,Uridine-5'-diphosphate-glucose,"UDP-glucose|URIDINE DIPHOSPHATE GLUCOSE|UDPG|133-89-1|UDP-alpha-D-Glucose|URIDINE-5'-DIPHOSPHATE-GLUCOSE|UNII-V50K1D7P4Y|5'-Diphosphoglucose|UDP-D-glucose|UDPglucose|V50K1D7P4Y|[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate|CHEBI:46229|URIDINE-5'-DIPHOSPHOGLUCOSE|UDP-Glc|Uridine diphosphoglucose|GLUCOSE-URIDINE-C1,5'-DIPHOSPHATE|co-waldenase|UDP-a-D-Glucose|Uridine 5'-(trihydrog",566.300,C15H24N2O17P2,292.000,964.000,-6.300,36,9,17,9,"InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8-,9-,10+,11-,12-,13-,14-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O,HSCJRCZFDFQWRP-JZMIEXBBSA-N,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate",Uridine Diphosphate Glucose,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,286300|305271|444562|444563|450300|450301|450303|531168|531169|531170|531171|531172|531173|531174|531175|531176|531177|531178|531404|531405|531406|531407|1137668|1232374|1346389|1346390|1346395|1346857|1346914,20040916,"AAA Chemistry|abcr GmbH|ABI Chem|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|BIND|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|CSNpharm|DiscoveryGate|DrugBank|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
11850,Galactitol,"dulcitol|galactitol|608-66-2|dulcite|D-Galactitol|dulcose|Euonymit|Melampyrin|Melampyrit|D-Dulcitol|(2R,3S,4R,5S)-Hexane-1,2,3,4,5,6-hexaol|Melampyrum|(2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexol|meso-galactitol|L-galactitol|UNII-113ZQ1Y7DD|CHEBI:16813|MFCD00064288|113ZQ1Y7DD|Dulcitol, 99+%|DSSTox_CID_26051|DSSTox_RID_81307|DSSTox_GSID_46051|Melampyrite|CAS-608-66-2|C6H14O6|galacto-Hexitol|Dulcitol, puriss.|NCGC00159410-03|NCGC00159410-04|NSC 1944|EINECS 210-165-2|Ambap5938|Dulcitol, >=99%|AI3-19423|Epitope ID:11",182.170,C6H14O6,121.000,105.000,-3.100,12,6,6,5,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5+,6-",C([C@H]([C@@H]([C@@H]([C@H](CO)O)O)O)O)O,FBPFZTCFMRRESA-GUCUJZIJSA-N,"(2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexol",Galactitol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Micromolar,11,2517|588834|595446|595447|595448|595449|595450|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Ambeed|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|BePharm Ltd.|BioCyc|Biopurify Phytochemicals|BLD Pharm|BOC Sciences|CCSbase|Center for Chemical Genomics, Uni",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
13712,2'-Deoxyuridine,"2'-DEOXYURIDINE|deoxyuridine|951-78-0|Uracil deoxyriboside|Uridine, 2'-deoxy-|2-Deoxyuridine|1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione|Deoxyribose uracil|2'-Desoxyuridine|UNII-W78I7AY22C|dURD|MFCD00006527|1-(2-Deoxy-beta-D-ribofuranosyl)uracil|W78I7AY22C|2 -Deoxyuridine|CHEBI:16450|CCRIS 2832|NSC 23615|2'-Deoxyuridine, 99+%|Desoxyuridine|1-(2-Deoxy-beta-D-erythro-pentofuranoxyl)uracil|Uracil desoxyuridine|1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydro-fur",228.200,C9H12N2O5,99.100,343.000,-1.600,16,3,5,2,"InChI=1S/C9H12N2O5/c12-4-6-5(13)3-8(16-6)11-2-1-7(14)10-9(11)15/h1-2,5-6,8,12-13H,3-4H2,(H,10,14,15)/t5-,6+,8+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)CO)O,MXHRCPNRJAMMIM-SHYZEUOFSA-N,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione",Deoxyuridine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,875|880|881|884|885|887|889|892|893|894|900|901|902|923|924|995|1030|1376|1379|1385|1422|1452|1454|1457|1460|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1490|1511|1519|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1766|1768|1813|1814|1832|1850|1863|1865|1875|1885|1899|1903|1906|1910|1947|1948|1950|1956|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2107|2112|2129|2130|2147|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2451|246,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Ambeed|Ambinter|Angene Chemical|Anward|Apexmol|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|AX Molecules Inc|BenchChem|BePharm Ltd.|BerrChem|BioCrick|BioCyc|Biological Magnetic Resonance Data Bank (BM",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
74688,5-Hydroxyindole-3-acetaldehyde,"5-Hydroxyindole-3-acetaldehyde|1892-21-3|5-Hial|Hydroxyindoleacetaldehyde|2-(5-hydroxy-1H-indol-3-yl)acetaldehyde|1H-INDOLE-3-ACETALDEHYDE, 5-HYDROXY-|5-Hydroxyindoleacetaldehyde|5-hydroxyindole acetaldehyde|(5-hydroxyindol-3-yl)acetaldehyde|(5-Hydroxy-1H-indol-3-yl)acetaldehyde|Indole-3-acetaldehyde, 5-hydroxy-|5-Hydroxytryptaldehyde|5-Hydroxyindolylacetaldehyde|SCHEMBL308460|GTPL6634|CHEBI:50157|DTXSID60172318|ZINC895828|5-hydroxy-1H-Indole-3-acetaldehyde|(5-Hydroxy-1H-indol-3-yl)acetaldehyde #|C05634|Q27",175.180,C10H9NO2,53.100,195.000,0.300,13,2,2,2,"InChI=1S/C10H9NO2/c12-4-3-7-6-11-10-2-1-8(13)5-9(7)10/h1-2,4-6,11,13H,3H2",C1=CC2=C(C=C1O)C(=CN2)CC=O,OBFAPCIUSYHFIE-UHFFFAOYSA-N,2-(5-hydroxy-1H-indol-3-yl)acetaldehyde,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20040916,"A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BioCyc|ChEBI|ChemDB|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|Day Biochem|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (N",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
87642,Coenzyme A,"coenzyme A|CoASH|85-61-0|CoA|CoA-SH|Zeel|Depot-Zeel|HSCoA|Coenzym A|co-enzyme-A|Coenzyme ASH|UNII-SAA04E81UX|HS-CoA|COENZYME_A|SAA04E81UX|CHEBI:15346|3'-phosphoadenosine-(5')diphospho(4')pantatheine|Coenzyme A hydrate|Co-A-SH|Reduced CoA|[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]methyl (3R)-3-hydroxy-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)-2,2-dimethyl-4-oxobutyl dihydrogen diphosphate|3'-phosphoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-",767.500,C21H36N7O16P3S,348.000,1270.000,-5.800,48,10,21,18,"InChI=1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/t11-,14-,15-,16+,20-/m1/s1",CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCS)O,RGJOEKWQDUBAIZ-IBOSZNHHSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate",Coenzyme A,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,12,52124|367361|367362|367364|367365|498509|498510|498511|498512|498513|498514|498515|498516|498526|1409598,20050608,"A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|BLD Pharm|Broad Institute|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|CSNpharm|DAOGE BIOPHARMA|Davey Lab, Department of Microbiology, NEIDL, Bo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, WikiPathways]"
92746,Zymosterol,"Zymosterol|5alpha-Cholesta-8,24-dien-3beta-ol|128-33-6|UNII-PU2755PT4O|5-alpha-Cholesta-8,24-dien-3-beta-ol|8,24(5-Alpha)-Cholestadien-3-beta-ol|PU2755PT4O|CHEMBL4171014|delta8,24-Cholestadien-3beta-ol|(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol|Cholesta-8,24-dien-3-ol|Cholesta-8,24-dien-3-ol #|zymostrol|Cholest-8,24-dien-3.beta.-ol|EINECS 204-880-9|SCHEMBL95293|Cholest-8,24-dien-3b-ol|CHEBI:18252|delta8, ",384.600,C27H44O,20.200,653.000,7.500,28,1,1,4,"InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h7,19-21,23-24,28H,6,8-17H2,1-5H3/t19-,20+,21+,23-,24+,26+,27-/m1/s1",C[C@H](CCC=C(C)C)[C@H]1CC[C@@H]2[C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,CGSJXLIKVBJVRY-XTGBIJOFSA-N,"(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,1502696|1505269,20040916,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|AHH Chemical co.,ltd|Ambinter|BindingDB|BioCyc|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|Jap",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
151276,Homovanillin,"Homovanillin|2-(4-hydroxy-3-methoxyphenyl)acetaldehyde|5703-24-2|(4-Hydroxy-3-methoxyphenyl)acetaldehyde|HMPAL|Benzeneacetaldehyde, 4-hydroxy-3-methoxy-|3-Methoxy-4-hydroxyphenylacetaldehyde|4-hydroxy-3-methoxybenzeneacetaldehyde|Ethanal, 2-(4-hydroxy-3-methoxyphenyl)|SCHEMBL917723|CHEBI:28111|DTXSID70205641|ZINC895803|8365AB|AKOS006289526|2-(4-hydroxy-3-methoxyphenyl) Ethanal|4-hydroxy-3-methoxy-Benzeneacetaldehyde|DB-072236|A8145|BB 0262130|FT-0682420|C05581|Q27103508",166.170,C9H10O3,46.500,147.000,0.300,12,1,3,3,"InChI=1S/C9H10O3/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,5-6,11H,4H2,1H3",COC1=C(C=CC(=C1)CC=O)O,GOQGGGANVKPMNH-UHFFFAOYSA-N,2-(4-hydroxy-3-methoxyphenyl)acetaldehyde,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20040916,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|Achemtek|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|BePharm Ltd.|BLD Pharm|BOC Sciences|ChEBI|Chembase.cn|ChemDB|Chemenu Inc.|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|EDASA Scientific|Egon Willighagen (Dept. of Bioinformatics - BiGC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
160666,Saicar,SAICAR|3031-95-6|Succino-AICAR|UNII-K1PVR64RIF|K1PVR64RIF|5-Amino-4-imidazole-N-succinocarboxamide ribonucleotide|1-(5'-Phosphoribosyl)-5-amino-4-(N-succinocarboxamide)-imidazole|5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole|1-(5'-Phosphoribosyl)-4-(N-succinocarboxamide)-5-aminoimidazole|Phosphoribosylaminoimidazolesuccinocarboxamide|(S)-2-[5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido]succinate|N-((5-Amino-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-4-yl)carbonyl)-L-aspartic a,454.280,C13H19N4O12P,264.000,718.000,-4.300,30,8,14,9,"InChI=1S/C13H19N4O12P/c14-10-7(11(22)16-4(13(23)24)1-6(18)19)15-3-17(10)12-9(21)8(20)5(29-12)2-28-30(25,26)27/h3-5,8-9,12,20-21H,1-2,14H2,(H,16,22)(H,18,19)(H,23,24)(H2,25,26,27)/t4-,5+,8+,9+,12+/m0/s1",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O,NAQGHJTUZRHGAC-ZZZDFHIKSA-N,"(2S)-2-[[5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazole-4-carbonyl]amino]butanedioic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050608,"A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AKos Consulting & Solutions|BIND|BioChemPartner|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|Human Met",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
161500,5-Aminoimidazole ribonucleotide,"5-aminoimidazole ribotide|Aminoimidazole ribotide|5-aminoimidazole ribonucleotide|25635-88-5|5'-phosphoribosyl-5-aminoimidazole|5-Amino-1-ribofuranosylimidazole 5'-phosphate|Aminoimidazole ribonucleotide|1-(5'-phosphoribosyl)-5-aminoimidazole|1-(5-Phospho-D-ribosyl)-5-aminoimidazole|5-Amino-1-(5-phospho-D-ribosyl)imidazole|1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-amine|(2R,3R,4S,5R)-2-(5-Amino-1H-imidazol-1-yl)-tetrahydro-5-(phosphomethyl)furan-3,4-diol|AIR[nucleotide]|CHEMBL1230914|CHEBI:138560",295.190,C8H14N3O7P,160.000,366.000,-3.600,19,5,9,4,"InChI=1S/C8H14N3O7P/c9-5-1-10-3-11(5)8-7(13)6(12)4(18-8)2-17-19(14,15)16/h1,3-4,6-8,12-13H,2,9H2,(H2,14,15,16)/t4-,6-,7-,8-/m1/s1",C1=C(N(C=N1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N,PDACUKOKVHBVHJ-XVFCMESISA-N,"[(2R,3S,4R,5R)-5-(5-aminoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,1272393,20040916,"A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Amadis Chemical|BIND|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|Nature Chemical Biology|NCBI Structure|NextBio|NextMove Software|NovoSeek|P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
165388,Carboxyaminoimidazole ribotide,Carboxyaminoimidazole ribotide|CAIR|6001-14-5|Carboxy-air|5'-phosphoribosyl-4-carboxy-5-aminoimidazole|AICOR|UNII-5MA501Z5DO|1-(5-Phospho-D-ribosyl)-5-amino-4-imidazolecarboxylate|5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylate|5MA501Z5DO|5'-Phosphoribosyl-5-amino-4-imidazolecarboxylate|1-(5'-phosphoribosyl)-4-carboxy-5-aminoimidazole|1-(5'-Phosphoribosyl)-5-amino-4-carboxyimidazole|5-amino-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazole-4-carboxylic acid|1-(5'-Phosphoribosyl)-5-amino-4-imidazole,339.200,C9H14N3O9P,198.000,473.000,-3.200,22,6,11,5,"InChI=1S/C9H14N3O9P/c10-7-4(9(15)16)11-2-12(7)8-6(14)5(13)3(21-8)1-20-22(17,18)19/h2-3,5-6,8,13-14H,1,10H2,(H,15,16)(H2,17,18,19)/t3-,5-,6-,8-/m1/s1",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)C(=O)O,XFVULMDJZXYMSG-ZIYNGMLESA-N,"5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazole-4-carboxylic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,NULL,20040916,"A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Amadis Chemical|BIND|BioCyc|BLD Pharm|ChEBI|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|NCBI Structure|NextBio|NovoSeek|PATENTSCOPE",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439153,"1,4-Dihydronicotinamide adenine dinucleotide","NADH|DPNH|beta-NADH|beta-DPNH|Dihydrocozymase|Coenzyme I, reduced|Cozymase I, reduced|NADH2|1,4-Dihydronicotinamide adenine dinucleotide|Dihydrocodehydrogenase I|58-68-4|Reduced codehydrogenase I|dihydronicotinamide adenine dinucleotide|Codehydrase I, reduced|Dihydronicotinamide-adenine dinucleotide|Reduced nicotinamide adenine diphosphate|Dihydronicotinamide mononucleotide|Codehydrogenase I, reduced|Reduced diphosphopyridine nucleotide|Reduced nicotinamide-adenine dinucleotide|UNII-4J24DQ0916|606-68-8|Redu",665.400,C21H29N7O14P2,318.000,1230.000,-5.700,44,8,19,11,"InChI=1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O,BOPGDPNILDQYTO-NNYOXOHSSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",NAD,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,11,1409598,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acorn PharmaTech Product List|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Aurora Fine Chemicals LLC|BIND|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|Broad Institute|ChangChem|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemFish To",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439196,"2,3-Dihydroxy-1,4-dithiobutane","L-Dithiothreitol|16096-97-2|L-Dtt|L-1,4-Dithiothreitol|1,4-Dithiothreitol|Dithiothreitol|2,3-DIHYDROXY-1,4-DITHIOBUTANE|(2R,3R)-1,4-dimercaptobutane-2,3-diol|3483-12-3|2,3-Butanediol, 1,4-dimercapto-, (2R,3R)-rel-|L-threo-1,4-Dimercapto-2,3-butanediol|DL-threo-1,4-Dimercapto-2,3-butanediol|(-)-1,4-dithio-l-threitol|(2R,3R)-1,4-disulfanylbutane-2,3-diol|CHEBI:42106|MFCD00064305|L-(-)-Dithiothreitol|Sputolysin|DTT|dl-Dithiothreitol|Threitol, 1,4-dithio-, DL-|Cleland's reagent|rac-Dithiothreitol|threo-1,4-Dime",154.300,C4H10O2S2,42.500,52.000,-0.400,8,4,4,3,"InChI=1S/C4H10O2S2/c5-3(1-7)4(6)2-8/h3-8H,1-2H2/t3-,4-/m0/s1",C([C@@H]([C@H](CS)O)O)S,VHJLVAABSRFDPM-IMJSIDKUSA-N,"(2R,3R)-1,4-bis(sulfanyl)butane-2,3-diol",Dithiothreitol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,12,322756|534106|534107|534108|534109|534110|534111|534112|637281|657488|695851|695876|695877|699332|1259409,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BePharm Ltd.|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemExper Chemical Directory|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplu",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439242,Raffinose,"RAFFINOSE|Melitose|Gossypose|d-(+)-Raffinose|Melitriose|512-69-6|D-Raffinose|6G-alpha-D-galactosylsucrose|UNII-N5O3QU595M|Raffinose (8CI)|NSC 2025|NSC 170228|beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside|AI3-19427|N5O3QU595M|CHEBI:16634|C18H32O16|alpha-D-glucopyranoside, beta-D-fructofuranosyl O-alpha-D-galactopyranosyl-(1->6)-|rafinose|raflinose|Raffinose, pure|NSC170228|RAF|EINECS 208-146-9|Melitriose, Raffinose|PubChem19429|bmse000221|SCHEMBL33743|CHEMBL603717|DTXSID80411",504.400,C18H32O16,269.000,655.000,-5.800,34,11,16,8,"InChI=1S/C18H32O16/c19-1-5-8(22)11(25)13(27)16(31-5)30-3-7-9(23)12(26)14(28)17(32-7)34-18(4-21)15(29)10(24)6(2-20)33-18/h5-17,19-29H,1-4H2/t5-,6-,7-,8+,9-,10-,11+,12+,13-,14-,15+,16+,17-,18+/m1/s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)O[C@]3([C@H]([C@@H]([C@H](O3)CO)O)O)CO)O)O)O)O)O)O)O,MUPFEKGTMRGPLJ-ZQSKZDJDSA-N,"(2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",Raffinose,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,10,15120|18847|28392|28399|29844|29845|73340|156202|156204|231333|236268|236912|236913|236914|236916|237585|276649|276651|276653|276656|276659|276668|276669|276670|276671|276672|276673|567091|1411091,20040916,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Aurora Fine Chemicals LLC|AvaChem Scientific|Avantor Inc|BenchChem|BIND|BindingDB|BioCrick|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BOC Sciences|CAPOT|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439281,N-Acetyl-D-Mannosamine,2-Acetamido-2-Deoxy-D-Mannopyranose|2-Acetamido-2-Deoxy-D-Mannopyranoside|2-Acetamido-2-Deoxy-D-Mannose|2-Acetamido-2-Deoxy-Mannopyranose|2-Acetamido-2-Deoxy-Mannopyranoside|2-Acetamido-2-Deoxy-Mannose|2-Deoxy-2-Acetamido-D-Mannopyranose|2-Deoxy-2-Acetamido-D-Mannopyranoside|2-Deoxy-2-Acetamido-D-Mannose|2-Deoxy-2-Acetamido-Mannopyranose|2-Deoxy-2-Acetamido-Mannopyranoside|2-Deoxy-2-Acetamido-Mannose|D-ManNAc|ManNAc|N-Acetyl-D-Mannosamine|N-Acetyl-Mannosamine|N-acetylmannosamine|7772-94-3|CHEBI:63153|CHEMBL,221.210,C8H15NO6,119.000,235.000,-1.700,15,5,6,2,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5+,6-,7-,8?/m1/s1",CC(=O)N[C@H]1[C@H]([C@@H]([C@H](OC1O)CO)O)O,OVRNDRQMDRJTHS-ZTVVOAFPSA-N,"N-[(3S,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,11,1418325,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alichem|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemMol|ChemSpider|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinfo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439322,Pantetheine,"pantetheine|(R)-Pantetheine|D-Pantetheine|496-65-1|Lactobacillus bulgaricus factor|UNII-VCH6X4IARE|D-Pantethine hydrate|VCH6X4IARE|CHEBI:16753|(2R)-2,4-dihydroxy-3,3-dimethyl-N-{3-oxo-3-[(2-sulfanylethyl)amino]propyl}butanamide|pantotheine|(R)-2,4-DIHYDROXY-N-[3-[(2-MERCAPTOETHYL)AMINO]-3-OXOPROPYL]-3,3-DIMETHYLBUTYRAMIDE|(2R)-2,4-Dihydroxy-N-[3-[(2-mercaptoethyl)amino]-3-oxopropyl]-3,3-dimethylbutanamide|(R)-2,4-Dihydroxy-N-(3-((2-mercaptoethyl)amino)-3-oxopropyl)-3,3-dimethylbutyramide|LBF|EINECS 207-824-",278.370,C11H22N2O4S,99.700,284.000,-1.000,18,5,5,8,"InChI=1S/C11H22N2O4S/c1-11(2,7-14)9(16)10(17)13-4-3-8(15)12-5-6-18/h9,14,16,18H,3-7H2,1-2H3,(H,12,15)(H,13,17)/t9-/m0/s1",CC(C)(CO)[C@H](C(=O)NCCC(=O)NCCS)O,ZNXZGRMVNNHPCA-VIFPVBQESA-N,"(2R)-2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(2-sulfanylethylamino)propyl]butanamide",Pantetheine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity,10,1152960|1152961,20040916,"AbaChemScene|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|AOBIOUS INC|Aurora Fine Chemicals LLC|BioCyc|BOC Sciences|CCSbase|ChEBI|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Glentham Life Sciences Ltd.|Google Patents|Hairui Chemical|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MedChemexpress MCE|MetabolomicsWorkbench|NCBI Structure|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439905,5-Phosphoribosylamine,"5-phosphoribosylamine|5-Phospho-beta-D-ribosylamine|5-O-PHOSPHONO-BETA-D-RIBOFURANOSYLAMINE|5-Phosphoribosyl-1-amine|5-P-beta-D-ribosyl-amine|5-phospho-delta-ribosylamine|5-P-beta-delta-ribosyl-amine|5-phospho-  -D-ribosylamine|SCHEMBL188787|5-phospho-beta-D-ribosyl-amine|CHEBI:37737|5-phospho-beta-delta-ribosylamine|5-phospho-beta-delta-ribosyl-amine|GRF|C03090|Q27104425|{[(2R,3S,4R,5R)-5-amino-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid|5-O-phosphono-beta-D-ribosylamine; 5-O-phosphono-D-ribosylamine;",229.130,C5H12NO7P,143.000,242.000,-6.200,14,5,8,3,"InChI=1S/C5H12NO7P/c6-5-4(8)3(7)2(13-5)1-12-14(9,10)11/h2-5,7-8H,1,6H2,(H2,9,10,11)/t2-,3-,4-,5-/m1/s1",C([C@@H]1[C@H]([C@H]([C@@H](O1)N)O)O)OP(=O)(O)O,SKCBPEVYGOQGJN-TXICZTDVSA-N,"[(2R,3S,4R,5R)-5-amino-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"ABI Chem|BioCyc|ChEBI|ChemSpider|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|NCBI Structure|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SMID|Springer Nature|SureChEMBL|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440113,4-Hydroxyphenylacetaldehyde,"2-(4-Hydroxyphenyl)acetaldehyde|7339-87-9|4-Hydroxyphenylacetaldehyde|p-Hydroxyphenylacetaldehyde|4-hydroxyphenyl acetaldehyde|(4-hydroxyphenyl)acetaldehyde|pOH-Ph-CH2CHO|Benzeneacetaldehyde, 4-hydroxy-|HPAL|4-hydoxyphenylacetaldehyde|2-(4-hydroxyphenyl)ethanone|SCHEMBL105690|GTPL6635|(4-Hydroxy-phenyl)-acetaldehyde|CHEBI:15621|DTXSID00223631|2-(4-hydroxyphenyl)-acetaldehyde|ZINC901834|ANW-61912|MFCD03411043|BENZENEACETALDEHYDE,4-HYDROXY-|AKOS004120647|FT-0669947|Y9945|C03765|J-506016|Q9552908|4-Hydroxyphen",136.150,C8H8O2,37.300,104.000,0.500,10,1,2,2,"InChI=1S/C8H8O2/c9-6-5-7-1-3-8(10)4-2-7/h1-4,6,10H,5H2",C1=CC(=CC=C1CC=O)O,IPRPPFIAVHPVJH-UHFFFAOYSA-N,2-(4-hydroxyphenyl)acetaldehyde,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,8,NULL,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemo Scientific Limited|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Angel Pharmatech Ltd.|Angene Chemical|Anward|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEBI|Chembase.cn|ChemDB|Chemenu Inc.|Chemical Synthesis Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440272,N-Acetylglucosamine-1-phosphate,N-Acetyl-D-glucosamine 1-phosphate|6866-69-9|2-acetamido-2-deoxy-D-glucopyranose 1-phosphate|N-Acetylglucosamine-1-phosphate|N-Acetylglucosamine 1-phosphate|N-Acetyl-glucosamine 1-phosphate|GlcNAc-1-Phosphate|bmse000163|delta-glucosamine 1-phosphate|CHEBI:7125|SCHEMBL5679031|DTXSID90988348|N-ACETYL-D-GLUCOSAMINE-1-P|N-acetyl-delta-glucosamine 1-phosphate|N-acetyl-alpha-delta-glucosamine 1-phosphate|C04256|2-acetamido-2-deoxy-1-O-phosphono-D-glucopyranose|Q27107444|2-acetamido-2-deoxy-D-glucopyranose 1-(dihy,301.190,C8H16NO9P,166.000,371.000,-3.700,19,6,9,4,"InChI=1S/C8H16NO9P/c1-3(11)9-5-7(13)6(12)4(2-10)17-8(5)18-19(14,15)16/h4-8,10,12-13H,2H2,1H3,(H,9,11)(H2,14,15,16)/t4-,5-,6-,7-,8?/m1/s1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1OP(=O)(O)O)CO)O)O,FZLJPEPAYPUMMR-RTRLPJTCSA-N,"[(3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"ABI Chem|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|CCSbase|ChEBI|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|NextBio|Norris Pharm|NovoSeek|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|Thomson Pharma|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440736,3-Hydroxykynurenamine,3-Hydroxykynurenamine|C05636|3-amino-1-(2-amino-3-hydroxyphenyl)propan-1-one|99362-47-7|AC1L99UY|2-Amino-3-(beta-alanyl)phenol|3-Amino-1-(2-amino-3-hydroxyphenyl)-1-propanone|3-amino-1-(2-amino-3-hydroxy-phenyl)propan-1-one|Q65718454,180.200,C9H12N2O2,89.300,185.000,0.100,13,3,4,3,"InChI=1S/C9H12N2O2/c10-5-4-7(12)6-2-1-3-8(13)9(6)11/h1-3,13H,4-5,10-11H2",C1=CC(=C(C(=C1)O)N)C(=O)CCN,ODOPEICAGBYCFH-UHFFFAOYSA-N,3-amino-1-(2-amino-3-hydroxyphenyl)propan-1-one,NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20050624,"A2B Chem|AA BLOCKS|ABI Chem|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|MolPort|NextBio|SureChEMBL|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440737,"Quinoline-4,8-diol","Quinoline-4,8-diol|4,8-Dihydroxyquinoline|8-Hydroxyquinolin-4(1H)-one|14959-84-3|4,8-Quinolinediol|53846-46-1|8-hydroxy-1H-quinolin-4-one|C05637|SCHEMBL1333120|CHEBI:28883|DTXSID40879696|ACT10441|7462AA|7692AB|ZINC16343212|AKOS006285408|DA-19561|FT-0769762|Q27103942",161.160,C9H7NO2,49.300,225.000,1.200,12,2,3,0,"InChI=1S/C9H7NO2/c11-7-4-5-10-9-6(7)2-1-3-8(9)12/h1-5,12H,(H,10,11)",C1=CC2=C(C(=C1)O)NC=CC2=O,PYELIMVFIITPER-UHFFFAOYSA-N,8-hydroxy-1H-quinolin-4-one,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|Achemo Scientific Limited|Acorn PharmaTech Product List|ACT Chemical|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|BePharm Ltd.|Biocore|BLD Pharm|ChEBI|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Debye Scientific Co., Ltd|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
446718,"N,N'-Bis(3-ammoniopropyl)butane-1,4-diaminium","spermine(4+)|SPERMINE (FULLY PROTONATED FORM)|N,N'-bis(3-ammoniopropyl)butane-1,4-diaminium|diaminopropyl-tetramethylenediamine|3kwa|SAMPL5, CBC-G3|spermine (fully protonated)|CHEBI:45725|BDBM197316|1,5,10,14-Tetraazoniatetradecane|Q27120621|SPW",206.370,C10H30N4+4,88.500,86.100,-1.100,14,4,0,11,"InChI=1S/C10H26N4/c11-5-3-9-13-7-1-2-8-14-10-4-6-12/h13-14H,1-12H2/p+4",C(CC[NH2+]CCC[NH3+])C[NH2+]CCC[NH3+],PFNFFQXMRSDOHW-UHFFFAOYSA-R,3-azaniumylpropyl-[4-(3-azaniumylpropylazaniumyl)butyl]azanium,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977610,20050624,"A&J Pharmtech CO., LTD.|ABI Chem|BindingDB|BioCyc|ChEBI|Chembase.cn|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|SCRIPDB|Shanghai Institute of Organic Chemistry|SMID|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
447920,"2,3-Dimethoxy-5-methyl-6-(3-methylbut-2-enyl)benzene-1,4-diol","QH(2)|a ubiquinol|ubiquinol-1|Ubiquinol 1|ubiquinol(1)|UQ1|SCHEMBL11407178|CHEBI:17976|CHEBI:177490|2,3-dimethoxy-5-methyl-6-(3-methylbut-2-enyl)benzene-1,4-diol|2,3-Dimethoxy-5-methyl-6-(3-methyl-2-buten-1-yl)-1,4-benzenediol|52590-98-4",252.310,C14H20O4,58.900,286.000,3.200,18,2,4,4,"InChI=1S/C14H20O4/c1-8(2)6-7-10-9(3)11(15)13(17-4)14(18-5)12(10)16/h6,15-16H,7H2,1-5H3",CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)C,TVLSKGDBUQMDPR-UHFFFAOYSA-N,"2,3-dimethoxy-5-methyl-6-(3-methylbut-2-enyl)benzene-1,4-diol",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20040916,"ABI Chem|BioCyc|ChEBI|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SureChEMBL|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
1492348,Orotate,"orotate|73-97-2|Orotic acidanion|CHEBI:30839|DTXSID80363448|AG-G-93379|21317-EP2281559A1|21317-EP2284172A1|21317-EP2314295A1|Q27104157|2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate",155.090,C5H3N2O4-,98.300,262.000,-0.800,11,2,4,0,"InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)/p-1",C1=C(NC(=O)NC1=O)C(=O)[O-],PXQPEWDEAKTCGB-UHFFFAOYSA-M,"2,4-dioxo-1H-pyrimidine-6-carboxylate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|CCSbase|ChEBI|ChemDB|ChemTik|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|SLING Consortium|Therapeutic Target Database (TTD)|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
1778309,UMP dianion,"UMP(2-)|5'-uridylic acid (8CI)(9CI)|3387-36-8|UMP dianion|2qaf|2qcd|2qcn|3bar|3dxg|5'-uridylate|2j4k|2zz6|3ex3|5'-O-phosphonatouridine|uridine 5'-monophosphate(2-)|CHEBI:57865|A832094|Q27125012|[(2R,3S,4R,5R)-5-(2,4-dioxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]methyl phosphate|[(2R,3S,4R,5R)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphate",322.170,C9H11N2O9P-2,172.000,506.000,-3.800,21,3,9,3,"InChI=1S/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O,DJJCXFVJDGTHFX-XVFCMESISA-L,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,1811|977608|977610|977611,20050712,"3WAY PHARM INC|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Shanghai Institute of Organic Chemistry|Thieme Chemistry|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3081372,Angiotensin I,"ANGIOTENSIN I|484-42-4|Human angiotensin I|Pepsitensin|Proangiotensin|Angiotensin I (human)|Angiotensin I, ile(5)-|5-Ile-angiotensin I|Angiotensin I (rat)|Angiotensin I (mouse)|UNII-9C880YQG7C|ANGIOTENSIN I, HUMAN|9C880YQG7C|CHEBI:2718|Angiotensin 1 (Human)|9041-90-1|Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu|Q32039285|Angiotensin I (human, mouse, rat)|L-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanyl-L-histidyl-L-leucine|AC1MIWSO|(Ile5)-Angiotensin I|(Ile5)-Ang I|5-Isoleuci",1296.500,C62H89N17O14,496.000,2550.000,-1.100,93,16,18,37,"InChI=1S/C62H89N17O14/c1-7-35(6)51(78-56(87)44(25-37-17-19-40(80)20-18-37)74-58(89)50(34(4)5)77-53(84)42(15-11-21-68-62(64)65)71-52(83)41(63)28-49(81)82)59(90)75-46(27-39-30-67-32-70-39)60(91)79-22-12-16-48(79)57(88)73-43(24-36-13-9-8-10-14-36)54(85)72-45(26-38-29-66-31-69-38)55(86)76-47(61(92)93)23-33(2)3/h8-10,13-14,17-20,29-35,41-48,50-51,80H,7,11-12,15-16,21-28,63H2,1-6H3,(H,66,69)(H,67,70)(H,71,83)(H,72,85)(H,73,88)(H,74,89)(H,75,90)(H,76,86)(H,77,84)(H,78,87)(H,81,82)(H,92,93)(H4,64,65,68)/t35-,41-,42",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CN=CN4)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,ORWYRWWVDCYOMK-HBZPZAIKSA-N,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid",Angiotensin I,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|198996|485281|485290|504327|504847|588579|602332|720532|720533|1133747|1133749,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BioCyc|Biosynth Carbosynth|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|Japan Chemica",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways, COVID-19 Disease Map]"
3082042,Angiotensin III,"ANGIOTENSIN III|UNII-XH7F04LXTF|12687-51-3|Angiotensin III, human, mouse|Angiotensin III, Human|XH7F04LXTF|CHEBI:89666|Angiotensin III,human|13602-53-4|(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid|5-Ile-angiotensin III|Angiotensin III, 5-ile-|1-Desaspartyl-5-isoleucine angiot",931.100,C46H66N12O9,342.000,1680.000,-0.500,67,11,12,25,"InChI=1S/C46H66N12O9/c1-5-27(4)38(57-40(61)33(21-29-15-17-31(59)18-16-29)53-42(63)37(26(2)3)56-39(60)32(47)13-9-19-51-46(48)49)43(64)54-34(23-30-24-50-25-52-30)44(65)58-20-10-14-36(58)41(62)55-35(45(66)67)22-28-11-7-6-8-12-28/h6-8,11-12,15-18,24-27,32-38,59H,5,9-10,13-14,19-23,47H2,1-4H3,(H,50,52)(H,53,63)(H,54,64)(H,55,62)(H,56,60)(H,57,61)(H,66,67)(H4,48,49,51)/t27-,32-,33-,34-,35-,36-,37-,38-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)N,QMMRCKSBBNJCMR-KMZPNFOHSA-N,"(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid",Angiotensin III,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|39185|167773|169066|485281|485290|504327|504847|588579|602332|720532|720533|1146282,20050809,"3B Scientific (Wuhan) Corp|AbaChemScene|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BindingDB|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LabNetwork, a WuXi AppTec Company|MedChemex",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3330960,2-(Trimethylazaniumyl)ethyl phosphate,choline phosphate(1-)|2-(trimethylazaniumyl)ethyl phosphate|choline-phosphate|3ujc|3ujd|3uj9|SCHEMBL1359253|DTXSID90910205|CHEBI:295975|2-(trimethylammonio)ethyl phosphate|Q27225724,182.130,C5H13NO4P-,72.400,147.000,-1.700,11,0,4,3,"InChI=1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)/p-1",C[N+](C)(C)CCOP(=O)([O-])[O-],YHHSONZFOIEMCP-UHFFFAOYSA-M,2-(trimethylazaniumyl)ethyl phosphate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20050907,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|NextBio|NMRShiftDB|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|SureChEMBL|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3527278,4-Methyl-2-oxopentanoate,4-methyl-2-oxopentanoate|alpha-ketoisocaproate|2-ketoisocaproate|2-keto-4-methyl-pentanoate|CHEBI:17865|4-methyl-2-oxidanylidene-pentanoate|A840181|Q27102672,129.130,C6H9O3-,57.200,121.000,1.600,9,0,3,2,"InChI=1S/C6H10O3/c1-4(2)3-5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)/p-1",CC(C)CC(=O)C(=O)[O-],BKAJNAXTPSGJCU-UHFFFAOYSA-M,4-methyl-2-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata|WikiPathways|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
4048638,Serotonin(1+),serotonin(1+)|serotonin cation|2ymd|3adv|3brn|3q6k|CHEBI:350546|2-(5-hydroxy-1H-indol-3-yl)ethanaminium|2-(5-oxidanyl-1H-indol-3-yl)ethylazanium|A828245|Q27225733,177.220,C10H13N2O+,63.700,174.000,0.200,13,3,1,2,"InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2/p+1",C1=CC2=C(C=C1O)C(=CN2)CC[NH3+],QZAYGJVTTNCVMB-UHFFFAOYSA-O,2-(5-hydroxy-1H-indol-3-yl)ethylazanium,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,8,977611,20050913,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|LeadScope|NextBio|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5188693,2-Oxoglutarate(1-),2-oxoglutarate(1-)|2-ketoglutarate|CHEBI:30916|4-carboxy-2-oxobutanoate|Q27114020,145.090,C5H5O5-,94.500,165.000,-0.200,10,1,5,3,"InChI=1S/C5H6O5/c6-3(5(9)10)1-2-4(7)8/h1-2H2,(H,7,8)(H,9,10)/p-1",C(CC(=O)O)C(=O)C(=O)[O-],KPGXRSRHYNQIFN-UHFFFAOYSA-M,"5-hydroxy-2,5-dioxopentanoate",Ketoglutaric Acids,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"ABI Chem|ChEBI|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|PATENTSCOPE (WIPO)|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5459934,4-Fumarylacetoacetate(2-),"4-fumarylacetoacetate(2-)|Fumarylacetoacetate|4-Fumarylacetoacetate|(2E)-4,6-dioxooct-2-enedioate|4-fumarylacetoacetate dianion|4-fumaryl-acetoacetate|CHEBI:18034|Q27102778",198.130,C8H6O6-2,114.000,290.000,0.600,14,0,6,4,"InChI=1S/C8H8O6/c9-5(1-2-7(11)12)3-6(10)4-8(13)14/h1-2H,3-4H2,(H,11,12)(H,13,14)/p-2/b2-1+",C(C(=O)CC(=O)[O-])C(=O)/C=C/C(=O)[O-],GACSIVHAIFQKTC-OWOJBTEDSA-L,"(E)-4,6-dioxooct-2-enedioate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"ABI Chem|BioCyc|ChEBI|ChemSpider|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5459996,2-Methylidenebutanedioate,"itaconate(2-)|Methylenesuccinate(2-)|2-methylidenebutanedioate|Succinic acid, methylene-, ion(2-)|2964-00-3|2-methylenebutanedioate|CHEBI:17240|methylenesuccinic acid, ion(2-)|DTXSID50183817|124744-EP2295426A1|124744-EP2295427A1|A845736|Q27102278",128.080,C5H4O4-2,80.300,147.000,1.100,9,0,4,1,"InChI=1S/C5H6O4/c1-3(5(8)9)2-4(6)7/h1-2H2,(H,6,7)(H,8,9)/p-2",C=C(CC(=O)[O-])C(=O)[O-],LVHBHZANLOWSRM-UHFFFAOYSA-L,2-methylidenebutanedioate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemIDplus|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|SLING Consortium|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460257,N-Carbamoyl-L-aspartate(2-),N-carbamoyl-L-aspartate(2-)|L-Ureidosuccinate|carbamyl-aspartate|carbamoyl-aspartate|carbamyul-aspartate|carbamyl-L-aspartate|carbamyul-L-aspartate|16649-79-9|N-carbamoyl-L-aspartate dianion|CHEBI:32814|Q27104235,174.110,C5H6N2O5-2,135.000,203.000,-0.400,12,2,5,2,"InChI=1S/C5H8N2O5/c6-5(12)7-2(4(10)11)1-3(8)9/h2H,1H2,(H,8,9)(H,10,11)(H3,6,7,12)/p-2/t2-/m0/s1",C([C@@H](C(=O)[O-])NC(=O)N)C(=O)[O-],HLKXYZVTANABHZ-REOHCLBHSA-L,(2S)-2-(carbamoylamino)butanedioate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460314,Cholate,"cholate|3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-oate|Cholic acidanion|3qps|CHEBI:29747|3alpha,7alpha,12alpha-trihydroxy-5-beta-cholanoate|Q27104085|3alpha,7alpha,12alpha-trihydroxy-5-beta-cholanoic acid",407.600,C24H39O5-,101.000,631.000,4.200,29,3,5,3,"InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/p-1/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1",C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,BHQCQFFYRZLCQQ-OELDTZBJSA-M,"(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate",Cholates,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20040916,"ABI Chem|BioCyc|ChEBI|ChemSpider|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460350,"(3,4-Dihydroxyphenyl)acetate","(3,4-dihydroxyphenyl)acetate|2-(3,4-dihydroxyphenyl)acetate|(dihydroxyphenyl)acetic acid|CHEBI:17612|2-[3,4-bis(oxidanyl)phenyl]ethanoate|A800559|Q27102477|3,4-Dihydroxyphenylacetic acid, homoprotocatechuic acid, homoprotocatechuate",167.140,C8H7O4-,80.600,163.000,1.100,12,2,4,1,"InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)/p-1",C1=CC(=C(C=C1CC(=O)[O-])O)O,CFFZDZCDUFSOFZ-UHFFFAOYSA-M,"2-(3,4-dihydroxyphenyl)acetate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5462266,5'-Phosphoribosylformylglycinamidine,"5'-phosphoribosylformylglycinamidine|5'-Phosphoribosyl-N-formylglycinamidine|2-(formamido)-N1-(5-phospho-beta-D-ribosyl)acetamidine|1-(5'-Phosphoribosyl)-N-formylglycinamidine|2-(Formamido)-N1-(5'-phosphoribosyl)acetamidine|6157-85-3|SCHEMBL4358717|C04640|((2R,3S,4R,5R)-5-(2-Formamidoacetimidamido)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate",313.200,C8H16N3O8P,184.000,413.000,-4.600,20,6,9,6,"InChI=1S/C8H16N3O8P/c9-5(1-10-3-12)11-8-7(14)6(13)4(19-8)2-18-20(15,16)17/h3-4,6-8,13-14H,1-2H2,(H2,9,11)(H,10,12)(H2,15,16,17)/t4-,6-,7-,8-/m1/s1",C([C@@H]1[C@H]([C@H]([C@@H](O1)/N=C(/CNC=O)\\N)O)O)OP(=O)(O)O,PMCOGCVKOAOZQM-XVFCMESISA-N,"[(2R,3S,4R,5R)-5-[(Z)-(1-amino-2-formamidoethylidene)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"ABI Chem|BioCyc|BLD Pharm|ChEBI|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|KEGG|NovoSeek|PATENTSCOPE (WIPO)|Prof. Malboobi, Plant Biotechnology Lab, National Institute of Genetic Engineering and Biotechnology|Springer Nature|SureChEMBL|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5497105,"(2E,6E,10E)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-tetraen-1-yl diphosphate","Geranylgeranyl diphosphate|geranylgeranyl diphosphate(3-)|GGPP|2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-)|(E,E,E)-Geranylgeranyl diphosphate|(2E,6E,10E)-geranylgeranyl diphosphate|(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl diphosphate|all-trans-geranylgeranyl-PP|Geranylgeraniol pyrophosphate|all-trans-geranyl-geranyl-pp|trans-Geranylgeranyl pyrophosphate|6699-20-3|trans,trans,trans-Geranylgeranyl diphosphate|trans,trans,trans-Geranylgeranyl pyrophosphate|geranylgeranylpyro",447.400,C20H33O7P2-3,122.000,691.000,4.200,29,0,7,13,"InChI=1S/C20H36O7P2/c1-17(2)9-6-10-18(3)11-7-12-19(4)13-8-14-20(5)15-16-26-29(24,25)27-28(21,22)23/h9,11,13,15H,6-8,10,12,14,16H2,1-5H3,(H,24,25)(H2,21,22,23)/p-3/b18-11+,19-13+,20-15+",CC(=CCC/C(=C/CC/C(=C/CC/C(=C/COP(=O)([O-])OP(=O)([O-])[O-])/C)/C)/C)C,OINNEUNVOZHBOX-QIRCYJPOSA-K,"[oxido-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoxy]phosphoryl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,1811|977610,20050601,"ABI Chem|BIND|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Isoprenoids|Nature Chemical Biology|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|Shanghai Institute of Organic Chemistry|Springer Nature|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6921840,"(2R)-2-(3,4-Dihydroxyphenyl)-2-hydroxyethanaminium","(R)-noradrenaline(1+)|(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethanaminium|(R)-noradrenaline cation|E5E|(R)-noradrenalinium cation|(R)-noradrenalinium(1+)|CHEBI:72587|J3.615.923E|(R)-2-(3,4-Dihydroxyphenyl)-2-hydroxyethaneaminium|Q27139997",170.190,C8H12NO3+,88.300,142.000,-1.200,12,4,3,2,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/p+1/t8-/m0/s1",C1=CC(=C(C=C1[C@H](C[NH3+])O)O)O,SFLSHLFXELFNJZ-QMMMGPOBSA-O,"[(2R)-2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]azanium",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20060728,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6971070,3-(4-Hydroxyphenyl)pyruvate,3-(4-Hydroxyphenyl)pyruvate|p-hydroxyphenylpyruvate|3-(4-hydroxyphenyl)-2-oxopropanoate|para-Hydroxyphenylpyruvat|hydroxyphenylpyruvate|3-(p-Hydroxyphenyl)pyruvate|(4-hydroxyphenyl)pyruvate|CHEBI:36242|BDBM50269993|3-(4-hydroxyphenyl)-2-oxidanylidene-propanoate|78068-EP2272846A1|78068-EP2277868A1|78068-EP2277869A1|78068-EP2277870A1|78068-EP2308866A1|78068-EP2374791A1|A809744|Q27104348,179.150,C9H7O4-,77.400,198.000,1.300,13,1,4,2,"InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13)/p-1",C1=CC(=CC=C1CC(=O)C(=O)[O-])O,KKADPXVIOXHVKN-UHFFFAOYSA-M,3-(4-hydroxyphenyl)-2-oxopropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060728,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|Aurora Fine Chemicals LLC|BindingDB|BioCyc|ChEBI|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|labseeker|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SLING Consortium|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6971086,Erythro-4-hydroxy-L-glutamate(1-),"erythro-4-hydroxy-L-glutamate(1-)|(4S)-4-hydroxy-L-glutamate|erythro-4-hydroxy-L-glutamate|(2S,4R)-2-ammonio-4-hydroxypentanedioate|CHEBI:6331|(2S,4R)-2-amino-4-hydroxypentanedioate|Q27107143",162.120,C5H8NO5-,128.000,157.000,-2.800,11,2,5,2,"InChI=1S/C5H9NO5/c6-2(4(8)9)1-3(7)5(10)11/h2-3,7H,1,6H2,(H,8,9)(H,10,11)/p-1/t2-,3+/m0/s1",C([C@@H](C(=O)[O-])[NH3+])[C@H](C(=O)[O-])O,HBDWQSHEVMSFGY-STHAYSLISA-M,"(2S,4R)-2-azaniumyl-4-hydroxypentanedioate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20060728,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6991994,4-Acetamidobutanoate,4-Acetamidobutanoate|N-acetyl-4-aminobutyrate|CHEBI:11951|2-(ACETYLAMINO)ETHYLACETATE|DB-004145|A820281|Q27108906,144.150,C6H10NO3-,69.200,127.000,0.000,10,1,3,3,"InChI=1S/C6H11NO3/c1-5(8)7-4-2-3-6(9)10/h2-4H2,1H3,(H,7,8)(H,9,10)/p-1",CC(=O)NCCCC(=O)[O-],UZTFMUBKZQVKLK-UHFFFAOYSA-M,4-acetamidobutanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060728,"A&J Pharmtech CO., LTD.|Amadis Chemical|BioCyc|ChEBI|ChemSpider|Debye Scientific Co., Ltd|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6992097,Spermidine(3+),"spermidine(3+)|N~1~-(3-azaniumylpropyl)butane-1,4-diaminium|3ttn|fully protonated form|4qf8|1,5,10-Triazoniadecane|CHEBI:57834|N-(3-ammoniopropyl)butane-1,4-diaminium|(4-azaniumylbutyl)(3-azaniumylpropyl)azanium|Q27124988",148.270,C7H22N3+3,71.900,56.800,-1.000,10,3,0,7,"InChI=1S/C7H19N3/c8-4-1-2-6-10-7-3-5-9/h10H,1-9H2/p+3",C(CC[NH2+]CCC[NH3+])C[NH3+],ATHGHQPFGPMSJY-UHFFFAOYSA-Q,4-azaniumylbutyl(3-azaniumylpropyl)azanium,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,977611,20060728,"A&J Pharmtech CO., LTD.|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|SCRIPDB|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7009568,(2S)-2-Azaniumyl-5-{[(1S)-1-carboxylatoethyl]amino}-5-oxopentanoate,gamma-Glutamylalanine|gamma-Glu-Ala(1-)|gamma-glutamylalanine(1-)|L-gamma-Glu-L-Ala(1-)|L-gamma-glutamyl-L-alanine(1-)|CHEBI:133091|(2S)-2-azaniumyl-5-{[(1S)-1-carboxylatoethyl]amino}-5-oxopentanoate,217.200,C8H13N2O5-,137.000,255.000,-2.500,15,2,5,4,"InChI=1S/C8H14N2O5/c1-4(7(12)13)10-6(11)3-2-5(9)8(14)15/h4-5H,2-3,9H2,1H3,(H,10,11)(H,12,13)(H,14,15)/p-1/t4-,5-/m0/s1",C[C@@H](C(=O)[O-])NC(=O)CC[C@@H](C(=O)[O-])[NH3+],WQXXXVRAFAKQJM-WHFBIAKZSA-M,(2S)-2-azaniumyl-5-[[(1S)-1-carboxylatoethyl]amino]-5-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20060729,BioCyc|ChEBI|ChemSpider|NextBio,Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7048684,Glutathionate,glutathionate|glutathionate(1-)|[Glu(-Cys)]n-Gly|glutathionate ion|glutathionate anion|3lvw|3c8e|[Glu(-Cys)]n-Gly(1-)|CHEBI:57925|CHEBI:131728,306.320,C10H16N3O6S-,167.000,378.000,-3.200,20,4,7,7,"InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/p-1/t5-,6-/m0/s1",C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],RWSXRVCMGQZWBV-WDSKDSINSA-M,(2S)-2-azaniumyl-5-[[(2R)-1-(carboxylatomethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977610|977611,20060729,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|Google Patents|NextBio|PATENTSCOPE (WIPO)|Shanghai Institute of Organic Chemistry|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7048686,Sn-glycerol 3-phosphate(2-),"sn-glycerol 3-phosphate(2-)|(2R)-2,3-dihydroxypropyl phosphate|alpha-glycerophosphate|L-alpha-glycerophosphate|4aq4|L-glycerol 3-phosphate|CHEBI:57597|(2R)-3-(phosphonatooxy)propane-1,2-diol|Q26711901",170.060,C3H7O6P-2,113.000,117.000,-3.000,10,2,6,3,"InChI=1S/C3H9O6P/c4-1-3(5)2-9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)/p-2/t3-/m1/s1",C([C@H](COP(=O)([O-])[O-])O)O,AWUCVROLDVIAJX-GSVOUGTGSA-L,"[(2R)-2,3-dihydroxypropyl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,977611,20060729,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NMRShiftDB|Shanghai Institute of Organic Chemistry|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7058165,Cytidine-monophosphate,"CMP(2-)|cytidine-monophosphate|CMP dianion|5'-O-phosphonatocytidine|CMP|cytidine 5'-monophosphate(2-)|Cytidine-5-monophosphate dianion|CHEBI:60377|A834351|Q27104867|[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]methyl phosphate|[(2R,3S,4R,5R)-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphate",321.180,C9H12N3O8P-2,181.000,520.000,-3.600,21,3,8,3,"InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O,IERHLVCPSMICTF-XVFCMESISA-L,"[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20060729,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemShuttle|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|LeadScope|NextBio|Therapeutic Target Database (TTD)|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7059434,2-Ammonioethyl phosphate,2-ammonioethyl phosphate|2-azaniumylethyl phosphate|O-phosphonatoethanaminium|O-phosphonatoethanaminium(1-)|2-AMINOETHYL PHOSPHATE|3kqr|3l2y|GTPL6628|CHEBI:58190|A801586,140.060,C2H7NO4P-,100.000,86.700,-4.900,8,1,4,2,"InChI=1S/C2H8NO4P/c3-1-2-7-8(4,5)6/h1-3H2,(H2,4,5,6)/p-1",C(COP(=O)([O-])[O-])[NH3+],SUHOOTKUPISOBE-UHFFFAOYSA-M,2-azaniumylethyl phosphate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20060729,ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|NextBio|Shanghai Institute of Organic Chemistry|Therapeutic Target Database (TTD),Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9548816,Protoporphyrinate,protoporphyrinate|protoporphyrinate IX|ppIX|ppIX(2-)|CHEBI:36159|Q27116721,560.600,C34H32N4O4-2,102.000,1010.000,4.300,42,2,8,8,"InChI=1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42)/p-2",CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)O)CCC(=O)O,PRFMATRBBQRQBM-UHFFFAOYSA-L,"3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20061004,"ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|MetabolomicsWorkbench|NextBio|NovoSeek|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9904001,13-cis-Retinol,"13-cis-Retinol|Neovitamin A|13-cis Retinol|2052-63-3|UNII-J72YRO1DWF|13Z-retinol|J72YRO1DWF|CHEBI:45479|beta-Retinol|9-cis retinol|Retinol, (13Z)-|(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol|Retinol, 13-cis-|11-cis-Vitamin A alcohol|neo-Retinol|b-Retinol|cis-11-Retinol|(13cis)-retinol|13-cis-Vitamin A|Spectrum5_001999|GTPL6672|CHEMBL1454290|SCHEMBL13449078|11-cis-13-cis-Retinol acetate|11-cis-13-cis-Retinyl acetate|11,13-Di-cis-vitamin A acetate|(11-cis,13-cis)-Ret",286.500,C20H30O,20.200,496.000,5.700,21,1,1,5,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13-",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\CO)/C)/C,FPIPGXGPPPQFEQ-HWCYFHEPSA-N,"(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,11,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1865|2101|2107|2112|2517|2549|485281|485290|504327|504332|504845|504847|588579|602332|686978|686979|720532|720533|720579|720580|1159524|1347131|1347154,20061025,"AK Scientific, Inc. (AKSCI)|BioCyc|BLD Pharm|BOC Sciences|Broad Institute|ChEBI|Chem-Space.com Database|ChemBank|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|LIPID MAPS|MassBank of North America (MoNA)|MetabolomicsWorkbench|MuseChem|National",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
11966213,1-Pyrroline-5-carboxylate,1-pyrroline-5-carboxylate|CHEBI:15893|Q27098284,112.110,C5H6NO2-,52.500,125.000,0.100,8,0,3,0,"InChI=1S/C5H7NO2/c7-5(8)4-2-1-3-6-4/h3-4H,1-2H2,(H,7,8)/p-1",C1CC(N=C1)C(=O)[O-],DWAKNKKXGALPNW-UHFFFAOYSA-M,"3,4-dihydro-2H-pyrrole-2-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20061222,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
11966314,3-Hydroxyisobutyrate,3-Hydroxyisobutyrate|3-Hydroxy-2-methylpropanoate|3-hydroxy-2-isobutyrate|3-hydroxy-2-methylpropionate|3-hydroxy-isobutyrate|CHEBI:11805|3-hydroxy-isobutanoate|STL483480|Q28487650,103.100,C4H7O3-,60.400,63.800,0.300,7,1,3,1,"InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1",CC(CO)C(=O)[O-],DBXBTMSZEOQQDU-UHFFFAOYSA-M,3-hydroxy-2-methylpropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20061222,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|Vitas-M Laboratory|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
12311285,"9Z,12Z-Octadecadienoic-9,10,12,13-D4acid","79050-23-0|Linoleic Acid-d4|LinoleicAcid-d4|9Z,12Z-octadecadienoic acid(d4)|Linoleic acid(d4)|9Z,12Z-OCTADECADIENOIC-9,10,12,13-D4ACID|LMFA01030809|LINOLEIC-9,10,12,13-D4 ACID",284.500,C18H32O2,37.300,267.000,6.800,20,1,2,14,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-/i6D,7D,9D,10D",[2H]/C(=C(\\[2H])/C/C(=C(/[2H])\\CCCCCCCC(=O)O)/[2H])/CCCCC,OYHQOLUKZRVURQ-GPTDOFLBSA-N,"(9Z,12Z)-9,10,12,13-tetradeuteriooctadeca-9,12-dienoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry|Use and Manufacturing,5,NULL,20070207,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Ambinter|BOC Sciences|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemMol|Collaborative Drug Discovery, Inc.|DiscoveryGate|eNovation Chemicals|LabNetwork, a WuXi AppTec Company|LIPID MAPS|MolPort|MuseChem",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15642160,2-Hydroxy-3-methylbut-2-enoic acid,"2-Hydroxy-3-methylbut-2-enoic acid|104092-72-0|hydroxysenecioic acid|2-Butenoic acid, 2-hydroxy-3-methyl-|ACMC-20m6vn|SCHEMBL1704043|DTXSID00576179|CHEBI:132177|2-hydroxy-3-methyl-2-butenoic acid",116.110,C5H8O3,57.500,131.000,1.100,8,2,3,1,"InChI=1S/C5H8O3/c1-3(2)4(6)5(7)8/h6H,1-2H3,(H,7,8)",CC(=C(C(=O)O)O)C,YXHQZJPTLDUABH-UHFFFAOYSA-N,2-hydroxy-3-methylbut-2-enoic acid,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20070212,Achemica|BLD Pharm|ChEBI|ChemTik|EPA DSSTox|Google Patents|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15938972,Coenzyme II,"coenzyme II|NADP(3-)|NADP|triphosphopyridine nucleotide|NADP(+)|beta-NADP+|TPN-ox|53-59-8|TPN+|[(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate|nicotinamide adenine dinucleotide-P|nchembio867-comp15|nicotinamide adenine dinucleotide phosphate|NADP trianion|NADP-oxidized|NADP-ox|[[(2R,3R,4R,5R)-5-(6-Aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]metho",740.400,C21H25N7O17P3-3,376.000,1270.000,-7.300,48,5,21,12,"InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p-3/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)([O-])[O-])O)O)O)C(=O)N,XJLXINKUBYWONI-NNYOXOHSSA-K,"[(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate",NADP,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,9,NULL,20070215,"BioCyc|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|NextBio|Smolecule|Springer Nature|THE BioTek|Thieme Chemistry|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15942892,Thiamin phosphate,"thiamin phosphate|thiamine(1+) monophosphate(2-)|Thiamine phosphate|thiamine monophosphate|532-40-1|2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl phosphate|thiamine-Pi|thiamin-P|2qry|2-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl}ethyl phosphate|CHEBI:37575|Q27117196",343.320,C12H16N4O4PS-,156.000,401.000,-0.200,22,1,8,5,"InChI=1S/C12H17N4O4PS/c1-8-11(3-4-20-21(17,18)19)22-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H3-,13,14,15,17,18,19)/p-1",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)([O-])[O-],HZSAJDVWZRBGIF-UHFFFAOYSA-M,"2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl phosphate",Thiamine Monophosphate,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,977611,20070301,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Shanghai Institute of Organic Chemistry|Smolecule|THE BioTek|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15983957,3-Methylbut-3-enyl pyrophosphate,isopentenyl diphosphate(3-)|3-methylbut-3-enyl diphosphate|3-methylbut-3-enyl pyrophosphate|CHEBI:128769|isopentenyl-pp|3-methylbut-3-enyl diphosphate trianion|delta(3)-isopentenyl-PP|Delta3-isopentenyl-PP|Epitope ID:150902|3-methylbut-3-en-1-yl diphosphate|Q27221807,243.070,C5H9O7P2-3,122.000,273.000,-1.200,14,0,7,5,"InChI=1S/C5H12O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h1,3-4H2,2H3,(H,9,10)(H2,6,7,8)/p-3",CC(=C)CCOP(=O)([O-])OP(=O)([O-])[O-],NUHSROFQTUXZQQ-UHFFFAOYSA-K,[3-methylbut-3-enoxy(oxido)phosphoryl] phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20070325,"BioCyc|ChEBI|Chembase.cn|ChemSpider|ChemTik|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Immune Epitope Database (IEDB)|Nature Chemical Biology|PATENTSCOPE (WIPO)|Springer Nature|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16755646,"2,5-Diammoniopentanoate","2,5-Diaminopentanoate|ornithinium|ornithine monocation|2,5-diammoniopentanoate|CHEBI:46912",133.170,C5H13N2O2+,95.400,89.400,-3.800,9,2,2,3,"InChI=1S/C5H12N2O2/c6-3-1-2-4(7)5(8)9/h4H,1-3,6-7H2,(H,8,9)/p+1",C(CC(C(=O)[O-])[NH3+])C[NH3+],AHLPHDHHMVZTML-UHFFFAOYSA-O,"2,5-bis(azaniumyl)pentanoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20071102,BioCyc|ChEBI,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16755648,Thymidine 5'-(hydrogen phosphate),dTMP(-)|Thymidine 5'-monophosphate|thymidine 5'-phosphate(1-)|CHEBI:46960|thymidine 5'-(hydrogen phosphate)|5'-O-(hydroxyphosphinato)thymidine|Q27120734,321.200,C10H14N2O8P-,149.000,527.000,-2.900,21,3,8,4,"InChI=1S/C10H15N2O8P/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(20-8)4-19-21(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,11,14,15)(H2,16,17,18)/p-1/t6-,7+,8+/m0/s1",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)[O-])O,GYOZYWVXFNDGLU-XLPZGREQSA-M,"[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20071102,"ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|Springer Nature|Therapeutic Target Database (TTD)|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16755653,(R)-4'-Phosphonatopantothenate(3-),"(R)-4'-phosphonatopantothenate(3-)|(R)-4'-phosphopantothenate|D-4'-phosphopantothenate|4'-P-Pantothenate|4'-phosphopantothenate|CHEBI:10986|Q27108681|3-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonatooxy)butanamido]propanoate",296.190,C9H15NO8P-3,162.000,359.000,-1.700,19,2,8,6,"InChI=1S/C9H18NO8P/c1-9(2,5-18-19(15,16)17)7(13)8(14)10-4-3-6(11)12/h7,13H,3-5H2,1-2H3,(H,10,14)(H,11,12)(H2,15,16,17)/p-3/t7-/m0/s1",CC(C)(COP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)[O-])O,XHFVGHPGDLDEQO-ZETCQYMHSA-K,"3-[[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonatooxybutanoyl]amino]propanoate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071102,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
18601100,Deoxyuridine-phosphate,dUMP(2-)|dUMP dianion|2yaz|deoxyurdine-phosphate|deoxyuridine-phosphate|3hb8|deoxyuridine 5'-phosphate(2-)|2'-deoxyuridine 5-monophosphate|deoxyuridine 5'-phosphate dianion|CHEBI:246422|2'-deoxy-5'-O-phosphonatouridine|Q27225714,306.170,C9H11N2O8P-2,151.000,477.000,-3.400,20,2,8,3,"InChI=1S/C9H13N2O8P/c12-5-3-8(11-2-1-7(13)10-9(11)14)19-6(5)4-18-20(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,10,13,14)(H2,15,16,17)/p-2/t5-,6+,8+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)COP(=O)([O-])[O-])O,JSRLJPSBLDHEIO-SHYZEUOFSA-L,"[(2R,3S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20071204,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NORMAN Suspect List Exchange|Shanghai Institute of Organic Chemistry|Thieme Chemistry|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
20849104,Protoporphyrinogen(2-),"protoporphyrinogen(2-)|CHEBI:57307|Q27124410|3,3'-(8,13-diethynyl-3,7,12,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,18-diyl)dipropanoate",566.700,C34H38N4O4-2,143.000,995.000,6.900,42,4,4,6,"InChI=1S/C34H40N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,35-38H,1-2,9-16H2,3-6H3,(H,39,40)(H,41,42)/p-2",CC1=C2CC3=C(C(=C(N3)CC4=C(C(=C(N4)CC5=C(C(=C(N5)CC(=C1CCC(=O)[O-])N2)CCC(=O)[O-])C)C=C)C)C=C)C,UHSGPDMIQQYNAX-UHFFFAOYSA-L,"3-[18-(2-carboxylatoethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
20849114,Coproporphyrinogen III(4-),"coproporphyrinogen III(4-)|3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoate|CHEBI:57309|Q27124412",656.700,C36H40N4O8-4,224.000,1150.000,6.200,48,4,8,8,"InChI=1S/C36H44N4O8/c1-17-21(5-9-33(41)42)29-14-27-19(3)22(6-10-34(43)44)30(39-27)15-28-20(4)24(8-12-36(47)48)32(40-28)16-31-23(7-11-35(45)46)18(2)26(38-31)13-25(17)37-29/h37-40H,5-16H2,1-4H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48)/p-4",CC1=C2CC3=C(C(=C(N3)CC4=C(C(=C(N4)CC5=C(C(=C(N5)CC(=C1CCC(=O)[O-])N2)C)CCC(=O)[O-])C)CCC(=O)[O-])CCC(=O)[O-])C,NIUVHXTXUXOFEB-UHFFFAOYSA-J,"3-[8,12,17-tris(2-carboxylatoethyl)-3,7,13,18-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21226158,5-Oxoprolinate,5-oxoprolinate|5-oxoprolinate anion|5-oxopyrrolidine-2-carboxylate|CHEBI:57606|VC30960|Q27124809,128.110,C5H6NO3-,69.200,149.000,-0.100,9,1,3,0,"InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/p-1",C1CC(=O)NC1C(=O)[O-],ODHCTXKNWHHXJC-UHFFFAOYSA-M,5-oxopyrrolidine-2-carboxylate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071205,"ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Vesino Industrial Co., Ltd|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23421194,D-Fructofuranose 1-phosphate(2-),D-fructofuranose 1-phosphate(2-)|CHEBI:58674|1-O-phosphonato-D-fructofuranose|Q27125950,258.120,C6H11O9P-2,163.000,278.000,-4.100,16,4,9,3,"InChI=1S/C6H13O9P/c7-1-3-4(8)5(9)6(10,15-3)2-14-16(11,12)13/h3-5,7-10H,1-2H2,(H2,11,12,13)/p-2/t3-,4-,5+,6?/m1/s1",C([C@@H]1[C@H]([C@@H](C(O1)(COP(=O)([O-])[O-])O)O)O)O,RHKKZBWRNHGJEZ-VRPWFDPXSA-L,"[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20071206,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23421198,D-Glucopyranose 1-phosphate(2-),D-glucopyranose 1-phosphate(2-)|1-O-phosphonato-D-glucopyranose|CHEBI:57629|D-glucopyranose 1-phosphate anion|D-glucopyranose 1-phosphate dianion|Q27124823,258.120,C6H11O9P-2,163.000,266.000,-4.000,16,4,9,2,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5-,6?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)OP(=O)([O-])[O-])O)O)O)O,HXXFSFRBOHSIMQ-GASJEMHNSA-L,"[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071206,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23421200,D-Mannopyranose 6-phosphate(2-),D-mannopyranose 6-phosphate(2-)|D-Mannose 6-phosphate|D-mannopyranose-6-P|6-O-phosphonato-D-mannopyranose|CHEBI:58735|Q27126005,258.120,C6H11O9P-2,163.000,266.000,-4.400,16,4,9,2,"InChI=1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5+,6?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@@H](C(O1)O)O)O)O)OP(=O)([O-])[O-],NBSCHQHZLSJFNQ-QTVWNMPRSA-L,"[(2R,3S,4S,5S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20071206,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Thieme Chemistry|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23615194,"Adenosine 3',5'-bismonophosphate(4-)","adenosine 3',5'-bismonophosphate(4-)|adenosine-3',5'-bisphosphate|CHEBI:58343|DTXSID50909413|3',5'-di-O-phosphonatoadenosine|adenosine 3',5'-bismonophosphate tetraanion|Q27125713|9-(3,5-Di-O-phosphonatopentofuranosyl)-9H-purin-6-amine",423.170,C10H11N5O10P2-4,244.000,609.000,-4.900,27,2,14,4,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(25-27(20,21)22)4(24-10)1-23-26(17,18)19/h2-4,6-7,10,16H,1H2,(H2,11,12,13)(H2,17,18,19)(H2,20,21,22)/p-4/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])OP(=O)([O-])[O-])O)N,WHTCPDAXWFLDIH-KQYNXXCUSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(phosphonatooxymethyl)oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071212,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|PATENTSCOPE (WIPO)|ToxPlanet|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23617374,3-Carbamoyl-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium,"NMN(-)|beta-nicotinamide nucleotide|SCHEMBL19064261|CHEBI:14649|Q27108995|3-carbamoyl-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium|[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",333.210,C11H14N2O8P-,169.000,446.000,-3.600,22,3,8,4,"InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/p-1/t7-,8-,9-,11-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O)C(=O)N,DAYLJWODMCOQEW-TURQNECASA-M,"[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071212,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23657868,Triphosphate(1-),triphosphate(1-)|tetrahydrogen triphosphate|CHEBI:48313|H4P3O10(-)|Q27121138,256.950,H4O10P3-,174.000,298.000,-4.400,13,4,10,4,"InChI=1S/H5O10P3/c1-11(2,3)9-13(7,8)10-12(4,5)6/h(H,7,8)(H2,1,2,3)(H2,4,5,6)/p-1",OP(=O)(O)OP(=O)(O)OP(=O)(O)[O-],UNXRWKVEANCORM-UHFFFAOYSA-M,[hydroxy(phosphonooxy)phosphoryl] hydrogen phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20080131,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
24762165,AdoMet,"S-adenosyl-L-methionine|S-adenosylmethionine|AdoMet|adenosylmethionine|S-adenosyl-methionine|(S,S)-AdoMet|2-S-adenosyl-L-methionine|29908-03-0|S-adenosyl-L-methionine zwitterion|SAM|(R,S)-AdoMet zwitterion|(S,S)-AdoMet zwitterion|CHEBI:59789|CHEBI:142093|CHEBI:142094|(R)-S-adenosyl-L-methionine zwitterion|(S)-S-adenosyl-L-methionine zwitterion|(R,S)-S-adenosyl-L-methionine zwitterion|(S,S)-S-adenosyl-L-methionine zwitterion|[(3S)-3-azaniumyl-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)sulfonium|(2S)",399.400,C15H23N6O5S+,188.000,527.000,-2.800,27,4,9,6,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1",C[S+](CC[C@@H](C(=O)[O-])[NH3+])C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,MEFKEPWMEQBLKI-AIRLBKTGSA-O,"(2S)-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]-2-azaniumylbutanoate",S-Adenosylmethionine,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards,8,NULL,20080409,"A&J Pharmtech CO., LTD.|BioCyc|ChEBI|DiscoveryGate|Nature Chemical Biology|Smolecule|Springer Nature|ToxPlanet",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
24794348,Pyridoxine 5'-phosphate,PYRIDOXINE 5'-PHOSPHATE|pyridoxine 5'-phosphate(2-)|pyridoxine-P|pyridoxine-5P|[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl phosphate|pyridoxine-5-phosphate|CHEBI:58589|Q27125898,247.140,C8H10NO6P-2,126.000,258.000,-2.000,16,2,7,3,"InChI=1S/C8H12NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2,10-11H,3-4H2,1H3,(H2,12,13,14)/p-2",CC1=NC=C(C(=C1O)CO)COP(=O)([O-])[O-],WHOMFKWHIQZTHY-UHFFFAOYSA-L,[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20080521,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
24794350,D-Glyceraldehyde 3-phosphate(2-),D-glyceraldehyde 3-phosphate(2-)|d-glyceraldehyde 3-phosphate|Triose phosphate|glyceraldehyde-P|glyceraldehyde-3-P|D-glyceraldehyde-3-P|glyceraldehyde-phosphate|2clk|CHEBI:59776|D-glyceraldehyde 3-phosphate dianion|(2R)-2-hydroxy-3-oxopropyl phosphate|(2R)-2-hydroxy-3-(phosphooxy)-propanal|gap|Q27126894,168.040,C3H5O6P-2,110.000,138.000,-2.800,10,1,6,3,"InChI=1S/C3H7O6P/c4-1-3(5)2-9-10(6,7)8/h1,3,5H,2H2,(H2,6,7,8)/p-2/t3-/m0/s1",C([C@H](C=O)O)OP(=O)([O-])[O-],LXJXRIRHZLFYRP-VKHMYHEASA-L,[(2R)-2-hydroxy-3-oxopropyl] phosphate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,1811|977611,20080521,"BioCyc|ChEBI|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|Springer Nature|Thieme Chemistry|ToxPlanet|Wikidata|Wiley",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25201153,"5-Diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate","5-diphospho-1D-myo-inositol pentakisphosphate(13-)|5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate|CHEBI:58628|J3.529.504F|Q27125925|1D-myoinositol 5-diphosphate 1,2,3,4,6-pentakisphosphate|1,2,3,4,6-pentakis-O-phosphonato-1D-myo-inositol 5-diphosphate|[1-O,3-O,4-O,5-O,6-O-Pentakis(dioxylatophosphinyl)-D-myo-inositol 2-diphosphoric acid]trianion|1-O,2-O,3-O,4-O,6-O-Pentaphosphonato-5-O-(phosphonatooxyoxylato(oxo)phosphoranyl)-D-myo-inositol",726.910,C6H6O27P7-13,484.000,1080.000,-12.400,40,0,27,8,"InChI=1S/C6H19O27P7/c7-34(8,9)27-1-2(28-35(10,11)12)4(30-37(16,17)18)6(32-40(25,26)33-39(22,23)24)5(31-38(19,20)21)3(1)29-36(13,14)15/h1-6H,(H,25,26)(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/p-13/t1?,2-,3+,4+,5-,6?",[C@H]1([C@H](C([C@H]([C@@H](C1OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-],UPHPWXPNZIOZJL-UYSNGIAKSA-A,"[oxido-[(2S,3R,5S,6R)-2,3,4,5,6-pentaphosphonatooxycyclohexyl]oxyphosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20090331,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|Wikidata",Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25201573,Histaminium,histaminium|peremin|histaminium cation|3rxh|3bu1|CHEBI:58432|DTXSID20984171|5-(2-Aminioethyl)-1H-imidazole|2-(1H-imidazol-4-yl)ethanaminium|2-(1H-imidazol-5-yl)ethylazanium|2-(1H-imidazol-5-yl)ethylammonium|2-(1H-Imidazol-5-yl)ethan-1-aminium|FT-0669215|A828600|Q27125787,112.150,C5H10N3+,56.300,64.700,-0.700,8,2,1,2,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)/p+1",C1=C(NC=N1)CC[NH3+],NTYJJOPFIAHURM-UHFFFAOYSA-O,2-(1H-imidazol-5-yl)ethylazanium,Histamine,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,8,977608|977611,20090331,"A&J Pharmtech CO., LTD.|Amadis Chemical|BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Finetech Industry Limited|Japan Chemical Substance Dictionary (Nikkaji)|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25202645,Uroporphyrinogen III(8-),"uroporphyrinogen III(8-)|CHEBI:57308|Q27124411|3,3',3'',3'''-[3,8,13,17-tetrakis(carboxylatomethyl)-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrayl]tetrapropanoate|3,8,13,17-tetrakis(carboxylatomethyl)-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoate",828.700,C40H36N4O16-8,384.000,1580.000,5.200,60,4,16,12,"InChI=1S/C40H44N4O16/c45-33(46)5-1-17-21(9-37(53)54)29-14-27-19(3-7-35(49)50)22(10-38(55)56)30(43-27)15-28-20(4-8-36(51)52)24(12-40(59)60)32(44-28)16-31-23(11-39(57)58)18(2-6-34(47)48)26(42-31)13-25(17)41-29/h41-44H,1-16H2,(H,45,46)(H,47,48)(H,49,50)(H,51,52)(H,53,54)(H,55,56)(H,57,58)(H,59,60)/p-8",C1C2=C(C(=C(N2)CC3=C(C(=C(N3)CC4=C(C(=C(N4)CC5=C(C(=C1N5)CCC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CCC(=O)[O-])CC(=O)[O-])CCC(=O)[O-])CC(=O)[O-])CCC(=O)[O-],HUHWZXWWOFSFKF-UHFFFAOYSA-F,"3-[7,12,18-tris(2-carboxylatoethyl)-3,8,13,17-tetrakis(carboxylatomethyl)-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20090331,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25243905,"P1,P4-Bis(5'-adenosyl) tetraphosphate","Ap4A|P(1),P(4)-bis(5'-adenosyl) tetraphosphate(4-)|P1,P4-Bis(5'-adenosyl) tetraphosphate|3loo|ADENOSYL-P4|GTPL1732|bis(5'-adenosyl) tetraphosphate|CHEBI:58141|P(1),P(4)-bis(5'-adenosyl)tetraphosphate|Q4778853|P(1),P(4)-bis(5'-adenosyl) tetraphosphate tetraanion|[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphinato]oxy}phosphinato)oxy]phosphonate",832.400,C20H24N10O19P4-4,445.000,1370.000,-8.600,53,6,27,14,"InChI=1S/C20H28N10O19P4/c21-15-9-17(25-3-23-15)29(5-27-9)19-13(33)11(31)7(45-19)1-43-50(35,36)47-52(39,40)49-53(41,42)48-51(37,38)44-2-8-12(32)14(34)20(46-8)30-6-28-10-16(22)24-4-26-18(10)30/h3-8,11-14,19-20,31-34H,1-2H2,(H,35,36)(H,37,38)(H,39,40)(H,41,42)(H2,21,23,25)(H2,22,24,26)/p-4/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)N,YOAHKNVSNCMZGQ-XPWFQUROSA-J,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,977610|1346293|1346305|1346320|1347028,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Shanghai Institute of Organic Chemistry|Therapeutic Target Database (TTD)|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245217,3-Sulfonatopyruvate(2-),3-sulfonatopyruvate(2-)|3-sulfonatopyruvate|3moe|3-sulfonatopyruvate dianion|2-oxo-3-sulfonatopropanoate|CHEBI:57940|Q27125070,166.110,C3H2O6S-2,123.000,224.000,-0.800,10,0,6,1,"InChI=1S/C3H4O6S/c4-2(3(5)6)1-10(7,8)9/h1H2,(H,5,6)(H,7,8,9)/p-2",C(C(=O)C(=O)[O-])S(=O)(=O)[O-],BUTHMSUEBYPMKJ-UHFFFAOYSA-L,2-oxo-3-sulfonatopropanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,7,977610,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Shanghai Institute of Organic Chemistry|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245418,L-Selenocysteine,L-selenocysteine|selenocys|L-selenocysteine zwitterion|CHEBI:57843|(2R)-2-ammonio-3-selanylpropanoate|(2R)-2-azaniumyl-3-selanylpropanoate,167.060,C3H6NO2Se,67.800,69.800,NULL,7,1,2,1,"InChI=1S/C3H6NO2Se/c4-2(1-7)3(5)6/h2H,1,4H2,(H,5,6)/t2-/m0/s1",C([C@@H](C(=O)[O-])[NH3+])[Se],FDKWRPBBCBCIGA-REOHCLBHSA-N,NULL,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20090514,BioCyc|ChEBI,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245502,N(Tele)-methylhistaminium,N(tele)-methylhistaminium|N(tau)-methylhistamine|methylhistamine|N(T)-methylhistamine|4-(1-aminoethyl)-1-methyl-1H-imidazole|N-methyl-histamine|CHEBI:58600|2-(1-methyl-1H-imidazol-4-yl)ethanaminium|Q27125905,126.180,C6H12N3+,45.500,84.400,-0.600,9,1,1,2,"InChI=1S/C6H11N3/c1-9-4-6(2-3-7)8-5-9/h4-5H,2-3,7H2,1H3/p+1",CN1C=C(N=C1)CC[NH3+],FHQDWPCFSJMNCT-UHFFFAOYSA-O,2-(1-methylimidazol-4-yl)ethylazanium,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245548,3-Phosphonato-D-glycerate(3-),3-phosphonato-D-glycerate(3-)|3-P-D-glycerate|(2R)-2-hydroxy-3-(phosphonatooxy)propanoate|3fjg|4gwk|D-glycerate-3-P|(2R)-3-phosphoglycerate|3-phosphonato-D-glycerate|d-3-phospho-glyceric acid|CHEBI:58272|3-phosphonato-D-glycerate trianion|BDBM50067783|Q27125660,183.030,C3H4O7P-3,133.000,165.000,-2.100,11,1,7,2,"InChI=1S/C3H7O7P/c4-2(3(5)6)1-10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/p-3/t2-/m1/s1",C([C@H](C(=O)[O-])O)OP(=O)([O-])[O-],OSJPPGNTCRNQQC-UWTATZPHSA-K,(2R)-2-hydroxy-3-phosphonatooxypropanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20090514,"BindingDB|BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|PATENTSCOPE (WIPO)|Shanghai Institute of Organic Chemistry|ToxPlanet|Wikidata|WikiPathways",Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245905,D-Pantetheine 4'-phosphate(2-),"D-pantetheine 4'-phosphate(2-)|phosphopantotheine|CHEBI:61723|Q27131336|N(3)-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonatooxy)butanoyl]-N-(2-sulfanylethyl)-beta-alaninamide",356.330,C11H21N2O7PS-2,152.000,415.000,-2.300,22,4,8,9,"InChI=1S/C11H23N2O7PS/c1-11(2,7-20-21(17,18)19)9(15)10(16)13-4-3-8(14)12-5-6-22/h9,15,22H,3-7H2,1-2H3,(H,12,14)(H,13,16)(H2,17,18,19)/p-2/t9-/m0/s1",CC(C)(COP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCS)O,JDMUPRLRUUMCTL-VIFPVBQESA-L,"[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25246037,Dudp trianion,dUDP(3-)|2'-deoxyuridine-5'-diphosphate|dUDP trianion|2hr6|CHEBI:60471|2'-deoxyuridine 5'-diphosphate(3-)|2'-deoxyuridine 5'-diphosphate trianion|2'-deoxy-5'-O-[(phosphonatooxy)phosphinato]uridine|Q27127304,385.140,C9H11N2O11P2-3,201.000,626.000,-4.600,24,2,11,5,"InChI=1S/C9H14N2O11P2/c12-5-3-8(11-2-1-7(13)10-9(11)14)21-6(5)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,10,13,14)(H2,15,16,17)/p-3/t5-,6+,8+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)COP(=O)([O-])OP(=O)([O-])[O-])O,QHWZTVCCBMIIKE-SHYZEUOFSA-K,"[[(2R,3S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Shanghai Institute of Organic Chemistry|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25246250,S-Formylglutathionate(1-),S-formylglutathionate(1-)|CHEBI:57688|Q27124862|(2S)-2-azaniumyl-5-{[(2R)-1-[(carboxylatomethyl)amino]-3-(formylsulfanyl)-1-oxopropan-2-yl]amino}-5-oxopentanoate,334.330,C11H16N3O7S-,209.000,432.000,-3.000,22,3,8,9,"InChI=1S/C11H17N3O7S/c12-6(11(20)21)1-2-8(16)14-7(4-22-5-15)10(19)13-3-9(17)18/h5-7H,1-4,12H2,(H,13,19)(H,14,16)(H,17,18)(H,20,21)/p-1/t6-,7-/m0/s1",C(CC(=O)N[C@@H](CSC=O)C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],FHXAGOICBFGEBF-BQBZGAKWSA-M,(2S)-2-azaniumyl-5-[[(2R)-1-(carboxylatomethylamino)-3-formylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
36688062,2-Aminoadipate semialdehyde,2-aminoadipate semialdehyde|2-aminoadipate-6-semialdehyde|L-allysine zwitterion|(2S)-2-ammonio-6-oxohexanoate|alpha-aminoadipate 6-semialdehyde|CHEBI:58321|(2S)-2-azaniumyl-6-oxohexanoate|(S)-2-aminoadipate 6-semialdehyde,145.160,C6H11NO3,84.800,119.000,-2.600,10,1,3,4,"InChI=1S/C6H11NO3/c7-5(6(9)10)3-1-2-4-8/h4-5H,1-3,7H2,(H,9,10)/t5-/m0/s1",C(CC=O)C[C@@H](C(=O)[O-])[NH3+],GFXYTQPNNXGICT-YFKPBYRVSA-N,(2S)-2-azaniumyl-6-oxohexanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20090529,BioCyc|ChEBI|DiscoveryGate,Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
36688186,6-Phosphonatooxy-D-gluconate,6-phosphonatooxy-D-gluconate|6-p gluconate|3axm|6-phospho gluconate|6-phospho D-gluconate|D-gluconate 6-phosphate|6-O-phosphonato-D-gluconate|CHEBI:58759|Q27126028,273.110,C6H10O10P-3,194.000,282.000,-4.000,17,4,10,5,"InChI=1S/C6H13O10P/c7-2(1-16-17(13,14)15)3(8)4(9)5(10)6(11)12/h2-5,7-10H,1H2,(H,11,12)(H2,13,14,15)/p-3/t2-,3-,4+,5-/m1/s1",C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)OP(=O)([O-])[O-],BIRSGZKFKXLSJQ-SQOUGZDYSA-K,"(2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-6-phosphonatooxyhexanoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977610,20090529,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Prof. Malboobi, Plant Biotechnology Lab, National Institute of Genetic Engineering and Biotechnology|Shanghai Institute of Organic Chemistry|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
42609788,Dttp trianion,dTTP(3-)|dTTP trianion|CHEBI:58370|Q27125733,479.140,C10H14N2O14P3-3,247.000,834.000,-5.300,29,3,14,8,"InChI=1S/C10H17N2O14P3/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(24-8)4-23-28(19,20)26-29(21,22)25-27(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,21,22)(H,11,14,15)(H2,16,17,18)/p-3/t6-,7+,8+/m0/s1",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O,NHVNXKFIZYSCEB-XLPZGREQSA-K,"[[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20090619,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|Springer Nature|Thieme Chemistry|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
44192273,Alamandine,"alamandine|1176306-10-7|GTPL6065|ZINC198141523|C20971|L-Alanyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline|(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid",855.000,C40H62N12O9,342.000,1540.000,-2.100,61,11,12,23,"InChI=1S/C40H62N12O9/c1-6-22(4)32(37(58)49-29(18-25-19-44-20-46-25)38(59)52-16-8-10-30(52)39(60)61)51-35(56)28(17-24-11-13-26(53)14-12-24)48-36(57)31(21(2)3)50-34(55)27(47-33(54)23(5)41)9-7-15-45-40(42)43/h11-14,19-23,27-32,53H,6-10,15-18,41H2,1-5H3,(H,44,46)(H,47,54)(H,48,57)(H,49,58)(H,50,55)(H,51,56)(H,60,61)(H4,42,43,45)/t22-,23-,27-,28-,29-,30-,31-,32-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)N,QVMYBFKDLPBYSO-GIGALADGSA-N,"(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20090914,"abcr GmbH|BLD Pharm|Chemieliva Pharmaceutical Co., Ltd|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|MolPort|Smolecule|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
44256492,"Eicosanoic-20,20,20-d3 Acid","Eicosanoic-20,20,20-d3 Acid|202480-70-4|Arachidic acid(d3)|Eicosanoic acid(d3)|LMFA01010049|20,20,20-trideuterioicosanoic acid|EICOSANOIC -20,20,20-D3 ACID|Eicosanoic acid-20,20,20-d3, 99 atom % D, 98% (CP)",315.500,C20H40O2,37.300,226.000,8.500,22,1,2,18,"InChI=1S/C20H40O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h2-19H2,1H3,(H,21,22)/i1D3",[2H]C([2H])([2H])CCCCCCCCCCCCCCCCCCC(=O)O,VKOBVWXKNCXXDE-FIBGUPNXSA-N,"20,20,20-trideuterioicosanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Pharmacology and Biochemistry|Use and Manufacturing,4,NULL,20091116,"A2B Chem|AA BLOCKS|Alsachim|Ambinter|Aurora Fine Chemicals LLC|BOC Sciences|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemMol|Collaborative Drug Discovery, Inc.|DiscoveryGate|LIPID MAPS|Sigma-Aldrich|Smolecule",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266540,Acetoacetyl-CoA(4-),"acetoacetyl-CoA(4-)|acetoacetyl-S-CoA|1420-36-6|acetoacetyl-CoA tetraanion|acetoacetyl-coenzyme A(4-)|CHEBI:57286|Q27124395|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-{[3-oxo-3-({2-[(3-oxobutanoyl)sulfanyl]ethyl}amino)propyl]amino}butyl] diphosphate}",847.600,C25H36N7O18P3S-4,417.000,1470.000,-6.100,54,5,23,21,"InChI=1S/C25H40N7O18P3S/c1-13(33)8-16(35)54-7-6-27-15(34)4-5-28-23(38)20(37)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-19(49-51(39,40)41)18(36)24(48-14)32-12-31-17-21(26)29-11-30-22(17)32/h11-12,14,18-20,24,36-37H,4-10H2,1-3H3,(H,27,34)(H,28,38)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t14-,18-,19-,20+,24-/m1/s1",CC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,OJFDKHTZOUZBOS-CITAKDKDSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-(3-oxobutanoylsulfanyl)ethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266545,Succinyl-CoA,"succinyl-CoA(5-)|succinyl-CoA|Succinyl-coenzyme A|suc-coa|succ-coenzyme-A|succ-CoA|succinyl-S-CoA|succinylcoenzyme-A|succ-S-CoA|succ-S-coenzyme-A|succinyl-S-coenzyme-A|succinyl-CoA pentaanion|604-98-8|succinyl-coenzyme A(5-)|S-(hydrogen succinyl)CoA(5-)|CHEBI:57292|S-(3-carboxy-propionyl)-CoA(5-)|Q27124401|3'-phosphonatoadenosine 5'-{3-[(3R)-4-{[3-({2-[(3-carboxylatopropanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl]diphosphate}",862.600,C25H35N7O19P3S-5,440.000,1480.000,-5.900,55,5,24,21,"InChI=1S/C25H40N7O19P3S/c1-25(2,20(38)23(39)28-6-5-14(33)27-7-8-55-16(36)4-3-15(34)35)10-48-54(45,46)51-53(43,44)47-9-13-19(50-52(40,41)42)18(37)24(49-13)32-12-31-17-21(26)29-11-30-22(17)32/h11-13,18-20,24,37-38H,3-10H2,1-2H3,(H,27,33)(H,28,39)(H,34,35)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/p-5/t13-,18-,19-,20+,24-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)CCC(=O)[O-])O,VNOYUJKHFWYWIR-ITIYDSSPSA-I,"4-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonatooxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-4-oxobutanoate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266565,Crotonoyl-CoA(4-),"crotonoyl-CoA(4-)|(E)-2-Butenoyl coenzyme A|crotonyl-CoA|2-butenoyl-CoA|(2E)-butenoyl-CoA|crotonyl-S-CoA|(E)-but-2-enoyl-CoA(4-)|CHEBI:57332|CHEBI:58669|102680-35-3|Q27124432|3'-phosphonatoadenosine 5'-{3-[(3R)-4-({3-[(2-{[(2E)-but-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-3-hydroxy-2,2-dimethyl-4-oxobutyl] diphosphate}|3'-phosphonatoadenosine 5'-{3-[(3R)-4-{[3-({2-[(but-2-enoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] diphosphate}",831.600,C25H36N7O17P3S-4,400.000,1430.000,-5.100,53,5,22,20,"InChI=1S/C25H40N7O17P3S/c1-4-5-16(34)53-9-8-27-15(33)6-7-28-23(37)20(36)25(2,3)11-46-52(43,44)49-51(41,42)45-10-14-19(48-50(38,39)40)18(35)24(47-14)32-13-31-17-21(26)29-12-30-22(17)32/h4-5,12-14,18-20,24,35-36H,6-11H2,1-3H3,(H,27,33)(H,28,37)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/b5-4+/t14-,18-,19-,20+,24-/m1/s1",C/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,KFWWCMJSYSSPSK-PAXLJYGASA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-[2-[(E)-but-2-enoyl]sulfanylethylamino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266570,2-Methylpropanoyl-CoA,"isobutyryl-CoA(4-)|2-Methylpropanoyl-CoA|isobutanoyl-CoA|2-Methylpropionyl-CoA|S-(2-methylpropanoyl)-CoA|isobutyryl-CoA tetraanion|15621-60-0|isobutyryl-coenzyme A(4-)|2-methylpropanoyl-CoA(4-)|2-methylpropionyl-CoA(4-)|CHEBI:57338|S-(2-methylpropanoyl)-coenzyme A(4-)|Q28529703|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-{[3-({2-[(2-methylpropanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl]diphosphate}",833.600,C25H38N7O17P3S-4,400.000,1400.000,-4.900,53,5,22,20,"InChI=1S/C25H42N7O17P3S/c1-13(2)24(37)53-8-7-27-15(33)5-6-28-22(36)19(35)25(3,4)10-46-52(43,44)49-51(41,42)45-9-14-18(48-50(38,39)40)17(34)23(47-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,34-35H,5-10H2,1-4H3,(H,27,33)(H,28,36)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/t14-,17-,18-,19+,23-/m1/s1",CC(C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,AEWHYWSPVRZHCT-NDZSKPAWSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-(2-methylpropanoylsulfanyl)ethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266576,Isovaleryl-CoA(4-),"isovaleryl-CoA(4-)|3-methylbutanoyl-CoA|3-methylbutyryl-CoA|iso-valeryl-CoA|isopentanoyl-CoA(4-)|isovaleryl-CoA tetraanion|6244-91-3|isovaleryl-coenzyme A(4-)|3-methylbutanoyl-CoA(4-)|isopentanoyl-coenzyme A(4-)|CHEBI:57345|Q27124445|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-{[3-({2-[(3-methylbutanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl] diphosphate}",847.600,C26H40N7O17P3S-4,400.000,1420.000,-4.700,54,5,22,21,"InChI=1S/C26H44N7O17P3S/c1-14(2)9-17(35)54-8-7-28-16(34)5-6-29-24(38)21(37)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-20(49-51(39,40)41)19(36)25(48-15)33-13-32-18-22(27)30-12-31-23(18)33/h12-15,19-21,25,36-37H,5-11H2,1-4H3,(H,28,34)(H,29,38)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/t15-,19-,20-,21+,25-/m1/s1",CC(C)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,UYVZIWWBJMYRCD-ZMHDXICWSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-(3-methylbutanoylsulfanyl)ethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266604,Glutaryl-CoA(5-),"glutaryl-CoA(5-)|glutaryl-CoA pentaanion|glutaryl-coenzyme A(5-)|4-carboxylatobutanoyl-CoA(5-)|CHEBI:57378|Q27124535|3'-phosphonatoadenosine 5'-{3-[(3R)-4-{[3-({2-[(4-carboxylatobutanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] diphosphate}",876.600,C26H37N7O19P3S-5,440.000,1500.000,-5.500,56,5,24,22,"InChI=1S/C26H42N7O19P3S/c1-26(2,21(39)24(40)29-7-6-15(34)28-8-9-56-17(37)5-3-4-16(35)36)11-49-55(46,47)52-54(44,45)48-10-14-20(51-53(41,42)43)19(38)25(50-14)33-13-32-18-22(27)30-12-31-23(18)33/h12-14,19-21,25,38-39H,3-11H2,1-2H3,(H,28,34)(H,29,40)(H,35,36)(H,44,45)(H,46,47)(H2,27,30,31)(H2,41,42,43)/p-5/t14-,19-,20-,21+,25-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)CCCC(=O)[O-])O,SYKWLIJQEHRDNH-CKRMAKSASA-I,"5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonatooxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-5-oxopentanoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266606,Itaconyl-CoA(5-),"itaconyl-CoA(5-)|Itaconyl-CoA|CHEBI:57381|Q27124547|3'-phosphonatoadenosine 5'-{3-[(3R)-4-{[3-({2-[(3-carboxybut-3-enoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] diphosphate}",874.600,C26H35N7O19P3S-5,440.000,1560.000,-5.300,56,5,24,21,"InChI=1S/C26H40N7O19P3S/c1-13(25(39)40)8-16(35)56-7-6-28-15(34)4-5-29-23(38)20(37)26(2,3)10-49-55(46,47)52-54(44,45)48-9-14-19(51-53(41,42)43)18(36)24(50-14)33-12-32-17-21(27)30-11-31-22(17)33/h11-12,14,18-20,24,36-37H,1,4-10H2,2-3H3,(H,28,34)(H,29,38)(H,39,40)(H,44,45)(H,46,47)(H2,27,30,31)(H2,41,42,43)/p-5/t14-,18-,19-,20+,24-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)CC(=C)C(=O)[O-])O,NFVGYLGSSJPRKW-CITAKDKDSA-I,"4-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonatooxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-2-methylidene-4-oxobutanoate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266608,Malonyl coenzyme A,"malonyl-CoA(5-)|MALONYL COENZYME A|CHEBI:57384|Q27124561|3'-phosphonatoadenosine 5'-{3-[(3R)-4-{[3-({2-[(3-carboxylatoacetyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] diphosphate}",848.500,C24H33N7O19P3S-5,440.000,1460.000,-5.600,54,5,24,20,"InChI=1S/C24H38N7O19P3S/c1-24(2,19(37)22(38)27-4-3-13(32)26-5-6-54-15(35)7-14(33)34)9-47-53(44,45)50-52(42,43)46-8-12-18(49-51(39,40)41)17(36)23(48-12)31-11-30-16-20(25)28-10-29-21(16)31/h10-12,17-19,23,36-37H,3-9H2,1-2H3,(H,26,32)(H,27,38)(H,33,34)(H,42,43)(H,44,45)(H2,25,28,29)(H2,39,40,41)/p-5/t12-,17-,18-,19+,23-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)CC(=O)[O-])O,LTYOQGRJFJAKNA-DVVLENMVSA-I,"3-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonatooxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-oxopropanoate",Malonyl Coenzyme A,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266613,Propanoyl-CoA,"propionyl-CoA(4-)|propanoyl-CoA|N-PROPIONYL-COA|CHEBI:57392|Q27124603|3'-phosphonatoadenosine 5'-(3-{(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[(3-oxo-3-{[2-(propanoylsulfanyl)ethyl]amino}propyl)amino]butyl} diphosphate)",819.600,C24H36N7O17P3S-4,400.000,1370.000,-5.500,52,5,22,20,"InChI=1S/C24H40N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,34-35H,4-10H2,1-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/p-4/t13-,17-,18-,19+,23-/m1/s1",CCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,QAQREVBBADEHPA-IEXPHMLFSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-propanoylsulfanylethylamino)propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|ToxPlanet|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266641,N(2)-Formyl-N(1)-(5-phospho-D-ribosyl)glycinamide(2-),N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide(2-)|CHEBI:58426|Q27125783|N-(N-formylglycyl)-5-O-phosphonato-D-ribofuranosylamine,312.170,C8H13N2O9P-2,180.000,388.000,-4.400,20,4,9,5,"InChI=1S/C8H15N2O9P/c11-3-9-1-5(12)10-8-7(14)6(13)4(19-8)2-18-20(15,16)17/h3-4,6-8,13-14H,1-2H2,(H,9,11)(H,10,12)(H2,15,16,17)/p-2/t4-,6-,7-,8?/m1/s1",C([C@@H]1[C@H]([C@H](C(O1)NC(=O)CNC=O)O)O)OP(=O)([O-])[O-],VDXLUNDMVKSKHO-ZRTZXPPTSA-L,"[(2R,3S,4R)-5-[(2-formamidoacetyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100507,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266654,5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-),5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)|5-Phosphoribosyl-5-formamido-4-imid-carboxamide|5'-p-Ribosyl-5-formamido-4-imidazole carboxamide|5'-phosphoribosyl-5-formamido-4-imidazole carboxamide|CHEBI:58467|5'-phosphoribosyl-formamido-carboxamide|5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide dianion|5'-p-Ribosyl-5-formamido-4-imidazolecarboxamide|5-formylamidoimidazole-4-carboxamide ribonucleotide|Q27125809|5-formamido-1-(5-phospho-D-ribosyl)-imidazole-4-carboxamide|1-(4-carb,364.210,C10H13N4O9P-2,212.000,519.000,-4.100,24,4,10,5,"InChI=1S/C10H15N4O9P/c11-8(18)5-9(13-3-15)14(2-12-5)10-7(17)6(16)4(23-10)1-22-24(19,20)21/h2-4,6-7,10,16-17H,1H2,(H2,11,18)(H,13,15)(H2,19,20,21)/p-2/t4-,6-,7-,10-/m1/s1",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O)NC=O)C(=O)N,ABCOOORLYAOBOZ-KQYNXXCUSA-L,"[(2R,3S,4R,5R)-5-(4-carbamoyl-5-formamidoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266657,Aminoimidazole carboxamide ribonucleotide,Z-nucleotide|5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide(2-)|aminoimidazole carboxamide ribonucleotide|5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide|5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide|CHEBI:58475|Q27125815|5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide dianion|5-amino-1-(5-O-phosphonato-beta-D-ribofuranosyl)-1H-imidazole-4-carboxamide,336.200,C9H13N4O8P-2,209.000,463.000,-4.000,22,4,10,4,"InChI=1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/p-2/t3-,5-,6-,9-/m1/s1",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O)N)C(=O)N,NOTGFIUVDGNKRI-UUOKFMHZSA-L,"[(2R,3S,4R,5R)-5-(5-amino-4-carbamoylimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266677,S-Methyl-5-thio-alpha-D-ribose 1-phosphate(2-),S-methyl-5-thio-alpha-D-ribose 1-phosphate(2-)|1-phosphomethylthioribose|5-methylthioribose-1-phosphate|1-phospho-5-S-methylthioribose|5-methylthio-D-ribose-1-phosphate|1-PMTR|CHEBI:58533|1-phospho-5-S-methylthio-alpha-D-ribofuranoside|S-methyl-5-thio-  -D-ribose 1-phosphate(2-)|Q27125852|5-S-methyl-1-O-phosphonato-5-thio-alpha-D-ribofuranose,258.190,C6H11O7PS-2,147.000,244.000,-2.400,15,2,8,3,"InChI=1S/C6H13O7PS/c1-15-2-3-4(7)5(8)6(12-3)13-14(9,10)11/h3-8H,2H2,1H3,(H2,9,10,11)/p-2/t3-,4-,5-,6-/m1/s1",CSC[C@@H]1[C@H]([C@H]([C@H](O1)OP(=O)([O-])[O-])O)O,JTFITTQBRJDSTL-KVTDHHQDSA-L,"[(2R,3R,4S,5S)-3,4-dihydroxy-5-(methylsulfanylmethyl)oxolan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata|WikiPathways",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266741,2-Ammonio-2-deoxy-D-glucopyranose,2-ammonio-2-deoxy-D-glucopyranose|chitosamine|2-amino-2-deoxyglucose|CHEBI:58723|2-Deoxy-2-ammonio-D-glucopyranose|2-azaniumyl-2-deoxy-D-glucopyranose|Q27125993,180.180,C6H14NO5+,118.000,155.000,-2.800,12,5,5,1,"InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/p+1/t2-,3-,4-,5-,6?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)[NH3+])O)O)O,MSWZFWKMSRAUBD-IVMDWMLBSA-O,"[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]azanium",Glucosamine,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|Wikidata",Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878382,Nicotinic acid mononucleotide,nicotinate D-ribonucleotide(2-)|nicotinate mononucleotide|nicotinic acid ribonucleotide|nicotinate ribonucleotide|Nicotinate D-ribonucleotide|nicotinic acid mononucleotide|Beta-nicotinate D-ribonucleotide|nicotinate beta-D-ribonucleotide|321-02-8|nicotinate dinucleotide|nicotinic acid nucleotide|beta-nicotinate-D-nucleotide|CHEBI:57502|nicotinate D-ribonucleotide dianion|Q27124739|1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium-3-carboxylate|3-carboxylato-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridiniu,333.190,C11H12NO9P-2,166.000,438.000,-2.300,22,2,9,3,"InChI=1S/C11H14NO9P/c13-8-7(5-20-22(17,18)19)21-10(9(8)14)12-3-1-2-6(4-12)11(15)16/h1-4,7-10,13-14H,5H2,(H2-,15,16,17,18,19)/p-2/t7-,8-,9-,10-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O)C(=O)[O-],JOUIQRNQJGXQDC-ZYUZMQFOSA-L,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|PATENTSCOPE (WIPO)|ToxPlanet|Wikidata",Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878398,"N(6)-(1,2-Dicarboxylatoethyl)-AMP(4-)","N(6)-(1,2-dicarboxylatoethyl)-AMP(4-)|adenylo-succ|adenylo-succinate|CHEBI:57567|N(6)-(1,2-dicarboxylatoethyl)-AMP tetraanion|N-(1,2-dicarboxylatoethyl)-5'-O-phosphonatoadenosine|Q27104823",459.260,C14H14N5O11P-4,258.000,702.000,-2.000,31,3,15,6,"InChI=1S/C14H18N5O11P/c20-7(21)1-5(14(24)25)18-11-8-12(16-3-15-11)19(4-17-8)13-10(23)9(22)6(30-13)2-29-31(26,27)28/h3-6,9-10,13,22-23H,1-2H2,(H,20,21)(H,24,25)(H,15,16,18)(H2,26,27,28)/p-4/t5?,6-,9-,10-,13-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)NC(CC(=O)[O-])C(=O)[O-],OFBHPPMPBOJXRT-DPXQIYNJSA-J,"2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878417,"(2S,4R,5S)-2,4,5,6-Tetrahydroxy-3-oxohexanoate","3-dehydro-L-gulonate|3-keto-L-gulonate|L-xylo-hex-3-ulosonate|3-dehydro-L-gulonate anion|CHEBI:57655|(2S,4R,5S)-2,4,5,6-tetrahydroxy-3-oxohexanoate|Q27124840",193.130,C6H9O7-,138.000,196.000,-2.200,13,4,7,4,"InChI=1S/C6H10O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-3,5,7-9,11H,1H2,(H,12,13)/p-1/t2-,3+,5-/m0/s1",C([C@@H]([C@H](C(=O)[C@@H](C(=O)[O-])O)O)O)O,WTAHRPBPWHCMHW-LWKDLAHASA-M,"(2S,4R,5S)-2,4,5,6-tetrahydroxy-3-oxohexanoate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata|WikiPathways",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878426,CMP-N-acetyl-beta-neuraminate(2-),"CMP-N-acetyl-beta-neuraminate(2-)|CMP-N-acetyl-beta-neuraminate|CMP-N-acetyl-beta-neuraminate dianion|CHEBI:57812|CMP-N-acetyl-  -neuraminate(2-)|cytidine monophosphate N-acetyl-beta-neuraminate|cytidine monophosphate N-acetyl-beta-neuraminic acid|Q27124965|cytidine 5'-(5-acetamido-3,5-dideoxy-D-glycero-beta-D-galacto-non-2-ulopyranosylonate monophosphate)",612.400,C20H29N4O16P-2,326.000,1110.000,-6.200,41,8,16,10,"InChI=1S/C20H31N4O16P/c1-7(26)22-12-8(27)4-20(18(32)33,39-16(12)13(29)9(28)5-25)40-41(35,36)37-6-10-14(30)15(31)17(38-10)24-3-2-11(21)23-19(24)34/h2-3,8-10,12-17,25,27-31H,4-6H2,1H3,(H,22,26)(H,32,33)(H,35,36)(H2,21,23,34)/p-2/t8-,9+,10+,12+,13+,14+,15+,16+,17+,20+/m0/s1",CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)[O-])OP(=O)([O-])OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=NC3=O)N)O)O)O,TXCIAUNLDRJGJZ-BILDWYJOSA-L,"(2R,4S,5R,6R)-5-acetamido-2-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Thieme Chemistry|ToxPlanet|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878428,Sphinganine(1+),"sphinganine(1+)|C18-sphinganine|d18:0|sphinganine (C18)|C18-sphinganine(1+)|dihydrosphingosine (C18)|D-erythro-DHS (C18)|D-erythro-sphinganine (C18)|CHEBI:57817|D-erythro-dihydrosphingosine (C18)|(2S,3R)-1,3-dihydroxyoctadecan-2-aminium|d18:0(1+)|Q27124972",302.500,C18H40NO2+,68.100,200.000,5.800,21,3,2,16,"InChI=1S/C18H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17-18,20-21H,2-16,19H2,1H3/p+1/t17-,18+/m0/s1",CCCCCCCCCCCCCCC[C@H]([C@H](CO)[NH3+])O,OTKJDMGTUTTYMP-ZWKOTPCHSA-O,"[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]azanium",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878432,"(2S,3R)-2-Azaniumyl-3-hydroxyoctadecyl phosphate","sphinganine 1-phosphate|sphinganine 1-phosphate(1-)|(2S,3R)-2-azaniumyl-3-hydroxyoctadecyl phosphate|DHS-1-P|GTPL6621|CHEBI:57939|(2S,3R)-2-ammonio-3-hydroxyoctadecyl phosphate|Q27088848|(2S,3R)-3-hydroxy-1-(phosphonatooxy)octadecan-2-aminium",380.500,C18H39NO5P-,120.000,326.000,2.300,25,2,5,17,"InChI=1S/C18H40NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h17-18,20H,2-16,19H2,1H3,(H2,21,22,23)/p-1/t17-,18+/m0/s1",CCCCCCCCCCCCCCC[C@H]([C@H](COP(=O)([O-])[O-])[NH3+])O,YHEDRJPUIRMZMP-ZWKOTPCHSA-M,"[(2S,3R)-2-azaniumyl-3-hydroxyoctadecyl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Therapeutic Target Database (TTD)|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878460,"(2S,3S)-2-Methylcitrate","(2S,3S)-2-methylcitrate(3-)|(2S,3S)-2-methylcitrate|(2S,3S)-2-hydroxybutane-1,2,3-tricarboxylate|CHEBI:58853|Q27126292|(1S,2S)-2-hydroxy-1-methylpropane-1,2,3-tricarboxylate|3-C-carboxylato-2,4-dideoxy-4-methyl-D-erythro-pentarate",203.130,C7H7O7-3,141.000,255.000,0.500,14,1,7,2,"InChI=1S/C7H10O7/c1-3(5(10)11)7(14,6(12)13)2-4(8)9/h3,14H,2H2,1H3,(H,8,9)(H,10,11)(H,12,13)/p-3/t3-,7+/m1/s1",C[C@H](C(=O)[O-])[C@@](CC(=O)[O-])(C(=O)[O-])O,YNOXCRMFGMSKIJ-NFNCENRGSA-K,"(2S,3S)-2-hydroxybutane-1,2,3-tricarboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46926300,"(3R,5S)-1-Pyrroline-3-hydroxy-5-carboxylate","(3R,5S)-1-Pyrroline-3-hydroxy-5-carboxylate|(3R,5S)-3-hydroxy-1-pyrroline-5-carboxylate|L-Delta1-pyrroline 3-hydroxy-5-carboxylate|CHEBI:62612|L-1-pyrroline-3-hydroxy-5-carboxylate(1-)|L-Delta(1)-pyrroline 3-hydroxy-5-carboxylate|Q27132042|(2S,4R)-4-hydroxy-3,4-dihydro-2H-pyrrole-2-carboxylate",128.110,C5H6NO3-,72.700,149.000,-0.400,9,1,4,0,"InChI=1S/C5H7NO3/c7-3-1-4(5(8)9)6-2-3/h2-4,7H,1H2,(H,8,9)/p-1/t3-,4+/m1/s1",C1[C@H](C=N[C@@H]1C(=O)[O-])O,WFOFKRKDDKGRIK-DMTCNVIQSA-M,"(2S,4R)-4-hydroxy-3,4-dihydro-2H-pyrrole-2-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20101025,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46931118,FADH2 dianion,"FADH2(2-)|FADH2 (2-)|FADH2 dianion|1,5-dihydro-FAD dianion|1,5-dihydro-FAD(2-)|CHEBI:58307|dihydroflavin adenine dinucleotide(2-)|dihydroflavin adenine dinucleotide dianion|Q26998317|Q27125687|(2R,3S,4S)-5-{7,8-dimethyl-2,4-dioxo-1H,2H,3H,4H,5H,10H-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl ({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate|adenosine 5'-(3-{D-ribo-5-[7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2H)-yl]-2,3,4-trihydroxyp",785.500,C27H33N9O15P2-2,361.000,1500.000,-5.000,53,9,21,13,"InChI=1S/C27H35N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,32,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H2,33,34,42,43)/p-2/t14-,15+,16+,19-,20+,21+,26+/m0/s1",CC1=CC2=C(C=C1C)N(C3=C(N2)C(=O)NC(=O)N3)C[C@@H]([C@@H]([C@@H](COP(=O)([O-])OP(=O)([O-])OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O,YPZRHBJKEMOYQH-UYBVJOGSSA-L,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-1,5-dihydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20101103,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49791982,"5-(1,2-Dihydroxyethyl)-4-hydroxyfuran-2,3-dione",NULL,174.110,C6H6O6,104.000,265.000,-1.200,12,3,6,2,"InChI=1S/C6H6O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,7-9H,1H2",C(C(C1=C(C(=O)C(=O)O1)O)O)O,JMMUPWYGEQCUML-UHFFFAOYSA-N,"5-(1,2-dihydroxyethyl)-4-hydroxyfuran-2,3-dione",NULL,Biomolecular Interactions and Pathways|Pharmacology and Biochemistry,2,NULL,20101217,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Human Metabolome Database (HMDB)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49791998,L-3-Hydroxykynurenine,3-hydroxy-L-kynurenine zwitterion|3-hydroxy-kynurenine|L-3-Hydroxykynurenine|CHEBI:58125|(2S)-4-(2-amino-3-hydroxyphenyl)-2-azaniumyl-4-oxobutanoate,224.210,C10H12N2O4,131.000,277.000,-1.900,16,3,5,3,"InChI=1S/C10H12N2O4/c11-6(10(15)16)4-8(14)5-2-1-3-7(13)9(5)12/h1-3,6,13H,4,11-12H2,(H,15,16)/t6-/m0/s1",C1=CC(=C(C(=C1)O)N)C(=O)C[C@@H](C(=O)[O-])[NH3+],VCKPUUFAIGNJHC-LURJTMIESA-N,(2S)-4-(2-amino-3-hydroxyphenyl)-2-azaniumyl-4-oxobutanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20101217,BioCyc|ChEBI|DiscoveryGate|Google Patents,Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49867164,2h-Imidazol-4-Ylacetic Acid,2h-Imidazol-4-Ylacetic Acid|2-(2H-imidazol-4-yl)ethanoic acid|CHEBI:43615|Q27120521,126.110,C5H6N2O2,62.000,183.000,-0.800,9,1,4,2,"InChI=1S/C5H6N2O2/c8-5(9)1-4-2-6-3-7-4/h2H,1,3H2,(H,8,9)",C1N=CC(=N1)CC(=O)O,RMEAVYUMFHJQAD-UHFFFAOYSA-N,2-(2H-imidazol-4-yl)acetic acid,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20110217,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|MetabolomicsWorkbench|Protein Data Bank in Europe (PDBe)|Wikidata",Curation Efforts|Governmental Organizations|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
52921580,(2S)-2-Ammonio-4-{[(2R)-2-ammonio-2-carboxylatoethyl]selanyl}butanoate,L-selenocystathionine zwitterion|CHEBI:62226|(2S)-2-ammonio-4-{[(2R)-2-ammonio-2-carboxylatoethyl]selanyl}butanoate|(2S)-2-azaniumyl-4-{[(2R)-2-azaniumyl-2-carboxylatoethyl]selanyl}butanoate,269.170,C7H14N2O4Se,136.000,201.000,NULL,14,2,4,5,"InChI=1S/C7H14N2O4Se/c8-4(6(10)11)1-2-14-3-5(9)7(12)13/h4-5H,1-3,8-9H2,(H,10,11)(H,12,13)/t4-,5-/m0/s1",C(C[Se]C[C@@H](C(=O)[O-])[NH3+])[C@@H](C(=O)[O-])[NH3+],ZNWYDQPOUQRDLY-WHFBIAKZSA-N,(2S)-2-azaniumyl-4-[(2R)-2-azaniumyl-2-carboxylatoethyl]selanylbutanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20110606,BioCyc|ChEBI|Google Patents,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53262325,Methacrylyl-coenzyme A,"methacrylyl-CoA(4-)|Methylacrylyl-CoA|methacrylyl-coenzyme A|2-Methylprop-2-enoyl-CoA|6008-91-9|(2E)-2-methylpropenoyl-CoA|CHEBI:62500|2-methylprop-2-enoyl-CoA(4-)|Q27131960|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-{[3-({2-[(2-methylprop-2-enoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl] diphosphate}",831.600,C25H36N7O17P3S-4,400.000,1450.000,-5.000,53,5,22,20,"InChI=1S/C25H40N7O17P3S/c1-13(2)24(37)53-8-7-27-15(33)5-6-28-22(36)19(35)25(3,4)10-46-52(43,44)49-51(41,42)45-9-14-18(48-50(38,39)40)17(34)23(47-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-12,14,17-19,23,34-35H,1,5-10H2,2-4H3,(H,27,33)(H,28,36)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/t14-,17-,18-,19+,23-/m1/s1",CC(=C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,NPALUEYCDZWBOV-NDZSKPAWSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-(2-methylprop-2-enoylsulfanyl)ethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20110801,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477568,2-Deoxy-D-ribofuranose 5-phosphate(2-),"2-deoxy-D-ribofuranose 5-phosphate(2-)|CHEBI:62877|2-deoxy-D-erythro-pentofuranose 5-phosphate|2-deoxy-D-ribofuranose 5-monophosphate(2-)|2-deoxy-5-O-phosphonato-D-erythro-pentofuranose|[(2R,3S)-3,5-dihydroxyoxolan-2-yl]methyl phosphate|Q27132249|[(2R,3S)-3,5-dihydroxytetrahydrofuran-2-yl]methyl phosphate",212.090,C5H9O7P-2,122.000,201.000,-2.800,13,2,7,2,"InChI=1S/C5H11O7P/c6-3-1-5(7)12-4(3)2-11-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/p-2/t3-,4+,5?/m0/s1",C1[C@@H]([C@H](OC1O)COP(=O)([O-])[O-])O,KKZFLSZAWCYPOC-PYHARJCCSA-L,"[(2R,3S)-3,5-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20111108,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477637,Chenodeoxycholoyl-CoA(4-),chenodeoxycholoyl-CoA(4-)|chenodeoxychololyl-CoA|CHEBI:62989|chenodeoxycholoyl-coenzyme A(4-)|Q27132322,1138.100,C45H70N7O19P3S-4,441.000,2150.000,-0.800,75,7,24,23,"InChI=1S/C45H74N7O19P3S/c1-24(27-7-8-28-34-29(11-14-45(27,28)5)44(4)13-10-26(53)18-25(44)19-30(34)54)6-9-33(56)75-17-16-47-32(55)12-15-48-41(59)38(58)43(2,3)21-68-74(65,66)71-73(63,64)67-20-31-37(70-72(60,61)62)36(57)42(69-31)52-23-51-35-39(46)49-22-50-40(35)52/h22-31,34,36-38,42,53-54,57-58H,6-21H2,1-5H3,(H,47,55)(H,48,59)(H,63,64)(H,65,66)(H2,46,49,50)(H2,60,61,62)/p-4/t24-,25+,26-,27-,28+,29+,30-,31-,34+,36-,37-,38+,42-,44+,45-/m1/s1",C[C@H](CCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O)[C@H]4CC[C@@H]5[C@@]4(CC[C@H]6[C@H]5[C@@H](C[C@H]7[C@@]6(CC[C@H](C7)O)C)O)C,IIWDDMINEZBCTG-RUAADODMSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-[2-[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]sulfanylethylamino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20111108,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477733,"[(2R,3S)-5-(6-Aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",NULL,411.200,C10H15N5O9P2,212.000,607.000,-3.300,26,5,13,6,"InChI=1S/C10H15N5O9P2/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(23-7)2-22-26(20,21)24-25(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7?/m0/s1",C1[C@@H]([C@H](OC1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)OP(=O)(O)O)O,DAEAPNUQQAICNR-GFCOJPQKSA-N,"[(2R,3S)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20111109,Human Metabolome Database (HMDB)|MassBank of North America (MoNA),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477850,(2E)-Octadecenoyl-Coenzyme A,(2E)-Octadecenoyl-Coenzyme A,1032.000,C39H68N7O17P3S,389.000,1700.000,2.700,67,9,22,35,"InChI=1S/C39H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h18-19,26-28,32-34,38,49-50H,4-17,20-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/b19-18+/t28-,32?,33+,34+,38-/m1/s1",CCCCCCCCCCCCCCC/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@@H](C([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,NBCCUIHOHUKBMK-XCRBYWPRSA-N,"S-[2-[3-[[(2R)-4-[[[(2R,3R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (E)-octadec-2-enethioate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Pharmacology and Biochemistry,3,NULL,20111109,Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477854,(a-D-Mannosyl)2-b-D-mannosyl-N-acetylglucosamine,"(a-D-mannosyl)2-b-D-mannosyl-N-acetylglucosamine|(alpha-D-mannosyl)2-beta-D-mannosyl-N-acetylglucosamine|(alpha-delta-mannosyl)2-beta-delta-mannosyl-N-acetylglucosamine|N-[(2R,3R,4R,5S,6R)-5-{[(2R,3R,4R,5S,6S)-4-{[(2R,3R,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",707.600,C26H45NO21,357.000,1030.000,-7.900,48,14,21,11,"InChI=1S/C26H45NO21/c1-6(32)27-11-15(36)20(10(5-31)42-23(11)41)46-25-18(39)22(14(35)8(3-29)44-25)48-26-19(40)21(13(34)9(4-30)45-26)47-24-17(38)16(37)12(33)7(2-28)43-24/h7-26,28-31,33-41H,2-5H2,1H3,(H,27,32)/t7-,8-,9-,10+,11+,12-,13-,14-,15+,16+,17+,18+,19+,20+,21+,22+,23+,24-,25+,26+/m0/s1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O[C@@H]2[C@@H]([C@@H]([C@H]([C@@H](O2)CO)O)O[C@@H]3[C@@H]([C@@H]([C@H]([C@@H](O3)CO)O)O[C@H]4[C@@H]([C@@H]([C@H]([C@@H](O4)CO)O)O)O)O)O)O,ANPUOEHHKRCFGW-NRDBFSGKSA-N,"N-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6S)-4-[(2R,3R,4R,5S,6S)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Patents|Pharmacology and Biochemistry,4,NULL,20111109,Google Patents|Human Metabolome Database (HMDB)|MetabolomicsWorkbench,Curation Efforts|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
71448892,(E)-3-Methylglutaconyl-1-CoA,"3-Methylglutaconyl-CoA|(E)-3-Methylglutaconyl-1-CoA|SCHEMBL188195|C03231|(E)-5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-methyl-5-oxopent-3-enoic acid",893.600,C27H42N7O19P3S,426.000,1620.000,-5.100,57,10,24,23,"InChI=1S/C27H42N7O19P3S/c1-14(8-17(36)37)9-18(38)57-7-6-29-16(35)4-5-30-25(41)22(40)27(2,3)11-50-56(47,48)53-55(45,46)49-10-15-21(52-54(42,43)44)20(39)26(51-15)34-13-33-19-23(28)31-12-32-24(19)34/h9,12-13,15,20-22,26,39-40H,4-8,10-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,45,46)(H,47,48)(H2,28,31,32)(H2,42,43,44)/b14-9+/t15-,20-,21-,22+,26-/m1/s1",C/C(=C\\C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O)/CC(=O)O,GXKSHRDAHFLWPN-RKYLSHMCSA-N,"(E)-5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-methyl-5-oxopent-3-enoic acid",NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20130527,"BioCyc|ECI Group, LCSB, University of Luxembourg|Google Patents|KEGG|SureChEMBL",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
74000474,3-Ketostearoyl-coenzyme A,3-Ketostearoyl-coenzyme A,1048.000,C39H68N7O18P3S,406.000,1740.000,1.500,68,9,23,36,"InChI=1S/C39H68N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-27(47)22-30(49)68-21-20-41-29(48)18-19-42-37(52)34(51)39(2,3)24-61-67(58,59)64-66(56,57)60-23-28-33(63-65(53,54)55)32(50)38(62-28)46-26-45-31-35(40)43-25-44-36(31)46/h25-26,28,32-34,38,50-51H,4-24H2,1-3H3,(H,41,48)(H,42,52)(H,56,57)(H,58,59)(H2,40,43,44)(H2,53,54,55)",CCCCCCCCCCCCCCCC(=O)CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,LGOGWHDPDVAUNY-UHFFFAOYSA-N,"S-[2-[3-[[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-oxooctadecanethioate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20140604,Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
86289088,Saicar(4-),"SAICAR(4-)|CHEBI:58443|Q27125795|(2S)-2-[5-amino-1-(5-O-phosphonato-beta-D-ribosyl)imidazole-4-carboxamido]succinate|(2S)-2-[5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamido]succinate|5-amino-N-[(1S)-1,2-dicarboxylatoethyl]-1-(5-O-phosphonato-beta-D-ribofuranosyl)-1H-imidazole-4-carboxamide",450.250,C13H15N4O12P-4,275.000,696.000,-3.200,30,4,14,6,"InChI=1S/C13H19N4O12P/c14-10-7(11(22)16-4(13(23)24)1-6(18)19)15-3-17(10)12-9(21)8(20)5(29-12)2-28-30(25,26)27/h3-5,8-9,12,20-21H,1-2,14H2,(H,16,22)(H,18,19)(H,23,24)(H2,25,26,27)/p-4/t4-,5+,8+,9+,12+/m0/s1",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O)N)C(=O)N[C@@H](CC(=O)[O-])C(=O)[O-],NAQGHJTUZRHGAC-ZZZDFHIKSA-J,"(2S)-2-[[5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]imidazole-4-carbonyl]amino]butanedioate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20141218,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
129630972,5-Phosphoribosylglycinamide,5-phosphoribosylglycinamide,286.180,C7H15N2O8P,172.000,346.000,-6.700,18,6,9,6,"InChI=1S/C7H15N2O8P/c8-4(10)1-9-7-6(12)5(11)3(17-7)2-16-18(13,14)15/h3,5-7,9,11-12H,1-2H2,(H2,8,10)(H2,13,14,15)/t3-,5-,6-,7?/m1/s1",C([C@@H]1[C@H]([C@H](C(O1)NCC(=O)N)O)O)OP(=O)(O)O,IXSPYRJFXGEAMF-HJZCUYRDSA-N,"[(2R,3S,4R)-5-[(2-amino-2-oxoethyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Literature|Patents|Pharmacology and Biochemistry,4,NULL,20170913,Google Patents|PATENTSCOPE (WIPO)|Springer Nature,Governmental Organizations|Journal Publishers|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
129652037,5-Phosphoribosyl-n-formylglycinamide,5-phosphoribosyl-n-formylglycinamide,314.190,C8H15N2O9P,175.000,399.000,-6.500,20,6,10,6,"InChI=1S/C8H15N2O9P/c11-3-10-5(12)1-9-8-7(14)6(13)4(19-8)2-18-20(15,16)17/h3-4,6-9,13-14H,1-2H2,(H,10,11,12)(H2,15,16,17)/t4-,6-,7-,8?/m1/s1",C([C@@H]1[C@H]([C@H](C(O1)NCC(=O)NC=O)O)O)OP(=O)(O)O,ADLAKTDQAWVTRY-ZRTZXPPTSA-N,"[(2R,3S,4R)-5-[(2-formamido-2-oxoethyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Literature|Patents|Pharmacology and Biochemistry,4,NULL,20170913,Google Patents|PATENTSCOPE (WIPO)|Springer Nature,Governmental Organizations|Journal Publishers|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
131769850,4-Methylzymosterol intermediate 1,4-Methylzymosterol intermediate 1,442.700,C29H46O3,57.500,820.000,7.600,32,2,3,5,"InChI=1S/C29H46O3/c1-18(2)8-7-9-19(3)21-11-12-22-20-10-13-24-28(5,23(20)14-16-27(21,22)4)17-15-25(30)29(24,6)26(31)32/h8,19,21-22,24-25,30H,7,9-17H2,1-6H3,(H,31,32)/t19-,21-,22-,24-,25-,27+,28+,29-/m0/s1",C[C@@H](CCC=C(C)C)[C@@H]1CC[C@@H]2[C@@]1(CCC3=C2CC[C@H]4[C@@]3(CC[C@@H]([C@@]4(C)C(=O)O)O)C)C,MYWAIWDQTCHPTH-VBLXKELWSA-N,"(3S,4S,5S,10S,13R,14R,17S)-3-hydroxy-4,10,13-trimethyl-17-[(2S)-6-methylhept-5-en-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-4-carboxylic acid",NULL,Biomolecular Interactions and Pathways|Literature|Patents|Pharmacology and Biochemistry,4,NULL,20171122,Google Patents|Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398593,2'-Deoxyinosine,"2'-Deoxyinosine|890-38-0|deoxyinosine|Inosine, 2'-deoxy-|9-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-ol|UNII-HN0RQ6SBWQ|delta-Ino|d-Ino|9-(2-Deoxy-beta-D-ribofuranosyl)hypoxanthine|HN0RQ6SBWQ|MFCD00005762|CHEBI:28997|9-(2-deoxy-beta-D-erythro-pentofuranosyl)-9H-purin-6-ol|9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-ol|2'-Deoxyinosine, 98+%|9-(2-deoxy-b-D-erythro-pentofuranosyl)-Hypoxanthine|9-(2-deoxy-beta-D-erythro-pentofuranosyl)-Hypoxanthine|9-(2-deoxy-b",252.230,C10H12N4O4,109.000,377.000,-1.700,18,3,6,2,"InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=CNC3=O)CO)O,VGONTNSXDCQUGY-RRKCRQDMSA-N,"9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,33651|485290|504339|504444|504648|504845|504847|504891|540267|540317|588453|588456|588579|588590|588795|588855|588856|602310|602332|624178|624202|624263|624414|651965|652106|686978|686979|720579|720580|1347041|1347075|1347076,20190115,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BerrChem|BindingDB|BioCyc|Biological Magneti",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398597,2'-Deoxyguanosine 5'-monophosphate,"Deoxyguanylic acid|Deoxy-GMP|2'-Deoxyguanosine 5'-phosphate|2'-deoxyguanosine 5'-monophosphate|2'-Deoxyguanylic acid|Deoxyguanylate|Deoxyguanosine monophosphate|Deoxyguanosine 5'-monophosphate|dGMP|2'-Deoxy-GMP|2'-dGMP|Deoxyguanosine 5'-phosphate|2'-Deoxy-5'-guanylic acid|5'-DGMP|902-04-5|2'-Deoxyguanosine-5'-Monophosphate|5'-Deoxyguanylic acid|Deoxy GMP|5'-Guanylic acid, 2'-deoxy-|2'-Deoxyguanosine 5'MP|deoxyguanosine-phosphate|2'-dG-5'-MP|2'-Deoxy-5'-GMP|UNII-7EAM4TG712|2'-Deoxyguanosine 5'-phosphoric aci",347.220,C10H14N5O7P,182.000,568.000,-3.000,23,5,9,4,"InChI=1S/C10H14N5O7P/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(22-6)2-21-23(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)O)O,LTFMZDNNPPEQNG-KVQBGUIXSA-N,"[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,18082|23335|359798|359799|359800|359801|359802|359803|359804|359805|359812|359813|359814|359815|359816|359817|359818|359819|1259310|1259374|1259422,20190115,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|AstaTech, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398604,Dihydrofolic acid,"Dihydrofolic acid|dihydrofolate|7,8-Dihydrofolic acid|4033-27-6|7,8-dihydrofolate|UNII-KXP0KNM559|7,8-Dihydropteroylglutamate|CHEBI:15633|H2PteGlu|7,8-Dihydro-L-folic acid|KXP0KNM559|CHEMBL46294|N-(7,8-dihydropteroyl)-L-glutamic acid|H2PteGlu1|(2S)-2-[[4-[(2-amino-4-oxo-7,8-dihydro-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid|N-(4-{[(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid|DIHYDROFOLICACID|N-(4-(((2-amino-1,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methy",443.400,C19H21N7O6,208.000,889.000,-0.900,32,7,10,9,"InChI=1S/C19H21N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,12,21H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t12-/m0/s1",C1C(=NC2=C(N1)N=C(NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,OZRNSSUDZOLUSN-LBPRGKRZSA-N,"(2S)-2-[[4-[(2-amino-4-oxo-7,8-dihydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,11,57085|57086|57087|57088|57251|57253|57256|57258|57262|57264|57266|57267|57268|57269|58118|58120|89920|89922|89924|91439|91440|91559|134195|134197|227964|227965|500670|500671|1147634|1147640|1147642|1147653,20190115,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|AbaChemScene|ABI Chem|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BindingDB|BioCyc|BOC Sciences|CCSbase|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DC Chemicals|DiscoveryGate|DrugBank|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Glentham Life Sciences Lt",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398634,Guanine,"guanine|73-40-5|2-Amino-6-hydroxypurine|Guanin|2-Aminohypoxanthine|Mearlmaid|Pearl essence|Guanine enol|Stella Polaris|Dew Pearl|Natural pearl essence|Natural white 1|6H-Purin-6-one, 2-amino-1,7-dihydro-|2-Amino-6-purinol|C.I. Natural White 1|CI Natural white 1|Hypoxanthine, 2-amino-|6-Hydroxy-2-aminopurine|2-Amino-1,7-dihydro-6H-purin-6-one|2-amino-1H-purin-6(7H)-one|2-amino-1,9-dihydro-6H-purin-6-one|C.I. 75170|HSDB 2127|CI 75170|Mearlmaid AA|6H-Purin-6-one, 2-amino-1,9-dihydro-|2-amino-9H-purin-6-ol|AI3-",151.130,C5H5N5O,96.200,225.000,-1.100,11,3,3,0,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",C1=NC2=C(N1)C(=O)NC(=N2)N,UYTPUPDQBNUYGX-UHFFFAOYSA-N,"2-amino-1,7-dihydropurin-6-one",Guanine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,19262|47311|66419|155106|155120|155299|164770|164911|217732|230017|274547|274548|274549|274550|274562|274563|338748|502384|515780|694063|694065|694066|694067|694069|1129827|1129829|1136401|1136403|1204895|1259408|1272365|1324536|1324537|1324539|1324540|1324541|1324542|1324543|1324544|1324545|1324549|1324550|1324551|1324552|1348882|1348887|1452128,20190115,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Aromalake Chemical|Assembly Block",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398640,Inosinic acid,"Inosinic acid|5'-inosinic acid|131-99-7|inosine 5'-monophosphate|inosine monophosphate|5'-IMP|inosine 5'-phosphate|INOSINE-5'-MONOPHOSPHATE|5'-inosinate|IMP|5'-inosine monophosphate|Inosine-5'-monophosphoric acid|Inosine 5'-Monophosphoric acid|UNII-TAO7US05G5|BRN 0630517|Polyinosinic acid|TAO7US05G5|Polyinosine|PolyI|CHEBI:17202|Oligoinosinic acid|Poly(rI)|Polyriboinosinic acid|ribosylhypoxanthine monophosphate|POLY I|30918-54-8|5'-Inosinic acid polymers|Polyinosinic acids|((2R,3S,4R,5R)-3,4-Dihydroxy-5-(6-",348.210,C10H13N4O8P,176.000,555.000,-3.000,23,5,10,4,"InChI=1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,GRSZFWQUAKGDAV-KQYNXXCUSA-N,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",Inosine Monophosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1811|92479|92482|92603|767228|977610|977611|1226508|1226509|1226510|1259555,20190115,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A1 BioChem Labs|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|BindingDB|BioCrick|BioCyc|Biological Magnetic Resonanc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
135398652,"5,10-Methylene-THF","5,10-methylene-THF|5,10-methylenetetrahydrofolate|3432-99-3|SCHEMBL258730|5,10-Methylene-6-Hydrofolate|DTXSID90955873|N5>,N10-methylenetetrahydrofolate|C00143|2-({4-[(6aR)-3-amino-1-oxo-1H,2H,5H,6H,6aH,7H,8H,9H-imidazolidino[1,5-f]pteridin-8-yl]phenyl}formamido)pentanedioic acid|N-[4-(1-Hydroxy-3-imino-3,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]glutamic acid",457.400,C20H23N7O6,190.000,911.000,-0.500,33,6,10,7,"InChI=1S/C20H23N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,12-13H,5-9H2,(H,23,30)(H,28,29)(H,32,33)(H4,21,22,24,25,31)/t12-,13?/m1/s1",C1[C@@H]2CN(CN2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O,QYNUQALWYRSVHF-PZORYLMUSA-N,"2-[[4-[(6aR)-3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl]benzoyl]amino]pentanedioic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,NULL,20190115,"ABI Chem|ChemSpider|ECI Group, LCSB, University of Luxembourg|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|KEGG|MetabolomicsWorkbench|NextBio|NextMove Software|PATENTSCOPE (WIPO)|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135421870,Deaminocozymase,"Deaminocozymase|Desamino-DPN|Deamino DPN|Deamino-NAD|Deaminodiphosphopyridine nucleotide|Nicotinamide-hypoxanthine dinucleotide|1851-07-6|Deamino nicotinamide adenine dinucleotide|Codehydrogenase I, deamino hydroxy analog|Nicotinamide-adenine dinucleotide, desamino-|NHD|Deamino NAD|NSC20271|Hypoxanthine-nicotinamide dinucleotide|NSC 20271|NSC-20271|[[5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [3,4-dihydroxy-5-(6-oxo-3H-purin-9-yl)oxolan-2-yl]methyl hydrogen phospha",665.400,C21H27N6O15P2+,308.000,1220.000,-6.200,44,8,17,11,"InChI=1S/C21H26N6O15P2/c22-17(32)9-2-1-3-26(4-9)20-15(30)13(28)10(40-20)5-38-43(34,35)42-44(36,37)39-6-11-14(29)16(31)21(41-11)27-8-25-12-18(27)23-7-24-19(12)33/h1-4,7-8,10-11,13-16,20-21,28-31H,5-6H2,(H4-,22,23,24,32,33,34,35,36,37)/p+1",C1=CC(=C[N+](=C1)C2C(C(C(O2)COP(=O)(O)OP(=O)(O)OCC3C(C(C(O3)N4C=NC5=C4N=CNC5=O)O)O)O)O)C(=O)N,DGVSIBCCYUVRNA-UHFFFAOYSA-O,"[[5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20190115,AAA Chemistry|ABI Chem|Aurora Fine Chemicals LLC|BOC Sciences|Chembase.cn|ChemDB|ChemIDplus|ChemSpider|DTP/NCI|EPA DSSTox|Google Patents|Kingston Chemistry|MassBank of North America (MoNA)|NextBio|NORMAN Suspect List Exchange|NovoSeek|Sigma-Aldrich|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135440065,6-Pyruvoyl tetrahydropteridine,"(R)-dyspropterin|Pyruvoyl-H4-pterin|PPH4|101383-42-0|(6R)-6-pyruvoyl-5,6,7,8-tetrahydropterin|6-Pyruvoyl tetrahydropteridine|6(R)-pyruvoyltetra-hydropterin|(6R)-Pyruvoyl-tetrahydropterin|DTXSID90906108|(6R)-6-pyruvoyl tetrahydropterin|CHEBI:136564|1-[(6R)-2-amino-4-oxo-5,6,7,8-tetrahydro-1H-pteridin-6-yl]propane-1,2-dione|6-pyr-uvoyl-5,6,7,8-tetrahydropterin|Q64221167|1,2-Propanedione, 1-(2-amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)-(R)|1,2-propanedione, 1-[(6R)-2-amino-3,4,5,6,7,8-hexahydro-4-oxo-6-pt",237.220,C9H11N5O3,126.000,479.000,-1.700,17,4,6,2,"InChI=1S/C9H11N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h4,12H,2H2,1H3,(H4,10,11,13,14,17)/t4-/m1/s1",CC(=O)C(=O)[C@H]1CNC2=C(N1)C(=O)NC(=N2)N,WBJZXBUVECZHCE-SCSAIBSYSA-N,"1-[(6R)-2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl]propane-1,2-dione",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20190115,"ABI Chem|BIND|BioCyc|ChEBI|ChemSpider|ChemTik|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|MuseChem|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|Springer Nature|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135459889,"2,6,8-Trihydroxypurin-7-ide","2,6,8-trihydroxypurin-7-ide|2,8-dihydroxy-1H-purin-6-olate|3106-08-9|biurate|hydrogen urate ion|Uric acid, ion(1-)|CHEBI:46820|CHEBI:46821|CHEBI:46822|CHEBI:46824|CHEBI:62585|DTXSID80953166|2,8-Dihydroxy-9H-purin-6-olate|2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-olate|6,8-Dioxo-1,6,7,8-tetrahydro-9H-purine-2-olate|2,6,8-Trioxo-3,7,8,9-tetrahydro-1H-purine-9-ide|6-hydroxy-2,8-dioxo-2,7,8,9-tetrahydropurin-1-ide|1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-, ion(1-)|7232-81-7",167.100,C5H3N4O3-,106.000,343.000,-0.900,12,3,4,0,"InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)/p-1",C12=C(NC(=O)N1)N=C(NC2=O)[O-],LEHOTFFKMJEONL-UHFFFAOYSA-M,"6,8-dioxo-7,9-dihydro-1H-purin-2-olate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents,4,NULL,20190115,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemDB|ChemIDplus|ChemSpider|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|NextBio|PATENTSCOPE (WIPO)|SCRIPDB",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135476784,"6,7-Dihydrobiopterin","6,7-Dihydrobiopterin|(6R)-Tetrahydrobiopterin; (6R)-Tetrahydrobiopterin; 6R-BH4|Quinoid-dihydrobiopterin|q-dihydrobiopterin|a q-dihydrobiopterin|a 6,7-dihydrobiopterin|a quinoid dihydrobiopterin|SCHEMBL188302|CHEBI:20680|ZINC00895152|Q28529687|2-amino-6-(1,2-dihydroxypropyl)-7,8-dihydropteridin-4(6H)-one|4(3H)-Pteridinone, 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-",239.230,C9H13N5O3,133.000,442.000,-2.600,17,4,5,2,"InChI=1S/C9H13N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,15-16H,2H2,1H3,(H3,10,11,13,14,17)",CC(C(C1CN=C2C(=N1)C(=O)NC(=N2)N)O)O,ZHQJVZLJDXWFFX-UHFFFAOYSA-N,"2-amino-6-(1,2-dihydroxypropyl)-6,7-dihydro-3H-pteridin-4-one",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20190115,"001Chemical|A2B Chem|AA BLOCKS|Abbott Labs|ABI Chem|Biocore|BioCyc|ChEBI|ChemDB|ChemSpider|ChemTik|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IBM|MolCore BioPharmatech|NextBio|NovoSeek|SureChEMBL|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135483998,5-Methyltetrahydrofolate,"5-methyl-THF|5-Methyltetrahydrofolate|5-methyl-tetrahydrofolate|N5-Methyl-tetrahydrofolic acid|5-Methyltetrahydropteroylglutamate|5-METHYLTETRAHYDROFOLIC ACID|N5-methylfolate|n5-methyltetrahydrofolate|methyl-tetrahydrofolate|5-Methyl tetrahydrofolate|N5-Methyl-tetrahydrofolate|N5-methyltetrahydropteroyl mono-L-glutamate|N( 5)-Methyltetrahydrofolate|GTPL4684|SCHEMBL16466806|5-methyl-5,6,7,8-tetrahydrofolate|N-(4-(((2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-Glutamic aci",459.500,C20H25N7O6,199.000,865.000,-0.500,33,7,10,9,"InChI=1S/C20H25N7O6/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31)/t12?,13-/m1/s1",CN1C(CNC2=C1C(=O)NC(=N2)N)CNC3=CC=C(C=C3)C(=O)N[C@H](CCC(=O)O)C(=O)O,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,"(2R)-2-[[4-[(2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,NULL,20190115,ABI Chem|CCSbase|Chembase.cn|ChemSpider|DiscoveryGate|Google Patents|Human Metabolome Database (HMDB)|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SureChEMBL|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135573953,Riboxin,IDP(3-)|Riboxin|IDP trianion|inosine 5'-diphosphate(3-)|CHEBI:58280|5'-OO-[(phosphonatooxy)phosphinato]inosine|Q27125667,425.160,C10H11N4O11P2-3,231.000,696.000,-4.300,27,3,13,5,"InChI=1S/C10H14N4O11P2/c15-6-4(1-23-27(21,22)25-26(18,19)20)24-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,11,12,17)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1",C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])[O-])O)O,JPXZQMKKFWMMGK-KQYNXXCUSA-K,"[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-oxidophosphoryl] phosphate",Inosine Diphosphate,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20190115,"ABI Chem|AN PharmaTech|BioCyc|ChEBI|ChemMol|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NORMAN Suspect List Exchange|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135823198,Leucovorin calcium,"5-formyltetrahydrofolate(2-)|LEUCOVORIN CALCIUM|CHEBI:65340|NCGC00178756-05|AB00171941|6035-45-6|AB00171941-04|AB00171941_06|Q27133789|(2S)-2-[(4-{[(2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}benzoyl)amino]pentanedioate",471.400,C20H21N7O7-2,221.000,900.000,0.100,34,5,10,7,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/p-2/t12?,13-/m0/s1",C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],VVIAGPKUTFNRDU-ABLWVSNPSA-L,"(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,12,1332|686977|1117326|1117329|1117336|1117340|1117341|1117342|1117343|1117346|1159580|1224863|1479145|1479147|1479149|1479150,20190118,"ApexBio Technology|ChEBI|chemical genetic matrix|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|National Center for Advancing Translational Sciences (NCATS)|Southern Research Institute|University of Kansas High Throughput Screening Laboratory|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135873450,GTP trianion,GTP(3-)|guanosine 5'-triphosphate|GTP trianion|CHEBI:57600|Q27124804,520.159,C10H13N5O14P3-3,303.000,908.000,-6.000,32,5,16,8,"InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/p-3/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O)O)N=C(NC2=O)N,XKMLYUALXHKNFT-UUOKFMHZSA-K,"[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20190118,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135884481,GDP dianion,GDP(2-)|GDP dianion|GDP group|guanosine 5'-diphosphate(2-)|CHEBI:65180|guanosine 5'-diphosphate dianion|5'-O-{[(hydroxyphosphinato)oxy]phosphinato}guanosine|Q27133726,441.180,C10H13N5O11P2-2,254.000,750.000,-4.800,28,5,13,6,"InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/p-2/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)(O)[O-])O)O)N=C(NC2=O)N,QGWNDRXFNXRZMB-UUOKFMHZSA-L,"[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20190118,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135957086,5-Formimidoyltetrahydrofolate(2-),"5-formimidoyltetrahydrofolate(2-)|CHEBI:57456|5-formimidoyltetrahydrofolate dianion|Q27124702|N-[4-({[(6S)-2-amino-5-formimidoyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate",470.400,C20H22N8O6-2,228.000,900.000,0.100,34,6,10,8,"InChI=1S/C20H24N8O6/c21-9-28-12(8-24-16-15(28)18(32)27-20(22)26-16)7-23-11-3-1-10(2-4-11)17(31)25-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,21,23H,5-8H2,(H,25,31)(H,29,30)(H,33,34)(H4,22,24,26,27,32)/p-2/t12-,13-/m0/s1",C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],YCWUVLPMLLBDCU-STQMWFEESA-L,"(2S)-2-[[4-[[(6S)-2-amino-5-methanimidoyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20190119,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
136234289,"5,6,7,8-Tetrahydrofolate(2-)","5,6,7,8-tetrahydrofolate(2-)|(2S)-5,6,7,8-tetrahydrofolate(2-)|tetrahydrofolyl-(L-Glu)n|CHEBI:68437|CHEBI:68469|tetrahydrofolyl-poly(L-glutamate) macromolecule|Q27136936|(2S)-2-[(4-{[(2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}benzoyl)amino]pentanedioate",443.400,C19H21N7O6-2,213.000,823.000,0.700,32,6,10,7,"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/p-2/t11?,12-/m0/s1",C1C(NC2=C(N1)N=C(NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],MSTNYGQPCMXVAQ-KIYNQFGBSA-L,"(2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20190123,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
136351786,2-Azaniumyl-3-(3-oxoprop-1-enyl)but-2-enedioate,CHEBI:77803|2-amino-3-carboxymuconate 6-semialdehyde|2-azaniumyl-3-(3-oxoprop-1-enyl)but-2-enedioate|(Z)-2-azaniumyl-3-[(E)-3-oxoprop-1-enyl]but-2-enedioate,184.130,C7H6NO5-,121.000,297.000,0.200,13,2,6,3,"InChI=1S/C7H7NO5/c8-5(7(12)13)4(6(10)11)2-1-3-9/h1-3H,8H2,(H,10,11)(H,12,13)/p-1/b2-1+,5-4-",C(=C/C(=C(\\C(=O)O)/N)/C(=O)[O-])\\C=O,KACPVQQHDVBVFC-OMUGJNSGSA-M,"(E,2Z)-2-[amino(carboxy)methylidene]-5-oxopent-3-enoate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20190123,ChEBI|Google Patents,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
136630940,GDP-D-mannose(2-),GDP-D-mannose(2-)|GDP-mannose(2-)|CHEBI:84881|guanosine 5'-[3-(D-mannopyranosyl) diphosphate]|Q27158147,603.300,C16H23N5O16P2-2,333.000,1040.000,-6.400,39,8,18,9,"InChI=1S/C16H25N5O16P2/c17-16-19-12-6(13(28)20-16)18-3-21(12)14-10(26)8(24)5(34-14)2-33-38(29,30)37-39(31,32)36-15-11(27)9(25)7(23)4(1-22)35-15/h3-5,7-11,14-15,22-27H,1-2H2,(H,29,30)(H,31,32)(H3,17,19,20,28)/p-2/t4-,5-,7-,8-,9+,10-,11+,14-,15?/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OC4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)N=C(NC2=O)N,MVMSCBBUIHUTGJ-XIYWIPNQSA-L,"[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20190124,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
187,Acetylcholine,"acetylcholine|Choline acetate|O-Acetylcholine|51-84-3|(2-Acetoxyethyl)trimethylammonium|Acetyl choline ion|Acetylcholinum|Acetyl choline cation|Ach|Choline acetate (ester)|2-(Acetyloxy)-N,N,N-trimethylethanaminium|Azetylcholin|ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-|2-acetyloxyethyl(trimethyl)azanium|UNII-N9YNS0M02X|BRN 1764436|CHEBI:15355|CHEMBL667|N9YNS0M02X|[2-(acetyloxy)ethyl]trimethylazanium|Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl- (9CI)|2-acetyloxyethyl-trimethylazanium|[3H]acetylcholine|NCGC",146.210,C7H16NO2+,26.300,115.000,0.200,10,0,2,4,"InChI=1S/C7H16NO2/c1-7(9)10-6-5-8(2,3)4/h5-6H2,1-4H3/q+1",CC(=O)OCC[N+](C)(C)C,OIPILFWXSMYKGL-UHFFFAOYSA-N,2-acetyloxyethyl(trimethyl)azanium,Acetylcholine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,12,423|880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1766|1768|1811|1865|2062|2101|2107|2112|2451|2472|2517|2528|2546|2549|2551|15289|17473|18078|24950|30377|30516|66345|71789|82390|82391|82392|82393|82394|82513|82514|82515|82516|141035|141063|141190|141531|141534|141545|141546|141812|141819|142144|142161|142352|142356|145338|145339|145340|145341|145356|145357|145657|145685|145983|146006|146153|146158|146162|146164|146302|146316|146464|146477|146486|146631|146770|146772|146774|146779|146792|165415,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Am",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
243,Benzoic acid,"benzoic acid|65-85-0|Dracylic acid|benzenecarboxylic acid|Carboxybenzene|Benzeneformic acid|phenylformic acid|Benzenemethanoic acid|Phenylcarboxylic acid|Retardex|Benzoesaeure GK|Benzoesaeure GV|Retarder BA|Tenn-Plas|Acide benzoique|Salvo liquid|Solvo powder|Benzoesaeure|Flowers of benzoin|Flowers of benjamin|Benzoic acid, tech.|Unisept BZA|HA 1 (acid)|Kyselina benzoova|Benzoic acid (natural)|Benzoate (VAN)|HA 1|Benzoesaeure [German]|Caswell No. 081|Diacylic acid|Oracylic acid|Acide benzoique [French]|Acido",122.120,C7H6O2,37.300,104.000,1.900,9,1,2,1,"InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)",C1=CC=C(C=C1)C(=O)O,WPYMKLBDIGXBTP-UHFFFAOYSA-N,benzoic acid,Benzoic Acid,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,155|157|161|165|167|175|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1189|1194|1201|1208|1452|1457|1458|1469|1471|1476|1477|1478|1479|1811|1948|2016|2023|2025|2029|2052|2066|2101|2107|,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Acesobio|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
4971,Protoporphyrin IX,"protoporphyrin IX|protoporphyrin|553-12-8|Ooporphyrin|Protoporpyrin IX|ppIX|Porphyrinogen IX|Protoporphyrin IX disodium|Kammerer's prophyrin|H2ppIX|Kammerer's porphyrin|MLS001074731|UNII-C2K325S808|CHEBI:15430|NSC2632|C34H34N4O4|3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic acid|SMR000127405|21H,23H-Porphine-2,18-dipropanoic acid, 7,12-diethenyl-3,8,13,17-tetramethyl-|CHEMBL267548|3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid|CHEMBL19",562.700,C34H34N4O4,132.000,1010.000,4.600,42,4,6,8,"InChI=1S/C34H34N4O4/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25/h7-8,13-16,35-36H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42)",CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C=C,ZCFFYALKHPIRKJ-UHFFFAOYSA-N,"3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,155|157|161|165|167|175|357|365|366|367|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|608|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|910|912|914|915|917|918|923|924|925|926|927|928|930|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1033|1376|1379|1385|1422|1452|1454|1457|1458|1459|1460|1461|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1529|1530|1531|15,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acros Organics|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|ApexBio Technology|Aurora Fine Chemicals LLC|BenchChem|BIND|BindingDB|BioChemPartner|Bio",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5839,Aldosterone,"ALDOSTERONE|52-39-1|Electrocortin|Aldocortin|Aldocorten|Aldocortene|(+)-Aldosterone|Elektrocortin|d-Aldosterone|Reichstein X|18-Oxocorticosterone|[3H]aldosterone|11beta,21-Dihydroxypregn-4-ene-3,18,20-trione|(11BETA)-11,21-DIHYDROXY-3,20-DIOXOPREGN-4-EN-18-AL|11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al|11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al|Aldosteronum|NSC 73856|18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione|UNII-4964P6T9RB|Pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11b)-|(8S,9S,10R",360.400,C21H28O5,91.700,682.000,1.100,26,2,5,3,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C=O)O,PQSUYGKTWSAVDQ-ZVIOFETBSA-N,"(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde",Aldosterone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,13,1195|1204|1469|1479|1511|1554|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1962|1974|1979|1987|1999|2002|2003|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2277|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|23943|39320|51054|51055|51057|51059|53796|74244|74373|743,20040916,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|Acadechem|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|AN PharmaTech|Aurora Fine Chemicals LLC|BIDD|BIND|BindingDB|BioCyc|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug D",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6031,Uridine-5'-diphosphate,"Uridine 5'-diphosphate|URIDINE DIPHOSPHATE|58-98-0|uridine-5'-diphosphate|Uridine 5'-(trihydrogen diphosphate)|UDP|UNII-5G0F599A1Y|5'-UDP|Uridine 5'-pyrophosphate|CHEMBL130266|Uridine 5'-pyrophosphoric acid|CHEBI:17659|5G0F599A1Y|[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate|uridine-diphosphate|((2R,3S,4R,5R)-5-(2,4-Dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate|Uridine Pyrophosphate|EINECS 200-4",404.160,C9H14N2O12P2,212.000,676.000,-4.700,25,6,12,6,"InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O)O)O,XCCTYIAWTASOJW-XVFCMESISA-N,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",Uridine Diphosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,11,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1811|1865|2101|2107|2112|2517|2549|50022|89268|89269|89272|89273|150321|150331|150635|150636|197979|197980|256769|271163|272716|272719|272722|330914|330915|330916|330917|330918|330919|330920|330921|330923|330924|330925|330926|330927|330928|330930|330931|330932|330934|330935|330937|330938|330939|367517|367518|373704|404830|431263|431265|444562|444563|460573|460576|460812|469230|469231|484782|484784|485281|485290|504327|504332|504845|504847|540276|568,20040916,"3B Scientific (Wuhan) Corp|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BM",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, WikiPathways]"
7339,alpha-Phosphoribosylpyrophosphoric Acid,"PRPP|PHOSPHORIBOSYL PYROPHOSPHATE|5-Phospho-alpha-D-ribose 1-diphosphate|Alpha-Phosphoribosylpyrophosphoric Acid|PRib-PP|5-Phosphoribosyl diphosphate|7540-64-9|phosphoribosylpyrophosphate|5-Phosphoribosyl 1-pyrophosphate|5-Phosphorylribose 1-pyrophosphate|alpha-D-Ribofuranose 5-(dihydrogen phosphate) 1-(trihydrogen diphosphate)|5-O-phosphono-alpha-D-ribofuranosyl diphosphate|5-PHOSPHORYLRIBOSE-1-PYROPHOSPHATE|Ribofuranose, 5-phosphate 1-pyrophosphate|1-O-pyrophosphono-5-O-phosphono-alpha-D-ribofuranose|alph",390.070,C5H13O14P3,230.000,521.000,-5.800,22,7,14,7,"InChI=1S/C5H13O14P3/c6-3-2(1-16-20(8,9)10)17-5(4(3)7)18-22(14,15)19-21(11,12)13/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/t2-,3-,4-,5-/m1/s1",C([C@@H]1[C@H]([C@H]([C@H](O1)OP(=O)(O)OP(=O)(O)O)O)O)OP(=O)(O)O,PQGCEDQWHSBAJP-TXICZTDVSA-N,"[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl] phosphono hydrogen phosphate",Phosphoribosyl Pyrophosphate,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,9,NULL,20040916,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|ABI Chem|Alfa Chemistry|Alichem|Ambinter|Aurora Fine Chemicals LLC|BindingDB|BioCyc|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|DiscoveryGate|DrugBank|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Golm Metabolome Database (GMD), Max Planck Institute of Molecular Plant Physiolo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
8955,Pregnenolone,"pregnenolone|145-13-1|3beta-Hydroxypregn-5-en-20-one|Arthenolone|Pregnetan|Pregneton|Pregnolon|Prenolon|Regnosone|Skinostelon|5-Pregnen-3beta-ol-20-one|Enelone|Natolone|Bina-Skin|delta5-Pregnenolone|5-Pregnen-3-beta-ol-20-one|(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE|5-Pregnenolone|3-beta-Hydroxypregn-5-en-20-one|NSC 1616|Prestwick_859|UNII-73R90F7MQ8|3beta-Hydroxy-5-pregnen-20-one|Pregn-5-en-20-one, 3-hydroxy-, (3beta)-|Prestwick3_000546|Pregnenolone (JAN/INN)|1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethy",316.500,C21H32O2,37.300,550.000,4.200,23,1,2,1,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,ORNBQBCIOKFOEO-QGVNFLHTSA-N,"1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone",Pregnenolone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,377|1332|1850|1863|1899|1903|1906|1947|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2101|2129|2130|2174|2177|2234|2235|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2557|2599|2606|2629|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|23943|39451|50906|51048|51049|51052|51054|51055|51056|51058|51059|51062|212737|212919|212920|212931|220020|228061|237685|311367|318680|322753|376843|377110|377115|377120|377125|377131|377136|378939|378940|378941|378942|428444|42,20050601,"A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|AN PharmaTech|Aurora Fine Chemicals LLC|AvaChem Scientific|BePharm Ltd.|BIDD|BIND|BindingDB|BioChemPartner|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|CCSbase|Center for Chemical Genomics, University ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
13711,2'-Deoxycytidine,"2'-deoxycytidine|deoxycytidine|951-77-9|CYTIDINE, 2'-DEOXY-|dCYD|Deoxyribose cytidine|Cytosine deoxyriboside|4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one|Desoxycytidin [German]|Cytosine, deoxyribonucleoside|d-cytidine|207121-53-7|1beta-2'-Deoxyribofuranosylcytosine, d-|UNII-0W860991D6|DC|C9H13N3O4|CHEBI:15698|2 -Deoxycytidine|1-(2-Deoxy-beta-D-ribofuranosyl)cytosine|0W860991D6|MFCD00006547|2'-Deoxycytidine, 99+%|Desoxycytidine|Desoxycytidin|2'-deoxy-cytidine|DCZ|",227.220,C9H13N3O4,108.000,355.000,-1.800,16,3,4,2,"InChI=1S/C9H13N3O4/c10-7-1-2-12(9(15)11-7)8-3-5(14)6(4-13)16-8/h1-2,5-6,8,13-14H,3-4H2,(H2,10,11,15)/t5-,6+,8+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O,CKTSBUTUHBMZGZ-SHYZEUOFSA-N,"4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one",Deoxycytidine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,875|880|881|884|885|887|889|892|893|894|900|901|902|923|924|995|1030|1379|1452|1454|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|20871|32065|32066|55385|55974|55976|56586|56587|97846|97848|98851|100244|105747|105750|105756|105762|105764|105767|126594|126600|126601|210535|210536|210863|210864|210866|210890|278932|278933|278936|278937|278947|278949|282609|334938|334944|342012|342013|342517|369218|381856|381857|39937,20050601,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Apexmol|Assembly Blocks Pv",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
13730,2'-Deoxyadenosine,"2'-deoxyadenosine|deoxyadenosine|958-09-8|Adenyldeoxyriboside|Adenine deoxyribose|(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol|2-Deoxyadenosine|Adenine deoxyribonucleoside|Desoxyadenosine|2'-Deoxyformycin A|ADENOSINE, 2'-DEOXY-|CCRIS 1782|UNII-P582C98ULC|Adenine deoxy nucleoside|CHEBI:17256|AI3-52383|Adenosine, 2'-deoxy,|Adenine deoxyriboside|beta-D-erythro-Pentofuranoside, adenine-9 2-deoxy-|(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol|9H-Purin-6-amine, 9-",251.240,C10H13N5O3,119.000,307.000,-0.500,18,3,7,2,"InChI=1S/C10H13N5O3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(17)6(2-16)18-7/h3-7,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)O,OLXZPDWKRNYJJZ-RRKCRQDMSA-N,"(2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,28386|31247|32065|32066|32353|33205|33765|33813|33830|33834|33836|34585|68252|68253|68254|68255|68256|68257|81069|81438|81802|83196|83197|83198|83199|84402|85279|86485|86488|105750|105753|105756|105762|105765|105766|105779|105780|105782|202930|202931|210695|210718|220033|220034|224916|225768|226341|228408|228985|229026|229234|229236|342012|342013|344442|344443|344444|344445|344446|344447|344448|344449|353131|369218|372435|372436|445467|445471|445472|445473|485290|504339|504444|504648|504845|504847|504891|51,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|AstaTech, Inc.|Aurora Fine Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
14180,Nicotinamide mononucleotide,"beta-Nicotinamide mononucleotide|1094-61-7|nicotinamide mononucleotide|Nicotinamide ribotide|beta-NMN|NMN zwitterion|nicotinamide ribonucleotide|nicotinamide D-ribonucleotide|nicotinamide nucleotide|NMN|beta-nicotinamide D-ribonucleotide|UNII-2KG6QX4W0V|beta-Nicotinamide ribonucleotide|3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium|2KG6QX4W0V|((2R,3S,4R,5R)-5-(3-Carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen phosphate|CHEBI:16171|Pyridinium, 3-(aminocarb",334.220,C11H15N2O8P,166.000,455.000,-3.500,22,4,8,5,"InChI=1S/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8-,9-,11-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)[O-])O)O)C(=O)N,DAYLJWODMCOQEW-TURQNECASA-N,"[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",Nicotinamide Mononucleotide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,9,33858|72741|72743|74662|99369|106791|269132,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Ambeed|BIND|BindingDB|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Compa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15939,Paraquat,"PARAQUAT|4685-14-7|1,1'-Dimethyl-4,4'-bipyridinium|Gramoxone|Paraquat ion|Dextrone X|Dimethyl viologen|Paraquat dication|4,4'-Bipyridinium, 1,1'-dimethyl-|Starfire|Weedol|Spraytop-graze|Methyl viologen ion(2+)|Esgram|Methyl viologen (2+)|CCRIS 7731|1,1'-Dimethyl-4,4'-bipyridyldiylium|1-methyl-4-(1-methylpyridin-1-ium-4-yl)pyridin-1-ium|HSDB 1668|N,N'-Dimethyl-4,4'-bipyridinium|Pillarquat|Pillarxone|Cekuquat|Crisquat|Dexuron|Galokson|Gramixel|Gramuron|Herbaxon|Herboxone|Parakwat|Pathclear|UNII-PLG39H7695|Par",186.250,C12H14N2+2,7.800,145.000,1.700,14,0,0,1,"InChI=1S/C12H14N2/c1-13-7-3-11(4-8-13)12-5-9-14(2)10-6-12/h3-10H,1-2H3/q+2",C[N+]1=CC=C(C=C1)C2=CC=[N+](C=C2)C,INFDPOAKFNIJBF-UHFFFAOYSA-N,1-methyl-4-(1-methylpyridin-1-ium-4-yl)pyridin-1-ium,Paraquat,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,15,61001|61002|369249|369250|369251|369252|369253|369625|485350|485395|492967|493033|493162|504770|538370|540238|540299|588208|588209|588210|588220|588519|602314|720641|1077673|1077674|1077675|1077676|1077677|1085464|1090175|1090176|1090177|1092853|1092854|1092855|1092856|1092857|1092858|1092859|1092860|1097874|1097875|1097876|1097919|1097920|1097921|1097962|1107420|1110701|1110702|1110703|1110704|1110705|1224905|1259407|1259408|1259409|1272365,20050327,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Anward|Aurora Fine Chemicals LLC|BIDD|BIND|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Databa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
18068,Galactose-uridine-5'-diphosphate,UDP-galactose|Udp galactose|uridine diphosphate galactose|Udpgal|Uridine diphosphogalactose|UDP-D-galactopyranose|Uridine pyrophosphogalactose|UDP-alpha-D-Galactose|Uridinediphosphogalactose|2956-16-3|UDP-Gal|GALACTOSE-URIDINE-5'-DIPHOSPHATE|Uridine diphosphategalactose|UDP-galactopyranose|UDP-D-galactose|UNII-O2HY4WY2W1|Uridinediphosphate galactose|O2HY4WY2W1|CHEMBL439009|Uridine diphosphate-D-galactose|CHEBI:67119|Uridine 5'-diphosphate galactose|UDP-alpha-D-galactopyranose|Uridine 5'-diphosphogalactose|[,566.300,C15H24N2O17P2,292.000,964.000,-6.300,36,9,17,9,"InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8+,9-,10+,11-,12-,13-,14-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O,HSCJRCZFDFQWRP-ABVWGUQPSA-N,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate",Uridine Diphosphate Galactose,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,286300|450300|450303|677172|677178|677179|1346389|1346390|1346395|1346857|1346914,20050601,"ABI Chem|AbMole Bioscience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Aurora Fine Chemicals LLC|BenchChem|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
64959,Xanthosine,"xanthosine|146-80-5|Xanthine riboside|9-beta-D-Ribofuranosylxanthine|UNII-BM66HT53C3|2,3-Dihydroxanthosine|beta-D-Ribofuranoside, xanthine-9|AI3-52693|BM66HT53C3|CHEBI:18107|1H-Purine-2,6-dione, 3,9-dihydro-9-beta-D-ribofuranosyl-|9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purine-2,6-diol|9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-dihydropurine -2,6-dione|5968-90-1|xanthosin|4UO|EINECS 205-679-9|NSC 18930|(3R,4S)-4-Cyclobutyl-3-fluoropiperidinedihydrochlor",284.230,C10H12N4O6,146.000,434.000,-2.400,20,5,7,2,"InChI=1S/C10H12N4O6/c15-1-3-5(16)6(17)9(20-3)14-2-11-4-7(14)12-10(19)13-8(4)18/h2-3,5-6,9,15-17H,1H2,(H2,12,13,18,19)/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)NC2=O,UBORTCNDUKBEOP-UUOKFMHZSA-N,"9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-2,6-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,70684|70686|329451|329453|584546|584547|584550|1259312,20040916,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Anward|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|Buhrlage Lab, Dana-Farber Cancer Institute and Novartis Institutes for BioMedical Research (Cambridge, Mass)|CCSbase|Center for Chemical Genomics, Univers",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
73323,Xanthosine-5'-monophosphate,"xanthosine monophosphate|5'-Xanthylic acid|Xanthosine 5'-phosphate|Xanthylic acid|523-98-8|xanthosine-5'-monophosphate|(9-D-ribosylxanthine)-5'-phosphate|XMP|CHEBI:15652|25249-23-4|xanthosine-5'-P|Poly(xanthylic acid)|1lol|1pkx|xanthosine-5-phosphate|1m9n|xanthosine-5'-phosphate|5'-xanthonylate monophosphate|SCHEMBL188739|9-(5-O-Phosphonopentofuranosyl)-9H-purine-2,6-diol|5'-Xanthylic acid, homopolymer|CHEMBL1206243|DTXSID40948098|ZINC4228292|[(2R,3S,4R,5R)-5-(2,6-dioxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-",364.210,C10H13N4O9P,193.000,585.000,-4.000,24,6,10,4,"InChI=1S/C10H13N4O9P/c15-5-3(1-22-24(19,20)21)23-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H2,19,20,21)(H2,12,13,17,18)/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)NC(=O)NC2=O,DCTLYFZHFGENCW-UUOKFMHZSA-N,"[(2R,3S,4R,5R)-5-(2,6-dioxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,1811|977610,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AAA Chemistry|abcr GmbH|ABI Chem|Acadechem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Combi-Blocks|DAOGE BIOPHARMA|Day Biochem|DC Chemicals|DiscoveryGate|ECI ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
93556,Dihydrothymine,"Dihydrothymine|5,6-Dihydro-5-methyluracil|696-04-8|5,6-Dihydrothymine|5-Methyl-5,6-dihydrouracil|5-Methyldihydropyrimidine-2,4(1H,3H)-dione|5-methyl-1,3-diazinane-2,4-dione|Hydrouracil, 5-methyl-|2,4(1H,3H)-Pyrimidinedione, dihydro-5-methyl-|dihydro-5-methyl-2,4(1H,3H)-Pyrimidinedione|MFCD00023159|5,6-Dihydro-2,4-dihydroxy-5-methylpyrimidine|5-methyl-hydrouracil|334473-42-6|5-methyl-1,3,5,6-tetrahydropyrimidine-2,4-dione|EINECS 211-787-7|NSC 44131|AI3-25480|dihydrothymine crystalline|Thymine, 5,6-dihydro-|5",128.130,C5H8N2O2,58.200,155.000,-0.600,9,2,2,0,"InChI=1S/C5H8N2O2/c1-3-2-6-5(9)7-4(3)8/h3H,2H2,1H3,(H2,6,7,8,9)",CC1CNC(=O)NC1=O,NBAKTGXDIBVZOO-UHFFFAOYSA-N,"5-methyl-1,3-diazinane-2,4-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,330|485350|485395|493033|504770|540299|588519|720641|1347385,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|Achemtek|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BIND|Biocore|BioCyc|BLD Pharm|BOC Sciences|CCSbase|Center for Chemical Genomics, University of Michigan|ChangChem|ChEBI|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|ChemExper Chemical ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
119219,"3,4-Dihydroxyphenylacetaldehyde","3,4-Dihydroxyphenylacetaldehyde|2-(3,4-dihydroxyphenyl)acetaldehyde|5707-55-1|Protocatechuatealdehyde|Benzeneacetaldehyde,3,4-dihydroxy-|SCHEMBL891837|GTPL6632|2-(3,4-dihydroxyphenyl)ethanal|CHEBI:27978|DTXSID10205680|(3,4-dihydroxyphenyl)acetaldehyde|3,4-dihydroxy-Benzeneacetaldehyde|ZINC901908|Benzeneacetaldehyde, 3,4-dihydroxy-|AKOS022634762|C04043|Q4634065",152.150,C8H8O3,57.500,135.000,0.400,11,2,3,2,"InChI=1S/C8H8O3/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,4-5,10-11H,3H2",C1=CC(=C(C=C1CC=O)O)O,IADQVXRMSNIUEL-UHFFFAOYSA-N,"2-(3,4-dihydroxyphenyl)acetaldehyde",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,8,NULL,20050624,"A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Acadechem|AKos Consulting & Solutions|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|BioCyc|BLD Pharm|ChEBI|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|I",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
161234,D-Ribosylnicotinic acid,D-ribosylnicotinic acid|Nicotinate D-ribonucleoside|nicotinic acid riboside|CHEBI:27748|ribosylnicotinate|nicotinic acid ribose|C05841|CHEMBL396943|SCHEMBL18090711|ZINC4096931|3-carboxy-1-(D-ribofuranosyl)pyridinium|Q27103299,256.230,C11H14NO6+,111.000,312.000,-1.100,18,4,6,3,"InChI=1S/C11H13NO6/c13-5-7-8(14)9(15)10(18-7)12-3-1-2-6(4-12)11(16)17/h1-4,7-10,13-15H,5H2/p+1/t7-,8-,9-,10-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)O,PUEDDPCUCPRQNY-ZYUZMQFOSA-O,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,304777|304778|304779|304783|304784|304785,20050624,"A2B Chem|AA BLOCKS|AAA Chemistry|abcr GmbH|ABI Chem|AbMole Bioscience|BioCyc|BLD Pharm|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Key Organics/BIONET|Kingston Chemistry|MetabolomicsWorkbench|MolPort|MuseChem|NextBio|NovoSeek|PATENTSCOPE (WIPO)|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439167,D-Ribofuranose 5-phosphate,"D-ribofuranose 5-phosphate|D-ribofuranose 5-phosphate (closed ring structure, partial stereochemistry)|ribose-5-phosphorate|D-ribose-5-phosphorate|bmse000204|d-ribofuranose 5-O-phosphate|SCHEMBL708955|CHEBI:52742|D-Ribofuranose 5-phosphoric acid|D-ribofuranose 5-(dihydrogen phosphate)|C00117|Q27123582|{[(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methoxy}phosphonic acid",230.110,C5H11O8P,137.000,238.000,-3.600,14,5,8,3,"InChI=1S/C5H11O8P/c6-3-2(1-12-14(9,10)11)13-5(8)4(3)7/h2-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5?/m1/s1",C([C@@H]1[C@H]([C@H](C(O1)O)O)O)OP(=O)(O)O,KTVPXOYAKDPRHY-SOOFDHNKSA-N,"[(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"3B Scientific (Wuhan) Corp|abcr GmbH|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chembase.cn|ChemExper Chemical Directory|ChemSpider|ChemTik|Combi-Blocks|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Glentham Life Sciences Ltd.|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439218,3-Hydroxy-3-methylglutaryl-coenzyme A,HMG-CoA|3-Hydroxy-3-methylglutaryl-CoA|3-hydroxy-3-methylglutaryl-coenzyme A|3-hydroxy-3-methyl-glutaryl-CoA|S-(Hydrogen 3-hydroxy-3-methylglutaryl)coenzyme A|S-(Hydrogen 3-hydroxy-3-methylpentanedioate) coenzyme A|Hydroxymethylglutaryl-Coenzyme A|BDBM18373|3-hydroxy-3-methyl-Glutaryl-Coenzyme A|S-(Hydrogen 3-hydroxy-3-methylpentanedioate|S-(Hydrogen 3-hydroxy-3-methylpentanedioic acid,911.700,C27H44N7O20P3S,447.000,1610.000,-6.600,58,11,25,24,"InChI=1S/C27H44N7O20P3S/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45)/t14-,19-,20-,21?,25-,27+/m1/s1",C[C@](CC(=O)O)(CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O)O,CABVTRNMFUVUDM-MIGRVSMKSA-N,"(3S)-5-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-hydroxy-3-methyl-5-oxopentanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,ABI Chem|BindingDB|ChemSpider|Google Patents|Human Metabolome Database (HMDB)|MassBank of North America (MoNA)|NextBio|NovoSeek,Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439236,Ribose-1-phosphate,"ribose-1-phosphate|ribose 1-phosphate|alpha-D-Ribose 1-phosphate|D-ribose-1-phosphate|CHEBI:16300|1-O-phosphono-alpha-D-ribofuranose|alpha-D-ribofuranose 1-(dihydrogen phosphate)|alpha-D-ribose-1-phosphate|alpha-D-ribofuranose 1-phosphate|R1P|14075-00-4|D-ribofuranose 1-(dihydrogen phosphate)|D-ribose-1P|ribofuranose 1-phosphate|a-D-ribose 1-phosphate|D-ribofuranose 1-phosphate|alpha-D-Ribofuranose, 1-(dihydrogen phosphate)|1-phospho-alpha-D-ribofuranose|CHEMBL603367|SCHEMBL1995711|ZINC4228268|alpha-D-Ribof",230.110,C5H11O8P,137.000,238.000,-3.100,14,5,8,3,"InChI=1S/C5H11O8P/c6-1-2-3(7)4(8)5(12-2)13-14(9,10)11/h2-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5-/m1/s1",C([C@@H]1[C@H]([C@H]([C@H](O1)OP(=O)(O)O)O)O)O,YXJDFQJKERBOBM-TXICZTDVSA-N,"[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl] dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,216549,20040916,"ABI Chem|BioCyc|ChEBI|Chembase.cn|ChEMBL|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MassBank of North America (MoNA)|MetabolomicsWorkbench|NCBI Structure|NextBio|NextMove Software|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Prof. Malboobi, Plant Biotechnology Lab, National I",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439531,Stachyose,"Stachyose|D-Stachyose|470-55-3|Lupeose|CHEBI:17164|stachyose hydrate|MFCD00149457|Manneotetrose|alpha-D-Galp-(1->6)-alpha-D-Galp-(1->6)-alpha-D-Glcp-(1<->2)-beta-D-Fruf|O-alpha-D-galactopyranosyl-(1->6)o-alpha-D-galactopyranosyl-(1->6)O-alpha-D-galactopyranosyl-beta-D-fructofuranoside|10094-58-3|54261-98-2|(2S,3R,4S,5R,6R)-2-[[(2R,3R,4S,5R,6S)-6-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hyd",666.600,C24H42O21,348.000,933.000,-8.000,45,14,21,11,"InChI=1S/C24H42O21/c25-1-6-10(28)14(32)17(35)21(41-6)39-3-8-11(29)15(33)18(36)22(42-8)40-4-9-12(30)16(34)19(37)23(43-9)45-24(5-27)20(38)13(31)7(2-26)44-24/h6-23,25-38H,1-5H2/t6-,7-,8-,9-,10+,11+,12-,13-,14+,15+,16+,17-,18-,19-,20+,21+,22+,23-,24+/m1/s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)OC[C@@H]3[C@H]([C@@H]([C@H]([C@H](O3)O[C@]4([C@H]([C@@H]([C@H](O4)CO)O)O)CO)O)O)O)O)O)O)O)O)O)O,UQZIYBXSHAGNOE-XNSRJBNMSA-N,"(2S,3R,4S,5R,6R)-2-[[(2R,3R,4S,5R,6S)-6-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,1272365,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|BioCrick|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemFaces|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemS",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439924,Nicotinamide riboside,"nicotinamide riboside|nicotinamide ribose|1341-23-7|N-ribosylnicotinamide|nicotinamide-beta-riboside|nicotinamide ribonucleoside|ribosylnicotinamide|1-(beta-D-Ribofuranosyl)nicotinamide|UNII-0I8H2M0L7N|0I8H2M0L7N|CHEBI:15927|3-Carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium|Pyridinium, 3-(aminocarbonyl)-1-beta-D-ribofuranosyl-|3-carbamoyl-1-beta-D-ribofuranosylpyridinium|1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxamide|Niage",255.250,C11H15N2O5+,117.000,314.000,-1.800,18,4,5,3,"InChI=1S/C11H14N2O5/c12-10(17)6-2-1-3-13(4-6)11-9(16)8(15)7(5-14)18-11/h1-4,7-9,11,14-16H,5H2,(H-,12,17)/p+1/t7-,8-,9-,11-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,JLEBZPBDRKPWTD-TURQNECASA-O,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,9,304768|304769|304770|304783|304784|304785,20040916,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acorn PharmaTech Product List|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|Alichem|Ambeed|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|BioCyc|BLD Pharm|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastric",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
440658,6-O-(alpha-D-Galactopyranosyl)-D-glucopyranose,"melibiose|Gal-alpha(1,6)Glc|6-O-alpha-D-Galactopyranosyl-D-glucopyranose|6-O-(alpha-D-Galactopyranosyl)-D-glucopyranose|D-Gal-alpha1->6D-Glucose|CHEBI:28053|alpha-D-Gal-(1->6)-D-Glc|alpha-D-galactosyl-(1->6)-D-glucose|D-mellibiose|bmse000233|Epitope ID:140529|SCHEMBL2504901|alpha-D-Galp-(1->6)-D-Glc|D-Gal-alpha(1->6)-D-glucose|alpha-D-Galp-(1->6)-D-Glcp|6-(alpha-D-galactosido)-D-glucose|(3R,4S,5S,6R)-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol|M0050|alpha-",342.300,C12H22O11,190.000,382.000,-4.700,23,8,11,4,"InChI=1S/C12H22O11/c13-1-3-5(14)8(17)10(19)12(23-3)21-2-4-6(15)7(16)9(18)11(20)22-4/h3-20H,1-2H2/t3-,4-,5+,6-,7+,8+,9-,10-,11?,12+/m1/s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H](C(O2)O)O)O)O)O)O)O)O,DLRVVLDZNNYCBX-ABXHMFFYSA-N,"(3R,4S,5S,6R)-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol",Melibiose,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"3WAY PHARM INC|ABI Chem|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|CCSbase|ChEBI|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|GlyTouCan Project|Google Patents|Immune Epitope Database (IEDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MassBank Europe|MassBank of North America (MoNA)|MetabolomicsWorkbench|MolPort|NextBio|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|TargetMol (Target Molecule Corp.)|TCI (Tokyo Chemi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440738,"4,6-Dihydroxyquinoline","4,6-Dihydroxyquinoline|3517-61-1|Quinoline-4,6-diol|4,6-Quinolinediol|6-hydroxy-1H-quinolin-4-one|C05639|SCHEMBL1332713|SCHEMBL14242737|CHEBI:28799|DTXSID20331520|ACT10416|4349AB|ANW-61488|MFCD09261119|ZINC12496248|AKOS006330120|AC-9587|BS-16649|DB-028668|FT-0716473|Q27103902",161.160,C9H7NO2,49.300,225.000,0.200,12,2,3,0,"InChI=1S/C9H7NO2/c11-6-1-2-8-7(5-6)9(12)3-4-10-8/h1-5,11H,(H,10,12)",C1=CC2=C(C=C1O)C(=O)C=CN2,XFALURCRIGINGT-UHFFFAOYSA-N,6-hydroxy-1H-quinolin-4-one,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|Anward|Aurora Fine Chemicals LLC|BePharm Ltd.|BLD Pharm|ChEBI|Chem-Space.com Database|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Debye Scientific Co., Ltd|Egon Willighagen (Dept.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440850,4-Acetamidobutanal,4-acetamidobutanal|N4-Acetylaminobutanal|N-(4-oxobutyl)acetamide|4-(acetylamino)butanal|N-acetyl-4-aminobutanal|24431-54-7|4-Acetamidobutyraldehyde|C05936|SCHEMBL293574|CHEBI:7386|N-acetyl-gamma-aminobutyraldehyde|DTXSID30331531|AKOS006348119|Q27107484,129.160,C6H11NO2,46.200,101.000,-0.700,9,1,2,4,"InChI=1S/C6H11NO2/c1-6(9)7-4-2-3-5-8/h5H,2-4H2,1H3,(H,7,9)",CC(=O)NCCCC=O,DDSLGZOYEPKPSJ-UHFFFAOYSA-N,N-(4-oxobutyl)acetamide,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BioCyc|ChEBI|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Smolecule|Springer Nature|SureChEMBL|Thomson ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440995,Lactobiose,"Milchzucker|Laktobiose|Laktose|beta-Gal1,4-Glc|beta-D-Galp-(1->4)-D-Glcp|(Gal)1 (Glc)1|Lactobiose|Galbeta1-4-Glc|beta-D-Gal-(1->4)-D-Glc|1-beta-D-Galactopyranosyl-4-D-glucopyranose|CHEBI:17716|beta-D-galactopyranosyl-(1->4)-D-glucopyranose|x-ray exposed (1000 rad)lactose|Lactose (TN)|lactose group|Galbeta1-4Glc|Gal(b1-4)Glc|Epitope ID:142487|Anhydrous lactose (JP17)|SCHEMBL8446|BENZOICACIDDODECYLESTER|Lactose, anhydrous (JAN/NF)|DTXSID501015196|DB04465|C00243|D00046|Q27890379|F_FULL_20000000000000_GS_4019|1",342.300,C12H22O11,190.000,382.000,-4.700,23,8,11,4,"InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5+,6+,7-,8-,9-,10-,11?,12+/m1/s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](OC([C@@H]([C@H]2O)O)O)CO)O)O)O)O,GUBGYTABKSRVRQ-QKKXKWKRSA-N,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,NULL,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|AN PharmaTech|BioCyc|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Glentham Life Sciences Ltd.|GlyTouCan Project|Google Patents|Hairui Chemical|IBM|iChemical Technology USA Inc|Immune Epitope Data",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
444514,Triacetylchitotriose,"TRIACETYLCHITOTRIOSE|beta-N,N',N''-triacetylchitotriose|N,N',N''-triacetyl chitotriose beta-anomer|CHEBI:71404|beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc|GlcNAcbeta1-4GlcNAcbeta1-4GlcNAcbeta|(beta)-N,N',N''-triacetyl chitotriose|beta-D-GlcNAc-(1->4)-beta-D-GlcNAc-(1->4)-beta-D-GlcNAc|2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose|N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->4)-",627.600,C24H41N3O16,295.000,962.000,-6.900,43,11,16,10,"InChI=1S/C24H41N3O16/c1-7(31)25-13-18(36)20(11(5-29)39-22(13)38)42-24-15(27-9(3)33)19(37)21(12(6-30)41-24)43-23-14(26-8(2)32)17(35)16(34)10(4-28)40-23/h10-24,28-30,34-38H,4-6H2,1-3H3,(H,25,31)(H,26,32)(H,27,33)/t10-,11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23+,24+/m1/s1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)NC(=O)C)O)NC(=O)C)O,WZZVUHWLNMNWLW-VFCSDQTKSA-N,"N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,1811|501262|977611,20050624,"ABI Chem|Aurora Fine Chemicals LLC|Biosynth Carbosynth|ChEBI|ChEMBL|ChemSpider|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|GlyTouCan Project|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|NCBI Structure|NextBio|NORMAN Suspect List Exchange|Shanghai Institute of Organic Chemistry|SMID|Thomson Pharma|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
448751,2-Phenylethanaminium,2-phenylethanaminium|phenethylammonium|Q28529712|Phenethyl-ammonium|2-phenylethylammonium|BDBM36023|CHEBI:225237,122.190,C8H12N+,27.600,65.000,1.400,9,1,0,2,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2/p+1",C1=CC=C(C=C1)CC[NH3+],BHHGXPLMPWCGHP-UHFFFAOYSA-O,2-phenylethylazanium,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050624,"A&J Pharmtech CO., LTD.|ABI Chem|BindingDB|BioCyc|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SMID|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3423467,Carbamoyl phosphate(2-),carbamoyl phosphate(2-)|carbamoyl-P|carbamyl-phosphate|CHEMBL186043|carbamoyl phosphate dianion|Carbamoyl phosphate; di sodium|CHEBI:58228|BDBM50155535|Q27125628|63082-13-3,139.000,CH2NO5P-2,116.000,124.000,-2.300,8,1,5,1,"InChI=1S/CH4NO5P/c2-1(3)7-8(4,5)6/h(H2,2,3)(H2,4,5,6)/p-2",C(=O)(N)OP(=O)([O-])[O-],FFQKYPRQEYGKAF-UHFFFAOYSA-L,carbamoyl phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050908,"ABI Chem|BindingDB|BioCyc|ChEBI|ChemDB|ChemSpider|ChemTik|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3464811,Pyridoxal(1+),pyridoxal(1+)|pyridoxal cation|CHEBI:131530|Q27225157|4-formyl-3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-1-ium,168.170,C8H10NO3+,71.700,162.000,0.200,12,3,3,2,"InChI=1S/C8H9NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,4,10,12H,3H2,1H3/p+1",CC1=[NH+]C=C(C(=C1O)C=O)CO,RADKZDMFGJYCBB-UHFFFAOYSA-O,3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-1-ium-4-carbaldehyde,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20050908,"ABI Chem|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|NextBio|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
4182595,3-Mercaptopyruvate,3-mercaptopyruvate|2-oxo-3-sulfanylpropanoate|CHEBI:57678|DTXSID30947575|MCULE-7466669113|Q27124856,119.120,C3H3O3S-,58.200,92.800,0.600,7,1,4,1,"InChI=1S/C3H4O3S/c4-2(1-7)3(5)6/h7H,1H2,(H,5,6)/p-1",C(C(=O)C(=O)[O-])S,OJOLFAIGOXZBCI-UHFFFAOYSA-M,2-oxo-3-sulfanylpropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050913,"ABI Chem|BioCyc|ChEBI|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Mcule|NextBio|SCRIPDB|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
4186339,3-Hydroxypyruvate,3-hydroxypyruvate|3-hydroxy-2-oxopropanoate|OH-pyruvate|OH-pyr|CHEBI:17180|3-Hydroxypyruvic acidanion|Q27102252,103.050,C3H3O4-,77.400,89.600,-0.300,7,1,4,1,"InChI=1S/C3H4O4/c4-1-2(5)3(6)7/h4H,1H2,(H,6,7)/p-1",C(C(=O)C(=O)[O-])O,HHDDCCUIIUWNGJ-UHFFFAOYSA-M,3-hydroxy-2-oxopropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
4643300,Glycerone phosphate(2-),glycerone phosphate(2-)|dihydroxyacetone-P|di-OH-acetone-P|3bxe|dihydroxy-acetone phosphate|glycerone phosphate dianion|CHEBI:57642|dihydroxyacetone phosphate dianion|Q27124834,168.040,C3H5O6P-2,110.000,147.000,-2.600,10,1,6,3,"InChI=1S/C3H7O6P/c4-1-3(5)2-9-10(6,7)8/h4H,1-2H2,(H2,6,7,8)/p-2",C(C(=O)COP(=O)([O-])[O-])O,GNGACRATGGDKBX-UHFFFAOYSA-L,(3-hydroxy-2-oxopropyl) phosphate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20050916,"ABI Chem|BioCyc|ChEBI|Chembase.cn|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemistry|NextBio|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|Springer Nature|Thieme Chemistry|Wikidata|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5249538,Tyraminium,tyraminium|tyraminium cation|tyraminium(1+)|para-Tyramine|2-(4-hydroxyphenyl)ethylazanium|3bra|4-Hydroxyphenethylaminium|(4-hydroxyphenethyl)ammonium|2-(4-hydroxyphenyl)ethanaminium|2-(4-hydroxyphenyl)ethylammonium|CHEBI:327995|4-Hydroxyphenethylamine ((tyramine)|BDBM50067723|2-(4-Hydroxy-phenyl)-ethyl-ammonium|A828724|Q27225727,138.190,C8H12NO+,47.900,87.300,1.100,10,2,1,2,"InChI=1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2/p+1",C1=CC(=CC=C1CC[NH3+])O,DZGWFCGJZKJUFP-UHFFFAOYSA-O,2-(4-hydroxyphenyl)ethylazanium,Tyramine,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20051007,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BindingDB|BioCyc|ChEBI|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|NextBio|SCRIPDB|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5459842,Anthranilate,anthranilate|2-aminobenzoate|o-Aminobenzoate|Anthranic acid|Vitamin L|Ortho-amidobenzoic acid|2-azanylbenzoate|CHEBI:16567|DTXSID80420080|3h78|c0345|9031-59-8|C(=O)(O)C1=C(C=CC=C1)[NH-]|3302-EP1441224A2|39767-EP2277867A2|39767-EP2280003A2|39767-EP2301927A1|39767-EP2311830A1|A804127|Q27101976,136.130,C7H6NO2-,66.200,130.000,1.900,10,1,3,0,"InChI=1S/C7H7NO2/c8-6-4-2-1-3-5(6)7(9)10/h1-4H,8H2,(H,9,10)/p-1",C1=CC=C(C(=C1)C(=O)[O-])N,RWZYAGGXGHYGMB-UHFFFAOYSA-M,2-aminobenzoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|Aurora Fine Chemicals LLC|BioCyc|ChEBI|ChemSpider|ChemTik|DiscoveryGate|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|SLING Consortium|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460052,trans-Urocanate,trans-urocanate|urocanate|104-98-3|(E)-3-(imidazol-4-yl)propenoate|(E)-3-(1H-imidazol-5-yl)prop-2-enoate|CHEBI:17771|CHEBI:27247|1H-Imidazole-4-acrylic acidanion|3-(1H-imidazol-4-yl)prop-2-enoate|(E)-3-(1H-imidazol-5-yl)-2-propenoate|(2E)-3-(1H-imidazol-4-yl)prop-2-enoate|A801123|Q27102598|Q27109942,137.120,C6H5N2O2-,68.800,150.000,0.700,10,1,3,1,"InChI=1S/C6H6N2O2/c9-6(10)2-1-5-3-7-4-8-5/h1-4H,(H,7,8)(H,9,10)/p-1/b2-1+",C1=C(NC=N1)/C=C/C(=O)[O-],LOIYMIARKYCTBW-OWOJBTEDSA-M,(E)-3-(1H-imidazol-5-yl)prop-2-enoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20040916,"ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NovoSeek|Thieme Chemistry|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460307,Fumarate,"fumarate|Fumarate(2-)|(2E)-but-2-enedioate|142-42-7|(E)-2-Butenedioate|(E)-Butenedioic acid|Fumarates|Fumarate dianion|Fumerate|but-2-enedioate|2-Butenedioic acid (E)-, ion(2-)|Fumaric acid, ion(2-)|DTXSID9037660|CHEBI:29806|CHEBI:36180|trans-1,2-Ethenedicarboxylic acid|(E)-1,2-Ethylenedicarboxylic acid|(E)-2-butenedioic acid, ion(2-)|trans-1,2-Ethylenediccarboxylic acid|3861-EP2269977A2|3861-EP2269978A2|3861-EP2269985A2|3861-EP2269991A2|3861-EP2269992A1|3861-EP2269993A1|3861-EP2270004A1|3861-EP2270006A1|38",114.060,C4H2O4-2,80.300,108.000,1.000,8,0,4,0,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/p-2/b2-1+",C(=C/C(=O)[O-])\\C(=O)[O-],VZCYOOQTPOCHFL-OWOJBTEDSA-L,(E)-but-2-enedioate,Fumarates,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,NULL,20040916,"A&J Pharmtech CO., LTD.|AAA Chemistry|ABI Chem|BioCyc|CCSbase|ChEBI|Chembase.cn|ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Kingston Chemistry|NextBio|NextMove Software|NMRShiftDB|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|SLING Consortium|SMID|Therapeutic Target Database (TTD)|Thieme Chemistry|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5461108,Adenosinetriphosphate,"ATP(4-)|adenylpyrophosphate|CHEMBL2364735|Adenosinetriphosphate|3b2q|adenosine 5'-triphosphate(4-)|CHEBI:30616|2hmu|2hmw|2kmx|2pze|2vhq|2xbp|2ych|3dgl|3dgo|3dnt|3efs|3ncq|3qxc|4fut|4fvq|4fvr|2e5y|2j9l|2p0x|2vt3|2w5g|2w5i|3d2e|3lf0|3qx9|3ta0|adenosine 5''-triphosphate(4-)|2p09|cid_16654697|BDBM50192459|BDBM50422407|AKOS026750622|5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-ylmethoxy-hydroxy-phosphoryloxy-hydroxy-phosphoryl oxyphosphonic acid|(Adenosine 5'-triphosphoric acid)tetraanion|J3.502.432H|A831137|Q27",503.150,C10H12N5O13P3-4,290.000,772.000,-6.000,31,3,17,7,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/p-4/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O)N,ZKHQWZAMYRWXGA-KQYNXXCUSA-J,"[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate",Adenosine Triphosphate,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,1811|977610|977611,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|AKos Consulting & Solutions|Amadis Chemical|BindingDB|BioCyc|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|Nature Chemical Biology|NextBio|Shanghai Institute of Organic Chemistry|Springer Nature|Therapeutic Target Database (TTD)|Thieme Chemistry|ToxPlanet|Wikidata|WikiPathways|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, WikiPathways]"
6436079,13-cis-Retinal,"13-cis-Retinal|13-cis-Retinaldehyde|Neoretinene a|13Z-Retinal|Neovitamin A aldehyde|472-86-6|UNII-IBP64540CD|(13Z)-retinal|13-Cis retinal|Retinal, 13-cis-|IBP64540CD|CHEBI:45487|(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenal|(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenal|cis-Retinal|13-cis-Retinal 95%|EINECS 207-456-1|NSC 122756|13-cis-Vitamin A aldehyde|epsilon-Retinal|cis-9-Retinal|cis-11-retinal|cis-13-retinal|(13cis)-retinal|al",284.400,C20H28O,17.100,522.000,6.200,21,0,1,5,"InChI=1S/C20H28O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,15H,7,10,14H2,1-5H3/b9-6+,12-11+,16-8+,17-13-",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C=O)/C)/C,NCYCYZXNIZJOKI-HWCYFHEPSA-N,"(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenal",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1452|1457|1458|1469|1471|1476|1477|1478|1479|1948|2101|2107|2112|2120|2517|2546|2549|2551|485290|588513|588514|588515|588516|588526|588527|,20060428,"3WAY PHARM INC|ABI Chem|AK Scientific, Inc. (AKSCI)|Alfa Chemistry|Alichem|Ambinter|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Glentham Life Sciences Ltd.|Google Patents|Human Metabolome Database (HMDB)|IBM|IUPHA",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6560210,Biotinate,"biotinate|biotinate anion|2jgs|2uyw|2zsc|3efr|3rdo|4dve|2c1q|3ew2|CHEBI:57586|Q27124798|5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoate",243.310,C10H15N2O3S-,107.000,292.000,1.000,16,2,4,4,"InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/p-1/t6-,7-,9-/m0/s1",C1[C@H]2[C@@H]([C@@H](S1)CCCCC(=O)[O-])NC(=O)N2,YBJHBAHKTGYVGT-ZKWXMUAHSA-M,"5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,9,1811|977611,20060523,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|PATENTSCOPE (WIPO)|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6857435,2-Acetamido-5-oxopentanoate,2-Acetamido-5-oxopentanoate|CHEBI:29123|(2S)-2-acetamido-5-oxopentanoate|2-acetamido-5-oxovalerate|N-acetylglutamate semialdehyde|N-acetyl-L-glutamate semialdehyde|N-acetylglutamate gamma-semialdehyde|N-acetyl-L-glutamate-5-semialdehyde|Q27109953,172.160,C7H10NO4-,86.300,184.000,-0.400,12,1,4,4,"InChI=1S/C7H11NO4/c1-5(10)8-6(7(11)12)3-2-4-9/h4,6H,2-3H2,1H3,(H,8,10)(H,11,12)/p-1/t6-/m0/s1",CC(=O)N[C@@H](CCC=O)C(=O)[O-],BCPSFKBPHHBDAI-LURJTMIESA-M,(2S)-2-acetamido-5-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060621,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6921588,Porphobilinogen(1-),porphobilinogen(1-)|porphobilinogen anion|CHEBI:58126|Q27125200|3-[5-(azaniumylmethyl)-4-(carboxylatomethyl)-1H-pyrrol-3-yl]propanoate,225.220,C10H13N2O4-,124.000,259.000,-2.200,16,2,4,4,"InChI=1S/C10H14N2O4/c11-4-8-7(3-10(15)16)6(5-12-8)1-2-9(13)14/h5,12H,1-4,11H2,(H,13,14)(H,15,16)/p-1",C1=C(C(=C(N1)C[NH3+])CC(=O)[O-])CCC(=O)[O-],QSHWIQZFGQKFMA-UHFFFAOYSA-M,3-[5-(azaniumylmethyl)-4-(carboxylatomethyl)-1H-pyrrol-3-yl]propanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20060728,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6931663,L-Pipecolate,"L-pipecolate|(S)-pipecolate|L-pipecolic acid zwitterion|CHEBI:61185|(2S)-piperidinium-2-carboxylate|dl-homoproline, dl-pipecolic acid|(S)-2-carboxypiperidinium betaine",129.160,C6H11NO2,56.700,108.000,-1.700,9,1,2,0,"InChI=1S/C6H11NO2/c8-6(9)5-3-1-2-4-7-5/h5,7H,1-4H2,(H,8,9)/t5-/m0/s1",C1CC[NH2+][C@@H](C1)C(=O)[O-],HXEACLLIILLPRG-YFKPBYRVSA-N,(2S)-piperidin-1-ium-2-carboxylate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20060728,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|Crystallography Open Database|DiscoveryGate|NextBio|SCRIPDB",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6971058,(R)-3-Hydroxybutyrate,(R)-3-hydroxybutyrate|(3R)-3-hydroxybutanoate|D-3-hydroxybutyrate|D-beta-hydroxybutyrate|3-D-hydroxybutyrate|(R)-(-)-beta-hydroxybutyrate|b-Hydroxybutyric acid|(3r)-3-hydroxybutyrate|(3R)-3-oxidanylbutanoate|[(3R)-hydroxybutanoate]n|poly[(r)-3-hydroxybutanoate]|CHEBI:8298|Poly[(R)-3-hydroxybutanoate]n|Poly[(R)-3-hydroxybutanoate]x|CHEBI:10983|A833857|Q27108680|UNII-FG2UN5EP9V component WHBMMWSBFZVSSR-GSVOUGTGSA-M|UNII-FG2UN5EP9V component WHBMMWSBFZVSSR-VKHMYHEASA-M,103.100,C4H7O3-,60.400,63.800,0.100,7,1,3,1,"InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1/t3-/m1/s1",C[C@H](CC(=O)[O-])O,WHBMMWSBFZVSSR-GSVOUGTGSA-M,(3R)-3-hydroxybutanoate,NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20060728,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|Thomson Pharma|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6971087,(S)-2-Hydroxybutyrate,(S)-2-hydroxybutyrate|L-2-hydroxybutyrate|L-alpha-hydroxybutyrate|(S)-2-hydroxybutanoate|a-Hydroxybutyric acid|(2S)-2-hydroxybutanoate|L-2-hydroxybutanoate|(2S)-hydroxybutanoate|L-alpha-hydroxybutanoate|(S)-2-hydroxybutyrate(1-)|CHEBI:73709|Q27144059,103.100,C4H7O3-,60.400,63.800,0.700,7,1,3,1,"InChI=1S/C4H8O3/c1-2-3(5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1/t3-/m0/s1",CC[C@@H](C(=O)[O-])O,AFENDNXGAFYKQO-VKHMYHEASA-M,(2S)-2-hydroxybutanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060728,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|SCRIPDB|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6992003,Trimethyllysine,"N6-trimethyl-L-lysine|Trimethyllysine|(S)-2-amino-6-(trimethylammonio)hexanoic acid|N(6),N(6),N(6)-trimethyl-L-lysine zwitterion|N6-trimethyllysine|epsilon-trimethyl-lysine|CHEBI:58100|N6,N6,N6-trimethyl-L-lysin-N6-ium|(2S)-2-azaniumyl-6-(trimethylazaniumyl)hexanoate|(5-amino-5-carboxylato-pentyl)-trimethyl-ammonium",189.280,C9H21N2O2+,67.800,158.000,-1.600,13,1,2,5,"InChI=1S/C9H20N2O2/c1-11(2,3)7-5-4-6-8(10)9(12)13/h8H,4-7,10H2,1-3H3/p+1/t8-/m0/s1",C[N+](C)(C)CCCC[C@@H](C(=O)[O-])[NH3+],MXNRLFUSFKVQSK-QMMMGPOBSA-O,(2S)-2-azaniumyl-6-(trimethylazaniumyl)hexanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20060728,BioCyc|ChEBI|DiscoveryGate|Nature Chemical Biology|NextBio|Springer Nature,Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6992099,4-Azaniumylbutanoate,4-azaniumylbutanoate|4-ammoniobutanoate|gamma-aminobutyrate|4euo|gamma-amino-N-butyrate|g-amino-n-butyric acid|3ip9|CHEBI:59888|gamma-aminobutyric acid zwitterion|A830919,103.120,C4H9NO2,67.800,57.200,-2.500,7,1,2,2,"InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)",C(CC(=O)[O-])C[NH3+],BTCSSZJGUNDROE-UHFFFAOYSA-N,4-azaniumylbutanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,977611,20060728,"A&J Pharmtech CO., LTD.|Amadis Chemical|BioCyc|ChEBI|Crystallography Open Database|DiscoveryGate|NextBio|SCRIPDB|Shanghai Institute of Organic Chemistry|Smolecule|Therapeutic Target Database (TTD)|Thieme Chemistry",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7048523,5-Azaniumyl-4-oxopentanoate,5-azaniumyl-4-oxopentanoate|5-ammonio-4-oxopentanoate|delta-aminolevulinate|5-ammoniolevulinate|5-ammonio-4-oxovalerate|CHEBI:356416|5-azaniumyl-4-oxidanylidene-pentanoate|A801471,131.130,C5H9NO3,84.800,116.000,-3.200,9,1,3,3,"InChI=1S/C5H9NO3/c6-3-4(7)1-2-5(8)9/h1-3,6H2,(H,8,9)",C(CC(=O)[O-])C(=O)C[NH3+],ZGXJTSGNIOSYLO-UHFFFAOYSA-N,5-azaniumyl-4-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20060729,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BioCyc|ChEBI|DiscoveryGate|NextBio|Smolecule",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7059571,"3',5'-Cyclic AMP(1-)","3',5'-cyclic AMP(1-)|adenosine-cyclic-phosphate|adenosine cyclic-monophosphate|MLS001333136|adenosine-cyclic-phosphoric-acid|cyclic-AMP|adenosine-3',5'-cyclic monophosphate|SMR000875274|3clp|3ocp|3otf|Adenosine 3',5'-cyclic monophosphate sodium salt monohydrate|2k0g|3',5'-cyclic AMP anion|adenosine-3',5'-monophosphate|BDBM81289|CHEBI:58165|3u10|cid_23669773|adenosine cyclic-3',5'-monophosphate|cyclic-3',5'-adenosine monophosphate|NCGC00485221-01|adenosine 3',5'-cyclic monophosphate anion|adenosine 3',5'-cyc",328.200,C10H11N5O6P-,158.000,490.000,-2.600,22,2,10,1,"InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/p-1/t4-,6-,7-,10-/m1/s1",C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)[O-],IVOMOUWHDPKRLL-KQYNXXCUSA-M,"(4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol",Cyclic AMP,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,977611|1159607|1272365|1296008|1296009|1345084|1346986|1346987|1347055|1347159|1347160,20060729,"3WAY PHARM INC|ABI Chem|Amadis Chemical|BindingDB|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|NovoSeek|Shanghai Institute of Organic Chemistry|Springer Nature|Thieme Chemistry|UW Madison, Small Molecule Screening Facility|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7098639,alpha-D-Galactose 1-phosphate(2-),alpha-D-galactose 1-phosphate(2-)|galactose-1-P|19046-60-7|D-galactose-1-phosphate|CHEBI:58336|alpha-D-galactose 1-phosphate dianion|1-O-phosphonato-alpha-D-galactopyranose|1-O-(Dioxylatophosphinyl)-alpha-D-galactopyranose|Q27125709,258.120,C6H11O9P-2,163.000,266.000,-4.000,16,4,9,2,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3+,4+,5-,6-/m1/s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)OP(=O)([O-])[O-])O)O)O)O,HXXFSFRBOHSIMQ-FPRJBGLDSA-L,"[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060729,"3WAY PHARM INC|ABI Chem|BioCyc|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|Thieme Chemistry|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7173827,N-Acetyl-beta-neuraminate,"N-acetyl-beta-neuraminate|N-acetyl-  -neuraminate|beta-N-acetylneuraminate|CHEBI:58705|3b50|3e81|Q27125980|5-acetamido-3,5-dideoxy-D-glycero-beta-D-galacto-non-2-ulopyranosonate",308.260,C11H18NO9-,180.000,398.000,-2.800,21,6,9,4,"InChI=1S/C11H19NO9/c1-4(14)12-7-5(15)2-11(20,10(18)19)21-9(7)8(17)6(16)3-13/h5-9,13,15-17,20H,2-3H2,1H3,(H,12,14)(H,18,19)/p-1/t5-,6+,7+,8+,9+,11-/m0/s1",CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)[O-])O)O,SQVRNKJHWKZAKO-PFQGKNLYSA-M,"(2S,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,977610|977611,20060729,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9543252,2-Aminomuconate 6-semialdehyde(1-),"2-aminomuconate 6-semialdehyde(1-)|2-aminomuconate semialdehyde|CHEBI:57495|(2E,4Z)-2-amino-6-oxohexa-2,4-dienoate|Q27124735|(1E,3Z)-1-Amino-5-oxo-1,3-pentadiene-1-carboxylic acid anion",140.120,C6H6NO3-,83.200,188.000,0.300,10,1,4,2,"InChI=1S/C6H7NO3/c7-5(6(9)10)3-1-2-4-8/h1-4H,7H2,(H,9,10)/p-1/b2-1-,5-3+",C(=C\\C=O)\\C=C(/C(=O)[O-])\\N,QCGTZPZKJPTAEP-REDYYMJGSA-M,"(2E,4Z)-2-amino-6-oxohexa-2,4-dienoate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20060802,"ChEBI|ChemSpider|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NovoSeek|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9548580,3-(4-Hydroxyphenyl)lactate,3-(4-Hydroxyphenyl)lactate|p-Hydroxyphenyllactate|4-Hydroxyphenyllactate|ACMC-20anjv|CHEBI:36659|AMY2445|BDBM50269986|Q27104379,181.160,C9H9O4-,80.600,167.000,1.400,13,2,4,2,"InChI=1S/C9H10O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8,10-11H,5H2,(H,12,13)/p-1",C1=CC(=CC=C1CC(C(=O)[O-])O)O,JVGVDSSUAVXRDY-UHFFFAOYSA-M,2-hydroxy-3-(4-hydroxyphenyl)propanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20061004,"Achemica|Achemo Scientific Limited|Apexmol|BindingDB|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|Tractus|Wikidata|Wiley",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
12358530,"Palmitic acid-16,16,16-d3","Palmitic acid-16,16,16-d3|75736-53-7|Palmitic acid(d3)|hexadecanoic-16,16,16-d3 acid|16,16,16-trideuteriohexadecanoic acid|Hexadecanoic acid(d3)|Palmitic Acid-[d3]|SCHEMBL1332261|DTXSID10493909|CHEBI:168544|Hexadecanoic-16,16,16-d3acid|FA 16:0-d3|LMFA01010046|(16,16,16-~2~H_3_)Hexadecanoic acid|Palmitic acid-16,16,16-d3, >=99 atom % D, >=99% (CP)",259.440,C16H32O2,37.300,178.000,6.400,18,1,2,14,"InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)/i1D3",[2H]C([2H])([2H])CCCCCCCCCCCCCCC(=O)O,IPCSVZSSVZVIGE-FIBGUPNXSA-N,"16,16,16-trideuteriohexadecanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,8,NULL,20070207,"A2B Chem|AA BLOCKS|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|Biocore|BOC Sciences|ChEBI|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|EPA DSSTox|Google Patents|IBM|LIPID MAPS|MassBank of North America (MoNA)|MuseChem|Sigma-Aldrich|Smolecule|SureChEMBL|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
14671060,Pristanal,"pristanal|2,6,10,14-tetramethylpentadecanal|(2R)-pristanal|(2S)-pristanal|2(R)-pristanal|2(S)-pristanal|2SPr-al|SCHEMBL2870971|CHEBI:49189|DTXSID30883161|LMPR0104010012|2RPr-al (2R,6R,10R,14)-tetramethylpentadecanal|(2R,6R,10R)-2,6,10,14-tetramethylpentadecanal|(2S,6R,10R)-2,6,10,14-tetramethylpentadecanal|Q15313798|105373-75-9",282.500,C19H38O,17.100,222.000,7.800,20,0,1,13,"InChI=1S/C19H38O/c1-16(2)9-6-10-17(3)11-7-12-18(4)13-8-14-19(5)15-20/h15-19H,6-14H2,1-5H3",CC(C)CCCC(C)CCCC(C)CCCC(C)C=O,IZJRIIWUSIGEAJ-UHFFFAOYSA-N,"2,6,10,14-tetramethylpentadecanal",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20070209,"BioCyc|ChEBI|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LIPID MAPS|MetabolomicsWorkbench|NovoSeek|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15938963,Thiamin diphosphate,thiamine(1+) diphosphate(3-)|thiamine-PPi|thiamin-PPi|thiamin diphosphate|thiamin pyrophosphate|2qta|3exf|3exh|3iaf|nchembio867-comp2|3lq2|3lq4|thiamine diphosphate(2-)|thiamine diphosphate dianion|CHEBI:58937|Q27126356,422.290,C12H16N4O7P2S-2,206.000,548.000,-1.400,26,1,11,7,"InChI=1S/C12H18N4O7P2S/c1-8-11(3-4-22-25(20,21)23-24(17,18)19)26-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H4-,13,14,15,17,18,19,20,21)/p-2",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)([O-])OP(=O)([O-])[O-],AYEKOFBPNLCAJY-UHFFFAOYSA-L,"[2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-oxidophosphoryl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,8,1811|977610|977611,20070215,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|NextBio|Shanghai Institute of Organic Chemistry|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15938964,Thiamine(1+) triphosphate(4-),Thiamine triphosphate|thiamine(1+) triphosphate(4-)|nchembio867-comp3|15666-52-1|thiamine triphosphate(3-)|thiamine triphosphate trianion|CHEBI:58938|Q27126357,501.270,C12H16N4O10P3S-3,255.000,700.000,-2.600,30,1,14,9,"InChI=1S/C12H19N4O10P3S/c1-8-11(30-7-16(8)6-10-5-14-9(2)15-12(10)13)3-4-24-28(20,21)26-29(22,23)25-27(17,18)19/h5,7H,3-4,6H2,1-2H3,(H5-,13,14,15,17,18,19,20,21,22,23)/p-3",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-],IWLROWZYZPNOFC-UHFFFAOYSA-K,"[[2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate",Thiamine Triphosphate,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20070215,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|MuseChem|Nature Chemical Biology|NextBio|Springer Nature|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15938971,Diphosphopyridine nucleotide,"nicotinamide adenine dinucleotide|coenzyme I|diphosphopyridine nucleotide|NAD+|53-84-9|NAD(1-)|NAD-oxidized|Nicotinamide-adenine dinucleotide|DPN-ox|Q28529711|DPN+|NAD|diphosphopyridine nucleotide oxidized|nchembio867-comp14|nicotinamide adenine dinucleotide oxidized|beta-Nicotinamide adenine dinucleotide hydrate, 98+%|NAD anion|2zit|NAD-ox|3b8h|CHEBI:57540|3b78|DTXSID201016357|adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] diphosphate}|[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydr",662.400,C21H26N7O14P2-,324.000,1110.000,-6.100,44,6,18,11,"InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p-1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N,BAWFJGJZGIEFAR-NNYOXOHSSA-M,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NAD,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,11,977611,20070215,"3WAY PHARM INC|Acros Organics|BioCyc|ChangChem|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Nature Chemical Biology|NextBio|Shanghai Institute of Organic Chemistry|Springer Nature|THE BioTek|Thieme Chemistry|ToxPlanet|Wikidata|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, WikiPathways]"
16740916,"D-Glucopyranuronic acid, ion(1-)","D-Glucopyranuronic acid, ion(1-)|148-00-5|Glucopyranuronic acid, ion(1-), D-|D-Glucopyranuronic acid ion|CHEBI:58720|DTXSID70163858|Q27125989|(2S,3S,4S,5R)-3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-carboxylate",193.130,C6H9O7-,130.000,200.000,-1.700,13,4,7,0,"InChI=1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/p-1/t1-,2-,3+,4-,6?/m0/s1",[C@@H]1([C@@H]([C@H](OC([C@@H]1O)O)C(=O)[O-])O)O,AEMOLEFTQBMNLQ-AQKNRBDQSA-M,"(2S,3S,4S,5R)-3,4,5,6-tetrahydroxyoxane-2-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071003,"BioCyc|ChEBI|ChemIDplus|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|Nature Chemical Biology|Springer Nature|ToxPlanet|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
20056867,CDP trianion,"CDP(3-)|CDP trianion|cytidine 5'-diphosphate(2-)|cytidine 5'-pyrophosphate(2-)|CHEBI:58069|5'-O-[(phosphonatooxy)phosphinato]cytidine|A834354|Q27125163|[[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]methoxy-oxidophosphoryl] phosphate|[[(2R,3S,4R,5R)-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanidyl-phosphoryl] phosphate",400.150,C9H12N3O11P2-3,230.000,671.000,-4.800,25,3,11,5,"InChI=1S/C9H15N3O11P2/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H2,10,11,15)(H2,16,17,18)/p-3/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])[O-])O)O,ZWIADYZPOWUWEW-XVFCMESISA-K,"[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071205,"Amadis Chemical|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Therapeutic Target Database (TTD)|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
20057076,[3H]Dehydroepiandrosterone sulfate,"CCG-204473|3-beta-hydroxyandrost-5-en-17-one 3-sulfate|[3H]dehydroepiandrosterone sulfate|[3H]dehydroepiandrosterone sulphate|[3H]DHEAS|GTPL4528|GTPL5577|CHEBI:57905|dehydroepiandrosterone sulfate(1-)|3beta-sulfooxy-androst-5-en-17-one|17-oxoandrost-5-en-3beta-yl sulfate|NCGC00162137-02|3  -hydroxyandrost-5-en-17-one 3-sulfate(1-)|3beta-hydroxyandrost-5-en-17-one 3-sulfate anion|3beta-hydroxyandrost-5-en-17-one 3-sulfate(1-)|Q27077014|(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11",367.500,C19H27O5S-,91.900,707.000,2.800,25,0,5,1,"InChI=1S/C19H28O5S/c1-18-9-7-13(24-25(21,22)23)11-12(18)3-4-14-15-5-6-17(20)19(15,2)10-8-16(14)18/h3,13-16H,4-11H2,1-2H3,(H,21,22,23)/p-1/t13-,14-,15-,16-,18-,19-/m0/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)[O-])C,CZWCKYRVOZZJNM-USOAJAOKSA-M,"[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] sulfate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,1159607|1272365|1479145|1479147|1479149|1479150,20071205,"BioCyc|Center for Chemical Genomics, University of Michigan|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|National Center for Advancing Translational Sciences (NCATS)|Therapeutic Target Database (TTD)|UW Madison, Small Molecule Screening Facility|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21122964,Deoxycytidine-diphosphate,dCDP(3-)|deoxycytidine-diphosphate|2'-deoxycytosine 5'-diphosphate|CHEBI:58593|Q27125901,384.150,C9H12N3O10P2-3,210.000,640.000,-4.800,24,2,10,5,"InChI=1S/C9H15N3O10P2/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(21-8)4-20-24(18,19)22-23(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H2,10,11,14)(H2,15,16,17)/p-3/t5-,6+,8+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)COP(=O)([O-])OP(=O)([O-])[O-])O,FTDHDKPUHBLBTL-SHYZEUOFSA-K,"[[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071205,"BioCyc|CCSbase|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|ToxPlanet|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21584050,Myo-inositol hexakisphosphate(12-),"myo-inositol hexakisphosphate(12-)|InsP6|(1s,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexayl hexaphosphate|2lha|3eeb|3fzy|CHEBI:58130|Q27125203|myo-Inositol, hexakis(dihydrogen phosphate), ion(12-)|[2,3,4,5,6-pentakis(phosphonatooxy)cyclohexyl] phosphate|1-O,2-O,3-O,4-O,5-O,6-O-Hexaphosphonato-myo-inositol|(1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexayl hexakis(phosphate)|3929-21-3",647.940,C6H6O24P6-12,435.000,749.000,-11.300,36,0,24,6,"InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/p-12",C1(C(C(C(C(C1OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-])OP(=O)([O-])[O-],IMQLKJBTEOYOSI-UHFFFAOYSA-B,"(2,3,4,5,6-pentaphosphonatooxycyclohexyl) phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,977611,20071205,"Alfa Chemistry|BioCyc|ChEBI|ChemIDplus|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|Nature Chemical Biology|SCRIPDB|Shanghai Institute of Organic Chemistry|Springer Nature|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21604863,beta-D-Fructofuranose 6-phosphate(2-),beta-D-fructofuranose 6-phosphate(2-)|fruc6p|3bxh|3n1c|CHEBI:57634|6-O-phosphonato-beta-D-fructofuranose|beta-D-fructofuranose 6-phosphate dianion|Q27124826,258.120,C6H11O9P-2,163.000,278.000,-4.100,16,4,9,3,"InChI=1S/C6H13O9P/c7-2-6(10)5(9)4(8)3(15-6)1-14-16(11,12)13/h3-5,7-10H,1-2H2,(H2,11,12,13)/p-2/t3-,4-,5+,6-/m1/s1",C([C@@H]1[C@H]([C@@H]([C@](O1)(CO)O)O)O)OP(=O)([O-])[O-],BGWGXPAPYGQALX-ARQDHWQXSA-L,"[(2R,3S,4S,5R)-3,4,5-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,7,977611,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Shanghai Institute of Organic Chemistry|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21668242,N-Methylputrescinium(2+),"N-methylputrescinium(2+)|N-methylputrescinium dication|N-methylbutane-1,4-diaminium|CHEBI:58039|(4-azaniumylbutyl)(methyl)azanium|Q27125144",104.190,C5H16N2+2,44.200,29.300,-0.400,7,2,0,4,"InChI=1S/C5H14N2/c1-7-5-3-2-4-6/h7H,2-6H2,1H3/p+2",C[NH2+]CCCC[NH3+],RMIVMBYMDISYFZ-UHFFFAOYSA-P,4-azaniumylbutyl(methyl)azanium,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21917715,2-Methyl-3-oxopropanoate,"2-methyl-3-oxopropanoate|ch3-malonate-semialdehyde|GTPL6611|CHEBI:57700|Q27072236|2-methyl-3-oxopropanoate, Methylmalonic acid semialdehyde",101.080,C4H5O3-,57.200,81.400,0.600,7,0,3,1,"InChI=1S/C4H6O3/c1-3(2-5)4(6)7/h2-3H,1H3,(H,6,7)/p-1",CC(C=O)C(=O)[O-],VOKUMXABRRXHAR-UHFFFAOYSA-M,2-methyl-3-oxopropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071205,"BioCyc|ChEBI|ChemSpider|DiscoveryGate|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Therapeutic Target Database (TTD)|Thomson Pharma|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
22833604,"(2S,4R,5S)-5-(Hydroxymethyl)oxolane-2,4-diol","2-Deoxy-beta-L-erythro-pentofuranose|113890-38-3|2'-Deoxy-D-ribose|(2S,4R,5S)-5-(Hydroxymethyl)oxolane-2,4-diol|(2S,4R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2,4-diol|SCHEMBL5834564|2-Deoxy-b-L-erythro-pentofuranose|ZINC5600727|AKOS006288998|890D383",134.130,C5H10O4,69.900,95.000,-1.000,9,3,4,1,"InChI=1S/C5H10O4/c6-2-4-3(7)1-5(8)9-4/h3-8H,1-2H2/t3-,4+,5+/m1/s1",C1[C@H]([C@@H](O[C@@H]1O)CO)O,PDWIQYODPROSQH-WISUUJSJSA-N,"(2S,4R,5S)-5-(hydroxymethyl)oxolane-2,4-diol",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071205,"3WAY PHARM INC|Achemtek|AKos Consulting & Solutions|Ambinter|BLD Pharm|BOC Sciences|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|eNovation Chemicals|Google Patents|Human Metabolome Database (HMDB)|IBM|MassBank of North America (MoNA)|MuseChem|OChem|Smolecule|SureChEMBL|THE BioTek|ZINC",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
22848660,Deoxyadenosine-phosphate,"dAMP(2-)|deoxyadenosine-phosphate|CHEBI:58245|2'-deoxy-5'-O-phosphonatoadenosine|2'-deoxyadenosine 5''-monophosphate|2'-deoxyadenosine 5'-monophosphate(2-)|5'-O-(Dioxylatophosphinyl)-2'-deoxyadenosine|A835089|Q27125645|[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-2-oxolanyl]methyl phosphate|[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-oxidanyl-oxolan-2-yl]methyl phosphate",329.210,C10H12N5O6P-2,172.000,440.000,-2.400,22,2,10,3,"InChI=1S/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/p-2/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)([O-])[O-])O,KHWCHTKSEGGWEX-RRKCRQDMSA-L,"[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071205,"A&J Pharmtech CO., LTD.|Amadis Chemical|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23421199,D-Glucopyranose 6-phosphate,D-glucopyranose 6-phosphate(2-)|D-glucopyranose 6-phosphate|D-glucopyranose-6-P|6-O-phosphonato-D-glucopyranose|CHEBI:61548|D-glucopyranose 6-phosphate dianion|(D-Glucopyranose-6-O-yl)phosphonic acid dianion|Q27131151,258.120,C6H11O9P-2,163.000,266.000,-4.400,16,4,9,2,"InChI=1S/C6H13O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5-,6?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)O)O)OP(=O)([O-])[O-],NBSCHQHZLSJFNQ-GASJEMHNSA-L,"[(2R,3S,4S,5R)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20071206,"BioCyc|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|Thieme Chemistry|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23615443,alpha-D-Ribofuranose 1-phosphate,alpha-D-ribose 1-phosphate(2-)|alpha-D-ribofuranose 1-phosphate|D-ribose-1-phosphate|alpha-D-ribose-1-phosphate|alpha-D-ribose-1P|1-O-Phosphonatopentofuranose|CHEBI:57720|DTXSID00930914|alpha-D-ribose 1-phosphate dianion|1-O-phosphonato-alpha-D-ribofuranose|Q27124890,228.090,C5H9O8P-2,142.000,226.000,-3.400,14,3,8,2,"InChI=1S/C5H11O8P/c6-1-2-3(7)4(8)5(12-2)13-14(9,10)11/h2-8H,1H2,(H2,9,10,11)/p-2/t2-,3-,4-,5-/m1/s1",C([C@@H]1[C@H]([C@H]([C@H](O1)OP(=O)([O-])[O-])O)O)O,YXJDFQJKERBOBM-TXICZTDVSA-L,"[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20071212,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|ToxPlanet|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23724459,CID 23724459,"UDP-D-xylose|C00190|[[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate",536.280,C14H22N2O16P2,271.000,916.000,-6.600,34,8,16,8,"InChI=1S/C14H22N2O16P2/c17-5-3-28-13(11(22)8(5)19)31-34(26,27)32-33(24,25)29-4-6-9(20)10(21)12(30-6)16-2-1-7(18)15-14(16)23/h1-2,5-6,8-13,17,19-22H,3-4H2,(H,24,25)(H,26,27)(H,15,18,23)/t5-,6-,8+,9-,10-,11-,12?,13-/m1/s1",C1[C@H]([C@@H]([C@H]([C@H](O1)OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H](C(O2)N3C=CC(=O)NC3=O)O)O)O)O)O,DQQDLYVHOTZLOR-WJCCNOJNSA-N,"[[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Literature|Patents|Pharmacology and Biochemistry,4,NULL,20080208,BLD Pharm|Google Patents|KEGG|MassBank of North America (MoNA)|NovoSeek,Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
24755499,Hydrogen isocitrate,hydrogen isocitrate|CHEBI:36453,190.110,C6H6O7-2,141.000,217.000,NULL,13,2,7,2,"InChI=1S/C6H8O7/c7-3(8)1-2(5(10)11)4(9)6(12)13/h2,4,9H,1H2,(H,7,8)(H,10,11)(H,12,13)/p-2",[H+].C(C(C(C(=O)[O-])O)C(=O)[O-])C(=O)[O-],ODBLHEXUDAPZAU-UHFFFAOYSA-L,"hydron;1-hydroxypropane-1,2,3-tricarboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20080326,ChEBI,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
24916915,(R)-5-Diphosphomevalonate,(R)-5-diphosphonatomevalonate(4-)|(R)-5-Diphosphomevalonate|mevalonate-5-PP|2oi2|(R)-mevalonate diphosphate|CHEBI:57557|4872-34-8|Q27124779|(3R)-3-hydroxy-3-methyl-5-{[(phosphonatooxy)phosphinato]oxy}pentanoate,304.080,C6H10O10P2-4,182.000,363.000,-2.800,18,1,10,6,"InChI=1S/C6H14O10P2/c1-6(9,4-5(7)8)2-3-15-18(13,14)16-17(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H,13,14)(H2,10,11,12)/p-4/t6-/m1/s1",C[C@@](CCOP(=O)([O-])OP(=O)([O-])[O-])(CC(=O)[O-])O,SIGQQUBJQXSAMW-ZCFIWIBFSA-J,(3R)-3-hydroxy-3-methyl-5-[oxido(phosphonatooxy)phosphoryl]oxypentanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,1811|977611,20081003,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Shanghai Institute of Organic Chemistry|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25202847,CDP-ethanolamine(1-),CDP-ethanolamine(1-)|CDP-ethanolamine cation|CHEBI:57876|Q27125020|5'-O-({[(2-ammonioethoxy)phosphinato]oxy}phosphinato)cytidine,445.240,C11H19N4O11P2-,244.000,730.000,-5.100,28,4,11,9,"InChI=1S/C11H20N4O11P2/c12-2-4-23-27(19,20)26-28(21,22)24-5-6-8(16)9(17)10(25-6)15-3-1-7(13)14-11(15)18/h1,3,6,8-10,16-17H,2,4-5,12H2,(H,19,20)(H,21,22)(H2,13,14,18)/p-1/t6-,8-,9-,10-/m1/s1",C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OCC[NH3+])O)O,WVIMUEUQJFPNDK-PEBGCTIMSA-M,"[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-azaniumylethyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20090331,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25203490,S-Adenosyl-L-methioninamine,"S-Adenosyl-L-methioninamine|decarboxylated SAM|decarboxylated AdoMet|S-adenosylmethioninaminium|S-adenosyl 3-(methylsulfanyl)propylamine|S-adenosyl 3-(methylthio)propylamine|dcSAM|(5-deoxy-5-adenosyl)(3-aminopropyl) methylsulfonium salt|3-amino-propyl-S-adenosine|GTPL5121|CHEBI:57443|S-methyl-S-adenosyl homocysteamine|Q27088682|(3-azaniumylpropyl)(5'-deoxyadenosin-5'-yl)(methyl)sulfonium|{[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl}(3-azaniumylpropyl)methylsulfanium",356.450,C14H24N6O3S+2,148.000,422.000,-0.800,24,4,7,6,"InChI=1S/C14H23N6O3S/c1-24(4-2-3-15)5-8-10(21)11(22)14(23-8)20-7-19-9-12(16)17-6-18-13(9)20/h6-8,10-11,14,21-22H,2-5,15H2,1H3,(H2,16,17,18)/q+1/p+1/t8-,10-,11-,14-,24?/m1/s1",C[S+](CCC[NH3+])C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,ZUNBITIXDCPNSD-LSRJEVITSA-O,"3-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]propylazanium",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090331,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Therapeutic Target Database (TTD)|Wikidata|WikiPathways",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25243963,N-Acetyl-D-glucosamine 6-phosphate(2-),N-acetyl-D-glucosamine 6-phosphate(2-)|N-acetylglucosamine-6-P|N-acetyl-glucosamine-6-P|N-acetyl-D-glucosamine-6-P|102029-88-9|CHEBI:57513|N-acetyl-glucosamine 6-phosphate|N-acetyl-D-glucosamine 6-phosphate dianion|2-acetamido-2-deoxy-D-glucopyranose 6-phosphate|2-acetamido-2-deoxy-6-O-phosphonato-D-glucopyranose|N-ACETYL-D-GLUCOSAMINE6-PHOSPHATEDISODIUMSALT|Q27124747,299.170,C8H14NO9P-2,171.000,360.000,-4.400,19,4,9,3,"InChI=1S/C8H16NO9P/c1-3(10)9-5-7(12)6(11)4(18-8(5)13)2-17-19(14,15)16/h4-8,11-13H,2H2,1H3,(H,9,10)(H2,14,15,16)/p-2/t4-,5-,6-,7-,8?/m1/s1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](OC1O)COP(=O)([O-])[O-])O)O,BRGMHAYQAZFZDJ-RTRLPJTCSA-L,"[(2R,3S,4R,5R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards,6,NULL,20090514,"3WAY PHARM INC|BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25244163,Dtdp-4-dehydro-6-deoxy-alpha-D-glucose(2-),dTDP-4-dehydro-6-deoxy-alpha-D-glucose(2-)|dTDP-4-dehydro-6-deoxy-alpha-D-glucopyranose|CHEBI:57649|TDP-4-oxo-6-deoxy--alpha-D-glucose|dTDP-4-oxo-6-deoxy--alpha-D-glucose|dTDP-6-deoxy-alpha-D-xylohex-4-ulose|TDP-4-keto-6-deoxy--alpha-D-glucose|dTDP-6-deoxy-alpha-D-xylo-4-hexosulose|dTDP-4-dehydro-6-deoxy-  -D-glucose(2-)|dTDP-6-deoxy-alpha-D-xylo-4-hexulose(2-)|dTDP-6-deoxy-alpha-D-xylo-hex-4-ulose(2-)|dTDP-4-dehydro-6-deoxy-alpha-D-glucose dianion|Q27104826|thymidine 5'-[3-(6-deoxy-alpha-D-xylo-hexopyranos,544.300,C16H22N2O15P2-2,254.000,987.000,-4.500,35,4,15,8,"InChI=1S/C16H24N2O15P2/c1-6-4-18(16(24)17-14(6)23)10-3-8(19)9(31-10)5-29-34(25,26)33-35(27,28)32-15-13(22)12(21)11(20)7(2)30-15/h4,7-10,12-13,15,19,21-22H,3,5H2,1-2H3,(H,25,26)(H,27,28)(H,17,23,24)/p-2/t7-,8+,9-,10-,12+,13-,15-/m1/s1",C[C@@H]1C(=O)[C@@H]([C@H]([C@H](O1)OP(=O)([O-])OP(=O)([O-])OC[C@@H]2[C@H](C[C@@H](O2)N3C=C(C(=O)NC3=O)C)O)O)O,PSXWNITXWWECNY-UCBTUHGZSA-L,"[(2R,3R,4R,6R)-3,4-dihydroxy-6-methyl-5-oxooxan-2-yl] [[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25244191,3-Oxohexadecanoyl-CoA,"3-oxopalmitoyl-CoA(4-)|3-Oxohexadecanoyl-CoA|3-ketopalmitoyl-CoA|CHEBI:57349|Q27124449|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-{[3-oxo-3-({2-[(3-oxohexadecanoyl)sulfanyl]ethyl}amino)propyl]amino}butyl] diphosphate}",1015.900,C37H60N7O18P3S-4,417.000,1680.000,0.100,66,5,23,33,"InChI=1S/C37H64N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-25(45)20-28(47)66-19-18-39-27(46)16-17-40-35(50)32(49)37(2,3)22-59-65(56,57)62-64(54,55)58-21-26-31(61-63(51,52)53)30(48)36(60-26)44-24-43-29-33(38)41-23-42-34(29)44/h23-24,26,30-32,36,48-49H,4-22H2,1-3H3,(H,39,46)(H,40,50)(H,54,55)(H,56,57)(H2,38,41,42)(H2,51,52,53)/p-4/t26-,30-,31-,32+,36-/m1/s1",CCCCCCCCCCCCCC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,NQMPLXPCRJOSHL-BBECNAHFSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-(3-oxohexadecanoylsulfanyl)ethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25244548,(R)-5-Phosphonatomevalonate(3-),(R)-5-phosphonatomevalonate(3-)|73566-35-5|(R)-5-phosphonatomevalonate|(R)-mevalonate 5-phosphate|CHEBI:58146|DTXSID30994347|(R)-5-phosphonatomevalonate trianion|3-Hydroxy-3-methyl-5-(phosphonatooxy)pentanoate|(3R)-3-hydroxy-3-methyl-5-(phosphonatooxy)pentanoate|Q27125216,225.110,C6H10O7P-3,133.000,230.000,-1.600,14,1,7,4,"InChI=1S/C6H13O7P/c1-6(9,4-5(7)8)2-3-13-14(10,11)12/h9H,2-4H2,1H3,(H,7,8)(H2,10,11,12)/p-3/t6-/m1/s1",C[C@@](CCOP(=O)([O-])[O-])(CC(=O)[O-])O,OKZYCXHTTZZYSK-ZCFIWIBFSA-K,(3R)-3-hydroxy-3-methyl-5-phosphonatooxypentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Wikidata",Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245316,3-Oxotetradecanoyl-CoA(4-),"3-oxotetradecanoyl-CoA(4-)|3-oxomyristoyl-CoA(4-)|3-oxo-myristoyl-CoA(4-)|CHEBI:62543|Q27132003|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-{[3-oxo-3-({2-[(3-oxotetradecanoyl)sulfanyl]ethyl}amino)propyl]amino}butyl] diphosphate}",987.800,C35H56N7O18P3S-4,417.000,1640.000,-1.000,64,5,23,31,"InChI=1S/C35H60N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-23(43)18-26(45)64-17-16-37-25(44)14-15-38-33(48)30(47)35(2,3)20-57-63(54,55)60-62(52,53)56-19-24-29(59-61(49,50)51)28(46)34(58-24)42-22-41-27-31(36)39-21-40-32(27)42/h21-22,24,28-30,34,46-47H,4-20H2,1-3H3,(H,37,44)(H,38,48)(H,52,53)(H,54,55)(H2,36,39,40)(H2,49,50,51)/p-4/t24-,28-,29-,30+,34-/m1/s1",CCCCCCCCCCCC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,IQNFBGHLIVBNOU-QSGBVPJFSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-(3-oxotetradecanoylsulfanyl)ethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245492,Pyridoxaminium(1+),pyridoxaminium(1+)|pyridoxaminium cation|CHEBI:57761|Q27124924|[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methanaminium,169.200,C8H13N2O2+,81.000,143.000,-1.000,12,3,3,2,"InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3/p+1",CC1=NC=C(C(=C1O)C[NH3+])CO,NHZMQXZHNVQTQA-UHFFFAOYSA-O,[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylazanium,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20090514,"A&J Pharmtech CO., LTD.|BioCyc|ChEBI|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245603,Leukotriene C4(2-),"leukotriene C4(2-)|leukotriene C4 dianion|CHEBI:57973|Q27125092|(5S,6R,7E,9E,11Z,14Z)-6-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-5-hydroxyicosa-7,9,11,14-tetraenoate",623.800,C30H45N3O9S-2,252.000,965.000,2.600,43,4,10,22,"InChI=1S/C30H47N3O9S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(34)15-14-17-27(36)37)43-21-23(29(40)32-20-28(38)39)33-26(35)19-18-22(31)30(41)42/h6-7,9-13,16,22-25,34H,2-5,8,14-15,17-21,31H2,1H3,(H,32,40)(H,33,35)(H,36,37)(H,38,39)(H,41,42)/p-2/b7-6-,10-9-,12-11+,16-13+/t22-,23-,24-,25+/m0/s1",CCCCC/C=C\\C/C=C\\C=C\\C=C\\[C@H]([C@H](CCCC(=O)[O-])O)SC[C@@H](C(=O)NCC(=O)[O-])NC(=O)CC[C@@H](C(=O)[O-])[NH3+],GWNVDXQDILPJIG-NXOLIXFESA-L,"(5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-[[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino]-3-(carboxylatomethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245711,Octanoyl-CoA,"octanoyl-CoA(4-)|octanoyl-CoA|capryloyl-CoA(4-)|octanoyl-CoA tetraanion|capryloyl-CoA tetraanion|octanoyl-coenzyme A(4-)|capryloyl-coenzyme A(4-)|Octanoyl-CoA (n-C8:0CoA)|CHEBI:57386|Q27124570|3'-phosphonatoadenosine 5'-(3-{(3R)-3-hydroxy-2,2-dimethyl-4-[(3-{[2-(octanoylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-4-oxobutyl} diphosphate)",889.700,C29H46N7O17P3S-4,400.000,1460.000,-3.000,57,5,22,25,"InChI=1S/C29H50N7O17P3S/c1-4-5-6-7-8-9-20(38)57-13-12-31-19(37)10-11-32-27(41)24(40)29(2,3)15-50-56(47,48)53-55(45,46)49-14-18-23(52-54(42,43)44)22(39)28(51-18)36-17-35-21-25(30)33-16-34-26(21)36/h16-18,22-24,28,39-40H,4-15H2,1-3H3,(H,31,37)(H,32,41)(H,45,46)(H,47,48)(H2,30,33,34)(H2,42,43,44)/p-4/t18-,22-,23-,24+,28-/m1/s1",CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,KQMZYOXOBSXMII-CECATXLMSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-(2-octanoylsulfanylethylamino)-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25246271,Pyridoxamine 5'-phosphate(1-),pyridoxamine 5'-phosphate(1-)|pyridoxamine 5'-phosphate anion|CHEBI:58451|Q27125799|[4-(ammoniomethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl phosphate,247.160,C8H12N2O5P-,133.000,260.000,-4.600,16,2,6,3,"InChI=1S/C8H13N2O5P/c1-5-8(11)7(2-9)6(3-10-5)4-15-16(12,13)14/h3,11H,2,4,9H2,1H3,(H2,12,13,14)/p-1",CC1=NC=C(C(=C1O)C[NH3+])COP(=O)([O-])[O-],ZMJGSOSNSPKHNH-UHFFFAOYSA-M,[4-(azaniumylmethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20090514,"A&J Pharmtech CO., LTD.|BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25246274,N-Formimidoyl-L-glutamate(1-),N-formimidoyl-L-glutamate(1-)|formimino-glu|formiminoglutamate|N-formimino-glutamate|alpha-formamidinoglutarate|N-formimidoyl-L-glutamate anion|CHEBI:58928|N-(iminiumylmethyl)-L-glutamic acid|(2S)-2-[(iminiomethyl)amino]pentanedioate|(2S)-2-[(iminiumylmethyl)amino]pentanedioate|Q27126350,173.150,C6H9N2O4-,120.000,191.000,0.200,12,2,4,3,"InChI=1S/C6H10N2O4/c7-3-8-4(6(11)12)1-2-5(9)10/h3-4H,1-2H2,(H2,7,8)(H,9,10)(H,11,12)/p-1/t4-/m0/s1",C(CC(=O)[O-])[C@@H](C(=O)[O-])[NH+]=CN,NRXIKWMTVXPVEF-BYPYZUCNSA-M,(2S)-2-(aminomethylideneazaniumyl)pentanedioate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
44229199,Flavin mononucleotide(3-),"flavin mononucleotide(3-)|flavin mononucleotide|FMN trianion|flavin mononucleotide trianion|riboflavin 5'-phosphate(3-)|CHEBI:58210|riboflavin 5'-phosphate trianion|riboflavin 5'-monophosphate(3-)|riboflavin 5'-monophosphate trianion|Q28529692|1-deoxy-1-(7,8-dimethyl-2,4-dioxo-2H-benzo[g]pteridin-3-id-10(4H)-yl)-5-O-phosphonato-D-ribitol|7,8-dimethyl-2,4-dioxo-10-[(2S,3S,4R)-2,3,4-trihydroxy-5-(phosphonatooxy)pentyl]-2H,3H,4H,10H-benzo[g]pteridin-3-ide",453.300,C17H18N4O9P-3,214.000,845.000,-1.700,31,3,10,6,"InChI=1S/C17H21N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-12,14,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/p-3/t11-,12+,14-/m0/s1",CC1=CC2=C(C=C1C)N(C3=NC(=NC(=O)C3=N2)[O-])C[C@@H]([C@@H]([C@@H](COP(=O)([O-])[O-])O)O)O,FVTCRASFADXXNN-SCRDCRAPSA-K,"[(2R,3S,4S)-5-(7,8-dimethyl-2-oxido-4-oxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] phosphate",Flavin Mononucleotide,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20091015,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
44457531,L-gamma-Glutamyl phosphate(2-),L-gamma-glutamyl phosphate(2-)|gamma-L-glutamyl-5-P|gamma-L-glutamyl 5-phosphate|CHEBI:58274|L-gamma-glutamyl phosphate dianion|(2S)-2-ammonio-5-oxo-5-(phosphonatooxy)pentanoate|(2S)-2-azaniumyl-5-oxo-5-(phosphonatooxy)pentanoate|Q27125662,225.090,C5H8NO7P-2,157.000,254.000,-4.300,14,1,7,4,"InChI=1S/C5H10NO7P/c6-3(5(8)9)1-2-4(7)13-14(10,11)12/h3H,1-2,6H2,(H,8,9)(H2,10,11,12)/p-2/t3-/m0/s1",C(CC(=O)OP(=O)([O-])[O-])[C@@H](C(=O)[O-])[NH3+],PJRXVIJAERNUIP-VKHMYHEASA-L,(2S)-2-azaniumyl-5-oxo-5-phosphonatooxypentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20091119,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266562,3'-Dephospho-CoA(2-),"3'-dephospho-CoA(2-)|3633-59-8|3-dephospho-CoA|CHEBI:57328|Q27124428|adenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] diphosphate}",685.500,C21H33N7O13P2S-2,307.000,1080.000,-4.800,44,7,18,16,"InChI=1S/C21H35N7O13P2S/c1-21(2,16(32)19(33)24-4-3-12(29)23-5-6-44)8-39-43(36,37)41-42(34,35)38-7-11-14(30)15(31)20(40-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-32,44H,3-8H2,1-2H3,(H,23,29)(H,24,33)(H,34,35)(H,36,37)(H2,22,25,26)/p-2/t11-,14-,15-,16+,20-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)[C@H](C(=O)NCCC(=O)NCCS)O,KDTSHFARGAKYJN-IBOSZNHHSA-L,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"3WAY PHARM INC|BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Therapeutic Target Database (TTD)|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266575,3-Methylbut-2-enoyl-CoA(4-),"3-methylbut-2-enoyl-CoA(4-)|3-methyl-2-butenoyl-CoA|beta-methylcrotonoyl-CoA|3-methyl-(2E)-butenoyl-CoA|CHEBI:57344|3-methylbut-2-enoyl-CoA tetraanion|3-methylbut-2-enoyl-coenzyme A(4-)|Q27124444|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-{[3-({2-[(3-methylbut-2-enoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl]diphosphate}",845.600,C26H38N7O17P3S-4,400.000,1480.000,-4.500,54,5,22,20,"InChI=1S/C26H42N7O17P3S/c1-14(2)9-17(35)54-8-7-28-16(34)5-6-29-24(38)21(37)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-20(49-51(39,40)41)19(36)25(48-15)33-13-32-18-22(27)30-12-31-23(18)33/h9,12-13,15,19-21,25,36-37H,5-8,10-11H2,1-4H3,(H,28,34)(H,29,38)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/t15-,19-,20-,21+,25-/m1/s1",CC(=CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O)C,BXIPALATIYNHJN-ZMHDXICWSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-(3-methylbut-2-enoylsulfanyl)ethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266595,Acryloyl-CoA(4-),"acryloyl-CoA(4-)|CHEBI:57367|Q27124484|3'-phosphonatoadenosine 5'-(3-{(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[(3-oxo-3-{[2-(prop-2-enoylsulfanyl)ethyl]amino}propyl)amino]butyl} diphosphate)",817.600,C24H34N7O17P3S-4,400.000,1400.000,-5.300,52,5,22,20,"InChI=1S/C24H38N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h4,11-13,17-19,23,34-35H,1,5-10H2,2-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/p-4/t13-,17-,18-,19+,23-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)C=C)O,POODSGUMUCVRTR-IEXPHMLFSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-prop-2-enoylsulfanylethylamino)propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266651,N(1)-(5-Phospho-D-ribosyl)glycinamide(1-),N(1)-(5-phospho-D-ribosyl)glycinamide(1-)|CHEBI:58457|N-(ammonioacetyl)-5-O-phosphonato-D-ribofuranosylamine|Q27125800,285.170,C7H14N2O8P-,179.000,335.000,-7.000,18,4,8,4,"InChI=1S/C7H15N2O8P/c8-1-4(10)9-7-6(12)5(11)3(17-7)2-16-18(13,14)15/h3,5-7,11-12H,1-2,8H2,(H,9,10)(H2,13,14,15)/p-1/t3-,5-,6-,7?/m1/s1",C([C@@H]1[C@H]([C@H](C(O1)NC(=O)C[NH3+])O)O)OP(=O)([O-])[O-],OBQMLSFOUZUIOB-HJZCUYRDSA-M,"[(2R,3S,4R)-5-[(2-azaniumylacetyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100507,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266658,N-(2-Formamido-1-iminioethyl)-5-O-phosphonato-D-ribofuranosylamine,CHEBI:58478|1-deoxy-1-[2-(formamido)acetimidamido]-D-ribofuranose 5-phosphate|N-(2-formamido-1-iminioethyl)-5-O-phosphonato-D-ribofuranosylamine,312.190,C8H15N3O8P-,191.000,401.000,-4.700,20,5,8,5,"InChI=1S/C8H16N3O8P/c9-5(1-10-3-12)11-8-7(14)6(13)4(19-8)2-18-20(15,16)17/h3-4,6-8,13-14H,1-2H2,(H2,9,11)(H,10,12)(H2,15,16,17)/p-1/t4-,6-,7-,8?/m1/s1",C([C@@H]1[C@H]([C@H](C(O1)/[NH+]=C(/CNC=O)\\N)O)O)OP(=O)([O-])[O-],PMCOGCVKOAOZQM-ZRTZXPPTSA-M,"[(2R,3S,4R)-5-(1-amino-2-formamidoethylidene)azaniumyl-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100507,ChEBI,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266724,5-Phospho-beta-D-ribosylaminium(1-),5-phospho-beta-D-ribosylaminium(1-)|5-P-beta-D-ribosylamine|CHEBI:58681|5-phospho-  -D-ribosylaminium(1-)|5-O-phosphonato-beta-D-ribofuranosylaminium|Q27125956,228.120,C5H11NO7P-,150.000,231.000,-6.300,14,3,7,2,"InChI=1S/C5H12NO7P/c6-5-4(8)3(7)2(13-5)1-12-14(9,10)11/h2-5,7-8H,1,6H2,(H2,9,10,11)/p-1/t2-,3-,4-,5-/m1/s1",C([C@@H]1[C@H]([C@H]([C@@H](O1)[NH3+])O)O)OP(=O)([O-])[O-],SKCBPEVYGOQGJN-TXICZTDVSA-M,"[(2R,3S,4R,5R)-5-azaniumyl-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46173506,3-Oxolauroyl-CoA(4-),"3-oxolauroyl-CoA(4-)|3-oxododecanoyl-CoA(4-)|CHEBI:62615|Q27132045|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-{[3-oxo-3-({2-[(3-oxododecanoyl)sulfanyl]ethyl}amino)propyl]amino}butyl] diphosphate}",959.800,C33H52N7O18P3S-4,417.000,1610.000,-2.000,62,5,23,29,"InChI=1S/C33H56N7O18P3S/c1-4-5-6-7-8-9-10-11-21(41)16-24(43)62-15-14-35-23(42)12-13-36-31(46)28(45)33(2,3)18-55-61(52,53)58-60(50,51)54-17-22-27(57-59(47,48)49)26(44)32(56-22)40-20-39-25-29(34)37-19-38-30(25)40/h19-20,22,26-28,32,44-45H,4-18H2,1-3H3,(H,35,42)(H,36,46)(H,50,51)(H,52,53)(H2,34,37,38)(H2,47,48,49)/p-4/t22-,26-,27-,28+,32-/m1/s1",CCCCCCCCCC(=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,HQANBZHVWIDNQZ-GMHMEAMDSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-(3-oxododecanoylsulfanyl)ethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100630,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878379,D-Sedoheptulose 7-phosphate,sedoheptulose 7-phosphate(2-)|D-Sedoheptulose 7-phosphate|sedoheptulose-7-P|D-Sedoheptulose-7-P|2646-35-7|heptulose 7-phosphate|D-altro-hept-2-ulose 7-phosphate(2-)|sedo-heptulose-7-phosphate|7-O-Phosphonatohept-2-ulose|CHEBI:57483|DTXSID40949343|7-O-phosphonato-D-altro-hept-2-ulose|Q24063435,288.150,C7H13O10P-2,191.000,302.000,-5.100,18,5,10,7,"InChI=1S/C7H15O10P/c8-1-3(9)5(11)7(13)6(12)4(10)2-17-18(14,15)16/h4-8,10-13H,1-2H2,(H2,14,15,16)/p-2/t4-,5-,6-,7+/m1/s1",C([C@H]([C@H]([C@H]([C@@H](C(=O)CO)O)O)O)O)OP(=O)([O-])[O-],JDTUMPKOJBQPKX-GBNDHIKLSA-L,"[(2R,3R,4R,5S)-2,3,4,5,7-pentahydroxy-6-oxoheptyl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Thieme Chemistry|ToxPlanet|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878498,(2R)-2-Ammonio-4-(2-formamidophenyl)-4-oxobutanoate,N-formyl-D-kynurenine zwitterion|CHEBI:60051|(2R)-2-ammonio-4-(2-formamidophenyl)-4-oxobutanoate|(2R)-2-azaniumyl-4-(2-formamidophenyl)-4-oxobutanoate,236.220,C11H12N2O4,114.000,300.000,-1.700,17,2,4,4,"InChI=1S/C11H12N2O4/c12-8(11(16)17)5-10(15)7-3-1-2-4-9(7)13-6-14/h1-4,6,8H,5,12H2,(H,13,14)(H,16,17)/t8-/m1/s1",C1=CC=C(C(=C1)C(=O)C[C@H](C(=O)[O-])[NH3+])NC=O,BYHJHXPTQMMKCA-MRVPVSSYSA-N,(2R)-2-azaniumyl-4-(2-formamidophenyl)-4-oxobutanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100920,ChEBI,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878578,XTP trianion,XTP(3-)|XTP trianion|CHEBI:59885|xanthosine 5' triphosphate(3-)|xanthosine 5'-triphosphate(3-)|Q27126941|5'-OO-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]xanthosine,521.140,C10H12N4O15P3-3,294.000,893.000,-6.400,32,5,16,8,"InChI=1S/C10H15N4O15P3/c15-5-3(1-26-31(22,23)29-32(24,25)28-30(19,20)21)27-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H2,12,13,17,18)/p-3/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O)O)NC(=O)NC2=O,CAEFEWVYEZABLA-UUOKFMHZSA-K,"[[[(2R,3S,4R,5R)-5-(2,6-dioxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100920,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46926099,3'-Phosphonato-5'-adenylyl sulfate(4-),3'-phosphonato-5'-adenylyl sulfate(4-)|PAPS tetraanion|PAPS(4-)|3'-phosphonato-5'-adenylyl sulfate|3'-phosphonatoadenosine 5'-phosphosulfate|3'-phosphonato-5'-adenylyl sulfate tetraanion|3'-phosphonatoadenosine 5'-phosphosulfate(4-)|CHEBI:58339|3'-phosphonatoadenosine 5'-phosphosulfate tetraanion|phosphoadenosine-5'-phosphosulfate|Q27125711|3'-O-phosphonato-5'-O-[(sulfonatooxy)phosphinato]adenosine,503.240,C10H11N5O13P2S-4,296.000,819.000,-5.300,31,2,17,6,"InChI=1S/C10H15N5O13P2S/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7(27-29(17,18)19)4(26-10)1-25-30(20,21)28-31(22,23)24/h2-4,6-7,10,16H,1H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)(H,22,23,24)/p-4/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OS(=O)(=O)[O-])OP(=O)([O-])[O-])O)N,GACDQMDRPRGCTN-KQYNXXCUSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[oxido(sulfonatooxy)phosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20101025,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46926335,"6-O-Phosphonato-D-glucono-1,5-lactone(2-)","6-O-phosphonato-D-glucono-1,5-lactone(2-)|D-6-P-glucono-delta-lactone|6-O-phosphonato-D-glucono-1,5-lactone dianion|CHEBI:57955|6-phospho D-glucono-1,5-lactone|D-glucono-delta-lactone 6-phosphate|[(2R,3S,4S,5R)-3,4,5-trihydroxy-6-oxotetrahydro-2H-pyran-2-yl]methyl phosphate|Q27125080|[(2R,3S,4S,5R)-3,4,5-trihydroxy-6-oxooxan-2-yl]methyl phosphate",256.100,C6H9O9P-2,159.000,300.000,-3.800,16,3,9,2,"InChI=1S/C6H11O9P/c7-3-2(1-14-16(11,12)13)15-6(10)5(9)4(3)8/h2-5,7-9H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5-/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H](C(=O)O1)O)O)O)OP(=O)([O-])[O-],IJOJIVNDFQSGAB-SQOUGZDYSA-L,"[(2R,3S,4S,5R)-3,4,5-trihydroxy-6-oxooxan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20101025,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Prof. Malboobi, Plant Biotechnology Lab, National Institute of Genetic Engineering and Biotechnology|ToxPlanet|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49791951,N-Acetyl-L-gamma-glutamyl phosphate(3-),N-acetyl-L-gamma-glutamyl phosphate(3-)|N-acetylglutamyl-P|N-acetyl-glutamyl-P|N-acetylglutamyl-phosphate|CHEBI:57936|N-acetyl-L-glutamate-5-phosphate|N-acetyl-L-  -glutamyl phosphate(3-)|N-acetyl-L-gamma-glutamyl phosphate trianion|(2S)-2-acetamido-5-oxo-5-(phosphonatooxy)pentanoate|Q27125068,266.120,C7H9NO8P-3,159.000,344.000,-2.600,17,1,8,5,"InChI=1S/C7H12NO8P/c1-4(9)8-5(7(11)12)2-3-6(10)16-17(13,14)15/h5H,2-3H2,1H3,(H,8,9)(H,11,12)(H2,13,14,15)/p-3/t5-/m0/s1",CC(=O)N[C@@H](CCC(=O)OP(=O)([O-])[O-])C(=O)[O-],FCVIHFVSXHOPSW-YFKPBYRVSA-K,(2S)-2-acetamido-5-oxo-5-phosphonatooxypentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20101217,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Prof. Malboobi, Plant Biotechnology Lab, National Institute of Genetic Engineering and Biotechnology|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49791979,(2S)-2-Ammonio-5-oxopentanoate,glutamate-semialdehyde|L-glutamate-5-semialdehyde|SCHEMBL20376818|CHEBI:58066|(2S)-2-ammonio-5-oxopentanoate|(2S)-2-azaniumyl-5-oxopentanoate|L-glutamic 5-semialdehyde zwitterion,131.130,C5H9NO3,84.800,107.000,-2.900,9,1,3,3,"InChI=1S/C5H9NO3/c6-4(5(8)9)2-1-3-7/h3-4H,1-2,6H2,(H,8,9)/t4-/m0/s1",C(C[C@@H](C(=O)[O-])[NH3+])C=O,KABXUUFDPUOJMW-BYPYZUCNSA-N,(2S)-2-azaniumyl-5-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20101217,BioCyc|ChEBI|DiscoveryGate|SureChEMBL,Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49852308,2'-Deoxy-5'-O-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]uridine,dUTP trianion|dUTP(3-)|CHEBI:58212|2'-deoxyuridine 5'-triphosphate(3-)|2'-deoxyuridine 5'-triphosphate trianion|2'-deoxy-5'-O-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]uridine,465.120,C9H12N2O14P3-3,247.000,789.000,-5.700,28,3,14,8,"InChI=1S/C9H15N2O14P3/c12-5-3-8(11-2-1-7(13)10-9(11)14)23-6(5)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,12H,3-4H2,(H,18,19)(H,20,21)(H,10,13,14)(H2,15,16,17)/p-3/t5-,6+,8+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O,AHCYMLUZIRLXAA-SHYZEUOFSA-K,"[[[(2R,3S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20110208,ChEBI|Thieme Chemistry,Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
52921618,5-Hydroxykynurenaminium(1+),5-hydroxykynurenaminium(1+)|5-hydroxykynurenamine(1+)|5-hydroxykynurenaminium cation|CHEBI:62214|3-(2-amino-5-hydroxyphenyl)-3-oxopropan-1-aminium|Q27131688,181.210,C9H13N2O2+,91.000,185.000,0.100,13,3,3,3,"InChI=1S/C9H12N2O2/c10-4-3-9(13)7-5-6(12)1-2-8(7)11/h1-2,5,12H,3-4,10-11H2/p+1",C1=CC(=C(C=C1O)C(=O)CC[NH3+])N,JANBBPTXDKFOQR-UHFFFAOYSA-O,[3-(2-amino-5-hydroxyphenyl)-3-oxopropyl]azanium,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20110606,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
52921643,L-Adenosylselenomethionine zwitterion,L-adenosylselenomethionine zwitterion|CHEBI:62227|Se-adenosyl-L-selenomethionine zwitterion|[(3S)-3-azaniumyl-3-carboxylatopropyl](5'-deoxyadenosin-5'-yl)(methyl)selenonium,446.400,C15H23N6O5Se+,187.000,527.000,NULL,27,4,9,6,"InChI=1S/C15H22N6O5Se/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1",C[Se+](CC[C@@H](C(=O)[O-])[NH3+])C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,GGJFWMOVUFBSIN-AIRLBKTGSA-O,"(2S)-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylselaniumyl]-2-azaniumylbutanoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20110606,ChEBI|Google Patents,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53262363,Seleno-L-methionine,Seleno-L-methionine|selenium L-methionine|L-selenomethionine zwitterion|CHEBI:62621|(2S)-2-ammonio-4-(methylselanyl)butanoate|(2S)-2-azaniumyl-4-(methylselanyl)butanoate,196.120,C5H11NO2Se,67.800,91.400,NULL,9,1,2,3,"InChI=1S/C5H11NO2Se/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1",C[Se]CC[C@@H](C(=O)[O-])[NH3+],RJFAYQIBOAGBLC-BYPYZUCNSA-N,(2S)-2-azaniumyl-4-methylselanylbutanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20110801,BioCyc|ChEBI,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53356674,Protoheme IX,"ferriheme b(1-)|ferroheme b(2-)|protoheme|ferriheme b|protoheme IX|heme b|Ferriprotoporphyrin IX|Ferroprotoporphyrin IX|Fe-protoporphyrin IX|CHEBI:55376|CHEBI:60344|Q27104814|[3,3'-(3,7,12,17-tetramethyl-8,13-divinylporphyrin-2,18-diyl-kappa(4)N(21),N(22),N(23),N(24))dipropanoato(4-)]ferrate(2-)|[3,3'-(7,12-diethenyl-3,8,13,17-tetramethylporphyrin-2,18-diyl-kappa(4)N(21),N(22),N(23),N(24))dipropanoato(4-)]iron(1-)",614.500,C34H30FeN4O4-4,107.000,1570.000,NULL,43,0,8,6,"InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/p-4",CC1=C(C2=CC3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=N5)C=C1[N-]2)C=C)C)C=C)C)C(=C3CCC(=O)[O-])C)CCC(=O)[O-].[Fe],RNQMHXMGXVQRMV-UHFFFAOYSA-J,"3-[18-(2-carboxylatoethyl)-7,12-bis(ethenyl)-3,8,13,17-tetramethylporphyrin-21,23-diid-2-yl]propanoate;iron",Heme,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20110916,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477679,UDP-Glc,Uridine 5'-diphosphoglucose|UDPglucose|UDP-D-glucose|UDP-a-D-Glucose|UDP-Glc|Uridine diphosphoglucose|Uridine diphosphate-glucose|Uridine diphospho-D-glucose|Uridine pyrophosphate-glucose|Uridine 5'-diphosphate glucose|Uridine 5'-diphospho-alpha-D-glucose|UDP glucose|(UDP)glucose|UDP-delta-glucose|(UPD)-glucose|UDP-alpha-delta-Glucose|Uridine diphospho-delta-glucose|CHEBI:167608|Uridine 5'-diphospho-a-D-glucose|Uridine 5'-diphospho-alpha-delta-glucose|Uridine 5'-pyrophosphate a-D-glucopyranosyl ester|Uridin,566.300,C15H24N2O17P2,292.000,964.000,-6.300,36,9,17,9,"InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/t5-,6-,8-,9-,10+,11-,12-,13-,14?/m0/s1",C1=CN(C(=O)NC1=O)[C@@H]2[C@H]([C@H]([C@@H](O2)COP(=O)(O)OP(=O)(O)OC3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)O)O)O,HSCJRCZFDFQWRP-LPTOLDDLSA-N,"[[(2S,3R,4S,5S)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate",Uridine Diphosphate Glucose,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20111109,"ChEBI|ECI Group, LCSB, University of Luxembourg|Google Patents|Human Metabolome Database (HMDB)|MassBank of North America (MoNA)|MetabolomicsWorkbench",Curation Efforts|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477791,Tetradecanoylcarnitine,"Tetradecanoylcarnitine|Myristoyllevocarnitine|L-Myristoylcarnitine|Myristoyl-L-carnitine|(-)-Myristoylcarnitine|Tetradecanoyl-L-carnitine|(R)-Tetradecanoylcarnitine|O-tetradecanoyl-L-carnitine|Myristoyl-L-(-)-carnitine|O-myristoyl-L-carnitine|25597-07-3|(-)-Tetradecanoylcarnitine|UNII-3IBA3JH87O|3IBA3JH87O|(3R)-3-(tetradecanoyloxy)-4-(trimethylazaniumyl)butanoate|CHEBI:84634|(R)-myristoylcarnitine|Myristoylcarnitine, (-)-|O-tetradecanoyl-(R)-carnitine|CHEMBL3392072|CAR(14:0)|LMFA07070107|AKOS037645163|AS-57",371.600,C21H41NO4,66.400,371.000,6.600,26,0,4,17,"InChI=1S/C21H41NO4/c1-5-6-7-8-9-10-11-12-13-14-15-16-21(25)26-19(17-20(23)24)18-22(2,3)4/h19H,5-18H2,1-4H3/t19-/m1/s1",CCCCCCCCCCCCCC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,PSHXNVGSVNEJBD-LJQANCHMSA-N,(3R)-3-tetradecanoyloxy-4-(trimethylazaniumyl)butanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20111109,"A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BioCyc|CCSbase|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|DC Chemicals|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|Key Organics/BIONET|LIPID MAPS|MassBank Europe|MassBank of North America (MoNA)|MedChemexpress MCE|MetabolomicsWorkbench|MolPort|PATENTSCOPE (WIPO)|Sigma-Aldrich|Springer Nature|THE BioTek|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477807,25-Hydroxy-cholesterol,"25-Hydroxycholest-5-en-3-ol|5-cholestene-3beta-25-diol|cholest-5-en-3beta-25-diol|Cholest-5-ene-3-b,25-diol|cholest-5-ene-3beta-25-diol|Cholest-5-ene-3-beta,25-diol|(beta)-cholest-5-ene-3-25-diol",402.700,C27H46O2,40.500,636.000,6.800,29,2,2,5,"InChI=1S/C27H46O2/c1-18(7-6-14-25(2,3)29)22-10-11-23-21-9-8-19-17-20(28)12-15-26(19,4)24(21)13-16-27(22,23)5/h8,18,20-24,28-29H,6-7,9-17H2,1-5H3/t18-,20+,21+,22-,23?,24?,26+,27-/m1/s1",C[C@H](CCCC(C)(C)O)[C@H]1CCC2[C@@]1(CCC3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,INBGSXNNRGWLJU-POAVOMIWSA-N,"(3S,8S,10R,13R,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20111109,Google Patents|Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477844,"(5S)-4,5,6-Trihydroxy-2,3-dioxohexanoic acid","L-threo-2,3-hexodiulosonic acid|2,3-Diketo-L gulonic acid|(5S)-4,5,6-trihydroxy-2,3-dioxohexanoic acid",192.120,C6H8O7,132.000,233.000,-1.800,13,4,7,5,"InChI=1S/C6H8O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-3,7-9H,1H2,(H,12,13)/t2-,3?/m0/s1",C([C@@H](C(C(=O)C(=O)C(=O)O)O)O)O,GJQWCDSAOUMKSE-SCQFTWEKSA-N,"(5S)-4,5,6-trihydroxy-2,3-dioxohexanoic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20111109,Google Patents|Human Metabolome Database (HMDB)|MetabolomicsWorkbench,Curation Efforts|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477907,Chenodeoxyglycocholic acid,Chenodeoxyglycocholate|Chenodeoxyglycocholic acid,449.600,C26H43NO5,107.000,727.000,4.300,32,4,5,6,"InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15?,16?,17-,18?,19?,20?,21-,24?,25+,26-/m1/s1",CC(CCC(=O)NCC(=O)O)C1CCC2[C@@]1(CCC3C2[C@@H](CC4[C@@]3(CC[C@H](C4)O)C)O)C,GHCZAUBVMUEKKP-AFQLCFGXSA-N,"2-[4-[(3R,7R,10S,13R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]acetic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Literature|Pharmacology and Biochemistry,4,NULL,20111109,Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
54675871,3-Hydroxyanthranilate,3-hydroxyanthranilate|2-Amino-3-hydroxybenzoate|2-azanyl-3-oxidanyl-benzoate|CHEBI:36559|C(=O)(O)C1=C(C(=CC=C1)O)[NH-]|A830395|Q27104371,152.130,C7H6NO3-,86.400,160.000,1.600,11,2,4,1,"InChI=1S/C7H7NO3/c8-6-4(7(10)11)2-1-3-5(6)9/h1-3,9H,8H2,(H,10,11)/p-1",C1=CC(=C(C(=C1)[O-])N)C(=O)O,WJXSWCUQABXPFS-UHFFFAOYSA-M,2-amino-3-carboxyphenolate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20111226,"A&J Pharmtech CO., LTD.|Amadis Chemical|BioCyc|ChEBI|ChemSpider|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
56928068,Selenophosphoric acid,selenophosphoric acid|C05172|Q20861498,160.970,H3O3PSe,57.500,61.300,NULL,5,2,3,0,"InChI=1S/H3O3PSe/c1-4(2,3)5/h(H3,1,2,3,5)",OP(=O)(O)[SeH],JRPHGDYSKGJTKZ-UHFFFAOYSA-N,selanylphosphonic acid,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20120405,"Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|KEGG|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
60038355,2-Phosphoglycerate(3-),2-phosphoglycerate(3-)|3-hydroxy-2-(phosphonatooxy)propanoate|2-phosphonatoglycerate(3-)|CHEBI:88350|Q27160201,183.030,C3H4O7P-3,133.000,165.000,-2.100,11,1,7,2,"InChI=1S/C3H7O7P/c4-1-2(3(5)6)10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)/p-3",C(C(C(=O)[O-])OP(=O)([O-])[O-])O,GXIURPTVHJPJLF-UHFFFAOYSA-K,3-hydroxy-2-phosphonatooxypropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20120820,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
70699279,5alpha-Cholest-8-en-3beta-ol-d7,Zymostenol-d7|5alpha-cholest-8-en-3beta-ol-d7|LMST01010365|5alpha-cholest-8(9)-en-3beta-ol-d7,393.700,C27H46O,20.200,603.000,8.000,28,1,1,5,"InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h18-21,23-24,28H,6-17H2,1-5H3/t19-,20+,21+,23-,24+,26+,27-/m1/s1/i1D3,2D3,18D",[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)C([2H])([2H])[2H],QETLKNDKQOXZRP-HJSPSJIWSA-N,"(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol",NULL,Biomolecular Interactions and Pathways|Classification|Pharmacology and Biochemistry|Use and Manufacturing,4,NULL,20130214,LIPID MAPS,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
71581051,alpha-Linolenoyl-CoA(4-),"alpha-linolenoyl-CoA(4-)|alpha-Linolenoyl-CoA|18:3Delta9,12,15|CHEBI:74034|(omega-3)-linolenoyl-CoA(4-)|alpha-linolenoyl-coenzyme A(4-)|(9Z,12Z,15Z)-octadecatrienoyl-CoA(4-)|9cis,12cis,15cis-octadecatrienoyl-CoA(4-)|(9Z,12Z,15Z)-octadecatrienoyl-coenzyme A(4-)|Q27144349|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-4-oxobutyl] diphosphate}",1023.900,C39H60N7O17P3S-4,400.000,1770.000,0.100,67,5,22,32,"InChI=1S/C39H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h5-6,8-9,11-12,26-28,32-34,38,49-50H,4,7,10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/b6-5-,9-8-,12-11-/t28-,32-,33-,34+,38-/m1/s1",CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,OMKFKBGZHNJNEX-PQBHNYBOSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]sulfanylethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20130702,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
71768143,Nicotinate-adenine dinucleotide phosphate(4-),nicotinate-adenine dinucleotide phosphate(4-)|nicotinate-adenine dinucleotide phosphate|Nicotinate adenine dinucleotide phosphate|Nicotinic acid adenine dinucleotide phosphate|NAADP(4+)|CHEBI:75967|Q27145664,740.400,C21H23N6O18P3-4,373.000,1270.000,-6.000,48,4,22,11,"InChI=1S/C21H27N6O18P3/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(44-46(33,34)35)14(29)11(43-20)6-41-48(38,39)45-47(36,37)40-5-10-13(28)15(30)19(42-10)26-3-1-2-9(4-26)21(31)32/h1-4,7-8,10-11,13-16,19-20,28-30H,5-6H2,(H6-,22,23,24,31,32,33,34,35,36,37,38,39)/p-4/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)([O-])[O-])O)O)O)C(=O)[O-],QOTXBMGJKFVZRD-HISDBWNOSA-J,"1-[(2R,3R,4S,5R)-5-[[[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonatooxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]pyridin-1-ium-3-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20131105,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
90659042,Seleno-L-homocysteine,seleno-L-homocysteine|2-amino-4-selanyl-butanoate|CHEBI:84850|(2S)-2-azaniumyl-4-selanylbutanoate,181.080,C4H8NO2Se,67.800,80.600,NULL,8,1,2,2,"InChI=1S/C4H8NO2Se/c5-3(1-2-8)4(6)7/h3H,1-2,5H2,(H,6,7)/t3-/m0/s1",C(C[Se])[C@@H](C(=O)[O-])[NH3+],IGDAEYVCCNGPNW-VKHMYHEASA-N,NULL,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20150306,BioCyc|ChEBI,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
91691124,Angiotensin A,"angiotensin A|51833-76-2|ang A|GTPL6894|Ala-Arg-Val-Tyr-Ile-His-Pro-Phe|AKOS025142093|C20970|Angiotensin A trifluoroacetate salt, >=98% (HPLC)|(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]py|(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-(diaminomethylide",1002.200,C49H71N13O10,372.000,1860.000,-0.800,72,12,13,27,"InChI=1S/C49H71N13O10/c1-6-28(4)40(46(69)58-36(24-32-25-53-26-55-32)47(70)62-21-11-15-38(62)44(67)59-37(48(71)72)23-30-12-8-7-9-13-30)61-43(66)35(22-31-16-18-33(63)19-17-31)57-45(68)39(27(2)3)60-42(65)34(56-41(64)29(5)50)14-10-20-54-49(51)52/h7-9,12-13,16-19,25-29,34-40,63H,6,10-11,14-15,20-24,50H2,1-5H3,(H,53,55)(H,56,64)(H,57,68)(H,58,69)(H,59,67)(H,60,65)(H,61,66)(H,71,72)(H4,51,52,54)/t28-,29-,34-,35-,36-,37-,38-,39-,40-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)N,CHCOFDZSJYMQMX-NOQNJSOHSA-N,"(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20150428,"abcr GmbH|AKos Consulting & Solutions|Chemieliva Pharmaceutical Co., Ltd|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MolPort|NextMove Biologics|Sigma-Aldrich|THE BioTek|Tocris Bioscience",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
101087010,"(2Z,4E)-4-Hydroxy-6-oxo-2,4-octadienedioic acid","(2Z,4E)-4-Hydroxy-6-oxo-2,4-octadienedioic acid|CHEBI:133872|(2Z,4E)-4-hydroxy-6-oxoocta-2,4-dienedioic acid",200.140,C8H8O6,112.000,312.000,0.000,14,3,6,5,"InChI=1S/C8H8O6/c9-5(1-2-7(11)12)3-6(10)4-8(13)14/h1-3,9H,4H2,(H,11,12)(H,13,14)/b2-1-,5-3+",C(C(=O)/C=C(\\C=C/C(=O)O)/O)C(=O)O,XBRPTASPFXQXPJ-REDYYMJGSA-N,"(2Z,4E)-4-hydroxy-6-oxoocta-2,4-dienedioic acid",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20151217,ChEBI|Japan Chemical Substance Dictionary (Nikkaji),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398610,Dihydroneopterin triphosphate,"dihydroneopterin triphosphate|7,8-dihydroneopterin 3'-triphosphate|7,8-dihydroneopterin triphosphate|6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin|20574-65-6|6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin|2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate|SCHEMBL1533829|CHEBI:18372|DTXSID60174579|C04895|Q4642857|6-(L-erythro-1,2-dihydroxy-3-triphosphooxypropyl)-7,8-dihydropterin|2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl) dihydr",495.170,C9H16N5O13P3,292.000,956.000,-6.500,30,9,16,9,"InChI=1S/C9H16N5O13P3/c10-9-13-7-5(8(17)14-9)12-3(1-11-7)6(16)4(15)2-25-29(21,22)27-30(23,24)26-28(18,19)20/h4,6,15-16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H4,10,11,13,14,17)/t4-,6+/m1/s1",C1C(=NC2=C(N1)N=C(NC2=O)N)[C@@H]([C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,DGGUVLXVLHAAGT-XINAWCOVSA-N,"[[(2R,3S)-3-(2-amino-4-oxo-7,8-dihydro-3H-pteridin-6-yl)-2,3-dihydroxypropoxy]-hydroxyphosphoryl] phosphono hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20190115,"ABI Chem|BioCyc|ChEBI|Chembase.cn|ChemIDplus|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|NextBio|NextMove Software|NovoSeek|Springer Nature|SureChEMBL|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398619,Guanosine-5'-diphosphate,"Guanosine 5'-diphosphate|GUANOSINE DIPHOSPHATE|guanosine-5'-diphosphate|146-91-8|GDP|Guanosine 5'-(trihydrogen diphosphate)|Guanosine pyrophosphate|GRPP|CHEBI:17552|Guanosine 5'-pyrophosphate|5'-GDP|CHEMBL384759|guanosine 5'-diphosphate (RRSR form)|guanosine-diphosphate|1dar|((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate|Guanosine-8-t 5'-(trihydrogen diphosphate) (9CI)|guanosindiphosphat|1fzq|1ryf|1tpz|1vjj|1d2e|1i4d|1r5n|1tq4|1u2r|1vg1|[a",443.200,C10H15N5O11P2,248.000,760.000,-4.600,28,7,13,6,"InChI=1S/C10H15N5O11P2/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(25-9)1-24-28(22,23)26-27(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,QGWNDRXFNXRZMB-UUOKFMHZSA-N,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",Guanosine Diphosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,11,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1811|1865|2101|2107|2112|2517|2549|71972|72098|269136|271163|271168|271169|271170|330929|485281|485290|504327|504332|504845|504847|588579|602332|686978|686979|712072|720532|720533|720579|720580|977611|1159524|1172275|1172276|1331368|1331369|1346625|1347082|1347083|1347085|1347086|1347131|1347154|1425594|1425595|1425596|1425607|1425632,20190115,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|Achemtek|ACT Chemical|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|AstaTech, Inc.|Aurora Fine Chemicals LLC|AX Molecules Inc|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Databas",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, PDB, Protein Data Bank]"
135398635,Guanosine,"guanosine|118-00-3|guanine riboside|vernine|Guanozin|Guanosin|Inosine, 2-amino-|USAF CB-11|Vernine (VAN)|9-beta-D-Ribofuranosylguanine|Guanine-9-beta-D-ribofuranoside|beta-D-Ribofuranoside, guanine-9|Guanine, 9-beta-D-ribofuranosyl-|2(3H)-Imino-9-beta-D-ribofuranosyl-9H-purin-6(1H)-one|Inosine, 2-amino- (VAN)|Ribofuranoside, guanine-9, beta-D-|2-Amino-1,9-dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one|MFCD00010182|GUANINE-9:BETA-D-RIBOFURANOSIDE|Guo|AI3-52065|NSC 19994|9-beta-D-ribofuranosyl-guanine|2-Amino-",283.240,C10H13N5O5,155.000,446.000,-1.900,20,5,7,2,"InChI=1S/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N,NYHBQMYGNKIUIF-UUOKFMHZSA-N,"2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one",Guanosine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,875|880|881|884|885|887|889|892|893|894|900|901|902|923|924|995|1030|1379|1452|1454|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1811|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|71649|71650|82319|93194|106497|155467|157569|158514|199616|199747|199751|209954|217433|217743|278354|278355|278356|278357|278366|278367|278376|278377|485290|504327|504845|504847|504865|584546|584547|584550|588379|588579|602332|610951|610952|610953|613867|636715|636716|636717|666648|,20190115,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135884483,Inosine triphosphate trianion,ITP(3-)|ITP trianion|inosine triphosphate(3-)|inosine triphosphate trianion|inosine 5'-triphosphate(3-)|CHEBI:57614|inosine 5'-triphosphate trianion|Q27124814|5'-O-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]inosine,505.140,C10H12N4O14P3-3,277.000,862.000,-5.400,31,4,16,8,"InChI=1S/C10H15N4O14P3/c15-6-4(1-25-30(21,22)28-31(23,24)27-29(18,19)20)26-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,23,24)(H,11,12,17)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1",C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O)O,HAEJPQIATWHALX-KQYNXXCUSA-K,"[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20190118,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135912259,Dgtp trianion,dGTP(3-)|dGTP trianion|CHEBI:57794|Q27124951|2'-deoxy-5'-O-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]guanosine,504.160,C10H13N5O13P3-3,283.000,876.000,-5.400,31,4,15,8,"InChI=1S/C10H16N5O13P3/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/p-3/t4-,5+,6+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O,HAAZLUGHYHWQIW-KVQBGUIXSA-K,"[[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20190119,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Thieme Chemistry|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5757,Estradiol,estradiol|beta-Estradiol|17beta-Estradiol|50-28-2|Oestradiol|Dihydrofolliculin|Estrace|Ovocyclin|Vivelle|progynon|Dihydrotheelin|Dihydroxyestrin|Aquadiol|Diogynets|Gynergon|Gynoestryl|Diogyn|Oestroglandol|Aerodiol|Corpagen|Dimenformon|Estrovite|Femestral|Follicyclin|Ginosedol|Macrodiol|Oestergon|Ovahormon|Ovasterol|Ovastevol|Perlatanol|Primofol|Profoliol|Altrad|Bardiol|Climara|Divigel|Evorel|Femogen|Lamdiol|Syndiol|Vagifem|Dihydromenformon|estradiol-17beta|cis-Estradiol|Estraderm TTS|Estraderm|Estraldine|Es,272.400,C18H24O2,40.500,382.000,4.000,20,2,2,0,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",Estradiol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,180|192|200|206|210|212|220|228|248|256|264|268|296|328|421|422|426|427|429|433|434|435|436|445|485|530|540|541|542|543|544|545|546|547|568|583|584|585|595|596|598|602|603|605|606|618|620|629|630|631|633|639|648|654|655|656|657|658|659|660|661|662|663|664|665|666|667|687|694|701|719|731|732|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|875|878|879|880|881|884|885|886|887|889|892|893|894|895|898|900|901|902|912|917|918|920|921|923|924|925|926|,20040916,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alsachim|Amadis Chemical|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora F",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5880,Etiocholanolone,"etiocholanolone|53-42-9|5-Isoandrosterone|Etiocholan-3alpha-ol-17-one|Aetiocholanolone|3alpha-Etiocholanolone|5beta-Androsterone|3alpha-Hydroxy-5beta-androstan-17-one|Androsterone, (5beta)-|5beta-Androstan-3alpha-ol-17-one|UNII-97CGB1M48I|alpha-Etiocholanolone|5.beta.-Androsterone|3.alpha.-Etiocholanolone|NSC 50908|Androsterone, (5.beta.)-|CHEMBL85799|97CGB1M48I|Androstan-17-one,3-hydroxy-, (3a,5b)-|3alpha-Hydroxyetiocholan-17-one|CHEBI:28195|Etiocholan-3.alpha.-ol-17-one|5b-androsterone|(3R,5R,8R,9S,10S,13",290.400,C19H30O2,37.300,459.000,3.700,21,1,2,0,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-16,20H,3-11H2,1-2H3/t12-,13-,14+,15+,16+,18+,19+/m1/s1",C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O,QGXBDMJGAMFCBF-BNSUEQOYSA-N,"(3R,5R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one",Etiocholanolone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,248|328|1511|1554|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|51049|51052|51054|51055|51056|51058|51059|51062|188186|203344|203345|212737|212919|212920,20040916,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|ABI Chem|Achemtek|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|BindingDB|BioCyc|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bio",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
33576,ADP-D-ribose,"adpribose|ADP-D-ribose|CHEBI:16960|Poly ADP ribose|Adenosine 5'-diphosphoribose|AdoPPRib|Adenosine 5'-(trihydrogen diphosphate), P'-5-ester with D-ribose|ADP-Rib|D-ribofuranose, 5-5'-ester with adenosine 5'-(trihydrogen pyrophosphate)|(Rib5)ppA|A5'pp5Rib|POLY ADENOSINE DIPHOSPHATE RIBOSE|Polyadenosine diphosphate ribose|ADP-riboses|26656-46-2|CHEMBL2360089|Adenosine 5'-(trihydrogen diphosphate), P'-5-ester with D-ribose, homopolymer|NCGC00163321-01|D-Ribofuranose 5-diphosphoric acid beta-(5'-adenosyl) ester",559.320,C15H23N5O14P2,292.000,877.000,-6.100,36,8,18,9,"InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15?/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H](C(O4)O)O)O)O)O)N,SRNWOUGRCWSEMX-TYASJMOZSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate",Adenosine Diphosphate Ribose,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1865|2101|2107|2112|2517|2549|485281|485290|504327|504332|504845|504847|588579|602332|686978|686979|720532|720533|720579|720580|1065923|1159524|1347082|1347083|1347085|1347086|1347131|1347142|1347144|1347145|1347146|1347147|1347154,20050808,"ABI Chem|BioCyc|ChEBI|ChEMBL|ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|MetabolomicsWorkbench|National Center for Advancing Translational Sciences (NCATS)|Nature Chemical Biology|NextBio|NORMAN Suspect List Exchange|NovoSeek|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
119389,Octanoate,"octanoate|Caprylate|n-octanoate|n-octic acid|capryloate|Octanoic acid, ion(1-)|hexylacetat|caprilate|n-caprylate|n-octoate|n-octylate|1-heptanecarboxylate|74-81-7|CH3-[CH2]6-COO(-)|Caprylates|octanoate, 1|Octanoic acid anion|3nq9|octanoate (n-C8:0)|BDBM23432|CHEBI:25646|DTXSID70995277|STL483483|3003-EP2295438A1|3373-EP2289876A1|3373-EP2308857A1|3373-EP2311842A2|89705-EP2287158A1|89705-EP2305033A1|A805133|Q27109891",143.200,C8H15O2-,40.100,83.700,3.700,10,0,2,5,"InChI=1S/C8H16O2/c1-2-3-4-5-6-7-8(9)10/h2-7H2,1H3,(H,9,10)/p-1",CCCCCCCC(=O)[O-],WWZKQHOCKIZLMA-UHFFFAOYSA-M,octanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,977611,20040916,"3WAY PHARM INC|AAA Chemistry|ABI Chem|Amadis Chemical|BindingDB|BioCyc|ChEBI|ChemDB|ChemIDplus|ChemSpider|ChemTik|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NextMove Software|NMRShiftDB|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|SLING Consortium|Vitas-M Laboratory|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
121992,Nicotinate mononucleotide,nicotinic acid D-ribonucleotide|nicotinate ribonucleotide|nicotinic acid mononucleotide|nicotinate mononucleotide|Nicotinate D-ribonucleotide|nicotinic acid ribonucleotide|321-02-8|Nicotinic acid mono nucleotide|Beta-nicotinate D-ribonucleotide|nicotinate beta-D-ribonucleotide|SCHEMBL18289322|CHEBI:15763|ZINC4095572|C01185|Q27098220|3-carboxy-1-(5-O-phosphono-beta-D-ribofuranosyl)pyridinium|1-Deoxy-1-(3-carboxypyridinio)-5-O-oxylatophosphonyl-beta-D-ribofuranose,336.210,C11H15NO9P+,158.000,455.000,-2.700,22,5,9,5,"InChI=1S/C11H14NO9P/c13-8-7(5-20-22(17,18)19)21-10(9(8)14)12-3-1-2-6(4-12)11(15)16/h1-4,7-10,13-14H,5H2,(H2-,15,16,17,18,19)/p+1/t7-,8-,9-,10-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)C(=O)O,JOUIQRNQJGXQDC-ZYUZMQFOSA-O,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxylic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20040916,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|ABI Chem|AHH Chemical co.,ltd|Alfa Chemistry|Ambinter|BioCyc|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Glentham Life Sciences Ltd.|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikka",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
123805,Angiotensin (1-7),"Angiotensin (1-7)|angiotensin 1-7|51833-78-4|TXA127|Angiotensin i (1-7)|Angiotensin II (1-7) heptapeptide|angiotensin-(1-7)|angiotensin II (1-7)|ASP-ARG-VAL-TYR-ILE-HIS-PRO|8-Des-phe-angiotensin II|UNII-IJ3FUK8MOF|TXA-127|IJ3FUK8MOF|Angiotensin, Canine, Rat|Angiotensin I/II (1-7)|CHEBI:55438|Ile(5)-angiotensin II (1-7)|MFCD00153513|Ang-(1-7)|39386-80-6|L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline|L-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-proline|Human a",899.000,C41H62N12O11,380.000,1660.000,-3.000,64,12,14,25,"InChI=1S/C41H62N12O11/c1-5-22(4)33(38(61)50-29(17-24-19-45-20-47-24)39(62)53-15-7-9-30(53)40(63)64)52-36(59)28(16-23-10-12-25(54)13-11-23)49-37(60)32(21(2)3)51-35(58)27(8-6-14-46-41(43)44)48-34(57)26(42)18-31(55)56/h10-13,19-22,26-30,32-33,54H,5-9,14-18,42H2,1-4H3,(H,45,47)(H,48,57)(H,49,60)(H,50,61)(H,51,58)(H,52,59)(H,55,56)(H,63,64)(H4,43,44,46)/t22-,26-,27-,28-,29-,30-,32-,33-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,PVHLMTREZMEJCG-GDTLVBQBSA-N,"(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,10,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|485281|485290|504327|504847|588579|602332|720532|720533|1159865|1259416|1259421|1345372|1346340|1409598,20050808,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|BindingDB|BioCyc|BOC Sciences|Broad Institute|ChEBI|Chem-Space.com Database|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Comparative Toxicogenomics Database (CTD)|CreativePeptides|Da",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
123912,alpha-D-Galactose 1-phosphate,"galactose-1-phosphate|2255-14-3|alpha-D-galactose-1-phosphate|alpha-D-Galactose 1-phosphate|Galactose 1-phosphate|1-O-phosphono-alpha-D-galactopyranose|alpha-D-Galactosyl phosphate|alpha-D-Gal-1-P|alpha-D-Galactopyranosyl phosphate|alpha-D-Galactopyranose 1-phosphate|alpha-D-galactopyranose, 1-(dihydrogen phosphate)|CHEBI:17973|galactose-1-P|(2R,3R,4S,5R,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl dihydrogen phosphate|GL1|D-Galactose 1-phosphate|galactose-1P|1z4n|1z4o|a-d-galactose-1-phos",260.140,C6H13O9P,157.000,277.000,-3.800,16,6,9,3,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3+,4+,5-,6-/m1/s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)OP(=O)(O)O)O)O)O)O,HXXFSFRBOHSIMQ-FPRJBGLDSA-N,"[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,1811|977610,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|Alichem|Angene Chemical|Aurora Fine Chemicals LLC|BIND|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Co",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
151725,"3,4-Dihydroxymandelaldehyde","3,4-Dihydroxymandelaldehyde|13023-73-9|3,4-Dihydroxyphenylglycolaldehyde|2-(3,4-dihydroxyphenyl)-2-hydroxyacetaldehyde|3,4-dihydroxyphenylglycolic aldehyde|2-(3,4-DIHYDROXYPHENYL)-2-HYDROXY-ACETALDEHYDE|Benzeneacetaldehyde, alpha,3,4-trihydroxy-|DHMAL|DHPGALD|DOPEGAL|3,4-dihydroxymandelic aldehyde|SCHEMBL1332823|CHEBI:27852|DTXSID30897223|a,3,4-trihydroxy-Benzeneacetaldehyde|alpha,3,4-trihydroxyphenylacetaldehyde|alpha,3,4-trihydroxybenzeneacetaldehyde|alpha,3,4-trihydroxy-Benzeneacetaldehyde|C05577|2-(3,4-",168.150,C8H8O4,77.800,159.000,-0.600,12,3,4,2,"InChI=1S/C8H8O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-4,8,10-12H",C1=CC(=C(C=C1C(C=O)O)O)O,YUGMCLJIWGEKCK-UHFFFAOYSA-N,"2-(3,4-dihydroxyphenyl)-2-hydroxyacetaldehyde",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"A2B Chem|AA BLOCKS|ABI Chem|Ambinter|BLD Pharm|ChEBI|Chem-Space.com Database|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|MuseChem|NextBio|NORMAN Suspect List Exchange|Norris Pharm|NovoSeek|PATENT",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
166760,Faicar,"Faicar|5-Formamidoimidazole-4-carboxamide ribotide|phosphoribosyl formamidocarboxamide|13018-54-7|5-Formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide|CHEBI:18381|1-(5'-Phosphoribosyl)-5-formamido-4-imidazolecarboxamide|5'-Phosphoribosyl-5-formamido-4-imidazolecarboxamide|5-Formamido-1-(5-phosphoribosyl)imidazole-4-carboxamide|5-(Formylamino)-1-(5-O-Phosphono-Beta-D-Ribofuranosyl)-1h-Imidazole-4-Carboxamide|{[(2R,3S,4R,5R)-5-(4-carbamoyl-5-formamido-1H-imidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}p",366.220,C10H15N4O9P,207.000,531.000,-4.000,24,6,10,6,"InChI=1S/C10H15N4O9P/c11-8(18)5-9(13-3-15)14(2-12-5)10-7(17)6(16)4(23-10)1-22-24(19,20)21/h2-4,6-7,10,16-17H,1H2,(H2,11,18)(H,13,15)(H2,19,20,21)/t4-,6-,7-,10-/m1/s1",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)NC=O)C(=O)N,ABCOOORLYAOBOZ-KQYNXXCUSA-N,"[(2R,3S,4R,5R)-5-(4-carbamoyl-5-formamidoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,360482,20050624,"AAA Chemistry|ABI Chem|BindingDB|BioCyc|BLD Pharm|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|ChemSpider|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|MuseChem|NCBI Structure|NextBio|NovoSeek|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|THE BioTek|Therapeutic Target Database (",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
176077,Migalastat,"Migalastat|1-deoxygalactonojirimycin|(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol|108147-54-2|1-Deoxygalactostatin|UNII-C4XNY919FW|D-Galactitol, 1,5-dideoxy-1,5-imino-|C4XNY919FW|DEOXYGALACTONOJIRIMYCIN|CHEMBL110458|108147-54-2 (free base)|Amigal|galafold|DDIG|3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3S,4R,5S)-|1,5-Dideoxy-1,5-iminogalactitol|Migalastat [USAN:INN]|GR181413A|1,5-Dideoxy-1,5-imino-D-galactitol|D-Galactitol, 1,5-dideoxy-1,5-imino|NSC658776|Tocris-1258|Migalastat (USAN/INN)|D-gal",163.170,C6H13NO4,93.000,132.000,-2.300,11,5,5,1,"InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5+,6-/m1/s1",C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,LXBIFEVIBLOUGU-DPYQTVNSSA-N,"(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,410|411|445|447|448|450|451|526|530|584|585|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|923|924|926|938|995|1030|1379|1452|1454|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1851|1865|1948|2100|2101|2107|2108|2109|2112|2113|2115|2147|2451|2472|2517|2528|2546|2549|2551|2590|2671|36831|220744|220749|220892|220896|240897|240929|240937|241236|241411|243638|243639|243640|243641|243650|243651|243664|243694|243726|243727|243739|24,20050801,"A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|Achemtek|Alfa Chemistry|Angene Chemical|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|CSNpharm|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemica",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
246983,Lanosterol,"lanosterol|79-63-0|Lanosterin|Lanster|Botalan base 138|Lanosta-8,24-dienol|(3beta)-lanosta-8,24-dien-3-ol|Lanosta-8,24-dien-3beta-ol|Lanostereol|UNII-1J05Z83K3M|CHEBI:16521|NSC60677|NSC 60677|Lanosta-8,24-dien-3.beta.-ol|1J05Z83K3M|Lanosta-8,24-dien-3-ol|(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-((R)-6-methylhept-5-en-2-yl)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol|Lanosta-8,24-dien-3-ol, (3.beta.)-|4,4',14alpha-Trimethyl-5alpha-cholesta-8,24-dien-3beta-ol",426.700,C30H50O,20.200,767.000,8.900,31,1,1,4,"InChI=1S/C30H50O/c1-20(2)10-9-11-21(3)22-14-18-30(8)24-12-13-25-27(4,5)26(31)16-17-28(25,6)23(24)15-19-29(22,30)7/h10,21-22,25-26,31H,9,11-19H2,1-8H3/t21-,22-,25+,26+,28-,29-,30+/m1/s1",C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C,CAHGCLMLTWQZNJ-BQNIITSRSA-N,"(3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol",Lanosterol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,10,155|157|161|165|167|175|1469|1479|284043|284044|284047|284048|284049|322754|399113|575757|575758|575759|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|651741|651743|651749|651751|651777|651778|651838|671391|671392|671393|671397|671398|671400|671401|720636|720653|720659|743288|743292|977599|977602|1063364|1063365|1159550|1378835|1386474|1386475|1386476|1386477|1386478|1386479|1386480,20040916,"001Chemical|3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|AvaChem Scientific|BenchChem|BindingDB|BioCyc|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Chen Lab, School of Medicine, Emory University|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DC Chemicals|DiscoveryGate|DrugBank|DTP/NCI|ECI Group, LCSB, ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439165,Glucose 1-phosphate,"glucose 1-phosphate|D-glucopyranose 1-phosphate|a-D-Galactose 1-phosphate|GLC-1-P|Glucose monophosphate|Galactose 1-phosphate|D-Galactose 1-phosphate|D-glucose-1-phosphate|delta-glucose-1-P|D-glucose-1-P|a-D-Galactosyl phosphate|glucopyranose 1-phosphate|.alpha.-D-Glucopyranose, 1-(dihydrogen phosphate)|a-D-Glucose 1-phosphate|delta-glucose 1-phosphate|delta-Glucose-1-phosphate|Galactopyranose 1-phosphate|a-D-Glucopyranosyl phosphate|a-D-Galactopyranosyl phosphate|SCHEMBL104855|1-O-phosphono-D-glucopyranose",260.140,C6H13O9P,157.000,277.000,-3.800,16,6,9,3,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/t2-,3-,4+,5-,6?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)OP(=O)(O)O)O)O)O)O,HXXFSFRBOHSIMQ-GASJEMHNSA-N,"[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20040916,"3B Scientific (Wuhan) Corp|abcr GmbH|ABI Chem|BioCyc|BOC Sciences|CCSbase|ChEBI|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|MassBank of North America (MoNA)|MetabolomicsWorkbench|NextBio|NextMove Software|NIST Mass Spectrometry Data Center",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439176,5'-Deoxy-5'-methylthioadenosine,"Methylthioadenosine|5'-methylthioadenosine|2457-80-9|5'-S-methyl-5'-thioadenosine|5'-Deoxy-5'-(methylthio)adenosine|5-Methylthioadenosine|Thiomethyladenosine|Vitamin L2|ADENOSINE, 5'-S-METHYL-5'-THIO-|(2R,3R,4S,5S)-2-(6-Amino-9H-purin-9-yl)-5-((methylthio)methyl)tetrahydrofuran-3,4-diol|S-methyl-5'-thioadenosine|5'-(Methylthio)adenosine|MTA|5'-S-Methylthioadenosine|Vitamin L(sub 2)|5'-DEOXY-5'-METHYLTHIOADENOSINE|5'-(Methylthio)-5'-deoxyadenosine|UNII-634Z2VK3UQ|NSC 335422|634Z2VK3UQ|CHEMBL277041|5'-CH3S-5'",297.340,C11H15N5O3S,145.000,352.000,-0.300,20,3,8,3,"InChI=1S/C11H15N5O3S/c1-20-2-5-7(17)8(18)11(19-5)16-4-15-6-9(12)13-3-14-10(6)16/h3-5,7-8,11,17-18H,2H2,1H3,(H2,12,13,14)/t5-,7-,8-,11-/m1/s1",CSC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,WUUGFSXJNOTRMR-IOSLPCCCSA-N,"(2R,3R,4S,5S)-2-(6-aminopurin-9-yl)-5-(methylsulfanylmethyl)oxolane-3,4-diol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,31540|31541|32197|32198|32199|32638|32875|32876|33289|33290|33909|34158|34274|34423|34729|44035|50094|71601|91847|94272|97371|97373|97375|98358|98650|99499|99503|99505|99507|99509|99513|99526|99528|99529|100526|100643|100644|105643|105907|105909|199460|199461|199462|199463|199464|203872|203891|203892|203898|239738|239753|242855|243020|317708|317709|327641|327642|384284|422446|422447|422448|422451|425815|425816|425817|667488,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Activate Scientific|AK Scientific, Inc. (AKSCI)|Alfa Chemistry|Alichem|Ambeed|Anward|Aurora Fine Chemicals LLC|AX Molecules Inc|BePharm Ltd.|BIND|BindingDB|BioCyc|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|Chemenu Inc.|ChemFaces|Chemical Probes Portal|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439208,Trioxidosulfidosulfate(.1-),trioxidosulfidosulfate(.1-)|hydroxidodioxidosulfidosulfate(1-)|Q28487688|trioxidosulfanidosulfate(1-)|HS2O3-|CHEBI:33539|CHEBI:33542|S2O3-|[SO2(OH)S](-)|[SO3(SH)](-)|S(=O)(=O)([O-])[S]|C00320|Q27110039,113.140,HO3S2-,101.000,95.000,0.300,5,1,4,0,"InChI=1S/H2O3S2/c1-5(2,3)4/h(H2,1,2,3,4)/p-1",OS(=O)(=S)[O-],DHCDFWKWKRSZHF-UHFFFAOYSA-M,hydroxy-oxido-oxo-sulfanylidene-lambda6-sulfane,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20040916,"ABI Chem|BioCyc|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|KEGG|NextBio|NovoSeek|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439255,L-Arabinitol,"L-arabinitol|L-arabitol|7643-75-6|L-(-)-Arabitol|L-arabinol|L-lyxitol|(2S,4S)-pentane-1,2,3,4,5-pentol|L-(-)-Arabinitol|UNII-45Z1K06N9V|(2S,4S)-Pentane-1,2,3,4,5-pentaol|Arabinitol, L-|MFCD00064290|CHEBI:18403|45Z1K06N9V|L(-)-Arabitol, 99%|Lyxitol|C5H12O5|Adonite Adonitol|L-Arabit|EINECS 231-582-6|NSC 83253|L-(+)-Arabitol|bmse000068|bmse000802|bmse000869|Epitope ID:114706|SCHEMBL195279|DTXSID30884411|L-(-)-Arabitol, >=98%|ZINC895208|AMY31292|KM1766|s6045|AKOS027320561|CCG-214165|CS-W020881|HY-W040141|AS-142",152.150,C5H12O5,101.000,76.100,-2.500,10,5,5,4,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4-/m0/s1",C([C@@H](C([C@H](CO)O)O)O)O,HEBKCHPVOIAQTA-IMJSIDKUSA-N,"(2S,4S)-pentane-1,2,3,4,5-pentol",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambinter|Angene Chemical|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Center for Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439287,Deoxyribose 1-phosphate,"2-deoxy-D-ribofuranose 1-phosphate|Deoxyribose 1-phosphate|2-Deoxy-D-ribose 1-phosphate|deoxyribose-1-phosphate|17210-42-3|2-Deoxyribofuranose 1-phosphate|2-Deoxy-D-erythro-pentofuranose 1-phosphate|2-Deoxyribose 1-phosphate|2-Deoxy-D-erythro-pentofuranose 1-(dihydrogen phosphate)|D-erythro-Pentofuranose, 2-deoxy-, 1-(dihydrogen phosphate)|2-deoxy-D-ribose-1-phosphate|SCHEMBL1061827|CHEBI:28542|2-deoxy-delta-ribose 1-phosphate|2-deoxy-delta-ribose-1-phosphate|d-2-deoxy-ribofuranose 1-phosphate|2-deoxy-1-O-p",214.110,C5H11O7P,116.000,213.000,-2.100,13,4,7,3,"InChI=1S/C5H11O7P/c6-2-4-3(7)1-5(11-4)12-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/t3-,4+,5?/m0/s1",C1[C@@H]([C@H](OC1OP(=O)(O)O)CO)O,KBDKAJNTYKVSEK-PYHARJCCSA-N,"[(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl] dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050601,"3B Scientific (Wuhan) Corp|ABI Chem|Alfa Chemistry|BIND|BioCyc|BOC Sciences|ChEBI|ChemIDplus|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Glentham Life Sciences Ltd.|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|MassBank of North America (MoNA)|MetabolomicsWorkbench|MuseChem|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SureChEMBL|Thomson Pharma|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439357,alpha D-Galactose,"alpha-D-galactose|Alpha-D-Galactopyranose|3646-73-9|Alpha D-Galactose|Gal-alpha|5abp|8abp|alpha-D-Gal|Galactose (NF)|UNII-7IOF6H4H77|CHEBI:28061|7IOF6H4H77|(2S,3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol|D-hexose|(+)-Galactose|(2S,3R,4S,5R,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol|a-D-galactopyranose|Galactose [USAN:NF]|alphaGal|alpha-galactose|MFCD00066772|Alpha-D-Galactoside|I+/--D-Galactose|PubChem23904|6-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetraol|alpha-aD-aGalactopyranose|bmse0",180.160,C6H12O6,110.000,151.000,-2.600,12,5,6,1,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3+,4+,5-,6+/m1/s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O,WQZGKKKJIJFFOK-PHYPRBDBSA-N,"(2S,3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,1811|30432|51624|71736|220224|261924|261925|362218|362219|362220|362221|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|977611|1453085,20050623,"abcr GmbH|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Angene Chemical|ApexBio Technology|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|Boerchem|CAPOT|ChangChem|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Crystallography Open Database|DC Chemicals|DiscoveryGate|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EP",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440615,Decanoyl-coenzyme A,"decanoyl CoA|Decanoyl-coenzyme A|s-decanoate|s-decanoic acid|Decanoyl coenzyme A monohydrate|s-decanoate coenzyme a|CHEMBL1949897|Decanoyl-CoA (n-C10:0CoA)|Decanoyl-CoA; (Acyl-CoA); [M+H]+;|{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-[({[({3-[(2-{[2-(decanoylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-hydroxy-2,2-dimethylpropoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-4-hydroxyoxolan-3-yl]oxy}phosphonic acid",921.800,C31H54N7O17P3S,389.000,1520.000,-1.600,59,9,22,28,"InChI=1S/C31H54N7O17P3S/c1-4-5-6-7-8-9-10-11-22(40)59-15-14-33-21(39)12-13-34-29(43)26(42)31(2,3)17-52-58(49,50)55-57(47,48)51-16-20-25(54-56(44,45)46)24(41)30(53-20)38-19-37-23-27(32)35-18-36-28(23)38/h18-20,24-26,30,41-42H,4-17H2,1-3H3,(H,33,39)(H,34,43)(H,47,48)(H,49,50)(H2,32,35,36)(H2,44,45,46)/t20-,24-,25-,26?,30-/m1/s1",CCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,CNKJPHSEFDPYDB-BOJFXZHGSA-N,"S-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] decanethioate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,646518|646519,20040916,ABI Chem|ChEMBL|ChemSpider|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|MassBank of North America (MoNA)|NextBio,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
445160,"6,8-Dimercapto-octanoic acid amide","6,8-DIMERCAPTO-OCTANOIC ACID AMIDE|(R)-dihydrolipoamide|(6R)-6,8-disulfanyloctanamide|LPM|Red|CHEBI:43711|ZINC3869863|LMFA08010014|DB08120|Q27097350",207.400,C8H17NOS2,45.100,130.000,1.100,12,3,3,7,"InChI=1S/C8H17NOS2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H2,9,10)/t7-/m1/s1",C(CCC(=O)N)C[C@H](CCS)S,VLYUGYAKYZETRF-SSDOTTSWSA-N,"(6R)-6,8-bis(sulfanyl)octanamide",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,6,NULL,20050624,"ABI Chem|BioCyc|ChEBI|Chembase.cn|ChemSpider|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|LIPID MAPS|MetabolomicsWorkbench|NCBI Structure|NextBio|NORMAN Suspect List Exchange|Protein Data Bank in Europe (PDBe)|SMID|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
449688,Choline C-11,"CHOLINE C-11|Choline C11|(11)C-Choline|UNII-M4AS4XGD4Q|M4AS4XGD4Q|94793-58-5|[N-methyl-(11)C]choline|Choline C-11 (TN)|Ethanaminium, 2-hydroxy-N,N-dimethyl-N-(methyl-11C)-|SCHEMBL14330721|CHEBI:72322|DTXSID10241624|MOLI000071|MOLI001374|C[N+](C)([11CH3])CCO|DB09563|D10498|Q27139902",103.170,C5H14NO+,20.200,46.500,-0.400,7,1,1,2,"InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1/i1-1",C[N+](C)([11CH3])CCO,OEYIOHPDSNJKLS-BJUDXGSMSA-N,2-hydroxyethyl-dimethyl-(111C)methylazanium,NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20050327,"ABI Chem|ChEBI|ChEMBL|ChemIDplus|ChemSpider|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|KEGG|MetabolomicsWorkbench|Molecular Imaging Database (MOLI)|NextBio|PATENTSCOPE (WIPO)|SureChEMBL|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
643975,Flavin adenine dinucleotide,flavin adenine dinucleotide|146-14-5|Flavin-adenine dinucleotide|FAD|Flavine-adenine dinucleotide|flavitan|Riboflavin 5'-adenosine diphosphate|Adenine-flavin dinucleotide|Adenine-flavine dinucleotide|Flavine adenosine diphosphate|Adenine-riboflavin dinucleotide|Riboflavin-adenine dinucleotide|Adenine-riboflavine dinucleotide|Riboflavine-adenine dinucleotide|Flanin F|Isoalloxazine-adenine dinucleotide|Flavin adenin dinucleotide|UNII-ZC44YTI8KK|Flavinat|Flamitajin B|ZC44YTI8KK|Flaziren (free acid)|CHEBI:16238,785.500,C27H33N9O15P2,356.000,1560.000,-5.000,53,9,20,13,"InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/t14-,15+,16+,19-,20+,21+,26+/m0/s1",CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@@H]([C@@H]([C@@H](COP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O,VWWQXMAJTJZDQX-UYBVJOGSSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate",Flavin-Adenine Dinucleotide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,554814|554815|554816|554817|554818|554819|554820|554821|1259318,20050608,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|abcr GmbH|ABI Chem|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Ambeed|Ambinter|Anward|Aronis|Aurora Fine Chemicals LLC|BIND|BioCyc|BLD Pharm|BOC Sciences|Burnham Center for Chemical Genomics|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemExper Chemical Directory|ChemFish Tokyo co.,ltd|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
644168,Pyridoxal 5'-phosphate(2-),"pyridoxal 5'-phosphate(2-)|124051-94-1|pyridoxal 5'-phosphate dianion|(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate|CHEBI:597326|A825565|Q27225781|(4-formyl-5-hydroxy-6-methyl-3-pyridinyl)methyl phosphate|(4-methanoyl-6-methyl-5-oxidanyl-pyridin-3-yl)methyl phosphate|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate dianion|3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde 5-phosphate(2-)|4-Pyridinecarboxaldehyde, 3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-, ion (2-)",245.130,C8H8NO6P-2,123.000,281.000,-1.200,16,1,7,3,"InChI=1S/C8H10NO6P/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14/h2-3,11H,4H2,1H3,(H2,12,13,14)/p-2",CC1=NC=C(C(=C1O)C=O)COP(=O)([O-])[O-],NGVDGCNFYWLIFO-UHFFFAOYSA-L,(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050601,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BIND|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|NextBio|NovoSeek|Springer Nature|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
657272,Choline Alfoscerate,Choline Alfoscerate|SN-glycero-3-phosphocholine|Choline glycerophosphate|28319-77-9|Glycerophosphocholine|Glycerophosphorylcholine|Choline Alphoscerate|L-alpha-Glycerophosphorylcholine|L-alpha-Glycerophosphocholine|Cholini glycerophosphas|Cholini alfosceras|Glicerofosfato de colina|Glycerophosphate de choline|Alfoscerato de colina|L-alpha-Glycerylphosphorylcholine|Alfoscerate de choline|GPCho|Sn-3-GPC|alpha-Glycerophosphorylcholine|Glycerol phosphorylcholine|glycerol-3-phosphocholine|L-A-glycerophosphorylch,257.220,C8H20NO6P,99.000,233.000,-2.300,16,2,6,8,"InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1",C[N+](C)(C)CCOP(=O)([O-])OC[C@@H](CO)O,SUHOQUVVVLNYQR-MRVPVSSYSA-N,"[(2R)-2,3-dihydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate",Glycerylphosphorylcholine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,13,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|680|684|686|687|701|708|709|719|731|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|793|795|797|,20050629,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acorn PharmaTech Product List|ACT Chemical|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BioCyc|BLD Pharm|BOC Sciences|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5257176,Agmatinium(2+),agmatinium(2+)|agmatinium|agmatinium dication|CHEBI:58145|{amino[(4-azaniumylbutyl)amino]methylidene}azanium|Q27125215,132.210,C5H16N4+2,93.600,85.000,-1.500,9,4,0,4,"InChI=1S/C5H14N4/c6-3-1-2-4-9-5(7)8/h1-4,6H2,(H4,7,8,9)/p+2",C(CC[NH+]=C(N)N)C[NH3+],QYPPJABKJHAVHS-UHFFFAOYSA-P,4-azaniumylbutyl(diaminomethylidene)azanium,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20051007,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|PATENTSCOPE (WIPO)|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5314029,Cholesterol-d7,"Cholesterol-d7|83199-47-7|(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol|7alpha-Hydroxy Cholesterol-D7|cholest-5-en-3beta-ol(d7)|d7-cholesterol|Cholesterol_d7|Cholesterol(d7)|Cholesterol-25,26,26,26,27,27,27-d7|DTXSID50415625|CHEBI:172955|LMST01010093|AKOS030242857|cholesterol (D7), cholest-5-en-3beta-ol(d7), methanol solution|Cholesterol-25,26,26,26,27,27,27-d7, 99 atom % D",393.700,C27H46O,20.200,591.000,8.700,28,1,1,5,"InChI=1S/C27H46O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9,18-19,21-25,28H,6-8,10-17H2,1-5H3/t19-,21+,22+,23-,24+,25+,26+,27-/m1/s1/i1D3,2D3,18D",[2H]C([2H])([2H])C([2H])(CCC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C([2H])([2H])[2H],HVYWMOMLDIMFJA-IFAPJKRJSA-N,"(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20060113,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|DiscoveryGate|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|LIPID MAPS|MassBank of North America (MoNA)|MolPort|MuseChem|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Sigma-Aldrich|Smolecule|Springer Nature|T",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5362119,Lisinopril,lisinopril|Prinivil|Zestril|76547-98-3|Linopril|Lysinopril|83915-83-7|Acercomp|Inhibril|Lisinopril dihydrate|Lisipril|Noperten|Presiten|Sinopril|Tensopril|Acerbon|Carace|Vivatec|Coric|Lisinopril anhydrous|Alapril|Inopril|Lisinal|Lisoril|Lispril|Novatec|Sinopryl|Cipral|Linvas|Lipril|Loril|Prinil|Tensyn|Tersif|Lisinoprilum|Longes|Hipril|UNII-7Q3P4BS2FD|MK-521|Lisinopril (INN)|[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE|Lisinopril (Zestril)|C21H31N3O5|N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proli,405.500,C21H31N3O5,133.000,550.000,-2.900,29,4,7,12,"InChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1",C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O,RLAWWYSOJDYHDC-BZSNNMDCSA-N,(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid,Lisinopril,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,940|1332|1422|1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1621|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1979|1984|1986|1987|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|207,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|Auru",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460375,Phosphohydroxypyruvate,3-phosphonatooxypyruvate(3-)|3-Phosphooxypyruvate|phosphohydroxypyruvate|2-oxo-3-(phosphonatooxy)propanoate|3-p-hydroxy-pyr|3-p-OH-pyruvate|phosphohydroxypyruate|3-P-hydroxypyruvate|3-phosphohydroxy-pyr|3-p-OH-pyr|3-phospho-hydroxypyruvate|CHEBI:18110|DTXSID70959935|Q27102826,181.020,C3H2O7P-3,130.000,197.000,-1.600,11,0,7,2,"InChI=1S/C3H5O7P/c4-2(3(5)6)1-10-11(7,8)9/h1H2,(H,5,6)(H2,7,8,9)/p-3",C(C(=O)C(=O)[O-])OP(=O)([O-])[O-],LFLUCDOSQPJJBE-UHFFFAOYSA-K,2-oxo-3-phosphonatooxypropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|NextBio|NovoSeek|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6183479,Fumarate(1-),fumarate(1-)|hydrogen fumarate|fumarate monoanion|3-carboxyacrylate|3-carboxyprop-2-enoate|(2E)-3-carboxyacrylate|3-Carboxyacrylic acidanion|(E)-3-Carboxylatoacrylic acid|(2E)-3-carboxyprop-2-enoate|CHEBI:37154|CHEBI:37155|(E)-3-Carboxyacrylic acid anion|Q27117051,115.060,C4H3O4-,77.400,130.000,0.300,8,1,4,1,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/p-1/b2-1+",C(=C/C(=O)[O-])\\C(=O)O,VZCYOOQTPOCHFL-OWOJBTEDSA-M,(E)-4-hydroxy-4-oxobut-2-enoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050916,"ABI Chem|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6857447,beta-Tocopherol,"BETA-TOCOPHEROL|16698-35-4|d-beta-Tocopherol|148-03-8|.beta.-Tocopherol|(R)-2,5,8-Trimethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol|UNII-9U6A490501|5,8-Dimethyltocol|Cumotocopherol|p-Xylotocopherol|2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-|9U6A490501|(2R)-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol|(2R)-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol|beta Tocopherol|beta-D-Toc",416.700,C28H48O2,29.500,475.000,10.300,30,1,2,12,"InChI=1S/C28H48O2/c1-20(2)11-8-12-21(3)13-9-14-22(4)15-10-17-28(7)18-16-25-24(6)26(29)19-23(5)27(25)30-28/h19-22,29H,8-18H2,1-7H3/t21-,22-,28-/m1/s1",CC1=CC(=C(C2=C1O[C@](CC2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O,WGVKWNUPNGFDFJ-DQCZWYHMSA-N,"(2R)-2,5,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol",beta-Tocopherol,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,9,NULL,20060621,"3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|Angene Chemical|Ark Pharma Scientific Limited|BePharm Ltd.|BIDD|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Comparative Toxicogenomics Database (CTD)|CSNpharm|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6918493,Ambrisentan,"Ambrisentan|177036-94-1|Letairis|Volibris|BSF 208075|LU-208075|(S)-2-((4,6-Dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid|(S)-2-(4,6-Dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic acid|BSF-208075|UNII-HW6NV07QEC|HW6NV07QEC|CHEMBL1111|(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid|DSSTox_CID_26282|DSSTox_RID_81508|DSSTox_GSID_46282|LU 208075|LU208075|(s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic acid|CAS-177036-94-1|Ambrisen",378.400,C22H22N2O4,81.500,475.000,3.800,28,1,6,7,"InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,OUJTZYPIHDYQMC-LJQANCHMSA-N,"(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,66523|68318|169570|175125|186073|197008|197010|588211|588212|588213|588834|603845|625276|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743,20060728,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambeed|Anward|ApexBio Technology|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BePharm Ltd.|BindingDB|Biosynth Carbosy",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
6971064,(2R)-3-Ammonio-2-methylpropanoate,(2R)-3-ammonio-2-methylpropanoate|(2R)-3-azaniumyl-2-methylpropanoate|(R)-3-aminoisobutyric acid zwitterion|CHEBI:57731,103.120,C4H9NO2,67.800,66.600,-2.300,7,1,2,1,"InChI=1S/C4H9NO2/c1-3(2-5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m1/s1",C[C@H](C[NH3+])C(=O)[O-],QCHPKSFMDHPSNR-GSVOUGTGSA-N,(2R)-3-azaniumyl-2-methylpropanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20060728,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|DiscoveryGate|NextBio|THE BioTek|Therapeutic Target Database (TTD)",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6992093,(R)-Lipoamide,"(R)-lipoamide|5-(1,2-dithiolan-3-yl)-pentanamide|(R)-Lipamide|DL-.alpha.-Lipoamide|6,8-dithiooctanoic amide|SCHEMBL41833|CHEBI:83094|ZINC1532583|5-[(3R)-1,2-dithiolan-3-yl]pentanamide|Q312205|UNII-Q1GT04827L component FCCDDURTIIUXBY-SSDOTTSWSA-N",205.300,C8H15NOS2,93.700,152.000,1.000,12,1,3,5,"InChI=1S/C8H15NOS2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H2,9,10)/t7-/m1/s1",C1CSS[C@@H]1CCCCC(=O)N,FCCDDURTIIUXBY-SSDOTTSWSA-N,5-[(3R)-dithiolan-3-yl]pentanamide,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060728,"A&J Pharmtech CO., LTD.|BioCyc|ChEBI|Chembase.cn|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|NextMove Software|NIST Mass Spectrometry Data Center|PATENTSCOPE (WIPO)|SCRIPDB|SureChEMBL|Thomson Pharma|Wikidata|WikiPathways|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7045767,Acetyl-L-carnitine,"Acetyl-L-carnitine|acetylcarnitine|L-ACETYLCARNITINE|O-Acetyl-L-carnitine|Levocarnitine acetyl|(-)-Acetylcarnitine|O-acetylcarnitine|L-O-Acetylcarnitine|(R)-Acetylcarnitine|ALCAR|R-Acetylcarnitine|Nicetile|3040-38-8|L-Carnitine acetyl ester|Acetyl-L-(-)-carnitine|(3R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate|UNII-6DH1W9VH8Q|6DH1W9VH8Q|CHEBI:57589|14992-62-2|L-Acetyl carnitine|Acetylcarnitine, L-|Carnitine, acetyl-, L-|acetyl-carnitine|HSDB 7587|acetyl l-carnitine|(-)O-acetylcarnitine|(+-)-Acetylcarnitine",203.240,C9H17NO4,66.400,214.000,0.400,14,0,4,5,"InChI=1S/C9H17NO4/c1-7(11)14-8(5-9(12)13)6-10(2,3)4/h8H,5-6H2,1-4H3/t8-/m1/s1",CC(=O)O[C@H](CC(=O)[O-])C[N+](C)(C)C,RDHQFKQIGNGIED-MRVPVSSYSA-N,(3R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate,Acetylcarnitine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,14,588211|588212|588213|678795|679144|680378|680965|681169|681271|681714|977599|977602|1159550,20060729,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|Alfa Chemistry|BioCyc|BOC Sciences|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Chen Lab, School of Medicine, Emory University|Comparative Toxicogenomics Database (CTD)|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|Hairui Chemical|Huma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
7058055,Adenosine-diphosphate,"ADP(3-)|adenosine-diphosphate|ADP trianion|2hmv|2rio|2vhj|2zfi|2zkj|3atu|3atv|3bxz|3dgn|3llm|3mle|3ncr|3qxh|3rup|3tif|2e2p|2fr8|2ja3|2o1v|2qv7|2r6f|2y8i|2y8l|2y8q|2z4r|3a1d|3ay9|3bf1|3c7n|3cf1|3d2r|3k1j|3qc9|3rv3|3rv4|3t4n|3ta1|4i3z|20398-34-9|DTXSID70942564|3i73|3p23|CHEBI:456216|5'-O-[(phosphonatooxy)phosphinato]adenosine|A831962|Q27225748|9-{5-O-[(Phosphonatooxy)phosphinato]pentofuranosyl}-9H-purin-6-amine|[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanidyl-phosphoryl] p",424.180,C10H12N5O10P2-3,241.000,618.000,-4.900,27,3,14,5,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/p-3/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])[O-])O)O)N,XTWYTFMLZFPYCI-KQYNXXCUSA-K,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,1811|977608|977610|977611,20060729,"ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|NextBio|PATENTSCOPE (WIPO)|Shanghai Institute of Organic Chemistry|Wikidata|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, WikiPathways]"
7098621,Cys-Gly,L-cysteinylglycine zwitterion|Cys-Gly zwitterion|2-[[(2R)-2-azaniumyl-3-sulfanylpropanoyl]amino]acetate|CHEBI:61694,178.210,C5H10N2O3S,97.900,156.000,-3.100,11,3,4,3,"InChI=1S/C5H10N2O3S/c6-3(2-11)5(10)7-1-4(8)9/h3,11H,1-2,6H2,(H,7,10)(H,8,9)/t3-/m0/s1",C([C@@H](C(=O)NCC(=O)[O-])[NH3+])S,ZUKPVRWZDMRIEO-VKHMYHEASA-N,2-[[(2R)-2-azaniumyl-3-sulfanylpropanoyl]amino]acetate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20060729,ABI Chem|BioCyc|ChEBI|DiscoveryGate|NextBio|THE BioTek,Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7140381,L-Cysteate,L-cysteate(1-)|L-Cysteate|L-cysteate anion|(R)-cysteate|(2R)-2-azaniumyl-3-sulfonatopropanoate|CHEBI:58090|(2R)-2-ammonio-3-sulfonatopropanoate|AKOS015898718|Q27125178,168.150,C3H6NO5S-,133.000,195.000,-3.900,10,1,5,1,"InChI=1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)/p-1/t2-/m0/s1",C([C@@H](C(=O)[O-])[NH3+])S(=O)(=O)[O-],XVOYSCVBGLVSOL-REOHCLBHSA-M,(2R)-2-azaniumyl-3-sulfonatopropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060729,"ABI Chem|AKos Consulting & Solutions|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Innovapharm|ISpharm|NextBio|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9811784,"Estra-1,3,5(10)-triene-3,17-diol","CHEBI:23965|Estra-1,3,5(10)-triene-3,17-diol|estradiols|estradiol group|Estra-1(10),2,4-triene-3,17-diol|Epitope ID:140085|SCHEMBL1649986|Q12415847",272.400,C18H24O2,40.500,382.000,4.000,20,2,2,0,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17?,18+/m1/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2O)CCC4=C3C=CC(=C4)O,VOXZDWNPVJITMN-WKUFJEKOSA-N,"(8R,9S,13S,14S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20061025,"ChEBI|ChemSpider|ChemTik|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IBM|Immune Epitope Database (IEDB)|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|MolPort|NextBio|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9860744,"(3S,10R,13S)-3-Hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one","(3S,10R,13S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one|BSPBio_001732|CHEMBL309821|MEGxm0_000469|SCHEMBL8242191|ACon1_002040|CHEBI:93823|3ss-Hydroxy-5-androsten-17-one|NCGC00179051-01|NCGC00179051-02|Q27165553",288.400,C19H28O2,37.300,508.000,3.200,21,1,2,0,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14?,15?,16?,18-,19-/m0/s1",C[C@]12CCC3C(C1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C,FMGSKLZLMKYGDP-INNQQZFDSA-N,"(3S,10R,13S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,51048|51052|51062|212920|212931|1346200,20061025,"Aurora Fine Chemicals LLC|ChEBI|ChemBank|ChEMBL|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|IBM|labseeker|MassBank of North America (MoNA)|MolPort|National Center for Advancing Translational Sciences (NCATS)|NextBio|Oakwood Products|PATENTSCOPE (WIPO)|SCRIPDB|SureChEMBL|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
10462221,3-Hydroxybut-3-enoic Acid,3-hydroxybut-3-enoic Acid|3-hydroxy-3-butenoic acid|SCHEMBL1980408|CHEBI:131367|180713-85-3,102.090,C4H6O3,57.500,95.100,0.000,7,2,3,2,"InChI=1S/C4H6O3/c1-3(5)2-4(6)7/h5H,1-2H2,(H,6,7)",C=C(CC(=O)O)O,YMXHTKKMLXGXDC-UHFFFAOYSA-N,3-hydroxybut-3-enoic acid,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20061025,BLD Pharm|ChEBI|ChemSpider|Google Patents|IBM|NextBio|PATENTSCOPE (WIPO)|SCRIPDB|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
12998487,"Succinic acid-2,2,3,3-d4","14493-42-6|Succinic-d4 acid|Succinic acid-2,2,3,3-d4|succinic acid-d4|2,2,3,3-tetradeuteriobutanedioic acid|Succinic-2,2,3,3-d4 Acid|(~2~H_4_)Butanedioic acid|((2)H4)butanedioic acid|SCHEMBL1331119|Butanedioic-2,2,3,3-d4acid|CHEBI:90372|DTXSID10514628|Succinic acid-[2,2,3,3-d4]|2,2,3,3-tetradeuteriosuccinic acid|AKOS015910326|Succinic acid-2,2,3,3-d4, 98 atom % D|J-008026",122.110,C4H6O4,74.600,92.600,-0.600,8,2,4,3,"InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)/i1D2,2D2",[2H]C([2H])(C(=O)O)C([2H])([2H])C(=O)O,KDYFGRWQOYBRFD-LNLMKGTHSA-N,"2,2,3,3-tetradeuteriobutanedioic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,7,NULL,20070208,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|Biosynth Carbosynth|BOC Sciences|ChEBI|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|DiscoveryGate|eNovation Chemicals|EPA DSSTox|Google Patents|IBM|ISpharm|Japan Chemical Substance Dictionary (Nikkaji)|MolCore BioPharmatech|MuseChem|PATENTSCOPE (WIPO)|Sigma-Aldrich|Smolecule|Springer Nature|SureChEMBL|THE BioTek|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15983959,"2-trans,6-trans-Farnesyl diphosphate(3-)","2-trans,6-trans-farnesyl diphosphate(3-)|(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl diphosphate|13058-04-3|E-E-farnesyl diphosphate|FPP|farnesyl pyrophosphate(3-)|all-trans-farnesyl diphosphate|omega,E,E-farnesyl diphosphate|C15-PP|trans, trans-farnesyl diphosphate|(E,E)-farnesyl diphosphate(3-)|CHEBI:175763|(2E,6E)-farnesyl diphosphate(3-)|trans,trans-farnesyl diphosphate(3-)|(2-trans,6-trans)-farnesyl diphosphate(3-)|Q27225693|(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl (phosphonatooxy)phosphon",379.300,C15H25O7P2-3,122.000,549.000,2.300,24,0,7,10,"InChI=1S/C15H28O7P2/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-21-24(19,20)22-23(16,17)18/h7,9,11H,5-6,8,10,12H2,1-4H3,(H,19,20)(H2,16,17,18)/p-3/b14-9+,15-11+",CC(=CCC/C(=C/CC/C(=C/COP(=O)([O-])OP(=O)([O-])[O-])/C)/C)C,VWFJDQUYCIWHTN-YFVJMOTDSA-K,"[oxido-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoxy]phosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20070325,"BioCyc|ChEBI|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|Nature Chemical Biology|Nature Chemistry|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16213464,"Octadecanoic-18,18,18-d3 acid","Octadecanoic-18,18,18-d3 acid|62163-39-7|Stearic acid(d3)|18,18,18-trideuteriooctadecanoic acid|Stearic acid-18,18,18-d3|Octadecanoic acid(d3)|SCHEMBL1331648|DTXSID30583972|CHEBI:168383|18,18,18-trideuterostearic acid|LMFA01010047|AKOS015893936|(18,18,18-~2~H_3_)Octadecanoic acid|Stearic acid-18,18,18-d3, 98 atom % D, 99% (CP)",287.500,C18H36O2,37.300,202.000,7.400,20,1,2,16,"InChI=1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20)/i1D3",[2H]C([2H])([2H])CCCCCCCCCCCCCCCCC(=O)O,QIQXTHQIDYTFRH-FIBGUPNXSA-N,"18,18,18-trideuteriooctadecanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,8,NULL,20070712,"AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|Biocore|BOC Sciences|ChEBI|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|eNovation Chemicals|EPA DSSTox|Google Patents|ISpharm|LIPID MAPS|Sigma-Aldrich|Smolecule|Springer Nature|SureChEMBL|THE BioTek",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16654696,"[(3S,2R,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydroge n phosphate","ADP(2-)|[(3S,2R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydroge n phosphate|ADP group|CHEBI:87518|AKOS024282553|ST057081|MLS-0111622.0001|5'-O-{[(hydroxyphosphinato)oxy]phosphinato}adenosine|Q27159692",425.190,C10H13N5O10P2-2,238.000,627.000,-4.800,27,4,14,6,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/p-2/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)(O)[O-])O)O)N,XTWYTFMLZFPYCI-KQYNXXCUSA-L,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] hydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,8,1193|1227|1259312,20070807,"AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BioCyc|Burnham Center for Chemical Genomics|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Keith Lab, Institute of Cancer Science, University of Glasgow|Nature Chemical Biology|Springer Nature|TimTec|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16667373,UDP-N-acetyl-alpha-D-glucosamine,"UDP-N-acetyl-alpha-D-glucosamine|UDP-N-acetyl-alpha-D-glucosamine(2-) ion|Uridine 5'-(trihydrogen diphosphate), P'-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl) ester|UDP-N-acetyl-glucosamine|UDP-alpha-N-acetyl-D-glucosamine|UDP-N-acetyl-alpha-D-glucosamine(2-)|UDP-N-acetyl-alpha-D-glucosamine dianion|CHEBI:57705|UDP-N-acetyl-  -D-glucosamine(2-)|UDP-2-acetamido-2-deoxy-alpha-D-glucose|Q27124875|uridine 5'-[3-(acetamido-2-deoxy-alpha-D-glucopyranosyl) diphosphate]",605.300,C17H25N3O17P2-2,306.000,1060.000,-6.500,39,7,17,10,"InChI=1S/C17H27N3O17P2/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28)/p-2/t7-,8-,10-,11-,12-,13-,14-,15-,16-/m1/s1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)([O-])OP(=O)([O-])OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)CO)O)O,LFTYTUAZOPRMMI-CFRASDGPSA-L,"[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20070814,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, WikiPathways]"
16722119,CID 16722119,Jsp000591|CHEBI:12109|Q27108930,130.120,C5H8NO3-,83.200,116.000,-3.200,9,1,4,3,"InChI=1S/C5H9NO3/c6-3-4(7)1-2-5(8)9/h1-3,6H2,(H,8,9)/p-1",C(CC(=O)[O-])C(=O)CN,ZGXJTSGNIOSYLO-UHFFFAOYSA-M,5-amino-4-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20070831,"Aurora Fine Chemicals LLC|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Jamson Pharmachem Technology|NovoSeek|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
20056717,Uridine-diphosphate,"UDP(3-)|uridine-diphosphate|CHEMBL1096401|uridine diphosphate trisodium salt|UDP trianion|2wzf|3djq|3dxh|4dmw|2vl8|4ay5|uridine 5'-diphosphate(3-)|uridine 5'-diphosphate trianion|CHEBI:58223|BDBM50318022|5'-O-[(phosphonatooxy)phosphinato]uridine|A832095|Q27125623|[[(2R,3S,4R,5R)-5-(2,4-dioxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]methoxy-oxidophosphoryl] phosphate|[[(2R,3S,4R,5R)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanidyl-phosphoryl] phosphate",401.140,C9H11N2O12P2-3,221.000,656.000,-5.000,25,3,12,5,"InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/p-3/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])[O-])O)O,XCCTYIAWTASOJW-XVFCMESISA-K,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,977608|977610|977611,20071205,"Amadis Chemical|BindingDB|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Shanghai Institute of Organic Chemistry|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
20848909,L-Kynureninate,L-kynureninate|CHEBI:67010|3-(2-aminobenzoyl)-L-alanine(1-)|(2S)-2-amino-4-(2-aminophenyl)-4-oxobutanoate|Q27135573,207.210,C10H11N2O3-,109.000,250.000,-1.400,15,2,5,3,"InChI=1S/C10H12N2O3/c11-7-4-2-1-3-6(7)9(13)5-8(12)10(14)15/h1-4,8H,5,11-12H2,(H,14,15)/p-1/t8-/m0/s1",C1=CC=C(C(=C1)C(=O)C[C@@H](C(=O)[O-])N)N,YGPSJZOEDVAXAB-QMMMGPOBSA-M,(2S)-2-amino-4-(2-aminophenyl)-4-oxobutanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20071205,"ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
20849128,Thromboxane A2(1-),"thromboxane A2(1-)|thromboxane A2 anion|CHEBI:57445|Q27124690|(5Z,13E,15S)-9alpha,11alpha-epoxy-15-hydroxythromboxa-5,13-dien-1-oate|(5Z, 9alpha,11 alpha,13E,15S)-9,11-epoxy-15-hydroxythromboxa- 5,13-dien-1-oic acid",351.500,C20H31O5-,78.800,454.000,4.100,25,1,5,11,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18-14-20(24-17)25-18)10-7-4-5-8-11-19(22)23/h4,7,12-13,15-18,20-21H,2-3,5-6,8-11,14H2,1H3,(H,22,23)/p-1/b7-4-,13-12+/t15-,16+,17+,18-,20+/m0/s1",CCCCC[C@@H](/C=C/[C@@H]1[C@H]([C@@H]2C[C@@H](O2)O1)C/C=C\\CCCC(=O)[O-])O,DSNBHJFQCNUKMA-SCKDECHMSA-M,"(Z)-7-[(1S,3R,4S,5S)-3-[(E,3S)-3-hydroxyoct-1-enyl]-2,6-dioxabicyclo[3.1.1]heptan-4-yl]hept-5-enoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21124327,Thymidine-diphosphate,dTDP(3-)|thymidine-diphosphate|thymidine 5'-(trihydrogen diphosphate) (9CI)|dTDP trianion|thymidine 5'-diphosphate(3-)|CHEBI:58369|thymidine 5'-pyrophosphate(3-)|thymidine 5'-diphosphate trianion|2v54|thymidine 5'-pyrophosphate trianion|5'-O-[(phosphonatooxy)phosphinato]thymidine|Q27125732,399.160,C10H13N2O11P2-3,201.000,669.000,-4.200,25,2,11,5,"InChI=1S/C10H16N2O11P2/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(22-8)4-21-25(19,20)23-24(16,17)18/h3,6-8,13H,2,4H2,1H3,(H,19,20)(H,11,14,15)(H2,16,17,18)/p-3/t6-,7+,8+/m0/s1",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])[O-])O,UJLXYODCHAELLY-XLPZGREQSA-K,"[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977610,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Shanghai Institute of Organic Chemistry|ToxPlanet|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
22833512,Dihydrocodehydrogenase II,Dihydrocodehydrogenase II|NADP-reduced|reduced Coenzyme II|reduced Cozymase II|b-NADPH|reduced Codehydrase II|dihydronicotinamide adenine dinucleotide-P|GTPL3041|Reduced triphosphopyridine nucleotide|Triphosphopyridine nucleotide reduced|dihydrotriphosphopyridine nucleotide reduced|Nicotinamide-adenine-dinucleotide-phosphorate|b-Nicotinamide-adenine-dinucleotide-phosphorate|beta-Nicotinamide-adenine-dinucleotide-phosphorate|Nicotinamide-adenine-dinucleotide-phosphoric acid|b-Nicotinamide-adenine-dinucleotid,745.400,C21H30N7O17P3,364.000,1410.000,-6.800,48,9,22,13,"InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m0/s1",C1C=CN(C=C1C(=O)N)[C@@H]2[C@H]([C@H]([C@@H](O2)COP(=O)(O)OP(=O)(O)OC[C@H]3[C@@H]([C@@H]([C@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O,ACFIXJIJDZMPPO-NCHANQSKSA-N,"[[(2S,3S,4S,5S)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2S,3R,4S,5S)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Literature|Patents|Pharmacology and Biochemistry,4,NULL,20071205,ChemSpider|Google Patents|Human Metabolome Database (HMDB)|IUPHAR/BPS Guide to PHARMACOLOGY|MassBank of North America (MoNA)|THE BioTek|Therapeutic Target Database (TTD),Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23421208,5'-Xanthylate(2-),5'-xanthylate(2-)|xanthosine-5'-P|5'-xanthylate dianion|XMP|xanthosine-5-P|xanthosine 5-phosphate|5'-O-phosphonatoxanthosine|CHEMBL253328|CHEBI:57464|(9-D-ribosylxanthine) 5'-phosphate|BDBM50231945|9-(5-phospho-beta-D-ribosyl)xanthine|xanthosine-5''-monophosphate disodium salt|Q27124710,362.190,C10H11N4O9P-2,198.000,573.000,-4.200,24,4,10,3,"InChI=1S/C10H13N4O9P/c15-5-3(1-22-24(19,20)21)23-9(6(5)16)14-2-11-4-7(14)12-10(18)13-8(4)17/h2-3,5-6,9,15-16H,1H2,(H2,19,20,21)(H2,12,13,17,18)/p-2/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])[O-])O)O)NC(=O)NC2=O,DCTLYFZHFGENCW-UUOKFMHZSA-L,"[(2R,3S,4R,5R)-5-(2,6-dioxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071206,"BindingDB|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23615192,2-Oxoadipate(2-),2-oxoadipate(2-)|alpha-ketoadipate|2-oxohexanedioate|CHEBI:57499|Q27124738,158.110,C6H6O5-2,97.300,172.000,0.800,11,0,5,3,"InChI=1S/C6H8O5/c7-4(6(10)11)2-1-3-5(8)9/h1-3H2,(H,8,9)(H,10,11)/p-2",C(CC(=O)C(=O)[O-])CC(=O)[O-],FGSBNBBHOZHUBO-UHFFFAOYSA-L,2-oxohexanedioate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071212,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata|WikiPathways",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
24906333,8-[(Aminomethyl)sulfanyl]-6-sulfanyloctanamide,S(8)-aminomethyldihydrolipoamide|S-aminomethyldihydrolipoamide|8-[(aminomethyl)sulfanyl]-6-sulfanyloctanamide|CHEBI:50622|LMFA08010025|Q27122152,236.400,C9H20N2OS2,95.400,156.000,0.700,14,3,4,9,"InChI=1S/C9H20N2OS2/c10-7-14-6-5-8(13)3-1-2-4-9(11)12/h8,13H,1-7,10H2,(H2,11,12)",C(CCC(=O)N)CC(CCSCN)S,KALYVIJGKPJBQV-UHFFFAOYSA-N,8-(aminomethylsulfanyl)-6-sulfanyloctanamide,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20080930,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|LIPID MAPS|MetabolomicsWorkbench|Wikidata",Curation Efforts|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25202509,Cytidine diphosphate choline,"CDP-choline(1-)|CDP-choline|CDP-choline (1-)|citicholine|citicoline|cyticholine|Citicoline, 98%|cytidine diphosphate choline|987-78-0|cidifos|CHEBI:58779|MLS-0072913|NCGC00186005-01|NCGC00186005-03|Q27126045|5'-O-[({[2-(trimethylazaniumyl)ethoxy]phosphinato}oxy)phosphinato]cytidine",487.320,C14H25N4O11P2-,216.000,813.000,-4.100,31,3,11,10,"InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/p-1/t9-,11-,12-,13-/m1/s1",C[N+](C)(C)CCOP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O,RZZPDXZPRHQOCG-OJAKKHQRSA-M,"[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(trimethylazaniumyl)ethyl phosphate",Cytidine Diphosphate Choline,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Micromolar,10,2660|2666|2667|2668|463106|485295|485297|485298|485313|485342|485345|485366|485368|488772|488773|488816|488837|488949|488953|488978|488981|488982|488983|493106|493107|493153|493164|504327|504332|504536|504547|504548|504810|504812|504836|504845|504847|504865|540256|540276|588349|588378|588453|588456|588579|588795|602332|624146|624147|624148|624149|624455|651635|652106|720538|720559|720572|720573|743205|743206|743207|743244|1224859|1224865|1272365|1346378|1346428|1347045|1347049|1347050|1347053|1347057|134705,20090331,"Acros Organics|BioCyc|Burnham Center for Chemical Genomics|ChEBI|Collaborative Drug Discovery, Inc.|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|National Center for Advancing Translational Sciences (NCATS)|UW Madison, Small Molecule Screening Facility|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25244365,alpha-D-Glucuronate 1-phosphate,1-phosphonato-alpha-D-glucuronate(3-)|alpha-D-glucuronate 1-phosphate|1-Phospho-alpha-D-glucuronate|glucuronate-1-P|D-glucuronate-1-P|glucuronate-1-phosphate|D-glucuronate-1-phosphate|CHEBI:57897|1-phosphonato-alpha-D-glucuronate|1-O-phosphonato-alpha-D-glucuronate|1-phosphonato-  -D-glucuronate(3-)|1-phosphonato-alpha-D-glucuronate trianion|Q27125044,271.100,C6H8O10P-3,183.000,321.000,-3.000,17,3,10,1,"InChI=1S/C6H11O10P/c7-1-2(8)4(5(10)11)15-6(3(1)9)16-17(12,13)14/h1-4,6-9H,(H,10,11)(H2,12,13,14)/p-3/t1-,2-,3+,4-,6+/m0/s1",[C@@H]1([C@@H]([C@H](O[C@@H]([C@@H]1O)OP(=O)([O-])[O-])C(=O)[O-])O)O,AIQDYKMWENWVQJ-QIUUJYRFSA-K,"(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-phosphonatooxyoxane-2-carboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25245607,alpha-D-Mannose 1-phosphate(2-),alpha-D-mannose 1-phosphate(2-)|mannose-1-phosphate|alpha-D-Mannopyranose 1-phosphate|1-O-phosphonatohexopyranose|27251-84-9|CHEBI:58409|DTXSID60949986|1-O-phosphonato-alpha-D-mannopyranose|1-O-(Dioxylatophosphinyl)-alpha-D-mannopyranose|Q27125768,258.120,C6H11O9P-2,163.000,266.000,-4.000,16,4,9,2,"InChI=1S/C6H13O9P/c7-1-2-3(8)4(9)5(10)6(14-2)15-16(11,12)13/h2-10H,1H2,(H2,11,12,13)/p-2/t2-,3-,4+,5+,6-/m1/s1",C([C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)OP(=O)([O-])[O-])O)O)O)O,HXXFSFRBOHSIMQ-RWOPYEJCSA-L,"[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|Wikidata",Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25320183,Deoxyadenosine-triphosphate,"dATP(4-)|deoxyadenosine-triphosphate|1927-31-7|[[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate|dATP tetraanion|2'-deoxyATP|CHEBI:61404|2/'-Deoxyadenosine 5/'-triphosphate|2'-deoxyadenosine 5'-triphosphate(4-)|2'-deoxyadenosine 5'-triphosphate tetraanion|Q27131078",487.150,C10H12N5O12P3-4,270.000,741.000,-4.700,30,2,16,7,"InChI=1S/C10H16N5O12P3/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(25-7)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H,22,23)(H2,11,12,13)(H2,17,18,19)/p-4/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O,SUYVUBYJARFZHO-RRKCRQDMSA-J,"[[[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090527,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Smolecule|THE BioTek|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
40467895,Glutathione disulfide(2-),"glutathione disulfide(2-)|glutathione ox|3gx0|3m8u|glutathione disulfide dianion|CHEBI:58297|(2S,2'S)-5,5'-[disulfanediylbis({(2R)-3-[(carboxylatomethyl)amino]-3-oxopropane-1,2-diyl}imino)]bis(2-azaniumyl-5-oxopentanoate)",610.600,C20H30N6O12S2-2,383.000,857.000,-6.500,40,6,14,17,"InChI=1S/C20H32N6O12S2/c21-9(19(35)36)1-3-13(27)25-11(17(33)23-5-15(29)30)7-39-40-8-12(18(34)24-6-16(31)32)26-14(28)4-2-10(22)20(37)38/h9-12H,1-8,21-22H2,(H,23,33)(H,24,34)(H,25,27)(H,26,28)(H,29,30)(H,31,32)(H,35,36)(H,37,38)/p-2/t9-,10-,11-,12-/m0/s1",C(CC(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)[O-])NC(=O)CC[C@@H](C(=O)[O-])[NH3+])C(=O)NCC(=O)[O-])[C@@H](C(=O)[O-])[NH3+],YPZRWBKMTBYPTK-BJDJZHNGSA-L,(2S)-2-azaniumyl-5-[[(2R)-3-[[(2R)-2-[[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino]-3-(carboxylatomethylamino)-3-oxopropyl]disulfanyl]-1-(carboxylatomethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20090530,BioCyc|ChEBI|Google Patents|Shanghai Institute of Organic Chemistry,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
42609815,Dctp trianion,dCTP(3-)|dCTP trianion|CHEBI:57724|Q27124893,464.130,C9H13N3O13P3-3,257.000,805.000,-5.900,28,3,13,8,"InChI=1S/C9H16N3O13P3/c10-7-1-2-12(9(14)11-7)8-3-5(13)6(23-8)4-22-27(18,19)25-28(20,21)24-26(15,16)17/h1-2,5-6,8,13H,3-4H2,(H,18,19)(H,20,21)(H2,10,11,14)(H2,15,16,17)/p-3/t5-,6+,8+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O,RGWHQCVHVJXOKC-SHYZEUOFSA-K,"[[[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20090619,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|Springer Nature|Thieme Chemistry|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
42609821,Adenosine diphosphate glucose,ADP alpha-D-glucoside(2-)|adenosine diphosphate glucose|ADP-alpha-D-glucose|ADP-D-glucose|ADP alpha-D-glucoside dianion|ADP   -D-glucoside(2-)|CHEBI:57498|Q27124737|adenosine 5'-[3-(alpha-D-glucopyranosyl) diphosphate],587.300,C16H23N5O15P2-2,317.000,908.000,-6.400,38,7,19,9,"InChI=1S/C16H25N5O15P2/c17-13-7-14(19-3-18-13)21(4-20-7)15-11(26)9(24)6(33-15)2-32-37(28,29)36-38(30,31)35-16-12(27)10(25)8(23)5(1-22)34-16/h3-6,8-12,15-16,22-27H,1-2H2,(H,28,29)(H,30,31)(H2,17,18,19)/p-2/t5-,6-,8-,9-,10+,11-,12-,15-,16-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O)N,WFPZSXYXPSUOPY-ROYWQJLOSA-L,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate",Adenosine Diphosphate Glucose,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090619,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
44229096,UDP-D-galactose(2-),UDP-D-galactose(2-)|UDP-D-galactose dianion|CHEBI:58439|uridine 5'-[3-(D-galactopyranosyl) diphosphate]|Q27125792,564.290,C15H22N2O17P2-2,297.000,948.000,-6.500,36,7,17,9,"InChI=1S/C15H24N2O17P2/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25)/p-2/t5-,6-,8+,9-,10+,11-,12-,13-,14?/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OC3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O,HSCJRCZFDFQWRP-LNYDKVEPSA-L,"[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20091015,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
44229175,3-Hydroxypropanoyl-CoA(4-),"3-hydroxypropanoyl-CoA(4-)|3-hydroxypropionyl-coenzyme A|CHEBI:58528|Q27125848|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-4-{[3-({2-[(3-hydroxypropanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-2,2-dimethyl-4-oxobutyl] diphosphate}",835.600,C24H36N7O18P3S-4,421.000,1390.000,-6.700,53,6,23,21,"InChI=1S/C24H40N7O18P3S/c1-24(2,19(36)22(37)27-5-3-14(33)26-6-8-53-15(34)4-7-32)10-46-52(43,44)49-51(41,42)45-9-13-18(48-50(38,39)40)17(35)23(47-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,32,35-36H,3-10H2,1-2H3,(H,26,33)(H,27,37)(H,41,42)(H,43,44)(H2,25,28,29)(H2,38,39,40)/p-4/t13-,17-,18-,19+,23-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)CCO)O,BERBFZCUSMQABM-IEXPHMLFSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-4-[[3-[2-(3-hydroxypropanoylsulfanyl)ethylamino]-3-oxopropyl]amino]-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20091015,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266551,"(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA(4-)","(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA(4-)|3-hydroxy-2-methylbutyryl-CoA|(2S,3S)-3-hydroxy-2-methylbutyryl-CoA|CHEBI:57312|(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA tetraanion|(2S,3S)-3-hydroxy-2-methylbutanoyl-coenzyme A(4-)|Q27124415|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(2S,3S)-3-hydroxy-2-methylbutanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] diphosphate}",863.600,C26H40N7O18P3S-4,421.000,1450.000,-5.700,55,6,23,21,"InChI=1S/C26H44N7O18P3S/c1-13(14(2)34)25(39)55-8-7-28-16(35)5-6-29-23(38)20(37)26(3,4)10-48-54(45,46)51-53(43,44)47-9-15-19(50-52(40,41)42)18(36)24(49-15)33-12-32-17-21(27)30-11-31-22(17)33/h11-15,18-20,24,34,36-37H,5-10H2,1-4H3,(H,28,35)(H,29,38)(H,43,44)(H,45,46)(H2,27,30,31)(H2,40,41,42)/p-4/t13-,14-,15+,18+,19+,20-,24+/m0/s1",C[C@@H]([C@H](C)O)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,PEKYNTFSOBAABV-LQUDNSJZSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-4-[[3-[2-[(2S,3S)-3-hydroxy-2-methylbutanoyl]sulfanylethylamino]-3-oxopropyl]amino]-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Protein Data Bank in Europe (PDBe)|Wikidata",Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266568,2-Methylacetoacetyl-CoA(4-),"2-methylacetoacetyl-CoA(4-)|2-Methylacetoacetyl-coa|2-methyl-3-acetoacetyl-CoA|6712-01-2|2-methyl-3-oxobutanoyl-CoA|2-methylacetoacetyl coenzyme A|CHEBI:57335|2-methylacetoacetyl-CoA tetraanion|2-methylacetoacetyl-coenzyme A(4-)|Q27124435|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-{[3-({2-[(2-methyl-3-oxobutanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl]diphosphate}",861.600,C26H38N7O18P3S-4,417.000,1500.000,-5.500,55,5,23,21,"InChI=1S/C26H42N7O18P3S/c1-13(14(2)34)25(39)55-8-7-28-16(35)5-6-29-23(38)20(37)26(3,4)10-48-54(45,46)51-53(43,44)47-9-15-19(50-52(40,41)42)18(36)24(49-15)33-12-32-17-21(27)30-11-31-22(17)33/h11-13,15,18-20,24,36-37H,5-10H2,1-4H3,(H,28,35)(H,29,38)(H,43,44)(H,45,46)(H2,27,30,31)(H2,40,41,42)/p-4/t13?,15-,18-,19-,20+,24-/m1/s1",CC(C(=O)C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,NHNODHRSCRALBF-NQNBQJKNSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-(2-methyl-3-oxobutanoyl)sulfanylethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266584,trans-4-Coumaroyl-CoA(4-),"trans-4-coumaroyl-CoA(4-)|(E)-4-coumaroyl-CoA|4-Hydroxycinnamoyl-CoA|p-coumaryl-CoA|4-coumaryl-CoA|CHEBI:57355|CHEBI:85008|Q27158285|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[3-(4-hydroxyphenyl)prop-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] diphosphate}",909.600,C30H38N7O18P3S-4,421.000,1590.000,-4.200,59,6,23,21,"InChI=1S/C30H42N7O18P3S/c1-30(2,25(42)28(43)33-10-9-20(39)32-11-12-59-21(40)8-5-17-3-6-18(38)7-4-17)14-52-58(49,50)55-57(47,48)51-13-19-24(54-56(44,45)46)23(41)29(53-19)37-16-36-22-26(31)34-15-35-27(22)37/h3-8,15-16,19,23-25,29,38,41-42H,9-14H2,1-2H3,(H,32,39)(H,33,43)(H,47,48)(H,49,50)(H2,31,34,35)(H2,44,45,46)/p-4/b8-5+/t19-,23-,24-,25+,29-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCSC(=O)/C=C/C4=CC=C(C=C4)O)O,DMZOKBALNZWDKI-MATMFAIHSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-4-[[3-[2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]sulfanylethylamino]-3-oxopropyl]amino]-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266605,Palmitoyl CoA,"palmitoyl-CoA(4-)|palmitoyl CoA|palmityl-CoA|1763-10-6|CHEBI:57379|Palmitoyl-CoA (n-C16:0CoA)|PALMITOYLCOENZYMEAPOTASSIUMSALT|Q27124538|3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(hexadecanoylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate)",1001.900,C37H62N7O17P3S-4,400.000,1590.000,1.400,65,5,22,33,"InChI=1S/C37H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h24-26,30-32,36,47-48H,4-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/t26-,30-,31-,32+,36-/m1/s1",CCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,MNBKLUUYKPBKDU-BBECNAHFSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-(2-hexadecanoylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate",Palmitoyl Coenzyme A,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"3WAY PHARM INC|BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266685,N-Acetyl-D-mannosamine 6-phosphate(2-),N-acetyl-D-mannosamine 6-phosphate(2-)|2-acetamido-2-deoxy-D-mannose 6-phosphate|CHEBI:58557|2-acetamido-2-deoxy-6-O-phosphonato-D-mannose|Q27125874,299.170,C8H14NO9P-2,179.000,345.000,-4.700,19,4,9,7,"InChI=1S/C8H16NO9P/c1-4(11)9-5(2-10)7(13)8(14)6(12)3-18-19(15,16)17/h2,5-8,12-14H,3H2,1H3,(H,9,11)(H2,15,16,17)/p-2/t5-,6-,7-,8-/m1/s1",CC(=O)N[C@H](C=O)[C@H]([C@@H]([C@@H](COP(=O)([O-])[O-])O)O)O,QDSLHWJDSQGPEE-WCTZXXKLSA-L,"[(2R,3S,4R,5S)-5-acetamido-2,3,4-trihydroxy-6-oxohexyl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100507,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266696,5-Amino-1-(5-phosphonato-D-ribosyl)imidazol-3-ium,5-amino-1-(5-phosphonato-D-ribosyl)imidazol-3-ium|CHEBI:58592|Q27125900|5-amino-1-(5-O-phosphonato-D-ribofuranosyl)-1H-imidazol-3-ium,294.180,C8H13N3O7P-,168.000,355.000,-3.600,19,4,8,3,"InChI=1S/C8H14N3O7P/c9-5-1-10-3-11(5)8-7(13)6(12)4(18-8)2-17-19(14,15)16/h1,3-4,6-8,12-13H,2,9H2,(H2,14,15,16)/p-1/t4-,6-,7-,8?/m1/s1",C1=C([N+](=CN1)C2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O)N,PDACUKOKVHBVHJ-ZRTZXPPTSA-M,"[(2R,3S,4R)-5-(4-amino-1H-imidazol-3-ium-3-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100507,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45480541,Riboflavin(1-),"riboflavin(1-)|CHEBI:57986|Q27125100|1-deoxy-1-(7,8-dimethyl-2,4-dioxo-2H-benzo[g]pteridin-3-id-10(4H)-yl)-D-ribitol|7,8-dimethyl-2,4-dioxo-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2H,3H,4H,10H-benzo[g]pteridin-3-ide",375.400,C17H19N4O6-,161.000,693.000,-0.500,27,4,7,5,"InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/p-1/t11-,12+,14-/m0/s1",CC1=CC2=C(C=C1C)N(C3=NC(=NC(=O)C3=N2)[O-])C[C@@H]([C@@H]([C@@H](CO)O)O)O,AUNGANRZJHBGPY-SCRDCRAPSA-M,"7,8-dimethyl-4-oxo-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridin-2-olate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100603,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46173176,(E)-Hexadec-2-enoyl-CoA(4-),(E)-hexadec-2-enoyl-CoA(4-)|trans-2-Hexadecenoyl-CoA|trans-Hexadec-2-enoyl-CoA|trans-C16:1 n-14-CoA|trans-2-hexadecenoyl-CoA(4-)|CHEBI:61526|trans-hexadec-2-enoyl-CoA(4-)|(E)-C16:1 n-14-CoA|(E)-hexadec-2-enoyl-CoA tetraanion|trans-2-hexadecenoyl-coenzyme A(4-)|(E)-hexadec-2-enoyl-coenzyme A(4-)|(E)-hexadec-2-enoyl-coenzyme A tetraanion|trans-2-hexadecenoyl-coenzyme A tetraanion|Q27131126,999.900,C37H60N7O17P3S-4,400.000,1640.000,1.200,65,5,22,32,"InChI=1S/C37H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h16-17,24-26,30-32,36,47-48H,4-15,18-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/p-4/b17-16+/t26-,30-,31-,32+,36-/m1/s1",CCCCCCCCCCCCC/C=C/C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,JUPAQFRKPHPXLD-MSHHSVQMSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-[2-[(E)-hexadec-2-enoyl]sulfanylethylamino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100630,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46783527,"2-[[(4R)-4-[(3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid",C05122,515.700,C26H45NO7S,153.000,891.000,2.200,35,5,7,7,"InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24?,25+,26-/m1/s1",C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3C2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,WBWWGRHZICKQGZ-IECFWMJSSA-N,"2-[[(4R)-4-[(3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid",NULL,Biomolecular Interactions and Pathways|Classification|Pharmacology and Biochemistry,3,NULL,20100728,KEGG,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878376,(N(omega)-L-Arginino)succinate(1-),(N(omega)-L-arginino)succinate(1-)|arginino-succinate|L-arginino-succinate|N-(L-arginino)-succinate|CHEBI:57472|Q27124717|2-{[{[(4S)-4-ammonio-4-carboxylatobutyl]amino}(iminio)methyl]amino}succinate|2-{[{[(4S)-4-azaniumyl-4-carboxylatobutyl]amino}(iminiumyl)methyl]amino}butanedioate,289.270,C10H17N4O6-,200.000,381.000,-2.700,20,4,6,7,"InChI=1S/C10H18N4O6/c11-5(8(17)18)2-1-3-13-10(12)14-6(9(19)20)4-7(15)16/h5-6H,1-4,11H2,(H,15,16)(H,17,18)(H,19,20)(H3,12,13,14)/p-1/t5-,6?/m0/s1",C(C[C@@H](C(=O)[O-])[NH3+])C[NH+]=C(N)NC(CC(=O)[O-])C(=O)[O-],KDZOASGQNOPSCU-ZBHICJROSA-M,2-[[amino-[(4S)-4-azaniumyl-4-carboxylatobutyl]azaniumylidenemethyl]amino]butanedioate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46926269,UDP-N-acetyl-D-galactosamine(2-),UDP-N-acetyl-D-galactosamine(2-)|CHEBI:57847|UDP-N-acetyl-D-galactosamine dianion|Q27124999|uridine 5'-[3-(2-acetamido-2-deoxy-D-galactopyranosyl) diphosphate],605.300,C17H25N3O17P2-2,306.000,1060.000,-6.500,39,7,17,10,"InChI=1S/C17H27N3O17P2/c1-6(22)18-10-13(26)11(24)7(4-21)35-16(10)36-39(31,32)37-38(29,30)33-5-8-12(25)14(27)15(34-8)20-3-2-9(23)19-17(20)28/h2-3,7-8,10-16,21,24-27H,4-5H2,1H3,(H,18,22)(H,29,30)(H,31,32)(H,19,23,28)/p-2/t7-,8-,10-,11+,12-,13-,14-,15-,16?/m1/s1",CC(=O)N[C@@H]1[C@H]([C@H]([C@H](OC1OP(=O)([O-])OP(=O)([O-])OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=O)NC3=O)O)O)CO)O)O,LFTYTUAZOPRMMI-LDDHHVEYSA-L,"[(3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20101025,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49792077,3-Sulfinato-L-alaninate(2-),3-sulfinato-L-alaninate(2-)|3-sulfinato-L-alaninate|3-sulfinato-L-alaninate dianion|CHEBI:224037|(2R)-2-amino-3-sulfinatopropanoate|Q27225707,151.140,C3H5NO4S-2,126.000,125.000,-4.100,9,1,6,1,"InChI=1S/C3H7NO4S/c4-2(3(5)6)1-9(7)8/h2H,1,4H2,(H,5,6)(H,7,8)/p-2/t2-/m0/s1",C([C@@H](C(=O)[O-])N)S(=O)[O-],ADVPTQAUNPRNPO-REOHCLBHSA-L,(2R)-2-amino-3-sulfinatopropanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20101217,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49852317,5'-Adenylyl sulfate(2-),5'-adenylyl sulfate(2-)|adenylyl-sulfate|adenosine 5'-sulphatophosphate|5'-adenylyl sulfate dianion|CHEBI:58243|5'-O-[(sulfonatooxy)phosphinato]adenosine|Q27125643,425.270,C10H12N5O10PS-2,244.000,671.000,-4.100,27,3,14,5,"InChI=1S/C10H14N5O10PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-26(18,19)25-27(20,21)22/h2-4,6-7,10,16-17H,1H2,(H,18,19)(H2,11,12,13)(H,20,21,22)/p-2/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OS(=O)(=O)[O-])O)O)N,IRLPACMLTUPBCL-KQYNXXCUSA-L,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl sulfonato phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20110208,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49866637,N1-Protonated adenosine-5'-monophosphate,AMP(1+)|N1-PROTONATED ADENOSINE-5'-MONOPHOSPHATE|adenosine 5'-monophosphate(1+)|CHEBI:40721|Q27120405,348.230,C10H15N5O7P+,188.000,481.000,-3.300,23,6,10,4,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H4,11,12,13,18,19,20)/p+1/t4-,6-,7-,10-/m1/s1",C1=[N+](C2=NC=NC(=C2N1)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,UBYZUTJNKIGNJS-KQYNXXCUSA-O,"[(2R,3S,4R,5R)-5-(6-amino-7H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20110217,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Protein Data Bank in Europe (PDBe)|Wikidata",Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
52922023,"9Z,12Z-Octadecadienoyl-CoA","9Z,12Z-octadecadienoyl-CoA|Coenzyme A, S-9,12-octadecadienoate, (Z,Z)|linoleoyl-coenzyme A, (E,E)-isomer|linoleoyl-coenzyme A, (E,Z)-isomer|linoleoyl-coenzyme A, (Z,Z)-isomer|linoleoyl-coenzyme A, octadecadienoate-1-(14)C-labeled, (Z,Z)-isomer|CoA(18:2(9Z,12Z))",1030.000,C39H66N7O17P3S,389.000,1750.000,1.100,67,9,22,34,"InChI=1S/C39H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h8-9,11-12,26-28,32-34,38,49-50H,4-7,10,13-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/b9-8-,12-11-/t28-,32?,33?,34+,38-/m1/s1",CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1C(C([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,YECLLIMZHNYFCK-YGAJQYQWSA-N,"S-[2-[3-[[(2R)-4-[[[(2R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (9Z,12Z)-octadeca-9,12-dienethioate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20110609,Comparative Toxicogenomics Database (CTD)|Human Metabolome Database (HMDB)|MetabolomicsWorkbench,Curation Efforts|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53262285,4-Hydroxy-2-oxoglutarate(1-),4-hydroxy-2-oxoglutarate(1-)|2-oxo-4-hydroxyglutarate(1-)|2-keto-4-hydroxyglutarate(1-)|4-hydroxy-2-ketoglutarate(1-)|CHEBI:36148|hydrogen 2-hydroxy-4-oxopentanedioate|Q27116716,161.090,C5H5O6-,118.000,184.000,NULL,11,2,6,2,"InChI=1S/C5H6O6/c6-2(4(8)9)1-3(7)5(10)11/h2,6H,1H2,(H,8,9)(H,10,11)/p-1",[H+].C(C(C(=O)[O-])O)C(=O)C(=O)[O-],WXSKVKPSMAHCSG-UHFFFAOYSA-M,hydron;2-hydroxy-4-oxopentanedioate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20110801,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
53477853,"beta-1,4-Mannose-N-acetylglucosamine","Beta-1,4-mannose-N-acetylglucosamine|Man(a1-4)b-GlcNAc|CHEBI:150430|alpha-D-Manp-(1->4)-beta-D-GlcpNAc|2-acetamido-2-deoxy-4-O-alpha-D-mannopyranosyl-beta-D-glucopyranose|alpha-D-manno-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranose|WURCS=2.0/2,2,1/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1a_1-5]/1-2/a4-b1|N-[(2R,3R,4R,5S,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-3-yl]acetamide",383.350,C14H25NO11,198.000,480.000,-4.700,26,8,11,5,"InChI=1S/C14H25NO11/c1-4(18)15-7-9(20)12(6(3-17)24-13(7)23)26-14-11(22)10(21)8(19)5(2-16)25-14/h5-14,16-17,19-23H,2-3H2,1H3,(H,15,18)/t5-,6-,7-,8-,9-,10+,11+,12-,13-,14-/m1/s1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O[C@@H]2[C@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,KFEUJDWYNGMDBV-MMOUBBDDSA-N,"N-[(2R,3R,4R,5S,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20111109,ChEBI|GlyTouCan Project|Google Patents|Human Metabolome Database (HMDB)|MetabolomicsWorkbench,Curation Efforts|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
70678861,S-Adenosyl-L-homocysteinate,S-adenosyl-L-homocysteinate|CHEBI:67009|J3.515.842A|(S)-2-Amino-4-(5'-adenosylthio)butyric acid anion|Q27135572|5'-S-[(3S)-3-amino-3-carboxylatopropyl]-5'-thioadenosine,383.410,C14H19N6O5S-,211.000,499.000,-2.900,26,4,11,6,"InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/p-1/t6-,7+,9+,10+,13+/m0/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CSCC[C@@H](C(=O)[O-])N)O)O)N,ZJUKTBDSGOFHSH-WFMPWKQPSA-M,"(2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]butanoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20121212,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|Wikidata",Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
72193709,2''-O-Acetyl-ADP-D-ribose,"OAADPr|O-Acetyl-ADP-Ribose|2''-O-acetyl-ADP-D-ribose|2'-O-acetyl-ADP-ribose|2''-O-acetyl-ADP-ribose|AADPR|AC1MMT9E|O-acetyl-ADP ribose|2'-O-ACETYL ADENOSINE-5-DIPHOSPHORIBOSE|2'-OAADPr|2'-O-AADPR|GTPL6333|CHEBI:76279|C20658|adenosine 5'-[3-(2-O-acetyl-D-ribofuranos-5-O-yl) dihydrogen diphosphate]|[(3R,4R,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2,4-dihydroxyoxolan-3-yl] acetate",601.400,C17H25N5O15P2,298.000,983.000,-5.600,39,7,19,11,"InChI=1S/C17H25N5O15P2/c1-6(23)34-13-11(25)8(36-17(13)27)3-33-39(30,31)37-38(28,29)32-2-7-10(24)12(26)16(35-7)22-5-21-9-14(18)19-4-20-15(9)22/h4-5,7-8,10-13,16-17,24-27H,2-3H2,1H3,(H,28,29)(H,30,31)(H2,18,19,20)/t7-,8-,10-,11-,12-,13-,16-,17?/m1/s1",CC(=O)O[C@@H]1[C@@H]([C@H](OC1O)COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)O,BFNOPXRXIQJDHO-YDKGJHSESA-N,"[(3R,4R,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2,4-dihydroxyoxolan-3-yl] acetate",O-Acetyl-ADP-Ribose,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,1346628,20131210,"BioCyc|Biosynth Carbosynth|ChEBI|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|NextMove Software|Therapeutic Target Database (TTD)|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
73242173,5-Epi-Leukotriene A4,"5-epi-Leukotriene A4|5-epi-LTA4|5R,6S-epoxy-7E,9E,11Z,14Z-eicosatetraenoic acid|LMFA03020038",318.400,C20H30O3,49.800,432.000,5.300,23,1,3,13,"InChI=1S/C20H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-19(23-18)16-14-17-20(21)22/h6-7,9-13,15,18-19H,2-5,8,14,16-17H2,1H3,(H,21,22)/b7-6-,10-9-,12-11+,15-13+/t18-,19+/m0/s1",CCCCC/C=C\\C/C=C\\C=C\\C=C\\[C@H]1[C@H](O1)CCCC(=O)O,UFPQIRYSPUYQHK-XWYPZHSRSA-N,"4-[(2R,3S)-3-[(1E,3E,5Z,8Z)-tetradeca-1,3,5,8-tetraenyl]oxiran-2-yl]butanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Pharmacology and Biochemistry|Use and Manufacturing,5,NULL,20140319,BioCyc|LIPID MAPS|MetabolomicsWorkbench,Curation Efforts|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
86289309,5-Amino-1-(5-phosphonato-D-ribosyl)imidazolium-4-carboxylate(2-),5-amino-1-(5-phosphonato-D-ribosyl)imidazolium-4-carboxylate(2-)|CHEBI:77657|Q27147250|5-amino-1-(5-O-phosphonato-beta-D-ribofuranosyl)-1H-imidazol-3-ium-4-carboxylate,337.180,C9H12N3O9P-2,203.000,462.000,-3.300,22,4,11,4,"InChI=1S/C9H14N3O9P/c10-7-4(9(15)16)11-2-12(7)8-6(14)5(13)3(21-8)1-20-22(17,18)19/h2-3,5-6,8,13-14H,1,10H2,(H,15,16)(H2,17,18,19)/p-2/t3-,5-,6-,8-/m1/s1",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])[O-])O)O)N)C(=O)O,XFVULMDJZXYMSG-ZIYNGMLESA-L,"[(2R,3S,4R,5R)-5-(5-amino-4-carboxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20141218,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
131750429,"S-[2-[3-[[(2R)-4-[[[(2R,4S,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 4-hydroxybenzenecarbothioate",NULL,887.600,C28H40N7O18P3S,409.000,1540.000,-4.300,57,10,23,21,"InChI=1S/C28H40N7O18P3S/c1-28(2,22(39)25(40)31-8-7-18(37)30-9-10-57-27(41)15-3-5-16(36)6-4-15)12-50-56(47,48)53-55(45,46)49-11-17-21(52-54(42,43)44)20(38)26(51-17)35-14-34-19-23(29)32-13-33-24(19)35/h3-6,13-14,17,20-22,26,36,38-39H,7-12H2,1-2H3,(H,30,37)(H,31,40)(H,45,46)(H,47,48)(H2,29,32,33)(H2,42,43,44)/t17-,20+,21?,22+,26-/m1/s1",CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1C([C@@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)[C@H](C(=O)NCCC(=O)NCCSC(=O)C4=CC=C(C=C4)O)O,LTVXPVBFJBTNIJ-LLXKUOMWSA-N,"S-[2-[3-[[(2R)-4-[[[(2R,4S,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 4-hydroxybenzenecarbothioate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Pharmacology and Biochemistry,3,NULL,20171122,Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398557,2-Ammoniomuconate(1-),"2-ammoniomuconate(1-)|(2Z,4E)-2-aminomuconate|(2Z,4E)-2-aminohexa-2,4-dienedioate|CHEBI:77859|(2Z,4E)-2-ammoniohexa-2,4-dienedioate|(2Z,4E)-2-azaniumylhexa-2,4-dienedioate|Q27147467",156.120,C6H6NO4-,103.000,223.000,0.400,11,2,5,2,"InChI=1S/C6H7NO4/c7-4(6(10)11)2-1-3-5(8)9/h1-3H,7H2,(H,8,9)(H,10,11)/p-1/b3-1+,4-2-",C(=C/C(=O)O)\\C=C(\\C(=O)[O-])/N,ZRHONLCTYUYMIQ-TZFCGSKZSA-M,"(2Z,4E)-2-amino-6-hydroxy-6-oxohexa-2,4-dienoate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20190115,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398616,2'-Deoxyinosine triphosphate,"dITP|2'-Deoxyinosine triphosphate|2'-Ditp|16595-02-1|2'-Deoxyinosine-5'-triphosphate|deoxyinosine triphosphate|deoxyinosine 5'-triphosphate|2'-Deoxyinosine 5'-triphosphate|(((2R,3S,5R)-3-Hydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl)triphosphoric acid|2'-Deoxyinosine-5'-triphosphate trisodium salt|SCHEMBL245486|CHEBI:28807|DTXSID10168049|ZINC8217141|AKOS024464700|C01345|2'-deoxyinosine 5'-(tetrahydrogen triphosphate)|2'-deoxy-Inosine 5'-(tetrahydrogen triphosphate)|Inosine 5'-(tetrahydrogen",492.170,C10H15N4O13P3,249.000,849.000,-5.000,30,6,15,8,"InChI=1S/C10H15N4O13P3/c15-5-1-7(14-4-13-8-9(14)11-3-12-10(8)16)25-6(5)2-24-29(20,21)27-30(22,23)26-28(17,18)19/h3-7,15H,1-2H2,(H,20,21)(H,22,23)(H,11,12,16)(H2,17,18,19)/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=CNC3=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,UFJPAQSLHAGEBL-RRKCRQDMSA-N,"[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20190115,"A&J Pharmtech CO., LTD.|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|AN PharmaTech|AstaTech, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BioCyc|Biosynth Carbosynth|BLD Pharm|Boerchem|ChEBI|Chem-Space.com Database|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Founder Pharma|Google Patents|Hang",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398621,GDP-4-keto-6-deoxymannose,"GDP-4-keto-6-deoxymannose|GDP-4-dehydro-D-rhamnose|GDP-4-keto-6-deoxy-D-mannose|GDP-4-dehydro-6-deoxy-D-mannose|GDP-4-dehydro-6-deoxy-alpha-D-mannose|GDP-4-oxo-6-deoxy-D-mannose|GDP-4-dehydro-6-deoxy-D-talose|Guanosine diphosphate-4-keto-6-deoxy-D-mannose|18186-48-6|[[(2~{R},3~{S},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},6~{R})-6-methyl-3,4-bis(oxidanyl)-5-oxidanylidene-oxan-2-yl] hydrogen phosphate|Guanosine 5'-",587.300,C16H23N5O15P2,304.000,1080.000,-5.300,38,8,17,8,"InChI=1S/C16H23N5O15P2/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27/h3-5,8-11,14-15,23-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27)/t4-,5-,8-,9+,10-,11+,14-,15-/m1/s1",C[C@@H]1C(=O)[C@@H]([C@@H]([C@H](O1)OP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3N=C(NC4=O)N)O)O)O)O,PNHLMHWWFOPQLK-BKUUWRAGSA-N,"[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,6R)-3,4-dihydroxy-6-methyl-5-oxooxan-2-yl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20190115,"ABI Chem|BioCyc|ChEBI|ChemIDplus|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|MuseChem|NCBI Structure|NextBio|NextMove Software|NovoSeek|Protein Data Bank in Europe (PDBe)|SureChEMBL|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398631,Guanosine-5'-monophosphate,"5'-Guanylic acid|guanosine monophosphate|guanylic acid|85-32-5|guanosine-5'-monophosphate|Guanosine 5'-monophosphate|5'-Gmp|Guanosine 5'-phosphate|Guanidine monophosphate|guanylate|CHEBI:17345|GMP|guanosine-phosphate|guanosine-monophosphate|AI3-28539|UNII-16597955EP|Guanosine 5' Monophosphate|Guanosine 5'-phosphoric acid|CHEMBL283807|Guanosine 5'-(dihydrogen phosphate)|16597955EP|E 626|Polyguanylic acids|((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen p",363.220,C10H14N5O8P,202.000,598.000,-3.500,24,6,10,4,"InChI=1S/C10H14N5O8P/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21/h2-3,5-6,9,16-17H,1H2,(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N=C(NC2=O)N,RQFCJASXJCIDSX-UUOKFMHZSA-N,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",Guanosine Monophosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1811|75475|421026|421027|421028|767224|767225|767229|977610|977611|1136399|1136402|1136403|1172275|1172276|1226508|1226509|1226510,20190115,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Anward|Ark Pharm, Inc.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BIND|BindingDB|BioCyc|Bi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, PDB, Protein Data Bank]"
135409384,"5,6,7,8-Tetrahydrobiopterin","tetra-H-biopterin|tetra-hydro-biopterin|5,6,7,8-tetrahydrobiopterin|5,6,7,8-tetra-H-biopterin|(6R)-5,6,7,8-Tetrahydrobiopterin|a tetrahydrobiopterin|NCGC00160393-01|Lopac0_001167|CHEMBL270788|SCHEMBL8531437|phenylalanine hydroxylase cofactor|CHEBI:136570|17528-72-2|HSCI1_000255|CCG-205241|SDCCGSBI-0051134.P002|NCGC00162357-01|NCGC00162357-02|NCGC00162357-03|4(1H)-pteridinone, 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-, (6R)-",241.250,C9H15N5O3,132.000,405.000,-1.900,17,6,6,2,"InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3?,4-,6?/m1/s1",CC(C([C@H]1CNC2=C(N1)C(=O)NC(=N2)N)O)O,FNKQXYHWGSIFBK-NHTYNGABSA-N,"(6R)-2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,10,880|1469|1471|1479|1487|1490|1688|1766|1768|2528|2546|2551|2660|2662|2666|2667|2668|463106|485290|485295|485297|485298|485313|485342|485345|485366|485368|488772|488773|488816|488837|488949|488953|488978|488981|488982|488983|492961|493106|493107|493153|493164|504327|504332|504536|504547|504548|504749|504810|504812|504832|504834|504836|504845|504847|504865|540256|540276|588349|588378|588453|588456|588579|588795|602332|624030|624031|624032|624044|624146|624147|624148|624149|624170|624172|624173|624296|624297|6,20190115,"ABI Chem|BIND|BioCyc|Burnham Center for Chemical Genomics|Calbiochem|Center for Chemical Genomics, University of Michigan|ChEBI|ChemBank|ChEMBL|chemical genetic matrix|ChemSpider|Circadian Research, Kay Laboratory, University of California at San Diego (UCSD)|EMD Millipore|Emory University Molecular Libraries Screening Center|Gulick Lab, Department of Structural Biology, University at Buffalo|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dictionary (Nikkaji)|Milwaukee Ins",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135761165,Folate(2-),"folate(2-)|CHEBI:62501|Q27131961|N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamate(2-)",439.400,C19H17N7O6-2,215.000,756.000,0.200,32,4,10,7,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/p-2/t12-/m0/s1",C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-])NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,OVBPIULPVIDEAO-LBPRGKRZSA-L,(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20190117,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|PATENTSCOPE (WIPO)|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135874855,Deoxyinosine diphosphate,Didp|deoxyinosine diphosphate|2'-deoxyinosine-5'-diphosphate(3-)|dIDP(3-)|CHEBI:62286|2'-deoxyinosine 5'-diphosphate(3-)|2'-deoxy-5'-O-[(phosphonatooxy)phosphinato]inosine|Q27131745,409.160,C10H11N4O10P2-3,211.000,665.000,-4.200,26,2,12,5,"InChI=1S/C10H14N4O10P2/c15-5-1-7(14-4-13-8-9(14)11-3-12-10(8)16)23-6(5)2-22-26(20,21)24-25(17,18)19/h3-7,15H,1-2H2,(H,20,21)(H,11,12,16)(H2,17,18,19)/p-3/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=CNC3=O)COP(=O)([O-])OP(=O)([O-])[O-])O,BKUSIKGSPSFQAC-RRKCRQDMSA-K,"[[(2R,3S,5R)-3-hydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20190118,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
136181831,GDP-L-fucose(2-),"GDP-L-fucose(2-)|GDP-L-fucose|guanosine diphosphate fucose|GDP-L-fucose dianion|CHEBI:57984|Q27125099|guanosine 5'-(trihydrogen diphosphate), P'-(6-deoxy-beta-L- galactopyranosyl) ester|2-amino-9-[3,4-dihydroxy-5-[[hydroxy-[hydroxy-(3,4,5-trihydroxy- 6-methyl-tetrahydropyran-2-yl)oxy-phosphinoyl]oxy-phosphinoyl] oxymethyl]tetrahydrofuran-2-yl]-1,9-dihydropurin-6-one",587.300,C16H23N5O15P2-2,313.000,1020.000,-5.900,38,7,17,8,"InChI=1S/C16H25N5O15P2/c1-4-7(22)9(24)11(26)15(33-4)35-38(30,31)36-37(28,29)32-2-5-8(23)10(25)14(34-5)21-3-18-6-12(21)19-16(17)20-13(6)27/h3-5,7-11,14-15,22-26H,2H2,1H3,(H,28,29)(H,30,31)(H3,17,19,20,27)/p-2/t4-,5+,7+,8+,9+,10+,11-,14+,15?/m0/s1",C[C@H]1[C@H]([C@H]([C@@H](C(O1)OP(=O)([O-])OP(=O)([O-])OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3N=C(NC4=O)N)O)O)O)O)O,LQEBEXMHBLQMDB-QIXZNPMTSA-L,"[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl] phosphate",Guanosine Diphosphate Fucose,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20190121,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5280353,Biliverdin,"biliverdin|biliverdine|Biliverdin IX alpha|Biliverdine Ix Alpha|uteroverdine|UNII-O9MIA842K9|dehydrobilirubin|Oocyan|114-25-0|O9MIA842K9|CHEBI:17033|3-[(2Z,5Z)-2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid|Biliverdin IX|21H-Biline-8,12-dipropanoic acid, 3,18-diethenyl-1,19,22,24-tetrahydro-2,7,13,17-tetramethyl-1,19-dioxo-|8,12-bis(2-carboxyethyl)-2,7",582.600,C33H34N4O6,161.000,1530.000,2.500,43,5,7,11,"InChI=1S/C33H34N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h7-8,13-15,34-35H,1-2,9-12H2,3-6H3,(H,37,42)(H,38,39)(H,40,41)/b24-13-,27-14-,28-15-",CC\\1=C(/C(=C/C2=C(C(=C(N2)/C=C\\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/N/C1=C\\C4=NC(=O)C(=C4C)C=C)CCC(=O)O,RCNSAJSGRJSBKK-NSQVQWHSSA-N,"3-[(2Z,5Z)-2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid",Biliverdine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,10,381952|381953|381954|381955|381958|381959|596686|596688|596689|596694|596695|596697|596700|596701|596702|596778|624606|1070902|1070904|1070905|1070906|1070908|1070909|1070911,20040916,"ABI Chem|AHH Chemical co.,ltd|Alfa Chemistry|BenchChem|BioCyc|BOC Sciences|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Comparative Toxicogenomics Database (CTD)|DrugBank|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|KEGG|MassBank Europe|MassBank of North America (MoNA)|MetabolomicsWorkbench|NextBio|NIST Mass Spectrometry Data Center|NovoSeek|Protein Data Bank in Europe (PDBe)|Sigma-Aldrich|SMID|Springer Nature|SureChEMBL|THE BioTe",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
998,Phenylacetaldehyde,"phenylacetaldehyde|2-phenylacetaldehyde|122-78-1|Benzeneacetaldehyde|Hyacinthin|Phenylethanal|alpha-Tolualdehyde|2-Phenylethanal|Phenylacetic aldehyde|alpha-Toluic aldehyde|Oxophenylethane|Acetaldehyde, phenyl-|Benzylcarboxaldehyde|1-Oxo-2-phenylethane|Phenacetaldehyde|phenyl acetaldehyde|phenyl-Acetaldehyde|Benzenacetaldehyde|UNII-U8J5PLW9MR|Phenylacetaldehyde (natural)|.alpha.-Tolualdehyde|Acetaldehyde, phenyl- (8CI)|alpha-Phenylacetaldehyde|FEMA No. 2974|Benzacetaldehyde|NSC 406309|.alpha.-Toluic aldehyd",120.150,C8H8O,17.100,82.600,1.800,9,0,1,2,"InChI=1S/C8H8O/c9-7-6-8-4-2-1-3-5-8/h1-5,7H,6H2",C1=CC=C(C=C1)CC=O,DTUQWGWMVIHBKE-UHFFFAOYSA-N,2-phenylacetaldehyde,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,13,1201|651631|651632|651633|651634|720516|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemica|Achemtek|Acros Organics|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|AN PharmaTech|Angene Chemical|Anward|Aurora Fine Chemicals LLC|BioCrick|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BOC Sciences|Boerchem|CAPOT|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
2966,Debrisoquine,"Debrisoquine|Debrisoquin|1131-64-2|Debrisochinum|Isocaramidine|3,4-dihydroisoquinoline-2(1H)-carboximidamide|Debrisoquina|Debrisoquinum|DEBRISOQUIN SULFATE|Declinax|Equitonil|2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-|Isocaramidine sulfate|Debrisoquin hemisulfate|UNII-X31CDK040E|3,4-Dihydro-2(1H)-isoquinolinecarboxamidine|3,4-Dihydro-2(1H)-isoquinolinecarboximidamide|Debrisoquine; Isocaramidine|CHEMBL169901|X31CDK040E|3,4-dihydro-1H-isoquinoline-2-carboximidamide|CHEBI:34665|2(1H)-Isoquinolinecarboximi",175.230,C10H13N3,53.100,202.000,0.800,13,2,1,1,"InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12)",C1CN(CC2=CC=CC=C21)C(=N)N,JWPGJSVJDAJRLW-UHFFFAOYSA-N,"3,4-dihydro-1H-isoquinoline-2-carboximidamide",Debrisoquin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,10,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|995|1030|1195|1332|1379|1452|1454|1457|1458|1467|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1851|1865|1948|2101|2107|2112|2147|2451|2472|2528|2546|2549|2551|2662|54562|54564|54565|54566|54570|352980|352981|352982|352983|409954|409956|485281|485290|492961|496817|496818|496819,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alinda Chemical|Ambinter|Angene Chemical|AOBIOUS INC|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BIND|BindingDB|BioChemPartner|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemB",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
65110,AICA ribonucleotide,AICA ribonucleotide|Z-nucleotide|3031-94-5|5-amino-4-imidazolecarboxamide ribotide|5'-Phosphoribosyl-5-amino-4-imidazolecarboxamide|UNII-F0X88YW0YK|Acadesine 5'-monophosphate|AICA-ribonucleotide|1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide|5-Amino-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazole-4-carboxamide|5-Amino-4-imidazole carboxamide ribonucleotide|aminoimidazole carboxamide ribonucleotide|5-Aminoimidazole-4-carboxamide ribotide|F0X88YW0YK|CHEMBL483849|5-Amino-4-imidazolecarboxamide ribonu,338.210,C9H15N4O8P,203.000,475.000,-3.800,22,6,10,5,"InChI=1S/C9H15N4O8P/c10-7-4(8(11)16)12-2-13(7)9-6(15)5(14)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,14-15H,1,10H2,(H2,11,16)(H2,17,18,19)/t3-,5-,6-,9-/m1/s1",C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)C(=O)N,NOTGFIUVDGNKRI-UUOKFMHZSA-N,"[(2R,3S,4R,5R)-5-(5-amino-4-carbamoylimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,31299|92595|92597|152713|275002|275003|275004|275005|275006|275007|275008|275009|275010|275011|275012|275013|275014|275015|275016|275017|354019|354022|360486|381560|389354|509612|509613|580979|580980|580981|741697|741698|741699|741701|741702|741703|741704|741705|741706|741708|741710|741711|741712|741713|741714|741718|741719|741720|741721|741722|741723|741725|741726|741728|741729|741731|741735|741736|741737|741738|741739|741740|741741|741742|741744|741745|741748|741750|741751|741752|741753|741754|741757|7417,20040916,"A2B Chem|AA BLOCKS|ABI Chem|Alsachim|Apexmol|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|Biosynth Carbosynth|CCSbase|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DC Chemicals|DiscoveryGate|DrugBank|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikka",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
123814,Angiotensin IV,"Angiotensin IV|Nle-angiv|Human angiotensin IV|Ile3-angiotensin IV|23025-68-5|Angiotensin II (3-8), human|ANGIOTENSIN I/II (3-8)|Huamn angiotensin (3-8)|VAL-TYR-ILE-HIS-PRO-PHE|1-De-asp-2-de-arg-5-ile-angiotensin II|(Ile5)-angiotensin II (3-8)|(3-8)-5-Isoleucine-angiotensin II|Human angiotensin hexapeptide (3-8)|(Des(Asp1,Arg2)-Ile5)angiotensin II|(Isoleucine5)-angiotensin II hexapeptide|CHEMBL261120|5-Isoleucine-angiotensin II 3-8-hexapeptide|12676-15-2|(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-",774.900,C40H54N8O8,249.000,1340.000,0.900,56,8,10,19,"InChI=1S/C40H54N8O8/c1-5-24(4)34(47-35(50)29(44-37(52)33(41)23(2)3)18-26-13-15-28(49)16-14-26)38(53)45-30(20-27-21-42-22-43-27)39(54)48-17-9-12-32(48)36(51)46-31(40(55)56)19-25-10-7-6-8-11-25/h6-8,10-11,13-16,21-24,29-34,49H,5,9,12,17-20,41H2,1-4H3,(H,42,43)(H,44,52)(H,45,53)(H,46,51)(H,47,50)(H,55,56)/t24-,29-,30-,31-,32-,33-,34-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)N,QSBGWDDCOJYQGY-KOQODJNWSA-N,"(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,485|631|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1,20050808,"3B Scientific (Wuhan) Corp|AA BLOCKS|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Alfa Chemistry|Aurora Fine Chemicals LLC|BindingDB|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Google Patents|Human Metabolome Database (HMDB)|ICCB-Longwood Scr",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
164550,Oxalacetate,"oxalacetate|2-oxobutanedioate|Oxobutanedioate|oxaloacetate(2-)|oxosuccinate|keto-oxaloacetate|149-63-3|Butanedioic acid, oxo-, ion(2-)|oxaloacetate dianion|3p4q|oxobutanedioic acid, ion(2-)|CHEBI:16452|Q27101912",130.060,C4H2O5-2,97.300,147.000,0.700,9,0,5,1,"InChI=1S/C4H4O5/c5-2(4(8)9)1-3(6)7/h1H2,(H,6,7)(H,8,9)/p-2",C(C(=O)C(=O)[O-])C(=O)[O-],KHPXUQMNIQBQEV-UHFFFAOYSA-L,2-oxobutanedioate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,977610,20050711,"A&J Pharmtech CO., LTD.|AAA Chemistry|ABI Chem|BioCyc|ChEBI|ChemIDplus|ChemSpider|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|MuseChem|NextBio|NextMove Software|NovoSeek|Shanghai Institute of Organic Chemistry|Smolecule|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata|WikiPathways|Wiley",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
644102,Pyrophosphate ion,"Pyrophosphate ion|14000-31-8|UNII-X3SSV2V6L3|pyrophosphate anion|Diphosphate(4-)|X3SSV2V6L3|phosphonato phosphate|Diphosphates|diphospate|Diphosphat|Pyrophosphat|Pyrophosphate(4-)|2o1c|mu-oxo-hexaoxodiphosphate|Phosphate (P2O74-)|Diphosphate (P2O74-)|Diphosphoric acid tetraanion|Pyrophosphate (P2O74-)|diphosphoric acid, ion(4-)|DTXSID4074514|CHEBI:18361|3c14|[O3POPO3](4-)|BDBM50278316|mu-oxido-bis(trioxidophosphate)(4-)|P2O7(4-)|Q290828|DF048DC2-F386-4F01-8876-FD4CD8DE4A9F",173.940,O7P2-4,136.000,124.000,-3.500,9,0,7,0,"InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-4",[O-]P(=O)([O-])OP(=O)([O-])[O-],XPPKVPWEQAFLFU-UHFFFAOYSA-J,phosphonato phosphate,Diphosphates,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active,9,977610,20040916,"001Chemical|ABI Chem|BIND|BindingDB|ChEBI|Chembase.cn|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|EPA Substance Registry Services|FDA/SPL Indexing Data|Golm Metabolome Database (GMD), Max Planck Institute of Molecular Plant Physiology|Google Patents|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|MassBank of North",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3985862,Tryptaminium,"tryptaminium|2-(1H-indol-3-yl)ethylazanium|2pql|3atm|3rxi|tryptaminium cation|tryptaminium(1+)|Tryptamine, 15|4ge1|1H-Indole-3-(ethanaminium)|2-(1H-indol-3-yl)ethanaminium|BDBM92693|CHEBI:57887|2-(1H-indol-3-yl)ethylammonium|A822216|Q27125029",161.220,C10H13N2+,43.400,147.000,1.600,12,2,0,2,"InChI=1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2/p+1",C1=CC=C2C(=C1)C(=CN2)CC[NH3+],APJYDQYYACXCRM-UHFFFAOYSA-O,2-(1H-indol-3-yl)ethylazanium,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,1811|977608|977611,20050912,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|BindingDB|BioCyc|ChEBI|ChemDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|NextBio|NMRShiftDB|PATENTSCOPE (WIPO)|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
4097574,[Hydroxy(oxido)phosphoryl] phosphate,diphosphate(3-)|hydrogen diphosphate|diphosphate(3-) anion|[hydroxy(oxido)phosphoryl] phosphate|HP2O7(3-)|CHEBI:33019|a pyrophosphate group|DTXSID60399285|BDBM50079022|[oxidanidyl(oxidanyl)phosphoryl] phosphate|42499-21-8|Oxylatophosphonyloxyphosphonic acid dianion|A817426|Q27115222,174.950,HO7P2-3,133.000,154.000,-3.400,9,1,7,1,"InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-3",OP(=O)([O-])OP(=O)([O-])[O-],XPPKVPWEQAFLFU-UHFFFAOYSA-K,[hydroxy(oxido)phosphoryl] phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"ABI Chem|Amadis Chemical|BindingDB|BioCyc|ChEBI|ChemDB|ChemSpider|ChemTik|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|Nature Chemical Biology|NextBio|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5459862,D-Erythrose 4-phosphate(2-),"D-erythrose 4-phosphate(2-)|CHEBI:16897|4-O-phosphonato-D-erythrose|DTXSID40974054|2,3-Dihydroxy-4-oxobutyl phosphate|(2R,3R)-2,3-dihydroxy-4-oxobutyl phosphate|Q2520005",198.070,C4H7O7P-2,130.000,174.000,-3.500,12,2,7,4,"InChI=1S/C4H9O7P/c5-1-3(6)4(7)2-11-12(8,9)10/h1,3-4,6-7H,2H2,(H2,8,9,10)/p-2/t3-,4+/m0/s1",C([C@H]([C@H](C=O)O)O)OP(=O)([O-])[O-],NGHMDNPXVRFFGS-IUYQGCFVSA-L,"[(2R,3R)-2,3-dihydroxy-4-oxobutyl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20040916,"ABI Chem|BioCyc|ChEBI|Chembase.cn|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|NextBio|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5460326,Lipoate,"lipoate|6,8-thioctate|liponate|thioctate|6-thioctate|6-thiotate|6,8-thiotate|1,2-dithiolane-3-valerate|5-(dithiolan-3-yl)valerate|1,2-dithiolane-3-pentanoate|CHEBI:30313|5-(1,2-dithiolan-3-yl)valerate|5-(1,2-dithiolan-3-yl)pentanoate|5-[1,2]Dithiolan-3-yl-pentanoate|5-[3-(1,2-dithiolanyl)]pentanoate|5-(1,2-Dithiolane-3-yl)valeric acidanion|Q27104127",205.300,C8H13O2S2-,90.700,145.000,2.300,12,0,4,4,"InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/p-1",C1CSSC1CCCCC(=O)[O-],AGBQKNBQESQNJD-UHFFFAOYSA-M,5-(dithiolan-3-yl)pentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"ABI Chem|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6971254,N-Carbamoyl-beta-alaninate,N-carbamoyl-beta-alaninate|3-(carbamoylamino)propanoate|ureidopropanoate|3-[(aminocarbonyl)amino]propanoate|N-carbamoyl-  -alaninate|CHEBI:11892|Q27108902,131.110,C4H7N2O3-,95.200,118.000,-0.900,9,2,3,2,"InChI=1S/C4H8N2O3/c5-4(9)6-2-1-3(7)8/h1-2H2,(H,7,8)(H3,5,6,9)/p-1",C(CNC(=O)N)C(=O)[O-],JSJWCHRYRHKBBW-UHFFFAOYSA-M,3-(carbamoylamino)propanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20060728,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6992102,Acetylornithine,acetylornithine|(2S)-2-acetamido-5-azaniumylpentanoate|N(2)-acetyl-L-ornithine zwitterion|N2-acetyl-ornithine|N-acetyl-L-ornithine|N-alpha-acetylornithine|CHEBI:57805|(2S)-2-acetamido-5-ammoniopentanoate,174.200,C7H14N2O3,96.900,165.000,-4.200,12,2,3,4,"InChI=1S/C7H14N2O3/c1-5(10)9-6(7(11)12)3-2-4-8/h6H,2-4,8H2,1H3,(H,9,10)(H,11,12)/t6-/m0/s1",CC(=O)N[C@@H](CCC[NH3+])C(=O)[O-],JRLGPAXAGHMNOL-LURJTMIESA-N,(2S)-2-acetamido-5-azaniumylpentanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20060728,BioCyc|ChEBI|DiscoveryGate|Google Patents|NextBio|Smolecule|THE BioTek,Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7059430,L-gamma-Glutamyl-L-cysteinate(1-),L-gamma-glutamyl-L-cysteinate(1-)|gamma-L-glutamylcysteine|L-gamma-glutamyl-L-cysteinate|CHEBI:58173|L-  -glutamyl-L-cysteinate(1-)|L-gamma-glutamyl-L-cysteinate anion|Q27125421|(2S)-2-azaniumyl-5-{[(1R)-1-carboxylato-2-sulfanylethyl]amino}-5-oxopentanoate,249.270,C8H13N2O5S-,138.000,273.000,-2.500,16,3,6,5,"InChI=1S/C8H14N2O5S/c9-4(7(12)13)1-2-6(11)10-5(3-16)8(14)15/h4-5,16H,1-3,9H2,(H,10,11)(H,12,13)(H,14,15)/p-1/t4-,5-/m0/s1",C(CC(=O)N[C@@H](CS)C(=O)[O-])[C@@H](C(=O)[O-])[NH3+],RITKHVBHSGLULN-WHFBIAKZSA-M,(2S)-2-azaniumyl-5-[[(1R)-1-carboxylato-2-sulfanylethyl]amino]-5-oxopentanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060729,"ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9543238,4-Oxobutanoate,"4-Oxobutanoate|succinate semialdehyde|succ-S-ald|4-Oxobutyric acid|semialdehyde succinique|Succinic semialdehyde solution|Butanoic acid, 4-oxo- (9CI)|Semi-aldehyde succinique [French]|BRN 1745187|C00232|4-03-00-01554 (Beilstein Handbook Reference)|4-oxobutyrate|succinyl semialdehyde|4-oxidanylidenebutanoate|Butanoic acid, 4-oxo-|Succinic semialdehyde monomer|S1505_SIGMA|GTPL6608|14075_FLUKA|CHEBI:57706|c0311|LS-147265|C02127|A836403|Q27073958",101.080,C4H5O3-,57.200,71.500,-0.200,7,0,3,2,"InChI=1S/C4H6O3/c5-3-1-2-4(6)7/h3H,1-2H2,(H,6,7)/p-1",C(CC(=O)[O-])C=O,UIUJIQZEACWQSV-UHFFFAOYSA-M,4-oxobutanoate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060802,"A&J Pharmtech CO., LTD.|Amadis Chemical|BioCyc|ChEBI|ChemSpider|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Therapeutic Target Database (TTD)|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
9548902,Taurochenodeoxycholate anion,"taurochenodeoxycholate anion|taurochenodeoxycholate(1-)|CHEBI:9407|Q27089379|N-(3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl)taurine|2-[(3alpha,7alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate",498.700,C26H44NO6S-,135.000,845.000,3.500,34,3,6,6,"InChI=1S/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/p-1/t16-,17+,18-,19-,20+,21+,22-,24+,25+,26-/m1/s1",C[C@H](CCC(=O)NCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,BHTRKEVKTKCXOH-BJLOMENOSA-M,"2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20061004,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Wikidata|WikiPathways",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15938966,3'-O-Phosphonatoadenosine,"3'-AMP(2-)|3'-adenylate|nchembio867-comp6|3'-O-phosphonatoadenosine|adenine-3'-monophosphate (2-)|CHEBI:60880|VA10158|A840743|Q27129356|ADENOSINE 3 inverted exclamation marka-MONOPHOSPHATE FROM YEAST|[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl] phosphate|[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-oxidanyl-oxolan-3-yl] phosphate",345.210,C10H12N5O7P-2,192.000,469.000,-2.900,23,3,11,3,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(17)7(4(1-16)21-10)22-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/p-2/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])[O-])O)N,LNQVTSROQXJCDD-KQYNXXCUSA-L,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20070215,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|Advanced Technology & Industrial Co., Ltd.|Amadis Chemical|BioCyc|ChEBI|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|NextBio|PATENTSCOPE (WIPO)|Springer Nature|ToxPlanet|Vesino Industrial Co., Ltd|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
15983958,delta-Prenyl diphosphate,dimethylallyl-PP|di-CH3-allyl-PPi|prenyl diphosphate(3-)|prenyl diphosphate trianion|delta-Prenyl diphosphate|prenyl-diphosphate|dimethylallylpyrophosphate|delta2-isopentenyl-diphosphate|DPP|prenyl pyrophosphate trianion|polycis-polyprenyl diphosphate|GTPL3049|CHEBI:57623|CHEBI:58914|CHEBI:83374|an all-trans-polyprenyl diphosphate|Dimethylallyl pyrophosphate trianion|3-methylbut-2-en-1-yl diphosphate|all-cis-polyprenyl diphosphate(3-)|poly-cis-polyprenyl diphosphate(3-)|all-trans-polyprenyl diphosphate(3-)|,243.070,C5H9O7P2-3,122.000,279.000,-1.400,14,0,7,4,"InChI=1S/C5H12O7P2/c1-5(2)3-4-11-14(9,10)12-13(6,7)8/h3H,4H2,1-2H3,(H,9,10)(H2,6,7,8)/p-3",CC(=CCOP(=O)([O-])OP(=O)([O-])[O-])C,CBIDRCWHNCKSTO-UHFFFAOYSA-K,[3-methylbut-2-enoxy(oxido)phosphoryl] phosphate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,1346823,20070325,"BioCyc|ChEBI|ChemSpider|ChemTik|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Nature Chemical Biology|NextMove Software|PATENTSCOPE (WIPO)|Springer Nature|Therapeutic Target Database (TTD)|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16213286,"Citric acid-2,2,4,4-d4","Citric acid-2,2,4,4-d4|citric acid-d4|147664-83-3|1,1,3,3-tetradeuterio-2-hydroxypropane-1,2,3-tricarboxylic acid|Citric-2,2,4,4-d4 acid|SCHEMBL1331787|CHEBI:76049|DTXSID20583845|AKOS030241841|2-hydroxy((2)H4)propane-1,2,3-tricarboxylic acid|J-008383|2-Hydroxy(~2~H_4_)propane-1,2,3-tricarboxylic acid|Q27145700|Citric acid-2,2,4,4-d4, 98 atom % D, 98% (CP)|1,2,3-Propane-1,1,3,3-d4-tricarboxylic acid, 2-hydroxy- (9CI)",196.150,C6H8O7,132.000,227.000,-1.700,13,4,7,5,"InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/i1D2,2D2",[2H]C([2H])(C(=O)O)C(C(=O)O)(C([2H])([2H])C(=O)O)O,KRKNYBCHXYNGOX-LNLMKGTHSA-N,"1,1,3,3-tetradeuterio-2-hydroxypropane-1,2,3-tricarboxylic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,7,NULL,20070712,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Biocore|Biosynth Carbosynth|BOC Sciences|ChEBI|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Clearsynth|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|LabNetwork, a WuXi AppTec Company|MolPort|MuseChem|PATENTSCOPE (WIPO)|Sigma-Aldrich|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
19379894,Geranyl diphosphate(3-),"geranyl diphosphate(3-)|geranyl-diphosphate|geranyl-pyrophosphate|(E)-3,7-dimethylocta-2,6-dien-1-yl diphosphate|GPP|(2E)-geranyl diphosphate|omega,E-geranyl diphosphate|CHEBI:58057|(2E)-3,7-dimethylocta-2,6-dien-1-yl diphosphate|Q27125155",311.180,C10H17O7P2-3,122.000,411.000,0.500,19,0,7,7,"InChI=1S/C10H20O7P2/c1-9(2)5-4-6-10(3)7-8-16-19(14,15)17-18(11,12)13/h5,7H,4,6,8H2,1-3H3,(H,14,15)(H2,11,12,13)/p-3/b10-7+",CC(=CCC/C(=C/COP(=O)([O-])OP(=O)([O-])[O-])/C)C,GVVPGTZRZFNKDS-JXMROGBWSA-K,"[[(2E)-3,7-dimethylocta-2,6-dienoxy]-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071204,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|NextMove Software|Paragos|PATENTSCOPE (WIPO)|Springer Nature|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
20848918,5-Phosphoribosyl 1-pyrophosphate,5-O-phosphonato-alpha-D-ribofuranosyl diphosphate(5-)|5-Phosphoribosyl 1-pyrophosphate|5-phosphoribosyl-1-pyrophosphate|13270-65-0|3dkj|5-phosphoribosyl-PP|5-phosphonatoribosyl 1-pyrophosphate|3c2f|5-phosphoribosyl-1-PP|alpha-D-5-P-RibosylPP|alpha-D-5-phosphoribosylPP|5-phosphoribosylpyrophosphate|5-phospho-ribosyl-pyrophosphate|CHEBI:58017|DTXSID50927778|5-O-phosphonato-alpha-D-ribofuranosyl diphosphate pentaanion|5-O-phosphonato-  -D-ribofuranosyl diphosphate(5-)|Q27125125|5-O-Phosphonato-1-O-[(phosphonat,385.030,C5H8O14P3-5,244.000,489.000,-6.200,22,2,14,5,"InChI=1S/C5H13O14P3/c6-3-2(1-16-20(8,9)10)17-5(4(3)7)18-22(14,15)19-21(11,12)13/h2-7H,1H2,(H,14,15)(H2,8,9,10)(H2,11,12,13)/p-5/t2-,3-,4-,5-/m1/s1",C([C@@H]1[C@H]([C@H]([C@H](O1)OP(=O)([O-])OP(=O)([O-])[O-])O)O)OP(=O)([O-])[O-],PQGCEDQWHSBAJP-TXICZTDVSA-I,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-[oxido(phosphonatooxy)phosphoryl]oxyoxolan-2-yl]methyl phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Prof. Malboobi, Plant Biotechnology Lab, National Institute of Genetic Engineering and Biotechnology|Shanghai Institute of Organic Chemistry|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21117974,"beta-D-Fructofuranose 2,6-bisphosphate(4-)","beta-D-fructofuranose 2,6-bisphosphate(4-)|beta-D-fructofuranose 2,6-bisphosphate|fru 2,6-P2|CHEBI:58579|2,6-di-O-phosphonato-beta-D-fructofuranose|Q27125892",336.080,C6H10O12P2-4,215.000,405.000,-5.400,20,3,12,4,"InChI=1S/C6H14O12P2/c7-2-6(18-20(13,14)15)5(9)4(8)3(17-6)1-16-19(10,11)12/h3-5,7-9H,1-2H2,(H2,10,11,12)(H2,13,14,15)/p-4/t3-,4-,5+,6+/m1/s1",C([C@@H]1[C@H]([C@@H]([C@](O1)(CO)OP(=O)([O-])[O-])O)O)OP(=O)([O-])[O-],YXWOAJXNVLXPMU-ZXXMMSQZSA-J,"[(2S,3S,4S,5R)-3,4-dihydroxy-2-(hydroxymethyl)-5-(phosphonatooxymethyl)oxolan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
22814150,Glucosyl ether,glucosyl ether|SCHEMBL375939|CHEBI:27082|Q27109935,342.300,C12H22O11,190.000,348.000,-4.200,23,8,11,4,"InChI=1S/C12H22O11/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12/h3-20H,1-2H2/t3-,4-,5-,6-,7+,8+,9-,10-,11?,12?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)OC2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)O,HDTRYLNUVZCQOY-MFAKQEFJSA-N,"(2R,3S,4S,5R)-2-(hydroxymethyl)-6-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20071205,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|GlyTouCan Project|Google Patents|IBM|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
23419734,2-Deoxy-alpha-D-ribose 1-phosphate(2-),2-deoxy-alpha-D-ribose 1-phosphate(2-)|2-deoxy-alpha-D-ribose 1-phosphate|2-deoxy-D-ribose-1-phosphate|deoxy-D-ribose 1-phosphate|CHEBI:57259|2-deoxy-  -D-ribose 1-phosphate(2-)|2-deoxy-alpha-D-erythro-pentofuranose 1-phosphate|2-deoxy-1-O-phosphonato-alpha-D-erythro-pentofuranose|Q27124379,212.090,C5H9O7P-2,122.000,201.000,-2.300,13,2,7,2,"InChI=1S/C5H11O7P/c6-2-4-3(7)1-5(11-4)12-13(8,9)10/h3-7H,1-2H2,(H2,8,9,10)/p-2/t3-,4+,5+/m0/s1",C1[C@@H]([C@H](O[C@@H]1OP(=O)([O-])[O-])CO)O,KBDKAJNTYKVSEK-VPENINKCSA-L,"[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20071206,"BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25201126,4-Hydroxyglutamate semialdehyde,"4-hydroxyglutamate semialdehyde|L-4-hydroxyglutamate semialdehyde zwitterion|CHEBI:62637|(2S,4R)-2-amino-4-hydroxy-5-oxopentanoate|(2S,4R)-2-ammonio-4-hydroxy-5-oxopentanoate|(2S,4R)-2-azaniumyl-4-hydroxy-5-oxopentanoate",147.130,C5H9NO4,105.000,130.000,-3.500,10,2,4,3,"InChI=1S/C5H9NO4/c6-4(5(9)10)1-3(8)2-7/h2-4,8H,1,6H2,(H,9,10)/t3-,4+/m1/s1",C([C@H](C=O)O)[C@@H](C(=O)[O-])[NH3+],XCXUZPXOFFRGGP-DMTCNVIQSA-N,"(2S,4R)-2-azaniumyl-4-hydroxy-5-oxopentanoate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090331,BioCyc|ChEBI|Google Patents,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25243990,N-Acetylputrescinium,N-acetylputrescinium|monoacetylputrescine|N-acetylputrescinium(1+)|N-acetylputrescinium cation|4-acetamidobutan-1-aminium|CHEBI:58263|Q27125655,131.200,C6H15N2O+,56.700,83.100,-0.700,9,2,1,4,"InChI=1S/C6H14N2O/c1-6(9)8-5-3-2-4-7/h2-5,7H2,1H3,(H,8,9)/p+1",CC(=O)NCCCC[NH3+],KLZGKIDSEJWEDW-UHFFFAOYSA-O,4-acetamidobutylazanium,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"A&J Pharmtech CO., LTD.|BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|PATENTSCOPE (WIPO)|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25244582,Myristoyl-CoA,"myristoyl-CoA(4-)|tetradecanoyl-CoA|myristoyl-CoA|n-C14:0CoA|myristoyl-CoA tetraanioni|tetradecanoyl-CoA tetraanion|myristoyl-coenzyme tetraanion|CHEBI:57385|tetradecanoyl-coenzyme A tetraanion|Q27124564|3'-phosphonatoadenosine 5'-(3-{(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[(3-oxo-3-{[2-(tetradecanoylsulfanyl)ethyl]amino}propyl)amino]butyl} diphosphate)",973.900,C35H58N7O17P3S-4,400.000,1560.000,0.300,63,5,22,31,"InChI=1S/C35H62N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-26(44)63-19-18-37-25(43)16-17-38-33(47)30(46)35(2,3)21-56-62(53,54)59-61(51,52)55-20-24-29(58-60(48,49)50)28(45)34(57-24)42-23-41-27-31(36)39-22-40-32(27)42/h22-24,28-30,34,45-46H,4-21H2,1-3H3,(H,37,43)(H,38,47)(H,51,52)(H,53,54)(H2,36,39,40)(H2,48,49,50)/p-4/t24-,28-,29-,30+,34-/m1/s1",CCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,DUAFKXOFBZQTQE-QSGBVPJFSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-tetradecanoylsulfanylethylamino)propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090514,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
42607286,9Z-Octadecenoic acid (d5),Oleic acid (d5)|9Z-octadecenoic acid (d5)|LMFA01030763,287.500,C18H34O2,37.300,234.000,6.500,20,1,2,15,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-/i1D3,2D2",[2H]C([2H])([2H])C([2H])([2H])CCCCCC/C=C\\CCCCCCCC(=O)O,ZQPPMHVWECSIRJ-JEGJVYCWSA-N,"(Z)-17,17,18,18,18-pentadeuteriooctadec-9-enoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Pharmacology and Biochemistry|Use and Manufacturing,4,NULL,20090610,"Collaborative Drug Discovery, Inc.|LIPID MAPS",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
42609798,CTP trianion,CTP(3-)|CTP trianion|cytidine 5'-triphosphate(3-)|CHEBI:58231|cytidine 5'-triphosphate trianion|Q27125631|5'-O-[({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphinato]cytidine,480.130,C9H13N3O14P3-3,277.000,836.000,-5.900,29,4,14,8,"InChI=1S/C9H16N3O14P3/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/p-3/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OP(=O)(O)[O-])O)O,PCDQPRRSZKQHHS-XVFCMESISA-K,"[[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20090619,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|Springer Nature|Therapeutic Target Database (TTD)|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266534,2-Methylcrotonoyl-CoA(4-),"2-methylcrotonoyl-CoA(4-)|2-methylbut-2-enoyl-CoA|2-methylbut-2-enoyl-CoA(4-)|tigloyl-CoA|(E)-2-Methylcrotonoyl-CoA|trans-2-methylbut-2-enoyl-CoA|3'-phosphonatoadenosine 5'-[3-(3-hydroxy-2,2-dimethyl-4-{[3-({2-[(2-methylbut-2-enoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-4-oxobutyl) diphosphate]|6247-62-7|2-METHYL-CROTONYL-COA|(E)-2-methylbut-2-enoyl-CoA|CHEBI:57260|CHEBI:57337|(2E)-2-methylbut-2-enoyl-CoA|Q27124437|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-({3-[(2-{[(2E)-2-methylbut-2-e",845.600,C26H38N7O17P3S-4,400.000,1480.000,-4.800,54,5,22,20,"InChI=1S/C26H42N7O17P3S/c1-5-14(2)25(38)54-9-8-28-16(34)6-7-29-23(37)20(36)26(3,4)11-47-53(44,45)50-52(42,43)46-10-15-19(49-51(39,40)41)18(35)24(48-15)33-13-32-17-21(27)30-12-31-22(17)33/h5,12-13,15,18-20,24,35-36H,6-11H2,1-4H3,(H,28,34)(H,29,37)(H,42,43)(H,44,45)(H2,27,30,31)(H2,39,40,41)/p-4/b14-5+/t15-,18-,19-,20+,24-/m1/s1",C/C=C(\\C)/C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,PMWATMXOQQZNBX-DKBZLLMOSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-[2-[(E)-2-methylbut-2-enoyl]sulfanylethylamino]-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|MetabolomicsWorkbench|Wikidata",Curation Efforts|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266598,Butanoyl-CoA,"butyryl-CoA(4-)|butanoyl-CoA|butyryl-CoA|Butyryl coenzyme A|butyryl-coenzyme A(4-)|butanoyl-coenzyme A(4-)|butyryl-coenzyme A tetraanion|CHEBI:57371|Q27124504|3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(butanoylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate)",833.600,C25H38N7O17P3S-4,400.000,1390.000,-5.100,53,5,22,21,"InChI=1S/C25H42N7O17P3S/c1-4-5-16(34)53-9-8-27-15(33)6-7-28-23(37)20(36)25(2,3)11-46-52(43,44)49-51(41,42)45-10-14-19(48-50(38,39)40)18(35)24(47-14)32-13-31-17-21(26)29-12-30-22(17)32/h12-14,18-20,24,35-36H,4-11H2,1-3H3,(H,27,33)(H,28,37)(H,41,42)(H,43,44)(H2,26,29,30)(H2,38,39,40)/p-4/t14-,18-,19-,20+,24-/m1/s1",CCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,CRFNGMNYKDXRTN-CITAKDKDSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-(2-butanoylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Nature Chemical Biology|Springer Nature|Wikidata",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266614,Stearoyl-CoA(4-),"stearoyl-CoA(4-)|stearyl-CoA|stearoyl-CoA tetraanion|stearoyl-coenzyme A(4-)|n-C18:0CoA|stearoyl-coenzyme A tetraanion|CHEBI:57394|Q27124612|3'-phosphonatoadenosine 5'-(3-{(3R)-3-hydroxy-2,2-dimethyl-4-[(3-{[2-(octadecanoylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-4-oxobutyl} diphosphate)",1030.000,C39H66N7O17P3S-4,400.000,1630.000,2.400,67,5,22,35,"InChI=1S/C39H70N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-30(48)67-23-22-41-29(47)20-21-42-37(51)34(50)39(2,3)25-60-66(57,58)63-65(55,56)59-24-28-33(62-64(52,53)54)32(49)38(61-28)46-27-45-31-35(40)43-26-44-36(31)46/h26-28,32-34,38,49-50H,4-25H2,1-3H3,(H,41,47)(H,42,51)(H,55,56)(H,57,58)(H2,40,43,44)(H2,52,53,54)/p-4/t28-,32-,33-,34+,38-/m1/s1",CCCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,SIARJEKBADXQJG-LFZQUHGESA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-[[3-(2-octadecanoylsulfanylethylamino)-3-oxopropyl]amino]-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266646,Deamidonicotinamide adenine dinucleoetide,"deamido-NAD(2-)|NAAD|deamidonicotinamide adenine dinucleoetide|6450-77-7|3dla|CHEBI:58437|adenosine 5'-{3-[1-(3-carboxypyridinio)-1,4-anhydro-D-ribitol-5-yl] diphosphate}",662.400,C21H24N6O15P2-2,321.000,1110.000,-4.800,44,5,19,10,"InChI=1S/C21H26N6O15P2/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(31)14(29)11(41-20)6-39-44(36,37)42-43(34,35)38-5-10-13(28)15(30)19(40-10)26-3-1-2-9(4-26)21(32)33/h1-4,7-8,10-11,13-16,19-20,28-31H,5-6H2,(H4-,22,23,24,32,33,34,35,36,37)/p-2/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)[O-],SENPVEZBRZQVST-HISDBWNOSA-L,"1-[(2R,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]pyridin-1-ium-3-carboxylate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20100507,BioCyc|ChEBI|Google Patents|Shanghai Institute of Organic Chemistry|ToxPlanet,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266742,2-Ammonio-2-deoxy-D-glucopyranose 6-phosphate(1-),2-ammonio-2-deoxy-D-glucopyranose 6-phosphate(1-)|CHEBI:58725|2-azaniumyl-2-deoxy-D-glucopyranose 6-phosphate|2-azaniumyl-2-deoxy-6-O-phosphonato-D-glucopyranose|Q27125995,258.140,C6H13NO8P-,170.000,270.000,-6.900,16,4,8,2,"InChI=1S/C6H14NO8P/c7-3-5(9)4(8)2(15-6(3)10)1-14-16(11,12)13/h2-6,8-10H,1,7H2,(H2,11,12,13)/p-1/t2-,3-,4-,5-,6?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)[NH3+])O)O)OP(=O)([O-])[O-],XHMJOUIAFHJHBW-IVMDWMLBSA-M,"[(2R,3S,4R,5R)-5-azaniumyl-3,4,6-trihydroxyoxan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46173510,(S)-3-Hydroxyisobutyryl-CoA(4-),"(S)-3-hydroxyisobutyryl-CoA(4-)|(S)-3-hydroxy-isobutyryl-CoA|(S)-3-hydroxy-isobutanoyl-CoA|(S)-beta-hydroxy-isobutyryl-CoA|CHEBI:62611|(S)-3-hydroxyisobutanoyl-CoA(4-)|(S)-3-hydroxy-isobutyryl-coenzyme A|(S)-3-hydroxy-2-methylpropanoyl-CoA|(S)-3-Hydroxy-2-methylpropionyl-CoA|(S)-3-hydroxy-2-methylpropanoyl-coenzyme A(4-)|Q27132041|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-4-({3-[(2-{[(2S)-3-hydroxy-2-methylpropanoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] diphosphate}",849.600,C25H38N7O18P3S-4,421.000,1420.000,-6.100,54,6,23,21,"InChI=1S/C25H42N7O18P3S/c1-13(8-33)24(38)54-7-6-27-15(34)4-5-28-22(37)19(36)25(2,3)10-47-53(44,45)50-52(42,43)46-9-14-18(49-51(39,40)41)17(35)23(48-14)32-12-31-16-20(26)29-11-30-21(16)32/h11-14,17-19,23,33,35-36H,4-10H2,1-3H3,(H,27,34)(H,28,37)(H,42,43)(H,44,45)(H2,26,29,30)(H2,39,40,41)/p-4/t13-,14+,17+,18+,19-,23+/m0/s1",C[C@@H](CO)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,WWEOGFZEFHPUAM-UQCJFRAESA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-4-[[3-[2-[(2S)-3-hydroxy-2-methylpropanoyl]sulfanylethylamino]-3-oxopropyl]amino]-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100630,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46878406,O-Phosphonato-L-homoserine(2-),O-phosphonato-L-homoserine(2-)|CHEBI:57590|(2S)-2-azaniumyl-4-(phosphonatooxy)butanoate|Q27124800,197.080,C4H8NO6P-2,140.000,183.000,-4.300,12,1,6,3,"InChI=1S/C4H10NO6P/c5-3(4(6)7)1-2-11-12(8,9)10/h3H,1-2,5H2,(H,6,7)(H2,8,9,10)/p-2/t3-/m0/s1",C(COP(=O)([O-])[O-])[C@@H](C(=O)[O-])[NH3+],FXDNYOANAXWZHG-VKHMYHEASA-L,(2S)-2-azaniumyl-4-phosphonatooxybutanoate,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20100920,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49791958,ADP-D-ribose(2-),ADP-D-ribose(2-)|ADP-D-ribose|adenosine diphosphate D-ribose|D-ribofuranos-5-yl-ADP dianion|CHEBI:57967|adenosine 5'-[3-(D-ribofuranos-5-O-yl) diphosphate]|Q27125087|adenosine 5'-(5-deoxy-D-ribofuranos-5-yl diphosphate),557.300,C15H21N5O14P2-2,297.000,860.000,-6.300,36,6,18,9,"InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/p-2/t5-,6-,8-,9-,10-,11-,14-,15?/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)([O-])OP(=O)([O-])OC[C@@H]4[C@H]([C@H](C(O4)O)O)O)O)O)N,SRNWOUGRCWSEMX-TYASJMOZSA-L,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20101217,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
49852310,3-Dehydrosphinganinium(1+),3-dehydrosphinganinium(1+)|3-oxosphinganine|3-dehydrosphinganinium|3-dehydrosphinganinium cation|3-dehydrosphinganine (C18)|KDHS (C18)|3-ketodihydrosphingosine (C18)|CHEBI:58299|3-dehydro-D-sphinganine (C18)|(2S)-1-hydroxy-3-oxooctadecan-2-aminium|Q27125680,300.500,C18H38NO2+,64.900,231.000,5.700,21,2,2,16,"InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17,20H,2-16,19H2,1H3/p+1/t17-/m0/s1",CCCCCCCCCCCCCCCC(=O)[C@H](CO)[NH3+],KBUNOSOGGAARKZ-KRWDZBQOSA-O,[(2S)-1-hydroxy-3-oxooctadecan-2-yl]azanium,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20110208,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
54675830,4-Hydroxybenzoate,"4-hydroxybenzoate|p-hydroxybenzoate|Benzoic acid, 4-hydroxy-, ion(1-)|456-23-5|4-oxidanylbenzoate|3pcc|3pch|Hydroxybenzoic acid|4-hydroxy-benzoate|Benzoic acid, p-hydroxy|Benzoic acid, 4-hydroxy|WLN: QVR DQ|CHEMBL1762656|HSDB 7233|NSC4961|EINECS 202-804-9|DB04242|NCGC00166040-01|AI3-01003|C00156|AE-848/32195059|parahydroxybenzoate|4-Oxylatobenzoate|4-Carboxyphenoxide|para-hydroxybenzoate|Benzoic acid, p-hydroxy-, ion(1-)|4-Hydroxybenzoate ion|p-Hydroxybenzoate anion|4e3g|H20059_ALDRICH|W398608_ALDRICH|p-Hyd",137.110,C7H5O3-,60.400,125.000,2.500,10,1,3,1,"InChI=1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10)/p-1",C1=CC(=CC=C1C(=O)O)[O-],FJKROLUGYXJWQN-UHFFFAOYSA-M,4-carboxyphenolate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,977610,20111226,"A&J Pharmtech CO., LTD.|AAA Chemistry|ABI Chem|Amadis Chemical|BIND|BindingDB|BioCyc|CCSbase|ChEBI|ChemDB|ChemIDplus|ChemSpider|ChemTik|DiscoveryGate|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|iChemical Technology USA Inc|Japan Chemical Substance Dictionary (Nikkaji)|Nature Chemical Biology|NextBio|NextMove Software|NMRShiftDB|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|SLING ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
74441046,3-Ketohexacosanoyl-CoA(4-),3-oxocerotoyl-CoA(4-)|3-ketocerotoyl-CoA(4-)|3-ketohexacosanoyl-CoA(4-)|3-oxohexacosanoyl-coenzyme A(4-)|3-ketohexacosanoyl-coenzyme A(4-),1160.200,C47H84N7O18P3S,406.000,1880.000,5.900,76,9,23,44,"InChI=1S/C47H84N7O18P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-35(55)30-38(57)76-29-28-49-37(56)26-27-50-45(60)42(59)47(2,3)32-69-75(66,67)72-74(64,65)68-31-36-41(71-73(61,62)63)40(58)46(70-36)54-34-53-39-43(48)51-33-52-44(39)54/h33-34,36,40-42,46,58-59H,4-32H2,1-3H3,(H,49,56)(H,50,60)(H,64,65)(H,66,67)(H2,48,51,52)(H2,61,62,63)",CCCCCCCCCCCCCCCCCCCCCCCC(=O)CC(=O)SCCNC(=O)CCNC(=O)C(C(C)(C)COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,VOMUIFOBQMYJPJ-UHFFFAOYSA-N,"S-[2-[3-[[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-oxohexacosanethioate",NULL,Biomolecular Interactions and Pathways|Literature|Pharmacology and Biochemistry,3,NULL,20140614,Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
86289686,L-2-Amino-3-oxobutanoate,L-2-amino-3-oxobutanoate|L-2-amino-3-oxobutanoic acid zwitterion|3-oxothreonine|3-keto-L-threonine|L-2-amino-3-oxobutyrate|L-2-amino-3-ketobutyrate|alpha-amino-beta-ketobutyrate|(2S)-2-ammonio-3-oxobutanoate|CHEBI:78948|(2S)-2-azaniumyl-3-oxobutanoate,117.100,C4H7NO3,84.800,115.000,-2.800,8,1,3,1,"InChI=1S/C4H7NO3/c1-2(6)3(5)4(7)8/h3H,5H2,1H3,(H,7,8)/t3-/m0/s1",CC(=O)[C@@H](C(=O)[O-])[NH3+],SAUCHDKDCUROAO-VKHMYHEASA-N,(2S)-2-azaniumyl-3-oxobutanoate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20141218,BioCyc|ChEBI,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
131769846,4-Methylzymosterol intermediate 2,4-Methylzymosterol intermediate 2,396.600,C28H44O,17.100,723.000,7.700,29,0,1,4,"InChI=1S/C28H44O/c1-18(2)8-7-9-19(3)22-12-13-24-21-10-11-23-20(4)26(29)15-17-28(23,6)25(21)14-16-27(22,24)5/h8,19-20,22-24H,7,9-17H2,1-6H3/t19-,20-,22-,23-,24-,27-,28+/m1/s1",C[C@@H]1[C@H]2CCC3=C([C@]2(CCC1=O)C)CC[C@]4([C@@H]3CC[C@@H]4[C@H](C)CCC=C(C)C)C,DBPZYKHQDWKORQ-QUKNFXNKSA-N,"(4R,5R,10S,13R,14S,17R)-4,10,13-trimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-1,2,4,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",NULL,Biomolecular Interactions and Pathways|Literature|Patents|Pharmacology and Biochemistry,4,NULL,20171122,Google Patents|Human Metabolome Database (HMDB),Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135444742,Tetrahydrofolic acid,"tetrahydrofolic acid|tetrahydrofolate|135-16-0|5,6,7,8-tetrahydrofolic acid|Tetrahydropteroylglutamic acid|tetrahydropteroylglutamate|5,6,7,8-tetrahydrofolate|(6S)-tetrahydrofolate|CHEBI:20506|C19H23N7O6|MFCD00135583|(2S)-5,6,7,8-tetrahydrofolic acid|(2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid|tetrahydrofolyl-(L-Glu)n|EINECS 205-181-1|L-Tetrahydrofolic Acid|SCHEMBL82453|N-(4-(((2-Amino-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L",445.400,C19H23N7O6,207.000,834.000,-0.600,32,8,10,9,"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1",C1C(NC2=C(N1)N=C(NC2=O)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MSTNYGQPCMXVAQ-KIYNQFGBSA-N,"(2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,12,57085|57086|57087|57088|57251|57256|57262|57427|57428|57429|57430|57431|57432|57433|57434|71200|71203|71205|71218|71229|71382|230430|1409598,20190115,"3B Scientific (Wuhan) Corp|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|Activate Scientific|AK Scientific, Inc. (AKSCI)|Alfa Chemistry|Alsachim|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|BindingDB|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DrugBank|ECI Group, LCSB, University of Luxembourg|Egon Will",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
445580,Docosahexaenoic acid,"Docosahexaenoic acid|Doconexent|Cervonic acid|6217-54-5|cis-4,7,10,13,16,19-Docosahexaenoic acid|(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid|all-cis-DHA|Doconexento|Doconexentum|Doxonexent|Docosahexaenoate|AquaGrow Advantage|all-Z-Docosahexaenoic acid|Martek DHA HM|Ropufa 60|UNII-ZAD9OKH9JC|all-cis-4,7,10,13,16,19-Docosahexaenoic acid|(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid|Docosahexaenoic acid (all-Z)|CCRIS 7670|ZAD9OKH9JC|all-cis-docosa-4,7,10,13,16,19-hexaenoic acid|DOCOSA-4,7,10,1",328.500,C22H32O2,37.300,462.000,6.200,24,1,2,14,"InChI=1S/C22H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-",CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)O,MBMBGCFOFBJSGT-KUBAVDMBSA-N,"(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid",Docosahexaenoic Acids,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,880|894|1030|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1688|1766|1768|1811|1865|2101|2107|2112|2147|2240|2241|2275|2313|2316|2322|2330|2451|2472|2517|2528|2546|2549|2551|2662|243367|319010|319011|319012|319013|319014|319015|319016|319017|323922|360927|360928|360929|376615|376617|376618|396469|406142|434959|444970|444971|444972|444973|444974|485281|485290|485350|492961|493033|493140|493162|499580|504327|504332|504749|504832|504834|504845|504847|504865|540299|588211|58821,20040916,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|BindingDB|BioCyc|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|Chemical Carcinogenesis Research Inf",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5281915,Coenzyme Q10,"Coenzyme Q10|ubidecarenone|303-98-0|ubiquinone-10|CoQ10|Ubiquinone 50|Neuquinon|Justquinon|Emitolon|Heartcin|Inokiten|Terekol|Udekinon|Ubiquinone|Coenzyme Q|coenzyme-Q10|Coenzyme Q-10|Vitamin Q|Coenzyme Q 10|Neuquinone|NSC 140865|Ubiquinone Q10|Q 199|Ube-Q|UNII-EJ27X76M46|C59H90O4|API-31510|CHEBI:46245|EJ27X76M46|NSC-140865|2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione|NCGC0",863.300,C59H90O4,52.600,1840.000,19.400,63,0,4,31,"InChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+",CC1=C(C(=O)C(=C(C1=O)OC)OC)C/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CCC=C(C)C,ACTIUHUUMQJHFO-UPTCCGCDSA-N,"2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,179|200|206|212|220|256|266|296|300|330|880|881|894|1030|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|379638|379639|379640|379641|379642|379643|379644|379645|379646|379647|485281|485290|492961|504327|504332|504749|504832|504834|504847|504865|588211|588212|588213|588579|588834|602332|611405|611407|624030|624031|624032|624044|624170|624172|624173|624296|624297|642427|651631|651632|651633|651,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|AN PharmaTech|ApexBio Technology|AstaTech, Inc.|Aurum Pharmatech LLC|BenchChem|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|CAPOT|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
190,Adenine,"adenine|73-24-5|1H-Purin-6-amine|6-Aminopurine|9H-Purin-6-amine|Vitamin B4|7H-Purin-6-amine|Adenin|Adeninimine|Leuco-4|6-Amino-1H-purine|6-Amino-3H-purine|6-Amino-7H-purine|6-Amino-9H-purine|3,6-Dihydro-6-iminopurine|1,6-Dihydro-6-iminopurine|Purine, 6-amino-|USAF CB-18|1H-Purine, 6-amino|ADE|9H-Purine, 1,6-dihydro-6-imino-|1H-Purine-6-amine|CCRIS 2556|AI3-50679|3H-Purin-6(7H)-imine|MFCD00041790|NSC 14666|UNII-JAC85A2161|9H-Purine-6-amine|9H-purin-6-ylamine|CHEBI:16708|1H-Purine, 6-amino-|1H-purin-6(9H)-imi",135.130,C5H5N5,80.500,127.000,-0.100,10,2,4,0,"InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10)",C1=NC2=NC=NC(=C2N1)N,GFFGJBXGBJISGV-UHFFFAOYSA-N,7H-purin-6-amine,Adenine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1|3|5|7|9|11|13|15|19|21|23|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|93|99|101|103|105|107|109|111|113|117|119|121|123|125|127|129|131|133|143|145|155|157|161|165|167|175|192|210|220|222|226|256|270|274|302|330|342|608|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1033|1195|1376|1379|1385|1405|1422|1452|1454|1457|1458|1460|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1529|1530|1531|1532|1549|1552|1554|1621|16,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank, COVID-19 Disease Map]"
1174,Uracil,"uracil|66-22-8|2,4-Dihydroxypyrimidine|2,4(1H,3H)-Pyrimidinedione|2,4-Pyrimidinediol|pyrimidine-2,4(1H,3H)-dione|2,4-Dioxopyrimidine|pyrimidine-2,4-diol|2,4-Pyrimidinedione|Pirod|Pyrod|Hybar X|1H-Pyrimidine-2,4-dione|51953-14-1|RU 12709|MFCD00006016|Ura|Uracil [USAN]|1,2,3,4-tetrahydropyrimidine-2,4-dione|CCRIS 3077|Uracyl|Urazil|2-Hydroxy-4(3H)-pyrimidinone|SQ 6201|SQ 7726|SQ 8493|BMS 205603-01|AI3-25470|UNII-56HH86ZVCT|NSC 3970|2-Hydroxy-4(1H)-pyrimidinone|CHEBI:17568|pyrimidine-2,4-dione|pyrimidinedione|",112.090,C4H4N2O2,58.200,161.000,-1.100,8,2,2,0,"InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)",C1=CNC(=O)NC1=O,ISAKRJDGNUQOIC-UHFFFAOYSA-N,"1H-pyrimidine-2,4-dione",Uracil,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1|3|5|7|9|11|13|15|19|21|23|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|93|99|101|103|105|107|109|111|113|117|119|121|123|125|127|129|131|133|143|145|155|157|161|165|167|175|192|222|274|302|330|1188|1189|1194|1199|1205|1208|1471|1490|1511|1554|1662|1663|1672|1688|1766|1768|1811|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6083,Adenosine monophosphate,adenosine 5'-monophosphate|5'-adenylic acid|adenosine phosphate|Adenosine monophosphate|61-19-8|adenylic acid|adenosine 5'-phosphate|5'-AMP|adenylate|Phosphentaside|Adenovite|Phosphaden|Cardiomone|Lycedan|Phosaden|AMP|Vitamin B8|Adenosine-5'-monophosphate|My-B-Den|Myoston|Ergadenylic acid|Monophosphadenine|Muscle adenylic acid|Muskeladenylsaeure|5'-adenosine monophosphate|AMP (nucleotide)|Adenosine 5'-(dihydrogen phosphate)|Adenosine 5'-phosphoric acid|Adenosini phosphas|Adenosine-5-monophosphoric acid|Aden,347.220,C10H14N5O7P,186.000,481.000,-3.500,23,5,11,4,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N,UDMBCSSLTHHNCD-KQYNXXCUSA-N,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",Adenosine Monophosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,880|1030|1195|1332|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1688|1766|1768|1811|1865|2101|2107|2112|2517|2528|2546|2549|2551|2662|33710|34777|34901|34915|34916|34928|35062|35063|35067|35078|35081|35089|35091|35098|35099|52123|54327|54484|68444|70545|77348|77354|77361|87300|88304|88426|89523|91555|91558|92478|96606|108461|150332|150488|150493|150498|150626|150632|155601|155652|157042|157043|160455|160766|160767|162253|162706|165253|165257|165258|167145|167868|167873|167875|196094|196095|196096|19917,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank, COVID-19 Disease Map]"
5282315,Prograf,"Tacrolimus hydrate|TACROLIMUS MONOHYDRATE|109581-93-3|Prograf|Tsukubaenolide hydrate|FK-506 monohydrate|Tacrolimus (monohydrate)|UNII-WM0HAQ4WNM|Astagraf XL|LCP-Tacro|WM0HAQ4WNM|Prograf (TN)|FK 506|FR900506|FR 900506|(-)-(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotr",822.000,C44H71NO13,179.000,1480.000,NULL,58,4,13,7,"InChI=1S/C44H69NO12.H2O/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7;/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3;1H2/b25-19+,27-21+;/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+;/m0./s1",C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC.O,NWJQLQGQZSIBAF-MLAUYUEBSA-N,"(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone;hydrate",Tacrolimus,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,9,NULL,20050624,"AbaChemScene|AbovChem LLC|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|AN PharmaTech|AOBIOUS INC|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|BioCrick|Biosynth Carbosynth|BOC Sciences|Boerchem|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|ChemMol|ChemSpider|Chiralblock Biosciences|Combi-Blocks|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA/",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11513676,Alisporivir,"Alisporivir|Debio-025|254435-95-5|Debio 025|UNIL 025|UNIL-025|UNII-VBP9099AA6|DEB-025|DEB025|VBP9099AA6|CHEMBL1651956|(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-25,30-diethyl-33-((1R,2R,E)-1-hydroxy-2-methylhex-4-en-1-yl)-6,9,18-triisobutyl-3,21,24-triisopropyl-1,4,7,10,12,15,19,27,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone|Alisporivir [USAN:INN]|UNIL025|MeAla(3)EtVal(4)-cyclosporin|Alisporivir (USAN)|SCHEMBL6850787|DEB 025|CHEBI:149837|BD",1216.600,C63H113N11O12,279.000,2360.000,7.900,86,5,12,15,"InChI=1S/C63H113N11O12/c1-26-29-30-40(16)52(75)51-56(79)66-44(27-2)59(82)68(20)43(19)58(81)74(28-3)49(38(12)13)55(78)67-48(37(10)11)62(85)69(21)45(31-34(4)5)54(77)64-41(17)53(76)65-42(18)57(80)70(22)46(32-35(6)7)60(83)71(23)47(33-36(8)9)61(84)72(24)50(39(14)15)63(86)73(51)25/h26,29,34-52,75H,27-28,30-33H2,1-25H3,(H,64,77)(H,65,76)(H,66,79)(H,67,78)/b29-26+/t40-,41+,42-,43-,44+,45+,46+,47+,48+,49+,50+,51+,52-/m1/s1",CC[C@H]1C(=O)N([C@@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,OLROWHGDTNFZBH-XEMWPYQTSA-N,"(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-25,30-diethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21,24-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,12,555925|555926|555927|555928|555929|555932|555933|555934|555935|555936|555937|555938|555939|555950|555951|555952|555953|555954|555955|573105|573106|573107|573108|573109|573110|573111|573112|581761|581762|581763|581764|581765|581767|581768|581770|581771|581773|581774|581775|581776|581777|581778|581779|581780|581781|581782|581783|581784|581785|581786|581787|581788|581789|581790|581791|581792|581793|581794|581795|581796|581797|581798|581799|581800|581801|581802|581803|581804|581805|581913|581914|581915|581916|5,20061026,"A2B Chem|AA BLOCKS|AbaChemScene|BindingDB|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Comparative Toxicogenomics Database (CTD)|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MedChemexpress MCE|MuseChem|NextBio|PATENTSCOPE (WIPO)|Prous Science Drugs of the Future|Smolec",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
892,Inositol,"inositol|myo-inositol|Scyllo-inositol|Muco-Inositol|epi-Inositol|Allo-inositol|i-Inositol|meso-Inositol|87-89-8|Neo-inositol|1L-Chiro-inositol|1D-Chiro-inositol|cis-Inositol|D-chiro-Inositol|D-(+)-chiro-Inositol|643-12-9|Myoinositol|488-59-5|Scyllitol|Cyclohexane-1,2,3,4,5,6-hexaol|6917-35-7|cyclohexane-1,2,3,4,5,6-hexol|mesoinositol|Meat sugar|Myoinosite|Quercinitol|488-58-4|Dambose|Cocositol|Inositene|Inositina|Phaseomannite|551-72-4|Inosital|Inosite|Iso-inositol|L-chiro-Inositol|Cyclohexitol|Phaseomannit",180.160,C6H12O6,121.000,104.000,-3.700,12,6,6,0,InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H,C1(C(C(C(C(C1O)O)O)O)O)O,CDAISMWEOUEBRE-UHFFFAOYSA-N,"cyclohexane-1,2,3,4,5,6-hexol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1|3|5|7|9|13|19|23|25|29|31|33|35|37|39|41|43|45|49|53|55|59|65|67|71|77|79|81|83|85|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|133|137|139|141|143|145|155|157|161|165|167|175|248|256|330|880|881|894|1030|1195|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1554|1662|1663|1672|1688|1766|1768|1811|1813|1814|1832|1850|1863|1865|1875|1885|1899|1903|1906|1910|1947|1948|1950|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2107,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5090,Rofecoxib,"rofecoxib|162011-90-7|Vioxx|Ceoxx|MK 966|4-(4-(Methylsulfonyl)phenyl)-3-phenylfuran-2(5H)-one|4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one|MK-966|MK 0966|MK-0966|4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone|MK0966|UNII-0QTW8Z7MCR|3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one|Rofecoxib (Vioxx)|C17H14O4S|3-phenyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone|0QTW8Z7MCR|CHEMBL122|4-(4-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone|CHEBI:8887|TRM-201|2(5H)-Furanone, 4-[4-(methylsulfonyl)phen",314.400,C17H14O4S,68.800,556.000,2.300,22,0,4,3,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,RZJQGNCSTQAWON-UHFFFAOYSA-N,3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|67|71|73|77|79|81|83|85|87|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1195|1376|1379|1385|1422|1452|1454|1457|1458|1460|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1688|1766|1768|1813|1814|1832|1850|1863|1865|1875|1885|1899|1903|1906|191,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|AOBIOUS INC|ApexBio",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5961,Glutamine,"L-glutamine|glutamine|56-85-9|Levoglutamide|L-(+)-Glutamine|Glutamic acid amide|H-Gln-OH|Stimulina|Cebrogen|glumin|Levoglutamid|Glavamin|(S)-2,5-Diamino-5-oxopentanoic acid|glutamic acid 5-amide|L-Glutamide|Polyglutamine|2-aminoglutaramic acid|Miglu-P|Saforis|L-2-Aminoglutaramidic acid|L-Glutamic acid gamma-amide|L-Glutamin|Glumin (amino acid)|(2S)-2-amino-4-carbamoylbutanoic acid|Glutamine (VAN)|L-2-Aminoglutaramic acid|L-Glutamic acid 5-amide|Levoglutamida|Levoglutamidum|2-Aminoglutaramic acid, L-|(2S)-2,",146.140,C5H10N2O3,106.000,146.000,-3.100,10,3,4,4,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",C(CC(=O)N)[C@@H](C(=O)O)N,ZDXPYRJPNDTMRX-VKHMYHEASA-N,"(2S)-2,5-diamino-5-oxopentanoic acid",Glutamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,422|429|436|547|608|694|732|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1033|1195|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1476|1477|1478|1479|1487|1490|1519|1549|1552|1637|1648|1705|1707|1708|1766|1768|1811|1815|1816|1828|1865|1876|1877|1882|1883|1886|1948|1967|2101|2107|2112|2147|2323|2326|2353|2364|2451|2472|2517|2528|2546|2549|2551|2660|2662|2666|2667|2668|2675|2732|2774|22735|26797|58929|233320|463096|463097|463106|463189|485281|485290|485295,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Angene Chemical|Anward|ApexBio Te",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918486,Voclosporin,"Voclosporin|Luveniq|ISA-247|ISATX247|ISA247|ISAtx-247|515814-01-4|UNII-2PN063X6B1|R 1524|ISA(TX)247|R-1524|2PN063X6B1|LX211|(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhepta-4,6-dienyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone|515814-00-3|Voclosporin [USAN]|trans-ISA 247|ISA 247|LX-211|(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30",1214.600,C63H111N11O12,279.000,2380.000,7.900,86,5,12,16,"InChI=1S/C63H111N11O12/c1-25-27-28-29-41(15)53(76)52-57(80)66-44(26-2)59(82)68(18)34-49(75)69(19)45(30-35(3)4)56(79)67-50(39(11)12)62(85)70(20)46(31-36(5)6)55(78)64-42(16)54(77)65-43(17)58(81)71(21)47(32-37(7)8)60(83)72(22)48(33-38(9)10)61(84)73(23)51(40(13)14)63(86)74(52)24/h25,27-28,35-48,50-53,76H,1,26,29-34H2,2-24H3,(H,64,78)(H,65,77)(H,66,80)(H,67,79)/b28-27+/t41-,42+,43-,44+,45+,46+,47+,48+,50+,51+,52+,53-/m1/s1",CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,BICRTLVBTLFLRD-PTWUADNWSA-N,"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhepta-4,6-dienyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,977611,20060728,"A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|ChEBI|Chem-Space.com Database|Chembase.cn|ChemIDplus|ChemSpider|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MedChemexpress MCE|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Prous Science Drugs of the Future|SCRIPDB|Shanghai Instit",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5284373,Cyclosporin A,cyclosporin A|cyclosporine|Ciclosporin|59865-13-3|Cyclosporine A|Sandimmune|Sandimmun|Neoral|Cyclosporin|Ciclosporine|Gengraf|Ramihyphin A|Sandimmun Neoral|Sang-35|Ciclosporina|Ciclosporinum|Consupren|Equoral|Neoplanta|UNII-83HN0GTJ6D|Antibiotic S 7481F1|SangCyA|MFCD00274558|83HN0GTJ6D|MLS001333756|CHEBI:4031|CSA|S-Neoral|Cipol N|Sigmasporin Microoral|Cyclosporin A solution|DSSTox_CID_365|Ciclosporin (Ciclosporin A)|DSSTox_RID_75541|DSSTox_GSID_20365|SDZ-OXL 400|Ciclosporin A|OL 27-400|Abrammune|Imusporin|O,1202.600,C62H111N11O12,279.000,2330.000,7.500,85,5,12,15,"InChI=1S/C62H111N11O12/c1-25-27-28-40(15)52(75)51-56(79)65-43(26-2)58(81)67(18)33-48(74)68(19)44(29-34(3)4)55(78)66-49(38(11)12)61(84)69(20)45(30-35(5)6)54(77)63-41(16)53(76)64-42(17)57(80)70(21)46(31-36(7)8)59(82)71(22)47(32-37(9)10)60(83)72(23)50(39(13)14)62(85)73(51)24/h25,27,34-47,49-52,75H,26,28-33H2,1-24H3,(H,63,77)(H,64,76)(H,65,79)(H,66,78)/b27-25+/t40-,41+,42-,43+,44+,45+,46+,47+,49+,50+,51+,52-/m1/s1",CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PMATZTZNYRCHOR-CGLBZJNRSA-N,"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",Cyclosporine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,377|781|782|798|800|873|880|940|1021|1022|1046|1085|1189|1194|1199|1205|1208|1230|1236|1242|1274|1332|1376|1377|1381|1385|1415|1422|1423|1430|1434|1439|1440|1441|1443|1445|1454|1456|1460|1461|1463|1465|1467|1468|1469|1471|1477|1479|1490|1496|1529|1530|1531|1532|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1665|1688|1721|1722|1766|1775|1777|1778|1779|1817|1850|1863|1865|1868|1899|1903|1906|1947|1950|1956|1961|1962|1974|1984|1986|1987|1996|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|,20051120,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|AOBIOUS INC|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|BioCyc|Biopurify Phytochemicals|Biosynth Carbosynth|BOC Sciences|Broad Institute|Buhrlage Lab, D",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
445643,Tacrolimus,"tacrolimus|Fujimycin|Prograf|104987-11-3|Protopic|FK506|Tacrolimus anhydrous|Advagraf|Modigraf|Protopy|Fk-506|LCP-Tacro|Anhydrous Tacrolimus|tacrolimus (fk506)|FK 506|FR-900506|8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN|UNII-Y5L2157C4J|FR900506|Astagraf XL|FR 900506|(-)-FK 506|Tsukubaenolide|Prograf (TN)|CHEMBL269732|CHEBI:61049|Y5L2157C4J|K506|NCGC00163470-03|Prograft|Avagraf|Envarsus|Graceptor|Envarsus XR|(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,1",804.000,C44H69NO12,178.000,1480.000,2.700,57,3,12,7,"InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1",C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,QJJXYPPXXYFBGM-LFZNUXCKSA-N,"(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone",Tacrolimus,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1469|1471|1477|1479|1490|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1688|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|13709|18971|18973|21330|21331|24844|45444|45445|45450|50622|69089|69095|69100|69104|69106|69107|69108|69113|69114|69122|69250|69253|69259|90649|90650|91890|131392|132576|132577|140246|142478|142574|142575|172316|172317|172318|172319|173625|17,20050608,"AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Active Biopharma|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|AmicBase - Antimicrobial Activities|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BIND|BindingDB|BioCrick|Biosynth Carbosynth|BOC Sciences|Boer",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5311181,Iloprost,"ILOPROST|Ciloprost|Ventavis|78919-13-8|Iloprostum|ZK 36374|ZK-36374|CHEMBL494|CHEBI:63916|[3H]-Iloprost|Endoprost|Ilomedin|Ventavis (TN)|ZK 00036374|73873-87-7|(16R,S)-methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I2|(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid|Iloprostum [Latin]|SR-05000001498|Iloprost [USAN:INN:BAN]|Ilomedine|BAY Q6256|(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3",360.500,C22H32O4,77.800,606.000,2.800,26,3,4,8,"InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1",CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O,HIFJCPQKFCZDDL-ACWOEMLNSA-N,"(5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid",Iloprost,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,44748|89295|89296|89297|92241|92377|92390|92396|92397|92410|93128|160748|160749|160755|160760|195020|212622|222764|234879|238689|247935|248516|301228|302640|346448|540209|540210|540211|540212|540213|540214|540215|540216|540217|540218|540219|540220|540221|588211|588212|588213|624349|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651828|681173|681367|681576|682149|711593|717844|720641|720717|751858|752221|1224905|1259251|1259310|1259374|1259422|1285652|133635,20051216,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AbovChem LLC|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BindingDB|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CSNpharm|DiscoveryG",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
439302,Oxytocin,"OXYTOCIN|50-56-6|Pitocin|Ocytocin|Syntocinon|Endopituitrina|Orasthin|Oxitocina|Oxytocine|Oxytocinum|Oxytocin acetate|alpha-Hypophamine|(1-Hemicystine)oxytocin|Piton S|3-Isoleucine-8-leucine vasopressin|UNII-1JQS135EYN|Oxytocic hormone|1JQS135EYN|CHEBI:7872|CHEMBL395429|MFCD00076731|Oxystin|Partocon|Synthetic oxytocin|OXT|Ocytocinum|Ossitocina|Syntocinone|Oxetakain|Oxoject|Oxtocin|Presoxin|Synpitan|Syntocin|Utedrin|Uteracon|Di-sipidin|Nobitocin S|Atonin O|[3H]oxytocin|Oxetakain [Czech]|1-({(4R,7S,10S,13S,16S",1007.200,C43H66N12O12S2,450.000,1870.000,-2.600,69,12,15,17,"InChI=1S/C43H66N12O12S2/c1-5-22(4)35-42(66)49-26(12-13-32(45)57)38(62)51-29(17-33(46)58)39(63)53-30(20-69-68-19-25(44)36(60)50-28(40(64)54-35)16-23-8-10-24(56)11-9-23)43(67)55-14-6-7-31(55)41(65)52-27(15-21(2)3)37(61)48-18-34(47)59/h8-11,21-22,25-31,35,56H,5-7,12-20,44H2,1-4H3,(H2,45,57)(H2,46,58)(H2,47,59)(H,48,61)(H,49,66)(H,50,60)(H,51,62)(H,52,65)(H,53,63)(H,54,64)/t22-,25-,26-,27-,28-,29-,30-,31-,35-/m0/s1",CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,XNOPRXBHLZRZKH-DSZYJQQASA-N,"(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide",Oxytocin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|13117|53017|151627|151793|151797|151927|151936|151937|151938|151940|168372|168538|168661|168662|168663|169007|169008|169009|169040|169041|169130|169132|169133|171590|171775|171776|175675|175676|176218|180441|186071|186824|186826|188258|188260|190023|190050|190051|190052|190056|190392|190395|195309|197053|197054|197216|197217|217086|217245|217359|217392|217544|217708|217709|230136|230138|230251|230252|294434|294438|2944,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|Biosynth Carbosynth|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|CCSbase|Center for Chemical Genomics, University of Michiga",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5280795,Cholecalciferol,"Vitamin D3|cholecalciferol|67-97-0|Calciol|Colecalciferol|Oleovitamin D3|Arachitol|Ricketon|Trivitan|Deparal|Vigorsan|Activated 7-dehydrocholesterol|Colecalcipherol|Delsterol|Ebivit|Quintox|Cholecalciferolum|(+)-Vitamin D3|D3-Vicotrat|D3-Vigantol|vitamin d-3|Vi-de-3-hydrosol|NEO Dohyfral D3|Vitinc Dan-Dee-3|Colecalciferolum|Cholecalciferol, D3|1406-16-2|Vi-De3|Duphafral D3 1000|FeraCol|MFCD00078131|CC|CHEBI:28940|NSC 375571|9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol|Provitina|7-Dehydrocholesterol activate",384.600,C27H44O,20.200,610.000,7.900,28,1,1,6,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C,QYSXJUFSXHHAJI-YRZJJWOYSA-N,"(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol",Cholecalciferol,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,18,377|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|999|1004|1030|1332|1379|1452|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1688|1766|1768|1865|1948|2101|2107|2112|2120|2,20040916,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Achemtek|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|BindingDB|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BOC Sciences|Broad Institute|CC_PML",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6427057,"(1R,4S,6R,10E,14E,16E,21R)-6'-Butan-2-yl-21,24-dihydroxy-12-[(2R,4S,6S)-5-[(2S,4S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one","IVERMECTIN|MK-933|GTPL2373|(1'R,2R,4'S,10'E,14'E,16'E,21'R)-6-(butan-2-yl)-21',24'-dihydroxy-12'-{[(2R,4S,6S)-5-{[(2S,4S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-5,11',13',22'-tetramethyl-3',7',19'-trioxaspiro[oxane-2,6'-tetracyclo[15.6.1.1^{4,8}.0^{20,24}]pentacosane]-10',14',16',22'-tetraen-2'-one",875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25?,26?,28?,30-,31-,33?,34-,35-,36-,37-,38-,39-,40+,41?,42?,43?,44?,45?,47+,48?/m0/s1",CCC(C)C1C(CC[C@@]2(O1)C[C@@H]3CC(O2)C/C=C(/C(C(/C=C/C=C/4\\COC5C4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H](C([C@@H](O6)C)O[C@H]7C[C@@H](C([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-ZLRQRZFZSA-N,"(1R,4S,6R,10E,14E,16E,21R)-6'-butan-2-yl-21,24-dihydroxy-12-[(2R,4S,6S)-5-[(2S,4S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Biological Test Results|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,1346552|1346583|1346612,20060428,ChemSpider|IUPHAR/BPS Guide to PHARMACOLOGY|NextBio|Therapeutic Target Database (TTD),Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
248,Trimethyl glycine,"TRIMETHYL GLYCINE|N,N,N-trimethylglycinium|Cystadane|CHEBI:41139|carboxy-N,N,N-trimethylmethanaminium|.alpha.-Earleine|NSC-166511|NCGC00015150-03|NCGC00015150-04|BET|betainium|SR-01000075714|Spectrum_001264|1r9l|1sw2|2b4l|Spectrum2_000880|Spectrum4_000735|Spectrum5_001577|Lopac-B-3501|Betaine solution, 0.1 M|(Trimethylammonio)acetate #|NCIOpen2_001196|Lopac0_000172|BSPBio_002550|KBioGR_001030|KBioSS_001744|CHEMBL95889|DivK1c_000642|SCHEMBL134333|SPBio_000959|FEMA NO. 4223|KBio1_000642|KBio2_001744|KBio2_004",118.150,C5H12NO2+,37.300,93.100,-0.100,8,1,2,2,"InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3/p+1",C[N+](C)(C)CC(=O)O,KWIUHFFTVRNATP-UHFFFAOYSA-O,carboxymethyl(trimethyl)azanium,Betaine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|881|883|884|885|886|887|889|891|892|893|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1452|1471|1811|1851|2660|2666|2667|2668|463106|485295|485297|485298|485313|485342|485345|485366|485368|488772|488773|488816|488837|488949|488953|488978|488981|488982|488983|493106|493107|493153|493164|504327|504332|504536|504547|504548|,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
588,Creatinine,"creatinine|60-27-5|2-Imino-1-methylimidazolidin-4-one|1-Methylglycocyamidine|1-Methylhydantoin-2-imide|2-amino-1-methylimidazolin-4-one|Kreatinin|2-amino-1-methyl-1,5-dihydro-4H-imidazol-4-one|2-Imino-N-methylhydantoin|Creatine anhydride|2-amino-3-methyl-4H-imidazol-5-one|2-Amino-1-methyl-2-imidazolin-4-one|CHEBI:16737|2-Amino-1,5-dihydro-1-methyl-4H-imidazol-4-one|Creatinine, 98%|NSC-13123|NCGC00095762-01|DSSTox_CID_25987|DSSTox_RID_81274|DSSTox_GSID_45987|4H-Imidazol-4-one, 2-imino-1,5-dihydro-1-methyl-|C",113.120,C4H7N3O,58.700,151.000,-1.800,8,1,1,0,"InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8)",CN1CC(=O)N=C1N,DDRJAANPRJIHGJ-UHFFFAOYSA-N,2-amino-3-methyl-4H-imidazol-5-one,Creatinine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Micromolar,12,155|157|161|165|167|175|180|218|248|270|328|330|342|608|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1033|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1478|1479|1487|1490|1511|1519|1527|1529|1530|1531|1549|1552|1554|1556|1565|1566|1578|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1621|1631|1634|1637|1648|1654|1656|1662|1663|1672|1688|,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|ApexBi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
597,Cytosine,"cytosine|71-30-7|4-Amino-2-hydroxypyrimidine|Cytosinimine|2(1H)-Pyrimidinone, 4-amino-|4-aminopyrimidin-2(1H)-one|4-Amino-2(1H)-pyrimidinone|6-Aminopyrimidin-2(1h)-One|4-aminopyrimidin-2-ol|MFCD00006034|2(1H)-pyrimidinone, 6-amino-|Cyt|6-amino-1H-pyrimidin-2-one|4-amino-2-oxo-1,2-dihydropyrimidine|Cytosin|Zytosin|AI3-52281|UNII-8J337D1HZY|4-Amino-1H-pyrimidin-2-one|CHEBI:16040|4-amino-2-pyrimidinol|8J337D1HZY|4-amino-1,2-dihydropyrimidin-2-one|NSC-27787|Cytosine, 99+%|CID 5274263|6-amino-3-hydropyrimidin-2-",111.100,C4H5N3O,67.500,170.000,-1.700,8,2,2,0,"InChI=1S/C4H5N3O/c5-3-1-2-6-4(8)7-3/h1-2H,(H3,5,6,7,8)",C1=C(NC(=O)N=C1)N,OPTASPLRGRRNAP-UHFFFAOYSA-N,6-amino-1H-pyrimidin-2-one,Cytosine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,192|222|274|302|330|1511|1554|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1962|1974|1979|1987|1996|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|19262|97843|97848|434955|434962|434973|434989|435003|435005|435022|43503,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
649,Dihydrouracil,"dihydrouracil|5,6-dihydrouracil|504-07-4|Hydrouracil|DIHYDROPYRIMIDINE-2,4(1H,3H)-DIONE|5,6-Dihydro-2,4-dihydroxypyrimidine|Dihydrouracile|2,4(1H,3H)-Pyrimidinedione, dihydro-|1,3-diazinane-2,4-dione|Dihydro-2,4(1H,3H)-pyrimidinedione|DI-H-uracil|Hydrouracil (8CI)|2,4-Dioxotetrahydropyrimidine|4,5-dihydrouracil|UNII-016FR52RU5|MFCD00006029|Dihydro-pyrimidine-2,4-dione|5,6-Dihydro-2,4(1H,3H)-pyrimidinedione|AI3-50443|016FR52RU5|NSC11867|DUC|1,3,5,6-tetrahydropyrimidine-2,4-dione|181516-96-1|3,4-DIHYDROURACIL",114.100,C4H6N2O2,58.200,132.000,-1.100,8,2,2,0,"InChI=1S/C4H6N2O2/c7-3-1-2-5-4(8)6-3/h1-2H2,(H2,5,6,7,8)",C1CNC(=O)NC1=O,OIVLITBTBDPEFK-UHFFFAOYSA-N,"1,3-diazinane-2,4-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,10,155|157|161|165|167|175|256|1347080|1347385|1508586,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BIND|Biocore|BioCyc|Biological Magnet",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
802,Indole-3-acetic acid,"indole-3-acetic acid|87-51-4|3-Indoleacetic acid|indoleacetic acid|Heteroauxin|1H-Indole-3-acetic acid|1H-indol-3-ylacetic acid|2-(1H-Indol-3-yl)acetic acid|Rhizopin|Indol-3-ylacetic acid|3-Iaa|Rhizopon A|3-Indolylacetic acid|Hexteroauxin|beta-Indoleacetic acid|3-(Carboxymethyl)indole|auxin|indoleacetate|Acetic acid, indolyl-|Heteroauxinhexteroauxiniaa|IAA|Indolylacetic acid|beta-Indolylacetic acid|indole-3-acetate|Indolyl-3-acetic acid|omega-Skatole carboxylic acid|Kyselina 3-indolyloctova|(1H-Indol-3-yl)-",175.180,C10H9NO2,53.100,205.000,1.400,13,2,2,2,"InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)",C1=CC=C2C(=C1)C(=CN2)CC(=O)O,SEOVTRFCIGRIMH-UHFFFAOYSA-N,2-(1H-indol-3-yl)acetic acid,NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,155|157|161|165|167|175|330|342|422|608|811|833|1033|1044|1189|1194|1199|1205|1376|1385|1422|1465|1511|1529|1530|1531|1532|1549|1552|1554|1621|1626|1637|1648|1662|1663|1672|1792|1813|1814|1823|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1979|1987|1996|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2291|2300|2380|2435|2445|2462|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
936,Nicotinamide,nicotinamide|niacinamide|98-92-0|3-Pyridinecarboxamide|Nicotinic acid amide|pyridine-3-carboxamide|vitamin PP|Papulex|Aminicotin|Amixicotyn|Nicobion|Nicotylamide|Nikotinamid|Savacotyl|Benicot|Dipegyl|Endobion|Hansamid|Pelmine|Nicotinic amide|Delonin amide|Pelonin amide|Vi-Nicotyl|Austrovit PP|Inovitan PP|Vitamin B|Nicosylamide|Nicotilamide|Nicotililamido|Amnicotin|Niacevit|Nicamina|Nicamindon|Nicofort|Nicomidol|Nicotamide|Nicovitina|Nicovitol|Nicozymin|Niocinamide|Niozymin|Niamide|Nicasir|Nicogen|Nicota|Nic,122.120,C6H6N2O,56.000,114.000,-0.400,9,1,2,1,"InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)",C1=CC(=CN=C1)C(=O)N,DFPAKSUCGFBDDF-UHFFFAOYSA-N,pyridine-3-carboxamide,Niacinamide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,155|157|161|165|167|175|256|330|368|374|485|539|555|556|565|568|573|577|583|606|618|620|631|645|708|709|731|750|757|758|759|760|761|764|774|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|847|861|862|868|871|873|875|878|880|881|886|887|889|892|893|894|898|900|902|920|923|924|926|932|938|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1189|1195|1199|1203|1205|1209|1214|1216|1217|1220|1222|1229|1236|1239|1,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, WikiPathways, PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
938,Nicotinic acid,nicotinic acid|niacin|59-67-6|Pyridine-3-carboxylic acid|3-pyridinecarboxylic acid|3-Carboxypyridine|wampocap|Niaspan|Apelagrin|Pellagrin|Akotin|Daskil|Efacin|Pelonin|Acidum nicotinicum|Linic|nicamin|nicobid|nicocap|nicolar|Enduracin|Nicodelmine|Niconacid|Nicotinipca|Pellagramin|Direktan|Nicacid|Nicangin|Peviton|vitamin B3|Bionic|Diacin|Nicyl|Nyclin|Niac|Vitaplex N|Davitamon PP|Nico-Span|Tega-Span|Nicocidin|Nicocrisina|Niconazid|Nicoside|Nicotamin|Nicotene|Nicovasan|Nicovasen|Nipellen|SK-Niacin|Naotin|Nicod,123.110,C6H5NO2,50.200,114.000,0.400,9,1,3,1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",C1=CC(=CN=C1)C(=O)O,PVNIIMVLHYAWGP-UHFFFAOYSA-N,pyridine-3-carboxylic acid,Niacin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,192|248|357|410|411|444|445|446|447|448|450|451|485|526|530|568|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|605|606|607|608|618|620|629|630|631|633|639|648|662|687|701|719|731|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|875|878|880|881|883|884|885|886|887|889|891|892|893|894|898|899|900|901|902|910|912|914|915|920|923|924|925|926|927|930|932|938|940|950|951|952|995|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|10,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
984,Hexadecanal,"hexadecanal|palmitaldehyde|629-80-1|N-hexadecanal|1-hexadecanal|palmitoyl aldehyde|16-Hexadecanal|Palmitic aldehyde|UNII-WQD27655QE|WQD27655QE|CHEBI:17600|EINECS 211-111-0|AI3-24252|Hexadecanaldehyde|hexadecan-1-one|Palmityl Aldehyde|ACMC-209nbe|SCHEMBL4481|GTPL6627|Palmitaldehyde, 16-Hexadecanal|QSPL 064|CHEMBL1235338|DTXSID5042039|ZINC8216082|6369AF|ANW-34488|LMFA06000088|MFCD00055568|RB3019|AKOS005145523|CS-W004305|DB03381|HY-W004305|MCULE-1337115097|AS-56311|DB-073236|FT-0626966|C00517|Q27077978|16:0 al",240.420,C16H32O,17.100,143.000,7.100,17,0,1,14,"InChI=1S/C16H32O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h16H,2-15H2,1H3",CCCCCCCCCCCCCCCC=O,NIOYUNMRJMEDGI-UHFFFAOYSA-N,hexadecanal,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,11,646965|646966|1409598,20040916,"001Chemical|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Angene Chemical|Anward|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BioCyc|BLD Pharm|BOC Sciences|Broad Institute|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|Chemical Synthesis Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttl",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
1054,Pyridoxine,"pyridoxine|65-23-6|vitamin B6|Pyridoxol|Gravidox|Pyridoxin|3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine|Hydoxin|Adermine|Pyridoxolum|3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-|4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol|5-Hydroxy-6-methyl-3,4-pyridinedimethanol|Pyridoxinum|Piridossina [DCIT]|3-Hydroxy-4,5-dimethylol-alpha-picoline|Pyridoxinum [INN-Latin]|Piridossina|Piridoxina [INN-Spanish]|Piridoxina|Pyridoxine [INN:BAN]|Aderoxine|2-Picoline-4,5-dimethanol, 3-hydroxy-|2-Methyl-3-hydroxy-4,5-di(hydrox",169.180,C8H11NO3,73.600,142.000,-0.800,12,3,4,2,"InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3",CC1=NC=C(C(=C1O)CO)CO,LXNHXLLTXMVWPM-UHFFFAOYSA-N,"4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol",Pyridoxine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|995|1030|1195|1332|1379|1452|1454|1457|1458|1467|1469|1471|1476|1477|1478|1479|1487|1490|1519|1766|1768|1851|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|251387|251393|251394|251419|405621|405622|405625|405626|464423|485281|485290|504327|504332|504847|504865|588209|588210,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
1066,Quinolinic acid,"quinolinic acid|Pyridine-2,3-dicarboxylic acid|2,3-pyridinedicarboxylic acid|89-00-9|quinolinate|339155-13-4|Pyridine-2,3-dicarboxylate|UNII-F6F0HK1URN|AI3-63017|MFCD00006295|2,3-pyridine dicarboxylic acid|pyridine-2,3-carboxylate|F6F0HK1URN|CHEMBL286204|CHEBI:16675|2,3-Pyridinedicarboxylic acid, 99%|2,3-pyridinedicarboxylate|SMR000112287|SR-01000075472|EINECS 201-874-8|NSC 13127|quinolinic-acid|HSDB 7511|PubChem8035|2,3-dipicolinic acid|Spectrum_001525|Tocris-0225|pyridinedicarboxylic acid|ACMC-1CIWY|pyrid",167.120,C7H5NO4,87.500,204.000,0.200,12,2,5,2,"InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)",C1=CC(=C(N=C1)C(=O)O)C(=O)O,GJAWHXHKYYXBSV-UHFFFAOYSA-N,"pyridine-2,3-dicarboxylic acid",Quinolinic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,155|157|161|165|167|175|330|357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|910|912|914|915|917|918|923|924|925|926|927|928|930|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2Z Chemical|AAA Chemistry|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambeed|Ampyridi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
1135,Thymine,"thymine|5-methyluracil|65-71-4|2,4-Dihydroxy-5-methylpyrimidine|Thymin|5-methylpyrimidine-2,4(1H,3H)-dione|Thymine anhydrate|2,4(1H,3H)-Pyrimidinedione, 5-methyl-|5-methyl-2,4(1H,3H)-pyrimidinedione|Thymin (purine base)|5-methyl-1H-pyrimidine-2,4-dione|5-Methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione|CCRIS 5584|UNII-QR26YLT7LT|MFCD00006026|5-methylpyrimidine-2,4-diol|5-Methylpyrimidine-2,4-dione|4-Hydroxy-5-methylpyrimidin-2(1H)-one|CHEBI:17821|AI3-25479|NSC14705|QR26YLT7LT|CHEMBL993|5-Methyl-2,4-dihydroxypy",126.110,C5H6N2O2,58.200,195.000,-0.600,9,2,2,0,"InChI=1S/C5H6N2O2/c1-3-2-6-5(9)7-4(3)8/h2H,1H3,(H2,6,7,8,9)",CC1=CNC(=O)NC1=O,RWQNBRDOKXIBIV-UHFFFAOYSA-N,"5-methyl-1H-pyrimidine-2,4-dione",Thymine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,155|157|161|165|167|175|192|210|220|222|226|248|274|302|328|330|47311|155106|155120|155299|211081|217732|477229|501986|501987|501988|1149713|1149714|1149715|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159555|1224834|1224835|1224836|1224837|1224838|1224839|1224840|1224841|1224842|1224843|1224844|1224845|1224846|1224847|1224848|1224849|1224867|1224868|1224869|1224870|1224871|1224872|1224873|1224874|1224875|1224876|1224877|1224878|1224879|1224880|1224881|1224882|122,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2Z Chemical|AAA Chemistry|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Allbio Pharm Co., Ltd|Ambeed|Ambinter|AN PharmaTech|Anward|Apexmol|Ark Pharm, Inc.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
1188,Xanthine,"xanthine|69-89-6|2,6-Dihydroxypurine|Isoxanthine|Xanthin|2,6-dioxopurine|Pseudoxanthine|1H-Purine-2,6(3H,7H)-dione|Xanthic oxide|1H-Purine-2,6-diol|9H-Purine-2,6-diol|Purine-2,6-diol|1H-Purine-2,6-dione, 3,7-dihydro-|3,7-Dihydro-1H-purine-2,6-dione|2,6(1,3)-Purinedion|3,7-dihydropurine-2,6-dione|Purine-2(3H),6(1H)-dione|USAF CB-17|XAN|2,6-Dioxo-1,2,3,6-tetrahydropurine|3,9-dihydro-1H-purine-2,6-dione|9H-Purine-2,6-(1H,3H)-dione|1H-Purine-2,6-dione, 3,9-dihydro-|Purine-2,6-(1H,3H)-dione|9H-xanthine|UNII-1AVZ",152.110,C5H4N4O2,86.900,217.000,-0.700,11,3,3,0,"InChI=1S/C5H4N4O2/c10-4-2-3(7-1-6-2)8-5(11)9-4/h1H,(H3,6,7,8,9,10,11)",C1=NC2=C(N1)C(=O)NC(=O)N2,LRFVTYWOQMYALW-UHFFFAOYSA-N,"3,7-dihydropurine-2,6-dione",Xanthine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,155|157|161|165|167|175|248|270|608|1033|1469|1479|1549|1552|1637|1648|2842|32155|55471|66419|74022|75917|187182|202405|219846|227877|239883|252792|252796|274549|274550|274551|274554|274562|274563|363284|363291|453742|453743|453745|453746|485350|485395|493033|502389|502390|504770|540299|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|651741|651743|651749|651751|651777|651778|651828|651838|705460|720636|720641|720653|720659|720717|,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aronis|Assembly ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, PDB, Protein Data Bank]"
3191,Ebastine,"ebastine|90729-43-4|Kestine|Ebastel|Ebastin|Kestin|Bactil|LAS W-090|RP 64305|UNII-TQD7Q784P1|1-(4-tert-butylphenyl)-4-[4-(diphenylmethoxy)piperidin-1-yl]butan-1-one|LAS-W 090;RP64305|4-(4-benzhydryloxypiperidin-1-yl)-1-(4-tert-butylphenyl)butan-1-one|CHEMBL305660|TQD7Q784P1|LAS-W-090|MFCD00865661|1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone|NCGC00164603-01|Evastel|RP-64305|4-(4-(benzhydryloxy)piperidin-1-yl)-1-(4-(tert-butyl)phenyl)butan-1-one|RP64305|1-(4-(1,1-Dimethylet",469.700,C32H39NO2,29.500,594.000,7.200,35,0,3,10,"InChI=1S/C32H39NO2/c1-32(2,3)28-18-16-25(17-19-28)30(34)15-10-22-33-23-20-29(21-24-33)35-31(26-11-6-4-7-12-26)27-13-8-5-9-14-27/h4-9,11-14,16-19,29,31H,10,15,20-24H2,1-3H3",CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,MJJALKDDGIKVBE-UHFFFAOYSA-N,4-(4-benzhydryloxypiperidin-1-yl)-1-(4-tert-butylphenyl)butan-1-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,12,880|1469|1471|1479|1487|1490|1688|1766|1768|2528|2546|2551|2660|2662|2666|2667|2668|2701|2707|3500|17268|19453|24863|35986|62637|76623|76625|86582|135327|140895|142102|234883|243151|250135|463106|485290|485295|485297|485298|485313|485342|485345|485366|485368|488772|488773|488816|488837|488949|488953|488978|488981|488982|488983|492961|493106|493107|493153|493164|504327|504332|504536|504547|504548|504749|504810|504812|504832|504834|504836|504845|504847|504865|540256|540276|576612|588349|588378|588453|588456|5,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|ApexBio Technology|Ark Pharm, Inc.|Aromalake Chemical|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|AvaChem Scient",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3961,Losartan,losartan|114798-26-4|DUP 89|Lortaan|Cozaar|LOSARTAN POTASSIUM|Hyzaar|UNII-JMS50MPO89|CHEBI:6541|MK-954|JMS50MPO89|(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DTXSID7023227|DuP 753|MFCD00865831|[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol|NCGC00095125-01|Losartan [INN:BAN]|DSSTox_CID_3227|DSSTox_RID_76933|DSSTox_GSID_23227|(1-((2,422.900,C22H23ClN6O,92.500,520.000,4.300,30,2,5,8,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,PSIFNNKUMBGKDQ-UHFFFAOYSA-N,[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol,Losartan,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1195|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1865|1948|2063|2101|2107|2112|2147|2240|2241|2275|2313|2322|2330|2451|2472|2517|2528|2546|2549|2551|2662|8003|9310|10690|13548|18415|23693|37514|37517|37524|37538|37542|37543|37546|37673|37674|37676|37686|37687|37689|37691|37696|37698|37699|37705|37824|37827|37830|37837|37841|37843|37844|37969|37973|37998|38130|381,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Alomone Labs|Alsachim|Amadis Chemical|Am",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
5884,NADPH,"NADPH|53-57-6|Dihydronicotinamide-adenine dinucleotide phosphate|TPNH|UNII-381Q4X082D|CHEBI:16474|2646-71-1|381Q4X082D|beta-NADPH|Reduced Nicotinamide Adenine Dinucleotide Phosphate|reduced nicotinamide-adenine dinucleotide phosphate|reducednicotinamide-adenine dinucleotide phosphate|Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'-5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide|nadph hydride|dihydronicotinamide adenine dinucleotide phosphate|EINECS 200-177-6|beta",745.400,C21H30N7O17P3,364.000,1410.000,-6.800,48,9,22,13,"InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O,ACFIXJIJDZMPPO-NNYOXOHSSA-N,"[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",NADP,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,1409598,20040916,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|Aurora Fine Chemicals LLC|BIND|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|CCSbase",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5886,Codehydrase II,NADP+|NADP|Codehydrase II|coenzyme II|triphosphopyridine nucleotide|NAD phosphate|nicotinamide adenine dinucleotide phosphate|Cozymase II|Nadide phosphate|b-NADP|53-59-8|nicotinamide adenine dinucleotide phosphate (NADP)|NADP(+)|beta-TPN|Nicotinamide-adenine dinucleotide phosphate|beta-NADP+|BRN 3885115|beta-nicotinamide adenine dinucleotide phosphate|TPN|beta-NADP|Adenine-nicotinamide dinucleotide phosphate|nadp nicotinamide-adenine-dinucleotide phosphate|b-TPN|Spectrum_001530|Spectrum2_000023|Spectrum4_00,744.400,C21H29N7O17P3+,365.000,1300.000,-7.000,48,9,21,13,"InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)OP(=O)(O)O)O)O)O)C(=O)N,XJLXINKUBYWONI-NNYOXOHSSA-O,"[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",NADP,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,11,1259398|1259399,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Allbio Pharm Co., Ltd|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BePharm Ltd.|BI",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5892,Nadide,"nadide|NAD+|53-84-9|coenzyme I|beta-NAD|nicotinamide adenine dinucleotide|beta-NAD+|Codehydrase I|diphosphopyridine nucleotide|beta-nicotinamide adenine dinucleotide|Cozymase I|Codehydrogenase I|beta-Diphosphopyridine nucleotide|Enzopride|NAD|CO-1|CO-I|Pyridine, nucleotide diphosphate|COZYMASE|Nicotinamide-adenine dinucleotide|Nicotinamide dinucleotide|beta-DPN|Oxidized diphosphopyridine nucleotide|Nadidum [INN-Latin]|Nadida [INN-Spanish]|Adenine-nicotinamide dinucleotide|C21H27N7O14P2|MFCD00036253|beta-Dip",663.400,C21H27N7O14P2,321.000,1120.000,-6.000,44,7,18,11,"InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N,BAWFJGJZGIEFAR-NNYOXOHSSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NAD,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,13,940|1332|1422|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1611|1612|1613|1614|1616|2517|33708|33861|52125|70969|74665|74666|99367|99370|106792|106795|268956|269134|269136|492967|493162|588211|588212|588213|588834|597364|597365|624349|651631|651632|651633|651634|652048|652051|686977|686978|686979|720516|720532|720533|720552|720634|720635|720637|720641|720674|720675|720678|720679|720680|720681|720682|720683|72,20050608,"A2B Chem|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acorn PharmaTech Product List|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Anward|Aurora Fine Chemicals LLC|BIND|BindingDB|BLD Pharm|BOC Sciences|Burnham Center for Chemical Genomics|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5893,Nicotinamide adenine dinucleotide,nicotinamide adenine dinucleotide|NAD+|beta-NAD|Codehydrase I|coenzyme I|Cozymase I|Codehydrogenase I|NAD(+)|diphosphopyridine nucleotide|Nicotineamide adenine dinucleotide|Enzopride|Nicotinamide dinucleotide|beta-Diphosphopyridine nucleotide|NAD|COZYMASE|53-84-9|Adenine-nicotinamide dinucleotide|Nadidum [INN-Latin]|Nadida [INN-Spanish]|Oxidized diphosphopyridine nucleotide|CHEBI:15846|NAD trihydrate|NAD-oxidized|Nicotinamide-adenine dinucleotide|BRN 3584133|Endopride|Nicotinamide-Adenine-Dinucleotide|dipho,664.400,C21H28N7O14P2+,318.000,1130.000,-5.900,44,8,18,11,"InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N,BAWFJGJZGIEFAR-NNYOXOHSSA-O,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate",NAD,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,11,1259251|1259310|1259374|1259416|1259421|1259422|1409598,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AN PharmaTech|Anward|Aurora Fine Chemicals LLC|BenchChem|BIND|BindingDB|BioCyc|Biological Magnetic Reson",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5957,Adenosine-5'-triphosphate,Adenosine triphosphate|Adenosine 5'-triphosphate|56-65-5|Triphosphaden|ATP|Myotriphos|Striadyne|Triadenyl|Adephos|Atriphos|Atipi|Adenosine 5'-(tetrahydrogen triphosphate)|adenosine-5'-triphosphate|Glucobasin|Adetol|Adynol|5'-Atp|Triphosaden|Adenylpyrophosphoric acid|Triphosphoric acid adenosine ester|ATP (nucleotide)|Adenosine 5'-triphosphoric acid|Cardenosine|Fosfobion|Adenosintriphosphorsaeure|adenosine-triphosphate|Ado-5'-P-P-P|H4atp|UNII-8L70Q75FXE|9-beta-D-Arabinofuranosyladenine 5'-triphosphate|CHEBI:,507.180,C10H16N5O13P3,279.000,800.000,-5.700,31,7,17,8,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,ZKHQWZAMYRWXGA-KQYNXXCUSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",Adenosine Triphosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,880|1030|1195|1457|1458|1460|1463|1468|1469|1471|1477|1479|1487|1490|1688|1766|1768|1811|1865|2101|2107|2112|2517|2528|2546|2549|2551|2662|17440|17441|17442|20490|20491|20492|20493|22448|22584|22585|22586|26386|27130|27131|27132|27133|30121|30122|34777|34901|34916|34926|35063|35067|35078|35103|50024|68445|68446|70375|70376|70377|70544|75732|77349|77355|77357|88431|88434|88442|88446|88451|88452|91555|91556|91558|107746|107748|107767|107768|107905|107906|126592|146705|146808|150144|150151|150161|150166|150170,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Anward|Apexmol|AstaTech,",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5960,Aspartic acid,"L-aspartic acid|aspartic acid|56-84-8|H-Asp-OH|L-aspartate|Asparagic acid|(2S)-2-aminobutanedioic acid|Aspatofort|L-Aminosuccinic acid|aspartate|(S)-2-Aminosuccinic acid|L-Asparagic acid|Asparaginic acid|L-Asparaginic acid|(S)-Aspartic acid|(2S)-Aspartic acid|(S)-Aminobutanedioic acid|L-Aspartinsaeure|L-Asparaginsaeure|L-Asparaginsyra|Aspartic acid, L-|Acidum asparticum|L-(+)-Aspartic acid|L-Asp|L-2-Aminobutanedioic acid|Aspartate, L-|Asparaginsaeure [German]|Aminosuccinic acid|Butanedioic acid, amino-, (S)",133.100,C4H7NO4,101.000,133.000,-2.800,9,3,5,3,"InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1",C([C@@H](C(=O)O)N)C(=O)O,CKLJMWTZIZZHCS-REOHCLBHSA-N,(2S)-2-aminobutanedioic acid,Aspartic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,410|411|422|429|436|445|447|448|450|451|526|530|547|584|585|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|917|918|923|924|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1195|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1705|1707|1708|1766|1768|1815|1816|1828|1851|1865|1876|1877|1882|1883|1886|1948|1967|2101|2107|2112|2147|2323|2326|2353|2364|2451|2472|2517|2,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5988,Sucrose,"sucrose|57-50-1|saccharose|Cane sugar|Table sugar|White sugar|D-Sucrose|sugar|Rohrzucker|Saccharum|Granulated sugar|Amerfand|Amerfond|Microse|Beet sugar|Rock candy|Confectioner's sugar|Sucrose, dust|Sucrose, pure|D(+)-Saccharose|sacarosa|D-(+)-Sucrose|Sucraloxum [INN-Latin]|D-(+)-Saccharose|beta-D-Fructofuranosyl alpha-D-glucopyranoside|beta-D-Fructofuranosyl-alpha-D-glucopyranoside|D(+)-Sucrose|CCRIS 2120|HSDB 500|Sacharose|alpha-D-Glucopyranosyl beta-D-fructofuranoside|CHEBI:17992|D-Saccharose|AI3-09085|(",342.300,C12H22O11,190.000,395.000,-3.700,23,8,11,5,"InChI=1S/C12H22O11/c13-1-4-6(16)8(18)9(19)11(21-4)23-12(3-15)10(20)7(17)5(2-14)22-12/h4-11,13-20H,1-3H2/t4-,5-,6-,7-,8+,9-,10+,11-,12+/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)CO)O)O)CO)O)O)O)O,CZMRCDWAGMRECN-UGDNZRGBSA-N,"(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",Sucrose,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,1189|1194|1199|1205|1469|1471|1479|1490|1688|1766|1768|1811|2528|2546|2551|2662|23672|24032|26811|78477|89762|90086|90224|90258|90259|90260|91480|189629|311367|337692|337693|369769|369774|369781|369782|369783|369784|369785|369786|369787|369788|369789|369790|369791|369793|369795|369797|369799|369800|369805|455986|485290|492961|504327|504332|504749|504832|504834|504847|504865|588211|588212|588213|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|58,20040916,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|ApexBio Technology|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|CCSbase|Changzhou Highassay Chemical C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6022,Adenosine-5'-diphosphate,Adenosine 5'-diphosphate|Adenosine diphosphate|58-64-0|Adenosine 5'-(trihydrogen diphosphate)|ADP|adenosine-5'-diphosphate|adenosine pyrophosphate|5'-Adenylphosphoric acid|adenosine 5'-pyrophosphate|ADP (nucleotide)|5'-Adp|Adenosindiphosphorsaeure|adenosine-diphosphate|Adenosine 5'-pyrophosphoric acid|Adenosine-5'-diphosphat|Adenosine 5'-diphosphoric acid|Adenosine diphosphoric acid|Ado-5'-P-P|UNII-61D2G4IYVH|H3adp|BRN 0067722|CHEBI:16761|adenosine-5-diphosphate|adenosine 5' diphosphate|61D2G4IYVH|CHEMBL148,427.200,C10H15N5O10P2,233.000,638.000,-4.600,27,6,14,6,"InChI=1S/C10H15N5O10P2/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(24-10)1-23-27(21,22)25-26(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O)N,XTWYTFMLZFPYCI-KQYNXXCUSA-N,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",Adenosine Diphosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1811|1865|2101|2107|2112|2517|2549|54140|70544|77349|77352|77360|88903|90064|91204|91216|91555|91556|91557|91558|146705|150151|150166|150170|150172|150321|150470|150495|152476|152489|155650|155653|162978|162984|162985|162990|162991|163119|167868|167870|167875|196094|196095|196096|198128|219831|227514|227517|250016|250020|250031|253000|253001|253002|266546|266547|269131|269135|269136|270492|271163|271168|271169|271171|325369|325372|325375|325378|3309,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambeed|Ambinter|Apexmol|AstaTech, Inc.|Aurora Fine Chemicals LLC|Avantor Inc|BePharm L",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, PDB, Protein Data Bank]"
6042,Vitamin B1,"vitamin B1|59-43-8|Thiamine monochloride|Thiamine chloride|3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-5-(2-hydroxyethyl)-4-methylthiazol-3-ium chloride|Aneurine|Thiaminum|Tiamina|thiamine(1+) chloride|Betabion|UNII-X66NSO3N35|X66NSO3N35|CHEBI:33283|Bethiamin|Oryzanin|Oryzanine|Vitaneurin|Beivon|Apatate drape|Thiamine (Vit B1)|3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-methylthiazolium chloride|Thiamine, chloride|B-Amin|3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-meth",300.810,C12H17ClN4OS,104.000,269.000,NULL,19,2,6,4,"InChI=1S/C12H17N4OS.ClH/c1-8-11(3-4-17)18-7-16(8)6-10-5-14-9(2)15-12(10)13;/h5,7,17H,3-4,6H2,1-2H3,(H2,13,14,15);1H/q+1;/p-1",CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.[Cl-],MYVIATVLJGTBFV-UHFFFAOYSA-M,"2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol;chloride",Thiamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,1195|1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1984|1986|1987|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|2073|2094|2097|2098|2099|2100|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2288|2289|2300|2314|2315|2326|2380|2391|2435|2445|2451|2462|2472|25,20050719,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BioCrick|Biosynth Carbosynth|BLD Pharm|Boerchem|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemExper",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
10918,(3-Carboxy-2-(R)-hydroxy-propyl)-trimethyl-ammonium,"(R)-carnitinium|(3-CARBOXY-2-(R)-HYDROXY-PROPYL)-TRIMETHYL-AMMONIUM|CHEBI:39547|(2R)-3-carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium|[(2R)-3-carboxy-2-hydroxypropyl]-trimethylazanium|541-15-1|DEXTROCARNITINE|44984-08-9|SCHEMBL1069009|CHEMBL1229656|DTXSID20274509|ZINC3079340|DB02648|SBI-0206849.P001|Trimethyl[(R)-3-carboxy-2-hydroxypropyl]aminium|SR-05000002013|SR-01000765388-6|SR-05000002013-1|Q27093606",162.210,C7H16NO3+,57.500,139.000,-0.800,11,2,3,4,"InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/p+1/t6-/m1/s1",C[N+](C)(C)C[C@@H](CC(=O)O)O,PHIQHXFUZVPYII-ZCFIWIBFSA-O,[(2R)-3-carboxy-2-hydroxypropyl]-trimethylazanium,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,1259310|1259318|1259374|1259397|1259398|1259399|1259416|1259421|1259422|1259423|1272365,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambint",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
12599,2'-Deoxyadenosine-5'-monophosphate,"2'-deoxyadenosine-5'-monophosphate|653-63-4|dAMP|2'-Deoxyadenosine 5'-monophosphate|2'-Deoxyadenylic acid|Deoxyadenylic acid|Deoxy-AMP|Deoxyadenosine monophosphate|2'-Deoxyadenosine 5'-phosphate|5'-Adenylic acid, 2'-deoxy-|2'-Deoxy-AMP|Deoxyadenosine 5'-monophosphate|2'-dAMP|Deoxyadenosine 5'-phosphate|Deoxy-5'-adenylic acid|Poly(dA)|2'-DEOXY-5'-ADENYLIC ACID|2'-Deoxyadenosine monophosphate|2-Deoxyadenosine-5-monophosphate|d-AMP|2'-Deoxy-5'-adenosine monophosphate|PdA (VAN)|UNII-VFR8I97ORM|2'-Deoxyadenosine",331.220,C10H14N5O6P,166.000,452.000,-2.200,22,4,10,4,"InChI=1S/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)O)O,KHWCHTKSEGGWEX-RRKCRQDMSA-N,"[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Micromolar,9,485|568|583|598|602|606|618|620|629|630|631|633|639|648|687|701|719|731|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|142,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Anward|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BIND|BioCyc|Biological Magnetic ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
18950,D-Mannose,"D-Man|D-Mannopyranose|D-Mannopyranoside|D-Mannose|Man|Mannopyranose|Mannopyranoside|Mannose|Carubinose|Seminose|D-(+)-Mannose|530-26-7|(+)-Mannose|(3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol|CHEBI:4208|DL-Mannose|D(+)-Mannose|(+-)-Mannose|MFCD00064122|SMR000857125|2h-pyran-2,3,4,5-tetraol|D-Mannose,(S)|alpha,beta-D-mannopyranose|bmse000018|bmse000874|bmse000882|Epitope ID:152206|SCHEMBL38300|MLS001332527|MLS001332528|CHEMBL469448|GTPL4650|DTXSID5040463|HMS2236J04|BDBM50448403|s5763|AKOS025212856|D-(",180.160,C6H12O6,110.000,151.000,-2.600,12,5,6,1,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@@H](C(O1)O)O)O)O)O,WQZGKKKJIJFFOK-QTVWNMPRSA-N,"(3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol",Mannose,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,11,1469|1477|1479|1490|1511|1554|1662|1663|1672|1766|1768|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2107|2112|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2314|2315|2380|2391|2435|2445|2451|2462|2472|2517|2520|2521|2524|2528|2540|2544|2546|2549|2550|2551|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|30427|30429|10810,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemtek|Acorn PharmaTech Product List|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|Burnham Center for Chemical Genomics|CCSbase|ChangChem|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collabora",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
33032,Glutamic acid,"L-glutamic acid|GLUTAMIC ACID|56-86-0|(2S)-2-Aminopentanedioic acid|H-Glu-OH|(S)-2-Aminopentanedioic acid|L-glutamate|Glutaton|Aciglut|(S)-Glutamic acid|L-Glutaminic acid|Glutamicol|Glutamidex|Glusate|glutacid|glutaminic acid|L-glu|Glutaminol|D-Glutamiensuur|Acidum glutamicum|Poly-L-glutamate|alpha-aminoglutaric acid|L-(+)-glutamic acid|L-2-Aminoglutaric acid|POLYGLUTAMIC ACID|Acido glutamico|Glutamic acid polymer|Acide glutamique|1-Aminopropane-1,3-dicarboxylic acid|glut|glutamate|Glutamic acid, L-|(S)-(+)",147.130,C5H9NO4,101.000,145.000,-3.700,10,3,5,4,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",C(CC(=O)O)[C@@H](C(=O)O)N,WHUUTDBJXJRKMK-VKHMYHEASA-N,(2S)-2-aminopentanedioic acid,Glutamic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,410|411|445|447|448|450|451|526|530|584|585|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|923|924|926|938|995|1030|1189|1194|1195|1199|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1811|1851|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|2660|2666|2667|2668|18077|22598|22733|25112|26351|26365|26366|26367|26636|26797|26845|26874|30257|39376|57548|57550|58931|66956|74669|74816|74817|74818|7,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Apexmol|Assembly ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, PDB, Protein Data Bank]"
34755,S-Adenosylmethionine,"S-adenosyl-L-methionine|S-adenosylmethionine|Ademetionine|AdoMet|29908-03-0|SAM-e|SAMe|Donamet|L-S-Adenosylmethionine|Methioninyladenylate|S Amet|adenosylmethionine|Active methionine|L-Methionine, S-adenosyl-|CCRIS 7130|S-adenosyl-L-methioninate|(R)-ademetionine|(S)-ademetionine|UNII-6EZ5466ZUX|UNII-K093C397UL|Methionine, S-adenosyl-|Ademetionine, (S)-|SAM|6EZ5466ZUX|(2S)-2-Amino-4-((((2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(methyl)sulfonio)butanoate|CHEBI:67040|UNII",398.400,C15H22N6O5S,187.000,527.000,-2.800,27,4,10,6,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1",C[S+](CC[C@@H](C(=O)[O-])N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,MEFKEPWMEQBLKI-AIRLBKTGSA-N,"(2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]butanoate",S-Adenosylmethionine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,13,27327|50099|164153|164154|199770|199771|199775|199778|199779|199903|199908|199909|199916|199920|199921|282842|282843|282844|282845|282846|282847|327641|327642|476872|498926|498929|613026|638161|638162|638247|638248|638249|638250|642179|642180|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1133261|1133262|1259409|1296008|1296009|1345084|1346986|1346987|1347055|1347159|1347160,20050608,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambeed|AN PharmaTech|BIND|BindingDB|BLD Pharm|Boerchem|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFaces|Chemical Carcinogenesis Research Information System (CCRIS",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
35717,N-Acetyl-D-Galactosamine,"2-Acetamido-2-Deoxy-D-Galactopyranose|2-Acetamido-2-Deoxy-D-Galactopyranoside|2-Acetamido-2-Deoxy-D-Galactose|2-Acetamido-2-Deoxy-Galactopyranose|2-Acetamido-2-Deoxy-Galactopyranoside|2-Acetamido-2-Deoxy-Galactose|2-Deoxy-2-Acetamido-D-Galactopyranose|2-Deoxy-2-Acetamido-D-Galactopyranoside|2-Deoxy-2-Acetamido-D-Galactose|2-Deoxy-2-Acetamido-Galactopyranose|2-Deoxy-2-Acetamido-Galactopyranoside|2-Deoxy-2-Acetamido-Galactose|D-GalNAc|GalNAc|N-Acetyl-D-Galactosamine|N-Acetyl-Galactosamine|14215-68-0|N-((3R,4R",221.210,C8H15NO6,119.000,235.000,-1.700,15,5,6,2,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8?/m1/s1",CC(=O)N[C@@H]1[C@H]([C@H]([C@H](OC1O)CO)O)O,OVRNDRQMDRJTHS-KEWYIRBNSA-N,"N-[(3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",Acetylgalactosamine,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,71968|381592|381593|381594|381595|381596|381597|452767,20040916,"3B Scientific (Wuhan) Corp|abcr GmbH|ABI Chem|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Anward|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChangChem|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
60961,Adenosine,"adenosine|58-61-7|Adenocard|Adenoscan|Adenine riboside|beta-D-Adenosine|Nucleocardyl|Adenosin|Boniton|Sandesin|Myocol|Adenine nucleoside|Adenocor|beta-Adenosine|9-beta-D-Ribofuranosyladenine|9-beta-D-Ribofuranosidoadenine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|Adenosin [German]|USAF CB-10|9beta-D-Ribofuranosyladenine|6-Amino-9-beta-D-ribofuranosyl-9H-purine|Ade-Rib|Caswell No. 010B|Adenosine [USAN:BAN]|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|beta-D-Ribofuranoside, adenine-9|6-",267.240,C10H13N5O4,140.000,335.000,-1.100,19,4,8,2,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,OIRDTQYFTABQOQ-KQYNXXCUSA-N,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol",Adenosine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|608|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|653|680|684|686|687|701|708|709|719|731|734|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alinda Chemical|Ambeed|Anward|Apexmol|Ark Pharma Scientifi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank, COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
79025,alpha-D-Glucose,"alpha-D-glucose|alpha-D-Glucopyranose|492-62-6|alpha-Dextrose|alpha-glucose|Glucopyranose, alpha-D-|alpha-D-Glc|a-D-Glucopyranose|UNII-5J5I9EB41E|Grape sugar|CHEBI:17925|(2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol|glucoses|(2S,3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol|Corn sugar|5J5I9EB41E|CHEMBL423707|D-gluose|alpha-D-Glucopyranose, homopolymer|alpha-D-glucose, Phase I|alpha-D-glucose, Phase II|alpha-D-glucopyranose, Phase I|alpha-D-glucopyranose, Phase II|a-Dextrose|.alp",180.160,C6H12O6,110.000,151.000,-2.600,12,5,6,1,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6+/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O,WQZGKKKJIJFFOK-DVKNGEFBSA-N,"(2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,11,28956|28957|28958|264487|453252|480616|614129|667422|768836|1186738|1186739|1249212|1333322|1333323|1333327|1353852|1409598,20040916,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|AN PharmaTech|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCrick|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Databas",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, PDB, Protein Data Bank]"
124886,Glutathione,"glutathione|70-18-8|L-Glutathione|Glutathion|Isethion|Tathion|L-Glutathione reduced|reduced glutathione|Glutathione-SH|Glutinal|Deltathione|Neuthion|Copren|Glutide|Tathione|Triptide|Ledac|GSH|Glutatione|Glutatiol|Glutathione (reduced)|glutathione reduced|Panaron|gamma-L-Glutamyl-L-cysteinylglycine|L-gamma-glutamyl-L-cysteinylglycine|Glutathione SH|L-Glutatione|Agifutol S|L-Glutathione, reduced|gamma-L-glutamyl-L-cysteinyl-glycine|5-L-Glutamyl-L-cysteinylglycine|gamma-L-Glutamylcysteinylglycine|glutathione r",307.330,C10H17N3O6S,160.000,389.000,-4.500,20,6,8,9,"InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1",C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,RWSXRVCMGQZWBV-WDSKDSINSA-N,(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid,Glutathione,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,608|940|1033|1195|1422|1549|1552|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1611|1612|1613|1614|1616|1637|1648|1811|2517|25778|25787|26023|26336|74123|75134|316417|316421|323194|360084|370723|389190|389193|390209|390210|390211|390212|390216|390217|390218|390219|390220|390221|390222|390223|390224|390225|390226|390227|390228|404304|410195|447535|485350|492967|493033|493162|498723|504770|520297|520298|520299|5,20050608,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alfa Aesar|Ambeed|Ambinter|Anward|ApexBio Technology|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BIND|BindingDB|BioCrick|BioCyc|Biological Magnetic Resonanc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
188966,2'-Deoxyadenosine-5'-diphosphate,"dADP|Deoxyadenosine diphosphate|2'-deoxyadenosine-5'-diphosphate|2'-Deoxyadenosine 5'-diphosphate|2'-deoxyadenosine 5'-(trihydrogen diphosphate)|2793-06-8|UNII-APQ916I0QD|APQ916I0QD|72003-83-9|2'-Deoxyadenosine-5'-diphosphate disodium salt|deoxy-ADP|2'-deoxy-ADP|bmse000253|SCHEMBL77641|2'-Deoxyadenosine diphosphate|Deoxyadenosine 5'-diphosphate|CHEBI:16174|2'-Deoxyadenosine 5'-pyrophosphate|2'-Deoxyadenosine-5'- diphosphate|ZINC8215728|Adenosine, 2'-deoxy-, 5'-pyrophosphate|C00206|Adenosine, 2'-deoxy-, 5'-(",411.200,C10H15N5O9P2,212.000,607.000,-3.300,26,5,13,6,"InChI=1S/C10H15N5O9P2/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(23-7)2-22-26(20,21)24-25(17,18)19/h3-7,16H,1-2H2,(H,20,21)(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)COP(=O)(O)OP(=O)(O)O)O,DAEAPNUQQAICNR-RRKCRQDMSA-N,"[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,7,NULL,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|AstaTech, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Combi-Bloc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439341,Maltose,"alpha-Maltose|maltose|Amylodextrin|Starch, soluble|9005-84-9|Thyodene|Starch solution|Glcalpha1-4Glca|4482-75-1|UNII-15SUG9AD26|Glcalpha1-4Glcalpha|alpha-D-Glucopyranose, 4-o-alpha-D-glucopyranosyl-|15SUG9AD26|4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranose|alpha-D-Glcp-(1->4)-alpha-D-Glcp|(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol|D-(+)-Maltose|Thyodene™ Indicator|Starch, ACS reagent, soluble|Starch, for analysis, soluble|a",342.300,C12H22O11,190.000,382.000,-4.700,23,8,11,4,"InChI=1S/C12H22O11/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17/h3-20H,1-2H2/t3-,4-,5-,6+,7-,8-,9-,10-,11+,12-/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O,GUBGYTABKSRVRQ-ASMJPISFSA-N,"(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1811|977610|977611,20040916,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|Acros Organics|AHH Chemical co.,ltd|AKos Consulting & Solutions|BenchChem|BindingDB|BioCyc|Biosynth Carbosynth|ChEBI|Chem-Space.com Database|Chemenu Inc.|ChemIDplus|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|EPA Substance Registry Services|FDA/SPL Indexing Data|Fisher Chemical|GlyTouCan P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map]"
439373,L-Gulonolactone,"L-Gulono-1,4-lactone|L-Gulonolactone|1128-23-0|L-Gulono-gamma-lactone|(3S,4R,5R)-5-((S)-1,2-Dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-one|gamma-Gulonolactone|L-Gulonic gamma-lactone|L-Gulonic acid gamma-lactone|L-(+)-Gulonic Acid gamma-Lactone|MFCD00064331|L-Gulonic acid |A-lactone|(3S,4R,5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-one|UNII-56830VTX9G|L-(+)-Gulono-1,4-lactone|L(+)-Gulonic acid gaMMa-lactone|56830VTX9G|Gulonolactone|L(+)-Gulonic acid gamma-lactone, 95+%|L-Gulonic acid g-lacto",178.140,C6H10O6,107.000,181.000,-2.000,12,4,6,2,"InChI=1S/C6H10O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2-5,7-10H,1H2/t2-,3+,4-,5+/m0/s1",C([C@@H]([C@@H]1[C@@H]([C@@H](C(=O)O1)O)O)O)O,SXZYCXMUPBBULW-SKNVOMKLSA-N,"(3S,4R,5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-one",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|ChemIDplus|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
439586,Pullulan,"maltotriose|1109-28-0|D-MALTOTRIOSE|Amylotriose|(2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol|(2R,3R,4S,5S,6R)-2-{[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol|113158-51-3|n+2 maltodextrin|Maltooligosaccharide|delta-(+)-Maltotriose|Glcalpha1-4Glcalpha1-4Gl",504.400,C18H32O16,269.000,641.000,-6.900,34,11,16,7,"InChI=1S/C18H32O16/c19-1-4-7(22)8(23)12(27)17(31-4)34-15-6(3-21)32-18(13(28)10(15)25)33-14-5(2-20)30-16(29)11(26)9(14)24/h4-29H,1-3H2/t4-,5-,6-,7-,8+,9-,10-,11-,12-,13-,14-,15-,16?,17-,18-/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](OC([C@@H]([C@H]3O)O)O)CO)CO)O)O)O)O,FYGDTMLNYKFZSV-DZOUCCHMSA-N,"(2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,10,NULL,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemSpider|Combi-Blocks|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA D",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
440101,5-O-Phosphono-alpha-D-ribofuranose,alpha-D-ribose-5-phosphate|alpha-D-Ribose 5-phosphate|5-O-phosphono-alpha-D-ribofuranose|alpha-D-ribofuranose 5-phosphate|CHEBI:18189|alpha-D-ribofuranose 5-(dihydrogen phosphate)|34980-65-9|HSX|5-phospho-alpha-d-ribose|SCHEMBL187934|CHEMBL605020|ZINC4096190|C03736|Q27102887|5-O-phosphono-alpha-D-ribose; 5-O-phosphono-D-ribose; 5-O-phosphono-ribose,230.110,C5H11O8P,137.000,238.000,-3.600,14,5,8,3,"InChI=1S/C5H11O8P/c6-3-2(1-12-14(9,10)11)13-5(8)4(3)7/h2-8H,1H2,(H2,9,10,11)/t2-,3-,4-,5+/m1/s1",C([C@@H]1[C@H]([C@H]([C@H](O1)O)O)O)OP(=O)(O)O,KTVPXOYAKDPRHY-AIHAYLRMSA-N,"[(2R,3S,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,8,30432|50023|94662,20050624,"A2B Chem|AA BLOCKS|ABI Chem|Alfa Chemistry|BioCyc|ChEBI|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|GlyTouCan Project|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MassBank Europe|MassBank of North America (MoNA)|MetabolomicsWorkbench|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Phion Ltd|Protein Data Bank in Europe (PDBe)|Springer Nature|SureChEMBL|Thomson Pharma|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
445528,"(4S,5S)-1,2-Dithiane-4,5-diol","(4S,5S)-1,2-DITHIANE-4,5-DIOL|4,5-Dihydroxy-1,2-dithiane|trans-4,5-Dihydroxy-1,2-dithiane|14193-38-5|(4S,5S)-dithiane-4,5-diol|37031-12-2|UNII-8T052MD8AP|trans-1,2-Dithiane-4,5-diol|8T052MD8AP|D1D|1,2-Dithiane-4,5-diol,(4R,5R)-rel-|L-4,5-Dihydroxy-1,2-dithiane|Oxidized DTT|cyclo-DTT|MFCD00006661|PubChem21314|(4S,5S)-4,5-dihydroxy-1,2-dithiane|o-DITHIANE, 4,5-DIHYDROXY-, L-|L-4,5-Dihydroxy-o-dithiane|SCHEMBL1628866|CHEBI:41837|YPGMOWHXEQDBBV-QWWZWVQMSA-|DTXSID80190534|ZINC895503|trans-4,5-Dihydroxy-1,2-dithi",152.200,C4H8O2S2,91.100,68.400,-0.600,8,2,4,0,"InChI=1S/C4H8O2S2/c5-3-1-7-8-2-4(3)6/h3-6H,1-2H2/t3-,4-/m1/s1",C1[C@H]([C@@H](CSS1)O)O,YPGMOWHXEQDBBV-QWWZWVQMSA-N,"(4S,5S)-dithiane-4,5-diol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity,8,811|833|1044|1792|1823|2291|434982|652031|1159607|1259370,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Aceschem Inc|Activate Scientific|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Biosynth Carbosynth|BOC Sciences|CAPOT|Center for Chemical Genomics, University of Michigan|ChEBI|Chembase.cn|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Chiralblock Biosciences|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics -",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
637568,Dimethyl fumarate,"Dimethyl fumarate|624-49-7|Tecfidera|(E)-Dimethyl fumarate|Fumaric acid dimethyl ester|Fumaric acid, dimethyl ester|Dimethyl (E)-but-2-enedioate|BG-12|Boletic acid dimethyl ester|Dimethyl trans-ethylenedicarboxylate|Dimethyl 2-butenedioate|Methyl fumarate|trans-Butenedioic acid dimethyl ester|BG00012|BG-00012|Fumaderm|Allomaleic acid dimethyl ester|trans-1,2-Ethylenedicarboxylic acid dimethyl ester|BIS-METHYL ESTER|Dimethyl fumar|FAG-201|BG 00012|2-Butenedioic acid (E)-, dimethyl ester|UNII-FO2303MNI2|(E)-b",144.120,C6H8O4,52.600,141.000,0.700,10,0,4,4,"InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+",COC(=O)/C=C/C(=O)OC,LDCRTTXIJACKKU-ONEGZZNKSA-N,dimethyl (E)-but-2-enedioate,Dimethyl Fumarate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,14,155|157|161|165|167|175|248|651828|651834|757414|757415|757416|757417|1063372|1136542|1136544|1136546|1136547|1136549|1136551|1136553|1136555|1136557|1136559|1136561|1136563|1136565|1136567|1136569|1136572|1224863|1230959|1230961|1230962|1230963|1230964|1230965|1230966|1259251|1259397|1259398|1259416|1259421|1259423|1345086|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347080|1347411|1348749|1348750|1409598|1409605|1409606|1432751|1432752|1432754|1432755|1432756|1432759|1432760|14,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Ark Pharm, Inc.|Aromsyn catalogue|Aurum Pharmatech LLC|BindingDB|BioCrick|BLD Pharm|Boerchem|Broad Institute|Center for Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
1738118,Aldehydo-N-acetyl-D-glucosamine,"aldehydo-N-acetyl-D-glucosamine|UNII-V956696549|2-Acetamido-2-deoxyglucose|D-Glucose, 2-(acetylamino)-2-deoxy-|N-((2R,3R,4S,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl)acetamide|N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide|D-Glucose, 2-(acetylamino)-2-deoxy-, homopolymer|V956696549|D-Glucose, 2-acetamido-2-deoxy-|Marine Sweet|GreenNAG|NSC 524344|134451-94-8|27555-50-6|Bio-NAG|shrimp shell|CCRIS 9357|MFCD00136044|NCGC00159338-02|NCGC00159338-03|EINECS 231-368-2|NSC 400525|PubChem14432|N Acety",221.210,C8H15NO6,127.000,221.000,-3.400,15,5,6,6,"InChI=1S/C8H15NO6/c1-4(12)9-5(2-10)7(14)8(15)6(13)3-11/h2,5-8,11,13-15H,3H2,1H3,(H,9,12)/t5-,6+,7+,8+/m0/s1",CC(=O)N[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O,MBLBDJOUHNCFQT-LXGUWJNJSA-N,"N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide",Acetylglucosamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,11,880|881|894|1030|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2528|2546|2549|2551|485281|485290|504327|504332|504847|588579|602332|624030|624170|624172|624173|1259411|1259416|1259421|1347041|1347165|1409598,20050712,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Angene Chemical|Anward|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|BePharm Ltd.|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|BroadPharm|CAPOT|ChEBI|Chem-Space.com Database|Chembase.cn|C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
2723872,D-Fructose,"D-Arabino-Hex-2-ulo-Pyranose|D-Fru|D-Fructopyranose|D-Fructopyranoside|D-Fructose|Fru|Fructopyranose|Fructopyranoside|Fructose|CHEBI:37714|C6H12O6|[14C]-Fructose|D-arabino-Hex-2-ulopyranose|SCHEMBL239448|CHEMBL2325229|AKOS004910390|F0317|C05003|Q27117234|EB37038E-44A6-4AF7-B0D8-47A315AD2F74|(3S,4R,5R)-2-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol",180.160,C6H12O6,110.000,162.000,-2.800,12,5,6,1,"InChI=1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4-,5+,6?/m1/s1",C1[C@H]([C@H]([C@@H](C(O1)(CO)O)O)O)O,LKDRXBCSQODPBY-VRPWFDPXSA-N,"(3S,4R,5R)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol",Fructose,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,14,728618|728620|728624,20050719,"3B Scientific (Wuhan) Corp|ABI Chem|AKos Consulting & Solutions|BioCyc|BLD Pharm|CCSbase|ChEBI|ChEMBL|ChemExper Chemical Directory|ChemSpider|ChemTik|DiscoveryGate|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Essentials of Glycobiology, 3rd edition|Golm Metabolome Database (GMD), Max Planck Institute of Molecular Plant Physiology|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LabNetwork, a WuXi AppTec Company|MassBank of No",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
3593277,2-Oxobutanoate,"2-oxobutanoate|2-ketobutyrate|alpha-ketobutyrate|alpha-Oxobutyrate|ethylglyoxylate|Ethyl glyoxalate, 50% in toluene|2-Ketobutanoate|a-Ketobutyric acid|ethylglyoxalate|2-oxobutanate|2uyn|2-oxidanylidenebutanoate|CHEBI:16763|ANW-56382|BDBM50273975|AKOS024437973|DB-002808|113525-EP2281820A2|113525-EP2298754A1|A832573|Q27102062",101.080,C4H5O3-,57.200,89.600,0.800,7,0,3,1,"InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)/p-1",CCC(=O)C(=O)[O-],TYEYBOSBBBHJIV-UHFFFAOYSA-M,2-oxobutanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20040916,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Amadis Chemical|Anward|BindingDB|BioCyc|ChEBI|ChemDB|ChemSpider|Debye Scientific Co., Ltd|DiscoveryGate|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NextMove Software|NMRShiftDB|Norris Pharm|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Shanghai Institute of Organic Chemistry|SLING Consortium|Smolecule|Tractus|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
5280793,Ergocalciferol,ergocalciferol|VITAMIN D2|Calciferol|50-14-6|Ercalciol|Viosterol|Oleovitamin D2|Deltalin|Ergorone|Sterogyl|Detalup|Drisdol|Condocaps|Crystallina|Fortodyl|Mulsiferol|Radsterin|Condol|Deratol|Diactol|Ertron|Geltabs|Ostelin|Daral|Novovitamin-D|Divit urto|D-Tracetten|Hi-Deratol|Calciferon 2|Dee-Ronal|Vitavel-D|D-Arthin|Dee-Ron|De-rat concentrate|Vio-D|Rodine C|Activated ergosterol|Calciferolum|Hyperkil|Rodinec|Mina D2|Viosterol in Oil|Radiostol|Haliver|Ergocalciferolum|Davitin|Metadee|Mykostin|(+)-Vitamin D2|De,396.600,C28H44O,20.200,678.000,7.400,29,1,1,5,"InChI=1S/C28H44O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-20,22,25-27,29H,4,7-8,11,14-18H2,1-3,5-6H3/b10-9+,23-12+,24-13-/t20-,22+,25-,26+,27-,28+/m0/s1",C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C,MECHNRXZTMCUDQ-RKHKHRCZSA-N,"(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol",Ergocalciferols,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,377|1189|1199|1332|1850|1863|1899|1903|1906|1947|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2101|2129|2130|2174|2177|2234|2235|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2557|2599|2606|2629|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|323922|323923|323924|323925|323928|323929|323932|434955|434962|434973|434989|435003|435005|435022|435030|449728|449762|449763|463079|463082|463104|463141|463190|463195|463210|463212|463254|485270|485272|485273|485275|4,20050624,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|ApexBio Technology|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|Broad Institute|BroadPharm|CAPOT|CCSbase|Center for Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5283731,Calcifediol,"Calcifediol|Calcidiol|25-hydroxyvitamin D3|25-Hydroxycholecalciferol|19356-17-3|Hidroferol|Calcifediol anhydrous|Didrogyl|25-Hydroxyvitamin D|Calderol|Calcifediolum|Rayaldee|Ro 8-8892|5,6-cis-25-Hydroxyvitamin D3|Cholecalciferol, 25-hydroxy-|UNII-T0WXW8F54E|CHEBI:17933|(3S,5Z,7E)-9,10-secocholesta-5,7,10-triene-3,25-diol|T0WXW8F54E|MFCD00867077|3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL|NCGC00161326-04|Calcifidiol|Delakmin|(3beta,5Z,7E)-9",400.600,C27H44O2,40.500,655.000,6.200,29,2,2,6,"InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C,JWUBBDSIWDLEOM-DTOXIADCSA-N,"(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol",Calcifediol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,880|894|1030|1195|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1688|1766|1768|1865|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|2662|25537|25549|55257|82334|121188|121189|121190|171532|171533|171535|171536|190592|190593|190594|190595|190597|190599|190601|190602|190603|190604|190606|190608|190610|190611|190612|190613|190615|190617|190619|190620|190741|190742|190744|190746|191093|191094|191095|191096|191098|191100|191102|191103|191104|191105|191107|191109|191111|19,20040916,"A2B Chem|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Achemtek|ACT Chemical|Active Biopharma|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|AN PharmaTech|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|CAPOT|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5461005,alpha-Linolenate,"alpha-Linolenate|(9Z,12Z,15Z)-octadeca-9,12,15-trienoate|(9,12,15)-linolenate|CHEMBL3122087|(9Z,12Z,15Z)-Octadecatrienoate|cis,cis,cis-9,12,15-octadecatrienoate|9Z,12Z,15Z-octadecatrienoate|CHEBI:32387|BDBM50448436|all-cis--9,12,15-octadecatrienoate|A827033|Q27114912",277.400,C18H29O2-,40.100,295.000,6.500,20,0,2,12,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/p-1/b4-3-,7-6-,10-9-",CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)[O-],DTOSIQBPPRVQHS-PDBXOOCHSA-M,"(9Z,12Z,15Z)-octadeca-9,12,15-trienoate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,9,NULL,20040916,"ABI Chem|Amadis Chemical|BindingDB|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|THE BioTek|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
7058168,Uridine-triphosphate,"UTP(4-)|Uridine-5'-Triphosphate Tetrasodium Salt|Uridine 5'-triphosphate trisodium salt hydrate|19817-92-6|uridine-triphosphate|CHEBI:46398|Uridine-5''-triphosphoricacidtrisodiumsalt|A834359|Q27104565|[[[(2R,3S,4R,5R)-5-(2,4-dioxo-1-pyrimidinyl)-3,4-dihydroxy-2-oxolanyl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate|[[[(2R,3S,4R,5R)-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanidyl-phosphoryl]oxy-oxidanidyl-phosphoryl] phosphate",480.110,C9H11N2O15P3-4,270.000,811.000,-6.100,29,3,15,7,"InChI=1S/C9H15N2O15P3/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H,10,12,15)(H2,16,17,18)/p-4/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])[O-])O)O,PGAVKCOVUIYSFO-XVFCMESISA-J,"[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20060729,"ABI Chem|Amadis Chemical|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|NextBio|Parchem|Phion Ltd|Thomson Pharma|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
16004692,Macitentan,Macitentan|441798-33-0|Opsumit|ACT-064992|ACT 064992|UNII-Z9K9Y9WMVL|N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide|ACT064992|Z9K9Y9WMVL|CHEBI:76607|Actelion-1|N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]-N'- propylsulfamide|Macitentan [USAN:INN]|macitentanum|zlchem 5|Opsumit (TN)|Macitentan (JAN/USAN)|(non-labelled)Macitentan-d7|MLS006011174|C19H20Br2N6O4S|GTPL7352|SCHEMBL1445625|CHEMBL2103873|DTXSID50196063|EX-A544|ZLA0005|HM,588.300,C19H20Br2N6O4S,137.000,642.000,3.700,32,2,10,11,"InChI=1S/C19H20Br2N6O4S/c1-2-7-26-32(28,29)27-17-16(13-3-5-14(20)6-4-13)18(25-12-24-17)30-8-9-31-19-22-10-15(21)11-23-19/h3-6,10-12,26H,2,7-9H2,1H3,(H,24,25,27)",CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,JGCMEBMXRHSZKX-UHFFFAOYSA-N,5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,699104|699106|699107|699108|699109|699110|699111|699112|699113|699114|699115|699116|699117|699118|699119|699120|699121|699122|699123|699124|699125|699126|699127|699128|699132|699133|699136|699137|743344|743345|743346|743347|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259398|1259399|1259421|1259423|1296008|1296009|1345807|1345905|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347080|1347082|1347083|1347085|1347086|1347089|1347090|,20070402,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alsachim|Ambinter|Angene Chemical|AOBIOUS INC|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|BioChemPartner|Biocore|BioCrick|BOC Sciences|Boer",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
21604869,NADH dianion,"NADH(2-)|nicotinamide adenine dinucleotide reduced|NAD-reduced|NADH dianion|2fsv|NADH+H+|CHEBI:57945|dihydrodiphosphopyridine nucleotide|diphosphopyridine nucleotide reduced|dihydronicotinamide-adeninedinucleotide|Nicotinamide adenine dinucleotide, reduced form|Q27125072|[5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate|adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5",663.400,C21H27N7O14P2-2,323.000,1210.000,-5.900,44,6,19,11,"InChI=1S/C21H29N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1,3-4,7-8,10-11,13-16,20-21,29-32H,2,5-6H2,(H2,23,33)(H,34,35)(H,36,37)(H2,22,24,25)/p-2/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1",C1C=CN(C=C1C(=O)N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O,BOPGDPNILDQYTO-NNYOXOHSSA-L,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,9,1811|977611,20071205,"3WAY PHARM INC|BioCyc|ChEBI|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Shanghai Institute of Organic Chemistry|Springer Nature|ToxPlanet|Wikidata|Wiley",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25113190,Coenzyme A(4-),"coenzyme A(4-)|Co-A-SH|CoA|2wl4|2wl5|CHEBI:57287|BDBM213239|Q27124396|3'-phosphonatoadenosine 5'-{3-[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl] diphosphate}",763.500,C21H32N7O16P3S-4,359.000,1240.000,-6.100,48,6,21,17,"InChI=1S/C21H36N7O16P3S/c1-21(2,16(31)19(32)24-4-3-12(29)23-5-6-48)8-41-47(38,39)44-46(36,37)40-7-11-15(43-45(33,34)35)14(30)20(42-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-31,48H,3-8H2,1-2H3,(H,23,29)(H,24,32)(H,36,37)(H,38,39)(H2,22,25,26)(H2,33,34,35)/p-4/t11-,14-,15-,16+,20-/m1/s1",CC(C)(COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])[C@H](C(=O)NCCC(=O)NCCS)O,RGJOEKWQDUBAIZ-IBOSZNHHSA-J,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977611,20090114,"BindingDB|BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Shanghai Institute of Organic Chemistry|Springer Nature|Wikidata|WikiPathways",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25202390,Dtdp-alpha-D-glucose,dTDP-alpha-D-glucose|dTDP-glucose|Thymidine 5'-diphospo-alpha-D-glucopyranoside|TDP-Glucose|dTDP-glucose dianion|dTDP-glucose(2-)|dTDP-alpha-D-glucose(2-)|dTDP-  -D-glucose(2-)|CHEBI:57477|thymidine 5'-[3-(alpha-D-glucopyranosyl) diphosphate],562.300,C16H24N2O16P2-2,277.000,961.000,-5.700,36,6,16,9,"InChI=1S/C16H26N2O16P2/c1-6-3-18(16(25)17-14(6)24)10-2-7(20)9(31-10)5-30-35(26,27)34-36(28,29)33-15-13(23)12(22)11(21)8(4-19)32-15/h3,7-13,15,19-23H,2,4-5H2,1H3,(H,26,27)(H,28,29)(H,17,24,25)/p-2/t7-,8+,9+,10+,11+,12-,13+,15+/m0/s1",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,YSYKRGRSMLTJNL-URARBOGNSA-L,"[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20090331,BioCyc|ChEBI|Google Patents|Nature Chemical Biology|Springer Nature,Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
25202620,UDP-alpha-D-glucuronate(3-),UDP-alpha-D-glucuronate(3-)|udp-glcua|UDP-D-glucuronic acid|uridine diphosphate glucuronate|3pjg|(UDP-GlcA)1|UDP-  -D-glucuronate(3-)|CHEBI:58052|UDP-alpha-D-glucuronate trianion|Q27125151,577.260,C15H19N2O18P2-3,317.000,1020.000,-5.900,37,6,18,8,"InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/p-3/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)[O-])O)O)O)O)O,HDYANYHVCAPMJV-LXQIFKJMSA-K,"(2S,3S,4S,5R,6R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,977610,20090331,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Shanghai Institute of Organic Chemistry|ToxPlanet|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
45266541,Acetyl-CoA(4-),"acetyl-CoA(4-)|acetylcoenzyme-A|acetyl coenzyme-A|acetyl-CoA tetraanion|acetyl-coenzyme A(4-)|AcCoA(4-)|CHEBI:57288|Q27124397|3'-phosphonatoadenosine 5'-(3-{(3R)-4-[(3-{[2-(acetylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethyl-4-oxobutyl} diphosphate)",805.500,C23H34N7O17P3S-4,400.000,1350.000,-5.900,51,5,22,19,"InChI=1S/C23H38N7O17P3S/c1-12(31)51-7-6-25-14(32)4-5-26-21(35)18(34)23(2,3)9-44-50(41,42)47-49(39,40)43-8-13-17(46-48(36,37)38)16(33)22(45-13)30-11-29-15-19(24)27-10-28-20(15)30/h10-11,13,16-18,22,33-34H,4-9H2,1-3H3,(H,25,32)(H,26,35)(H,39,40)(H,41,42)(H2,24,27,28)(H2,36,37,38)/p-4/t13-,16-,17-,18+,22-/m1/s1",CC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)([O-])OP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)([O-])[O-])O,ZSLZBFCDCINBPY-ZSJPKINUSA-J,"[(2R,3S,4R,5R)-2-[[[[(3R)-4-[[3-(2-acetylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20100507,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Nature Chemical Biology|Nature Chemistry|Springer Nature|Wikidata|WikiPathways",Curation Efforts|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
46906035,FAD trianion,FAD trianion|146-14-5|CHEBI:57692,782.500,C27H30N9O15P2-3,368.000,1560.000,-4.100,53,6,20,13,"InChI=1S/C27H33N9O15P2/c1-10-3-12-13(4-11(10)2)35(24-18(32-12)25(42)34-27(43)33-24)5-14(37)19(39)15(38)6-48-52(44,45)51-53(46,47)49-7-16-20(40)21(41)26(50-16)36-9-31-17-22(28)29-8-30-23(17)36/h3-4,8-9,14-16,19-21,26,37-41H,5-7H2,1-2H3,(H,44,45)(H,46,47)(H2,28,29,30)(H,34,42,43)/p-3/t14-,15+,16+,19-,20+,21+,26+/m0/s1",CC1=CC2=C(C=C1C)N(C3=NC(=NC(=O)C3=N2)[O-])C[C@@H]([C@@H]([C@@H](COP(=O)([O-])OP(=O)([O-])OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O,VWWQXMAJTJZDQX-UYBVJOGSSA-K,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4S)-5-(7,8-dimethyl-2-oxido-4-oxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] phosphate",Flavin-Adenine Dinucleotide,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20101006,BioCyc|ChEBI,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398570,Cyclic guanosine monophosphate,"cGMP|cyclic gmp|7665-99-8|Cyclic guanosine monophosphate|3',5'-cyclic GMP|Guanosine cyclic monophosphate|Guanosine 3',5'-monophosphate|guanosine 3',5'-cyclic phosphate|UNII-H2D2X058MU|Guanosine 3',5'-cyclic monophosphate|CHEBI:16356|Guanosine cyclic 3',5'-phosphate|GUANOSINE-3',5'-MONOPHOSPHATE|3',5'-guanosine monophosphate|CHEMBL395336|H2D2X058MU|guanosine-cyclic-phosphoric-acid|GUANOSINE-3',5'-cyclic-MONOPHOSPHORIC ACID|Cyclic guanosine 3',5'-monophosphate|guanosine 3',5'-cyclic-monophosphate|Guanosine-3'",345.210,C10H12N5O7P,171.000,616.000,-3.400,23,4,9,1,"InChI=1S/C10H12N5O7P/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-5(16)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,16H,1H2,(H,18,19)(H3,11,13,14,17)/t3-,5-,6-,9-/m1/s1",C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C3N=C(NC4=O)N)O)OP(=O)(O1)O,ZOOGRGPOEVQQDX-UUOKFMHZSA-N,"9-[(4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-amino-1H-purin-6-one",Cyclic GMP,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,11,159198|159203|297178|297179|588979|679496|680352|680353|680357|680604|681362|681904|681922|1219952|1346482|1346487|1346505|1346529|1346533,20190115,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|abcr GmbH|ABI Chem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BIND|BindingDB|BioCyc|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Crystallography Open Database|DrugBan",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398592,2'-Deoxyguanosine,"2'-deoxyguanosine|deoxyguanosine|961-07-9|Guanosine, 2'-deoxy-|Guanine deoxy nucleoside|Guanine deoxyriboside|2-Deoxyguanosine|2'-DEOXY-GUANOSINE|663615-45-0|UNII-G9481N71RO|2-Amino-9-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one|Guanine, 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-|2(acute)-Deoxyguanosine|9H-Purin-6-ol, 2-amino-9-(2-deoxy-9-beta-D-ribofuranosyl)-|CHEBI:17172|G9481N71RO|9-(2-Deoxy-b-D-erythro-pentofuranosyl)guanine|C00330|312693-72-4|Desoxyguanosine|2'-Deoxyg",267.240,C10H13N5O4,135.000,417.000,-0.900,19,4,6,2,"InChI=1S/C10H13N5O4/c11-10-13-8-7(9(18)14-10)12-3-15(8)6-1-4(17)5(2-16)19-6/h3-6,16-17H,1-2H2,(H3,11,13,14,18)/t4-,5+,6+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N)CO)O,YKBGVTZYEHREMT-KVQBGUIXSA-N,"2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one",Deoxyguanosine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,1811|28386|44363|71649|71650|81069|81438|82319|82698|82699|82700|82701|84253|84255|210695|210718|235874|342014|342015|344442|344443|344444|344445|344446|344447|344448|344449|485290|504339|504444|504648|504845|504847|504891|540267|540317|588453|588456|588579|588590|588795|588855|588856|602310|602332|624178|624202|624263|624414|651965|652106|686978|686979|720579|720580|977599|977602|977611|1122015|1122016|1122017|1122018|1122019|1136399|1159550|1225471|1225472|1259310|1259312|1259374|1259397|1259398|1259408|1,20190115,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Angene Chemical|Anward|ApexBio Technology|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398595,2'-Deoxyguanosine-5'-diphosphate,"dGDP|2'-deoxyguanosine-5'-diphosphate|CHEBI:28862|2'-Deoxyguanosine 5'-diphosphate|Deoxyguanosine 5'-diphosphate|deoxyguanosine diphosphate|CHEMBL1232205|3493-09-2|2'-deoxyguanosine 5'-(trihydrogen diphosphate)|deoxyguanosine-diphosphate|2'-Deoxy-GDP|5'-dGDP|SCHEMBL157937|ZINC8215878|BDBM50035297|DB03491|C00361|Q27103932|[({[(2R,3S,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid|[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2",427.200,C10H15N5O10P2,228.000,729.000,-4.500,27,6,12,6,"InChI=1S/C10H15N5O10P2/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(24-6)2-23-27(21,22)25-26(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)OP(=O)(O)O)O,CIKGWCTVFSRMJU-KVQBGUIXSA-N,"[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,1172275|1172277,20190115,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|abcr GmbH|ABI Chem|Achemo Scientific Limited|AHH Chemical co.,ltd|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|AstaTech, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|Combi-Blocks|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maast",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398599,2'-Deoxyguanosine-5'-triphosphate,"dGTP|Deoxyguanosine triphosphate|deoxy-GTP|Deoxyguanosine 5'-triphosphate|2'-Deoxyguanosine 5'-triphosphate|5'-DGTP|2'-deoxyguanosine-5'-triphosphate|2564-35-4|2'-Deoxyguanosine 5'-(tetrahydrogen triphosphate)|UNII-8C2O37Y44Q|Guanosine 2'-deoxy-, 5'-triphosphate|CHEBI:16497|2'-Deoxyguanosine triphosphate|Guanosine, 2'-deoxy-, 5'-(tetrahydrogen triphosphate)|8C2O37Y44Q|93919-41-6|Guanosine 5'-(tetrahydrogen triphosphate), 2'-deoxy- (9CI)|9-[2-Deoxy-5-O-(hydroxy{[hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl",507.180,C10H16N5O13P3,275.000,895.000,-5.600,31,7,15,8,"InChI=1S/C10H16N5O13P3/c11-10-13-8-7(9(17)14-10)12-3-15(8)6-1-4(16)5(26-6)2-25-30(21,22)28-31(23,24)27-29(18,19)20/h3-6,16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,HAAZLUGHYHWQIW-KVQBGUIXSA-N,"[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,18096|22610|24495|28239|28240|229453|357985|359795|359796|359797|359810|359811|572770|572771|572772|618865|618875|618876|711522|711538|711539,20190115,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|AN PharmaTech|AstaTech, Inc.|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Comparati",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398614,2'-Deoxyinosine 5'-monophosphate,"2'-Deoxyinosine 5'-monophosphate|Deoxyinosine monophosphate|2'-deoxy-5'-inosinic acid|Hypoxanthine deoxyriboside|2'-deoxyinosine-5'-monophosphate|2'-Deoxyinosine 5'-phosphate|3393-18-8|CHEBI:28806|9-(2-deoxy-5-O-phosphono-beta-D-erythro-pentofuranosyl)-9H-purin-6-ol|9-(2-deoxy-5-O-phosphono-beta-delta-erythro-pentofuranosyl)-9H-purin-6-ol|[(2R,3S,4R,5R)-3-hydroxy-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-2-yl]methyl dihydrogen phosphate|EINECS 222-237-0|deoxyinosine phosphate|14999-52-1|Epitope ID:158627|S",332.210,C10H13N4O7P,156.000,525.000,-2.800,22,4,9,4,"InChI=1S/C10H13N4O7P/c15-5-1-7(21-6(5)2-20-22(17,18)19)14-4-13-8-9(14)11-3-12-10(8)16/h3-7,15H,1-2H2,(H,11,12,16)(H2,17,18,19)/t5-,6+,7+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=CNC3=O)COP(=O)(O)O)O,PHNGFPPXDJJADG-RRKCRQDMSA-N,"[(2R,3S,5R)-3-hydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,8,NULL,20190115,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|AstaTech, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BioCyc|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Day Biochem|Egon Willighagen (Dept. ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398638,Hypoxanthine,"hypoxanthine|68-94-0|6-Hydroxypurine|7H-Purin-6-ol|9H-Purin-6-ol|Sarkin|6-Oxopurine|Sarcine|1,7-Dihydro-6H-purin-6-one|Purin-6(1H)-one|Purin-6-ol|Sarkine|3H-Purin-6-ol|Hypoxanthine enol|6(1H)-Purinone|9H-Purin-6(1H)-one|6H-Purin-6-one, 1,7-dihydro-|Purin-6(3H)-one|6-Hydroxy-1H-purine|Purine-6-ol|3,7-dihydropurin-6-one|1,9-dihydro-6H-purin-6-one|1H-Purin-6(9H)-one|1h-purin-6-ol|6H-Purin-6-one, 1,9-dihydro-|9H-Purin-6-ol (VAN)|MFCD00005725|146469-94-5|NSC 14665|UNII-2TN51YD919|CHEBI:17368|AI3-52242|1,9-dihydr",136.110,C5H4N4O,70.100,190.000,-0.500,10,2,3,0,"InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",C1=NC2=C(N1)C(=O)NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,"1,7-dihydropurin-6-one",Hypoxanthine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,155|157|161|165|167|175|248|270|608|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1033|1379|1405|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1478|1479|1487|1490|1519|1549|1552|1637|1648|1688|1766|1768|1811|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|2662|2842|97843|97848|164770|230017|252792|274547|274549|274550|274561|274562|274563|282398|282400|282402|282410|282809|282810|338748|401477|485281|485290|492961|504327|504332|504749|504832|,20190115,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Allbio Pharm Co., Ltd|Ambeed|Ambinter|AN Ph",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135398641,Inosine,"inosine|58-63-9|Hypoxanthosine|Ribonosine|Atorel|Oxiamin|Trophicardyl|Selfer|Pantholic-L|Panholic-L|Hypoxanthine riboside|beta-Inosine|Hypoxanthine D-riboside|Hypoxanthine ribonucleoside|(-)-Inosine|9-beta-D-Ribofuranosylhypoxanthine|Hypoxanthine nucleoside|INO 495|Inosina|Inosinum|Inosie|iso-prinosine|Inosine [INN:JAN]|Inosinum [INN-Latin]|Inosina [INN-Spanish]|hypoxanthine-ribose|Hypoxanthine-9-beta-D-ribofuranoside|NSC 20262|Hypoxanthine, 9-beta-D-ribofuranosyl-|Inosin|AI3-52241|INO|MFCD00066770|beta-D-R",268.230,C10H12N4O5,129.000,405.000,-1.300,19,4,7,2,"InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1",C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,UGQMRVRMYYASKQ-KQYNXXCUSA-N,"9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one",Inosine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,485|568|583|598|602|606|618|620|629|630|631|633|639|648|687|701|719|731|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|142,20190115,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Ambeed|Ambinter|AN PharmaTech|Anward|ApexBio Technology|Apexmol|Aronis|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135450591,10-Formyltetrahydropteroylglutamic acid,"10-Fthf|10-Formyltetrahydrofolate|N10-formyl-THF|10-formyl-tetrahydrofolate|10-formyltetrahydropteroylglutamic acid|10-formyl-THF|n10-formyltetrahydrofolate|10-Formyltetrahydrofolic acid|2800-34-2|10-Formyltetrahydrofolate (1 stereocenter specified)|10-formyl-H4PteGlu1|N10-formyl-H4F|N10-Formyltetrahydrofolic acid|SCHEMBL13418310|DTXSID60903987|10-formyltetrahydropteroylglutamate|N10-Formyltetrahydropteroylglutamate|10-Formyl-(6RS)-tetrahydrofolic acid|N10-Formyl-5,6,7,8-tetrahydrofolate|10-Formyl-5,6,7,8-t",473.400,C20H23N7O7,216.000,911.000,-1.200,34,7,10,9,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)23-11(7-22-16)8-27(9-28)12-3-1-10(2-4-12)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,11,13,23H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,22,25,26,32)/t11?,13-/m0/s1",C1C(NC2=C(N1)N=C(NC2=O)N)CN(C=O)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,AUFGTPPARQZWDO-YUZLPWPTSA-N,"(2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methyl-formylamino]benzoyl]amino]pentanedioic acid",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20190115,"AAA Chemistry|ABI Chem|BIND|BLD Pharm|ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Human Metabolome Database (HMDB)|IBM|iChemical Technology USA Inc|Innovapharm|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|Nature Chemical Biology|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|SureC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
135926594,"(6R)-5,10-Methenyltetrahydrofolate","(6R)-5,10-methenyltetrahydrofolate|anhydroleucovorin|5,10-Methenyltetrahydropteroylglutamate|CH-THF mono-L-glutamate|5,10-methenyl-H4PteGlu1|methenyl-THF mono-L-glutamate|methenyl-H4F mono-L-glutamate|CHEBI:57455|anhydroleucovorin mono-L-glutamate|N5-N10-CH-THF mono-L-glutamate|5,10-methenyl-THF mono-L-glutamate|methenyl-tetrahydrofolate mono-L-glutamate|5,10-methenyltetrahydrofolate mono-L-glutamate|N5-N10-methenyltetrahydrofolate mono-L-glutamate|Q27124701|N-{4-[(6aR)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydro-",454.400,C20H20N7O6-,195.000,955.000,-0.400,33,4,8,5,"InChI=1S/C20H21N7O6/c21-20-24-16-15(18(31)25-20)27-9-26(8-12(27)7-22-16)11-3-1-10(2-4-11)17(30)23-13(19(32)33)5-6-14(28)29/h1-4,9,12-13H,5-8H2,(H6-,21,22,23,24,25,28,29,30,31,32,33)/p-1/t12-,13+/m1/s1",C1[C@@H]2CN(C=[N+]2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-],MEANFMOQMXYMCT-OLZOCXBDSA-M,"(2S)-2-[[4-[(6aR)-3-amino-1-oxo-5,6,6a,7-tetrahydro-2H-imidazo[1,5-f]pteridin-10-ium-8-yl]benzoyl]amino]pentanedioate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20190119,"BioCyc|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Human Metabolome Database (HMDB)|Wikidata",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
146025955,(Rel)-AR234960,"(rel)-AR234960|HY-120006A|CS-0119417|1-[[(3R,4R)-4-(3-fluorophenyl)-1-(2-methoxy-4-nitrophenyl)sulfonylpyrrolidin-3-yl]methyl]-4-pyridin-2-ylpiperazine|1408311-94-3",555.600,C27H30FN5O5S,120.000,925.000,3.600,39,0,10,7,"InChI=1S/C27H30FN5O5S/c1-38-25-16-23(33(34)35)8-9-26(25)39(36,37)32-18-21(24(19-32)20-5-4-6-22(28)15-20)17-30-11-13-31(14-12-30)27-7-2-3-10-29-27/h2-10,15-16,21,24H,11-14,17-19H2,1H3/t21-,24+/m1/s1",COC1=C(C=CC(=C1)[N+](=O)[O-])S(=O)(=O)N2C[C@H]([C@@H](C2)C3=CC(=CC=C3)F)CN4CCN(CC4)C5=CC=CC=N5,TUSCHIFEASZBBF-QPPBQGQZSA-N,"1-[[(3R,4R)-4-(3-fluorophenyl)-1-(2-methoxy-4-nitrophenyl)sulfonylpyrrolidin-3-yl]methyl]-4-pyridin-2-ylpiperazine",NULL,Biomolecular Interactions and Pathways,1,NULL,20200430,AbaChemScene|BenchChem|MedChemexpress MCE|MolPort,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per COVID-19 Disease Map]"
6288,l-Threonine,"L-threonine|threonine|72-19-5|L-(-)-Threonine|Threonin|(2S,3R)-2-amino-3-hydroxybutanoic acid|(S)-Threonine|H-Thr-OH|2-amino-3-hydroxybutyric acid|Threonine (VAN)|(2S,3R)-2-Amino-3-hydroxybutyric acid|Threoninum [Latin]|Treonina [Spanish]|Threonine [USAN:INN]|Threonine, L-|thre|L-Threonin|L-thr|(2S)-threonine|MFCD00064270|L-alpha-Amino-beta-hydroxybutyric acid|(2S,3R)-(-)-Threonine|2-Amino-3-hydroxybutanoic acid, (R-(R*,S*))-|UNII-2ZD004190S|Butanoic acid, 2-amino-3-hydroxy-, (R-(R*,S*))-|L-2-Amino-3-hydrox",119.120,C4H9NO3,83.600,93.300,-2.900,8,3,4,2,"InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1",C[C@H]([C@@H](C(=O)O)N)O,AYFVYJQAPQTCCC-GBXIJSLDSA-N,"(2S,3R)-2-amino-3-hydroxybutanoic acid",Threonine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,26797|157604|233320|500825|588834|651631|651632|651633|651634|652048|652051|681113|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|74,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|Angene Chemical|Anward|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals L",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
35370,Zidovudine,"zidovudine|Azidothymidine|30516-87-1|3'-Azido-3'-deoxythymidine|Retrovir|AZT|Thymidine, 3'-azido-3'-deoxy-|Zidovudinum|ZIDOVUDINE [AZT]|Compound S|Trizivir|Zidovudina|BW A509U|zidovudin|BWA509U|ZDV|UNII-4B9XT59T7S|Aztec|BW-A509U|BW-A-509U|MFCD00006536|1-((2R,4S,5S)-4-AZIDO-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE|CHEMBL129|MLS000028548|4B9XT59T7S|CHEBI:10110|3'-Deoxy-3'-azidothymidine|NSC 602670|1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dion",267.240,C10H13N5O4,93.200,484.000,0.000,19,2,6,3,"InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],HBOMLICNUCNMMY-XLPZGREQSA-N,"1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",Zidovudine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|361|364|368|371|373|374|375|411|421|422|425|426|427|429|430|431|432|433|434|435|436|438|440|441|444|445|446|449|450|453|454|455|456|457|460|461|483|485|487|488|501|518|521|522|524|525|527|528|529|530|538|539|540|541|542|543|544|545|546|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|639|641|645|648|654|655|656|657|658|659|660|661|662|,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|AAA Chemistry|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambinter|Angene Chemical|Anward|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BindingDB|BioCrick|BioCyc|Biosynth Ca",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
969516,Curcumin,"curcumin|458-37-7|Diferuloylmethane|Natural yellow 3|Turmeric yellow|Turmeric|Indian saffron|Curcuma|Kacha haldi|Gelbwurz|Curcumin I|Souchet|Haidr|Halad|Haldar|Halud|Merita earth|Terra Merita|Yellow Ginger|(1E,6E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione|Yellow Root|Safran d'Inde|Yo-Kin|Curcuma oil|Golden seal|Orange Root|C.I. Natural Yellow 3|Curcumine|Hydrastis|Indian turmeric|Yellow puccoon|Diferaloylmethane|Turmeric oleoresin|Kurkumin [Czech]|Tumeric yellow|CI Natural Yellow 3|Zlut pr",368.400,C21H20O6,93.100,507.000,3.200,27,2,6,8,"InChI=1S/C21H20O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3-12,24-25H,13H2,1-2H3/b7-3+,8-4+",COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O,VFLDPWHFBUODDF-FCXRPNKRSA-N,"(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione",Curcumin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,1|3|5|7|9|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|179|330|357|361|364|368|371|373|374|375|382|383|384|389|393|396|397|411|421|422|425|426|427|429|430|431|432|433|434|435|436|438|440|441|444|445|446|449|450|453|454|455|456|457|460|483|485|487|488|501|504|505|512|513|514|518|521|522|524|525|527|528|529|530|538|539|540|541|542|543|544|545|546|552|5,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alomone Labs|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Apexmol|Aurum Pharm",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4330618,"6'-Butan-2-yl-21,24-dihydroxy-12-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|70288-86-7|FT-0601609,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3",CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,AZSNMRSAGSSBNP-UHFFFAOYSA-N,"6'-butan-2-yl-21,24-dihydroxy-12-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20050914,"ABI Chem|Biocore|Cangzhou Enke Pharma Tech Co.,Ltd.|ChemDB|ChemMol|ChemSpider|Clearsynth|DAOGE BIOPHARMA|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Finetech Industry Limited|ICCB-Longwood Screening Facility, Harvard Medical School|MP Biomedicals|NextBio|NORMAN Suspect List Exchange|Shanghai Send Pharmaceutical Technology Co., Ltd|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
5353987,"(18Z)-1,14-Dihydroxy-12-[(E)-1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone",SCHEMBL385444|SCHEMBL385446,804.000,C44H69NO12,178.000,1480.000,2.700,57,3,12,7,"InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19-,27-21+",CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(/C=C(\\C1)/C)CC=C)O)C)/C(=C/C4CCC(C(C4)OC)O)/C)O)C)OC)OC,QJJXYPPXXYFBGM-PGDOHDMCSA-N,"(18Z)-1,14-dihydroxy-12-[(E)-1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone",NULL,Patents,1,NULL,20050325,AbMole Bioscience|ChemSpider|ISpharm|SureChEMBL,Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6419971,"(1R,4S,5'S,6R,6'R,8R,10E,13S,14E,16E,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one","IVERMECTIN|70288-86-7|Prestwick_516|Prestwick2_000156|SCHEMBL13259385|HMS1568O14|(2R,5'S,6'R)-dihydroxy-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-5'-tetramethyl-6'-[(1S)-1-methylpropyl]spiro[[?]-2,2'-tetrahydropyran]one",875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42?,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/C([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-KKWNAUQJSA-N,"(1R,4S,5'S,6R,6'R,8R,10E,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Biological Test Results|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,377|485350|492967|493033|493140|540299|588519|602314|624349|720717,20060414,"ChemBank|ChemSpider|Collaborative Drug Discovery, Inc.|ICCB-Longwood Screening Facility, Harvard Medical School|NextBio|NIAID ChemDB|PDSP|SCRIPDB|SureChEMBL|ToxPlanet|UCLA Molecular Screening Shared Resource",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
10158453,Prasugrel hydrochloride,"Prasugrel hydrochloride|389574-19-0|Prasugrel HCl|Prasugrel (hydrochloride)|LY 640315|PCR 4099 (hydrochloride)|DSSTox_CID_28993|DSSTox_RID_83258|DSSTox_GSID_49067|5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride|Ethanone, 2-(2-(acetyloxy)-6,7-dihydrothieno(3,2-c)pyridin-5(4H)-yl)-1-cyclopropyl-2-(2-fluorophenyl)-, hydrochloride|Ethanone, 2-[2-(acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)-, hydrochloride",409.900,C20H21ClFNO3S,74.800,555.000,NULL,27,1,6,6,"InChI=1S/C20H20FNO3S.ClH/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21;/h2-5,10,13,19H,6-9,11H2,1H3;1H",CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4.Cl,JALHGCPDPSNJNY-UHFFFAOYSA-N,"[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate;hydrochloride",Prasugrel Hydrochloride,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|7,20061025,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acorn PharmaTech Product List|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Apexmol|Assembly Blocks Pvt. Ltd.|AvaChem Scientific|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|CAPOT|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFish Tokyo co.,ltd|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11957587,Sdccgsbi-0050671.P002,"IVERMECTIN|SR-01000075941|MK-933|Lopac0_000693|CHEMBL1876587|HMS3262K07|70288-86-7|Tox21_500693|ZINC253630390|CCG-204778|LP00693|SDCCGSBI-0050671.P002|NCGC00094047-01|NCGC00094047-02|NCGC00094047-05|NCGC00094047-10|NCGC00261378-01|EU-0100693|I 8898|SR-01000075941-1|SR-01000075941-6|SR-01000075941-7|(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2R)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-",875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26+,28+,30+,31+,33-,34+,35+,36+,37+,38+,39+,40-,41+,42+,43-,44+,45-,47-,48-/m1/s1",CC[C@@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-ZGXOMDHGSA-N,"(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2R)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Biological Test Results|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,422|429|436|547|694|732|880|894|940|1030|1379|1422|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1476|1477|1478|1479|1487|1519|1705|1707|1708|1766|1768|1815|1816|1828|1865|1876|1877|1882|1883|1886|1948|1967|2101|2107|2112|2147|2323|2326|2353|2364|2451|2517|2528|2549|2662|2675|2732|2774|463096|463097|463189|485290|485314|488745|488752|488949|488979|488980|492980|493127|493189|504332|504364|504821|540256|540276|588453|588590|588591|588834|651828|687035|687037|1159580|1159607|1224818|1224819|1224820|122482,20061201,"AKos Consulting & Solutions|Aurum Pharmatech LLC|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|ChemBank|Chembase.cn|ChEMBL|chemical genetic matrix|ChemSpider|Circadian Research, Kay Laboratory, University of California at San Diego (UCSD)|Clearsynth|DrugBank|Emory University Molecular Libraries Screening Center|ICCB-Longwood Screening Facility, Harvard Medical School|Milwaukee Institute for Drug Discovery|MolPort|National Center for Advancing Translational Science",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
21584398,"(10Z,14Z,16Z)-6'-Butan-2-yl-21,24-dihydroxy-12-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",NULL,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12-,27-15-,32-14-",CCC(C)C1C(CCC2(O1)CC3CC(O2)C/C=C(\\C(C(/C=C\\C=C/4\\COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)/C)C,AZSNMRSAGSSBNP-JHJAMYNOSA-N,"(10Z,14Z,16Z)-6'-butan-2-yl-21,24-dihydroxy-12-[5-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",NULL,Classification|Literature,2,NULL,20071205,ISpharm|NORMAN Suspect List Exchange,Chemical Vendors|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
46216796,Pacritinib,"Pacritinib|937272-79-2|Pacritinib (SB1518)|SB1518|SB-1518|UNII-G22N65IL3O|G22N65IL3O|11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene|ONX-0803|Pacritinib(SB1518)|CHEMBL2181330|SB 1518|Pacritinib (USAN/INN)|Pacritinib [USAN:INN]|SB-1518  TFA salt|GTPL7793|SCHEMBL1108221|CHEMBL2035187|SCHEMBL22819303|EX-A240|AMY23364|AOB87797|BCP09091|2626AH|BDBM50210177|BDBM50400312|MFCD22572772|NSC759674|NSC781626|s8057|AKOS037515",472.600,C28H32N4O3,68.700,644.000,3.800,35,1,7,4,"InChI=1S/C28H32N4O3/c1-2-13-32(12-1)14-17-35-27-9-8-25-19-24(27)21-34-16-4-3-15-33-20-22-6-5-7-23(18-22)26-10-11-29-28(30-25)31-26/h3-11,18-19H,1-2,12-17,20-21H2,(H,29,30,31)/b4-3+",C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,HWXVIOGONBBTBY-ONEGZZNKSA-N,"(16E)-11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8(26),9,11,16,21(25),22-decaene",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,664219|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1337199|1337253|1337254|1337255|1337256|1337257|1337258|1337259|1337278|1337279|1337280|1337281|1337282|1337283|1337285|1337286|1337287|1337288|1337289|1337290|1337292|1337293|1337302|1337303|1337330|1345084|1345503|1345714|1345744|1345757|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1347412|1347414|1409598|1409605|1409606|1424889|1424890|1424891|1424892|1424894|1424895|1424896|1424899|1424900|1424901|1,20100706,"A2Z Chemical|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambinter|AOBIOUS INC|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|BioChemPartner|BioCrick|BOC Sciences|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Comparative Toxicogenomics Database (CTD)",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
57182275,"(1R,4S,5'S,6R,6'R,8R,12S,13S,20R,21R,24S)-6'-[(2R)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|70288-86-7,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/t25-,26+,28+,30+,31+,33-,34+,35+,36+,37+,38+,39+,40-,41+,42+,43-,44+,45-,47-,48-/m1/s1",CC[C@@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C([C@H]([C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)C)C,AZSNMRSAGSSBNP-NQSNVJSVSA-N,"(1R,4S,5'S,6R,6'R,8R,12S,13S,20R,21R,24S)-6'-[(2R)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20120614,Chemenu Inc.|IBM|NORMAN Suspect List Exchange,Chemical Vendors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
70678590,Rubramin,"cyanocobalamin|Cytamen|Rubesol|Cyomin|vitamin B-12|Rubramin|Crystamine|vitamin B12|Cyanocob(III)alamin|CN-Cbl|68-19-9|cyanoject|hydrobexan|Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-cyanocobamide|CHEBI:17439",1355.400,C63H88CoN14O14P-3,476.000,3220.000,NULL,93,9,21,16,"InChI=1S/C62H90N13O14P.CN.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-2;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);;/q;-1;/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,6",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co],ILZDURAAGGSKOQ-WZHZPDAFSA-L,"cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide",Vitamin B 12,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,14,NULL,20121212,"BioCyc|ChEBI|Milbrandt Lab, Department of Genetics, Washington University School of Medicine|ToxPlanet",Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
71308642,"(1R,4S,5'S,6R,6'R,8R,10Z,12S,13S,14Z,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|70288-86-7,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12-,27-15-,32-14?/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(\\[C@H]([C@H](/C=C\\C=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)/C)C,AZSNMRSAGSSBNP-PKKUKZFLSA-N,"(1R,4S,5'S,6R,6'R,8R,10Z,12S,13S,14Z,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20130517,AA BLOCKS|Aaron Chemicals LLC|Chem-Space.com Database|Chembase.cn|MolPort|ToxPlanet,Chemical Vendors|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
71749648,"(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4R,5S,6S)-5-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|70288-86-7|ZINC301054281|VA11120,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36+,37+,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-NDJJZKGWSA-N,"(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4R,5S,6S)-5-[(2S,4R,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20131101,"Chembase.cn|Google Patents|ToxPlanet|Vesino Industrial Co., Ltd|ZINC",Chemical Vendors|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
123134034,Methylcobalamin,methylcobalamin|vitamin B12|13422-55-4|s4994|68-19-9|422M554,1345.400,C63H92CoN13O14P,449.000,3160.000,NULL,92,10,20,26,"InChI=1S/C62H90N13O14P.CH3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);1H3;/q;-1;+2/p-1/t31?,34-,35-,36-,37+,41-,52-,53-,56-,57+,59",[CH3-].CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)(O)OC(C)CNC(=O)CC[C@@]4([C@H]([C@@H]5[C@]6([C@@]([C@@H](/C(=C(/C7=N/C(=C\\C8=N/C(=C(\\C4=N5)/C)/[C@H](C8(C)C)CCC(=O)N)/[C@H]([C@]7(C)CC(=O)N)CCC(=O)N)\\C)/[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+2],QXOMMGINPOYKPR-WYVZQNDMSA-M,"carbanide;cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate",NULL,Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,NULL,20170119,OChem|Pi Chemicals|Selleck Chemicals,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
124870718,"(1R,4S,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|ZINC253388066,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43-,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-LFOOHIAMSA-N,"(1R,4S,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20170410,The Natural Products Atlas|ZINC,Chemical Vendors|Curation Efforts,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
124870720,"(1S,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|ZINC253388068,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35+,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-TYECJXEWSA-N,"(1S,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",NULL,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20170410,Broad Institute|MassBank of North America (MoNA)|ZINC,Chemical Vendors|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
126480146,"[5-(5,6-Dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate",vitamin B12|HYDROXOCOBALAMIN|SR-05000001730|BDBM420299|BDBM420313|SR-05000001730-2,1270.400,C62H88N13O14P-2,452.000,3140.000,-3.400,90,9,19,26,"InChI=1S/C62H90N13O14P/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86)/p-2",CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC\\4(C(C5C6(C(C(C(=N6)/C(=C\\7/C(C(C(=N7)/C=C\\8/C(C(C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O,RHYVGCKRBKDRDX-UHFFFAOYSA-L,"[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate",NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,12,1259310|1259374|1259422,20170414,BindingDB|The Scripps Research Institute Molecular Screening Center,Curation Efforts|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3085416,"(1R,4S,5'S,6R,6'R,8R,12S,13S,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",LSM-5397|IVERMECTIN|SMR000857211|MLS001333247|MLS001333248|MLS002153248|CHEMBL1699565|HMS2233J07|Q27166389,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C([C@H]([C@H](C=CC=C4CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)C)C,AZSNMRSAGSSBNP-VRFQAOMKSA-N,"(1R,4S,5'S,6R,6'R,8R,12S,13S,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Biological Test Results|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,1850|1863|1899|1903|1906|1947|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2129|2130|2174|2177|2234|2235|2280|2300|2380|2391|2435|2445|2462|2520|2521|2524|2540|2544|2557|2599|2606|2629|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|434955|434962|434973|434989|435003|435005|435022|435030|449728|449748|449762|449763|463074|463079|463082|463104|463141|463190|463195|463210|463212|485270|485272|485273|485275|485317|485346|488839|488847|488862|488890|488895|488896|488899|488965|488966|48897,20050809,"ABI Chem|ChEMBL|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|ICCB-Longwood Screening Facility, Harvard Medical School|MLSMR|UW Madison, Small Molecule Screening Facility|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
24892715,Dolichyl phosphate,"Dolichyl phosphate|Dolichol monophosphate|Dolichyl monophosphate|Dolicholmonophosphate|dolichyl-4 phosphate|12698-55-4|Dolichol, dihydrogen phosphate|SCHEMBL396770|CHEBI:16214|LMPR03080015|C00110|Q5289051|[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] dihydrogen phosphate|alpha-[2-methyl-4-(phosphonooxy)butyl]-omega-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]poly[(2Z)-2-methylbut-2-ene-1,4-diyl]",440.600,C25H45O4P,66.800,634.000,7.700,30,2,4,16,"InChI=1S/C25H45O4P/c1-21(2)11-7-12-22(3)13-8-14-23(4)15-9-16-24(5)17-10-18-25(6)19-20-29-30(26,27)28/h11,13,15,17,25H,7-10,12,14,16,18-20H2,1-6H3,(H2,26,27,28)/b22-13+,23-15+,24-17-",CC(CC/C=C(/C)\\CC/C=C(\\C)/CC/C=C(\\C)/CCC=C(C)C)CCOP(=O)(O)O,GYBNOAFGEKAZTA-QOLULZROSA-N,"[(6Z,10E,14E)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20080910,"ChEBI|ChemIDplus|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|iChemical Technology USA Inc|KEGG|LIPID MAPS|MetabolomicsWorkbench|MuseChem|SureChEMBL|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
122172888,"(4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|70288-86-7,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35?,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4(C(C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-RDKIRRGNSA-N,"(4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20161008,ApexBio Technology,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
135391144,"(1S,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|SW219099-1,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14?/t25-,26-,28-,30-,31-,33+,34-,35+,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C4CO[C@H]5[C@@]4([C@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-XTMCYPOKSA-N,"(1S,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20181218,UCSC Chemical Screening Center,Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
4893,Prazosin,"prazosin|19216-56-9|Furazosin|Prazosine|Prazocin|Prazosina|Prazosinum|Prazosine [INN-French]|Prazosinum [INN-Latin]|Prazosina [INN-Spanish]|[3H]-Prazosin|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine|UNII-XM03YJ541D|(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone|CHEMBL2|Minipress (TN)|Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-|4-(4-Amino-6,7-dimethoxyquin",383.400,C19H21N5O4,107.000,544.000,2.000,28,1,8,4,"InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,IENZQIKPVFGBNW-UHFFFAOYSA-N,"[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone",Prazosin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|995|1030|1332|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1766|1768|1851|1865|1948|2062|2101|2107|2112|2147|2240|2241|2275|2313|2316|2322|2330|2451|2472|2517|2528|2546|2549|2551|2660|2666|2667|2668|3793|3828|3920|3935|4028|4235|4358|4381|4407|482,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6435110,Ivomec,Ivermectine|Hyvermectin|Cardomec|Eqvalan|Mectizan|Ivomec|MK 933|Heartgard-30|Cardotek-30|UNII-8883YP2R6D|Ivermectine [INN-French]|Ivermectinum [INN-Latin]|Ivermectino [INN-Spanish]|Equimectrin|Ivermectino|Ivermectinum|Noromectin|Phoenectin|Zimecterin|8883YP2R6D|Acarexx|Bimectin|Ivermax|Oramec|Uvemec|Vermic|Vetmec|CCRIS 8839|Agri-Mectin|Bimectin pour-on|EINECS 274-536-0|MK-0933|Alverin Plus for Cattle|L 640471|Noromectin for cattle and swine|Endo-Mectin for Cattle and Swine|Ivermectin [USAN:USP:INN:BAN]|NSC ,1736.200,C95H146O28,340.000,3340.000,NULL,123,6,28,15,"InChI=1S/C48H74O14.C47H72O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38;1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3;11-14,18,24-25,27,29-30,",CCC(C)[C@@H]1[C@H](CC[C@@]2(O1)CC3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)OC7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C.C[C@H]1CC[C@]2(CC3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)OC7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)O[C@@H]1C(C)C,SPBDXSGPUHCETR-VHJJIYNUSA-N,"(1R,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-butan-2-yl-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;(1R,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethyl-6'-prop",Ivermectin,Biological Test Results|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry|Toxicity,6,1259411,20060428,Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|ChemSpider|LeadScope|NextBio|NovoSeek,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
9812534,Plitidepsin,"plitidepsin|aplidin|Aplidine|137219-37-5|Dehydrodidemnin B|UNII-Y76ID234HW|Y76ID234HW|CHEBI:90205|(2S)-N-[(2R)-1-[[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino]-4-methyl-1-oxopentan-2-yl]-N-methyl-1-(2-oxopropanoyl)pyrrolidine-2-carboxamide|Plitidepsin [INN:BAN]|plitidepsina|plitidepsine|plitidepsium|Plitidepsin (INN",1110.300,C57H87N7O15,285.000,2200.000,5.700,79,4,15,15,"InChI=1S/C57H87N7O15/c1-15-33(8)46-44(66)29-45(67)79-49(32(6)7)48(68)34(9)50(69)58-39(26-30(2)3)54(73)64-25-17-19-41(64)56(75)62(13)43(28-37-20-22-38(77-14)23-21-37)57(76)78-36(11)47(52(71)59-46)60-51(70)42(27-31(4)5)61(12)55(74)40-18-16-24-63(40)53(72)35(10)65/h20-23,30-34,36,39-44,46-47,49,66H,15-19,24-29H2,1-14H3,(H,58,69)(H,59,71)(H,60,70)/t33-,34-,36+,39-,40-,41-,42+,43-,44-,46+,47-,49-/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC(=O)O[C@H](C(=O)[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O,UUSZLLQJYRSZIS-LXNNNBEUSA-N,"(2S)-N-[(2R)-1-[[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino]-4-methyl-1-oxopentan-2-yl]-N-methyl-1-(2-oxopropanoyl)pyrrolidine-2-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,357836|357842,20061025,"A2B Chem|AA BLOCKS|Achemtek|Alfa Chemistry|Aurum Pharmatech LLC|BenchChem|Biosynth Carbosynth|BOC Sciences|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CreativePeptides|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|iChemical Technology USA Inc|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|Nex",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9812710,Ivermectine,Ivermectine|UNII-8883YP2R6D|8883YP2R6D|MK 933|L 640471|SCHEMBL44294|CHEMBL1200633|CD5024|CD-5024|Ivermectine 100 microg/mL in Acetonitrile|L-640471,1736.200,C95H146O28,340.000,3340.000,NULL,123,6,28,15,"InChI=1S/C48H74O14.C47H72O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38;1-24(2)41-27(5)16-17-46(61-41)22-33-19-32(60-46)15-14-26(4)42(25(3)12-11-13-31-23-54-44-39(48)28(6)18-34(45(50)57-33)47(31,44)51)58-38-21-36(53-10)43(30(8)56-38)59-37-20-35(52-9)40(49)29(7)55-37/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3;11-14,18,24-25,27,29-30,",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)O[C@@H]1C(C)C,SPBDXSGPUHCETR-JFUDTMANSA-N,"(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-",Ivermectin,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,19468|38004|39067|39069|39071|39076|42864|45299|45300|45302|54923|74944|85642|103345|103486|103495|103502|103505|131026|132962|150751|150752|150753|150754|150755|150756|204334|204753|204759|204895|204901|204907|204913|211489|213065|214618|219158|237429|251379|293136|319056|332314|332315|332316|348162|348163|348164|348165|521220|524579|524580|524581|524582|524583|524790|524791|524792|524793|524794|524795|524796|567091|588211|588212|588213|588220|604271|625144|625145|625146|625147|625148|625149|625150|625151|,20061025,"Chem-Space.com Database|ChEMBL|ChemSpider|Collaborative Drug Discovery, Inc.|FDA/SPL Indexing Data|LGC Standards|MassBank of North America (MoNA)|MolPort|NextBio|NextMove Software|SureChEMBL|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
71587734,Unii-EY1WA413UL,"UNII-EY1WA413UL|EY1WA413UL|Avasopasem manganese|Avasopasem manganese [USAN]|GC4419|SC-72325A|435327-40-5|Manganese, dichloro((4aS,13aS,17aS,21aS)-1,2,3,4,4a,5,6,12,13,13a,14,15,16,17,17a,18,19,20,21,21a-eicosahydro-7,11-nitrilo-7H-dibenzo(b,H)-5,13,18,21-tetraazacycloheptadecine-kappaN5,kappaN13,kappaN18,kappaN21,kappaN22)-, (pb-7-11-2344'3')-",483.400,C21H35Cl2MnN5,61.000,381.000,NULL,29,4,7,0,"InChI=1S/C21H35N5.2ClH.Mn/c1-3-10-20-18(8-1)22-12-13-23-19-9-2-4-11-21(19)25-15-17-7-5-6-16(26-17)14-24-20;;;/h5-7,18-25H,1-4,8-15H2;2*1H;/q;;;+2/p-2/t18-,19-,20-,21-;;;/m0.../s1",C1CC[C@H]2[C@H](C1)NCCN[C@H]3CCCC[C@@H]3NCC4=CC=CC(=N4)CN2.[Cl-].[Cl-].[Mn+2],WXEMWBBXVXHEPU-NDOCQCNASA-L,"manganese(2+);(4S,9S,14S,19S)-3,10,13,20,26-pentazatetracyclo[20.3.1.04,9.014,19]hexacosa-1(26),22,24-triene;dichloride",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20130708,ChemIDplus|FDA/SPL Indexing Data,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
134687046,"(1R,4S,5'S,6R,6'R,8R,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-Butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",IVERMECTIN|70288-86-7,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15?,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)CC=C([C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)C)C,AZSNMRSAGSSBNP-HEBHSACISA-N,"(1R,4S,5'S,6R,6'R,8R,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20180713,3B Scientific (Wuhan) Corp,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
6293,Alizarin,"Alizarin|72-48-0|1,2-dihydroxyanthracene-9,10-dione|Alizarin Red|Mordant Red 11|1,2-Dihydroxyanthraquinone|Alizarin B|Turkey Red|1,2-Dihydroxy-9,10-anthracenedione|1,2-Anthraquinonediol|ALIZARINE|Alizarina|Alizarine Red|Alizarine B|Eljon Madder|Alizarine NAC|Alizerine NAC|Alizarine Red B|Alizarine Red L|Alizarine 3B|Eljon Madder M|Alizarine L paste|Turkey Red W|1,2-Dihydroxy-9,10-anthraquinone|Alizarine Red IP|Alizarine indicator|Certiqual Alizarine|Alizarine Red B2|Alizarine Red IPP|Alizerine Red IPP|Mitsu",240.210,C14H8O4,74.600,378.000,3.200,18,2,4,0,"InChI=1S/C14H8O4/c15-10-6-5-9-11(14(10)18)13(17)8-4-2-1-3-7(8)12(9)16/h1-6,15,18H",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)O,RGCKGOZRHPZPFP-UHFFFAOYSA-N,"1,2-dihydroxyanthracene-9,10-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1|3|5|7|9|13|15|17|19|21|23|25|27|31|33|35|39|45|47|49|51|53|55|57|59|61|65|67|69|71|73|77|79|81|99|101|105|107|109|113|115|119|121|123|129|131|133|137|139|141|143|145|155|157|161|165|167|175|179|256|608|875|880|881|884|885|887|889|892|893|894|900|901|902|910|923|924|927|930|940|995|1030|1033|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1549|1552|1637|1648|1688|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|2564|2565|2572|2573|2662|2778|278,20040916,"001Chemical|3B Scientific (Wuhan) Corp|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Aronis|Aurora Fine Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
7340,o-Aminoazotoluene,o-Aminoazotoluene|97-56-3|Fast Garnet GBC Base|Solvent Yellow 3|C.I. Solvent Yellow 3|o-Aminoazotoluol|Toluazotoluidine|2-AMINO-5-AZOTOLUENE|Fast Oil Yellow|Somalia Yellow R|Fast Yellow AT|Fat Yellow B|Oil Yellow C|Oil Yellow I|Oil Yellow AT|Hidaco Oil Yellow|Sudan Yellow RRA|Oil Yellow 2R|Waxakol Yellow NL|Aminoazotoluene|Organol Yellow 2T|Oil Yellow 21|ortho-Aminoazotoluene|OAAT|o-Amidoazotoluol|o-Aminoazotolueno|Oil Yellow 2681|o-Tolueneazo-o-toluidine|Tulabase Fast Garnet GB|O-AT|Brasilazina Oil Yellow ,225.290,C14H15N3,50.700,264.000,3.700,17,1,3,2,"InChI=1S/C14H15N3/c1-10-5-3-4-6-14(10)17-16-12-7-8-13(15)11(2)9-12/h3-9H,15H2,1-2H3",CC1=CC=CC=C1N=NC2=CC(=C(C=C2)N)C,PFRYFZZSECNQOL-UHFFFAOYSA-N,2-methyl-4-[(2-methylphenyl)diazenyl]aniline,o-Aminoazotoluene,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1|3|5|7|9|13|19|21|23|25|29|31|33|35|37|39|41|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|93|95|97|99|101|103|105|107|109|115|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|97,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|Acros Organics|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BioCrick|BLD Pharm|BOC Sciences|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborativ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
62880,Deferoxamine hydrochloride,"Deferoxamine hydrochloride|1950-39-6|UNII-G9VYJ96FOJ|Deferoxamine hydrochloride [USAN]|Ba-29837|G9VYJ96FOJ|Ba 29837|Desferal|Desferal (TN)|Deferoxamine hydrochloride (USAN)|MLS002702118|Deferoxamine HCl|NSC268993|EINECS 217-767-4|N-(5- 3-((5-Aminopentyl)hydroxycarbamoyl)propionamido pentyl)-3- (5-(N-hydroxyacetamido)pentyl)carbamoyl propionohydroxamic acid monohydrochloride|Desferrioxamine B hydrochloride|SCHEMBL3115584|CHEMBL2002581|DTXSID50173157|NSC 268993|NSC-268993|Butanediamide, N'-(5-((4-((5-(acetylh",597.100,C25H49ClN6O8,206.000,739.000,NULL,40,7,9,23,"InChI=1S/C25H48N6O8.ClH/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H",CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.Cl,KCRQZLMAZHZDCL-UHFFFAOYSA-N,N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;hydrochloride,Deferoxamine,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,9,1|3|5|7|9|11|13|15|17|19|21|23|25|27|29|31|33|35|37|39|41|43|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|135|137|139|141|143|145|155|157|161|165|167|175|179|328,20050808,"3WAY PHARM INC|ABI Chem|Biosynth Carbosynth|BOC Sciences|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|KEGG|LeadScope|NextBio|NextMove Software|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
65708,Procodazole,"Procodazole|23249-97-0|2-Benzimidazolepropionic acid|3-(1H-Benzimidazol-2-yl)propanoic acid|Procodazol|Propazol|1H-Benzimidazole-2-propanoic acid|UNII-SG5IU7FD3R|NSC35790|NSC 35790|3-(1H-Benzoimidazol-2-yl)-propionic acid|3-(1H-benzo[d]imidazol-2-yl)propanoic acid|3-(1H-1,3-Benzodiazol-2-Yl)Propanoic Acid|SG5IU7FD3R|Propionic acid, 2-(2-benzimidazolyl)-|CHEMBL596009|2-Benzimidazolepropionic acid, 97%|NSC-35790|Propazol;2-Benzimidazolepropionic acid|NCGC00013414-03|DSSTox_CID_25093|DSSTox_RID_80666|DSSTox_GS",190.200,C10H10N2O2,66.000,220.000,1.100,14,2,3,3,"InChI=1S/C10H10N2O2/c13-10(14)6-5-9-11-7-3-1-2-4-8(7)12-9/h1-4H,5-6H2,(H,11,12)(H,13,14)",C1=CC=C2C(=C1)NC(=N2)CCC(=O)O,XYWJNTOURDMTPI-UHFFFAOYSA-N,3-(1H-benzimidazol-2-yl)propanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,10,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|248|348|357|376|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|630|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|902|912|914|915|923|924|925|926|938|940|995|1030|1379|1422|1452|1457|1458|1471|1476|1478|1490|1688|176,20050326,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Acros Organics|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alinda Chemical|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|BroadPharm|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
68289,Sesamol,"Sesamol|1,3-Benzodioxol-5-ol|533-31-3|3,4-(Methylenedioxy)phenol|3,4-Methylenedioxyphenol|5-Hydroxy-1,3-benzodioxole|3,4-Methylendioxyphenol|Methylene ether of oxyhydroquinone|2H-1,3-Benzodioxol-5-Ol|MFCD00005827|Phenol, 3,4-(methylenedioxy)-|5-Benzodioxolol|UNII-94IEA0NV89|benzo[d][1,3]dioxol-5-ol|Sesamol, 98%|94IEA0NV89|CHEBI:9126|1,2,4-Benzenetriol methylene ether|2H-benzo[d]1,3-dioxolen-5-ol|sesamol lithium|sesamol sodium|CCRIS 1386|sesamol, ion (1+)|sesamol titanium (+4)|EINECS 208-561-5|NSC 59256|BRN ",138.120,C7H6O3,38.700,126.000,1.200,10,1,3,0,"InChI=1S/C7H6O3/c8-5-1-2-6-7(3-5)10-4-9-6/h1-3,8H,4H2",C1OC2=C(O1)C=C(C=C2)O,LUSZGTFNYDARNI-UHFFFAOYSA-N,"1,3-benzodioxol-5-ol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|608|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1033|1189|1199|1205|1208|1452|1457|1458|1469|1471|1476|1477|1478|1479|1549|1552|1637|1648|1948|2101|2107|2112|2120|2517|2546|2549|2551|,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Anward|Aurora Fi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
73078,Tetrandrine,"tetrandrine|518-34-3|D-Tetrandrine|(+)-Tetrandrine|Fanchinine|Tetrandrin|Sinomenine A|hanjisong|(S,S)-Tetrandrine|DL-Tetrandine|NSC 77037|NSC-77037|(S,S)-(+)-Tetrandrine|Hanfangchin A|(+-)-Tetrandine|d-Tetrandr|CHEBI:49|UNII-29EX23D5AJ|S,S-(+)-Tetrandrine|NSC77037|NSC91771|23495-89-8|MLS002153946|29EX23D5AJ|(11S,31S)-16,36,37,54-tetramethoxy-12,32-dimethyl-11,12,13,14,31,32,33,34-octahydro-2,6-dioxa-1(7,1),3(8,1)-diisoquinolina-5(1,3),7(1,4)-dibenzenacyclooctaphane|SMR000445630|(1beta)-6,6',7,12-Tetramethox",622.700,C38H42N2O6,61.900,979.000,6.400,46,0,8,4,"InChI=1S/C38H42N2O6/c1-39-15-13-25-20-32(42-4)34-22-28(25)29(39)17-23-7-10-27(11-8-23)45-33-19-24(9-12-31(33)41-3)18-30-36-26(14-16-40(30)2)21-35(43-5)37(44-6)38(36)46-34/h7-12,19-22,29-30H,13-18H2,1-6H3/t29-,30-/m0/s1",CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC,WVTKBKWTSCPRNU-KYJUHHDHSA-N,"(1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-3(36),4,6(35),8,10,12(34),18,20,22(33),24,26,31-dodecaene",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1|3|5|7|9|11|13|15|19|21|23|25|27|29|31|33|35|37|39|41|43|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|111|113|115|117|119|121|123|125|127|129|131|133|137|139|141|143|145|155|157|161|165|167|175|179|190|192|196|206|210|214|220|226|248|250|260|266|296|328|330|334|608|781|782|798|800|873|875|880|881|884|885|887|889|892|893|894|900|901|902|923|924|940|995|1021|1022|1030|1033|1046|1085|1230|1236|1242|1274|1332|1376|1377|1379|1381|1385|1415|1422|1423|143,20050326,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AN PharmaTech|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|BindingDB|BioChemPartner|Bio",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
89105,Tretazicar,"Tretazicar|21919-05-1|CB 1954|CB1954|5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE|5-(1-Aziridinyl)-2,4-dinitrobenzamide|5-Aziridino-2,4-dinitrobenzamide|CB-1954|5-Aziridinyl-2,4-dinitrobenzamide|2,4-Dinitroethyleneiminobenzamide|Benzamide,5-(1-aziridinyl)-2,4-dinitro-|2,4-Dinitro-5-ethyleneiminobenzamide|CHEMBL23330|UNII-7865D5D01M|MFCD00869490|7865D5D01M|NSC-115829|CB1|5-[aziridin-1-yl]-2,4-dinitrobenzamide|SMR000326847|Tretazicar [INN]|NSC 115829|CCRIS 1631|BRN 5825582|CB1954(Tretazicar)|CB1954; Tretazicar|CB 1",252.180,C9H8N4O5,138.000,385.000,0.000,18,1,6,2,"InChI=1S/C9H8N4O5/c10-9(14)5-3-7(11-1-2-11)8(13(17)18)4-6(5)12(15)16/h3-4H,1-2H2,(H2,10,14)",C1CN1C2=C(C=C(C(=C2)C(=O)N)[N+](=O)[O-])[N+](=O)[O-],WOCXQMCIOTUMJV-UHFFFAOYSA-N,"5-(aziridin-1-yl)-2,4-dinitrobenzamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1|3|5|7|9|13|15|17|19|21|23|25|27|29|31|33|35|37|39|41|43|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|135|137|139|141|143|145|192|248|256|272|288|330|357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|801|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|93,20050326,"001Chemical|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Achemtek|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|BindingDB|BioChemPartner|Biocore|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6321424,Ivermectin,"IVERMECTIN|Ivermectin B1a|70288-86-7|Dihydroavermectin B1a|22,23-Dihydroavermectin B1a|avermectin H2B1a|71827-03-7|UNII-91Y2202OUW|Ivermectin Component B1a|CHEBI:63941|91Y2202OUW|(2ae,4e,5's,6s,6'r,7s,8e,11r,13r,15s,17ar,20r,20ar,20bs)-6'-[(2s)-Butan-2-Yl]-20,20b-Dihydroxy-5',6,8,19-Tetramethyl-17-Oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-Tetradecahydro-2h,7h-Spiro[11,15-Methanofuro[4,3,2-Pq][2,6]benzodioxacyclooctadecine-13,2'-Pyran]-7-Yl 2,6-Dideoxy-4-O-(2,6-Dideoxy-3-O-Methyl-Alpha-L-Arabino-Hexopy",875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1",CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-XPNPUAGNSA-N,"(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1189|1195|1208|1332|2517|588834|624101|624136|624138|624139|624141|624151|624349|651631|651632|651633|651634|651828|652048|652051|686977|686978|686979|720516|720532|720533|720552|720634|720635|720637|720641|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720717|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|7430,20051120,"AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|BioCrick|Biosynth Carbosynth|BOC Sciences|Broad Institute|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11004289,"(3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one","55094-52-5|(3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one|2,3,5-TRI-O-BENZYL-D-RIBONOLACTONE|2,3,5-Tri-O-benzyl-D-ribono-1,4-lactone|(3R,4R,5R)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-one|2,3,5-Tri-O-benzyl-D-ribonic Acid 1,4-lactone|MFCD08703966|Remdesivir intermediate|PubChem10807|Remedesivir intermediate|AntinCoV drug intermediate|Anti-nCoV drug intermediate|SCHEMBL3304205|DTXSID00451513|(3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)-methyl)dihydrofuran-2(3H)-one|E",418.500,C26H26O5,54.000,520.000,4.100,31,0,5,10,"InChI=1S/C26H26O5/c27-26-25(30-18-22-14-8-3-9-15-22)24(29-17-21-12-6-2-7-13-21)23(31-26)19-28-16-20-10-4-1-5-11-20/h1-15,23-25H,16-19H2/t23-,24-,25-/m1/s1",C1=CC=C(C=C1)COC[C@@H]2[C@H]([C@H](C(=O)O2)OCC3=CC=CC=C3)OCC4=CC=CC=C4,LDHBSABBBAUMCZ-UBFVSLLYSA-N,"(3R,4R,5R)-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolan-2-one",NULL,Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,5,NULL,20061026,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Anward|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CAPOT|Chem-Space.com Database|Chemenu Inc.|ChemFish Tokyo co.,ltd|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemTik|Chiralblock Biosciences|Combi-Blocks|DiscoveryGate|Elsa Bi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,NULL
133082085,MaxEPA,"MaxEPA|Marincap|Omegaven|Promega|Sonergx|Pro-Mega|omega-3 Fatty acid|omega-3-Fatty acid|EPA-PLUS|EPA 28|N-3 fatty acid-high fish oils|Fish oils, n-3 fatty acid-high|Fish oils, omega-3 fatty acid-high|TG 361724|Fats and Glyceridic oils, fish, n-3 fatty acid-high|308064-99-5",645.000,C43H64O4,74.600,874.000,NULL,47,2,4,28,"InChI=1S/C22H32O2.C21H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24;1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(22)23/h3-4,6-7,9-10,12-13,15-16,18-19H,2,5,8,11,14,17,20-21H2,1H3,(H,23,24);4-5,7-8,10-11,13-14,16-17H,2-3,6,9,12,15,18-20H2,1H3,(H,22,23)/b4-3-,7-6-,10-9-,13-12-,16-15-,19-18-;5-4+,8-7+,11-10+,14-13+,17-16+",CCC/C=C/C/C=C/C/C=C/C/C=C/C/C=C/CCCC(=O)O.CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)O,YZXDIHSFJORZKY-GTCDFJJPSA-N,"(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid;(5E,8E,11E,14E,17E)-henicosa-5,8,11,14,17-pentaenoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Use and Manufacturing,7,NULL,20180513,ChemIDplus|Comparative Toxicogenomics Database (CTD),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135398700,Isoxanthopterin,"Isoxanthopterin|529-69-1|2-Amino-4,7-dihydroxypteridine|2-Aminopteridine-4,7-diol|Ranachrome 4|2-Amino-4,7(3H,8H)-pteridinedione|2-Aminopteridine-4,7(1H,8H)-dione|2-AMINO-4,7(1H,8H)-PTERIDINEDIONE|UNII-XR11PF6TYR|XR11PF6TYR|2-aminopteridine-4,7(3H,8H)-dione|4,7(3H,8H)-Pteridinedione, 2-amino-|CHEBI:16713|NSC118090|2-amino-1,4,7,8-tetrahydropteridine-4,7-dione|EINECS 208-469-5|NSC 118090|2-Amino-4,7-pteridinediol|7-hydroxypterin|Isoxanthopterin, 97%|Spectrum_000248|2-amino-1,8-dihydropteridine-4,7-dione|4,7(",179.140,C6H5N5O2,109.000,392.000,-2.100,13,3,4,0,"InChI=1S/C6H5N5O2/c7-6-10-4-3(5(13)11-6)8-1-2(12)9-4/h1H,(H4,7,9,10,11,12,13)",C1=NC2=C(NC1=O)N=C(NC2=O)N,GLKCOBIIZKYKFN-UHFFFAOYSA-N,"2-amino-3,8-dihydropteridine-4,7-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,1|3|5|7|9|11|13|15|19|21|23|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|93|99|101|103|105|107|109|111|113|117|119|121|123|125|127|129|131|133|143|145|155|157|161|165|167|175|192|248|270|330|357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|9,20190115,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|ABI Chem|Achemo Scientific Limited|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambinter|Angayarkanni Lab, Department of Microbial Biotechnology, Bharathiar University|Angene Chemical|Aurora Fine Chemicals LLC|BioCyc|Biosynth Carbosynth|BLD Pharm|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemBank|Chembase.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3715,Indomethacin,indomethacin|53-86-1|indometacin|Indocin|Indometacine|Indomethacine|Indocid|Metindol|Amuno|Indomethazine|Imbrilon|Tannex|Indomethacinum|Artracin|Artrinovo|Artrivia|Confortid|Idomethine|Indomecol|Indoptic|Indoptol|Inflazon|Infrocin|Metartril|Methazine|Mikametan|Reumacide|Sadoreum|Dolovin|Inacid|Indacin|Indomed|Indomee|Lausit|Metacen|Mobilan|Indo-rectolmin|Indo-tablinen|Inteban sp|Indometacyna|Indometicina|Mezolin|2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid|Indometacina|Indometacinum|D,357.800,C19H16ClNO4,68.500,506.000,4.300,25,1,4,4,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,CGIGDMFJXJATDK-UHFFFAOYSA-N,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid,Indomethacin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|361|364|368|371|373|374|375|377|388|410|411|421|422|425|426|427|429|430|431|432|433|434|435|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|540|541|542|543|544|545|546|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|607|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Achemtek|Acros Organics|ACT Chemical|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambinter|AN PharmaTec",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5754,Hydrocortisone,hydrocortisone|Cortisol|50-23-7|Acticort|Cetacort|Hydrasson|Hydrocortisyl|Cobadex|Hydrocortone|Cortef|Hycort|Hytone|Signef|17-Hydroxycorticosterone|Optef|Kendall's compound F|Cortanal|Cortenema|Corticreme|Cortifan|Cortiment|Cortispray|Cortonema|Dermacort|Dermolate|Efcorbin|Efcortelan|Ficortril|Genacort|Hycortol|Hycortole|Permicort|Proctocort|Tarcortin|Traumaide|Alacort|Cleiton|Cortril|Dihydrocostisone|Hytone lotion|Hidro-Colisona|Hydro-Adreson|Scheroson F|Incortin-H|Reichstein's substance M|Cort-Dome|Domole,362.500,C21H30O5,94.800,684.000,1.600,26,3,5,2,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,JYGXADMDTFJGBT-VWUMJDOOSA-N,"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one",Hydrocortisone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|180|190|192|206|210|212|220|248|250|258|264|268|270|276|296|316|328|357|361|364|368|371|373|374|375|377|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|547|552|555|556|559|560|561|565|567|568|570|571|57,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alsachim|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|BIND|BindingDB|BioChemPartner|BioCyc|Biosynt",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5994,Progesterone,"progesterone|57-83-0|Pregn-4-ene-3,20-dione|Agolutin|Luteohormone|Crinone|4-Pregnene-3,20-dione|Corpus luteum hormone|Syngesterone|Utrogestan|Luteol|Glanducorpin|Pregnenedione|Progesterol|Syngestrets|Corlutin|Cyclogest|Gesterol|Gestone|Gestormone|Progestin|Progestone|Progestron|Prometrium|Hormoflaveine|Methylpregnone|Progestasert|Progesteronum|Progestronol|Corlutina|Corluvite|Corporin|Flavolutan|Fologenon|Gynlutin|Gynolutone|Hormoluton|Lingusorbs|Lucorteum|Luteodyn|Luteogan|Luteopur|Luteosan|Luteostab|Luteo",314.500,C21H30O2,34.100,589.000,3.900,23,0,2,1,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,RJKFOVLPORLFTN-LEKSSAKUSA-N,"(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",Progesterone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|179|180|192|228|248|270|328|342|357|361|364|368|371|373|374|375|377|381|411|421|422|425|426|427|429|430|431|432|433|434|435|436|438|440|441|444|445|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|530|538|539|540|541|542|543|544|545|546|547|552|555|556|559|560|561|565|567|568|57,20040916,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|BIDD|BIND|BindingDB|BioChemPartner|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6451,Bromocresol green,"Bromocresol green|76-60-8|BROMCRESOL GREEN|bromo cresol green|3,3-Bis(3,5-dibromo-4-hydroxy-2-methylphenyl)-3H-benzo[c][1,2]oxathiole 1,1-dioxide|Tetrabromo-m-cresolphthalein sulfone|3',3'',5',5''-Tetrabromo-m-cresolsulfonephthalein|Bromocresol blue|NSC 7817|UNII-8YGN0Y942M|MFCD00005874|8YGN0Y942M|CHEMBL145704|Bromocresol Green, ACS reagent|NSC7817|2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxy-2-methylphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]-3-methylphenol|Bromocresolgreen|3,3-Bis(3,5-dibromo-4-hydroxy-2-m",698.000,C21H14Br4O5S,92.200,742.000,6.500,31,2,5,2,"InChI=1S/C21H14Br4O5S/c1-9-12(7-14(22)19(26)17(9)24)21(13-8-15(23)20(27)18(25)10(13)2)11-5-3-4-6-16(11)31(28,29)30-21/h3-8,26-27H,1-2H3",CC1=C(C(=C(C=C1C2(C3=CC=CC=C3S(=O)(=O)O2)C4=CC(=C(C(=C4C)Br)O)Br)Br)O)Br,FRPHFZCDPYBUAU-UHFFFAOYSA-N,"2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxy-2-methylphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]-3-methylphenol",Bromcresol Green,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,179|80624|80631|651631|651632|651633|651634|679000|679398|720516|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BindingDB|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9403,Estradiol cypionate,"estradiol cypionate|Depofemin|313-06-4|Depoestradiol|Depo-Estradiol|Depoestra|Estradep|Estrapo|Estro-Depo|Dep-Estro|Femogen CYP|depGynogen|Depoestradiol cypionate|beta-Estradiol 17-cypionate|Estradiol 17-cypionate|Estradiol cyclopentylpropionate|Estradiol (cypionate)|E. Ionate P.A.|Estradiol 17-cyclopentylpropionate|Depo-estradiol cyclopentylpropionate|NSC 3354|Estradiol, 17-cyclopentanepropionate|UNII-7E1DV054LO|Cyclopentanepropionic acid, 17-ester with estradiol|Estradiol cypionate [USP]|17.beta.-Estradio",396.600,C26H36O3,46.500,597.000,7.100,29,1,3,5,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O,UOACKFBJUYNSLK-XRKIENNPSA-N,"[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,1|3|5|7|9|11|13|15|17|19|21|23|25|27|29|31|33|35|37|39|41|43|45|47|49|51|53|57|59|61|63|65|67|69|71|73|75|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|248|328|1195|1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|22,20050326,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alfa Chemistry|Anward|ApexBio Technology|Aurora Fine Chemicals LLC|BioChemPartner|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChE",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
83818,Tanakan,"Chloroquine monophosphate|TCMDC-123988|Tanakan|1446-17-9|Araten phosphate|Arechin|Chloroin|Delagil|Khingamin|Miniquine|Rivoquine|Tanakene|Arolen|Aralen diphosphate|Chingamin phosphate|Gontochin phosphate|Chloroquin diphosphate|Ipsen 225|Chloroquine, phosphate|NSC14050|NSC-14050|3377 RP|SN 7,618|EGb761|Resochin diphosphate|Quinoline, diphosphate|CQ|CHEMBL1326|SCHEMBL40829|DTXSID10932343|Pharmakon1600-01500179|NSC756681|AKOS025310652|NSC-756681|VZ31565|1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diet",417.900,C18H29ClN3O4P,106.000,359.000,NULL,27,4,7,8,"InChI=1S/C18H26ClN3.H3O4P/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18;1-5(2,3)4/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21);(H3,1,2,3,4)",CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O,AEUAEICGCMSYCQ-UHFFFAOYSA-N,"4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;phosphoric acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,10,1|5|7|9|13|15|17|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|85|87|91|93|95|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|135|137|139|141|143|145|155|157|161|165|167|175|179|248|328|2297|2302|2303|2304|2305|2306|159312|159313|159318|159319|159320|159326|159327|159333|159334|159337|159338|159454|159457|159458|159464|159467|159474|159475|159476|159481|159482|159597|159598|159602|159603|159604|159607|159608|320717|320718|320724|320725|397125|5402,20050326,"A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|AKos Consulting & Solutions|Amadis Chemical|BindingDB|BLD Pharm|Chembase.cn|ChEMBL|ChemIDplus|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|GlaxoSmithKline (GSK)|Gregory J. Crowther|labseeker|LeadScope|MP Biomedicals|MuseChem|National Center for Advancing Translational Sciences (NCATS)|NextBio|NovoSeek|OChem|PATENTSCOP",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
445354,Retinol,retinol|Vitamin A|all-trans-Retinol|68-26-8|Vitamin A1|Alphalin|Axerophthol|Afaxin|Vitamin A alcohol|Oleovitamin A|Chocola A|Alphasterol|Apostavit|Aquasynth|Biosterol|Epiteliol|Ophthalamin|Agiolan|Agoncal|Anatola|Myvpack|Prepalin|Testavol|Veroftal|Aoral|Apexol|Avibon|Avitol|Axerol|Dofsol|Vaflol|Vitpex|Vogan|Disatabs Tabs|Lard Factor|all-trans-Retinyl alcohol|Bentavit A|Dohyfral A|Alcovit A|Anatola A|Vogan-Neu|A-Mulsal|Plivit A|Vi-Alpha|A-Vitan|All-trans retinol|Atars|trans-retinol|Vafol|all-trans-Vitamin A ,286.500,C20H30O,20.200,496.000,5.700,21,1,1,5,"InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,FPIPGXGPPPQFEQ-OVSJKPMPSA-N,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol",Vitamin A,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|81|85|87|91|93|95|99|101|103|105|107|115|119|121|123|125|129|131|133|137|139|143|145|155|157|161|165|167|175|192|194|206|212|220|248|256|264|270|274|296|302|328|330|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|608|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|901|902|910|912|921|923|924|925|926|927|930|938|940|946|947|948|955|96,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|BIDD|BIND|BindingDB|BioChemPartner|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|Burnham Center for Chemical Gen",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
44148932,Acrivastine and pseudoephedrine hydrochloride,"Duact|Acrivastine and pseudoephedrine|Acrivastine and pseudoephedrine hydrochloride|Acrivastine mixture with pseudoephedrine hydrochloride|926042-19-5|2-Propenoic acid, 3-(6-((1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl)-2-pyridinyl)-, (2E)-, mixt. with alphaS,alpha-((1S)-1-(methylamino)ethyl)benzenemethanol hydrochloride (1:1)",550.100,C32H40ClN3O3,85.700,635.000,NULL,39,4,6,9,"InChI=1S/C22H24N2O2.C10H15NO.ClH/c1-17-7-9-18(10-8-17)20(13-16-24-14-2-3-15-24)21-6-4-5-19(23-21)11-12-22(25)26;1-8(11-2)10(12)9-6-4-3-5-7-9;/h4-13H,2-3,14-16H2,1H3,(H,25,26);3-8,10-12H,1-2H3;1H/b12-11+,20-13+;;/t;8-,10+;/m.0./s1",CC1=CC=C(C=C1)/C(=C\\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O.C[C@@H]([C@H](C1=CC=CC=C1)O)NC.Cl,SQXPPECBPHSOSQ-GNWPWZHSSA-N,"(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol;(E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid;hydrochloride",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20090820,ChemIDplus|ToxPlanet,Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
45114068,Pharmakon1600-01300027,IVERMECTIN|SR-05000001905|70288-86-7|CHEBI:91732|HMS2091E11|Pharmakon1600-01300027|NSC755843|CCG-213693|NSC-755843|I1850|AB01563172_01|SR-05000001905-1|SR-05000001905-2|BRD-A48570745-001-01-1,875.100,C48H74O14,170.000,1680.000,4.100,62,3,14,8,"InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25?,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39?,40+,41-,42-,43+,44?,45+,47+,48+/m0/s1",CCC(C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)OC6C[C@@H](C([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\\C)C,AZSNMRSAGSSBNP-ONDMGMIHSA-N,"(1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-butan-2-yl-21,24-dihydroxy-12-[(4S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one",Ivermectin,Biological Test Results|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,624349|720641|720717|1159580|1224863|1259310|1259332|1259333|1259334|1259343|1259374|1259397|1259398|1259416|1259421|1259422|1259423|1347080,20100420,"Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|chemical genetic matrix|DTP/NCI|ICCB-Longwood Screening Facility, Harvard Medical School|Southern Research Institute|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|The Scripps Research Institute Molecular Screening Center|ToxPlanet|VanderVen Lab, College of Veterinary Medicine, Cornell University",Curation Efforts|Governmental Organizations|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
91820207,Coenzyme B12,"Cobamamide|Dibencozide|Funacomide|Calomide|adenosylcobalamin|coenzyme B12|Deoxyadenosylcobalamin|Cobamamid|5'-Deoxyadenosyl vitamin B12|Cobamide coenzyme|Cobalamin coenzyme|Adenosylcob(III)alamin|vitamin B12|5'-Deoxy-5'-adenosylcobalamin|5'-Deoxyadenosylcobalamin|(5'-Deoxy-5'-adenosyl)cobamide coenzyme|(5,6-dimethylbenzimidazolyl)cobamide coenzyme|5'-Deoxyadenosyl-5,6-dimethylbenzimidazolylcobamide|13870-90-1|5,6-Dimethylbenzimidazolyl-5-deoxyadenosyl-cobamide|5,6-Dimethylbenzimidazolyl-Co-5'-deoxyadenosylc",1579.600,C72H100CoN18O17P-3,571.000,3730.000,NULL,109,12,27,17,"InChI=1S/C62H90N13O14P.C10H12N5O3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);2-",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@@H](C)CNC(=O)CC[C@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[CH2-][C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O.[Co],DFDCDQDATCDZSO-YGHJOQEPSA-L,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(1R,2R,3S,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate",Vitamin B 12,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20150717,BioCyc|ToxPlanet,Curation Efforts|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
91864495,Solnatide,"Solnatide|UNII-17ZS80333G|17ZS80333G|259206-53-6|L-Cysteine, L-cysteinylglycyl-L-glutaminyl-L-arginyl-L-alpha-glutamyl-L-threonyl-L-prolyl-L-alpha-glutamylglycyl-L-alanyl-L-alpha-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-, cyclic (1->17)-disulfide|Solnatide [INN]|TIP-peptide|AP301 peptide|AP-301|Cys-gly-gln-arg-glu-thr-pro-glu-gly-ala-glu-ala-lys-pro-trp-tyr-cys cyclic (1->17)-disulfide",1923.100,C82H119N23O27S2,861.000,4170.000,-10.700,134,27,32,27,"InChI=1S/C82H119N23O27S2/c1-40-67(117)95-52(23-27-64(113)114)71(121)93-41(2)68(118)99-54(13-6-7-29-83)79(129)104-31-9-15-58(104)78(128)101-56(34-44-35-89-48-12-5-4-11-46(44)48)76(126)100-55(33-43-17-19-45(107)20-18-43)75(125)102-57(81(131)132)39-134-133-38-47(84)69(119)90-37-62(110)94-51(21-25-60(85)108)73(123)96-49(14-8-30-88-82(86)87)72(122)97-53(24-28-65(115)116)74(124)103-66(42(3)106)80(130)105-32-10-16-59(105)77(127)98-50(22-26-63(111)112)70(120)91-36-61(109)92-40/h4-5,11-12,17-20,35,40-42,47,49-59,66,",C[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)NCC(=O)N1)CCC(=O)O)[C@@H](C)O)CCC(=O)O)CCCNC(=N)N)CCC(=O)N)N)C(=O)O)CC4=CC=C(C=C4)O)CC5=CNC6=CC=CC=C65)CCCCN)C)CCC(=O)O,LKVFMOMQYXIFRK-KSVAIKAXSA-N,"(3S,6S,9S,12S,18S,21S,27S,30S,33S,36S,42R,47R,50S,53S,56S)-42-amino-3-(4-aminobutyl)-36-(3-amino-3-oxopropyl)-33-(3-carbamimidamidopropyl)-9,18,30-tris(2-carboxyethyl)-27-[(1R)-1-hydroxyethyl]-50-[(4-hydroxyphenyl)methyl]-53-(1H-indol-3-ylmethyl)-6,12-dimethyl-2,5,8,11,14,17,20,26,29,32,35,38,41,49,52,55-hexadecaoxo-44,45-dithia-1,4,7,10,13,16,19,25,28,31,34,37,40,48,51,54-hexadecazatricyclo[54.3.0.021,25]nonapentacontane-47-carboxylic acid",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20150911,ChemIDplus|FDA/SPL Indexing Data|PATENTSCOPE (WIPO)|Springer Nature|THE BioTek|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
126941,Methotrexate,"methotrexate|59-05-2|Rheumatrex|Amethopterin|Abitrexate|Trexall|Metatrexan|Hdmtx|Methylaminopterinum|MTX|4-Amino-10-methylfolic acid|Methotrexate hydrate|(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid|Methylaminopterin|Methotrexatum|Metotrexato|Maxtrex|Rasuvo|Mexate-Aq|N-Bismethylpteroylglutamic acid|NSC-740|NCI-C04671|Methotrexate Lpf|133073-73-1|CL-14377|UNII-YL5FZ2Y5U1|Amethopterine|Farmitrexat|EMT 25,299|L-Amethopterin|Methotrexat-Ebewe|TCMDC-125858|(+)-4-Amino-10-",454.400,C20H22N8O5,211.000,704.000,-1.800,33,5,12,9,"InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,FBOZXECLQNJBKD-ZDUSSCGKSA-N,"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid",Methotrexate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|3|5|7|9|11|13|15|17|19|21|23|25|27|29|31|33|35|37|39|41|43|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|111|113|115|117|119|121|123|125|127|129|131|133|135|137|139|141|143|145|147|149|151|153|155|157|159|161|163|165|167|169|171|173|175|177|179|180|182|184|186|188|190|192|194|196|198|200|206|208|210|212|214|216|218|220|224|226|228|230|232|236|242|244|246|248|250|252|254|256|258|260|264|266|270|272|274|276|278|280|282|284|286|288|290|292|296|298|300,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
288216,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-","(R)-Tegafur|37076-68-9|UNII-5317337V7V|CHEMBL235993|2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-|NSC148958|5-fluoro-1-[(2R)-oxolan-2-yl]pyrimidine-2,4-dione|5317337V7V|(R)-Ftorafur|Ftorafur, (R)-|Tegafur, (R)-|C8H9FN2O3|5-fluoro-1-[(2R)-2-oxolanyl]pyrimidine-2,4-dione|5-fluoranyl-1-[(2R)-oxolan-2-yl]pyrimidine-2,4-dione|2,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (R)-|FT-207 (NSC 148958)|NSC 148958|5-FLUORO-1-(TETRAHYDRO-2-FURFURYL)URACIL|R-1-(Tetrahydrofuran-2-yl)-5-f",200.170,C8H9FN2O3,58.600,316.000,-0.300,14,1,4,1,"InChI=1S/C8H9FN2O3/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12/h4,6H,1-3H2,(H,10,12,13)/t6-/m1/s1",C1C[C@@H](OC1)N2C=C(C(=O)NC2=O)F,WFWLQNSHRPWKFK-ZCFIWIBFSA-N,"5-fluoro-1-[(2R)-oxolan-2-yl]pyrimidine-2,4-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,9,1|3|5|7|9|11|13|15|19|21|23|25|27|29|31|33|35|37|39|41|43|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|111|113|115|117|119|121|123|125|127|129|131|133|137|139|141|143|145|179|186|192|194|200|206|208|212|214|220|222|226|248|250|252|256|264|272|274|288|296|328|330|1146868|1146869|1146870|1146871|1146872|1146873|1146874|1146875|1146876|1146877|1146878|1146879|1146880|1146881|1146882|1146883|1224817|1259421|1296008|1296009|1345084|1346986|1346987|134705,20050326,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|ABI Chem|Achemtek|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Aurora Fine Chemicals LLC|BindingDB|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Crystallography Open Database|Cure First|Davey Lab, Department of Micro",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4338791,N-(2-Chloropyridin-3-yl)acetamide,"N-(2-chloropyridin-3-yl)acetamide|21352-19-2|N-(2-chloro-3-pyridinyl)Acetamide|N-(2-Chloro-3-pyridinyl)-acetamide|Acetamide,N-(2-chloro-3-pyridinyl)-|2-Chloro-3-acetylaminopyridine|3-acetylamino-2-chloropyridine|SCHEMBL6143237|DTXSID90402074|N-(2-chloro-3-pyridyl)acetamide|N-acetyl 2-chloro-3-pyridinamine|ALBB-003552|ZINC3130108|N-(2-chloropyridin-3-yl)ethanamide|7247AD|MFCD00223341|STK415083|AKOS003273988|N-(2-chloro-pyridin-3-yl)-acetamide|MCULE-4243267035|Acetamide, N-(2-chloro-3-pyridinyl)-|BS-11743|DA-",170.590,C7H7ClN2O,42.000,151.000,1.000,11,1,2,1,"InChI=1S/C7H7ClN2O/c1-5(11)10-6-3-2-4-9-7(6)8/h2-4H,1H3,(H,10,11)",CC(=O)NC1=C(N=CC=C1)Cl,KWZIDENWDCKKPW-UHFFFAOYSA-N,N-(2-chloropyridin-3-yl)acetamide,NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20050914,"3WAY PHARM INC|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemBridge|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|Combi-Blocks|Debye Scientific Co., Ltd|DiscoveryGate|EDASA Scientific|eNovation Chemicals|EPA DSSTox|Fine",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5460183,Cob(II)alamin,"Cob(II)alamin|Cob(III)alamin|cobalamin(III)|Cobalamin (III)|vitamin B-12r|Hydroxomin|cobalamin|cob(I)alamin|Rubratope-60|vitamin B12|Cbl|Cobalamine|14463-33-3|Rubratope-57|cobalamin(1+)|RUBIVITE|RUVITE|18534-66-2|B12r|B12s|CHEBI:16304|CHEBI:28911|CHEBI:60488|alpha-(5,6-dimethylbenzimidazolyl)cobamide|13408-78-1|5,6-dimethyl-1-a-D-ribofuranosylbenzimidazole|5,6-dimethyl-1-alpha-delta-ribofuranosylbenzimidazole|Cobinamide ion(1+) dihydrogen phosphate (ester) inner salt 3'-ester|Cobinamide ion(1+) dihydrogen p",1329.300,C62H88CoN13O14P-2,452.000,3150.000,NULL,91,9,19,16,"InChI=1S/C62H90N13O14P.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56-,57+,59-,60+,61+,62+;/m1",CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@H](C)CNC(=O)CC[C@@]\\4([C@H]([C@@H]5[C@]6([C@@]([C@@H](C(=N6)/C(=C\\7/[C@@]([C@@H](C(=N7)/C=C\\8/C([C@@H](C(=N8)/C(=C4\\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co],FEZWOUWWJOYMLT-DSRCUDDDSA-L,"cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20040916,Acorn PharmaTech Product List|BioCyc|ChEBI|ChemSpider|Comparative Toxicogenomics Database (CTD)|Human Metabolome Database (HMDB)|MetabolomicsWorkbench|NextBio|ToxPlanet,Chemical Vendors|Curation Efforts|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9815453,Aspartyl-alanyl-diketopiperazine,"aspartyl-alanyl-diketopiperazine|Ampion|UNII-R9CHM391D5|R9CHM391D5|110954-19-3|2-((2S,5S)-5-methyl-3,6-dioxopiperazin-2-yl)acetic acid|2-[(2S,5S)-5-methyl-3,6-dioxopiperazin-2-yl]acetic acid|CHEMBL4297349|ZINC33961611|AKOS026716132|DB14940|HY-107091|CS-0027308|Q27288007|F2147-2995|2-Piperazineacetic acid, 5-methyl-3,6-dioxo-, (2S,5S)-|[(2S,5S)-5-METHYL-3,6-DIOXOPIPERAZIN-2-YL]ACETIC ACID",186.170,C7H10N2O4,95.500,263.000,-1.400,13,3,4,2,"InChI=1S/C7H10N2O4/c1-3-6(12)9-4(2-5(10)11)7(13)8-3/h3-4H,2H2,1H3,(H,8,13)(H,9,12)(H,10,11)/t3-,4-/m0/s1",C[C@H]1C(=O)N[C@H](C(=O)N1)CC(=O)O,RVLCUCVJZVRNDC-IMJSIDKUSA-N,"2-[(2S,5S)-5-methyl-3,6-dioxopiperazin-2-yl]acetic acid",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20061025,"A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|Alfa Chemistry|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Life Chemicals|MedChemexpress MCE|MolPort|MuseChem|NextBio|Smolecule|TargetMol (Target Molecule Corp.)|THE BioTek|Thomson Pharma|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
20558664,"2-Amino-N-(1,3-thiazol-2-yl)acetamide","2-amino-N-(1,3-thiazol-2-yl)acetamide|73326-19-9|2-Amino-N-(thiazol-2-yl)acetamide|N~1~-1,3-thiazol-2-ylglycinamide|2-azanyl-~{N}-(1,3-thiazol-2-yl)ethanamide|N-1,3-thiazol-2-ylglycinamide|MFCD09933720|DE5|SCHEMBL11312790|BBL031633|STK497968|ZINC19093156|Acetamide,  2-amino-N-2-thiazolyl-|AKOS000174557|2-Amino-N-1,3-thiazol-2-ylacetamide|MCULE-4975122693|VS-0143|ACETAMIDE,2-AMINO-N-THIAZOL-2-YL-|BB 0217105|EN300-52985|Y-6005|AB01004594-01",157.200,C5H7N3OS,96.200,130.000,-0.100,10,2,4,2,"InChI=1S/C5H7N3OS/c6-3-4(9)8-5-7-1-2-10-5/h1-2H,3,6H2,(H,7,8,9)",C1=CSC(=N1)NC(=O)CN,JVRRHVNPKGSGSX-UHFFFAOYSA-N,"2-amino-N-(1,3-thiazol-2-yl)acetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Literature|Patents,4,1224863,20071205,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambeed|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChemBridge|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|EDASA Scientific|Enamine|Google Patents|IBM|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Mcule|MolPort|NCBI Structure|Oakwood Products|PATENTSCOPE (WIPO)|Protein Da",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
45266509,(Glc)3(GlcNAc)2(Man)9(PP-Dol)1,"glycan G00008|CHEBI:53019|(Glc)3(GlcNAc)2(Man)9(PP-Dol)1|[(2R,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3S,4S,5R,6R)-4-[(2R,3S,4S,5S,6R)-3-[(2R,3S,4S,5S,6R)-3-[(2R,3S,4S,5R,6R)-4-[(2R,3R,4S,5R,6R)-4-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(h",2872.600,C113H192N2O77P2,1240.000,5750.000,-19.100,194,45,77,62,"InChI=1S/C113H192N2O77P2/c1-37(2)13-9-14-38(3)15-10-16-39(4)17-11-18-40(5)19-12-20-41(6)21-22-165-193(159,160)192-194(161,162)191-101-59(115-43(8)129)71(141)89(53(32-125)175-101)180-100-58(114-42(7)128)70(140)90(52(31-124)174-100)181-110-88(158)96(69(139)57(179-110)36-164-103-85(155)95(184-107-84(154)79(149)92(55(34-127)177-107)183-105-81(151)73(143)61(131)45(24-117)167-105)68(138)56(178-103)35-163-102-83(153)78(148)91(54(33-126)176-102)182-104-80(150)72(142)60(130)44(23-116)166-104)187-112-99(77(147)65(135",CC(CC/C=C(\\C)/CC/C=C(\\C)/CC/C=C(\\C)/CCC=C(C)C)CCOP(=O)(O)OP(=O)(O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)CO[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO[C@@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O[C@@H]6[C@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)O)O)O)O[C@@H]7[C@H]([C@H]([C@@H]([C@H](O7)CO)O[C@@H]8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)O)O[C@@H]9[C@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O[C@@H]1[C@H]([C@H]([C@@H],MSRIEQBVNYLVDQ-PCAUIPACSA-N,"[(2R,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3S,4S,5R,6R)-4-[(2R,3S,4S,5S,6R)-3-[(2R,3S,4S,5S,6R)-3-[(2R,3S,4S,5R,6R)-4-[(2R,3R,4S,5R,6R)-4-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5R,6R)-4-[(2S,3S,4R,5S,",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Pharmacology and Biochemistry,5,NULL,20100507,ChEBI|Google Patents,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
126456119,Lactoferrin,Lactoferrin|Lactoferrin (Bovine)|151186-19-5|J-008279,3125.800,C141H226N46O29S3,1360.000,7330.000,6.800,219,51,65,108,InChI=1S/C141H226N46O29S3/c1-11-77(6)111(133(212)186-112(80(9)189)134(213)183-106(74-218)130(209)184-110(76(4)5)132(211)176-97(49-32-61-161-141(155)156)120(199)170-93(45-28-57-157-137(147)148)116(195)166-78(7)113(192)180-103(136(215)216)66-82-36-16-13-17-37-82)185-128(207)104(72-188)181-131(210)107-50-33-62-187(107)135(214)79(8)165-109(191)71-164-115(194)100(64-75(2)3)177-121(200)92(44-24-27-56-144)168-117(196)91(43-23-26-55-143)169-125(204)99(53-63-219-10)175-119(198)94(46-29-58-158-138(149)150)172-126(205,CC[C@H](C)[C@@H](C(=N[C@@H]([C@@H](C)O)C(=N[C@@H](CS)C(=N[C@@H](C(C)C)C(=N[C@@H](CCCNC(=N)N)C(=N[C@@H](CCCNC(=N)N)C(=N[C@@H](C)C(=N[C@@H](CC1=CC=CC=C1)C(=O)O)O)O)O)O)O)O)O)N=C([C@H](CO)N=C([C@@H]2CCCN2C(=O)[C@H](C)N=C(CN=C([C@H](CC(C)C)N=C([C@H](CCCCN)N=C([C@H](CCCCN)N=C([C@H](CCSC)N=C([C@H](CCCNC(=N)N)N=C([C@H](CC3=CNC4=CC=CC=C43)N=C([C@H](CCC(=N)O)N=C([C@H](CC5=CNC6=CC=CC=C65)N=C([C@H](CCCNC(=N)N)N=C([C@H](CCCNC(=N)N)N=C([C@H](CS)N=C([C@H](CCCCN)N=C([C@H](CC7=CC=CC=C7)N)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O,CSSYQJWUGATIHM-IKGCZBKSSA-N,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[[(2S)-1-[(2S)-2-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-1-hydroxy-3-phenylpropylidene]amino]-1-hydroxyhexylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-5-carbamimidamido-1-hydroxypentylidene]amino]-5-carbamimidamido-1-hydroxypentylidene]amino]-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino]-1,5-dihydroxy-5-i",Lactoferrin,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Use and Manufacturing,6,NULL,20170411,Biosynth Carbosynth|Parchem|U-M Center for Drug Repurposing,Chemical Vendors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
131634231,"S3,S13-Cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide)","AMY-101|UNII-4Z4DFR9BX7|4Z4DFR9BX7|Compstatin 40|Compstatin analog peptide CP40|CHEMBL4297260|1427001-89-5 (free base)|1427001-89-5|L-Isoleucinamide, D-tyrosyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-alpha-aspartyl-L-tryptophyl-N-methylglycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N2-methyl-, cyclic (3->13)-disulfide|S3,S13-Cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginy",1789.100,C83H117N23O18S2,692.000,3770.000,-2.100,126,21,23,30,"InChI=1S/C83H117N23O18S2/c1-11-43(5)68(103-72(114)53(84)30-46-23-25-50(107)26-24-46)80(122)100-61-39-125-126-40-62(82(124)106(10)69(70(86)112)44(6)12-2)101-73(115)55(21-17-29-90-83(87)88)94-76(118)58(33-49-36-89-41-92-49)96-71(113)45(7)93-65(109)38-105(9)81(123)60(31-47-35-91-54-20-15-13-18-51(47)54)99-77(119)59(34-66(110)111)97-74(116)56(27-28-64(85)108)95-75(117)57(98-79(121)67(42(3)4)102-78(61)120)32-48-37-104(8)63-22-16-14-19-52(48)63/h13-16,18-20,22-26,35-37,41-45,53,55-62,67-69,91,107H,11-12,17,21,27-",CC[C@H](C)[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)CC2=CN(C3=CC=CC=C32)C)CCC(=O)N)CC(=O)O)CC4=CNC5=CC=CC=C54)C)C)CC6=CN=CN6)CCCNC(=N)N)C(=O)N(C)[C@@H]([C@@H](C)CC)C(=O)N)NC(=O)[C@@H](CC7=CC=C(C=C7)O)N,MUSGYEMSJUFFHT-UWABRSFTSA-N,"2-[(4R,7S,10S,13S,19S,22S,25S,28S,31S,34R)-34-[[(2S,3S)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]-methylcarbamoyl]-25-(3-amino-3-oxopropyl)-7-(3-carbamimidamidopropyl)-10-(1H-imidazol-5-ylmethyl)-19-(1H-indol-3-ylmethyl)-13,17-dimethyl-28-[(1-methylindol-3-yl)methyl]-6,9,12,15,18,21,24,27,30,33-decaoxo-31-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29,32-decazacyclopentatriacont-22-yl]acetic acid",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Use and Manufacturing,5,NULL,20171017,Ambeed|BLD Pharm|ChEMBL|ChemIDplus|CSNpharm|FDA/SPL Indexing Data|MolPort|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2726,Chlorpromazine,"chlorpromazine|Thorazine|50-53-3|Largactil|Contomin|Chloropromazine|Chlorderazin|Aminazine|Chlorpromados|Fenactil|Megaphen|Propaphenin|Chlorpromazin|2-Chloropromazine|Aminazin|Ampliactil|Fenaktyl|Largactyl|Phenactyl|Promactil|Promazil|Psychozine|Sanopron|Torazina|Wintermin|Elmarin|Esmind|Prozil|Proma|Chlor-Promanyl|Largactilothiazine|Clorpromazina|Novomazina|Fraction AB|3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine|Chlorpromazinum|Amplictil|SKF 2601-A|Cromedazine|Plegomasine|Aminasine|Ampli",318.900,C17H19ClN2S,31.800,339.000,5.200,21,0,3,4,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,ZPEIMTDSQAKGNT-UHFFFAOYSA-N,"3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine",Chlorpromazine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,192|248|330|357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1195|1332|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|16,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Alomone Labs|Alsachim|Ambinter|AN PharmaTech|An",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3108,Dipyridamole,"dipyridamole|58-32-2|Dipyridamol|Persantin|Dipyridamine|Dipyudamine|Persantine|Curantyl|Stimolcardio|Cardoxin|Kurantil|Stenocardil|Cardioflux|Dipiridamol|Dipyridan|Peridamol|Anginal|Apricor|Coribon|Corosan|Coroxin|Stenocardiol|Agilease|Chilcolan|Justpertin|Permiltin|Piroan|Cleridium 150|Coronarine|Gulliostin|Prandiol|Natyl|Prandiol 75|Usaf Ge-12|Dypyridamol|2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol|Dipyridamolum|RA 8|RA-8|NSC-515776|Dipyridamole (P",504.600,C24H40N8O4,145.000,561.000,0.700,36,4,12,12,"InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2",C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,IZEKFCXSFNUWAM-UHFFFAOYSA-N,"2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol",Dipyridamole,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1|3|5|7|9|13|15|19|21|23|25|29|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|91|93|95|97|99|101|105|107|109|113|115|119|121|123|125|131|137|139|141|143|145|155|157|161|165|167|175|179|357|361|364|368|371|373|374|375|377|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|461|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|ApexBio Technolo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
445154,Resveratrol,"resveratrol|501-36-0|trans-resveratrol|3,4',5-Trihydroxystilbene|(E)-5-(4-Hydroxystyryl)benzene-1,3-diol|3,5,4'-Trihydroxystilbene|(E)-resveratrol|3,4',5-Stilbenetriol|5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol|Resvida|3,4',5-Trihydroxy-trans-stilbene|SRT-501|SRT501|5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|3,5,4'-Trihydroxy-trans-stilbene|Resveratol|trans-3,4',5-trihydroxystilbene|5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol|Resveratrol, natural|UNII-Q369O8926L|CHEBI:45713|C14H12O3|tr",228.240,C14H12O3,60.700,246.000,3.100,17,3,3,2,"InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1+",C1=CC(=CC=C1/C=C/C2=CC(=CC(=C2)O)O)O,LUKBXSAWLPMMSZ-OWOJBTEDSA-N,"5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol",Resveratrol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,1|3|7|9|13|19|21|25|31|33|35|39|41|43|45|47|49|53|55|59|65|67|71|73|77|81|83|85|87|89|91|93|95|99|103|105|107|109|113|115|119|121|123|125|129|131|133|139|141|143|145|330|357|361|364|368|371|373|374|375|377|411|421|422|425|426|427|429|430|431|432|433|434|435|436|438|440|441|444|445|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|530|538|539|540|541|542|543|544|545|546|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|58,20050325,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5280343,Quercetin,"quercetin|117-39-5|Meletin|Sophoretin|Xanthaurine|Quercetine|Quercetol|3,3',4',5,7-Pentahydroxyflavone|Quercitin|Quertine|2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one|Flavin meletin|3,5,7,3',4'-Pentahydroxyflavone|Cyanidelonon 1522|T-Gelb bzw. grun 1|C.I. Natural Yellow 10|Quercetin content|Kvercetin|Quertin|2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one|C.I. Natural red 1|C.I. 75670|4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-|3',4',5,7-Tetrahydroxyflavan-3-",302.230,C15H10O7,127.000,488.000,1.500,22,5,7,1,"InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H",C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,REFJWTPEDVJJIY-UHFFFAOYSA-N,"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one",Quercetin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,5|7|9|11|15|17|19|21|23|25|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|67|69|71|73|75|77|79|81|99|101|103|105|107|109|115|119|121|123|125|129|131|133|135|137|139|141|143|145|155|157|161|165|167|175|179|192|200|210|220|222|248|256|270|272|328|330|351|357|365|366|367|382|383|384|386|393|395|396|410|411|422|429|436|444|445|446|447|448|450|451|505|506|513|514|515|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|747|875|879|880|881|883|884|885|886|887|889|891|892|893,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Cons",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5362129,Ramipril,"ramipril|87333-19-5|Tritace|Altace|Carasel|Ramace|Triatec|Delix|Hoe-498|Ramiprilum [Latin]|Ramiprilum|Vesdil|HOE 498|Quark|Altace (TN)|Pramace|UNII-L35JN3I7SJ|Acovil|C23H32N2O5|Lostapres|MFCD00865775|Hytren|CHEMBL1168|L35JN3I7SJ|Unipril|CHEBI:8774|(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid|(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carb",416.500,C23H32N2O5,95.900,619.000,1.400,30,2,6,10,"InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1",CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,HDACQVRGBOVJII-JBDAPHQKSA-N,"(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid",Ramipril,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,940|1195|1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1987|1996|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|39767|409954|434955|434962|434973|434989|435003|,20050808,"3WAY PHARM INC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|AN PharmaTech|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|AvaChem Scientific|BePharm Ltd.|BIDD|BindingDB|BioCrick|BLD Pharm|BOC Sciences|Boerchem|Boone Lab, Chemical Genomics, Univer",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6441383,Calcifediol monohydrate,"Calcifediol|Calcifediol monohydrate|63283-36-3|Calcifediol (monohydrate)|UNII-P6YZ13C99Q|Calderol|P6YZ13C99Q|U-32,070E|Calcifediol hydrate|25-Hydroxycholecalciferol monohydrate|(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol;hydrate|U 32070 E|Diaverene|Calderol (TN)|U-32070E|25-Hydroxyvitamin D3 monohydrate|Vitamin D3 25-hydroxy monohydrate|C27H44O2.H2O|Rayaldee (TN)|(S,Z)-3-(2-((1R,3aS,7aR,E)",418.700,C27H46O3,41.500,655.000,NULL,30,3,3,6,"InChI=1S/C27H44O2.H2O/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29;/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3;1H2/b21-11+,22-12-;/t20-,23+,24-,25+,27-;/m1./s1",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]\\2[C@@]1(CCC/C2=C\\C=C/3\\C[C@H](CCC3=C)O)C.O,WRLFSJXJGJBFJQ-WPUCQFJDSA-N,"(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol;hydrate",Calcifediol,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,10,51368|132145|588209|588210|625295,20060428,"AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Achemtek|Active Biopharma|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|AN PharmaTech|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|BioCrick|Boerchem|Chem-Space.com Database|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|CSNpharm|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|FondChemical Co., Ltd|iChemical Technology US",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
71600085,Uproleselan,"Uproleselan|UNII-PE952ANF83|PE952ANF83|GMI-1271|1983970-12-2|Uproleselan [USAN]|Uproleselan (USAN/INN)|GMI-1271 FREE ACID|CHEMBL3989971|DB14829|D11332|(2S)-2-(((2R,3R,4R,5R,6R)-3-acetamido-2-(((1R,2R,3S,5R)-5-((2-(4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxaoctatriacontanamido)ethyl)carbamoyl)-3-ethyl-2-(alpha-L-galactopyranosyloxy)cyclohexyl)oxy)-5-hydroxy-6-(hydroxymethyl)oxan-4-yl)oxy)-3-cyclohexylpropanoic acid|4,7,10,13,16,19,22,25,28,31,34,37-Dodecaoxaoctatriacontanamide, N-(2-((((1R,3R,4R,5S)-3-((2-(a",1304.500,C60H109N3O27,383.000,1870.000,-2.000,90,9,27,52,"InChI=1S/C60H109N3O27/c1-5-44-38-45(39-46(55(44)90-60-54(70)53(69)51(67)41(2)86-60)88-59-50(63-42(3)65)56(52(68)48(40-64)89-59)87-47(58(72)73)37-43-9-7-6-8-10-43)57(71)62-13-12-61-49(66)11-14-75-17-18-77-21-22-79-25-26-81-29-30-83-33-34-85-36-35-84-32-31-82-28-27-80-24-23-78-20-19-76-16-15-74-4/h41,43-48,50-56,59-60,64,67-70H,5-40H2,1-4H3,(H,61,66)(H,62,71)(H,63,65)(H,72,73)/t41-,44-,45+,46+,47-,48+,50+,51+,52-,53+,54-,55+,56+,59+,60-/m0/s1",CC[C@H]1C[C@H](C[C@H]([C@@H]1O[C@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)O)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@@H](CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,LYSYOXNOOPBOSC-NGSKMYNLSA-N,"(2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R,3S,5R)-3-ethyl-5-[2-[3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]ethylcarbamoyl]-2-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20130715,ChEMBL|ChemIDplus|DrugBank|eNovation Chemicals|FDA/SPL Indexing Data|KEGG|PATENTSCOPE (WIPO)|Springer Nature|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6137,Methionine,"L-methionine|63-68-3|methionine|h-Met-oh|(S)-2-Amino-4-(methylthio)butanoic acid|Cymethion|L-(-)-Methionine|Liquimeth|S-Methionine|L-Methioninum|Methilanin|Neo-methidin|(L)-Methionine|Methionine (VAN)|Acimethin|Metionina [DCIT]|(S)-methionine|L-alpha-Amino-gamma-methylmercaptobutyric acid|h-Met-h|Methioninum [INN-Latin]|metionina|Methioninum|Polymethionine|L-Homocysteine, S-methyl-|L-Methionin|(2S)-2-amino-4-(methylsulfanyl)butanoic acid|METHIONINE, L-|Poly-L-methionine|L(-)-Amino-gamma-methylthiobutyric ac",149.210,C5H11NO2S,88.600,97.000,-1.900,9,2,4,4,"InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1",CSCC[C@@H](C(=O)O)N,FFEARJCKVFRZRR-BYPYZUCNSA-N,(2S)-2-amino-4-methylsulfanylbutanoic acid,Methionine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,15,1811|16315|17451|26797|34131|34138|51033|71601|71712|107897|200229|230503|230665|233322|264583|264584|264585|264586|264587|401471|401472|401473|401474|401475|401476|498932|498933|498934|588211|588212|588213|681113|977610|977611|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1100820|1100821|1100827|1100829|1100831|1100833|1100835|1100837|1100838|1100840|1100841|1100842|1100843|1100844|1100845|1117326|1117,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
17625,2-Acetamidothiazole,"2-Acetamidothiazole|2719-23-5|2-Acetylaminothiazole|N-(thiazol-2-yl)acetamide|N-(1,3-Thiazol-2-yl)acetamide|Acetamide, N-2-thiazolyl-|2-Acetamido-1,3-thiazole|2-Acetaminothiazole|N-2-Thiazolylacetamide|Thiazole, 2-acetamido-|UNII-O94697VKTV|MFCD00016892|ACETAMIDE, N-(2-THIAZOLYL)-|O94697VKTV|154446-32-9|N-Thiazol-2-ylacetamide|EINECS 220-321-1|NSC 18750|NSC 44844|AI3-32922|acetylamino thiazole|2-acetylamino thiazole|ACETAMIDOTHIAZOLE|N-2-thiazolyl acetamide|n-thiazol-2-yl-acetamide|Acetamide,N-2-thiazolyl-|",142.180,C5H6N2OS,70.200,118.000,0.800,9,1,3,1,"InChI=1S/C5H6N2OS/c1-4(8)7-5-6-2-3-9-5/h2-3H,1H3,(H,6,7,8)",CC(=O)NC1=NC=CS1,WXPLRSVMGRAIGW-UHFFFAOYSA-N,"N-(1,3-thiazol-2-yl)acetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Toxicity|Use and Manufacturing,9,248|328|1347385,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Angene Chemical|Anward|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
21109,Trimetazidine,"TRIMETAZIDINE|5011-34-7|1-(2,3,4-Trimethoxybenzyl)piperazine|1-[(2,3,4-trimethoxyphenyl)methyl]piperazine|1-(2,3,4-Trimethoxy-benzyl)-piperazine|UNII-N9A0A0R9S8|Piperazine, 1-((2,3,4-trimethoxyphenyl)methyl)-|N9A0A0R9S8|Vasartel|Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-|Trimetazidina|Trimetazidinum|MLS001240268|Trimetazidinum [INN-Latin]|Trimetazidina [INN-Spanish]|Trimetazidine [INN:BAN:DCF]|1,2,3-trimethoxy-4-(piperazinylmethyl)benzene|NCGC00016697-01|SMR000674573|EINECS 225-690-2|CAS-13171-25-0|Pre",266.340,C14H22N2O3,43.000,259.000,1.000,19,1,5,5,"InChI=1S/C14H22N2O3/c1-17-12-5-4-11(13(18-2)14(12)19-3)10-16-8-6-15-7-9-16/h4-5,15H,6-10H2,1-3H3",COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,UHWVSEOVJBQKBE-UHFFFAOYSA-N,"1-[(2,3,4-trimethoxyphenyl)methyl]piperazine",Trimetazidine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,12,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|940|995|1030|1332|1379|1422|1452|1454|1457|1458|1467|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1850|1851|1863|1865|1899|1903|1906|1947|1948|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2101|2107|2112|2129|2130|2147|2174|2177|2234|2235|2240|2241|2275|2280|2300|2313,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alinda Chemical|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Angene Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
27125,Estetrol,"ESTETROL|15183-37-6|UNII-ENB39R14VF|ENB39R14VF|Estetrol (USAN)|Estetrol [USAN]|(8R,9S,13S,14S,15R,16R,17R)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,15,16,17-tetraol|(8R,9S,13S,14S,15R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,15,16,17-tetrol|E4|(14beta,15alpha,16alpha,17alpha)-Estra-1,3,5(10)-Triene-3,15,16,17-Tetrol|estell|estetrolum|oestetrol|Donesta|Estetrol anhydrous|Estetrol (anhydrous)|15alpha-hydroxyestriol|15 alpha-hydroxye",304.400,C18H24O4,80.900,441.000,1.500,22,4,4,0,"InChI=1S/C18H24O4/c1-18-7-6-12-11-5-3-10(19)8-9(11)2-4-13(12)14(18)15(20)16(21)17(18)22/h3,5,8,12-17,19-22H,2,4,6-7H2,1H3/t12-,13-,14-,15-,16-,17+,18+/m1/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1[C@H]([C@H]([C@@H]2O)O)O)CCC4=C3C=CC(=C4)O,AJIPIJNNOJSSQC-NYLIRDPKSA-N,"(8R,9S,13S,14S,15R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,15,16,17-tetrol",Estetrol,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,1258858|1258859|1258884|1258885|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1409598,20050808,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AKos Consulting & Solutions|Axon Medchem|BindingDB|Biosynth Carbosynth|BOC Sciences|Broad Institute|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
31193,Cadmium ion,"Cadmium ion|Cadmium cation|Cadmium(2+)|UNII-T494FZ4G8G|T494FZ4G8G|Cd(2+)|Cadmium ions|Cadmium(2+)ions|22537-48-0|Cadmium(2+) ion|Cadmium, ion (Cd2+)|Cadmium, ion(Cd2+)|Cadmium elemental|Cadmium metallicum|cadmium(II)|CdII|Cadmium (II) ion|Cd++|Cd2+|CHEBI:48775|DTXSID60177060|MCULE-5126836649|NCGC00090932-02|NCGC00090932-03|NCGC00090932-04|Q26841251",112.410,Cd+2,0.000,0.000,NULL,1,0,0,0,InChI=1S/Cd/q+2,[Cd+2],WLZRMCYVCSSEQC-UHFFFAOYSA-N,cadmium(2+),NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity,8,NULL,20040916,"ABI Chem|BioCyc|ChEBI|ChemDB|ChemIDplus|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|LeadScope|Mcule|National Center for Advancing Translational Sciences (NCATS)|NCBI Structure|NextBio|NIAID ChemDB|NovoSeek|Protein Data Bank in Europe (PDBe)|SMID|Thomson Pharma|ToxPlanet|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
46153,6-Amino-2H-chromen-2-one,"6-Amino-2H-chromen-2-one|6-Aminocoumarin|14415-44-2|6-Amino-chromen-2-one|6-aminochromen-2-one|6-Amino-1,2-benzopyrone|2H-1-Benzopyran-2-one, 6-amino-|6-ABP|Coumarin, 6-amino-|UNII-S9W3L9R2NA|S9W3L9R2NA|MFCD00115435|NSC613801|6-Amino-2H-1-benzopyran-2-one|2H-1-Benzopyran-2-one,6-amino-|4JQ|Oprea1_467607|Oprea1_644760|SCHEMBL483027|6-Amino-2H-chromen-2-one #|CHEMBL1829962|DTXSID70162624|HMS1749K04|ALBB-023917|ZINC1612349|6-Amino-chromen-2-one, AldrichCPR|(2-oxochromen-6-yl)azanium chloride|4355AD|BBL007836|S",161.160,C9H7NO2,52.300,225.000,0.700,12,1,3,0,"InChI=1S/C9H7NO2/c10-7-2-3-8-6(5-7)1-4-9(11)12-8/h1-5H,10H2",C1=CC2=C(C=CC(=O)O2)C=C1N,ZOJAINJCZSVZGW-UHFFFAOYSA-N,6-aminochromen-2-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active,10,485350|485395|493033|504770|540299|588519|619823|619824|720641|1259343|1259397|1259398|1259423,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Achemica|Achemo Scientific Limited|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.c",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
76313,1-Naphthoxyacetic acid,"2976-75-2|1-Naphthoxyacetic acid|(1-Naphthyloxy)acetic acid|1-Naphthyloxyacetic acid|2-(naphthalen-1-yloxy)acetic acid|NAPHTHYLOXYACETIC ACID|2-naphthalen-1-yloxyacetic acid|2-(1-naphthyloxy)acetic acid|UNII-9QI2464POA|(naphthalen-1-yloxy)acetic acid|(1-Naphthoxy)acetic acid|(1-naphthalenyloxy)acetic acid|9QI2464POA|CHEBI:44588|Acetic acid, (1-naphthalenyloxy)-|MFCD00003927|NSC 9847|EINECS 221-023-4|naphthoxy-acetic acid|Acetic acid, 2-(1-naphthalenyloxy)-|1-naphthoxy acetic acid|ACMC-1CJ8T|1-Naphthylenylox",202.210,C12H10O3,46.500,227.000,2.800,15,1,3,3,"InChI=1S/C12H10O3/c13-12(14)8-15-11-7-3-5-9-4-1-2-6-10(9)11/h1-7H,8H2,(H,13,14)",C1=CC=C2C(=C1)C=CC=C2OCC(=O)O,GHRYSOFWKRRLMI-UHFFFAOYSA-N,2-naphthalen-1-yloxyacetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,8,155|157|161|165|167|175|422|583|598|602|618|619|620|629|630|631|633|639|640|648|685|687|688|690|693|696|697|701|704|707|710|717|719|720|727|729|731|736|738|739|740|745|748|750|757|758|759|760|761|764|775|777|778|781|782|793|796|797|798|799|800|802|803|804|808|811|817|818|819|827|828|833|834|841|845|848|861|862|868|871|873|878|880|881|894|898|901|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1024|1025|1027|1029|1030|1032|1040|1044|1046|1049|1063|1066|1085|1135|1136|1203|,20040916,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Ambeed|Angel Pharmatech Ltd.|Angene Chemical|Anward|Aronis|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biosynth Carbosynth|BLD Pharm|Center fo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
114805,Prostacyclin (not favourable),Prostacyclin (not favourable)|KBioGR_000216|KBioSS_000216|KBio2_000216|KBio2_002784|KBio2_005352|KBio3_000431|KBio3_000432|Bio2_000216|Bio2_000696|Q26998032,352.500,C20H32O5,87.000,485.000,2.900,25,3,5,10,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/t14-,16+,17+,18+,19-/m0/s1",CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)O)O2)O)O,KAQKFAOMNZTLHT-IJCBKZNRSA-N,"5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid",NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20050624,"ABI Chem|ChemBank|ChemSpider|ChemTik|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|IBM|NextBio|NovoSeek|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
118569,"Methanesulfonamide, N-(2-phenylethyl)-","N-(2-phenylethyl)methanesulfonamide|33893-36-6|N-Phenethylmethanesulphonamide|N-phenethylmethanesulfonamide|Methanesulfonamide, N-(2-phenylethyl)-|(methylsulfonyl)(2-phenylethyl)amine|N-Phenethyl-methanesulfonamide|JFM|EINECS 251-724-0|ChemDiv3_000831|SCHEMBL4520702|DTXSID2067799|ZINC93607|HMS1475F17|MFCD01181933|STK093587|AKOS000384274|CCG-104985|GS-0400|MCULE-8612315110|N-(methylsulfonyl)(2-phenylethyl)amine|IDI1_019797|AM806020|N-(methylsulfonyl)-N-(2-phenylethyl)amine|EU-0002702|ST45143060|SR-0100041028",199.270,C9H13NO2S,54.600,225.000,1.500,13,1,3,4,"InChI=1S/C9H13NO2S/c1-13(11,12)10-8-7-9-5-3-2-4-6-9/h2-6,10H,7-8H2,1H3",CS(=O)(=O)NCCC1=CC=CC=C1,JGDDFCYMSLNOGJ-UHFFFAOYSA-N,N-(2-phenylethyl)methanesulfonamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Use and Manufacturing,6,422|436|745|2275|485350|485395|492967|493033|493162|504770|540299|588519|602314|720641|1224905|1259310|1259370|1259374|1259389|1259422|1347074,20050708,"A1 BioChem Labs|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Angel Pharmatech Ltd.|Apexmol|ASINEX|BLD Pharm|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|ChemDB|ChemDiv|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|DiscoveryGate|Emory University Molecular Libraries Screening Center|eNovation Chemicals|EPA DSSTox|EPA Su",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
161225,Udp galactosamine,"Udp galactosamine|UDP-galactosamine|UDP-alpha-D-galactosamine|CHEBI:16846|Uridine diphosphate galactosamine|Uridine 5'-diphosphogalactosamine|17479-06-0|AC1Q6SAB|UDPgalactosamine|UDP-GalN|UDP-  -D-galactosamine|Uracil Diphosphate galactosamine|CHEMBL2092918|ZINC30724430|[(2R,3R,4R,5R,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate|C02467|Q27102108|uridine 5'-[3-(2-amino-2-deoxygalactopyra",565.320,C15H25N3O16P2,297.000,967.000,-9.200,36,9,17,9,"InChI=1S/C15H25N3O16P2/c16-8-11(23)9(21)5(3-19)32-14(8)33-36(28,29)34-35(26,27)30-4-6-10(22)12(24)13(31-6)18-2-1-7(20)17-15(18)25/h1-2,5-6,8-14,19,21-24H,3-4,16H2,(H,26,27)(H,28,29)(H,17,20,25)/t5-,6-,8-,9+,10-,11-,12-,13-,14-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)N)O)O,CYKLRRKFBPBYEI-KBQKSTHMSA-N,"[(2R,3R,4R,5R,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,74257,20050808,"AAA Chemistry|ABI Chem|BioCyc|Biosynth Carbosynth|ChEBI|ChEMBL|ChemIDplus|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Kingston Chemistry|MetabolomicsWorkbench|NextBio|NextMove Software|NovoSeek|Smolecule|THE BioTek|ToxPlanet|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
290549,"N-(1,3-Benzodioxol-5-ylmethyl)acetamide","N-(1,3-benzodioxol-5-ylmethyl)acetamide|59682-83-6|NSC154573|N-(benzo[d][1,3]dioxol-5-ylmethyl)acetamide|Oprea1_387294|SCHEMBL4991673|DTXSID60975083|ZINC1564847|STK395778|AKOS003284199|MCULE-7575232678|NSC-154573|1,3-Benzodioxol, 5-(acetylaminomethyl)|DB-101405|ST4132000|N~1~-(1,3-benzodioxol-5-ylmethyl)acetamide|AO-080/40107532|N-[(2H-1,3-Benzodioxol-5-yl)methyl]ethanimidic acid|N-(2H-benzo[3,4-d]1,3-dioxolan-5-ylmethyl)acetamide",193.200,C10H11NO3,47.600,219.000,1.000,14,1,3,2,"InChI=1S/C10H11NO3/c1-7(12)11-5-8-2-3-9-10(4-8)14-6-13-9/h2-4H,5-6H2,1H3,(H,11,12)",CC(=O)NCC1=CC2=C(C=C1)OCO2,YFWYIWVJRPDXQD-UHFFFAOYSA-N,"N-(1,3-benzodioxol-5-ylmethyl)acetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Names and Identifiers|Patents,5,256,20050326,"AAA Chemistry|ABI Chem|AKos Consulting & Solutions|Ambinter|Chem-Space.com Database|ChemBank|ChemBlock|ChemDB|ChemDiv|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Debye Scientific Co., Ltd|DiscoveryGate|DTP/NCI|EPA DSSTox|Google Patents|IBM|Mcule|MolPort|MuseChem|NextBio|NextMove Software|NIST Mass Spectrometry Data Center|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Specs|SureChEMBL|Thomson Pharma|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
452949,"Zinc, bis(D-gluconato-kO1,kO2)-","Zinc;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate|4468-02-4|Zinc, bis(D-gluconato-kO1,kO2)-|(3R,8R)-3,8-bis[(1S,2R,3R)-1,2,3,4-tetrahydroxybutyl]-[?]spiro[4.4]nonane-2,7-dione",455.700,C12H22O14Zn,283.000,385.000,NULL,27,10,14,8,"InChI=1S/2C6H12O7.Zn/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1",C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Zn+2],WHMDKBIGKVEYHS-IYEMJOQQSA-L,"zinc;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate",NULL,Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20050801,NextBio|NIAID ChemDB|Smolecule|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
456309,(+)-Mefloquine,"(+)-Mefloquine|mefloquine|(+)-(11R,2'S)-erythro-Mefloquine|51688-68-7|CHEBI:63684|(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol|(R)-(2,8-bis(trifluoromethyl)quinolin-4-yl)((S)-piperidin-2-yl)methanol|(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2S)-piperidin-2-yl]methanol|[(11R,2'S)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|53230-10-7|RTI1188-1-1|51744-83-3|RO 13-7224|(S,R)-MEFLOQUINE|NSC157387|(R)-[2,8-bis(trifluoromethyl)-4-quinolyl]-[(2S)-2-piperidyl]methano",378.310,C17H16F6N2O,45.200,483.000,3.600,26,2,9,2,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/m0/s1",C1CCN[C@@H](C1)[C@@H](C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,XEEQGYMUWCZPDN-SWLSCSKDSA-N,"(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol",Mefloquine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,331674|331675|558029|602156|1138020|1138021|1138023|1138024|1138025|1159389,20050801,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|ABI Chem|Achemo Scientific Limited|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|BOC Sciences|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemMol|ChemShuttle|ChemSpider|Collaborative Drug Discovery, Inc.|Combi-Blocks|Crystallography Open Database|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
461573,"(2S,5R,6R)-6-[[(2S)-2-[(4-Ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-propanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","piperacillin + tazobactam|piperacillin / tazobactam|piperacillin and tazobactam|Piperacillin & Tazobactam|(2S,5R,6R)-6-[[(2S)-2-[(4-ethyl-2,3-dioxo-piperazine-1-carbonyl)amino]-2-phenyl-propanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",831.900,C34H41N9O12S2,313.000,1600.000,NULL,57,4,15,9,"InChI=1S/C24H29N5O7S.C10H12N4O5S/c1-5-27-11-12-28(18(32)17(27)31)22(36)26-24(4,13-9-7-6-8-10-13)21(35)25-14-16(30)29-15(20(33)34)23(2,3)37-19(14)29;1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h6-10,14-15,19H,5,11-12H2,1-4H3,(H,25,35)(H,26,36)(H,33,34);2-3,7-8H,4-5H2,1H3,(H,16,17)/t14-,15+,19-,24+;7-,8+,10+/m11/s1",CCN1CCN(C(=O)C1=O)C(=O)N[C@@](C)(C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O.C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,OMHKGGVTRDBBEJ-WVPIKCCXSA-N,"(2S,5R,6R)-6-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylpropanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",NULL,Drug and Medication Information|Literature|Use and Manufacturing,3,NULL,20050801,ABI Chem|AmicBase - Antimicrobial Activities|NextBio|NIAID ChemDB,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
611621,"7-Bromo-5-methyl-1H-indole-2,3-dione","108938-16-5|7-Bromo-5-methylindoline-2,3-dione|7-Bromo-5-methyl-1H-indole-2,3-dione|7-bromo-5-methylisatin|1H-Indole-2,3-dione,7-bromo-5-methyl-|MFCD00462954|7-bromo-5-methyl-indoline-2,3-dione|CHEMBL3128208|7-BROMO-5-METHYL-2,3-DIHYDRO-1H-INDOLE-2,3-DIONE|7-bromo-5-methyl-1H-benzo[d]azolidine-2,3-dione|4kwg|2AK|PubChem7944|ACMC-1BVCL|Cambridge id 6378722|SCHEMBL10679123|DTXSID20346371|BUTTPARK 50\\07-85|ZERENEX E/6110157|ZINC2977810|BBL012540|BDBM50448790|SBB038760|STK977275|AKOS000141646|MB01226|MCULE-1134",240.050,C9H6BrNO2,46.200,266.000,1.800,13,1,2,0,"InChI=1S/C9H6BrNO2/c1-4-2-5-7(6(10)3-4)11-9(13)8(5)12/h2-3H,1H3,(H,11,12,13)",CC1=CC2=C(C(=C1)Br)NC(=O)C2=O,NPDJRIGMWAQKTQ-UHFFFAOYSA-N,"7-bromo-5-methyl-1H-indole-2,3-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,8,372|977610|1074876|1074877|1074878|1074880|1074881|1074882|1074883|1074884|1074885|1159537|1259310|1259374|1259397|1259398|1259422|1259423,20050327,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambinter|AN PharmaTech|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|BLD Pharm|BOC Sciences|Boroncore|CAPOT|ChangChem|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemBridge|ChemDB|Chemenu In",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
712421,(S)-2-Amino-3-cyclohexylpropanoic acid,"27527-05-5|(S)-2-amino-3-cyclohexylpropanoic acid|H-Cha-OH|3-Cyclohexyl-L-alanine|L-Cyclohexylalanine|(2S)-2-amino-3-cyclohexylpropanoic acid|BETA-CYCLOHEXYL-ALANINE|L-3-Cyclohexylalanine|(S)-2-Amino-3-cyclohexylpropionic acid|beta-cyclohexyl-l-alanine|L-beta-Cyclohexylalanine|GYR4SF0FVQ|UNII-GYR4SF0FVQ|CHEMBL383208|2-AMINO-3-CYCLOHEXYL-PROPIONIC ACID|Cyclohexanepropanoic acid, alpha-amino-, (alphaS)-|MFCD00153484|(s)-2-amino-3-cyclohexyl-propionic acid|3-cyclohexylalanine|b-cyclohexyl alanine|beta-cyclohex",171.240,C9H17NO2,63.300,153.000,-0.300,12,2,3,3,"InChI=1S/C9H17NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h7-8H,1-6,10H2,(H,11,12)/t8-/m0/s1",C1CCC(CC1)C[C@@H](C(=O)O)N,ORQXBVXKBGUSBA-QMMMGPOBSA-N,(2S)-2-amino-3-cyclohexylpropanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,9,261154|261155|261157|485350|492967|493033|493162|504770|540299|588519|602314|720641|1224905|1398359|1398360|1398361,20050708,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acemol|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2760997,N-[4-(Aminomethyl)phenyl]methanesulfonamide,"N-[4-(aminomethyl)phenyl]methanesulfonamide|129872-50-0|Methanesulfonamide,N-[4-(aminomethyl)phenyl]-|Methanesulfonamide, N-[4-(aminomethyl)phenyl]-|4-(METHYLSULFONYLAMINO)BENZYLAMINE|RY4|ACMC-20mteo|SCHEMBL1752626|DTXSID60375468|ZINC1494962|AKOS000128720|MCULE-2636483854|DB-012750|FT-0707918",200.260,C8H12N2O2S,80.600,237.000,-0.200,13,2,4,3,"InChI=1S/C8H12N2O2S/c1-13(11,12)10-8-4-2-7(6-9)3-5-8/h2-5,10H,6,9H2,1H3",CS(=O)(=O)NC1=CC=C(C=C1)CN,IZJVPNBRAKIMBK-UHFFFAOYSA-N,N-[4-(aminomethyl)phenyl]methanesulfonamide,NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20050719,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Anward|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2776521,[1-(Pyrimidin-2-yl)piperidin-4-yl]methanol,"111247-61-1|(1-pyrimidin-2-ylpiperidin-4-yl)methanol|[1-(pyrimidin-2-yl)piperidin-4-yl]methanol|[1-(2-Pyrimidinyl)-4-piperidinyl]methanol|4-Piperidinemethanol,1-(2-pyrimidinyl)-|(1-(Pyrimidin-2-yl)piperidin-4-yl)methanol|1-(2-PYRIMIDINYL)PIPERIDINE-4-METHANOL|1-(Pyrimidin-2yl)piperidin-4-ylmethanol|NXS|ACMC-1BTOT|SCHEMBL460460|DTXSID60380153|ZINC158945|MFCD03086127|SBB054840|AKOS009157639|MCULE-9548260848|PS-4298|SDCCGMLS-0066028.P001|4-Piperidinemethanol, 1-(2-pyrimidinyl)-|DB-010873|(1-pyrimidin-2-yl-4-pi",193.250,C10H15N3O,49.200,163.000,0.700,14,1,4,2,"InChI=1S/C10H15N3O/c14-8-9-2-6-13(7-3-9)10-11-4-1-5-12-10/h1,4-5,9,14H,2-3,6-8H2",C1CN(CCC1CO)C2=NC=CC=N2,ZUNGTEUNVMHDIX-UHFFFAOYSA-N,(1-pyrimidin-2-ylpiperidin-4-yl)methanol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,5,608|1033|1549|1552|1637|1648,20050719,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemica|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Angene Chemical|Aurum Pharmatech LLC|Biosynth Carbosynth|BLD Pharm|Burnham Center for Chemical Genomics|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Combi-Blocks|Day Biochem|Debye Scientific Co., Ltd|DiscoveryGate|eN",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3005573,Toremifene,"toremifene|89778-26-7|Farestone|Toremifeno|Toremifenum|UNII-7NFE54O27T|GTx-006|Z-Toremifene|{2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine|7NFE54O27T|CHEBI:9635|Toremifenum [Latin]|Toremifeno [Spanish]|89778-26-7 (free base)|2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine|2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine|Ethanamine, 2-(4-((1Z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-|Toremifene Base|GTx 006|Toremife",406.000,C26H28ClNO,12.500,483.000,7.200,29,0,2,9,"InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-",CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\\C2=CC=CC=C2)/C3=CC=CC=C3,XFCLJVABOIYOMF-QPLCGJKRSA-N,"2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine",Toremifene,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,880|1195|1469|1471|1479|1487|1490|1688|1766|1768|2528|2546|2551|2662|411793|476929|485290|492961|503305|504327|504332|504749|504832|504834|504847|504865|588211|588212|588213|588220|588579|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|624349|625277|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651828|681359|691260|720641|720717|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|107,20050325,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambinter|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BIDD|BindingDB|BioCrick|Boerchem|Broad Institute|Burnham Center for Chemical Genomics|C. David ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4149241,N-[(Cyclohexylamino)carbonyl]glycine,"N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE|2-[(cyclohexylcarbamoyl)amino]acetic acid|33557-91-4|2-(3-cyclohexylureido)acetic acid|CHEMBL66380|NC3|2-(cyclohexylcarbamoylamino)acetic acid|Glycine, N-[(cyclohexylamino)carbonyl]-|1zd2|4-(3-CYCLOHEXYLURIEDO)-ETHANOIC ACID|N-(cyclohexylcarbamoyl)glycine|DTXSID90399930|HMS3604L13|(3-Cyclohexyl-ureido)-acetic acid|ZINC6691828|BDBM50143914|AKOS000132958|DB08256|MCULE-8014113453|NE25644|2-[(N-cyclohexylcarbamoyl)amino]acetic acid|ST51002769|EN300-51463|J-507613|Q27097479|Z",200.230,C9H16N2O3,78.400,212.000,0.800,14,3,3,3,"InChI=1S/C9H16N2O3/c12-8(13)6-10-9(14)11-7-4-2-1-3-5-7/h7H,1-6H2,(H,12,13)(H2,10,11,14)",C1CCC(CC1)NC(=O)NCC(=O)O,NVORCMBCUHQRDL-UHFFFAOYSA-N,2-(cyclohexylcarbamoylamino)acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Biological Test Results: Active,6,70210|70212|274279|274280|274292|977608|1347080|1508586,20050913,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|Biosynth Carbosynth|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|EPA DSSTox|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|Molepedia|MolPort|NCBI",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5280581,Dihomo-gamma-linolenic acid,"Dihomo-gamma-linolenic acid|DGLA|1783-84-2|gamma-Homolinolenic acid|8,11,14-Eicosatrienoic acid|(8Z,11Z,14Z)-icosa-8,11,14-trienoic acid|cis-8,11,14-Eicosatrienoic Acid|Homo-gamma-linolenic acid|diroleuton|Bishomo-gamma-linolenic acid|8Z,11Z,14Z-eicosatrienoic acid|all-cis-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|8,11,14-Icosatrienoate|Ro 12-1989|8,11,14-Eicosatrienoate|(Z,Z,Z)-8,11,14-Icosatrienoate|(Z,Z,Z)-8,11,14-Icosatrienoic acid|cis,cis,cis-8,11,1",306.500,C20H34O2,37.300,327.000,7.200,22,1,2,15,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",CCCCC/C=C\\C/C=C\\C/C=C\\CCCCCCC(=O)O,HOBAELRKJCKHQD-QNEBEIHSSA-N,"(8Z,11Z,14Z)-icosa-8,11,14-trienoic acid","8,11,14-Eicosatrienoic Acid",Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,11,880|894|1030|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1766|1768|1865|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|402793|402794|402795|485281|485290|485350|493033|493140|493162|504327|504332|504845|504847|540299|588519|588579|602314|602332|624101|624136|624137|624138|624139|624141|624151|624260|651548|720532|720533|720717|1067780|1094404|1114582|1114583|1114584|1259325|1259374|1259409|1259416|1259421|1347080|1347148,20050608,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AHH Chemical co.,ltd|Alfa Chemistry|Alichem|Ambinter|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|BLD Pharm|BOC Sciences|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|CCSbase|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Databa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
5280933,gamma-Linolenic acid,"gamma-Linolenic acid|GAMOLENIC ACID|506-26-3|(6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid|(Z,Z,Z)-6,9,12-Octadecatrienoic acid|(6,9,12)-linolenic acid|CCRIS 7668|all-cis-6,9,12-Octadecatrienoic acid|gamoleic acid|Ligla|UNII-78YC2MAX4O|6,9,12-Octadecatrienoic acid, (Z,Z,Z)-|GLA|(6Z,9Z,12Z)-Octadecatrienoic acid|Gamma-?Linolenic acid|.gamma.-Linolenic Acid|6Z,9Z,12Z-octadecatrienoic acid|78YC2MAX4O|cis-Delta(6,9,12)-octadecatrienoic acid|6(Z),9(Z),12(Z)-Octadecatrienoic acid|6-cis,9-cis,12-cis-Octadecatrienoic a",278.400,C18H30O2,37.300,301.000,5.900,20,1,2,13,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",CCCCC/C=C\\C/C=C\\C/C=C\\CCCCC(=O)O,VZCCETWTMQHEPK-QNEBEIHSSA-N,"(6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid",gamma-Linolenic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,880|894|1030|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1850|1863|1865|1899|1903|1906|1947|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2101|2107|2112|2129|2130|2147|2174|2177|2234|2235|2240|2241|2275|2280|2300|2313|2316|2322|2330|2380|2391|2435|2445|2451|2462|2472|2517|2520|2521|2524|2528|2540|2544|2546|2549|2551|2557|2599|2606|2629|2650|2661|2662|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|402793|402794|402795|402796|402797,20040916,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AN PharmaTech|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|BindingDB|BioCyc|BLD Pharm|BOC Sciences|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|CCSbase|ChEBI|Chem-Space.com Database|ChemBank|ChEMBL|Chemenu Inc.|Chemical Carcinogenesis Research Information Syst",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
6604117,"4-[(1R,2S)-2-(4-Benzylpiperidin-1-yl)-1-hydroxypropyl]phenol","CHEMBL49623|4-[(1R,2S)-2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol|Ifenprodil, erythro-|Ifenprodil,(+/-)|Tocris-0545|(R,S)-IFENPRODIL|4-[2-(4-Benzyl-piperidin-1-yl)-1-hydroxy-propyl]-phenol|UNII-T8N3S4QE90|T8N3S4QE90|SCHEMBL12618846|ZINC14669|BDBM50007674|NCGC00024643-01|Q27464717|UNII-R8OE3P6O5S component UYNVMODNBIQBMV-KKSFZXQISA-N|(1R,2S)-2-(4-Benzylpiperidino)-1-(4-hydroxyphenyl)propan-1-ol|4-[(1R,2S)-2-(4-Benzyl-piperidin-1-yl)-1-hydroxy-propyl]-phenol|4-[(R)-2-(4-Benzyl-piperidin-1-yl)-1-(S)-hyd",325.400,C21H27NO2,43.700,353.000,3.900,24,2,3,5,"InChI=1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3/t16-,21-/m0/s1",C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3,UYNVMODNBIQBMV-KKSFZXQISA-N,"4-[(1R,2S)-2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,7,410|411|445|447|448|450|451|526|530|584|585|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|923|924|926|938|995|1030|1379|1452|1454|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1851|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|36105|36705|36844|36845|37005|37444|130365|131357|143249|143376|143451|143915|144751|144752|146070|146080|146089|197260|217466|233255|235022|235214|485290|504327|504845|504847|504865|,20060530,"A&J Pharmtech CO., LTD.|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Angene Chemical|Aurora Fine Chemicals LLC|BindingDB|ChEMBL|ChemIDplus|ChemSpider|ChemTik|Davey Lab, Department of Microbiology, NEIDL, Boston University|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dict",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7131673,"(5S)-1-(4-Chlorophenyl)-5-methylimidazolidine-2,4-dione","(5S)-1-(4-chlorophenyl)-5-methylimidazolidine-2,4-dione|ZINC4219004|W3Y",224.640,C10H9ClN2O2,49.400,287.000,1.700,15,1,2,1,"InChI=1S/C10H9ClN2O2/c1-6-9(14)12-10(15)13(6)8-4-2-7(11)3-5-8/h2-6H,1H3,(H,12,14,15)/t6-/m0/s1",C[C@H]1C(=O)NC(=O)N1C2=CC=C(C=C2)Cl,YRTFBBSKIRZNAW-LURJTMIESA-N,"(5S)-1-(4-chlorophenyl)-5-methylimidazolidine-2,4-dione",NULL,Biomolecular Interactions and Pathways,1,NULL,20060729,ABI Chem|ChemSpider|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8741413,"6,7-Dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-amine","6,7-dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-amine|859320-59-5|6,7-Dihydro-5H-cyclopenta[d][1,2,4]triazolo[1,5-a]pyrimidin-8-ylamine|ZINC7636250|BBL030924|SBB079687|STL257896|STL317437|AKOS000276303|AKOS022133647|ZINC105893472|CCG-320934|MCULE-1012733760|VS-10120|VU0607328-1|F3250-0707|Z431973746|1,8,10,12-TETRAAZATRICYCLO[7.3.0.0(3),?]DODECA-2,7,9,11-TETRAEN-2-AMINE|1,8,10,12-tetraazatricyclo[7.3.0.0?,?]dodeca-2,7,9,11-tetraen-2-amine|1,8,10,12-tetraazatricyclo[7.3.0.0^{3,7}]dodeca-2,7,9,1",175.190,C8H9N5,69.100,209.000,0.400,13,1,4,0,"InChI=1S/C8H9N5/c9-7-5-2-1-3-6(5)12-8-10-4-11-13(7)8/h4H,1-3,9H2",C1CC2=C(N3C(=NC=N3)N=C2C1)N,IMQBKTYGTJTOGV-UHFFFAOYSA-N,"1,8,10,12-tetrazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraen-2-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways,2,1159607|1259245|1259324|1272365,20060730,"A2B Chem|AA BLOCKS|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|C. David Weaver Laboratory, Vanderbilt University|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|Chembase.cn|ChemBridge|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Enamine|Innovapharm|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Life Chemicals|Mcule|MolPort|NCBI Structure|NextBio|Norris Pharm|Protein Data Bank in Europe (PDBe)|TimTec|UW Madison, Small ",Chemical Vendors|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9570985,Ceftriaxone sodium,Rocephin|Lendacin|Longaceph|ceftriaxone|CEFTRIAXONE SODIUM|Rocephalin|UNII-R598PB148Q|Ceftriaxone Sodium [USP]|R598PB148Q|Rocefin|Rocephine|74578-69-1|Ceftriaxone and Dextrose in Duplex Container|Tartriakson|Ceftriaxone disodium|CEFTRIAXONE SODIUM TRIHYDRATE|Ro-139904|104376-79-6|Ceftriaxone Disodium Salt|Ceftriaxone disodium salt hemi(heptahydrate)|Rocefalin|MFCD01750405|Ceftriaxone in plastic container|EINECS 277-930-0|Ro 13-9904/001|ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER|SCHEMBL5880185|X 13-9904|Ceftr,598.600,C18H16N8Na2O7S3,297.000,1120.000,NULL,38,2,14,7,"InChI=1S/C18H18N8O7S3.2Na/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);;/q;2*+1/p-2/b24-8-;;/t9-,15-;;/m1../s1",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+].[Na+],FDRNWTJTHBSPMW-BBJOQENWSA-L,"disodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",Ceftriaxone,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,NULL,20061024,"abcr GmbH|Alfa Chemistry|BOC Sciences|CCSbase|ChemIDplus|ChemSpider|DiscoveryGate|EPA DSSTox|FDA/SPL Indexing Data|Glentham Life Sciences Ltd.|Hello Bio|iChemical Technology USA Inc|Milbrandt Lab, Department of Genetics, Washington University School of Medicine|MolPort|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Prous Science Drugs of the Future|Springer Nature|SureChEMBL|Thomson Pharma|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9884233,Ventolin,"Salbutamol sulfate|51022-70-9|Ventolin|Asthavent|Ventorlin|Asthalin|39971-61-4|4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol sulfate|MFCD00055200|Salbutamol hemisulfate, 98%|Asmaven sulfate|SMR000058513|NSC-289928|Salbutamol hemisulphate|CPD000058513|Salbutamol hemisulphate salt|SCHEMBL33280|Salbutamol sulfate(Albuterol)|MLS000758199|MLS001423971|Salbutamol sulfate (Albuterol)|Salbutamol sulfate - Albuterol|C13H21NO3.H2O4S|CHEMBL1201026|HMS2051A09|HMS3393A09|AMY38244|BCP02974|2200AH|NSC2899",337.390,C13H23NO7S,156.000,309.000,NULL,22,6,8,5,"InChI=1S/C13H21NO3.H2O4S/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)",CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O,OVICLFZZVQVVFT-UHFFFAOYSA-N,4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfuric acid,Albuterol,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,1376|1385|1422|1465|1529|1530|1531|1532|1621|1626|1956|449739|449768|521220|624349|651828|720554|720641|720717|743268|743270|743271|743272|743281|1259251|1259310|1259374|1259389|1259413|1259422|1347080,20061025,"3WAY PHARM INC|ABBLIS Chemicals|AbMole Bioscience|Acros Organics|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Ambinter|Angene Chemical|Apexmol|Aurora Fine Chemicals LLC|BePharm Ltd.|BioChemPartner|Biocore|BOC Sciences|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|DC Chemicals|DiscoveryGate|DTP/NCI|Finetech",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10796917,"7,8-Dihydro-5H-pyrano[4,3-B]pyridin-3-amine","7,8-DIHYDRO-5H-PYRANO[4,3-B]PYRIDIN-3-AMINE|151225-39-7|3-amino-7,8-dihydro-5H-pyrano[4,3-b]pyridine|5H,7H,8H-pyrano[4,3-b]pyridin-3-amine|SCHEMBL1210409|SCHEMBL6770428|5H-Pyrano[4,3-b]pyridin-3-amine,7,8-dihydro-(9CI)|5H-PYRANO[4,3-B]PYRIDIN-3-AMINE, 7,8-DIHYDRO-|DTXSID70934202|MFCD13178971|ZINC34478730|AKOS023666571|AB66643|NE36931|AM806386|AS-39669|DB-095628|CS-0037636|7,8-DIHYDRO-5H-PYRANO[4,3-B]PYRIDIN-3-YLAMINE|WQJ",150.180,C8H10N2O,48.100,140.000,-0.100,11,1,3,0,"InChI=1S/C8H10N2O/c9-7-3-6-5-11-2-1-8(6)10-4-7/h3-4H,1-2,5,9H2",C1COCC2=C1N=CC(=C2)N,MDASSZXVCIBITR-UHFFFAOYSA-N,"7,8-dihydro-5H-pyrano[4,3-b]pyridin-3-amine",NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20061026,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Achemo Scientific Limited|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Combi-Blocks|Debye Scientific Co., Ltd|DiscoveryGate|eNovation Chemicals|EPA DSSTox|Google Patents|IBM|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|MolCore BioPharmatech|MolPort|Muse",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11953897,Ceftriaxone disodium salt hemiheptahydrate,"Ceftriaxone disodium salt hemiheptahydrate|UNII-023Z5BR09K|104376-79-6|ate;heptahydrate|023Z5BR09K|Rocephin|CTRX|tetrasodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;heptahydrate|CEFTRIAXONE SODIUM|Ceftriaxone sodium (USP)|Rocephin (TN)|tetrasodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triaz",1323.200,C36H46N16Na4O21S6,601.000,1120.000,NULL,83,11,35,14,"InChI=1S/2C18H18N8O7S3.4Na.7H2O/c2*1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;;;;;;;;;;/h2*5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);;;;;7*1H2/q;;4*+1;;;;;;;/p-4/b2*24-8-;;;;;;;;;;;/t2*9-,15-;;;;;;;;;;;/m11.........../s1",CN1N=C(C(=O)N=C1SCC2=C(N3C(=O)[C@H]([C@H]3SC2)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)C(=O)[O-])[O-].CN1N=C(C(=O)N=C1SCC2=C(N3C(=O)[C@H]([C@H]3SC2)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)C(=O)[O-])[O-].O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[Na+],KTAVBOYXMBQFGR-MAODNAKNSA-J,"tetrasodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;heptahydrate",Ceftriaxone,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,8,NULL,20061122,"BenchChem|ChEBI|ChemIDplus|ChemSpider|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|iChemical Technology USA Inc|KEGG|LGC Standards|MolPort|NextBio|NovoSeek|Smolecule|THE BioTek|ToxPlanet|VladaChem|VWR, Part of Avantor|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
12681829,1-(2-Aminoethyl)-3-phenylurea,1-(2-aminoethyl)-3-phenylurea|53673-01-1|n-(2-aminoethyl)-n'-phenylurea|1-Phenyl-3-(2-aminoethyl)urea|SCHEMBL4406536|DTXSID30506742|BBL029427|STL156072|ZINC35287544|2-(Phenylaminocarbonylamino)ethylamine|AKOS005755540|MCULE-3425250766|3-(2-AMINOETHYL)-1-PHENYLUREA|VS-09231|WUY,179.220,C9H13N3O,67.200,155.000,0.300,13,3,2,3,"InChI=1S/C9H13N3O/c10-6-7-11-9(13)12-8-4-2-1-3-5-8/h1-5H,6-7,10H2,(H2,11,12,13)",C1=CC=C(C=C1)NC(=O)NCCN,YZKMURMKJCXVIE-UHFFFAOYSA-N,1-(2-aminoethyl)-3-phenylurea,NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20070208,"A2B Chem|AA BLOCKS|abcr GmbH|Achemo Scientific Limited|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Combi-Blocks|DiscoveryGate|EPA DSSTox|Eximed Laboratory|Google Patents|IBM|Innovapharm|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|Li",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
16039797,3-{[5-(Azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide,AZD1656|AZD-1656|919783-22-5|AZD 1656|3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-5-[(2S)-1-methoxypropan-2-yl]oxy-N-(5-methylpyrazin-2-yl)benzamide|3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide|SCHEMBL321593|GTPL7701|CHEMBL3219124|UNII-660M185X4D|660M185X4D|DB14810|HY-15675|CS-0008226|89961-EP2301929A1|89961-EP2301935A1|89961-EP2305674A1|Q27074714|(S)-3-(5-(Azetidine-1-carbonyl)pyrazin-2-yloxy)-5-(1-methoxypropan-2-yloxy)-N-(5-met,478.500,C24H26N6O5,129.000,710.000,1.300,35,1,9,9,"InChI=1S/C24H26N6O5/c1-15-10-27-21(12-25-15)29-23(31)17-7-18(34-16(2)14-33-3)9-19(8-17)35-22-13-26-20(11-28-22)24(32)30-5-4-6-30/h7-13,16H,4-6,14H2,1-3H3,(H,27,29,31)/t16-/m0/s1",CC1=CN=C(C=N1)NC(=O)C2=CC(=CC(=C2)O[C@@H](C)COC)OC3=NC=C(N=C3)C(=O)N4CCC4,FJEJHJINOKKDCW-INIZCTEOSA-N,3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-5-[(2S)-1-methoxypropan-2-yl]oxy-N-(5-methylpyrazin-2-yl)benzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,1120241|1120242|1120243|1120244|1120245|1120246|1120247|1120248|1120249|1120250|1120251|1120252|1120253|1120255|1226049|1227396|1227397|1227398|1227399|1227400|1227401|1227404|1227405|1346158,20070416,"AbaChemScene|AbMole Bioscience|Axon Medchem|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Chris Southan|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|MolPort|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|SLING Consortium|Smolecule|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|Wi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16136245,Degarelix,Degarelix|214766-78-6|Firmagon|Degarelix acetate|UNII-SX0XJI3A11|SX0XJI3A11|CHEMBL415606|FE200486 (AS ACETATE SALT)|FE200486|Uglypeptide1|Degarelix (INN/USAN)|Degarelix [USAN:INN:BAN]|GTPL5585|SCHEMBL1397034|SCHEMBL21050504|HSDB 7817|CHEBI:135961|BDBM50102450|HY-16168A|NSC771648|CS-5350|DB06699|NSC-771648|QC-10170|A12840|D08901|Z-3147|766D786|Q1182795|Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-[Aph(DHor)]-D-[Aph(Cbm)]-Leu-ILys-Pro-DAla-NH2|Acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenyl,1632.300,C82H103ClN18O16,513.000,3390.000,3.500,117,17,18,41,"InChI=1S/C82H103ClN18O16/c1-45(2)35-60(72(107)92-59(16-9-10-33-87-46(3)4)80(115)101-34-12-17-68(101)79(114)88-47(5)70(84)105)93-74(109)63(38-51-23-30-58(31-24-51)91-81(85)116)95-76(111)64(39-50-21-28-57(29-22-50)90-71(106)66-42-69(104)100-82(117)99-66)97-78(113)67(44-102)98-77(112)65(41-53-13-11-32-86-43-53)96-75(110)62(37-49-19-26-56(83)27-20-49)94-73(108)61(89-48(6)103)40-52-18-25-54-14-7-8-15-55(54)36-52/h7-8,11,13-15,18-32,36,43,45-47,59-68,87,102H,9-10,12,16-17,33-35,37-42,44H2,1-6H3,(H2,84,105)(H,88,1",C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=C(C=C2)NC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)NC(=O)[C@@H]4CC(=O)NC(=O)N4)NC(=O)[C@H](CO)NC(=O)[C@@H](CC5=CN=CC=C5)NC(=O)[C@@H](CC6=CC=C(C=C6)Cl)NC(=O)[C@@H](CC7=CC8=CC=CC=C8C=C7)NC(=O)C,MEUCPCLKGZSHTA-XYAYPHGZSA-N,"(4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[4-(carbamoylamino)phenyl]-1-oxopropan-2-yl]amino]-3-oxopropyl]phenyl]-2,6-dioxo-1,3-diazinane-4-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,74279|74429|104505|241421|266056|266057|266062|266063|1346002|1409598|1474166|1474167,20070704,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Adooq BioScience|Alsachim|AN PharmaTech|Aurum Pharmatech LLC|BindingDB|BOC Sciences|CEGChem|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|CreativePeptides|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|Drug Induced Liver Injury Rank (DILIrank) Dataset|DrugBank|DrugCentral|DTP/NCI|Egon Willighagen (Dep",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16741093,(3S)-3-Amino-6-(diaminomethylideneazaniumyl)hex-1-en-2-olate,ARM,172.230,C7H16N4O,115.000,174.000,-0.800,12,4,2,5,"InChI=1S/C7H16N4O/c1-5(12)6(8)3-2-4-11-7(9)10/h6,12H,1-4,8H2,(H4,9,10,11)/t6-/m0/s1",C=C([C@H](CCC[NH+]=C(N)N)N)[O-],KDXQCFMEMPJHOB-LURJTMIESA-N,(3S)-3-amino-6-(diaminomethylideneazaniumyl)hex-1-en-2-olate,NULL,Biomolecular Interactions and Pathways|Drug and Medication Information,2,NULL,20071003,ChemSpider|NCBI Structure,Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
19261749,5-Acetamido-2-fluorobenzoic acid,5-acetamido-2-fluorobenzoic acid|5-(acetylamino)-2-fluorobenzoic acid|939909-22-5|SCHEMBL1655468|ZINC37500397|AKOS005216499|MCULE-2667422693|NE15419|EN300-53857|Z364321922|VVD,197.160,C9H8FNO3,66.400,244.000,1.500,14,2,4,2,"InChI=1S/C9H8FNO3/c1-5(12)11-6-2-3-8(10)7(4-6)9(13)14/h2-4H,1H3,(H,11,12)(H,13,14)",CC(=O)NC1=CC(=C(C=C1)F)C(=O)O,HGFZDZZEWWPKIB-UHFFFAOYSA-N,5-acetamido-2-fluorobenzoic acid,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20071204,A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemSpider|ChemTik|DiscoveryGate|Enamine|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
24701445,6-(Ethylamino)pyridine-3-carbonitrile,"6-(ethylamino)pyridine-3-carbonitrile|6-(ethylamino)nicotinonitrile|1016813-34-5|RZS|SCHEMBL3060340|MFCD09940529|ZINC19483176|AKOS000183814|MCULE-6408587178|NE38871|6-(ethylamino) pyridine-3-carbonitrile|3-Pyridinecarbonitrile, 6-(ethylamino)-|6-(ethylamino)nicotinonitrile, AldrichCPR|AS-43097|CS-0090976|Z6380|EN300-36248",147.180,C8H9N3,48.700,158.000,1.300,11,1,3,2,"InChI=1S/C8H9N3/c1-2-10-8-4-3-7(5-9)6-11-8/h3-4,6H,2H2,1H3,(H,10,11)",CCNC1=NC=C(C=C1)C#N,MVJDUNKELBBNKM-UHFFFAOYSA-N,6-(ethylamino)pyridine-3-carbonitrile,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20080229,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Angel Pharmatech Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemTik|Combi-Blocks|DiscoveryGate|Enamine|Google Patents|IBM|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Mcule|MolCore BioPharmatech|MolPort|N",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
24758425,Aldosteronum,"Aldosteronum|delta-Aldosterone|11,21-Dihydroxy-3,20-dioxopregn-4-en-18-al|SCHEMBL14373307|11b,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al|11beta,21-Dihydroxy-3,20-dioxo-pregn-4-en-18-al|(11b)-11,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al|(11beta)-11,21-dihydroxy-3,20-dioxo-Pregn-4-en-18-al|(2R,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde|11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydr",360.400,C21H28O5,91.700,682.000,1.100,26,2,5,3,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14?,15?,16-,17+,19?,20+,21-/m1/s1",C[C@]12CCC(=O)C=C1CCC3C2[C@H](C[C@]4(C3CC[C@@H]4C(=O)CO)C=O)O,PQSUYGKTWSAVDQ-SRPWZAMTSA-N,"(10R,11S,13R,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde",NULL,Biomolecular Interactions and Pathways|Patents|Pharmacology and Biochemistry,3,NULL,20080407,Google Patents|Human Metabolome Database (HMDB)|PATENTSCOPE (WIPO)|SCRIPDB|SureChEMBL|Thomson Pharma,Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
25271637,(S)-Climbazole,"(S)-climbazole|(1~{S})-1-(4-chloranylphenoxy)-1-imidazol-1-yl-3,3-dimethyl-butan-2-one|UNII-Q5UTA9TR5Q|Q5UTA9TR5Q|ZINC164|SCHEMBL6235296|CHEBI:83722|A16457|Q27157148|UNII-9N42CW7I54 component OWEGWHBOCFMBLP-AWEZNQCLSA-N|(1S)-1-(4-chlorophenoxy)-1-(1H-imidazol-1-yl)-3,3-dimethylbutan-2-one|RQH",292.760,C15H17ClN2O2,44.100,335.000,3.700,20,0,3,5,"InChI=1S/C15H17ClN2O2/c1-15(2,3)13(19)14(18-9-8-17-10-18)20-12-6-4-11(16)5-7-12/h4-10,14H,1-3H3/t14-/m0/s1",CC(C)(C)C(=O)[C@@H](N1C=CN=C1)OC2=CC=C(C=C2)Cl,OWEGWHBOCFMBLP-AWEZNQCLSA-N,"(1S)-1-(4-chlorophenoxy)-1-imidazol-1-yl-3,3-dimethylbutan-2-one",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents,4,NULL,20090527,"A&J Pharmtech CO., LTD.|Adooq BioScience|ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
40091305,"7-Fluoro-N,2-dimethylquinoline-3-carboxamide","7-fluoro-N,2-dimethylquinoline-3-carboxamide|AKOS033724227|MCULE-5013412592|WRY",218.230,C12H11FN2O,42.000,272.000,2.000,16,1,3,1,"InChI=1S/C12H11FN2O/c1-7-10(12(16)14-2)5-8-3-4-9(13)6-11(8)15-7/h3-6H,1-2H3,(H,14,16)",CC1=C(C=C2C=CC(=CC2=N1)F)C(=O)NC,XTBYDIXZNAOPDG-UHFFFAOYSA-N,"7-fluoro-N,2-dimethylquinoline-3-carboxamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20090530,AKos Consulting & Solutions|DiscoveryGate|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
44263865,Bromelain,BROMELAIN|MUXF|carbohydrate moiety of bromelain|M0XF(3)|CHEBI:53469|9001-00-7|alpha-L-Fucp-(1->3)-[alpha-D-Manp-(1->6)-[beta-D-Xylp-(1->2)]-beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)]-D-GlcpNAc|Fuc-alpha-(1->3)-[Man-alpha-(1->6)-[Xyl-beta-(1->2)]-Man-beta-(1->4)-GlcNAc-beta-(1->4)]-GlcNAc|alpha-L-Fuc-(1->3)-[alpha-D-Man-(1->6)-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)]-D-GlcNAc|alpha-L-fucopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->6)-[beta-D-xylopyranosyl-(1->2)]-beta-D-mannopyranosyl-(1->,1026.900,C39H66N2O29,483.000,1680.000,-11.600,70,18,29,16,"InChI=1S/C39H66N2O29/c1-9-19(48)24(53)29(58)38(62-9)69-32-18(41-11(3)46)34(59)63-15(6-44)31(32)68-35-17(40-10(2)45)23(52)30(14(5-43)65-35)67-39-33(70-37-27(56)20(49)12(47)7-60-37)26(55)22(51)16(66-39)8-61-36-28(57)25(54)21(50)13(4-42)64-36/h9,12-39,42-44,47-59H,4-8H2,1-3H3,(H,40,45)(H,41,46)/t9-,12+,13+,14+,15+,16+,17+,18+,19+,20-,21+,22+,23+,24+,25-,26-,27+,28-,29-,30+,31+,32+,33-,34?,35-,36-,37-,38-,39-/m0/s1",C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@H]2[C@@H]([C@H](OC([C@@H]2NC(=O)C)O)CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O[C@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO[C@@H]5[C@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)O)NC(=O)C)O)O)O,UNMLVGNWZDHBRA-UFAVQCRNSA-N,"N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5R)-5-acetamido-6-hydroxy-2-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-5-[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",Bromelains,Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,NULL,20091119,"ChEBI|China MainChem Co., Ltd|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA Substance Registry Services|GlyTouCan Project|Google Patents|Immune Epitope Database (IEDB)|MetabolomicsWorkbench|Smolecule|Springer Nature|UniCarbKB|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56841909,Natrii chloridi solutio composita,"Compound solution of sodium chloride|8026-10-6|Ringer solution|Solutio ringeri|Ringer's solution|Ringer's injection|Ringer-locke solution|Isotonic ringer's solution|Ringer's solution for injection|Natrii chloridi solutio composita|Sodium chloride compound solution|DTXSID70230195|Solucion de cloruro sodico compuesta|Solute de chlorure de sodium compose|Named reagents and solutions, Ringer's|Natrii chloridi solutio composita [INN-Latin]|Solute de chlorure de sodium compose [INN-French]|Solucion de cloruro sod",309.110,CH5CaCl2KNa2O6,63.400,24.800,NULL,13,4,8,0,"InChI=1S/CH2O3.Ca.2ClH.K.2Na.3H2O/c2-1(3)4;;;;;;;;;/h(H2,2,3,4);;2*1H;;;;3*1H2/q;+2;;;3*+1;;;/p-5",C(=O)(O)[O-].O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2],BMLSTPRTEKLIPM-UHFFFAOYSA-I,calcium;potassium;disodium;hydrogen carbonate;dichloride;dihydroxide;hydrate,Ringer's Solution,Classification|Drug and Medication Information|Literature|Names and Identifiers|Toxicity,5,NULL,20120321,ChemIDplus|EPA DSSTox,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
57327017,Prezcobix,Prezcobix|Cobicistat / darunavir|Darunavir / Cobicistat|Cobicistat and darunavir|Darunavir and cobicistat|Cobicistat mixture with darunavir|S900006400,1323.700,C67H90N10O12S3,343.000,1980.000,NULL,92,6,19,32,"InChI=1S/C40H53N7O5S2.C27H37N3O7S/c1-29(2)38-43-34(27-53-38)25-46(3)39(49)45-36(16-17-47-18-20-51-21-19-47)37(48)42-32(22-30-10-6-4-7-11-30)14-15-33(23-31-12-8-5-9-13-31)44-40(50)52-26-35-24-41-28-54-35;1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h4-13,24,27-29,32-33,36H,14-23,25-26H2,1-3H3,(H,42,48)(H,44,50)(H,45,49);3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t32-,33-,36+;22-,23-,24+,25-,26+/m10/s1",CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N.CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,CXORHDVSJFELCV-HWDLLDTBSA-N,"[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate;1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20120618,ChemIDplus|Thomson Pharma,Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
124547413,"(2R,3R)-1-Benzyl-2-methylpiperidin-3-ol","(2R,3R)-1-benzyl-2-methylpiperidin-3-ol|ZINC107242045|T1M",205.300,C13H19NO,23.500,189.000,2.100,15,1,2,2,"InChI=1S/C13H19NO/c1-11-13(15)8-5-9-14(11)10-12-6-3-2-4-7-12/h2-4,6-7,11,13,15H,5,8-10H2,1H3/t11-,13+/m1/s1",C[C@@H]1[C@H](CCCN1CC2=CC=CC=C2)O,ZFJGRVQFTNBLRP-YPMHNXCESA-N,"(2R,3S)-1-benzyl-2-methylpiperidin-3-ol",NULL,Biomolecular Interactions and Pathways,1,NULL,20170410,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
137348969,"(1R,2S)-1-Hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,485.600,C21H31N3O8S,180.000,777.000,0.700,33,5,8,12,"InChI=1S/C21H31N3O8S/c1-13(2)10-16(24-21(28)32-12-14-6-4-3-5-7-14)19(26)23-17(20(27)33(29,30)31)11-15-8-9-22-18(15)25/h3-7,13,15-17,20,27H,8-12H2,1-2H3,(H,22,25)(H,23,26)(H,24,28)(H,29,30,31)/t15-,16-,17-,20+/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@H](O)S(=O)(=O)O)NC(=O)OCC2=CC=CC=C2,BSPZFJDYQHDZNR-OGNFBWPZSA-N,"(1R,2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20190312,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037573,2-(5-Cyanopyridin-3-yl)-N-(pyridin-3-yl)acetamide,2-(5-cyanopyridin-3-yl)-N-(pyridin-3-yl)acetamide|UGM,238.240,C13H10N4O,78.700,335.000,0.300,18,1,4,3,"InChI=1S/C13H10N4O/c14-6-11-4-10(7-16-8-11)5-13(18)17-12-2-1-3-15-9-12/h1-4,7-9H,5H2,(H,17,18)",C1=CC(=CN=C1)NC(=O)CC2=CC(=CN=C2)C#N,DQOFNGNCBXHENB-UHFFFAOYSA-N,2-(5-cyanopyridin-3-yl)-N-pyridin-3-ylacetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037577,N-(5-Methylthiophen-2-yl)-N'-pyridin-3-ylurea,N-(5-methylthiophen-2-yl)-N'-pyridin-3-ylurea|UH4,233.290,C11H11N3OS,82.300,249.000,1.800,16,2,3,2,"InChI=1S/C11H11N3OS/c1-8-4-5-10(16-8)14-11(15)13-9-3-2-6-12-7-9/h2-7H,1H3,(H2,13,14,15)",CC1=CC=C(S1)NC(=O)NC2=CN=CC=C2,OCXJDZBTSLHCNX-UHFFFAOYSA-N,1-(5-methylthiophen-2-yl)-3-pyridin-3-ylurea,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146673001,N-[(1R)-2-(2-Ethyl-6-methylanilino)-2-oxo-1-pyridin-3-ylethyl]-N-(6-propan-2-ylpyridin-3-yl)propanamide,NULL,444.600,C27H32N4O2,75.200,640.000,4.500,33,1,4,8,"InChI=1S/C27H32N4O2/c1-6-20-11-8-10-19(5)25(20)30-27(33)26(21-12-9-15-28-16-21)31(24(32)7-2)22-13-14-23(18(3)4)29-17-22/h8-18,26H,6-7H2,1-5H3,(H,30,33)/t26-/m1/s1",CCC1=CC=CC(=C1NC(=O)[C@@H](C2=CN=CC=C2)N(C3=CN=C(C=C3)C(C)C)C(=O)CC)C,HPKVUDPRFZVZGF-AREMUKBSSA-N,N-[(1R)-2-(2-ethyl-6-methylanilino)-2-oxo-1-pyridin-3-ylethyl]-N-(6-propan-2-ylpyridin-3-yl)propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200702,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146681429,5-[(Carbamoylcarbamoyl)amino]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide,5-[(carbamoylcarbamoyl)amino]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide|Y95,390.400,C22H22N4O3,113.000,611.000,4.000,29,4,3,4,"InChI=1S/C22H22N4O3/c1-13-10-11-16(25-22(29)26-21(23)28)12-19(13)20(27)24-14(2)17-9-5-7-15-6-3-4-8-18(15)17/h3-12,14H,1-2H3,(H,24,27)(H4,23,25,26,28,29)/t14-/m1/s1",CC1=C(C=C(C=C1)NC(=O)NC(=O)N)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32,SIBDGNTYRQIIGV-CQSZACIVSA-N,5-(carbamoylcarbamoylamino)-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200806,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
154815733,2-Methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]-5-{[(prop-2-en-1-yl)carbamoyl]amino}benzamide,2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]-5-{[(prop-2-en-1-yl)carbamoyl]amino}benzamide|Y94,387.500,C24H25N3O2,70.200,579.000,4.400,29,3,2,6,"InChI=1S/C24H25N3O2/c1-4-14-25-24(29)27-19-13-12-16(2)22(15-19)23(28)26-17(3)20-11-7-9-18-8-5-6-10-21(18)20/h4-13,15,17H,1,14H2,2-3H3,(H,26,28)(H2,25,27,29)/t17-/m1/s1",CC1=C(C=C(C=C1)NC(=O)NCC=C)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32,UPLVMSAQDITPGI-QGZVFWFLSA-N,2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]-5-(prop-2-enylcarbamoylamino)benzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20201124,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294421,"1-[(5S,8R)-6,7,8,9-Tetrahydro-5H-5,8-epiminocyclohepta[b]pyridin-10-yl]ethan-1-one","1-[(5S,8R)-6,7,8,9-tetrahydro-5H-5,8-epiminocyclohepta[b]pyridin-10-yl]ethan-1-one|W27",202.250,C12H14N2O,33.200,279.000,0.800,15,0,2,0,"InChI=1S/C12H14N2O/c1-8(15)14-9-4-5-12(14)10-3-2-6-13-11(10)7-9/h2-3,6,9,12H,4-5,7H2,1H3/t9-,12+/m1/s1",CC(=O)N1[C@@H]2CC[C@H]1C3=C(C2)N=CC=C3,VZERDZVLLIAWDV-SKDRFNHKSA-N,"1-[(1S,9R)-6,12-diazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-trien-12-yl]ethanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294425,"(3S,4S)-4-(3-Methoxyphenyl)oxane-3-carboxylic acid","(3S,4S)-4-(3-methoxyphenyl)oxane-3-carboxylic acid|W2V",236.260,C13H16O4,55.800,266.000,1.500,17,1,4,3,"InChI=1S/C13H16O4/c1-16-10-4-2-3-9(7-10)11-5-6-17-8-12(11)13(14)15/h2-4,7,11-12H,5-6,8H2,1H3,(H,14,15)/t11-,12-/m1/s1",COC1=CC=CC(=C1)[C@H]2CCOC[C@H]2C(=O)O,RGWPZWUASAWZRN-VXGBXAGGSA-N,"(3S,4S)-4-(3-methoxyphenyl)oxane-3-carboxylic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155801621,"5-[(Azetidin-3-yl)amino]-N-[(1R)-1-{3-[5-({[(1R,3S)-3-hydroxycyclopentyl]amino}methyl)thiophen-2-yl]phenyl}ethyl]-2-methylbenzamide","5-[(azetidin-3-yl)amino]-N-[(1R)-1-{3-[5-({[(1R,3S)-3-hydroxycyclopentyl]amino}methyl)thiophen-2-yl]phenyl}ethyl]-2-methylbenzamide|Y54",504.700,C29H36N4O2S,114.000,721.000,3.900,36,5,6,9,"InChI=1S/C29H36N4O2S/c1-18-6-7-23(33-24-15-30-16-24)14-27(18)29(35)32-19(2)20-4-3-5-21(12-20)28-11-10-26(36-28)17-31-22-8-9-25(34)13-22/h3-7,10-12,14,19,22,24-25,30-31,33-34H,8-9,13,15-17H2,1-2H3,(H,32,35)/t19-,22-,25+/m1/s1",CC1=C(C=C(C=C1)NC2CNC2)C(=O)N[C@H](C)C3=CC=CC(=C3)C4=CC=C(S4)CN[C@@H]5CC[C@@H](C5)O,IGVYCVBUHQMNRZ-QNIAMRLHSA-N,"5-(azetidin-3-ylamino)-N-[(1R)-1-[3-[5-[[[(1R,3S)-3-hydroxycyclopentyl]amino]methyl]thiophen-2-yl]phenyl]ethyl]-2-methylbenzamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20210226,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804569,N-(4-Tert-butylphenyl)-N-[(1R)-2-(3-methoxypropylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,411.500,C24H33N3O3,71.500,538.000,3.600,30,1,4,10,"InChI=1S/C24H33N3O3/c1-6-21(28)27(20-12-10-19(11-13-20)24(2,3)4)22(18-9-7-14-25-17-18)23(29)26-15-8-16-30-5/h7,9-14,17,22H,6,8,15-16H2,1-5H3,(H,26,29)/t22-/m1/s1",CCC(=O)N(C1=CC=C(C=C1)C(C)(C)C)[C@H](C2=CN=CC=C2)C(=O)NCCCOC,BWBBQIUIWNQPIO-JOCHJYFZSA-N,N-(4-tert-butylphenyl)-N-[(1R)-2-(3-methoxypropylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155926085,Hemi-sulfate salt of AT-511,AT527|AT-527|RO7496998|RO-7496998|UNII-DAI4WL7JQ6|DAI4WL7JQ6|Hemi-sulfate salt of AT-511|AT 527|RG6422|RG 6422|RG-6422|RO 7496998|2241337-84-6,1261.100,C48H68F2N14O18P2S,453.000,1000.000,NULL,85,10,32,24,"InChI=1S/2C24H33FN7O7P.H2O4S/c2*1-13(2)37-21(34)14(3)31-40(35,39-15-9-7-6-8-10-15)36-11-16-18(33)24(4,25)22(38-16)32-12-28-17-19(27-5)29-23(26)30-20(17)32;1-5(2,3)4/h2*6-10,12-14,16,18,22,33H,11H2,1-5H3,(H,31,35)(H3,26,27,29,30);(H2,1,2,3,4)/t2*14-,16+,18+,22+,24+,40-;/m00./s1",C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=NC3=C(N=C(N=C32)N)NC)(C)F)O)OC4=CC=CC=C4.C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=NC3=C(N=C(N=C32)N)NC)(C)F)O)OC4=CC=CC=C4.OS(=O)(=O)O,QIGYBLSWYRTXCA-NVSCJZCKSA-N,"propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-[2-amino-6-(methylamino)purin-9-yl]-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate;sulfuric acid",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20210701,ChemIDplus|FDA/SPL Indexing Data,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
1023,Pyrophosphoric acid,"Diphosphoric acid|Pyrophosphoric acid|2466-09-3|phosphono dihydrogen phosphate|Phosphonooxyphosphonic acid|H4P2O7|CHEBI:29888|UNII-4E862E7GRQ|4E862E7GRQ|PPV|Diphosphorsaeure|Pyrophosphorsaeure|acide diphosphorique|pyrophosphate TMS4|EINECS 219-574-0|(P2O74-)Diphosphate|Pyrophosphoric acid, syrupy|(4-)Diphosphoric acid ion|Oxy-1,1-diphosphonic acid|NCIStruc1_000506|NCIStruc2_000426|(phosphonooxy)phosphonic acid|GTPL3151|CHEMBL1160571|DTXSID4075035|EBD14815|NCI56751|ZINC6827695|Pyrophosphoric acid, technical ",177.980,H4O7P2,124.000,147.000,-3.200,9,4,7,2,"InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)",OP(=O)(O)OP(=O)(O)O,XPPKVPWEQAFLFU-UHFFFAOYSA-N,phosphono dihydrogen phosphate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active,12,330|348|357|376|400|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|630|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|902|912|914|915|923|924|925|926|938|940|995|1030|1379|1422|1452|1457|1458|1469|1471|1476|1478|1479|1487|1490|1688|1766|1768|1851|1948|2063|2326|2528|2546|2551|2662|151017|151018|151019|318593|318594|360400|360401|360402|485290|492961|504327|504332|504749|504832|504834|504847|504865|525264|525266|525267|588579|60233,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|BIND|BindingDB|BioChemPartner|Bioco",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
1983,Acetaminophen,acetaminophen|Paracetamol|4-Acetamidophenol|103-90-2|Tylenol|N-(4-Hydroxyphenyl)acetamide|APAP|Panadol|Acetaminofen|Datril|N-Acetyl-p-aminophenol|p-Hydroxyacetanilide|4'-Hydroxyacetanilide|p-Acetamidophenol|Algotropyl|Lonarid|Naprinol|p-Acetaminophenol|Acamol|Acenol|Anelix|Multin|Abensanil|Acetagesic|Acetalgin|Clixodyne|Gelocatil|Injectapap|Liquagesic|Pyrinazine|Servigesic|Alvedon|Anaflon|Apamide|Dymadon|Febridol|Febrilix|Febrolin|Finimal|Homoolan|Lestemp|Paracet|Tabalgin|Tralgon|Tussapap|Valadol|Valgesic|A,151.160,C8H9NO2,49.300,139.000,0.500,11,2,2,1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",CC(=O)NC1=CC=C(C=C1)O,RZVAJINKPMORJF-UHFFFAOYSA-N,N-(4-hydroxyphenyl)acetamide,Acetaminophen,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,155|157|161|165|167|175|248|357|377|410|411|421|426|427|433|434|435|444|445|446|447|448|450|451|526|530|540|541|542|543|544|545|546|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|910|912|914|915|921|923|924|925|926|927|930|938|940|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Alsach",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2083,Salbutamol,Salbutamol|albuterol|18559-94-9|Proventil|Sultanol|Volmax|Broncovaleas|Aerolin|dl-Salbutamol|dl-Albuterol|Ventolin Inhaler|Ventolin|Proventil HFA|Buventol|Cobutolin|Salbulin|Salbuvent|Saventol|Ventoline|Asmaven|Salamol|Spreor|Asmol|Sultanol N|Proventil Inhaler|Novosalmol|Salbuhexal|Salbutalan|Salbutamolum|Servitamol|Ventiloboi|Ventodisks|Almotex|Anebron|Asmadil|Asmanil|Asmasal|Asmatol|Asmidon|Bronter|Bugonol|Butamol|Butohaler|Butotal|Butovent|Dilatamol|Farcolin|Gerivent|Grafalin|Libretin|Medolin|Parasma|Pne,239.310,C13H21NO3,72.700,227.000,0.300,17,4,4,5,"InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3",CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,NDAUXUAQIAJITI-UHFFFAOYSA-N,4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,Albuterol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,377|422|429|436|547|694|732|880|894|940|1030|1189|1195|1208|1332|1379|1422|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1688|1705|1707|1708|1766|1768|1815|1816|1828|1865|1876|1877|1882|1883|1886|1948|1967|2062|2101|2107|2112|2147|2240|2241|2275|2313|2322|2323|2326|2330|2353|2364|2451|2472|2517|2528|25,20050325,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alfa Aesar|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Angel Pha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2353,Berberine,"berberine|2086-83-1|Umbellatine|Berberin|Berbericine|UNII-0I8Y3P32UF|0I8Y3P32UF|CHEBI:16118|Berberal|ST055798|9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium|Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-|9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium|Berbamine sulphate acid|16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene|Berberine hydrogen sulfate|CHEMBL12089|Benz",336.400,C20H18NO4+,40.800,488.000,3.600,25,0,4,2,"InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1",COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC,YBHILYKTIRIUTE-UHFFFAOYSA-N,"16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene",Berberine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,12,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|608|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|995|999|1004|1030|1033|1332|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1498|1519|1549|1552|1637|1648|1766|1768|1851|1865|1948|2101|2107|2112|2147|2240|2241|2275|2313|2316|2322|2330|2451|2472|2517|2528|2546|2549|2551|434959|485281|485290|504327|50,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2442,Bromhexine,"bromhexine|3572-43-8|Bisolvon|Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-|Bromhexinum|Bromhexina|2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline|UNII-Q1J152VB1P|2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline|2,4-dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline|Q1J152VB1P|CHEBI:77032|NA-274|Toluene-.alpha.,2-diamine, 3,5-dibromo-N.alpha.-cyclohexyl-N.alpha.-methyl-|[(2-amino-3,5-dibromophenyl)methyl]cyclohexylmethylamine|N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)amin",376.130,C14H20Br2N2,29.300,256.000,4.300,18,1,2,3,"InChI=1S/C14H20Br2N2/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17/h7-8,12H,2-6,9,17H2,1H3",CN(CC1=C(C(=CC(=C1)Br)Br)N)C2CCCCC2,OJGDCBLYJGHCIH-UHFFFAOYSA-N,"2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline",Bromhexine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,1195|2240|2241|2275|2313|2322|2330|311932|311934|409954|434959|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|496830|496831|496832|497005|540234|567091|588208|588220|624101|624137|624156|624260|624349|625144|625145|625146|625147|625148|625149|625150|625151|625152|625153|625154|625155|625156|625157|625158|625159|625160|625161|625162|625163|625164|625165|625166|625167|625168|625169|625170|625171|625172|625173|625174|625175|625176|625177|625178|625179|625180|625181|625182|6,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2803,Clonidine,"clonidine|4205-90-7|Clonidin|Catapres|Duraclon|Chlornidinum|Catapres-TTS|Adesipress|Catarpres|Catarpresan|N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine|ST 155BS|ST-155-BS|Catapresan|Clonidinum [INN-Latin]|CATAPRES-TTS-1|CATAPRES-TTS-2|CATAPRES-TTS-3|Clonidinhydrochlorid|2-(2,6-Dichloroanilino)-2-imidazoline|SKF 34427|2-((2,6-Dichlorophenyl)imino)imidazolidine|M-5041T|CLORPRES|clonidine (amino form)|2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)|CCRIS 7787|Combipres|2,6-Dichloro-N-2-imidazolidiny",230.090,C9H9Cl2N3,36.400,222.000,1.600,14,2,1,2,"InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)",C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,GJSURZIOUXUGAL-UHFFFAOYSA-N,"N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine",Clonidine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1030|1195|1332|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1851|1865|1948|2062|2101|2107|2112|2147|2240|2241|2275|2313|2316|2322|2330|2451|2472|2517|2528|2546|2549|255,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2913,Cyproheptadine,"CYPROHEPTADINE|129-03-3|Periactin|Eiproheptadine|Periactinol|Dronactin|4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine|Ciproheptadina|Cyproheptadinum|MK 141|4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine|UNII-2YHB6175DO|CHEMBL516|Piperidine, 4-(5H-dibenz",287.400,C21H21N,3.200,423.000,4.700,22,0,1,0,"InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3",CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,JJCFRYNCJDLXIK-UHFFFAOYSA-N,"1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine",Cyproheptadine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1030|1195|1332|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1851|1865|1948|2062|2101|2107|2112|2147|2240|2241|2275|2313|2316|2322|2330|2451|2472|2517|2528|2546|2549|255,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Ambinter|AN PharmaTech|Ange",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3194,Ebselen,"ebselen|60940-34-3|2-Phenyl-1,2-benzisoselenazol-3(2H)-one|Ebselenum|2-phenyl-1,2-benzoselenazol-3-one|2-phenylbenzo[d][1,2]selenazol-3(2H)-one|Ebselene|Ebseleno|SPI-1005|Ebselene [French]|Ebselenum [Latin]|Ebselen [INN]|Ebseleno [Spanish]|PZ 51|C13H9NOSe|Harmokisane|PZ-51|DR-3305|MLS000028488|UNII-40X2P7DPGH|CCRIS 3714|PZ51|1,2-Benzisoselenazol-3(2H)-one, 2-phenyl-|2-Phenyl-1,2-benzisoselenazolin-3-one|SMR000058445|2-phenyl-1,2-benzoisoselenazol-3(2H)-one|CHEMBL51085|NSC 639762|Prestwick_1057|SPI-3005|Pres",274.190,C13H9NOSe,20.300,275.000,NULL,16,0,1,1,InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H,C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2,DYEFUKCXAQOFHX-UHFFFAOYSA-N,"2-phenyl-1,2-benzoselenazol-3-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,13,155|157|161|165|167|175|179|357|361|364|368|371|373|374|375|377|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|547|549|550|552|555|556|557|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|601|603|604|605|606|607|609|614|615|618|620|622|623|624|625|626|628|631|634|636|637|641|645|651|652|662|680|684|686|694|703|708|709|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemtek|Acros Organics|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|AvaChem Scientific|Axon Medchem|BePharm Ltd.|BindingDB|BioChemPartner|Biocore|BLD Pharm|BOC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3386,Fluoxetine,"fluoxetine|54910-89-3|Prozac|Pulvules|Portal|Eufor|Animex-On|Fluoxetina|Fluoxetina [Spanish]|Fluoxetinum|Fluoxetinum [INN-Latin]|Fluoxetina [INN-Spanish]|N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine|Fontex|Reconcile|Fluctine|Fluoxac|Fludac|Fluxil|Fluoxetin|(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine|N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine|CHEMBL41|dl-3-(p-Trifluoromethylp",309.330,C17H18F3NO,21.300,308.000,4.000,22,1,5,6,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,Fluoxetine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,330|880|1030|1195|1332|1457|1458|1460|1463|1468|1469|1471|1477|1479|1487|1490|1688|1766|1768|1865|2062|2101|2107|2112|2240|2241|2275|2313|2316|2322|2330|2517|2528|2546|2549|2551|2660|2666|2667|2668|3511|3514|3541|3544|3804|5064|5241|22293|26304|29359|29811|35273|35630|36017|36349|36350|37309|37367|50342|50343|61413|64372|64630|65171|65486|129284|130135|130137|130138|131869|131871|132117|134215|134216|134217|144700|145392|145396|145563|145881|161281|170352|170353|170354|170355|170356|170357|170358|170359|170,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alfa Chemistry|Alinda Chemical|Allbio Pharm Co., Ltd|Alomone Labs|Alsachim|Amadis Chemical|AN PharmaTech|Angene Chemical|An",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3410,Formoterol,formoterol|73573-87-2|n-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide|Formoterolum [INN-Latin]|N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide|FORMOTEROL FUMARATE|CHEBI:63082|2'-hydroxy-5'-(1-hydroxy-2-((p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|2'-hydroxy-5'-{1-hydroxy-2-[(p-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]fo,344.400,C19H24N2O4,90.800,388.000,1.800,25,4,5,8,"InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)",CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,BPZSYCZIITTYBL-UHFFFAOYSA-N,N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide,Formoterol Fumarate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1471|1490|1688|1766|1768|2062|2528|2546|2551|2662|236903|238673|248534|251147|414891|414892|414893|414894|414895|414916|414917|414918|414919|415158|438906|438907|438908|438909|438910|447901|447902|447903|447904|447907|447908|447910|447911|447912|447913|481512|481513|481516|481517|481519|481520|481521|481523|481524|481525|492961|501435|501436|501437|501438|504327|504332|504749|504832|504834|504847|504865|510458|510459|510460|510462|521220|524790|524792|524795|524796|578408|578409|588579|602332|606103|606106|,20050325,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemtek|ACT Chemical|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alsachim|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Assembly Blocks Pvt. Ltd.|AvaChem Scientific|BindingDB|BioChemPartner|Biocore|BioCrick|BOC Sciences|Boerchem|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemIDplus|Chemieliv",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3676,Lidocaine,"lidocaine|137-58-6|Lignocaine|Xylocaine|2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide|Lidoderm|Anestacon|Esracaine|Duncaine|Alphacaine|Cappicaine|Gravocain|Isicaina|L-Caine|Leostesin|Maricaine|Xylocain|Xylocitin|Solcain|Isicaine|Xylestesin|Rucaina|Xilina|Xycaine|Xylotox|Cito optadren|Lida-Mantle|Dalcaine|2-(Diethylamino)-2',6'-acetoxylidide|Xyloneural (free base)|Cuivasil|Jetocaine|Remicaine|Xilocaina|2-Diethylamino-N-(2,6-dimethylphenyl)acetamide|Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-|Dieth",234.340,C14H22N2O,32.299,228.000,2.300,17,1,2,5,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,NNJVILVZKWQKPM-UHFFFAOYSA-N,"2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide",Lidocaine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,256|357|361|364|368|371|373|374|375|410|411|422|423|424|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|552|555|556|559|560|561|565|567|570|571|572|573|574|575|576|577|580|581|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|607|609|614|615|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|662|680|684|686|687|701|708|709|719|731|746|751|757|758|759|760|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Anward|ApexBio T",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3827,Ketotifen,"ketotifen|34580-13-7|Ketotifene|Zaditor|Ketotifeno|Ketotifenum|Ketotifene [INN-French]|Ketotifenum [INN-Latin]|Ketotifeno [INN-Spanish]|HC 20-511|UNII-X49220T18G|HC 20511 fumarate|4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one|4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one|CHEMBL534|10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-|X49220T18G|NCGC00015580-08|DSSTox_CID_3190|Keto",309.400,C19H19NOS,48.600,476.000,3.200,22,0,3,0,"InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,"2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one",Ketotifen,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1030|1195|1332|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1851|1865|1948|2062|2101|2107|2112|2147|2240|2241|2275|2313|2322|2330|2451|2472|2517|2528|2546|2549|2551|266,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Ark Pharm, Inc.|ASINEX|Assembly Blocks Pvt. Ltd.|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4046,Mefloquine,"mefloquine|Lariam|49752-90-1|GNF-Pf-5544|53230-10-7|alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol|CHEMBL416956|CHEBI:63681|Racemic mefloquine|[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol|[2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol|Mefloquinone|(2,8-bis(trifluoromethyl)quinolin-4-yl)(piperidin-2-yl)methanol|[2,8-bis(trifluoromethyl)quinolin-4-yl](piperidin-2-yl)methanol|Ro 21-5998|WR-142490|W",378.310,C17H16F6N2O,45.200,483.000,3.600,26,2,9,2,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2",C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,XEEQGYMUWCZPDN-UHFFFAOYSA-N,"[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol",Mefloquine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1332|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1766|1768|1865|1948|2101|2107|2112|2147|2240|2241|2275|2313|2316|2322|2330|2451|2472|2517|2528|2546|2549|2551|135327|151999|152000|157690|157692|157848|157849|157850|15785,20050325,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Abbott Labs|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|AKos Consulting & Solutions|Ambinter|AN PharmaTech|Ark Pharm, Inc.|Ark Pharma Scientific Limited|BindingDB|BioChemPartner|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|chemical genetic matrix|ChemIDplus|ChemMol|ChemSpi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4091,Metformin,"metformin|657-24-9|1,1-Dimethylbiguanide|N,N-dimethylimidodicarbonimidic diamide|Metformine|Metiguanide|Dimethylbiguanide|Haurymelin|Fluamine|Flumamine|Gliguanid|Diabex|Melbin|N,N-Dimethylbiguanide|Glumetza|Imidodicarbonimidic diamide, N,N-dimethyl-|N1,N1-Dimethylbiguanide|DMGG|NNDG|N,N-Dimethyldiguanide|1,1-Dimethyl biguanide|LA-6023|BIGUANIDE, 1,1-DIMETHYL-|3-(diaminomethylidene)-1,1-dimethylguanidine|Fortamet|UNII-9100L32L2N|CHEMBL1431|CHEBI:6801|Glifage|Islotin|Siofor|Dimethyldiguanide|Diaformin|9100L32",129.160,C4H11N5,91.500,132.000,-1.300,9,3,1,2,"InChI=1S/C4H11N5/c1-9(2)4(7)8-3(5)6/h1-2H3,(H5,5,6,7,8)",CN(C)C(=N)N=C(N)N,XZWYZXLIPXDOLR-UHFFFAOYSA-N,"3-(diaminomethylidene)-1,1-dimethylguanidine",Metformin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|995|1030|1195|1332|1379|1452|1454|1457|1458|1467|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1851|1865|1948|2101|2107|2112|2147|2451|2472|2528|2546|2549|2551|2662|111563|114265|131964|131966|179728|179879|179890|179896|179898|182469|236268|236912|236913|236914|236916|250500|2,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambeed|Ambinter",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4192,Midazolam,"midazolam|Dormicum|59467-70-8|Buccolam|Versed|8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine|Midazolamum|Midazolamum [INN-Latin]|Midazolam Base|mezolam|Ro 21-3981|DEA No. 2884|UNII-R60L0SM5BC|USL261|CHEMBL655|R60L0SM5BC|CHEBI:6931|Hypnovel|59467-70-8 (free)|4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-|4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-|8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine|",325.800,C18H13ClFN3,30.200,471.000,2.500,23,0,3,1,"InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,DDLIGBOFAVUZHB-UHFFFAOYSA-N,"8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine",Midazolam,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1195|1471|1490|1688|1766|1768|2528|2546|2551|2662|7783|8002|19468|20881|21850|21851|21852|21855|21857|21859|26380|27167|28681|29359|29812|39933|41742|54923|150751|150752|150753|150754|150755|150756|187598|187601|187603|187604|298031|298032|311524|373867|395324|395325|395327|411793|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|455986|467612|467613|492961|504327|504332|504749|504832|504834|504847|504865|520313|539464|539474|540209|540210|540211|540212|540213|540222|540223|540224,20050325,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|AbaChemScene|ABI Chem|Acadechem|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BIDD|BindingDB|BioChemPartner|BioCyc|BOC Sciences|C. David Weaver Laboratory, Vanderbilt University|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chembase.cn|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4510,Nitroglycerin,nitroglycerin|Glyceryl trinitrate|Trinitroglycerin|Nitroglycerine|Nitroglycerol|Nitrostat|55-63-0|Trinitroglycerol|Glycerol trinitrate|Nitro-dur|Minitran|Nitroderm|Nitroglyn|Nitronet|Nitrospan|Tridil|Transderm-nitro|Transderm Nitro|Epinitril|Lenitral|Natispray|Nitrocine|Nitrolan|Nitrolingual|Perlinganit|Susadrin|Sustonit|Trinitrin|Nitrong|Niong|Nitro-Bid|Nitroderm TTS|Angiolingual|Cordipatch|Corditrine|Klavikordal|Myoglycerin|Nitroglicerina|Nitroletten|Nitroplast|Nitrorectal|Nitroretard|Nitrostabilin|Nyscon,227.090,C3H5N3O9,165.000,219.000,1.600,15,0,9,5,"InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2",C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],SNIOPGDIGTZGOP-UHFFFAOYSA-N,"1,3-dinitrooxypropan-2-yl nitrate",Nitroglycerin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1189|1205|1208|58416|58418|58420|59574|59741|60299|60813|60814|60816|60819|60820|60821|76451|76452|77510|77511|77513|77514|167355|167787|173808|175471|175492|175666|178068|178994|187573|195179|218879|218881|219085|225247|225250|226296|227028|227030|232773|245849|309710|311367|318681|321898|321900|352262|352494|352500|374756|374757|374758|374759|374760|374762|374763|374764|395247|409957|437026|437027|437029|457931|457932|496817|496818|496819|496820|496821|496823|496824|496825|496826|496827|496828|496829|4968,20040916,"3B Scientific (Wuhan) Corp|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambinter|AN PharmaTech|Angene Chemical|Aurora Fine Chemicals LLC|BIDD|BioCyc|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chembase.cn|ChEMBL|ChemDB|Chemhere|Chemical Carcinogenesis Research Information System (CCRIS)|Chemical Synthesis Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Drug Ind",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4594,Omeprazole,omeprazole|73590-58-6|Prilosec|Losec|Antra|Esomeprazole|Omeprazon|Audazol|Omapren|Omepral|Parizac|Zegerid|Mopral|Miol|Belmazol|Ceprandal|Dizprazol|Dudencer|Emeproton|Epirazole|Gastrimut|Gastroloc|Gibancer|Indurgan|Inhibitron|Inhipump|Logastric|Pepticum|Peptilcer|Prazidec|Sanamidol|Secrepina|Ulcometion|Mepral|Miracid|Omeprol|Omezol|Omisec|Omizac|Ompanyt|Ozoken|Prysma|Ramezol|Ulceral|Ulcesep|Ulcozol|Zefxon|Zoltum|Desec|Elgam|Lomac|Ulsen|Ultop|Zimor|Ocid|Omed|Omid|OMEP|Demeprazol|Nopramin|Omeprazol|Omezolan|Pa,345.400,C17H19N3O3S,96.300,453.000,2.200,24,1,6,5,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,SUBDBMMJDZJVOS-UHFFFAOYSA-N,"6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole",Omeprazole,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,357|361|364|368|371|373|374|375|377|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|552|555|556|559|560|561|565|567|570|571|572|573|574|575|576|577|580|581|584|585|587|588|589|590|591|592|593|594|595|596|597|601|603|604|605|607|609|614|615|622|623|624|625|626|628|631|636|637|641|645|651|662|680|684|686|708|709|731|734|746|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|793|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4943,Propofol,"propofol|2,6-DIISOPROPYLPHENOL|2078-54-8|Diprivan|Disoprofol|Disoprivan|Diisopropylphenol|2,6-Bis(1-methylethyl)phenol|Fresofol|Ampofol|Phenol, 2,6-bis(1-methylethyl)-|Rapinovet|Propofolum|Recofol|Ivofol|Propofol-Lipuro|2,6-di(propan-2-yl)phenol|Pofol|ICI 35868|2,6-Diisopropyl phenol|Diprifusor|Diprofol|Propovan|Phenol, 2,6-diisopropyl-|Diprivan 10|UNII-YI7VU623SF|NSC 5105|ICI-35868|2,6-bis(propan-2-yl)phenol|2,6-diisopropyl-phenol|MFCD00008885|2,6-bis(Isopropyl)phenol|CHEMBL526|ICI 35,868|YI7VU623SF|CHEBI:",178.270,C12H18O,20.200,135.000,3.800,13,1,1,2,"InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3",CC(C)C1=C(C(=CC=C1)C(C)C)O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,"2,6-di(propan-2-yl)phenol",Propofol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,155|157|161|165|167|175|179|357|410|411|421|422|426|427|429|433|434|435|436|444|445|446|447|448|450|451|526|530|540|541|542|543|544|545|546|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|654|655|656|657|658|659|660|661|662|663|664|665|666|667|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|910|912|914|915|917|918|921|923|924|925|926|927|928|930|938|940|943|944|945|946|947|948|954|955|957|958|959|960|961|962|963|964|965|966|967|968|969|970|971|972|973|,20050325,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Angene Chemical|Anward",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4995,Pyrophosphate 2-,pyrophosphate 2-|diphosphate(2-)|dihydrogen diphosphate|diphosphate(2-) anion|CHEBI:45212|H2P2O7(2-)|NCGC00248841-01|Q27104547,175.960,H2O7P2-2,130.000,143.000,-3.300,9,2,7,2,"InChI=1S/H4O7P2/c1-8(2,3)7-9(4,5)6/h(H2,1,2,3)(H2,4,5,6)/p-2",OP(=O)([O-])OP(=O)(O)[O-],XPPKVPWEQAFLFU-UHFFFAOYSA-L,[hydroxy(oxido)phosphoryl] hydrogen phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20040916,"ABI Chem|ChEBI|Chembase.cn|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|National Center for Advancing Translational Sciences (NCATS)|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SMID|Therapeutic Target Database (TTD)|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5002,Quetiapine,"quetiapine|111974-69-7|Seroquel|Quetiapine fumarate|UNII-BGL0JSY5SI|C21H25N3O2S|2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-|BGL0JSY5SI|CHEMBL716|2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol|CHEBI:8707|2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol|FK949E|NCGC00095911-03|Co-Quetiapine|2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol|DSSTox_CID",383.500,C21H25N3O2S,73.600,496.000,2.100,27,1,5,6,"InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2",C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,URKOMYMAXPYINW-UHFFFAOYSA-N,"2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol",Quetiapine Fumarate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1195|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1688|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1865|1875|1885|1899|1903|1906|1910|1947|1948|1950|1961|1962|1974|1984|1986|1987|1996|2006|2012|2013|2014|2016|2023|2025|2029|2052|2,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5755,Prednisolone,prednisolone|50-24-8|Metacortandralone|Hydroretrocortine|Predonine|Delta-Cortef|Deltacortril|Meticortelone|Deltahydrocortisone|Prenolone|Hydroretrocortin|PRDL|Deltacortenol|Hydrodeltalone|Hydrodeltisone|Codelcortone|Cortalone|Cotogesic|Decaprednil|Delcortol|Deltisilone|Dicortol|Donisolone|Dydeltrone|Erbacort|Erbasona|Estilsona|Fernisolone|Hydeltra|Hydeltrone|Lentosone|Paracortol|Paracotol|Precortancyl|Precortilon|Precortisyl|Prednelan|Prednicen|Predniliderm|Predonin|Rolisone|Scherisolon|Sterolone|Cordrol|Pr,360.400,C21H28O5,94.800,724.000,1.600,26,3,5,2,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,OIGNJSKKLXVSLS-VWUMJDOOSA-N,"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one",Prednisolone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,192|204|206|212|220|224|230|236|238|240|248|250|256|266|268|270|276|282|284|290|296|304|306|312|316|320|328|330|332|336|338|340|377|1189|1194|1195|1208|1332|1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1984|1986|1987|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|2073|2094|2097|2098|,20050326,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|AN PharmaTech|ApexBio Technology|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|Boerchem|Broad Institute|C. David Weaver Labo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5793,D-Glucose,"D-Glc|D-Glucopyranose|D-Glucopyranoside|D-Glucose|Glc|Glucopyranose|Glucopyranoside|Glucose|2280-44-6|Grape sugar|D-Glcp|Traubenzucker|Glucodin|Goldsugar|Meritose|Vadex|Glucose solution|Clintose L|CPC hydrate|Roferose ST|a-D-Glucose|Clearsweet 95|Staleydex 95M|Staleydex 111|(+)-Glucose|Corn sugar|CHEBI:4167|Cerelose 2001|Tabfine 097(HS)|(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol|Glucopyranose, D-|DSSTox_CID_2910|D-glucose (closed ring structure, complete stereochemistry)|(3R,4S,5S,6R)-6-(Hydroxymet",180.160,C6H12O6,110.000,151.000,-2.600,12,5,6,1,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)O)O)O,WQZGKKKJIJFFOK-GASJEMHNSA-N,"(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1195|1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|15712|21264|26580|29845|30427|53797|71968|73340|73810|73815|73817|73819|73820|73821|73824|73825|73826|74399|141119|156202|156204|204248|204249|204254|204259|204574|226604|227718|337229|350509|377830|377831|377832|381592|381593|381594|381595|381596|381597|389773|389774|481439|481441|481442|481444|481446|485281|485290|500279|504327|504847|588211|588212|588213|588579|602332|651631|651632|651633|651634|652048|652051|6,20050608,"3B Scientific (Wuhan) Corp|AAA Chemistry|ABBLIS Chemicals|ABI Chem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|ChEMBL|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Drug Ind",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5920,Liothyronine,"liothyronine|triiodothyronine|3,3',5-Triiodo-L-thyronine|6893-02-3|Liothyronin|3,5,3'-triiodothyronine|Tresitope|O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|L-Liothyronine|3,5,3'-Triiodo-L-thyronine|T3|triothyrone|Liothyroninum|Liotironina|L-T3|3,3',5-Triiodothyronine|3,5,3'TRIIODOTHYRONINE|L-3,5,3'-Triiodothyronine|L-3,3',5-TriioDOThyronine|(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid|(S)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic acid|Triiodo-L-th",650.970,C15H12I3NO4,92.800,402.000,1.700,23,3,5,5,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,AUYYCJSJGJYCDS-LBPRGKRZSA-N,"(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid",Triiodothyronine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,377|485|527|631|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1254|1255|1273|1274|1276|1285|1296|1304|1321|1325|1326|1332|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|144,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|ApexBio Techno",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6030,Uridine-5'-monophosphate,"Uridine 5'-monophosphate|5'-URIDYLIC ACID|Uridylic acid|Uridine monophosphate|58-97-9|uridine-5'-monophosphate|Uridine 5'-phosphate|Uridine phosphate|5'-UMP|Uridine 5'-phosphoric acid|UMP|Uridine 5'-(dihydrogen phosphate)|UMP (nucleic acid)|5'Uridylic acid|uridylate|UNII-E2OU15WN0N|BRN 0047486|CHEBI:16695|E2OU15WN0N|CHEMBL214393|MFCD00067346|U 5'-P|27416-86-0|{[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid|2,4(1H,3H)-pyrimidinedione, 1-(5-O-pho",324.180,C9H13N2O9P,166.000,517.000,-3.600,21,5,9,4,"InChI=1S/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O,DJJCXFVJDGTHFX-XVFCMESISA-N,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",Uridine Monophosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1811|1865|2101|2107|2112|2517|2549|271165|278934|278935|431259|431261|485281|485290|504327|504332|504845|504847|588579|602332|686978|686979|707245|707246|707247|718079|720532|720533|720579|720580|977610|977611|1159524|1347082|1347083|1347085|1347086|1347131|1347154|1370007,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|AstaTech, Inc.|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbos",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6076,Cyclic AMP,"Cyclic AMP|cAMP|60-92-4|Adenosine 3',5'-cyclic monophosphate|3',5'-cyclic AMP|Adenosine 3',5'-cyclophosphate|Adenosine 3',5'-phosphate|cyclic 3',5'-AMP|Adenosine cyclic monophosphate|Adenosine-3',5'-cyclophosphate|cyclic 3',5'-Adenylic acid|Adenosine 3',5'-monophosphate|cyclic Adenosine 3',5'-phosphate|Cyclic adenylic acid|Adenosine 3',5'-cyclic phosphate|Adenosine, cyclic 3',5'-(hydrogen phosphate)|3',5'-AMP|cyclic Adenosine 3',5'-monophosphate|Adenosine cyclic 3',5'-monophosphate|Adenosine cyclic 3',5'-ph",329.210,C10H12N5O6P,155.000,498.000,-2.600,22,3,10,1,"InChI=1S/C10H12N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-6(16)7-4(20-10)1-19-22(17,18)21-7/h2-4,6-7,10,16H,1H2,(H,17,18)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)O,IVOMOUWHDPKRLL-KQYNXXCUSA-N,"(4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol",Cyclic AMP,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,13,422|429|436|547|694|732|880|894|940|1030|1379|1422|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1476|1477|1478|1479|1487|1519|1705|1707|1708|1766|1768|1815|1816|1828|1865|1876|1877|1882|1883|1886|1948|1967|2101|2107|2112|2147|2323|2326|2353|2364|2451|2517|2528|2549|2660|2662|2666|2667|2668|2675|2732|2774|33710|84060|84938|85090|86027|97751|154165|155571|155572|158111|158280|158285|158420|158734|158735|164454|217820|217969|218494|219685|219691|219819|219827|219982|220152|220153|220154|297178|463096|4630,20050608,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|Anward|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6140,Phenylalanine,"L-phenylalanine|phenylalanine|63-91-2|(S)-2-Amino-3-phenylpropanoic acid|3-Phenyl-L-alanine|(S)-Phenylalanine|(2S)-2-amino-3-phenylpropanoic acid|(S)-2-Amino-3-phenylpropionic acid|beta-Phenyl-L-alanine|(L)-Phenylalanine|3-Phenylalanine|H-Phe-OH|Antibiotic FN 1636|L-Alanine, phenyl-|Alanine, 3-phenyl-|L-Antibiotic FN 1636|(S)-alpha-Amino-beta-phenylpropionic acid|L-Alanine, 3-phenyl-|Phenylalanine (VAN)|Fenilalanina [Spanish]|Phenylalaninum [Latin]|(S)-alpha-Aminohydrocinnamic acid|Alanine, phenyl-, L-|(S)-",165.190,C9H11NO2,63.300,153.000,-1.500,12,2,3,3,"InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1",C1=CC=C(C=C1)C[C@@H](C(=O)O)N,COLNVLDHVKWLRT-QMMMGPOBSA-N,(2S)-2-amino-3-phenylpropanoic acid,Phenylalanine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,348|357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|630|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|902|910|912|914|915|923|924|925|926|927|930|938|940|995|1030|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1688|1766|1768|1811|1851|1865|1948|2101|2107|2112|2147|2326|2451|2472|2517|2528|2546|2549|2551|2662|13453|21129|21130|21131|21132|21143|21145|22012|22013|22148|22149|24263|24265,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6267,Asparagine,"L-asparagine|asparagine|70-47-3|H-Asn-OH|(S)-asparagine|Aspartamic acid|agedoite|altheine|Crystal VI|Asparamide|asparagine acid|(S)-2,4-diamino-4-oxobutanoic acid|(-)-asparagine|2-Aminosuccinamic acid|L-Aspartamine|alpha-aminosuccinamic acid|Asparagine, L-|L-2,4-diamino-4-oxobutanoic acid|L-Asparagine anhydrous|L-b-Asparagine|aspartic acid beta-amide|Asparagine (VAN)|(2S)-2-amino-3-carbamoylpropanoic acid|ASN|L-beta-Asparagine (VAN)|2-aminosuccinamic acid, L-|butanoic acid, 2,4-diamino-4-oxo-, (S)-|MFCD0006",132.120,C4H8N2O3,106.000,134.000,-3.400,9,3,4,3,"InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)/t2-/m0/s1",C([C@@H](C(=O)O)N)C(=O)N,DCXYFEDJOCDNAF-REOHCLBHSA-N,"(2S)-2,4-diamino-4-oxobutanoic acid",Asparagine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,14,26797|80832|80836|233320|681113|1117326|1117329|1117336|1117340|1117341|1117342|1117343|1117346|1343125|1343137|1397319|1397320|1397321|1397322|1409598|1425568|1425569|1425571|1425575|1425576|1425577|1425582|1425584,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|An",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6287,Valine,"L-valine|valine|72-18-4|(S)-Valine|H-Val-OH|(S)-2-Amino-3-methylbutanoic acid|2-Amino-3-methylbutyric acid|(2S)-2-amino-3-methylbutanoic acid|(S)-2-Amino-3-methylbutyric acid|L-alpha-Amino-beta-methylbutyric acid|Valinum [Latin]|Valina [Spanish]|Valine (VAN)|Butanoic acid, 2-amino-3-methyl-|Valine [USAN:INN]|L-valin|VALINE, L-|L(+)-alpha-Aminoisovaleric acid|(S)-alpha-Amino-beta-methylbutyric acid|Butanoic acid, 2-amino-3-methyl-, (S)-|2-Amino-3-methylbutyric acid, (S)-|2-Amino-3-methylbutanoic acid, (S)-|L",117.150,C5H11NO2,63.300,90.400,-2.300,8,2,3,2,"InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1",CC(C)[C@@H](C(=O)O)N,KZSNJWFQEVHDMF-BYPYZUCNSA-N,(2S)-2-amino-3-methylbutanoic acid,Valine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,15,1811|26797|51033|224503|233318|266246|266247|266248|266249|447578|681113|695510|722038|722292|722293|722294|722295|722296|722297|722298|722299|722302|722304|722305|722306|722307|722308|722309|722310|722311|722312|722313|722314|722315|722316|722317|722318|722319|722320|722321|722322|722323|722324|722325|722326|722327|722328|722329|722330|722331|977610|1092307|1092308|1092309|1117326|1117329|1117336|1117340|1117341|1117342|1117343|1117346|1259318|1398359|1398360|1398361|1425584|1479145|1479147|1479149|1479150,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6306,l-Isoleucine,"l-isoleucine|Isoleucine|73-32-5|(2S,3S)-2-Amino-3-methylpentanoic acid|(S)-Isoleucine|H-Ile-OH|(S,S)-Isoleucine|2S,3S-Isoleucine|L-(+)-Isoleucine|2-Amino-3-methylvaleric acid|erythro-L-Isoleucine|L-Ile|alpha-Amino-beta-methylvaleric acid|443-79-8|Isoleucine (VAN)|Isoleucinum [Latin]|Isoleucina [Spanish]|Norvaline, 3-methyl-|Valeric acid, 2-amino-3-methyl-|L-Norvaline, 3-methyl-, erythro-|Acetic acid, amino-sec-butyl-|ISOLEUCINE, L-|Pentanoic acid, 2-amino-3-methyl-|CCRIS 5229|iso-leucine|(2S,3S)-alpha-Amino",131.170,C6H13NO2,63.300,103.000,-1.700,9,2,3,3,"InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1",CC[C@H](C)[C@@H](C(=O)O)N,AGPKZVBTJJNPAG-WHFBIAKZSA-N,"(2S,3S)-2-amino-3-methylpentanoic acid",Isoleucine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,14,630741|681113|1259318|1259410|1398359|1398361|1409605|1508614,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Apexmol|Aurora Fine Chemicals L",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
10378,Oxanilic acid,"OXANILIC ACID|500-72-1|Anilino(oxo)acetic acid|Acetic acid, oxo(phenylamino)-|2-anilino-2-oxoacetic acid|N-Phenyloxamic acid|Oxamic acid, phenyl-|Kyselina oxalanilova|NSC 47546|Acetic acid, 2-oxo-2-(phenylamino)-|UNII-136B46378D|2-Oxo-2-(phenylamino)acetic acid|(phenylcarbamoyl)formic acid|CHEMBL3248231|136B46378D|2-Oxidanylidene-2-Phenylazanyl-Ethanoic Acid|Anilino(oxo)acetic acid; Kyselina oxalanilova|oxo(phenylamino)acetic acid|oxanilicacid|Kyselina oxalanilova [Czech]|N-Phenyloxalamic acid|EINECS 207-91",165.150,C8H7NO3,66.400,185.000,0.800,12,2,3,2,"InChI=1S/C8H7NO3/c10-7(8(11)12)9-6-4-2-1-3-5-6/h1-5H,(H,9,10)(H,11,12)",C1=CC=C(C=C1)NC(=O)C(=O)O,PQJZHMCWDKOPQG-UHFFFAOYSA-N,2-anilino-2-oxoacetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Toxicity|Use and Manufacturing,9,155|157|161|165|167|175|1133374|1298930,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Activate Scientific|AKos Consulting & Solutions|Alichem|Alinda Chemical|Angel Pharmatech Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|Chemhere|Chemical Synthesis Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Combi-Blocks|Crystallography Open ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11023,Zinc citrate,"Zinc citrate|546-46-3|Trizinc dicitrate|Citric acid, zinc salt|UNII-K72I3DEX9B|1,2,3-Propanetricarboxylic acid, 2-hydroxy-, zinc salt (2:3)|K72I3DEX9B|trizinc;2-hydroxypropane-1,2,3-tricarboxylate|EINECS 208-901-2|Zinccitrate|Kopcitrate-Zn|CITRIC ACID, ZINC SALT (2:3)|EC 208-901-2|trizinc 2-hydroxypropane-1,2,3-tricarboxylate|2-Hydroxy-1,2,3-propanetricarboxylic acid zinc salt|2-Hydroxy-1,2,3-propanetricarboxylic acid, zinc salt|C12H10O14Zn3|DTXSID90889427|AKOS015918265|DB11154|H262|FT-0658839|trizinc 2-oxi",574.300,C12H10O14Zn3,281.000,211.000,NULL,29,2,14,4,"InChI=1S/2C6H8O7.3Zn/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;;3*+2/p-6",C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Zn+2].[Zn+2].[Zn+2],WGIWBXUNRXCYRA-UHFFFAOYSA-H,"trizinc;2-hydroxypropane-1,2,3-tricarboxylate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,9,NULL,20050808,"3WAY PHARM INC|Aaron Chemicals LLC|ABI Chem|Achemtek|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|AN PharmaTech|Angene Chemical|Aurora Fine Chemicals LLC|BOC Sciences|Chem-Space.com Database|ChemIDplus|ChemMol|ChemSpider|ChemTik|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|EPA Substance Registry Services|FDA/SPL Indexing Data|Finetech Industry Limited|Hairui Chemical|iChemical Technology USA Inc|IS",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11375,3-Aminoquinoline,"3-AMINOQUINOLINE|580-17-6|quinolin-3-amine|3-Quinolinamine|3-Quinolylamine|Quinolin-3-ylamine|3-Quinolineamine|Quinoline, 3-amino-|3-Amino quinoline|UNII-98OVL5K3R4|MFCD00006772|quinolin-3-yl-amine|CHEMBL80298|98OVL5K3R4|3-Aminoquinoline, 99%|CCRIS 1678|NSC 7934|EINECS 209-455-1|BRN 0113317|3-amino-quinoline|4FS|(Quinolin-3-yl)amine|PubChem12769|3-Aminoquinoline, 98%|WLN: T66 BNJ DZ|SCHEMBL14678|5-22-10-00233 (Beilstein Handbook Reference)|BIDD:GT0637|ACMC-209m24|DTXSID8060379|ZINC39224|NSC7934|CHEBI:166512",144.170,C9H8N2,38.900,136.000,1.600,11,1,2,0,"InChI=1S/C9H8N2/c10-8-5-7-3-1-2-4-9(7)11-6-8/h1-6H,10H2",C1=CC=C2C(=C1)C=C(C=N2)N,SVNCRRZKBNSMIV-UHFFFAOYSA-N,quinolin-3-amine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,11,155|157|161|165|167|175|3697|5267|158544|219087|226297|1259407,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|As",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
12035,Acetylcysteine,N-Acetyl-L-cysteine|acetylcysteine|616-91-1|N-Acetylcysteine|mercapturic acid|Acetadote|L-Acetylcysteine|Mucomyst|N-Acetyl-cysteine|Broncholysin|Fluimucil|Parvolex|Fluprowit|Acetein|Airbron|Fabrol|Fluimucetin|Flumucetin|Mucosolvin|Mucosil|Brunac|Fluimicil Infantil|Acetilcisteina|Acetylcysteinum|Lysomucil|Mucofilin|Respaire|Exomuc|Inspir|Ac-Cys-OH|Mucolyticum Lappe|Mucolytikum Lappe|(R)-2-Acetamido-3-mercaptopropanoic acid|Acetyl-L-cysteine|N-Acetyl cysteine|Mucolyticum|LNAC|N-Acetyl-3-mercaptoalanine|N-Acet,163.200,C5H9NO3S,67.400,148.000,0.400,10,3,4,3,"InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1",CC(=O)N[C@@H](CS)C(=O)O,PWKSKIMOESPYIA-BYPYZUCNSA-N,(2R)-2-acetamido-3-sulfanylpropanoic acid,Acetylcysteine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|461|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|639|641|645|648|680|684|686|687|694|701|708|709|719|731|732|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|793|795|,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
14992,Clonitralid,Niclosamide-olamine|1420-04-8|Clonitralid|Niclosamide ethanolamine salt|Niclosamidel|Bayluscide|CLONITRALIDE|5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide compound with 2-aminoethanol (1:1)|UNII-QT8YUD1Z0W|Niclosamide (olamine)|5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide 2-aminoethanol salt|QT8YUD1Z0W|SR 73|5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide compd. with 2-aminoethanol (1:1)|Mollutox|Baylucit|Phenasal ethanolamine salt|Caswell No. 314|Molluscicide bayer 73|Bay 73|Bayer,388.200,C15H15Cl2N3O5,141.000,414.000,NULL,25,4,6,3,"InChI=1S/C13H8Cl2N2O4.C2H7NO/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15;3-1-2-4/h1-6,18H,(H,16,19);4H,1-3H2",C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O.C(CO)N,XYCDHXSQODHSLG-UHFFFAOYSA-N,2-aminoethanol;5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide,Niclosamide,Agrochemical Information|Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,13,1189|1199|1205|1208|1259411|1294185|1294186,20050808,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Ark Pharm, Inc.|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChEMBL|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|CSNpharm|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16623,Hydrocortisone hemisuccinate,"hydrocortisone hemisuccinate|Hydrocortisone succinate|Cortisol succinate|Hydrocortisone 21-hemisuccinate|2203-97-6|Cortisol hemisuccinate|Cortisol 21-hemisuccinate|Solu-Cortef|Hydrocortisone hydrogen succinate|CHEBI:31677|UNII-IHV1VP592V|IHV1VP592V|MLS000028530|NSC-7576|Buccalsone|Flebocortid|Solucortef|Arcocort|Hycorace|Intracort|Nordicort|Oralsone|Corlan|Emi-Corlin|Solu-Hizon|Solu-Glyc|SMR000058328|ST075193|11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione 21-succinate|EF-Cortelan soluble|4-[2-[(8S,9S,10",462.500,C25H34O8,138.000,908.000,1.800,33,3,8,7,"InChI=1S/C25H34O8/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30)/t16-,17-,18-,22+,23-,24-,25-/m0/s1",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)O)O)C)O,VWQWXZAWFPZJDA-CGVGKPPMSA-N,"4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|680|684|686|687|701|708|709|719|731|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|793|795|797|,20050624,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Aceschem Inc|Acorn PharmaTech Product List|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|AN PharmaTech|Aurora Fine Chemicals LLC|AvaChem Scientific|BePharm Ltd.|BindingDB|Biosynth Carbosynth|BOC Sciences|C. David Weaver Laboratory, Vanderbilt University|CCSbase|Center for Chemical Genomics, Univer",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16842,N-Ethylsuccinimide,"N-Ethylsuccinimide|2314-78-5|1-ethylpyrrolidine-2,5-dione|2,5-Pyrrolidinedione, 1-ethyl-|1-ETHYL-PYRROLIDINE-2,5-DIONE|Succinimide, N-ethyl-|n-ethyl-succinimide|UNII-MC084H847A|MC084H847A|ethylsuccinimide|succinimide, N-ethyl|2, 1-ethyl-|ACMC-1CN4U|SCHEMBL435413|CHEBI:44348|GHAZCVNUKKZTLG-UHFFFAOYSA-|DTXSID10177712|1-Ethyl-2,5-pyrrolidinedione #|NSC38693|ZINC1670837|ANW-25064|MFCD00059748|NSC 38693|NSC-38693|AKOS002845658|DB01902|AS-47864|E0175|FT-0758747|Q27093016",127.140,C6H9NO2,37.400,137.000,-0.500,9,0,2,1,"InChI=1S/C6H9NO2/c1-2-7-5(8)3-4-6(7)9/h2-4H2,1H3",CCN1C(=O)CCC1=O,GHAZCVNUKKZTLG-UHFFFAOYSA-N,"1-ethylpyrrolidine-2,5-dione",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Ambeed|Anward|Aurora Fine Chemicals LLC|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Combi-Blocks|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
16923,Methylprednisolone hemisuccinate,"METHYLPREDNISOLONE HEMISUCCINATE|2921-57-5|Methylprednisolone succinate|Methylprednisolone Hemisuccinate [USP]|UNII-5GMR90S4KN|4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid|Methylprednisolone hydrogen hemisuccinate|5GMR90S4KN|6alpha-Methylprednisolone hemisuccinate|Methylprednisolone hydrogen succinate|Methylprednisolone hemisuccinate (USP)|NCGC00185763-01|EINECS 220-863-9|EC 220-",474.500,C26H34O8,138.000,981.000,2.200,34,3,8,7,"InChI=1S/C26H34O8/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31)/t14-,16-,17-,19-,23+,24-,25-,26-/m0/s1",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O,IMBXEJJVJRTNOW-XYMSELFBSA-N,"4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid",Methylprednisolone Hemisuccinate,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,9,588214|588215|588216|588217|588218|588219|602332|624030|624170|624172|624173|1479145|1479147|1479149|1479150,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|AvaChem Scientific|BePharm Ltd.|BioCrick|Biosynth Carbosynth|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
20543,Pleo zinc,"Pleo zinc|Zinc gluconate [USP]|UNII-U6WSN5SQ1Z|U6WSN5SQ1Z|Zinkgluconaat|4468-02-4|MFCD00868110|Rubozine|bis((2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoyloxy)zinc|gluconate zinc|Helshas Zn|Zinc Verla|Bis(D-gluconato-O1,O2)zinc|Givobio G Zn|BioZn-AAS|Zinc Gluconate,(S)|Zinc D-gluconate (1:2)|D-Gluconic acid, zinc complex|Gluconic acid zinc (II) salt|Bis(D-gluconato-O1,O2) zinc|Zinc bis(D-gluconato-O1,O2)|HSDB 1054|D-Gluconic acid zinc (II) salt|Zinc, bis(D-gluconato-O1,O2)-|EINECS 224-736-9|Bis(D-gluconato-O(s",457.700,C12H24O14Zn,277.000,385.000,NULL,27,12,14,10,"InChI=1S/2C6H12O7.Zn/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/t2*2-,3-,4+,5-;/m11./s1",C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)O)O)O)O)O)O.[Zn],ZSKINHGFQOKUDM-IYEMJOQQSA-N,"(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid;zinc",NULL,Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20050808,3B Scientific (Wuhan) Corp|Alfa Chemistry|Aurora Fine Chemicals LLC|BOC Sciences|ChemIDplus|ChemSpider|Glentham Life Sciences Ltd.|NextBio|Springer Nature|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
23954,Silver,"7440-22-4|Ag|Silver|Argentum|Silver metal|Colloidal silver|Silver, colloidal|Silver, elemental|Silber|Silver nanoparticles|Lead refinery silver bullion|Silver nanowires|UNII-3M4G523W1G|CI 77820|C.I. 77820|Silver needles|Silver powder|Silver flake|Silver foil|Silver shot|Silver wire|Silver, metal|Silver on alumina|3M4G523W1G|Lead refinery silver|Silver, bullion|Caswell No. 735|argent|plata|SILVER COMPOUNDS|Silver Nanowire|Silver Granufoam|Silver nanowires (stored in ethanol)|Metz 3000-1|Silver and compounds|",107.868,Ag,0.000,0.000,NULL,1,0,0,0,InChI=1S/Ag,[Ag],BQCADISMDOOEFD-UHFFFAOYSA-N,silver,NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,15,1259407,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AmicB",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
26879,Levamisole,"levamisole|14769-73-4|Levamisol|L-Tetramisole|Wormicid|Lepuron|LEVOMYSOL|(S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole|Ergamisol|Levamisolum|Levamisol [INN-Spanish]|Levamisolum [INN-Latin]|Ketrax|(-)-Tetramisole|(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole|TCMDC-125847|(S)-(-)-Levamisole|Vermisol 150|dl-Tetramisole|L-tetramisol|UNII-2880D3468G|(6S)-6-phenyl-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole|CHEMBL1454|CHEBI:6432|Levotetramisole|Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl",204.290,C11H12N2S,40.900,246.000,1.800,14,0,2,1,"InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1",C1CSC2=N[C@H](CN21)C3=CC=CC=C3,HLFSDGLLUJUHTE-SNVBAGLBSA-N,"(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole",Levamisole,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,402|406|1195|1332|2240|2241|2275|2297|2302|2303|2304|2305|2306|2313|2322|2330|2660|2666|2667|2668|110748|116162|116163|116164|116165|116166|116167|116168|116169|116170|116171|116172|116173|116174|116175|116176|116177|116718|116719|117835|117836|117837|117838|117839|117840|117841|117842|117843|117844|117845|117846|117847|117848|117849|117850|117851|117852|136619|136620|136622|136623|136625|136627|147181|147183|147184|147185|171880|171883|171889|172190|172194|173995|173997|173999|182858|182860|182981|191934|2,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Assembly Blocks Pvt. Ltd.|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
29852,1-Isopropyl-3-phenylurea,"1-ISOPROPYL-3-PHENYLUREA|19895-44-4|1-phenyl-3-propan-2-ylurea|UNII-B1675C5R46|1-phenyl-3-(propan-2-yl)urea|Urea, N-(1-methylethyl)-N'-phenyl-|N-phenyl-N'-propan-2-ylurea|N-(1-methylethyl)-N'-phenyl-urea|B1675C5R46|[(methylethyl)amino]-N-benzamide|1-phenyl-3-i-propylurea|SCHEMBL2625563|DTXSID2074744|ZINC396199|SBB056571|Urea,N-(1-methylethyl)-N'-phenyl-|AKOS003440900|MCULE-9091264534|NE22078|ST50549357|Q27274240|XY4",178.230,C10H14N2O,41.100,162.000,1.900,13,2,1,2,"InChI=1S/C10H14N2O/c1-8(2)11-10(13)12-9-6-4-3-5-7-9/h3-8H,1-2H3,(H2,11,12,13)",CC(C)NC(=O)NC1=CC=CC=C1,CIBUQXSYGPGEGX-UHFFFAOYSA-N,1-phenyl-3-propan-2-ylurea,NULL,Agrochemical Information|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,9,NULL,20050327,"ABI Chem|AKos Consulting & Solutions|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBio|NextMove Software|NIST Chemistry WebBook|NORMAN Suspect List Exchange|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in E",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
31390,Sulfabenz,"4-Amino-N-phenylbenzenesulfonamide|Sulfabenz|127-77-5|Benzenesulfonamide, 4-amino-N-phenyl-|4-Amino-N-phenyl-benzenesulfonamide|SULFANILANILIDE|Sulfa Vet|Eastman-4770|p-Aminobenzenesulfonanilide|4-Aminobenzenesulfonanilide|N(sup1)-Phenylsulfanilamide|4-amino-N-phenylbenzene-1-sulfonamide|UNII-2Y70F6K03F|p-Amino-N-phenylbenzenesulfonamide|NSC2619|2Y70F6K03F|NSC-2619|[(4-aminophenyl)sulfonyl]phenylamine|NCGC00160668-01|DSSTox_CID_26287|DSSTox_RID_81513|DSSTox_GSID_46287|Solfabenzo|Sulfabenzo|Sulfabenzum|CAS-1",248.300,C12H12N2O2S,80.600,323.000,1.600,17,2,4,3,"InChI=1S/C12H12N2O2S/c13-10-6-8-12(9-7-10)17(15,16)14-11-4-2-1-3-5-11/h1-9,14H,13H2",C1=CC=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)N,YBUXKQSCKVQATK-UHFFFAOYSA-N,4-amino-N-phenylbenzenesulfonamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing|Biological Test Results: Micromolar,10,155|157|161|165|167|175|179|1469|1471|1479|1490|1688|1766|1768|2528|2546|2551|2662|236594|284322|284323|408742|485290|485350|485395|492961|493033|504327|504332|504749|504770|504832|504834|504847|504865|540299|588519|588579|588834|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720641|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|72,20050326,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|Ark Pharma Scientific Limited|Aronis|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|BLD Pharm|BroadPharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
33887,Almitrine,"ALMITRINE|27469-53-0|Almitrina|Almitrinum|Almitrine dimesilate|UNII-9A1222NBG4|Almitrin|2,4-Bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine|CHEBI:53778|9A1222NBG4|6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine|Almitrine [INN:BAN]|Almitrinum [INN-Latin]|Almitrina [INN-Spanish]|Almitrine (INN)|C26H29F2N7|EINECS 248-475-5|S 2620|6-(4-(Bis(4-fluorphenyl)methyl)-1-piperazinyl)-N,N'-di-2-propenyl-1,3,5-triazin-2,4-diamin|1,3,5-Triazin",477.600,C26H29F2N7,69.200,602.000,5.600,35,2,9,10,"InChI=1S/C26H29F2N7/c1-3-13-29-24-31-25(30-14-4-2)33-26(32-24)35-17-15-34(16-18-35)23(19-5-9-21(27)10-6-19)20-7-11-22(28)12-8-20/h3-12,23H,1-2,13-18H2,(H2,29,30,31,32,33)",C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C,OBDOVFRMEYHSQB-UHFFFAOYSA-N,"6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine",Almitrine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,9,567091|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1259416|1259421|1409605,20050808,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|AvaChem Scientific|BioChemPartner|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|CAPOT|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
36462,Etoposide,"etoposide|33419-42-0|VePesid|Toposar|trans-Etoposide|Lastet|(-)-Etoposide|Zuyeyidal|Etoposido|Etoposidum|Etoposidum [INN-Latin]|VP-16|Etoposide (VP16)|VP 16-213|Vepesid J|VP-16-213|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|UNII-6PLQ3CP4P3|NSC-141540|VP 16 (pharmaceutical)|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|VP 16|6PLQ3CP4P3|Epipodophyllotoxin VP-16213|CHEMBL44657|CHEBI:4911|NK 171|Demethylepipodophyllotoxin-beta-D-ethylideneglucoside|NSC 141540|4'-Deme",588.600,C29H32O13,161.000,969.000,0.600,42,3,13,5,"InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1",C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,VJJPUSNTGOMMGY-MRVIYFEKSA-N,"(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one",Etoposide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1332|1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2240|2241|2247|2275|2280|2300|2313|2322|2330|2380|2391|2435|2445|2462|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|7222|7900|8459|8471|8624|8677|86,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BindingDB|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|C. David Weaver Laboratory, Vanderbilt University|Center for Chemical Genom",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
39859,Albuterol sulfate,ALBUTEROL SULFATE|Salbutamol sulfate|51022-70-9|Salbutamol hemisulfate|Albuterol hemisulfate|Proventil-HFA|Ventolin|Ventolin Rotacaps|Sch 13949W sulfate|VoSpire ER|AccuNeb|Albuterol sulfate(2:1)|Salbutamol hemisulfate salt|36519-31-0|Bronchospray|Aerotec|Aloprol|Amocasin|Broncodil|Dipulmin|Fartolin|Inspiryl|Venetlin|Emican|Loftan|Proventil (TN)|Epaq|Broncho Inhalat|Huma-Salmol|Ventolin HFA|4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfuric acid|dl-Salbutamol sulfate|ProAir|(+-)-Salbutam,576.700,C26H44N2O10S,228.000,309.000,NULL,39,10,12,10,"InChI=1S/2C13H21NO3.H2O4S/c2*1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;1-5(2,3)4/h2*4-6,12,14-17H,7-8H2,1-3H3;(H2,1,2,3,4)",CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O,BNPSSFBOAGDEEL-UHFFFAOYSA-N,4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;sulfuric acid,Albuterol,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Micromolar,11,422|429|436|547|694|732|880|894|940|1030|1379|1422|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1476|1477|1478|1479|1487|1519|1705|1707|1708|1766|1768|1815|1816|1828|1865|1876|1877|1882|1883|1886|1948|1967|2101|2107|2112|2147|2323|2326|2353|2364|2451|2517|2528|2549|2662|2675|2732|2774|463096|463097|463189|485290|485314|488745|488752|488949|488979|488980|493127|493189|504332|504364|504821|540256|540276|588453|588590|588591|588834|651828|687035|687037|1159580|1224818|1224819|1224820|1224821|1224822|12248,20050624,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Achemtek|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Angene Chemical|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BioCrick|BOC Sciences|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFish Tokyo co.,ltd|chemical genetic matrix|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Circadian Rese",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
40000,Dexbudesonide,"Dexbudesonide|UNII-2HI1006KPH|51372-29-3|Pulmicort|51333-22-3|(22R)-Budesonide|2HI1006KPH|DSSTox_CID_202|DSSTox_RID_75430|DSSTox_GSID_20202|R-Budesonide|(1~{s},2~{s},4~{r},6~{r},8~{s},9~{s},11~{s},12~{s},13~{r})-9,13-Dimethyl-11-Oxidanyl-8-(2-Oxidanylethanoyl)-6-Propyl-5,7-Dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-Dien-16-One|Dexbudesonide [INN]|Budesonide-22R|NCGC00016862-01|EINECS 257-161-7|CAS-51333-22-3|BUDESONIDE (11beta,16alpha(R))|SCHEMBL4095|CHEMBL2110662|DTXSID401017799|ZINC39387",430.500,C25H34O6,93.100,862.000,2.500,31,2,6,4,"InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21+,22+,23-,24-,25+/m0/s1",CCC[C@@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,VOVIALXJUBGFJZ-VXKMTNQYSA-N,"(1S,2S,4R,6R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",Budesonide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1189|1195|1208|2517|588834|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|74,20050808,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|ABBLIS Chemicals|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|AN PharmaTech|BioChemPartner|BioCrick|BOC Sciences|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Da",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
51966,"2,2-Dimethyl-4-(chloromethyl)-1,3-dioxa-2-silacyclopentane","73639-62-0|4-(chloromethyl)-2,2-dimethyl-1,3,2-dioxasilolane|2,2-Dimethyl-4-(chloromethyl)-1,3-dioxa-2-silacyclopentane|SOC organosilicone|4-(Chloromethyl)-2,2-dimethyl-1,3-dioxa-2-silacyclopentane|SOC|DTXSID70994447|1,3-DIOXA-2-SILACYCLOPENTANE, 4-(CHLOROMETHYL)-2,2-DIMETHYL-|AKOS006278216",166.680,C5H11ClO2Si,18.500,107.000,NULL,9,0,2,1,"InChI=1S/C5H11ClO2Si/c1-9(2)7-4-5(3-6)8-9/h5H,3-4H2,1-2H3",C[Si]1(OCC(O1)CCl)C,RQKYYWBMXHYBAP-UHFFFAOYSA-N,"4-(chloromethyl)-2,2-dimethyl-1,3,2-dioxasilolane",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Toxicity,5,NULL,20050808,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambinter|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|DiscoveryGate|EPA DSSTox|LeadScope|NextBio|NovoSeek|Smolecule|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
60606,Clopidogrel,"clopidogrel|113665-84-2|(S)-Clopidogrel|Plavix|(+)-Clopidogrel|CLOPIDOGREL SULFATE|(+)-(S)-Clopidogrel|UNII-A74586SNO7|SR 25990|CHEBI:37941|A74586SNO7|R 130964|(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate|Zyllt|Clopidogrel (TN)|Plavix (TN)|SR-25990C|methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate|Thrombo|Clopidogrel [INN:BAN]|120202-66-6|Clopidogrel BMS|Clopidogrel Acino|Clopidogrel Hexal|CHEMBL1083385|methyl (2S)-2-(2-chlorophenyl)-2-{4H,",321.800,C16H16ClNO2S,57.800,381.000,3.800,21,0,4,4,"InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1",COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,GKTWGGQPFAXNFI-HNNXBMFYSA-N,"methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate",Clopidogrel,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1195|1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1621|1631|1634|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1979|1984|1986|1987|1996|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|20,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
60846,Valsartan,"valsartan|137862-53-4|Diovan|Tareg|CGP 48933|Provas|CGP-48933|Exforge|(S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid|UNII-80M03YXJ7I|MFCD00865840|N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|137863-60-6|CHEMBL1069|(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid|80M03YXJ7I|CHEBI:9927|(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid|L-Valine, N-(1-oxopentyl)-N-[[2'-",435.500,C24H29N5O3,112.000,608.000,4.400,32,2,6,10,"InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1",CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O,ACWBQPMHZXGDFX-QFIPXVFZSA-N,(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid,Valsartan,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|880|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1466|1467|1468|1469|1477|1479|1481|1486|1487|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|16,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alomone Labs|Alsachim|Ambeed|Ambinte",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
60947,Tirofiban,"tirofiban|144494-65-5|Aggrastat|MK-383|N-(Butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine|UNII-GGX234SI5H|Tirofiban HCl|(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid|(S)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid|N-(BUTYLSULFONYL)-O-[4-(4-PIPERIDINYL)BUTYL]-L-TYROSINE|GGX234SI5H|N-(butylsulfonyl)-O-(4-piperidin-4-ylbutyl)-L-tyrosine|CHEBI:9605|L-700462|L700462;MK383|Tirofiban [INN:BAN]|tirofibanum|L-Tyrosine, N-(butylsulfonyl)-O-(4-(4-piperi",440.600,C22H36N2O5S,113.000,579.000,1.400,30,3,7,14,"InChI=1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1",CCCCS(=O)(=O)N[C@@H](CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,COKMIXFXJJXBQG-NRFANRHFSA-N,(2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid,Tirofiban,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,24332|32990|73143|73144|73151|73156|84810|84811|84812|84830|92833|93006|93041|93153|161599|161600|217295|217306|220877|220879|220881|220882|220887|221747|222789|225586|233840|425652|425653|540209|540210|540211|540212|540213|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|645256|649223|649224|649225|730659|730660|730661|753175|753176|753177|753178|761290|761291|1069980|1159175|1159180|1250220|1250225|1250228|1251257|1251258|1251259|1251260|1251263|1259416|125,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alsachim|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aur",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
62881,Deferoxamine mesylate,Deferoxamine mesylate|138-14-7|Desferrioxamine B mesylate|Desferal|Deferoxamine mesilate|Desferrioxamine mesylate|Deferoxamine B mesylate|Deferoxamine (mesylate)|Deferoxamine methanesulfonate|Desferal mesylate|UNII-V9TKO7EO6K|Desferioxamine mesylate|V9TKO7EO6K|DESFERRIOXAMINE MESILATE|MLS000028713|Desferrioxamine B mesylate;DFOM|MFCD00058605|NCGC00017021-01|CAS-138-14-7|Desferal (TN)|Deferoxamine-D8 mesylate|Deferoxamine mesylate salt|DSSTox_CID_17649|DSSTox_RID_79351|DSSTox_GSID_37649|N-[5-[[4-[5-[acetyl(h,656.800,C26H52N6O11S,269.000,832.000,NULL,44,7,12,23,"InChI=1S/C25H48N6O8.CH4O3S/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26;1-5(2,3)4/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34);1H3,(H,2,3,4)",CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O,IDDIJAWJANBQLJ-UHFFFAOYSA-N,N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid,Deferoxamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,155|157|161|165|167|175|179|357|377|410|411|444|445|446|447|448|450|451|485|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|631|662|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|875|878|880|881|883|884|885|886|887|889|891|892|893|894|898|899|900|901|902|910|912|914|915|920|923|924|925|926|927|930|932|938|940|950|951|952|995|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|,20050326,"001Chemical|3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acros Organics|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|BioChemPartner|BioCyc|BLD Pharm|BOC Sciences|Boerchem|Calbiochem|CCSbase|Center for Chemical Genomics, University of Mi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
64927,Chloroquine phosphate,"Chloroquine diphosphate|Chloroquine phosphate|50-63-5|Aralen phosphate|Chloroquine bis(phosphate)|Arechin|Delagil|Chloroquine diphosphate salt|Chloroquine (phosphate)|Chingamin phosphate|Khingamin|Miniquine|Tanakan|Tanakene|Aralen diphosphate|Gontochin phosphate|Chloroquin diphosphate|NSC 14050|Ipsen 225|N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine bis(phosphate)|MFCD00069852|1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2)|3377 RP|50-63-5 (DIPHOSPHATE)|SN 7,618|",515.900,C18H32ClN3O8P2,184.000,359.000,NULL,32,7,11,8,"InChI=1S/C18H26ClN3.2H3O4P/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18;2*1-5(2,3)4/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21);2*(H3,1,2,3,4)",CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,QKICWELGRMTQCR-UHFFFAOYSA-N,"4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;phosphoric acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,377|422|429|436|547|694|732|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1705|1707|1708|1766|1768|1815|1816|1828|1865|1876|1877|1882|1883|1886|1948|1967|2101|2107|2112|2147|2323|2326|2353|2364|2451|2472|251,20050624,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Accela ChemBio Inc.|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|Ambeed|AN PharmaTech|Anward|Ark Pharm, Inc.|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Boerchem|CCSbase|Center for Chemical Genomics, University of Michigan|Chem-Sp",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
65482,Sinefungin,"sinefungin|58944-73-3|ADENOSYL-ORNITHINE|Antibiotic A 9145|Sinefungina|Sinefungine|Sinefunginum|Compound 57926|A 9145|UNII-W2U467CIIL|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxydecofuranuronic acid|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-beta-D-ribo-decofuranuronic acid|W2U467CIIL|CHEBI:45453|(2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid|(2S,5S)-2,5-diamino-6-[(2R,3S,R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydr",381.390,C15H23N7O5,209.000,529.000,-4.300,27,6,11,7,"InChI=1S/C15H23N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h4-8,10-11,14,23-24H,1-3,16-17H2,(H,25,26)(H2,18,19,20)/t6-,7-,8+,10+,11+,14+/m0/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)C[C@H](CC[C@@H](C(=O)O)N)N)O)O)N,LMXOHSDXUQEUSF-YECHIGJVSA-N,"(2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,11,1811|96105|164155|164156|476872|476874|496828|772713|772725|772726|772727|977610|977611|1137571|1137572|1179566|1226489|1259389|1259416|1259418|1259420|1259421|1347142|1347144|1347145|1347149|1347150|1347151|1347155|1347167|1347168|1347169|1390742|1408347|1408348|1409598|1461876|1461877|1461878|1461879|1461881|1461882|1461884|1461885,20050624,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|Ambinter|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|BioChemPartner|BLD Pharm|Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|Chemical Probes Portal|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Creative Biolabs|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
66898,2-[N-Cyclohexylamino]ethane sulfonic acid,"103-47-9|N-Cyclohexyltaurine|CHES|2-(Cyclohexylamino)ethanesulfonic acid|Ethanesulfonic acid, 2-(cyclohexylamino)-|2-Cyclohexylaminoethanesulfonic Acid|2-(N-Cyclohexylamino)ethanesulfonic acid|MFCD00003835|2-(cyclohexylamino)ethane-1-sulfonic acid|UNII-71X53V3RZ1|2-(Cyclohexylamino)ethanesulphonic acid|N-Cyclohexyl-2-aminoethanesulfonic acid|2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID|Taurine, N-cyclohexyl-|2-(Cyclohexylamino)Ethane Sulphonic Acid|71X53V3RZ1|CHES, 98+%, for biochemistry|NHE|EINECS 203-115-6|N",207.290,C8H17NO3S,74.800,226.000,-1.200,13,2,4,4,"InChI=1S/C8H17NO3S/c10-13(11,12)7-6-9-8-4-2-1-3-5-8/h8-9H,1-7H2,(H,10,11,12)",C1CCC(CC1)NCCS(=O)(=O)O,MKWKNSIESPFAQN-UHFFFAOYSA-N,2-(cyclohexylamino)ethanesulfonic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing,9,155|157|161|165|167|175|1259310|1259374|1259422|1347080|1508586,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|BePharm Ltd.|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CAPOT|ChEBI|Chem-Space.com Da",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
70931,"2,5,8,11,14,17-Hexaoxaoctadecane","2,5,8,11,14,17-Hexaoxaoctadecane|1191-87-3|pentaglyme|Pentaethyleneglycol dimethyl ether|1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE|1,14-dimethoxy-3,6,9,12-tetraoxa-tetradecane|1-methoxy-2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethane|EINECS 214-743-5|SCHEMBL124091|CHEBI:44934|DTXSID80152319|ZINC4530388|2,8,11,14,17-Hexaoxaoctadecane|MFCD00055429|NSC244990|AKOS025396478|DB02580|NSC 244990|NSC-244990|Q27093554",266.330,C12H26O6,55.400,129.000,-0.800,18,0,6,15,"InChI=1S/C12H26O6/c1-13-3-5-15-7-9-17-11-12-18-10-8-16-6-4-14-2/h3-12H2,1-2H3",COCCOCCOCCOCCOCCOC,DMDPGPKXQDIQQG-UHFFFAOYSA-N,1-methoxy-2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethane,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents,7,248,20050326,"001Chemical|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alichem|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Biocore|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChemDB|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Crystallography Open Database|DiscoveryGate|DrugBank|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Elsa Biotechnolo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
71616,Voriconazole,"Voriconazole|137234-62-9|Vfend|(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol|UK-109496|UK 109496|UK-109,496|UNII-JFU09I87TR|(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol|C16H14F3N5O|(+/-)-Voriconazole|VCZ|CHEMBL638|JFU09I87TR|CPD000466350|(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol|CHEBI:10023|(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-b",349.310,C16H14F3N5O,76.700,448.000,1.500,25,1,8,5,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,BCEHBSKCWLPMDN-MGPLVRAMSA-N,"(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol",Voriconazole,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|880|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1359|1362|1376|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1466|1467|1468|1469|1477|1479|1481|1486|1490|1496|1509|1510|1515|1527|1529|1530|1531|1532|1533|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1665|1700|1706|1721|1722|1,20050624,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Ambinter|AmicBase - Antimicrobial Activities|AN PharmaTech|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
73115,Clevudine,"Clevudine|163252-36-6|L-FMAU|Levovir|1-((2S,3R,4S,5S)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione|UNII-IN51MVP5F1|Clevudine (Levovir)|IN51MVP5F1|1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)thymine|2'-Fluoro-5-methyl-beta-L-arabinofuranosyluracil|MFCD00935785|Clevudine [USAN:INN]|Revovir|Clevudine (USAN)|Clevudine (Form 2)|PubChem23138|1-(2-Deoxy-2-fluoro-ss-L-arabinofuranosyl)-5-methyl-2,4-(1H,3H)-pyrimidinedione|MLS006011168|SCHEMBL233494|CHEMBL458875|ZINC1",260.220,C10H13FN2O5,99.100,413.000,-0.900,18,3,6,2,"InChI=1S/C10H13FN2O5/c1-4-2-13(10(17)12-8(4)16)9-6(11)7(15)5(3-14)18-9/h2,5-7,9,14-15H,3H2,1H3,(H,12,16,17)/t5-,6+,7-,9-/m0/s1",CC1=CN(C(=O)NC1=O)[C@@H]2[C@@H]([C@H]([C@@H](O2)CO)O)F,GBBJCSTXCAQSSJ-XQXXSGGOSA-N,"1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,369218|498380|498381|498383|498384|498385|498386|498387|498388|498389|498390|498391|498392|498393|498394|498395|498396|498397|498398|498399|498400|498401|498402|498403|498404|498405|498406|1254743|1259398|1259399|1259423|1409605,20050801,"A&J Pharmtech CO., LTD.|AAA Chemistry|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|AN PharmaTech|Anward|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|BioCrick|BLD Pharm|BOC Sciences|Boerchem|CAPOT|Center for Chemical Genomics, University of Michigan|ChangChem|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Lt",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
74655,4-Acetylphenoxyacetic acid,"4-Acetylphenoxyacetic acid|1878-81-5|2-(4-acetylphenoxy)acetic acid|(4-Acetylphenoxy)acetic Acid|(p-Acetylphenoxy)acetic acid|CHEMBL84623|(4-Acetyl-phenoxy)-acetic acid|Acetic acid, (4-acetylphenoxy)-|MFCD00014363|Acetic acid, 2-(4-acetylphenoxy)-|Acetic acid,2-(4-acetylphenoxy)-|EINECS 217-524-2|AI3-15464|4-acetylphenoxy acetic acid|ACMC-1CH47|SCHEMBL459533|(4-Acetylphenyloxy)acetic acid|DTXSID60172090|NSC9356|4-Acetylphenoxyacetic acid, 99%|ZINC115002|NSC 9356|NSC-9356|5656AF|ANW-23366|BDBM50145807|SBB063",194.180,C10H10O4,63.600,216.000,0.900,14,1,4,4,"InChI=1S/C10H10O4/c1-7(11)8-2-4-9(5-3-8)14-6-10(12)13/h2-5H,6H2,1H3,(H,12,13)",CC(=O)C1=CC=C(C=C1)OCC(=O)O,KMXZEXUYXUMHEQ-UHFFFAOYSA-N,2-(4-acetylphenoxy)acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,8,155|157|161|165|167|175|248|146231,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Achemica|Achemo Scientific Limited|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
74833,N-[(4-Sulfamoylphenyl)methyl]acetamide,"2015-14-7|N-[(4-sulfamoylphenyl)methyl]acetamide|N-[4-(aminosulfonyl)benzyl]acetamide|n-(4-sulfamoylbenzyl)acetamide|Acetamide, N-[[4-(aminosulfonyl)phenyl]methyl]-|N-((4-(Aminosulphonyl)phenyl)methyl)acetamide|Acetamide, N-(p-sulfamoylbenzyl)-|NSC29831|T0S|EINECS 217-942-5|N4-Acetylhomosulfanilamide|Oprea1_556804|CBDivE_009616|CHEMBL72962|SCHEMBL635110|DTXSID50173975|p-acetaminomethylbenzenesulfonamide|4-Acetamidomethylbenzenesulfonamide|HMS1749C02|ZINC1655993|NSC 29831|NSC-29831|AKOS000138767|MCULE-234420",228.270,C9H12N2O3S,97.600,313.000,-0.400,15,2,4,3,"InChI=1S/C9H12N2O3S/c1-7(12)11-6-8-2-4-9(5-3-8)15(10,13)14/h2-5H,6H2,1H3,(H,11,12)(H2,10,13,14)",CC(=O)NCC1=CC=C(C=C1)S(=O)(=O)N,AHQONKCJXWTTOW-UHFFFAOYSA-N,N-[(4-sulfamoylphenyl)methyl]acetamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,25623|485350|485395|493033|504770|540299|588519|720641|1259310|1259374|1259422,20050326,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|AKos Consulting & Solutions|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|DiscoveryGate|DTP/NCI|Enamine|eNovation Chemicals|EPA DSSTox|Google Patents|Hairui Chemical|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|iChemical Technology USA Inc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
86554,1-Palmitoylphosphatidylcholine,"1-Palmitoyl-rac-glycero-3-phosphocholine|17364-18-0|1-Palmitoylphosphatidylcholine|Lysolecithin|DL-gamma-Palmitoyl-alpha-lysolecithin|PC(16:0/0:0)[rac]|14863-27-5|Palmitoyllysolectithin|3-Palmitoyl-rac-glycerol-1-phosphorylcholine|(3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate|1-Palmitoyllysolecithin|LPC(16:0)|Palmitoyl lysophosphatidyl choline|We 201|alpha-(beta-Palmitoyl)-lysolecithin|LPC 16:0|EINECS 241-396-7|4,7-Dihydroxy-N,N,N-trimethyl-10-oxo-3,5,9-trioxa-4-phosphapentacosan",495.600,C24H50NO7P,105.000,517.000,5.600,33,1,7,24,"InChI=1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3",CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O,ASWBNKHCZGQVJV-UHFFFAOYSA-N,(3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Toxicity|Use and Manufacturing,8,NULL,20050808,"001Chemical|A2B Chem|AA BLOCKS|AAA Chemistry|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|Biocore|Biosynth Carbosynth|BOC Sciences|CCSbase|Chem-Space.com Database|Chembase.cn|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Finetech Industry Limited|Google Patents|LeadScope|LEAPCHEM|LIPID MAPS|MassBank Europe|MassBank of North America (MoNA)|Mcule|MetabolomicsWorkbench|MolCore BioPharmatech|Mo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
89594,Nicotine,nicotine|L-Nicotine|54-11-5|(-)-Nicotine|(S)-Nicotine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|Habitrol|(S)-(-)-Nicotine|Nicoderm|Nicotrol|3-[(2S)-1-methylpyrrolidin-2-yl]pyridine|Fumetobac|Nicotine polacrilex|Flux MAAG|Ortho N-4 dust|Ortho N-5 dust|XL All Insecticide|Niagara P.A. dust|Nicorette|Nicotina|Nikotyna|Destruxol orchid spray|3-(N-Methylpyrollidino)pyridine|3-(N-Methylpyrrolidino)pyridine|L-3-(1-Methyl-2-pyrrolidyl)pyridine|L(-)-nicotine|(-)-3-(1-Methyl-2-pyrrolidyl)pyridine|Ortho N-4 and N-5 dusts,162.230,C10H14N2,16.100,147.000,1.200,12,0,2,1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",CN1CCC[C@H]1C2=CN=CC=C2,SNICXCGAKADSCV-JTQLQIEISA-N,3-[(2S)-1-methylpyrrolidin-2-yl]pyridine,Nicotine,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|608|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|901|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1033|1189|1194|1205|1208|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1511|1519|1549|1552|1554|1,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|AN PharmaTech|Angene Chemical|ApexBio Technology|Aurora Fine Chemicals LLC|BePharm Ltd.|BIDD|BindingDB|BioCrick|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
90561,4-Chloro-1H-indole-2-carboxylic acid,"4-Chloro-1H-indole-2-carboxylic acid|24621-73-6|4-Chloroindole-2-carboxylic acid|1H-Indole-2-carboxylic acid, 4-chloro-|MFCD02664470|EINECS 246-364-6|NSC148347|1H-INDOLE-2-CARBOXYLIC ACID,4-CHLORO-|Oprea1_600492|SCHEMBL970309|CHEMBL312668|4-Chloroindole-2-carboxylicacid|DTXSID60179367|ALBB-005030|ZINC1683100|ANW-59237|BBL012513|SBB010941|STK501548|AKOS000118422|MCULE-5240160491|NSC 148347|NSC-148347|SB36153|VI30433|4-chlor-1H-indole-2-carbonsäure|4-chloranyl-1H-indole-2-carboxylic acid|AC-22700|BS-1379",195.600,C9H6ClNO2,53.100,222.000,2.900,13,2,2,1,"InChI=1S/C9H6ClNO2/c10-6-2-1-3-7-5(6)4-8(11-7)9(12)13/h1-4,11H,(H,12,13)",C1=CC2=C(C=C(N2)C(=O)O)C(=C1)Cl,VXZHQADIRFFCMJ-UHFFFAOYSA-N,4-chloro-1H-indole-2-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Micromolar,8,256|330|146231,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Ark Pharma Scientific Limited|ASINEX|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Bio",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
91441,Chloroquine sulfate,"Chloroquine sulfate|Chloroquine sulphate|132-73-0|Nivaquine|Chlorquine sulfate|Chloroquin sulfate|Cisplaquin|Lariago|NSC-292296|N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine sulfate|CHEBI:50178|EINECS 205-077-6|NSC 292296|Nivaquine (TN)|1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, sulfate (1:1)|7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline sulfate (1:1)|1,4-Pentanediamine, N(sub 4)-(7-chloro-4-quinolinyl)-N(sub 1),N(sub 1)-diethyl-, sulfate|N(sub 4)-(7-Chloro-4-",418.000,C18H28ClN3O4S,111.000,390.000,NULL,27,3,7,8,"InChI=1S/C18H26ClN3.H2O4S/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18;1-5(2,3)4/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21);(H2,1,2,3,4)",CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OS(=O)(=O)O,OJPWHUOVKVKBQB-UHFFFAOYSA-N,"4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;sulfuric acid",Chloroquine,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity,7,NULL,20050326,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|AN PharmaTech|Apexmol|Aurora Fine Chemicals LLC|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Debye Scientific Co., Ltd|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Finetech Industry Limited|Hairui Chemical|Hangzhou APIChem Technology|iChemical Technology USA",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
92721,Argatroban monohydrate,"Argatroban monohydrate|argatroban|141396-28-3|Argatroban hydrate|Argatroban (monohydrate)|Argipidine|Acova|GN1600|Argatroban Injection|Argatroban In Sodium Chloride|C23H36N6O5S.H2O|Argatra|Exembol|Novastan|Slonnon|Argatroban [USAN:INN:BAN:JAN]|Novastan (TN)|Argatroban (USP)|MQPA|(2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid|Argatroban hydrate (JP17)|SCHEMBL3447908|HY-B0375A|MDI-805|BCP09304|3449AH|M",526.700,C23H38N6O6S,190.000,887.000,NULL,36,6,9,9,"InChI=1S/C23H36N6O5S.H2O/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19;/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26);1H2/t14-,15?,17+,18-;/m1./s1",C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C.O,AIEZTKLTLCMZIA-CZSXTPSTSA-N,"(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid;hydrate",NULL,Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20050808,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|AN PharmaTech|Angene Chemical|AvaChem Scientific|BioChemPartner|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Combi-",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
92722,Argatroban,"argatroban|74863-84-6|Argatroban anhydrous|MCI-9038|MD-805|(2R,4R)-1-((2S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic acid|GN-1600|C23H36N6O5S|Argatroban Injection|(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid|DK-7419|CHEMBL1166|74863-84-6 (anhydrous)|Argatroban In Sodium Chloride|Argatroban [INN:JAN]|(2R,4R)-1-((2S)-5-Guanidino-2-(3-methy",508.600,C23H36N6O5S,189.000,887.000,1.300,35,5,8,9,"InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1",C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,KXNPVXPOPUZYGB-IOVMHBDKSA-N,"(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,485|631|731|781|782|880|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1466|1467|1468|1469|1477|1479|1481|1486|1490|1496|1509|1510|1515|1527|1529|1530|1531|1532|1533|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1665|1700|1706|1721|1,20050808,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|Ambeed|AN PharmaTech|Angene Chemical|Anward|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|AvaChem Scientific|BePharm Lt",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
92786,Allopregnanolone,"Allopregnanolone|516-54-1|Brexanolone|Allopregnan-3alpha-ol-20-one|Allotetrahydroprogesterone|SAGE-547|3alpha-hydroxy-5alpha-pregnan-20-one|3alpha-OH DHP|3alpha,5alpha-THP|5alpha-Pregnan-3alpha-ol-20-one|Zulresso|(3alpha,5alpha)-3-hydroxypregnan-20-one|UNII-S39XZ5QV8Y|3alpha-Hydroxy-5alpha-dihydroprogesterone|3a-Hydroxy-5a-pregnan-20-one|SGE-102|3a,5a-THP|S39XZ5QV8Y|CHEMBL207538|Pregnan-20-one, 3-hydroxy-, (3a,5a)-|CHEBI:50169|3alpha,5alpha-tetrahydroprogesterone|1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-1",318.500,C21H34O2,37.300,500.000,4.900,23,1,2,1,"InChI=1S/C21H34O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h14-19,23H,4-12H2,1-3H3/t14-,15+,16-,17+,18-,19-,20-,21+/m0/s1",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,AURFZBICLPNKBZ-SYBPFIFISA-N,"1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone",Pregnanolone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,2240|2241|2275|2313|2322|2330|2517|50906|52291|71697|71834|71841|71842|71982|71999|72140|72141|72142|72143|72151|72451|72453|114282|119225|167988|167989|167990|167991|187593|187594|188186|191308|196544|197261|197264|219787|219789|219900|219901|221372|226453|227352|233476|233477|233478|239779|242285|243126|243127|243128|243131|246863|246875|265566|265567|265569|265570|265572|266554|266555|266556|266557|266558|266559|266560|324687|377080|377081|382391|382392|382394|382396|382397|382398|382399|414515|414516|42,20040916,"AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Acorn PharmaTech Product List|AKos Consulting & Solutions|Alsachim|Ambinter|AN PharmaTech|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|AvaChem Scientific|BIDD|BindingDB|BioCrick|Broad Institute|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Clearsynth|Collaborative Drug Discovery,",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
97328,"L-2,3-Diaminopropionic acid","4033-39-0|L-2,3-Diaminopropionic acid|(S)-2,3-Diaminopropanoic acid|L-Alanine, 3-amino-|3-amino-L-alanine|(2S)-2,3-diaminopropanoic acid|UNII-JE1TUV83JA|beta-Aminoalanine|2,3-diamino-propionic acid|diaminopropanoic acid|L-2,3-Diaminopropanoate|JE1TUV83JA|Alanine, 3-amino-|2S,3-diamino-propionic acid|L-2,3-Diaminopropanoic acid|(s)-2,3-diaminopropionic acid|(+)-2,3-diaminopropionic acid|CHEBI:16303|(2S)-2,3-diaminopropanoate|L-2,3-Diaminopropionate|(S)-2,3-diaminopropanoate|D-2,3-Diaminopropionic acid|2,3-Di",104.110,C3H8N2O2,89.300,73.300,-4.300,7,3,4,2,"InChI=1S/C3H8N2O2/c4-1-2(5)3(6)7/h2H,1,4-5H2,(H,6,7)/t2-/m0/s1",C([C@@H](C(=O)O)N)N,PECYZEOJVXMISF-REOHCLBHSA-N,"(2S)-2,3-diaminopropanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,198301|198302|450165|450166,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
104938,Lactose monohydrate,"Lactose monohydrate|5989-81-1|alpha-Lactose monohydrate|alpha-D-Lactose monohydrate|a-Lactose monohydrate|64044-51-5|UNII-EWQ57Q8I5X|D-Lactose monohydrate|alpha-lactose hydrate|Lactose, monohydrate|Lactose monohydrate [NF]|EWQ57Q8I5X|a-D-Glucopyranose, 4-O-b-D-galactopyranosyl-, monohydrate|Lactose monohydrate (NF)|(2S,3R,4R,5S,6R)-6-(Hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2,3,4-triol hydrate|ALPHA-LACTOSEMONOHYDRATE|Lactose Mon",360.310,C12H24O12,191.000,382.000,NULL,24,9,12,4,"InChI=1S/C12H22O11.H2O/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17;/h3-20H,1-2H2;1H2/t3-,4-,5+,6+,7-,8-,9-,10-,11+,12+;/m1./s1",C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O.O,WSVLPVUVIUVCRA-KPKNDVKVSA-N,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol;hydrate",NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Use and Manufacturing,8,1508614,20050719,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABI Chem|Achemtek|Acros Organics|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Anward|Aurora Fine Chemicals LLC|BePharm Ltd.|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Crystallography Open Database|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
105102,"2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)-","2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)-|80449-32-7|80499-32-7|3-(FURAN-2-YL)-2,4-DIOXASPIRO[5.5]UNDEC-8-ENE|2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-|3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-9-ene|Urinary trypsin inhibitor|Trypsin inhibitor MR-20|MR-20 (Magnetic powder)|Uti(68)|Acid-stable protease inhibitor|Urinary trypsin inhibitor (68)|MR 20|UNII-OR3S9IF86U|Uristatin|Mingin|Urinary trypsin inhibitor-like inhibitor (43)|Trypsin inhibitor UTI|Trypsin inhibitor (human urine urinastatin protein mo",220.260,C13H16O3,31.600,266.000,2.100,16,0,3,1,"InChI=1S/C13H16O3/c1-2-6-13(7-3-1)9-15-12(16-10-13)11-5-4-8-14-11/h1-2,4-5,8,12H,3,6-7,9-10H2",C1CC2(CC=C1)COC(OC2)C3=CC=CO3,ODVKSTFPQDVPJZ-UHFFFAOYSA-N,"3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-9-ene",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20050801,001Chemical|AAA Chemistry|AbaChemScene|ABI Chem|AKos Consulting & Solutions|AvaChem Scientific|BioChemPartner|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChemIDplus|ChemSpider|DC Chemicals|DiscoveryGate|EPA DSSTox|Google Patents|Hangzhou APIChem Technology|LeadScope|MedChemexpress MCE|MolCore BioPharmatech|MuseChem|NextBio|NIAID ChemDB|Smolecule|TargetMol (Target Molecule Corp.)|THE BioTek|Therapeutic Target Database (TTD)|ToxPlanet|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
115358,Tafenoquine,"Tafenoquine|106635-80-7|Etaquine|WR 238605|Tafenoquine free base|SB-252263-AAB|106635-80-7 (free base)|WR238605|Krintafel|N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)quinolin-8-yl)pentane-1,4-diamine|1,4-Pentanediamine, N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-|SB-252263|Arakoda|Tafenoquine [USAN:INN:BAN]|1,4-Pentanediamine, N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]-|N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinol",463.500,C24H28F3N3O3,78.600,597.000,5.400,33,2,9,9,"InChI=1S/C24H28F3N3O3/c1-14-11-20(32-4)30-22-18(29-15(2)7-6-10-28)13-19(31-3)23(21(14)22)33-17-9-5-8-16(12-17)24(25,26)27/h5,8-9,11-13,15,29H,6-7,10,28H2,1-4H3",CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,LBHLFPGPEGDCJG-UHFFFAOYSA-N,"4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,117301|117439|117445|117448|117453|117456|117459|117463|125812|125816|125819|125822|162092|184458|184592|184597|184598|230860|256128|256129|256131|256133|256137|256314|256318|330903|330906|330907|330908|330909|330910|330911|341780|341781|341782|341783|341784|341785|341786|341787|341788|341789|341790|341791|341792|341793|341794|341795|341796|341797|341798|341799|341800|341801|341802|341803|341804|341805|341806|341807|341808|341809|496819|509078|509079|509080|509081|509082|509083|509084|509085|509086|509087|5,20050801,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AKos Consulting & Solutions|Alsachim|Ambeed|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|BOC Sciences|Broad Institute|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CSNpharm|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSST",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
123683,IB-Meca,"IB-MECA|piclidenoson|152918-18-8|3-IB-Meca|CF-101|N(6)-Ibamu|CF 101|N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine|UNII-30679UMI0N|1-Deoxy-1-(6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-N-methyl-beta-D-ribofuranuronamide|CHEMBL119709|3-iodobenzyl-5'-N-methylcarboxamidoadenosine|CHEBI:73286|30679UMI0N|Cf101|RPR-113090|(2S,3S,4R,5R)-3,4-dihydroxy-5-(6-((3-iodobenzyl)amino)-9H-purin-9-yl)-N-methyltetrahydrofuran-2-carboxamide|(2S,3S,4R,5R)-3,4-dihydroxy-5-(6-(3-iodobenzylamino)-9H-purin-9-yl)-N-methylt",510.300,C18H19IN6O4,134.000,589.000,0.900,29,4,8,5,"InChI=1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t12-,13+,14-,18+/m0/s1",CNC(=O)[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)NCC4=CC(=CC=C4)I)O)O,HUJXGQILHAUCCV-MOROJQBDSA-N,"(2S,3S,4R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methyloxolane-2-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1850|1863|1865|1899|1903|1906|1947|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2099|2101|2107|2112|2129|2130|2174|2177|2234|2235|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2549|2557|2599|2606|2629|2650|2660|2661|2666|2667|2668|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|30451|30907|31885|32002|32021|32024|32188|32345|32349|32513|32633|32773|32864|32878|32890|33052|33162|33206|33208|33211|33323|33337|3,20050808,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|AOBIOUS INC|Aurora Fine Chemicals LLC|BindingDB|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|Combi-Blocks|Comparative Toxicog",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
126410,[SeH]C1=CC=CC=C1C(=O)NC1=CC=CC=C1,[SeH]C1=CC=CC=C1C(=O)NC1=CC=CC=C1,276.200,C13H11NOSe,29.100,238.000,NULL,16,1,1,2,"InChI=1S/C13H11NOSe/c15-13(11-8-4-5-9-12(11)16)14-10-6-2-1-3-7-10/h1-9,16H,(H,14,15)",C1=CC=C(C=C1)NC(=O)C2=CC=CC=C2[SeH],PVPUYGNPKBMXGO-UHFFFAOYSA-N,N-phenyl-2-selanylbenzamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050808,Google Patents,Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
148031,N-Hydroxy-2-quinolinecarboxamide,"N-hydroxyquinoline-2-carboxamide|N-Hydroxy-2-quinolinecarboxamide|37137-42-1|2-Quinolinecarboxamide, N-hydroxy-|CHEMBL3798481|Quinoline-2-carbohydroxamic acid|BRN 0148428|2-Quinolinecarboxamide,N-hydroxy-|VWG|quinolinecarbohydroxamic|quinolyl hydroximic acid|EC-000.1745|Oprea1_434332|5-22-03-00190 (Beilstein Handbook Reference)|2-Quinolinecarbohydroximic acid|SCHEMBL7010475|SCHEMBL18530693|DTXSID70190624|ZINC500969|BDBM50164660|AKOS000186816|MCULE-5487007398|Quinoline-2-carboxylic acid hydroxyamide|Z5918194",188.180,C10H8N2O2,62.200,220.000,0.900,14,2,3,1,"InChI=1S/C10H8N2O2/c13-10(12-14)9-6-5-7-3-1-2-4-8(7)11-9/h1-6,14H,(H,12,13)",C1=CC=C2C(=C1)C=CC(=N2)C(=O)NO,RLBGLCXAYWCPDM-UHFFFAOYSA-N,N-hydroxyquinoline-2-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,1296346|1296347|1296348|1296349|1296353|1296354|1296361|1446915,20050709,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambinter|BindingDB|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Crystallography Open Database|DiscoveryGate|Enamine|EPA DSSTox|Exclusive Chemistry Ltd|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|Mcule|MolPort|NCBI Structure|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|R&D Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
152946,Moxifloxacin,"moxifloxacin|151096-09-2|Avelox|1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|Moxeza|UNII-U188XYD42P|BAY 12-8039|U188XYD42P|1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid|CHEBI:63611|Izilox|(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|1-Cyclopropyl-6-Fluoro-",401.400,C21H24FN3O4,82.100,727.000,0.600,29,2,8,4,"InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1",COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,FABPRXSRWADJSP-MEDUHNTESA-N,"7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid",Moxifloxacin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,51930|66572|66574|66576|66578|66893|67078|69597|69933|96072|105998|158681|159910|161281|164231|164393|206214|206629|206650|206728|207483|208611|208626|209273|209591|210029|227415|227416|237034|237037|237457|237458|243151|243188|244720|244721|244722|244877|244891|244924|244926|244929|244934|244935|244953|244957|244968|244972|244977|244988|244990|244991|244995|244996|244998|245007|245029|245040|245137|245138|245172|245205|245237|245330|245331|245695|245696|245697|246828|246829|246862|249968|249969|249970|2617,20050801,"3A SpeedChemical Inc|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|AmicBase - Antimi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
193409,Naphthalene-2-carboximidamide,naphthalene-2-carboximidamide|beta-Naphthamidine|Naphthalene-2-carboxamidine|5651-14-9|2-Naphthalenecarboximidamide|2-Naphthimidamide|CHEMBL105171|2-naphthamidine|2UP|uPa_6|2-Naphthalenecarboxamidine|SCHEMBL3370031|DTXSID40205052|ZINC1442764|BDBM50138663|AKOS009312986|DA-04828|FT-0763708|Q27453295|Z2146514452,170.210,C11H10N2,49.900,200.000,2.700,13,2,1,1,"InChI=1S/C11H10N2/c12-11(13)10-6-5-8-3-1-2-4-9(8)7-10/h1-7H,(H3,12,13)",C1=CC=C2C=C(C=CC2=C1)C(=N)N,URXJHZXEUUFNKM-UHFFFAOYSA-N,naphthalene-2-carboximidamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active,7,95041|150768|157977|158340|210752|210919|213441|215587|215747|215835|419413,20050711,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|B&C Chemical|BindingDB|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemDB|Chemenu Inc.|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|EPA DSSTox|Finetech Industry Limited|Google Patents|IBM|J",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
219024,Regadenoson,"Regadenoson|313348-27-5|Lexiscan|Rapiscan|UNII-7AXV542LZ4|CVT-3146|7AXV542LZ4|CHEMBL317052|2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine|Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-|1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide|Lexiscan (TN)|CVT 3146|Regadenoson [USAN:INN]|Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-|Regadenoson anhydrous|Regadenoson monohydrate|Regadenoson (USAN/INN)|Rega",390.350,C15H18N8O5,187.000,587.000,-1.500,28,5,10,4,"InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1",CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N,LZPZPHGJDAGEJZ-AKAIJSEGSA-N,"1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,30784|33011|33508|34679|34853|238913|238932|647885|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|1117298|1117304|1117305|1117310|1117312|1117314|1117326|1117329|1117336|1117340|1117341|1117342|1117343|1117346|1138011|1138014|1138015|1138018|1138020|1138036|1138039|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|,20050809,"A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Activate Scientific|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Apexmol|BindingDB|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|Collaborative",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
228459,1h-Benzimidazole-2-sulfonamide,"1H-Benzo[d]imidazole-2-sulfonamide|1h-benzimidazole-2-sulfonamide|5435-31-4|1H-1,3-benzodiazole-2-sulfonamide|2-Benzimidazolesulfonamide|1H-benzoimidazole-2-Sulfonic|NSC21405|benzimidazole sulfonamide|SCHEMBL830431|1H-Benzoimidazole-2-sulfonamide|DTXSID50281362|3s72|ZINC6490906|7836AB|ANW-70716|NSC-21405|AKOS016007897|MCULE-9090236179|NE33989|AM100931|EN300-61671|J3.520.248J|Q27460078|Z992716944",197.220,C7H7N3O2S,97.200,285.000,0.200,13,2,4,1,"InChI=1S/C7H7N3O2S/c8-13(11,12)7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H,9,10)(H2,8,11,12)",C1=CC=C2C(=C1)NC(=N2)S(=O)(=O)N,XRGHQBXKSHAQRB-UHFFFAOYSA-N,1H-benzimidazole-2-sulfonamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,7,977611,20050326,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Angene Chemical|Anward|Apexmol|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Ena",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
265827,"7-Methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine","7-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-amine|7752-54-7|7-methylpyrrolo[2,3-d]pyrimidin-4-amine|NSC102338|7H-Pyrrolo[2, 7-methyl-|SCHEMBL10051003|DTXSID40295498|AMY32267|ZINC1674697|7H-Pyrrolo[2, 4-amino-7-methyl-|MFCD12924275|AKOS006339947|NSC-102338|QC-5505|SB14122|4-Amino-7-methylpyrrolo[2,3-d]pyrimidine|1-Methyl-4-amino-1,5,7-triaza-1H-indene|CS-0054376|7-Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, AldrichCPR|W4S",148.170,C7H8N4,56.700,149.000,0.300,11,1,3,0,"InChI=1S/C7H8N4/c1-11-3-2-5-6(8)9-4-10-7(5)11/h2-4H,1H3,(H2,8,9,10)",CN1C=CC2=C(N=CN=C21)N,KSOREMDAQHJJKY-UHFFFAOYSA-N,"7-methylpyrrolo[2,3-d]pyrimidin-4-amine",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20050326,"001Chemical|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Activate Scientific|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Apexmol|Aurora Fine Chemicals LLC|BLD Pharm|CEGChem|Chem-Space.com Database|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Combi-Blocks|Day Biochem|DiscoveryGate|DTP/NCI|eNovation Chemicals|EPA DSSTox|FondChemical Co., Ltd|Google Patents|Heterocyclics Research Chemicals & Building",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
301729,"2-(1,2-Benzisoxazol-3-yl)acetic acid","4865-84-3|2-(1,2-Benzisoxazol-3-yl)acetic acid|1,2-Benzisoxazole-3-acetic Acid|1,2-benzisoxazol-3-ylacetic acid|2-(1,2-benzoxazol-3-yl)acetic acid|2-(benzo[d]isoxazol-3-yl)acetic acid|benzo[d]isoxazol-3-yl-acetic acid|2-(1,2-Benzoxazol-3-Yl)ethanoic Acid|CHEMBL3792472|2-benzo[d]isoxazol-3-ylacetic acid|1,2-benzoxazol-3-ylacetic acid|NVU|NSC179803|zlchem 388|PubChem8653|2-(1,2-Benzisoxazol-3-yl)aceticacid|ACMC-1CTWL|Maybridge1_005391|Oprea1_695883|SCHEMBL75124|BEN014|HMS556N01|DTXSID80306794|EBD8849|ZLC0234|",177.160,C9H7NO3,63.300,207.000,1.200,13,1,4,2,"InChI=1S/C9H7NO3/c11-9(12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H,11,12)",C1=CC=C2C(=C1)C(=NO2)CC(=O)O,BVSIAYQIMUUCRW-UHFFFAOYSA-N,"2-(1,2-benzoxazol-3-yl)acetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,248|330|608|811|833|1033|1044|1549|1552|1637|1648|1792|1823|2291|492967|602314|652031|1159607|1259370|1259397|1259398|1259423|1293675|1347385,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|Apexmol|Aromalake Chemical|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|Biocor",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
316817,4-(1H-Imidazol-2-yl)pyridine,"4-(1H-imidazol-2-yl)pyridine|21202-42-6|4-(1H-2-Imidazolyl)-pyridine|4-(1H-IMIDAZOL-2-YL)-PYRIDINE|PYRIDINE, 4-(1H-IMIDAZOL-2-YL)-|176964-60-6|4-(2H-Imidazol-2-ylidene)-1,4-dihydropyridine|Pyridine,4-(1H-imidazol-2-yl)-|4FL|NSC245206|mono(imidazolyl)pyridine|4-(2-Imidazolyl)pyridine|SCHEMBL1688472|CHEMBL3274310|DTXSID90311778|2-(Pyridin-4-yl)-1H-imidazole|BDBM225674|GTC000447A|ALBB-022336|AMY32738|7194AD|MFCD08668556|ZINC13283576|ZINC39051116|AKOS010225940|AB45833|MCULE-7169257398|NSC-245206|QC-4708|AB00765",145.160,C8H7N3,41.600,121.000,0.800,11,1,2,1,"InChI=1S/C8H7N3/c1-3-9-4-2-7(1)8-10-5-6-11-8/h1-6H,(H,10,11)",C1=CN=CC=C1C2=NC=CN2,QWZSAEUNIBEKIZ-UHFFFAOYSA-N,4-(1H-imidazol-2-yl)pyridine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,155|157|161|165|167|175|248|256|1150143,20050326,"001Chemical|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|Biosynth Carbosynth|BLD Pharm|CEGChem|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
346160,5-Phenylnicotinic Acid,"5-Phenylnicotinic Acid|10177-12-5|5-phenylpyridine-3-carboxylic acid|3-PYRIDINECARBOXYLIC ACID, 5-PHENYL-|5-phenyl-3-pyridinecarboxylic acid|CHEMBL3617324|0LO|NSC404257|3-PHENYL-5-PYRIDINECARBOXYLIC ACID|ACMC-1BSTF|SCHEMBL569730|DTXSID60323545|ZINC159004|3-Pyridinecarboxylicacid,5-phenyl-|5-phenylnicotinic acid, AldrichCPR|ANW-14519|BDBM50122014|MFCD03086176|SBB052847|AKOS000124671|AB13116|MCULE-1799607241|NSC-404257|SDCCGMLS-0066049.P001|TS-02814|DB-081322|BB 0222812|CS-0067984|FT-0620764|ST50949590|Y6804|",199.200,C12H9NO2,50.200,224.000,2.000,15,1,3,2,"InChI=1S/C12H9NO2/c14-12(15)11-6-10(7-13-8-11)9-4-2-1-3-5-9/h1-8H,(H,14,15)",C1=CC=C(C=C1)C2=CC(=CN=C2)C(=O)O,VKFXHYRIHRTEIV-UHFFFAOYSA-N,5-phenylpyridine-3-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,155|157|161|165|167|175|248|608|1033|1549|1552|1637|1648|1247843|1247844,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambinter|Angel Pharmatech Ltd.|Anward|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Burnham Center for Chemical Genomics|Chem-Space.com Database|Chembase.cn|ChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
358641,Sulfamethoxazole and trimethoprim,sulfamethoxazole & trimethoprim|sulfamethoxazole + trimethoprim|Trimosulfa|CO-Trimoxazole|Cotrimoxazole|Septra|8064-90-2|Gantrim|Sulfamethoxazole-trimethoprim|Trimethoprim-sulfamethoxazole|TMP-SMX|TRIMETHOPRIM/SULFAMETHOXAZOLE|SULFAMETHOXAZOLE AND TRIMETHOPRIM|Trimethoprim-sulfamethoxazole combination|TMP/SMX|Trimethoprim and sulphamethoxazole|Sulfamethoxazole Trimethoprim|Sulfamethoxazole / trimethoprim|Trimethoprim and sulfamethoxazole|Sulfamethoxazole mixture with trimethoprim|Trimethoprimsulfa|NSC618652,543.600,C24H29N7O6S,212.000,653.000,NULL,38,4,13,8,"InChI=1S/C14H18N4O3.C10H11N3O3S/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h5-7H,4H2,1-3H3,(H4,15,16,17,18);2-6H,11H2,1H3,(H,12,13)",CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N.COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,WZRJTRPJURQBRM-UHFFFAOYSA-N,"4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine","Trimethoprim, Sulfamethoxazole Drug Combination",Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,13,54429|151986|157425|157427|162072|162073|162074|162075|162076|162077|162078|162081|162084|162086|162087|225922|409954|409956,20050326,"ABI Chem|Alfa Chemistry|AmicBase - Antimicrobial Activities|BLD Pharm|BOC Sciences|ChEMBL|ChemIDplus|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DC Chemicals|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|EPA Substance Registry Services|Immune Epitope Database (IEDB)|KEGG|LeadScope|MuseChem|NextBio|NextMove Software|NIAID ChemDB|NovoSeek|PATENTSCOPE (WIPO)|Smolecule|Springer N",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
365537,"8-[[3-[(3-Aminobenzoyl)amino]-4-methylbenzoyl]amino]naphthalene-1,3,5-trisulfonic acid","NSC633234|8-(3-(3-aminobenzamido)-4-methylbenzamido)naphthalene-1,3,5-trisulfonic acid|CHEMBL2009384|SCHEMBL17903265|ZINC82186151|8-[[3-[(3-aminobenzoyl)amino]-4-methylbenzoyl]amino]naphthalene-1,3,5-trisulfonic acid|NCI60_011027|8-[[3-[(3-aminobenzoyl)amino]-4-methyl-benzoyl]amino]naphthalene-1,3,5-trisulfonic acid|8-[3-(m-Aminobenzamido)-4-methylbenzamido]-1,3,5- naphthalenetrisulfonic acid|H3U",635.600,C25H21N3O11S3,273.000,1340.000,0.800,42,6,12,7,"InChI=1S/C25H21N3O11S3/c1-13-5-6-15(10-20(13)28-24(29)14-3-2-4-16(26)9-14)25(30)27-19-7-8-21(41(34,35)36)18-11-17(40(31,32)33)12-22(23(18)19)42(37,38)39/h2-12H,26H2,1H3,(H,27,30)(H,28,29)(H,31,32,33)(H,34,35,36)(H,37,38,39)",CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)N,FWPDBHFZCRXISJ-UHFFFAOYSA-N,"8-[[3-[(3-aminobenzoyl)amino]-4-methylbenzoyl]amino]naphthalene-1,3,5-trisulfonic acid",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050326,"ABI Chem|BOC Sciences|ChemBank|ChEMBL|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|DTP/NCI|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|NIAID ChemDB|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|ToxPlanet|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
409423,"N,1-Dimethyl-N-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine","N,1-dimethyl-N-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|K1G|ZINC1577349|AKOS034191003|MCULE-9886284668|Z328695024|117864-83-2",205.260,C10H15N5,46.800,220.000,1.400,15,0,4,2,"InChI=1S/C10H15N5/c1-7(2)14(3)9-8-5-13-15(4)10(8)12-6-11-9/h5-7H,1-4H3",CC(C)N(C)C1=NC=NC2=C1C=NN2C,ACQZDWVVKAKBAO-UHFFFAOYSA-N,"N,1-dimethyl-N-propan-2-ylpyrazolo[3,4-d]pyrimidin-4-amine",NULL,Biomolecular Interactions and Pathways,1,NULL,20050326,ABI Chem|AKos Consulting & Solutions|Ambinter|ChemDB|ChemSpider|DiscoveryGate|DTP/NCI|Enamine|Mcule|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
439155,S-Adenosyl-L-homocysteine,"S-adenosylhomocysteine|S-adenosyl-L-homocysteine|979-92-0|AdoHcy|S-(5'-adenosyl)-L-homocysteine|adenosylhomocysteine|S-(5'-deoxyadenosin-5'-yl)-L-homocysteine|Formycinylhomocysteine|Adenosyl-L-homocysteine|5'-Deoxy-S-adenosyl-L-homocysteine|2-S-adenosyl-L-homocysteine|L-Homocysteine, S-(5'-deoxyadenosin-5'-yl)-|S-adenosyl-homocysteine|S-Adenosyl Homocysteine|L-S-Adenosylhomocysteine|adenosylhomo-cys|adenosyl-homo-cys|SAH|UNII-8K31Q2S66S|BRN 5166233|(S)-5'-(S)-(3-Amino-3-carboxypropyl)-5'-thioadenosine|S-(5'",384.410,C14H20N6O5S,208.000,504.000,-3.500,26,5,11,7,"InChI=1S/C14H20N6O5S/c15-6(14(23)24)1-2-26-3-7-9(21)10(22)13(25-7)20-5-19-8-11(16)17-4-18-12(8)20/h4-7,9-10,13,21-22H,1-3,15H2,(H,23,24)(H2,16,17,18)/t6-,7+,9+,10+,13+/m0/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CSCC[C@@H](C(=O)O)N)O)O)N,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,"(2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]butanoic acid",S-Adenosylhomocysteine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,11,1811|27157|49929|49930|70364|70365|71601|90042|90043|90044|91847|155165|155166|155171|199294|199295|230419|317708|317709|327641|327642|327643|327644|424221|424222|424255|424256|461001|461002|461003|461004|613026|631009|631010|657292|657293|657294|670019|670021|702364|702365|702371|702372|702373|702374|738916|738930|977610|977611|1054110|1054111|1054112|1072835|1133245|1133246|1133247|1133248|1133249|1133250|1133251|1133252|1133261|1133262|1144306|1144307|1144308|1144309|1145525|1145526|1145527|1145529|11455,20050608,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChE",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank, WikiPathways]"
439201,Bradykinin,"BRADYKININ|58-82-2|L-Bradykinin|Kallidin I|Synthetic bradykinin|Bradykinin (synthetic)|Callidin I|Kallidin 9|UNII-S8TIM42R2W|BRS 640|PRS 640|Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg|S8TIM42R2W|CHEBI:3165|CHEMBL406291|Bradykinin, Lysyl|(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-(",1060.200,C50H73N15O11,419.000,2080.000,-4.800,76,12,14,27,"InChI=1S/C50H73N15O11/c51-32(16-7-21-56-49(52)53)45(72)65-25-11-20-39(65)47(74)64-24-9-18-37(64)43(70)58-28-40(67)59-34(26-30-12-3-1-4-13-30)41(68)62-36(29-66)46(73)63-23-10-19-38(63)44(71)61-35(27-31-14-5-2-6-15-31)42(69)60-33(48(75)76)17-8-22-57-50(54)55/h1-6,12-15,32-39,66H,7-11,16-29,51H2,(H,58,70)(H,59,67)(H,60,69)(H,61,71)(H,62,68)(H,75,76)(H4,52,53,56)(H4,54,55,57)/t32-,33-,34-,35-,36-,37-,38-,39-/m0/s1",C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,QXZGBUJJYSLZLT-FDISYFBBSA-N,(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid,Bradykinin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,12,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|16165|24166|24342|24343|24344|42977|42978|42982|42985|42988|42993|43145|43286|43290|43292|43305|59130|73863|73988|73989|76465|79670|89831|92418|92423|92586|92588|92692|165424|165499|167729|167730|167732|168238|168242|171718|171719|197172|197173|197180|232231|232387|232390|375520|375527|485281|485290|504327|504847|588579|602332|720532|720533|751692|751757|1238148|1238149|1346473|1346495|1346510|1346530|1346532,20050608,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AbMole Bioscience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BIND|BindingDB|BOC Sciences|CCSbase|ChangChem|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|DC Chemicals|DrugBank|ECI Group, LCSB, University of Luxemb",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
443376,Teprotide,"TEPROTIDE|35115-60-7|Angiotensin Converting Enzyme Inhibitor|angiotensin-converting enzyme inhibitor|UNII-C3E5QBF1R6|Bpp 9a|Teprotide (USAN/INN)|C3E5QBF1R6|SQ-20881|CHEBI:9444|CHEMBL408983|(2S)-1-[(2S)-1-[(2S,3S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-3-(1H-indol-3-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-car",1101.300,C53H76N14O12,387.000,2330.000,-0.900,79,10,13,24,"InChI=1S/C53H76N14O12/c1-3-29(2)43(51(77)66-25-9-16-39(66)50(76)67-26-10-17-40(67)52(78)79)63-45(71)34(18-20-41(54)68)60-46(72)37-14-7-23-64(37)48(74)35(13-6-22-57-53(55)56)61-47(73)38-15-8-24-65(38)49(75)36(62-44(70)33-19-21-42(69)59-33)27-30-28-58-32-12-5-4-11-31(30)32/h4-5,11-12,28-29,33-40,43,58H,3,6-10,13-27H2,1-2H3,(H2,54,68)(H,59,69)(H,60,72)(H,61,73)(H,62,70)(H,63,71)(H,78,79)(H4,55,56,57)/t29-,33-,34-,35-,36-,37-,38-,39-,40-,43-/m0/s1",CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@@H]7CCC(=O)N7,UUUHXMGGBIUAPW-CSCXCSGISA-N,"(2S)-1-[(2S)-1-[(2S,3S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-3-(1H-indol-3-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid",Teprotide,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,37635|37964|1259409,20050624,"3B Scientific (Wuhan) Corp|abcr GmbH|ABI Chem|Alfa Chemistry|Aurora Fine Chemicals LLC|ChEBI|Chembase.cn|ChEMBL|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Glentham Life Sciences Ltd.|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LabNetwork, a WuXi AppTec Company|Metabolomics",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
445794,ADP-ribose,"ADP-ribose|ADP-D-ribose|Adenosine 5'-diphosphoribose|1ihy|1szd|CHEMBL1231026|ZINC17654550|[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate|C00301|((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl (((2R,3S,4R,5R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl) dihydrogen diphosphate|[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,",559.320,C15H23N5O14P2,292.000,877.000,-6.100,36,8,18,9,"InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)O)O)O)O)O)N,SRNWOUGRCWSEMX-KEOHHSTQSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate",Adenosine Diphosphate Ribose,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,1811|977610|977611,20040916,ABI Chem|BLD Pharm|ChEMBL|ChemSpider|Google Patents|KEGG|MassBank of North America (MoNA)|MetabolomicsWorkbench|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Shanghai Institute of Organic Chemistry|SMID|Thomson Pharma|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
448155,"[(2r,3r,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3-Hydroxy-4-(Phosphonooxy)tetrahydrofuran-2-Yl]methyl [(2r,3s,4r,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]methyl Dihydrogen Diphosphate","2'-MONOPHOSPHOADENOSINE-5'-DIPHOSPHORIBOSE|[(2r,3r,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3-Hydroxy-4-(Phosphonooxy)tetrahydrofuran-2-Yl]methyl [(2r,3s,4r,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]methyl Dihydrogen Diphosphate|A2R|ADPRP|C03246|Q27095268|[(2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxy-4-(phosphonooxy)tetrahydrofuran-2-yl]methyl [(2R,3S,4R,5R)-3,4,5-trihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)",639.300,C15H24N5O17P3,338.000,1040.000,-7.200,40,9,21,11,"InChI=1S/C15H24N5O17P3/c16-12-7-13(18-3-17-12)20(4-19-7)14-11(36-38(25,26)27)9(22)6(34-14)2-33-40(30,31)37-39(28,29)32-1-5-8(21)10(23)15(24)35-5/h3-6,8-11,14-15,21-24H,1-2H2,(H,28,29)(H,30,31)(H2,16,17,18)(H2,25,26,27)/t5-,6-,8-,9-,10-,11-,14-,15-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)O)O)O)O)OP(=O)(O)O)N,ICNHOLCERMYLRZ-KEOHHSTQSA-N,"[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Pharmacology and Biochemistry,4,NULL,20050624,"ABI Chem|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Shanghai Institute of Organic Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
450268,3-Hydroxyhippuric acid,"3-hydroxyhippuric acid|m-Hydroxyhippuric acid|1637-75-8|(3-Hydroxybenzoylamino)acetic acid|2-[(3-hydroxyphenyl)formamido]acetic acid|Glycine, N-(3-hydroxybenzoyl)-|N-m-Hydroxylbenzoylglycine|UNII-17HCX0HNRT|3-Hydroxybenzoylglycine|3-Hydroxyhippurate|17HCX0HNRT|CHEMBL447627|(3-hydroxybenzamido)acetic acid|CHEBI:70824|m-Hydroxyhippurate|Glycine,N-(3-hydroxybenzoyl)-|3XH|3-Hydroxyhippuricacid|(3-hydroxybenzoyl)glycine|N-(3-hydroxybenzoyl)glycine|SCHEMBL600772|DTXSID30167650|HMS3604N06|ZINC6534965|BDBM50265459|",195.170,C9H9NO4,86.600,229.000,0.000,14,3,4,3,"InChI=1S/C9H9NO4/c11-7-3-1-2-6(4-7)9(14)10-5-8(12)13/h1-4,11H,5H2,(H,10,14)(H,12,13)",C1=CC(=CC(=C1)O)C(=O)NCC(=O)O,XDOFWFNMYJRHEW-UHFFFAOYSA-N,2-[(3-hydroxybenzoyl)amino]acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,9,412639|1347080|1508586,20050327,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angene Chemical|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Combi-Blocks|DiscoveryGate|DrugBank|Egon ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
565340,4-Acetyl 1-(2-furoyl)piperazine,4-Acetyl 1-(2-furoyl)piperazine|768292-07-5|BAS 09536583|MLS001216880|1-[4-(Furan-2-carbonyl)-piperazin-1-yl]-ethanone|1-(4-(FURAN-2-CARBONYL)PIPERAZIN-1-YL)ETHANONE|CHEMBL1719073|SCHEMBL13804475|DTXSID90340508|HMS2909G19|ZINC815570|STK176136|1-Acetyl-4-(2-furoyl)piperazine #|AKOS000654795|MCULE-6052345915|1-acetyl-4-(2-furylcarbonyl)piperazine|SMR000612834|ST50287189|1-[4-(2-furylcarbonyl)piperazino]-1-ethanone|SR-01000324539|1-[4-(furan-2-ylcarbonyl)piperazin-1-yl]ethanone|SR-01000324539-1,222.240,C11H14N2O3,53.800,285.000,0.100,16,0,3,1,"InChI=1S/C11H14N2O3/c1-9(14)12-4-6-13(7-5-12)11(15)10-3-2-8-16-10/h2-3,8H,4-7H2,1H3",CC(=O)N1CCN(CC1)C(=O)C2=CC=CO2,IVYZJWUTDZYPEB-UHFFFAOYSA-N,1-[4-(furan-2-carbonyl)piperazin-1-yl]ethanone,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,940|1422|1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1868|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1979|1984|1986|1987|1996|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|2073|2094|2097|2098|2099|2100|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2288|2289|2300|2314|2315|2326|2380|2391|2435|2445|2451|246,20050327,"ABI Chem|AKos Consulting & Solutions|ASINEX|Chem-Space.com Database|ChEMBL|ChemDB|ChemDiv|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|Emory University Molecular Libraries Screening Center|EPA DSSTox|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|labseeker|Mcule|MLSMR|MolPort|NextBio|NIST Mass Spectrometry Data Center|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|The Scripps Research In",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
569547,"N-(1,3-Thiazol-2-yl)benzamide","N-(1,3-Thiazol-2-yl)benzamide|13053-82-2|N-Thiazol-2-yl-benzamide|N-(thiazol-2-yl)benzamide|Benzamide, N-2-thiazolyl-|n-thiazol-2-yl benzamide|N-(2-Thiazolyl)benzamide|MLS000711892|CHEMBL90846|SCHEMBL995829|Benzamide, N-(2-thiazolyl)-|IFLab1_003538|ZINC39994|HMS1422A18|HMS2643F11|N-(1,3-Thiazol-2-yl)benzamide #|STK018313|AKOS000638160|AKOS005145274|MCULE-9395155160|IDI1_009645|phenyl-N-(1,3-thiazol-2-yl)carboxamide|SMR000281659|DB-084994|ST50454675|SR-01000358724|SR-01000358724-1|Z28173683|F0808-0927|W6V",204.250,C10H8N2OS,70.200,204.000,2.400,14,1,3,2,"InChI=1S/C10H8N2OS/c13-9(8-4-2-1-3-5-8)12-10-11-6-7-14-10/h1-7H,(H,11,12,13)",C1=CC=C(C=C1)C(=O)NC2=NC=CS2,SCQBDADQAVXTMZ-UHFFFAOYSA-N,"N-(1,3-thiazol-2-yl)benzamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,6,485|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1251|1274|1276|1285|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1460|1461|1463|1465|1466|1467|1468|1469|1471|1477|1479|1481,20050327,"ABI Chem|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|ChEMBL|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Crystallography Open Database|Debye Scientific Co., Ltd|DiscoveryGate|Enamine|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Innovapharm|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|Life Chemicals|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|N",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
586354,"4-N,4-N-Dimethylpyridine-2,4-diamine","N4,N4-dimethylpyridine-2,4-diamine|4-N,4-N-dimethylpyridine-2,4-diamine|50426-31-8|N~4~,N~4~-dimethylpyridine-2,4-diamine|4-Dimethylaminopyridin-2-amine|2,4-Pyridinediamine, N4,N4-dimethyl-|SCHEMBL1099323|SCHEMBL9024931|2-amino-4-dimethylaminopyridine|ZINC32175846|AKOS006339210|N4,N4-dimethyl-pyridine-2,4-diamine|CCG-358814|KS-9164|X4V",137.180,C7H11N3,42.200,103.000,0.600,10,1,3,1,"InChI=1S/C7H11N3/c1-10(2)6-3-4-9-7(8)5-6/h3-5H,1-2H3,(H2,8,9)",CN(C)C1=CC(=NC=C1)N,QEDNABCLVCJRLV-UHFFFAOYSA-N,"4-N,4-N-dimethylpyridine-2,4-diamine",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Patents|Safety and Hazards,5,NULL,20050327,"001Chemical|A2B Chem|AA BLOCKS|ABI Chem|Activate Scientific|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Center for Chemical Genomics, University of Michigan|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|eNovation Chemicals|Google Patents|IBM|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Life Chemicals|MolCore BioPharmatech|MolPort|NCBI Structure|NextBio|NextMove Software|NIST Mass Spectrometry Data Center|PATEN",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
587724,1-(Furan-2-ylmethyl)urea,"1-(furan-2-ylmethyl)urea|5962-13-0|furan-2-ylmethylurea|(furan-2-ylmethyl)urea|furfurylurea|Furan-2-ylmethyl-urea|N-(2-Furylmethyl)urea|N-[(furan-2-yl)methyl]urea|N-(furan-2-ylmethyl)urea|N-Furfurylurea|[(furan-2-yl)methyl]urea|N-(2-Furylmethyl)urea #|Urea, N-(2-furfuryl)-|Oprea1_477147|amino-N-(2-furylmethyl)amide|SCHEMBL4448151|DTXSID20343143|HMS1724A02|ZINC162619|8875AB|MFCD00466605|STK367294|AKOS000117208|MCULE-8058725801|ST50876897|EN300-05369|L-5336|Z56900771|F1967-1591|WUJ",140.140,C6H8N2O2,68.300,127.000,-0.400,10,2,2,2,"InChI=1S/C6H8N2O2/c7-6(9)8-4-5-2-1-3-10-5/h1-3H,4H2,(H3,7,8,9)",C1=COC(=C1)CNC(=O)N,AUHRREWMYVOMRT-UHFFFAOYSA-N,furan-2-ylmethylurea,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,5,485350|485395|493033|504770|540299|588519|720554|720641|1272365|1347385,20050327,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|BLD Pharm|Chem-Space.com Database|ChemBank|Chembase.cn|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|DiscoveryGate|Enamine|eNovation Chemicals|EPA DSSTox|Google Patents|IBM|ICCB-Longwood Screening Facility, Ha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
597283,2-Hydroxy-5-(methylsulfanyl)benzoic acid,"32318-42-6|2-Hydroxy-5-(methylsulfanyl)benzoic acid|Benzoic acid, 2-hydroxy-5-(methylthio)-|2-hydroxy-5-(methylthio)benzoic acid|2-hydroxy-5-methylsulfanylbenzoic acid|5-(methylthio)salicylic acid|CHEMBL3126334|5-(METHYLTHIO)-SALICYLIC ACID|Salicylic acid, 5-(methylthio)-|3R6|SCHEMBL3187695|DTXSID60344492|ZINC4787230|5-methylthio-2-hydroxy-benzoic acid|BDBM50449368|5-(METHYLTHIO)SALICYLIC ACID)|AKOS022641649|MCULE-8366731578|DA-06904|2-Hydroxy-5-(methylsulfanyl)benzoic acid #|FT-0759001|Q27454059|Z258303624",184.210,C8H8O3S,82.800,172.000,3.100,12,2,4,2,"InChI=1S/C8H8O3S/c1-12-5-2-3-7(9)6(4-5)8(10)11/h2-4,9H,1H3,(H,10,11)",CSC1=CC(=C(C=C1)O)C(=O)O,DATDARDTUZHWMK-UHFFFAOYSA-N,2-hydroxy-5-methylsulfanylbenzoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,6,1076884,20050327,"A2B Chem|AA BLOCKS|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BindingDB|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|EPA DSSTox|Finetech Industry Limited|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|MuseChem|NCBI Structure|Next",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
641599,L-Lysinium(1+),"L-lysinium(1+)|Enisyl|L-lysine monocation|lysinium group|l lysine|Acetate, lysine|2-Ammonio-2-deamino-L-lysine|(2S)-2,6-Diammoniohexanoic acid|2-Ammonio-2-deamino-L-lysine anion|BDBM50352165|Q27114986",147.200,C6H15N2O2+,91.000,106.000,-3.000,10,3,3,5,"InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/p+1/t5-/m0/s1",C(CC[NH3+])C[C@@H](C(=O)O)N,KDXKERNSBIXSRK-YFKPBYRVSA-O,[(5S)-5-amino-5-carboxypentyl]azanium,Lysine,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20051129,"ABI Chem|BindingDB|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|NMRShiftDB|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SMID|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
644019,Cannabidiol,"cannabidiol|13956-29-1|(-)-Cannabidiol|(-)-trans-Cannabidiol|Epidiolex|CBD|UNII-19GBJ60SN5|(-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol|delta1(2)-trans-Cannabidiol|(-)-CBD|GWP42003-P|19GBJ60SN5|CHEMBL190461|CHEBI:69478|Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (-)-(E)-|2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol|2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol|C21H30O2|1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cycloh",314.500,C21H30O2,40.500,414.000,6.500,23,2,2,6,"InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1",CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,QHMBSVQNZZTUGM-ZWKOTPCHSA-N,"2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol",Cannabidiol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,49325|49491|49851|49852|130147|130160|132300|132306|132309|132313|133446|133447|165405|167511|167517|227699|243998|260280|260281|260282|260283|260286|260287|362541|362542|362543|362544|362545|362546|482146|482746|482747|482748|482749|482752|482753|482754|588211|588212|588213|624672|1127482|1127483|1127484|1193113|1193114|1193115|1193116|1193117|1193118|1193119|1193120|1193121|1193122|1193123|1193124|1193125|1193126|1193127|1252763|1252765|1252767|1257322|1259408|1303151|1303152|1303153|1303154|1303155|13031,20050608,"4C Pharma Scientific Inc|ABI Chem|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Axon Medchem|BenchChem|BIND|BindingDB|BioCyc|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFaces|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Comparative Toxicogenomics Database (CTD)|Crystallography Open Database|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|Egon Willighagen ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
656604,Bucillamine,"bucillamine|65002-17-7|Tiobutarit|Rimatil|N-(2-Mercapto-2-methylpropionyl)-L-cysteine|UNII-R80LRA5WTF|(R)-3-mercapto-2-(2-mercapto-2-methylpropanamido)propanoic acid|De-019|N-(2-Mercapto-2-methylpropanoyl)-L-cysteine|R80LRA5WTF|N-(2-Mercapto-2-methyl-1-oxopropyl)-L-cysteine|CHEMBL80830|L-CYSTEINE, N-(2-MERCAPTO-2-METHYL-1-OXOPROPYL)-|Thiobutarit|(2R)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid|DSSTox_CID_28513|DSSTox_RID_82785|DSSTox_GSID_48587|Bucilamina|Bucillaminum|(R)-3-Mercapto-2-(",223.300,C7H13NO3S2,68.400,218.000,0.400,13,4,5,4,"InChI=1S/C7H13NO3S2/c1-7(2,13)6(11)8-4(3-12)5(9)10/h4,12-13H,3H2,1-2H3,(H,8,11)(H,9,10)/t4-/m0/s1",CC(C)(C(=O)N[C@@H](CS)C(=O)O)S,VUAFHZCUKUDDBC-BYPYZUCNSA-N,(2R)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active,10,39018|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743244|1079931|1079933|1079935|1079936|1079937|1079,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|abcr GmbH|ABI Chem|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Amadis Chemical|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|BindingDB|BioChemPartner|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|CEGChem|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|Chemhere|Chemical Car",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
716315,3-Fluoro-L-phenylalanine,"3-Fluoro-L-phenylalanine|19883-77-3|L-3-fluorophenylalanine|m-Fluoro-L-phenylalanine|(2S)-2-amino-3-(3-fluorophenyl)propanoic acid|3-fluoro-l-phe|h-phe(3-f)-oh|3-Fluorophenylalanine|(s)-2-amino-3-(3-fluorophenyl)propanoic acid|l-3-fluorophe|l-3-fluoro phenylalanine|(S)-2-Amino-3-(3-fluorophenyl)propionic Acid|l-(3-fluorophenyl)alanine|Phenylalanine, 3-fluoro-|CHEBI:77957|L-Phenylalanine, 3-fluoro-|MFCD00066450|m-Fl-phenylalanine|h-m-fluoro-phe-oh|m-Fluoro-phenylalanine|PubChem17964|FL-PHE|(s)-3-fluorophenyl",183.180,C9H10FNO2,63.300,187.000,-1.900,13,2,4,3,"InChI=1S/C9H10FNO2/c10-7-3-1-2-6(4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m0/s1",C1=CC(=CC(=C1)F)C[C@@H](C(=O)O)N,VWHRYODZTDMVSS-QMMMGPOBSA-N,(2S)-2-amino-3-(3-fluorophenyl)propanoic acid,NULL,Biological Test Results|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,42710|42711|1303218|1303219,20050708,"3B Scientific (Wuhan) Corp|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Anward|Apexmol|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|BePharm Ltd.|BLD Pharm|BOC Science",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
736506,(R)-(4-Benzylmorpholin-2-yl)methanol,(R)-(4-benzylmorpholin-2-yl)methanol|943442-96-4|[(2R)-4-benzylmorpholin-2-yl]methanol|((R)-4-benzylmorpholin-2-yl)methanol|(R)-4-Benzyl-2-(hydroxymethyl)morpholine|[(2~{R})-4-(phenylmethyl)morpholin-2-yl]methanol|MFCD11848685|S7V|SCHEMBL1877824|DTXSID20353045|ZINC19851665|AKOS015856184|DS-14061|(R)-(4-Benzyl-morpholin-2-yl)-methanol|(2R)-4-Benzyl-2-(hydroxymethyl)morpholine|CS-0043179|W9675|S-1160,207.270,C12H17NO2,32.700,181.000,0.800,15,1,3,3,"InChI=1S/C12H17NO2/c14-10-12-9-13(6-7-15-12)8-11-4-2-1-3-5-11/h1-5,12,14H,6-10H2/t12-/m1/s1",C1CO[C@H](CN1CC2=CC=CC=C2)CO,WQNIKIMRIXHNFF-GFCCVEGCSA-N,[(2R)-4-benzylmorpholin-2-yl]methanol,NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20050708,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Aurum Pharmatech LLC|BePharm Ltd.|BLD Pharm|BOC Sciences|ChangChem|Chem-Space.com Database|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|Day Biochem|DiscoveryGate",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
739875,4-[2-(Phenylsulfanyl)ethyl]morpholine,4-[2-(phenylsulfanyl)ethyl]morpholine|4-(2-phenylsulfanylethyl)morpholine|JJG|Oprea1_705462|SCHEMBL11539203|4-[2-(Phenylthio)ethyl]morpholine|STK053397|ZINC19811418|AKOS001636232|MCULE-7700534089|EU-0043645|SR-01000481423|SR-01000481423-1|364739-42-4,223.340,C12H17NOS,37.800,165.000,2.100,15,0,3,4,"InChI=1S/C12H17NOS/c1-2-4-12(5-3-1)15-11-8-13-6-9-14-10-7-13/h1-5H,6-11H2",C1COCCN1CCSC2=CC=CC=C2,QDTNFZGZGSMNCU-UHFFFAOYSA-N,4-(2-phenylsulfanylethyl)morpholine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,422|1259310|1259374|1259422,20050708,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BenchChem|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Crystallography Open Database|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|Emory University Molecular Libraries Screening Center|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|Mcule|MolPort|NCBI Structure|NextBi",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
751089,"N-(1H-1,3-Benzodiazol-2-ylmethyl)butanamide","N-(1H-1,3-benzodiazol-2-ylmethyl)butanamide|N-(1H-benzimidazol-2-ylmethyl)butanamide|N-[(1H-benzimidazol-2-yl)methyl]butanamide|497230-46-3|N-(benzimidazol-2-ylmethyl)butanamide|W0A|IFLab1_002420|SCHEMBL8278816|HMS1418N22|ZINC200671|SBB046210|STL356889|AKOS000275545|MCULE-2410706457|NE48471|N-(1H-Benzoimidazol-2-ylmethyl)-butyramide|BB 0241993|EU-0056150|ST50086252|EN300-42304",217.270,C12H15N3O,57.800,244.000,1.500,16,2,2,4,"InChI=1S/C12H15N3O/c1-2-5-12(16)13-8-11-14-9-6-3-4-7-10(9)15-11/h3-4,6-7H,2,5,8H2,1H3,(H,13,16)(H,14,15)",CCCC(=O)NCC1=NC2=CC=CC=C2N1,MXDONONSXPZRMO-UHFFFAOYSA-N,N-(1H-benzimidazol-2-ylmethyl)butanamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,422|1949|485395|492967|493162|504770,20050708,"ABI Chem|AKos Consulting & Solutions|Ambeed|Ambinter|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChemBank|Chembase.cn|ChemBridge|ChemDB|ChemDiv|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|EDASA Scientific|Emory University Molecular Libraries Screening Center|Enamine|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Innovapharm|LabNetwork, a WuXi AppTec Company|Mcule|MolPort|NCBI Structure|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Protein D",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
755211,N-[(4-Phenyloxan-4-yl)methyl]acetamide,N-[(4-phenyloxan-4-yl)methyl]acetamide|N-[(4-phenyltetrahydro-2H-pyran-4-yl)methyl]acetamide|N-((4-phenyltetrahydro-2H-pyran-4-yl)methyl)acetamide|JHS|ChemDiv1_023123|Oprea1_234693|SCHEMBL15630668|HMS652L01|ZINC209570|STK831388|AKOS001629078|MCULE-3893958925|SDCCGMLS-0064994.P001|EU-0040541|SR-01000453647|SR-01000453647-1|F0911-4226|14006-33-8,233.310,C14H19NO2,38.300,253.000,1.600,17,1,2,3,"InChI=1S/C14H19NO2/c1-12(16)15-11-14(7-9-17-10-8-14)13-5-3-2-4-6-13/h2-6H,7-11H2,1H3,(H,15,16)",CC(=O)NCC1(CCOCC1)C2=CC=CC=C2,NGIANCGROXYCRZ-UHFFFAOYSA-N,N-[(4-phenyloxan-4-yl)methyl]acetamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,422|608|1033|1549|1552|1637|1648|492967|1224905|1259310|1259374|1259422,20050708,"ABI Chem|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|BenchChem|Burnham Center for Chemical Genomics|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|ChemDiv|ChemSpider|DiscoveryGate|Emory University Molecular Libraries Screening Center|Google Patents|ICCB-Longwood Screening Facility, Harvard Medical School|LabNetwork, a WuXi AppTec Company|Life Chemicals|Mcule|MolPort|MuseChem|NCBI Structure|NextBio|Pan Lab, Icahn School of Medicine at Mount Sinai|PATENTSCOPE (WIPO)|Protein Data Bank in E",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
782539,1-[4-(Naphthalen-1-ylmethyl)piperazin-1-yl]ethanone,1-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]ethanone|Oprea1_147631|STK483956|ZINC19632960|1-acetyl-4-(naphthylmethyl)piperazine|AKOS003391201|CCG-318225|MCULE-3389515096|ST50904636|AB00084730-01|SR-01000208594|SR-01000208594-1,268.350,C17H20N2O,23.600,336.000,2.300,20,0,2,2,"InChI=1S/C17H20N2O/c1-14(20)19-11-9-18(10-12-19)13-16-7-4-6-15-5-2-3-8-17(15)16/h2-8H,9-13H2,1H3",CC(=O)N1CCN(CC1)CC2=CC=CC3=CC=CC=C32,OCMXSYZDVBVSSV-UHFFFAOYSA-N,1-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]ethanone,NULL,Biological Test Results|Biomolecular Interactions and Pathways,2,1259310|1259374|1259422,20050708,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Mcule|MolPort|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|The Scripps Research Institute Molecular Screening Center|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
811874,"Methyl 2-methyl-4-phenyl-1,3-thiazol-5-ylcarbamate","methyl (2-methyl-4-phenyl-1,3-thiazol-5-yl)carbamate|MLS000107126|K1Y|methyl 2-methyl-4-phenyl-1,3-thiazol-5-ylcarbamate|CBMicro_022809|Cambridge id 5526752|CHEMBL1874922|methyl N-(2-methyl-4-phenyl-1,3-thiazol-5-yl)carbamate|HMS1694A07|HMS2494G10|ZINC323795|CCG-9919|STK822275|AKOS000524824|MCULE-9622838432|41260-96-2|SMR000111498|BIM-0022746.P001|AG-690/36830006|SR-01000420096|SR-01000420096-1|Z979145504",248.300,C12H12N2O2S,79.500,269.000,2.900,17,1,4,3,"InChI=1S/C12H12N2O2S/c1-8-13-10(9-6-4-3-5-7-9)11(17-8)14-12(15)16-2/h3-7H,1-2H3,(H,14,15)",CC1=NC(=C(S1)NC(=O)OC)C2=CC=CC=C2,WVXKXRCDQRXTDH-UHFFFAOYSA-N,"methyl N-(2-methyl-4-phenyl-1,3-thiazol-5-yl)carbamate",NULL,Biological Test Results|Biomolecular Interactions and Pathways,2,368|372|373|374|411|422|425|429|430|431|432|436|445|447|448|449|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|595|596|597|598|602|603|604|605|606|612|614|615|618|619|620|626|628|629|630|631|633|639|640|641|645|648|662|680|684|685|688|689|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|793|797|798|799|800|803|804|813|817|818|827|828|834|841|,20050708,"ABI Chem|AKos Consulting & Solutions|ASINEX|BenchChem|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|ChEMBL|ChemBridge|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|Enamine|ICCB-Longwood Screening Facility, Harvard Medical School|Innovapharm|Mcule|MLSMR|MolPort|MTDP|MuseChem|NCBI Structure|NextBio|Protein Data Bank in",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
828139,N-[3-(Carbamoylamino)phenyl]acetamide,N-[3-(carbamoylamino)phenyl]acetamide|720670-20-2|LJA|SCHEMBL8532903|ZINC349236|AKOS000173090|MCULE-4409551623|N-{3-[(aminocarbonyl)amino]phenyl}acetamide|AE-848/32797033,193.200,C9H11N3O2,84.200,230.000,-0.100,14,3,2,2,"InChI=1S/C9H11N3O2/c1-6(13)11-7-3-2-4-8(5-7)12-9(10)14/h2-5H,1H3,(H,11,13)(H3,10,12,14)",CC(=O)NC1=CC(=CC=C1)NC(=O)N,GVNXANNAMKHSRF-UHFFFAOYSA-N,N-[3-(carbamoylamino)phenyl]acetamide,NULL,Biomolecular Interactions and Pathways|Classification|Patents|Safety and Hazards,4,NULL,20050709,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambeed|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Google Patents|Mcule|MolPort|MuseChem|NCBI Structure|NextBio|Pan Lab, Icahn School of Medicine at Mount Sinai|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Specs|SureChEMBL|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
852723,"Acetamide, N-[(1R)-1-(1-naphthalenyl)ethyl]-","51117-53-4|N-[(1R)-1-naphthalen-1-ylethyl]acetamide|Acetamide,N-[(1R)-1-(1-naphthalenyl)ethyl]-|Acetamide, N-[(1R)-1-(1-naphthalenyl)ethyl]-|SCHEMBL6529748|DTXSID10357375|ZINC387735|N-[(R)-1-(1-Naphthyl)ethyl]acetamide|(R)-N-(1-(Naphthalen-1-yl)ethyl)acetamide",213.270,C14H15NO,29.100,251.000,2.700,16,1,1,2,"InChI=1S/C14H15NO/c1-10(15-11(2)16)13-9-5-7-12-6-3-4-8-14(12)13/h3-10H,1-2H3,(H,15,16)/t10-/m1/s1",C[C@H](C1=CC=CC2=CC=CC=C21)NC(=O)C,RFWQKLFRYNTMOB-SNVBAGLBSA-N,N-[(1R)-1-naphthalen-1-ylethyl]acetamide,NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20050709,"ABI Chem|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|PATENTSCOPE (WIPO)|SCRIPDB|SureChEMBL|Thieme Chemistry|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
871955,"N-(1,3,4-Thiadiazol-2-yl)benzenesulfonamide","N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide|5559-06-8|Cambridge id 5559068|Oprea1_079068|SCHEMBL299526|DTXSID70357937|ZINC438614|STK203976|AKOS000646711|MCULE-7171084770|ST50320885|(phenylsulfonyl)-1,3,4-thiadiazol-2-ylamine|benzenesulfonamide, N-1,3,4-thiadiazol-2-yl-|AB00089130-01|N-(1,3,4-thiadiazol-2-yl)-1-benzenesulfonamide|26907-49-3|W6G",241.300,C8H7N3O2S2,109.000,296.000,1.200,15,1,6,3,"InChI=1S/C8H7N3O2S2/c12-15(13,7-4-2-1-3-5-7)11-8-10-9-6-14-8/h1-6H,(H,10,11)",C1=CC=C(C=C1)S(=O)(=O)NC2=NN=CS2,CQVBWAMMROBBPU-UHFFFAOYSA-N,"N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Names and Identifiers|Patents,4,372|1159537,20050709,"AAA Chemistry|ABI Chem|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|ChemDiv|ChemSpider|ChemTik|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|EPA DSSTox|Google Patents|IBM|Mcule|MolPort|MTDP|NCBI Structure|NextBio|NIST Mass Spectrometry Data Center|Oakwood Products|Protein Data Bank in Europe (PDBe)|Southern Research Institute|SureChEMBL|TimTec|University of Kansas High Throughput Screening Laboratory|Vitas-M Labo",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
910270,"Pyrrolidine, 1-(phenoxyacetyl)-","1-(phenoxyacetyl)pyrrolidine|Pyrrolidine, 1-(phenoxyacetyl)-|2-phenoxy-1-(pyrrolidin-1-yl)ethan-1-one|112283-41-7|2-phenoxy-1-pyrrolidin-1-ylethanone|ACMC-20mfx9|MLS000719235|ARONIS25888|CHEMBL1351238|DTXSID20358691|HMS2712H16|ZINC493235|2-phenoxy-1-pyrrolidinylethan-1-one|STK416882|AKOS003410951|MCULE-1816868677|2-phenoxy-1-(pyrrolidin-1-yl)ethanone|SMR000291503|ST064699|2-oxo-2-(1-pyrrolidinyl)ethyl phenyl ether|AO-854/11152169|VVY",205.250,C12H15NO2,29.500,206.000,1.500,15,0,2,3,"InChI=1S/C12H15NO2/c14-12(13-8-4-5-9-13)10-15-11-6-2-1-3-7-11/h1-3,6-7H,4-5,8-10H2",C1CCN(C1)C(=O)COC2=CC=CC=C2,FYNNGWZCHCSIQA-UHFFFAOYSA-N,2-phenoxy-1-pyrrolidin-1-ylethanone,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,485|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1229|1230|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1469|1471|1477|1479,20050709,"ABI Chem|Achemica|AKos Consulting & Solutions|Aronis|ASINEX|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemBridge|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|EPA DSSTox|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|King Scientific|Mcule|MLSMR|MolPort|MuseChem|NCBI Structure|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Specs|TimTec|UW Madison, Small Molecule Screening Facility|Vitas-M L",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
923827,N-(2-Phenylethyl)-1H-benzimidazol-2-amine,N-(2-phenylethyl)-1H-benzimidazol-2-amine|benzimidazol-2-yl(2-phenylethyl)amine|727392-70-3|LUY|JHICC02029|SCHEMBL2674051|HMS1599J12|ZINC513006|MFCD06192754|SBB082475|STK210322|AKOS002267653|MCULE-5540790876|SDCCGSBI-0099606.P001|(1H-Benzoimidazol-2-yl)-phenethyl-amine|ST50161139|SR-01000301186|SR-01000301186-1|WNG,237.300,C15H15N3,40.700,250.000,3.500,18,2,2,4,"InChI=1S/C15H15N3/c1-2-6-12(7-3-1)10-11-16-15-17-13-8-4-5-9-14(13)18-15/h1-9H,10-11H2,(H2,16,17,18)",C1=CC=C(C=C1)CCNC2=NC3=CC=CC=C3N2,OWETVOGOOABRTJ-UHFFFAOYSA-N,N-(2-phenylethyl)-1H-benzimidazol-2-amine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents|Biological Test Results: Active,4,1949|485350|485395|492967|493033|504770|540299|588519|602314|651828|720641|720717|1224905|1259310|1259374|1259417|1259422|1347422,20050709,"abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Burnham Center for Chemical Genomics|Chem-Space.com Database|ChemBridge|ChemDB|Chemhere|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Innovapharm|Johns Hopkins Ion Channel Center|LabNetwork, a WuXi AppTec Company|Mcule|MolPort|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Race Chemical|Southern Research Inst",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
935612,2-Fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide,"SMR000080105|MLS000065521|2-fluoro-N-(2-pyridin-4-ylethyl)benzamide|2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide|2-fluoro-N-[2-(4-pyridinyl)ethyl]benzamide|U0V|cid_935612|CHEMBL1440644|BDBM48594|HMS2425E03|ZINC529238|STK775412|AKOS005617877|MCULE-2684784593|ST093825|2-fluoro-N-[2-(4-pyridyl)ethyl]benzamide|2-fluoranyl-N-(2-pyridin-4-ylethyl)benzamide|2-fluoro-N~1~-[2-(4-pyridyl)ethyl]benzamide|Benzamide, 2-fluoro-N-[2-(4-pyridinyl)ethyl]-|SR-01000290645|SR-01000290645-1|(2-fluorophenyl)-N-(2-(4-pyridyl)ethyl",244.260,C14H13FN2O,42.000,267.000,2.200,18,1,3,4,"InChI=1S/C14H13FN2O/c15-13-4-2-1-3-12(13)14(18)17-10-7-11-5-8-16-9-6-11/h1-6,8-9H,7,10H2,(H,17,18)",C1=CC=C(C(=C1)C(=O)NCCC2=CC=NC=C2)F,HQJMILNSKHZGJL-UHFFFAOYSA-N,2-fluoro-N-(2-pyridin-4-ylethyl)benzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents|Biological Test Results: Micromolar,4,360|361|368|373|374|411|422|425|429|430|431|432|436|445|447|448|449|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|552|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|612|618|619|620|626|628|629|630|631|633|639|640|641|645|648|662|680|684|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|784|793|796|797|798|799|800|802|803|,20050709,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BindingDB|Chem-Space.com Database|ChEMBL|ChemBlock|ChemBridge|ChemDB|ChemDiv|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|NIST Mass Spectrometry Data Center|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Southern Research Institute|The Scripps Research Institute Molecular Screening Center|TimTec|Univer",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
949147,N-(1H-Benzimidazol-2-ylmethyl)-2-methylpropanamide,"N-(1H-1,3-benzodiazol-2-ylmethyl)-2-methylpropanamide|500269-41-0|N-[(1H-benzimidazol-2-yl)methyl]-2-methylpropanamide|N-(1H-benzimidazol-2-ylmethyl)-2-methylpropanamide|SCHEMBL13396939|ZINC549915|SBB046209|STL300406|AKOS000275544|MCULE-2821300626|NE47382|BB 0241992|EN300-38864|N-(1H-Benzoimidazol-2-ylmethyl)-isobutyram ide|N-(benzimidazol-2-ylmethyl)-2-methylpropanamide|Z26781943|N-[(1H-1,3-benzodiazol-2-yl)methyl]-2-methylpropanamide|W0V",217.270,C12H15N3O,57.800,255.000,1.900,16,2,2,3,"InChI=1S/C12H15N3O/c1-8(2)12(16)13-7-11-14-9-5-3-4-6-10(9)15-11/h3-6,8H,7H2,1-2H3,(H,13,16)(H,14,15)",CC(C)C(=O)NCC1=NC2=CC=CC=C2N1,KBFKODIOYYFXAF-UHFFFAOYSA-N,N-(1H-benzimidazol-2-ylmethyl)-2-methylpropanamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050709,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambeed|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemDB|ChemSpider|ChemTik|DiscoveryGate|EDASA Scientific|Enamine|Google Patents|Innovapharm|LabNetwork, a WuXi AppTec Company|Mcule|MolPort|NCBI Structure|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
961874,4-Methanesulfonamidobenzamide,4-methanesulfonamidobenzamide|4-[(methylsulfonyl)amino]benzamide|4-(methylsulfonylamino)benzamide|329043-17-6|4-(methanesulfonamido)benzamide|S2S|Oprea1_172998|4-methanesulfonylamino-benzamide|SCHEMBL2026762|ZINC571755|STK416798|AKOS003001339|MCULE-1633598801|ST50913652|Z45656995,214.240,C8H10N2O3S,97.600,299.000,0.100,14,2,4,3,"InChI=1S/C8H10N2O3S/c1-14(12,13)10-7-4-2-6(3-5-7)8(9)11/h2-5,10H,1H3,(H2,9,11)",CS(=O)(=O)NC1=CC=C(C=C1)C(=O)N,DVCWUTSWCVQZSC-UHFFFAOYSA-N,4-(methanesulfonamido)benzamide,NULL,Biomolecular Interactions and Pathways|Literature|Patents,3,NULL,20050709,"ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Enamine|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
978238,3-Chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide,3-chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide|(3-chlorophenyl)-N-(2-hydroxy-tert-butyl)carboxamide|JOV|ZINC621626|SBB042362|AKOS000270752|MCULE-1141464160|ST50762238|SR-01000275693|SR-01000275693-1,227.690,C11H14ClNO2,49.300,231.000,1.800,15,2,2,3,"InChI=1S/C11H14ClNO2/c1-11(2,7-14)13-10(15)8-4-3-5-9(12)6-8/h3-6,14H,7H2,1-2H3,(H,13,15)",CC(C)(CO)NC(=O)C1=CC(=CC=C1)Cl,XZDXDRPMHCVWBK-UHFFFAOYSA-N,3-chloro-N-(1-hydroxy-2-methylpropan-2-yl)benzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways,2,1949|1259310|1259374|1259422,20050709,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|ChemBridge|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Mcule|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|The Scripps Research Institute Molecular Screening Center|TimTec|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1096336,"3-(3,5-Dimethyl-1H-1,2,4-triazol-1-yl)propanoic acid","842971-05-5|3-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)propanoic acid|3-(dimethyl-1H-1,2,4-triazol-1-yl)propanoic acid|MFCD05668680|3-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-propionic acid|3-(3,5-dimethyl-1,2,4-triazolyl)propanoic acid|BAS 09717458|1H-1,2,4-Triazole-1-propanoicacid, 3,5-dimethyl-|3-(3,5-dimethyl-1,2,4-triazol-1-yl)propanoic acid|DTXSID70360264|ZINC818919|5-Phenylpyridine-2-carboxylic?acid|BBL010698|SBB042060|STK387014|AKOS000270524|MCULE-5295932906|VS-02626|BB 0219140|ST50288357|EN300-41366|L-2501|F3",169.180,C7H11N3O2,68.000,174.000,0.200,12,1,4,3,"InChI=1S/C7H11N3O2/c1-5-8-6(2)10(9-5)4-3-7(11)12/h3-4H2,1-2H3,(H,11,12)",CC1=NN(C(=N1)C)CCC(=O)O,ZEQPXXPPGJVSJN-UHFFFAOYSA-N,"3-(3,5-dimethyl-1,2,4-triazol-1-yl)propanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Names and Identifiers,3,940|1422,20050710,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Angene Chemical|ASINEX|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|DiscoveryGate|EDASA Scientific|Emory University Molecular Libraries Screening Center|Enamine|eNovation Chemicals|EPA DSSTox|Eximed Laboratory|Innovapharm|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Life Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1224835,1-Methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide,1-methyl-N-{[(2S)-oxolan-2-yl]methyl}-1H-pyrazole-3-carboxamide|JGY|ZINC1001271|AKOS034815661|(S)-1-Methyl-N-((tetrahydrofuran-2-yl)methyl)-1H-pyrazole-3-carboxamide|2196041-45-7,209.240,C10H15N3O2,56.200,235.000,0.300,15,1,3,3,"InChI=1S/C10H15N3O2/c1-13-5-4-9(12-13)10(14)11-7-8-3-2-6-15-8/h4-5,8H,2-3,6-7H2,1H3,(H,11,14)/t8-/m0/s1",CN1C=CC(=N1)C(=O)NC[C@@H]2CCCO2,WBAZBPMBDLSPCX-QMMMGPOBSA-N,1-methyl-N-[[(2S)-oxolan-2-yl]methyl]pyrazole-3-carboxamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20050710,ABI Chem|AKos Consulting & Solutions|BLD Pharm|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1480347,"Methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate","methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate|GQJ|ZINC1393275|AKOS034798485",239.220,C11H13NO5,80.000,319.000,0.200,17,1,5,3,"InChI=1S/C11H13NO5/c1-16-11(15)8-5-7(13)6-12(8)10(14)9-3-2-4-17-9/h2-4,7-8,13H,5-6H2,1H3/t7-,8+/m1/s1",COC(=O)[C@@H]1C[C@H](CN1C(=O)C2=CC=CO2)O,GVYWVRYDCMRUCE-SFYZADRCSA-N,"methyl (2S,4R)-1-(furan-2-carbonyl)-4-hydroxypyrrolidine-2-carboxylate",NULL,Biomolecular Interactions and Pathways,1,NULL,20050711,ABI Chem|AKos Consulting & Solutions|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1530178,N-[2-(4-Fluorophenyl)ethyl]methanesulfonamide,N-[2-(4-fluorophenyl)ethyl]methanesulfonamide|432529-74-3|S9S|Cambridge id 6834895|ZINC1457001|STK084624|AKOS003299020|MCULE-4588528201|N-(4-fluorophenethyl)methanesulfonamide|BS-34560|ST094230|[2-(4-fluorophenyl)ethyl](methylsulfonyl)amine|Z45705015,217.260,C9H12FNO2S,54.600,253.000,1.400,14,1,4,4,"InChI=1S/C9H12FNO2S/c1-14(12,13)11-7-6-8-2-4-9(10)5-3-8/h2-5,11H,6-7H2,1H3",CS(=O)(=O)NCCC1=CC=C(C=C1)F,JZUQJFQXYYHUJT-UHFFFAOYSA-N,N-[2-(4-fluorophenyl)ethyl]methanesulfonamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Safety and Hazards,4,1159537,20050711,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambeed|BLD Pharm|Chem-Space.com Database|ChemBridge|ChemDB|ChemDiv|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Combi-Blocks|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|Enamine|Key Organics/BIONET|Mcule|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|TimTec|University of Kansas High Throughput Screening Laboratory|Vitas-M Laboratory|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1549073,2-Amino-5-guanidinovaleric acid,L-arginine(+)|arginine|L-arginine cation|arginine(1+)|L-argininium(1+)|L-arginine monocation|2-amino-5-guanidinovaleric acid|(2S)-2-ammonio-5-guanidiniopentanoate|L-argininium|CHEBI:32682|Q28529679|(2S)-2-azaniumyl-5-{[azaniumyl(imino)methyl]amino}pentanoate,175.210,C6H15N4O2+,134.000,171.000,-3.500,12,4,2,4,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/p+1/t4-/m0/s1",C(C[C@@H](C(=O)[O-])[NH3+])C[NH+]=C(N)N,ODKSFYDXXFIFQN-BYPYZUCNSA-O,(2S)-2-azaniumyl-5-(diaminomethylideneazaniumyl)pentanoate,Arginine,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,9,NULL,20040916,"A&J Pharmtech CO., LTD.|ABI Chem|BioCyc|ChEBI|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|IBM|NextBio|NovoSeek|SCRIPDB|Thieme Chemistry|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways, PDB, Protein Data Bank]"
2517697,2-Amino-N-(3-chloro-2-methylphenyl)acetamide,N-(3-chloro-2-methylphenyl)glycinamide|2-amino-N-(3-chloro-2-methylphenyl)acetamide|887359-01-5|VXD|SCHEMBL2986016|ZINC3399182|BBL019456|HTS008602|MFCD06386704|STL183965|AKOS000204980|MCULE-2504112533|N1-(3-Chloro-2-methylphenyl)glycinamide|H2980|2-Amino-N-(3-chloro-2-methyl-phenyl)-acetamide,198.650,C9H11ClN2O,55.100,187.000,0.900,13,2,2,2,"InChI=1S/C9H11ClN2O/c1-6-7(10)3-2-4-8(6)12-9(13)5-11/h2-4H,5,11H2,1H3,(H,12,13)",CC1=C(C=CC=C1Cl)NC(=O)CN,FPQHYOUXKZRHSA-UHFFFAOYSA-N,2-amino-N-(3-chloro-2-methylphenyl)acetamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050716,"A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Combi-Blocks|DiscoveryGate|Enamine|Google Patents|IBM|Key Organics/BIONET|King Scientific|Matrix Scientific|Mcule|MolPort|NCBI Structure|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Sigma-Aldrich|Smolec",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2763377,"Ethyl 2-(1,1-dioxidothiomorpholino)acetate","343334-01-0|Ethyl 2-(1,1-dioxidothiomorpholino)acetate|ethyl 2-(1,1-dioxo-1lambda6,4-thiazinan-4-yl)acetate|Ethyl (1,1-dioxo-1lambda~6~,4-thiazinan-4-yl)acetate|Ethyl 2-(1,1-dioxo-1lambda6,4-thiazinan-4-yl)-acetate|Ethyl 2-(1,1-dioxo-1,4-thiazinan-4-yl)acetate|VWV|MLS000721374|CHEMBL1308529|SCHEMBL12551108|DTXSID50376929|ethyl 2-(1,1-dioxo-1lambda~6~,4-thiazinan-4-yl)acetate|HMS2674B15|0944AE|MFCD02081985|SBB096164|ZINC34785075|AKOS005069478|MCULE-5369422532|VZ32016|SMR000335449|DB-048600|FT-0644464|Ethyl 2",221.280,C8H15NO4S,72.100,279.000,-0.300,14,0,5,4,"InChI=1S/C8H15NO4S/c1-2-13-8(10)7-9-3-5-14(11,12)6-4-9/h2-7H2,1H3",CCOC(=O)CN1CCS(=O)(=O)CC1,KWVBKMSCALADDC-UHFFFAOYSA-N,"ethyl 2-(1,1-dioxo-1,4-thiazinan-4-yl)acetate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents|Biological Test Results: Active,7,485|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1251|1274|1276|1285|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1469|1471|1477|1479,20050719,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambinter|Angene Chemical|Biosynth Carbosynth|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|Debye Scientific Co., Ltd|D",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2772402,"1-(Pyridin-2-YL)-1,4-diazepane","287114-32-3|1-(PYRIDIN-2-YL)-1,4-DIAZEPANE|1-Pyridin-2-yl-[1,4]diazepane|1-(2-Pyridyl)homopiperazine|1-pyridin-2-yl-1,4-diazepane|1-(2-Pyridinyl)hexahydro-1H-1,4-diazepine|1-(2-pyridyl)-1,4-diazaperhydroepine|1-(2-pyridyl)-1,4-diazepane|ACMC-20a4d8|1H-1,4-Diazepine, hexahydro-1-(2-pyridinyl)-|SCHEMBL1484965|CHEMBL4515199|DTXSID90378245|ACT03780|AMY24745|ANW-56586|MFCD06409204|SBB014428|ZINC19015194|AKOS000181968|MCULE-6644187768|NE32723|AS-41687|1-(2-Pyridyl)hexahydro-1H-1,4-diazepine|A5421|BB 0256856|FT-06",177.250,C10H15N3,28.200,149.000,1.000,13,1,3,1,"InChI=1S/C10H15N3/c1-2-6-12-10(4-1)13-8-3-5-11-7-9-13/h1-2,4,6,11H,3,5,7-9H2",C1CNCCN(C1)C2=CC=CC=N2,YIVVBOYHOANILT-UHFFFAOYSA-N,"1-pyridin-2-yl-1,4-diazepane",NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20050719,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|ASINEX|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BLD Pharm|BOC Sciences|ChangChem|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2795474,1-Methyl-5-phenyl-1H-pyrazole-4-carboxylic acid,"1-Methyl-5-phenyl-1H-pyrazole-4-carboxylic acid|105994-75-0|1-methyl-5-phenylpyrazole-4-carboxylic acid|1H-Pyrazole-4-carboxylicacid, 1-methyl-5-phenyl-|1FF|SDCCGMLS-0066070.P001|ACMC-1C8OT|SCHEMBL826906|1H-Pyrazole-4-carboxylic acid, 1-methyl-5-phenyl-|CHEMBL2326886|DTXSID30383696|ZINC159056|MFCD04038957|SBB092924|AKOS009159066|PS-3429|FT-0608075|Y6937|K-0519|W-204596|Q27452014|1-methyl-5-phenyl-1H-pyrazole-4-carboxylic acid, AldrichCPR",202.210,C11H10N2O2,55.100,239.000,1.400,15,1,3,2,"InChI=1S/C11H10N2O2/c1-13-10(8-5-3-2-4-6-8)9(7-12-13)11(14)15/h2-7H,1H3,(H,14,15)",CN1C(=C(C=N1)C(=O)O)C2=CC=CC=C2,MXGOKNNGBUOAGF-UHFFFAOYSA-N,1-methyl-5-phenylpyrazole-4-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,6,608|1033|1549|1552|1637|1648|726865|1259397|1259398|1259423,20050719,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemica|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Angel Pharmatech Ltd.|Angene Chemical|Aurum Pharmatech LLC|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Burnham Center for Chemical Genomics|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Combi-Blocks|Day Biochem|DiscoveryGate|Egon ",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2815595,N-(6-Methoxypyridin-3-yl)-N'-thiophen-2-ylurea,N-(6-methoxypyridin-3-yl)-N'-thiophen-2-ylurea|VZM|MLS001181964|CHEMBL1580797|HMS2853M11|ZINC157953|CCG-53690|MCULE-6218639569|SMR000567651|SR-01000642840-1,249.290,C11H11N3O2S,91.500,265.000,1.700,17,2,4,3,"InChI=1S/C11H11N3O2S/c1-16-9-5-4-8(7-12-9)13-11(15)14-10-3-2-6-17-10/h2-7H,1H3,(H2,13,14,15)",COC1=NC=C(C=C1)NC(=O)NC2=CC=CS2,QQTNSKDCQAMODS-UHFFFAOYSA-N,1-(6-methoxypyridin-3-yl)-3-thiophen-2-ylurea,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Biological Test Results: Active,4,811|833|1044|1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1792|1800|1813|1814|1817|1822|1823|1825|1832|1845|1850|1861|1863|1868|1875|1885|1903|1910|1961|1979|1984|1986|1996|2006|2012|2013|2014|2016|2023|2025|2029|2052|2058|2066|2071|2073|2094|2097|2098|2099|2100|2101|2156|2216|2221|2227|2237|2239|2247|2288|2289|2291|2314|2315|2326|2391|2451|2462|2472|2517|2528|2546|2550|2551|2553|2557|2563|2629|2642|2648|2650|2661|2662,20050719,"ABI Chem|Center for Chemical Genomics, University of Michigan|ChEMBL|ChemDB|ChemExper Chemical Directory|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|The Scripps Research Institute Molecular Screening Center|UW Madison, Small Molecule Screening Facility|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3000226,Fusidic acid,"fusidic acid|Fusidine|6990-06-3|Ramycin|Fucithalmic|Fucidic acid|Fucidin acid|FUCIDIN|Fusidate|Fucidate|Flucidin|SQ 16,603|(-)-Fusidic acid|SQ 16603|UNII-59XE10C19C|MLS001332649|(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid|CHEBI:29013|CEM-102|59XE10C19C|MFCD00865135|NSC-56192|SMR000857101|(Z)-2-((3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetoxy-3,11-dihyd",516.700,C31H48O6,104.000,994.000,5.500,37,3,6,6,"InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1",C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\\C(=O)O)OC(=O)C)C)O)C,IECPWNUMDGFDKC-MZJAQBGESA-N,"(2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid",Fusidic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,248|1195|1511|1554|1662|1663|1672|1811|1813|1814|1832|1850|1863|1875|1885|1899|1900|1902|1903|1906|1910|1914|1915|1947|1950|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2102|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2501|2517|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|91481|224494|261273|261274|261275|261276|261277|26127,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|ACT Chemical|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|AmicBase - Antimicrobial Activities|AN PharmaTech|AOBIOUS INC|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Av",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3000506,"(R)-[2,8-Bis(trifluoromethyl)-4-quinolyl]-[(2R)-2-piperidyl]methanol","(-)-Threo-Mefloquine|mefloquine|RTI1174-1-1|51744-84-4|(R)-[2,8-bis(trifluoromethyl)-4-quinolyl]-[(2R)-2-piperidyl]methanol|(?)-threo-Mefloquine|(R,R)-MEFLOQUINE|SCHEMBL21781|CHEMBL411686|ZINC537964|BDBM50377454|NSC790107|NSC-790107|RTI1172-1-1|NCGC00016864-01|UNII-GB2GL4S36Z component XEEQGYMUWCZPDN-IUODEOHRSA-N|(+/-)-threo-4-Quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-|(-)-threo-4-Quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, (11R, 2'R)-|(-)-threo-4-Quinolinemet",378.310,C17H16F6N2O,45.200,483.000,3.600,26,2,9,2,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15-/m1/s1",C1CCN[C@H](C1)[C@@H](C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,XEEQGYMUWCZPDN-IUODEOHRSA-N,"(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol",Mefloquine,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|995|1030|1379|1452|1454|1457|1458|1467|1469|1471|1476|1477|1478|1479|1487|1490|1519|1766|1768|1851|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|135327|331674|331675|485281|485290|504327|504332|504847|504865|588579|602332|651635|720532|720533|743244|743322|743323|743324|74,20050801,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|DTP/NCI|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LGC Standards|MolPort|National Center for Advancing Translational Scie",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
3057354,Tetramethylol-melamin-dioxy-propylen [German],"Tetramethylol-melamin-dioxy-propylen [German]|74037-62-0|MAF|Tetramethylol-melamin-dioxy-propylen|((6-Bis(1-hydroxy-2-propenyl)amino)-s-triazine-2,4-diyl)dinitrilotetramethanol|Methanol, ((6-bis(1-hydroxy-2-propenyl)amino)-s-triazine-2,4-diyl)dinitrilotetra-|DTXSID20995363|1-[[4,6-bis[bis(hydroxymethyl)amino]-1,3,5-triazin-2-yl]-(1-hydroxyprop-2-enyl)amino]prop-2-en-1-ol|1,1'-({4,6-Bis[bis(hydroxymethyl)amino]-1,3,5-triazin-2-yl}azanediyl)di(prop-2-en-1-ol)",358.350,C13H22N6O6,170.000,377.000,-0.800,25,6,12,11,"InChI=1S/C13H22N6O6/c1-3-9(24)19(10(25)4-2)13-15-11(17(5-20)6-21)14-12(16-13)18(7-22)8-23/h3-4,9-10,20-25H,1-2,5-8H2",C=CC(N(C1=NC(=NC(=N1)N(CO)CO)N(CO)CO)C(C=C)O)O,JANNWOSDBXOFPU-UHFFFAOYSA-N,"1-[[4,6-bis[bis(hydroxymethyl)amino]-1,3,5-triazin-2-yl]-(1-hydroxyprop-2-enyl)amino]prop-2-en-1-ol",NULL,Classification|Drug and Medication Information|Names and Identifiers|Toxicity,4,NULL,20050809,ABI Chem|ChemIDplus|ChemSpider|DiscoveryGate|EPA DSSTox|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|NextBio|Smolecule|THE BioTek|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3086464,Heme arginate,Heme arginate|Q14035818,792.700,C40H48FeN8O6+2,260.000,1180.000,NULL,55,8,10,13,"InChI=1S/C34H34N4O4.C6H14N4O2.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;7-4(5(11)12)2-1-3-10-6(8)9;/h7-8,13-16,35-36H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42);4H,1-3,7H2,(H,11,12)(H4,8,9,10);/q;;+2/t;4-;/m.0./s1",CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C=C.C(C[C@@H](C(=O)O)N)CN=C(N)N.[Fe+2],MGQITOFVXOEWNL-INZIHYEWSA-N,"(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid;3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid;iron(2+)",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers,5,NULL,20050809,"ABI Chem|ChemSpider|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|LeadScope|NextBio|NovoSeek|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3613666,"N-(4-Methyl-1,3-thiazol-2-yl)propanamide","N-(4-methyl-1,3-thiazol-2-yl)propanamide|N-(4-Methylthiazol-2-yl)propionamide|13808-59-8|JFP|SCHEMBL4097866|CHEMBL4096653|ZINC69044|AKOS001620463|MCULE-9548596266|EU-0040052|SR-01000449565|SR-01000449565-1|Z30820160",170.230,C7H10N2OS,70.200,151.000,1.300,11,1,3,2,"InChI=1S/C7H10N2OS/c1-3-6(10)9-7-8-5(2)4-11-7/h4H,3H2,1-2H3,(H,8,9,10)",CCC(=O)NC1=NC(=CS1)C,AIOZNYOAFODHNA-UHFFFAOYSA-N,"N-(4-methyl-1,3-thiazol-2-yl)propanamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Patents|Safety and Hazards,6,422|1259310|1259374|1259422|1465872|1465873|1465874,20050909,ABI Chem|AKos Consulting & Solutions|Ambeed|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|ChEMBL|ChemDB|DiscoveryGate|Emory University Molecular Libraries Screening Center|Enamine|Google Patents|IBM|Mcule|MolPort|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|The Scripps Research Institute Molecular Screening Center|Thieme Chemistry|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3759658,1-[4-(Thiophene-2-sulfonyl)-piperazin-1-yl]-ethanone,SCHEMBL18711517|ZINC7308571|AKOS001305776|UPCMLD0ENAT5691330:001|AB00014135-01|1-[4-(Thiophene-2-sulfonyl)-piperazin-1-yl]-ethanone,274.400,C10H14N2O3S2,94.300,383.000,0.400,17,0,5,2,"InChI=1S/C10H14N2O3S2/c1-9(13)11-4-6-12(7-5-11)17(14,15)10-3-2-8-16-10/h2-3,8H,4-7H2,1H3",CC(=O)N1CCN(CC1)S(=O)(=O)C2=CC=CS2,YYXLVWKAHWXWTR-UHFFFAOYSA-N,1-(4-thiophen-2-ylsulfonylpiperazin-1-yl)ethanone,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,1259398|1259399|1259423,20050910,ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|ChemDB|ChemSpider|DiscoveryGate|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|SureChEMBL|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|UPCMLD|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3784209,"1-[4-(2,6-Difluorophenyl)sulfonylpiperazin-1-yl]ethanone",AB00018221-01,304.320,C12H14F2N2O3S,66.100,448.000,0.500,20,0,6,2,"InChI=1S/C12H14F2N2O3S/c1-9(17)15-5-7-16(8-6-15)20(18,19)12-10(13)3-2-4-11(12)14/h2-4H,5-8H2,1H3",CC(=O)N1CCN(CC1)S(=O)(=O)C2=C(C=CC=C2F)F,IQKBRWMUAKOXSG-UHFFFAOYSA-N,"1-[4-(2,6-difluorophenyl)sulfonylpiperazin-1-yl]ethanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20050911,ABI Chem|Ambinter|ChemDB|ChemSpider|DiscoveryGate|MolPort|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute,Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4291023,2-Thiophen-2-yl-1H-imidazole,"2-thiophen-2-yl-1H-imidazole|136103-77-0|2-(thiophen-2-yl)-1H-imidazole|2-(thiophen-2-yl)imidazole|1H-Imidazole, 2-(2-thienyl)-|2-(2-thienyl)-1H-imidazole|JG4|2-thiophenyl-imidazole|PubChem19943|2-(thienyl-2)imidazole|ACMC-20e06w|SCHEMBL11655|DTXSID60401615|ZINC389924|AMY32847|MFCD02677596|AKOS010146675|MB02450|MCULE-5219555940|NE12127|AS-38557|DA-11384|FT-0725765|EN300-51092|A807028|J-006809|F2198-0039",150.200,C7H6N2S,56.900,118.000,1.400,10,1,2,1,"InChI=1S/C7H6N2S/c1-2-6(10-5-1)7-8-3-4-9-7/h1-5H,(H,8,9)",C1=CSC(=C1)C2=NC=CN2,UZLSJAUHCCPJMC-UHFFFAOYSA-N,2-thiophen-2-yl-1H-imidazole,NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20050914,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemica|Achemtek|AKos Consulting & Solutions|Alichem|Amadis Chemical|Angel Pharmatech Ltd.|Angene Chemical|Apexmol|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CAPOT|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|Chemical Synthesis Database|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|Enamine|eNovat",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4379552,1-(4-(2-Nitrophenyl)piperazin-1-yl)ethanone,1-(4-(2-nitrophenyl)piperazin-1-yl)ethanone|1-[4-(2-nitrophenyl)piperazin-1-yl]ethanone|1-[4-(2-nitrophenyl)piperazin-1-yl]ethan-1-one|100138-76-9|Oprea1_142892|SCHEMBL12890005|ZINC4115622|1-acetyl-4-{2-nitrophenyl}piperazine|AKOS008920651|MCULE-6565547530|DS-021213|AE-562/12222859|F1911-3585,249.270,C12H15N3O3,69.400,321.000,1.100,18,0,4,1,"InChI=1S/C12H15N3O3/c1-10(16)13-6-8-14(9-7-13)11-4-2-3-5-12(11)15(17)18/h2-5H,6-9H2,1H3",CC(=O)N1CCN(CC1)C2=CC=CC=C2[N+](=O)[O-],LEDSXFUCNNKEDB-UHFFFAOYSA-N,1-[4-(2-nitrophenyl)piperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050914,"ABI Chem|AKos Consulting & Solutions|Chem-Space.com Database|ChemBank|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Debye Scientific Co., Ltd|DiscoveryGate|Google Patents|Life Chemicals|Mcule|MolPort|MuseChem|NextBio|Pan Lab, Icahn School of Medicine at Mount Sinai|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Specs|SureChEMBL|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4693938,N-(2-Fluorophenyl)ethanesulfonamide,"N-(2-fluorophenyl)ethanesulfonamide|N-(2-fluorophenyl)ethane-1-sulfonamide|544662-80-8|VVG|Ethanesulfonamide,N-(2-fluorophenyl)-|SCHEMBL3712510|CHEMBL4539250|ZINC6048796|AKOS003959960|MCULE-1542581640|NE40736|AO-854/43464170",203.240,C8H10FNO2S,54.600,247.000,1.400,13,1,4,3,"InChI=1S/C8H10FNO2S/c1-2-13(11,12)10-8-6-4-3-5-7(8)9/h3-6,10H,2H2,1H3",CCS(=O)(=O)NC1=CC=CC=C1F,MRTGYFRQZQCITC-UHFFFAOYSA-N,N-(2-fluorophenyl)ethanesulfonamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050916,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Google Patents|IBM|Mcule|MolPort|MuseChem|NCBI Structure|NextBio|NextMove Software|Protein Data Bank in Europe (PDBe)|SCRIPDB|Specs|SureChEMBL|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4961407,Best,Best|SCHEMBL9475749,572.300,C10H8S4Se4,101.000,412.000,NULL,18,0,4,0,InChI=1S/C10H8S4Se4/c1-2-16-8-7(15-1)11-5(12-8)6-13-9-10(14-6)18-4-3-17-9/h1-4H2,C1C[Se]C2=C([Se]1)SC(=C3SC4=C(S3)[Se]CC[Se]4)S2,LVVFDYVGKLFIMU-UHFFFAOYSA-N,"2-(5,6-dihydro-[1,4]diselenino[2,3-d][1,3]dithiol-2-ylidene)-5,6-dihydro-[1,4]diselenino[2,3-d][1,3]dithiole",NULL,Drug and Medication Information|Patents,2,NULL,20050917,ABI Chem|ChemDB|ChemSpider|DiscoveryGate|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|PATENTSCOPE (WIPO)|SCRIPDB|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4962113,"7-(Furan-2-ylmethyl)-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine","103026-12-6|7-(furan-2-ylmethyl)-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine|7-(2-furylmethyl)-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine|7-[(Furan-2-yl)methyl]-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine|7-(furan-2-ylmethyl)-5,6-dimethylpyrrolo[2,3-d]pyrimidin-4-amine|ACMC-20ebr3|DTXSID70407007|ZINC3888754|MFCD06655548|STK603717|7H-Pyrrolo[2,3-d]pyrimidin-4-amine,7-(2-furanylmethyl)-5,6-dimethyl-|AKOS005539829|MCULE-2833226187|NE13375|EN300-12875|SR-01000065935|J-519024|SR-01000065935-1|Z85933",242.280,C13H14N4O,69.900,301.000,1.700,18,1,4,2,"InChI=1S/C13H14N4O/c1-8-9(2)17(6-10-4-3-5-18-10)13-11(8)12(14)15-7-16-13/h3-5,7H,6H2,1-2H3,(H2,14,15,16)",CC1=C(N(C2=NC=NC(=C12)N)CC3=CC=CO3)C,JOCMWXDUQHVTDD-UHFFFAOYSA-N,"7-(furan-2-ylmethyl)-5,6-dimethylpyrrolo[2,3-d]pyrimidin-4-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Names and Identifiers,3,1259310|1259374|1259422,20050917,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemica|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Aurum Pharmatech LLC|Biosynth Carbosynth|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|Enamine|eNovation Chemicals|EPA DSSTox|Founder Pharma|LabNetwork, a WuXi AppTec Company|Mcule|Molepedia|MolPort|MuseChem|NCBI Structure|NextBio|Protein Data",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5271809,Favipiravir-rtp,"T-705RTP|Favipiravir-rtp|UNII-F0JG9C0OQD|F0JG9C0OQD|Favipiravir riboside triphosphate|740790-94-7|[[(2~{R},3~{S},4~{R},5~{R})-5-(3-aminocarbonyl-5-fluoranyl-2-oxidanylidene-pyrazin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate|GE6|T-705 ribosyl triphosphate|SCHEMBL6380766|CHEMBL3818050|T-705 RTP|CHEBI:170009|T-705-4-ribofuranosyl-5'-triphosphate|HY-135803|CS-0114203|((2R,3S,4R,5R)-5-(3-Carbamoyl-5-fluoro-2-oxopyrazin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)",529.160,C10H15FN3O15P3,285.000,995.000,-5.700,32,7,17,9,"InChI=1S/C10H15FN3O15P3/c11-4-1-14(9(18)5(13-4)8(12)17)10-7(16)6(15)3(27-10)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h1,3,6-7,10,15-16H,2H2,(H2,12,17)(H,22,23)(H,24,25)(H2,19,20,21)/t3-,6-,7-,10-/m1/s1",C1=C(N=C(C(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)C(=O)N)F,UUKPXXBDUCDZDA-KAFVXXCXSA-N,"[[(2R,3S,4R,5R)-5-(3-carbamoyl-5-fluoro-2-oxopyrazin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Biological Test Results: Active,6,1308446|1505522|1505523,20051007,AbaChemScene|ABI Chem|BLD Pharm|ChEBI|ChEMBL|ChemIDplus|ChemSpider|FDA/SPL Indexing Data|Google Patents|IBM|MedChemexpress MCE|MuseChem|NCBI Structure|NextBio|NIAID ChemDB|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Smolecule|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5280450,Linoleic acid,"linoleic acid|60-33-3|Linolic acid|Telfairic acid|cis,cis-Linoleic acid|(9Z,12Z)-octadeca-9,12-dienoic acid|Grape seed oil|Linoleate|cis,cis-9,12-Octadecadienoic acid|cis-9,cis-12-Octadecadienoic acid|(Z,Z)-9,12-Octadecadienoic acid|9Z,12Z-Linoleic acid|Emersol 315|9,12-Linoleic acid|Unifac 6550|9Z,12Z-octadecadienoic acid|Extra Linoleic 90|9-cis,12-cis-Linoleic acid|Emersol 310|Polylin 515|all-cis-9,12-Octadecadienoic acid|Polylin No. 515|9,12-Octadecadienoic acid (9Z,12Z)-|Linoleic|acide linoleique|9,12-O",280.400,C18H32O2,37.300,267.000,6.800,20,1,2,14,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",CCCCC/C=C\\C/C=C\\CCCCCCCC(=O)O,OYHQOLUKZRVURQ-HZJYTTRNSA-N,"(9Z,12Z)-octadeca-9,12-dienoic acid",Linoleic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,330|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1865|1948|2101|2107|2112|2120|2147|,20040916,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|B",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank, WikiPathways]"
5281004,Budesonide,"budesonide|Entocort|51333-22-3|Preferid|Pulmicort|Rhinocort Aqua|Rhinocort|Entocort EC|Pulmicort Respules|Budesonidum|Uceris|Budeson|Pulmicort Flexhaler|Cortivent|Micronyl|Respules|Spirocort|Bidien|Budenofalk|CHEBI:3207|MAP-0010|51372-29-3|MLS000028507|Budesonide MMX|Rhinocort alpha|(R)-Budesonide|16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione|S-1320|(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione|Budesonido|SMR000058337|Budecort Inhaler|(+)-16alph",430.500,C25H34O6,93.100,862.000,2.500,31,2,6,4,"InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1",CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,VOVIALXJUBGFJZ-KWVAZRHASA-N,"(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",Budesonide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|361|364|368|371|373|374|375|377|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|680|684|686|687|694|701|708|709|719|731|732|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|,20050624,"A2B Chem|AA BLOCKS|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|ACT Chemical|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AvaChem Scientific|BindingDB|BioChemPartner|Biosynth Carbosynth|Boone Lab, Chemical Genomics, University of Toronto|Broad Institute|Burnham Center for Chemical Genomics|C. David Weaver Laboratory, Vanderbilt University|CCSbase|Center for Chemical Genomics, University of Michigan|Cha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5281232,Crocetin,"Crocetin|Transcrocetin|27876-94-4|8,8'-Diapocarotenedioic acid|trans-Crocetin|Transcrocetinate|(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioic acid|8,8'-Diapo-psi,psi-carotenedioic acid|8,8'-Diapocarotene-8,8'-dioic acid|UNII-20TC155L9C|CHEBI:3918|CHEMBL464792|LEAF-4L6715|20TC155L9C|27876-94-4 (free acid)|8,8'-diapo-8,8'-carotenedioic acid|alpha-Crocetin|.alpha.-Crocetin|CCRIS 7484|Transcrocetin [INN]|EINECS 248-708-0|NSC 407300|alpha Crocetin|Crocetin aglycon|NSC40730",328.400,C20H24O4,74.600,608.000,5.400,24,2,4,8,"InChI=1S/C20H24O4/c1-15(11-7-13-17(3)19(21)22)9-5-6-10-16(2)12-8-14-18(4)20(23)24/h5-14H,1-4H3,(H,21,22)(H,23,24)/b6-5+,11-7+,12-8+,15-9+,16-10+,17-13+,18-14+",C/C(=C\\C=C\\C=C(\\C=C\\C=C(\\C(=O)O)/C)/C)/C=C/C=C(/C(=O)O)\\C,PANKHBYNKQNAHN-MQQNZMFNSA-N,"(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,10,403341|725307|1259409,20050624,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|Acorn PharmaTech Product List|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|AvaChem Scientific|BenchChem|BindingDB|BioCrick|BioCyc|Biopurify Phytochemicals|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFaces|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5282379,Isotretinoin,"4759-48-2|Isotretinoin|13-cis-Retinoic acid|Accutane|Roaccutane|Neovitamin A acid|13-cis-Vitamin A acid|13-cis retinoic acid|Claravis|Amnesteem|Isotrex|Teriosal|Sotret|ISOTRETINON|isotretinoino|Isotretinoine|Isotretinoinum|Roaccutan|13-RA|Absorica|Roacutan|Isotretinoine [INN-French]|Isotretinoinum [INN-Latin]|Isotretinoino [INN-Spanish]|CIP-Isotretinoin|Accutane (TN)|Isotretinoin (USP)|Ro-4-3780|UNII-EH28UP18IF|cis-RA|(7E,9E,11E,13Z)-retinoic acid|Ro 4-3780|(13cis)-retinoic acid|13-cis RA|(2Z,4E,6E,8E)-3,7-",300.400,C20H28O2,37.300,567.000,6.300,22,1,2,5,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-",CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C,SHGAZHPCJJPHSC-XFYACQKRSA-N,"(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid",Isotretinoin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,377|422|429|436|547|694|732|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1195|1332|1376|1379|1385|1422|1452|1454|1457|1458|1459|1460|1461|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1705|1707|1708|1766|1768|1813|1814|1815|1816|1828|1832|1850|1863|1865|1875|1876|1877|1882|1883|1885|1886|1899|1903|1906|1910|1947|1948|1950|1956|1962|1967|1974|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|209,20050624,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemo Scientific Limited|Achemtek|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|AN PharmaTech|AvaChem Scientific|BindingDB|BioChemPartner|BioCrick|BioCyc|BLD Pharm|Boone Lab, Chemical Genomics, University of Toronto|Broad Institute|Burnham Center fo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5282411,Epoprostenol,"prostacyclin|epoprostenol|prostaglandin I2|PGI2|Vasocyclin|Prostaglandin X|Flolan|Prostacyclin I2|35121-78-9|Prostaglandin 12|UNII-DCR9Z582X0|PGX|DCR9Z582X0|CHEBI:15552|Epoprostenolum|ACT-385781A|(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|63859-31-4|U-53,217|6,9S-epoxy-11R,15S-dihydoxy-5Z,13E-prostadienoic acid|PGI(sub 2)|Epoprostenol [USAN:INN]|Epoprostenolum [INN-Latin]|KB-IV-24|(5Z,13E)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|PG-I2|VentaProst|Pr",352.500,C20H32O5,87.000,485.000,2.900,25,3,5,10,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1",CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/O2)O)O,KAQKFAOMNZTLHT-OZUDYXHBSA-N,"(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid",Epoprostenol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,880|894|1030|1195|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1766|1768|1865|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|24484|44748|51039|89295|195020|195433|222762|222777|222778|222797|228182|346025|485281|485290|485350|493033|504327|504332|504845|504847|588214|588215|588216|588217|588218|588219|588220|588519|588579|602314|602332|624101|624136|624138|624139|624141|624151|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|62529,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|ABI Chem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|AvaChem Scientific|BIDD|BioCrick|BioCyc|BLD Pharm|BOC Sciences|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5287667,N-[(Benzyloxy)carbonyl]-L-Leucyl-N-[(2s)-1-Hydroxy-4-Methylpentan-2-Yl]-L-Leucinamide,"N-[(Benzyloxy)carbonyl]-L-Leucyl-N-[(2s)-1-Hydroxy-4-Methylpentan-2-Yl]-L-Leucinamide|L-Leucinamide,N-[(phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-(hydroxymethyl)-3-methylbutyl]-|CS-0007596|Q27457418",477.600,C26H43N3O5,117.000,618.000,4.600,34,4,5,15,"InChI=1S/C26H43N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,17-19,21-23,30H,12-16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1",CC(C)C[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1,WUJQMWDTZKIKQZ-VABKMULXSA-N,benzyl N-[(2S)-1-[[(2S)-1-[[(2S)-1-hydroxy-4-methylpentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate,NULL,Biomolecular Interactions and Pathways|Names and Identifiers,2,NULL,20051129,"AbaChemScene|ABI Chem|Achemtek|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|NextBio|Protein Data Bank in Europe (PDBe)|SMID|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5288559,3-(1H-Imidazol-3-ium-4-yl)-L-alanine,3-(1H-imidazol-3-ium-4-yl)-L-alanine,156.160,C6H10N3O2+,93.200,151.000,-3.100,11,4,3,3,"InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/p+1/t5-/m0/s1",C1=C(NC=[NH+]1)C[C@@H](C(=O)O)N,HNDVDQJCIGZPNO-YFKPBYRVSA-O,(2S)-2-amino-3-(1H-imidazol-3-ium-5-yl)propanoic acid,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20051129,ABI Chem|ChemSpider|LeadScope|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SMID,Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5289131,Dtxsid90960063,"DTXSID90960063|Q27464386|4-Hydroxy-7-(octadecanoyloxy)-4,10-dioxo-3,5,9-trioxa-4lambda~5~-phosphaheptacosan-1-aminium",749.100,C41H83NO8P+,136.000,815.000,12.400,51,2,8,43,"InChI=1S/C41H82NO8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(43)47-37-39(38-49-51(45,46)48-36-35-42)50-41(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h39H,3-38,42H2,1-2H3,(H,45,46)/p+1/t39-/m1/s1",CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[NH3+])OC(=O)CCCCCCCCCCCCCCCCC,LVNGJLRDBYCPGB-LDLOPFEMSA-O,"2-[[(2R)-2,3-di(octadecanoyloxy)propoxy]-hydroxyphosphoryl]oxyethylazanium",NULL,Biomolecular Interactions and Pathways|Classification|Use and Manufacturing,3,NULL,20051129,"ABI Chem|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|NCBI Structure|NextBio|SMID|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5324346,Fluvoxamine,"fluvoxamine|54739-18-3|Fluvoxaminum|Fluvoxamina|(Z)-Fluvoxamine|UNII-O4L1XPO44W|Fluvoxaminum [INN-Latin]|Fluvoxamina [INN-Spanish]|2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine|CHEMBL814|O4L1XPO44W|CHEBI:5138|Fluvoxamine [INN:BAN]|(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime|DSSTox_CID_24002|DSSTox_RID_80097|DSSTox_GSID_44002|(E)-5-Methoxy-1-(4-(trifluoromethyl)phenyl)-pentan-1-one O-(2-aminoethyl) oxime|1-Pentanone, 5-methoxy-1-(4-(trifluor",318.330,C15H21F3N2O2,56.800,327.000,2.600,22,1,7,9,"InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+",COCCCC/C(=N\\OCCN)/C1=CC=C(C=C1)C(F)(F)F,CJOFXWAVKWHTFT-XSFVSMFZSA-N,2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine,Fluvoxamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,880|1030|1332|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1688|1766|1768|1865|2101|2107|2112|2240|2241|2275|2313|2322|2330|2517|2528|2546|2549|2551|2660|2666|2667|2668|27167|28681|29359|29813|54410|64522|64525|65511|143648|179927|179960|179973|204209|204863|229148|229149|298031|298032|434959|463106|479102|479103|485290|485295|485297|485298|485313|485342|485345|485366|485368|488772|488773|488816|488837|488949|488953|488978|488981|488982|488983|493106|493107|493153|493164|504327|504332|504536|504547|504,20050325,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|AvaChem Scientific|Axon Medchem|BIDD|BindingDB|BioCrick|BioCyc|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|Burn",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5360515,Naltrexone,"naltrexone|16590-41-3|ReVia|N-Cyclopropylmethylnoroxymorphone|Vivitrex|Vivitrol|Celupan|UNII-5S6W795CQM|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one|5S6W795CQM|CHEBI:7465|Nemexin|EN-1639A [AS HYDROCHLORIDE]|UM-792|DSSTox_CID_26313|DSSTox_RID_81532|DSSTox_GSID_46313|Naltrexonum [INN-Latin]|Naltrexona [INN-Spanish]|Naltrexona|Naltrexonum|(-)-Naltrexone|(1S,5R,13R,17S)-4-(cyclop",341.400,C20H23NO4,70.000,621.000,1.900,25,2,5,2,"InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1",C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,DQCKKXVULJGBQN-XFWGSAIBSA-N,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one",Naltrexone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1332|2240|2241|2275|2313|2316|2322|2330|2517|2954|17665|22293|23449|23717|26304|29359|29811|42547|42548|76379|76403|76582|79203|88603|88604|111971|112396|117734|117735|123368|125752|125760|128019|128214|135326|138325|138326|141490|141506|141511|141762|146642|146643|146644|147087|147088|147882|147884|147886|147908|147947|147958|147960|147963|147964|147978|147987|147999|148025|148030|148038|148040|148041|148045|148055|148056|148057|148058|148065|148070|148119|148122|148123|148132|148182|148220|148229|148289|1,20050624,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambinter|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BIDD|BindingDB|BioChemPartner|BioCrick|BioCyc|BOC Sciences|Broad Institute|C. David Weaver ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5459840,20-Hydroxyecdysone,"20-HYDROXYECDYSONE|5289-74-7|Ecdysterone|beta-Ecdysone|Crustecdysone|Polypodine A|Commisterone|Crustecdyson|Isoinokosterone|Viticosterone|Ecdysteron|20-OH ecdysone|beta-ECDYSTERONE|THE-7|Hydroxyecdysone|Insect moulting hormone|UNII-779A7KPL0Y|(2beta,3beta,5beta,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one|779A7KPL0Y|CHEMBL224128|CHEBI:16587|MFCD00036740|20-E|Cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2b,3b,5b,22R)-|20E|Ekdisten|beta-Ecdisone|C27H44O7|b-Ecdysone|Polypodine C|(2b,3b,5b,22R)-2,3,",480.600,C27H44O7,138.000,869.000,0.500,34,6,7,5,"InChI=1S/C27H44O7/c1-23(2,32)9-8-22(31)26(5,33)21-7-11-27(34)16-12-18(28)17-13-19(29)20(30)14-24(17,3)15(16)6-10-25(21,27)4/h12,15,17,19-22,29-34H,6-11,13-14H2,1-5H3/t15-,17-,19+,20-,21-,22+,24+,25+,26+,27+/m0/s1",C[C@]12CC[C@H]3C(=CC(=O)[C@H]4[C@@]3(C[C@@H]([C@@H](C4)O)O)C)[C@@]1(CC[C@@H]2[C@](C)([C@@H](CCC(C)(C)O)O)O)O,NKDFYOWSKOHCCO-YPVLXUMRSA-N,"(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one",Ecdysterone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1654|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1868|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1979|1984|1986|1987|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|2073|2094|2097|2098|2099|2100|2101|2129|2130|2156|2174|2176|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2288|2289|2300|2314|2315|2326|2380|2391|2435|2445|2451|2462|2472|2517|25,20040916,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|ApexBio Technology|Aurora Fine Chemicals LLC|AvaChem Scientific|BenchChem|BindingDB|Biopurify Phytochemicals|Biosynth Carbosynth|BOC Sciences|CCSbase|Center for Chemical Geno",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5479530,Ceftriaxone,"ceftriaxone|Biotrakson|Rocephin|73384-59-5|Ceftriazone|Rocefin|Ceftriaxonum [INN-Latin]|Ceftriaxona [INN-Spanish]|Ceftriaxona|Ceftriaxonum|Rocephine|CEFTRIAXONE SODIUM|Rocephalin|CHEBI:29007|UNII-75J73V1629|CHEMBL161|CTRX|75J73V1629|Ceftriaxone and Dextrose in Duplex Container|74578-69-1|Ro 139904|Rophex|(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid|DRG-0071|Ce",554.600,C18H18N8O7S3,288.000,1110.000,-1.300,36,4,13,8,"InChI=1S/C18H18N8O7S3/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32)/b24-8-/t9-,15-/m1/s1",CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O,VAAUVRVFOQPIGI-SPQHTLEESA-N,"(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",Ceftriaxone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1195|19419|20050|20342|40924|43105|43754|43755|43756|43757|43758|52958|66381|66741|67568|68366|68853|69139|69824|69825|89996|91060|163919|193178|202540|206194|206315|206456|206457|206458|206459|206460|206461|207361|207362|207880|208139|208140|208463|209467|209885|209886|209887|210362|210363|210364|210365|210366|210367|210368|238858|264468|264469|264470|264471|264472|264473|264474|278088|278089|278090|278091|278092|278094|278095|278096|279254|279255|279256|279257|279258|279259|279260|279261|279262|279263|279,20050801,"3B Scientific (Wuhan) Corp|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Ambinter|AmicBase - Antimicrobial Activities|AN PharmaTech|Aurora Fine Chemicals LLC|AvaChem Scientific|BenchChem|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5485201,Naltrexone hydrochloride,"Naltrexone hydrochloride|Naltrexone Hcl|16676-29-2|Depade|Trexan|Antaxone|ReVia|Naltrexone (Hydrochloride)|NIH 8503|EN-1639A|UNII-Z6375YW9SF|Celupan|Nemexin|Vivitrol|N-Cyclopropylmethyl-noroxymorphone hydrochloride|MLS000069607|Naltrexone hydrochloride [USP]|Z6375YW9SF|Vivitrex|MFCD00069324|(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride|17-(Cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-one hydrochloride|Nalorex|SMR000058767|En 1639A|Naltrexone hydrochlo",377.900,C20H24ClNO4,70.000,621.000,NULL,26,3,5,2,"InChI=1S/C20H23NO4.ClH/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11;/h3-4,11,15,18,22,24H,1-2,5-10H2;1H/t15-,18+,19+,20-;/m1./s1",C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O.Cl,RHBRMCOKKKZVRY-ITLPAZOVSA-N,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one;hydrochloride",Naltrexone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,357|361|364|368|371|373|374|375|377|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|680|684|686|687|701|708|709|719|731|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|793|795|,20050808,"3WAY PHARM INC|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|AOBIOUS INC|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BioChemPartner|BioCrick|BOC Sciences|Cangzhou Enke Pharma Tech Co.,Ltd.|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6436016,Andrographis Paniculata,"Andrographis Paniculata|Andrographis Extract|SCHEMBL8215625|AKOS004119972|A830479|(3E)-3-[2-[(1R,8aS)-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-6-oxidanyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-oxidanyl-oxolan-2-one|(3E)-3-[2-[(1R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxy-2-oxolanone|(3E,4S)-4-Hydroxy-3-{2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydronaphthalen-1-yl]ethy",350.400,C20H30O5,87.000,597.000,2.200,25,3,5,3,"InChI=1S/C20H30O5/c1-12-4-7-16-19(2,9-8-17(23)20(16,3)11-21)14(12)6-5-13-15(22)10-25-18(13)24/h5,14-17,21-23H,1,4,6-11H2,2-3H3/b13-5+/t14-,15?,16?,17?,19+,20?/m1/s1",C[C@@]12CCC(C(C1CCC(=C)[C@H]2C/C=C/3\\C(COC3=O)O)(C)CO)O,BOJKULTULYSRAS-ZJFCSBQFSA-N,"(3E)-3-[2-[(1R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one",NULL,Drug and Medication Information|Patents,2,NULL,20060428,ABI Chem|Activate Scientific|AKos Consulting & Solutions|Amadis Chemical|ChemSpider|DiscoveryGate|Google Patents|LeadScope|NextBio|Parchem|PATENTSCOPE (WIPO)|Phion Ltd|Race Chemical|SCRIPDB|SureChEMBL|Thomson Pharma|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6450800,Artemether and lumefantrine,"artemether + lumefantrine|Artemether and lumefantrine|141204-94-6|Co-Artemether|Exafal|Riamet|Artemether mixture with lumefantrine|Falcynate-LF|Lumether forte DT|Artemether-Lumefantrine|Artemether-lumefantrine combination|Artemether / lumefantrine|CGP 56697|Artemether-lumefantrine mixt|UNII-5T2U51A0MW|Lumefantrine - artemether mixt.|Coartem (TN)|Artemether/lumefantrine|Artemether, Lumefantrine Drug Combination|artemether & lumefantrine|5T2U51A0MW|DTXSID70894857|9H-Fluorene-4-methanol, 2,7-dichloro-9-((4-chl",827.300,C46H58Cl3NO6,69.600,1100.000,NULL,56,1,7,11,"InChI=1S/C30H32Cl3NO.C16H26O5/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28;1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3;9-14H,5-8H2,1-4H3/b25-15-;/t;9-,10-,11+,12+,13+,14-,15?,16-/m.1/s1",CCCCN(CCCC)CC(C1=CC(=CC\\2=C1C3=C(/C2=C/C4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O.C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CCC(O3)(OO4)C)OC)C,ZVAQGQOEHFIYMQ-PRLJFWCFSA-N,"2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol;(4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane","Artemether, Lumefantrine Drug Combination",Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20060429,ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|EPA DSSTox|KEGG|NextBio|NIAID ChemDB|ToxPlanet,Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6483745,Quinolin-3-ylmethanamine,"quinolin-3-ylmethanamine|7521-70-2|C-Quinolin-3-yl-methylamine|3-QUINOLINEMETHANAMINE|1-(quinolin-3-yl)methanamine|3-aminomethylquinoline|QUINOLIN-3-YLMETHYL-AMINE|(QUINOLIN-3-YLMETHYL)AMINE|3-(AMINOMETHYL)QUINOLINE|3-quinolylmethylamine|quinolin-3-ylmethylamine|(3-Quinolinyl)methylamine|Quinolin-3-yl-methanamine|1-quinolin-3-ylmethanamine|SCHEMBL263918|CHEMBL4556301|DTXSID60424324|3-quinolinylmethanamine, AldrichCPR|ALBB-011839|BCP11483|ZINC4854975|MFCD00465220|SBB010402|STK346965|AKOS000301165|AB06242|ST0",158.200,C10H10N2,38.900,147.000,1.000,12,1,2,1,"InChI=1S/C10H10N2/c11-6-8-5-9-3-1-2-4-10(9)12-7-8/h1-5,7H,6,11H2",C1=CC=C2C(=C1)C=C(C=N2)CN,VKKZSJQQRIGUIE-UHFFFAOYSA-N,quinolin-3-ylmethanamine,NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20060430,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|ASINEX|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BioChemPartner|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Sp",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6918172,Icatibant acetate,"Icatibant acetate|Icatibant (acetate)|UNII-325O8467XK|Firazyr|325O8467XK|138614-30-9|Icatibant acetate [USAN]|CHEMBL2028852|JE-049|(R)-Arginyl-(S)-arginyl-(S)-prolyl-(2S,4R)-(4-hydroxyprolyl)glycyl-(S)-(3-(2-thienyl)alanyl)-(S)-seryl-(R)-((1,2,3,4-tetrahydro-3-isoquinolyl)carbonyl)-(2S,3aS,7aS)-((hexahydro-2-indolinyl)carbonyl)-(S)-arginine acetate (salt)|HY-108896|CS-0031296|Q27256146|L-Arginine, D-arginyl-L-arginyl-L-prolyl-trans-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-D-1,2,3,4-tetrahydro",1364.600,C61H93N19O15S,589.000,2750.000,NULL,96,16,20,30,"InChI=1S/C59H89N19O13S.C2H4O2/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66;1-2(3)4/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69);1H3,(H,3,4)/t33-,35+,37+,38-,",CC(=O)O.C1CC[C@H]2[C@@H](C1)C[C@H](N2C(=O)[C@H]3CC4=CC=CC=C4CN3C(=O)[C@H](CO)NC(=O)[C@H](CC5=CC=CS5)NC(=O)CNC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H]7CCCN7C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)N)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O,HKMZRZUEADSZDQ-DZJWSCHMSA-N,"(2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid;acetic acid",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20060728,"AbaChemScene|ABI Chem|Achemtek|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|MedChemexpress MCE|MolPort|NextBio|Prous Science Drugs of the Future|Smolecule|TargetMol (Target Molecule Corp.)|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918606,Isavuconazonium,"Isavuconazonium|Isavuconazonium ion|742049-41-8|Isavuconazonium [USAN]|BAL-8557|CHEBI:85978|Isavuconazonium (USAN)|UNII-VH2L779W8Q|VH2L779W8Q|BAL8557-000|BAL 8557-000|CHEMBL1183349|SCHEMBL13133195|BAL8557|DTXSID70225203|BCP23773|ACN-048059|DB06636|BAL-8557000|NCGC00532509-01|1-((2R,3R)-3-(4-(4-Cyanophenyl)-1,3-thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-((1RS)-1-(methyl-(3-(((methylamino)acetyloxy)methyl)pyridin-2-yl)carbamoyloxy(ethyl)-1,2,4-triazolium|BAL-8557-000|Glycine, N-methyl-, (2-(((1-(1",717.800,C35H35F2N8O5S+,188.000,1210.000,4.100,51,2,13,15,"InChI=1S/C35H35F2N8O5S/c1-22(33-42-30(18-51-33)25-9-7-24(15-38)8-10-25)35(48,28-14-27(36)11-12-29(28)37)19-45-21-44(20-41-45)23(2)50-34(47)43(4)32-26(6-5-13-40-32)17-49-31(46)16-39-3/h5-14,18,20-23,39,48H,16-17,19H2,1-4H3/q+1/t22-,23?,35+/m0/s1",C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=[N+](C=N3)C(C)OC(=O)N(C)C4=C(C=CC=N4)COC(=O)CNC)(C5=C(C=CC(=C5)F)F)O,RSWOJTICKMKTER-QXLBVTBOSA-N,"[2-[1-[1-[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,5-difluorophenyl)-2-hydroxybutyl]-1,2,4-triazol-4-ium-4-yl]ethoxycarbonyl-methylamino]pyridin-3-yl]methyl 2-(methylamino)acetate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity,9,1479145|1479147|1479149|1479150,20060728,"A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|Achemtek|Acorn PharmaTech Product List|AKos Consulting & Solutions|BioChemPartner|Cangzhou Enke Pharma Tech Co.,Ltd.|ChEBI|Chem-Space.com Database|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|CSNpharm|DC Chemicals|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatech|Google Patents|Hangzhou APIChem Technology|IBM|Japan Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918639,"5'-O-[(S)-{[(S)-{[(2R,3R,4S)-3,4-Dihydroxypyrrolidin-2-YL]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]adenosine","[(2R,3R,4S)-3,4-dihydroxypyrrolidin-2-yl]methyl-ADP|CHEMBL1230692|CHEBI:40454|5'-O-[(S)-{[(S)-{[(2R,3R,4S)-3,4-DIHYDROXYPYRROLIDIN-2-YL]METHOXY}(HYDROXY)PHOSPHORYL]OXY}(HYDROXY)PHOSPHORYL]ADENOSINE|adenosine 5'-diphosphate (hydroxymethyl)pyrrolidinediol|adenosine 5'-(3-{[(2R,3R,4S)-3,4-dihydroxypyrrolidin-2-yl]methyl} dihydrogen diphosphate)|A1R|ADP-HPD|ADP-(hydroxymethyl)pyrrolidinediol|BDBM50350107|Q27120396|Adenosine 5'-diphosphoric acid beta-[(3beta,4beta-dihydroxypyrrolidin-2alpha-yl)methyl] ester",542.330,C15H24N6O12P2,274.000,846.000,-8.200,35,8,17,9,"InChI=1S/C15H24N6O12P2/c16-13-9-14(19-4-18-13)21(5-20-9)15-12(25)11(24)8(32-15)3-31-35(28,29)33-34(26,27)30-2-6-10(23)7(22)1-17-6/h4-8,10-12,15,17,22-25H,1-3H2,(H,26,27)(H,28,29)(H2,16,18,19)/t6-,7+,8-,10-,11-,12-,15-/m1/s1",C1[C@@H]([C@@H]([C@H](N1)COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)O)O,NDQDTBCXPOIQGT-UHNJQBFTSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S)-3,4-dihydroxypyrrolidin-2-yl]methyl hydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,31124|31125|31126|144370|144371|162263|162264|162265|162266|162389|162390|162391|162574|162575|225939|225940|610957|610958|1184468,20060728,"ABI Chem|BindingDB|ChEBI|ChEMBL|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|NCBI Structure|NextBio|NovoSeek|Protein Data Bank in Europe (PDBe)|Prous Science Drugs of the Future|Shanghai Institute of Organic Chemistry|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6952762,2-(4-Methylphenoxy)-1-(4-methylpiperazin-4-ium-1-yl)ethanone,2-(4-methylphenoxy)-1-(4-methylpiperazin-4-ium-1-yl)ethanone,249.330,C14H21N2O2+,34.000,267.000,1.300,18,1,2,3,"InChI=1S/C14H20N2O2/c1-12-3-5-13(6-4-12)18-11-14(17)16-9-7-15(2)8-10-16/h3-6H,7-11H2,1-2H3/p+1",CC1=CC=C(C=C1)OCC(=O)N2CC[NH+](CC2)C,GIIIJZOPGUFGBF-UHFFFAOYSA-O,2-(4-methylphenoxy)-1-(4-methylpiperazin-4-ium-1-yl)ethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20060728,ChemSpider|NextBio|Protein Data Bank in Europe (PDBe),Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7058063,"(2S)-2-Methyl-3,4-dihydro-2H-naphthalen-1-one","(s)-2-methyltetralone|(2S)-2-methyl-3,4-dihydro-2H-naphthalen-1-one|(2S)-2-Methyltetralin-1-one|ZINC3861252|A809991|(R,S)-2-Methyl-3,4-dihydro-2H-naphthalen-1-one",160.210,C11H12O,17.100,185.000,2.600,12,0,1,0,"InChI=1S/C11H12O/c1-8-6-7-9-4-2-3-5-10(9)11(8)12/h2-5,8H,6-7H2,1H3/t8-/m0/s1",C[C@H]1CCC2=CC=CC=C2C1=O,GANIBVZSZGNMNB-QMMMGPOBSA-N,"(2S)-2-methyl-3,4-dihydro-2H-naphthalen-1-one",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Literature|Patents,4,NULL,20060729,"A&J Pharmtech CO., LTD.|ABI Chem|Amadis Chemical|Ambinter|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|Protein Data Bank in Europe (PDBe)|SCRIPDB|Springer Nature|SpringerMaterials|Thieme Chemistry|Thomson Pharma|Wiley|ZINC",Chemical Vendors|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7131170,N-Methyl-1-(1-phenyl-1H-pyrazol-4-YL)methanamine,868552-05-0|N-METHYL-1-(1-PHENYL-1H-PYRAZOL-4-YL)METHANAMINE|N-methyl-N-[(1-phenyl-1H-pyrazol-4-yl)methyl]amine|N-methyl-1-(1-phenylpyrazol-4-yl)methanamine|N-methyl(1-phenyl-1H-pyrazol-4-yl)methanamine|SCHEMBL4810042|CHEMBL4539197|DTXSID00427899|HMS1741J18|ALBB-020802|ZINC4218603|AKOS000264196|MCULE-4833524103|DA-01918|FT-0706314|EN300-14859|methyl[(1-phenyl-1H-pyrazol-4-yl)methyl]amine|W-9608|J-523710|Z102768020|methyl[(1-phenyl-1H-pyrazol-4-yl)methyl]amine hydrochloride|W1Y,187.240,C11H13N3,29.800,166.000,1.300,14,1,2,3,"InChI=1S/C11H13N3/c1-12-7-10-8-13-14(9-10)11-5-3-2-4-6-11/h2-6,8-9,12H,7H2,1H3",CNCC1=CN(N=C1)C2=CC=CC=C2,SZXULAAYIBSASF-UHFFFAOYSA-N,N-methyl-1-(1-phenylpyrazol-4-yl)methanamine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,6,485350|485395|493033|504770|540299|588519|720554|720641,20060729,"A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alinda Chemical|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemBridge|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|Enamine|eNovation Chemicals|EPA DSSTox|Finetech Industry Limited|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7131995,"3-(5-Chloro-1,3-benzothiazol-2-yl)propanoic acid","3-(5-chloro-1,3-benzothiazol-2-yl)propanoic acid|3-(5-Chloranyl-1,3-Benzothiazol-2-Yl)propanoic Acid|CHEMBL4069423|885527-36-6|6U6|SCHEMBL16198162|ZINC4219237|BDBM50242196|AKOS000205646|MCULE-6107525772|EN300-71902|Q27456561|Z228584328",241.690,C10H8ClNO2S,78.400,252.000,2.800,15,1,4,3,"InChI=1S/C10H8ClNO2S/c11-6-1-2-8-7(5-6)12-9(15-8)3-4-10(13)14/h1-2,5H,3-4H2,(H,13,14)",C1=CC2=C(C=C1Cl)N=C(S2)CCC(=O)O,UMBLVHSXXWQLDL-UHFFFAOYSA-N,"3-(5-chloro-1,3-benzothiazol-2-yl)propanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Biological Test Results: Active,6,1375636|1465872|1465873|1465874,20060729,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BindingDB|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemSpider|ChemTik|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|Google Patents|IBM|Mcule|MolPort|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7510236,"1-Acetyl-4-[(2,5-dimethylphenyl)sulfonyl]piperazine","1-acetyl-4-[(2,5-dimethylphenyl)sulfonyl]piperazine|ZINC5120545|AKOS002285325|MCULE-4231061770|903354-15-4|ST50808423|AP-263/43418110|Z29484510|1-[4-(2,5-dimethylbenzenesulfonyl)piperazin-1-yl]ethan-1-one",296.390,C14H20N2O3S,66.100,450.000,1.100,20,0,4,2,"InChI=1S/C14H20N2O3S/c1-11-4-5-12(2)14(10-11)20(18,19)16-8-6-15(7-9-16)13(3)17/h4-5,10H,6-9H2,1-3H3",CC1=CC(=C(C=C1)C)S(=O)(=O)N2CCN(CC2)C(=O)C,ISTPGRLEOGSGGV-UHFFFAOYSA-N,"1-[4-(2,5-dimethylphenyl)sulfonylpiperazin-1-yl]ethanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20060729,"ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Enamine|Mcule|MolPort|MuseChem|NextBio|Protein Data Bank in Europe (PDBe)|Specs|TimTec|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8042144,(2R)-2-(2-Fluorophenoxy)propanoic acid,"(2R)-2-(2-fluorophenoxy)propanoic acid|144371-60-8|ZINC6678534|(R)-2-(2-Fluorophenoxy)propanoic acid|Propanoic acid, 2-(2-fluorophenoxy)-, (2R)-|W0P",184.160,C9H9FO3,46.500,184.000,2.000,13,1,4,3,"InChI=1S/C9H9FO3/c1-6(9(11)12)13-8-5-3-2-4-7(8)10/h2-6H,1H3,(H,11,12)/t6-/m1/s1",C[C@H](C(=O)O)OC1=CC=CC=C1F,MMWXPDDADHYFFS-ZCFIWIBFSA-N,(2R)-2-(2-fluorophenoxy)propanoic acid,NULL,Biomolecular Interactions and Pathways,1,NULL,20060730,"ABI Chem|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Thomson Pharma|ZINC",Chemical Vendors|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8120202,(S)-n-Methyl-1-(4-fluorophenyl)ethylamine,(S)-n-methyl-1-(4-fluorophenyl)ethylamine|672906-67-1|(S)-1-(4-fluorophenyl)-N-methylethanamine|(1S)-1-(4-fluorophenyl)-N-methylethanamine|(1S)-1-(4-fluorophenyl)-N-methylethan-1-amine|VWA|[(1S)-1-(4-fluorophenyl)ethyl](methyl)amine|SCHEMBL13262062|ZINC6950492|AKOS017382617|(1S)-1-(4-fluorophenyl)-N-methyl-ethanamine|A835696,153.200,C9H12FN,12.000,108.000,1.800,11,1,2,2,"InChI=1S/C9H12FN/c1-7(11-2)8-3-5-9(10)6-4-8/h3-7,11H,1-2H3/t7-/m0/s1",C[C@@H](C1=CC=C(C=C1)F)NC,YORRIBKELCOOIJ-ZETCQYMHSA-N,(1S)-1-(4-fluorophenyl)-N-methylethanamine,NULL,Biomolecular Interactions and Pathways|Classification|Patents|Safety and Hazards,4,NULL,20060730,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Alichem|Amadis Chemical|Ambinter|Aurora Fine Chemicals LLC|BLD Pharm|BOC Sciences|Chembase.cn|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Combi-Blocks|DiscoveryGate|eNovation Chemicals|Google Patents|IBM|NCBI Structure|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Smolecule|SureChEMBL|THE BioTek|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8405578,1-Acetyl-4-[(4-chlorophenyl)sulfonyl]piperazine,1-acetyl-4-[(4-chlorophenyl)sulfonyl]piperazine|Oprea1_608706|ZINC7308566|AKOS002302050|CCG-316011|MCULE-6226185180|905403-15-8|ST50780202|AP-263/12121957|Z29408376|1-[4-(4-chlorobenzenesulfonyl)piperazin-1-yl]ethan-1-one,302.780,C12H15ClN2O3S,66.100,419.000,1.000,19,0,4,2,"InChI=1S/C12H15ClN2O3S/c1-10(16)14-6-8-15(9-7-14)19(17,18)12-4-2-11(13)3-5-12/h2-5H,6-9H2,1H3",CC(=O)N1CCN(CC1)S(=O)(=O)C2=CC=C(C=C2)Cl,VTRBWFKJTCGLDP-UHFFFAOYSA-N,1-[4-(4-chlorophenyl)sulfonylpiperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20060730,"ABI Chem|AKos Consulting & Solutions|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Enamine|Mcule|MolPort|MuseChem|NextBio|Protein Data Bank in Europe (PDBe)|Specs|TimTec|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9234227,"1-[(3R)-3-(1,3-Benzothiazol-2-yl)piperidin-1-yl]ethanone",NULL,260.360,C14H16N2OS,61.400,323.000,2.500,18,0,3,1,"InChI=1S/C14H16N2OS/c1-10(17)16-8-4-5-11(9-16)14-15-12-6-2-3-7-13(12)18-14/h2-3,6-7,11H,4-5,8-9H2,1H3/t11-/m1/s1",CC(=O)N1CCC[C@H](C1)C2=NC3=CC=CC=C3S2,VRHLKEQAZUIMQF-LLVKDONJSA-N,"1-[(3R)-3-(1,3-benzothiazol-2-yl)piperidin-1-yl]ethanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20060730,ABI Chem|ChemSpider|NextBio|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9798466,"(3~{S})-3-[2-[4-(3,4-Dimethylphenyl)piperazin-1-yl]ethyl]-2,3-dihydroisoindol-1-one","CHEMBL37170|PD-172938|(3~{S})-3-[2-[4-(3,4-dimethylphenyl)piperazin-1-yl]ethyl]-2,3-dihydroisoindol-1-one|PD-18126|SCHEMBL18215446|ZINC3827164|BDBM50070514|(S)-PD-172938|3-(2-(4-(3,4-Dimethylphenyl)piperazin-1-yl)ethyl)isoindolin-1-one|(S)-3-{2-[4-(3,4-Dimethyl-phenyl)-piperazin-1-yl]-ethyl}-2,3-dihydro-isoindol-1-one|3-{2-[4-(3,4-Dimethyl-phenyl)-piperazin-1-yl]-ethyl}-2,3-dihydro-isoindol-1-one (PD-18126)|RMZ",349.500,C22H27N3O,35.600,488.000,3.500,26,1,3,4,"InChI=1S/C22H27N3O/c1-16-7-8-18(15-17(16)2)25-13-11-24(12-14-25)10-9-21-19-5-3-4-6-20(19)22(26)23-21/h3-8,15,21H,9-14H2,1-2H3,(H,23,26)/t21-/m0/s1",CC1=C(C=C(C=C1)N2CCN(CC2)CC[C@H]3C4=CC=CC=C4C(=O)N3)C,WQEPZBNLBWDIRZ-NRFANRHFSA-N,"(3S)-3-[2-[4-(3,4-dimethylphenyl)piperazin-1-yl]ethyl]-2,3-dihydroisoindol-1-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,7,4475|5143|35787|36327|63065|63535|63537|168173,20061025,BindingDB|ChEMBL|ChemSpider|DiscoveryGate|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|Therapeutic Target Database (TTD)|Thieme Chemistry|Thomson Pharma|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9887712,Dapagliflozin,"Dapagliflozin|461432-26-8|BMS-512148|Forxiga|Farxiga|BMS 512148|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|UNII-1ULL0QJ8UC|(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol|1ULL0QJ8UC|CHEMBL429910|CHEBI:85078|Dapagliflozin [USAN:INN]|BMS512148|(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|Forxiga (TN)|(2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-",408.900,C21H25ClO6,99.400,472.000,2.300,28,4,6,6,"InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1",CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl,JVHXJTBJCFBINQ-ADAARDCZSA-N,"(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,318036|318037|318038|318039|318040|318041|318042|318043|318044|318045|318046|318047|318048|318049|318050|318051|318052|318053|318054|318055|318056|318057|318058|318059|418681|418688|418689|418690|418691|418692|418693|418694|418695|418696|418697|418698|418699|418700|418701|418702|418703|418704|418945|418947|418949|418950|418951|418952|418953|418954|418955|418956|418957|418958|418959|418960|418961|418962|418963|418964|418965|418966|418967|418968|418969|418970|418971|418972|418973|418974|418975|418976|418983|4,20061025,"A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acesobio|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Arromax Pharmatech Co., Ltd|Aurora Fine Chemicals LLC|Aurum Pharmatech L",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9894479,CID 9894479,CEFTRIAXONE SODIUM|SCHEMBL40849|376C796,577.600,C18H18N8NaO7S3,288.000,1110.000,NULL,37,4,13,8,"InChI=1S/C18H18N8O7S3.Na/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);/b24-8-;/t9-,15-;/m1./s1",CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)O.[Na],XKYJAZULGNDPLX-VKZZUTNHSA-N,NULL,Ceftriaxone,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,8,NULL,20061025,ChemSpider|NextBio|OChem|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9913795,CID 9913795,"METHYLPREDNISOLONE SODIUM SUCCINATE|2375-03-3|Pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodiumsalt, (6a,11b)-|s6593|375M033|6alpha-Methylprednisolone 21-hemisuccinate sodium salt, lyophilized powder",497.500,C26H34NaO8,138.000,981.000,NULL,35,3,8,7,"InChI=1S/C26H34O8.Na/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24;/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31);/t14-,16-,17-,19-,23+,24-,25-,26-;/m0./s1",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O.[Na],WOARBZBOZOGFGA-SGJOWKDISA-N,NULL,Methylprednisolone Hemisuccinate,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,7,NULL,20061025,"A2B Chem|AA BLOCKS|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|NextBio|NovoSeek|OChem|Selleck Chemicals|Sigma-Aldrich|Springer Nature|Thomson Pharma",Chemical Vendors|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9918881,Piperacillin/tazobactam,piperacillin/tazobactam|piperacillin tazobactam|CHEMBL436129|SCHEMBL1325039|Q7197337,817.900,C33H39N9O12S2,313.000,1550.000,NULL,56,4,15,9,"InChI=1S/C23H27N5O7S.C10H12N4O5S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28;1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34);2-3,7-8H,4-5H2,1H3,(H,16,17)/t13-,14-,15+,20-;7-,8+,10+/m11/s1",CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O.C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,LITBAYYWXZOHAW-XDZRHBBOSA-N,"(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","Piperacillin, Tazobactam Drug Combination",Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,44223|68376|68377|69015|69016|69017|205219|207372|250257|250258|250263|250284|250287|250288|250289|250290|250292|250293|250294|250295|250296|250297|250298|250299|250300|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949,20061025,"ChEMBL|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|NextBio|NextMove Software|SureChEMBL|Thomson Pharma|Wikidata",Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10089466,Enisamium iodide,Enisamium iodide|Amizon|201349-37-3|UNII-G22FG6Q00B|4-(Benzylcarbamoyl)-1-methylpyridin-1-ium iodide|Enisamium iodide [INN]|G22FG6Q00B|Enisamium iodide (INN)|carbabenzpyride|MLS001211478|4-Benzylcarbamoyl-1-methyl-pyridinium|SMR000514553|N-Methyl-4-benzylcarbamidopyridinium iodide|CHEMBL1716983|DTXSID00173960|1-methyl-4-(((phenylmethyl)amino)carbonyl)-pyridinium iodide|HMS2825L03|STL194198|AKOS001033439|MCULE-2382080856|4-(benzylcarbamoyl)-1-methylpyridinium iodide|4-Benzylcarbamoyl-1-methylpyridin-1-ium io,354.190,C14H15IN2O,33.000,241.000,NULL,18,1,2,3,"InChI=1S/C14H14N2O.HI/c1-16-9-7-13(8-10-16)14(17)15-11-12-5-3-2-4-6-12;/h2-10H,11H2,1H3;1H",C[N+]1=CC=C(C=C1)C(=O)NCC2=CC=CC=C2.[I-],ILSOAHPXYZRFBA-UHFFFAOYSA-N,N-benzyl-1-methylpyridin-1-ium-4-carboxamide;iodide,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1868|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1979|1984|1986|1987|1996|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|2073|2094|2097|2098|2099|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2288|2289|2300|2314|2315|2326|2380|2391|2435|2445|2451|2462|24,20061025,"001Chemical|A2B Chem|AA BLOCKS|Achemtek|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambinter|AN PharmaTech|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|Crystallography Open Database|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|ICCB-Longwood Screening Facility, Harvard ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10280735,Edoxaban,"EDOXABAN|480449-70-5|SAVAYSA|DU-176|UNII-NDU3J18APO|912273-65-5|DU-176b|NDU3J18APO|CHEMBL1269025|CHEBI:85973|480449-70-5 (free base)|N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide|C24H30ClN7O4S|Edoxaban [USAN:INN]|N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide|Edoxaban (USAN/INN)|SCHEMBL330046|AMY5",548.100,C24H30ClN7O4S,165.000,880.000,1.400,37,3,8,5,"InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15-,17+/m0/s1",CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,HGVDHZBSSITLCT-JLJPHGGASA-N,"N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,527394|527398|527399|527405|1259398|1259399|1259423|1296008|1296009|1345084|1345896|1346986|1346987|1347055|1347159|1347160|1409605|1414363|1453444|1479145|1479147|1479149|1479150,20061025,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambinter|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Cangzhou Enke Pharma Tech Co.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10287099,Transcrocetinate sodium,"Trans sodium crocetinate|Transcrocetinate sodium|TRANS-SODIUM CROCETINATE|591230-99-8|Trans-crocetin sodium|UNII-YP57637WMX|YP57637WMX|591230-99-8 (sodium 1|Transcrocetinate disodium|sodium (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate|64603-92-5|Crocetin sodium|Transcrocetinate sodium [USAN]|CHEMBL3137335|AKOS037515031|Q27294636|Transcrocetinate disodium (Disodium trans-crocetinate)|Disodium (all-E)-2,6,11,15-tetramethylhexadecahepta-2,4,6,8,10,12,14-enedioate|2,4,",372.400,C20H22Na2O4,80.300,597.000,NULL,26,0,4,6,"InChI=1S/C20H24O4.2Na/c1-15(11-7-13-17(3)19(21)22)9-5-6-10-16(2)12-8-14-18(4)20(23)24;;/h5-14H,1-4H3,(H,21,22)(H,23,24);;/q;2*+1/p-2/b6-5+,11-7+,12-8+,15-9+,16-10+,17-13+,18-14+;;",C/C(=C\\C=C\\C=C(\\C=C\\C=C(\\C(=O)[O-])/C)/C)/C=C/C=C(/C(=O)[O-])\\C.[Na+].[Na+],RMDMBHQVNHQDDD-VFWKRBOSSA-L,"disodium;(2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20061025,"A2B Chem|AA BLOCKS|Achemtek|Acorn PharmaTech Product List|AKos Consulting & Solutions|Ambinter|BioCrick|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemFaces|ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Japan Chemical Substance Dictionary (Nikkaji)|MolPort|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Smolecule|Springer Nature|TargetMol (Target Molecule Co",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10951514,Adenosine Diphosphate (Hydroxymethyl)pyrrolidine monoalcohol,Adenosine Diphosphate (Hydroxymethyl)pyrrolidine monoalcohol|A3R,526.330,C15H24N6O11P2,254.000,815.000,-7.200,34,7,16,9,"InChI=1S/C15H24N6O11P2/c16-13-10-14(19-5-18-13)21(6-20-10)15-12(24)11(23)9(31-15)4-30-34(27,28)32-33(25,26)29-3-7-1-8(22)2-17-7/h5-9,11-12,15,17,22-24H,1-4H2,(H,25,26)(H,27,28)(H2,16,18,19)/t7-,8+,9+,11+,12+,15+/m0/s1",C1[C@H](CN[C@@H]1COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O)O,PHEYQOBMMIEFLO-IBCGMDAMSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2S,4R)-4-hydroxypyrrolidin-2-yl]methyl hydrogen phosphate",NULL,Biomolecular Interactions and Pathways,1,NULL,20061026,ChemSpider|DiscoveryGate|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Thomson Pharma,Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11527330,Apilimod mesylate,Apilimod mesylate|Apilimod dimesylate|870087-36-8|UNII-5G3P5OK11S|Apilimod mesylate [USAN]|STA 5326 mesylate|5G3P5OK11S|Apilimod (mesylate)|(E)-4-(6-(2-(3-methylbenzylidene)hydrazinyl)-2-(2-(pyridin-2-yl)ethoxy)pyrimidin-4-yl)morpholine dimethanesulfonate|Apilimod mesylate (USAN)|STA-5326 mesylate|STA 5326 dimesylate|SCHEMBL3082380|EX-A909|HY-14644A|MFCD28167749|AS-16911|S0785|D06556|J-690369|2-(5-Chloro-2-{[3-(4-methyl-1-piperazinyl)propyl]amino}-4-pyrimidinyl)-N-cyclopropyl-1-benzothiophene-4-carboxamide|,610.700,C25H34N6O8S2,210.000,637.000,NULL,41,3,14,8,"InChI=1S/C23H26N6O2.2CH4O3S/c1-18-5-4-6-19(15-18)17-25-28-21-16-22(29-10-13-30-14-11-29)27-23(26-21)31-12-8-20-7-2-3-9-24-20;2*1-5(2,3)4/h2-7,9,15-17H,8,10-14H2,1H3,(H,26,27,28);2*1H3,(H,2,3,4)/b25-17+;;",CC1=CC(=CC=C1)/C=N/NC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4.CS(=O)(=O)O.CS(=O)(=O)O,GAJWNIKZLYZYSY-OKUPSQOASA-N,methanesulfonic acid;N-[(E)-(3-methylphenyl)methylideneamino]-6-morpholin-4-yl-2-(2-pyridin-2-ylethoxy)pyrimidin-4-amine,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20061026,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|Achemtek|Axon Medchem|BioCrick|Biosynth Carbosynth|ChemIDplus|ChemShuttle|ChemSpider|DiscoveryGate|Excenen Pharmatech|FDA/SPL Indexing Data|KEGG|Key Organics/BIONET|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NextBio|Selleck Chemicals|Smolecule|SureChEMBL|Thomson Pharma|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11561899,N-[(2S)-1-({(2S)-4-Hydroxy-3-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide,"PF-00835231|PF00835231|870153-29-0|N-[(2S)-1-({(2S)-4-hydroxy-3-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide|GTPL11250|CHEBI:172918|BDBM420298|EX-A4701|s9731|compound 4 [Hoffman et al., 2020]|PF-0835231|PF 00835231|(2S)-N-[(2S)-4-hydroxy-3-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]-2-[(4-methoxy-1H-indol-2-yl)formamido]-4-methylpentanamide",472.500,C24H32N4O6,150.000,760.000,1.600,34,5,6,11,"InChI=1S/C24H32N4O6/c1-13(2)9-18(23(32)27-17(20(30)12-29)10-14-7-8-25-22(14)31)28-24(33)19-11-15-16(26-19)5-4-6-21(15)34-3/h4-6,11,13-14,17-18,26,29H,7-10,12H2,1-3H3,(H,25,31)(H,27,32)(H,28,33)/t14-,17-,18-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO)NC(=O)C2=CC3=C(N2)C=CC=C3OC,QDIMHKWNHMVDJB-WBAXXEDZSA-N,N-[(2S)-1-[[(2S)-4-hydroxy-3-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20061026,BindingDB|ChEBI|ChemSpider|DC Chemicals|DiscoveryGate|Excenen Pharmatech|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Selleck Chemicals|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11614223,"Disodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrate",NULL,616.600,C18H18N8Na2O8S3,298.000,1120.000,NULL,39,3,15,7,"InChI=1S/C18H18N8O7S3.2Na.H2O/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);;;1H2/q;2*+1;/p-2/b24-8-;;;/t9-,15-;;;/m1.../s1",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-].O.[Na+].[Na+],NTQTUYCYXGWAPN-PZSKLDMFSA-L,"disodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrate",NULL,NULL,0,NULL,20061026,ChemMol|DiscoveryGate|LeadScope|NextBio|Thomson Pharma|ToxPlanet,Chemical Vendors|Journal Publishers|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11949646,Empagliflozin,"Empagliflozin|864070-44-0|JARDIANCE|BI 10773|Empagliflozin (BI 10773)|BI-10773|BI10773|UNII-HDC1R2M35U|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|HDC1R2M35U|1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene|CHEBI:82720|(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol|(1S)-1,5-anhydro-1-C-{4-chloro-3-((4-{((3S)-oxolan-3-yl)oxy}phenyl)methyl)phenyl}-D-glucito",450.900,C23H27ClO7,109.000,558.000,2.000,31,4,7,6,"InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1",C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl,OBWASQILIWPZMG-QZMOQZSNSA-N,"(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1258654|1258655|1259398|1259399|1259416|1259421|1259423|1346950|1346965|1396969|1409594|1409598|1409605|1413441|1413442,20061120,"4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|Angene Chemical|ApexBio Technology|Apexmol|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem|B&C Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11954236,Emtricitabine and tenofovir disoproxil fumarate,"emtricitabine & tenofovir|emtricitabine + tenofovir|emtricitabine and tenofovir|Tenofovir/emtricitabine|Emtricitabine / tenofovir|Tenofovir / Emtricitabine|Emtricitabine mixture with tenofovir disoproxil fumarate|731772-45-5|Tenofovir mixture with Emtricitabine|Tenofovir disoproxil fumarate/emtricitabine|Emtricitabine / Tenofovir disoproxil fumarate|Emtricitabine Tenofovir DF|Emtricitabine and tenofovir disoproxil fumarate|Emtricitabine mixture with tenofovir disoproxil|SCHEMBL17373214|Emtricitabine, Tenofo",882.800,C31H44FN8O17PS,374.000,1190.000,NULL,59,5,23,21,"InChI=1S/C19H30N5O10P.C8H10FN3O3S.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1,5-6,13H,2-3H2,(H2,10,11,14);1-2H,(H,5,6)(H,7,8)/b;;2-1+/t14-;5-,6+;/m10./s1",C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F.C(=C/C(=O)O)\\C(=O)O,VERWQPYQDXWOGT-LVJNJWHOSA-N,"4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid","Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination",Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20061122,"ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|LeadScope|NextBio|NextMove Software|SureChEMBL|ToxPlanet|Wikidata",Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11957582,N6-Ethanimidoyl-D-lysine,CHEMBL340800|NIL|L-N6-(1-Iminoethyl)lysine|N6-ethanimidoyl-D-lysine|Lopac0_000663|GTPL5231|ZINC2384265|BDBM50030277|CCG-204749|SDCCGSBI-0050642.P002|NCGC00162216-01|NCGC00162216-02|(2R)-2-amino-6-ethanimidamidohexanoic acid|(R)-6-Acetimidoylamino-2-amino-hexanoic acid|(2R)-2-amino-6-(1-aminoethylideneamino)hexanoic acid|Q27087931,187.240,C8H17N3O2,102.000,192.000,-3.100,13,3,4,6,"InChI=1S/C8H17N3O2/c1-6(9)11-5-3-2-4-7(10)8(12)13/h7H,2-5,10H2,1H3,(H2,9,11)(H,12,13)/t7-/m1/s1",CC(=NCCCC[C@H](C(=O)O)N)N,ONYFNWIHJBLQKE-SSDOTTSWSA-N,(2R)-2-amino-6-(1-aminoethylideneamino)hexanoic acid,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,9,2660|2666|2667|2668|67823|91995|92167|92181|146106|146136|218912|234295|463106|485295|485297|485298|485313|485342|485345|485366|485368|488772|488773|488816|488837|488949|488953|488978|488981|488982|488983|493106|493107|493153|493164|504327|504332|504536|504547|504548|504810|504812|504836|504845|504847|504865|540256|540276|588349|588378|588453|588456|588579|588795|602332|624146|624147|624148|624149|624455|651635|652106|720538|720559|720572|720573|743205|743206|743207|743244|1159580|1159607|1224859|1259398|12,20061201,"Ambinter|BindingDB|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|ChemBank|ChEMBL|chemical genetic matrix|ChemSpider|Circadian Research, Kay Laboratory, University of California at San Diego (UCSD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Emory University Molecular Libraries Screening Center|Google Patents|Gulick Lab, Department of Structural Biology, University at Buffalo|ICCB-Longwood Screening Facility, Harvard Medical School|IU",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
12000240,Emricasan,"Emricasan|254750-02-2|IDN-6556|PF-03491390|UNII-P0GMS9N47Q|(S)-3-((S)-2-(2-((2-(tert-Butyl)phenyl)amino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid|(S)-3-((S)-2-(2-(2-TERT-BUTYLPHENYLAMINO)-2-OXOACETAMIDO)PROPANAMIDO)-4-OXO-5-(2,3,5,6-TETRAFLUOROPHENOXY)PENTANOIC ACID|PF 03491390|P0GMS9N47Q|VAY785|C26H27F4N3O7|VAY-785|IDN 6556|(3S)-3-[[(2S)-2-[[2-(2-tert-butylanilino)-2-oxoacetyl]amino]propanoyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid|Emricasan [USAN:INN",569.500,C26H27F4N3O7,151.000,934.000,3.600,40,4,11,11,"InChI=1S/C26H27F4N3O7/c1-12(31-24(38)25(39)32-16-8-6-5-7-13(16)26(2,3)4)23(37)33-17(10-19(35)36)18(34)11-40-22-20(29)14(27)9-15(28)21(22)30/h5-9,12,17H,10-11H2,1-4H3,(H,31,38)(H,32,39)(H,33,37)(H,35,36)/t12-,17-/m0/s1",C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,SCVHJVCATBPIHN-SJCJKPOMSA-N,"(3S)-3-[[(2S)-2-[[2-(2-tert-butylanilino)-2-oxoacetyl]amino]propanoyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,255191|255192|255193|255194|255698|255770|255771|588211|588212|588213|638176|638177|743344|743345|743346|743347|1224824|1224825|1224852|1224853|1224854|1224855|1224856|1224857|1224858|1224859|1224860|1224861|1224862|1259252|1259253|1259255|1259256|1296008|1296009|1345414|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|,20070205,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|Achemtek|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|BLD Pharm|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|CSNpharm|Davey Lab, Department of Microbiology, NEIDL, Boston Uni",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
12422527,"4-Bromo-1,8-naphthyridine","4-Bromo-1,8-naphthyridine|54569-28-7|4-Bromo-[1,8]naphthyridine|1,8-Naphthyridine, 4-bromo-|4-bromanyl-1,8-naphthyridine|HH8|SCHEMBL1907362|DTXSID30497525|AMY38545|7902AB|ANW-72773|MFCD11520860|ZINC36533204|AKOS005136196|AB64248|NE63492|AS-33181|AB0072758|CS-0055002|FT-0648624|569B287|J-514526",209.040,C8H5BrN2,25.800,140.000,2.100,11,0,2,0,InChI=1S/C8H5BrN2/c9-7-3-5-11-8-6(7)2-1-4-10-8/h1-5H,C1=CC2=C(C=CN=C2N=C1)Br,QYXNSNJTMIEAPG-UHFFFAOYSA-N,"4-bromo-1,8-naphthyridine",NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20070208,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Achemo Scientific Limited|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Bioco",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
14196351,2-Methanesulfonyl-N-methylaniline,2-methanesulfonyl-N-methylaniline|10224-69-8|N-methyl-2-methylsulfonylaniline|N-methyl-2-(methylsulfonyl)aniline|SCHEMBL2634765|ZINC34246003|AKOS009152977|MCULE-2181539317|NE25399|Z285782452,185.250,C8H11NO2S,54.600,230.000,1.700,12,1,3,2,"InChI=1S/C8H11NO2S/c1-9-7-5-3-4-6-8(7)12(2,10)11/h3-6,9H,1-2H3",CNC1=CC=CC=C1S(=O)(=O)C,YLDKGNWSSXYUAH-UHFFFAOYSA-N,N-methyl-2-methylsulfonylaniline,NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20070209,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|Combi-Blocks|DiscoveryGate|Enamine|Google Patents|IBM|Lan Pharmatech|Mcule|MolPort|NCBI Structure|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Smolecule|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
14741611,N-Hexylcarbamic acid,hexylcarbamic acid|N-Hexylcarbamic acid|CCCCCCNC([O])=O|SCHEMBL671912|CHEBI:156060|AKOS006353553,145.200,C7H15NO2,49.300,93.600,2.000,10,2,2,5,"InChI=1S/C7H15NO2/c1-2-3-4-5-6-8-7(9)10/h8H,2-6H2,1H3,(H,9,10)",CCCCCCNC(=O)O,YAQPZDICKJDHTR-UHFFFAOYSA-N,hexylcarbamic acid,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20070209,AKos Consulting & Solutions|ChEBI|ChemSpider|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
15160483,L-Homotyrosine,"L-Homotyrosine|221243-01-2|(S)-2-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID|homotyrosine|Homotyrosine, (+)-|(+)-homotyrosine|UNII-15X6A9Y291|15X6A9Y291|(S)-2-AMINO-4-(4-HYDROXY-PHENYL)-BUTYRIC ACID|H-HoTyr-OH.HBr|(2S)-2-amino-4-(4-hydroxyphenyl)butanoic acid|alpha-Homotyrosine, (+)-|homo-tyrosine|(S)-4-HYDROXY-HOMOPHENYLALANINE|Benzenebutanoic acid, a-amino-4-hydroxy-, (aS)-|SCHEMBL1768639|Benzenebutanoic acid, alpha-amino-4-hydroxy-, (alphaS)-|CHEBI:81871|DTXSID40569328|ZINC2572524|MFCD03490505|AKOS006275844|A",195.210,C10H13NO3,83.600,188.000,-1.600,14,3,4,4,"InChI=1S/C10H13NO3/c11-9(10(13)14)6-3-7-1-4-8(12)5-2-7/h1-2,4-5,9,12H,3,6,11H2,(H,13,14)/t9-/m0/s1",C1=CC(=CC=C1CC[C@@H](C(=O)O)N)O,LOOZZTFGSTZNRX-VIFPVBQESA-N,(2S)-2-amino-4-(4-hydroxyphenyl)butanoic acid,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20070209,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|ChEBI|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|ChemIDplus|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
15168139,N-[N-[(Phenylmethoxy)carbonyl]-L-leucyl]-L-norleucinol,SCHEMBL1837558|N-[N-[(Phenylmethoxy)carbonyl]-L-leucyl]-L-norleucinol|benzyl N-[(2S)-1-[[(2S)-1-hydroxyhexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate,364.500,C20H32N2O4,87.700,409.000,3.700,26,3,4,12,"InChI=1S/C20H32N2O4/c1-4-5-11-17(13-23)21-19(24)18(12-15(2)3)22-20(25)26-14-16-9-7-6-8-10-16/h6-10,15,17-18,23H,4-5,11-14H2,1-3H3,(H,21,24)(H,22,25)/t17-,18-/m0/s1",CCCC[C@@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1,JDNZSBPOIODDLU-ROUUACIJSA-N,benzyl N-[(2S)-1-[[(2S)-1-hydroxyhexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20070209,Google Patents|IBM|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL,Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
15277004,5'-Thiothymidine,"5'-thiothymidine|7150-83-6|Thymidine, 5'-thio-|SCHEMBL778860|5'-deoxy-5'-mercaptothymidine|5'-Mercapto-5'-deoxythymidine|CHEMBL463853|ZINC17327965|1-[(2R,4S,5S)-4-hydroxy-5-(sulfanylmethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione|WUV",258.300,C10H14N2O4S,79.900,385.000,-0.700,17,3,5,2,"InChI=1S/C10H14N2O4S/c1-5-3-12(10(15)11-9(5)14)8-2-6(13)7(4-17)16-8/h3,6-8,13,17H,2,4H2,1H3,(H,11,14,15)/t6-,7+,8+/m0/s1",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CS)O,CPEAGKYEYPXTSP-XLPZGREQSA-N,"1-[(2R,4S,5S)-4-hydroxy-5-(sulfanylmethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents,5,381854|381860,20070209,"AX Molecules Inc|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
15477891,(2R)-2-(4-Chlorophenoxy)propanamide,"(2R)-2-(4-chlorophenoxy)propanamide|W0M|ZINC12937614|[R,(?)]-2-(p-Chlorophenoxy)propionamide",199.630,C9H10ClNO2,52.300,179.000,1.700,13,1,2,3,"InChI=1S/C9H10ClNO2/c1-6(9(11)12)13-8-4-2-7(10)3-5-8/h2-6H,1H3,(H2,11,12)/t6-/m1/s1",C[C@H](C(=O)N)OC1=CC=C(C=C1)Cl,GLBNTBLOLXXOFK-ZCFIWIBFSA-N,(2R)-2-(4-chlorophenoxy)propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20070209,DiscoveryGate|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
16132300,Aviptadil,invicorp|Vasoactive intestinal octacosapeptide|RLF-100|Aviptadil [INN:BAN]|GTPL10891|Invicorp (aviptadil + phentolamine)|L-Histidyl-L-seryl-L-aspartyl-L-alanyl-L-valyl-L-phenylalanyl-L-threonyl-L-aspartyl-L-asparaginyl-L-tyrosyl-L-threonyl-L-arginyl-L-leucyl-L-arginyl-L-lysyl-L-glutaminyl-L-methionyl-L-alanyl-L-valyl-L-lysyl-L-lysyl-L-tyrosyl-L-leucyl-L-asparaginyl-L-seryl-L-isoleucyl-L-leucyl-L-asparagine,3326.800,C147H237N43O43S,1470.000,7580.000,-15.900,234,51,51,115,InChI=1S/C147H237N43O43S/c1-18-75(12)115(142(229)180-96(56-72(6)7)131(218)183-104(145(232)233)63-110(155)200)188-139(226)106(68-192)185-134(221)101(62-109(154)199)177-130(217)95(55-71(4)5)174-132(219)97(58-81-37-41-84(195)42-38-81)175-125(212)88(33-23-26-49-149)167-123(210)89(34-24-27-50-150)171-140(227)113(73(8)9)186-118(205)76(13)164-121(208)93(47-53-234-17)170-127(214)92(45-46-107(152)197)169-122(209)87(32-22-25-48-148)166-124(211)90(35-28-51-161-146(156)157)168-129(216)94(54-70(2)3)173-126(213)91(36-29-,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O,VBUWHHLIZKOSMS-RIWXPGAOSA-N,"(2S)-4-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-carboxypro",NULL,Classification|Literature|Names and Identifiers|Patents,4,NULL,20070703,AKos Consulting & Solutions|AN PharmaTech|ChemIDplus|ChemMol|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Google Patents|iChemical Technology USA Inc|ISpharm|IUPHAR/BPS Guide to PHARMACOLOGY|NovoSeek|PATENTSCOPE (WIPO)|Smolecule|Springer Nature|THE BioTek|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16167347,Aviptadil Acetate,"Aviptadil Acetate|Guinea pig VIP|Guinea pig VIP octacosapeptide|VIP, human, porcine, rat VIP (28 amino acids)|VIP (guinea pig)|96886-24-7|AKOS034834067",3344.900,C147H239N43O42S2,1480.000,7510.000,-13.700,234,51,51,116,InChI=1S/C147H239N43O42S2/c1-71(2)55-97(175-120(207)77(12)165-130(217)105(65-112(201)202)181-140(227)107(68-191)185-121(208)87(151)62-84-67-160-70-163-84)133(220)179-102(59-81-29-19-18-20-30-81)137(224)189-117(80(15)195)145(232)184-106(66-113(203)204)139(226)190-116(79(14)194)144(231)183-103(61-83-38-42-86(197)43-39-83)138(225)188-115(78(13)193)143(230)173-92(35-28-52-162-147(158)159)127(214)176-98(56-72(3)4)131(218)170-91(34-27-51-161-146(156)157)125(212)167-89(32-22-25-49-149)124(211)171-93(44-45-109(152),CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(C(C)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(CCSC)C(=O)NC(C)C(=O)NC(CCSC)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)N)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CNC=N4)N,UGKBLTCXYMBLJU-UHFFFAOYSA-N,"4-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[6-amino-1-[[5-amino-1-[[1-[[1-[[1-[[6-amino-1-[[6-amino-1-[[1-[[1-[[4-amino-1-[[1-[[1-[[1-[(1,4-diamino-1,4-dioxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-o",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20070704,001Chemical|Achemtek|Acorn PharmaTech Product List|AKos Consulting & Solutions|Clearsynth|eNovation Chemicals|MolCore BioPharmatech|MolPort|Nextpeptide|THE BioTek,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16219411,Hydrocortisone 21-hemisuccinate sodium salt,"Hydrocortisone sodium succinate|Hydrocortisone 21-hemisuccinate sodium salt|125-04-2|Hydrocortisone hemisuccinate sodium salt|C25H33NaO8|3-{[2-((1S,10S,11S,15S,17S,2R,14R)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyc lo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl)-2-oxoethyl]oxycarbonyl}propanoic acid, sodium salt|SCHEMBL1320103|AKOS024386295|ST51037292|125H042|sodium;4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-o",485.500,C25H34NaO8,138.000,908.000,NULL,34,3,8,7,"InChI=1S/C25H34O8.Na/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30;/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30);/t16-,17-,18-,22+,23-,24-,25-;/m0./s1",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)O)O)C)O.[Na],LGKJVUKNTHOZJH-CODXZCKSSA-N,NULL,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,8,NULL,20070716,"A2B Chem|AA BLOCKS|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|MolPort|OChem|PATENTSCOPE (WIPO)|Pi Chemicals|Smolecule|Springer Nature|SureChEMBL|TimTec|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16226828,N-(2-Methoxy-5-methylphenyl)glycinamide,N-(2-methoxy-5-methylphenyl)glycinamide|887359-06-0|N~1~-(2-methoxy-5-methylphenyl)glycinamide|2-Amino-N-(2-methoxy-5-methylphenyl)acetamide|NY7|ZINC4201706|BBL019241|MFCD06662113|STK497991|AKOS000205135|MCULE-2743261263|BB 0243017|Y-2390|2-Amino-N-(2-methoxy-5-methyl-phenyl)-acetamide|2-Amino-N-(2-methoxy-5-methyl-phenyl)-acet amide,194.230,C10H14N2O2,64.400,197.000,0.500,14,2,3,3,"InChI=1S/C10H14N2O2/c1-7-3-4-9(14-2)8(5-7)12-10(13)6-11/h3-5H,6,11H2,1-2H3,(H,12,13)",CC1=CC(=C(C=C1)OC)NC(=O)CN,SRFLDWOWAGQZAD-UHFFFAOYSA-N,2-amino-N-(2-methoxy-5-methylphenyl)acetamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20070730,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemBridge|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|EDASA Scientific|Enamine|Key Organics/BIONET|Mcule|MolPort|NCBI Structure|Oakwood Products|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Smolecule|Vitas-M Laboratory|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
16653131,2-(Isopropylamino)-1H-benzoimidazole,"N-(propan-2-yl)-1H-benzimidazol-2-amine|1H-Benzimidazol-2-amine, N-(1-methylethyl)-|SCHEMBL11989038|SCHEMBL18656071|benzimidazol-2-yl(methylethyl)amine|ZINC8701455|SBB082663|2-(Isopropylamino)-1H-benzoimidazole|AKOS002671423|N-propan-2-yl-1H-benzimidazol-2-amine|924872-04-8|N-(propan-2-yl)-1H-1,3-benzodiazol-2-amine|Z2467208649|VWJ",175.230,C10H13N3,40.700,170.000,2.400,13,2,2,2,"InChI=1S/C10H13N3/c1-7(2)11-10-12-8-5-3-4-6-9(8)13-10/h3-7H,1-2H3,(H2,11,12,13)",CC(C)NC1=NC2=CC=CC=C2N1,KRNAPWQWOXYDPY-UHFFFAOYSA-N,N-propan-2-yl-1H-benzimidazol-2-amine,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20070731,"AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Chem-Space.com Database|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Enamine|Google Patents|IBM|Innovapharm|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|TimTec|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
16755630,Tetratriacontaethylene glycol monomethyl ether,"tetratriacontaethylene glycol monomethyl ether|POLYETHYLENE GLYCOL (N=34)|2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80,83,86,89,92,95,98,101-tetratriacontaoxatrihectan-103-ol|CHEBI:39558|Q27120365",1529.800,C69H140O35,334.000,1310.000,-5.500,104,1,35,101,"InChI=1S/C69H140O35/c1-71-4-5-73-8-9-75-12-13-77-16-17-79-20-21-81-24-25-83-28-29-85-32-33-87-36-37-89-40-41-91-44-45-93-48-49-95-52-53-97-56-57-99-60-61-101-64-65-103-68-69-104-67-66-102-63-62-100-59-58-98-55-54-96-51-50-94-47-46-92-43-42-90-39-38-88-35-34-86-31-30-84-27-26-82-23-22-80-19-18-78-15-14-76-11-10-74-7-6-72-3-2-70/h70H,2-69H2,1H3",COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,VUYXVWGKCKTUMF-UHFFFAOYSA-N,2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers,3,NULL,20071102,"ChEBI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Protein Data Bank in Europe (PDBe)|Wikidata",Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
16760703,Sodium valproate,"Sodium valproate|Sodium 2-propylpentanoate|1069-66-5|Valproate sodium|Valproic acid sodium salt|Valproic acid sodium|Epilim|Valproic Acid (sodium salt)|Pentanoic acid, 2-propyl-, sodium salt|Sodium 2-propylvalerate|2-Propylvaleric acid sodium salt|2-Propylpentanoic acid sodium salt|UNII-5VOM6GYJ0D|Valproic acid sodium salt (1:1)|Valproic Acid, Sodium Salt|Valproic acid sodium salt (Sodium valproate)|2-propylpentanoic acid sodium|Valproate|MFCD00078604|5VOM6GYJ0D|Abbott 44090|CHEBI:9925|Eurekene|Labazene|Orf",166.190,C8H15NaO2,40.100,98.300,NULL,11,0,2,5,"InChI=1S/C8H16O2.Na/c1-3-5-7(6-4-2)8(9)10;/h7H,3-6H2,1-2H3,(H,9,10);/q;+1/p-1",CCCC(CCC)C(=O)[O-].[Na+],AEQFSUDEHCCHBT-UHFFFAOYSA-M,sodium;2-propylpentanoate,Valproic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|910|912|914|915|917|918|923|924|925|926|927|928|930|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|15,20071113,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemtek|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alsachim|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmat",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
19325187,1-[4-[(3-Chlorophenyl)methyl]piperazin-1-yl]ethanone,AKOS017093947,252.740,C13H17ClN2O,23.600,264.000,1.700,17,0,2,2,"InChI=1S/C13H17ClN2O/c1-11(17)16-7-5-15(6-8-16)10-12-3-2-4-13(14)9-12/h2-4,9H,5-8,10H2,1H3",CC(=O)N1CCN(CC1)CC2=CC(=CC=C2)Cl,OACABXAYQRNFDV-UHFFFAOYSA-N,1-[4-[(3-chlorophenyl)methyl]piperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20071204,AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|ChemSpider|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
19325375,1-[4-[(3-Methylphenyl)methyl]piperazin-1-yl]ethanone,SCHEMBL12660179|AKOS017096644,232.320,C14H20N2O,23.600,259.000,1.400,17,0,2,2,"InChI=1S/C14H20N2O/c1-12-4-3-5-14(10-12)11-15-6-8-16(9-7-15)13(2)17/h3-5,10H,6-9,11H2,1-2H3",CC1=CC(=CC=C1)CN2CCN(CC2)C(=O)C,CMCBVCKQOHOWJO-UHFFFAOYSA-N,1-[4-[(3-methylphenyl)methyl]piperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20071204,AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|ChemSpider|Google Patents|IBM|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
19786643,N-Methyl-1H-indole-7-carboxamide,N-methyl-1H-indole-7-carboxamide|1519477-17-8|O2A|SCHEMBL6219389|CHEMBL4576940|ZINC76189815|AKOS015013539|Z1273312153,174.200,C10H10N2O,44.900,205.000,1.300,13,2,1,1,"InChI=1S/C10H10N2O/c1-11-10(13)8-4-2-3-7-5-6-12-9(7)8/h2-6,12H,1H3,(H,11,13)",CNC(=O)C1=CC=CC2=C1NC=C2,OKVUYVXDTGOYRU-UHFFFAOYSA-N,N-methyl-1H-indole-7-carboxamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20071205,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChEMBL|Enamine|Google Patents|IBM|MolPort|NCBI Structure|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
20754800,N-(1-Acetylpiperidin-4-yl)benzamide,577778-27-9|N-(1-Acetyl-4-piperidinyl)benzamide|N-(1-Acetylpiperidin-4-yl)benzamide|CHEMBL433117|SCHEMBL14590545|DTXSID80609636|ZINC26388353|AKOS009013412,246.300,C14H18N2O2,49.400,303.000,1.300,18,1,2,2,"InChI=1S/C14H18N2O2/c1-11(17)16-9-7-13(8-10-16)15-14(18)12-5-3-2-4-6-12/h2-6,13H,7-10H2,1H3,(H,15,18)",CC(=O)N1CCC(CC1)NC(=O)C2=CC=CC=C2,KFVWQRVNMHXHKB-UHFFFAOYSA-N,N-(1-acetylpiperidin-4-yl)benzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Names and Identifiers|Patents,4,131283|131284|131285|134633,20071205,"AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|EPA DSSTox|Google Patents|IBM|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
22123056,"N-(5-Bromo-2-oxo-1,2-dihydropyridin-3-yl)acetamide","N-(5-bromo-2-oxo-1,2-dihydropyridin-3-yl)acetamide|ZINC67936997|MCULE-2975387620|N-(5-bromo-2-hydroxypyridin-3-yl)acetamide|WQV",231.050,C7H7BrN2O2,58.200,294.000,0.000,12,2,2,1,"InChI=1S/C7H7BrN2O2/c1-4(11)10-6-2-5(8)3-9-7(6)12/h2-3H,1H3,(H,9,12)(H,10,11)",CC(=O)NC1=CC(=CNC1=O)Br,DZPXAAPHBCJNCQ-UHFFFAOYSA-N,N-(5-bromo-2-oxo-1H-pyridin-3-yl)acetamide,NULL,Biomolecular Interactions and Pathways|Names and Identifiers,2,NULL,20071205,"AHH Chemical co.,ltd|Ambinter|Aurora Fine Chemicals LLC|ChemSpider|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
22882465,"(R)-N-(1,2,3,4-Tetrahydroquinolin-3-yl)acetamide","SCHEMBL8568429|ZINC19274807|(R)-N-(1,2,3,4-Tetrahydroquinolin-3-yl)acetamide|2022944-69-8",190.240,C11H14N2O,41.100,217.000,1.300,14,2,2,1,"InChI=1S/C11H14N2O/c1-8(14)13-10-6-9-4-2-3-5-11(9)12-7-10/h2-5,10,12H,6-7H2,1H3,(H,13,14)/t10-/m1/s1",CC(=O)N[C@@H]1CC2=CC=CC=C2NC1,HCEIEGOMGWEGOJ-SNVBAGLBSA-N,"N-[(3R)-1,2,3,4-tetrahydroquinolin-3-yl]acetamide",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20071205,BLD Pharm|IBM|NCBI Structure|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
23662274,Sodium pyruvate,"SODIUM PYRUVATE|113-24-6|sodium 2-oxopropanoate|Pyruvic acid sodium salt|Pyruvate Sodium|Pyruvic acid, sodium salt|Propanoic acid, 2-oxo-, sodium salt|2-Oxopropanoic acid sodium salt|UNII-POD38AIF08|MFCD00002586|113-24-6 (Sodium)|alpha-Ketopropionic acid sodium salt|POD38AIF08|2-KETOPROPIONIC ACID SODIUM SALT|CHEBI:50144|Natriumpyruvat|Propanoic acid, 2-oxo-, sodium salt (1:1)|Sodium alpha-ketopropionate|Pyruvic acid, sodium salt, 99+%|Natrum pyruvicum|CHEMBL181886|sodium-pyruvate|Guna-flam|Guna-hypertensio",110.040,C3H3NaO3,57.200,88.200,NULL,7,0,3,1,"InChI=1S/C3H4O3.Na/c1-2(4)3(5)6;/h1H3,(H,5,6);/q;+1/p-1",CC(=O)C(=O)[O-].[Na+],DAEPDZWVDSPTHF-UHFFFAOYSA-M,sodium;2-oxopropanoate,NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,10,238510|238528|238529|238530|238792|414637|414638|414639|651631|651632|651633|651634|720516|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|7,20080205,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|Acadechem|Achemica|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Aromalake Chemical|Aurora Fine Chemicals LLC|Avantor Inc|BIND|BioChemPartner|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|Changzho",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
23666110,Liothyronine sodium,"LIOTHYRONINE SODIUM|55-06-1|Cytomel|3,3',5-Triiodo-L-thyronine sodium salt|Triostat|Tertroxin|Triiodothyronine sodium|Liothyronin sodium|Liothyronine sodium salt|L-Triiodothyronine sodium salt|3,3',5-Triiodo-L-thyronine sodium|3,3',5-Triiodothyronine sodium salt|T3 sodium salt|UNII-GCA9VV7D2N|CHEBI:6484|Liothyronine (sodium)|L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-, monosodium salt|MFCD00002594|GCA9VV7D2N|LIOTHYRONINE (L- isomer) SODIUM|Monosodium L-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)",672.950,C15H11I3NNaO4,95.600,408.000,NULL,24,2,5,5,"InChI=1S/C15H12I3NO4.Na/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22;/h1-4,6,12,20H,5,19H2,(H,21,22);/q;+1/p-1/t12-;/m0./s1",C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)[O-])N)I)I)O.[Na+],SBXXSUDPJJJJLC-YDALLXLXSA-M,"sodium;(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate",Triiodothyronine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,12,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|454|455|456|457|460|461|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|639|641|645|648|680|684|686|687|701|708|709|719|731|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|793|795|797|798|799|,20080205,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbovChem LLC|Acadechem|Achemtek|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|ApexBio Technology|Apexmol|Aromalake Chemical|Aurora Fine Chemicals LLC|AvaChem Scientific|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|Center for Chemical Genomics, University of Michigan|ChangCh",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
23671691,Potassium canrenoate,potassium canrenoate|CANRENOATE POTASSIUM|Canrenoic acid potassium salt|canrenoic acid potassium|2181-04-6|UNII-M671F9NLEA|M671F9NLEA|SC-14266|MLS002154212|Soldactone|Canrenoate potassium (USAN)|Canrenoate Potassium [USAN]|Soludactone|Potassium aldadiene|Apiroctan|Venactone|Kalii canrenoas|Aldadiene-kalium|Kalium canrenoat|Soldactone (TN)|Aldadiene-potassium|Canrenoato potasico|NCGC00017146-01|Prestwick_910|Canrenoate de potassium|SC 14266|Aldadiene potassium salt|Aldadiene-kalium [German]|Potassium canreno,396.600,C22H29KO4,77.400,713.000,NULL,27,1,4,3,"InChI=1S/C22H30O4.K/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21,26)12-8-19(24)25;/h3-4,13,16-18,26H,5-12H2,1-2H3,(H,24,25);/q;+1/p-1/t16-,17+,18+,20+,21+,22-;/m1./s1",C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(CCC(=O)[O-])O)C.[K+],JTZQCHFUGHIPDF-RYVBEKKQSA-M,"potassium;3-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoate",Canrenoic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,12,377|1850|1863|1899|1903|1906|1947|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2101|2129|2130|2174|2177|2234|2235|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2557|2599|2606|2629|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|434955|434962|434973|434989|435003|435005|435022|435030|449728|449762|449763|463079|463082|463104|463141|463190|463195|463210|463212|463254|485270|485272|485273|485275|485294|485297|485298|485313|485317|485341|485344|485346|485347|48,20080205,"AbMole Bioscience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|ApexBio Technology|Biosynth Carbosynth|BOC Sciences|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|Chemenu Inc.|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|ChemMol|Chen Lab, School of Medicine, Emory University|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinform",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
23679441,[(2S)-1-(4-Amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid,"CEFTRIAXONE SODIUM|ceftriaxone|74578-69-1|104376-79-6|[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid|Ro-139904|Ceftriaxone sodium salt|OCTX|CEFTRIAXONE SODIUM TRIHYDRATE|SCHEMBL537013|CHEMBL1200995|AKOS015961150|AC-1851|sodium (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((6-hydroxy-2-methyl-5-oxo-2,5-dihydro-1,2,4-triazin-3-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",576.600,C18H17N8NaO7S3,291.000,1120.000,NULL,37,3,13,8,"InChI=1S/C18H18N8O7S3.Na/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);/q;+1/p-1/b24-8-;/t9-,15-;/m1./s1",CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-].[Na+],YOBPSXOHCHDCMU-VKZZUTNHSA-M,"sodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",Ceftriaxone,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,521220|1508614,20080205,"3B Scientific (Wuhan) Corp|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AKos Consulting & Solutions|AmicBase - Antimicrobial Activities|AvaChem Scientific|Boerchem|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|ChEMBL|ChemMol|ChemSpider|DC Chemicals|eNovation Chemicals|Gulick Lab, Department of Structural Biology, University at Buffalo|Hangzhou APIChem Technology|ISpharm|LeadScope|Matrix Scientific|NextBio|NovoSeek|PATENTSCOPE (WIPO)|SCRIPDB|Smolecule|Springer ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
23724843,Piperacillin-tazobactam,"Tazocin (TN)|Zosyn (TN)|Piperacillin-tazobactam|Piperacillin-tazobactam mixt.|Piperacillin-tazobactam mixture|NIOSH/XI0191450|Piperacillin sodium and tazobactam|DTXSID001016418|Tazobactam and piperacillin (JP17)|Piperacillin-tazobactam mixt. (4:1)|Tazobactam-piperacillin mixt. (1:4)|XI01914500|D02505|4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S-(2-alpha,3-beta,5-alpha))-, mixt. with (2S-(2-alpha,5-alpha,6-beta(S*)))-6-(((((4-ethyl-2,3",839.800,C33H38N9NaO12S2,315.000,1560.000,NULL,57,3,15,9,"InChI=1S/C23H27N5O7S.C10H12N4O5S.Na/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28;1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19;/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34);2-3,7-8H,4-5H2,1H3,(H,16,17);/q;;+1/p-1/t13-,14+,15-,20+;7-,8+,10+;/m01./s1",CCN1CCN(C(=O)C1=O)C(=O)N[C@@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3.[Na+],TUPFOYXHAYOHIB-WZGOVNIISA-M,"sodium;(2S,5R,6R)-6-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Toxicity,5,NULL,20080208,ChemIDplus|EPA DSSTox|KEGG,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
24875259,Antroquinonol,"antroquinonol|Hocena|1010081-09-0|UNII-AX9P92T7JZ|AX9P92T7JZ|CHEBI:65415|J3.387.174K|antroquinonol D|Antroquinonol A|(4R,5R,6R)-4-hydroxy-2,3-dimethoxy-6-methyl-5-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)cyclohex-2-en-1-one|(4R,5R,6R)-4-hydroxy-2,3-dimethoxy-6-methyl-5-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]cyclohex-2-en-1-one|(+)-Antroquinonol A|(+)-Antroquinonol|CHEMBL3235620|SCHEMBL16919581|DB12326|Q27133859|(4R)-2,3-Dimethoxy-4alpha-hydroxy-5alpha-((2E,6E)-3,7,11-trimethyl-2,6,10-dod",390.600,C24H38O4,55.800,648.000,5.800,28,1,4,10,"InChI=1S/C24H38O4/c1-16(2)10-8-11-17(3)12-9-13-18(4)14-15-20-19(5)21(25)23(27-6)24(28-7)22(20)26/h10,12,14,19-20,22,26H,8-9,11,13,15H2,1-7H3/b17-12+,18-14+/t19-,20-,22-/m1/s1",C[C@@H]1[C@H]([C@H](C(=C(C1=O)OC)OC)O)C/C=C(\\C)/CC/C=C(\\C)/CCC=C(C)C,LJTSIMVOOOLKOL-FNRDIUJOSA-N,"(4R,5R,6R)-4-hydroxy-2,3-dimethoxy-6-methyl-5-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]cyclohex-2-en-1-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Use and Manufacturing|Biological Test Results: Active,9,1129217|1129218|1129219|1129220|1415843|1415844|1501978|1501979,20080818,"BLD Pharm|ChEBI|ChEMBL|ChemIDplus|Comparative Toxicogenomics Database (CTD)|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|Smolecule|Springer Nature|SureChEMBL|THE BioTek|The Natural Products Atlas|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
24941262,5-Amino-2-Methyl-N-[(1r)-1-Naphthalen-1-Ylethyl]benzamide,GRL0617|5-Amino-2-Methyl-N-[(1r)-1-Naphthalen-1-Ylethyl]benzamide|GRL-0617|5-Amino-2-methyl-N-[(1R)-1-(1-naphthalenyl)ethyl]benzamide|5-Amino-2-methyl-N-[(R)-1-(1-naphthyl)ethyl]benzamide|5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)-benzamide|CHEMBL549695|SCHEMBL1319181|BDBM31524|GTPL11078|CHEBI:167176|5-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide|EX-A4032|GRL 0617|s6845|ZINC43012570|AKOS015840255|AKOS015924263|DB08656|compound 25 [PMID: 19645480]|NCGC00188640-01|Naphthalene and Benzamide Der,304.400,C20H20N2O,55.100,410.000,4.000,23,2,2,3,"InChI=1S/C20H20N2O/c1-13-10-11-16(21)12-19(13)20(23)22-14(2)17-9-5-7-15-6-3-4-8-18(15)17/h3-12,14H,21H2,1-2H3,(H,22,23)/t14-/m1/s1",CC1=C(C=C(C=C1)N)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32,UVERBUNNCOKGNZ-CQSZACIVSA-N,5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,428667|428668|724828|724829|725109,20081008,"A2B Chem|AA BLOCKS|AbaChemScene|Achemtek|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AvaChem Scientific|BindingDB|BLD Pharm|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemMol|CSNpharm|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|Lan Pharmatech|MedChemexpress MCE|MolPort|Nati",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
24978514,Phosphate-Buffered Saline,Phosphate-Buffered Saline|Phosphate buffered saline|sodium chloride-disodium hydrogen phosphate-potassium chloride-potassium dihydrogen phosphate (1:1:1:1),411.040,Cl2H3K2Na3O8P2,164.000,96.300,NULL,17,3,10,0,"InChI=1S/2ClH.2K.3Na.2H3O4P/c;;;;;;;2*1-5(2,3)4/h2*1H;;;;;;2*(H3,1,2,3,4)/q;;5*+1;;/p-5",OP(=O)(O)[O-].OP(=O)([O-])[O-].[Na+].[Na+].[Na+].[Cl-].[Cl-].[K+].[K+],LOKCTEFSRHRXRJ-UHFFFAOYSA-I,dipotassium;trisodium;dihydrogen phosphate;hydrogen phosphate;dichloride,NULL,Drug and Medication Information|Literature|Names and Identifiers|Patents,4,NULL,20081027,EPA DSSTox|NextMove Software,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
25022378,Edoxaban tosylate monohydrate,"edoxaban tosylate hydrate|Edoxaban tosylate monohydrate|1229194-11-9|Lixiana|DU-176b|Edoxaban (tosylate monohydrate)|UNII-972203R4EW|Edoxaban tosilate|Edoxaban tosilate hydrate|SAVAYSA|1229194-11-9 (tosylate hydrate)|972203R4EW|N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide 4-methylbenzenesulfonate hydrate|Edoxaban tosilate monohydrate|MFCD28400751|Savaysa (TN)|Edoxaban p-toluenesulfonate monohydrate|LIX",738.300,C31H40ClN7O8S2,229.000,1090.000,NULL,49,5,12,6,"InChI=1S/C24H30ClN7O4S.C7H8O3S.H2O/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23;1-6-2-4-7(5-3-6)11(8,9)10;/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34);2-5H,1H3,(H,8,9,10);1H2/t13-,15-,17+;;/m0../s1",CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C.O,PSMMNJNZVZZNOI-SJILXJHISA-N,"N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide;4-methylbenzenesulfonic acid;hydrate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20081110,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Angene Chemical|AOBIOUS INC|Aurora Fine Chemicals LLC|BioChemPartner|BioCrick|Cangzhou Enke Pharma Tech Co.,Ltd.|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|Discove",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
25023695,Brilacidin,"Brilacidin|1224095-98-0|UNII-I1679X069H|I1679X069H|PMX30063|N4,N6-bis(3-(5-guanidinopentanamido)-2-(((R)-pyrrolidin-3-yl)oxy)-5-(trifluoromethyl)phenyl)pyrimidine-4,6-dicarboxamide|Brilacidin [USAN:INN]|Brilacidin (USAN)|PMX30063 FREE BASE|SCHEMBL2878543|CHEMBL2219413|PMX-30063 FREE BASE|DTXSID90153594|CS-6677|DB12997|HY-19892|D10414|Q15408420|4,6-Pyrimidinedicarboxamide, N4,N6-bis(3-((5-((aminoiminomethyl)amino)-1-oxopentyl)amino)-2-((3R)-3-pyrrolidinyloxy)-5-(trifluoromethyl)phenyl)-|N,N'-Bis(3-((5-(carba",936.900,C40H50F6N14O6,314.000,1560.000,0.300,66,10,18,20,"InChI=1S/C40H50F6N14O6/c41-39(42,43)21-13-25(57-31(61)5-1-3-9-53-37(47)48)33(65-23-7-11-51-18-23)27(15-21)59-35(63)29-17-30(56-20-55-29)36(64)60-28-16-22(40(44,45)46)14-26(34(28)66-24-8-12-52-19-24)58-32(62)6-2-4-10-54-38(49)50/h13-17,20,23-24,51-52H,1-12,18-19H2,(H,57,61)(H,58,62)(H,59,63)(H,60,64)(H4,47,48,53)(H4,49,50,54)/t23-,24-/m1/s1",C1CNC[C@@H]1OC2=C(C=C(C=C2NC(=O)C3=CC(=NC=N3)C(=O)NC4=CC(=CC(=C4O[C@@H]5CCNC5)NC(=O)CCCCN=C(N)N)C(F)(F)F)C(F)(F)F)NC(=O)CCCCN=C(N)N,QPDYBCZNGUJZDK-DNQXCXABSA-N,"4-N,6-N-bis[3-[5-(diaminomethylideneamino)pentanoylamino]-2-[(3R)-pyrrolidin-3-yl]oxy-5-(trifluoromethyl)phenyl]pyrimidine-4,6-dicarboxamide",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,6,1199317|1199318|1199319|1199320|1199321|1199323|1199324|1199325|1199326|1445699|1445700|1445701|1445702|1445703|1445704|1445705|1445706|1445707|1445708|1445709|1445710|1445711|1445712|1445713|1445714|1445715|1445716|1445717|1445718|1445719|1445720|1445721|1445722,20081110,"A2B Chem|AA BLOCKS|AbaChemScene|Angene Chemical|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemIDplus|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|KEGG|MedChemexpress MCE|MolPort|MuseChem|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|SCRIPDB|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
25051804,4'-C-Azido-2'-deoxy-2'-fluoro-b-D-arabinocytidine,Azvudine|1011529-10-4|4'-C-Azido-2'-deoxy-2'-fluoro-b-D-arabinocytidine|4-amino-1-[5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one,286.220,C9H11FN6O4,123.000,533.000,-0.800,20,3,7,3,"InChI=1S/C9H11FN6O4/c10-5-6(18)9(3-17,14-15-12)20-7(5)16-2-1-4(11)13-8(16)19/h1-2,5-7,17-18H,3H2,(H2,11,13,19)",C1=CN(C(=O)N=C1N)C2C(C(C(O2)(CO)N=[N+]=[N-])O)F,KTOLOIKYVCHRJW-UHFFFAOYSA-N,4-amino-1-[5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20081124,BOC Sciences|DiscoveryGate|Google Patents|IBM|NIAID ChemDB|PATENTSCOPE (WIPO)|SCRIPDB|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
25154714,Daclatasvir,"Daclatasvir|1009119-64-5|BMS-790052|Daclatasvir (BMS-790052)|Daklinza|EBP 883|Daclatasvir dihydrochloride|1214735-16-6|BMS 790052|CHEBI:82977|BMS790052|UNII-LI2427F9CI|C40H50N8O6|1009119-65-6|Dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dica|methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]p",738.900,C40H50N8O6,175.000,1190.000,5.100,54,4,8,13,"InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1",CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,FKRSSPOQAMALKA-CUPIEXAXSA-N,methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,658165|658166|658167|658330|658331|658332|658333|658337|670532|670533|670534|670535|670536|670540|670541|670542|670543|670544|670545|670546|738377|738381|738382|738383|738384|738385|738386|738387|738388|743965|1070367|1070368|1070369|1070370|1071188|1071189|1072013|1072014|1072015|1072016|1072019|1072020|1072021|1072022|1072023|1072024|1072025|1072026|1072027|1072029|1072030|1072031|1072032|1072033|1072034|1072035|1072036|1072037|1072038|1072046|1072062|1072065|1072067|1072068|1072069|1072070|1072072|107207,20090223,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|Alsachim|Ambeed|Ambinter|AOBIOUS INC|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BindingDB|BioCrick|Biosynth Carbosynth|Boerchem|Broad Institute|Cangzhou Enke Pharma Tech Co.,Ltd.|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
27046747,1-Acetyl-4-[(4-methylphenyl)carbonyl]piperazine,CHEMBL4583025|SCHEMBL10194850|ZINC16291906|AKOS016374464|MCULE-2385579136|ST51041148|1-acetyl-4-[(4-methylphenyl)carbonyl]piperazine|1-[4-(4-methylbenzoyl)piperazin-1-yl]ethan-1-one|Z31727365|943410-52-4,246.300,C14H18N2O2,40.600,314.000,1.000,18,0,2,1,"InChI=1S/C14H18N2O2/c1-11-3-5-13(6-4-11)14(18)16-9-7-15(8-10-16)12(2)17/h3-6H,7-10H2,1-2H3",CC1=CC=C(C=C1)C(=O)N2CCN(CC2)C(=O)C,DRKSMECTOWRXKP-UHFFFAOYSA-N,1-[4-(4-methylbenzoyl)piperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20090528,AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChEMBL|DiscoveryGate|Enamine|Google Patents|IBM|Mcule|MolPort|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|TimTec|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
27646027,1-Acetyl-N-(6-methoxypyridin-3-yl)piperidine-4-carboxamide,NULL,277.320,C14H19N3O3,71.500,354.000,0.300,20,1,4,3,"InChI=1S/C14H19N3O3/c1-10(18)17-7-5-11(6-8-17)14(19)16-12-3-4-13(20-2)15-9-12/h3-4,9,11H,5-8H2,1-2H3,(H,16,19)",CC(=O)N1CCC(CC1)C(=O)NC2=CN=C(C=C2)OC,ZIGOYOFMTWMITB-UHFFFAOYSA-N,1-acetyl-N-(6-methoxypyridin-3-yl)piperidine-4-carboxamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20090528,DiscoveryGate|Protein Data Bank in Europe (PDBe),Governmental Organizations|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
29891930,N-(Cyclopentanecarbonyl)-L-alanine,N-(cyclopentanecarbonyl)-L-alanine|SCHEMBL6288389|ZINC21951982|AKOS015840761|(2S)-2-(cyclopentanecarbonylamino)propanoic acid|W21,185.220,C9H15NO3,66.400,209.000,1.100,13,2,3,3,"InChI=1S/C9H15NO3/c1-6(9(12)13)10-8(11)7-4-2-3-5-7/h6-7H,2-5H2,1H3,(H,10,11)(H,12,13)/t6-/m0/s1",C[C@@H](C(=O)O)NC(=O)C1CCCC1,WLHVFWMGYCZXDM-LURJTMIESA-N,(2S)-2-(cyclopentanecarbonylamino)propanoic acid,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20090528,"A&J Pharmtech CO., LTD.|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|ChemTik|Google Patents|IBM|NCBI Structure|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|Wubei-Biochem|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
33381566,"N-(Cyclobutylmethyl)-1,5-dimethyl-1H-pyrazole-4-carboxamide","HR5|ZINC26143362|AKOS034276132|MCULE-9540823747|Z396380540|N-(cyclobutylmethyl)-1,5-dimethyl-1H-pyrazole-4-carboxamide|1281013-68-0",207.270,C11H17N3O,46.900,240.000,1.200,15,1,2,3,"InChI=1S/C11H17N3O/c1-8-10(7-13-14(8)2)11(15)12-6-9-4-3-5-9/h7,9H,3-6H2,1-2H3,(H,12,15)",CC1=C(C=NN1C)C(=O)NCC2CCC2,WFWUJGIABNGBBR-UHFFFAOYSA-N,"N-(cyclobutylmethyl)-1,5-dimethylpyrazole-4-carboxamide",NULL,Biomolecular Interactions and Pathways|Literature,2,NULL,20090529,AKos Consulting & Solutions|Ambinter|Chem-Space.com Database|Enamine|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
40231279,1-Acetyl-N-methyl-N-phenylpiperidine-4-carboxamide,AKOS027589464|MCULE-2414191548,260.329,C15H20N2O2,40.600,329.000,1.200,19,0,2,2,"InChI=1S/C15H20N2O2/c1-12(18)17-10-8-13(9-11-17)15(19)16(2)14-6-4-3-5-7-14/h3-7,13H,8-11H2,1-2H3",CC(=O)N1CCC(CC1)C(=O)N(C)C2=CC=CC=C2,UGFUNCZTAQSFHR-UHFFFAOYSA-N,1-acetyl-N-methyl-N-phenylpiperidine-4-carboxamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20090530,AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Mcule|MolPort|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
40505715,"N-[(3R)-1,1-Dioxo-2,3-dihydrothiophen-3-yl]-N-(4-fluorophenyl)acetamide",ZINC5071275,269.290,C12H12FNO3S,62.800,446.000,0.800,18,0,4,2,"InChI=1S/C12H12FNO3S/c1-9(15)14(11-4-2-10(13)3-5-11)12-6-7-18(16,17)8-12/h2-7,12H,8H2,1H3/t12-/m1/s1",CC(=O)N([C@H]1CS(=O)(=O)C=C1)C2=CC=C(C=C2)F,ZNQRDHIQBZKZBG-GFCCVEGCSA-N,"N-[(3R)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-N-(4-fluorophenyl)acetamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20090530,Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
44123754,Fosmanogepix,"Fosmanogepix|APX001|2091769-17-2|UNII-1XQ871489P|1XQ871489P|E1211|1169701-00-1|(2-amino-3-(3-(4-((pyridin-2-yloxy)methyl)benzyl)isoxazol-5-yl)pyridin-1-ium-1-yl)methyl hydrogen phosphate|Fosmanogepix [INN]|Fosmanogepix [USAN]|Fosmanogepix (USAN/INN)|CHEMBL4297591|SCHEMBL22749842|APX-001|EX-A5184|WHO 10818|DB15183|D11694|(12-Amino-6-oxa-1(3),7(2)-dipyridina-2(5,3)-(1,2)oxazola- 4(1,4)-benzenaheptaphan-11-ium-11-yl)methyl hydrogen phosphate|[2-amino-3-[3-[[4-(pyridin-2-yloxymethyl)phenyl]methyl]-1,2-oxazol-5-",468.400,C22H21N4O6P,148.000,644.000,1.600,33,2,9,9,"InChI=1S/C22H21N4O6P/c23-22-19(4-3-11-26(22)15-31-33(27,28)29)20-13-18(25-32-20)12-16-6-8-17(9-7-16)14-30-21-5-1-2-10-24-21/h1-11,13,23H,12,14-15H2,(H2,27,28,29)",C1=CC=NC(=C1)OCC2=CC=C(C=C2)CC3=NOC(=C3)C4=C([N+](=CC=C4)COP(=O)(O)[O-])N,JQONJQKKVAHONF-UHFFFAOYSA-N,"[2-amino-3-[3-[[4-(pyridin-2-yloxymethyl)phenyl]methyl]-1,2-oxazol-5-yl]pyridin-1-ium-1-yl]methyl hydrogen phosphate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20090727,BLD Pharm|ChEMBL|ChemIDplus|DC Chemicals|DiscoveryGate|DrugBank|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|KEGG|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
44208849,"Benzamide, 4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluoro-","MUT056399|1269055-85-7|FAB-001|4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluorobenzamide|MUT-056399|UNII-B52RPV7VRM|B52RPV7VRM|FAB001|CHEMBL2178284|Benzamide, 4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluoro-|4-(4-ethyl-5-fluoranyl-2-oxidanyl-phenoxy)-3-fluoranyl-benzamide|SCHEMBL1498707|GTPL11000|BCP24828|BDBM50399407|ZINC43207055|CS-5339|HY-18169|Q27274378|RQN",293.260,C15H13F2NO3,72.600,369.000,3.000,21,2,5,4,"InChI=1S/C15H13F2NO3/c1-2-8-6-12(19)14(7-10(8)16)21-13-4-3-9(15(18)20)5-11(13)17/h3-7,19H,2H2,1H3,(H2,18,20)",CCC1=CC(=C(C=C1F)OC2=C(C=C(C=C2)C(=O)N)F)O,QUHARGDBJJUOEB-UHFFFAOYSA-N,4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluorobenzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,710019|710020|710021|710022|710023|710024|710025|710026|710027|710028|710029|710030|710031|710032|710033|710034|710035|710036|710037|710038|710039|710040|710041|710042|710043|710044|710045|710046|710047|710048|710049|710050|710051|710052|710053|710054|710055|710056|710057|710058|710132|710133|710134|710135|710136|710137|710138|710139|710140|710141|710142|710143|710144|710145|710146|710147|710148|710150|710151|1159387|1409598,20090928,"001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|Achemtek|BindingDB|BioChemPartner|BOC Sciences|Broad Institute|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|LabNetwork, a WuXi AppTec Company|MedChemexpress MCE|MolCore BioPharmatech|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
44286042,Thymosin,THYMOSIN|61512-21-8|CHEMBL412531,3051.300,C128H216N32O51S,1370.000,6930.000,-22.000,212,47,57,109,InChI=1S/C128H216N32O51S/c1-19-62(14)99(159-113(195)76(36-42-89(173)174)143-118(200)83(53-162)152-120(202)84(54-163)153-124(206)95(58(6)7)156-117(199)81(51-93(181)182)150-123(205)94(57(4)5)154-103(185)65(17)134-101(183)63(15)136-114(196)79(49-91(177)178)149-119(201)82(52-161)151-104(186)67(133)55-212)126(208)160-100(66(18)164)127(209)158-97(60(10)11)121(203)144-71(31-23-27-47-132)109(191)148-80(50-92(179)180)116(198)147-78(48-56(2)3)115(197)139-70(30-22-26-46-131)108(190)141-73(33-39-86(167)168)110(192)138-,CC[C@H](C)[C@H](C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(=O)O)C(=O)O)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@@H](CO)NC(=O)[C@@H](CO)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CO)NC(=,LCJVIYPJPCBWKS-NXPQJCNCSA-N,"(2R)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R,3S)-2-[[(2R,3S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-amino-3-sulfanylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydro",Thymosin,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,6,112096|112097|112098|112099|1259409,20091119,ChEMBL|Chemical Carcinogenesis Research Information System (CCRIS)|Google Patents|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
44520175,Metformin glycinate,"METFORMIN GLYCINATE|UNII-YEI21W005Y|121369-64-0|YEI21W005Y|Metformin glycinate [INN]|SCHEMBL1557197|DTXSID80659257|SB19705|Q27294486|Glycine--N'-(diaminomethylidene)-N,N-dimethylguanidine (1/1)|N,N-Dimethyl-1,2,3-triimidodicarbonic diamide glycinate (1:1)|2-aminoacetic acid;3-(diaminomethylidene)-1,1-dimethylguanidine",204.230,C6H16N6O2,155.000,175.000,NULL,14,5,4,3,"InChI=1S/C4H11N5.C2H5NO2/c1-9(2)4(7)8-3(5)6;3-1-2(4)5/h1-2H3,(H5,5,6,7,8);1,3H2,(H,4,5)",CN(C)C(=N)N=C(N)N.C(C(=O)O)N,KOFRCHIVYXPUNL-UHFFFAOYSA-N,"2-aminoacetic acid;3-(diaminomethylidene)-1,1-dimethylguanidine",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20091228,"ChemIDplus|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Hairui Chemical|NextMove Software|Smolecule|SureChEMBL|Synblock Inc|Therapeutic Target Database (TTD)|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
45114162,CID 45114162,287714-41-4|cc-131|HMS2093M08|CCG-213362,520.600,C22H27CaFN3O6S+,152.000,761.000,NULL,34,2,10,9,"InChI=1S/C22H28FN3O6S.Ca/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/q;+2/p-1/b10-9+;/t16-,17-;/m1./s1",CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2],XDIJJHVJIZNZGO-DHMAKVBVSA-M,"calcium;(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate",NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,624349|720641|720717|1345086|1347080,20100420,"Acesobio|Ansion Pharma|Center for Chemical Genomics, University of Michigan|ICCB-Longwood Screening Facility, Harvard Medical School|NIH Clinical Collection|ToxPlanet|University of Iowa High-Throughput Screening Core (UIHTS)",Chemical Vendors|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
45138527,Unii-SJ5A8151JO,VB-201|UNII-SJ5A8151JO|SJ5A8151JO|630112-41-3|SCHEMBL2071230|CHEMBL4297333|VB 201|DB15259|(R)-2-(4-carboxybutoxy)-3-(hexadecyloxy)propyl (2-(trimethylammonio)ethyl) phosphate,581.800,C29H60NO8P,114.000,606.000,6.700,39,1,8,30,"InChI=1S/C29H60NO8P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-19-23-35-26-28(36-24-20-18-21-29(31)32)27-38-39(33,34)37-25-22-30(2,3)4/h28H,5-27H2,1-4H3,(H-,31,32,33,34)/t28-/m1/s1",CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OCCCCC(=O)O,JGGNOCUEWOGWPL-MUUNZHRXSA-N,[(2R)-2-(4-carboxybutoxy)-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate,NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,6,NULL,20100426,ChEMBL|ChemIDplus|DiscoveryGate|DrugBank|eNovation Chemicals|FDA/SPL Indexing Data|MuseChem|SureChEMBL|THE BioTek|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
46700782,Razuprotafib,"Razuprotafib|AKB-9778|UNII-0WAX4UT396|0WAX4UT396|1008510-37-9|Razuprotafib (USAN)|Razuprotafib [USAN]|[4-[(2S)-2-[[(2S)-2-(methoxycarbonylamino)-3-phenylpropanoyl]amino]-2-(2-thiophen-2-yl-1,3-thiazol-4-yl)ethyl]phenyl]sulfamic acid|N-(4-{(2S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-phenylpropanamido}-2-[2-(thiophen-2-yl)-1,3-thiazol-4-yl]ethyl}phenyl)sulfamic acid|Razuprotafib [INN]|Razuprotafib [USAN:INN]|SCHEMBL679459|CHEMBL3931971|GTPL11336|AKB9778|BDBM359124|US10220048, Compound AA34|WHO 10271|Compound AA",586.700,C26H26N4O6S3,212.000,906.000,3.700,39,4,10,12,"InChI=1S/C26H26N4O6S3/c1-36-26(32)29-21(15-17-6-3-2-4-7-17)24(31)27-20(22-16-38-25(28-22)23-8-5-13-37-23)14-18-9-11-19(12-10-18)30-39(33,34)35/h2-13,16,20-21,30H,14-15H2,1H3,(H,27,31)(H,29,32)(H,33,34,35)/t20-,21-/m0/s1",COC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)NS(=O)(=O)O)C3=CSC(=N3)C4=CC=CS4,KWJDHELCGJFUHW-SFTDATJTSA-N,"[4-[(2S)-2-[[(2S)-2-(methoxycarbonylamino)-3-phenylpropanoyl]amino]-2-(2-thiophen-2-yl-1,3-thiazol-4-yl)ethyl]phenyl]sulfamic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,1339822,20100726,AbaChemScene|BindingDB|ChEMBL|ChemIDplus|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|MedChemexpress MCE|MolPort|MuseChem|NextMove Software|Novartis Institutes for BioMedical Research|PATENTSCOPE (WIPO)|SCRIPDB|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
46835756,3-(5-(3-(Dimethylamino)phenoxy)pyrimidin-2-ylamino)phenol,956128-01-1|3-(5-(3-(dimethylamino)phenoxy)pyrimidin-2-ylamino)phenol|SEN-1269|SEN 1269|3-[[5-[3-(dimethylamino)phenoxy]-2-pyrimidinyl]amino]phenol|3-[[5-[3-(dimethylamino)phenoxy]pyrimidin-2-yl]amino]phenol|3-((5-(3-(Dimethylamino)phenoxy)pyrimidin-2-yl)amino)phenol|3-({5-[3-(dimethylamino)phenoxy]pyrimidin-2-yl}amino)phenol|SCHEMBL3602388|CHEMBL2386874|DTXSID40676566|4350AF|ZINC49582255|AKOS015850742|NCGC00387448-01|DB-080315|FT-0682533|S1W,322.400,C18H18N4O2,70.500,374.000,3.400,24,2,6,5,"InChI=1S/C18H18N4O2/c1-22(2)14-6-4-8-16(10-14)24-17-11-19-18(20-12-17)21-13-5-3-7-15(23)9-13/h3-12,23H,1-2H3,(H,19,20,21)",CN(C)C1=CC(=CC=C1)OC2=CN=C(N=C2)NC3=CC(=CC=C3)O,MFPAAKZZUIRMKR-UHFFFAOYSA-N,3-[[5-[3-(dimethylamino)phenoxy]pyrimidin-2-yl]amino]phenol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Biological Test Results: Micromolar,6,748709|1296008|1296009|1345084|1346986|1346987|1347055|1347159|1347160|1409598,20100806,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|Acadechem|Achemtek|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|BLD Pharm|BOC Sciences|Chembase.cn|ChEMBL|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemTik|Clearsynth|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|eNovation Chemicals|EPA DSSTox|Finetech Industry Limited|Google Patents|IBM|iChemical Technolo",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
47003500,"(5R)-5-Amino-5,6,7,8-tetrahydronaphthalen-1-ol","(5R)-5-amino-5,6,7,8-tetrahydronaphthalen-1-ol|SCHEMBL12674518|ZINC34206219|AKOS006237407|1228559-62-3|EN300-89297|WRD",163.220,C10H13NO,46.200,160.000,1.200,12,2,2,0,"InChI=1S/C10H13NO/c11-9-5-1-4-8-7(9)3-2-6-10(8)12/h2-3,6,9,12H,1,4-5,11H2/t9-/m1/s1",C1C[C@H](C2=C(C1)C(=CC=C2)O)N,JGBIMURCUPHILK-SECBINFHSA-N,"(5R)-5-amino-5,6,7,8-tetrahydronaphthalen-1-ol",NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20101125,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BLD Pharm|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemTik|DiscoveryGate|Enamine|NCBI Structure|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
47110626,1-Acetyl-N-(2-hydroxyphenyl)piperidine-4-carboxamide,NULL,262.300,C14H18N2O3,69.600,338.000,0.700,19,2,3,2,"InChI=1S/C14H18N2O3/c1-10(17)16-8-6-11(7-9-16)14(19)15-12-4-2-3-5-13(12)18/h2-5,11,18H,6-9H2,1H3,(H,15,19)",CC(=O)N1CCC(CC1)C(=O)NC2=CC=CC=C2O,YKBMCZDLJSTFOC-UHFFFAOYSA-N,1-acetyl-N-(2-hydroxyphenyl)piperidine-4-carboxamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20101126,Ambinter|Aurora Fine Chemicals LLC|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
47172017,"N'-Cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea","N'-cyclopropyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]urea|U0P|ZINC46885388|AKOS034250995|MCULE-1275205070|Z369936976|3-cyclopropyl-1-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]urea|1223010-53-4",209.240,C10H15N3O2,58.400,243.000,0.500,15,1,3,3,"InChI=1S/C10H15N3O2/c1-7-5-9(12-15-7)6-13(2)10(14)11-8-3-4-8/h5,8H,3-4,6H2,1-2H3,(H,11,14)",CC1=CC(=NO1)CN(C)C(=O)NC2CC2,QKUCRJSBLDVNFL-UHFFFAOYSA-N,"3-cyclopropyl-1-methyl-1-[(5-methyl-1,2-oxazol-3-yl)methyl]urea",NULL,Biomolecular Interactions and Pathways,1,NULL,20101126,AKos Consulting & Solutions|Ambinter|Chem-Space.com Database|Enamine|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
47265390,"4-Acetyl-3-Ethyl-N,5-Dimethyl-1h-Pyrrole-2-Carboxamide","4-Acetyl-3-Ethyl-N,5-Dimethyl-1h-Pyrrole-2-Carboxamide|CHEMBL3785648|4lzs|L46|BDBM50159140|NSC782467|ZINC48190740|AKOS034483219|MCULE-6363572241|NSC-782467|Q27462257|Z605596346|1427896-99-8",208.260,C11H16N2O2,62.000,265.000,1.200,15,2,2,3,"InChI=1S/C11H16N2O2/c1-5-8-9(7(3)14)6(2)13-10(8)11(15)12-4/h13H,5H2,1-4H3,(H,12,15)",CCC1=C(NC(=C1C(=O)C)C)C(=O)NC,LCSLEHAEHBSCSA-UHFFFAOYSA-N,"4-acetyl-3-ethyl-N,5-dimethyl-1H-pyrrole-2-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Biological Test Results: Active,5,977611|1289459|1289461|1289462|1289463,20101126,"AKos Consulting & Solutions|Ambinter|BindingDB|ChEMBL|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|Shanghai Institute of Organic Chemistry|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
47289091,N-[3-(Thiomorpholine-4-carbonyl)phenyl]acetamide,NULL,264.350,C13H16N2O2S,74.700,316.000,1.700,18,1,3,2,"InChI=1S/C13H16N2O2S/c1-10(16)14-12-4-2-3-11(9-12)13(17)15-5-7-18-8-6-15/h2-4,9H,5-8H2,1H3,(H,14,16)",CC(=O)NC1=CC=CC(=C1)C(=O)N2CCSCC2,GUMMRKWNILQOGK-UHFFFAOYSA-N,N-[3-(thiomorpholine-4-carbonyl)phenyl]acetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20101126,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
50905713,Duvelisib,"Duvelisib|1201438-56-3|IPI-145|INK-1197|(S)-3-(1-((9H-Purin-6-yl)amino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one|UNII-610V23S0JI|IPI 145|IPI145|IPI-145 (INK1197)|Duvelisib (IPI-145, INK1197)|(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one|610V23S0JI|INK-1147|Copiktra|Copiktra (TN)|Duvelisib [USAN:INN]|8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one|1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-|1(2H)-Isoquinolinone, 8-chlo",416.900,C22H17ClN6O,86.800,668.000,4.100,30,2,5,4,"InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1",C[C@@H](C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,SJVQHLPISAIATJ-ZDUSSCGKSA-N,8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1159710|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1317009|1317010|1317027|1317028|1317029|1317030|1317031|1317032|1317033|1317034|1317035|1339846|1339847|1339848|1339849|1339850|1345084|1345748|1345749|1345778|1345786|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1347412|1347414|1409598|1409605|1421358|1421359|1421360|1421361,20110307,"A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Angene Chemical|AOBIOUS INC|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Chemical G",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
51036475,3-Phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol,"APX-115 free base|Isuzinaxib|1270084-92-8|APX-115 (free base)|UNII-YP664UDC7T|YP664UDC7T|3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol|1-(pyridin-2-yl)-3-phenyl-4-propyl-1H-pyrazol-5-ol|Isuzinaxib [INN]|EWHA-18278 free base|CHEMBL4650894|SCHEMBL12003400|BCP33883|EX-A4040|Ewha-18278;APX-115 free base|HY-120801A|CS-0087247|S0777|APX115;APX 115;Ewha-18278;Ewha18278|3-Phenyl-4-propyl-1-(2-pyridinyl)-1H-pyrazol-5-ol|5-phenyl-4-propyl-2-pyridin-2-yl-1H-pyrazol-3-one|1H-Pyrazol-5-ol, 3-phenyl-4-propyl-1-(2-py",279.340,C17H17N3O,45.200,412.000,3.700,21,1,3,4,"InChI=1S/C17H17N3O/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15/h3-7,9-12,19H,2,8H2,1H3",CCCC1=C(NN(C1=O)C2=CC=CC=N2)C3=CC=CC=C3,GIWZEELPLKPYBA-UHFFFAOYSA-N,5-phenyl-4-propyl-2-pyridin-2-yl-1H-pyrazol-3-one,NULL,Classification|Literature|Names and Identifiers|Patents,4,NULL,20110425,A2B Chem|AA BLOCKS|AbaChemScene|AbMole Bioscience|Ambeed|Axon Medchem|BenchChem|BioChemPartner|Biosynth Carbosynth|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemIDplus|CSNpharm|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IBM|Lan Pharmatech|MedChemexpress MCE|MolPort|NextMove Software|Selleck Chemicals|SureChEMBL|TargetMol (Target Molecule Corp.)|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
52113406,1-[(2R)-2-(4-Fluorophenyl)morpholin-4-yl]ethanone,ZINC41172145,223.240,C12H14FNO2,29.500,251.000,1.000,16,0,3,1,"InChI=1S/C12H14FNO2/c1-9(15)14-6-7-16-12(8-14)10-2-4-11(13)5-3-10/h2-5,12H,6-8H2,1H3/t12-/m0/s1",CC(=O)N1CCO[C@@H](C1)C2=CC=C(C=C2)F,HUEBTMPZBSOCPP-LBPRGKRZSA-N,1-[(2R)-2-(4-fluorophenyl)morpholin-4-yl]ethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20110520,ZINC,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
52361231,"1-[4-[(2-Methylphenyl)methyl]-1,4-diazepan-1-yl]ethanone",NULL,246.350,C15H22N2O,23.600,280.000,1.800,18,0,2,2,"InChI=1S/C15H22N2O/c1-13-6-3-4-7-15(13)12-16-8-5-9-17(11-10-16)14(2)18/h3-4,6-7H,5,8-12H2,1-2H3",CC1=CC=CC=C1CN2CCCN(CC2)C(=O)C,ADMDDIGRGVTLSU-UHFFFAOYSA-N,"1-[4-[(2-methylphenyl)methyl]-1,4-diazepan-1-yl]ethanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20110520,Ambinter|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
52946595,Nalpha-[(4-Methylpiperazin-1-Yl)carbonyl]-N-[(3s)-1-Phenyl-5-(Phenylsulfonyl)pentan-3-Yl]-L-Phenylalaninamide,Nalpha-[(4-Methylpiperazin-1-Yl)carbonyl]-N-[(3s)-1-Phenyl-5-(Phenylsulfonyl)pentan-3-Yl]-L-Phenylalaninamide|SLV213|GTPL11515|S-001|K11777|Q27451108|N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide,576.800,C32H40N4O4S,107.000,897.000,4.400,41,2,5,12,"InChI=1S/C32H40N4O4S/c1-35-20-22-36(23-21-35)32(38)34-30(25-27-13-7-3-8-14-27)31(37)33-28(18-17-26-11-5-2-6-12-26)19-24-41(39,40)29-15-9-4-10-16-29/h2-16,28,30H,17-25H2,1H3,(H,33,37)(H,34,38)/t28-,30-/m0/s1",CN1CCN(CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC3=CC=CC=C3)CCS(=O)(=O)C4=CC=CC=C4,VZSXPUDQSLKVIR-JDXGNMNLSA-N,N-[(2S)-1-[[(3S)-1-(benzenesulfonyl)-5-phenylpentan-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers,5,NULL,20110616,"Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|IUPHAR/BPS Guide to PHARMACOLOGY|NCBI Structure|Protein Data Bank in Europe (PDBe)|Shanghai Institute of Organic Chemistry|Wikidata",Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
53379371,"(2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl)methanone","VERU-111|1332881-26-1|(2-(1H-indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl)methanone|[2-(1H-indol-3-yl)-1H-imidazol-5-yl](3,4,5-trimethoxyphenyl)methanone|[2-(1H-indol-3-yl)-1H-imidazol-5-yl]-(3,4,5-trimethoxyphenyl)methanone|SCHEMBL724794|UNII-37L1JX37J5|CHEMBL2163631|SCHEMBL20850747|GTPL11422|ABI-231|37L1JX37J5|HY-120599|CS-0078414|S6772|KUM",377.400,C21H19N3O4,89.200,534.000,3.400,28,2,5,6,"InChI=1S/C21H19N3O4/c1-26-17-8-12(9-18(27-2)20(17)28-3)19(25)16-11-23-21(24-16)14-10-22-15-7-5-4-6-13(14)15/h4-11,22H,1-3H3,(H,23,24)",COC1=CC(=CC(=C1OC)OC)C(=O)C2=CN=C(N2)C3=CNC4=CC=CC=C43,WQGVHOVEXMOLOK-UHFFFAOYSA-N,"[2-(1H-indol-3-yl)-1H-imidazol-5-yl]-(3,4,5-trimethoxyphenyl)methanone",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,9,697543|697545|697546|697547|697548|697549|697550|697551|697552|697553|697554|697745|1357204|1357205|1357206|1357215|1357216|1357217|1357218|1357219|1357220,20111011,A2B Chem|AA BLOCKS|AbaChemScene|ChEMBL|DC Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|MolPort|NCBI Structure|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Selleck Chemicals|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
54670067,Ascorbic acid,ascorbic acid|vitamin C|l-ascorbic acid|50-81-7|L(+)-Ascorbic acid|ascorbate|Cevitamic acid|Ascoltin|Ascorbicap|Cenolate|Natrascorb|Hybrin|Allercorb|Ascorbajen|Ascorbutina|Ascorteal|Cescorbat|Cetemican|Cevitamin|Citriscorb|Laroscorbine|Lemascorb|Proscorbin|Roscorbic|Secorbate|Testascorbic|Vitacimin|Vitamisin|Vitascorbol|Ascorin|Ascorvit|Cantaxin|Cebicure|Cebione|Cegiolan|Ceglion|Celaskon|Cemagyl|Cenetone|Cergona|Cetamid|Cevalin|Cevatine|Cevimin|Cevital|Cevitan|Cevitex|Colascor|Concemin|Redoxon|Vicelat|Vifor,176.120,C6H8O6,107.000,232.000,-1.600,12,4,6,2,"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1",C([C@@H]([C@@H]1C(=C(C(=O)O1)O)O)O)O,CIWBSHSKHKDKBQ-JLAZNSOCSA-N,"(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one",Ascorbic Acid,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,18,421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1189|1194|1195|1199|1205|1208|1332|1452|1457|1458|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1850|1863|1899|1903|1906|1947|1948,20111226,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Apexmol|Assembly Blocks",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
54671203,Doxycycline,doxycycline|Vibramycin|564-25-0|Doxytetracycline|Doxiciclina|Doxycyclinum|Doxycycline (anhydrous)|Monodox|Oracea|Vibra-tabs|Doxycycline hyclate|6alpha-Deoxy-5-oxytetracycline|5-Hydroxy-alpha-6-deoxytetracycline|6-alpha-Deoxy-5-oxytetracycline|Doxycyclin|alpha-6-Deoxy-5-hydroxytetracycline|BMY-28689|Doxycycline anhydrous|Liviatin|DOXY|Doxy-Caps|Vibravenos|UNII-334895S862|Deoxymykoin|Dossiciclina|Azudoxat|Doxitard|Doxivetin|Doxycen|Doxychel|Investin|Ronaxan|CHEBI:50845|Spanor|Doxy-Puren|alpha-Doxycycline|Doxy,444.400,C22H24N2O8,182.000,956.000,-0.700,32,6,9,2,"InChI=1S/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25-27,30,32H,1-3H3,(H2,23,31)/t7-,10+,14+,15-,17-,22-/m0/s1",C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,SGKRLCUYIXIAHR-AKNGSSGZSA-N,"(4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide",Doxycycline,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,880|881|894|999|1004|1030|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2660|2666|2667|2668|19006|40926|66383|67723|67724|67725|68990|69027|69132|69171|69172|69177|69181|70125|85794|86391|86403|86522|88519|91481|123074|147029|147030|164572|164573|206481|207660|207661|207666|207667|207857|222600|222601|232291|278065|278066|278568|278569|278570|278571|278572|278573|278664|278665|278666|278667|278668|278669|,20111226,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|AmicBase - Antimicrobial Activities|AN PharmaTech|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BIDD|BindingDB|BioCrick|BioCyc|Biosynth C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56639723,Aldose reductase-IN-1,"Aldose reductase-IN-1|1355612-71-3|AT-001|UNII-E8I3O45DDU|E8I3O45DDU|Pyrazino(2,3-d)pyridazine-5-acetic acid, 7,8-dihydro-8-oxo-7-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-|Caficrestat|SCHEMBL359604|CHEMBL4297455|EX-A4257|ZINC113653985|CS-5128|DB15121|NCGC00484072-01|HY-18967|2-[5-oxo-6-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]pyrazino[2,3-d]pyridazin-8-yl]acetic acid|7,8-Dihydro-8-oxo-7-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)pyrazino(2,3-d)pyridazine-5-acetic acid",421.400,C17H10F3N5O3S,137.000,706.000,2.300,29,1,11,4,"InChI=1S/C17H10F3N5O3S/c18-17(19,20)8-1-2-11-9(5-8)23-12(29-11)7-25-16(28)15-14(21-3-4-22-15)10(24-25)6-13(26)27/h1-5H,6-7H2,(H,26,27)",C1=CC2=C(C=C1C(F)(F)F)N=C(S2)CN3C(=O)C4=NC=CN=C4C(=N3)CC(=O)O,YRGPAXAVTDMKDK-UHFFFAOYSA-N,"2-[5-oxo-6-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]pyrazino[2,3-d]pyridazin-8-yl]acetic acid",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Micromolar,7,1296008|1296009|1345084|1346986|1346987|1347055|1347159|1347160,20120227,"A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|CSNpharm|DC Chemicals|DrugBank|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IBM|MedChemexpress MCE|MolPort|MuseChem|National Center for Advancing Translational Sciences (NCATS)|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.)|THE BioTek|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56841116,Budesonide and formoterol fumarate dihydrate,"Budesonide/formoterol|150693-37-1|Formoterol / budesonide|Budesonide-formoterol mixt|Formoterol-budesonide mixt|Symbicort Inhalation Aerosol|Budesonide/formoterol combination|Budesonide mixture with formoterol|Symbicort rapihaler|Budesonide and formoterol fumarate dihydrate|Budesonide-formoterol mixt.|Inhaled budesonide and formoterol|DTXSID80872449|Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-,     (11beta,16alpha)-, mixt with (R*,R*)-(+-)-N-(2-hydroxy-5-(1-hydroxy-2-((2-(4-metho",774.900,C44H58N2O10,184.000,1250.000,NULL,56,6,11,12,"InChI=1S/C25H34O6.C19H24N2O4/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26;1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3;3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t16-,17-,18-,20+,21?,22+,23-,24-,25+;13-,19+/m00/s1",CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C.C[C@@H](CC1=CC=C(C=C1)OC)NC[C@H](C2=CC(=C(C=C2)O)NC=O)O,PJFHZKIDENOSJB-JIVDDGRNSA-N,"(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one;N-[2-hydroxy-5-[(1S)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide","Budesonide, Formoterol Fumarate Drug Combination",Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20120321,"ChemIDplus|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|ToxPlanet|Wikidata",Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56841552,Rabeximod,"rabeximod|Rob 803|872178-65-9|UNII-J4D3K58W3Z|J4D3K58W3Z|Rabeximodum|2-(9-chloro-2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]acetamide|Rabeximod [INN]|Rabeximodum [INN]|Rob803|Rob-803|GTPL9856|SCHEMBL16053849|DTXSID701007428|DB05772|SB18674|Q27281185|2-(9-chloro-2,3-dimethyl-6H-indolo[2,3-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]acetamide|2-(9-Chloro-2,3-dimethyl-6H-indolo[2,3-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]ethanimidic acid",409.900,C22H24ClN5O,63.000,590.000,3.900,29,1,4,5,"InChI=1S/C22H24ClN5O/c1-13-9-17-18(10-14(13)2)26-22-21(25-17)16-11-15(23)5-6-19(16)28(22)12-20(29)24-7-8-27(3)4/h5-6,9-11H,7-8,12H2,1-4H3,(H,24,29)",CC1=CC2=C(C=C1C)N=C3C(=N2)C4=C(N3CC(=O)NCCN(C)C)C=CC(=C4)Cl,PDNNUMNEXITLCZ-UHFFFAOYSA-N,"2-(9-chloro-2,3-dimethylindolo[3,2-b]quinoxalin-6-yl)-N-[2-(dimethylamino)ethyl]acetamide",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20120321,"001Chemical|Achemtek|BOC Sciences|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|MolCore BioPharmatech|MuseChem|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|SureChEMBL|Synblock Inc|THE BioTek|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56841889,"[(1S,4R,6S,7Z,18R)-4-(Cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate","DANOPREVIR|850876-88-9|BDBM103839|(2R,13aS,14aR,16aS,Z)-6-((tert-butoxycarbonyl)amino)-14a-((cyclopropylsulfonyl)carbamoyl)-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 4-fluoroisoindoline-2-carboxylate",731.800,C35H46FN5O9S,189.000,1530.000,3.300,51,3,10,8,"InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7-/t22-,23-,27?,28+,35-/m1/s1",CC(C)(C)OC(=O)NC1CCCCC/C=C\\[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,ZVTDLPBHTSMEJZ-QIFYYAQYSA-N,"[(1S,4R,6S,7Z,18R)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20120321,BindingDB|Google Patents|THE BioTek|ToxPlanet,Chemical Vendors|Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
56841936,Kaolin,"KAOLIN|1332-58-7|China clay|Argilla|Glomax|Porcelain clay|Bolus alba|White bole|Hydrated aluminum silicate|Kaolin clay slurry|Kaolin, pure|Alphagloss|Altowhites|Alfaplate|Alphacoat|Altowhite|Apsilex|Argiflex|Bentone|Comalco|Electros|Emathlite|Hydrite|Kaopaous|Langford|Mcnamee|Parclay|Vanclay|Fitrol|Arcilla blanca|Argilla alba|Comalco Kaolin|Light kaolin|Osmo kaolin|Kaolin colloidal|beta Coat|Astra-Glaze|Snow tex|ASP Ultrafine|Kao-gel|Century HC|Kaophills-2|AA Kaolin|Clay (kaolin)|Acidic white clays|BOL Blan",258.160,Al2H4O9Si2,98.000,167.000,NULL,13,2,9,4,InChI=1S/2Al.O5Si2.2H2O.2O/c;;1-6(2)5-7(3)4;;;;/h;;;2*1H2;;/q2*+1;-2;;;;,O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O,NLYAJNPCOHFWQQ-UHFFFAOYSA-N,oxo-oxoalumanyloxy-[oxo(oxoalumanyloxy)silyl]oxysilane;dihydrate,Kaolin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,15,1259411,20120321,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Acros Organics|Alfa Chemistry|Ambinter|Biosynth Carbosynth|BOC Sciences|ChEBI|ChEMBL|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Comparative Toxicogenomics Database (CTD)|EPA Substance Registry Services|Finetech Industry Limited|Fisher Chemical|Glentham Life Sciences Ltd.|iChemical Technology USA Inc|MolPort|MuseChem|NextMove Software|ToxPlanet|VladaChem|VWR, Part of Avantor|Wutech|Yick-Vic Chemicals & Pharmaceuticals (H",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56842238,Essential amino acids,"Essential amino acids|Amino Acids, Essential|Amino acids, essential-|E500000000",1163.400,C52H94N10O17S,594.000,988.000,NULL,80,19,27,25,"InChI=1S/C11H12N2O2.C9H11NO2.C6H14N2O2.2C6H13NO2.C5H11NO2S.C5H11NO2.C4H9NO3/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10;10-8(9(11)12)6-7-4-2-1-3-5-7;7-4-2-1-3-5(8)6(9)10;1-4(2)3-5(7)6(8)9;1-3-4(2)5(7)6(8)9;1-9-3-2-4(6)5(7)8;1-3(2)4(6)5(7)8;1-2(6)3(5)4(7)8/h1-4,6,9,13H,5,12H2,(H,14,15);1-5,8H,6,10H2,(H,11,12);5H,1-4,7-8H2,(H,9,10);2*4-5H,3,7H2,1-2H3,(H,8,9);4H,2-3,6H2,1H3,(H,7,8);3-4H,6H2,1-2H3,(H,7,8);2-3,6H,5H2,1H3,(H,7,8)/t9-;8-;2*5-;4-,5-;2*4-;2-,3+/m00000001/s1",CC[C@H](C)[C@@H](C(=O)O)N.C[C@H]([C@@H](C(=O)O)N)O.CC(C)C[C@@H](C(=O)O)N.CC(C)[C@@H](C(=O)O)N.CSCC[C@@H](C(=O)O)N.C1=CC=C(C=C1)C[C@@H](C(=O)O)N.C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N.C(CCN)C[C@@H](C(=O)O)N,CSARAUHTYFKILW-HGFMUWJKSA-N,"(2S,3R)-2-amino-3-hydroxybutanoic acid;(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid;(2S)-2-amino-3-methylbutanoic acid;(2S)-2-amino-4-methylpentanoic acid;(2S,3S)-2-amino-3-methylpentanoic acid;(2S)-2-amino-4-methylsulfanylbutanoic acid;(2S)-2-amino-3-phenylpropanoic acid;(2S)-2,6-diaminohexanoic acid","Amino Acids, Essential",Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20120321,ChemIDplus,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56843331,Semaglutide,Semaglutide|NN9535|Ozempic|910463-68-2|NN 9535|NNC 0113-0217|NN-9535|Semaglutide [USAN:INN]|Sermaglutide|Rybelsus|Unknown (acetate)|Rybelsus (oral semaglutide)|GTPL9724|Ozempic (injectable semaglutide)|CHEBI:167574|EX-A2424|AC-32580|NNC-0113-0217|Rybelsus;Ozempic;NN9535;OG217SC;NNC 0113-0217,4114.000,C187H291N45O59,1650.000,9590.000,-5.800,291,57,63,151,InChI=1S/C187H291N45O59/c1-18-105(10)154(180(282)208-108(13)159(261)216-133(86-114-89-200-119-50-40-39-49-117(114)119)170(272)218-129(82-102(4)5)171(273)228-152(103(6)7)178(280)215-121(53-44-72-199-186(192)193)162(264)201-91-141(242)209-120(52-43-71-198-185(190)191)161(263)204-94-151(257)258)230-172(274)131(83-111-45-33-31-34-46-111)219-167(269)126(64-69-149(253)254)214-166(268)122(51-41-42-70-195-144(245)98-290-79-78-289-76-74-197-145(246)99-291-80-77-288-75-73-196-139(240)66-61-127(183(285)286)211-140(241,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H,DLSWIYLPEUIQAV-CCUURXOWSA-N,"18-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]a",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,11,1345996,20120321,AbMole Bioscience|BioCrick|ChEBI|ChemIDplus|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|Google Patents|Hangzhou APIChem Technology|IUPHAR/BPS Guide to PHARMACOLOGY|MolPort|Springer Nature|THE BioTek|Therapeutic Target Database (TTD)|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56944639,Vidofludimus calcium anhydrous,"UNII-FW5VY7926X|FW5VY7926X|Vidofludimus calcium anhydrous|1-Cyclopentene-1-carboxylic acid, 2-(((3-fluoro-3'-methoxy(1,1'-biphenyl)-4-yl)amino)carbonyl)-, calcium salt (2:1)|1354012-90-0",748.800,C40H34CaF2N2O8,157.000,571.000,NULL,53,2,10,8,"InChI=1S/2C20H18FNO4.Ca/c2*1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25;/h2*2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25);/q;;+2/p-2",COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)[O-])F.COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)[O-])F.[Ca+2],KWSJBFAXOPFZSO-UHFFFAOYSA-L,calcium;2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylate,NULL,Classification|Drug and Medication Information|Names and Identifiers|Safety and Hazards,4,NULL,20120423,ChemIDplus|FDA/SPL Indexing Data|Thomson Pharma,Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
59235547,"(1s,3Ar,6as)-2-[(2s)-2-({(2s)-2-Cyclohexyl-2-[(Pyrazin-2-Ylcarbonyl)amino]acetyl}amino)-3,3-Dimethylbutanoyl]-N-[(2r,3s)-1-(Cyclopropylamino)-2-Hydroxy-1-Oxohexan-3-Yl]octahydrocyclopenta[c]pyrrole-1-Carboxamide","(1s,3ar,6as)-2-[(2s)-2-({(2s)-2-Cyclohexyl-2-[(Pyrazin-2-Ylcarbonyl)amino]acetyl}amino)-3,3-Dimethylbutanoyl]-N-[(2r,3s)-1-(Cyclopropylamino)-2-Hydroxy-1-Oxohexan-3-Yl]octahydrocyclopenta[c]pyrrole-1-Carboxamide|3sv6|3sv7|3sv8|3sv9|SCHEMBL3265394|ZINC89364972|Q27465501|UNII-ZDU3WB34L8 component FTZGWEAUHOMNIG-FJRGXGLZSA-N|(1S,3aR,6aS)-2-((S)-2-((S)-2-cyclohexyl-2-(pyrazine-2-carboxamido)acetamido)-3,3-dimethylbutanoyl)-N-((2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl)octahydrocyclopenta[c]pyrrole-1",681.900,C36H55N7O6,183.000,1200.000,3.700,49,5,8,14,"InChI=1S/C36H55N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-30,44H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,29+,30+/m0/s1",CCC[C@@H]([C@H](C(=O)NC1CC1)O)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5,FTZGWEAUHOMNIG-FJRGXGLZSA-N,"(3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,6,977610,20120820,"Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|IBM|NCBI Structure|NextMove Software|Protein Data Bank in Europe (PDBe)|SCRIPDB|Shanghai Institute of Organic Chemistry|SureChEMBL|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
60634762,1-[4-(Piperidine-1-carbonyl)piperidin-1-yl]ethanone,AKOS008927861,238.330,C13H22N2O2,40.600,290.000,0.500,17,0,2,1,"InChI=1S/C13H22N2O2/c1-11(16)14-9-5-12(6-10-14)13(17)15-7-3-2-4-8-15/h12H,2-10H2,1H3",CC(=O)N1CCC(CC1)C(=O)N2CCCCC2,VFXWKIZCOQQJGS-UHFFFAOYSA-N,1-[4-(piperidine-1-carbonyl)piperidin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20121018,AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
60635968,1-[4-(Thiophene-2-carbonyl)piperazin-1-yl]ethan-1-one,1-[4-(thiophene-2-carbonyl)piperazin-1-yl]ethan-1-one|SCHEMBL12184245|ZINC41245459|AKOS008930201|MCULE-8370919754,238.310,C11H14N2O2S,68.900,288.000,0.700,16,0,3,1,"InChI=1S/C11H14N2O2S/c1-9(14)12-4-6-13(7-5-12)11(15)10-3-2-8-16-10/h2-3,8H,4-7H2,1H3",CC(=O)N1CCN(CC1)C(=O)C2=CC=CS2,VSORHSQQVYIMDG-UHFFFAOYSA-N,1-[4-(thiophene-2-carbonyl)piperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20121018,AKos Consulting & Solutions|Ambinter|Chem-Space.com Database|Google Patents|Mcule|MolPort|Norris Pharm|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
60645778,1-{4-[(5-Chlorothiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one,1-{4-[(5-chlorothiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one|ZINC45291477|AKOS008955239,258.769,C11H15ClN2OS,51.800,256.000,1.700,16,0,3,2,"InChI=1S/C11H15ClN2OS/c1-9(15)14-6-4-13(5-7-14)8-10-2-3-11(12)16-10/h2-3H,4-8H2,1H3",CC(=O)N1CCN(CC1)CC2=CC=C(S2)Cl,KIKCPJKIAGFHCO-UHFFFAOYSA-N,1-[4-[(5-chlorothiophen-2-yl)methyl]piperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20121018,AKos Consulting & Solutions|Ambinter|Norris Pharm|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
60655566,1-{4-[(Thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one,1-{4-[(thiophen-2-yl)methyl]piperazin-1-yl}ethan-1-one|AKOS008980021,224.320,C11H16N2OS,51.800,227.000,0.700,15,0,3,2,"InChI=1S/C11H16N2OS/c1-10(14)13-6-4-12(5-7-13)9-11-3-2-8-15-11/h2-3,8H,4-7,9H2,1H3",CC(=O)N1CCN(CC1)CC2=CC=CS2,PEHVQKQLQOREKN-UHFFFAOYSA-N,1-[4-(thiophen-2-ylmethyl)piperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20121018,AKos Consulting & Solutions|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
61865966,"3-{[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]carbamoyl}benzoic acid","3-{[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]carbamoyl}benzoic acid|AKOS011139523|W6M",261.230,C12H11N3O4,105.000,350.000,0.900,19,2,6,4,"InChI=1S/C12H11N3O4/c1-7-14-10(19-15-7)6-13-11(16)8-3-2-4-9(5-8)12(17)18/h2-5H,6H2,1H3,(H,13,16)(H,17,18)",CC1=NOC(=N1)CNC(=O)C2=CC(=CC=C2)C(=O)O,MSLQEHYKFTUMQL-UHFFFAOYSA-N,"3-[(3-methyl-1,2,4-oxadiazol-5-yl)methylcarbamoyl]benzoic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20121022,AKos Consulting & Solutions|Aurora Fine Chemicals LLC|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
62135164,(4-Fluoro-2-methylphenyl)methanesulfonamide,(4-fluoro-2-methylphenyl)methanesulfonamide|1247342-88-6|1-(4-fluoro-2-methylphenyl)methanesulfonamide|ZINC50580874|AKOS011415413|MCULE-8805466507|NE38476|Z1849009686|U1V,203.240,C8H10FNO2S,68.500,260.000,0.900,13,1,4,2,"InChI=1S/C8H10FNO2S/c1-6-4-8(9)3-2-7(6)5-13(10,11)12/h2-4H,5H2,1H3,(H2,10,11,12)",CC1=C(C=CC(=C1)F)CS(=O)(=O)N,NSTXYAFVZNXQTB-UHFFFAOYSA-N,(4-fluoro-2-methylphenyl)methanesulfonamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20121022,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|Enamine|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
62755740,"Ethyl[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]amine","ethyl[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]amine|1341638-33-2|N-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]ethanamine|SCHEMBL7974222|ZINC54858339|AKOS012049285|MCULE-6629740017|NE41963|N-[(1-methyltriazol-4-yl)methyl]ethanamine|Z1271660837",140.190,C6H12N4,42.700,95.700,-0.500,10,1,3,3,"InChI=1S/C6H12N4/c1-3-7-4-6-5-10(2)9-8-6/h5,7H,3-4H2,1-2H3",CCNCC1=CN(N=N1)C,LOLVREZTZUWBEQ-UHFFFAOYSA-N,N-[(1-methyltriazol-4-yl)methyl]ethanamine,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20121022,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Enamine|Google Patents|Mcule|MolPort|NCBI Structure|Norris Pharm|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
67505836,Ledipasvir,"Ledipasvir|1256388-51-8|GS-5885|GS5885|UNII-013TE6E4WV|Ledipasvir acetonate|GS 5885|CHEBI:85089|WHO 9796|013TE6E4WV|methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate|Methyl N-[(2S)-1-[(6S)-6-[5-[9,9-Difluoro-7-[2-[(1S,2S,4R)-3-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-3-azabicyclo[2.2.1]heptan-2-",889.000,C49H54F2N8O6,175.000,1820.000,7.400,65,4,10,12,"InChI=1S/C49H54F2N8O6/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63)/t29-,30+,38-,39-,40-,41-/m0/s1",CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,VRTWBAAJJOHBQU-KMWAZVGDSA-N,"methyl N-[(2S)-1-[(6S)-6-[5-[9,9-difluoro-7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzimidazol-5-yl]fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptan-5-yl]-3-methyl-1-oxobutan-2-yl]carbamate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,1071125|1071126|1071127|1071128|1071129|1071130|1071131|1071132|1071133|1071134|1071135|1071136|1071137|1071138|1071139|1071140|1071141|1071142|1071143|1071144|1071145|1071146|1071147|1071148|1071149|1071150|1071151|1071152|1071153|1071154|1071155|1071156|1071157|1071158|1071159|1071160|1071161|1071162|1071163|1071164|1071165|1071166|1071167|1071168|1071169|1071170|1071171|1071172|1071173|1071174|1071175|1071176|1071177|1071178|1071179|1071180|1071181|1071182|1071183|1071184|1071185|1071186|1071187|1071188|,20121130,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AK Scientific, Inc. (AKSCI)|Alsachim|Ambinter|Ansion Pharma|Arromax Pharmatech Co., Ltd|Axon Medchem|BenchChem|BindingDB|BioCrick|BOC Sciences|Boerchem|Broad Institute|Cangzhou Enke Pharma Tech Co.,Ltd.|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|Comparative Toxicogenomics Database (CTD)|Davey Lab, D",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
68234908,Telacebec,"Telacebec|1334719-95-7|Q203|Q-203|UNII-55G92WGH3X|55G92WGH3X|CHEMBL3298910|MMV687696|6-chloro-2-ethyl-n-(4-(4-(4-(trifluoromethoxy)phenyl)piperidin-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamide|6-chloro-2-ethyl-N-[(4-{4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl}phenyl)methyl]imidazo[1,2-a]pyridine-3-carboxamide|6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide|Telacebec (Q203)|Telacebec (USAN/INN)|IAP6; Telacebec; Q203|SCHEMBL12295312",557.000,C29H28ClF3N4O2,58.900,796.000,7.900,39,1,7,7,"InChI=1S/C29H28ClF3N4O2/c1-2-25-27(37-18-22(30)7-12-26(37)35-25)28(38)34-17-19-3-8-23(9-4-19)36-15-13-21(14-16-36)20-5-10-24(11-6-20)39-29(31,32)33/h3-12,18,21H,2,13-17H2,1H3,(H,34,38)",CCC1=C(N2C=C(C=CC2=N1)Cl)C(=O)NCC3=CC=C(C=C3)N4CCC(CC4)C5=CC=C(C=C5)OC(F)(F)F,OJICYBSWSZGRFB-UHFFFAOYSA-N,"6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,1158102|1158103|1158104|1158105|1158106|1158107|1158108|1158109|1158110|1158111|1158112|1158113|1158114|1158115|1158116|1158117|1158122|1158123|1158124|1162166|1162171|1162182|1174678|1194570|1244176|1244177|1244178|1259336|1314374|1314375|1314376|1314377|1314378|1314379|1314380|1314381|1314382|1314383|1314384|1314385|1314386|1314387|1314388|1314389|1314390|1314447|1329993|1329995|1345050|1345051|1381467|1409598|1507697|1507698|1507701|1507702|1507703|1507704|1507705|1507706|1507707|1507708,20121130,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|AbMole Bioscience|AKos Consulting & Solutions|Alichem|BindingDB|BioChemPartner|BOC Sciences|Broad Institute|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Collaborative Drug Discovery, Inc.|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IB",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
69188417,"9-Fluoranyl-3-propan-2-yl-5,6-dihydrobenzo[b][1]benzothiepine","9-fluoranyl-3-propan-2-yl-5,6-dihydrobenzo[b][1]benzothiepine|S8T|SCHEMBL4783727|ZINC142546492",272.400,C17H17FS,25.300,304.000,5.500,19,0,2,1,"InChI=1S/C17H17FS/c1-11(2)13-6-8-16-14(9-13)4-3-12-5-7-15(18)10-17(12)19-16/h5-11H,3-4H2,1-2H3",CC(C)C1=CC2=C(C=C1)SC3=C(CC2)C=CC(=C3)F,QEZUZXXLBLAREJ-UHFFFAOYSA-N,"9-fluoro-3-propan-2-yl-5,6-dihydrobenzo[b][1]benzothiepine",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20121130,NCBI Structure|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
71316139,"(1R,2S,5S)-N-[(2S,3R)-4-Amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl]-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide","CHEMBL3542332|ZINC53500066|(1R,2S,5S)-N-[(2S,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl]-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",521.700,C27H47N5O5,154.000,917.000,2.600,37,5,5,10,"InChI=1S/C27H47N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-20,33H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16-,17-,18-,19+,20+/m0/s1",CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)N[C@@H](CC3CCC3)[C@H](C(=O)N)O)C,FEBWCINGHXXUCV-GFLQDLJJSA-N,"(1R,2S,5S)-N-[(2S,3R)-4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl]-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Biological Test Results: Active,4,1217466|1217468|1217496|1217497|1217499|1217501|1217503|1217504|1217505|1217506|1217507|1217510|1217511|1217512|1217513|1217514|1217515|1217516|1217517|1217518|1217519|1217520|1217521|1217522|1217523|1217524|1217525|1217526|1217527|1217528|1217529|1217530|1217531|1217533|1217534|1217537|1217538|1217539|1217540|1217541|1217543|1217544|1217545|1217546|1217547|1217548|1217549,20130517,Chembase.cn|ChEMBL|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
71449007,Entresto,"Entresto|sacubitril valsartan sodium hydrate|UNII-WB8FT61183|LCZ 696|Sacubitril mixture with valsartan|WB8FT61183|Entresto (TN)|Valsartan mixture with AHU-377|C96H120N12Na6O21|EX-A2849|9052AF|MFCD29477717|ACN-036829|3-(1-Biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate|AC-29037|Sacubitril valsartan sodium hydrate (JAN)|D10226|Q27292546|L-Valine, N-(1-oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methy",1916.000,C96H120N12Na6O21,396.000,1140.000,NULL,135,7,29,40,"InChI=1S/2C24H29N5O3.2C24H29NO5.6Na.5H2O/c2*1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23;2*1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19;;;;;;;;;;;/h2*6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H2,25,26,27,28,31,32);2*4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28);;;;;;;5*1H2/q;;;;6*+1;;;;;/p-6/t2*22-;2*17-,21+;;;;;;;;;;;/m0011.........../s1",CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)[C@@H](C(C)C)C(=O)[O-].CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[N-]3)[C@@H](C(C)C)C(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)[O-].O.O.O.O.O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],ZASXKEGREHRXDL-CAWNUZPDSA-H,"hexasodium;4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoate;(2S)-3-methyl-2-[pentanoyl-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]amino]butanoate;pentahydrate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20130527,"Aaron Chemicals LLC|abcr GmbH|Acorn PharmaTech Product List|AK Scientific, Inc. (AKSCI)|Angel Pharmatech Ltd.|Chem-Space.com Database|ChemIDplus|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Excenen Pharmatech|FDA/SPL Indexing Data|Hangzhou APIChem Technology|KEGG|Lan Pharmatech|MolPort|Uchem Meditech|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
71583615,"N-1,2,3-Benzothiadiazol-6-yl-N'-[2-oxo-2-(1-piperidinyl)ethyl]urea","UNC2327|1426152-53-5|CHEMBL2325198|N-1,2,3-Benzothiadiazol-6-yl-N'-[2-oxo-2-(1-piperidinyl)ethyl]urea|UNC 2327|N-1,2,3-Benzothiadiazol-6-yl-N'-[2-oxo-2-(1-piperidinyl)ethyl]urea also called unc-2327|BDBM50427787|ZINC95581007|AKOS025147324|1-(1,2,3-benzothiadiazol-6-yl)-3-(2-oxidanylidene-2-piperidin-1-yl-ethyl)urea|RV5",319.380,C14H17N5O2S,116.000,416.000,1.200,22,2,5,3,"InChI=1S/C14H17N5O2S/c20-13(19-6-2-1-3-7-19)9-15-14(21)16-10-4-5-11-12(8-10)22-18-17-11/h4-5,8H,1-3,6-7,9H2,(H2,15,16,21)",C1CCN(CC1)C(=O)CNC(=O)NC2=CC3=C(C=C2)N=NS3,MYTRGTBDVGKKRO-UHFFFAOYSA-N,"1-(1,2,3-benzothiadiazol-6-yl)-3-(2-oxo-2-piperidin-1-ylethyl)urea",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Biological Test Results: Active|Biological Test Results: Micromolar,6,729422|1409598|1472768,20130708,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|BindingDB|BOC Sciences|Chem-Space.com Database|ChEMBL|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|eNovation Chemicals|MolPort|MuseChem|NCBI Structure|Novartis Institutes for BioMedical Research|Protein Data Bank in Europe (PDBe)|Smolecule|TargetMol (Target Molecule Corp.)|THE BioTek|Thomson Pharma|Tocris Bioscience|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
71594828,Daclastavir,Daclastavir|methyl N-[(2R)-2-[2-[5-[4-[4-[2-[1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-3-methyl-butyl]carbamate|methyl N-[(2R)-2-[2-[5-[4-[4-[2-[1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-3-methylbutyl]carbamate,752.900,C41H52N8O6,175.000,1300.000,5.000,55,4,8,14,"InChI=1S/C41H52N8O6/c1-24(2)30(21-44-40(52)54-5)38(50)48-19-7-9-33(48)36-42-22-31(45-36)28-15-11-26(12-16-28)27-13-17-29(18-14-27)32-23-43-37(46-32)34-10-8-20-49(34)39(51)35(25(3)4)47-41(53)55-6/h11-18,22-25,30,33-35H,7-10,19-21H2,1-6H3,(H,42,45)(H,43,46)(H,44,52)(H,47,53)/t30-,33?,34?,35-/m0/s1",CC(C)[C@H](CNC(=O)OC)C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC,OVPGYLMBPQNZNE-DAVBBFPVSA-N,methyl N-[(2R)-2-[2-[5-[4-[4-[2-[1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-3-methylbutyl]carbamate,NULL,Drug and Medication Information|Literature|Patents,3,NULL,20130709,Google Patents|NIAID ChemDB,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
71717295,"[(1S,4R,6S,7Z,14R,18R)-4-(Cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate","DANOPREVIR|RG7227|R7227|(2R,6S,12Z,13aS,14aR,16aS)-6-[(tert-Butoxycarbonyl)amino]-14a-[(cyclopropylsulfonyl)carbamoyl]-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl 4-fluoro-1,3-dihydro-2H-isoindole-2-carboxylate",731.800,C35H46FN5O9S,189.000,1530.000,3.300,51,3,10,8,"InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7-/t22-,23-,27-,28+,35-/m1/s1",CC(C)(C)OC(=O)N[C@@H]1CCCCC/C=C\\[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,ZVTDLPBHTSMEJZ-UPZRXNBOSA-N,"[(1S,4R,6S,7Z,14R,18R)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20130923,Google Patents|NIAID ChemDB,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
71745056,Angiotensin (1-9),Angiotensin (1-9)|Angiotensin I (1-9)|angiotensin-(1-9)|34273-12-6|Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His|ang 1-9|ANGIOTENSIN (1 - 9)|angiotensin 1-9|Angiotensin(1-9)|DRVYIHPFH|des-Leu angiotensin I|DRVYIHPFH-OH|Angiotensin i(1-9)|ang-(1-9)|GTPL5138|[des-Leu(10)]-angiotensin I|D-R-V-Y-I-H-P-F-H|CHEBI:80128|C15851|Q58310864|L-Asp-L-Arg-L-Val-L-Tyr-L-Ile-L-His-L-Pro-L-Phe-L-His|L-alpha-aspartyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-L-phenylalanyl-L-histidine,1183.300,C56H78N16O13,467.000,2300.000,-2.200,85,15,17,33,"InChI=1S/C56H78N16O13/c1-5-31(4)46(71-50(79)40(22-33-15-17-36(73)18-16-33)67-52(81)45(30(2)3)70-48(77)38(13-9-19-62-56(58)59)65-47(76)37(57)25-44(74)75)53(82)68-41(23-34-26-60-28-63-34)54(83)72-20-10-14-43(72)51(80)66-39(21-32-11-7-6-8-12-32)49(78)69-42(55(84)85)24-35-27-61-29-64-35/h6-8,11-12,15-18,26-31,37-43,45-46,73H,5,9-10,13-14,19-25,57H2,1-4H3,(H,60,63)(H,61,64)(H,65,76)(H,66,80)(H,67,81)(H,68,82)(H,69,78)(H,70,77)(H,71,79)(H,74,75)(H,84,85)(H4,58,59,62)/t31-,37-,38-,39-,40-,41-,42-,43-,45-,46-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CC4=CN=CN4)C(=O)O)NC(=O)[C@H](CC5=CC=C(C=C5)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,LJXGOQOPNPFXFT-JWRYNVNRSA-N,"(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(1S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl]amino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20131028,"abcr GmbH|Alfa Chemistry|ChEBI|Chemieliva Pharmaceutical Co., Ltd|ChemMol|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LabNetwork, a WuXi AppTec Company|MolPort|Shanghai Hanhong Scientific|TargetMol (Target Molecule Corp.)|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
71755948,2-Cyclopropyl-1H-imidazole-4-carboxamide,2-cyclopropyl-1H-imidazole-4-carboxamide|2-cyclopropyl-1~{H}-imidazole-4-carboxamide|1384430-46-9|GWP|ZINC74942043|MCULE-4161218362|NE55944|2-cyclopropyl-1H-imidazole-5-carboxamide,151.170,C7H9N3O,71.800,179.000,-0.200,11,2,2,2,"InChI=1S/C7H9N3O/c8-6(11)5-3-9-7(10-5)4-1-2-4/h3-4H,1-2H2,(H2,8,11)(H,9,10)",C1CC1C2=NC=C(N2)C(=O)N,ZIJDZTAYMWKMQH-UHFFFAOYSA-N,2-cyclopropyl-1H-imidazole-5-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Patents|Safety and Hazards,4,NULL,20131101,Ambeed|Ambinter|Aurum Pharmatech LLC|BLD Pharm|Chembase.cn|IBM|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
71757215,1-(Propan-2-yl)-1H-imidazole-4-sulfonamide,1-(propan-2-yl)-1H-imidazole-4-sulfonamide|1-propan-2-ylimidazole-4-sulfonamide|1423029-76-8|NYV|SCHEMBL20754559|ZINC83255308|AKOS019912461|MCULE-8242913519|NE26284|Z1509882419,189.240,C6H11N3O2S,86.400,244.000,-0.400,12,1,4,2,"InChI=1S/C6H11N3O2S/c1-5(2)9-3-6(8-4-9)12(7,10)11/h3-5H,1-2H3,(H2,7,10,11)",CC(C)N1C=C(N=C1)S(=O)(=O)N,DEJLCHRMKBBNPV-UHFFFAOYSA-N,1-propan-2-ylimidazole-4-sulfonamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Names and Identifiers|Patents,4,1259398|1259399|1259423,20131101,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chembase.cn|Enamine|Google Patents|Mcule|MolPort|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|The Rockefeller University High Throughput Screening and Spectroscopy Resource Center|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
71757930,"N-(8-Methyl-1,2,3,4-tetrahydroquinolin-5-yl)acetamide","N-(8-methyl-1,2,3,4-tetrahydroquinolin-5-yl)acetamide|1443980-33-3|ZINC95347520|AKOS026730398|NE26472|VW7",204.270,C12H16N2O,41.100,242.000,1.800,15,2,2,1,"InChI=1S/C12H16N2O/c1-8-5-6-11(14-9(2)15)10-4-3-7-13-12(8)10/h5-6,13H,3-4,7H2,1-2H3,(H,14,15)",CC1=C2C(=C(C=C1)NC(=O)C)CCCN2,RYRDUZSMONMBBE-UHFFFAOYSA-N,"N-(8-methyl-1,2,3,4-tetrahydroquinolin-5-yl)acetamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20131101,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|MolPort|NCBI Structure|Norris Pharm|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
72207407,3-Iodo-1H-indazole-7-carbaldehyde,"3-IODO-1H-INDAZOLE-7-CARBALDEHYDE|944899-03-0|1h-indazole-7-carbaldehyde,3-iodo-|ZINC100720200|PB20467|CS-0057601|Q-3317",272.040,C8H5IN2O,45.800,188.000,1.700,12,1,2,1,"InChI=1S/C8H5IN2O/c9-8-6-3-1-2-5(4-12)7(6)10-11-8/h1-4H,(H,10,11)",C1=CC2=C(NN=C2C(=C1)C=O)I,QWWAONJINWEHJL-UHFFFAOYSA-N,3-iodo-2H-indazole-7-carbaldehyde,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20131227,"001Chemical|AbaChemScene|Alichem|Ambeed|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|Combi-Blocks|eNovation Chemicals|Matrix Scientific|MolCore BioPharmatech|MolPort|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Synblock Inc|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
72551298,N-Isopropyl-5-(pyridin-4-ylethynyl)picolinamide,1401031-52-4|LSN2463359|N-Isopropyl-5-(pyridin-4-ylethynyl)picolinamide|LSN 2463359|CHEMBL2431212|LSN-2463359|N-propan-2-yl-5-(2-pyridin-4-ylethynyl)pyridine-2-carboxamide|N-(propan-2-yl)-5-[2-(pyridin-4-yl)ethynyl]pyridine-2-carboxamide|GTPL6394|SCHEMBL15539722|AOB3937|SYN5035|BDBM50441230|ZINC95642812|AKOS025142072|NCGC00370695-04|AS-16401|Q27081891|N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide|S8B,265.310,C16H15N3O,54.900,387.000,2.200,20,1,3,4,"InChI=1S/C16H15N3O/c1-12(2)19-16(20)15-6-5-14(11-18-15)4-3-13-7-9-17-10-8-13/h5-12H,1-2H3,(H,19,20)",CC(C)NC(=O)C1=NC=C(C=C1)C#CC2=CC=NC=C2,STAFRSGTRKNXHF-UHFFFAOYSA-N,N-propan-2-yl-5-(2-pyridin-4-ylethynyl)pyridine-2-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,9,773807|773846|773852|1296008|1296009|1345084|1346254|1346269|1346986|1346987|1347055|1347159|1347160|1409598,20140106,"001Chemical|A2B Chem|AA BLOCKS|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|Aurora Fine Chemicals LLC|BindingDB|BOC Sciences|Chem-Space.com Database|ChEMBL|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Google Patents|iChemical Technolog",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
72894274,"6-[4-(3,4-Dichlorophenyl)piperazin-1-yl]carbonyl-1~{H}-pyrimidine-2,4-dione","6-[4-(3,4-dichlorophenyl)piperazin-1-yl]carbonyl-1~{H}-pyrimidine-2,4-dione|YD1|ZINC95374297|MCULE-5948770040|6-{[4-(3,4-dichlorophenyl)-1-piperazinyl]carbonyl}-2,4(1H,3H)-pyrimidinedione",369.200,C15H14Cl2N4O3,81.800,575.000,1.500,24,2,4,2,"InChI=1S/C15H14Cl2N4O3/c16-10-2-1-9(7-11(10)17)20-3-5-21(6-4-20)14(23)12-8-13(22)19-15(24)18-12/h1-2,7-8H,3-6H2,(H2,18,19,22,24)",C1CN(CCN1C2=CC(=C(C=C2)Cl)Cl)C(=O)C3=CC(=O)NC(=O)N3,XREZIAMDGRLMGZ-UHFFFAOYSA-N,"6-[4-(3,4-dichlorophenyl)piperazine-1-carbonyl]-1H-pyrimidine-2,4-dione",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers,3,NULL,20140228,Ambinter|Chem-Space.com Database|ChemBridge|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
73774610,"3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-beta-D-Galactopyranosyl 3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-1-Thio-beta-D-Galactopyranoside","TD139|TD-139|1450824-22-2|UNII-60Y0GUO72B|TD 139|60Y0GUO72B|GB0139|(2R,2'R,3R,3'R,4S,4'S,5R,5'R,6S,6'S)-6,6'-Thiobis(4-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol)|3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-Beta-D-Galactopyranosyl 3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-1-Thio-Beta-D-Galactopyranoside|TD2|Gal-3 Inhibitor GB0139|Galectin-3 Inhibitor GB0139|CHEMBL4297442|SCHEMBL15657269|EX-A1688|ZINC208938373|CS-6265|DB12895|GB 0139|GB-0139|b",648.600,C28H30F2N6O8S,227.000,903.000,0.200,45,6,15,8,"InChI=1S/C28H30F2N6O8S/c29-15-5-1-3-13(7-15)17-9-35(33-31-17)21-23(39)19(11-37)43-27(25(21)41)45-28-26(42)22(24(40)20(12-38)44-28)36-10-18(32-34-36)14-4-2-6-16(30)8-14/h1-10,19-28,37-42H,11-12H2/t19-,20-,21+,22+,23+,24+,25-,26-,27+,28+/m1/s1",C1=CC(=CC(=C1)F)C2=CN(N=N2)[C@H]3[C@H]([C@H](O[C@H]([C@@H]3O)S[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O,YGIDGBAHDZEYMT-MQFIMZJJSA-N,"(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,5-diol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,7,1347060|1347064|1347065|1347067|1347068|1347411,20140526,"A2B Chem|AA BLOCKS|AbaChemScene|Activate Scientific|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NCBI Structure|NIH/NCATS RNAi|NORMAN Suspect List Exchange|Nova",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
75593290,Desidustat,"Desidustat|1616690-16-4|UNII-Y962PQA4KS|Y962PQA4KS|1,2-dihydroquinoline-3-carbonyl]glycine|N-[1-(cyclopropylmethoxy)-4-hydroxy-2-oxo-|2-(1-(cyclopropylmethoxy)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetic acid|ZYAN1 compound|Desidustat [INN]|ZYAN1|CHEMBL4650314|SCHEMBL15846922|BCP29692|EX-A2999|s9699|ZB1514|AKOS037515648|CS-8034|BS-16050|HY-103227|A16921|2-[[1-(cyclopropylmethoxy)-4-hydroxy-2-oxoquinoline-3-carbonyl]amino]acetic acid|Glycine, N-((1-(cyclopropylmethoxy)-1,2-dihydro-4-hydroxy-2-o",332.310,C16H16N2O6,116.000,583.000,1.900,24,3,6,6,"InChI=1S/C16H16N2O6/c19-12(20)7-17-15(22)13-14(21)10-3-1-2-4-11(10)18(16(13)23)24-8-9-5-6-9/h1-4,9,21H,5-8H2,(H,17,22)(H,19,20)",C1CC1CON2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O,IKRKQQLJYBAPQT-UHFFFAOYSA-N,2-[[1-(cyclopropylmethoxy)-4-hydroxy-2-oxoquinoline-3-carbonyl]amino]acetic acid,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20140714,"A2B Chem|AA BLOCKS|AbaChemScene|AbMole Bioscience|Adooq BioScience|AKos Consulting & Solutions|BioChemPartner|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IBM|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|PATENTSCOPE (WIPO)|Selleck Chemicals|Smolecule|Springer Nature|SureChEMBL|TargetMol (Target Molecule Corp.)",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
76419086,"7-[[2-Ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;acetate","400827-46-5|(6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;acetate",744.700,C24H25N8O10PS4,368.000,1240.000,NULL,47,5,19,11,"InChI=1S/C22H21N8O8PS4.C2H4O2/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10;1-2(3)4/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37);1H3,(H,3,4)",CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)O.CC(=O)[O-],UGHHNQFYEVOFIV-UHFFFAOYSA-N,"7-[[2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;acetate",NULL,Classification|Drug and Medication Information|Names and Identifiers|Safety and Hazards,4,NULL,20140731,Angel Pharmatech Ltd.|BOC Sciences|TargetMol (Target Molecule Corp.),Chemical Vendors|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
81371985,N-[(1S)-1-(3-Chlorophenyl)ethyl]acetamide,AKOS019946800,197.660,C10H12ClNO,29.100,184.000,2.100,13,1,1,2,"InChI=1S/C10H12ClNO/c1-7(12-8(2)13)9-4-3-5-10(11)6-9/h3-7H,1-2H3,(H,12,13)/t7-/m0/s1",C[C@@H](C1=CC(=CC=C1)Cl)NC(=O)C,XDFGWKFEFHPPQO-ZETCQYMHSA-N,N-[(1S)-1-(3-chlorophenyl)ethyl]acetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20141020,AKos Consulting & Solutions|Aurora Fine Chemicals LLC,Chemical Vendors|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
82373820,"(2,5-Dimethyl-1H-imidazol-4-yl)methanamine","(2,5-Dimethyl-1H-imidazol-4-yl)methanamine|933743-52-3|1-(2,4-dimethyl-1H-imidazol-5-yl)methanamine|WUG",125.170,C6H11N3,54.700,94.300,-0.200,9,2,2,1,"InChI=1S/C6H11N3/c1-4-6(3-7)9-5(2)8-4/h3,7H2,1-2H3,(H,8,9)",CC1=C(N=C(N1)C)CN,GEZOFSFHYQGWNK-UHFFFAOYSA-N,"(2,5-dimethyl-1H-imidazol-4-yl)methanamine",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20141020,"A2B Chem|AA BLOCKS|Alichem|Ambinter|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|ChemMol|Google Patents|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
83683266,[1-(Pyridin-2-yl)cyclopentyl]methanol,[1-(pyridin-2-yl)cyclopentyl]methanol|SCHEMBL15863115|(1-pyridin-2-ylcyclopentyl)methanol|ZINC84333727|(1-Pyridin-2-yl-cyclopentyl)-methanol|(1 -Pyridin-2-yl-cyclopentyl)-methanol|A1-34078|T5D,177.240,C11H15NO,33.100,164.000,1.800,13,1,2,2,"InChI=1S/C11H15NO/c13-9-11(6-2-3-7-11)10-5-1-4-8-12-10/h1,4-5,8,13H,2-3,6-7,9H2",C1CCC(C1)(CO)C2=CC=CC=N2,NQXVUFAYASZGFN-UHFFFAOYSA-N,(1-pyridin-2-ylcyclopentyl)methanol,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20141020,A1 BioChem Labs|Google Patents|IBM|NCBI Structure|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
86276129,N-[(3-Acetamidophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide,CHEMBL3233809|N-[(3-acetamidophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide|CHEBI:149900|BDBM50007788|N-[3-(Acetylamino)benzyl]-1-[(R)-1-(1-naphthyl)ethyl]piperidine-4-carboxamide,429.600,C27H31N3O2,61.400,630.000,3.900,32,2,3,6,"InChI=1S/C27H31N3O2/c1-19(25-12-6-9-22-8-3-4-11-26(22)25)30-15-13-23(14-16-30)27(32)28-18-21-7-5-10-24(17-21)29-20(2)31/h3-12,17,19,23H,13-16,18H2,1-2H3,(H,28,32)(H,29,31)/t19-/m1/s1",C[C@H](C1=CC=CC2=CC=CC=C21)N3CCC(CC3)C(=O)NCC4=CC(=CC=C4)NC(=O)C,YQRGVYYHRJBSOR-LJQANCHMSA-N,N-[(3-acetamidophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Biological Test Results: Active,5,1128591|1128595|1128596|1128597|1128598|1128599|1128600|1128601|1128602|1128603|1128604|1128605|1128606|1128607|1128608|1128609|1128610|1128611|1128612|1128613|1128614|1128615|1128616|1128617|1128618|1128619|1128620|1128621,20141110,BindingDB|ChEBI|ChEMBL|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|Protein Data Bank in Europe (PDBe)|Thomson Pharma,Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
87060529,CID 87060529,CEFTRIAXONE SODIUM|SCHEMBL40850|104376-79-6|76C796,577.600,C18H18N8NaO7S3,288.000,1110.000,NULL,37,4,13,8,"InChI=1S/C18H18N8O7S3.Na/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);/b24-8+;/t9-,15-;/m1./s1",CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N/OC)/C4=CSC(=N4)N)SC2)C(=O)O.[Na],XKYJAZULGNDPLX-IXIFSOOLSA-N,NULL,Ceftriaxone,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,9,NULL,20150212,OChem|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
87900910,CID 87900910,CEFTRIAXONE SODIUM|SCHEMBL5846120|s5644|104376-79-6|74578-69-1,600.600,C18H18N8Na2O7S3,288.000,1110.000,NULL,38,4,13,8,"InChI=1S/C18H18N8O7S3.2Na/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);;/b24-8+;;/t9-,15-;;/m1../s1",CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N/OC)/C4=CSC(=N4)N)SC2)C(=O)O.[Na].[Na],VUGBLGCUPUUDOI-GNXCPKRQSA-N,NULL,Ceftriaxone,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,9,NULL,20150212,Pi Chemicals|Selleck Chemicals|SureChEMBL,Chemical Vendors|Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
90469070,Descovy,emtricitabine & tenofovir alafenamide|emtricitabine + tenofovir alafenamide|Descovy|Emtricitabine / Tenofovir Alafenamide|Tenofovir Alafenamide / Emtricitabine|Emtricitabine and Tenofovir Alafenamide|Tenofovir Alafenamide and Emtricitabine|Emtricitabine mixture with Tenofovir Alafenamide|731772-56-8,723.700,C29H39FN9O8PS,257.000,1050.000,NULL,49,4,15,14,"InChI=1S/C21H29N6O5P.C8H10FN3O3S/c1-14(2)31-21(28)16(4)26-33(29,32-17-8-6-5-7-9-17)13-30-15(3)10-27-12-25-18-19(22)23-11-24-20(18)27;9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h5-9,11-12,14-16H,10,13H2,1-4H3,(H,26,29)(H2,22,23,24);1,5-6,13H,2-3H2,(H2,10,11,14)/t15-,16+,33+;5-,6+/m10/s1",C[C@H](CN1C=NC2=C(N=CN=C21)N)OC[P@@](=O)(N[C@@H](C)C(=O)OC(C)C)OC3=CC=CC=C3.C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F,NEPFAYPIICYVCG-CFISUTRVSA-N,"4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphoryl]amino]propanoate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20150216,ChemIDplus|Thomson Pharma|ToxPlanet,Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
91480799,4-Iodo-3H-pyridin-2-one,NULL,221.000,C5H4INO,29.400,171.000,0.000,8,0,1,0,"InChI=1S/C5H4INO/c6-4-1-2-7-5(8)3-4/h1-2H,3H2",C1C(=CC=NC1=O)I,GRVSGGNZRNHMQI-UHFFFAOYSA-N,4-iodo-3H-pyridin-2-one,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20150317,IBM|Protein Data Bank in Europe (PDBe),Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
91827409,"(2S,3R)-3-[(2-Aminopyridin-4-yl)methyl]-1-[[(1R)-1-cyclooctylethyl]carbamoyl]-4-oxoazetidine-2-carboxylic acid",SCHEMBL16998942|EP-7041|SB18717|1803271-82-0,402.500,C21H30N4O4,126.000,606.000,3.700,29,3,6,5,"InChI=1S/C21H30N4O4/c1-13(15-7-5-3-2-4-6-8-15)24-21(29)25-18(20(27)28)16(19(25)26)11-14-9-10-23-17(22)12-14/h9-10,12-13,15-16,18H,2-8,11H2,1H3,(H2,22,23)(H,24,29)(H,27,28)/t13-,16-,18+/m1/s1",C[C@H](C1CCCCCCC1)NC(=O)N2[C@@H]([C@H](C2=O)CC3=CC(=NC=C3)N)C(=O)O,QPVLDUCHRPJGCJ-QBIMZIAESA-N,"(2S,3R)-3-[(2-aminopyridin-4-yl)methyl]-1-[[(1R)-1-cyclooctylethyl]carbamoyl]-4-oxoazetidine-2-carboxylic acid",NULL,Drug and Medication Information|Patents,2,NULL,20150824,Google Patents|IBM|PATENTSCOPE (WIPO)|SureChEMBL|Synblock Inc|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
93616379,N-(3-Fluoro-4-methylphenyl)-N'-[(2S)-1-hydroxypropan-2-yl]urea,N-(3-fluoro-4-methylphenyl)-N'-[(2S)-1-hydroxypropan-2-yl]urea|ZINC40526072|WRV,226.250,C11H15FN2O2,61.400,238.000,1.100,16,3,3,3,"InChI=1S/C11H15FN2O2/c1-7-3-4-9(5-10(7)12)14-11(16)13-8(2)6-15/h3-5,8,15H,6H2,1-2H3,(H2,13,14,16)/t8-/m0/s1",CC1=C(C=C(C=C1)NC(=O)N[C@@H](C)CO)F,ONARABRJRRBWJE-QMMMGPOBSA-N,1-(3-fluoro-4-methylphenyl)-3-[(2S)-1-hydroxypropan-2-yl]urea,NULL,Biomolecular Interactions and Pathways,1,NULL,20151210,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
94347260,(2S)-2-Phenylpropane-1-sulfonamide,(2S)-2-phenylpropane-1-sulfonamide|ZINC50350615|VW4,199.270,C9H13NO2S,68.500,237.000,1.200,13,1,3,3,"InChI=1S/C9H13NO2S/c1-8(7-13(10,11)12)9-5-3-2-4-6-9/h2-6,8H,7H2,1H3,(H2,10,11,12)/t8-/m1/s1",C[C@H](CS(=O)(=O)N)C1=CC=CC=C1,HXLOQIXEAPZOSG-MRVPVSSYSA-N,(2S)-2-phenylpropane-1-sulfonamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20151211,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
96053363,"(8S)-5,6,7,8-Tetrahydroimidazo[1,2-a]pyridine-8-carboxamide","(8S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-carboxamide|ZINC75772338|W1S",165.190,C8H11N3O,60.900,195.000,-0.700,12,1,2,1,"InChI=1S/C8H11N3O/c9-7(12)6-2-1-4-11-5-3-10-8(6)11/h3,5-6H,1-2,4H2,(H2,9,12)/t6-/m1/s1",C1C[C@@H](C2=NC=CN2C1)C(=O)N,VSXNZKCCQSDVAD-ZCFIWIBFSA-N,"(8S)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine-8-carboxamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20151211,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
96635921,"(5R)-2-Methyl-4,5,6,7-tetrahydro-3H-benzimidazol-5-amine",ZINC82407965,151.210,C8H13N3,54.700,148.000,0.300,11,2,2,0,"InChI=1S/C8H13N3/c1-5-10-7-3-2-6(9)4-8(7)11-5/h6H,2-4,9H2,1H3,(H,10,11)/t6-/m1/s1",CC1=NC2=C(N1)C[C@@H](CC2)N,JGCNHPQMPGHGHT-ZCFIWIBFSA-N,"(5R)-2-methyl-4,5,6,7-tetrahydro-3H-benzimidazol-5-amine",NULL,Biomolecular Interactions and Pathways,1,NULL,20151211,Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
97598018,(5S)-7-(Pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane,(5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane|ZINC96462121|U0S,205.260,C11H15N3O,38.200,236.000,0.500,15,0,4,1,"InChI=1S/C11H15N3O/c1-5-14(10-7-12-3-4-13-10)8-11(1)2-6-15-9-11/h3-4,7H,1-2,5-6,8-9H2/t11-/m0/s1",C1CN(C[C@@]12CCOC2)C3=NC=CN=C3,ITTBXBSSJHVWJS-NSHDSACASA-N,(5S)-7-pyrazin-2-yl-2-oxa-7-azaspiro[4.4]nonane,NULL,Biomolecular Interactions and Pathways,1,NULL,20151211,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
97841134,5-Chloranyl-~{N}-methyl-~{N}-[[(3~{S})-oxolan-3-yl]methyl]pyrimidin-4-amine,5-chloranyl-~{N}-methyl-~{N}-[[(3~{S})-oxolan-3-yl]methyl]pyrimidin-4-amine|GWY|ZINC97166124,227.690,C10H14ClN3O,38.200,205.000,1.500,15,0,4,3,"InChI=1S/C10H14ClN3O/c1-14(5-8-2-3-15-6-8)10-9(11)4-12-7-13-10/h4,7-8H,2-3,5-6H2,1H3/t8-/m0/s1",CN(C[C@@H]1CCOC1)C2=NC=NC=C2Cl,OYKZBUOZAYBEHE-QMMMGPOBSA-N,5-chloro-N-methyl-N-[[(3S)-oxolan-3-yl]methyl]pyrimidin-4-amine,NULL,Biomolecular Interactions and Pathways,1,NULL,20151211,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
118737648,"(1s,2s)-2-({n-[(Benzyloxy)carbonyl]-L-Leucyl}amino)-1-Hydroxy-3-[(3s)-2-Oxopyrrolidin-3-Yl]propane-1-Sulfonic Acid","(1s,2s)-2-({n-[(Benzyloxy)carbonyl]-L-Leucyl}amino)-1-Hydroxy-3-[(3s)-2-Oxopyrrolidin-3-Yl]propane-1-Sulfonic Acid|CHEMBL3559293|SCHEMBL21114829|Q27461860",485.600,C21H31N3O8S,180.000,777.000,0.700,33,5,8,12,"InChI=1S/C21H31N3O8S/c1-13(2)10-16(24-21(28)32-12-14-6-4-3-5-7-14)19(26)23-17(20(27)33(29,30)31)11-15-8-9-22-18(15)25/h3-7,13,15-17,20,27H,8-12H2,1-2H3,(H,22,25)(H,23,26)(H,24,28)(H,29,30,31)/t15-,16-,17-,20?/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(O)S(=O)(=O)O)NC(=O)OCC2=CC=CC=C2,BSPZFJDYQHDZNR-HTCLRFROSA-N,(2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid,NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20160308,"BindingDB|ChEMBL|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|SureChEMBL|Wikidata",Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
124505295,(3R)-1-Acetyl-3-hydroxypiperidine-3-carboxylic acid,(3R)-1-acetyl-3-hydroxypiperidine-3-carboxylic acid|ZINC74279613|VWM,187.190,C8H13NO4,77.800,240.000,-1.000,13,2,4,1,"InChI=1S/C8H13NO4/c1-6(10)9-4-2-3-8(13,5-9)7(11)12/h13H,2-5H2,1H3,(H,11,12)/t8-/m1/s1",CC(=O)N1CCC[C@@](C1)(C(=O)O)O,CKOGPKPHDCYLTR-MRVPVSSYSA-N,(3R)-1-acetyl-3-hydroxypiperidine-3-carboxylic acid,NULL,Biomolecular Interactions and Pathways,1,NULL,20170410,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
124547039,"[(3R,5R)-5-Methylpiperidin-3-yl]methanol","[(3R,5R)-5-methylpiperidin-3-yl]methanol|ZINC107114818|W2J",129.199,C7H15NO,32.299,85.000,0.300,9,2,2,1,"InChI=1S/C7H15NO/c1-6-2-7(5-9)4-8-3-6/h6-9H,2-5H2,1H3/t6-,7-/m1/s1",C[C@@H]1C[C@H](CNC1)CO,SSKKCWRWVKPDIA-RNFRBKRXSA-N,"[(3R,5R)-5-methylpiperidin-3-yl]methanol",NULL,Biomolecular Interactions and Pathways,1,NULL,20170410,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
125137283,"5-Fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine","5-fluoro-1-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]-1,2,3,6-tetrahydropyridine|AKOS030709847|ZINC272584676|Z1619978933|U0M",213.280,C9H12FN3S,57.300,234.000,1.100,14,0,5,2,"InChI=1S/C9H12FN3S/c1-7-11-12-9(14-7)6-13-4-2-3-8(10)5-13/h3H,2,4-6H2,1H3",CC1=NN=C(S1)CN2CCC=C(C2)F,WRJUIVWNZADJJL-UHFFFAOYSA-N,"2-[(5-fluoro-3,6-dihydro-2H-pyridin-1-yl)methyl]-5-methyl-1,3,4-thiadiazole",NULL,Biomolecular Interactions and Pathways,1,NULL,20170410,AKos Consulting & Solutions|Chem-Space.com Database|Enamine|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
129317883,"[(1S,4R,6S,7E,18R)-4-(Cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",DANOPREVIR|850876-88-9|AKOS032947279,731.800,C35H46FN5O9S,189.000,1530.000,3.300,51,3,10,8,"InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7+/t22-,23-,27?,28+,35-/m1/s1",CC(C)(C)OC(=O)NC1CCCCC/C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,ZVTDLPBHTSMEJZ-FZRCRRBXSA-N,"[(1S,4R,6S,7E,18R)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20170814,AKos Consulting & Solutions|Ark Pharma Scientific Limited,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
129349503,"4-[(3R)-3-Fluoropiperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine","4-[(3R)-3-fluoropiperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine|ZINC336438344|W5P",220.250,C11H13FN4,44.800,250.000,2.000,16,1,4,1,"InChI=1S/C11H13FN4/c12-8-2-1-5-16(6-8)11-9-3-4-13-10(9)14-7-15-11/h3-4,7-8H,1-2,5-6H2,(H,13,14,15)/t8-/m1/s1",C1C[C@H](CN(C1)C2=NC=NC3=C2C=CN3)F,QSYGVQIPKLCKAM-MRVPVSSYSA-N,"4-[(3R)-3-fluoropiperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine",NULL,Biomolecular Interactions and Pathways,1,NULL,20170825,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
129628674,H-D-Lys-D-Leu-D-Leu-D-Leu-D-Leu-D-Lys-D-Leu-D-Leu-D-Leu-D-Leu-D-Lys-D-Leu-D-Leu-D-Leu-D-Leu-D-Lys-D-Leu-D-Leu-D-Leu-D-Leu-D-Lys-OH,ati02,2469.400,C126H238N26O22,775.000,4880.000,11.900,174,27,28,93,InChI=1S/C126H238N26O22/c1-69(2)53-90(137-106(153)85(132)43-33-38-48-127)114(161)145-98(61-77(17)18)122(169)149-99(62-78(19)20)118(165)141-91(54-70(3)4)110(157)133-86(44-34-39-49-128)107(154)138-95(58-74(11)12)115(162)146-103(66-82(27)28)123(170)150-100(63-79(21)22)119(166)142-92(55-71(5)6)111(158)134-87(45-35-40-50-129)108(155)139-96(59-75(13)14)116(163)147-104(67-83(29)30)124(171)151-101(64-80(23)24)120(167)143-93(56-72(7)8)112(159)135-88(46-36-41-51-130)109(156)140-97(60-76(15)16)117(164)148-105(68-84(31,CC(C)C[C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)O)NC(=O)[C@@H](CCCCN)N,QSIRXSYRKZHJHX-WAJAWWNLSA-N,"(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2,6-diaminohexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpenta",NULL,Literature|Patents,2,NULL,20170913,PATENTSCOPE (WIPO)|Springer Nature,Governmental Organizations|Journal Publishers,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135391051,Unii-KC3GI9UM9V,"UNII-KC3GI9UM9V|KC3GI9UM9V|2055649-81-3|Estetrol hydrous|Estetrol (JAN/USAN)|D11514|Estra-1,3,5(10)-triene-3,15alpha,16alpha,17beta-tetrol monohydrate|Estra-1,3,5(10)-triene-3,15,16,17-tetrol, hydrate (1:1), (15alpha,16alpha,17beta)-",322.400,C18H26O5,81.900,441.000,NULL,23,5,5,0,"InChI=1S/C18H24O4.H2O/c1-18-7-6-12-11-5-3-10(19)8-9(11)2-4-13(12)14(18)15(20)16(21)17(18)22;/h3,5,8,12-17,19-22H,2,4,6-7H2,1H3;1H2/t12-,13-,14-,15-,16-,17+,18+;/m1./s1",C[C@]12CC[C@H]3[C@H]([C@@H]1[C@H]([C@H]([C@@H]2O)O)O)CCC4=C3C=CC(=C4)O.O,XRJNAPXFAXBPAM-BVTDNVAGSA-N,"(8R,9S,13S,14S,15R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,15,16,17-tetrol;hydrate",NULL,Classification|Drug and Medication Information|Names and Identifiers|Patents,4,NULL,20181216,ChemIDplus|FDA/SPL Indexing Data|KEGG|PATENTSCOPE (WIPO),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135398658,Folic acid,folic acid|59-30-3|Folate|Pteroylglutamic acid|Vitamin M|Folacin|PteGlu|Folacid|Folvite|Vitamin B9|Vitamin Bc|Folicet|Pteroyl-L-glutamic acid|Acifolic|Cytofol|Folsan|Incafolic|Folettes|Foliamin|Folipac|Millafol|Folbal|Folsav|Vitamin Be|Pteroyl-L-monoglutamic acid|Mittafol|Facid|Folan|Pteroylmonoglutamic acid|Antianemia factor|Factor U|Folico (Italy)|Folina (Italy)|Foldine [France]|Acfol (Spain)|Pteroylmonoglutamate|Foldine|Folcysteine|Folasic (Australia)|Folcidin|Folsaure|Folaemin [Netherlands]|Nifolin [Den,441.400,C19H19N7O6,209.000,767.000,-1.100,32,6,10,9,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1",C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,OVBPIULPVIDEAO-LBPRGKRZSA-N,(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid,Folic Acid,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,18,357|377|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|608|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|940|995|1030|1033|1195|1204|1332|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1527|1529|1530|1531|1549|1552|1554|1556|1565|1566|1578|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1,20190115,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alsachim|Ambeed|Ambinter|AN PharmaTech|Angayarkanni Lab, Department of Microbial Biotechnology, Bharathiar University|Angene Chemical|ApexBio Technology|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135415790,"P1-7-Methylguanosine-P3-adenosine-5',5'-triphosphate","7-METHYL-GPPPA|P1-7-METHYLGUANOSINE-P3-ADENOSINE-5',5'-TRIPHOSPHATE|SCHEMBL4317980|DB01649|Q27092832|2-amino-9-[(2R,3R,4S,5R)-5-({[(R)-{[(R)-{[(S)-{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]oxy}methyl)-3,4-dihydroxytetrahydrofuran-2-yl]-7-methyl-6-oxo-6,9-dihydro-1H-purin-7-ium (non-preferred name)",787.400,C21H30N10O17P3+,394.000,1500.000,-7.900,51,10,22,12,"InChI=1S/C21H29N10O17P3/c1-29-6-31(17-10(29)18(36)28-21(23)27-17)20-14(35)12(33)8(46-20)3-44-50(39,40)48-51(41,42)47-49(37,38)43-2-7-11(32)13(34)19(45-7)30-5-26-9-15(22)24-4-25-16(9)30/h4-8,11-14,19-20,32-35H,2-3H2,1H3,(H7-,22,23,24,25,27,28,36,37,38,39,40,41,42)/p+1/t7-,8-,11-,12-,13-,14-,19-,20-/m1/s1",CN1C=[N+](C2=C1C(=O)NC(=N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O,QQOHNVHGNZYSBP-XPWFQUROSA-O,"[[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents,4,NULL,20190115,"ABI Chem|ChEBI|Chembase.cn|ChemSpider|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NCBI Structure|NextBio|NORMAN Suspect List Exchange|NovoSeek|Protein Data Bank in Europe (PDBe)|SMID|SureChEMBL|Therapeutic Target Database (TTD)|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
135419182,7-Methyl-guanosine-5'-triphosphate,7-methyl-GTP(1+)|7-methylguanosine 5'-(tetrahydrogen triphosphate)|7-METHYL-GUANOSINE-5'-TRIPHOSPHATE|m7GTP|SCHEMBL20597816|CHEBI:50226|DB02716|26554-26-7|Q27121989,538.220,C11H19N5O14P3+,286.000,959.000,-5.600,33,8,15,8,"InChI=1S/C11H18N5O14P3/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(28-10)2-27-32(23,24)30-33(25,26)29-31(20,21)22/h3-4,6-7,10,17-18H,2H2,1H3,(H6-,12,13,14,19,20,21,22,23,24,25,26)/p+1/t4-,6-,7-,10-/m1/s1",CN1C=[N+](C2=C1C(=O)NC(=N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O,DKVRNHPCAOHRSI-KQYNXXCUSA-O,"[[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20190115,"ABI Chem|BIND|BindingDB|BioCyc|ChEBI|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Comparative Toxicogenomics Database (CTD)|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|NCBI Structure|NextBio|NextMove Software|NORMAN Suspect List Exchange|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Shanghai Institute of Organic Chemistry|SMID|Springer ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
135564639,F-Arag F-18,"F-ARAG F-18|UNII-X96PT3B08G|X96PT3B08G|(18F)F-Arag|Q27895879|2-Amino-9-(2-deoxy-2-(fluoro-18F)-beta-D-arabinofuranosyl)-1,9-dihydro-6H-purin-6-one|6H-Purin-6-one, 2-amino-9-(2-deoxy-2-(fluoro-18F)-beta-D-arabinofuranosyl)-1,9-dihydro-|1268848-88-9|2-Amino-9-((2R,3S,4R,5R)-3-fluoranyl-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6-one",284.230,C10H12FN5O4,135.000,449.000,-0.900,20,4,7,2,"InChI=1S/C10H12FN5O4/c11-4-6(18)3(1-17)20-9(4)16-2-13-5-7(16)14-10(12)15-8(5)19/h2-4,6,9,17-18H,1H2,(H3,12,14,15,19)/t3-,4+,6-,9-/m1/s1/i11-1",C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)[18F])N=C(NC2=O)N,UXUZARPLRQRNNX-YXAALHNKSA-N,"2-amino-9-[(2R,3S,4R,5R)-3-(18F)fluoranyl-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one",NULL,Classification|Drug and Medication Information|Names and Identifiers,3,NULL,20190115,"ChemIDplus|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Thomson Pharma|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135565884,Zanubrutinib,"Zanubrutinib|1691249-45-2|Brukinsa|BGB-3111|UNII-AG9MHG098Z|AG9MHG098Z|1691249-45-2 (S-isomer)|BGB3111|(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide|(7S)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide|Brukinsa (TN)|Zanubrutinib [INN]|Zanubrutinib [USAN]|Zanubrutinib (USAN/INN)|Zanubrutinib [USAN:INN]|BGB-3111(Zanubrutinib)|Zanubrutinib (BGB-3111)|GTPL9861|CHEMBL39367",471.500,C27H29N5O3,103.000,756.000,3.500,35,2,5,6,"InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1",C=CC(=O)N1CCC(CC1)[C@@H]2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,RNOAOAWBMHREKO-QFIPXVFZSA-N,"(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,1344888|1345617,20190115,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|Activate Scientific|BindingDB|BioChemPartner|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|DTP/NCI|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Selleck Chemicals|Smolecule|Springer Nature|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135565962,Defibrotide,"STA-1474|Defibrotide|Defibrotide sodium|1118915-78-8|UNII-E1942E7K32|E1942E7K32|5-Hydroxy-2-isopropyl-4-(4-(1-methyl-1H-indol-5-yl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)phenyl dihydrogen phosphate|SCHEMBL419884|CHEMBL3674153|BDBM176684|BCP23704|BCP24376|3H-1,2,4-Triazol-3-one, 2,4-dihydro-5-(2-hydroxy-5-(1-methylethyl)-4-(phosphonooxy)phenyl)-4-(1-methyl-1H-indol-5-yl)-|83712-60-1|US9120745, 3|Q27276739|C1=C(OP(O)(O)=O)C(C(C)C)=CC(C=2N(C(=O)NN=2)C=2C=C3C=CN(C)C3=CC=2)=C1O|[(4Z)-4-[4-(1-methylindol-5-yl)-",444.400,C20H21N4O6P,137.000,773.000,1.800,31,4,7,5,"InChI=1S/C20H21N4O6P/c1-11(2)14-9-15(17(25)10-18(14)30-31(27,28)29)19-21-22-20(26)24(19)13-4-5-16-12(8-13)6-7-23(16)3/h4-11,25H,1-3H3,(H,22,26)(H2,27,28,29)",CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,JNWFIPVDEINBAI-UHFFFAOYSA-N,"[5-hydroxy-4-[4-(1-methylindol-5-yl)-5-oxo-1H-1,2,4-triazol-3-yl]-2-propan-2-ylphenyl] dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,1259220,20190115,"Achemtek|BindingDB|BioChemPartner|BOC Sciences|ChEMBL|ChemIDplus|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|MuseChem|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
136033680,Poly-ICLC,"Poly-ICLC|Poly I:CLC|Poly(ICLC)|UNII-7KYP9TKT70|7KYP9TKT70|Polyriboinosinic-polyribocytidylic acid-polylysine carboxymethylcellulose|5'-Inosinic acid, polymers, complex with 5'-cytidylic acid, polymers and L-lysine, homopolymer, compd. with cellulose carboxymethyl ether|59789-29-6",879.600,C26H43N9O21P2,484.000,1210.000,NULL,58,15,24,13,"InChI=1S/C10H13N4O8P.C9H14N3O8P.C5H12N2O2.C2H4O3/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17;10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18;6-3-1-2-4-7-5(8)9;3-1-2(4)5/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20);1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18);7H,1-4,6H2,(H,8,9);3H,1H2,(H,4,5)",C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O.C(CCNC(=O)O)CN.C(C(=O)O)O,MRYYMYCQXMFJNE-UHFFFAOYSA-N,"4-aminobutylcarbamic acid;[5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate;2-hydroxyacetic acid",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20190121,ChemIDplus,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
137176346,"4-Acetamidobenzoic acid;9-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one;1-(dimethylamino)propan-2-ol",Isoprinosine|36703-88-5,1115.200,C52H78N10O17,399.000,658.000,NULL,79,13,22,14,"InChI=1S/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3/t4-,6+,7-,10-;;;;;;/m1....../s1",CC(CN(C)C)O.CC(CN(C)C)O.CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@H]([C@H](O3)CO)O)O,YLDCUKJMEKGGFI-ZZFUHKRMSA-N,"4-acetamidobenzoic acid;9-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one;1-(dimethylamino)propan-2-ol",Inosine Pranobex,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20190125,Angene Chemical|King Scientific,Chemical Vendors|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
137348943,"Amino{[(4S)-4-amino-5,5-dihydroxypentyl]amino}methaniminium","amino{[(4S)-4-amino-5,5-dihydroxypentyl]amino}methaniminium",177.230,C6H17N4O2+,133.000,145.000,-2.700,12,6,3,5,"InChI=1S/C6H16N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4-5,11-12H,1-3,7H2,(H4,8,9,10)/p+1/t4-/m0/s1",C(C[C@@H](C(O)O)N)C[NH+]=C(N)N,GJQTZIGWTNAHJO-BYPYZUCNSA-O,"[(4S)-4-amino-5,5-dihydroxypentyl]-(diaminomethylidene)azanium",NULL,Biomolecular Interactions and Pathways,1,NULL,20190312,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
137705262,"[(1S,4R,6S)-4-(Cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",NULL,731.800,C35H46FN5O9S,189.000,1530.000,3.300,51,3,10,8,"InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/t22-,23?,27?,28+,35-/m1/s1",CC(C)(C)OC(=O)NC1CCCCCC=C[C@@H]2C[C@]2(NC(=O)[C@@H]3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,ZVTDLPBHTSMEJZ-PGQFWUPVSA-N,"[(1S,4R,6S)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20190415,"Ark Pharm, Inc.",Chemical Vendors|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
139052498,"1-(4-Fluorobenzene-6-id-1-yl)-N-phenylmethanimine;iridium(3+);1,2,3,4,5-pentamethylcyclopenta-1,3-diene;chloride",NULL,561.100,C23H24ClFIrN,12.400,601.000,NULL,27,0,5,1,"InChI=1S/C13H9FN.C10H15.ClH.Ir/c14-12-8-6-11(7-9-12)10-15-13-4-2-1-3-5-13;1-6-7(2)9(4)10(5)8(6)3;;/h1-6,8-10H;1-5H3;1H;/q2*-1;;+3/p-1",C[C-]1C(=C(C(=C1C)C)C)C.C1=CC=C(C=C1)N=CC2=[C-]C=C(C=C2)F.[Cl-].[Ir+3],OFHYNJAZUFRKPG-UHFFFAOYSA-M,"1-(4-fluorobenzene-6-id-1-yl)-N-phenylmethanimine;iridium(3+);1,2,3,4,5-pentamethylcyclopenta-1,3-diene;chloride",NULL,NULL,0,NULL,20191003,Crystallography Open Database,Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
145343771,Unii-T5UX5skk2S,"UNII-T5UX5SKK2S|T5UX5SKK2S|2103278-86-8|N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide|N-[(2S)-3-cyclohexyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1H-indole-2-carboxamide|Mpro inhibitor 11A|peptidomimetic aldehydes 11a|MPI-10|GTPL11070|CHEBI:152560|BDBM420296|compound 11a [PMID: 32321856]|Coronavirus protease 3clpro inhibitor 11A|1H-Indole-2-carboxamide, N-((1S)-1-(cyclohexylmethyl)-2-(((",452.500,C25H32N4O4,120.000,723.000,3.500,33,4,4,9,"InChI=1S/C25H32N4O4/c30-15-19(13-18-10-11-26-23(18)31)27-24(32)21(12-16-6-2-1-3-7-16)29-25(33)22-14-17-8-4-5-9-20(17)28-22/h4-5,8-9,14-16,18-19,21,28H,1-3,6-7,10-13H2,(H,26,31)(H,27,32)(H,29,33)/t18-,19-,21-/m0/s1",C1CCC(CC1)C[C@@H](C(=O)N[C@@H](C[C@@H]2CCNC2=O)C=O)NC(=O)C3=CC4=CC=CC=C4N3,HPKJGHVHQWJOOT-ZJOUEHCJSA-N,N-[(2S)-3-cyclohexyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1H-indole-2-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20191207,A2B Chem|AA BLOCKS|BindingDB|ChEBI|ChemIDplus|FDA/SPL Indexing Data|IUPHAR/BPS Guide to PHARMACOLOGY|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Thieme Chemistry,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
145722609,Lucinactant,"Lucinactant|Sinapultide acetate|825600-90-6|UNII-2287X9ME8X|2287X9ME8X|Surfaxin component sinapultide acetate|Lucinactant component sinapultide acetate|1802925-00-3|L-Lysine, L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-, acetate (1:1)|L-Lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leucyl-L-leucyl-L-leucyl-L-leucyl-L-lysyl-L-leu",2529.500,C128H242N26O24,813.000,4910.000,NULL,178,28,30,93,InChI=1S/C126H238N26O22.C2H4O2/c1-69(2)53-90(137-106(153)85(132)43-33-38-48-127)114(161)145-98(61-77(17)18)122(169)149-99(62-78(19)20)118(165)141-91(54-70(3)4)110(157)133-86(44-34-39-49-128)107(154)138-95(58-74(11)12)115(162)146-103(66-82(27)28)123(170)150-100(63-79(21)22)119(166)142-92(55-71(5)6)111(158)134-87(45-35-40-50-129)108(155)139-96(59-75(13)14)116(163)147-104(67-83(29)30)124(171)151-101(64-80(23)24)120(167)143-93(56-72(7)8)112(159)135-88(46-36-41-51-130)109(156)140-97(60-76(15)16)117(164)148-105(6,CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCCN)N.CC(=O)O,OSPNFKYGOFXGBX-YWWKUQGPSA-N,"acetic acid;(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Use and Manufacturing,5,NULL,20200123,ChemIDplus|eNovation Chemicals|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
145864875,"Azane;(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol",AKOS037651466|CS-16941,359.330,C12H25NO11,191.000,382.000,NULL,24,9,12,4,"InChI=1S/C12H22O11.H3N/c13-1-3-5(15)6(16)9(19)12(22-3)23-10-4(2-14)21-11(20)8(18)7(10)17;/h3-20H,1-2H2;1H3/t3-,4-,5-,6+,7-,8-,9-,10-,11+,12-;/m1./s1",C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O.N,AMHSIAGEEZQKAV-LSQXFEIASA-N,"azane;(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol",NULL,NULL,0,NULL,20200204,AKos Consulting & Solutions|Chem-Space.com Database|Key Organics/BIONET|MolPort,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
145998218,"1-(4-Methylpiperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethan-1-one","1-(4-methylpiperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethan-1-one",258.320,C14H18N4O,52.200,327.000,0.500,19,1,3,2,"InChI=1S/C14H18N4O/c1-17-5-7-18(8-6-17)13(19)9-11-10-16-14-12(11)3-2-4-15-14/h2-4,10H,5-9H2,1H3,(H,15,16)",CN1CCN(CC1)C(=O)CC2=CNC3=C2C=CC=N3,XAAUHRXDRLNFFL-UHFFFAOYSA-N,"1-(4-methylpiperazin-1-yl)-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)ethanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20200326,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146018720,"1-[(4S)-4-Phenyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone",NULL,251.320,C17H17NO,20.300,321.000,2.700,19,0,1,1,"InChI=1S/C17H17NO/c1-13(19)18-11-15-9-5-6-10-16(15)17(12-18)14-7-3-2-4-8-14/h2-10,17H,11-12H2,1H3/t17-/m0/s1",CC(=O)N1C[C@H](C2=CC=CC=C2C1)C3=CC=CC=C3,SORYMMAUHZPBJM-KRWDZBQOSA-N,"1-[(4S)-4-phenyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20200410,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146018721,1-Acetyl-N-methyl-N-propan-2-ylpiperidine-4-carboxamide,NULL,226.320,C12H22N2O2,40.600,268.000,0.500,16,0,2,2,"InChI=1S/C12H22N2O2/c1-9(2)13(4)12(16)11-5-7-14(8-6-11)10(3)15/h9,11H,5-8H2,1-4H3",CC(C)N(C)C(=O)C1CCN(CC1)C(=O)C,CELKOAKJTFSHIV-UHFFFAOYSA-N,1-acetyl-N-methyl-N-propan-2-ylpiperidine-4-carboxamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200410,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146035934,"N'-Acetyl-4,5,6,7-tetrahydro-1-benzothiophene-2-carbohydrazide",NULL,238.310,C11H14N2O2S,86.400,296.000,2.000,16,2,3,1,"InChI=1S/C11H14N2O2S/c1-7(14)12-13-11(15)10-6-8-4-2-3-5-9(8)16-10/h6H,2-5H2,1H3,(H,12,14)(H,13,15)",CC(=O)NNC(=O)C1=CC2=C(S1)CCCC2,DNSKRZJUSJXMPF-UHFFFAOYSA-N,"N'-acetyl-4,5,6,7-tetrahydro-1-benzothiophene-2-carbohydrazide",NULL,Biomolecular Interactions and Pathways,1,NULL,20200519,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037571,N-(3-{[(2R)-4-Oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide,N-(3-{[(2R)-4-oxoazetidin-2-yl]oxy}phenyl)-2-(pyrimidin-5-yl)acetamide|UGD,298.300,C15H14N4O3,93.200,412.000,0.100,22,2,5,5,"InChI=1S/C15H14N4O3/c20-13(4-10-7-16-9-17-8-10)18-11-2-1-3-12(5-11)22-15-6-14(21)19-15/h1-3,5,7-9,15H,4,6H2,(H,18,20)(H,19,21)/t15-/m1/s1",C1[C@H](NC1=O)OC2=CC=CC(=C2)NC(=O)CC3=CN=CN=C3,SGVQMOZIVBYLOT-OAHLLOKOSA-N,N-[3-[(2R)-4-oxoazetidin-2-yl]oxyphenyl]-2-pyrimidin-5-ylacetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037578,2-(5-Chlorothiophen-2-yl)-N-(pyridin-3-yl)acetamide,2-(5-chlorothiophen-2-yl)-N-(pyridin-3-yl)acetamide|UGV,252.720,C11H9ClN2OS,70.200,252.000,2.300,16,1,3,3,"InChI=1S/C11H9ClN2OS/c12-10-4-3-9(16-10)6-11(15)14-8-2-1-5-13-7-8/h1-5,7H,6H2,(H,14,15)",C1=CC(=CN=C1)NC(=O)CC2=CC=C(S2)Cl,VLAXFSPPTLAYDD-UHFFFAOYSA-N,2-(5-chlorothiophen-2-yl)-N-pyridin-3-ylacetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037579,(2R)-2-(3-Chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide,(2R)-2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide|UHA,274.740,C15H15ClN2O,42.000,311.000,3.200,19,1,2,3,"InChI=1S/C15H15ClN2O/c1-10-6-7-17-9-14(10)18-15(19)11(2)12-4-3-5-13(16)8-12/h3-9,11H,1-2H3,(H,18,19)/t11-/m1/s1",CC1=C(C=NC=C1)NC(=O)[C@H](C)C2=CC(=CC=C2)Cl,WNGGAWMEODUSED-LLVKDONJSA-N,(2R)-2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037583,"2-(Cyanomethoxy)-N-[(1,2-thiazol-4-yl)methyl]benzamide","2-(cyanomethoxy)-N-[(1,2-thiazol-4-yl)methyl]benzamide|UHM",273.310,C13H11N3O2S,103.000,355.000,1.500,19,1,5,5,"InChI=1S/C13H11N3O2S/c14-5-6-18-12-4-2-1-3-11(12)13(17)15-7-10-8-16-19-9-10/h1-4,8-9H,6-7H2,(H,15,17)",C1=CC=C(C(=C1)C(=O)NCC2=CSN=C2)OCC#N,PZOXHLAZHKNFDQ-UHFFFAOYSA-N,"2-(cyanomethoxy)-N-(1,2-thiazol-4-ylmethyl)benzamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146672992,"Ethyl (4R)-4-[[(2S)-4-methyl-2-[[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-2-(phenylmethoxycarbonylamino)butanoyl]amino]pentanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate",GTPL11107,632.800,C33H52N4O8,161.000,976.000,3.500,45,4,8,20,"InChI=1S/C33H52N4O8/c1-8-43-27(38)15-14-25(19-24-16-17-34-29(24)39)35-30(40)26(18-21(2)3)36-31(41)28(22(4)45-33(5,6)7)37-32(42)44-20-23-12-10-9-11-13-23/h9-13,21-22,24-26,28H,8,14-20H2,1-7H3,(H,34,39)(H,35,40)(H,36,41)(H,37,42)/t22-,24+,25-,26+,28+/m1/s1",CCOC(=O)CC[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)OC(C)(C)C)NC(=O)OCC2=CC=CC=C2,GENYQFMDDNZIRG-UCWBBBRQSA-N,"ethyl (4R)-4-[[(2S)-4-methyl-2-[[(2S,3R)-3-[(2-methylpropan-2-yl)oxy]-2-(phenylmethoxycarbonylamino)butanoyl]amino]pentanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate",NULL,Biomolecular Interactions and Pathways|Literature,2,NULL,20200702,IUPHAR/BPS Guide to PHARMACOLOGY|Protein Data Bank in Europe (PDBe),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146673002,N-(5-Tert-butyl-1H-pyrazol-3-yl)-N-[(1R)-2-(2-ethyl-6-methylanilino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,447.600,C26H33N5O2,91.000,664.000,4.800,33,2,4,8,"InChI=1S/C26H33N5O2/c1-7-18-12-9-11-17(3)23(18)28-25(33)24(19-13-10-14-27-16-19)31(22(32)8-2)21-15-20(29-30-21)26(4,5)6/h9-16,24H,7-8H2,1-6H3,(H,28,33)(H,29,30)/t24-/m1/s1",CCC1=CC=CC(=C1NC(=O)[C@@H](C2=CN=CC=C2)N(C3=NNC(=C3)C(C)(C)C)C(=O)CC)C,ATGHYXLOAJYKKJ-XMMPIXPASA-N,N-(5-tert-butyl-1H-pyrazol-3-yl)-N-[(1R)-2-(2-ethyl-6-methylanilino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200702,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146673003,N-[4-[(1S)-1-Methoxyethyl]phenyl]-N-[(1R)-2-(4-methoxy-2-methylanilino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,461.600,C27H31N3O4,80.800,652.000,3.700,34,1,5,9,"InChI=1S/C27H31N3O4/c1-6-25(31)30(22-11-9-20(10-12-22)19(3)33-4)26(21-8-7-15-28-17-21)27(32)29-24-14-13-23(34-5)16-18(24)2/h7-17,19,26H,6H2,1-5H3,(H,29,32)/t19-,26+/m0/s1",CCC(=O)N(C1=CC=C(C=C1)[C@H](C)OC)[C@H](C2=CN=CC=C2)C(=O)NC3=C(C=C(C=C3)OC)C,QDPHPMZTNKBBHJ-AFMDSPMNSA-N,N-[4-[(1S)-1-methoxyethyl]phenyl]-N-[(1R)-2-(4-methoxy-2-methylanilino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200702,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
153835436,3-Amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide,3-amino-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide|Y41,304.400,C20H20N2O,55.100,410.000,4.000,23,2,2,3,"InChI=1S/C20H20N2O/c1-13-16(10-6-12-19(13)21)20(23)22-14(2)17-11-5-8-15-7-3-4-9-18(15)17/h3-12,14H,21H2,1-2H3,(H,22,23)/t14-/m1/s1",CC1=C(C=CC=C1N)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32,PZEBTCMUWPLVEX-CQSZACIVSA-N,3-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200814,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
154573650,"2-Hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-6-O-(2-{[(9E)-octadec-9-enoyl]oxy}ethyl)-alpha-L-xylo-hexofuranoside","2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-6-O-(2-{[(9E)-octadec-9-enoyl]oxy}ethyl)-alpha-L-xylo-hexofuranoside|VCG",604.800,C32H60O10,133.000,632.000,5.300,42,3,10,31,"InChI=1S/C32H60O10/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-30(36)40-25-24-37-27-29(39-22-19-34)32-28(38-21-18-33)26-31(42-32)41-23-20-35/h9-10,28-29,31-35H,2-8,11-27H2,1H3/b10-9+/t28-,29+,31-,32+/m1/s1",CCCCCCCC/C=C/CCCCCCCC(=O)OCCOC[C@@H]([C@@H]1[C@@H](C[C@@H](O1)OCCO)OCCO)OCCO,RGPBUVUVZKQNHD-YPJAPDKZSA-N,"2-[(2S)-2-[(2S,3R,5R)-3,5-bis(2-hydroxyethoxy)oxolan-2-yl]-2-(2-hydroxyethoxy)ethoxy]ethyl (E)-octadec-9-enoate",NULL,Biomolecular Interactions and Pathways,1,NULL,20200829,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
154573806,"N-[(2S)-1-[[(1S,2S)-1-(1,3-Benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",GRL-024-20,577.700,C30H35N5O5S,174.000,939.000,3.900,41,5,7,11,"InChI=1S/C30H35N5O5S/c1-16(2)13-22(34-29(39)23-15-18-19(32-23)8-6-9-24(18)40-3)28(38)33-21(14-17-11-12-31-27(17)37)26(36)30-35-20-7-4-5-10-25(20)41-30/h4-10,15-17,21-22,26,32,36H,11-14H2,1-3H3,(H,31,37)(H,33,38)(H,34,39)/t17-,21-,22-,26-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@@H](C2=NC3=CC=CC=C3S2)O)NC(=O)C4=CC5=C(N4)C=CC=C5OC,DHQWCSDZTRDSRP-XIBGDNMGSA-N,"N-[(2S)-1-[[(1S,2S)-1-(1,3-benzothiazol-2-yl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20200902,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
154584707,Benzyl N-[(2S)-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate,NULL,439.500,C24H29N3O5,117.000,617.000,1.900,32,4,5,11,"InChI=1S/C24H29N3O5/c28-15-20(14-19-11-12-25-22(19)29)26-23(30)21(13-17-7-3-1-4-8-17)27-24(31)32-16-18-9-5-2-6-10-18/h1-10,19-21,28H,11-16H2,(H,25,29)(H,26,30)(H,27,31)/t19-,20-,21-/m0/s1",C1CNC(=O)[C@@H]1C[C@@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3,SDSQZWABGUFEMG-ACRUOGEOSA-N,benzyl N-[(2S)-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate,NULL,Biomolecular Interactions and Pathways,1,NULL,20200916,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
154585770,"1-(3,5-Di-O-phosphono-alpha-L-xylofuranosyl)pyrimidine-2,4(1H,3H)-dione","1-(3,5-di-O-phosphono-alpha-L-xylofuranosyl)pyrimidine-2,4(1H,3H)-dione|VQV",404.160,C9H14N2O12P2,212.000,670.000,-4.700,25,6,12,6,"InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(14)10-5)8-6(13)7(23-25(18,19)20)4(22-8)3-21-24(15,16)17/h1-2,4,6-8,13H,3H2,(H,10,12,14)(H2,15,16,17)(H2,18,19,20)/t4-,6-,7+,8+/m0/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@H]([C@@H]([C@@H](O2)COP(=O)(O)O)OP(=O)(O)O)O,ZPVPRWPOZBXDKD-ZAKLUEHWSA-N,"[(2S,3S,4S,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways,1,NULL,20200924,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
154699467,[(3S)-3-[[(2S)-2-[(4-Methoxy-1H-indole-2-carbonyl)amino]-4-methylpentanoyl]amino]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl] dihydrogen phosphate,Lufotrelvir|PF-07304814|PF07304814|Lufotrelvir [USAN]|UNII-XJ51YOB1SC|XJ51YOB1SC|GTPL11249|CHEBI:173073|EX-A4702|WHO 12095|PF 07304814|(3S)-3-({N-[(4-methoxy-1H-indol-2-yl)carbonyl]-L-leucyl}amino)-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl dihydrogen phosphate|(3S)-3-{[(2S)-2-{[(4-methoxy-1H-indol-2-yl)carbonyl]amino}-4-methylpentanoyl]amino}-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl dihydrogen phosphate|[(3S)-3-[(2S)-2-[(4-methoxy-1H-indol-2-yl)formamido]-4-methylpentanamido]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-,552.500,C24H33N4O9P,196.000,927.000,0.500,38,6,9,13,"InChI=1S/C24H33N4O9P/c1-13(2)9-18(28-24(32)19-11-15-16(26-19)5-4-6-21(15)36-3)23(31)27-17(10-14-7-8-25-22(14)30)20(29)12-37-38(33,34)35/h4-6,11,13-14,17-18,26H,7-10,12H2,1-3H3,(H,25,30)(H,27,31)(H,28,32)(H2,33,34,35)/t14-,17-,18-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)COP(=O)(O)O)NC(=O)C2=CC3=C(N2)C=CC=C3OC,FQKALOFOWPDTED-WBAXXEDZSA-N,[(3S)-3-[[(2S)-2-[(4-methoxy-1H-indole-2-carbonyl)amino]-4-methylpentanoyl]amino]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butyl] dihydrogen phosphate,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20200929,ChEBI|ChemIDplus|Excenen Pharmatech|FDA/SPL Indexing Data|IUPHAR/BPS Guide to PHARMACOLOGY,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
154701548,CID 154701548,Triazavirin|s6854,287.210,C5H8N6NaO5S,143.000,435.000,NULL,18,3,8,1,"InChI=1S/C5H4N6O3S.Na.2H2O/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5;;;/h1H3,(H,6,8,9);;2*1H2",CSC1=NC2=NN=C(C(=O)N2N1)[N+](=O)[O-].O.O.[Na],PNOMHWQEVJAFBG-UHFFFAOYSA-N,NULL,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20201012,Selleck Chemicals,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
154702382,Cbz-Val-Leu-Ala(((S)-2-oxopyrrolidin-3-yl))-ol,BDBM423467|WO2006061714-ID-12,504.600,C26H40N4O6,146.000,738.000,2.400,36,5,6,14,"InChI=1S/C26H40N4O6/c1-16(2)12-21(24(33)28-20(14-31)13-19-10-11-27-23(19)32)29-25(34)22(17(3)4)30-26(35)36-15-18-8-6-5-7-9-18/h5-9,16-17,19-22,31H,10-15H2,1-4H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20-,21-,22-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)CO)NC(=O)[C@H](C(C)C)NC(=O)OCC2=CC=CC=C2,GLZAWCKOCLSXEU-CMOCDZPBSA-N,benzyl N-[(2S)-1-[[(2S)-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate,NULL,Biomolecular Interactions and Pathways,1,NULL,20201021,BindingDB|Protein Data Bank in Europe (PDBe),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
154731616,Unii-V2YK90BZ31,"UNII-V2YK90BZ31|V2YK90BZ31|Stannous protoporphyrin|RBT-9|123307-75-5|Stannate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-kappaN21,kappaN22,kappaN23,kappaN24)-, dihydrogen, (sp-4-2)-",679.400,C34H32N4O4Sn,102.000,1010.000,NULL,43,2,8,8,"InChI=1S/C34H34N4O4.Sn/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,1-2,9-12H2,3-6H3,(H4,35,36,37,38,39,40,41,42);/q;+2/p-2",CC1=C(C2=CC3=C(C(=C([N-]3)C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C1[N-]2)C)C=C)C)C=C)C)CCC(=O)O)CCC(=O)O.[Sn+2],YFPCUOXWZGYBEL-UHFFFAOYSA-L,"3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;tin(2+)",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20201105,ChemIDplus|FDA/SPL Indexing Data,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
154844606,"(1R,5R)-N-Methyl-N-(1H-pyrazol-4-yl)bicyclo[3.1.0]hexane-1-carboxamide","(1R,5R)-N-methyl-N-(1H-pyrazol-4-yl)bicyclo[3.1.0]hexane-1-carboxamide|W7V",205.260,C11H15N3O,49.000,294.000,1.000,15,1,2,2,"InChI=1S/C11H15N3O/c1-14(9-6-12-13-7-9)10(15)11-4-2-3-8(11)5-11/h6-8H,2-5H2,1H3,(H,12,13)/t8-,11-/m1/s1",CN(C1=CNN=C1)C(=O)[C@@]23CCC[C@@H]2C3,KPSCQDHJPNEXSJ-LDYMZIIASA-N,"(1R,5R)-N-methyl-N-(1H-pyrazol-4-yl)bicyclo[3.1.0]hexane-1-carboxamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20201215,MolPort|NCBI Structure,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155289180,"4-[(2R)-2-Cyclobutylpyrrolidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine","4-[(2R)-2-cyclobutylpyrrolidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine|W7Y",242.320,C14H18N4,44.800,304.000,3.000,18,1,3,2,"InChI=1S/C14H18N4/c1-3-10(4-1)12-5-2-8-18(12)14-11-6-7-15-13(11)16-9-17-14/h6-7,9-10,12H,1-5,8H2,(H,15,16,17)/t12-/m1/s1",C1C[C@@H](N(C1)C2=NC=NC3=C2C=CN3)C4CCC4,BDDRHCCHCFMOJZ-GFCCVEGCSA-N,"4-[(2R)-2-cyclobutylpyrrolidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine",NULL,Biomolecular Interactions and Pathways,1,NULL,20201231,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155289328,"1-[(2R)-2-Hydroxypropyl]-3-[[(2R)-oxiran-2-yl]methyl]-5-[[(2S)-oxiran-2-yl]methyl]-1,3,5-triazinane-2,4,6-trione","1-[(2~{R})-2-oxidanylpropyl]-3-[[(2~{R})-oxiran-2-yl]methyl]-5-[[(2~{S})-oxiran-2-yl]methyl]-1,3,5-triazinane-2,4,6-trione",299.280,C12H17N3O6,106.000,448.000,-1.500,21,1,6,6,"InChI=1S/C12H17N3O6/c1-7(16)2-13-10(17)14(3-8-5-20-8)12(19)15(11(13)18)4-9-6-21-9/h7-9,16H,2-6H2,1H3/t7-,8-,9+/m1/s1",C[C@H](CN1C(=O)N(C(=O)N(C1=O)C[C@@H]2CO2)C[C@H]3CO3)O,MRWWCVUTOFNJLM-HLTSFMKQSA-N,"1-[(2R)-2-hydroxypropyl]-3-[[(2R)-oxiran-2-yl]methyl]-5-[[(2S)-oxiran-2-yl]methyl]-1,3,5-triazinane-2,4,6-trione",NULL,Biomolecular Interactions and Pathways,1,NULL,20201231,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294419,"(2R,3R)-2-Methyl-1-(methylsulfonyl)piperidine-3-carbonitrile","(2R,3R)-2-methyl-1-(methylsulfonyl)piperidine-3-carbonitrile|W2A",202.280,C8H14N2O2S,69.600,322.000,0.200,13,0,4,1,"InChI=1S/C8H14N2O2S/c1-7-8(6-9)4-3-5-10(7)13(2,11)12/h7-8H,3-5H2,1-2H3/t7-,8+/m1/s1",C[C@@H]1[C@@H](CCCN1S(=O)(=O)C)C#N,FANJRWOXJRSBJO-SFYZADRCSA-N,"(2R,3R)-2-methyl-1-methylsulfonylpiperidine-3-carbonitrile",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294426,"(2S,3S)-2-Methyl-1-(methylsulfonyl)piperidine-3-carboxamide","(2S,3S)-2-methyl-1-(methylsulfonyl)piperidine-3-carboxamide|W2Y",220.290,C8H16N2O3S,88.800,320.000,-0.700,14,1,4,2,"InChI=1S/C8H16N2O3S/c1-6-7(8(9)11)4-3-5-10(6)14(2,12)13/h6-7H,3-5H2,1-2H3,(H2,9,11)/t6-,7-/m0/s1",C[C@H]1[C@H](CCCN1S(=O)(=O)C)C(=O)N,ZHLDXLSBRBBGSZ-BQBZGAKWSA-N,"(2S,3S)-2-methyl-1-methylsulfonylpiperidine-3-carboxamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294427,"(3R,4S)-4-(3-Methoxyphenyl)oxan-3-amine","(3R,4S)-4-(3-methoxyphenyl)oxan-3-amine|W34",207.270,C12H17NO2,44.500,198.000,1.100,15,1,3,2,"InChI=1S/C12H17NO2/c1-14-10-4-2-3-9(7-10)11-5-6-15-8-12(11)13/h2-4,7,11-12H,5-6,8,13H2,1H3/t11-,12-/m0/s1",COC1=CC=CC(=C1)[C@@H]2CCOC[C@@H]2N,RNGNQMRREZVUSH-RYUDHWBXSA-N,"(3R,4S)-4-(3-methoxyphenyl)oxan-3-amine",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294428,"(2S,5R,6R)-7-Methyl-2,3,4,5,6,7-hexahydro-1H-2,6-methanoazocino[5,4-b]indol-5-ol","(2S,5R,6R)-7-methyl-2,3,4,5,6,7-hexahydro-1H-2,6-methanoazocino[5,4-b]indol-5-ol|W44",242.320,C15H18N2O,37.200,335.000,1.300,18,2,2,0,"InChI=1S/C15H18N2O/c1-17-13-5-3-2-4-10(13)11-6-9-7-12(15(11)17)14(18)8-16-9/h2-5,9,12,14,16,18H,6-8H2,1H3/t9-,12+,14+/m1/s1",CN1C2=CC=CC=C2C3=C1[C@H]4C[C@@H](C3)NC[C@@H]4O,QCWXHFWRNWEAIH-LQJRIPTKSA-N,"(1R,12S,15R)-3-methyl-3,13-diazatetracyclo[10.3.1.02,10.04,9]hexadeca-2(10),4,6,8-tetraen-15-ol",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155387694,"(3S,4R)-1-Acetyl-4-phenylpyrrolidine-3-carboxylic acid","(3S,4R)-1-acetyl-4-phenylpyrrolidine-3-carboxylic acid|VXG",233.260,C13H15NO3,57.600,310.000,0.800,17,1,3,2,"InChI=1S/C13H15NO3/c1-9(15)14-7-11(12(8-14)13(16)17)10-5-3-2-4-6-10/h2-6,11-12H,7-8H2,1H3,(H,16,17)/t11-,12+/m0/s1",CC(=O)N1C[C@H]([C@@H](C1)C(=O)O)C2=CC=CC=C2,UJHLINFGICYWPQ-NWDGAFQWSA-N,"(3S,4R)-1-acetyl-4-phenylpyrrolidine-3-carboxylic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210128,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155570128,"N-{3-[(1,3-Dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]propyl}-N'-[2-(morpholin-4-yl)ethyl]thiourea","N-{3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]propyl}-N'-[2-(morpholin-4-yl)ethyl]thiourea|XB1",441.600,C17H27N7O3S2,163.000,606.000,0.200,29,3,7,8,"InChI=1S/C17H27N7O3S2/c1-22-13-12(14(25)23(2)17(22)26)20-16(21-13)29-11-3-4-18-15(28)19-5-6-24-7-9-27-10-8-24/h3-11H2,1-2H3,(H,20,21)(H2,18,19,28)",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)SCCCNC(=S)NCCN3CCOCC3,DFOUYIHNRZAXAX-UHFFFAOYSA-N,"1-[3-[(1,3-dimethyl-2,6-dioxo-7H-purin-8-yl)sulfanyl]propyl]-3-(2-morpholin-4-ylethyl)thiourea",NULL,Biomolecular Interactions and Pathways,1,NULL,20210220,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155570129,"3-[(1,3-Dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]-N-{[2-(morpholin-4-yl)ethyl]sulfonyl}propanamide","3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]-N-{[2-(morpholin-4-yl)ethyl]sulfonyl}propanamide|XYJ",460.500,C16H24N6O6S2,179.000,769.000,-1.100,30,2,9,8,"InChI=1S/C16H24N6O6S2/c1-20-13-12(14(24)21(2)16(20)25)17-15(18-13)29-9-3-11(23)19-30(26,27)10-6-22-4-7-28-8-5-22/h3-10H2,1-2H3,(H,17,18)(H,19,23)",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)SCCC(=O)NS(=O)(=O)CCN3CCOCC3,JUFGUKJIZDHLKW-UHFFFAOYSA-N,"3-[(1,3-dimethyl-2,6-dioxo-7H-purin-8-yl)sulfanyl]-N-(2-morpholin-4-ylethylsulfonyl)propanamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20210220,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155801617,"5-[(Azetidin-3-yl)amino]-N-[(1R)-1-{3-[5-({[(1S,3R)-3-hydroxycyclopentyl]amino}methyl)thiophen-2-yl]phenyl}ethyl]-2-methylbenzamide","5-[(azetidin-3-yl)amino]-N-[(1R)-1-{3-[5-({[(1S,3R)-3-hydroxycyclopentyl]amino}methyl)thiophen-2-yl]phenyl}ethyl]-2-methylbenzamide|XT7",504.700,C29H36N4O2S,114.000,721.000,3.900,36,5,6,9,"InChI=1S/C29H36N4O2S/c1-18-6-7-23(33-24-15-30-16-24)14-27(18)29(35)32-19(2)20-4-3-5-21(12-20)28-11-10-26(36-28)17-31-22-8-9-25(34)13-22/h3-7,10-12,14,19,22,24-25,30-31,33-34H,8-9,13,15-17H2,1-2H3,(H,32,35)/t19-,22+,25-/m1/s1",CC1=C(C=C(C=C1)NC2CNC2)C(=O)N[C@H](C)C3=CC=CC(=C3)C4=CC=C(S4)CN[C@H]5CC[C@H](C5)O,IGVYCVBUHQMNRZ-RZTXVSJASA-N,"5-(azetidin-3-ylamino)-N-[(1R)-1-[3-[5-[[[(1S,3R)-3-hydroxycyclopentyl]amino]methyl]thiophen-2-yl]phenyl]ethyl]-2-methylbenzamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20210226,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155801618,5-[(Azetidin-3-yl)amino]-2-methyl-N-[(1R)-1-(3-{5-[(pyrrolidin-1-yl)methyl]thiophen-2-yl}phenyl)ethyl]benzamide,5-[(azetidin-3-yl)amino]-2-methyl-N-[(1R)-1-(3-{5-[(pyrrolidin-1-yl)methyl]thiophen-2-yl}phenyl)ethyl]benzamide|XR8,474.700,C28H34N4OS,84.600,667.000,4.600,34,3,5,8,"InChI=1S/C28H34N4OS/c1-19-8-9-23(31-24-16-29-17-24)15-26(19)28(33)30-20(2)21-6-5-7-22(14-21)27-11-10-25(34-27)18-32-12-3-4-13-32/h5-11,14-15,20,24,29,31H,3-4,12-13,16-18H2,1-2H3,(H,30,33)/t20-/m1/s1",CC1=C(C=C(C=C1)NC2CNC2)C(=O)N[C@H](C)C3=CC=CC(=C3)C4=CC=C(S4)CN5CCCC5,ZTKSBNLNPMUGBL-HXUWFJFHSA-N,5-(azetidin-3-ylamino)-2-methyl-N-[(1R)-1-[3-[5-(pyrrolidin-1-ylmethyl)thiophen-2-yl]phenyl]ethyl]benzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20210226,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155803728,"2-[3-(3,5-Dichlorophenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile","2-[3-(3,5-dichlorophenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile|XEY",418.300,C23H13Cl2N3O,57.000,730.000,4.700,29,0,3,3,"InChI=1S/C23H13Cl2N3O/c24-18-8-16(9-19(25)11-18)22-10-17(21-6-2-1-4-15(21)12-26)14-28(23(22)29)20-5-3-7-27-13-20/h1-11,13-14H",C1=CC=C(C(=C1)C#N)C2=CN(C(=O)C(=C2)C3=CC(=CC(=C3)Cl)Cl)C4=CN=CC=C4,KXGLBZMRWKVPSY-UHFFFAOYSA-N,"2-[5-(3,5-dichlorophenyl)-6-oxo-1-pyridin-3-ylpyridin-3-yl]benzonitrile",NULL,Biomolecular Interactions and Pathways,1,NULL,20210305,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155803729,"2-[3-(3-Chloro-5-propoxyphenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile","2-[3-(3-chloro-5-propoxyphenyl)-2-oxo[2H-[1,3'-bipyridine]]-5-yl]benzonitrile|GTPL11443|BDBM476977|Inhibitor 2 of SARS-CoV-2 Mpro|compound 5 [Zhang et al., 2021]|2-(3-(3-Chloro-5-propoxyphenyl)-2-oxo-2H [1,3'-bipyridin]-5-yl)benzonitrile|XF1",441.900,C26H20ClN3O2,66.200,785.000,4.900,32,0,4,6,"InChI=1S/C26H20ClN3O2/c1-2-10-32-23-12-19(11-21(27)14-23)25-13-20(24-8-4-3-6-18(24)15-28)17-30(26(25)31)22-7-5-9-29-16-22/h3-9,11-14,16-17H,2,10H2,1H3",CCCOC1=CC(=CC(=C1)C2=CC(=CN(C2=O)C3=CN=CC=C3)C4=CC=CC=C4C#N)Cl,KFGXONJZGIXSGH-UHFFFAOYSA-N,2-[5-(3-chloro-5-propoxyphenyl)-6-oxo-1-pyridin-3-ylpyridin-3-yl]benzonitrile,NULL,Biomolecular Interactions and Pathways,1,NULL,20210305,BindingDB|IUPHAR/BPS Guide to PHARMACOLOGY|NCBI Structure|Protein Data Bank in Europe (PDBe),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155803730,"(5S)-5-{3-[3-(Benzyloxy)-5-chlorophenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}pyrimidine-2,4(3H,5H)-dione","(5S)-5-{3-[3-(benzyloxy)-5-chlorophenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}pyrimidine-2,4(3H,5H)-dione|5-{3-[3-(benzyloxy)-5-chlorophenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}pyrimidine-2,4(1H,3H)-dione|XF4",498.900,C27H19ClN4O4,101.000,971.000,2.900,36,2,5,6,"InChI=1S/C27H19ClN4O4/c28-20-9-18(10-22(12-20)36-16-17-5-2-1-3-6-17)23-11-19(24-14-30-27(35)31-25(24)33)15-32(26(23)34)21-7-4-8-29-13-21/h1-15H,16H2,(H2,30,31,33,35)",C1=CC=C(C=C1)COC2=CC(=CC(=C2)C3=CC(=CN(C3=O)C4=CN=CC=C4)C5=CNC(=O)NC5=O)Cl,IVPUTCRGJCQUQU-UHFFFAOYSA-N,"5-[5-(3-chloro-5-phenylmethoxyphenyl)-6-oxo-1-pyridin-3-ylpyridin-3-yl]-1H-pyrimidine-2,4-dione",NULL,Biomolecular Interactions and Pathways,1,NULL,20210305,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155803731,"(5S)-5-(3-{3-Chloro-5-[(2-chlorophenyl)methoxy]phenyl}-2-oxo[2H-[1,3'-bipyridine]]-5-yl)pyrimidine-2,4(3H,5H)-dione","(5S)-5-(3-{3-chloro-5-[(2-chlorophenyl)methoxy]phenyl}-2-oxo[2H-[1,3'-bipyridine]]-5-yl)pyrimidine-2,4(3H,5H)-dione|5-(3-{3-chloro-5-[(2-chlorophenyl)methoxy]phenyl}-2-oxo[2H-[1,3'-bipyridine]]-5-yl)pyrimidine-2,4(1H,3H)-dione|XF7",533.400,C27H18Cl2N4O4,101.000,1010.000,3.500,37,2,5,6,"InChI=1S/C27H18Cl2N4O4/c28-19-8-17(9-21(11-19)37-15-16-4-1-2-6-24(16)29)22-10-18(23-13-31-27(36)32-25(23)34)14-33(26(22)35)20-5-3-7-30-12-20/h1-14H,15H2,(H2,31,32,34,36)",C1=CC=C(C(=C1)COC2=CC(=CC(=C2)C3=CC(=CN(C3=O)C4=CN=CC=C4)C5=CNC(=O)NC5=O)Cl)Cl,NFXZAFCZOMISJH-UHFFFAOYSA-N,"5-[5-[3-chloro-5-[(2-chlorophenyl)methoxy]phenyl]-6-oxo-1-pyridin-3-ylpyridin-3-yl]-1H-pyrimidine-2,4-dione",NULL,Biomolecular Interactions and Pathways,1,NULL,20210305,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804570,N-(4-Tert-butylphenyl)-N-[(1R)-2-(2-methoxyethylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,397.500,C23H31N3O3,71.500,524.000,3.200,29,1,4,9,"InChI=1S/C23H31N3O3/c1-6-20(27)26(19-11-9-18(10-12-19)23(2,3)4)21(17-8-7-13-24-16-17)22(28)25-14-15-29-5/h7-13,16,21H,6,14-15H2,1-5H3,(H,25,28)/t21-/m1/s1",CCC(=O)N(C1=CC=C(C=C1)C(C)(C)C)[C@H](C2=CN=CC=C2)C(=O)NCCOC,VGALAKWGAVFSCK-OAQYLSRUSA-N,N-(4-tert-butylphenyl)-N-[(1R)-2-(2-methoxyethylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804571,N-(4-Tert-butylphenyl)-N-[(1R)-2-(oxan-4-ylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,423.500,C25H33N3O3,71.500,589.000,3.800,31,1,4,7,"InChI=1S/C25H33N3O3/c1-5-22(29)28(21-10-8-19(9-11-21)25(2,3)4)23(18-7-6-14-26-17-18)24(30)27-20-12-15-31-16-13-20/h6-11,14,17,20,23H,5,12-13,15-16H2,1-4H3,(H,27,30)/t23-/m1/s1",CCC(=O)N(C1=CC=C(C=C1)C(C)(C)C)[C@H](C2=CN=CC=C2)C(=O)NC3CCOCC3,RRENCBKXJJGAMC-HSZRJFAPSA-N,N-(4-tert-butylphenyl)-N-[(1R)-2-(oxan-4-ylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804572,N-(4-Tert-butylphenyl)-N-[(1R)-2-(methylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,353.500,C21H27N3O2,62.300,478.000,3.400,26,1,3,6,"InChI=1S/C21H27N3O2/c1-6-18(25)24(17-11-9-16(10-12-17)21(2,3)4)19(20(26)22-5)15-8-7-13-23-14-15/h7-14,19H,6H2,1-5H3,(H,22,26)/t19-/m1/s1",CCC(=O)N(C1=CC=C(C=C1)C(C)(C)C)[C@H](C2=CN=CC=C2)C(=O)NC,ZEONMUILSPVEHQ-LJQANCHMSA-N,N-(4-tert-butylphenyl)-N-[(1R)-2-(methylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804575,N-[(Benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide,N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide,538.600,C29H38N4O6,146.000,810.000,2.600,39,5,6,14,"InChI=1S/C29H38N4O6/c1-19(2)25(33-29(38)39-18-21-11-7-4-8-12-21)28(37)32-24(15-20-9-5-3-6-10-20)27(36)31-23(17-34)16-22-13-14-30-26(22)35/h3-12,19,22-25,34H,13-18H2,1-2H3,(H,30,35)(H,31,36)(H,32,37)(H,33,38)/t22-,23-,24-,25-/m0/s1",CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C[C@@H]2CCNC2=O)CO)NC(=O)OCC3=CC=CC=C3,AGWXCVPSNAWKHO-QORCZRPOSA-N,benzyl N-[(2S)-1-[[(2S)-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate,NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804576,Cbz-Val-Cha-Ala(((S)-2-oxopyrrolidin-3-yl))-ol,NULL,544.700,C29H44N4O6,146.000,810.000,3.800,39,5,6,14,"InChI=1S/C29H44N4O6/c1-19(2)25(33-29(38)39-18-21-11-7-4-8-12-21)28(37)32-24(15-20-9-5-3-6-10-20)27(36)31-23(17-34)16-22-13-14-30-26(22)35/h4,7-8,11-12,19-20,22-25,34H,3,5-6,9-10,13-18H2,1-2H3,(H,30,35)(H,31,36)(H,32,37)(H,33,38)/t22-,23-,24-,25-/m0/s1",CC(C)[C@@H](C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](C[C@@H]2CCNC2=O)CO)NC(=O)OCC3=CC=CC=C3,LMWONCCZCSKLCL-QORCZRPOSA-N,benzyl N-[(2S)-1-[[(2S)-3-cyclohexyl-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate,NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804577,Cbz-Thr(tBu)-Leu-Ala(((S)-2-oxopyrrolidin-3-yl))-ol,NULL,562.700,C29H46N4O7,155.000,839.000,2.300,40,5,7,16,"InChI=1S/C29H46N4O7/c1-18(2)14-23(26(36)31-22(16-34)15-21-12-13-30-25(21)35)32-27(37)24(19(3)40-29(4,5)6)33-28(38)39-17-20-10-8-7-9-11-20/h7-11,18-19,21-24,34H,12-17H2,1-6H3,(H,30,35)(H,31,36)(H,32,37)(H,33,38)/t19-,21+,22+,23+,24+/m1/s1",C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)CO)NC(=O)OCC2=CC=CC=C2)OC(C)(C)C,AWESOLQTDOBPDY-FFYZIMEISA-N,"benzyl N-[(2S,3R)-1-[[(2S)-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxobutan-2-yl]carbamate",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804578,GC376 alpha-ketoamide analog (bound form),GC376 alpha-ketoamide analog (bound form),538.600,C29H38N4O6,146.000,810.000,2.500,39,5,6,14,"InChI=1S/C29H38N4O6/c1-19(2)15-24(33-29(38)39-18-21-11-7-4-8-12-21)27(36)32-23(16-22-13-14-30-26(22)35)25(34)28(37)31-17-20-9-5-3-6-10-20/h3-12,19,22-25,34H,13-18H2,1-2H3,(H,30,35)(H,31,37)(H,32,36)(H,33,38)/t22-,23-,24-,25+/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@H](C(=O)NCC2=CC=CC=C2)O)NC(=O)OCC3=CC=CC=C3,MPMTWRHFCLPCDF-OJJQZRKESA-N,"benzyl N-[(2S)-1-[[(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804602,"(1R,2S)-2-{[N-({[(1R,3R,5S)-Bicyclo[3.3.1]non-6-en-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid","(1R,2S)-2-{[N-({[(1R,3R,5S)-bicyclo[3.3.1]non-6-en-3-yl]methoxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",529.600,C24H39N3O8S,180.000,932.000,1.700,36,5,8,12,"InChI=1S/C24H39N3O8S/c1-14(2)8-19(27-24(31)35-13-17-10-15-4-3-5-16(9-15)11-17)22(29)26-20(23(30)36(32,33)34)12-18-6-7-25-21(18)28/h3-4,14-20,23,30H,5-13H2,1-2H3,(H,25,28)(H,26,29)(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19-,20-,23+/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@H](O)S(=O)(=O)O)NC(=O)OC[C@@H]2C[C@@H]3CC=C[C@@H](C3)C2,ZIWRGXZFSGDQST-ZDCSSWJMSA-N,"(1R,2S)-2-[[(2S)-2-[[(1R,3R,5S)-3-bicyclo[3.3.1]non-6-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804603,"(1R,2S)-2-[[(2S)-2-[[(1R,2S,4S)-2-Bicyclo[2.2.1]heptanyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,503.600,C22H37N3O8S,180.000,859.000,1.500,34,5,8,12,"InChI=1S/C22H37N3O8S/c1-12(2)7-17(25-22(29)33-11-16-9-13-3-4-14(16)8-13)20(27)24-18(21(28)34(30,31)32)10-15-5-6-23-19(15)26/h12-18,21,28H,3-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t13-,14+,15-,16+,17-,18-,21+/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@H](O)S(=O)(=O)O)NC(=O)OC[C@H]2C[C@H]3CC[C@@H]2C3,CDEICDIJDMTLMS-NFFJHMNLSA-N,"(1R,2S)-2-[[(2S)-2-[[(1R,2S,4S)-2-bicyclo[2.2.1]heptanyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804607,"(1S,2S)-2-[[(2S)-2-[[(1R,3R,5S)-3-Bicyclo[3.3.1]non-6-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,529.600,C24H39N3O8S,180.000,932.000,1.700,36,5,8,12,"InChI=1S/C24H39N3O8S/c1-14(2)8-19(27-24(31)35-13-17-10-15-4-3-5-16(9-15)11-17)22(29)26-20(23(30)36(32,33)34)12-18-6-7-25-21(18)28/h3-4,14-20,23,30H,5-13H2,1-2H3,(H,25,28)(H,26,29)(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19-,20-,23-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@@H](O)S(=O)(=O)O)NC(=O)OC[C@@H]2C[C@@H]3CC=C[C@@H](C3)C2,ZIWRGXZFSGDQST-LZHMTVEHSA-N,"(1S,2S)-2-[[(2S)-2-[[(1R,3R,5S)-3-bicyclo[3.3.1]non-6-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804608,"(1S,2S)-2-[[(2S)-2-[[(1S,2S,4S)-2-Bicyclo[2.2.1]hept-5-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,501.600,C22H35N3O8S,180.000,900.000,0.900,34,5,8,12,"InChI=1S/C22H35N3O8S/c1-12(2)7-17(25-22(29)33-11-16-9-13-3-4-14(16)8-13)20(27)24-18(21(28)34(30,31)32)10-15-5-6-23-19(15)26/h3-4,12-18,21,28H,5-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t13-,14+,15-,16+,17-,18-,21-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@@H](O)S(=O)(=O)O)NC(=O)OC[C@H]2C[C@@H]3C[C@H]2C=C3,WZJYVJHLXCYWFV-JBKSVKCVSA-N,"(1S,2S)-2-[[(2S)-2-[[(1S,2S,4S)-2-bicyclo[2.2.1]hept-5-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804609,"(1S,2S)-2-[[(2S)-2-[[(1R,2S,4S)-2-Bicyclo[2.2.1]heptanyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,503.600,C22H37N3O8S,180.000,859.000,1.500,34,5,8,12,"InChI=1S/C22H37N3O8S/c1-12(2)7-17(25-22(29)33-11-16-9-13-3-4-14(16)8-13)20(27)24-18(21(28)34(30,31)32)10-15-5-6-23-19(15)26/h12-18,21,28H,3-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t13-,14+,15-,16+,17-,18-,21-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@@H](O)S(=O)(=O)O)NC(=O)OC[C@H]2C[C@H]3CC[C@@H]2C3,CDEICDIJDMTLMS-JBKSVKCVSA-N,"(1S,2S)-2-[[(2S)-2-[[(1R,2S,4S)-2-bicyclo[2.2.1]heptanyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804611,"(1R,2S)-2-[[(2S)-2-[[(1R,3S,5S)-3-Bicyclo[3.3.1]non-6-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,529.600,C24H39N3O8S,180.000,932.000,1.700,36,5,8,12,"InChI=1S/C24H39N3O8S/c1-14(2)8-19(27-24(31)35-13-17-10-15-4-3-5-16(9-15)11-17)22(29)26-20(23(30)36(32,33)34)12-18-6-7-25-21(18)28/h3-4,14-20,23,30H,5-13H2,1-2H3,(H,25,28)(H,26,29)(H,27,31)(H,32,33,34)/t15-,16+,17+,18-,19-,20-,23+/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@H](O)S(=O)(=O)O)NC(=O)OC[C@H]2C[C@@H]3CC=C[C@@H](C3)C2,ZIWRGXZFSGDQST-REFFYEJJSA-N,"(1R,2S)-2-[[(2S)-2-[[(1R,3S,5S)-3-bicyclo[3.3.1]non-6-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
119,gamma-Aminobutyric acid,"4-aminobutyric acid|4-Aminobutanoic acid|gamma-aminobutyric acid|GABA|56-12-2|Piperidic acid|Piperidinic acid|Aminalon|butanoic acid, 4-amino-|Gaballon|Gammalon|Mielogen|Gammalone|Mielomade|Gamarex|Gammasol|Gammar|Reanal|gamma-amino-n-butyric acid|Immu-G|gamma-Aminobutanoic acid|Butyric acid, 4-amino-|Gamastan|Gammagee|Gamulin|.gamma.-Aminobutyric acid|4-aminobutyrate|4-aminobutanoate|omega-Aminobutyric acid|gamma-Amino butyric acid|3-Carboxypropylamine|gamma-Aminobuttersaeure|4-amino-butanoic acid|GAMMA-AM",103.120,C4H9NO2,63.300,62.700,-3.200,7,2,3,3,"InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)",C(CC(=O)O)CN,BTCSSZJGUNDROE-UHFFFAOYSA-N,4-aminobutanoic acid,gamma-Aminobutyric Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,155|157|161|165|167|175|190|248|328|357|410|411|422|429|436|444|445|446|447|448|450|451|485|526|530|547|568|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|605|606|607|618|620|629|630|631|633|639|648|662|687|694|701|719|731|732|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|875|878|879|880|881|883|884|885|886|887|889|891|892|893|894|895|898|899|900|901|902|910|912|914|915|917|918|920|923|924|925|926|927|928|930|932|938|940|,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Alsachim|Amadis Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
896,Melatonin,"Melatonin|73-31-4|Melatonine|N-Acetyl-5-methoxytryptamine|Circadin|N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide|5-Methoxy-N-acetyltryptamine|N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide|Melatol|Melovine|Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide|N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide|UNII-JL5DK93RCL|N-acetyl-5-methoxy-tryptamine|NSC 113928|CHEMBL45|JL5DK93RCL|Acetamide, N-(2-(5-methoxyindol-3-yl)ethyl)-|3-(n-acetyl-2-aminoethyl)-5-methoxyindole|8041-44-9|",232.280,C13H16N2O2,54.100,270.000,0.800,17,2,2,4,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,DRLFMBDRBRZALE-UHFFFAOYSA-N,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide,Melatonin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|5|7|9|11|13|15|17|19|21|23|25|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|79|81|99|101|103|105|107|109|113|119|121|123|125|129|131|133|137|139|141|143|145|179|351|357|377|410|411|421|422|426|427|429|433|434|435|436|444|445|446|447|448|450|451|526|530|540|541|542|543|544|545|546|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|608|654|655|656|657|658|659|660|661|662|663|664|665|666|667|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|90,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|Ambinter|Angene Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2157,Amiodarone,"amiodarone|1951-25-3|Cordarone|Amiodarona|Amiodaronum|Amiodaronum [INN-Latin]|Amiodarona [INN-Spanish]|L 3428|UNII-N3RQ532IUT|2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran|SKF 33134-A|2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran|(2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone|L-3428|2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone|CHEMBL633|N3RQ532IUT|2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diio",645.300,C25H29I2NO3,42.700,547.000,7.600,31,0,4,11,"InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3",CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,IYIKLHRQXLHMJQ-UHFFFAOYSA-N,"(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone",Amiodarone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1030|1195|1332|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1851|1865|1948|2062|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|2660|2666|2667|2668|7783|8002|194,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|AN PharmaTech|Angene Chemical|ApexBio Technology|Ark Pharm, Inc.|Assembly Blocks Pv",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2520,Verapamil,"VERAPAMIL|52-53-9|Iproveratril|Vasolan|Dilacoran|Isoptin|Falicard|Finoptin|Isoptine|Calan|Lekoptin|Verapamilo|Verapamilum|Isotopin|Securon|Verelan|Calcan|Tarka|D-365|Cardibeltin|Izoptin|CP-16533-1|Covera-HS|Verpamil|Verelan PM|2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile|5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile|Cardiagutt|Berkatens|Dignover|Geangin|Veramex|Quasar|Univer|5-((3,4-dimethoxyphenethyl)(methyl",454.600,C27H38N2O4,64.000,606.000,3.800,33,0,6,13,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,SGTNSNPWRIOYBX-UHFFFAOYSA-N,"2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile",Verapamil,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,880|894|1030|1332|1379|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1766|1768|1865|1948|2062|2101|2107|2112|2147|2240|2241|2275|2313|2316|2322|2330|2451|2472|2517|2528|2546|2549|2551|2660|2666|2667|2668|3216|7779|7783|7812|7974|8002|9983|18849|19006|19419|19468|20050|22293|23672|25870|26304|26362|26798|27572|27587|29139|29140|29338|29359|29811|42314|43400|43402|43526|43527|43867|43874|45602|45614|45634|45736|45740|45790|45792|47004|48348|48971|48973|51927|53606|53608|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|Ark Pharm, Inc.|Aronis|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2712,Chlordiazepoxide,"chlordiazepoxide|58-25-3|Methaminodiazepoxide|Librium|Chlordiazepoxid|Clopoxide|Lygen|Radepur|Chlordiazachel|7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide|A-Poxide|3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl-, 4-oxide|Chlordiazepoxide Hcl|UNII-6RZ6XEZ3CR|Chlozepid|Elenium|Chlorodiazepoxide|7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine|Chloridiazepide|Helogaphen|Kalmocaps|Librelease|Libritabs|Viopsicol|Control|Decacil|Ifibrium|Librinin|Menrium|Mesural|Mildme",299.750,C16H14ClN3O,48.200,580.000,2.400,21,1,3,1,"InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9,21H,10H2,1H3",CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,BUCORZSTKDOEKQ-UHFFFAOYSA-N,"7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine",Chlordiazepoxide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1195|1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|25,20050325,"3B Scientific (Wuhan) Corp|AAA Chemistry|Abbott Labs|ABI Chem|Acadechem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BindingDB|Biosynth Carbosynth|Boerchem|C. David Weaver Laboratory, Vanderbilt University|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|chemical genetic matrix|Chemical Syn",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2733,Chlorzoxazone,"chlorzoxazone|95-25-0|Paraflex|Chloroxazone|Chlorzoxazon|5-Chloro-2-benzoxazolone|5-Chloro-2-benzoxazolinone|2(3H)-Benzoxazolone, 5-chloro-|Biomioran|Escoflex|Myoflexin|Myoflexine|Pathorysin|5-Chloro-2-hydroxybenzoxazole|Mioran|Miotran|Neoflex|Solaxin|Parafon Forte DSC|5-Chlorobenzoxazolidone|Chlorzoxane|5-Chlorobenzo[d]oxazol-2(3H)-one|5-Chloro-2(3H)-benzoxazolone|5-Chloro-1,3-benzoxazol-2(3H)-one|5-Chloro-2-benzoxazolol|Usaf ma-10|5-Chlorobenzoxazol-2-one|Strifon Forte Dsc|5-Chlorobenzoxazolone|5-chloro-3",169.560,C7H4ClNO2,38.300,185.000,1.800,11,1,2,0,"InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)",C1=CC2=C(C=C1Cl)NC(=O)O2,TZFWDZFKRBELIQ-UHFFFAOYSA-N,"5-chloro-3H-1,3-benzoxazol-2-one",Chlorzoxazone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,357|368|374|377|410|411|422|429|436|444|445|446|447|448|450|451|485|526|530|539|547|555|556|565|568|573|577|583|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|606|607|618|620|631|645|662|694|708|709|731|732|750|757|758|759|760|761|764|774|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|847|861|862|868|871|873|875|878|879|880|881|883|884|885|886|887|889|891|892|893|894|895|898|899|900|901|902|910|912|914|915|917|918|920|923|924|925|926|927|928|930|932|938|940|943|944|945|950|951|952|,20050325,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2973,Deferoxamine,"deferoxamine|Desferrioxamine B|DESFERRIOXAMINE|70-51-9|Deferoxamine B|Deferrioxamine B|Deferrioxamine|Deferoxamin|Deferoxaminum|Desferin|DFOM|Desferan|Desferex|Desferral|Desferrin|N-Benzoylferrioxamine B|Desferal|DF B|DFOA|Deferoxamide B|Deferoxamina|NSC-527604|Ferrioxamine B, N-benzoyl-|UNII-J06Y7MXW4D|N1-(5-Aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-((5-(N-hydroxyacetamido)pentyl)amino)-4-oxobutanamido)pentyl)succinamide|Ba-33112|J06Y7MXW4D|CHEBI:4356|NSC527604|3,9,14,20,25-Pentaazatriacontane-2,10,13,21,",560.700,C25H48N6O8,206.000,739.000,-2.100,39,6,9,23,"InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34)",CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,UBQYURCVBFRUQT-UHFFFAOYSA-N,N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide,Deferoxamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,248|256|1195|1332|2240|2241|2275|2313|2322|2330|15378|15379|16354|16355|16356|16357|16358|16359|16360|16361|16362|16363|16364|16365|28234|28679|28924|28925|31897|31898|31899|51713|51717|72978|95167|116068|116069|116070|116071|119000|126474|126475|127150|127278|141384|143513|179828|179829|179832|181514|186664|186669|186670|186793|186794|186795|186796|186797|186798|186799|186800|186801|186802|186803|186804|186805|186806|186807|186808|186809|186810|186811|186812|187142|190960|190961|190962|190963|190964|190965,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acros Organics|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|BioChemPartner|BioCyc|Biosynth Car",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3100,Diphenhydramine,"diphenhydramine|58-73-1|Benadryl|Benzhydramine|2-(Benzhydryloxy)-N,N-dimethylethanamine|Alledryl|Probedryl|Dihidral|Antistominum|Benzhydraminum|Benzhydroamina|Diphantine|Diphenylhydramine|Difenhydramin|Allergical|Bagodryl|Baramine|Benachlor|Benadrin|Benodine|Benzantine|Benzhydril|Betramin|Debendrin|Dermistina|Dermodrin|Desentol|Diabenyl|Diabylen|Dibondrin|Difedryl|Drylistan|Histaxin|Hyadrine|Ibiodral|Medidryl|Mephadryl|Novamina|Syntedril|Amidryl|Antomin|Benapon|Benodin|Benylan|Benylin|Dabylen|Dylamon|Nausen",255.350,C17H21NO,12.500,211.000,3.300,19,0,2,6,"InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3",CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,"2-benzhydryloxy-N,N-dimethylethanamine",Diphenhydramine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|3|5|7|9|15|19|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|79|81|83|85|87|89|91|93|95|97|99|101|103|107|109|129|131|137|139|141|143|145|357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1030|1195|1332|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|147,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3117,Disulfiram,disulfiram|Tetraethylthiuram disulfide|97-77-8|Antabuse|Antabus|Bis(diethylthiocarbamoyl) disulfide|Alcophobin|Anticol|Esperal|Teturam|TETD|Dicupral|Exhorran|Hoca|Ethyldithiurame|Abstensil|Antaethyl|Antietanol|Antivitium|Contralin|Tetradine|Tetraetil|Teturamin|Abstinil|Abstinyl|Antadix|Antalcol|Antetan|Antetil|Antietil|Antikol|Aversan|Averzan|Cronetal|Krotenal|Refusal|Etabus|Ethyl tuads|Ethyl Thiram|Ethyl Thiurad|Ethyl Tuex|Antaenyl|Antaetil|Antiaethan|Contrapot|Disulfan|Disulfuram|Ephorran|Stopetyl|Thiuran,296.500,C10H20N2S4,121.000,201.000,3.900,16,0,4,7,"InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3",CCN(CC)C(=S)SSC(=S)N(CC)CC,AUZONCFQVSMFAP-UHFFFAOYSA-N,"diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate",Disulfiram,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,179|192|248|328|357|377|410|411|422|429|436|444|445|446|447|448|450|451|485|512|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|631|662|694|731|732|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|875|878|879|880|881|883|884|885|886|887|889|891|892|893|894|895|898|899|900|901|902|910|912|914|915|917|918|920|923|924|925|926|927|928|930|932|938|940|943|944|945|950|951|952|954|957|958|959|992|995|997|998|999|1001|1004|1006|1007|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemica|Acros Organics|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Aronis|Aurora Fine Chemicals LLC|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3957,Loratadine,"loratadine|79794-75-5|Claritin|Loratidine|Alavert|Clarityn|Lisino|Clarityne|Loracert|Loradex|Bonalerg|Claritine|Fristamin|Histaloran|Lertamine|Lorastine|Civeran|Loranox|Versal|Sch 29851|Anhissen|Sch-29851|UNII-7AJO3BO7QN|ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate|MFCD00672869|C22H23ClN2O2|Loratyne|Allertidin|Claratyne|Polaratyne|Restamine|Aerotina|Alerpriv|Biloina|Lesidas|Loradif|Lorantis|Loraver|Lorfast|Loritine|Lowadina|Nularef|Optimin|Sanelor|",382.900,C22H23ClN2O2,42.400,569.000,5.200,27,0,3,2,"InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3",CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,JCCNYMKQOSZNPW-UHFFFAOYSA-N,"ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate",Loratadine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1|3|5|7|9|13|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|133|137|139|141|143|145|357|361|364|368|371|373|374|375|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambe",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4740,Pentoxifylline,"pentoxifylline|Trental|Oxpentifylline|6493-05-6|Pentoxifyllin|Torental|Pentoxyphylline|Dimethyloxohexylxanthine|Pentoxiphyllium|Vazofirin|Pentoxiphylline|Rentylin|3,7-Dimethyl-1-(5-oxohexyl)xanthine|BL 191|Pentoxyphyllin|3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-dione|1-(5-Oxohexyl)theobromine|3,7-Dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione|BL-191|1H-Purine-2,6-dione, 3,7-dihydro-3,7-dimethyl-1-(5-oxohexyl)-|3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione|Pentoxyfilline|1-(5-Oxohexyl)-3,",278.310,C13H18N4O3,75.500,426.000,0.300,20,0,4,5,"InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3",CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,BYPFEZZEUUWMEJ-UHFFFAOYSA-N,"3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione",Pentoxifylline,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,179|357|360|361|368|373|374|377|410|411|422|425|429|432|436|444|445|446|447|448|449|450|451|453|460|463|465|485|488|501|518|521|522|524|525|526|530|538|539|547|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|607|612|614|615|618|619|620|626|628|629|630|631|633|639|640|641|645|648|662|680|684|690|693|694|696|697|704|707|708|709|710|717|719|720|727|729|731|732|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|,20050325,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Ambeed|Ambinter|AN PharmaTech|ASINEX|Aurum Pharmatech LLC|Axon Medchem|BIDD|BindingDB|BioChemPartner|BLD Pharm|BOC Sciences|Boone Lab, Chemical Genomics, University of Toronto|Broad Institute|Burnham Center for Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5143,Saccharin,"saccharin|81-07-2|o-Benzoic sulfimide|o-Sulfobenzimide|Saccharine|Saccharimide|Benzosulfimide|Benzoic sulfimide|Garantose|o-Benzosulfimide|Benzosulphimide|Saccharinose|Saccharinol|Gluside|Benzosulfinide|Hermesetas|Saccharol|Glucid|Sweeta|Saccharin acid|1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide|Benzoic sulphimide|Saccharin insoluble|Saccharina|Kandiset|Sacarina|Sucrette|Zaharina|Saxin|Sykose|Benzo-2-sulphimide|o-Benzoyl sulfimide|Sucre edulcor|o-Benzoic sulphimide|Benzoylsulfonic Imide|o-Sulfobenzoic acid im",183.190,C7H5NO3S,71.600,303.000,0.900,12,1,3,0,"InChI=1S/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9)",C1=CC=C2C(=C1)C(=O)NS2(=O)=O,CVHZOJJKTDOEJC-UHFFFAOYSA-N,"1,1-dioxo-1,2-benzothiazol-3-one",Saccharin,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,18,155|157|161|165|167|175|328|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1189|1194|1199|1205|1208|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1611|1612|1613|1614|1616|1688|1766|1768|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2530|2533|2534|2535|2546|2549|2551|2561|2562|257,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Am",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5833,Spironolactone,"spironolactone|52-01-7|Aldactone|Spirolactone|Verospiron|Euteberol|Spirolang|Verospirone|Spiroctan|Acelat|Aldactone A|Spironocompren|Melarcon|Spiresis|Spiridon|Uractone|Urusonin|Alderon|Spirone|Xenalon|Dira|Spiro-Tablinen|Spironolactone A|spironolattone|Aquareduct|Aldopur|Espironolactona|Spironolactonum|Aldace|Almatol|Deverol|Altex|Berlactone|SC 9420|SC-9420|UNII-27O7W4T232|MFCD00082250|CHEMBL1393|C24H32O4S|CHEBI:9241|Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)|Spironolattone [DCIT]|27O7W4T232|NS",416.600,C24H32O4S,85.700,818.000,2.900,29,0,5,2,"InChI=1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1",CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,LXMSZDCAJNLERA-ZHYRCANASA-N,"S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate",Spironolactone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,248|256|1332|1376|1385|1422|1465|1469|1479|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2240|2241|2247|2270|2271|2272|2273|2274|2275|2280|2300|2313|2316|2322|2330|2380|2391|2435|2445|2462|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797,20050326,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|AvaChem Scientific|BIDD|BindingDB|BioCrick|Biosynth Carbosynth|BOC ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5865,Prednisone,"prednisone|53-03-2|Dehydrocortisone|Decortin|Deltasone|Meticorten|Orasone|Rectodelt|Ultracorten|Dacortin|Encorton|1,2-Dehydrocortisone|Deltacortisone|Deltacortone|Ancortone|Colisone|Decortancyl|Decortisyl|Deltison|Encortone|Paracort|Prednilonga|Prednison|Sterapred|Cortan|Liquid Pred|Di-Adreson|Bicortone|Cortidelt|Dekortin|Diadreson|Enkorton|Hostacortin|Lisacort|Panafcort|Prednisonum|Prednizon|Pronison|Servisone|Supercortil|Ultracortene|Zenadrid|Adasone|Cotone|Deltra|Juvason|Lodotra|Nurison|Winpred|Wojtab|Me",358.400,C21H26O5,91.700,764.000,1.500,26,2,5,2,"InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,"(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione",Prednisone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|186|188|190|192|194|198|206|210|212|216|220|224|228|232|236|244|246|248|250|252|256|258|264|270|272|276|282|284|288|290|292|296|300|302|306|308|316|320|328|330|332|334|338|340|344|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|66,20050326,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BioChemPartner|BioCrick|BioCyc|BOC Sciences|Broad Institute|C. David Weaver Laboratory, Vanderbilt Un",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6269,P-Toluenesulfonamide,"P-TOLUENESULFONAMIDE|4-Methylbenzenesulfonamide|70-55-3|4-Toluenesulfonamide|Tosylamide|p-Tosylamide|Toluene-4-sulfonamide|Benzenesulfonamide, 4-methyl-|p-Tolylsulfonamide|para-Toluenesulfonamide|4-methylbenzene-1-sulfonamide|Tolylsulfonamide|p-Toluenesulfamide|p-Methylbenzenesulfonamide|p-Toluenesulfonylamide|Toluene-p-sulphonamide|tosylamine|MFCD00011692|UNII-I8266RI90M|CHEMBL574|CHEBI:34435|I8266RI90M|NSC-9908|Toluene-4-sulphonamide|DSSTox_CID_9105|p-Toluenesulfonamide, 99%|DSSTox_RID_78668|DSSTox_GSID_2",171.220,C7H9NO2S,68.500,209.000,0.800,11,1,3,1,"InChI=1S/C7H9NO2S/c1-6-2-4-7(5-3-6)11(8,9)10/h2-5H,1H3,(H2,8,9,10)",CC1=CC=C(C=C1)S(=O)(=O)N,LMYRWZFENFIFIT-UHFFFAOYSA-N,4-methylbenzenesulfonamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|41|43|45|47|49|53|59|65|67|71|73|77|79|81|83|85|87|89|91|93|97|99|101|103|107|109|113|115|119|121|123|125|129|133|137|139|141|143|145|155|157|161|165|167|175|248|256|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Ambinter|AN PharmaTech|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech L",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8189,Triglyme,"Triglyme|2,5,8,11-TETRAOXADODECANE|112-49-2|Triethylene glycol dimethyl ether|1,2-Bis(2-methoxyethoxy)ethane|Glyme 4|Ansul ether 161|Glyme-3|1-methoxy-2-[2-(2-methoxyethoxy)ethoxy]ethane|Dimethyl ether of triethylene glycol|UNII-32YXG88KK0|Ethane, 1,2-bis(2-methoxyethoxy)-|NSC 66400|triethyleneglycol dimethyl ether|1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE|32YXG88KK0|DTXSID8026224|CHEBI:44842|MFCD00008504|1,2-Bis(2-methoxyethoxy) Ethane, Reagent|TEGDIME|Triethylene glycol dimethyl ether, 99%, stabilized|EINE",178.230,C8H18O4,36.900,67.500,-0.500,12,0,4,9,"InChI=1S/C8H18O4/c1-9-3-5-11-7-8-12-6-4-10-2/h3-8H2,1-2H3",COCCOCCOCCOC,YFNKIDBQEZZDLK-UHFFFAOYSA-N,1-methoxy-2-[2-(2-methoxyethoxy)ethoxy]ethane,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Micromolar,11,1469|1479|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|651631|651632|651633|651634|651741|651743|651749|651751|651777|651778|651838|720516|720552|720634|720635|720636|720637|720653|720659|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|74307,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Aurora Fine Chemicals LLC|BePharm Ltd.|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|ChemIDpl",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8739,Carzenide,"4-Sulfamoylbenzoic acid|Carzenide|138-41-0|4-Carboxybenzenesulfonamide|4-(Aminosulfonyl)benzoic acid|Benzoic acid, 4-(aminosulfonyl)-|Carzenid|Dirnate|p-Carboxybenzenesulfonamide|p-Sulfamylbenzoic acid|p-Sulfamoylbenzoic acid|Benzoic acid p-sulfamide|p-Sulfonamidobenzoic acid|4-Aminosulfonylbenzoic acid|Carzenide [INN]|4-Sulfamoyl-benzoic acid|BENZOIC ACID, p-SULFAMOYL-|NSC22976|UNII-30Z5HQB5A4|NSC 22976|4-Sulfamidobenzoic acid|Benzoic acid 4-sulfamide|CHEMBL414|30Z5HQB5A4|Carzenide (INN)|MFCD00007938|NSC-2",201.200,C7H7NO4S,106.000,284.000,0.500,13,2,5,2,"InChI=1S/C7H7NO4S/c8-13(11,12)6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10)(H2,8,11,12)",C1=CC(=CC=C1C(=O)O)S(=O)(=O)N,UCAGLBKTLXCODC-UHFFFAOYSA-N,4-sulfamoylbenzoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,1|5|9|13|15|19|21|23|25|29|31|35|37|39|41|43|45|47|53|59|65|67|71|73|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|179|330|348|357|361|364|368|371|373|374|375|376|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|58,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aromsyn catalogue|Aurora Fine Chemicals LL",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9222,7-Azaindole,"7-Azaindole|1H-Pyrrolo[2,3-b]pyridine|271-63-6|1,7-Diazaindene|7H-Pyrrolo[2,3-b]pyridine|7-Aza-1-pyrindine|1,7-Dideazapurine|1H-PYRROLO(2,3-b)PYRIDINE|MFCD00005606|pyrrolo[2,3-b]pyridine|7-aza-indole|UNII-QX4465NR9T|7H-Pyrrolo(2,3-b)pyridine|7-Azaindole, 98%|Pyrrolo(2,3-b)pyridine|QX4465NR9T|89267-19-6|1H-Pyrrolo[2,3-b]pyridine, dimer|WLN: T56 BM INJ|25247-73-8|EINECS 205-981-0|NSC 67063|1 h-pyrrolo[2,3:b]pyridine|7-azaindol|7-aza indole|pyrrolo[b]pyridine|GVH|zlchem 221|PubChem7679|ACMC-20lk5f|ACMC-1CKM0|p",118.140,C7H6N2,28.700,103.000,1.800,9,1,1,0,"InChI=1S/C7H6N2/c1-2-6-3-5-9-7(6)8-4-1/h1-5H,(H,8,9)",C1=CC2=C(NC=C2)N=C1,MVXVYAKCVDQRLW-UHFFFAOYSA-N,"1H-pyrrolo[2,3-b]pyridine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity,9,54188|70363|73213|286919|286920|286921|327087|588453|588456|588579|588590|588795|588855|588856|602310|602332|613143|613144|613145|613147|613148|613149|613150|613151|613152|613153|613154|613155|613156|613157|613158|613159|613160|613161|613162|613163|613165|613166|613167|613168|613169|613170|613171|613172|613173|613174|613175|613176|624178|624414|651965|686978|686979|720579|720580|1078324|1078325|1078326|1078327|1078328|1078329|1078330|1078331|1078332|1078333|1078334|1078335|1078336|1078337|1078338|1078339|10,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9400,Dexamethasone phosphate,"dexamethasone phosphate|Dexamethasone 21-phosphate|312-93-6|Betnelan phosphate|Neodecadron|Hexadrol phosphate|Dexamethasone 21-orthophosphate|Dexamethasone-21-dihydrogen-phosphate|UNII-2BP70L44PR|2BP70L44PR|DEXAMETHASONE SODIUM PHOSPHATE|Wymesone|312-93-6 (acid)|CHEBI:68637|Oradexon phosphate|(11beta,16alpha)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl dihydrogen phosphate|Dexamethasone-21-phosphate|(11alpha,16alpha)-9-Fluoro-11,17-Dihydroxy-16-Methyl-3,20-Dioxopregna-1,4-Dien-21-Yl D",472.400,C22H30FO8P,141.000,973.000,0.100,32,4,9,4,"InChI=1S/C22H30FO8P/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30)/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)(O)O)O)C)O)F)C,VQODGRNSFPNSQE-CXSFZGCWSA-N,"[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,10,NULL,20050808,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Ambinter|AN PharmaTech|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|AvaChem Scientific|BePharm Ltd.|BindingDB|Bi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10006,Hydantoin,"HYDANTOIN|imidazolidine-2,4-dione|461-72-3|2,4-Imidazolidinedione|Glycolylurea|Imidazole-2,4(3H,5H)-dione|MFCD00005259|2,4(3H,5H)-Imidazoledione|HYDANTOINE|2-Imidazolin-4(or 5)-one, 2-hydroxy-|UNII-I6208298TA|CHEBI:27612|2,4-Imidazolidinedione, homopolymer|Hydantoin, 99%|I6208298TA|Hydantoins|25280-53-9|CCRIS 6532|NSC 9226|EINECS 207-313-3|4H-Imidazole-2,5-diol|EPA Pesticide Chemical Code 128826|BRN 0110598|Hydantoin, 98%|2,4-imidazolinedione|2,5H)-Imidazoledione|imidazolidine-2,4dione|Imidazole-2,5H)-dione",100.080,C3H4N2O2,58.200,120.000,-1.700,7,2,2,0,"InChI=1S/C3H4N2O2/c6-2-1-4-3(7)5-2/h1H2,(H2,4,5,6,7)",C1C(=O)NC(=O)N1,WJRBRSLFGCUECM-UHFFFAOYSA-N,"imidazolidine-2,4-dione",Hydantoins,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,1|3|5|7|9|11|13|15|19|21|23|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|93|99|101|103|105|107|109|111|113|117|119|121|123|125|127|129|131|133|143|145|155|157|161|165|167|175|248|1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1979|1984|1986|1987|1996|2006|2012|2013|20,20040916,"001Chemical|3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|Acros Organics|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11192,Zinc acetate,"ZINC ACETATE|Zinc diacetate|557-34-6|Zinc(II) acetate|Acetic acid, zinc salt|Dicarbomethoxyzinc|Zinc acetate anhydrous|Acetic acid, zinc(II) salt|Zinc di(acetate)|Zn(OAc)2|UNII-H2ZEY72PME|Acetic acid, zinc salt (2:1)|H2ZEY72PME|CHEBI:62984|MFCD00012454|Zinc acetate, 99%, pure|Siltex CL 4|CCRIS 3471|NSC-75801|HSDB 1043|EINECS 209-170-2|NSC 75801|zinc;diacetate|AI3-04465|zinc (II) acetate|zinc acetate carrageenan|ACMC-20aj8v|Zn(II)Ac2|ZA/CG|SCHEMBL51|ZINC ACETATE BASIC|C4H6O4Zn|Zinc Acetate 35% 40M|(CH3CO2)2Z",183.500,C4H6O4Zn,80.300,25.500,NULL,9,0,4,0,"InChI=1S/2C2H4O2.Zn/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2",CC(=O)[O-].CC(=O)[O-].[Zn+2],DJWUNCQRNNEAKC-UHFFFAOYSA-L,zinc;diacetate,Zinc Acetate,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1576|588211|588212|588213|651631|651632|651633|651634|720516|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743,20050801,"3WAY PHARM INC|Aaron Chemicals LLC|AbaChemScene|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Acros Organics|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|AN PharmaTech|Angene Chemical|BioCyc|BOC Sciences|ChEBI|Chembase.cn|ChEMBL|Chemenu Inc.|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|ChemMol|ChemSpider|ChemTik|Clearsynth|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|EPA Substance Regist",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
13399,1H-Indazol-3-amine,"1H-Indazol-3-amine|874-05-5|3-Amino-1H-indazole|1H-indazol-3-ylamine|3-AMINOINDAZOLE|3-Indazolamine|2H-Indazol-3-amine|1H-Indazole, 3-amino-|aminoindazole|Amino-indazole|NSC44677|MFCD00182045|1H-indazole-3-ylamine|54107-84-5|CHEMBL1331627|NSC-44677|3-Amino-1H-indazole, 95%|INDAZOL-3-AMINE|indazole amine|3nus|JNZ|3-amino benzpyrazole|NSC 44677|PubChem11848|NCIStruc1_001630|NCIStruc2_000161|Oprea1_470192|SCHEMBL18878|MLS001001985|SCHEMBL5299723|DTXSID5061243|SCHEMBL14041182|1H-Indazol-3-amine, AldrichCPR|CHEB",133.150,C7H7N3,54.700,126.000,1.200,10,2,2,0,"InChI=1S/C7H7N3/c8-7-5-3-1-2-4-6(5)9-10-7/h1-4H,(H3,8,9,10)",C1=CC=C2C(=C1)C(=NN2)N,YDTDKKULPWTHRV-UHFFFAOYSA-N,1H-indazol-3-amine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,10,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|200|214|248|256|258|278|280|286|298|330|348|357|376|410|411|444|445|446|447|448|450|451|485|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|630|631|662|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|875|878|880|881|883|884|885|886|887|889|891|892|893|8,20050326,"001Chemical|3A SpeedChemical Inc|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
14343,5-Methyl-3-phenylisoxazole-4-carboxylic acid,"5-Methyl-3-phenylisoxazole-4-carboxylic acid|1136-45-4|5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid|4-Isoxazolecarboxylic acid, 5-methyl-3-phenyl-|5-Methyl-3-phenyl-4-isoxazolecarboxylic acid|3-Phenyl-5-methylisoxazol-4-carbonsaeure|3-Phenyl-5-methylisoxazole-4-carboxylic acid|5-methyl-3-phenylisoxazole-4-carboxylicacid|ISOXAZOLE-4-CARBOXYLIC ACID, 5-METHYL-3-PHENYL-|5-Methyl-3-phenyl-isoxazole-4-carboxylic acid|UNII-ZL8HD4RP5B|ZL8HD4RP5B|MFCD00003153|Pmic acid|EINECS 214-497-9|NSC 76870|BRN 0164939|MOK|",203.190,C11H9NO3,63.300,238.000,2.000,15,1,4,2,"InChI=1S/C11H9NO3/c1-7-9(11(13)14)10(12-15-7)8-5-3-2-4-6-8/h2-6H,1H3,(H,13,14)",CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)O,PENHKTNQUJMHIR-UHFFFAOYSA-N,"5-methyl-3-phenyl-1,2-oxazole-4-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing,9,256|608|1033|1549|1552|1637|1648|1949|485350|485395|492967|493033|504770|540299|588519|588778|720641|720717|1159537|1224905|1259354|1259370|1259389,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Aronis|ASINEX|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BeP",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
24424,Zinc sulfate,"Zinc sulfate|Zinc sulphate|7733-02-0|Zinc sulfate anhydrous|Zincate|Zinc sulfate (1:1)|ZnSO4|zinc(II) sulfate|Sulfuric acid, zinc salt (1:1)|UNII-0J6Z13X3WO|0J6Z13X3WO|CHEBI:35176|Complexonat|Medizinc|Optised|Orazinc|Solvezinc|Zinklet|Neozin|Visine-ac|Zinci Sulfas|Prefrin-Z|Zincum Sulfuricum|Zink-Gro|Zinc vitriol (VAN)|Caswell No. 927|White vitriol (VAN)|Zincsulphate|Salvazinc|zinc;sulfate|NU-Z|Sulfuric acid, zinc salt|Zinc-200|Sulfate de zinc [French]|CCRIS 3664|Sulfuric acid zinc salt (VAN)|HSDB 1063|EINE",161.400,O4SZn,88.600,62.200,NULL,6,0,4,0,"InChI=1S/H2O4S.Zn/c1-5(2,3)4;/h(H2,1,2,3,4);/q;+2/p-2",[O-]S(=O)(=O)[O-].[Zn+2],NWONKYPBYAMBJT-UHFFFAOYSA-L,zinc;sulfate,Zinc Sulfate,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,15,678861|679852|680843|1259407|1259408,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|Aromalake Chemical|Aurora Fine Chemicals LLC|BioCyc|Biosynth Carbosynth|BLD Pharm|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chembase.cn|ChEMBL|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|ChemMol|ChemSpider|ChemTik|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGat",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
25032,2H-Chromene-3-carboxamide,2H-chromene-3-carboxamide|10185-00-9|Compound 69/20|Compound 69-20|2H-1-BENZOPYRAN-3-CARBOXAMIDE|delta(sup 3)-Chromene-3-carboxamide|BRN 1369323|chromene-3-carboxamide|5-18-06-00445 (Beilstein Handbook Reference)|SCHEMBL545827|delta(3)-chromene-3-carboxamide|DTXSID80144274|ZINC2023861|2H-Chromene-3-carboxylic acid amide|MFCD01662338|AKOS006243272|MCULE-2921215222|AB00996836-01|WRJ,175.180,C10H9NO2,52.300,247.000,0.800,13,1,2,1,"InChI=1S/C10H9NO2/c11-10(12)8-5-7-3-1-2-4-9(7)13-6-8/h1-5H,6H2,(H2,11,12)",C1C(=CC2=CC=CC=C2O1)C(=O)N,UVEVMKODWDQIAN-UHFFFAOYSA-N,2H-chromene-3-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Toxicity,6,NULL,20050808,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemo Scientific Limited|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Angel Pharmatech Ltd.|Angene Chemical|Aurora Fine Chemicals LLC|BePharm Ltd.|BLD Pharm|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|eNovation Chemicals|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Lan Pharmatech|LeadScope|Mcule|MolPort|MuseChem|NCBI Structure|NextBio|OXCHEM",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
27965,5-Methoxygramine,"5-Methoxygramine|16620-52-3|Methoxygramine|1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine|1H-Indole-3-methanamine, 5-methoxy-N,N-dimethyl-|3-Dimethylaminomethyl-5-methoxyindole|UNII-J6ZN008RY8|J6ZN008RY8|INDOLE, 3-((DIMETHYLAMINO)METHYL)-5-METHOXY-|N-[(5-Methoxy-1H-indol-3-yl)methyl]-N,N-dimethylamine|Indole, 3-[(dimethylamino)methyl]-5-methoxy-|1-(5-Methoxy-1h-Indol-3-Yl)-N,N-Dimethyl-Methanamine|3-((Dimethylamino)methyl)-5-methoxyindole|3-[(Dimethylamino)methyl]-5-methoxyindole|5-Methoxy-3-((dimethyl",204.270,C12H16N2O,28.300,208.000,1.900,15,1,2,3,"InChI=1S/C12H16N2O/c1-14(2)8-9-7-13-12-5-4-10(15-3)6-11(9)12/h4-7,13H,8H2,1-3H3",CN(C)CC1=CNC2=C1C=C(C=C2)OC,GOERTRUXQHDLHC-UHFFFAOYSA-N,"1-(5-methoxy-1H-indol-3-yl)-N,N-dimethylmethanamine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity,8,155|157|161|165|167|175|256|608|1033|1549|1552|1637|1648|485350|485395|492967|493033|504770|540299|588519|651828|720641|720717|1159607|1224905|1259310|1259374|1259422|1279733|1347074,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Achemo Scientific Limited|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Amadis Chemical|Angene Chemical|Apexmol|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|Biosynth Carbosynth|BOC Sciences|Burnham Center for Chemical Genomics|CAPOT|Center for Chemical Genomics, University of Michigan|ChangChem|Chem-Space.com Database|ChemBank|Chembase.cn|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
31348,Citrate,"126-44-3|Citrate|Citrate ion|2-hydroxypropane-1,2,3-tricarboxylate|2qpq|citrate(3-) anion|CITRATE ANION|UNII-664CCH53PI|664CCH53PI|citr|2-Hydroxy-1,2,3-propanetricarboxylate(3-)|ANIONSTANDARD-CITRATE|3itc|3kgq|citrate(3-)|2yg2|3ry8|4eu3|cit(3-)|1,2,3-Propanetricarboxylic acid, 2-hydroxy-, ion(3-)|BDBM92494|CHEBI:16947|DTXSID30155037|3r69|STL264199|AKOS022140114|2-oxidanylpropane-1,2,3-tricarboxylate|NCGC00164253-02|NCGC00164253-04|2572-63-6|FT-0622333|2541-EP2269977A2|2541-EP2269978A2|2541-EP2269985A2|2541-",189.100,C6H5O7-3,141.000,211.000,0.200,13,1,7,2,"InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3",C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O,KRKNYBCHXYNGOX-UHFFFAOYSA-K,"2-hydroxypropane-1,2,3-tricarboxylate",Citric Acid,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,977608|977610|977611|1159580|1224863|1479145|1479147|1479149|1479150,20050808,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|ABI Chem|Achemtek|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Aurora Fine Chemicals LLC|BindingDB|BioCyc|BOC Sciences|ChEBI|ChemDB|chemical genetic matrix|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Finetech Industry Limited|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|MassBank ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
33613,Amoxicillin,amoxicillin|Amoxycillin|26787-78-0|Amoxicillin anhydrous|Amoxicilline|p-Hydroxyampicillin|Amopenixin|Amolin|Moxal|D-Amoxicillin|Clamoxyl|Amoxil|Amoxicillinum|Amoxicilina|Imacillin|Hiconcil|Moxatag|Robamox|Amoxicilina [INN-Spanish]|Amoxicillin trihydrate|Amoxicilline [INN-French]|Amoxicillinum [INN-Latin]|alpha-Amino-p-hydroxybenzylpenicillin|Histocillin|Amoclen|Flemoxin|Unicillin|AMPC|Amoxycillin Trihydrate|BRL-2333|AMOXICILLIN CRYSTALLINE|6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid|Amoxicilli,365.400,C16H19N3O5S,158.000,590.000,-2.000,25,4,7,4,"InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C,LSQZJLSUYDQPKJ-NJBDSQKTSA-N,"(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",Amoxicillin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,377|485|568|583|598|602|606|618|620|629|630|631|633|639|648|687|701|719|731|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1332|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|Ambinter|AmicBase - Antimicrobial Activities|AN PharmaTech|Aur",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
33741,Tramadol,"Tramadol|(+)-Tramadol|27203-92-5|cis-Tramadol|Tramadolum [INN-Latin]|123154-38-1|(R,R) tramadol|UNII-0NG5TTM63P|0NG5TTM63P|CHEBI:75725|Ralivia flashtab|(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol|Ralivia ER|Ryzolt|NCGC00159343-02|Tramadon|Zytram|(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol|Racemic tramadol|DSSTox_CID_3691|DSSTox_RID_77150|DSSTox_GSID_23691|Tramadolum|Biomadol|Contramid|Labesfal|Tradolan|Tramadis|Tramadol [INN:BAN]|Tramaliv|Trapidol|CHEMBL201531|Tra",263.370,C16H25NO2,32.700,282.000,2.600,19,1,3,4,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3/t14-,16+/m1/s1",CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,TVYLLZQTGLZFBW-ZBFHGGJFSA-N,"(1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol",Tramadol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,485|781|782|798|800|873|880|881|894|940|1021|1022|1030|1046|1085|1195|1230|1236|1242|1274|1304|1321|1359|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1460|1461|1463|1465|1466|1467|1468|1469|1471|1476|1477|1478|1479|1481|1486|1487|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1662|1663|1665|1672|1688|1700|1706|1721|1722|1766|1768|1775|1778|1779|1789|1800|1813|1814|18,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|AN PharmaTech|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BIDD|BindingDB|Biosynth Carbosynth|Boerchem|C. David Weaver Laboratory, Vanderbilt ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
34756,S-Adenosyl-L-methionine,"S-adenosyl-L-methionine|S-adenosylmethionine|Ademetionine|AdoMet|SAMe|Donamet|S-adenosyl methionine|(R)-S-adenosyl-L-methionine|(S)-S-adenosyl-L-methionine|adenosylmethionine|485-80-3|CHEBI:15414|Active methionine|29908-03-0|CHEMBL224120|Methionine, S-adenosyl-|S-(5'-deoxyadenosin-5'-yl)-L-methionine|Adenosine, 5'-[[(3S)-3-amino-3-carboxypropyl]methylsulfonio]-5'-deoxy-|S-adenosyl-methionine|S-Adenosylmethionine (protonated carboxy group)|Ademetionine, (S)-|(S,S)-AdoMet|S-(5'-Adenosyl)-L-methionine|2-S-aden",399.400,C15H23N6O5S+,184.000,533.000,-3.500,27,5,10,7,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/p+1/t7-,8+,10+,11+,14+,27?/m0/s1",C[S+](CC[C@@H](C(=O)O)N)C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O,MEFKEPWMEQBLKI-AIRLBKTGSA-O,"[(3S)-3-amino-3-carboxypropyl]-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-methylsulfanium",S-Adenosylmethionine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,12,1471|1490|1688|1766|1768|2528|2546|2551|2662|492961|504327|504332|504749|504832|504834|504847|504865|588579|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|1272365|1347142|1347144|1347145|1409598,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Anward|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BerrChem|BIND|Bi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
41684,Nitazoxanide,"NITAZOXANIDE|55981-09-4|Alinia|Nitazoxamide|2-((5-nitrothiazol-2-yl)carbamoyl)phenyl acetate|Daxon|Nitazoxanidum [INN-Latin]|Nitazoxanida [INN-Spanish]|2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate|Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-|2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide|C12H9N3O5S|[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate|UNII-SOA12P041N|NSC697855|NTZ|2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide|Nitazoxanide (Alinia, Annita)|SOA12P041N|Nitazoxanida|2-(Acetyl",307.280,C12H9N3O5S,142.000,428.000,2.000,21,1,7,4,"InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)",CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],YQNQNVDNTFHQSW-UHFFFAOYSA-N,"[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1|3|5|7|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|121|123|129|131|133|137|139|141|143|145|421|426|427|433|434|435|445|485|530|540|541|542|543|544|545|546|584|585|595|596|603|605|631|654|655|656|657|658|659|660|661|662|663|664|665|666|667|731|781|782|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|950|951|952|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|97,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|ApexBio Technology|Ar",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
43672,Piperacillin,"piperacillin|61477-96-1|Pipracil|Piperacillin anhydrous|Piperacilline|PIPERACILLIN SODIUM|PIPC|Piperacillina|Piperacillin hydrate|Piperacillin (INN)|Piperacillin [INN]|CHEBI:8232|(2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|UNII-9I628532GX|Cl-227193|(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept",517.600,C23H27N5O7S,182.000,982.000,0.500,36,3,8,6,"InChI=1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/t13-,14-,15+,20-/m1/s1",CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,IVBHGBMCVLDMKU-GXNBUGAJSA-N,"(2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",Piperacillin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1195|2240|2241|2275|2313|2322|2330|33217|40322|43730|43897|43898|52956|52957|65041|66069|66130|66133|67553|67554|67555|67558|67559|67560|67561|67562|67713|67714|67715|67716|68362|68363|68364|68374|68375|68376|68377|68396|68397|68398|68399|68693|68828|68837|68838|68839|68840|68841|68842|68870|68871|68872|68873|68874|68875|68876|68877|68878|69001|69002|69003|69004|69005|69006|69007|69008|69009|69010|69011|69012|69013|69014|69015|69016|69017|69021|70152|70153|70724|70901|70946|70957|91387|91392|96416|96428|964,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|AmicBase - Antimicrobial Activities|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
44093,Captopril,"captopril|62571-86-2|Capoten|L-Captopril|Lopirin|Captopryl|Cesplon|Captolane|Tensoprel|Acepress|Captoril|Dilabar|Garranil|Hypertil|Tenosbon|Alopresin|Acepril|Lopril|Captoprilum|Acediur|Aceplus|(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Tensobon|Apopril|Captoprilum [INN-Latin]|SQ 14225|SQ-14225|D-2-Methyl-3-mercaptopropanoyl-L-proline|D-3-Mercapto-2-methylpropanoyl-L-proline|SQ 14,225|1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline|SA 333|D-3-Mercapto-2-methylpropionylproline|1-[",217.290,C9H15NO3S,58.600,244.000,0.300,14,2,4,3,"InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1",C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,FAKRSMQSSFJEIM-RQJHMYQMSA-N,(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid,Captopril,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|361|364|368|371|373|374|375|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|607|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|662|680|684|687|694|701|708|709|719|731|732|746|750|751|,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|Angene Chemical|Assembly Blocks P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
47528,Nicorandil,"NICORANDIL|65141-46-0|Ikorel|2-Nicotinamidoethyl nitrate|SG-75|Dancor|Adancor|Sigmart|Nicorandilum|2-(nicotinamido)ethyl nitrate|SG 75|N-(2-Hydroxyethyl)nicotinamide nitrate|2-(pyridine-3-carbonylamino)ethyl nitrate|N-(2-Hydroxyethyl)nicotinamide nitrate (ester)|Nicorandil (Ikorel)|UNII-260456HAM0|CHEBI:31905|N-[2-(NITROOXY)ETHYL]-3-PYRIDINECARBOXAMIDE|3-PYRIDINECARBOXAMIDE, N-[2-(NITROOXY)ETHYL]-|MFCD00186520|260456HAM0|NCGC00025357-01|3-Pyridinecarboxamide, N-(2-(nitrooxy)ethyl)-|DSSTox_CID_25692|DSSTox_R",211.170,C8H9N3O4,97.000,228.000,0.800,15,1,5,4,"InChI=1S/C8H9N3O4/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14/h1-3,6H,4-5H2,(H,10,12)",C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-],LBHIOVVIQHSOQN-UHFFFAOYSA-N,2-(pyridine-3-carbonylamino)ethyl nitrate,Nicorandil,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,410|411|445|447|448|450|451|485|526|530|584|585|595|596|597|603|605|607|631|662|731|781|782|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|923|924|926|938|950|951|952|995|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1379|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1460|1461|1463|1465|1,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|ApexBio Technology|Aronis|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
54454,Simvastatin,"simvastatin|79902-63-9|Zocor|Synvinolin|Sinvacor|Denan|Lipex|MK-733|Sivastin|Lodales|Simvastatine|Cholestat|Colemin|Simovil|Medipo|Pantok|Simvastatina|Simvastatinum|Velostatin|Zocord|Zorced|Simvastatin lactone|(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate|Simvastatin (Zocor)|Lipovas|Simcard|Simvacor|Simvoget|Rechol|Simlup|MK-0733|UNII-AGG2FN16EV|2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2",418.600,C25H38O5,72.800,706.000,4.700,30,1,5,7,"InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1",CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,RYMZZMVNJRMUDD-HGQWONQESA-N,"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate",Simvastatin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|5|7|9|11|13|17|19|21|25|27|31|33|35|39|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|99|101|103|105|109|113|115|119|121|123|125|129|131|133|135|137|139|143|145|377|410|411|445|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|883|886|891|899|912|926|938|940|1195|1332|1422|1471|1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|18,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AN PharmaTech|ApexBio Technology|Aronis|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scien",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
60823,Atorvastatin,"atorvastatin|134523-00-5|Cardyl|Lipitor|ATORVASTATIN CALCIUM|Torvast|(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid|UNII-A0JWA85V8F|110862-48-1|CI 981|Lipitor (TN)|Tozalip|Xavator|A0JWA85V8F|CHEMBL1487|(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid|CHEBI:39548|(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-di",558.600,C33H35FN2O5,112.000,822.000,5.000,41,4,6,12,"InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1",CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,XUKUURHRXDUEBC-KAYWLYCHSA-N,"(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid",Atorvastatin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,880|881|894|1030|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|241793|311524|312172|313843|313844|313910|313911|313912|313913|313914|384740|384741|384742|384743|384744|384745|384747|384748|384751|384752|384760|385183|385185|385187|385189|385190|385201|385202|385211|406854|406855|472694|485281|485290|496781|503308|504327|504332|504847|527839|527840|527841|527842|539467|558058|558059|558060|558826|558827|55,20050624,"3WAY PHARM INC|4C Pharma Scientific Inc|A1 BioChem Labs|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Alsachim|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|AOBIOUS INC|ApexBio Techno",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
65028,Oseltamivir,"oseltamivir|196618-13-0|Tamvir|Tamiflu-Free|GS-4104|(-)-oseltamivir|GS 4104|GS4104|HSDB 7433|UNII-20O93L6F9H|Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|GOP-A-Flu|ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate|Ro-640796|Ro-64-0796|CHEBI:7798|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|20O93L6F9H|(3R,4R,5S)-Ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-en",312.400,C16H28N2O4,90.600,418.000,1.100,22,2,5,8,"InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1",CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC,VSZGPKBBMSAYNT-RRFJBIMHSA-N,"ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate",Oseltamivir,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,498|2240|2241|2275|2313|2322|2330|147493|147494|236132|236505|236746|237325|283440|283441|283442|283443|283444|283445|283446|283447|283448|283455|283459|283463|283467|283471|286170|286171|286172|286173|286174|286175|286176|286177|286178|286179|286180|286181|286182|286183|286184|286185|286186|286187|286188|286189|286190|286191|286192|286193|286194|286195|286196|286197|286198|286199|286200|286201|286202|286203|294072|311524|314410|314411|350630|350631|350634|350635|384920|387575|387576|392525|392527|392528|39,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alsachim|Amadis Chemical|Amb",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
83357,1-(2-Ethoxyphenyl)piperazine,"1-(2-Ethoxyphenyl)piperazine|13339-01-0|1-(2-Ethoxy-phenyl)-piperazine|Piperazine,1-(2-ethoxyphenyl)-|CHEMBL273923|H04|EINECS 236-389-0|Oprea1_356570|4(2-eth-oxyphenyl)piperazine|2-ethoxy-1-piperazinylbenzene|SCHEMBL255189|N-(2-ethoxyphenyl)-piperazine|1-(2-ethoxyphenyl)-piperazine|N-(2-ethyoxyphenyl)-piperazine|1-(2-Ethoxyphenyl)piperazine #|DTXSID40928092|Piperazine, 1-(2-ethoxyphenyl)-|ZINC120262|ALBB-032936|EINECS 280-190-1|6073AA|ANW-66355|BBL029133|BDBM50017454|MFCD01026120|NSC 28773|STK374779|AKOS005",206.280,C12H18N2O,24.500,181.000,1.700,15,1,3,3,"InChI=1S/C12H18N2O/c1-2-15-12-6-4-3-5-11(12)14-9-7-13-8-10-14/h3-6,13H,2,7-10H2,1H3",CCOC1=CC=CC=C1N2CCNCC2,FBQIUSDQWOLCNY-UHFFFAOYSA-N,1-(2-ethoxyphenyl)piperazine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,9,3680|4226|4689|5228|37324|61372|65082|178197|194153,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Amadis Chemical|Angene Chemical|Anward|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|Biocore|Biosynth Carbosynth|BOC Sciences|ChangChem|Chem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
87736,"3,4,5-Trimethoxybenzylamine","3,4,5-Trimethoxybenzylamine|18638-99-8|(3,4,5-Trimethoxyphenyl)methanamine|1-(3,4,5-trimethoxyphenyl)methanamine|Benzenemethanamine, 3,4,5-trimethoxy-|3,4,5-(Trimethoxy)benzylamine|MFCD00017150|(3,4,5-trimethoxyphenyl)methylamine|3,4,5-Trimethoxybenzylamine, 96%|EINECS 242-468-0|NSC101336|PubChem16674|ACMC-1C5EZ|NCIOpen2_001669|SCHEMBL111191|3,4,5-trimethoxy benzylamine|3,4,5-trimethoxybenzyl amine|DTXSID10171891|ZINC389604|ALBB-023697|3,4,5-Trimethoxybenzylamine, 98%|9735AA|BBL003845|SBB028405|STK873740|AK",197.230,C10H15NO3,53.700,151.000,0.300,14,1,4,4,"InChI=1S/C10H15NO3/c1-12-8-4-7(6-11)5-9(13-2)10(8)14-3/h4-5H,6,11H2,1-3H3",COC1=CC(=CC(=C1OC)OC)CN,YUPUSBMJCFBHAP-UHFFFAOYSA-N,"(3,4,5-trimethoxyphenyl)methanamine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,248|1272365|1347385,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Amadis Chemical|Ambinter|Angene Chemical|Aromalake Chemical|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biosynth Carbosynth|BOC Sc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
92824,D-Malate,"D-malic acid|D-(+)-malic acid|636-61-3|D(+)-Malic acid|(R)-2-Hydroxysuccinic acid|(R)-malic acid|(2R)-2-hydroxybutanedioic acid|D-malate|(+)-D-malic acid|D-Hydroxybutanedioic acid|Butanedioic acid, hydroxy-, (2R)-|MFCD00004245|(r)-(+)-hydroxysuccinic acid|UNII-P750Y95K96|R-Malic acid|(R)-malate|MLS000069520|CHEBI:30796|P750Y95K96|Malic acid, D-|SMR000058580|D(+)-Malic acid, 98%|L(+)-Malic acid|Malic acid D-(+)-form|D-(+)-Apple Acid|(R)-Hydroxybutanedioic acid|Malic acid, L(+)-|EINECS 211-262-2|d-apple acid|",134.090,C4H6O5,94.800,129.000,-1.300,9,3,5,3,"InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/t2-/m1/s1",C([C@H](C(=O)O)O)C(=O)O,BJEPYKJPYRNKOW-UWTATZPHSA-N,(2R)-2-hydroxybutanedioic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity,10,485|568|583|598|602|606|618|620|629|630|631|633|639|648|687|701|719|731|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|142,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Aceschem Inc|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Bangyong Technology  Co., Lt",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
101543,3'-Uridylic acid,"3'-Uridylic acid|3'-UMP|Uridine 3'-phosphate|3'-URIDINEMONOPHOSPHATE|Uridine 3'-monophosphate|UNII-ZI74VYB8VZ|ZI74VYB8VZ|CHEMBL460741|CHEBI:28895|35170-03-7|[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate|U3P|Uracylsaure|4rsk|3''-uridylic acid|uridine-3'-phosphate|1o0n|3-UMPNA|Uridine 3'-phosphoric acid|SCHEMBL345577|3''-UMP|DTXSID401018973|Uridine 3'-(dihydrogen phosphate)|ZINC4095646|EINECS 201-538-0|BDBM50292722|DB02714|A23752|C01368|Q27103948",324.180,C9H13N2O9P,166.000,517.000,-3.600,21,5,9,4,"InChI=1S/C9H13N2O9P/c12-3-4-7(20-21(16,17)18)6(14)8(19-4)11-2-1-5(13)10-9(11)15/h1-2,4,6-8,12,14H,3H2,(H,10,13,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)(O)O)O,FOGRQMPFHUHIGU-XVFCMESISA-N,"[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,8,1811|345848|469230|469231|977610|977611,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|AAA Chemistry|abcr GmbH|ABI Chem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|Alfa Chemistry|Amadis Chemical|Ambinter|Aurora Fine Chemicals LLC|BindingDB|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Combi-Blocks|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Glentham Li",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
149096,Levofloxacin,"LEVOFLOXACIN|100986-85-4|Levaquin|Quixin|Iquix|Cravit|(-)-Ofloxacin|Ofloxacin S-(-)-form|Levofloxacine|(S)-Ofloxacin|Tavanic|Levofloxacino|Levofloxacinum|Oftaquix|L-Ofloxacin|Floxacin|DR-3355|Levofloxacin hydrate|UNII-RIX4E89Y14|MP-376|RWJ-25213|Levofloxacin (Levaquin)|Levaquin (TN)|Elequine|(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid|(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzo",361.400,C18H20FN3O4,73.300,634.000,-0.400,26,1,8,2,"InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1",C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,GSDSWSVVBLHKDQ-JTQLQIEISA-N,"(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid",Levofloxacin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|880|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1466|1467|1468|1469|1477|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1662|16,20050709,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alsachim|Ambeed|Ambinter|AmicBase - Antimicrobial Activities|AN PharmaTech|Angene Chemical|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
151480,"3-(3-Oxo-3,4-dihydroquinoxalin-2-yl)propanoic acid","7712-28-9|3-(3-Oxo-3,4-dihydro-quinoxalin-2-yl)-propionic acid|3-(3-oxo-3,4-dihydroquinoxalin-2-yl)propanoic acid|3-(3-hydroxyquinoxalin-2-yl)propanoic acid|3-(3-oxo-4H-quinoxalin-2-yl)propanoic acid|3-Hydroxy-2-quinoxalinepropionic acid|MFCD00843539|3-(2-carboxyethyl)-2(1h)-quinoxalinone|3-(3-Oxo-3,4-dihydro-2-quinoxalinyl)propanoic acid|Quinoxalinol-ketoglutarate|3-(2'-Hydroxycarbonylethyl)-2-quinoxalinol|DichloroacetaldehydeHydrate|ACMC-1BH7D|ChemDiv1_003696|Cambridge id 5913107|Cambridge id 6370605|TimT",218.210,C11H10N2O3,78.800,338.000,0.100,16,2,4,3,"InChI=1S/C11H10N2O3/c14-10(15)6-5-9-11(16)13-8-4-2-1-3-7(8)12-9/h1-4H,5-6H2,(H,13,16)(H,14,15)",C1=CC=C2C(=C1)NC(=O)C(=N2)CCC(=O)O,HROJWOXFEZYMGL-UHFFFAOYSA-N,3-(3-oxo-4H-quinoxalin-2-yl)propanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,6,608|1033|1549|1552|1637|1648|2842|485395|492967|493162|504770|540299|588519|602314|720641|1159537|1224905|1259310|1259370|1259374|1259389|1259422|1347074,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Activate Scientific|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Alinda Chemical|Ambeed|Ambinter|Angene Chemical|Anward|ASINEX|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|BOC Sciences|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemBl",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
156391,Naproxen,NAPROXEN|22204-53-1|(S)-Naproxen|(+)-Naproxen|Naprosyn|Equiproxen|Naproxene|Aleve|(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid|(S)-(+)-Naproxen|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid|Laraflex|d-Naproxen|Naproxenum|Calosen|Naprosyne|Naproxeno|Nycopren|Bonyl|Naixan|Reuxen|Axer|(+)-(S)-Naproxen|Ec-Naprosyn|naproxen(+)|(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid|Acusprain|Anexopen|Arthrisil|Artrixen|Artroxen|Bipronyl|Clinosyn|Danaprox|Flexipen|Leniartil|Novonaprox|Anaprox|Apronax|Artagen|Atiflan|C,230.260,C14H14O3,46.500,277.000,3.300,17,1,3,3,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CMWTZPSULFXXJA-VIFPVBQESA-N,(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,Naproxen,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|811|833|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|914|915|923|924|925|926|927|938|940|995|999|1004|1030|1044|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1611|1612|1613|16,20050629,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTe",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
172198,Angiotensin II,ANGIOTENSIN II|4474-91-3|Angiotensin II human|Hypertensin|Human angiotensin II|Angiotensin II (human)|Giapreza|Angiotensin II (mouse)|Ang II|5-Isoleucine-angiotensin II|5-L-Isoleucineangiotensin II|Asp-Arg-Val-Tyr-Ile-His-Pro-Phe|DRVYIHPF|1-8-Angiotensin I|Ile(5)-angiotensin II|Isoleucine5-angiotensin II|UNII-M089EFU921|CHEBI:2719|ANG-(1-8)Octapeptide|isoleucine(5)-angiotensin II|CHEMBL408403|M089EFU921|1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide|Angiotensin II (USAN)|11128-99-7|L-alpha-aspartyl-L-arg,1046.200,C50H71N13O12,409.000,1980.000,-1.700,75,13,15,29,"InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,38-,40-,41-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,CZGUSIXMZVURDU-JZXHSEFVSA-N,"(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid",Angiotensin II,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|24867|37530|37687|37702|37813|37822|37823|37824|37832|37844|37983|38135|38137|38138|38147|38149|39205|39206|39337|39346|39347|39363|39646|39647|165406|165418|165420|165422|166988|166989|167278|167344|167350|167449|167536|167602|168567|169065|224183|239110|239147|239602|239612|251009|254552|254557|272974|272975|281253|281254|330796|386482|386484|386485|466197|466198|485281|485290|503309|504327|504847|588579|602332|64762,20050601,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|ApexBio Technology|Aurora Fine Chemicals LLC|BenchChem|BePharm Ltd.|BIND|BindingDB|BioCyc|BOC Sciences|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
225773,"1h-Benzimidazole-1-propanamide, 2-methyl-","40508-01-8|3-(2-methyl-1H-benzimidazol-1-yl)propanamide|1h-benzimidazole-1-propanamide, 2-methyl-|3-(2-methyl-1H-1,3-benzodiazol-1-yl)propanamide|3-(2-methylbenzimidazolyl)propanamide|3-(2-methylbenzimidazol-1-yl)propanamide|NSC15509|UVJ|DTXSID60280104|ZINC560684|ALBB-028675|MFCD01106018|NSC-15509|SBB045134|AKOS000275412|MCULE-4674227563|NE42582|LS-09908|DS-004535|BB 0219660|ST50750174|EN300-38860|3-(2-METHYLBENZOIMIDAZOL-1-YL)PROPANAMIDE|3-(2-methyl-benzimidazol-1-yl)-propionic acid amide|Z53116498",203.240,C11H13N3O,60.900,244.000,0.600,15,1,2,3,"InChI=1S/C11H13N3O/c1-8-13-9-4-2-3-5-10(9)14(8)7-6-11(12)15/h2-5H,6-7H2,1H3,(H2,12,15)",CC1=NC2=CC=CC=C2N1CCC(=O)N,HZTUIHZIQKFSIL-UHFFFAOYSA-N,3-(2-methylbenzimidazol-1-yl)propanamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,6,155|157|161|165|167|175,20050326,"A2B Chem|AA BLOCKS|AAA Chemistry|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alinda Chemical|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Chem-Space.com Database|Chembase.cn|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Combi-Blocks|Debye Scientific Co., Ltd|DiscoveryGate|DTP/NCI|EDASA Scientific|Enamine|EPA DSSTox|Key Organics/BIONET|Matrix Scientific|Mcule|MolPort|NCBI Structure|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Ba",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
344600,3-(1-Methyl-1H-indol-3-yl)propanoic acid,"7479-20-1|3-(1-methyl-1H-indol-3-yl)propanoic acid|3-(1-Methyl-1H-indol-3-yl)-propionic acid|3-(1-methylindol-3-yl)propanoic acid|1H-Indole-3-propanoic acid, 1-methyl-|MFCD01548325|NSC401600|SCHEMBL1326755|1-Methylindole-3-propionic acid|DTXSID80322590|HMS1695B16|ZINC873830|ALBB-028602|9147AE|STL472215|1-Methyl-1H-indole-3-propionic acid|AKOS000262993|MCULE-1723021666|NE19550|NSC-401600|3-(1-methyl-indole-3-yl)propanoic acid|NS-02107|3-(1-Methyl-1H-indol-3-yl)propionic acid|ST50289531|SR-01000324996|SR-0100",203.240,C12H13NO2,42.200,242.000,1.800,15,1,2,3,"InChI=1S/C12H13NO2/c1-13-8-9(6-7-12(14)15)10-4-2-3-5-11(10)13/h2-5,8H,6-7H2,1H3,(H,14,15)",CN1C=C(C2=CC=CC=C21)CCC(=O)O,VVKVBQDZJLGAFG-UHFFFAOYSA-N,3-(1-methylindol-3-yl)propanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,5,155|157|161|165|167|175|463173|485350|485395|493033|504770|540299|588519|602314|720641|720717|1224905|1259310|1259374|1259422,20050326,"3WAY PHARM INC|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alinda Chemical|Angel Pharmatech Ltd.|Angene Chemical|ASINEX|Aurum Pharmatech LLC|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChemDB|ChemDiv|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Combi-Blocks|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DS",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
348621,"(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid","25947-11-9|2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid|(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid|2-(4-oxo-3H-phthalazin-1-yl)acetic acid|1-PHTHALAZINEACETIC ACID, 3,4-DIHYDRO-4-OXO-|3,4-Dihydro-4-oxo-1-phthalazineacetic acid|2-(4-Oxidanylidene-3~{h}-Phthalazin-1-Yl)ethanoic Acid|(4-Oxo-3,4-dihydro-phthalazin-1-yl)-acetic acid|MFCD00085017|2-(4-oxo-3-hydrophthalazinyl)acetic acid|5OF|NSC408027|Maybridge1_004772|ChemDiv2_002589|1-Phthalazineaceticacid, 3,4-dihydro-4-oxo-|EC-000.1620|phthalazon-4-yl-ac",204.180,C10H8N2O3,78.800,325.000,0.700,15,2,4,2,"InChI=1S/C10H8N2O3/c13-9(14)5-8-6-3-1-2-4-7(6)10(15)12-11-8/h1-4H,5H2,(H,12,15)(H,13,14)",C1=CC=C2C(=C1)C(=NNC2=O)CC(=O)O,ZEDQLIHBPGNGEC-UHFFFAOYSA-N,2-(4-oxo-3H-phthalazin-1-yl)acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,9,155|157|161|165|167|175|248|422|485|608|631|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1029|1030|1032|1033|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1246|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1379|1381|1415|1416|1422|1423|1424|1430|1434|1439|1440|,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2Z Chemical|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Apexmol|ASINEX|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biosynth Carbosynth|BLD ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
410087,Povidone-iodine,"Povidone iodine|25655-41-8|Povidone-iodine|Betadine|Isodine|PVP iodine|PVP-Iodine|PVP-I|Isobetadyne|Bridine|Disphex|Povadyne|Ultradine|Efo-dine|Iodopoly(vinyl pyrrolidinone)|Polyvinylpyrrolidone-iodine complex|NSC26245|1-ethenylpyrrolidin-2-one;molecular iodine|2-Pyrrolidinone, 1-ethenyl-, homopolymer, compd. with iodineOTHER CA INDEX NAMES:Iodine, compd. with 1-ethenyl-2-pyrrolidinone homopolymer|Iodine-poly(vinylpyrrolidinone)|Poly(vinylpyrrolidinone) iodide|Iodinated poly(vinylpyrrolidone)|Poly(vinylpyrr",364.950,C6H9I2NO,20.300,120.000,NULL,10,0,1,1,"InChI=1S/C6H9NO.I2/c1-2-7-5-3-4-6(7)8;1-2/h2H,1,3-5H2;",C=CN1CCCC1=O.II,CPKVUHPKYQGHMW-UHFFFAOYSA-N,1-ethenylpyrrolidin-2-one;molecular iodine,Povidone-Iodine,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,155|157|161|165|167|175|179,20050326,3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AKos Consulting & Solutions|Amadis Chemical|AmicBase - Antimicrobial Activities|AN PharmaTech|Angene Chemical|Aurora Fine Chemicals LLC|BioChemPartner|Chem-Space.com Database|Chembase.cn|ChemMol|ChemSpider|Clearsynth|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics ,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
439764,beta-L-Arabinose,"beta-L-Arabinose|beta-L-Arabinopyranose|7296-56-2|UNII-194RG7YBRS|b-L-Arabinopyranose|(2S,3R,4S,5S)-oxane-2,3,4,5-tetrol|194RG7YBRS|L(+)-Arabinose|87-72-9|Pentopyranose #|(2S,3R,4S,5S)-tetrahydro-2H-pyran-2,3,4,5-tetraol|alpha-L-Arabinose|ARB|.beta.-L-Arabinopyranose|Arabinopyranose, beta-L-|MFCD00067709|1bap|(3R,4S,5S)-Tetrahydropyran-2,3,4,5-tetrol|3tb6|bmse000213|SCHEMBL4430971|CHEBI:40886|ZINC3860202|s3986|AKOS025402335|AC-8171|CCG-266201|NCGC00160355-01|C02479|Q27120409|F0F57802-D37D-4858-8FE9-F6953042",150.130,C5H10O5,90.200,117.000,-2.500,10,4,5,0,"InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3-,4+,5-/m0/s1",C1[C@@H]([C@@H]([C@H]([C@H](O1)O)O)O)O,SRBFZHDQGSBBOR-KLVWXMOXSA-N,"(2S,3R,4S,5S)-oxane-2,3,4,5-tetrol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,1811|977611|1479145|1479147|1479149|1479150,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|ChEBI|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|GlyTouCan Project|Golm Metabolome Database (GMD), ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
441336,Mometasone furoate,"mometasone furoate|83919-23-7|Nasonex|mometasone 17-furoate|Sch 32088|UNII-04201GDN4R|Asmanex|CHEMBL1161|CHEBI:47564|04201GDN4R|(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate|Danitin|Ecural|Elomet|DSSTox_CID_3333|Asmanex Twisthaler|DSSTox_RID_76981|DSSTox_GSID_23333|(11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3",521.400,C27H30Cl2O6,93.800,1020.000,3.900,35,1,6,5,"InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C,WOFMFGQZHJDGCX-ZULDAHANSA-N,"[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate",Mometasone Furoate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,377|1195|1332|1850|1863|1899|1903|1906|1947|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2099|2101|2129|2130|2174|2177|2234|2235|2240|2241|2275|2280|2300|2313|2316|2322|2330|2358|2360|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2557|2599|2606|2629|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|162459|434955|434959|434962|434973|434989|435003|435005|435022|435030|449728|449762|449763|463079|463082|463104|463141|463190|463195|463210|463212|463254|485270|485272|48527,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|AN PharmaTech|Angene Chemical|ApexBio Technology|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|BioCrick|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|Changz",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
441476,Pectin,"pectin|BETA-D-GALACTOPYRANURONIC ACID|beta-D-galacturonic acid|UNII-55NG3O9NDD|55NG3O9NDD|(2S,3R,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid|oligogalacturonide|SCHEMBL3407163|CHEBI:47954|Galactopyranuronic acid, beta-D-|ZINC4097542|MFCD00006618|DB03652|C08348|(2S,3R,4S,5R,6R)-3,4,5,6-Tetrahydroxytetrahydro-2H-pyran-2-carboxylic acid",194.140,C6H10O7,127.000,205.000,-2.300,13,5,7,1,"InChI=1S/C6H10O7/c7-1-2(8)4(5(10)11)13-6(12)3(1)9/h1-4,6-9,12H,(H,10,11)/t1-,2+,3+,4-,6+/m0/s1",[C@@H]1([C@H]([C@H](O[C@H]([C@@H]1O)O)C(=O)O)O)O,AEMOLEFTQBMNLQ-DTEWXJGMSA-N,"(2S,3R,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid",Pectins,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,NULL,20050624,"3WAY PHARM INC|abcr GmbH|ABI Chem|Achemtek|Aurora Fine Chemicals LLC|BioCyc|BLD Pharm|ChEBI|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|EPA Substance Registry Services|FDA/SPL Indexing Data|GlyTouCan Project|Google Patents|Human Metabolome Database (HMDB)|IBM|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|labseeker|MassBank of North America (MoNA)|MetabolomicsWorkbench|MolPort|NCBI Str",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
445144,(s)-Atrolactic acid,"(s)-atrolactic acid|13113-71-8|(2S)-2-hydroxy-2-phenylpropanoic acid|(S)-(+)-2-HYDROXY-2-PHENYLPROPIONIC ACID|(S)-2-hydroxy-2-phenylpropanoic acid|(S)-(+)-ATROLACTIC ACID|(S)-2-Phenyllactic acid|UNII-22Y6G519RU|(+)-atrolactic acid|ATROLACTIC ACID (2-PHENYL-LACTIC ACID)|22Y6G519RU|MFCD00067700|Atrolactic acid, (+)-|(S)-(+)-2-HYDROXY-2-PHENYLPROPIONICACID|2-Hydroxy-2-phenylpropanoic acid #|1mns|(+)-Atrolactate|(S)-(+)-alpha-Methylmandelic acid|(S)-phenyl lactic acid|Benzeneacetic acid, a-hydroxy-a-methyl-, (a",166.170,C9H10O3,57.500,173.000,1.000,12,2,3,2,"InChI=1S/C9H10O3/c1-9(12,8(10)11)7-5-3-2-4-6-7/h2-6,12H,1H3,(H,10,11)/t9-/m0/s1",C[C@](C1=CC=CC=C1)(C(=O)O)O,NWCHELUCVWSRRS-VIFPVBQESA-N,(2S)-2-hydroxy-2-phenylpropanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active,7,1811|977610,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Allbio Pharm Co., Ltd|Ambinter|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
445639,Oleic acid,oleic acid|112-80-1|cis-9-Octadecenoic acid|oleate|(Z)-Octadec-9-enoic acid|Elaidoic acid|cis-Oleic acid|Glycon wo|Wecoline OO|Pamolyn 100|Glycon RO|Metaupon|Oelsauere|Vopcolene 27|Groco 5l|Groco 2|Groco 4|Groco 6|Tego-oleic 130|Emersol 211|cis-Octadec-9-enoic acid|Industrene 105|Industrene 205|Industrene 206|Pamolyn|Z-9-Octadecenoic acid|Oleinic acid|Emersol 210|Emersol 213|L'Acide oleique|Century cd fatty acid|Emersol 6321|Extraolein 90|Oleine 7503|9-Octadecenoic acid (Z)-|9-Octadecenoic acid (9Z)-|Elaini,282.500,C18H34O2,37.300,234.000,6.500,20,1,2,15,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-",CCCCCCCC/C=C\\CCCCCCCC(=O)O,ZQPPMHVWECSIRJ-KTKRTIGZSA-N,(Z)-octadec-9-enoic acid,Oleic Acid,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,1|3|5|7|9|11|13|15|19|21|23|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|83|93|99|101|103|105|107|109|111|113|117|119|121|123|125|127|129|131|133|143|145|155|157|161|165|167|175|330|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|781|782|798|800|873|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|940|946|947|948|955|960|961|962|963|964|965|966|967|968|9,20040916,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemtek|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BIND|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|BroadPharm|Buhrlage Lab, Dana-Farber Cancer Institute and Novartis Institutes for BioMedical R",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
446157,Rosuvastatin,"Rosuvastatin|287714-41-4|ZD4522|UNII-413KH5ZJ73|CHEMBL1496|CHEBI:38545|413KH5ZJ73|ZD-4522|(3R,5S,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(ethyl(methylsulfonyl)amino)-5-pyrimidinyl)-3,5-dihydroxy-6-heptenoic acid|(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid|(E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-[meth",481.500,C22H28FN3O6S,149.000,767.000,1.600,33,3,10,10,"InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1",CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,BPRHUIZQVSMCRT-VEUZHWNKSA-N,"(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Rosuvastatin Calcium,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,940|1422|238540|238872|241168|241793|300167|300168|300169|300170|300172|308508|308509|308510|308511|308512|309282|309283|309284|309285|309287|312172|312173|312174|312175|312176|312177|312178|312180|313843|313844|313910|313911|313912|313913|313914|313915|313916|313918|339211|339212|339213|339214|339215|339216|384740|384741|384742|384743|384744|384745|384747|384748|384751|384752|384760|385189|385190|385201|385202|385211|425652|425653|444050|444051|444052|444053|444054|444055|444056|444057|444058|485350|493033,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Ansion Pharma|ApexBio Technology|Apexmol|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
447048,"[(2r,3s,4r,5r)-5-(6-Aminopurin-9-Yl)-3,4-Dihydroxy-Oxolan-2-Yl]methyl [hydroxy-[[(2r,3s,4r,5s)-3,4,5-Trihydroxyoxolan-2-Yl]methoxy]phosphoryl] Hydrogen Phosphate","Adenosine-5-Diphosphoribose|Adenosine 5'-diphosphoribose|2bfq|[(2r,3s,4r,5r)-5-(6-Aminopurin-9-Yl)-3,4-Dihydroxy-Oxolan-2-Yl]methyl [hydroxy-[[(2r,3s,4r,5s)-3,4,5-Trihydroxyoxolan-2-Yl]methoxy]phosphoryl] Hydrogen Phosphate|AR6|SCHEMBL21067521|ZINC14880207|DB02059|Q27093142|[(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL|[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl [(2R,3S,4R,5S)-3,4,5-trihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (no",559.320,C15H23N5O14P2,292.000,877.000,-6.100,36,8,18,9,"InChI=1S/C15H23N5O14P2/c16-12-7-13(18-3-17-12)20(4-19-7)14-10(23)8(21)5(32-14)1-30-35(26,27)34-36(28,29)31-2-6-9(22)11(24)15(25)33-6/h3-6,8-11,14-15,21-25H,1-2H2,(H,26,27)(H,28,29)(H2,16,17,18)/t5-,6-,8-,9-,10-,11-,14-,15+/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@H](O4)O)O)O)O)O)N,SRNWOUGRCWSEMX-ZQSHOCFMSA-N,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,1811|977611,20050624,"ABI Chem|ChEBI|Chembase.cn|ChemSpider|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|MassBank of North America (MoNA)|MuseChem|NCBI Structure|NextBio|NORMAN Suspect List Exchange|Protein Data Bank in Europe (PDBe)|Shanghai Institute of Organic Chemistry|SMID|SureChEMBL|Therapeutic Target Database (TTD)|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
460612,Melphalan,melphalan|148-82-3|Alkeran|Melfalan|L-PAM|Phenylalanine mustard|L-Sarcolysine|L-Sarcolysin|p-L-Sarcolysin|Melphalanum|Melfalano|4-[Bis(2-chloroethyl)amino]-L-phenylalanine|Phenylalanine nitrogen mustard|L-Phenylalanine mustard|Levofalan|p-Di-(2-chloroethyl)amino-L-phenylalanine|Levopholan|Levofolan|p-Bis(beta-chloroethyl)aminophenylalanine|3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine|L-Sarkolysin|p-N-Bis(2-chloroethyl)amino-L-phenylalanine|4-(Bis(2-chloroethyl)amino)-L-phenylalanine|CB 3025|3-p-(Di(2-chl,305.200,C13H18Cl2N2O2,66.600,265.000,-0.500,19,2,4,8,"InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1",C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid,Melphalan,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,377|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|940|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1189|1190|1194|1195|1199|1205|1208|1422|1452|1457|1458|1469|1471|1476|1477|1478|1479|1490|1580|1581|1582|1583|1584|1585|1586|1587|1,20050801,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Achemtek|Acros Organics|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|AN PharmaTech|ApexBio Technology|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurum Pharmatech LLC|AvaChem Scientific|BIDD|BindingDB|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|Burnham C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
470909,N-Benzylpyrazine-2-carboxamide,N-benzylpyrazine-2-carboxamide|N-Benzylpyrazin-2-ylcarboxamide|Pyrazine-2-carboxylic acid benzylamide|N-benzyl-2-pyrazinecarboxamide|SCHEMBL3462236|ZINC311783|STK431915|AKOS000665658|MCULE-9949660137|347368-07-4|ST50910579|W7S,213.230,C12H11N3O,54.900,226.000,0.900,16,1,3,3,"InChI=1S/C12H11N3O/c16-12(11-9-13-6-7-14-11)15-8-10-4-2-1-3-5-10/h1-7,9H,8H2,(H,15,16)",C1=CC=C(C=C1)CNC(=O)C2=NC=CN=C2,LCEYIUAAVRLLIN-UHFFFAOYSA-N,N-benzylpyrazine-2-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Literature|Patents,4,1949,20050708,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBridge|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|Collaborative Drug Discovery, Inc.|DiscoveryGate|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBio|NIAID ChemDB|Protein Data Bank in Europe (PDBe)|Southern Research Institute|Springer Nature|SureChEMBL|Thomson Pharma|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
541661,5-Nitrothiazole,"5-nitrothiazole|5-Nitro-1,3-thiazole|14527-46-9|Thiazole, 5-nitro-|MFCD08436042|5-Nitro-thiazole|Thiazole,5-nitro-|ACMC-209cuk|Nandrolonephenylpropionate|5-Nitro-1,3-thiazole #|SCHEMBL375485|CHEMBL4065457|DTXSID70337299|ANW-20922|ZINC12471766|AKOS005146119|WT82726|AS-45763|BL006203|DB-063598|FT-0645821|V3357|B-3635",130.130,C3H2N2O2S,87.000,102.000,1.100,8,0,4,0,InChI=1S/C3H2N2O2S/c6-5(7)3-1-4-2-8-3/h1-2H,C1=C(SC=N1)[N+](=O)[O-],VVVCJCRUFSIVHI-UHFFFAOYSA-N,"5-nitro-1,3-thiazole",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active,7,1486932|1486933|1486934|1486935|1486937|1486938,20050327,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Anward|AstaTech, Inc.|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Clearsynth|Combi-Blocks|Debye Scientific Co., Ltd|DiscoveryGa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
545012,"N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)methanesulfonamide","N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)methanesulfonamide|SMR000062618|Oprea1_230510|Oprea1_826153|MLS000035972|CHEMBL1525092|HMS2324A22|ZINC340466|STL570650|AKOS001046093|MCULE-8175691600|ST071986|SR-01000510861|SR-01000510861-1|Z45612755|2,3-dimethyl-4-[(methylsulfonyl)amino]-1-phenyl-3-pyrazolin-5-one|Pyrazol-3(2H)-one, 1,5-dimethyl-4-methylsulfonylamino-2-phenyl-|N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)methanesulfonamide #|296245-48-2|WSJ",281.330,C12H15N3O3S,78.100,501.000,-0.200,19,1,5,3,"InChI=1S/C12H15N3O3S/c1-9-11(13-19(3,17)18)12(16)15(14(9)2)10-7-5-4-6-8-10/h4-8,13H,1-3H3",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NS(=O)(=O)C,BDOBGHXBYQIIGP-UHFFFAOYSA-N,"N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)methanesulfonamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents|Biological Test Results: Active,4,360|361|368|373|374|411|422|425|429|430|431|432|436|445|447|448|449|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|612|618|620|626|628|629|630|631|633|639|641|645|648|662|680|684|690|696|708|709|710|719|731|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|784|793|797|798|799|800|803|804|813|817|818|827|828|834|841|861|862|868|871|873|875|,20050327,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|ChEMBL|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Enamine|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|NIST Mass Spectrometry Data Center|Protein Data Bank in Europe (PDBe)|SCRIPDB|The Scripps Research Institute Molecular Screening Center|TimTec|UW Madison, Small Molecule Screening Facility|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
576829,"1-Propanone, 2-methyl-1-(4-methylphenyl)-","2,4'-Dimethylpropiophenone|50390-51-7|1-Propanone, 2-methyl-1-(4-methylphenyl)-|2-methyl-1-(4-methylphenyl)propan-1-one|2-Methyl-1-(p-tolyl)propan-1-one|2-methyl-1-p-tolyl-propan-1-one|1-(4-methylphenyl)-2-methyl-1-propanone|EINECS 256-572-9|p-tolyl isopropyl ketone|4'-methylisobutyrophenone|SCHEMBL585256|DTXSID8074578|ZINC2165411|MFCD00032353|AKOS000346257|MCULE-4256396079|1(4-methylphenyl)-2-methyl-1-propanone|2-Methyl-1-(4-methylphenyl)propane-1-one|BB 0221158|2-Methyl-1-(4-methylphenyl)-1-propanone #|AZ",162.230,C11H14O,17.100,152.000,3.100,12,0,1,2,"InChI=1S/C11H14O/c1-8(2)11(12)10-6-4-9(3)5-7-10/h4-8H,1-3H3",CC1=CC=C(C=C1)C(=O)C(C)C,VLKIRFAISMBUCB-UHFFFAOYSA-N,2-methyl-1-(4-methylphenyl)propan-1-one,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing,8,NULL,20050327,"A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Aurora Fine Chemicals LLC|AZEPINE|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChemDB|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|EDASA Scientific|eNovation Chemicals|EPA DSSTox|EPA Substance Registry Services|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|labseeker|Mcule|MolPort|NextBio|NextMove Software|NIST Mass Spectrometry Data Center|NORMAN Suspect Lis",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
594836,1H-Indole-4-carboxamide,1H-Indole-4-carboxamide|1670-86-6|INDOLE-4-CARBOXAMIDE|indol-4-carboxamide|SCHEMBL46523|1H-Indole-4-carboxamide(9CI)|CHEMBL4538677|BDBM93018|DTXSID80344171|MFCD09834878|ZINC32199226|AKOS009458749|MCULE-2008287966|NE21570|AS-48022|EN300-69507|Z1263714085|W6D,160.170,C9H8N2O,58.900,193.000,0.700,12,2,1,1,"InChI=1S/C9H8N2O/c10-9(12)7-2-1-3-8-6(7)4-5-11-8/h1-5,11H,(H2,10,12)",C1=CC(=C2C=CNC2=C1)C(=O)N,ACRGIRLCXXEJCS-UHFFFAOYSA-N,1H-indole-4-carboxamide,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Literature|Names and Identifiers|Patents,5,NULL,20050327,"A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alichem|Aurum Pharmatech LLC|BindingDB|BLD Pharm|BOC Sciences|Chembase.cn|ChEMBL|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|DiscoveryGate|Enamine|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|Mcule|MolPort|MuseChem|NCBI Structure|NextBio|NIST Mass Spectrometry Data Center|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Smolecu",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
604519,Ipidacrine,"Ipidacrine|62732-44-9|Amiridine|2,3,5,6,7,8-Hexahydro-1H-cyclopenta[b]quinolin-9-ylamine|2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinolin-9-amine|UNII-CV71VTP0VN|CV71VTP0VN|9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline|1H-Cyclopenta(b)quinolin-9-amine, 2,3,5,6,7,8-hexahydro-|CHEMBL130880|2,3,5,6,7,8-Hexahydro-1H-cyclopenta(b)quinolin-9-amine|1H,2H,3H,5H,6H,7H,8H-CYCLOPENTA[B]QUINOLIN-9-AMINE|1H-Cyclopenta[b]quinolin-9-amine, 2,3,5,6,7,8-hexahydro-, monohydrochloride- [CAS]|9-Amino-2,3,5,6,7,8-hexahy",188.270,C12H16N2,38.900,216.000,2.100,14,1,2,0,"InChI=1S/C12H16N2/c13-12-8-4-1-2-6-10(8)14-11-7-3-5-9(11)12/h1-7H2,(H2,13,14)",C1CCC2=C(C1)C(=C3CCCC3=N2)N,YLUSMKAJIQOXPV-UHFFFAOYSA-N,"2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinolin-9-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,12,485|631|731|781|782|880|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1466|1467|1468|1469|1477|1479|1481|1486|1487|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1662|1,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemo Scientific Limited|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Ark Pharma Scientific Limited|Aronis|ASINEX|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|Biocore|BL",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
644109,Palmitoyl-CoA,"palmitoyl-CoA|palmitoyl coenzyme A|Hexadecanoyl-CoA|palmitoyl CoA|Coenzyme A, S-hexadecanoate|palmityl-CoA|S-Palmitoylcoenzyme A|1763-10-6|(S)-palmitoyl-CoA|hexadecanoyl CoA|S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] hexadecanethioate|3'-phosphoadenosine 5'-(3-{(3R)-4-[(3-{[2-(hexadecanoylsulfanyl)ethyl]amino}-3-oxopropyl)amino]-3-hydroxy-2,2-dimethy",1005.900,C37H66N7O17P3S,389.000,1620.000,1.700,65,9,22,34,"InChI=1S/C37H66N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-28(46)65-21-20-39-27(45)18-19-40-35(49)32(48)37(2,3)23-58-64(55,56)61-63(53,54)57-22-26-31(60-62(50,51)52)30(47)36(59-26)44-25-43-29-33(38)41-24-42-34(29)44/h24-26,30-32,36,47-48H,4-23H2,1-3H3,(H,39,45)(H,40,49)(H,53,54)(H,55,56)(H2,38,41,42)(H2,50,51,52)/t26-,30-,31-,32+,36-/m1/s1",CCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)O,MNBKLUUYKPBKDU-BBECNAHFSA-N,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] hexadecanethioate",Palmitoyl Coenzyme A,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20050608,"3WAY PHARM INC|A2B Chem|AA BLOCKS|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|BIND|BioCyc|Biosynth Carbosynth|BOC Sciences|CCSbase|ChEBI|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|ECI Group, LCSB, University of Luxembourg|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|iChemical Technol",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
659559,"N-(1H-1,3-Benzodiazol-2-ylmethyl)furan-2-carboxamide","N-(1H-1,3-benzodiazol-2-ylmethyl)furan-2-carboxamide|MLS000079915|N-(1H-benzimidazol-2-ylmethyl)furan-2-carboxamide|SMR000040528|N-[(1H-benzimidazol-2-yl)methyl]furan-2-carboxamide|N-(benzimidazol-2-ylmethyl)-2-furylcarboxamide|W0D|cid_659559|CHEMBL1904688|BDBM41207|HMS2176I10|ZINC508336|SBB044393|STK738508|AKOS000272282|MCULE-6316986445|NE46219|N-(1H-benzimidazol-2-ylmethyl)-2-furamide|ST4118162|BB 0241995|EN300-42305|N-(1H-benzimidazol-2-ylmethyl)-2-furancarboxamide|Furan-2-carboxylic acid  (1H-benzoimida",241.240,C13H11N3O2,70.900,311.000,1.700,18,2,3,3,"InChI=1S/C13H11N3O2/c17-13(11-6-3-7-18-11)14-8-12-15-9-4-1-2-5-10(9)16-12/h1-7H,8H2,(H,14,17)(H,15,16)",C1=CC=C2C(=C1)NC(=N2)CNC(=O)C3=CC=CO3,WFEIYWNIMQWEHE-UHFFFAOYSA-N,N-(1H-benzimidazol-2-ylmethyl)furan-2-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Safety and Hazards,4,360|361|368|373|374|375|411|422|425|429|430|431|432|436|438|440|441|445|447|448|449|453|454|455|456|457|460|463|465|483|485|487|488|501|518|521|522|524|525|526|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|612|618|619|620|622|623|624|625|626|628|629|630|631|633|636|637|639|640|641|645|648|662|680|684|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|,20050629,"ABI Chem|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BindingDB|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemBlock|ChemBridge|ChemDB|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|EDASA Scientific|Enamine|ICCB-Longwood Screening Facility, Harvard Medical School|Innovapharm|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|Norris Pharm|Protein Data Bank in Europe (PDBe)|Sigma-Aldrich|TimTec|UW Madison, Small Molecule Screening Facility|Vi",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
662391,"Propanamide, 2-methyl-N-(2-methyl-2H-tetrazol-5-yl)-","2-methyl-N-(2-methyl-2H-tetrazol-5-yl)propanamide|62400-57-1|MLS000040666|K41|CHEMBL1352374|Propanamide, 2-methyl-N-(2-methyl-2H-tetrazol-5-yl)-|DTXSID20349802|HMS2424F11|ZINC526080|STL355824|AKOS003213545|MCULE-8385911726|SMR000043079|2-methyl-N-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)propanamide",169.190,C6H11N5O,72.700,171.000,0.700,12,1,4,2,"InChI=1S/C6H11N5O/c1-4(2)5(12)7-6-8-10-11(3)9-6/h4H,1-3H3,(H,7,9,12)",CC(C)C(=O)NC1=NN(N=N1)C,MJNGPLNGGSOMFS-UHFFFAOYSA-N,2-methyl-N-(2-methyltetrazol-5-yl)propanamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers,4,360|361|368|373|374|411|422|425|429|432|436|445|447|448|449|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|612|614|615|618|619|620|626|628|629|630|631|633|639|640|641|645|648|662|680|684|688|689|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|793|796|797|798|799|800|802|803|,20050629,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Chem-Space.com Database|ChEMBL|ChemDB|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|EPA DSSTox|ICCB-Longwood Screening Facility, Harvard Medical School|LabNetwork, a WuXi AppTec Company|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|UW Madison, Small Molecule Screening Facility|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
674807,1-Phenyl-3-pyridin-3-ylurea,1-phenyl-3-pyridin-3-ylurea|N-phenyl-N'-pyridin-3-ylurea|VU0010323-1|1-Phenyl-3-pyridin-3-yl-urea|K0G|Cambridge id 5250820|TimTec1_002641|Oprea1_348806|Oprea1_732744|2000-55-7|N-phenyl-N'-3-pyridyl urea|1-phenyl-3-(3-pyridyl)urea|1-(3-Pyridyl)-3-phenylurea|N-(3-pyridyl)-N'-phenylurea|cid_674807|1-phenyl-3-(3-pyridinyl)urea|CHEMBL1412642|N-phenyl-N'-(3-pyridinyl)urea|SCHEMBL10665495|BDBM65927|ZINC37406|DTXSID60350154|HMS1541I01|N-phenyl(3-pyridylamino)carboxamide|STK432107|AKOS003237448|MCULE-1256148828|3-PH,213.230,C12H11N3O,54.000,226.000,1.800,16,2,2,2,"InChI=1S/C12H11N3O/c16-12(14-10-5-2-1-3-6-10)15-11-7-4-8-13-9-11/h1-9H,(H2,14,15,16)",C1=CC=C(C=C1)NC(=O)NC2=CN=CC=C2,WBKYYDBHEGTTON-UHFFFAOYSA-N,1-phenyl-3-pyridin-3-ylurea,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,372|1949|2654|485395|492967|493162|504770|540299|588519|602314|720641|1159537|1259310|1259354|1259374|1259422,20050707,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|BindingDB|Chem-Space.com Database|ChemBank|ChEMBL|ChemBridge|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Crystallography Open Database|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|EPA DSSTox|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|MTDP|Nationa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
676583,"2,3-Dihydrobenzofuran-5-Carboxylic Acid","76429-73-7|2,3-Dihydrobenzofuran-5-Carboxylic Acid|2,3-dihydrobenzo[b]furan-5-carboxylic acid|2,3-dihydro-1-benzofuran-5-carboxylic acid|2,3-Dihydrobenzo[b]furan-5-carboxylicacid|5-Benzofurancarboxylic acid, 2,3-dihydro-|MFCD00085012|2,3-dihydrobenzo(b)furan-5-carboxylic acid|PubChem9983|CDS1_000209|PubChem14824|Maybridge1_002497|DivK1c_001249|SCHEMBL1395976|HMS548J11|ZINC39810|DTXSID10350321|dihydrobenzofuran-5-carboxylic acid|ACT01878|ANW-47795|SBB005420|STL512713|AKOS000157507|AC-3153|MCULE-3044288133|MS",164.160,C9H8O3,46.500,190.000,1.500,12,1,3,1,"InChI=1S/C9H8O3/c10-9(11)7-1-2-8-6(5-7)3-4-12-8/h1-2,5H,3-4H2,(H,10,11)",C1COC2=C1C=C(C=C2)C(=O)O,YXYOLVAXVPOIMA-UHFFFAOYSA-N,"2,3-dihydro-1-benzofuran-5-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,608|1033|1549|1552|1637|1648|492967|602314,20050707,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Assembly Blocks Pvt. Ltd.|Aurora",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
699127,N-[2-(5-Fluoro-1H-indol-3-yl)ethyl]acetamide,"N-[2-(5-fluoro-1H-indol-3-yl)ethyl]acetamide|CHEMBL284521|2806-01-1|HWH|N-[2-(5-Fluoro-1H-indol-3-yl)-ethyl]-acetamide|SCHEMBL4512654|ZINC77351|DTXSID30351390|BDBM50471827|STK087268|AKOS000623433|MCULE-9702651152|acetamide,n-[2-(5-fluoro-1h-indol-3-yl)ethyl]-|SR-01000312278|N-[2-(5-fluoranyl-1h-indol-3-yl)ethyl]ethanamide|SR-01000312278-1",220.240,C12H13FN2O,44.900,259.000,0.900,16,2,2,3,"InChI=1S/C12H13FN2O/c1-8(16)14-5-4-9-7-15-12-3-2-10(13)6-11(9)12/h2-3,6-7,15H,4-5H2,1H3,(H,14,16)",CC(=O)NCCC1=CNC2=C1C=C(C=C2)F,UDLASALUJLTGJV-UHFFFAOYSA-N,N-[2-(5-fluoro-1H-indol-3-yl)ethyl]acetamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,107400|107562|107566|107876|108040|234713|1259310|1259374|1259422,20050707,ABI Chem|AKos Consulting & Solutions|Ambinter|ASINEX|Aurora Fine Chemicals LLC|BindingDB|Chem-Space.com Database|ChEMBL|ChemDB|Chemhere|ChemSpider|ChemTik|DiscoveryGate|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBio|NextMove Software|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Springer Nature|SureChEMBL|The Scripps Research Institute Molecular Screening Center|Thomson Pharma|Vitas-M Laboratory|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
705607,"3,5-Dichlorobenzenesulfonamide","3,5-Dichlorobenzenesulfonamide|19797-32-1|3,5-dichlorobenzene-1-sulfonamide|3,5-dichlorobenzenesulphonamide|Benzenesulfonamide, 3,5-dichloro-|MFCD00117161|3,5-bis(chloranyl)benzenesulfonamide|6OT|PubChem11789|Maybridge1_001366|ACMC-209f2d|SPR_4|SCHEMBL1110301|CHEMBL3988825|BDBM36000|HMS545G02|ZINC90873|DTXSID50351635|ANW-23795|SBB003318|3,5-Dichlorobenzenesulfonamide, 97%|AKOS000141922|CCG-233497|MCULE-3641117906|NE52257|PS-3144|VF10173|Q467|SY050768|DB-022027|D3502|FT-0614555|EN300-85291|79308-EP2305695A2|",226.080,C6H5Cl2NO2S,68.500,239.000,1.700,12,1,3,1,"InChI=1S/C6H5Cl2NO2S/c7-4-1-5(8)3-6(2-4)12(9,10)11/h1-3H,(H2,9,10,11)",C1=C(C=C(C=C1Cl)Cl)S(=O)(=O)N,AHNOVNYOUPQVRX-UHFFFAOYSA-N,"3,5-dichlorobenzenesulfonamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,492967|602314|1345054|1347074,20050708,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|B",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
712045,1-Cyclohexyl-3-(2-pyridin-4-ylethyl)urea,"1-cyclohexyl-3-(2-pyridin-4-ylethyl)urea|1-Cyclohexyl-3-(2-pyridin-4-yl-ethyl)-urea|TimTec1_006074|HMS1551E02|ZINC104417|STK792018|AKOS000672120|MCULE-7444025528|ST4081735|1-cyclohexyl-3-[2-(pyridin-4-yl)ethyl]urea|N-Cyclohexyl-N'-[2-(4-pyridinyl)ethyl]urea|Urea, 1-cyclohexyl-3-(2-pyridin-4-yl-ethyl)-|N-cyclohexyl[(2-(4-pyridyl)ethyl)amino]carboxamide",247.340,C14H21N3O,54.000,245.000,2.100,18,2,2,4,"InChI=1S/C14H21N3O/c18-14(17-13-4-2-1-3-5-13)16-11-8-12-6-9-15-10-7-12/h6-7,9-10,13H,1-5,8,11H2,(H2,16,17,18)",C1CCC(CC1)NC(=O)NCCC2=CC=NC=C2,XUPGANVQJLTRNJ-UHFFFAOYSA-N,1-cyclohexyl-3-(2-pyridin-4-ylethyl)urea,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,1949|485395|492967|493162|504770|540299|588519|588778|602314|720641,20050708,"ABI Chem|AKos Consulting & Solutions|Ambinter|ASINEX|Aurora Fine Chemicals LLC|BLD Pharm|Chem-Space.com Database|ChemBank|ChemBlock|ChemBridge|ChemDB|ChemDiv|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MolPort|NCBI Structure|NextBio|NIST Mass Spectrometry Data Center|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Southern Research Institute|TimTec|University of Kansas High Throughput Screening La",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
762797,4-Methyl-N-phenylpiperazine-1-carboxamide,4-methyl-N-phenylpiperazine-1-carboxamide|CHEMBL1622367|NZD|CBMicro_015078|Cambridge id 5250824|Oprea1_062217|Oprea1_543013|SCHEMBL4300084|(4-methylpiperazinyl)-N-benzamide|ZINC236021|BDBM50462540|STK325711|AKOS000384279|MCULE-3669682522|4-methyl-N-phenyl-1-piperazinecarboxamide|65766-72-5|BIM-0015340.P001|1-methyl-4-(N-phenylamino)carbonylpiperazine|ST50277628|AB00076728-01,219.280,C12H17N3O,35.600,230.000,0.900,16,1,2,1,"InChI=1S/C12H17N3O/c1-14-7-9-15(10-8-14)12(16)13-11-5-3-2-4-6-11/h2-6H,7-10H2,1H3,(H,13,16)",CN1CCN(CC1)C(=O)NC2=CC=CC=C2,SXNAOFHNRSEHNL-UHFFFAOYSA-N,4-methyl-N-phenylpiperazine-1-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Patents,4,372|425|521|583|1010|1240|1992|1159537|1259354|1272365|1396144,20050708,"ABI Chem|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|BenchChem|BindingDB|Burnham Center for Chemical Genomics|Chem-Space.com Database|ChemBank|ChEMBL|ChemBridge|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MLSMR|MolPort|MTDP|NCBI St",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
777700,(3-Fluoro-benzyl)-furan-2-ylmethyl-amine,(3-Fluoro-benzyl)-furan-2-ylmethyl-amine|510723-71-4|N-(3-Fluorobenzyl)-1-(furan-2-yl)methanamine|1-(3-fluorophenyl)-N-[(furan-2-yl)methyl]methanamine|[(3-fluorophenyl)methyl](2-furylmethyl)amine|T0V|1-(3-fluorophenyl)-N-(furan-2-ylmethyl)methanamine|ZINC268556|SBB007193|STK129023|AKOS000128872|MCULE-9396647959|ST063672|N-(3-fluorobenzyl)-N-(2-furylmethyl)amine|AP-505/42535646|BRD-K94096950-001-01-8,205.230,C12H12FNO,25.200,189.000,2.000,15,1,3,4,"InChI=1S/C12H12FNO/c13-11-4-1-3-10(7-11)8-14-9-12-5-2-6-15-12/h1-7,14H,8-9H2",C1=CC(=CC(=C1)F)CNCC2=CC=CO2,AFHNQIFVWMDQAM-UHFFFAOYSA-N,1-(3-fluorophenyl)-N-(furan-2-ylmethyl)methanamine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,1259416,20050708,"A2B Chem|AA BLOCKS|ABI Chem|Acadechem|AKos Consulting & Solutions|Ambinter|Angene Chemical|ASINEX|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Broad Institute|Chem-Space.com Database|Chembase.cn|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Innovapharm|LabNetwork, a WuXi AppTec Company|Matrix Scientific|Mcule|MolPort|MuseChem|NCBI Structure|NextBio|Oakwood Products|Pan Lab, Icahn School of Medicine at Mount Sinai|PATENTSCOPE (WIPO)|Protein Data Bank i",Chemical Vendors|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
787400,2-[(1H-Benzimidazol-2-ylamino)methyl]phenol,2-[(1H-benzimidazol-2-ylamino)methyl]phenol|364599-60-0|2-{[(1H-benzimidazol-2-yl)amino]methyl}phenol|T1J|Cambridge id 6535386|Oprea1_294755|DTXSID10354945|CHEMBRDG-BB 6535386|ZINC285476|MFCD02735994|STK003904|AKOS005374933|MCULE-9892233659|2-[(1H-Benzoimidazole-2-ylamino)methyl]phenol|W-9734|2-(((1H-Benzo[d]imidazol-2-yl)amino)methyl)phenol,239.270,C14H13N3O,60.900,274.000,2.900,18,3,3,3,"InChI=1S/C14H13N3O/c18-13-8-4-1-5-10(13)9-15-14-16-11-6-2-3-7-12(11)17-14/h1-8,18H,9H2,(H2,15,16,17)",C1=CC=C(C(=C1)CNC2=NC3=CC=CC=C3N2)O,OCDMDLRMBVJKCG-UHFFFAOYSA-N,2-[(1H-benzimidazol-2-ylamino)methyl]phenol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Names and Identifiers,3,372|1159537,20050708,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambinter|Angene Chemical|ASINEX|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BOC Sciences|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Crystallography Open Database|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|EPA DSSTox|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|MTDP|NCBI Structure|NextBio|",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
788039,"[3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetic acid","333309-21-0|[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetic acid|(3-Trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-acetic acid|2-(3-(Trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetic acid|2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetic acid|2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetic acid|BAS 02104862|MLS000716944|SCHEMBL1008435|CHEMBL1604654|HMS2629P24|ALBB-009943|ZINC4976927|BBL040717|MFCD02732814|SBB023845|STK350900|AKOS000300113|ETHYL2-(METHYLD",248.200,C10H11F3N2O2,55.100,308.000,2.100,17,1,6,2,"InChI=1S/C10H11F3N2O2/c11-10(12,13)9-6-3-1-2-4-7(6)15(14-9)5-8(16)17/h1-5H2,(H,16,17)",C1CCC2=C(C1)C(=NN2CC(=O)O)C(F)(F)F,NOFFCWXIBYKMBU-UHFFFAOYSA-N,"2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,7,485|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1229|1230|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1469|1471|1477,20050708,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Ambeed|Angene Chemical|ASINEX|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|ChemDiv|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Combi-Blocks|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastrich",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
790557,N-[3-(2-Oxopyrrolidin-1-yl)phenyl]acetamide,N-[3-(2-oxopyrrolidin-1-yl)phenyl]acetamide|N-(3-(2-oxopyrrolidin-1-yl)phenyl)acetamide|CBMicro_015317|Cambridge id 5249307|Oprea1_828628|Oprea1_874290|MLS000061195|CHEMBL1565601|HMS2455F16|ZINC290981|AKOS000668445|SDCCGMLS-0044281.P002|SMR000069263|BIM-0015269.P001|N-[3-(2-oxo-1-pyrrolidinyl)phenyl]acetamide|AB00076677-01|F2783-0416,218.250,C12H14N2O2,49.400,291.000,0.500,16,1,2,2,"InChI=1S/C12H14N2O2/c1-9(15)13-10-4-2-5-11(8-10)14-7-3-6-12(14)16/h2,4-5,8H,3,6-7H2,1H3,(H,13,15)",CC(=O)NC1=CC(=CC=C1)N2CCCC2=O,CNXMKORZVSCVGQ-UHFFFAOYSA-N,N-[3-(2-oxopyrrolidin-1-yl)phenyl]acetamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents|Biological Test Results: Micromolar,4,360|361|368|372|373|374|411|422|425|429|430|431|432|436|445|447|448|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|608|612|618|619|620|629|630|631|633|639|640|641|645|648|662|680|684|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|784|793|796|797|798|799|800|802|803|804|808|,20050708,"ABI Chem|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|Burnham Center for Chemical Genomics|Chem-Space.com Database|ChemBank|ChEMBL|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|ICCB-Longwood Screening Facility, Harvard Medical School|Life Chemicals|MLSMR|MolPort|MTDP|NextBio|Norris Pharm|Paczesny and Yang Labs, IUPUI and University of Michigan|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Sou",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
831828,1-[4-(4-Methoxyphenyl)piperazin-1-yl]ethanone,"1-[4-(4-methoxyphenyl)piperazin-1-yl]ethanone|380374-85-6|1-[4-(4-methoxyphenyl)piperazin-1-yl]ethan-1-one|1-acetyl-4-(4-methoxyphenyl)piperazine|pMeOPP, AC|Piperazine, 1-acetyl-4-(4-methoxyphenyl)-|Cambridge id 6774044|Oprea1_406396|CHEMBL201837|SCHEMBL4182066|DTXSID50356761|HMS1675J18|ZINC355741|STK415258|1-(4-methoxyphenyl)piperazine, acetyl|AKOS000593249|GS-0450|MCULE-1570009396|ST50742023|AK-968/40146992|Z27906456",234.290,C13H18N2O2,32.800,254.000,1.300,17,0,3,2,"InChI=1S/C13H18N2O2/c1-11(16)14-7-9-15(10-8-14)12-3-5-13(17-2)6-4-12/h3-6H,7-10H2,1-2H3",CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC,AVCQLYXAEKNILW-UHFFFAOYSA-N,1-[4-(4-methoxyphenyl)piperazin-1-yl]ethanone,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents,6,260488|463173|485350|485395|493033|504770|540299|588519|602314|720641|720717|1159537|1224905|1259354,20050709,"ABI Chem|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|ChEMBL|ChemBridge|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|Enamine|EPA DSSTox|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Key Organics/BIONET|King Scientific|Mcule|MolPort|MuseChem|NextBio|NIST Mass Spectrometry Data Center|Paczesny and Yang Labs, IUPUI and University of Michigan|P",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
836055,N-(4-Hydroxyphenyl)-3-phenylpropanamide,N-(4-hydroxyphenyl)-3-phenylpropanamide|N0E|CHEMBL1801544|SCHEMBL11705109|ZINC362862|AKOS008980536|MCULE-7411611447|SR-01000259050|SR-01000259050-1,241.280,C15H15NO2,49.300,253.000,2.600,18,2,2,4,"InChI=1S/C15H15NO2/c17-14-9-7-13(8-10-14)16-15(18)11-6-12-4-2-1-3-5-12/h1-5,7-10,17H,6,11H2,(H,16,18)",C1=CC=C(C=C1)CCC(=O)NC2=CC=C(C=C2)O,OHWHQNCVWRVQFT-UHFFFAOYSA-N,N-(4-hydroxyphenyl)-3-phenylpropanamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Patents,4,606063|1259310|1259374|1259422,20050709,"ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChEMBL|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBio|Pan Lab, Icahn School of Medicine at Mount Sinai|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|The Scripps Research Institute Molecular Screening Center|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
894157,N-(2-Propyl-2H-tetrazol-5-yl)furan-2-carboxamide,"N-(2-propyl-2H-tetrazol-5-yl)furan-2-carboxamide|N-(2-propyl-2H-tetrazol-5-yl)-2-furamide|MLS000062859|CHEMBL1443189|HMS2477A04|ZINC470792|STK281718|AKOS000582904|MCULE-6897280676|SMR000073788|ST065013|N-(2-propyl-2H-tetraazol-5-yl)-2-furamide|AH-487/41974655|2-furyl-N-(2-propyl(1,2,3,4-tetraazol-5-yl))carboxamide|593241-52-2|W1J",221.220,C9H11N5O2,85.800,250.000,1.500,16,1,5,4,"InChI=1S/C9H11N5O2/c1-2-5-14-12-9(11-13-14)10-8(15)7-4-3-6-16-7/h3-4,6H,2,5H2,1H3,(H,10,12,15)",CCCN1N=C(N=N1)NC(=O)C2=CC=CO2,DFAKOYAKHWMEQD-UHFFFAOYSA-N,N-(2-propyltetrazol-5-yl)furan-2-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Biological Test Results: Micromolar,3,360|361|368|373|374|411|422|425|429|430|431|432|436|445|447|448|449|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|552|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|612|618|619|620|626|628|629|630|631|633|639|640|645|648|662|680|684|685|688|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|784|793|796|797|798|799|800|802|,20050709,"ABI Chem|AKos Consulting & Solutions|Ambinter|ASINEX|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChEMBL|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|ICCB-Longwood Screening Facility, Harvard Medical School|LabNetwork, a WuXi AppTec Company|Mcule|MLSMR|MolPort|MuseChem|NCBI Structure|NextBio|Pan Lab, Icahn School of Medicine at Mount Sinai|Protein Data Bank in Europe (PDBe)|Southern Research Institute|Specs|TimTec|UW Madison, Small Molecule Screening Facility|Vitas-M La",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1086839,(2~{S})-~{N}-(4-Aminocarbonylphenyl)oxolane-2-carboxamide,(2~{S})-~{N}-(4-aminocarbonylphenyl)oxolane-2-carboxamide|LWA|ZINC804618,234.250,C12H14N2O3,81.400,298.000,0.400,17,2,3,3,"InChI=1S/C12H14N2O3/c13-11(15)8-3-5-9(6-4-8)14-12(16)10-2-1-7-17-10/h3-6,10H,1-2,7H2,(H2,13,15)(H,14,16)/t10-/m0/s1",C1C[C@H](OC1)C(=O)NC2=CC=C(C=C2)C(=O)N,FSZYBIFIACXSAG-JTQLQIEISA-N,(2S)-N-(4-carbamoylphenyl)oxolane-2-carboxamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20050710,ABI Chem|ChemSpider|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1353764,"N-[(3S)-1,1-Dioxo-2,3-dihydrothiophen-3-yl]-N-phenylacetamide",ZINC1193291,251.300,C12H13NO3S,62.800,416.000,0.700,17,0,3,2,"InChI=1S/C12H13NO3S/c1-10(14)13(11-5-3-2-4-6-11)12-7-8-17(15,16)9-12/h2-8,12H,9H2,1H3/t12-/m0/s1",CC(=O)N([C@@H]1CS(=O)(=O)C=C1)C2=CC=CC=C2,KBIYZUQDVPCCPL-LBPRGKRZSA-N,"N-[(3S)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-N-phenylacetamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20050711,ABI Chem|ChemSpider|NextBio|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2140084,"N-[(3R)-1,1-Dioxo-2,3-dihydrothiophen-3-yl]-N-(4-methylphenyl)acetamide",ZINC2697128,265.330,C13H15NO3S,62.800,441.000,1.100,18,0,3,2,"InChI=1S/C13H15NO3S/c1-10-3-5-12(6-4-10)14(11(2)15)13-7-8-18(16,17)9-13/h3-8,13H,9H2,1-2H3/t13-/m1/s1",CC1=CC=C(C=C1)N([C@H]2CS(=O)(=O)C=C2)C(=O)C,PPKLPLWDJXRWSL-CYBMUJFWSA-N,"N-[(3R)-1,1-dioxo-2,3-dihydrothiophen-3-yl]-N-(4-methylphenyl)acetamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20050714,ABI Chem|ChemSpider|NextBio|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2566008,1-[4-(5-Chlorothiophen-2-yl)sulfonylpiperazin-1-yl]ethanone,Oprea1_713469|SCHEMBL18711914|AKOS016597969|AB00037608-01,308.800,C10H13ClN2O3S2,94.300,415.000,1.300,18,0,5,2,"InChI=1S/C10H13ClN2O3S2/c1-8(14)12-4-6-13(7-5-12)18(15,16)10-3-2-9(11)17-10/h2-3H,4-7H2,1H3",CC(=O)N1CCN(CC1)S(=O)(=O)C2=CC=C(S2)Cl,LFGOPTUHDODAIB-UHFFFAOYSA-N,1-[4-(5-chlorothiophen-2-yl)sulfonylpiperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050716,ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|ChemBank|ChemDB|ChemSpider|DiscoveryGate|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2774184,"N1,N1-Dimethyl-4-[(Isopropylamino)Methyl]Aniline","137379-64-7|N,N-dimethyl-4-{[(propan-2-yl)amino]methyl}aniline|N,N-Dimethyl-4-([(propan-2-yl)amino]methyl)aniline|N1,N1-Dimethyl-4-[(Isopropylamino)Methyl]Aniline|GWV|N,N-dimethyl-4-[(propan-2-ylamino)methyl]aniline|SCHEMBL9843973|ZINC152549|MFCD00114084|AKOS000228566|MCULE-9423327662|NE23475|EN300-32161|4-((Isopropylamino)methyl)-N,N-dimethylaniline|Z86129854|4-[(Isopropylamino)methyl]-N,N-dimethylaniline, AldrichCPR",192.300,C12H20N2,15.300,146.000,2.200,14,1,2,4,"InChI=1S/C12H20N2/c1-10(2)13-9-11-5-7-12(8-6-11)14(3)4/h5-8,10,13H,9H2,1-4H3",CC(C)NCC1=CC=C(C=C1)N(C)C,NZXPKDJRJFKEIC-UHFFFAOYSA-N,"N,N-dimethyl-4-[(propan-2-ylamino)methyl]aniline",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050719,"A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemDB|ChemExper Chemical Directory|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|Enamine|Google Patents|IBM|King Scientific|Matrix Scientific|Mcule|MolPort|NCBI Structure|NextBio|Norris Pharm|Oakwood Products|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Sigma-Aldrich|SureChEMBL|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2806372,Methyl 3-(Methylsulfonylamino)benzoate,"32087-05-1|Methyl 3-(methylsulfonamido)benzoate|methyl 3-(methanesulfonamido)benzoate|Methyl 3-(Methylsulfonylamino)benzoate|methyl 3-[(methylsulfonyl)amino]benzoate|methyl 3-methanesulfonamidobenzoate|3-[(Methylsulfonyl)amino]-benzoic acid methyl ester|3-(methanesulfonamido)benzoic acid methyl ester|6SU|Maybridge3_001259|Oprea1_379856|MLS000849935|SCHEMBL4186439|Benzoic acid, 3-[(methylsulfonyl)amino]-, methyl ester|CHEMBL1384742|CHEBI:109448|HMS1434J05|HMS2808J12|ZINC143593|MFCD00121326|Methyl 3-methylsul",229.260,C9H11NO4S,80.800,320.000,1.200,15,1,5,4,"InChI=1S/C9H11NO4S/c1-14-9(11)7-4-3-5-8(6-7)10-15(2,12)13/h3-6,10H,1-2H3",COC(=O)C1=CC(=CC=C1)NS(=O)(=O)C,UQIOKJVVJMHUTP-UHFFFAOYSA-N,methyl 3-(methanesulfonamido)benzoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents|Biological Test Results: Active,7,485|781|782|798|800|873|880|940|1021|1022|1046|1085|1230|1236|1242|1274|1304|1321|1359|1377|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1467|1468|1469|1471|1477|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1533|1554|1556|1565|1566|1578|1619|1621|1625|1628|1631|1634|1654|1656|1662|1663|1665|1672|1688|1700|1706|1721|1722|1766|1775|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1865|1868|1875|1885|1899|,20050719,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Activate Scientific|AKos Consulting & Solutions|Alichem|Ambeed|BenchChem|BLD Pharm|ChEBI|Chem-Space.com Database|ChemBank|ChEMBL|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Combi-Blocks|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|Google Patents|IBM|ICCB-Longwood Screening Fa",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3000516,(+)-Threo-Mefloquine,"(+)-Threo-Mefloquine|mefloquine|RTI1173-1-1|51744-85-5|(S)-[2,8-bis(trifluoromethyl)-4-quinolyl]-[(2S)-2-piperidyl]methanol|(S,S)-MEFLOQUINE|CHEMBL411685|SCHEMBL7278974|ZINC3874185|BDBM50377463|NSC790106|NSC-790106|UNII-GB2GL4S36Z component XEEQGYMUWCZPDN-WFASDCNBSA-N|(+)-threo-4-Quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, (11S, 2'S)-|(+)-threo-4-Quinolinemethanol, alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, (11S, 2'S)-",378.310,C17H16F6N2O,45.200,483.000,3.600,26,2,9,2,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15-/m0/s1",C1CCN[C@@H](C1)[C@H](C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,XEEQGYMUWCZPDN-WFASDCNBSA-N,"(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol",Mefloquine,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,13,135327|331674|331675,20050801,"ABI Chem|Adooq BioScience|BindingDB|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|DTP/NCI|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NIAID ChemDB|PATENTSCOPE (WIPO)|SCRIPDB|Smolecule|SureChEMBL|THE BioTek|Thieme Chemistry|Thomson Pharma|ToxPlanet|Tractus|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
3034756,"(S,S)-Formoterol","(S,S)-Formoterol|formoterol|(+)-formoterol|67346-48-9|CHEBI:63081|N-[2-hydroxy-5-[(1S)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide|73573-87-2|(S,S)-N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formaldehyde|N-{2-hydroxy-5-[(1S)-1-hydroxy-2-{[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide|NCGC00025167-01|Tocris-1448|ZINC856|BIDD:GT0743|SCHEMBL595410|CHEMBL1433762|DTXSID80110070|NCGC00025167-02|NCGC00025167-03|NCGC000251",344.400,C19H24N2O4,90.800,388.000,1.800,25,4,5,8,"InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m0/s1",C[C@@H](CC1=CC=C(C=C1)OC)NC[C@H](C2=CC(=C(C=C2)O)NC=O)O,BPZSYCZIITTYBL-ORAYPTAESA-N,N-[2-hydroxy-5-[(1S)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide,Formoterol Fumarate,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,410|411|445|447|448|450|451|526|530|584|585|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|923|924|926|938|995|1030|1379|1452|1454|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1688|1766|1768|1851|1865|1948|2101|2107|2112|2147|2451|2472|2528|2546|2549|2551|2662|485290|492961|504327|504332|504749|504832|504834|504845|504847|504865|588379|588579|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|1159607|1259310|1259325|,20050808,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABBLIS Chemicals|ABI Chem|Achemtek|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambinter|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BIDD|Broad Institute|Burnham Center for Chemical Genomics|C. David Weaver Laboratory, Vanderbilt University|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
3083544,Arformoterol,"Arformoterol|formoterol|(R,R)-Formoterol|67346-49-0|(-)-Formoterol|73573-87-2|Foradil|UNII-F91H02EBWT|Atimos|Arformoterol (INN)|Arformoterol [INN]|eformoterol|N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide|Oxis|CHEMBL1363|F91H02EBWT|CHEBI:408174|N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide|Formoterolum [INN-Latin]|FORMOTEROL FUMARATE|Formoterolum|Innovair|Fluir|Racemic formoterol|(+-)-Formoterol|YM-08",344.400,C19H24N2O4,90.800,388.000,1.800,25,4,5,8,"InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1",C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O,BPZSYCZIITTYBL-YJYMSZOUSA-N,N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide,Formoterol Fumarate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1195|611147|611234|611236|611237|611239|1060997|1060999|1159387|1159389|1159390|1159391|1159394|1159396|1298705|1298708|1346212|1346250|1346260,20050808,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|AN PharmaTech|Angene Chemical|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|BioCrick|Biosynth Carbosynth|BOC Sciences|CAPOT|Center for Chemical Genomic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
3083711,Bacitracin zinc,"Albac|Bacitracins zinc complex|Ziba-RX|Caswell No. 909A|Bacitracin zinc [USP]|Bacillus subtilis|EINECS 215-787-8|EPA Pesticide Chemical Code 006309|Bacitracins, zinc complex|Bacitracin Zinc free sample|SCHEMBL543112|AKOS015896384|FT-0622546|FT-0654564",1488.100,C66H103N17O16SZn,552.000,2950.000,NULL,101,16,21,31,"InChI=1S/C66H103N17O16S.Zn/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90;/h12-14,18-19,31,33-37,39-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(",CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3C=NC=N3)CC4=CC=CC=C4.[Zn],QSNOBVJFKSQBBD-UHFFFAOYSA-N,"4-[[2-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[1-[[3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-butan-2-yl-6-(carboxymethyl)-9-(4H-imidazol-4-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid;zinc",NULL,Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,NULL,20050809,ABI Chem|AKos Consulting & Solutions|AmicBase - Antimicrobial Activities|AN PharmaTech|ChemIDplus|ChemMol|ChemSpider|DiscoveryGate|Finetech Industry Limited|iChemical Technology USA Inc|ISpharm|labseeker|NextBio|Parchem|Phion Ltd|Race Chemical|SHANDONG OCTAGON CHEMICALS LIMITED|Smolecule|SureChEMBL|Thomson Pharma|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3511405,"N-(4-Methoxy-1,3-benzothiazol-2-yl)acetamide","N-(4-methoxy-1,3-benzothiazol-2-yl)acetamide|90915-52-9|acetamide,N-(4-methoxy-2-benzothiazolyl)-|N-(4-methoxy-benzothiazol-2-yl)-acetamide|Oprea1_370439|IFLab1_000092|SCHEMBL15376502|HMS1412E04|ZINC181061|AKOS002356320|MCULE-6241735395|IDI1_008311|DB-119687|N-(4-methoxybenzo[d]thiazol-2-yl)acetamide|SR-01000108479|SR-01000108479-1|F0015-0065",222.270,C10H10N2O2S,79.500,250.000,1.900,15,1,4,2,"InChI=1S/C10H10N2O2S/c1-6(13)11-10-12-9-7(14-2)4-3-5-8(9)15-10/h3-5H,1-2H3,(H,11,12,13)",CC(=O)NC1=NC2=C(C=CC=C2S1)OC,AQDZPXNDPBKKSZ-UHFFFAOYSA-N,"N-(4-methoxy-1,3-benzothiazol-2-yl)acetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Patents,4,485395|492967|493162|504770|1259310|1259354|1259374|1259422,20050908,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BenchChem|BOC Sciences|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Debye Scientific Co., Ltd|DiscoveryGate|Google Patents|ICCB-Longwood Screening Facility, Harvard Medical School|LabNetwork, a WuXi AppTec Company|Life Chemicals|Mcule|MolPort|NextBio|NIST Mass Spectrometry Data Center|Norris Pharm|Paczesny and Yang Labs, IUPUI and",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3541112,3-Hydroxybutyrate,"3-hydroxybutyrate|3-hydroxybutanoate|beta-hydroxybutyrate|beta-hydroxybutanoate|3-OH butyrate|3-OH-butyrate|beta-hydroxy-n-butyrate|DL-3-Hydroxybutyrate|UNII-FG2UN5EP9V|FG2UN5EP9V|DTXSID9040976|CHEBI:37054|BDBM50270275|Butanoic acid, 3-hydroxy-, ION(1-)|Q27117026|151-03-1",103.100,C4H7O3-,60.400,63.800,0.100,7,1,3,1,"InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1",CC(CC(=O)[O-])O,WHBMMWSBFZVSSR-UHFFFAOYSA-M,3-hydroxybutanoate,3-Hydroxybutyric Acid,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050908,"ABI Chem|BindingDB|BioCyc|ChEBI|ChemDB|ChemIDplus|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NextMove Software|PATENTSCOPE (WIPO)|SCRIPDB|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3695997,1-[4-(3-Fluorobenzenesulfonyl)piperazin-1-yl]ethan-1-one,Oprea1_293705|SCHEMBL18711335|ZINC12899778|AKOS001417836|MCULE-7368386825|Z30722976|1-[4-(3-fluorobenzenesulfonyl)piperazin-1-yl]ethan-1-one|941087-82-7,286.320,C12H15FN2O3S,66.100,427.000,0.400,19,0,5,2,"InChI=1S/C12H15FN2O3S/c1-10(16)14-5-7-15(8-6-14)19(17,18)12-4-2-3-11(13)9-12/h2-4,9H,5-8H2,1H3",CC(=O)N1CCN(CC1)S(=O)(=O)C2=CC=CC(=C2)F,XHJTYTNVOUGFFA-UHFFFAOYSA-N,1-[4-(3-fluorophenyl)sulfonylpiperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050910,ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|ChemDB|ChemSpider|DiscoveryGate|Enamine|Mcule|MolPort|NextBio|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3803220,2-(4-Acetylpiperazin-1-yl)sulfonylbenzonitrile,Oprea1_534591|SCHEMBL18711908|ZINC7308587|AKOS000186909|MCULE-5308959335|AB00005915-01,293.340,C13H15N3O3S,89.900,509.000,0.100,20,0,5,2,"InChI=1S/C13H15N3O3S/c1-11(17)15-6-8-16(9-7-15)20(18,19)13-5-3-2-4-12(13)10-14/h2-5H,6-9H2,1H3",CC(=O)N1CCN(CC1)S(=O)(=O)C2=CC=CC=C2C#N,GOCXXCRVJCAULM-UHFFFAOYSA-N,2-(4-acetylpiperazin-1-yl)sulfonylbenzonitrile,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050911,ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|ChemDB|ChemSpider|DiscoveryGate|Mcule|MolPort|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3875700,1-Carbamoylpiperidine-4-carboxylic Acid,"1-carbamoylpiperidine-4-carboxylic Acid|467430-50-8|1-(aminocarbonyl)piperidine-4-carboxylic acid|1-Carbamoyl-piperidine-4-carboxylic acid|851168-77-9|MFCD06655891|SCHEMBL487980|DTXSID40397688|HMS1746M01|ZINC4206640|4041AE|AKOS000263985|MCULE-5026938167|NE52101|PS-3205|1-Carbamoyl-piperidine-4-carboxylicacid|DA-02335|DB-015409|BB 0220149|FT-0709321|FT-0766179|EN300-13489|J3.515.725E|1-carbamoyl-piperidine-4-carboxylic acid, AldrichCPR|W3V",172.180,C7H12N2O3,83.600,197.000,-0.800,12,2,3,1,"InChI=1S/C7H12N2O3/c8-7(12)9-3-1-5(2-4-9)6(10)11/h5H,1-4H2,(H2,8,12)(H,10,11)",C1CN(CCC1C(=O)O)C(=O)N,SIYQEPJUSPTPGW-UHFFFAOYSA-N,1-carbamoylpiperidine-4-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Names and Identifiers|Patents,4,485350|485395|493033|504770|540299|588519|720554|720641|1259397|1259398|1259423|1347385,20050912,"3WAY PHARM INC|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|CHESS fine organics|Debye Scientific Co., Ltd|DiscoveryGate|EDASA Scientific|Enamine|eNovation Chemicals|EPA DSSTox|Finetech Industry Limited|Google Patents|",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4093508,N-Methyl-4-sulfamoylbenzamide,"N-methyl-4-sulfamoylbenzamide|10518-85-1|CHEMBL67676|4-sulfamoyl-benzoic acid methylamide|N-methyl-4-sulfamoyl-benzamide|W0Y|SCHEMBL7286004|DTXSID70399236|ZINC403245|N-Methyl-4-(aminosulfonyl)benzamide|BDBM50038961|AKOS008932985|MCULE-9177931115|NE40766|Z165170770|N-(4-Sulfamoylbenzoyl)aminomethyl-polystyrene, extent of labeling: ~0.9 mmol/g S loading",214.240,C8H10N2O3S,97.600,299.000,-0.300,14,2,4,2,"InChI=1S/C8H10N2O3S/c1-10-8(11)6-2-4-7(5-3-6)14(9,12)13/h2-5H,1H3,(H,10,11)(H2,9,12,13)",CNC(=O)C1=CC=C(C=C1)S(=O)(=O)N,CTDFBRMMEMHBEO-UHFFFAOYSA-N,N-methyl-4-sulfamoylbenzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,47908|50176|243139|243144,20050913,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambinter|Aurum Pharmatech LLC|BindingDB|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|Enamine|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Sigma-Aldrich|SureChEMBL|Thomson Pharma|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5095908,N-(Piperidin-4-ylmethyl)methanesulfonamide,"N-(piperidin-4-ylmethyl)methanesulfonamide|N-[(piperidin-4-yl)methyl]methanesulfonamide|SCHEMBL122137|ALBB-007902|ZINC4298645|STK504892|4-(methylsulfonyl)aminomethylpiperidine|AKOS000155141|MCULE-4369489793|N-Piperidin-4-ylmethylmethanesulfonamide|BB 0252357|Methanesulfonamide, N-(4-piperidinylmethyl)-|Z1741966151|W1A",192.280,C7H16N2O2S,66.600,214.000,-0.400,12,2,4,3,"InChI=1S/C7H16N2O2S/c1-12(10,11)9-6-7-2-4-8-5-3-7/h7-9H,2-6H2,1H3",CS(=O)(=O)NCC1CCNCC1,LULUGSQUPICPQM-UHFFFAOYSA-N,N-(piperidin-4-ylmethyl)methanesulfonamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050918,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alinda Chemical|Ambeed|Ambinter|Angene Chemical|Ark Pharm, Inc.|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|EDASA Scientific|Enamine|eNovation Chemicals|Google Patents|IBM|Key Organics/BIONET|Matrix S",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5280804,Isoquercitrin,Isoquercitrin|Isoquercetin|482-35-9|Quercetin 3-glucoside|Hirsutrin|Quercetin 3-o-glucopyranoside|3-Glucosylquercetin|Isotrifoliin|Glucosyl 3-quercetin|Quercetol 3-glucoside|Quercetin 3-D-glucoside|Quercetin 3-O-glucoside|Quercetin 3-monoglucoside|Quercetol 3-monoglucoside|Quercetin 3-beta-glucoside|quercetin-3-glucoside|Quercetin-3-O-glucopyranoside|Quercetin 3-beta-O-glucoside|quercetin-3-O-glucoside|UNII-6HN2PC637T|3-beta-D-Glucosylquercetin|6HN2PC637T|CHEMBL250450|CHEBI:68352|MFCD00017746|NSC-407304|Hyp,464.400,C21H20O12,207.000,758.000,0.400,33,8,12,4,"InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1",C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,OVSQVDMCBVZWGM-QSOFNFLRSA-N,"2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,485|631|731|781|782|880|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1466|1467|1468|1469|1477|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1650|1654|1656|1662|1,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|AvaChem Scientific|BindingDB|BioCyc|Biopurify Phytochemicals|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|Center for Chem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5281426,Umbelliferone,"Umbelliferone|7-hydroxycoumarin|93-35-6|7-Hydroxy-2H-chromen-2-one|Hydrangin|7-hydroxycoumarine|Skimmetin|Hydrangine|Skimmetine|7-Oxycoumarin|Umbelliferon|2H-1-Benzopyran-2-one, 7-hydroxy-|7-Hydroxy-2H-1-benzopyran-2-one|7-hydroxychromen-2-one|Coumarin, 7-hydroxy-|beta-Umbelliferone|NSC 19790|7 HC|7-hydroxy-coumarin|MFCD00006878|UNII-60Z60NTL4G|NSC19790|CHEMBL51628|60Z60NTL4G|7-HC|7-hydroxy-1-benzopyran-2-one|CHEBI:27510|32922-68-2|7-oxidanylchromen-2-one|7-Hydroxycoumarin, 99%|7-hydroxycumarin|CCRIS 3591|E",162.140,C9H6O3,46.500,222.000,1.600,12,1,3,0,"InChI=1S/C9H6O3/c10-7-3-1-6-2-4-9(11)12-8(6)5-7/h1-5,10H",C1=CC(=CC2=C1C=CC(=O)O2)O,ORHBXUUXSCNDEV-UHFFFAOYSA-N,7-hydroxychromen-2-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1|3|5|9|13|15|19|21|23|25|29|31|33|35|37|39|41|43|45|47|49|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|179|256|344|608|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1033|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1476|1478|1479|1487|1490|1519|1549|1552|1637|1648|1766|1768|1865|1948|2101|2107|2112|2147|2240|2241|2275|2313|2322|2330|2451|2472|2517|2528|254,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Alsachim|Amadis Chemical|Ambeed|Am",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5281614,Fisetin,"Fisetin|528-48-3|2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one|5-Desoxyquercetin|3,3',4',7-Tetrahydroxyflavone|Cotinin|Fustel|Viset|Fisetholz|Superfustel|Fietin|Fustet|Junger fustik|3,7,3',4'-Tetrahydroxyflavone|Ventin sumach|Young fustic|Zante fustic|Superfustel K|Ungarisches gelbholz|C.I. Natural Brown 1|Young fustic crystals|Bois bleu de Honqrie|C.I. 75620|2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-1-benzopyran-4-one|2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromen-4-one|4H-1-Benzopyran-4-one, 2-(3,4-",286.240,C15H10O6,107.000,459.000,2.000,21,4,6,1,"InChI=1S/C15H10O6/c16-8-2-3-9-12(6-8)21-15(14(20)13(9)19)7-1-4-10(17)11(18)5-7/h1-6,16-18,20H",C1=CC(=C(C=C1C2=C(C(=O)C3=C(O2)C=C(C=C3)O)O)O)O,XHEFDIBZLJXQHF-UHFFFAOYSA-N,"2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromen-4-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1|3|5|7|9|11|13|15|17|19|21|23|25|27|29|31|33|35|37|39|45|47|49|51|53|55|57|59|61|63|65|67|69|71|73|75|77|79|81|99|101|103|105|107|109|113|115|119|121|123|125|129|133|137|139|141|143|145|155|157|161|165|167|175|179|248|270|382|384|395|410|411|445|447|448|450|451|505|515|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|608|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|905|906|907|910|912|916|923|924|926|927|930|938|940|995|1030|1033|1204|1379|1422|1452|1454|14,20050326,"001Chemical|3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5281672,Myricetin,"myricetin|529-44-2|Cannabiscetin|Myricetol|Myricitin|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one|3,3',4',5,5',7-Hexahydroxyflavone|3,5,7,3',4',5'-Hexahydroxyflavone|3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one|3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one|UNII-76XC01FTOJ|3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one|4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-|NSC 407290|MFCD00006827|NSC407290|CHEMBL164|NSC-407290|76XC01FTOJ|CHEBI:",318.230,C15H10O8,148.000,506.000,1.200,23,6,8,1,"InChI=1S/C15H10O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,16-20,22H",C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O,IKMDFBPHZNJCSN-UHFFFAOYSA-N,"3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1|3|5|7|9|13|15|19|23|25|29|31|33|35|37|39|41|43|45|47|49|55|59|65|67|71|73|79|81|83|85|87|89|91|93|95|97|99|101|103|105|107|109|113|115|119|121|123|125|129|131|133|137|139|141|143|145|155|157|161|165|167|175|179|192|208|212|214|220|256|264|274|292|296|298|330|357|365|366|367|377|382|383|410|411|422|429|436|444|445|446|447|448|450|451|505|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914,20050325,"001Chemical|3B Scientific (Wuhan) Corp|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Accela ChemBio Inc.|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Ark Pharm, Inc.|Ark Pharma Scientific Limited|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5282452,Pitavastatin,"Pitavastatin|Itavastatin|147511-69-1|Livalo|Pitavastatin calcium|NK 104|UNII-M5681Q5F9P|NK-104|C25H24FNO4|CHEBI:32020|M5681Q5F9P|Zypitamag|(3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid|(3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid|Pitavastatin [INN]|Pitavastatin calcium (JAN)|(3R,5S,6E)-7-(2-Cyclopropyl-4-(p-fluorophenyl)-3-quinolyl)-3,5-dihydroxy-6-heptenoic acid|pitavastatia|pitavastatine|pitavastatinum|Itavastin|(",421.500,C25H24FNO4,90.600,631.000,3.500,31,3,6,8,"InChI=1S/C25H24FNO4/c26-17-9-7-15(8-10-17)24-20-3-1-2-4-22(20)27-25(16-5-6-16)21(24)12-11-18(28)13-19(29)14-23(30)31/h1-4,7-12,16,18-19,28-29H,5-6,13-14H2,(H,30,31)/b12-11+/t18-,19-/m1/s1",C1CC1C2=NC3=CC=CC=C3C(=C2/C=C/[C@H](C[C@H](CC(=O)O)O)O)C4=CC=C(C=C4)F,VGYFMXBACGZSIL-MCBHFWOFSA-N,"(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,588211|588212|588213|678974|679168|699539|699540|699541|1079931|1079932|1079933|1079934|1079935|1079936|1079937|1079938|1079939|1079940|1079941|1079942|1079943|1079944|1079945|1079946|1079947|1079948|1079949|1159387|1159389|1159390|1159391|1159394|1159395|1159396|1210299|1210301|1210302|1218862|1218866|1220811|1220813|1259318|1259416|1259421|1283247|1283271|1283275|1311581|1311584|1318771|1346838|1409605|1474166|1474167|1508614,20051011,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Apexmol|Aurora Fine Chemicals LLC|AvaChem Scientific|BerrChem|Bin",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5311101,Fluticasone,"fluticasone|90566-53-3|Fluticasonum|Fluticasona|Fluticaps (TN)|Fluticasone (INN)|UNII-CUT2W21N7U|CUT2W21N7U|CHEBI:5134|S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate|Fluticasone, Inhaled|Fluticasonum [Latin]|Fluticasona [Spanish]|Fluticasone [INN:BAN]|HSDB 7740|Fluticasone, topical|SCHEMBL4069|BIDD:GT0819|AND006|GTPL6699|CHEMBL1201396|DTXSID0044022|(6S,8S,9R,10S,11S,13S,14S,16R,",444.500,C22H27F3O4S,99.900,861.000,3.200,30,2,8,3,"InChI=1S/C22H27F3O4S/c1-11-6-13-14-8-16(24)15-7-12(26)4-5-19(15,2)21(14,25)17(27)9-20(13,3)22(11,29)18(28)30-10-23/h4-5,7,11,13-14,16-17,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1",C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)O)C)O)F)C)F,MGNNYOODZCAHBA-GQKYHHCASA-N,"S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate",Fluticasone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,14,311524|588214|588215|588216|588217|588218|588219|589039|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|639693|639736|1346849|1363681|1363682,20051216,"A2B Chem|AA BLOCKS|ABI Chem|Achemtek|Acorn PharmaTech Product List|AK Scientific, Inc. (AKSCI)|BIDD|Boerchem|ChEBI|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Excenen Pharmatech|FDA/SPL Indexing Data|Fragmenta|Google Patents|Hangzhou APIChem Technology|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|Metabolo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6713928,Metampicillin,"metampicillin|6489-97-0|METHAMPICILLIN|UNII-G0H6U7VSTK|Magnipen|CHEBI:52060|G0H6U7VSTK|METAMPICILLIN SODIUM|6beta-[(2R)-2-(methylideneamino)-2-phenylacetamido]penicillanic acid|(2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-(methylideneamino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|metampilene|Metampicillinum|Celinmicina|Elatocilline|Metampicilina|Metampicillina|Metampicilline|Pangocilin|Relyothenate|Blomopen|Bonopen|Filorex|Metambac|Micinovo|Probiotic|Ruticina|Rutizina|Sedomycin",361.400,C17H19N3O4S,124.000,603.000,3.000,25,2,6,5,"InChI=1S/C17H19N3O4S/c1-17(2)12(16(23)24)20-14(22)11(15(20)25-17)19-13(21)10(18-3)9-7-5-4-6-8-9/h4-8,10-12,15H,3H2,1-2H3,(H,19,21)(H,23,24)/t10-,11-,12+,15-/m1/s1",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N=C)C(=O)O)C,FZECHKJQHUVANE-MCYUEQNJSA-N,"(2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-(methylideneamino)-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,8,41896|238858|612540|624101|624136|624137|624138|624139|624141|624151|624260|651548|681114|681115|1159607|1259398|1259399|1259423,20060605,"3B Scientific (Wuhan) Corp|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AHH Chemical co.,ltd|BindingDB|BLD Pharm|BOC Sciences|Broad Institute|CCSbase|ChEBI|ChemBank|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|DrugBank|DrugCentral|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Fredberg Lab, Harvard T.H. Chan School of Public Health|Google Pat",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6912404,Eritoran,"ERITORAN|185955-34-4|UNII-551541VI0Y|CHEMBL501259|CHEBI:68609|551541VI0Y|[(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-[[(Z)-octadec-11-enoyl]amino]-5-phosphonooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] dihydrogen phosphate|Eritoran [INN]|3-O-decyl-2-deoxy-6-O-{2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[(11E)-octadec-11-enoylamino]-4-O-phosphonato-beta-D-glucopyranosyl}-2-[(3-oxotetradecanoyl)amino]-1-O-phosphono-alpha-D-glucop",1313.700,C66H126N2O19P2,294.000,1900.000,15.400,89,7,19,59,"InChI=1S/C66H126N2O19P2/c1-7-11-15-19-22-25-26-27-28-29-30-32-34-38-42-46-57(70)67-60-64(82-49-47-54(80-6)45-41-36-18-14-10-4)62(86-88(73,74)75)56(51-79-5)85-65(60)83-52-55-61(72)63(81-48-43-39-35-24-21-17-13-9-3)59(66(84-55)87-89(76,77)78)68-58(71)50-53(69)44-40-37-33-31-23-20-16-12-8-2/h25-26,54-56,59-66,72H,7-24,27-52H2,1-6H3,(H,67,70)(H,68,71)(H2,73,74,75)(H2,76,77,78)/b26-25-/t54-,55-,56-,59-,60-,61-,62-,63-,64-,65-,66-/m1/s1",CCCCCCCCCCCC(=O)CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)(O)O)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC)OP(=O)(O)O)OCC[C@@H](CCCCCCC)OC)NC(=O)CCCCCCCCC/C=C\\CCCCCC)O)OCCCCCCCCCC,BPSMYQFMCXXNPC-MFCPCZTFSA-N,"[(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-[[(Z)-octadec-11-enoyl]amino]-5-phosphonooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,10,540209|540210|540212|540213,20060704,"A2B Chem|AA BLOCKS|ABI Chem|AbMole Bioscience|Alfa Chemistry|AN PharmaTech|BindingDB|BLD Pharm|BOC Sciences|ChEBI|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Comparative Toxicogenomics Database (CTD)|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|Metabolomic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918296,Dutasteride,"Dutasteride|164656-23-9|Avodart|GG-745|GI 198745|GI-198745|UNII-O0J6XJN02I|C27H30F6N2O2|O0J6XJN02I|(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide|alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide|CHEMBL1200969|Avolve|CHEBI:521033|Dutasterid",528.500,C27H30F6N2O2,58.200,964.000,5.400,37,2,8,2,"InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,JWJOTENAMICLJG-QWBYCMEYSA-N,"(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide",Dutasteride,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,311524|588834|589039|591082|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|7,20060728,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Alsachim|AOBIOUS INC|AstaTech, Inc.|Aurum Pharmatech LLC|BerrChem|BindingDB|BioChemPartner|Biosynth Carbosynth|BOC Sciences|Broad Institute|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6997572,(R)-Carprofen,(R)-Carprofen|(-)-carprofen|52263-83-9|(2R)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid|(R)-(-)-carprofen|CHEMBL2171250|CHEBI:59206|(R)-6-chloro-alpha-methylcarbazole-2-acetic acid|(R)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid|(R)-2-(6-chloro-9H-carbazol-2-yl)-propionic acid|SCHEMBL3910|DTXSID40426422|ZINC1869694|BDBM50397557|(R)-2-(6-Chloro-9H-carbazol-2-yl)propanoic acid|Q27126532|UNII-FFL0D546HO component PUXBGTOOZJQSKH-MRVPVSSYSA-N|UHG,273.710,C15H12ClNO2,53.100,362.000,4.000,19,2,2,2,"InChI=1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19)/t8-/m1/s1",C[C@H](C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,PUXBGTOOZJQSKH-MRVPVSSYSA-N,(2R)-2-(6-chloro-9H-carbazol-2-yl)propanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,6,701504|701505|701506|1409598,20060729,"A&J Pharmtech CO., LTD.|ABI Chem|Alfa Chemistry|ApexBio Technology|BindingDB|BLD Pharm|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Crystallography Open Database|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|LabNetwork, a WuXi AppTec Company|MetabolomicsWorkbench|MuseChem|NCBI Structure|NextBio|NextMov",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9804984,AT2 Agonist C21,AT2 Agonist C21|477775-14-7|UNII-RC2V4W0EYC|RC2V4W0EYC|AT2 receptor agonist C21|C-21|compound 21 [PMID: 22802221]|M 24|CHEMBL189568|butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate|Butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate|C21|butyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-ylsulfonylcarbamate|N-[[3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]carbamic acid butyl ester|SCHE,475.600,C23H29N3O4S2,127.000,690.000,5.300,32,1,6,11,"InChI=1S/C23H29N3O4S2/c1-4-5-12-30-23(27)25-32(28,29)22-21(14-20(31-22)13-17(2)3)19-8-6-18(7-9-19)15-26-11-10-24-16-26/h6-11,14,16-17H,4-5,12-13,15H2,1-3H3,(H,25,27)",CCCCOC(=O)NS(=O)(=O)C1=C(C=C(S1)CC(C)C)C2=CC=C(C=C2)CN3C=CN=C3,XTEOJPUYZWEXFI-UHFFFAOYSA-N,butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,10,237160|237877|239506|239517|243119|250146|250809|250894|250956|340631|340632|486398|486399|486400|486401|486402|486403|486404|486405|486406|486407|486410|1058254|1058255|1064437|1064438|1064440|1169022|1169023|1191069|1191070|1277888|1277889|1296008|1296009|1345084|1346291|1346340|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1405280|1405281,20061025,"A2B Chem|AA BLOCKS|AbaChemScene|Ambeed|Angene Chemical|Axon Medchem|BindingDB|BioChemPartner|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|CSNpharm|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|MedChemexpress MCE|MolPort|Na",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9810132,"7-[[(2Z)-2-Ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",NULL,685.700,C22H22N8O8PS4+,328.000,1220.000,1.600,43,5,17,11,"InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/p+1/b26-13-",CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\\C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)O,ZCCUWMICIWSJIX-ZMFRSBBQSA-O,"7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",NULL,NULL,0,NULL,20061025,ChemSpider|DiscoveryGate|MolPort|NextBio|Thomson Pharma,Chemical Vendors|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9838712,Reparixin,reparixin|repertaxin|266359-83-5|DF 1681Y|UNII-U604E1NB3K|(R)-2-(4-isobutylphenyl)-N-(methylsulfonyl)propanamide|CHEMBL191413|U604E1NB3K|266359-83-5 (free base)|(2R)-2-[4-(2-methylpropyl)phenyl]-N-methylsulfonylpropanamide|Reparixin (Repertaxin)|Reparixin [USAN:INN]|(2R)-2-(4-(2-Methylpropyl)phenyl)-N-methylsulfonylpropanamide|2-(4-isobutylphenyl)propionylmethanesulfonamide|DF1681Y|DF-1681Y|Reparixin (USAN/INN)|DSSTox_CID_26509|DSSTox_RID_81678|DSSTox_GSID_46509|GTPL8498|SCHEMBL1884299|ZINC8717|DTXSID604650,283.390,C14H21NO3S,71.600,389.000,2.900,19,1,3,5,"InChI=1S/C14H21NO3S/c1-10(2)9-12-5-7-13(8-6-12)11(3)14(16)15-19(4,17)18/h5-8,10-11H,9H2,1-4H3,(H,15,16)/t11-/m1/s1",C[C@H](C1=CC=C(C=C1)CC(C)C)C(=O)NS(=O)(=O)C,KQDRVXQXKZXMHP-LLVKDONJSA-N,(2R)-2-[4-(2-methylpropyl)phenyl]-N-methylsulfonylpropanamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,2517|239780|243230|248424|251770|251807|297153|297154|297155|297156|588834|606366|651631|651632|651633|651634|652048|652051|657853|657854|657857|686978|686979|707876|707879|707880|707908|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743,20061025,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Adooq BioScience|Ambeed|Ambinter|Aurum Pharmatech LLC|AvaChem Scientific|BindingDB|BioChemPartner|BioCrick|BLD Pharm|Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Comparative Toxicogenomics Database (CTD)|CSNpharm|Davey Lab, Department of Microbiology, NE",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9867812,Remimazolam,"Remimazolam|308242-62-8|CNS 7056|UNII-7V4A8U16MB|CNS-7056|7V4A8U16MB|ONO-2745|308242-62-8 (freee base)|4H-Imidazo[1,2-a][1,4]benzodiazepine-4-propanoic acid, 8-bromo-1-methyl-6-(2-pyridinyl)-, methyl ester, (4S)-|methyl (S)-3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate|methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate|4H-Imidazo(1,2-a)(1,4)benzodiazepine-4-propanoic acid, 8-bromo-1-methyl-6-(2-pyridinyl)-, methyl ",439.300,C21H19BrN4O2,69.400,601.000,3.400,28,0,5,5,"InChI=1S/C21H19BrN4O2/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21/h3-6,8,10-12,17H,7,9H2,1-2H3/t17-/m0/s1",CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=N[C@H]2CCC(=O)OC)C4=CC=CC=N4,CYHWMBVXXDIZNZ-KRWDZBQOSA-N,"methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,11,1409598,20061025,"A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AKos Consulting & Solutions|Ambinter|Apexmol|Aurora Fine Chemicals LLC|AvaChem Scientific|Boerchem|Broad Institute|Chem-Space.com Database|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht Univers",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9897015,Azithromycin Monohydrate,"Azithromycin Monohydrate|121470-24-4|UNII-JTE4MNN1MD|JTE4MNN1MD|AZITHROMYCIN DIHYDRATE|(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one;hydrate|SCHEMBL139900|CHEMBL1200502|DTXSID10861063|C38H72N2O12.H2O|2245AH|470A244|Q27281692|UNII-F94OW58Y8V component HQUPLSLYZHKKQT-WVVFQGGUSA-N|1-Oxa-6-azacyclopenta",767.000,C38H74N2O13,181.000,1150.000,NULL,53,6,15,7,"InChI=1S/C38H72N2O12.H2O/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28;/h20-33,35,41-43,45-46H,15-19H2,1-14H3;1H2/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-;/m1./s1",CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O,HQUPLSLYZHKKQT-WVVFQGGUSA-N,"(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one;hydrate",Azithromycin,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,9,NULL,20061025,"A2B Chem|AA BLOCKS|Acorn PharmaTech Product List|AK Scientific, Inc. (AKSCI)|ChEMBL|ChemIDplus|ChemSpider|Clearsynth|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Hairui Chemical|MuseChem|NextBio|OChem|Smolecule|SureChEMBL|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9916461,Tradipitant,"Tradipitant|622370-35-8|LY686017|LY-686017|VLY-686|UNII-NY0COC51FI|NY0COC51FI|(2-(1-(3,5-bis(trifluoromethyl)benzyl)-5-(pyridin-4-yl)-1H-1,2,3-triazol-4-yl)pyridin-3-yl)(2-chlorophenyl)methanone|[2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-pyridin-4-yltriazol-4-yl]pyridin-3-yl]-(2-chlorophenyl)methanone|Tradipitant [USAN:INN]|Tradipitant(VLY-686)|Tradipitant (USAN/INN)|GTPL9278|SCHEMBL2898629|CHEMBL3544984|BCP30446|MFCD28127604|ZINC43194077|CS-8056|DB12580|SB18893|AS-35293|DA-31788|HY-16732|Methanone, (",587.900,C28H16ClF6N5O,73.600,865.000,6.200,41,0,11,6,"InChI=1S/C28H16ClF6N5O/c29-22-6-2-1-4-20(22)26(41)21-5-3-9-37-23(21)24-25(17-7-10-36-11-8-17)40(39-38-24)15-16-12-18(27(30,31)32)14-19(13-16)28(33,34)35/h1-14H,15H2",C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl,CAVRKWRKTNINFF-UHFFFAOYSA-N,"[2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-pyridin-4-yltriazol-4-yl]pyridin-3-yl]-(2-chlorophenyl)methanone",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,1346346,20061025,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Achemtek|Activate Scientific|Adooq BioScience|Angel Pharmatech Ltd.|BioChemPartner|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Finetech Industry Limited|Googl",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9962077,Teflaro,"Ceftaroline fosamil acetate|Teflaro|Zinforo|400827-46-5|CHEBI:70715|DSP-5990|ceftaroline fosamil acetate (anhydrous)|(6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate acetate",744.700,C24H25N8O10PS4,368.000,1240.000,NULL,47,5,19,10,"InChI=1S/C22H21N8O8PS4.C2H4O2/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10;1-2(3)4/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37);1H3,(H,3,4)/b26-13-;/t14-,19-;/m1./s1",CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-].CC(=O)O,UGHHNQFYEVOFIV-VRDMTWHKSA-N,"acetic acid;(6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,8,NULL,20061025,ChEBI|ChemSpider|DiscoveryGate|NextBio|NORMAN Suspect List Exchange|Prous Science Drugs of the Future|Race Chemical|Thomson Pharma|ToxPlanet,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11197252,"(S,S,S)-Triglycidyl Isocyanurate","(S,S,S)-Triglycidyl Isocyanurate|UNII-T9X7TNF4X2|T9X7TNF4X2|Teroxirone|1,3,5-tris[[(2S)-oxiran-2-yl]methyl]-1,3,5-triazinane-2,4,6-trione|SCHEMBL2097375|DTXSID40458480|ZINC3643619|beta-Triglycidyl isocyanurate, (-)-|Triglycidyl isocyanurate, (S,S,S)-|I0581|(S,S,S)-Tris(2,3-epoxypropyl) Isocyanurate|Q27289854|Isocyanuric Acid (S,S,S)-Tris(2,3-epoxypropyl) Ester|UNII-456V4159SL component OUPZKGBUJRBPGC-CIUDSAMLSA-N|UNII-58P91Z020D component OUPZKGBUJRBPGC-CIUDSAMLSA-N|UNII-987C8AU5FW component OUPZKGBUJRBPGC-",297.260,C12H15N3O6,98.500,416.000,-1.500,21,0,6,6,"InChI=1S/C12H15N3O6/c16-10-13(1-7-4-19-7)11(17)15(3-9-6-21-9)12(18)14(10)2-8-5-20-8/h7-9H,1-6H2/t7-,8-,9-/m0/s1",C1[C@@H](O1)CN2C(=O)N(C(=O)N(C2=O)C[C@H]3CO3)C[C@H]4CO4,OUPZKGBUJRBPGC-CIUDSAMLSA-N,"1,3,5-tris[[(2S)-oxiran-2-yl]methyl]-1,3,5-triazinane-2,4,6-trione",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20061026,"Alichem|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|NCBI Structure|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|TCI (Tokyo Chemical Industry)|THE",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11285588,Danoprevir,"DANOPREVIR|ITMN-191|850876-88-9|Danoprevir (ITMN-191)|RO5190591|Danoprevir (RG7227)|UNII-911Z9PCQ5F|ITMN 191|911Z9PCQ5F|R 7227|RG7227|R05190591|RG 7227|RO-5190591|R-05190591|Intermune ITMN-191|ITMN B|ITMN191|Danoprevir [USAN:INN]|R7227|Ganovo|Danoprevir (ITMN191)|R7227 cpd|R-7227|MLS006011139|C35H46FN5O9S|CHEMBL258734|R 05190591|SCHEMBL2289034|AOB87156|BDBM50495950|s1183|ZINC29058869|AKOS037515841|CCG-270417|DB11779|RG-7227|SMR004702916|SW219089-1|X7550|W-5603|Danoprevir (RG7227,ITMN-191,RO5190591|J-515317|",731.800,C35H46FN5O9S,189.000,1530.000,3.300,51,3,10,8,"InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7-/t22-,23-,27+,28+,35-/m1/s1",CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C\\[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,ZVTDLPBHTSMEJZ-JSZLBQEHSA-N,"[(1S,4R,6S,7Z,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,322946|322947|491860|491861|521264|521265|521266|521267|521268|521269|521270|521271|521272|521273|521274|521275|521277|521278|521279|538708|538709|538710|538711|538712|538713|538714|539674|539675|539676|539677|539678|584101|584102|584103|584104|584105|584106|584107|584108|584109|584110|612408|612410|656667|656668|656669|656670|656671|656672|656673|656674|656675|656676|664157|664158|664159|664160|664161|664162|664163|664164|664165|664166|664167|664168|664169|711493|711494|711495|711496|711497|711498|711499|7,20061026,"A2B Chem|AA BLOCKS|Achemtek|Acorn PharmaTech Product List|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AOBIOUS INC|ApexBio Technology|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BindingDB|BioCrick|Biosynth Carbosynth|Broad Institute|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Davey Lab, Department of Microbiology, NEIDL, Boston University|Discovery",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11583880,5-Cholesten-3beta-25-diol-3-sulfate,"UGX2V7MGMZ|UNII-UGX2V7MGMZ|Larsucosterol [USAN]|25-OHCS|25HC3S|SCHEMBL3505588|25-hydroxycholesterol-3-sulfate|DUR-928|DV-928|WHO 11633|5-Cholesten-3beta-25-diol-3-sulfate|5-Cholesten-3beta, 25-diol 3-sulfate|[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate|884905-07-1",482.700,C27H46O5S,92.200,858.000,6.400,33,2,5,7,"InChI=1S/C27H46O5S/c1-18(7-6-14-25(2,3)28)22-10-11-23-21-9-8-19-17-20(32-33(29,30)31)12-15-26(19,4)24(21)13-16-27(22,23)5/h8,18,20-24,28H,6-7,9-17H2,1-5H3,(H,29,30,31)/t18-,20+,21+,22-,23+,24+,26+,27-/m1/s1",C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C)C,PIUZYOCNZPYXOA-ZHHJOTBYSA-N,"[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20061026,ChemIDplus|ChemSpider|DiscoveryGate|FDA/SPL Indexing Data|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|PATENTSCOPE (WIPO)|Sigma-Aldrich|Springer Nature|SureChEMBL|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11751549,Cozaar,"LOSARTAN POTASSIUM|124750-99-8|Cozaar|ERYTHROPOIETIN|Lorzaar|Losaprex|losartan potassium salt|Hyzaar|losartanpotassium|MK 954|Lortaan|UNII-3ST302B24A|Losartan Potassium (DuP 753)|MK-0954|3ST302B24A|L-158086|DuP 753|MK0954|124750-99-8 (Ka+)|potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol|Lifezar|Lorzaan|Losacar|Losacor|Tenopres|C22H22CIKN6OK|Lotim|Niten|Ocsaar|DuP-753|Neo Lotan|2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-bip",461.000,C22H22ClKN6O,77.700,526.000,NULL,31,1,6,8,"InChI=1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1",CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],OXCMYAYHXIHQOA-UHFFFAOYSA-N,"potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol",Losartan,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,13,1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|434955|434962|434973|434989|435003|435022|435030|449728|449762,20061026,"3B Scientific (Wuhan) Corp|ABBLIS Chemicals|Achemtek|Acorn PharmaTech Product List|ACT Chemical|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alomone Labs|AN PharmaTech|Anward|ApexBio Technology|Assembly Blocks Pvt. Ltd.|AvaChem Scientific|BioChemPartner|BioCrick|BOC Sciences|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|Chembase.cn|ChemIDplus|ChemMol|ChemSpider|ChemTik|Clearsynth|Collaborative",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11844232,N-[(Benzyloxy)carbonyl]-O-(Tert-Butyl)-L-Threonyl-3-Cyclohexyl-N-[(1s)-2-Hydroxy-1-{[(3s)-2-Oxopyrrolidin-3-Yl]methyl}ethyl]-L-Alaninamide,"N-[(Benzyloxy)carbonyl]-O-(Tert-Butyl)-L-Threonyl-3-Cyclohexyl-N-[(1s)-2-Hydroxy-1-{[(3s)-2-Oxopyrrolidin-3-Yl]methyl}ethyl]-L-Alaninamide|GTPL11176|TG0205221|Q27463894|Cbz-Thr(tBu)-Cha-Ala(((S)-2-oxopyrrolidin-3-yl))-ol|benzyl N-[(2S,3R)-1-[[(2S)-3-cyclohexyl-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxobutan-2-yl]carbamate|N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-3-cyclohexyl-N-[(1S)-2-hydroxy-1-{[(3S)-2-oxopyrrolidin-3",602.800,C32H50N4O7,155.000,912.000,3.700,43,5,7,16,"InChI=1S/C32H50N4O7/c1-21(43-32(2,3)4)27(36-31(41)42-20-23-13-9-6-10-14-23)30(40)35-26(17-22-11-7-5-8-12-22)29(39)34-25(19-37)18-24-15-16-33-28(24)38/h6,9-10,13-14,21-22,24-27,37H,5,7-8,11-12,15-20H2,1-4H3,(H,33,38)(H,34,39)(H,35,40)(H,36,41)/t21-,24+,25+,26+,27+/m1/s1",C[C@H]([C@@H](C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](C[C@@H]2CCNC2=O)CO)NC(=O)OCC3=CC=CC=C3)OC(C)(C)C,YIWYOEOSWRXENJ-FFXRMZKPSA-N,"benzyl N-[(2S,3R)-1-[[(2S)-3-cyclohexyl-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxobutan-2-yl]carbamate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers,4,NULL,20061106,"ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|IUPHAR/BPS Guide to PHARMACOLOGY|NextBio|Protein Data Bank in Europe (PDBe)|Thomson Pharma|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11980957,"N-[5-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide;1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate",NULL,1349.700,C74H96N10O10S2,322.000,1980.000,NULL,96,8,14,33,"InChI=1S/C37H48N6O5S2.C37H48N4O5/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30;1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46);5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t28-,31-,32-,33-;/m0./s1",CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O.CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,OFFWOVJBSQMVPI-BWOCORGPSA-N,"N-[5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide;1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate",NULL,NULL,0,NULL,20070109,ChemSpider|LeadScope|NextBio,Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
12684717,(1R)-2-(Methylsulfonyl)-1-phenylethan-1-ol,(1R)-2-(methylsulfonyl)-1-phenylethan-1-ol|ZINC393328|(1R)-2-methylsulfonyl-1-phenylethanol|VWD,200.260,C9H12O3S,62.800,234.000,0.400,13,1,3,3,"InChI=1S/C9H12O3S/c1-13(11,12)7-9(10)8-5-3-2-4-6-8/h2-6,9-10H,7H2,1H3/t9-/m0/s1",CS(=O)(=O)C[C@@H](C1=CC=CC=C1)O,FVZQEVNJWREWHU-VIFPVBQESA-N,(1R)-2-methylsulfonyl-1-phenylethanol,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20070208,Google Patents|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
12714644,Dapansutrile,"Dapansutrile|54863-37-5|OLT1177|OLT-1177|3-(methylsulfonyl)propanenitrile|3-methanesulfonylpropanenitrile|3-(methanesulfonyl)propanenitrile|UNII-2Z03364G96|2Z03364G96|Dapansutrile [INN]|Dapansutrile(OLT1177)|Dapansutrile (USAN/INN)|Dapansutrile [USAN:INN]|Dapansutrile (OLT1177)|3-Methylsulfonylpropionitrile|3-methylsulfonylpropanenitrile|3-methylsulphonyl-propionitrile|SCHEMBL9934796|CHEMBL3989943|GTPL10056|EX-A4519|BDBM50505850|Propanenitrile, 3-(methylsulfonyl)-|s8907|ZINC32005410|AKOS010140086|HY-17629|C",133.170,C4H7NO2S,66.300,190.000,-0.700,8,0,3,2,"InChI=1S/C4H7NO2S/c1-8(6,7)4-2-3-5/h2,4H2,1H3",CS(=O)(=O)CCC#N,LQFRYKBDZNPJSW-UHFFFAOYSA-N,3-methylsulfonylpropanenitrile,NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,8,NULL,20070208,"AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Axon Medchem|BindingDB|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemSpider|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|IBM|iChemical Technology USA Inc|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|MedChemexpress MCE|Mo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
12986439,"(S)-[2,8-Bis(trifluoromethyl)-4-quinolyl]-(2-piperidyl)methanol","mefloquine|(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol|SCHEMBL8575605|4-Quinolinemethanol, .alpha.-(2R)-2-piperidinyl-2,8-bis(trifluoromethyl)-, (.alpha.S)-rel-|53230-10-7|(S)-[2,8-bis(trifluoromethyl)-4-quinolyl]-(2-piperidyl)methanol|(S)-alpha-(2-Piperidinyl)-2,8-bis(trifluoromethyl)-4-quinolinemethanol|[2,8-Bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol;hydrochloride",378.310,C17H16F6N2O,45.200,483.000,3.600,26,2,9,2,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12?,15-/m0/s1",C1CCNC(C1)[C@H](C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,XEEQGYMUWCZPDN-CVRLYYSRSA-N,"(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol",Mefloquine,Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,NULL,20070208,Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NIAID ChemDB|NIST Mass Spectrometry Data Center|PATENTSCOPE (WIPO)|Smolecule|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
13960589,(2~{S})-2-Azanyl-5-oxidanylidene-5-[[(2~{S})-1-oxidanylidene-1-[(2-oxidanylidene-2-propan-2-yloxy-ethyl)amino]-3-sulfanyl-propan-2-yl]amino]pentanoic acid,(2~{S})-2-azanyl-5-oxidanylidene-5-[[(2~{S})-1-oxidanylidene-1-[(2-oxidanylidene-2-propan-2-yloxy-ethyl)amino]-3-sulfanyl-propan-2-yl]amino]pentanoic acid|S8H,349.410,C13H23N3O6S,149.000,443.000,-3.400,23,5,8,11,"InChI=1S/C13H23N3O6S/c1-7(2)22-11(18)5-15-12(19)9(6-23)16-10(17)4-3-8(14)13(20)21/h7-9,23H,3-6,14H2,1-2H3,(H,15,19)(H,16,17)(H,20,21)/t8-,9+/m0/s1",CC(C)OC(=O)CNC(=O)[C@@H](CS)NC(=O)CC[C@@H](C(=O)O)N,MVNCPACIPXNJIW-DTWKUNHWSA-N,(2S)-2-amino-5-oxo-5-[[(2S)-1-oxo-1-[(2-oxo-2-propan-2-yloxyethyl)amino]-3-sulfanylpropan-2-yl]amino]pentanoic acid,NULL,Biomolecular Interactions and Pathways,1,NULL,20070208,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
15959240,Benzotriazol-1-yl 1H-indole-5-carboxylate,"Benzotriazole ester, 8|CHEMBL497141|BDBM59242|CHEBI:149976|benzotriazol-1-yl 1H-indole-5-carboxylate|1-[(1h-indol-5-ylcarbonyl)oxy]-1h-1,2,3-benzotriazole",278.260,C15H10N4O2,72.800,405.000,3.100,21,1,4,3,"InChI=1S/C15H10N4O2/c20-15(11-5-6-12-10(9-11)7-8-16-12)21-19-14-4-2-1-3-13(14)17-18-19/h1-9,16H",C1=CC=C2C(=C1)N=NN2OC(=O)C3=CC4=C(C=C3)NC=C4,YPFWNRLSYPAVJB-UHFFFAOYSA-N,benzotriazol-1-yl 1H-indole-5-carboxylate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Biological Test Results: Active|Biological Test Results: Micromolar,7,344686|344687|758717|1422435,20070308,BindingDB|ChEBI|ChEMBL|ChemSpider|NIAID ChemDB|Protein Data Bank in Europe (PDBe)|Springer Nature,Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
20112509,"4-(3-Aminopropyl)-3,4-dihydro-2H-1,4-benzoxazin-3-one","4-(3-aminopropyl)-2H-1,4-benzoxazin-3(4H)-one|SCHEMBL20774003|4-(3-AMINOPROPYL)-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-3-ONE|ZINC11568785|AKOS000150081|MCULE-4449984446|4-(3-aminopropyl)-1,4-benzoxazin-3-one|64929-04-0|WSM",206.240,C11H14N2O2,55.600,233.000,0.500,15,1,3,3,"InChI=1S/C11H14N2O2/c12-6-3-7-13-9-4-1-2-5-10(9)15-8-11(13)14/h1-2,4-5H,3,6-8,12H2",C1C(=O)N(C2=CC=CC=C2O1)CCCN,HKOUXYKBIBMSMY-UHFFFAOYSA-N,"4-(3-aminopropyl)-1,4-benzoxazin-3-one",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20071205,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemSpider|ChemTik|DiscoveryGate|Enamine|Google Patents|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
22949012,"9-Methyl-9H-purine-2,6-diamine","9-Methyl-9H-purine-2,6-diamine|30720-65-1|CHEMBL66076|SCHEMBL129642|DTXSID10629165|2,6-Diamino-9-methyl-9H-purine|9-METHYLPURINE-2,6-DIAMINE|AKOS030562438|W5M",164.170,C6H8N6,95.600,173.000,-0.400,12,2,5,0,"InChI=1S/C6H8N6/c1-12-2-9-3-4(7)10-6(8)11-5(3)12/h2H,1H3,(H4,7,8,10,11)",CN1C=NC2=C(N=C(N=C21)N)N,NMJOZGVQPPGGFV-UHFFFAOYSA-N,"9-methylpurine-2,6-diamine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents,5,155652,20071205,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|BLD Pharm|Chem-Space.com Database|ChEMBL|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Day Biochem|DiscoveryGate|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|MolPort|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
23559815,"(E,4S)-4-Azanyl-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pent-2-enoic acid","(E,4S)-4-azanyl-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pent-2-enoic acid",198.220,C9H14N2O3,92.400,263.000,-3.400,14,3,4,4,"InChI=1S/C9H14N2O3/c10-7(1-2-8(12)13)5-6-3-4-11-9(6)14/h1-2,6-7H,3-5,10H2,(H,11,14)(H,12,13)/b2-1+/t6-,7+/m0/s1",C1CNC(=O)[C@@H]1C[C@@H](/C=C/C(=O)O)N,DGQBDXFRBIXHDR-FJZRIBRESA-N,"(E,4S)-4-amino-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20071206,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
25127112,Ruxolitinib phosphate,"Ruxolitinib phosphate|1092939-17-7|(R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate|Jakafi|Jakavi|Ruxolitinib (phosphate)|Ruxolitinib phosphate salt|UNII-436LRU32H5|INCB018424 SALT|CHEBI:66917|436LRU32H5|1092939-17-7 (phosphate)|(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphate|(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile phosphate|INC-424|INCB-18424|INCB 018424 phos",404.400,C17H21N6O4P,161.000,503.000,NULL,28,4,8,4,"InChI=1S/C17H18N6.H3O4P/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16;1-5(2,3)4/h6,8-12,15H,1-5H2,(H,19,20,21);(H3,1,2,3,4)/t15-;/m1./s1",C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O,JFMWPOCYMYGEDM-XFULWGLBSA-N,"(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;phosphoric acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,690502|690503|690504|690505,20090119,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Alichem|Ambinter|Angene Chemical|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Com",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
25271624,"Adrafinil, (R)-","UNII-Z61JQF40LJ|(R)-adrafinil|Z61JQF40LJ|Adrafinil, (R)-|2-[(diphenylmethyl)-oxidanyl-$l^{3}-sulfanyl]-~{N}-oxidanyl-ethanamide|R-(+)-Adrafinil|827603-92-9|Acetamide, 2-((R)-(diphenylmethyl)sulfinyl)-N-hydroxy-|ZINC12|Q27295048|UNII-BI81Z4542G component CGNMLOKEMNBUAI-HXUWFJFHSA-N|RNW",289.400,C15H15NO3S,85.600,318.000,1.600,20,2,4,5,"InChI=1S/C15H15NO3S/c17-14(16-18)11-20(19)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15,18H,11H2,(H,16,17)/t20-/m1/s1",C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)NO,CGNMLOKEMNBUAI-HXUWFJFHSA-N,2-[(R)-benzhydrylsulfinyl]-N-hydroxyacetamide,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers,3,NULL,20090527,"A&J Pharmtech CO., LTD.|ChemIDplus|ChemTik|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|NCBI Structure|Protein Data Bank in Europe (PDBe)|ToxPlanet|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
26865112,"1-[4-(2,4-Dimethylphenyl)sulfonylpiperazin-1-yl]ethanone",NULL,296.390,C14H20N2O3S,66.100,450.000,1.100,20,0,4,2,"InChI=1S/C14H20N2O3S/c1-11-4-5-14(12(2)10-11)20(18,19)16-8-6-15(7-9-16)13(3)17/h4-5,10H,6-9H2,1-3H3",CC1=CC(=C(C=C1)S(=O)(=O)N2CCN(CC2)C(=O)C)C,VKTWNRQXKPNSFH-UHFFFAOYSA-N,"1-[4-(2,4-dimethylphenyl)sulfonylpiperazin-1-yl]ethanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20090528,Aurora Fine Chemicals LLC|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
28399469,2-(Methylamino)-N-(4-methylpyridin-2-yl)acetamide,2-(methylamino)-N-(4-methylpyridin-2-yl)acetamide|N~2~-methyl-N-(4-methylpyridin-2-yl)glycinamide|1019383-78-8|CHEMBL4528458|ZINC19844240|AKOS000215583|NE61545|EN300-64691|W04,179.220,C9H13N3O,54.000,172.000,0.300,13,2,3,3,"InChI=1S/C9H13N3O/c1-7-3-4-11-8(5-7)12-9(13)6-10-2/h3-5,10H,6H2,1-2H3,(H,11,12,13)",CC1=CC(=NC=C1)NC(=O)CNC,MKMXMYQLOQBORD-UHFFFAOYSA-N,2-(methylamino)-N-(4-methylpyridin-2-yl)acetamide,NULL,Biomolecular Interactions and Pathways|Classification|Safety and Hazards,3,NULL,20090528,A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambeed|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|DiscoveryGate|Enamine|MolPort|NCBI Structure|Norris Pharm|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
28742932,N-(4-Hydroxyphenyl)-1-methyl-1H-pyrazole-4-carboxamide,N-(4-hydroxyphenyl)-1-methyl-1H-pyrazole-4-carboxamide|1152949-71-7|ZINC20216228|AKOS008110398|MCULE-1203487039|NE39874|EN300-66525|N-(4-hydroxyphenyl)-1-methylpyrazole-4-carboxamide|Z1263529624|WS4,217.220,C11H11N3O2,67.200,252.000,0.700,16,2,3,2,"InChI=1S/C11H11N3O2/c1-14-7-8(6-12-14)11(16)13-9-2-4-10(15)5-3-9/h2-7,15H,1H3,(H,13,16)",CN1C=C(C=N1)C(=O)NC2=CC=C(C=C2)O,BOTWCSZQXQBVCZ-UHFFFAOYSA-N,N-(4-hydroxyphenyl)-1-methylpyrazole-4-carboxamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20090528,A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambeed|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|DiscoveryGate|Enamine|Mcule|MolPort|NCBI Structure|Norris Pharm|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
29987437,"(2~{S},3~{R},4~{R},5~{S},6~{S})-2-(Hydroxymethyl)-6-sulfanyl-oxane-3,4,5-triol","(2~{S},3~{R},4~{R},5~{S},6~{S})-2-(hydroxymethyl)-6-sulfanyl-oxane-3,4,5-triol|RVW",196.220,C6H12O5S,91.200,155.000,-1.600,12,5,6,1,"InChI=1S/C6H12O5S/c7-1-2-3(8)4(9)5(10)6(12)11-2/h2-10,12H,1H2/t2-,3-,4+,5-,6-/m0/s1",C([C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)S)O)O)O)O,JUSMHIGDXPKSID-QYESYBIKSA-N,"(2S,3R,4R,5S,6S)-2-(hydroxymethyl)-6-sulfanyloxane-3,4,5-triol",NULL,Biomolecular Interactions and Pathways,1,NULL,20090528,Ambinter|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
40004840,1-[4-(Thiophen-3-ylmethyl)piperazin-1-yl]ethanone,AKOS009036985|MCULE-6742272590,224.320,C11H16N2OS,51.800,227.000,0.700,15,0,3,2,"InChI=1S/C11H16N2OS/c1-10(14)13-5-3-12(4-6-13)8-11-2-7-15-9-11/h2,7,9H,3-6,8H2,1H3",CC(=O)N1CCN(CC1)CC2=CSC=C2,GHWOPOKXTBUQPP-UHFFFAOYSA-N,1-[4-(thiophen-3-ylmethyl)piperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20090530,AKos Consulting & Solutions|DiscoveryGate|Mcule|MolPort|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
40476772,1-(Thiophen-3-ylmethyl)piperidin-4-ol,1-(thiophen-3-ylmethyl)piperidin-4-ol|1-[(thiophen-3-yl)methyl]piperidin-4-ol|864388-84-1|T0Y|ZINC200753|AKOS011295944|MCULE-3565378887|NE48654|EN300-91632|F8889-6883,197.300,C10H15NOS,51.700,157.000,1.300,13,1,3,2,"InChI=1S/C10H15NOS/c12-10-1-4-11(5-2-10)7-9-3-6-13-8-9/h3,6,8,10,12H,1-2,4-5,7H2",C1CN(CCC1O)CC2=CSC=C2,JQJVNJKLFUBEBG-UHFFFAOYSA-N,1-(thiophen-3-ylmethyl)piperidin-4-ol,NULL,Biomolecular Interactions and Pathways,1,NULL,20090530,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemBridge|Enamine|Life Chemicals|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
43082989,2-(4-Cyanophenoxy)propanamide,2-(4-cyanophenoxy)propanamide|AKOS008908502|MCULE-9080950249|1040041-89-1|Z19739650,190.200,C10H10N2O2,76.100,248.000,0.800,14,1,3,3,"InChI=1S/C10H10N2O2/c1-7(10(12)13)14-9-4-2-8(6-11)3-5-9/h2-5,7H,1H3,(H2,12,13)",CC(C(=O)N)OC1=CC=C(C=C1)C#N,JHIGQTTZYWLCKT-UHFFFAOYSA-N,2-(4-cyanophenoxy)propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20090721,"AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BenchChem|Chemieliva Pharmaceutical Co., Ltd|DiscoveryGate|Enamine|Mcule|MolPort",Chemical Vendors|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
43539927,N-[(2-Fluorophenyl)methyl]-1H-pyrazol-4-amine,N-[(2-fluorophenyl)methyl]-1H-pyrazol-4-amine|1156177-23-9|UQS|ZINC35763759|AKOS009562815|NE50335|Z1454310449,191.200,C10H10FN3,40.700,177.000,1.800,14,2,3,3,"InChI=1S/C10H10FN3/c11-10-4-2-1-3-8(10)5-12-9-6-13-14-7-9/h1-4,6-7,12H,5H2,(H,13,14)",C1=CC=C(C(=C1)CNC2=CNN=C2)F,PDSIYANAENEXNZ-UHFFFAOYSA-N,N-[(2-fluorophenyl)methyl]-1H-pyrazol-4-amine,NULL,Biomolecular Interactions and Pathways|Classification|Safety and Hazards,3,NULL,20090721,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|DiscoveryGate|Enamine|MolPort|NCBI Structure|Norris Pharm|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
45266664,Ile(5)-angiotensin II dizwitterion,Ile(5)-angiotensin II dizwitterion|CHEBI:58506,1046.200,C50H71N13O12,418.000,1970.000,-0.400,75,12,13,27,"InChI=1S/C50H71N13O12/c1-5-28(4)41(47(72)59-36(23-31-25-54-26-56-31)48(73)63-20-10-14-38(63)45(70)60-37(49(74)75)22-29-11-7-6-8-12-29)62-44(69)35(21-30-15-17-32(64)18-16-30)58-46(71)40(27(2)3)61-43(68)34(13-9-19-55-50(52)53)57-42(67)33(51)24-39(65)66/h6-8,11-12,15-18,25-28,33-38,40-41,64H,5,9-10,13-14,19-24,51H2,1-4H3,(H,54,56)(H,57,67)(H,58,71)(H,59,72)(H,60,70)(H,61,68)(H,62,69)(H,65,66)(H,74,75)(H4,52,53,55)/t28-,33-,34-,35-,36-,37-,38-,40-,41-/m0/s1",CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)[O-])NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC[NH+]=C(N)N)NC(=O)[C@H](CC(=O)[O-])[NH3+],CZGUSIXMZVURDU-JZXHSEFVSA-N,"(3S)-3-azaniumyl-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxylato-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneazaniumyl)-1-oxopentan-2-yl]amino]-4-oxobutanoate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20100507,BioCyc|ChEBI|Google Patents|NORMAN Suspect List Exchange,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
45792228,3-Acetamido-4-fluorobenzoic acid,3-acetamido-4-fluorobenzoic acid|3-(acetylamino)-4-fluorobenzoic acid|401-37-6|NZG|SCHEMBL16234575|ZINC37500399|AKOS009267705|MCULE-3362518724|NE15420|EN300-53858|Z364328788,197.160,C9H8FNO3,66.400,244.000,0.800,14,2,4,2,"InChI=1S/C9H8FNO3/c1-5(12)11-8-4-6(9(13)14)2-3-7(8)10/h2-4H,1H3,(H,11,12)(H,13,14)",CC(=O)NC1=C(C=CC(=C1)C(=O)O)F,VOLGFCKUDWAJQS-UHFFFAOYSA-N,3-acetamido-4-fluorobenzoic acid,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20100621,A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemTik|DiscoveryGate|Enamine|Google Patents|Mcule|MolPort|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
49846599,8-Chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine,"ABX464|ABX-464|1258453-75-6|SPL-464|8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine|UNII-26RU378B9V|8-Chloro-N-(4-(trifluoromethoxy)phenyl)quinolin-2-amine|26RU378B9V|obefazimod|SCHEMBL1705888|CHEMBL4297344|GTPL11698|EX-A3322|DB14828|MMV1581032|SB18690|BS-14770|ABX464(ABX-464;ABX 464)|HY-100870|CS-0020537|S0076|A16912|Q27896117|2-Quinolinamine, 8-chloro-N-(4-(trifluoromethoxy)phenyl)-",338.710,C16H10ClF3N2O,34.200,388.000,5.900,23,1,6,3,"InChI=1S/C16H10ClF3N2O/c17-13-3-1-2-10-4-9-14(22-15(10)13)21-11-5-7-12(8-6-11)23-16(18,19)20/h1-9H,(H,21,22)",C1=CC2=C(C(=C1)Cl)N=C(C=C2)NC3=CC=C(C=C3)OC(F)(F)F,OZOGDCZJYVSUBR-UHFFFAOYSA-N,8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20110131,"A2B Chem|AA BLOCKS|AbaChemScene|Adooq BioScience|Angel Pharmatech Ltd.|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|Clearsynth|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|MedChemexpress MCE|MolPort|MuseChem|NIAID ChemDB|PATENTSCOPE (WIPO)",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
51078647,N-(1-Ethyl-1H-pyrazol-4-yl)-4-fluorobenzamide,N-(1-ethyl-1H-pyrazol-4-yl)-4-fluorobenzamide|ZINC37501556|AKOS009295217|MCULE-5349481387|Z373769142|1184471-80-4|WSG,233.240,C12H12FN3O,46.900,267.000,1.500,17,1,3,3,"InChI=1S/C12H12FN3O/c1-2-16-8-11(7-14-16)15-12(17)9-3-5-10(13)6-4-9/h3-8H,2H2,1H3,(H,15,17)",CCN1C=C(C=N1)NC(=O)C2=CC=C(C=C2)F,OBDJLTJVFBLJIR-UHFFFAOYSA-N,N-(1-ethylpyrazol-4-yl)-4-fluorobenzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20110503,AKos Consulting & Solutions|Ambinter|Enamine|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
51341732,"(2S)-2-Amino-4-(1,3-benzothiazol-2-yl)butanoic acid","AKOS030214496|(2S)-2-amino-4-(1,3-benzothiazol-2-yl)butanoic acid|1263047-05-7",236.290,C11H12N2O2S,104.000,262.000,-0.600,16,2,5,4,"InChI=1S/C11H12N2O2S/c12-7(11(14)15)5-6-10-13-8-3-1-2-4-9(8)16-10/h1-4,7H,5-6,12H2,(H,14,15)/t7-/m0/s1",C1=CC=C2C(=C1)N=C(S2)CC[C@@H](C(=O)O)N,QGQYYZFCDVMFIU-ZETCQYMHSA-N,"(2S)-2-amino-4-(1,3-benzothiazol-2-yl)butanoic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20110503,abcr GmbH|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
52941591,"(1r,2s,5s)-3-[n-({1-[(Tert-Butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-Methyl-L-Valyl]-N-{(1s)-1-[(1r)-2-(Cyclopropylamino)-1-Hydroxy-2-Oxoethyl]pentyl}-6,6-Dimethyl-3-Azabicyclo[3.1.0]hexane-2-Carboxamide","(1r,2s,5s)-3-[n-({1-[(Tert-Butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-Methyl-L-Valyl]-N-{(1s)-1-[(1r)-2-(Cyclopropylamino)-1-Hydroxy-2-Oxoethyl]pentyl}-6,6-Dimethyl-3-Azabicyclo[3.1.0]hexane-2-Carboxamide|SCHEMBL10310675|ZINC98209237|Q27463877|(1R,2S,5S)-3-[N-({1-[(tert-butylsulfonyl)methyl]cyclohexyl}carbamoyl)-3-methyl-L-valyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",710.000,C36H63N5O7S,182.000,1350.000,4.900,49,5,7,15,"InChI=1S/C36H63N5O7S/c1-10-11-15-24(27(42)30(44)37-22-16-17-22)38-29(43)26-25-23(35(25,8)9)20-41(26)31(45)28(33(2,3)4)39-32(46)40-36(18-13-12-14-19-36)21-49(47,48)34(5,6)7/h22-28,42H,10-21H2,1-9H3,(H,37,44)(H,38,43)(H2,39,40,46)/t23-,24-,25-,26-,27+,28+/m0/s1",CCCC[C@@H]([C@H](C(=O)NC1CC1)O)NC(=O)[C@@H]2[C@@H]3[C@@H](C3(C)C)CN2C(=O)[C@H](C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C,BZXRATSZUNDEEV-FZFXNXQRSA-N,"(1R,2S,5S)-3-[(2S)-2-[[1-(tert-butylsulfonylmethyl)cyclohexyl]carbamoylamino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-1-(cyclopropylamino)-2-hydroxy-1-oxoheptan-3-yl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20110616,"Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Protein Data Bank in Europe (PDBe)|SureChEMBL|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
52947239,Riamilovir sodium dihydrate,"Triazavirin|Riamilovir sodium dihydrate|928659-17-0|UNII-G1JE34QF2S|G1JE34QF2S|sodium;7-methylsulfanyl-3-nitro-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-olate;dihydrate|Sodium 7-(methylthio)-3-nitro-4-oxo-4H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-6-ide dihydrate|TRIAZAVIRINE|CHEMBL1256733|BCP33885|EX-A3433|MFCD30532663|HY-19743|CS-0016556|(1,2,4)Triazolo(5,1-C)(1,2,4)triazin-4(6H)-one, 7-(methylthio)-3-nitro-, sodium salt, hydrate",286.200,C5H7N6NaO5S,152.000,262.000,NULL,18,2,10,1,"InChI=1S/C5H4N6O3S.Na.2H2O/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5;;;/h12H,1H3;;2*1H2/q;+1;;/p-1",CSC1=NN2C(=C(N=NC2=N1)[N+](=O)[O-])[O-].O.O.[Na+],GDVSBVWTWGUDAW-UHFFFAOYSA-M,"sodium;7-methylsulfanyl-3-nitro-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-olate;dihydrate",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Safety and Hazards,6,523678|523679|523681|523682|523684|523685|523687|523688|523690|523691|523693|523694|523695|523696|523698|523699|523700|523702|523703|523704|523706|523707|523708|523710|523711|523838|523840|523841|523842|523844|523845|523846|523848|523849|523851|523852|523854|523855|523856|523857|523858|523859|523860|523861|523862|523863|523864|523865|523866|523868|523870|523872|523874|523876|523877|523878,20110616,"AbaChemScene|abcr GmbH|AbMole Bioscience|Ambeed|BioChemPartner|Chem-Space.com Database|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|CSNpharm|DC Chemicals|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Lan Pharmatech|MedChemexpress MCE|MolPort|Smolecule|TargetMol (Target Molecule Corp.)|THE BioTek|Thomson Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
53477736,Azythromycin,"Azythromycin|CHEBI:176304|(2S,3S,4R,5S,8S,10S,11S,12R,13S,14R)-11-[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2S,4S,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one",749.000,C38H72N2O12,180.000,1150.000,4.000,52,5,14,7,"InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,29-,30-,31+,32+,33-,35+,36-,37-,38+/m0/s1",CC[C@H]1[C@@]([C@@H]([C@@H](N(C[C@H](C[C@]([C@H]([C@@H]([C@@H]([C@H](C(=O)O1)C)O[C@@H]2C[C@]([C@@H]([C@H](O2)C)O)(C)OC)C)O[C@@H]3[C@H]([C@@H](C[C@@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,MQTOSJVFKKJCRP-HHZDEWPHSA-N,"(2S,3S,4R,5S,8S,10S,11S,12R,13S,14R)-11-[(2R,3S,4R,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2S,4S,5R,6R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one",Azithromycin,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20111109,ChEBI|Google Patents|MassBank of North America (MoNA)|ToxPlanet,Curation Efforts|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
53516552,N-Cycloheptyl-N-methylmethanesulfonamide,N-cycloheptyl-N-methylmethanesulfonamide|ZINC65576535|AKOS009100932|MCULE-6907504999|Z216450634|1281160-88-0|VVJ,205.320,C9H19NO2S,45.800,235.000,1.900,13,0,3,2,"InChI=1S/C9H19NO2S/c1-10(13(2,11)12)9-7-5-3-4-6-8-9/h9H,3-8H2,1-2H3",CN(C1CCCCCC1)S(=O)(=O)C,UXPPTRFZLSZETL-UHFFFAOYSA-N,N-cycloheptyl-N-methylmethanesulfonamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20111203,AKos Consulting & Solutions|Ambinter|BenchChem|Enamine|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
53613703,5-Chloro-2-(propan-2-yl)pyrimidine-4-carboxamide,5-chloro-2-(propan-2-yl)pyrimidine-4-carboxamide|1333872-58-4|K2G|ZINC50121209|AKOS011290329|MCULE-8901666044|NE52599|EN300-83951|5-chloro-2-propan-2-ylpyrimidine-4-carboxamide|Z906021418,199.640,C8H10ClN3O,68.900,198.000,1.200,13,1,3,2,"InChI=1S/C8H10ClN3O/c1-4(2)8-11-3-5(9)6(12-8)7(10)13/h3-4H,1-2H3,(H2,10,13)",CC(C)C1=NC=C(C(=N1)C(=O)N)Cl,PCWKLVQVDIXCTG-UHFFFAOYSA-N,5-chloro-2-propan-2-ylpyrimidine-4-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Safety and Hazards,3,NULL,20111203,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|Enamine|Mcule|MolPort|NCBI Structure|Norris Pharm|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
54605501,Solu-Medrol,"Solu-Medrone|Urbason solubile|Solu-Medrol|M-6-P|NSC-48989|Methylprednisolone sodium hemisuccinate|METHYLPREDNISOLONE SODIUM SUCCINATE|U 9088|Urabason|2375-03-3|NSC48989|Prednisolone, succinate, sodium salt|6.alpha.-Methylprednisolone sodium succinate|6.alpha.-Methylprednisolone 21-sodium succinate|6.alpha.-Methylprednisolone sodium hemisuccinate|6.alpha.-Methylpregnisolone 21-sodium succinate|6.alpha.-Methylprednisolone 21-sodium hemisuccinate|6.alpha.-Methylprednisolone 21-hemisuccinate sodium salt|Pregna-",497.500,C26H34NaO8+,138.000,981.000,NULL,35,3,8,7,"InChI=1S/C26H34O8.Na/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24;/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31);/q;+1/t14-,16-,17-,19-,23+,24-,25-,26-;/m0./s1",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O.[Na+],FQISKWAFAHGMGT-SGJOWKDISA-N,"sodium;4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid",Methylprednisolone Hemisuccinate,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,7,NULL,20111219,DTP/NCI,Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
57116692,"3-(1,3-Thiazol-2-yl)-4H-1,2,4-triazole","3-(1,3-thiazol-2-yl)-4H-1,2,4-triazole|1340241-97-5|2-(1H-1,2,4-triazol-5-yl)-1,3-thiazole|5-(1,3-thiazol-2-yl)-1H-1,2,4-triazole|K34|thiazolyl-1,3,4-triazole|SCHEMBL4904752|ZINC61844368|AKOS012244054|Z2027049478",152.180,C5H4N4S,82.700,120.000,0.700,10,1,4,1,"InChI=1S/C5H4N4S/c1-2-10-5(6-1)4-7-3-8-9-4/h1-3H,(H,7,8,9)",C1=CSC(=N1)C2=NC=NN2,WFEGFRJBAYCOHP-UHFFFAOYSA-N,"2-(1H-1,2,4-triazol-5-yl)-1,3-thiazole",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Patents|Safety and Hazards,5,NULL,20120613,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BLD Pharm|Chem-Space.com Database|Enamine|Google Patents|IBM|MolPort|NCBI Structure|Norris Pharm|Protein Data Bank in Europe (PDBe)|Smolecule|Springer Nature|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
60196280,Ceftriaxone disodium trihydrate,DSSTox_CID_25887|DSSTox_RID_81201|DSSTox_GSID_45887|Ceftriaxone disodium trihydrate|Ro 13-9904|CAS-104376-79-6|CEFTRIAXONE SODIUM|Ceftriaxone Disodium Salt|Ceftriaxone sodium hydrate|NCGC00095007-01|CHEMBL3183968|Ceftriaxone sodium sesquaterhydrate|Tox21_111386|Tox21_111386_1|NCGC00263961-02|Ro-13-9904,652.600,C18H22N8Na2O10S3,300.000,1120.000,NULL,41,5,17,7,"InChI=1S/C18H18N8O7S3.2Na.3H2O/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7;;;;;/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32);;;3*1H2/q;2*+1;;;/p-2/b24-8-;;;;;/t9-,15-;;;;;/m1...../s1",CN1C(=NC(=O)C(=N1)[O-])SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-].O.O.O.[Na+].[Na+],XMCDZRXQAGFWAK-PMCOHIMVSA-L,"disodium;(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;trihydrate",Ceftriaxone,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,10,2517|588834|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720579|720580|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743,20121006,ChEMBL|Tox21,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
63648807,1-(3-Fluoro-4-methylphenyl)methanesulfonamide,(3-fluoro-4-methylphenyl)methanesulfonamide|1-(3-fluoro-4-methylphenyl)methanesulfonamide|919354-68-0|UR7|SCHEMBL3217315|DTXSID70734628|ZINC82503857|AKOS012959317|MCULE-3802742995|NE53366|Z1703168683,203.240,C8H10FNO2S,68.500,260.000,0.900,13,1,4,2,"InChI=1S/C8H10FNO2S/c1-6-2-3-7(4-8(6)9)5-13(10,11)12/h2-4H,5H2,1H3,(H2,10,11,12)",CC1=C(C=C(C=C1)CS(=O)(=O)N)F,BRGBJOARAPZJCN-UHFFFAOYSA-N,(3-fluoro-4-methylphenyl)methanesulfonamide,NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20121022,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemTik|Enamine|EPA DSSTox|Google Patents|IBM|Mcule|MolPort|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
66714983,Vafidemstat,"Vafidemstat|UNII-LZ82JLT4UP|LZ82JLT4UP|1357362-02-7|5-((((1R,2S)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine|Vafidemstat [INN]|SCHEMBL528204|BCP29383|ORY-2001|HY-112623|CS-0058593|ORY 2001; ORY-2001; ORY2001|5-(((trans)-2-(4-(benzyloxy)phenyl)cyclopropylamino)methyl)-1,3,4-oxadiazol-2-amine|(1R,2S)-2-(4-(Benzyloxy)phenyl)-N-((5-imino-4,5-dihydro-1,3,4-oxadiazol-2-yl)methyl)cyclopropanamine|1,3,4-Oxadiazole-2-methanamine, 4,5-dihydro-5-imino-N-((1R,2S)-2-(4-(phenylmethoxy)phenyl)",336.400,C19H20N4O2,86.200,410.000,2.200,25,2,6,7,"InChI=1S/C19H20N4O2/c20-19-23-22-18(25-19)11-21-17-10-16(17)14-6-8-15(9-7-14)24-12-13-4-2-1-3-5-13/h1-9,16-17,21H,10-12H2,(H2,20,23)/t16-,17+/m0/s1",C1[C@H]([C@@H]1NCC2=NN=C(O2)N)C3=CC=C(C=C3)OCC4=CC=CC=C4,XBBRLCXCBCZIOI-DLBZAZTESA-N,"5-[[[(1R,2S)-2-(4-phenylmethoxyphenyl)cyclopropyl]amino]methyl]-1,3,4-oxadiazol-2-amine",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20121130,AbaChemScene|BioChemPartner|Chem-Space.com Database|ChemIDplus|FDA/SPL Indexing Data|Google Patents|IBM|Lan Pharmatech|MedChemexpress MCE|MolPort|NextMove Software|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|TargetMol (Target Molecule Corp.)|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
68423044,2-(Trifluoromethyl)pyrimidine-5-carboxamide,2-(trifluoromethyl)pyrimidine-5-carboxamide|1378340-42-1|S7J|SCHEMBL2871260|ZINC75847370|AKOS023098468|NE60814|Z1745658474,191.110,C6H4F3N3O,68.900,198.000,0.000,13,1,6,1,"InChI=1S/C6H4F3N3O/c7-6(8,9)5-11-1-3(2-12-5)4(10)13/h1-2H,(H2,10,13)",C1=C(C=NC(=N1)C(F)(F)F)C(=O)N,OKRNBFHZDGTDRX-UHFFFAOYSA-N,2-(trifluoromethyl)pyrimidine-5-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Patents|Safety and Hazards,4,NULL,20121130,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BLD Pharm|Chem-Space.com Database|Enamine|Google Patents|IBM|MolPort|NCBI Structure|OXCHEM CORPORATION|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
68475223,"3-Oxo-3,4-dihydro-2H-1,4-benzothiazine-7-carboxylic acid","3-oxo-3,4-dihydro-2H-1,4-benzothiazine-7-carboxylic acid|1094107-96-6|3-oxo-4H-1,4-benzothiazine-7-carboxylic acid|SCHEMBL3006703|ZINC98208711|AKOS023563048|Q27458570|Z2130641660|BXW",209.220,C9H7NO3S,91.700,269.000,0.900,14,2,4,1,"InChI=1S/C9H7NO3S/c11-8-4-14-7-3-5(9(12)13)1-2-6(7)10-8/h1-3H,4H2,(H,10,11)(H,12,13)",C1C(=O)NC2=C(S1)C=C(C=C2)C(=O)O,PMIQHWMFUZMWOX-UHFFFAOYSA-N,"3-oxo-4H-1,4-benzothiazine-7-carboxylic acid",NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20121130,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BLD Pharm|Chem-Space.com Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Enamine|Google Patents|IBM|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|Smolecule|SureChEMBL|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
71586775,Montmorillonite,"Montmorillonite|Bentolite|1318-93-0|Gelwhite L|Montmorillonite KSF|Montmorillonite K 10|UNII-A585MN1H2L|A585MN1H2L|dialuminum;dioxosilane;oxygen(2-);hydrate|Montmorillonite K-10, granules|Envirobent|Neokunibond|Arcillite|Bedelix|Deriton|Metaloid|Brock|Montmorrillonite|Lavioplast C|Gelwhite H|Gelwhite GP|Kunipia G|Flygtol GA|Imvite E|Imvite K|Kunipia TO|Optigel CL|Dis-Thix Extra|Osmos N|Alabama Blue Clay|Bentolite L 3|AMS (mineral)|Galleonite 136|Hydrocol 2D1|Furonaito 101|Furonaito 113|Kunipia G 4|Mineral C",360.310,Al2H2O12Si4,141.000,18.300,NULL,18,1,12,0,InChI=1S/2Al.4O2Si.H2O.3O/c;;4*1-3-2;;;;/h;;;;;;1H2;;;/q2*+3;;;;;;3*-2,O.[O-2].[O-2].[O-2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.[Al+3].[Al+3],GUJOJGAPFQRJSV-UHFFFAOYSA-N,dialuminum;dioxosilane;oxygen(2-);hydrate,Bentonite,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,13,NULL,20130708,"Acros Organics|AKos Consulting & Solutions|BOC Sciences|ChemIDplus|Comparative Toxicogenomics Database (CTD)|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA Substance Registry Services|FDA/SPL Indexing Data|Finetech Industry Limited|iChemical Technology USA Inc|MolPort|MuseChem|NextMove Software|Parchem|Smolecule|TargetMol (Target Molecule Corp.)|THE BioTek|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
72107716,"1-Methyl-1,2,3,4-tetrahydroquinoline-7-sulfonamide","1-methyl-1,2,3,4-tetrahydroquinoline-7-sulfonamide|1384429-63-3|ZINC74941908|AKOS033293657|MCULE-3775813675|NE32756|1-METHYL-3,4-DIHYDRO-2H-QUINOLINE-7-SULFONAMIDE|Z1367324110",226.300,C10H14N2O2S,71.800,323.000,1.000,15,1,4,1,"InChI=1S/C10H14N2O2S/c1-12-6-2-3-8-4-5-9(7-10(8)12)15(11,13)14/h4-5,7H,2-3,6H2,1H3,(H2,11,13,14)",CN1CCCC2=C1C=C(C=C2)S(=O)(=O)N,OUJFDUTZTPBMDN-UHFFFAOYSA-N,"1-methyl-3,4-dihydro-2H-quinoline-7-sulfonamide",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20131202,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|Enamine|Mcule|MolPort|PATENTSCOPE (WIPO)|Pomerantz Lab, Temple University Lewis Katz School of Medicine|Protein Data Bank in Europe (PDBe)|Smolecule|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
72710628,Nadide sodium,"Nadide sodium|20111-18-6|UNII-B1N53L892B|B1N53L892B|beta-Nicotinamide Adenine Dinucleotide Sodium Salt|beta-DPN|beta-NAD|COZYMASE|diphosphopyridine nucleotide|beta-Dpn sodium salt|NAD|Nicotinamide-adenine dinucleotide monosodium salt|C21H27N7O14P2.Na|MFCD00148917|Adenosine 5'-(trihydrogen diphosphate), p'->5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt, sodium salt (1:1)|beta-Nicotinamide adenine dinucleotide sodium|X3711|Q27274259|beta-Nicotinamide adenine dinucleotide sodium ",685.400,C21H26N7NaO14P2,324.000,1110.000,NULL,45,6,18,11,"InChI=1S/C21H27N7O14P2.Na/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33;/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37);/q;+1/p-1/t10-,11-,13-,14-,15-,16-,20-,21-;/m1./s1",C1=CC(=C[N+](=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C(N=CN=C54)N)O)O)O)O)C(=O)N.[Na+],OGCURMAMSJFXSG-QYZPTAICSA-M,"sodium;[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate",NAD,Classification|Drug and Medication Information|Literature|Names and Identifiers|Safety and Hazards,5,NULL,20140131,"3B Scientific (Wuhan) Corp|Achemtek|AK Scientific, Inc. (AKSCI)|Alfa Chemistry|BOC Sciences|ChemIDplus|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Glentham Life Sciences Ltd.|Smolecule|ToxPlanet|Wikidata|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.",Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
72734365,Harvoni,ledipasvir & sofosbuvir|ledipasvir + sofosbuvir|Harvoni|Sofosbuvir/Ledipasvir|Ledipasvir / sofosbuvir|Sofosbuvir / Ledipasvir|Ledipasvir and sofosbuvir|Sofosbuvir and Ledipasvir|Ledipasvir mixture with sofosbuvir|S900006370,1418.400,C71H83F3N11O15P,327.000,2730.000,NULL,101,7,21,23,"InChI=1S/C49H54F2N8O6.C22H29FN3O9P/c1-24(2)39(56-46(62)64-5)44(60)58-23-48(15-16-48)21-38(58)42-52-22-37(55-42)28-9-13-32-31-12-8-26(18-33(31)49(50,51)34(32)19-28)27-10-14-35-36(20-27)54-43(53-35)41-29-7-11-30(17-29)59(41)45(61)40(25(3)4)57-47(63)65-6;1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h8-10,12-14,18-20,22,24-25,29-30,38-41H,7,11,15-17,21,23H2,1-6H3,(H,52,55)(H,53,54)(H,56,62)(H,57,63);5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,",C[C@@H](C(=O)OC(C)C)N[P@@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3.CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,YWRYBUCQWKGONV-CABNZSRHSA-N,"methyl N-[(2S)-1-[(6S)-6-[5-[9,9-difluoro-7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzimidazol-5-yl]fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptan-5-yl]-3-methyl-1-oxobutan-2-yl]carbamate;propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20140218,ChemIDplus|Comparative Toxicogenomics Database (CTD),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
73425380,"(6R,7R)-7-[[(2E)-2-Ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate","TAK-599|400827-46-5|SCHEMBL1464044|GTPL10899|Q409712|(6R,7R)-7-((Z)-2-(ethoxyimino)-2-(5-(phosphonoamino)-1,2,4-thiadiazol-3-yl)acetamido)-3-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",684.700,C22H21N8O8PS4,330.000,1210.000,2.300,43,4,17,10,"InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/b26-13+/t14-,19-/m1/s1",CCO/N=C(\\C1=NSC(=N1)NP(=O)(O)O)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],ZCCUWMICIWSJIX-XHNDKCDBSA-N,"(6R,7R)-7-[[(2E)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,7,NULL,20140411,"Ambinter|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|NextMove Software|NORMAN Suspect List Exchange|Norris Pharm|SureChEMBL|Wikidata",Chemical Vendors|Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
76956344,Legalon SIL,UNII-57LSQ377IE|57LSQ377IE|Legalon SIL|Silibinin dihemisuccinate disodium|Silybin A disodium dihemisuccinate - Silybin B disodium dihemisuccinate mixt.|1265089-66-4,1453.100,C66H56Na4O32,495.000,1200.000,NULL,102,6,32,24,"InChI=1S/2C33H30O16.4Na/c2*1-44-21-10-15(2-4-18(21)35)31-24(14-45-27(41)8-6-25(37)38)46-20-5-3-16(11-22(20)47-31)32-33(49-28(42)9-7-26(39)40)30(43)29-19(36)12-17(34)13-23(29)48-32;;;;/h2*2-5,10-13,24,31-36H,6-9,14H2,1H3,(H,37,38)(H,39,40);;;;/q;;4*+1/p-4/t24-,31-,32+,33-;24-,31-,32-,33+;;;;/m01..../s1",COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)OC(=O)CCC(=O)[O-])COC(=O)CCC(=O)[O-])O.COC1=C(C=CC(=C1)[C@H]2[C@@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)OC(=O)CCC(=O)[O-])COC(=O)CCC(=O)[O-])O.[Na+].[Na+].[Na+].[Na+],OOOHZLBCDRROTF-KZWBABPKSA-J,"tetrasodium;4-[[(2S,3S)-6-[(2R,3R)-3-(3-carboxylatopropanoyloxy)-5,7-dihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-3-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methoxy]-4-oxobutanoate;4-[[(2R,3R)-6-[(2R,3R)-3-(3-carboxylatopropanoyloxy)-5,7-dihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-3-(4-hydroxy-3-methoxyphenyl)-2,3-dihydro-1,4-benzodioxin-2-yl]methoxy]-4-oxobutanoate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20140825,ChemIDplus|FDA/SPL Indexing Data|ToxPlanet,Curation Efforts|Governmental Organizations|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
78225172,GC373 bound form,4dcd|B1S|GC373 bound form|SCHEMBL19668576|4f49,405.500,C21H31N3O5,117.000,548.000,1.700,29,4,5,11,"InChI=1S/C21H31N3O5/c1-14(2)10-18(24-21(28)29-13-15-6-4-3-5-7-15)20(27)23-17(12-25)11-16-8-9-22-19(16)26/h3-7,14,16-18,25H,8-13H2,1-2H3,(H,22,26)(H,23,27)(H,24,28)/t16-,17-,18-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)CO)NC(=O)OCC2=CC=CC=C2,JUCVXDDMQHPCKT-BZSNNMDCSA-N,benzyl N-[(2S)-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,5,977608,20141002,NCBI Structure|Protein Data Bank in Europe (PDBe)|Shanghai Institute of Organic Chemistry|SureChEMBL,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
89468951,2-(3-Chlorophenyl)-N-(4-methylpyridin-3-yl)acetamide,2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)acetamide|SCHEMBL14818708|UH7,260.720,C14H13ClN2O,42.000,285.000,2.600,18,1,2,3,"InChI=1S/C14H13ClN2O/c1-10-5-6-16-9-13(10)17-14(18)8-11-3-2-4-12(15)7-11/h2-7,9H,8H2,1H3,(H,17,18)",CC1=C(C=NC=C1)NC(=O)CC2=CC(=CC=C2)Cl,ZROFBWFSOGSOQG-UHFFFAOYSA-N,2-(3-chlorophenyl)-N-(4-methylpyridin-3-yl)acetamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20150213,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
94171767,1-[(2~{S})-2-Methylmorpholin-4-yl]-2-pyrazol-1-yl-ethanone,1-[(2~{S})-2-methylmorpholin-4-yl]-2-pyrazol-1-yl-ethanone|ZINC48232216,209.240,C10H15N3O2,47.400,235.000,-0.100,15,0,3,2,"InChI=1S/C10H15N3O2/c1-9-7-12(5-6-15-9)10(14)8-13-4-2-3-11-13/h2-4,9H,5-8H2,1H3/t9-/m0/s1",C[C@H]1CN(CCO1)C(=O)CN2C=CC=N2,YJMLTHJLDUBVIC-VIFPVBQESA-N,1-[(2S)-2-methylmorpholin-4-yl]-2-pyrazol-1-ylethanone,NULL,Biomolecular Interactions and Pathways,1,NULL,20151210,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
96462663,"[(4S)-4-Methylazepan-1-yl]-(1,3-thiazol-4-yl)methanone",ZINC78482923,224.320,C11H16N2OS,61.400,235.000,2.400,15,0,3,1,"InChI=1S/C11H16N2OS/c1-9-3-2-5-13(6-4-9)11(14)10-7-15-8-12-10/h7-9H,2-6H2,1H3/t9-/m0/s1",C[C@H]1CCCN(CC1)C(=O)C2=CSC=N2,ORSJIQSXTAJDMZ-VIFPVBQESA-N,"[(4S)-4-methylazepan-1-yl]-(1,3-thiazol-4-yl)methanone",NULL,Biomolecular Interactions and Pathways,1,NULL,20151211,Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
101731853,CID 101731853,NULL,2088.600,C82H144N33O19S6,933.000,4400.000,3.100,140,40,48,73,"InChI=1S/C82H144N33O19S6/c1-8-42(6)61(76(133)112-57(39-140)74(131)115-62(43(7)117)77(134)100-45(33-116)19-12-24-94-78(84)85)114-73(130)56(38-139)108-66(123)49(23-16-28-98-82(92)93)105-71(128)55(37-138)111-75(132)60(41(4)5)113-59(119)32-99-63(120)46(20-13-25-95-79(86)87)102-64(121)47(21-14-26-96-80(88)89)103-69(126)52(34-135)109-67(124)50(29-40(2)3)106-72(129)54(36-137)107-65(122)48(22-15-27-97-81(90)91)104-70(127)53(35-136)110-68(125)51(101-58(118)31-83)30-44-17-10-9-11-18-44/h9-11,17-18,40-43,45-57,60-62,1",CC[C@@H](C)[C@@H](C(=N[C@H](CS)C(=N[C@@H](C(C)O)C(=N[C@@H](CCCNC(=N)N)[C]=O)O)O)O)N=C([C@H](CS)N=C([C@H](CCCNC(=N)N)N=C([C@H](CS)N=C([C@@H](C(C)C)N=C(CN=C([C@H](CCCNC(=N)N)N=C([C@H](CCCNC(=N)N)N=C([C@H](CS)N=C([C@H](CC(C)C)N=C([C@H](CS)N=C(C(CCCNC(=N)N)N=C([C@H](CS)N=C([C@@H](CC1=CC=CC=C1)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O)O)O,HDWNDHUGXLPURC-PCFJKTKMSA-N,NULL,NULL,NULL,0,NULL,20151218,Japan Chemical Substance Dictionary (Nikkaji),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
118877896,"2-(4-Bromo-2-oxo-1,2-dihydropyridin-1-yl)acetic acid","2-(4-bromo-2-oxo-1,2-dihydropyridin-1-yl)acetic acid|2092511-19-6|2-(4-Bromo-2-oxopyridin-1(2H)-yl)acetic acid|(4-bromo-2-oxopyridin-1(2H)-yl)acetic acid|SCHEMBL17512273|AKOS034008712|ZINC585134740|BrC1=CC(N(C=C1)CC(=O)O)=O|2-(4-bromo-2-oxopyridin-1-yl)acetic acid|CS-0101535|Z2740003180|W3D",232.030,C7H6BrNO3,57.600,282.000,0.400,12,1,3,2,"InChI=1S/C7H6BrNO3/c8-5-1-2-9(4-7(11)12)6(10)3-5/h1-3H,4H2,(H,11,12)",C1=CN(C(=O)C=C1Br)CC(=O)O,INCAMIFWGMKSNK-UHFFFAOYSA-N,2-(4-bromo-2-oxopyridin-1-yl)acetic acid,NULL,Biomolecular Interactions and Pathways|Classification|Patents|Safety and Hazards,4,NULL,20160409,001Chemical|A2B Chem|AA BLOCKS|AbaChemScene|AKos Consulting & Solutions|BenchChem|BLD Pharm|Chem-Space.com Database|Enamine|Google Patents|MolCore BioPharmatech|MolPort|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
122059464,"N-Methyl-N-7H-pyrrolo[2,3-d]pyrimidin-4-yl-beta-alanine","N-methyl-N-7H-pyrrolo[2,3-d]pyrimidin-4-yl-beta-alanine|AKOS027171213|W5J",220.230,C10H12N4O2,82.100,261.000,0.600,16,2,5,4,"InChI=1S/C10H12N4O2/c1-14(5-3-8(15)16)10-7-2-4-11-9(7)12-6-13-10/h2,4,6H,3,5H2,1H3,(H,15,16)(H,11,12,13)",CN(CCC(=O)O)C1=NC=NC2=C1C=CN2,GRUOKIVOQBHPDL-UHFFFAOYSA-N,"3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]propanoic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20160922,AKos Consulting & Solutions|Ambinter|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
127896820,"4-(5-Azaspiro[2.5]octan-5-yl)-7H-pyrrolo[2,3-d]pyrimidine","4-(5-azaspiro[2.5]octan-5-yl)-7H-pyrrolo[2,3-d]pyrimidine|SCHEMBL20470386|W5G",228.290,C13H16N4,44.800,302.000,2.200,17,1,3,1,"InChI=1S/C13H16N4/c1-3-13(4-5-13)8-17(7-1)12-10-2-6-14-11(10)15-9-16-12/h2,6,9H,1,3-5,7-8H2,(H,14,15,16)",C1CC2(CC2)CN(C1)C3=NC=NC4=C3C=CN4,GGTHBUVHAUVHID-UHFFFAOYSA-N,"4-(5-azaspiro[2.5]octan-5-yl)-7H-pyrrolo[2,3-d]pyrimidine",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20170618,Chem-Space.com Database|MolPort|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
130324311,"N-(4-Methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)-4-[(piperazin-1-yl)methyl]benzamide","N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)-4-[(piperazin-1-yl)methyl]benzamide|demethylated masitinib|SCHEMBL19236040|XNJ",484.600,C27H28N6OS,110.000,668.000,3.800,35,3,7,7,"InChI=1S/C27H28N6OS/c1-19-4-9-23(15-24(19)31-27-32-25(18-35-27)22-3-2-10-29-16-22)30-26(34)21-7-5-20(6-8-21)17-33-13-11-28-12-14-33/h2-10,15-16,18,28H,11-14,17H2,1H3,(H,30,34)(H,31,32)",CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCNCC3)NC4=NC(=CS4)C5=CN=CC=C5,LBWSNUMFQJZFGI-UHFFFAOYSA-N,"N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]-4-(piperazin-1-ylmethyl)benzamide",NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20171007,Google Patents|NCBI Structure|Protein Data Bank in Europe (PDBe)|SureChEMBL,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
131844884,CID 131844884,114870-03-0|s3736,1738.200,C31H53N3Na10O49S8,873.000,3450.000,NULL,101,19,52,30,"InChI=1S/C31H53N3O49S8.10Na/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56;;;;;;;;;;/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68);;;;;;;;;;/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17",CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O.[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na],XNHJPDRIKNIMPQ-JASSWCPGSA-N,NULL,NULL,Classification|Drug and Medication Information|Names and Identifiers|Safety and Hazards,4,NULL,20171218,"Chemieliva Pharmaceutical Co., Ltd|Selleck Chemicals",Chemical Vendors|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135398744,Sildenafil,"sildenafil|139755-83-2|VIAGRA|UK-92480|UNII-3M7OB98Y7H|1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine|5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one|CHEMBL192|3M7OB98Y7H|CHEBI:9139|UK 92480-10|5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|NCX-911|Sildenafil [INN:BAN]|5-{2-ETHOXY-5-[(4-METHYLPIPERAZ",474.600,C22H30N6O4S,118.000,838.000,1.500,33,1,8,7,"InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)",CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,BNRNXUUZRGQAQC-UHFFFAOYSA-N,"5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one",Sildenafil Citrate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1195|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1631|1634|1654|1656|1662|1663|1672|1688|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1856|1857|1861|1863|1865|1866|1875|1885|1899|1903|1906|1910|1947|1948|1950|1961|1962|1974|1984|1986|1987|2006|2012|2013|2014|2016|2023|2025|2,20190115,"3WAY PHARM INC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|ApexBio Technology|Apexmol|Ark Pharm, Inc.|ASINEX|Assembly Blocks",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135403814,2-Amino-3H-quinazolin-4-one,"2-Amino-3H-quinazolin-4-one|20198-19-0|2-AMINOQUINAZOLIN-4(3H)-ONE|2-aMinoquinazolin-4-ol|2-aminoquinazolin-4(1h)-one|4(1H)-Quinazolinone, 2-amino-|2-amino-3,4-dihydroquinazolin-4-one|CHEMBL6993|CHEBI:85558|2-imino-1,2,3,4-tetrahydroquinazolin-4-one|AQO|2-amino-1H-quinazolin-4-one|4-Quinazolinol, 2-amino-|2-Amino-4-hydroxyquinazoline|2-amino-4-quinazolone|2-Amino-4-quinazolinol|2-aminoquinazolin-4-one|Maybridge1_001418|2-Amino-quinazolin-4-ol|Oprea1_457085|Oprea1_828358|SCHEMBL103993|2-amino-4-(3H)-quinazol",161.160,C8H7N3O,67.500,237.000,0.100,12,2,2,0,"InChI=1S/C8H7N3O/c9-8-10-6-4-2-1-3-5(6)7(12)11-8/h1-4H,(H3,9,10,11,12)",C1=CC=C2C(=C1)C(=O)NC(=N2)N,SDTFBAXSPXZDKC-UHFFFAOYSA-N,2-amino-3H-quinazolin-4-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,248|422|811|833|1044|1792|1811|1823|2291|58164|405522|434982|492967|602314|652031|977610|1145385|1175065|1259310|1259370|1259374|1259422|1347080|1508586,20190115,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Aceschem Inc|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|BLD Pharm|BOC Sciences|Carbott PharmTech Inc.|Center for Chemical Genomics, Universi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
135415469,"Benzofuro[3,2-D]pyrimidin-4(3H)-one","39786-36-2|3H-Benzo[4,5]furo[3,2-d]pyrimidin-4-one|BENZOFURO[3,2-D]PYRIMIDIN-4(3H)-ONE|benzofuro[3,2-d]pyrimidin-4-ol|1H-[1]benzofuro[3,2-d]pyrimidin-4-one|[1]Benzofuro[3,2-d]pyrimidin-4(3H)-one|[1]Benzofuro[3,2-d]pyrimidin-4-ol|4-Oxo-3,4-dihydro[1]benzofuro[3,2-d]pyrimidin-4(3H)-one|8-oxa-3,5-diazatricyclo[7.4.0.0?,?]trideca-1(13),2(7),3,9,11-pentaen-6-one|3-hydrobenzo[d]pyrimidino[5,4-b]furan-4-one|JG8|SMR000068515|MLS000056019|SCHEMBL1857738|CHEMBL1491070|SCHEMBL22872914|DTXSID90345391|HMS1780D20|HMS2356",186.170,C10H6N2O2,54.600,290.000,1.400,14,1,3,0,"InChI=1S/C10H6N2O2/c13-10-9-8(11-5-12-10)6-3-1-2-4-7(6)14-9/h1-5H,(H,11,12,13)",C1=CC=C2C(=C1)C3=C(O2)C(=O)NC=N3,PCCWPSFTRGJXEF-UHFFFAOYSA-N,"3H-[1]benzofuro[3,2-d]pyrimidin-4-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,360|361|368|373|374|411|422|425|429|430|431|432|436|445|447|448|449|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|612|618|619|620|626|628|629|630|631|633|639|640|641|645|648|662|680|684|689|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|784|793|796|797|798|799|800|802|803|804|,20190115,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alinda Chemical|Amadis Chemical|Ambinter|Angel Pharmatech Ltd.|Anward|Apexmol|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BerrChem|BLD Pharm|Chem-Space.com Database|Chemba",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
135449284,Inosine pranobex,"INOSINE PRANOBEX|Isoprinosine|Inosiplex|Delimmun|36703-88-5|Methisoprinol|Imunovir|Isoviral|Aviral|Viruxan|UNII-W1SO0V223F|NP 113|NPT-10381|W1SO0V223F|Isoprinosin|Isoprinosina|Immunovir|4-Acetamidobenzoic acid,9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purin-6(9H)-one,1-(Dimethylamino)propan-2-ol (3:1:3)|Inosine pranobex [BAN:JAN]|EINECS 253-162-1|NTP 10381|Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3)|Isoprinosine (TN)|Inosine pranobex (JAN)|Inosine, compd.",1115.200,C52H78N10O17,399.000,658.000,NULL,79,13,22,14,"InChI=1S/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3/t4-,6-,7-,10-;;;;;;/m1....../s1",CC(CN(C)C)O.CC(CN(C)C)O.CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,YLDCUKJMEKGGFI-QCSRICIXSA-N,"4-acetamidobenzoic acid;9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one;1-(dimethylamino)propan-2-ol",Inosine Pranobex,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Toxicity,6,NULL,20190115,"AbaChemScene|ABI Chem|Acorn PharmaTech Product List|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|Aurora Fine Chemicals LLC|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|CSNpharm|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Elsa Biotechnology|eNovation Chemicals|FDA/SPL Indexing Data|Glentham Life Sci",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135460973,7-Methylguanosine 5'-diphosphate,7-methylguanosine 5'-diphosphate(1+)|7-Methylguanosine 5'-diphosphate|7-Methyl-gdp|N7-methylguanosine 5'-diphosphate|8NK|N7-Methyl-GDP|7-methyl-GDP(1+)|CHEBI:63730|7-methylguanosine diphosphate(1+)|ZINC15521877|7-Methylguanosine-7-ium5'-diphosphoric acid|C20183|Q27132761,458.240,C11H18N5O11P2+,239.000,791.000,-4.500,29,7,12,6,"InChI=1S/C11H17N5O11P2/c1-15-3-16(8-5(15)9(19)14-11(12)13-8)10-7(18)6(17)4(26-10)2-25-29(23,24)27-28(20,21)22/h3-4,6-7,10,17-18H,2H2,1H3,(H5-,12,13,14,19,20,21,22,23,24)/p+1/t4-,6-,7-,10-/m1/s1",CN1C=[N+](C2=C1C(=O)NC(=N2)N)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)O)O)O,SBASPRRECYVBRF-KQYNXXCUSA-O,"[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents,6,NULL,20190115,"3B Scientific (Wuhan) Corp|ABI Chem|Aurora Fine Chemicals LLC|BindingDB|BioCyc|Biosynth Carbosynth|BOC Sciences|ChEBI|Chembase.cn|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MetabolomicsWorkbench|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Sigma-Aldrich|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
135564839,Normosang,UNII-R1B526117P|Heme arginate|R1B526117P|hemearginat|Normosang|Haem arginate|Normosang (9CI)|heme arginate complex|100438-92-4,792.700,C40H48FeN8O6+2,260.000,1180.000,NULL,55,8,10,13,"InChI=1S/C34H34N4O4.C6H14N4O2.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;7-4(5(11)12)2-1-3-10-6(8)9;/h7-8,13-16,36,38H,1-2,9-12H2,3-6H3,(H,39,40)(H,41,42);4H,1-3,7H2,(H,11,12)(H4,8,9,10);/q;;+2/t;4-;/m.0./s1",CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C=C)C)C(=C4C)C=C)C(=C3CCC(=O)O)C)CCC(=O)O.C(C[C@@H](C(=O)O)N)CN=C(N)N.[Fe+2],HQBGGOLLNATNQC-INZIHYEWSA-N,"(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid;3-[18-(2-carboxyethyl)-7,12-bis(ethenyl)-3,8,13,17-tetramethyl-21,22-dihydroporphyrin-2-yl]propanoic acid;iron(2+)",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Toxicity,5,NULL,20190115,ChemIDplus|FDA/SPL Indexing Data,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
137229597,Isoprinosine,Isoprinosine|Inosine Acedobene Dimepranol|Inosine-2-hydroxypropyldimethylammonium 4-acetamidobenzoate (1:3)|DB13156,1115.200,C52H78N10O17,399.000,658.000,NULL,79,13,22,14,"InChI=1S/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3/t4-,6-,7-,10-;;;;3*5-/m1...111/s1",C[C@H](CN(C)C)O.C[C@H](CN(C)C)O.C[C@H](CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,YLDCUKJMEKGGFI-KSIULYHRSA-N,"4-acetamidobenzoic acid;9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one;(2R)-1-(dimethylamino)propan-2-ol",Inosine Pranobex,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Toxicity,6,NULL,20190125,DrugBank,Curation Efforts|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
137321960,Abivertinib maleate,"Abivertinib maleate|EX-ACEA0010MA|EX-ACEA-0010MA|A610MA|ACEA100610MA|ACEA-100610MA|AC-0010MA|A-610MA|AC0010MA|Abivertinib maleate (USAN)|Abivertinib maleate [USAN]|1822357-78-7|Abivertinib maleate dihydrate|UNII-Y50131AMFJ|Y50131AMFJ|CHEMBL4297866|STI-5656|D11362|2-Propenamide, N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)-, (2Z)-2-butenedioate, hydrate (1:1:2)|N-(3-(2-(3-Fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl",639.600,C30H34FN7O8,175.000,871.000,NULL,46,7,14,9,"InChI=1S/C26H26FN7O2.C4H4O4.2H2O/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34;5-3(6)1-2-4(7)8;;/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32);1-2H,(H,5,6)(H,7,8);2*1H2/b;2-1-;;",CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F.C(=C\\C(=O)O)\\C(=O)O.O.O,QITOONQVTOGMOJ-IUJXYRIYSA-N,"(Z)-but-2-enedioic acid;N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide;dihydrate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20190205,ChEMBL|ChemIDplus|KEGG,Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
145998279,N-(4-Tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide,X77|N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide|HY-136298A|CS-0127760|N-(4-t-butylphenyl)-N-[(1r)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl) ethyl]-1h-imidazole-4-carboxamide,459.600,C27H33N5O2,91.000,679.000,4.900,34,2,4,7,"InChI=1S/C27H33N5O2/c1-27(2,3)20-11-13-22(14-12-20)32(26(34)23-17-29-18-30-23)24(19-8-7-15-28-16-19)25(33)31-21-9-5-4-6-10-21/h7-8,11-18,21,24H,4-6,9-10H2,1-3H3,(H,29,30)(H,31,33)/t24-/m1/s1",CC(C)(C)C1=CC=C(C=C1)N([C@H](C2=CN=CC=C2)C(=O)NC3CCCCC3)C(=O)C4=CN=CN4,MUNFBYOTGGMQOS-XMMPIXPASA-N,N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-pyridin-3-ylethyl]-1H-imidazole-5-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers,4,NULL,20200326,AbaChemScene|MedChemexpress MCE|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|Springer Nature,Chemical Vendors|Governmental Organizations|Journal Publishers,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146018708,Chebi:147409,"GTPL10720|CHEBI:147409|compound 13b [PMID: 32198291]|Tert-butyl  (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-butan-2-yl)ami-no)-3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate|tert-butyl {1-[(2S)-1-({(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-3-cyclopropyl-1-oxopropan-2-yl]-2-oxo-1,2-dihydropyridin-3-yl}carbamate|tert-butyl N-{1-[(1S)-1-{[(1R,2S)-1-(benzylcarbamoyl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-",595.700,C31H41N5O7,166.000,1120.000,2.000,43,5,7,14,"InChI=1S/C31H41N5O7/c1-31(2,3)43-30(42)35-22-10-7-15-36(29(22)41)24(16-19-11-12-19)27(39)34-23(17-21-13-14-32-26(21)38)25(37)28(40)33-18-20-8-5-4-6-9-20/h4-10,15,19,21,23-25,37H,11-14,16-18H2,1-3H3,(H,32,38)(H,33,40)(H,34,39)(H,35,42)/t21-,23-,24-,25+/m0/s1",CC(C)(C)OC(=O)NC1=CC=CN(C1=O)[C@@H](CC2CC2)C(=O)N[C@@H](C[C@@H]3CCNC3=O)[C@H](C(=O)NCC4=CC=CC=C4)O,FRACPXUHUTXLCX-BELIEFIBSA-N,"tert-butyl N-[1-[(2S)-1-[[(2S,3R)-4-(benzylamino)-3-hydroxy-4-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl]amino]-3-cyclopropyl-1-oxopropan-2-yl]-2-oxopyridin-3-yl]carbamate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers,4,NULL,20200410,ChEBI|IUPHAR/BPS Guide to PHARMACOLOGY|Protein Data Bank in Europe (PDBe),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146035933,(2S)-2-Acetamido-N-prop-2-enylbutanediamide,NULL,213.230,C9H15N3O3,101.000,276.000,-1.400,15,3,3,6,"InChI=1S/C9H15N3O3/c1-3-4-11-9(15)7(5-8(10)14)12-6(2)13/h3,7H,1,4-5H2,2H3,(H2,10,14)(H,11,15)(H,12,13)/t7-/m0/s1",CC(=O)N[C@@H](CC(=O)N)C(=O)NCC=C,SLTSADPWEPQRIY-ZETCQYMHSA-N,(2S)-2-acetamido-N-prop-2-enylbutanediamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200519,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037572,2-(Isoquinolin-4-yl)-N-phenylacetamide,2-(isoquinolin-4-yl)-N-phenylacetamide|UGG,262.300,C17H14N2O,42.000,325.000,2.900,20,1,2,3,"InChI=1S/C17H14N2O/c20-17(19-15-7-2-1-3-8-15)10-14-12-18-11-13-6-4-5-9-16(13)14/h1-9,11-12H,10H2,(H,19,20)",C1=CC=C(C=C1)NC(=O)CC2=CN=CC3=CC=CC=C32,XBRJTBLYIAYTOZ-UHFFFAOYSA-N,2-isoquinolin-4-yl-N-phenylacetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037575,N-(4-Methoxypyridin-2-yl)-2-(naphthalen-2-yl)acetamide,N-(4-methoxypyridin-2-yl)-2-(naphthalen-2-yl)acetamide|UGS,292.300,C18H16N2O2,51.200,374.000,3.200,22,1,3,4,"InChI=1S/C18H16N2O2/c1-22-16-8-9-19-17(12-16)20-18(21)11-13-6-7-14-4-2-3-5-15(14)10-13/h2-10,12H,11H2,1H3,(H,19,20,21)",COC1=CC(=NC=C1)NC(=O)CC2=CC3=CC=CC=C3C=C2,LGUXBXKDCLNCEH-UHFFFAOYSA-N,N-(4-methoxypyridin-2-yl)-2-naphthalen-2-ylacetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037576,2-(3-Cyanophenyl)-N-(pyridin-3-yl)acetamide,2-(3-cyanophenyl)-N-(pyridin-3-yl)acetamide|UH1,237.260,C14H11N3O,65.800,333.000,1.300,18,1,3,3,"InChI=1S/C14H11N3O/c15-9-12-4-1-3-11(7-12)8-14(18)17-13-5-2-6-16-10-13/h1-7,10H,8H2,(H,17,18)",C1=CC(=CC(=C1)C#N)CC(=O)NC2=CN=CC=C2,DSTLUTUEFNLBST-UHFFFAOYSA-N,2-(3-cyanophenyl)-N-pyridin-3-ylacetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146672237,SARS-CoV MPro-IN-1,SARS-CoV MPro-IN-1|peptidomimetic aldehydes 11b|CHEBI:152561|BDBM420297|HY-136606|CS-0132246|2413716-71-7|3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide|N-[(1S)-1-[(3-fluorophenyl)methyl]-2-[[(1S)-1-formyl-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]amino]-2-oxoethyl]-1H-indole-2-carboxamide,464.500,C25H25FN4O4,120.000,765.000,2.400,34,4,5,9,"InChI=1S/C25H25FN4O4/c26-18-6-3-4-15(10-18)11-21(24(33)28-19(14-31)12-17-8-9-27-23(17)32)30-25(34)22-13-16-5-1-2-7-20(16)29-22/h1-7,10,13-14,17,19,21,29H,8-9,11-12H2,(H,27,32)(H,28,33)(H,30,34)/t17-,19-,21-/m0/s1",C1CNC(=O)[C@@H]1C[C@@H](C=O)NC(=O)[C@H](CC2=CC(=CC=C2)F)NC(=O)C3=CC4=CC=CC=C4N3,HCRBVFBQANEDDM-CUWPLCDZSA-N,N-[(2S)-3-(3-fluorophenyl)-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]propan-2-yl]-1H-indole-2-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers,3,NULL,20200702,A2B Chem|AA BLOCKS|AbaChemScene|BindingDB|ChEBI|MedChemexpress MCE|Protein Data Bank in Europe (PDBe),Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146672999,"N-[(1R)-2-(Tert-butylamino)-2-oxo-1-pyridin-3-ylethyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)propanamide",NULL,386.500,C21H30N4O3,88.300,553.000,3.200,28,1,5,7,"InChI=1S/C21H30N4O3/c1-8-17(26)25(16-12-15(28-24-16)20(2,3)4)18(14-10-9-11-22-13-14)19(27)23-21(5,6)7/h9-13,18H,8H2,1-7H3,(H,23,27)/t18-/m1/s1",CCC(=O)N(C1=NOC(=C1)C(C)(C)C)[C@H](C2=CN=CC=C2)C(=O)NC(C)(C)C,BFKJCDNTNNMOGO-GOSISDBHSA-N,"N-[(1R)-2-(tert-butylamino)-2-oxo-1-pyridin-3-ylethyl]-N-(5-tert-butyl-1,2-oxazol-3-yl)propanamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20200702,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146673000,"N-(5-Tert-butyl-1,2-oxazol-3-yl)-N-[(1R)-2-(4-methoxy-2-methylanilino)-2-oxo-1-pyridin-3-ylethyl]propanamide",NULL,450.500,C25H30N4O4,97.600,667.000,4.100,33,1,6,8,"InChI=1S/C25H30N4O4/c1-7-22(30)29(21-14-20(33-28-21)25(3,4)5)23(17-9-8-12-26-15-17)24(31)27-19-11-10-18(32-6)13-16(19)2/h8-15,23H,7H2,1-6H3,(H,27,31)/t23-/m1/s1",CCC(=O)N(C1=NOC(=C1)C(C)(C)C)[C@H](C2=CN=CC=C2)C(=O)NC3=C(C=C(C=C3)OC)C,UCJCNZJAAQBBMU-HSZRJFAPSA-N,"N-(5-tert-butyl-1,2-oxazol-3-yl)-N-[(1R)-2-(4-methoxy-2-methylanilino)-2-oxo-1-pyridin-3-ylethyl]propanamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20200702,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
154815735,5-[(E)-(Hydroxyimino)methyl]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide,5-[(E)-(hydroxyimino)methyl]-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide|Y96,332.400,C21H20N2O2,61.700,479.000,4.400,25,2,3,4,"InChI=1S/C21H20N2O2/c1-14-10-11-16(13-22-25)12-20(14)21(24)23-15(2)18-9-5-7-17-6-3-4-8-19(17)18/h3-13,15,25H,1-2H3,(H,23,24)/b22-13+/t15-/m1/s1",CC1=C(C=C(C=C1)/C=N/O)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32,UTAGJMUNTWRPTE-IKMPRTQCSA-N,5-[(E)-hydroxyiminomethyl]-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20201124,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155289181,{[(2S)-1-Oxo-1-(2-oxoimidazolidin-1-yl)propan-2-yl]sulfanyl}acetic acid,{[(2S)-1-oxo-1-(2-oxoimidazolidin-1-yl)propan-2-yl]sulfanyl}acetic acid|W8A,232.260,C8H12N2O4S,112.000,294.000,-0.200,15,2,5,4,"InChI=1S/C8H12N2O4S/c1-5(15-4-6(11)12)7(13)10-3-2-9-8(10)14/h5H,2-4H2,1H3,(H,9,14)(H,11,12)/t5-/m0/s1",C[C@@H](C(=O)N1CCNC1=O)SCC(=O)O,VUVWCZPJVQECKW-YFKPBYRVSA-N,2-[(2S)-1-oxo-1-(2-oxoimidazolidin-1-yl)propan-2-yl]sulfanylacetic acid,NULL,Biomolecular Interactions and Pathways,1,NULL,20201231,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155289416,"N-([1,1'-Biphenyl]-4-yl)-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]furan-2-carboxamide","N-([1,1'-biphenyl]-4-yl)-N-[(1R)-2-oxo-2-{[(1S)-1-phenylethyl]amino}-1-(pyridin-3-yl)ethyl]furan-2-carboxamide|X7V",501.600,C32H27N3O3,75.400,755.000,5.800,38,1,4,8,"InChI=1S/C32H27N3O3/c1-23(24-10-4-2-5-11-24)34-31(36)30(27-14-8-20-33-22-27)35(32(37)29-15-9-21-38-29)28-18-16-26(17-19-28)25-12-6-3-7-13-25/h2-23,30H,1H3,(H,34,36)/t23-,30+/m0/s1",C[C@@H](C1=CC=CC=C1)NC(=O)[C@@H](C2=CN=CC=C2)N(C3=CC=C(C=C3)C4=CC=CC=C4)C(=O)C5=CC=CO5,RYGJIKURQDMMQZ-YUDQIZAISA-N,N-[(1R)-2-oxo-2-[[(1S)-1-phenylethyl]amino]-1-pyridin-3-ylethyl]-N-(4-phenylphenyl)furan-2-carboxamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20201231,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294420,"(2S,3S)-N,2-Dimethyl-1-(methylsulfonyl)piperidine-3-carboxamide","(2S,3S)-N,2-dimethyl-1-(methylsulfonyl)piperidine-3-carboxamide|W24",234.320,C9H18N2O3S,74.900,334.000,-0.300,15,1,4,2,"InChI=1S/C9H18N2O3S/c1-7-8(9(12)10-2)5-4-6-11(7)15(3,13)14/h7-8H,4-6H2,1-3H3,(H,10,12)/t7-,8-/m0/s1",C[C@H]1[C@H](CCCN1S(=O)(=O)C)C(=O)NC,CPUIXPUDABQXEN-YUMQZZPRSA-N,"(2S,3S)-N,2-dimethyl-1-methylsulfonylpiperidine-3-carboxamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294423,"(2R)-1',4'-Dihydro-2'H-spiro[pyrrolidine-2,3'-quinolin]-2'-one","(2R)-1',4'-dihydro-2'H-spiro[pyrrolidine-2,3'-quinolin]-2'-one|W2M",202.250,C12H14N2O,41.100,279.000,1.100,15,2,2,0,"InChI=1S/C12H14N2O/c15-11-12(6-3-7-13-12)8-9-4-1-2-5-10(9)14-11/h1-2,4-5,13H,3,6-8H2,(H,14,15)/t12-/m1/s1",C1C[C@]2(CC3=CC=CC=C3NC2=O)NC1,ABOZUPQQWCLVDB-GFCCVEGCSA-N,"(3R)-spiro[1,4-dihydroquinoline-3,2'-pyrrolidine]-2-one",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294424,"(3R,4R)-4-(2-Methylphenyl)oxolane-3-carboxylic acid","(3R,4R)-4-(2-methylphenyl)oxolane-3-carboxylic acid|W2S",206.240,C12H14O3,46.500,239.000,1.500,15,1,3,2,"InChI=1S/C12H14O3/c1-8-4-2-3-5-9(8)10-6-15-7-11(10)12(13)14/h2-5,10-11H,6-7H2,1H3,(H,13,14)/t10-,11-/m0/s1",CC1=CC=CC=C1[C@@H]2COC[C@@H]2C(=O)O,HRNZEMTYRBZUGX-QWRGUYRKSA-N,"(3R,4R)-4-(2-methylphenyl)oxolane-3-carboxylic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155801623,5-(Azetidin-3-ylamino)-2-methyl-~{N}-[(1~{R})-1-[3-[5-[[[(3~{R})-oxolan-3-yl]amino]methyl]thiophen-2-yl]phenyl]ethyl]benzamide,5-(azetidin-3-ylamino)-2-methyl-~{N}-[(1~{R})-1-[3-[5-[[[(3~{R})-oxolan-3-yl]amino]methyl]thiophen-2-yl]phenyl]ethyl]benzamide|Y97,490.700,C28H34N4O2S,103.000,692.000,3.700,35,4,6,9,"InChI=1S/C28H34N4O2S/c1-18-6-7-22(32-24-14-29-15-24)13-26(18)28(33)31-19(2)20-4-3-5-21(12-20)27-9-8-25(35-27)16-30-23-10-11-34-17-23/h3-9,12-13,19,23-24,29-30,32H,10-11,14-17H2,1-2H3,(H,31,33)/t19-,23-/m1/s1",CC1=C(C=C(C=C1)NC2CNC2)C(=O)N[C@H](C)C3=CC=CC(=C3)C4=CC=C(S4)CN[C@@H]5CCOC5,JZRRCGQQCZGHEA-AUSIDOKSSA-N,5-(azetidin-3-ylamino)-2-methyl-N-[(1R)-1-[3-[5-[[[(3R)-oxolan-3-yl]amino]methyl]thiophen-2-yl]phenyl]ethyl]benzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20210226,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155803732,"2-{3-[3-Chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile","2-{3-[3-chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile|BDBM476978|Inhibitor 3 of SARS-CoV-2 Mpro|XFD",453.900,C27H20ClN3O2,66.200,842.000,4.800,33,0,4,6,"InChI=1S/C27H20ClN3O2/c28-22-10-20(11-24(13-22)33-17-18-7-8-18)26-12-21(25-6-2-1-4-19(25)14-29)16-31(27(26)32)23-5-3-9-30-15-23/h1-6,9-13,15-16,18H,7-8,17H2",C1CC1COC2=CC(=CC(=C2)C3=CC(=CN(C3=O)C4=CN=CC=C4)C5=CC=CC=C5C#N)Cl,UIXRRGFIAVPQEF-UHFFFAOYSA-N,2-[5-[3-chloro-5-(cyclopropylmethoxy)phenyl]-6-oxo-1-pyridin-3-ylpyridin-3-yl]benzonitrile,NULL,Biomolecular Interactions and Pathways,1,NULL,20210305,BindingDB|NCBI Structure|Protein Data Bank in Europe (PDBe),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804440,"(3S,3As,6aR)-2-[3-(3,5-difluorophenyl)propanoyl]-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide",MI-23|GTPL11432|compound 18i [PMID: 33602867],461.500,C24H29F2N3O4,95.600,756.000,1.800,33,2,6,8,"InChI=1S/C24H29F2N3O4/c25-17-8-14(9-18(26)11-17)4-5-21(31)29-12-16-2-1-3-20(16)22(29)24(33)28-19(13-30)10-15-6-7-27-23(15)32/h8-9,11,13,15-16,19-20,22H,1-7,10,12H2,(H,27,32)(H,28,33)/t15-,16-,19-,20-,22-/m0/s1",C1C[C@H]2CN([C@@H]([C@H]2C1)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C=O)C(=O)CCC4=CC(=CC(=C4)F)F,ZUAZJPLYYVHKFN-NAFADOBPSA-N,"(3S,3aS,6aR)-2-[3-(3,5-difluorophenyl)propanoyl]-N-[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide",NULL,Biomolecular Interactions and Pathways|Literature,2,NULL,20210316,IUPHAR/BPS Guide to PHARMACOLOGY|Protein Data Bank in Europe (PDBe),Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804568,Ethyl 3-[[(2R)-2-(4-tert-butyl-N-propanoylanilino)-2-pyridin-3-ylacetyl]amino]propanoate,NULL,439.500,C25H33N3O4,88.600,623.000,3.600,32,1,5,11,"InChI=1S/C25H33N3O4/c1-6-21(29)28(20-12-10-19(11-13-20)25(3,4)5)23(18-9-8-15-26-17-18)24(31)27-16-14-22(30)32-7-2/h8-13,15,17,23H,6-7,14,16H2,1-5H3,(H,27,31)/t23-/m1/s1",CCC(=O)N(C1=CC=C(C=C1)C(C)(C)C)[C@H](C2=CN=CC=C2)C(=O)NCCC(=O)OCC,XNMCYXJNJDNZGB-HSZRJFAPSA-N,ethyl 3-[[(2R)-2-(4-tert-butyl-N-propanoylanilino)-2-pyridin-3-ylacetyl]amino]propanoate,NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804573,N-(4-Tert-butylphenyl)-N-[(1R)-2-(ethylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,367.500,C22H29N3O2,62.300,492.000,3.800,27,1,3,7,"InChI=1S/C22H29N3O2/c1-6-19(26)25(18-12-10-17(11-13-18)22(3,4)5)20(21(27)24-7-2)16-9-8-14-23-15-16/h8-15,20H,6-7H2,1-5H3,(H,24,27)/t20-/m1/s1",CCC(=O)N(C1=CC=C(C=C1)C(C)(C)C)[C@H](C2=CN=CC=C2)C(=O)NCC,YWMXVWPDEYVMJP-HXUWFJFHSA-N,N-(4-tert-butylphenyl)-N-[(1R)-2-(ethylamino)-2-oxo-1-pyridin-3-ylethyl]propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804583,"4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1,4-oxazonane",NULL,246.310,C13H18N4O,54.000,263.000,1.800,18,1,4,1,"InChI=1S/C13H18N4O/c1-2-6-17(7-9-18-8-3-1)13-11-4-5-14-12(11)15-10-16-13/h4-5,10H,1-3,6-9H2,(H,14,15,16)",C1CCN(CCOCC1)C2=NC=NC3=C2C=CN3,UZDOXWRWKJXTPZ-UHFFFAOYSA-N,"4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,4-oxazonane",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804599,Cbz-Thr(tBu)-Phe-Ala(((S)-2-oxopyrrolidin-3-yl))-ol,NULL,596.700,C32H44N4O7,155.000,912.000,2.600,43,5,7,16,"InChI=1S/C32H44N4O7/c1-21(43-32(2,3)4)27(36-31(41)42-20-23-13-9-6-10-14-23)30(40)35-26(17-22-11-7-5-8-12-22)29(39)34-25(19-37)18-24-15-16-33-28(24)38/h5-14,21,24-27,37H,15-20H2,1-4H3,(H,33,38)(H,34,39)(H,35,40)(H,36,41)/t21-,24+,25+,26+,27+/m1/s1",C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C[C@@H]2CCNC2=O)CO)NC(=O)OCC3=CC=CC=C3)OC(C)(C)C,QJOPPFBQFHKESK-FFXRMZKPSA-N,"benzyl N-[(2S,3R)-1-[[(2S)-1-[[(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxobutan-2-yl]carbamate",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804600,"(2R,4R)-1-Phenyl-1,3-diazinane-2,4-diol",NULL,194.230,C10H14N2O2,55.700,183.000,0.800,14,3,4,1,"InChI=1S/C10H14N2O2/c13-9-6-7-12(10(14)11-9)8-4-2-1-3-5-8/h1-5,9-11,13-14H,6-7H2/t9-,10-/m1/s1",C1CN([C@@H](N[C@@H]1O)O)C2=CC=CC=C2,OYDNXLZZNODBTK-NXEZZACHSA-N,"(2R,4R)-1-phenyl-1,3-diazinane-2,4-diol",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804605,"(1R,2S)-2-[[(2S)-2-[[(1S,2S,4S)-2-Bicyclo[2.2.1]hept-5-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,501.600,C22H35N3O8S,180.000,900.000,0.900,34,5,8,12,"InChI=1S/C22H35N3O8S/c1-12(2)7-17(25-22(29)33-11-16-9-13-3-4-14(16)8-13)20(27)24-18(21(28)34(30,31)32)10-15-5-6-23-19(15)26/h3-4,12-18,21,28H,5-11H2,1-2H3,(H,23,26)(H,24,27)(H,25,29)(H,30,31,32)/t13-,14+,15-,16+,17-,18-,21+/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@H](O)S(=O)(=O)O)NC(=O)OC[C@H]2C[C@@H]3C[C@H]2C=C3,WZJYVJHLXCYWFV-NFFJHMNLSA-N,"(1R,2S)-2-[[(2S)-2-[[(1S,2S,4S)-2-bicyclo[2.2.1]hept-5-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804612,"(1S,2S)-2-[[(2S)-2-[[(1R,3S,5S)-3-Bicyclo[3.3.1]non-6-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,529.600,C24H39N3O8S,180.000,932.000,1.700,36,5,8,12,"InChI=1S/C24H39N3O8S/c1-14(2)8-19(27-24(31)35-13-17-10-15-4-3-5-16(9-15)11-17)22(29)26-20(23(30)36(32,33)34)12-18-6-7-25-21(18)28/h3-4,14-20,23,30H,5-13H2,1-2H3,(H,25,28)(H,26,29)(H,27,31)(H,32,33,34)/t15-,16+,17+,18-,19-,20-,23-/m0/s1",CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)[C@@H](O)S(=O)(=O)O)NC(=O)OC[C@H]2C[C@@H]3CC=C[C@@H](C3)C2,ZIWRGXZFSGDQST-UIEASHSYSA-N,"(1S,2S)-2-[[(2S)-2-[[(1R,3S,5S)-3-bicyclo[3.3.1]non-6-enyl]methoxycarbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
774,Histamine,histamine|51-45-6|2-(1H-imidazol-5-yl)ethanamine|Ergamine|1H-Imidazole-4-ethanamine|2-(4-Imidazolyl)ethylamine|Ergotidine|Eramin|5-Imidazoleethylamine|Theramine|2-Imidazol-4-ylethylamine|Free histamine|2-(1H-Imidazol-4-yl)ethanamine|beta-Aminoethylimidazole|Imidazole-4-ethylamine|2-(1H-imidazol-4-yl)ethan-1-amine|beta-Aminoethylglyoxaline|Histamine Base|4-(2-Aminoethyl)-1H-imidazole|65592-96-3|Istamina|4-Imidazoleethylamine|1H-Imidazole-5-ethanamine|beta-Imidazolyl-4-ethylamine|2-(3H-Imidazol-4-yl)-ethylami,111.150,C5H9N3,54.700,64.700,-0.700,8,2,2,2,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",C1=C(NC=N1)CCN,NTYJJOPFIAHURM-UHFFFAOYSA-N,2-(1H-imidazol-5-yl)ethanamine,Histamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|410|411|444|445|446|447|448|450|451|485|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|608|631|662|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|875|878|879|880|881|883|884|885|886|887|889|891|892|893|894|895|898|899|900|901|902|912|914|915|917|918|920|923|924|925|926|927|928|932|938|940|943|944|945|950|951|952|954|957|958|959|992|995|997|998|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5206,Sevoflurane,"sevoflurane|28523-86-6|Sevofluran|Ultane|1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane|Sevorane|Sojourn|MR6S4|Sevofluranum|Sevoflurano|Sevofluranum [INN-Latin]|Sevoflurano [INN-Spanish]|Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether|UNII-38LVP0K73A|Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-|MFCD00153189|38LVP0K73A|CHEBI:9130|MR-6S4|NCGC00167421-01|Sevofrane|Bax 3084|Petrem|fluoromethyl hexafluoroisopropyl ether|Ultane (TN)|BRN 2041023|Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether",200.050,C4H3F7O,9.200,121.000,2.800,12,0,8,2,"InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2",C(OC(C(F)(F)F)C(F)(F)F)F,DFEYYRMXOJXZRJ-UHFFFAOYSA-N,"1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane",Sevoflurane,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Micromolar,14,1471|1490|1688|1766|1768|2528|2546|2551|2662|492961|504327|504332|504749|504832|504834|504847|504865|588211|588212|588213|588214|588215|588216|588217|588218|588219|588579|588834|602332|603950|603951|603952|624030|624031|624032|624044|624170|624172|624173|624296|624297|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|651631|651632|651633|651634|651828|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|72068,20050325,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Amadis Chemical|Angene Chemical|Anward|Aurum Pharmatech LLC|Bangyong Technology  Co., Ltd.|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.co",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5862,Cysteine,"L-cysteine|52-90-4|cysteine|(R)-2-Amino-3-mercaptopropanoic acid|Cystein|Half-cystine|(R)-Cysteine|Thioserine|L-(+)-Cysteine|L-Cystein|beta-Mercaptoalanine|Half cystine|(2R)-2-amino-3-sulfanylpropanoic acid|FREE CYSTEINE|H-Cys-OH|Cysteine, L-|L-Cys|L-Alanine, 3-mercapto-|L-2-Amino-3-mercaptopropionic acid|Cisteinum [Latin]|Cisteina [Spanish]|cisteina|Polycysteine|Cisteinum|Cysteinum|(R)-2-Amino-3-mercaptopropionic acid|L Cysteine|L-Zystein|alpha-Amino-beta-thiolpropionic acid|L-2-Amino-3-mercaptopropanoic a",121.160,C3H7NO2S,64.300,75.300,-2.500,7,3,4,2,"InChI=1S/C3H7NO2S/c4-2(1-7)3(5)6/h2,7H,1,4H2,(H,5,6)/t2-/m0/s1",C([C@@H](C(=O)O)N)S,XUJNEKJLAYXESH-REOHCLBHSA-N,(2R)-2-amino-3-sulfanylpropanoic acid,Cysteine,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,1195|1811|7789|26336|26797|48474|51033|75140|75142|75144|75146|75147|75149|117055|232171|233322|299460|299461|376397|376398|376399|378146|390209|390210|390211|390212|390216|390217|390218|390219|390220|390224|390225|390226|390227|410195|450158|456218|456220|456221|456224|475771|628027|628028|630741|637281|657488|681113|695527|701010|977610|977611|1057590|1116936|1119916|1119917|1119918|1119922|1119923|1133029|1133031|1135698|1135699|1135700|1147029|1147030|1147031|1245190|1259407|1259408|1259409|1288382|1288,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6166,Desoxycortone,"Desoxycortone|desoxycorticosterone|11-Deoxycorticosterone|21-Hydroxyprogesterone|Deoxycorticosterone|Cortexone|64-85-7|Deoxycortone|11-Desoxycorticosterone|Reichstein's substance Q|4-Pregnen-21-ol-3,20-dione|Desossicortone|Desoxicortonum|Kendall's desoxy compound B|21-HYDROXYPREGN-4-ENE-3,20-DIONE|11-Dehydroxycorticosterone|Corticosterone, 11-deoxy-|21-Hydroxy-4-pregnene-3,20-dione|Desoxycorticosteronum|Progesterone, 21-hydroxy-|Pregn-4-ene-3,20-dione, 21-hydroxy-|DOC|1,2(3H)-Deoxycorticosterone|11-Deoxy Co",330.500,C21H30O3,54.400,606.000,2.900,24,1,3,2,"InChI=1S/C21H30O3/c1-20-9-7-14(23)11-13(20)3-4-15-16-5-6-18(19(24)12-22)21(16,2)10-8-17(15)20/h11,15-18,22H,3-10,12H2,1-2H3/t15-,16-,17-,18+,20-,21-/m0/s1",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)CO)CCC4=CC(=O)CC[C@]34C,ZESRJSPZRDMNHY-YFWFAHHUSA-N,"(8S,9S,10R,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",Desoxycorticosterone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|461|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|639|641|645|648|680|684|686|687|701|708|709|719|731|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|793|795|797|798|,20040916,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Aronis|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
9750,Citrulline,"L-citrulline|citrulline|372-75-8|H-cit-oh|delta-Ureidonorvaline|Sitrulline|N5-Carbamoyl-L-ornithine|L-Cytrulline|N(delta)-Carbamylornithine|L(+)-citrulline|N5-(Aminocarbonyl)ornithine|(S)-2-Amino-5-ureidopentanoic acid|Citrulline, L-|alpha-Amino-delta-ureidovaleric acid|N5-carbamoylornithine|Ornithine, N5-(aminocarbonyl)-|L-2-Amino-5-ureidovaleric acid|L-Ornithine, N5-(aminocarbonyl)-|2-Amino-5-ureidovaleric acid|N5-(Aminocarbonyl)-L-ornithine|L-citrullin|(2S)-2-amino-5-(carbamoylamino)pentanoic acid|UNII-2",175.190,C6H13N3O3,118.000,171.000,-4.300,12,4,4,5,"InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1",C(C[C@@H](C(=O)O)N)CNC(=O)N,RHGKLRLOHDJJDR-BYPYZUCNSA-N,(2S)-2-amino-5-(carbamoylamino)pentanoic acid,Citrulline,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,12,875|880|881|884|885|887|889|892|893|894|900|901|902|923|924|995|1030|1379|1452|1454|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|238114|409603|485290|500820|500826|500827|500828|500829|500830|500831|500832|500833|500834|500835|500836|500837|500838|500839|500840|500841|500842|500843|500844|500845|500846|500847|500849|500850|500851|500852|500853|500854|500855|500856|500857|500858|500859|500860|500861|500862|500863|5,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Alsachim|Amadis C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
18614,Methyl 4-aminobutanoate,"Methyl 4-aminobutanoate|Methyl 4-aminobutyrate|3251-07-8|GABA methyl ester|Methyl gamma-aminobutyrate|4-Aminobutyric acid methyl ester|H-GABA-OMe.HCl|H-gamma-Abu-OMe.HCl|Butanoic acid, 4-amino-, methyl ester|BRN 0635882|BUTYRIC ACID, 4-AMINO-, METHYL ESTER|Butanoic acid, 4-amino-, methyl ester (9CI)|methyl-4-aminobutyrate|bmse000249|UPCMLD00WMAL386|SCHEMBL380579|CHEBI:42955|DTXSID10954242|4-amino-butyric acid methyl ester|Butanoicacid,4-amino-,methylester|HMS1747L19|ALBB-016217|ZINC2019854|BBL022695|MFCD002",117.150,C5H11NO2,52.300,72.800,-0.200,8,1,3,4,"InChI=1S/C5H11NO2/c1-8-5(7)3-2-4-6/h2-4,6H2,1H3",COC(=O)CCCN,KVQGGLZHHFGHPU-UHFFFAOYSA-N,methyl 4-aminobutanoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Toxicity,8,485350|485395|493033|504770|540299|588519|720641|1347385,20050712,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alinda Chemical|Amadis Chemical|Ambeed|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
23830,4-(2-Hydroxyethyl)piperazin-1-ylethanesulphonic acid,"2-[4-(2-hydroxyethyl)piperazin-4-ium-1-yl]ethanesulfonate|4-(2-Hydroxyethyl)piperazin-1-ylethanesulphonic acid|BRN 0883043|2-[4-(2-hydroxyethyl)piperazin-1-ium-1-yl]ethanesulfonate|HEPES, Free Acid, ULTROL® Grade|bmse000202|bmse000792|bmse000877|bmse000890|SCHEMBL2417|(4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid|DTXSID5040382|CHEBI:46755|N-2-Hydroxyethylpiperazine-N′-2-ethanesulfonic Acid|AKOS025243245",238.310,C8H18N2O4S,93.500,254.000,-4.100,15,2,5,4,"InChI=1S/C8H18N2O4S/c11-7-5-9-1-3-10(4-2-9)6-8-15(12,13)14/h11H,1-8H2,(H,12,13,14)",C1CN(CC[NH+]1CCO)CCS(=O)(=O)[O-],JKMHFZQWWAIEOD-UHFFFAOYSA-N,2-[4-(2-hydroxyethyl)piperazin-4-ium-1-yl]ethanesulfonate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing,8,NULL,20050808,ABI Chem|AKos Consulting & Solutions|Biological Magnetic Resonance Data Bank (BMRB)|Calbiochem|ChEBI|Chembase.cn|ChemMol|ChemSpider|Crystallography Open Database|DiscoveryGate|EMD Millipore|EPA DSSTox|Hangzhou Trylead Chemical Technology|LeadScope|MP Biomedicals|NextBio|NORMAN Suspect List Exchange|NovoSeek|Smolecule|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
24310,beta-D-Fructopyranose,"beta-D-Fructopyranose|7660-25-5|UNII-R73GS1TJE0|R73GS1TJE0|CHEBI:41005|Frutabs|Fructopyranose, beta-D-|(2R,3S,4R,5R)-2-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol|BDF|HSDB 526|Fructose, pyranose form|(2R,3S,4R,5R)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol|BRN 1423189|3oay|beta-fructopyranose|beta-D,L-fructose|Epitope ID:164059|4-01-00-04402 (Beilstein Handbook Reference)|SCHEMBL366014|DTXSID0023082|HY-N0395|ZINC3861095|AKOS006272120|CS-8113|F0060|N1503|Q63390501|UNII-ED959S6ACY component LKDRXBCSQODPBY-A",180.160,C6H12O6,110.000,162.000,-2.800,12,5,6,1,"InChI=1S/C6H12O6/c7-2-6(11)5(10)4(9)3(8)1-12-6/h3-5,7-11H,1-2H2/t3-,4-,5+,6-/m1/s1",C1[C@H]([C@H]([C@@H]([C@](O1)(CO)O)O)O)O,LKDRXBCSQODPBY-ARQDHWQXSA-N,"(2R,3S,4R,5R)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,14,1195|977608|1259416|1259421,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AbMole Bioscience|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Ambinter|AN PharmaTech|ApexBio Technology|BioCrick|BioCyc|BLD Pharm|BOC Sciences|Broad Institute|ChEBI|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|ChemFaces|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Crystallography Open Database|DC Chemicals|DiscoveryGate|Egon Willigha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
101526,Moxifloxacin hydrochloride,"Moxifloxacin hydrochloride|186826-86-8|Moxifloxacin HCl|Avelox|Avalox|Vigamox|Moxifloxacin (Hydrochloride)|BAY 12-8039|Izilox|UNII-C53598599T|Bay-12-8039|Moxifloxacine hydrochloride|CHEBI:7008|Moxeza|MFCD00949117|C53598599T|DSSTox_CID_25921|DSSTox_RID_81224|DSSTox_GSID_45921|(4aS-cis)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(octahydro-6H-pyrrolol(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride|1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b",437.900,C21H25ClFN3O4,82.100,727.000,NULL,30,3,8,4,"InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1",COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,IDIIJJHBXUESQI-DFIJPDEKSA-N,"7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride",Moxifloxacin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1900|1902|1903|1906|1910|1914|1915|1947|1950|1956|1962|1974|1981|1985|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2252|2253|2280|2300|2380|2384|2391|2401|2435|2445|2462|2517|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|434955|43496,20050808,"3A SpeedChemical Inc|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Apexmol|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
253286,"[1,2,4]Triazolo[4,3-a]pyridin-3-amine","[1,2,4]triazolo[4,3-a]pyridin-3-amine|767-62-4|1,2,4-Triazolo[4,3-a]pyridin-3-amine|NSC76010|s-Triazolo[4,3-a]pyridine, 3-amino-|[1,2,4]Triazolo[4,3-a]pyridin-3-ylamine|(1,2,4)Triazolo(4,3-a)pyridin-3(2H)-imine|3-AMINO-1,2,4-TRIAZOLO[4,3-A]PYRIDINE|[1,2,4]Triazolo[4,3-a]pyridin-3(2H)-imine|4-hydro-1,2,4-triazolo[4,3-a]pyridine-3-ylamine|NSC 76010|s-Triazolo[4, 3-amino-|NCIOpen2_000740|SCHEMBL558515|DTXSID00227497|AMY36455|ZINC8616242|3-amino-s-triazolo[4,3-a]pyridine|1963AC|ANW-74589|MFCD03196503|NSC-76010|",134.140,C6H6N4,56.200,127.000,0.800,10,1,3,0,"InChI=1S/C6H6N4/c7-6-9-8-5-3-1-2-4-10(5)6/h1-4H,(H2,7,9)",C1=CC2=NN=C(N2C=C1)N,NCZQAIFOXJOCFI-UHFFFAOYSA-N,"[1,2,4]triazolo[4,3-a]pyridin-3-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,179,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Achemtek|Acorn PharmaTech Product List|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|ASINEX|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChemBank|Chembase.cn|ChemDB|ChemDiv|Chemenu Inc.|Chemhere|ChemIDplus",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
694486,1-(4-Methoxyphenyl)-3-pyridin-4-ylurea,1-(4-methoxyphenyl)-3-pyridin-4-ylurea|N-(4-methoxyphenyl)-N'-pyridin-4-ylurea|JHJ|Oprea1_201955|CHEMBL274733|SCHEMBL5638178|ZINC67722|STK241162|AKOS000670366|MCULE-5764321752|N-(4-Methoxyphenyl)-N'-(4-pyridyl)urea|1-[(4-Methoxyphenyl)]-3-(pyridin-4-yl)urea,243.260,C13H13N3O2,63.200,259.000,1.400,18,2,3,3,"InChI=1S/C13H13N3O2/c1-18-12-4-2-10(3-5-12)15-13(17)16-11-6-8-14-9-7-11/h2-9H,1H3,(H2,14,15,16,17)",COC1=CC=C(C=C1)NC(=O)NC2=CC=NC=C2,IFKGCTGEAFOLOL-UHFFFAOYSA-N,1-(4-methoxyphenyl)-3-pyridin-4-ylurea,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,132947|135628,20050707,ABI Chem|AKos Consulting & Solutions|Ambinter|ASINEX|Chem-Space.com Database|ChemBank|ChEMBL|ChemDB|ChemSpider|DiscoveryGate|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|Vitas-M Laboratory|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
727174,3-{[(1-Methyl-1H-pyrazol-3-yl)carbonyl]amino}benzoic acid,3-{[(1-methyl-1H-pyrazol-3-yl)carbonyl]amino}benzoic acid|1002651-89-9|3-[(1-methyl-1H-pyrazole-3-carbonyl)amino]benzoic acid|3-[(1-methylpyrazol-3-yl)carbonylamino]benzoic acid|Oprea1_375376|Oprea1_581603|ZINC136098|BBL038022|MFCD01834886|SBB001491|STK298900|AKOS000305987|MCULE-5629035735|ST029211|EN300-83641|3-(1-Methyl-1H-pyrazole-3-carboxamido)benzoic acid|W1M,245.230,C12H11N3O3,84.200,335.000,0.900,18,2,4,3,"InChI=1S/C12H11N3O3/c1-15-6-5-10(14-15)11(16)13-9-4-2-3-8(7-9)12(17)18/h2-7H,1H3,(H,13,16)(H,17,18)",CN1C=CC(=N1)C(=O)NC2=CC=CC(=C2)C(=O)O,CGFLTCVMZJDNKM-UHFFFAOYSA-N,3-[(1-methylpyrazole-3-carbonyl)amino]benzoic acid,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Safety and Hazards,4,NULL,20050708,"A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|Chembase.cn|ChemBridge|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|Enamine|Matrix Scientific|Mcule|NCBI Structure|NextBio|Norris Pharm|Protein Data Bank in Europe (PDBe)|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
743462,1-[4-[(5-Bromothiophen-2-yl)methyl]piperazin-1-yl]ethanone,SMR000103520|MLS000106553|Oprea1_324123|MLS002539755|CHEMBL1493596|HMS2453G04|ZINC19633911|AKOS008955325|MCULE-3225932282|SR-01000208882|SR-01000208882-1,303.220,C11H15BrN2OS,51.800,256.000,1.800,16,0,3,2,"InChI=1S/C11H15BrN2OS/c1-9(15)14-6-4-13(5-7-14)8-10-2-3-11(12)16-10/h2-3H,4-8H2,1H3",CC(=O)N1CCN(CC1)CC2=CC=C(S2)Br,DJIREERJIYHRHW-UHFFFAOYSA-N,1-[4-[(5-bromothiophen-2-yl)methyl]piperazin-1-yl]ethanone,NULL,Biological Test Results|Biomolecular Interactions and Pathways,2,368|373|374|375|422|425|429|430|431|432|436|438|440|441|449|454|455|456|457|460|461|463|465|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|598|601|602|604|606|612|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|680|684|690|696|708|709|710|719|731|738|739|740|746|748|750|751|757|758|759|760|761|764|774|775|777|778|781|782|793|795|797|798|799|800|803|804|813|817|818|827|828|834|841|861|862|868|,20050708,"ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|Chem-Space.com Database|ChemBank|ChEMBL|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MLSMR|MolPort|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|The Scripps Research Institute Molecular Screening Center|UW Madison, Small Molecule Screening Facility|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
782662,4-(3-Chlorobenzyl)morpholine,4-(3-chlorobenzyl)morpholine|4-[(3-chlorophenyl)methyl]morpholine|196792-37-7|Cambridge id 5423354|Oprea1_665931|SCHEMBL4115394|MFCD00090488|STK490412|ZINC19633220|AKOS003355409|MCULE-3073787559|AB00084820-01,211.690,C11H14ClNO,12.500,171.000,2.300,14,0,2,2,"InChI=1S/C11H14ClNO/c12-11-3-1-2-10(8-11)9-13-4-6-14-7-5-13/h1-3,8H,4-7,9H2",C1COCCN1CC2=CC(=CC=C2)Cl,NWMZWMSJQLEJTG-UHFFFAOYSA-N,4-[(3-chlorophenyl)methyl]morpholine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Literature|Patents,4,1159537|1259354,20050708,"ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Combi-Blocks|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|Google Patents|IBM|Mcule|MolPort|NCBI Structure|NextBio|Oakwood Products|Paczesny and Yang Labs, IUPUI and University of Michigan|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Riek",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
863558,4-(1H-Benzimidazol-1-ylmethyl)benzonitrile,"4-(1H-benzimidazol-1-ylmethyl)benzonitrile|4-(1H-1,3-benzodiazol-1-ylmethyl)benzonitrile|118001-91-5|4-(benzimidazol-1-ylmethyl)benzenecarbonitrile|RYM|4-(benzimidazol-1-ylmethyl)benzonitrile|Oprea1_707082|SCHEMBL3496995|HMS1623P18|ZINC419911|SBB098102|AKOS000196420|MCULE-1981371717|NE46376|DA-14989|4-(benzimidazolylmethyl)benzenecarbonitrile|4-(1H-Benzimidazole-1-ylmethyl)benzonitrile|FT-0757328|EN300-59821",233.270,C15H11N3,41.600,324.000,2.800,18,0,2,2,"InChI=1S/C15H11N3/c16-9-12-5-7-13(8-6-12)10-18-11-17-14-3-1-2-4-15(14)18/h1-8,11H,10H2",C1=CC=C2C(=C1)N=CN2CC3=CC=C(C=C3)C#N,KZMYEQMVROHICO-UHFFFAOYSA-N,4-(benzimidazol-1-ylmethyl)benzonitrile,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,485350|485395|492967|493033|504770|540299|588519|720641|720717|1224905,20050709,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|Chem-Space.com Database|ChemBank|Chembase.cn|ChemDB|ChemDiv|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|Enamine|Finetech Industry Limited|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBio|NextMove Software|PATENTSCOPE (WIPO)|Protein Data Ban",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2800022,2-Chloroisonicotinamide,"2-Chloroisonicotinamide|100859-84-5|2-Chloropyridine-4-carboxamide|4-PYRIDINECARBOXAMIDE, 2-CHLORO-|MFCD00221401|PubChem16074|2-chloro-isonicotinamide|ACMC-1BPCQ|Oprea1_265572|2-Chloro-4-pyridinecarboxamide|SCHEMBL1569241|DTXSID40384134|ZINC154099|2-Chloroisonicotinamide, AldrichCPR|ALBB-016300|BCP07880|STR07340|ANW-14383|BBL028416|SBB028324|STL249202|AKOS000205754|AB04952|AM81294|MCULE-2595547677|PS-4674|BP-10303|AB0039331|DB-015947|FT-0611957|ST51040102|Y6780|EN300-75861|A-4090|859C845|X4P",156.570,C6H5ClN2O,56.000,140.000,0.500,10,1,2,1,"InChI=1S/C6H5ClN2O/c7-5-3-4(6(8)10)1-2-9-5/h1-3H,(H2,8,10)",C1=CN=C(C=C1C(=O)N)Cl,DEMJOLRJLACBRX-UHFFFAOYSA-N,2-chloropyridine-4-carboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20050719,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Alinda Chemical|Ambeed|Ambinter|Ampyridine Co.,Ltd|AN PharmaTech|Angene Chemical|Anward|Apexmol|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|BePharm Ltd.|BioChemPartner|Biocore|BLD Pharm|BOC Sciences|BroadPharm|CAPOT",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5714038,5-[(E)-2-Thiophen-2-ylethenyl]-1H-pyrazole,"Terevalefim|UNII-GG91UXK2M5|GG91UXK2M5|SNV-003|ANG-3777|500128-99-4|Refanalin|Terevalefim [INN]|5-[(E)-2-thiophen-2-ylethenyl]-1H-pyrazole|SCHEMBL1225335|CHEMBL4650326|SCHEMBL10149623|ZINC4301780|3-[2-(2-thienyl)ethenyl]-1H-Pyrazole|5-((E)-2-Thiophen-2-yl-vinyl)-lh-pyrazole|(e)-5-(2-(thiophen-2-yl)vinyl)-1h-pyrazole|1H-Pyrazole, 3-((1E)-2-(2-thienyl)ethenyl)-",176.240,C9H8N2S,56.900,170.000,2.200,12,1,2,2,"InChI=1S/C9H8N2S/c1-2-9(12-7-1)4-3-8-5-6-10-11-8/h1-7H,(H,10,11)/b4-3+",C1=CSC(=C1)/C=C/C2=CC=NN2,FOHWAQGURRYJFK-ONEGZZNKSA-N,5-[(E)-2-thiophen-2-ylethenyl]-1H-pyrazole,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20050719,ABI Chem|Aurora Fine Chemicals LLC|ChEMBL|ChemExper Chemical Directory|ChemIDplus|DiscoveryGate|FDA/SPL Indexing Data|Google Patents|IBM|iChemical Technology USA Inc|NextBio|Norris Pharm|PATENTSCOPE (WIPO)|Pi Chemicals|SCRIPDB|SureChEMBL|Thomson Pharma|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
7063878,2-[(Methylsulfonyl)methyl]-1H-benzimidazole,"24092-75-9|2-[(methylsulfonyl)methyl]-1H-benzimidazole|2-(methanesulfonylmethyl)-1H-1,3-benzodiazole|2-methanesulfonylmethyl-1H-benzoimidazole|T6J|2-(methylsulfonylmethyl)-1H-benzimidazole|SCHEMBL18152895|DTXSID30427685|HMS1781C20|ZINC3888556|AKOS009041330|MCULE-3235276835|NE34477|2-(Methylsulfonylmethyl)-1H-benzoimidazole|2-[(Methanesulfonyl)methyl]-1H-benzimidazole|EN300-15256|2-((Methylsulfonyl)methyl)-1H-benzo[d]imidazole|Z126932614",210.260,C9H10N2O2S,71.200,296.000,1.000,14,1,3,2,"InChI=1S/C9H10N2O2S/c1-14(12,13)6-9-10-7-4-2-3-5-8(7)11-9/h2-5H,6H2,1H3,(H,10,11)",CS(=O)(=O)CC1=NC2=CC=CC=C2N1,WCWTYTQSZZWNEW-UHFFFAOYSA-N,2-(methylsulfonylmethyl)-1H-benzimidazole,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,485350|485395|493033|504770|540299|588519|720641,20060729,"3WAY PHARM INC|A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|Chembase.cn|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Day Biochem|DiscoveryGate|Enamine|eNovation Chemicals|EPA DSSTox|Google Patents|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MolPort|NCBI Structure|NextBi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9874518,Angiotensin (1-5),"Angiotensin (1-5)|Angiotensin I/II (1-5)|58442-64-1|Angiotensin(1-5)|Angiotensin I/II 1-5|Angiotensin i/ii(1-5)|ANGIOTENSIN (1 - 5)|HY-P1839|MFCD00214588|ZINC196152141|CS-0096565|C15852|Q58310855|(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoic acid",664.800,C30H48N8O9,302.000,1110.000,-4.700,47,10,11,20,"InChI=1S/C30H48N8O9/c1-5-16(4)24(29(46)47)38-27(44)21(13-17-8-10-18(39)11-9-17)36-28(45)23(15(2)3)37-26(43)20(7-6-12-34-30(32)33)35-25(42)19(31)14-22(40)41/h8-11,15-16,19-21,23-24,39H,5-7,12-14,31H2,1-4H3,(H,35,42)(H,36,45)(H,37,43)(H,38,44)(H,40,41)(H,46,47)(H4,32,33,34)/t16-,19-,20-,21-,23-,24-/m0/s1",CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,UVPBVMCAVNABKX-GXYVSGTKSA-N,"(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20061025,"AbaChemScene|abcr GmbH|Alfa Chemistry|BOC Sciences|ChEBI|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LabNetwork, a WuXi AppTec Company|MedChemexpress MCE|MolPort|NextBio|Smolecule|TargetMol (Target Molecule Corp.)|Thomson Pharma|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
11979606,Lopinavir and ritonavir,"lopinavir + ritonavir|Lopinavir/Ritonavir|Aluvia|Lopinavir and ritonavir|Lopinavir mixture with ritonavir|Lopinavir-Ritonavir mixt|Ritonavir-boosted lopinavir|Ritonavir and Lopinavir mixture|Lopinavir & Ritonavir|369372-47-4|ABT-378 & ABT-538|Lopimune|LPV/r|LPV / RTV|lopinavir-ritonavir|Kaletra(TM)|Aluvia(TM)|Kaletra (TN)|Lopinavir & Norvir|Lopinavir / Ritonavir|SCHEMBL1506739|DTXSID30190428|CHEBI:145924|D02498|Q3836750|(2S)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-",1349.700,C74H96N10O10S2,322.000,1980.000,NULL,96,8,14,33,"InChI=1S/C37H48N6O5S2.C37H48N4O5/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30;1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46);5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t28-,31-,32-,33-;30-,31-,32-,34-/m00",CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O.CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,OFFWOVJBSQMVPI-RMLGOCCBSA-N,"(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide;1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20070109,"ChEBI|ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|KEGG|LeadScope|NextBio|NIAID ChemDB|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|Thomson Pharma|ToxPlanet|Wikidata",Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
15991542,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2S)-2-[4-(2-methylpropyl)phenyl]propanethioate",SFC|(S)-Ibuprofenyl CoA|SFC; (Acyl-CoA); [M+H]+;|15225-EP2275398A1|15225-EP2287154A1|15225-EP2298770A1|15225-EP2301936A1|15225-EP2311842A2|15225-EP2316832A1|15225-EP2316833A1,955.800,C34H52N7O17P3S,389.000,1660.000,-1.900,62,9,22,24,"InChI=1S/C34H52N7O17P3S/c1-19(2)14-21-6-8-22(9-7-21)20(3)33(46)62-13-12-36-24(42)10-11-37-31(45)28(44)34(4,5)16-55-61(52,53)58-60(50,51)54-15-23-27(57-59(47,48)49)26(43)32(56-23)41-18-40-25-29(35)38-17-39-30(25)41/h6-9,17-20,23,26-28,32,43-44H,10-16H2,1-5H3,(H,36,42)(H,37,45)(H,50,51)(H,52,53)(H2,35,38,39)(H2,47,48,49)/t20-,23+,26+,27+,28-,32+/m0/s1",C[C@@H](C1=CC=C(C=C1)CC(C)C)C(=O)SCCNC(=O)CCNC(=O)[C@@H](C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O)O)O,ZWOQHSZKILPKKA-MIXAKNBRSA-N,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (2S)-2-[4-(2-methylpropyl)phenyl]propanethioate",NULL,Biomolecular Interactions and Pathways|Drug and Medication Information,2,NULL,20070328,BioCyc|ChEBI|ChemSpider|DiscoveryGate|Japan Chemical Substance Dictionary (Nikkaji)|MassBank of North America (MoNA)|NCBI Structure|SLING Consortium|Therapeutic Target Database (TTD),Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16791350,1-(2-Aminoethyl)pyridin-2(1H)-one,"1-(2-aminoethyl)pyridin-2(1H)-one|35597-92-3|1-(2-aminoethyl)-1,2-dihydropyridin-2-one|1-(2-aminoethyl)pyridin-2-one|SCHEMBL9342969|CHEMBL4578665|DTXSID50588560|MFCD09738145|ZINC22220049|AKOS000145491|MCULE-5650927848|1-(2-Amino-ethyl)-1H-pyridin-2-one|1-(2-Aminoethyl);pyridin-2(1H);-one|BS-13218|DB-013190|A6216|FT-0753728|Y8846|EN300-58471|597A923|J-502935|WQ7",138.170,C7H10N2O,46.300,184.000,-0.600,10,1,2,2,"InChI=1S/C7H10N2O/c8-4-6-9-5-2-1-3-7(9)10/h1-3,5H,4,6,8H2",C1=CC(=O)N(C=C1)CCN,IZSOENLZRWXCER-UHFFFAOYSA-N,1-(2-aminoethyl)pyridin-2-one,NULL,Biomolecular Interactions and Pathways|Names and Identifiers|Patents,3,NULL,20071113,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Achemtek|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Amadis Chemical|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChangChem|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Debye Scientific Co., Ltd|DiscoveryGate|Enamine|eNovation ",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
17754054,Lysine Nz-Carboxylic Acid,Lysine Nz-Carboxylic Acid|N(6)-carboxy-L-lysine|N(6)-carboxylysine|(2S)-2-amino-6-(carboxyamino)hexanoic acid|N6-carboxylysine|N~6~-carboxy-L-lysine|N(6)-carboxy-L-lysine group|SCHEMBL357483|CHEBI:43575|ZINC6753301|DB03801|Q27094690,190.200,C7H14N2O4,113.000,183.000,-2.700,13,4,5,6,"InChI=1S/C7H14N2O4/c8-5(6(10)11)3-1-2-4-9-7(12)13/h5,9H,1-4,8H2,(H,10,11)(H,12,13)/t5-/m0/s1",C(CCNC(=O)O)C[C@@H](C(=O)O)N,PWIKLEYMFKCERQ-YFKPBYRVSA-N,(2S)-2-amino-6-(carboxyamino)hexanoic acid,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20071120,"ChEBI|Chembase.cn|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|MetabolomicsWorkbench|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Smolecule|Springer Nature|SureChEMBL|Therapeutic Target Database (TTD)|ToxPlanet|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
20786326,N-(4-Methylpyridin-3-yl)acetamide,"N-(4-methylpyridin-3-yl)acetamide|52090-68-3|3-Acetamido-4-picoline|Acetamide, N-(4-methyl-3-pyridinyl)-|SZY|3-acetylamino-4-methylpyridine|SCHEMBL1637363|DTXSID10609801|3-(Acetylamino)-4-methylpyridine|MFCD07776942|N-(4-methylpyridin-3-yl)-acetamide|ZINC22200301|AKOS006283446|AS-30077|CS-0132172|FT-0693642|L-2164|Z1129283193",150.180,C8H10N2O,42.000,147.000,0.400,11,1,2,1,"InChI=1S/C8H10N2O/c1-6-3-4-9-5-8(6)10-7(2)11/h3-5H,1-2H3,(H,10,11)",CC1=C(C=NC=C1)NC(=O)C,WRPYDRDMRXJIJA-UHFFFAOYSA-N,N-(4-methylpyridin-3-yl)acetamide,NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20071205,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Acadechem|AKos Consulting & Solutions|Alichem|Ambeed|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Combi-Blocks|DiscoveryGate|Enamine|eNovation Chemicals|EPA DSSTox|Finetech Industry Limited|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|Key Organics/BIONET|LabNetwo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
23663126,Amoxicillin sodium,"Amoxicillin sodium|34642-77-8|Acuotricina|Ibiamox|Amoxicillin natrium|Amoxycillin|Amoxicillin (sodium)|UNII-544Y3D6MYH|Novabritine|Amoxicillin sodium (Amox)|Amoxicillin sodium [USAN]|544Y3D6MYH|BRL-2333AB-B|Riotapen|CHEBI:51255|Amoxicillin sodium (USAN)|Sodium [2S-[2alpha,5alpha,6beta(S*)]]-6-[[amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate|sodium amoxicillin|Danoxillin|Amitron|Penamox|Quimiopen|Trifamox|Alfida|Lamoxy|Alfoxil Enjektabl|Agram IM|Riotape",387.400,C16H18N3NaO5S,161.000,596.000,NULL,26,3,7,4,"InChI=1S/C16H19N3O5S.Na/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7;/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24);/q;+1/p-1/t9-,10-,11+,14-;/m1./s1",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)[O-])C.[Na+],BYHDFCISJXIVBV-YWUHCJSESA-M,"sodium;(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",Amoxicillin,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards,8,1409605,20080205,"AAA Chemistry|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|AKos Consulting & Solutions|Ambeed|AmicBase - Antimicrobial Activities|AN PharmaTech|Aurora Fine Chemicals LLC|AvaChem Scientific|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|ChemMol|ChemSpider|CSNpharm|DC Chemica",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
23694214,Hydrocortisone sodium succinate,Hydrocortisone sodium succinate|125-04-2|A-hydroCort|Hydrocortisone 21-hemisuccinate sodium salt|Solu-Cortef|UNII-50LQB69S1Z|Buccalsone|Flebocortid|Arcocort|Hycorace|Intracort|Nordicort|Oralsone|Corlan|Emi-Corlin|Solu-Hizon|Solu-Glyc|EF-Cortelan soluble|Hydrocortisone 21-sodium succinate|50LQB69S1Z|CHEBI:5782|Cortisol sodium succinate|Cortisol sodium hemisuccinate|Sodium hydrocortisone succinate|Cortisol hemisuccinate sodium salt|Hydrocortisone sodium hemisuccinate|Hydrocortisone 21-sodium succinide|Sodium ,484.500,C25H33NaO8,141.000,915.000,NULL,34,2,8,7,"InChI=1S/C25H34O8.Na/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30;/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30);/q;+1/p-1/t16-,17-,18-,22+,23-,24-,25-;/m0./s1",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COC(=O)CCC(=O)[O-])O)C)O.[Na+],HHZQLQREDATOBM-CODXZCKSSA-M,"sodium;4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|461|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|639|641|645|648|680|684|686|687|694|701|708|709|719|731|732|746|750|751|757|758|759|760|761|764|770|771|772|774|775|781|782|784|793|,20080205,"3WAY PHARM INC|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|AvaChem Scientific|BOC Sciences|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemSpider|Circadian Research, Kay Laboratory, University of California at San Diego (UCSD)|Collaborative Drug Discovery, Inc.|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Emory University Molecular Libraries Screening Center|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Glentham Life Sciences Ltd.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
52326918,(3R)-1-(2-Fluorophenyl)-3-(methylamino)pyrrolidin-2-one,(3R)-1-(2-fluorophenyl)-3-(methylamino)pyrrolidin-2-one|ZINC49647671|W0G,208.230,C11H13FN2O,32.299,247.000,1.100,15,1,3,2,"InChI=1S/C11H13FN2O/c1-13-9-6-7-14(11(9)15)10-5-3-2-4-8(10)12/h2-5,9,13H,6-7H2,1H3/t9-/m1/s1",CN[C@@H]1CCN(C1=O)C2=CC=CC=C2F,LXSCPIWTZCIAIQ-SECBINFHSA-N,(3R)-1-(2-fluorophenyl)-3-(methylamino)pyrrolidin-2-one,NULL,Biomolecular Interactions and Pathways,1,NULL,20110520,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
53487990,"[(1S,4R,6S,7E,14S,18R)-4-(Cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate","DANOPREVIR|850876-88-9|SCHEMBL2833159|ZINC150357979|CS-0337|AC-32903|HY-10238|2H-Isoindole-2-carboxylic acid, 4-fluoro-1,3-dihydro-, (2R,6S,13aS,14aR,16aS)-14a-[[(cyclopropylsulfonyl)amino]carbonyl]-6-[[(1,1-dimethylethoxy)carbonyl]amino]-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydro-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-2-yl ester",731.800,C35H46FN5O9S,189.000,1530.000,3.300,51,3,10,8,"InChI=1S/C35H46FN5O9S/c1-34(2,3)50-32(45)37-27-13-8-6-4-5-7-11-22-17-35(22,31(44)39-51(47,48)24-14-15-24)38-29(42)28-16-23(19-41(28)30(27)43)49-33(46)40-18-21-10-9-12-26(36)25(21)20-40/h7,9-12,22-24,27-28H,4-6,8,13-20H2,1-3H3,(H,37,45)(H,38,42)(H,39,44)/b11-7+/t22-,23-,27+,28+,35-/m1/s1",CC(C)(C)OC(=O)N[C@H]1CCCCC/C=C/[C@@H]2C[C@]2(NC(=O)[C@@H]3C[C@H](CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,ZVTDLPBHTSMEJZ-AIYSODCISA-N,"[(1S,4R,6S,7E,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20111116,A2Z Chemical|AbaChemScene|AbMole Bioscience|AbovChem LLC|Alsachim|AN PharmaTech|Chem-Space.com Database|ChemMol|ChemShuttle|DC Chemicals|Google Patents|Hairui Chemical|Hangzhou APIChem Technology|MedChemexpress MCE|MolPort|MuseChem|SureChEMBL|Thieme Chemistry|ToxPlanet|Yuhao Chemical|ZINC,Chemical Vendors|Curation Efforts|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
60194102,Proxalutamide,"Proxalutamide|1398046-21-3|UNII-QX6O64GP40|GT-0918|QX6O64GP40|4-(4,4-Dimethyl-3-(6-(3-(oxazol-2-yl)propyl)pyridin-3-yl)-5-oxo-2-thioxoimidazolidin-1-yl)-3-fluoro-2-(trifluoromethyl)benzonitrile|Proxalutamide [WHO-DD]|CHEMBL4594417|SCHEMBL12494226|SB17303|4-(4,4-Dimethyl-3-(6-(3-(2-oxazolyl)propyl)-3-pyridinyl)-5-oxo-2-thioxo-1-imidazolidinyl)-3-fluoro-2-(trifluoromethyl)-benzonitrile|HY-103184|CS-0025229|Q27287540|4-(4,4-dimethyl-3-(6-(3-(oxazol-2-yl)propyl)pyridin-3-yl)-5-oxo-2-thioxoimidazolidin-1-yl)-3-f",517.500,C24H19F4N5O2S,118.000,894.000,4.300,36,0,10,6,"InChI=1S/C24H19F4N5O2S/c1-23(2)21(34)32(17-9-6-14(12-29)19(20(17)25)24(26,27)28)22(36)33(23)16-8-7-15(31-13-16)4-3-5-18-30-10-11-35-18/h6-11,13H,3-5H2,1-2H3",CC1(C(=O)N(C(=S)N1C2=CN=C(C=C2)CCCC3=NC=CO3)C4=C(C(=C(C=C4)C#N)C(F)(F)F)F)C,KCBJGVDOSBKVKP-UHFFFAOYSA-N,"4-[4,4-dimethyl-3-[6-[3-(1,3-oxazol-2-yl)propyl]pyridin-3-yl]-5-oxo-2-sulfanylideneimidazolidin-1-yl]-3-fluoro-2-(trifluoromethyl)benzonitrile",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20121001,"A2B Chem|AA BLOCKS|AbaChemScene|BLD Pharm|ChEMBL|Chemenu Inc.|ChemIDplus|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|MedChemexpress MCE|MolPort|MuseChem|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|Synblock Inc|THE BioTek|Thomson Pharma|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
69211190,Unii-1EL1K52SH1,"Galidesivir HCl|BCX 4430|222631-44-9|UNII-1EL1K52SH1|Galidesivir (hydrochloride)|1EL1K52SH1|BCX4430|(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol hydrochloride|SCHEMBL4838048|CS-3778|SB16943|2-(4-Amino-5H-pyrrolo(3,2-d)pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol|HY-18649|222631-44-9 (HCl)|3,4-Pyrrolidinediol, 2-(4-amino-5H-pyrrolo3,2-dpyrimidin-7-yl)-5-(hydroxymethyl)-, monohydrochloride, (2S,3S,4R,5R)-",301.730,C11H16ClN5O3,140.000,334.000,NULL,20,7,7,2,"InChI=1S/C11H15N5O3.ClH/c12-11-8-6(14-3-15-11)4(1-13-8)7-10(19)9(18)5(2-17)16-7;/h1,3,5,7,9-10,13,16-19H,2H2,(H2,12,14,15);1H/t5-,7+,9-,10+;/m1./s1",C1=C(C2=C(N1)C(=NC=N2)N)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O.Cl,PCCHVYNGFMEGIG-QPAIBFMUSA-N,"(2S,3S,4R,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-(hydroxymethyl)pyrrolidine-3,4-diol;hydrochloride",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20121130,"A2B Chem|AA BLOCKS|AbaChemScene|AbovChem LLC|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|DC Chemicals|eNovation Chemicals|FDA/SPL Indexing Data|LabNetwork, a WuXi AppTec Company|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|Smolecule|SureChEMBL|Synblock Inc|TargetMol (Target Molecule Corp.)|THE BioTek|ToxPlanet",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
92044406,Heparin sodium,heparin sodium|Heparin (sodium salt)|BCP25408,1157.900,C26H42N2NaO37S5+,652.000,2410.000,NULL,71,15,38,21,"InChI=1S/C26H42N2O37S5.Na/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36;/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54);/q;+1",CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O.[Na+],JRTRSJGZMRQDHI-UHFFFAOYSA-N,"sodium;6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid",Heparin,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Use and Manufacturing,6,NULL,20151116,AbovChem LLC|BioChemPartner|MolPort|TargetMol (Target Molecule Corp.)|U-M Center for Drug Repurposing|University of Kansas High Throughput Screening Laboratory|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.,Chemical Vendors|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
94476470,(3R)-N-Methyl-1-(pyridazin-3-yl)piperidin-3-amine,(3R)-N-methyl-1-(pyridazin-3-yl)piperidin-3-amine|ZINC53205008|W0J,192.260,C10H16N4,41.000,174.000,0.400,14,1,4,2,"InChI=1S/C10H16N4/c1-11-9-4-3-7-14(8-9)10-5-2-6-12-13-10/h2,5-6,9,11H,3-4,7-8H2,1H3/t9-/m1/s1",CN[C@@H]1CCCN(C1)C2=NN=CC=C2,QLSDWIHANVSIEK-SECBINFHSA-N,(3R)-N-methyl-1-pyridazin-3-ylpiperidin-3-amine,NULL,Biomolecular Interactions and Pathways,1,NULL,20151211,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
122527270,"Propan-2-yl (2S)-2-[[[(3R,4R,5R)-5-[2-amino-6-(methylamino)purin-9-yl]-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",SCHEMBL18061556|2241337-84-6,581.500,C24H33FN7O7P,185.000,919.000,1.700,40,4,14,12,"InChI=1S/C24H33FN7O7P/c1-13(2)37-21(34)14(3)31-40(35,39-15-9-7-6-8-10-15)36-11-16-18(33)24(4,25)22(38-16)32-12-28-17-19(27-5)29-23(26)30-20(17)32/h6-10,12-14,16,18,22,33H,11H2,1-5H3,(H,31,35)(H3,26,27,29,30)/t14-,16?,18+,22+,24+,40-/m0/s1",C[C@@H](C(=O)OC(C)C)N[P@](=O)(OCC1[C@H]([C@@]([C@@H](O1)N2C=NC3=C(N=C(N=C32)N)NC)(C)F)O)OC4=CC=CC=C4,OISLSHLAXHALQZ-ZXWZJMKMSA-N,"propan-2-yl (2S)-2-[[[(3R,4R,5R)-5-[2-amino-6-(methylamino)purin-9-yl]-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate",NULL,Drug and Medication Information|Patents,2,NULL,20161208,DC Chemicals|Google Patents|PATENTSCOPE (WIPO)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
137254326,"[(1R,3R)-4-[(15Z,17E)-16-Formyl-18-(4-hydroxy-2,2,6,6-tetramethylcyclohexyl)-3,7,12-trimethyl-14-oxooctadeca-2,4,6,8,10,12,15,17-octaenylidene]-3-hydroxy-3,5,5-trimethylcyclohexyl] acetate",Ifx-1|J3.560.481B,672.900,C43H60O6,101.000,1480.000,9.300,49,2,6,13,"InChI=1S/C43H60O6/c1-30(17-14-18-31(2)19-21-39-42(9,10)27-37(49-33(4)45)28-43(39,11)48)15-12-13-16-32(3)23-35(46)24-34(29-44)20-22-38-40(5,6)25-36(47)26-41(38,7)8/h12-24,29,36-38,47-48H,25-28H2,1-11H3/b15-12?,16-13?,18-14?,22-20+,30-17?,31-19?,32-23?,34-24-,39-21?/t36?,37-,38?,43-/m1/s1",CC(=CC=CC(=CC=C1[C@](C[C@@H](CC1(C)C)OC(=O)C)(C)O)C)C=CC=CC(=CC(=O)/C=C(/C=C/C2C(CC(CC2(C)C)O)(C)C)\\C=O)C,XZAPEHKCHWMSPW-MTALQEDYSA-N,"[(1R,3R)-4-[(15Z,17E)-16-formyl-18-(4-hydroxy-2,2,6,6-tetramethylcyclohexyl)-3,7,12-trimethyl-14-oxooctadeca-2,4,6,8,10,12,15,17-octaenylidene]-3-hydroxy-3,5,5-trimethylcyclohexyl] acetate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20190126,Japan Chemical Substance Dictionary (Nikkaji),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
146019222,Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide,Nalpha-acetyl-N-(3-bromoprop-2-yn-1-yl)-L-tyrosinamide|T9J,339.180,C14H15BrN2O3,78.400,405.000,0.800,20,3,3,5,"InChI=1S/C14H15BrN2O3/c1-10(18)17-13(14(20)16-8-2-7-15)9-11-3-5-12(19)6-4-11/h3-6,13,19H,8-9H2,1H3,(H,16,20)(H,17,18)/t13-/m0/s1",CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCC#CBr,NITJFOXRSHCWBE-ZDUSSCGKSA-N,(2S)-2-acetamido-N-(3-bromoprop-2-ynyl)-3-(4-hydroxyphenyl)propanamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200416,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146037574,2-(3-Cyanophenyl)-N-(4-methylpyridin-3-yl)acetamide,2-(3-cyanophenyl)-N-(4-methylpyridin-3-yl)acetamide|UGP,251.280,C15H13N3O,65.800,360.000,1.700,19,1,3,3,"InChI=1S/C15H13N3O/c1-11-5-6-17-10-14(11)18-15(19)8-12-3-2-4-13(7-12)9-16/h2-7,10H,8H2,1H3,(H,18,19)",CC1=C(C=NC=C1)NC(=O)CC2=CC(=CC=C2)C#N,OTFRLGRHXMKEAF-UHFFFAOYSA-N,2-(3-cyanophenyl)-N-(4-methylpyridin-3-yl)acetamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200528,MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
146681430,5-(Acryloylamino)-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide,5-(acryloylamino)-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide|VBY,358.400,C23H22N2O2,58.200,547.000,4.500,27,2,2,5,"InChI=1S/C23H22N2O2/c1-4-22(26)25-18-13-12-15(2)21(14-18)23(27)24-16(3)19-11-7-9-17-8-5-6-10-20(17)19/h4-14,16H,1H2,2-3H3,(H,24,27)(H,25,26)/t16-/m1/s1",CC1=C(C=C(C=C1)NC(=O)C=C)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32,QMJFETCLZITVFG-MRXNPFEDSA-N,2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]-5-(prop-2-enoylamino)benzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20200806,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155294422,"(1R,2S)-2-(Thiophen-3-yl)cyclopentane-1-carboxylic acid","(1R,2S)-2-(thiophen-3-yl)cyclopentane-1-carboxylic acid|W2G",196.270,C10H12O2S,65.500,205.000,2.400,13,1,3,2,"InChI=1S/C10H12O2S/c11-10(12)9-3-1-2-8(9)7-4-5-13-6-7/h4-6,8-9H,1-3H2,(H,11,12)/t8-,9-/m1/s1",C1C[C@@H]([C@@H](C1)C(=O)O)C2=CSC=C2,GTNCFHPRVUWUBC-RKDXNWHRSA-N,"(1R,2S)-2-thiophen-3-ylcyclopentane-1-carboxylic acid",NULL,Biomolecular Interactions and Pathways,1,NULL,20210114,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155801622,N-[(1R)-1-(3-{5-[(Acetylamino)methyl]thiophen-2-yl}phenyl)ethyl]-5-[(azetidin-3-yl)amino]-2-methylbenzamide,N-[(1R)-1-(3-{5-[(acetylamino)methyl]thiophen-2-yl}phenyl)ethyl]-5-[(azetidin-3-yl)amino]-2-methylbenzamide|Y61,462.600,C26H30N4O2S,111.000,673.000,3.300,33,4,5,8,"InChI=1S/C26H30N4O2S/c1-16-7-8-21(30-22-13-27-14-22)12-24(16)26(32)29-17(2)19-5-4-6-20(11-19)25-10-9-23(33-25)15-28-18(3)31/h4-12,17,22,27,30H,13-15H2,1-3H3,(H,28,31)(H,29,32)/t17-/m1/s1",CC1=C(C=C(C=C1)NC2CNC2)C(=O)N[C@H](C)C3=CC=CC(=C3)C4=CC=C(S4)CNC(=O)C,XOTUFJPCITWJHW-QGZVFWFLSA-N,N-[(1R)-1-[3-[5-(acetamidomethyl)thiophen-2-yl]phenyl]ethyl]-5-(azetidin-3-ylamino)-2-methylbenzamide,NULL,Biomolecular Interactions and Pathways,1,NULL,20210226,NCBI Structure|Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
155804534,"5-[[(2-Bromoethylamino)-(ethylamino)phosphoryl]oxymethyl]-N,N-dihydroxy-1-methylimidazol-2-amine",NULL,372.160,C9H19BrN5O4P,112.000,338.000,-0.800,20,4,8,9,"InChI=1S/C9H19BrN5O4P/c1-3-12-20(18,13-5-4-10)19-7-8-6-11-9(14(8)2)15(16)17/h6,16-17H,3-5,7H2,1-2H3,(H2,12,13,18)/t20-/m1/s1",CCN[P@](=O)(NCCBr)OCC1=CN=C(N1C)N(O)O,GTMVCVDSEXJDHD-HXUWFJFHSA-N,"5-[[(2-bromoethylamino)-(ethylamino)phosphoryl]oxymethyl]-N,N-dihydroxy-1-methylimidazol-2-amine",NULL,Biomolecular Interactions and Pathways,1,NULL,20210316,Protein Data Bank in Europe (PDBe),Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
135,4-Hydroxybenzoic acid,"4-HYDROXYBENZOIC ACID|99-96-7|p-Hydroxybenzoic acid|4-Carboxyphenol|Benzoic acid, 4-hydroxy-|p-Salicylic acid|para-Hydroxybenzoic acid|Benzoic acid, p-hydroxy-|4-Hydroxybenzoesaeure|4-hydroxy benzoic acid|p-Oxybenzoesaure [German]|PHBA|4-hydroxy-benzoic acid|Paraben-acid|Acido p-idrossibenzoico [Italian]|Kyselina 4-hydroxybenzoova|Kyselina 4-hydroxybenzoova [Czech]|NSC 4961|UNII-JG8Z55Y12H|4-Hydroxybenzoicacid|HYDROXYBENZOIC ACID, PARA|p-hydroxy benzoic acid|p-hydroxy-Benzoic acid|Hydroxybenzoic acid|MFCD00",138.120,C7H6O3,57.500,125.000,1.600,10,2,3,1,"InChI=1S/C7H6O3/c8-6-3-1-5(2-4-6)7(9)10/h1-4,8H,(H,9,10)",C1=CC(=CC=C1C(=O)O)O,FJKROLUGYXJWQN-UHFFFAOYSA-N,4-hydroxybenzoic acid,NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,155|157|161|165|167|175|1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|23251|23252|23253|23254|23255|23256|24263|24265|25612|25613|26261|26793|28497|28691|28731|29132|40626|40936|55746|69558|69709|125426|147482|213093|226477|226478|237685|260086|260087|274670|278000|290547|290548|293934|320801|331291|331292|331293|337835|337837|338431|338432|338433|338434|338435|338436|338437|338438|338439|338440|338441|338442|338443|338444|338445|338446|338447|338448|338449|342475,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Anward|Apexmol|Ark Pharm,",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
244,Benzyl Alcohol,"benzyl alcohol|phenylmethanol|benzenemethanol|100-51-6|phenylcarbinol|Benzoyl alcohol|benzylalcohol|Benzenecarbinol|Hydroxytoluene|Phenylmethyl alcohol|alpha-Toluenol|(Hydroxymethyl)benzene|Phenolcarbinol|Benzal alcohol|alpha-hydroxytoluene|benzylic alcohol|Alcool benzylique|Benzylicum|Methanol, phenyl-|Phenylcarbinolum|hydroxymethylbenzene|Phenyl-Methanol|BENZYL-ALCOHOL|Euxyl K 100|Bentalol|Aromatic alcohol|Caswell No. 081F|.alpha.-Toluenol|Benzyl alcohol (natural)|Alcool benzilico [DCIT]|Itch-X|alcoholum ",108.140,C7H8O,20.200,55.400,1.100,8,1,1,1,"InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2",C1=CC=C(C=C1)CO,WVDDGKGOMKODPV-UHFFFAOYSA-N,phenylmethanol,Benzyl Alcohol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,155|157|161|165|167|175|192|248|328|330|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1189|1194|1195|1199|1204|1205|1208|1452|1457|1458|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Achemica|Achemtek|Acros Organics|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|Aromalake Chemical|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
311,Citric acid,"citric acid|77-92-9|2-hydroxypropane-1,2,3-tricarboxylic acid|Citric acid, anhydrous|Anhydrous citric acid|Citro|Citretten|Aciletten|Chemfill|Hydrocerol A|1,2,3-Propanetricarboxylic acid, 2-hydroxy-|Kyselina citronova|2-hydroxy-1,2,3-propanetricarboxylic acid|2-Hydroxytricarballylic acid|Citric acid anhydrous|Caswell No. 221C|F 0001 (polycarboxylic acid)|3-Carboxy-3-hydroxypentane-1,5-dioic acid|2-Hydroxypropanetricarboxylic acid|FEMA No. 2306|FEMA Number 2306|K-Lyte|Kyselina citronova [Czech]|K-Lyte DS|CCR",192.120,C6H8O7,132.000,227.000,-1.700,13,4,7,5,"InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)",C(C(=O)O)C(CC(=O)O)(C(=O)O)O,KRKNYBCHXYNGOX-UHFFFAOYSA-N,"2-hydroxypropane-1,2,3-tricarboxylic acid",Citric Acid,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,155|157|161|165|167|175|179|248|256|328|330|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1189|1195|1208|1376|1385|1422|1452|1457|1458|1465|1469|1471|1476|1477|1478|1479|1511|1529|1530|,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
447,3-Chlorobenzoic acid,"3-chlorobenzoic acid|535-80-8|m-chlorobenzoic acid|Benzoic acid, 3-chloro-|Benzoic acid, m-chloro-|3-chloro-benzoic acid|Acido m-clorobenzoico|meta-chlorobenzoic acid|MFCD00002491|UNII-02UOJ7064K|MCBA|CHEMBL20563|CHEBI:49410|02UOJ7064K|3-Chlorobenzoic acid, 99+%|CCRIS 5992|Acido m-clorobenzoico [Italian]|HSDB 6018|NSC 8443|EINECS 208-618-4|BRN 0907218|AI3-17210|3-cholro-benzoate|m-chloro benzoic acid|PubChem8991|3-chloro benzoic acid|3-cholro-benzoic acid|m-ClC6H4COOH|ACMC-1BMXG|meta-chloro benzoic acid|DSS",156.560,C7H5ClO2,37.300,136.000,2.700,10,1,2,1,"InChI=1S/C7H5ClO2/c8-6-3-1-2-5(4-6)7(9)10/h1-4H,(H,9,10)",C1=CC(=CC(=C1)Cl)C(=O)O,LULAYUGMBFYYEX-UHFFFAOYSA-N,3-chlorobenzoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Micromolar,12,155|157|161|165|167|175|248|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1452|1457|1458|1469|1471|1476|1477|1478|1479|1948|2101|2107|2112|2120|2517|2546|2549|2551|28497|28691|28692|286,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|An",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
985,Palmitic acid,"palmitic acid|Hexadecanoic acid|57-10-3|Cetylic acid|palmitate|n-Hexadecanoic acid|Hexadecylic acid|Hydrofol|n-Hexadecoic acid|1-Pentadecanecarboxylic acid|Palmitinic acid|Pentadecanecarboxylic acid|C16 fatty acid|hexaectylic acid|1-Hexyldecanoic Acid|hexadecoic acid|Industrene 4516|Emersol 140|Emersol 143|Hystrene 8016|Hystrene 9016|Palmitic acid, pure|Palmitinsaeure|Palmitic acid 95%|Palmitic acid (natural)|Fatty acids, C14-18|Prifac 2960|FEMA No. 2832|Pristerene 4934|Edenor C16|Kortacid 1698|Lunac P 95KC",256.420,C16H32O2,37.300,178.000,6.400,18,1,2,14,"InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)",CCCCCCCCCCCCCCCC(=O)O,IPCSVZSSVZVIGE-UHFFFAOYSA-N,hexadecanoic acid,Palmitic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,155|157|161|165|167|175|248|330|880|1201|1469|1471|1479|1487|1490|1688|1766|1768|2528|2546|2551|2662|18491|18492|18493|18494|18495|18496|18497|18498|18499|18665|18666|18667|18668|18669|18670|18671|18672|18673|18674|18675|18676|18677|18678|18679|18680|18681|18682|18683|18684|18685|32788|40631|71607|241812|241834|241835|242001|261940|268957|307907|307908|307909|337692|337693|359949|359950|359951|359952|359953|359954|359955|359956|359957|359958|359959|359960|360178|360179|360927|360928|361446|361447|361448|361,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
1046,Pyrazinamide,pyrazinamide|pyrazinecarboxamide|98-96-4|pyrazine-2-carboxamide|pyrazinoic acid amide|2-Pyrazinecarboxamide|Zinamide|Aldinamide|Tebrazid|Aldinamid|Pirazinamid|Pyrazineamide|Pyrafat|Unipyranamide|Farmizina|Pirazimida|pyrazine carboxylamide|Eprazin|Novamid|2-Carbamylpyrazine|Pyrazinecarboxylic acid amide|Pyrazinamidum|Pirazinamide|Pyrazine carboxamide|D-50|MK 56|C5H5N3O|PZA|NCI-C01785|UNII-2KNI5N06TI|MFCD00006132|NSC 14911|T 165|Pirazinamida|Tisamid|Isopas|2KNI5N06TI|MLS000069730|Pezetamid|Piraldina|CHEBI:452,123.110,C5H5N3O,68.900,115.000,-0.600,9,1,3,1,"InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)",C1=CN=C(C=N1)C(=O)N,IPEHBUMCGVEMRF-UHFFFAOYSA-N,pyrazine-2-carboxamide,Pyrazinamide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,155|157|161|165|167|175|357|368|374|377|410|411|421|422|426|427|429|433|434|435|436|444|445|446|447|448|450|451|485|526|530|539|540|541|542|543|544|545|546|547|555|556|565|568|573|577|583|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|606|607|618|620|631|645|654|655|656|657|658|659|660|661|662|663|664|665|666|667|694|708|709|731|732|750|757|758|759|760|761|764|774|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|847|861|862|868|871|873|875|878|879|880|881|883|884|885|886|887|889|891|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambe",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1110,Succinic acid,"succinic acid|butanedioic acid|110-15-6|Amber acid|Asuccin|Wormwood acid|Dihydrofumaric acid|Katasuccin|Bernsteinsaure|ethylenesuccinic acid|1,2-Ethanedicarboxylic acid|1,4-Butanedioic acid|Wormwood|Butandisaeure|Acidum succinicum|Butanedionic acid|Kyselina jantarova|Butane diacid|Ethylene dicarboxylic acid|Spirit of amber|Bernsteinsaure [German]|Kyselina jantarova [Czech]|MFCD00002789|Ammonium succinate|HSDB 791|succinic-acid|UNII-AB6MNQ6J6L|succ|NSC 106449|AI3-06297|Succinic acid, 99%|AB6MNQ6J6L|Butanedio",118.090,C4H6O4,74.600,92.600,-0.600,8,2,4,3,"InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)",C(CC(=O)O)C(=O)O,KDYFGRWQOYBRFD-UHFFFAOYSA-N,butanedioic acid,Succinic Acid,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,155|157|161|165|167|175|192|194|248|256|270|328|330|880|881|894|1030|1195|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1811|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|19262|95754|110255|121647|216185|258399|328866|344916|344917|344918|344926|349747|349748|398683|398684|429168|446352|446353|446356|447578|485281|485290|492961|504327|504332|504749|504832|504834|504847|504865|588220|588579|588834|602332|624030|624031|624032|624044|6241,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Acesobio|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., U",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1533,2-Amino-4-methylpyridine,"2-amino-4-methylpyridine|4-METHYLPYRIDIN-2-AMINE|695-34-1|2-Amino-4-picoline|Ascensil|2-Pyridinamine, 4-methyl-|4-Methyl-2-pyridinamine|4-Methyl-2-pyridylamine|4-Methyl-2-aminopyridine|W 45 Raschig|4-PICOLINE, 2-AMINO-|Methyl-4 amino-2-pyridine|4M2AP|Pyridine, 2-amino-4-methyl-|4-methylpyridin-2-ylamine|2-amino-4-methyl pyridine|RA 1226|NSC 1490|NSC 6972|VMI 20-4|MFCD00006321|UNII-394N1Z644H|2-amino-4-methyl-pyridine|4-Methyl-pyridin-2-ylamine|W 45|CHEMBL40833|394N1Z644H|2-Amino-4-methylpyridine (2-Amino-4-",108.140,C6H8N2,38.900,72.900,0.600,8,1,2,0,"InChI=1S/C6H8N2/c1-5-2-3-8-6(7)4-5/h2-4H,1H3,(H2,7,8)",CC1=CC(=NC=C1)N,ORLGLBZRQYOWNA-UHFFFAOYSA-N,4-methylpyridin-2-amine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,155|157|161|165|167|175|410|411|445|447|448|450|451|526|530|584|585|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|912|923|924|926|938|995|1030|1379|1452|1454|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1851|1865|1948|2101|2107|2112|2147|2240|2241|2275|2313|2316|2322|2330|2451|2472|2517|2528|2546|2549|2551|67996|68131|68141|91998|92001|92009|129606|146107|146109|146120|146264|197468|234083|234085|428579|428581|428583|434959|4852,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Ampyridine Co.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1738,Homovanillic acid,"Homovanillic acid|306-08-1|4-Hydroxy-3-methoxyphenylacetic acid|2-(4-hydroxy-3-methoxyphenyl)acetic acid|Vanillacetic acid|Benzeneacetic acid, 4-hydroxy-3-methoxy-|Homovanillate|Homovaniuic acid|Vanilacetic acid|3-Methoxy-4-hydroxyphenylacetic acid|(4-HYDROXY-3-METHOXYPHENYL)ACETIC ACID|4-Hydroxy-3-methoxybenzeneacetic acid|HVA|Homovanilic acid|Homovanillinic acid|UNII-X77S6GMS36|MFCD00004350|3-Methoxy-4-hydroxyphenylacetate|Homovanillic acid, 98%|NSC 16682|2-(4-hydroxy-3-methoxy-phenyl)acetic acid|X77S6GMS",182.170,C9H10O4,66.800,181.000,0.400,13,2,4,3,"InChI=1S/C9H10O4/c1-13-8-4-6(5-9(11)12)2-3-7(8)10/h2-4,10H,5H2,1H3,(H,11,12)",COC1=C(C=CC(=C1)CC(=O)O)O,QRMZSPFSDQBLIX-UHFFFAOYSA-N,2-(4-hydroxy-3-methoxyphenyl)acetic acid,Homovanillic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,155|157|161|165|167|175|357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|781|782|798|800|873|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1021|1022|1030|1046|1085|1230|1236|1242|1274|1376|1377|1379|1381|1385|1415|1422|1423|1430|1434|1439|1440|1441|1443|1445|1452|1454|1456|1457|1458|1459|1460|1,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2130,Amantadine,"amantadine|1-Adamantanamine|768-94-5|adamantan-1-amine|1-Adamantylamine|1-Aminoadamantane|Adamantanamine|Adamantylamine|Aminoadamantane|Symmetrel|Amantidine|Symadine|Pk-merz|Adamantamine|1-Adamantamine|Amantadina|Amantadinum|adamantan-1-ylamine|Gocovri|TCMDC-125869|1-adamantaneamine|UNII-BF4C9Z1J53|1-Aminotricyclo(3.3.1.1(sup 3,7))decane|MFCD00074732|NSC 341865|Tricyclo(3.3.1.13,7)decan-1-amine|tricyclo[3.3.1.1~3,7~]decan-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|CHEMBL660|adamantanylamine|(3s,5s,7s)-Tric",151.250,C10H17N,26.000,144.000,2.400,11,1,1,0,"InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2",C1C2CC3CC1CC(C2)(C3)N,DKNWSYNQZKUICI-UHFFFAOYSA-N,adamantan-1-amine,Amantadine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,179|292|330|357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|895|899|900|901|902|912|914|915|917|918|922|923|924|925|926|927|928|934|935|938|943|944|945|954|957|958|959|992|995|997|998|1030|1188|1195|1332|1452|1457|1458|1460|1463|1468|1469|1471|1477|1479|1487|1490|1688|1766|1768|1851|1865|2062|2101|2107|2112|2297|2302|2303|2304|2305|2306|2517|2528|2546|2549|2551|2660|2666|2667|2668|7783|800,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2162,Amlodipine,"amlodipine|88150-42-9|Norvasc|AMLODIPINE BASE|Amlodipino|Amlodipinum|Caduet|Istin|Amlodipine Free Base|Amvaz|Amlodis|CHEBI:2668|3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate|Norvasc (TN)|Amlocard|Coroval|Lipinox|3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate|UK-4834011|Amlor|Amlodipinum [Latin]|Amlodipino [Spanish]|88150-42-9 (free base)|Amdepin|Amdipin|Amlodin|Pelmec|MFCD00864687|3-O",408.900,C20H25ClN2O5,99.900,647.000,3.000,28,2,7,10,"InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3",CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,HTIQEAQVCYTUBX-UHFFFAOYSA-N,"3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate",Amlodipine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1195|1376|1385|1422|1465|1469|1477|1479|1490|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1766|1768|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2107|2112|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2240|2241|2247|2275|2280|2300|2313|2314|2315|2322|2330|2391|2435|2445|2451|2462|2472|2517|2528|2546|2549|2550|2551|2553|2557|2563|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|27,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Alsachim|Amadis ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2375,Bicalutamide,"bicalutamide|90357-06-5|Casodex|Cosudex|Bicalutamide (CDX)|Calutide|ICI 176334|ICI-176334|N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide|N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide|Bicalutamide (Casodex)|CHEMBL409|ICI 176,334|MFCD00869971|N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide|Raffolutil|Kalumid|Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4",430.400,C18H14F4N2O4S,116.000,750.000,2.300,29,2,9,5,"InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)",CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,LKJPYSCBVHEWIU-UHFFFAOYSA-N,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|880|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1466|1467|1468|1469|1477|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1662|1663|1,20050325,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Au",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2541,Candesartan,"candesartan|139481-59-7|CV-11974|1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid|CV 11974|2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid|UNII-S8Q36MD2XX|C24H20N6O3|CHEMBL1016|S8Q36MD2XX|2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|CHEBI:3347|2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid|Candesartan cilexetil related compound g|NCGC",440.500,C24H20N6O3,119.000,660.000,4.100,33,2,7,7,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,HTQMVQVXFRQIKW-UHFFFAOYSA-N,2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1195|1471|1490|1688|1766|1768|2063|2528|2546|2551|2662|16032|23226|23686|23918|26234|26605|27037|27862|29138|37516|37529|39030|39036|39038|39039|39652|39791|166990|167359|167803|181931|181935|183722|183723|183919|183920|183921|183922|183923|184050|184209|185262|185264|185267|185269|185270|185393|197344|237099|237841|237981|239874|239885|242919|243379|247116|311524|364008|364010|386623|412478|412480|492961|504327|504332|504749|504832|504834|504847|504865|568789|568897|568918|588209|588210|588579|588834|60233,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alomone Labs|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|ApexBio Technology|Apexmol|Ark ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2794,Clofazimine,"clofazimine|2030-63-9|Lamprene|Lampren|Chlofazimine|Clofazimina|Clofaziminum|B 663 (Pharmaceutical)|Clofaziminum [INN-Latin]|Clofazimina [INN-Spanish]|NSC-141046|G 30320|B-663|N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine|UNII-D959AE5USF|3-(p-Chloranilino)-10-(p-chlorphenyl)-2,10-dihydro-2-(isopropylimino)-phenazin|B 663|3-(p-Chloranilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)-phenazine|3-(p-Chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2-(isopropylimino)phenazine|D959AE5USF|CHE",473.400,C27H22Cl2N4,40.000,829.000,7.100,33,1,4,4,"InChI=1S/C27H22Cl2N4/c1-17(2)30-24-16-27-25(15-23(24)31-20-11-7-18(28)8-12-20)32-22-5-3-4-6-26(22)33(27)21-13-9-19(29)10-14-21/h3-17,31H,1-2H3",CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,WDQPAMHFFCXSNU-UHFFFAOYSA-N,"N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine",Clofazimine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,179|357|361|364|368|371|373|374|375|377|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|461|483|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|550|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|601|603|604|605|606|607|609|614|615|618|620|622|623|624|625|626|628|641|645|662|680|684|686|691|700|708|709|746|750|751|770|771|772|774|784|795|813|847|875|880|881|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|AmicBase - Antimicrobial Activities|AN PharmaTech|Angel Pharmatech Ltd.|ApexBio Technology|Apexmol|Ark",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
2955,Dapsone,"dapsone|80-08-0|4,4'-Sulfonyldianiline|4,4'-Diaminodiphenyl sulfone|Diaphenylsulfone|Dapson|4-Aminophenyl sulfone|4,4'-Diaminodiphenylsulfone|Diaphenylsulfon|Sulfona|DADPS|Bis(4-aminophenyl) sulfone|Avlosulfone|Diphenasone|Sulfadione|Sulphadione|Disulone|Udolac|p-Aminophenyl sulfone|Avlosulfon|Croysulfone|Dapsonum|Dumitone|Novophone|Aczone|Diphone|Eporal|Diaphenylsulphon|Diaphenylsulphone|Metabolite C|Sulfonyldianiline|Sumicure S|Bis(p-aminophenyl) sulfone|Sulphonyldianiline|p,p-Sulphonylbisbenzamine|Sulfon",248.300,C12H12N2O2S,94.600,306.000,1.000,17,2,4,2,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,MQJKPEGWNLWLTK-UHFFFAOYSA-N,4-(4-aminophenyl)sulfonylaniline,Dapsone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,155|157|161|165|167|175|179|192|200|212|220|222|226|248|302|330|357|361|364|368|371|373|374|375|410|411|421|422|425|426|427|429|430|431|432|433|434|435|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|540|541|542|543|544|545|546|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|607|609|614|615|618|620|622|623|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Achemica|Achemtek|Acros Organics|ACT Chemical|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alinda Chemical|Alsachim|Amadis Chemical|Ambeed|AmicBase - Antimicrobial Activities|AN PharmaTech|Angen",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3157,Doxazosin,"doxazosin|74191-85-8|Doxazosine|Doxazosina|Doxazosinum|UK 33274|1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone|CHEBI:4708|UK-33274|(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone|Doxazosine [French]|Doxazosinum [Latin]|Doxa",451.500,C23H25N5O5,112.000,678.000,2.500,33,1,9,4,"InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)",COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,"[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone",Doxazosin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,14,1195|1332|2062|2240|2241|2275|2313|2316|2322|2330|2660|2666|2667|2668|27167|28681|29123|29125|29127|29359|29813|35155|35266|35328|35468|35952|36124|36231|36259|36408|36469|36505|36506|36509|36618|36753|37033|37252|37335|37478|62832|62833|195503|195504|197367|197369|232245|232246|239799|239800|239801|247991|257357|257358|257359|257360|257361|257362|257363|257364|257365|257366|257369|294856|311524|386623|391760|422824|422825|422826|422827|422828|422829|422830|422831|422832|422833|422834|422835|422836|422837|4,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|Anward|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LL",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3325,Famotidine,famotidine|76824-35-6|Famotidinum|Famotidina|Brolin|Gastro|PEPCID|Apogastine|Gastrodomina|Gastrosidin|Amfamox|Antodine|Bestidine|Blocacid|Confobos|Cuantin|Famocid|Famodar|Famodil|Famodin|Famodine|Famogard|Famonit|Famopsin|Famosan|Famotal|Famotep|Famotin|Famovane|Famowal|Gastridan|Gastridin|Gastrion|Gastrofam|Gastropen|Huberdina|Ingastri|Invigan|Lecedil|Mensoma|Midefam|Neocidine|Nevofam|Notidin|Nulceran|Nulcerin|Panalba|Pepcidin|Pepdine|Pepfamin|Peptidin|Purifam|Quamatel|Quamtel|Renapepsa|Restadin|Rogasti|Ru,337.500,C8H15N7O2S3,238.000,469.000,-0.600,20,4,8,7,"InChI=1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)",C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,XUFQPHANEAPEMJ-UHFFFAOYSA-N,"3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide",Famotidine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,651631|651632|651633|651634|652048|652051|686978|686979|687035|687037|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|7,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|ABBLIS Chemicals|ABI Chem|Activate Scientific|AKos Consulting & Solutions|Alichem|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|BioChemPartner|C. David Weaver Laboratory, Vanderbilt University|CCSbase|ChEBI|Chem-Space.com Database|ChemBank|ChemDB|Chemenu Inc.|chemical genetic matrix|ChemIDplus|ChemSpider|Clearsynth|Combi-Blocks|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|Drug Induced Live",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3365,Fluconazole,"fluconazole|86386-73-4|Diflucan|Triflucan|Biozolene|Elazor|Biocanol|Fluconazol|Fungata|Fluconazolum|Flucostat|2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL|2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol|Flusol|Zoltec|UK 49858|UK-49858|2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol|C13H12F2N6O|UNII-8VZV102JFY|Pritenzol|Flucazol|Flukezol|Flunizol|Zonal|CHEMBL106|2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)-2-propanol|8VZV102JFY|2,4-Difluoro-alpha,alp",306.270,C13H12F2N6O,81.600,358.000,0.400,22,1,7,5,"InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2",C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,RFHAOTPXVQNOHP-UHFFFAOYSA-N,"2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol",Fluconazole,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,17,875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1189|1199|1208|1376|1379|1385|1422|1452|1454|1457|1458|1460|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1529|1530|1531|1532|1554|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1621|1626|1662|1663|1672|1688|1766|1768|1813|1814|1832|1850|1863|1865|1875|1885|1899|1903|1906|1910|1947|1948|1,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Active Biopharma|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambeed|AmicBase - Antimicrobial ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3671,Ibudilast,"ibudilast|50847-11-5|Ketas|KC-404|Ibudilastum|Ke Tas|Ibudilastum [Latin]|MN-166|Ibudilast [INN:JAN]|Eyevinal|AV-411|UNII-M0TTH61XC5|Ketas (TN)|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-one|2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one|3-Isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|Tocris-1694|Lopac-I-0157|1-Propanone, 2-methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridin",230.310,C14H18N2O,34.400,288.000,3.000,17,0,2,3,"InChI=1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-10H,1-4H3",CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,ZJVFLBOZORBYFE-UHFFFAOYSA-N,"2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1376|1379|1385|1422|1452|1454|1457|1458|1459|1460|1461|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1705|1707|1708|1766|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AvaChem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3749,Irbesartan,"irbesartan|138402-11-6|Avapro|Aprovel|Karvea|SR-47436|BMS-186295|BMS 186295|SR 47436|Irbesartan free base|UNII-J0E2756Z7N|CHEMBL1513|2-butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one|CHEBI:5959|J0E2756Z7N|138402-11-6 (free base)|MFCD00864464|2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one|1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'",428.500,C25H28N6O,87.100,682.000,4.100,32,1,5,7,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,YOSHYTLCDANDAN-UHFFFAOYSA-N,"2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one",Irbesartan,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|950|951|952|995|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1048|1049|1051|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1379|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1469|1471|1476|1477|1478|1479|1481|1486|1487|1490|1496|1509|1510,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambee",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3793,Sporanox,"itraconazole|84625-61-6|Sporanox|Itraconazolum [Latin]|ITRAZOLE|Itraconazol|MLS000863291|Itraconazole Impurity E|SMR000058959|2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one|R 51211|R-51211|4-(4-(4-(4-((2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-(sec-butyl)-1H-1,2,4-triazol-5(4H)-one|4-(4-(4-(4-((2-((1H-1,2,4-Triazol-1-yl)methyl)-2-",705.600,C35H38Cl2N8O4,101.000,1120.000,5.700,49,0,9,11,"InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3",CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,VHVPQPYKVGDNFY-UHFFFAOYSA-N,"2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one",Itraconazole,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|651|680|684|686|687|701|708|709|719|731|746|750|751|770|771|772|774|781|782|795|813|834|847|880|881|894|914|915|940|950|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|Aaron Chemicals LLC|ABI Chem|Acadechem|Achemo Scientific Limited|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Ambinter|Angene Chemical|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BePharm Ltd.|BindingDB|BioChemPartner|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|C. David Weaver Laboratory, V",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3821,Ketamine,"ketamine|Ketaject|Ketalar|dl-Ketamine|CI 581 base|Special K|(+-)-Ketamine|Ketaminum|CLSTA 20|6740-88-1|Ketanest|Ketalar base|2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone|(+/-)-Ketamine|KETAMINE HCL|2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone|Ketolar|2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone|2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one|NSC 70151|CHEMBL742|CHEBI:6121|Calypsol|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone|Cyclohexanone, 2-(o",237.720,C13H16ClNO,29.100,269.000,2.200,16,1,2,2,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",CNC1(CCCCC1=O)C2=CC=CC=C2Cl,YQEZLKZALYSWHR-UHFFFAOYSA-N,2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one,Ketamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,880|881|894|1030|1195|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|21246|21247|21248|24432|27167|28681|29359|29811|110161|144466|144606|144832|146725|146726|156805|175137|175138|204690|222489|223455|225475|411793|480448|480449|480451|480452|480453|480455|480457|480460|480463|480464|485281|485290|488839|488862|488895|488896|488899|488965|488966|492953|492956|492961|492972|493005|493008|4930,20050325,"ABI Chem|Achemo Scientific Limited|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|BePharm Ltd.|BIND|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|Boerchem|CCSbase|Changzhou Highassay Chemical Co., Ltd|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemDB|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative Toxicog",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3830,Kinetin,"kinetin|525-79-1|6-Furfurylaminopurine|6-Furfuryladenine|6-(Furfurylamino)purine|N6-Furfuryladenine|N-Furfuryladenine|Cytokinin|N-(furan-2-ylmethyl)-9H-purin-6-amine|N-(furan-2-ylmethyl)-7H-purin-6-amine|N6-(Furfurylamino)purine|Furfuryl(purin-6-yl)amine|Adenine, N-furfuryl-|1H-PURIN-6-AMINE, N-(2-FURANYLMETHYL)-|Kinetin (plant hormone)|9H-Purin-6-amine, N-(2-furanylmethyl)-|n(6)-furfuryladenine|2-Furanmethanamine, N-1H-purin-6-yl-|MFCD00075757|NSC 23119|N-(2-Furylmethyl)-9H-purin-6-amine|UNII-P39Y9652YJ|N-",215.210,C10H9N5O,79.600,239.000,1.000,16,2,5,3,"InChI=1S/C10H9N5O/c1-2-7(16-3-1)4-11-9-8-10(13-5-12-8)15-6-14-9/h1-3,5-6H,4H2,(H2,11,12,13,14,15)",C1=COC(=C1)CNC2=NC=NC3=C2NC=N3,QANMHLXAZMSUEX-UHFFFAOYSA-N,N-(furan-2-ylmethyl)-7H-purin-6-amine,Kinetin,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,248|328|357|368|373|374|377|410|411|422|425|429|430|431|432|436|444|445|446|447|448|449|450|451|453|460|463|465|485|488|501|518|521|522|524|525|526|530|538|539|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|607|608|612|618|620|626|628|629|630|631|633|639|641|644|645|648|662|680|684|690|696|708|709|710|719|731|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|793|797|798|799|800|803|804|811|813|817|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3899,Leflunomide,"leflunomide|75706-12-6|Arava|lefunamide|Leflunomida|Leflunomidum|5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide|HWA 486|Leflunomidum [INN-Latin]|HWA-486|SU101|5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide|Arava (TN)|5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide|5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide|4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-|alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide|UNII-",270.210,C12H9F3N2O2,55.100,327.000,2.500,19,1,6,2,"InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)",CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,VHOGYURTWQBHIL-UHFFFAOYSA-N,"5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide",Leflunomide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,357|361|364|368|371|373|374|375|377|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|607|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|662|680|684|686|687|694|701|708|709|719|731|732|741|,20050325,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|An",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4021,Edaravone,"edaravone|89-25-8|3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE|1-Phenyl-3-methyl-5-pyrazolone|Norphenazone|Radicut|MCI-186|Methylphenylpyrazolone|Developer Z|Norantipyrine|Phenylmethylpyrazolone|C.I. Developer 1|Phenyl methyl pyrazolone|3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one|5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one|Radicava|1-Phenyl-3-methyl-5-oxo-2-pyrazoline|3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-|1-Phenyl-3-methylpyrazolone|5-methyl-2-phenyl-4H-pyrazol-3-one|1-Phenyl-3-methylpyrazolone-5|2,4-Dihydr",174.200,C10H10N2O,32.700,241.000,1.300,13,0,2,1,"InChI=1S/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H3",CC1=NN(C(=O)C1)C2=CC=CC=C2,QELUYTUMUWHWMC-UHFFFAOYSA-N,5-methyl-2-phenyl-4H-pyrazol-3-one,Edaravone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,155|157|161|165|167|175|248|256|316|357|361|364|368|371|373|374|375|410|411|421|422|425|426|427|429|430|431|432|433|434|435|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|540|541|542|543|544|545|546|552|555|556|557|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|607|609|614|615|618|620|622|623|624|625|626|628|629|630|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Adooq BioScience|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|ApexBio Technology|Apexmol|Ark Phar",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4236,Modafinil,"modafinil|68693-11-8|Provigil|Modiodal|2-[(diphenylmethyl)sulfinyl]acetamide|Modafinilum [Latin]|2-(Benzhydrylsulfinyl)acetamide|Modafinilo [Spanish]|2-benzhydrylsulfinylacetamide|CRL 40476|Alertec|R Modafinil|CRL-40476|2-((Diphenylmethyl)sulfinyl)acetamide|Modavigil|CEP 1538|C15H15NO2S|CHEMBL1373|CHEBI:77585|2-(diphenylmethyl)sulfinylacetamide|CEP-1538|MFCD00868082|2-(Diphenyl-methanesulfinyl)-acetamide|NCGC00095176-03|Sparlon|Acetamide, 2-((diphenylmethyl)sulfinyl)-|DSSTox_CID_3329|Modafinil [USAN:INN]|DS",273.400,C15H15NO2S,79.400,302.000,1.700,19,1,3,5,"InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)",C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,YFGHCGITMMYXAQ-UHFFFAOYSA-N,2-benzhydrylsulfinylacetamide,Modafinil,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|950|951|952|995|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1048|1049|1051|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1379|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1458|1460|1461|1463|1466|1467|1468|1469|1471|1476|1477|1478|1479|1481|1486|1487|1490|1496|1509|1510|1515|1519|1527,20050325,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alsachim|Amadis Chemical|AN PharmaTech|AOBIOUS INC|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BerrChem|BIDD|BindingDB|BioChemPartner|Boerchem|Broad Institute|Burnham Center for Chemical Genomics|C. David Weaver Lab",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4477,Niclosamide,"niclosamide|50-65-7|5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide|Niclocide|Bayluscid|Phenasal|Tredemine|Fenasal|Yomesan|Dichlosale|Helmiantin|Atenase|Cestocid|Devermin|Devermine|Iomesan|Iomezan|Mansonil|Radeverm|Sagimid|Vermitid|Lintex|Nasemo|Sulqui|2',5-Dichloro-4'-nitrosalicylanilide|Mato|Fedal-Telmin|Bayer 73|Zestocarp|Bayer 2353|BAY 2353|Benzamide, 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxy-|Chemagro 2353|C13H8Cl2N2O4|5-Chloro-2'-chloro-4'-nitrosalicylanilide|nicolsamide|HL 2447|WR 46234|Sa",327.120,C13H8Cl2N2O4,95.200,404.000,4.000,21,2,4,2,"InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)",C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,RJMUSRYZPJIFPJ-UHFFFAOYSA-N,5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide,Niclosamide,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,248|357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|910|912|914|915|917|918|923|924|925|926|927|928|930|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1332|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|159,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|ApexBio Technology|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aur",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4649,4-Aminosalicylic acid,"4-Aminosalicylic acid|4-Amino-2-hydroxybenzoic acid|65-49-6|Aminosalicylic acid|P-AMINOSALICYLIC ACID|Rezipas|Aminopar|Pamisyl|Para-aminosalicylic acid|Parasalindon|Deapasil|Apacil|Parasal|Paser|Gabbropas|Paramycin|Parasalicil|Pasnodia|Aminox|Entepas|Osacyl|Pamacyl|Pasalon|Pasara|Pasdium|Pasmed|Pasolac|Propasa|Pasem|Pasa|2-Hydroxy-4-aminobenzoic acid|APAS|Benzoic acid, 4-amino-2-hydroxy-|PASK|Para-Pas|Sanipirol-4|para-Amino salicylic acid|Hellipidyl|Pascorbic|PAS-C|PAS (acid)|4-Aminosalicylate|Kyselina p-am",153.140,C7H7NO3,83.600,160.000,1.300,11,3,4,1,"InChI=1S/C7H7NO3/c8-4-1-2-5(7(10)11)6(9)3-4/h1-3,9H,8H2,(H,10,11)",C1=CC(=C(C=C1N)O)C(=O)O,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4-amino-2-hydroxybenzoic acid,Aminosalicylic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,155|157|161|165|167|175|180|192|200|210|212|222|228|248|302|330|342|357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|461|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|639|641|645|648|680|684|686|687|701|708|709|719|731|746|750|751|757|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4671,Palmitoylethanolamide,"Palmitoylethanolamide|Palmidrol|544-31-0|N-(2-Hydroxyethyl)hexadecanamide|Impulsin|Palmitoyl ethanolamide|N-palmitoylethanolamine|Palmitamide MEA|Hydroxyethylpalmitamide|N-(2-Hydroxyethyl)palmitamide|Palmitoyl-EA|Loramine P 256|Palmitic acid monoethanolamide|palmitylethanolamide|Palmidrolum|HEXADECANAMIDE, N-(2-HYDROXYETHYL)-|Palmidrol [INN]|Monoethanolamine palmitic acid amide|Anandamide (16:0)|N-palmitoyl ethanolamine|Palmitinsaeure-beta-hydroxyethylamid|UNII-6R8T1UDM3V|NSC 23320|hexadecanoyl ethanolamide",299.500,C18H37NO2,49.300,219.000,6.200,21,2,2,16,"InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21)",CCCCCCCCCCCCCCCC(=O)NCCO,HXYVTAGFYLMHSO-UHFFFAOYSA-N,N-(2-hydroxyethyl)hexadecanamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,248|328|330|357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1688|1705|1707|1708|1766|1768|1815|1816|1828|1850|1851|1863|1865|1876|1877|188,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|ApexBio Technology|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|AvaChem Scientific|Axon Medchem|BindingDB|BioChemPartner|Biocore|BioCrick|BioCyc|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|C. David Weaver Laboratory",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
4829,Pioglitazone,"Pioglitazone|111025-46-8|Actos|105355-27-9|Pioglitazona|Pioglitazonum|Glustin|Pioglitazonum [INN-Latin]|Pioglitazona [INN-Spanish]|5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione|Zactos|Duetact|U 72107|AD-4833|5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione|CHEBI:8228|Pioglitazone (Actos)|5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione|Actos (TN)|5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione|5-[4-[2-(5-ETHYL-2-PYRIDYL)",356.400,C19H20N2O3S,93.600,466.000,3.800,25,1,5,7,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,HYAFETHFCAUJAY-UHFFFAOYSA-N,"5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione",Pioglitazone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1865|2101|2107|2112|2240|2241|2275|2313|2322|2330|2517|2549|3419|3420|3423|23875|25727|25996|28252|28299|29634|30160|82573|91238|91243|91246|106695|109804|109805|109824|109827|109828|109829|110045|110560|110711|111650|112794|113348|113349|113350|114006|114051|114052|114053|115313|115314|115315|115316|115616|115625|119519|119521|119523|119525|119527|119529|122587|124440|124441|124442|136633|136634|136640|136642|141904|141910|141913|156146|156149|1562,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|Abbott Labs|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alsachim|Ama",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5147,Salicylamide,"salicylamide|2-Hydroxybenzamide|65-45-2|o-Hydroxybenzamide|Benzamide, 2-hydroxy-|Salicylic acid amide|2-Carbamoylphenol|Salamide|Urtosal|2-Carboxamidophenol|Flarpirina|Morsarinas|Algamon|Algiamida|Allevin|Amidosal|Andasol|Cetamide|Dolomide|Dropsprin|Eggosalil|Liquiprin|Novecyl|Panithal|Raspberin|Saliamid|Saliamin|Salicim|Salipur|Salizell|Salymid|Serramida|Acket|Anamid|Oramid|Salrin|Afko-Sal|Amid-Sal|Salicilamide|Benzamide, o-hydroxy-|Salicilamida|Salicylamidum|MFCD00007978|Amid kyseliny salicylove|OHB|UNII-",137.140,C7H7NO2,63.300,136.000,1.300,10,2,2,1,"InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)",C1=CC=C(C(=C1)C(=O)N)O,SKZKKFZAGNVIMN-UHFFFAOYSA-N,2-hydroxybenzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,155|157|161|165|167|175|421|422|426|427|433|434|435|436|445|485|530|540|541|542|543|544|545|546|568|583|584|585|595|596|598|602|603|605|618|620|629|630|631|633|639|648|654|655|656|657|658|659|660|661|662|663|664|665|666|667|687|701|719|731|745|750|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|834|841|861|862|868|871|873|875|878|880|881|884|885|886|887|889|892|893|894|898|900|902|910|912|920|921|923|924|925|926|927|930|932|938|940|946|947|948|950|951|952|955|960|961|962|963|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Anward|Ark Pharm, Inc.|Aurora Fine Chemica",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5329,Sulfamethoxazole,"sulfamethoxazole|723-46-6|Sulphamethoxazole|Gantanol|Sulfisomezole|Sulfamethoxazol|Metoxal|4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide|Sulfamethylisoxazole|Simsinomin|Radonil|Sinomin|Sulphamethoxazol|Sulpha-methoxizole|Bactrim|Sulfamethalazole|Azo-gantanol|4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide|Sulphamethylisoxazole|Urobak|Ro 4-2130|3-Sulfanilamido-5-methylisoxazole|Gantanol-DS|4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide|Sulphisomezole|5-Methyl-3-sulfanilamidoisoxazole|MS 53|",253.280,C10H11N3O3S,107.000,346.000,0.900,17,2,6,3,"InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,JLKIGFTWXXRPMT-UHFFFAOYSA-N,"4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide",Sulfamethoxazole,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,179|190|192|248|330|357|361|364|368|371|373|374|375|377|410|411|421|422|425|426|427|429|430|431|432|433|434|435|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|540|541|542|543|544|545|546|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|607|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Alsachim|Ambeed|Ambinter|AmicBase - Antimicrobial Activities|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5336,Sulfapyridine,sulfapyridine|144-83-2|Sulphapyridine|2-Sulfapyridine|Sulfidin|Sulfidine|2-Sulfanilamidopyridine|2-Sulfanilylaminopyridine|Streptosilpyridine|Coccoclase|Eubasinum|Piridazol|Pyridazol|Eubasin|Haptocil|Plurazol|Relbapiridina|Pyriamid|Septipulmon|Thioseptal|Adiplon|Dagenan|Trianon|Ronin|2-Sulfanilamidopyridin|N-2-Pyridylsulfanilamide|Solfapiridina|Sulfapiridina|Sulfapyridinum|4-amino-N-pyridin-2-ylbenzenesulfonamide|N1-2-Pyridylsulfanilamide|4-amino-N-(pyridin-2-yl)benzenesulfonamide|2-(p-Aminobenzenesulphonam,249.290,C11H11N3O2S,93.500,331.000,0.000,17,2,5,3,"InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)",C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,GECHUMIMRBOMGK-UHFFFAOYSA-N,4-amino-N-pyridin-2-ylbenzenesulfonamide,Sulfapyridine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,155|157|161|165|167|175|248|357|361|364|368|371|373|374|375|377|410|411|422|425|429|430|431|432|436|438|440|441|444|445|446|447|448|449|450|451|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|526|527|528|529|530|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|601|602|603|604|605|606|607|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|653|662|680|684|686|687|701|,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Allbio Pharm Co., L",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5526,Tranexamic acid,tranexamic acid|1197-18-8|trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Cyklokapron|4-(Aminomethyl)cyclohexanecarboxylic acid|Tranexamsaeure|Amstat|Trans AMCHA|Tranhexamic acid|Transamin|Tamcha|trans-Amcha|701-54-2|Amikapron|Anvitoff|Cyclocapron|Ugurol|Frenolyse|Rikavarin|Trasamlon|1197-17-7|Carxamin|Emorhalt|Tranexan|Mastop|AMCHA|Rikavarin-S|AMCA|Exacyl|cis-4-(Aminomethyl)cyclohexanecarboxylic acid|tranexmic acid|Hexapromin|Transamlon|Hexatron|Spiramin|Tranex|trans-4-Aminomethylcyclohexane-1-carboxylic a,157.210,C8H15NO2,63.300,139.000,-2.000,11,2,3,2,"InChI=1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)",C1CC(CCC1CN)C(=O)O,GYDJEQRTZSCIOI-UHFFFAOYSA-N,4-(aminomethyl)cyclohexane-1-carboxylic acid,Tranexamic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,155|157|161|165|167|175|179|200|206|212|220|256|264|296|330|357|377|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|910|912|914|915|923|924|925|926|927|930|938|940|995|1030|1332|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|16,20050325,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Al",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5951,Serine,"L-serine|serine|56-45-1|(S)-2-Amino-3-hydroxypropanoic acid|(S)-Serine|H-Ser-OH|beta-Hydroxyalanine|L-ser|L-Serin|L-(-)-Serine|Serine, L-|(2S)-2-amino-3-hydroxypropanoic acid|2-Amino-3-hydroxypropionic acid|Serinum [Latin]|Serina [Spanish]|Serine (VAN)|Polyserine|L-3-Hydroxy-alanine|(-)-Serine|beta-Hydroxy-L-alanine|L-2-Amino-3-hydroxypropionic acid|Serine [USAN:INN]|SER (IUPAC abbrev)|Poly-L-serine|(S)-2-Amino-3-hydroxypropionic acid|alpha-Amino-beta-hydroxypropionic acid|L-3-Hydroxy-2-aminopropionic acid|",105.090,C3H7NO3,83.600,72.600,-3.100,7,3,4,2,"InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1",C([C@@H](C(=O)O)N)O,MTCFGRXMJLQNBG-REOHCLBHSA-N,(2S)-2-amino-3-hydroxypropanoic acid,Serine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|943|944|945|954|957|958|959|992|995|997|998|1030|1379|1452|1454|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1851|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|26797|51033|224504|233320|328866|443653|485290|500825|504327|50,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Alomone Labs|Amadis Chemical|Ambeed|Amb",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6057,Tyrosine,"L-tyrosine|tyrosine|60-18-4|(S)-Tyrosine|p-Tyrosine|L-p-Tyrosine|H-Tyr-OH|(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|4-Hydroxy-L-phenylalanine|L-(-)-Tyrosine|Tyrosinum [Latin]|Tyrosine (VAN)|Tirosina [Spanish]|3-(4-Hydroxyphenyl)-L-alanine|(-)-alpha-Amino-p-hydroxyhydrocinnamic acid|L-Phenylalanine, 4-hydroxy-|beta-(p-Hydroxyphenyl)alanine|Tyrosine [USAN:INN]|Tyrosine, L-|(S)-alpha-Amino-4-hydroxybenzenepropanoic acid|FEMA No. 3736|L-2-Amino-3-p-hydroxyphenylpropanoic acid|L-tyrosinyl radical|(S)-3-(p-H",181.190,C9H11NO3,83.600,176.000,-2.300,13,3,4,3,"InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1",C1=CC(=CC=C1C[C@@H](C(=O)O)N)O,OUYCCCASQSFEME-QMMMGPOBSA-N,(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid,Tyrosine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,880|881|894|1030|1195|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1576|1688|1766|1768|1811|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|2662|24263|24265|26797|233318|274648|291061|291063|291065|291067|305774|305775|305776|305777|307896|307897|307898|318343|318344|318345|318346|365827|365828|365829|365830|375786|375787|403761|409983|409984|409985|409986|409987|409988|409989|409990|409991|409992|409993|414329|414330|414331|422805|422806|436236|436238|436,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambinter|AN PharmaTech|Angen",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6099,Methylene blue,"methylene blue|61-73-4|Basic blue 9|Methylthioninium chloride|Swiss Blue|Solvent blue 8|Chromosmon|3,7-Bis(dimethylamino)phenothiazin-5-ium chloride|Methylene Blue N|Methylene Blue BB|Methylene Blue anhydrous|Bleu de methylene|Methylene Blue chloride|External Blue 1|Methylene Blue A|Methylene Blue B|Methylene Blue D|Methylene Blue G|C.I. Basic Blue 9|Calcozine Blue ZF|Methylene Blue BD|Methylene Blue BP|Methylene Blue BX|Methylene Blue BZ|Methylene Blue FZ|Methylene Blue GZ|Methylene Blue NZ|Methylene Blue ",319.900,C16H18ClN3S,43.900,483.000,NULL,21,0,4,1,"InChI=1S/C16H18N3S.ClH/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13;/h5-10H,1-4H3;1H/q+1;/p-1",CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.[Cl-],CXKWCBBOMKCUKX-UHFFFAOYSA-M,[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride,Methylene Blue,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,155|157|161|165|167|175|180|192|228|248|328|485|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1246|1251|1262|1273|1274|1275|1276|1285|1296|1297|1300|1301|1304|1306|1316|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Biosynth Carbosynth|BLD P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6106,Leucine,"L-leucine|leucine|61-90-5|(S)-2-Amino-4-methylpentanoic acid|(S)-Leucine|H-Leu-OH|(2S)-2-amino-4-methylpentanoic acid|(S)-(+)-Leucine|Leucin|L-Norvaline, 4-methyl-|(S)-2-Amino-4-methylvaleric acid|L-alpha-Aminoisocaproic acid|Leucin [German]|leu|Leucine (VAN)|LEUCINE, L-|Leucinum|(2S)-alpha-leucine|L-(+)-Leucine|L-(-)-2-Amino-4-methylpentanoic acid|L-leucin|Leucine [USAN:INN]|Leucinum [INN-Latin]|Leucina [INN-Spanish]|FEMA No. 3297|Leucina [Latin,Spanish]|alpha-Aminoisocaproic acid|Valeric acid, 2-amino-4-m",131.170,C6H13NO2,63.300,101.000,-1.500,9,2,3,3,"InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1",CC(C)C[C@@H](C(=O)O)N,ROHFNLRQFUQHCH-YFKPBYRVSA-N,(2S)-2-amino-4-methylpentanoic acid,Leucine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,348|357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|630|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|902|912|914|915|923|924|925|926|938|940|995|1030|1195|1379|1422|1452|1457|1458|1471|1476|1478|1811|1851|1948|2326|15711|18849|18861|21264|24202|24203|24204|24420|24448|26611|26797|51033|156089|156203|233318|329209|459064|459065|459066|481439|481440|481441|481442|481444|481446|588220|630741|678712|678713|678714|678715|678716|67,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aur",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6131,Cytidine-5'-monophosphate,"5'-CYTIDYLIC ACID|63-37-6|Cytidine 5'-monophosphate|cytidylic acid|Cytidine monophosphate|Cytidine-5'-monophosphate|5'-CMP|cytidylate|Cytidine 5'-phosphate|CMP (nucleotide)|Polyribocytidylic acid|Cytidine 5'-phosphoric acid|Cytidine 5'-monophosphoric acid|Cytidine 5'-(dihydrogenphosphate)|cytidine-P|cytidine-phosphate|CMP|Cytidine 3'-(dihydrogen phosphate)|Poly(rC)|Polyribonucleotide complex C|((2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate|1b",323.200,C9H14N3O8P,175.000,531.000,-3.400,21,5,8,4,"InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1",C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O,IERHLVCPSMICTF-XVFCMESISA-N,"[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",Cytidine Monophosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,38074|43713|74254|74259|98043|98676|99156|99187|101082|101083|146812|146814|146818|218818|218819|227718|229265|278934|278935|415022|469221|469222|469224|469225|469227|469228|469230|469231|707245|707246|707247,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|AstaTech, Inc.|Auro",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
6251,Mannitol,"D-mannitol|mannitol|69-65-8|Mannite|Osmitrol|Manna sugar|Osmofundin|87-78-5|Cordycepic acid|Mannit|Osmosal|Mannazucker|Mannidex|Mannigen|Mannistol|Resectisol|Diosmol|Invenex|Isotol|Marine Crystal|Maniton-S|D-(-)-Mannitol|Mannogem 2080|(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol|Mannitol, D-|Mannitol (VAN)|Bronchitol|(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol|Aridol|SDM No. 35|Hexahydroxyhexane|NCI-C50362|UNII-3OWL53L36A|MFCD00064287|Mannitol (USP)|Mannitol [USP]|BRN 1721898|DL-Mannitol|CHEBI:16899|D-Mannitol, ACS r",182.170,C6H14O6,121.000,105.000,-3.100,12,6,6,5,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1",C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O,FBPFZTCFMRRESA-KVTDHHQDSA-N,"(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol",Mannitol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,880|1189|1194|1195|1199|1205|1208|1469|1471|1479|1487|1490|1511|1554|1662|1663|1672|1688|1766|1768|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2528|2540|2544|2546|2550|2551|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2662|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|758,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|Angene Chemical|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Ph",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6305,Tryptophan,L-tryptophan|tryptophan|73-22-3|L-Tryptophane|h-Trp-oh|(S)-Tryptophan|Tryptophane|Optimax|trofan|tryptacin|Ardeytropin|(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid|Pacitron|Indole-3-alanine|Kalma|L-beta-3-Indolylalanine|L-Tryptofan|L-Trp|L-(-)-Tryptophan|3-Indol-3-ylalanine|Tryptan|Lyphan|Tryptophan (VAN)|1-beta-3-Indolylalanine|Tryptophan (H-3)|Triptofano [Spanish]|Tryptophanum [Latin]|1H-Indole-3-alanine|1beta-3-Indolylalanine|2-Amino-3-indolylpropanoic acid|triptofano|Tryptophanum|(S)-alpha-Amino-1H-indo,204.220,C11H12N2O2,79.100,245.000,-1.100,15,3,3,3,"InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1",C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N,QIVBCDIJIAJPQS-VIFPVBQESA-N,(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid,Tryptophan,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|781|782|798|800|873|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1021|1022|1030|1046|1085|1189|1194|1195|1199|1205|1208|1230|1236|1242|1274|1376|1377|1379|1381|1385|1415|1422|1423|1430|1434|1439|1440|1441|1443|1445|1452|1454|1456|1457|1458|1459|,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6322,Arginine,"L-arginine|arginine|74-79-3|L-(+)-Arginine|L(+)-Arginine|L-Arg|(S)-2-Amino-5-guanidinopentanoic acid|H-Arg-OH|(L)-Arginine|Arginina|ARGININE, L-|Arginine (VAN)|L-Arginin|Argininum [INN-Latin]|Arginina [INN-Spanish]|L-Ornithine, N5-(aminoiminomethyl)-|Argamine|Argivene|Detoxargin|Levargin|L-alpha-Amino-delta-guanidinovaleric acid|Minophagen A|1-Amino-4-guanidovaleric acid|CCRIS 3609|(S)-(+)-arginine|NSC 206269|arg|HSDB 1429|AI3-24165|UNII-94ZLA3W45F|MFCD00002635|(S)-2-Amino-5-guanidinovaleric acid|BRN 172541",174.200,C6H14N4O2,128.000,176.000,-4.200,12,4,4,5,"InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1",C(C[C@@H](C(=O)O)N)CN=C(N)N,ODKSFYDXXFIFQN-BYPYZUCNSA-N,(2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid,Arginine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1379|1422|1452|1454|1457|1458|1459|1460|1461|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1705|1707|1708|1766|1768|1811|1815|1816|1828|1851|1865|1876|1877|1882|1883|1886|1948|1967|,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6422,Trifluoroacetic acid,"Trifluoroacetic acid|76-05-1|Perfluoroacetic acid|Trifluoracetic acid|Trifluoroethanoic acid|2,2,2-trifluoroacetic acid|Acetic acid, trifluoro-|trifluoroaceticacid|trifluoro acetic acid|TFA|trifluoro-acetic acid|Kyselina trifluoroctova|CF3COOH|MFCD00004169|trifluroacetic acid|NSC 77366|triflouroacetic acid|UNII-E5R8Z4G708|triflouro acetic acid|Acetic acid, 2,2,2-trifluoro-|water-trifluoroacetic acid|IPC-PFFA-2|peptide trifluoroacetic acid|Acetic acid-d, trifluoro-|wash buffer|2,2,2-trifluoro-acetic acid|C2H",114.020,C2HF3O2,37.300,83.400,0.900,7,1,5,0,"InChI=1S/C2HF3O2/c3-2(4,5)1(6)7/h(H,6,7)",C(=O)(C(F)(F)F)O,DTQVDTLACAAQTR-UHFFFAOYSA-N,"2,2,2-trifluoroacetic acid",Trifluoroacetic Acid,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,13,248|342464|448096|728441|1259408,20040916,"001Chemical|3A SpeedChemical Inc|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A1 BioChem Labs|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Acemol|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Co",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6917,N-Vinyl-2-pyrrolidone,"N-VINYL-2-PYRROLIDONE|88-12-0|N-Vinylpyrrolidone|1-Vinyl-2-pyrrolidone|1-vinylpyrrolidin-2-one|N-Vinyl-2-pyrrolidinone|POLYVINYLPYRROLIDONE|Vinylpyrrolidone|1-ethenylpyrrolidin-2-one|2-Pyrrolidinone, 1-ethenyl-|9003-39-8|1-Vinyl-2-pyrrolidinone|Povidone|N-Vinylpyrrolidinone|Polyvidone|1-Vinylpyrrolidone|Pvpp|Vinylbutyrolactam|Vinylpyrrolidinone|Luviskol|Plasdone|1-Vinylpyrrolidinone|Vinyl-2-pyrrolidone|Polyclar AT|V-Pyrol|2-Pyrrolidinone, 1-vinyl-|25249-54-1|Poly(N-vinylpyrrolidone)|1-Ethenyl-2-pyrrolidinon",111.140,C6H9NO,20.300,120.000,0.400,8,0,1,1,"InChI=1S/C6H9NO/c1-2-7-5-3-4-6(7)8/h2H,1,3-5H2",C=CN1CCCC1=O,WHNWPMSKXPGLAX-UHFFFAOYSA-N,1-ethenylpyrrolidin-2-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,155|157|161|165|167|175|179|186|188|248|256|330|1189|1194|1205|1208|1469|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|485281|485290|504327|504370|504374|504375|504847|588579|602332|651631|651632|651633|651634|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|74,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AmicBase - Antimicrobial Activities|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BenchChem|BePha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6973,5-Methylsalicylic acid,"5-Methylsalicylic acid|89-56-5|2-HYDROXY-5-METHYLBENZOIC ACID|p-Cresotic acid|6-Hydroxy-m-toluic acid|2,5-Cresotic acid|p-Cresotinic acid|p-Homosalicylic acid|Benzoic acid, 2-hydroxy-5-methyl-|5-Methyl-2-hydroxybenzoic acid|6-Hydroxy-3-methylbenzoic acid|UNII-6GAI2MTV5V|MFCD00002461|NSC 38518|5-methyl salicylic acid|.alpha.-Cresotinic acid|6GAI2MTV5V|5-Methylsalicylic acid, 98%|CHEMBL1161012|alpha-Cresotinic acid|EINECS 201-918-6|BRN 1909076|p-Kresotinsaure|AI3-25422|54G|5-metylsalicylic acid|ACMC-209r1p|4-",152.150,C8H8O3,57.500,155.000,2.800,11,2,3,1,"InChI=1S/C8H8O3/c1-5-2-3-7(9)6(4-5)8(10)11/h2-4,9H,1H3,(H,10,11)",CC1=CC(=C(C=C1)O)C(=O)O,DLGBEGBHXSAQOC-UHFFFAOYSA-N,2-hydroxy-5-methylbenzoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity,9,127482|566699|566700|566701|566702|566703|566704|566705|566706|566707|1059430|1252320|1449688|1449694|1449702|1449703|1449708|1453182|1453183|1453184,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|As",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7054,Isatin,"Isatin|91-56-5|1H-Indole-2,3-dione|Indoline-2,3-dione|2,3-Indolinedione|INDOLE-2,3-DIONE|Isatine|2,3-Dioxoindoline|Pseudoisatin|Isatic acid lactam|Isotin|2,3-Diketoindoline|Isatinic acid anhydride|2,3-Ketoindoline|o-Aminobenzoylformic anhydride|2,3-Dioxo-2,3-dihydroindole|NSC 9262|2,3-dihydro-1H-indole-2,3-dione|MFCD00005718|UNII-82X95S7M06|Tribulin|2,3-dihydroindole-2,3-dione|CHEMBL326294|CHEBI:27539|82X95S7M06|1186480-61-4|Isatin, 98%|1H-benzo[d]azoline-2,3-dione|EINECS 202-077-8|BRN 0383659|AI3-03111|3-I",147.130,C8H5NO2,46.200,212.000,0.800,11,1,2,0,"InChI=1S/C8H5NO2/c10-7-5-3-1-2-4-6(5)9-8(7)11/h1-4H,(H,9,10,11)",C1=CC=C2C(=C1)C(=O)C(=O)N2,JXDYKVIHCLTXOP-UHFFFAOYSA-N,"1H-indole-2,3-dione",Isatin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,155|157|161|165|167|175|248|256|330|392|1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1576|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|72521|200223|2136,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|Anward|Apexmol|Ark Pharm, Inc.|Aromalake Chemical|Aurora Fine Chemicals",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7196,Piperonylic acid,"PIPERONYLIC ACID|94-53-1|1,3-Benzodioxole-5-carboxylic acid|Benzo[d][1,3]dioxole-5-carboxylic acid|Heliotropic acid|3,4-Methylenedioxybenzoic acid|2H-1,3-Benzodioxole-5-Carboxylic Acid|benzo[1,3]dioxole-5-carboxylic acid|Protocatechuic acid methylene ether|MFCD00005830|5-Benzodioxolecarboxylic acid|3,4-Dioxymethylenebenzoic acid|3,4-Methylene dioxybenzoic acid|UNII-QX3V1NO0KH|3,4-(Methylenedioxy)benzoic acid|NSC 10072|Benzoic acid, 3,4-(methylenedioxy)-|Piperonylic acid, 99%|QX3V1NO0KH|PIPERONYLIC ACID-2,2-",166.130,C8H6O4,55.800,192.000,0.400,12,1,4,1,"InChI=1S/C8H6O4/c9-8(10)5-1-2-6-7(3-5)12-4-11-6/h1-3H,4H2,(H,9,10)",C1OC2=C(O1)C=C(C=C2)C(=O)O,VDVJGIYXDVPQLP-UHFFFAOYSA-N,"1,3-benzodioxole-5-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,12,155|157|161|165|167|175|248|608|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1033|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1476|1478|1479|1487|1490|1519|1549|1552|1637|1648|1766|1768|1865|1948|2101|2107|2112|2147|2240|2241|2275|2313|2322|2330|2451|2472|2517|2528|2546|2549|2551|434959|436559|436561|485281|485290|504327|504847|504865|588579|602332|624101|624137|624156|624260|624263|651548|667489|686978|686979|720532|720533|720579|720580|977611|1090826|1099910|,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Acemol|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Al",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7226,2-Amino-6-chlorobenzothiazole,"2-Amino-6-chlorobenzothiazole|95-24-9|6-Chlorobenzothiazol-2-ylamine|6-Chloro-1,3-benzothiazol-2-amine|2-Benzothiazolamine, 6-chloro-|6-chlorobenzo[d]thiazol-2-amine|6-Chloro-2-benzothiazolamine|MFCD00053557|6-Chloro-benzothiazol-2-ylamine|UNII-2U337T5UFG|2-AMINO-6-CHLOROBENZO[D]THIAZOLE|BENZOTHIAZOLE, 2-AMINO-6-CHLORO-|2U337T5UFG|2-Amino-6-chloro-1,3-benzothiazole|2-Amino-6-chlorobenzothiazole, 99%|6-chlorobenzothiazole-2-ylamine|EINECS 202-402-3|BRN 0127752|54T|C7H4BrClN2S|PubChem21696|Maybridge1_001187|A",184.650,C7H5ClN2S,67.200,155.000,2.900,11,1,3,0,"InChI=1S/C7H5ClN2S/c8-4-1-2-5-6(3-4)11-7(9)10-5/h1-3H,(H2,9,10)",C1=CC2=C(C=C1Cl)SC(=N2)N,VMNXKIDUTPOHPO-UHFFFAOYSA-N,"6-chloro-1,3-benzothiazol-2-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,11,485|631|731|757|758|759|760|761|764|781|782|797|798|800|811|833|861|862|868|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1044|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1229|1230|1236|1239|1242|1251|1274|1276|1285|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1469|1471|1,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Amadis Chemical|Ambeed|AN PharmaTech|Angel Pharmatech ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7364,Thiophene-2-carbaldehyde,Thiophene-2-carbaldehyde|2-Thiophenecarboxaldehyde|98-03-3|2-Thenaldehyde|Thiophene-2-aldehyde|Thiophene-2-carboxaldehyde|2-FORMYLTHIOPHENE|2-Thiophenealdehyde|2-Thienylaldehyde|2-Thiophenecarbaldehyde|formylthiophene|2-Thienylcarboxaldehyde|2-Thienaldehyde|alpha-Formylthiophene|2-Thiophene carboxaldehyde|Thenaldehyde|2-Thiophenaldehyde|alpha-Thiophenecarboxaldehyde|.alpha.-Formylthiophene|2-thiophencarboxaldehyde|2-thienal|NSC 2162|MFCD00005429|thiophenecarboxaldehyde|thiophen-2-carbaldehyde|2-thiophene ca,112.150,C5H4OS,45.300,72.500,1.000,7,0,2,1,InChI=1S/C5H4OS/c6-4-5-2-1-3-7-5/h1-4H,C1=CSC(=C1)C=O,CNUDBTRUORMMPA-UHFFFAOYSA-N,thiophene-2-carbaldehyde,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,11,155|157|161|165|167|175|248|165140|281491|452111|1082887|1082888|1082889|1337095,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aromalake C",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7381,4-Tert-Butylcatechol,"4-tert-Butylcatechol|98-29-3|p-tert-Butylcatechol|4-tert-Butylpyrocatechol|4-(tert-butyl)benzene-1,2-diol|4-tert-butylbenzene-1,2-diol|p-tert-Butyl catechol|1,2-Benzenediol, 4-(1,1-dimethylethyl)-|4-t-Butylpyrocatechol|p-tert-Butylpyrocatechol|4-T-BUTYLCATECHOL|4-tert-Butylcatechin|p-t-Butylpyrocatechol|Pyrocatechol, 4-tert-butyl-|Synox TBC|4-tert-Butyl-1,2-benzenediol|4-TBC|1,2-Dihydroxy-4-tert-butylbenzene|4-tert-Butyl-1,2-dihydroxybenzene|4-tert-Butylpyrokatechin|NSC 5310|UNII-9A069144KR|MFCD00002201|9A0",166.220,C10H14O2,40.500,148.000,2.700,12,2,2,1,"InChI=1S/C10H14O2/c1-10(2,3)7-4-5-8(11)9(12)6-7/h4-6,11-12H,1-3H3",CC(C)(C)C1=CC(=C(C=C1)O)O,XESZUVZBAMCAEJ-UHFFFAOYSA-N,"4-tert-butylbenzene-1,2-diol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,155|157|161|165|167|175|330|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1452|1457|1458|1469|1471|1476|1477|1478|1479|1948|1987|2016|2023|2025|2029|2052|2057|2066|2099|2101|2107|2112|2,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|Acros Organics|ACT Chemical|Advanced Technology & Industrial Co., Ltd.|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharm",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7478,4-Methoxybenzoic acid,"4-METHOXYBENZOIC ACID|p-Anisic acid|100-09-4|ANISIC ACID|p-Methoxybenzoic acid|4-Anisic acid|Benzoic acid, 4-methoxy-|Draconic acid|para-anisic acid|P-Methoxy Benzoic Acid|ANISIC ACID, PARA|MFCD00002542|4-methoxy-benzoic acid|Kyselina 4-methoxybenzoova|UNII-4SB6Y7DMM3|1335-08-6|4-Methoxy benzoic acid|Methoxybenzoic acid|4SB6Y7DMM3|CHEBI:40813|4-Methoxybenzoic acid;Draconic acid|p-methoxybenzoate|p-Anisic acid, 98%|Anisic acid, p-isomer|Kyselina 4-methoxybenzoova [Czech]|EINECS 202-818-5|NSC 32742|BRN 050891",152.150,C8H8O3,46.500,136.000,2.000,11,1,3,2,"InChI=1S/C8H8O3/c1-11-7-4-2-6(3-5-7)8(9)10/h2-5H,1H3,(H,9,10)",COC1=CC=C(C=C1)C(=O)O,ZEYHEAKUIGZSGI-UHFFFAOYSA-N,4-methoxybenzoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,155|157|161|165|167|175|330|1811|28497|28691|28692|28693|28731|29132|125426|213093|226477|226478|237685|287724|293934|462333|462342|485350|485395|493033|504770|540299|588519|589727|589728|589729|589730|589731|589732|611697|611698|611702|611780|720641|977611|1059449|1059453|1059454|1082323|1082324|1082325|1082326|1082327|1082328|1082329|1082330|1082331|1082332|1082333|1082334|1082335|1082336|1082337|1082338|1082339|1082340|1082341|1082342|1082343|1082344|1082345|1082346|1082347|1082348|1082349|1082350|108235,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|Advanced Technology & Industrial Co., Ltd.|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Am",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
7550,Pyridostigmine bromide,"PYRIDOSTIGMINE BROMIDE|101-26-8|Mestinon|3-(Dimethylcarbamoyloxy)-1-methylpyridinium Bromide|3-((Dimethylcarbamoyl)oxy)-1-methylpyridin-1-ium bromide|Kalimin|Kalymin|Regonal|Mestinon bromide|Pyridostigmine (bromide)|UNII-KVI301NA53|MLS000028385|3-[(dimethylcarbamoyl)oxy]-1-methylpyridin-1-ium bromide|KVI301NA53|(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide|Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-, bromide|Pyridinium, 3-[[(dimethylamino)carbonyl]oxy]-1-methyl-, bromide|Ro 1-5130|MF",261.120,C9H13BrN2O2,33.400,183.000,NULL,14,0,3,2,"InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1",C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-],VNYBTNPBYXSMOO-UHFFFAOYSA-M,"(1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate;bromide",Pyridostigmine Bromide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1|3|5|7|9|15|21|23|29|31|33|35|37|39|41|43|45|47|53|55|59|65|67|71|73|77|79|81|83|85|87|89|91|93|95|97|99|101|105|107|109|113|115|121|123|125|129|131|133|137|139|141|143|145|357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|62,20050326,"001Chemical|3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
7570,"4,4'-Diphenylmethane diisocyanate","4,4'-Diphenylmethane diisocyanate|101-68-8|Diphenylmethane diisocyanate|Bis(4-isocyanatophenyl)methane|Isonate|p,p'-Diphenylmethane diisocyanate|1,1'-Methylenebis(4-isocyanatobenzene)|4,4'-Methylenebis(phenyl isocyanate)|Methylbisphenyl isocyanate|4,4'-Methylenediphenyl diisocyanate|4,4'-Diisocyanatodiphenylmethane|Methylene bisphenyl isocyanate|Methylene diphenyl diisocyanate|Bis(p-isocyanatophenyl)methane|Diphenylmethyl diisocyanate|diphenylmethane-4,4'-diisocyanate|Caradate 30|Desmodur 44|Diphenylmethan-",250.250,C15H10N2O2,58.900,332.000,5.400,19,0,4,4,"InChI=1S/C15H10N2O2/c18-10-16-14-5-1-12(2-6-14)9-13-3-7-15(8-4-13)17-11-19/h1-8H,9H2",C1=CC(=CC=C1CC2=CC=C(C=C2)N=C=O)N=C=O,UPMLOUAZCHDJJD-UHFFFAOYSA-N,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,15,155|157|161|165|167|175|192|330|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1452|1457|1458|1469|1471|1476|1477|1478|1479|1948|2101|2107|2112|2120|2517|2546|2549|2551|485290|588513|588,20050326,"AA BLOCKS|AAA Chemistry|abcr GmbH|ABI Chem|Acadechem|Achemtek|Acros Organics|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Amadis Chemical|AN PharmaTech|Aurum Pharmatech LLC|Biosynth Carbosynth|BOC Sciences|Boerchem|Center for Chemical Genomics, University of Michigan|ChEBI|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemExper Chemical Directory|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Comparative Toxicog",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
8117,DI(Hydroxyethyl)ether,"DIETHYLENE GLYCOL|111-46-6|2,2'-Oxydiethanol|Diglycol|2,2'-Oxybisethanol|Bis(2-hydroxyethyl) ether|2-(2-Hydroxyethoxy)ethanol|Diethylenglykol|Ethanol, 2,2'-oxybis-|2-Hydroxyethyl ether|Digol|Glycol ether|Digenos|Dicol|Brecolane ndg|Deactivator E|Dissolvant APV|Ethylene diglycol|2,2'-Oxyethanol|Diethyleneglycol|DI(HYDROXYETHYL)ETHER|1,5-Dihydroxy-3-oxapentane|TL4N|3-Oxapentane-1,5-diol|Dihydroxydiethyl ether|2,2'-0xydiethanol|Bis(beta-hydroxyethyl) ether|2,2'-Dihydroxydiethyl ether|2-(2-hydroxyethoxy)ethan-1",106.120,C4H10O3,49.700,26.100,-1.300,7,2,3,4,"InChI=1S/C4H10O3/c5-1-3-7-4-2-6/h5-6H,1-4H2",C(COCCO)O,MTHSVFCYNBDYFN-UHFFFAOYSA-N,2-(2-hydroxyethoxy)ethanol,NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1188|1189|1194|1208|1452|1457|1458|1469|1471|1476|1477|1478|1479|1850|1899|1906|1947|1948|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemica|Achemtek|Acros Organics|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Aurora Fine Chemicals LLC|Avantor Inc|BePharm Ltd.|BIDD|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|BroadPh",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8134,2-(2-Methoxyethoxy)ethanol,"2-(2-Methoxyethoxy)ethanol|111-77-3|DIETHYLENE GLYCOL MONOMETHYL ETHER|Methyl carbitol|Methyl digol|Ethanol, 2-(2-methoxyethoxy)-|Methoxydiglycol|Methyl dioxitol|Diethylene glycol methyl ether|Dowanol DM|Poly-Solv DM|Diglycol monomethyl ether|DEGME|MECB|Ektasolve DM|2-(2-Methoxyethoxy)-Ethanol|3,6-Dioxa-1-heptanol|Methyldiglycol|Diethyleneglycol monomethyl ether|Methyl karbitol|Ethylene diglycol monomethyl ether|NSC 2261|UNII-465DDJ8G8K|Methyl-PEG2-alcohol|Ethanol, 2,2'-oxybis-, monomethyl ether|465DDJ8G8K|",120.150,C5H12O3,38.700,38.700,-0.900,8,1,3,5,"InChI=1S/C5H12O3/c1-7-4-5-8-3-2-6/h6H,2-5H2,1H3",COCCOCCO,SBASXUCJHJRPEV-UHFFFAOYSA-N,2-(2-methoxyethoxy)ethanol,NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,1469|1479|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|602332|624030|624170|624172|624173|651631|651632|651633|651634|651741|651743|651749|651751|651777|651778|651838|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720636|720637|720653|720659|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|74304,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|BePharm Ltd.|Biosynth Carbosynth|BLD Pharm|Br",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8172,Triethylene glycol,"TRIETHYLENE GLYCOL|112-27-6|Triglycol|2,2'-(Ethane-1,2-diylbis(oxy))diethanol|Triethyleneglycol|2,2'-Ethylenedioxydiethanol|Trigen|Triethylenglykol|1,2-Bis(2-hydroxyethoxy)ethane|2-[2-(2-Hydroxyethoxy)ethoxy]ethanol|2,2'-(Ethylenedioxy)diethanol|3,6-Dioxaoctane-1,8-diol|Ethanol, 2,2'-[1,2-ethanediylbis(oxy)]bis-|Di-beta-hydroxyethoxyethane|2,2'-Ethylenedioxybis(ethanol)|2,2'-Ethylenedioxyethanol|2,2'-[ethane-1,2-diylbis(oxy)]diethanol|Triethylene glcol|Glycol bis(hydroxyethyl) ether|Ethylene glycol dihydrox",150.170,C6H14O4,58.900,49.700,-1.600,10,2,4,7,"InChI=1S/C6H14O4/c7-1-3-9-5-6-10-4-2-8/h7-8H,1-6H2",C(COCCOCCO)O,ZIBGPFATKBEMQZ-UHFFFAOYSA-N,2-[2-(2-hydroxyethoxy)ethoxy]ethanol,NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,16,880|1188|1189|1194|1208|1469|1471|1479|1487|1490|1576|1688|1766|1768|2528|2546|2551|2662|485290|492961|504327|504332|504749|504832|504834|504847|504865|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|588579|588834|602332|624030|624031|624032|624044|624170|624172|624173|624296|624297|651631|651632|651633|651634|651741|651743|651749|651751|651777|651778|651838|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemtek|Acros Organics|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|Biocore|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|BroadPharm|Burnham Center for Chemical ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8200,Tetraethylene glycol,"TETRAETHYLENE GLYCOL|112-60-7|Tetraglycol|2,2'-((Oxybis(ethane-2,1-diyl))bis(oxy))diethanol|3,6,9-Trioxaundecane-1,11-diol|HI-Dry|Carbitol, diethyl|Ethanol, 2,2'-[oxybis(2,1-ethanediyloxy)]bis-|Bis[2-(2-hydroxyethoxy)ethyl] ether|PEG-4|MFCD00002879|Tetra(ethylene glycol)|3,6,9-Trioxaundecan-1,11-diol|NSC 1262|2,2'-[oxybis(ethane-2,1-diyloxy)]diethanol|Ethanol, 2,2'-(oxybis(ethyleneoxy))di-|PROTAC Linker 18|2,2'-[oxybis(2,1-ethanediyloxy)]diethanol|HO-PEG4-OH|2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethanol|Te",194.230,C8H18O5,68.200,78.600,-1.600,13,2,5,10,"InChI=1S/C8H18O5/c9-1-3-11-5-7-13-8-6-12-4-2-10/h9-10H,1-8H2",C(COCCOCCOCCO)O,UWHCKJMYHZGTIT-UHFFFAOYSA-N,2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethanol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,155|157|161|165|167|175|248|1469|1479|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|651631|651632|651633|651634|651741|651743|651749|651751|651777|651778|651838|720516|720552|720634|720635|720636|720637|720653|720659|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|74306,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|BroadPharm|ChEBI|Chem-Spac",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
8333,Diphenylacetic acid,"DIPHENYLACETIC ACID|2,2-diphenylacetic acid|117-34-0|Diphenylethanoic acid|Acetic acid, diphenyl-|Benzeneacetic acid, .alpha.-phenyl-|MFCD00004251|UNII-658NCZ0NKO|alpha-phenylbenzeneacetic acid|diphenyl acetic acid|Diphenyl-acetic acid|Benzeneacetic acid, alpha-phenyl-|658NCZ0NKO|CHEBI:41967|.alpha.,.alpha.-Diphenylacetic acid|.alpha.-Toluic acid, .alpha.-phenyl-|A-Toluic Acid, A-Phenyl-|Diphenylacetic acid, 99+%|1,1-Diphenylacetic acid|alpha-Toluic acid, alpha-phenyl-|EINECS 204-185-0|NSC 120417|BRN 191097",212.240,C14H12O2,37.300,207.000,3.100,16,1,2,3,"InChI=1S/C14H12O2/c15-14(16)13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10,13H,(H,15,16)",C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)O,PYHXGXCGESYPCW-UHFFFAOYSA-N,"2,2-diphenylacetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing,10,155|157|161|165|167|175|248|1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2227|2234|2235|2237|2239|2247|2280|2300|2380|2435|2445|2462|2520|2521|2524|2540|2544|2550|2553|2557|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|434955|434962|434973|434989|435003|435005|435022|,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|AstaTech, Inc.|Aurora Fine Chemicals LL",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9084,Malonate,"Propanedioate|malonate|Malonate dianion|Malonic acid, ion(2-)|MALONATE ION|Malonate ion(2-)|156-80-9|Propanedioic acid, ion(2-)|UNII-4N2NU7R76L|4N2NU7R76L|CHEMBL359504|BRN 3904386|malo|malonoate|malonyl|Sodium; Malonate|malonate(2-)|malonic acid dianion|1,3-dioxidopropane-1,3-dione|CHEBI:15792|DTXSID10166020|(-)OOC-CH2-COO(-)|BDBM50159797|Propanedioic acid, ion(2-) (9CI)|DB02201|BB 0254964|9193-EP2272847A1|9193-EP2272972A1|9193-EP2272973A1|9193-EP2275395A2|9193-EP2277861A1|9193-EP2277872A1|9193-EP2277876A1|",102.050,C3H2O4-2,80.300,72.100,0.800,7,0,4,0,"InChI=1S/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7)/p-2",C(C(=O)[O-])C(=O)[O-],OFOBLEOULBTSOW-UHFFFAOYSA-L,propanedioate,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20040916,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|Amadis Chemical|BIND|BindingDB|BioCyc|ChEBI|Chembase.cn|ChemDB|ChemIDplus|ChemSpider|ChemTik|DiscoveryGate|DrugBank|EDASA Scientific|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|MuseChem|Nature Chemical Biology|NextBio|NextMove Software|NIAID ChemDB|NMRShiftDB|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9221,Indazole,"1H-Indazole|INDAZOLE|271-44-3|2H-indazole|1H-Benzopyrazole|Isoindazole|2-Azaindole|1,2-Diazaindene|1,2-Benzodiazole|1H-indazol|Benzopyrazole|Azaindole|UNII-7C4VQE5C03|MFCD00005691|1,2-Benzopyrazole|271-42-1|7C4VQE5C03|CHEBI:36669|Indazole, 96%|WLN: T56 BMNJ|Indazoles|1,2-Diazaindene (VAN)|EINECS 205-978-4|NSC 26336|indazol|2-Azoindole|2vta|1-H-indazole|Indazole, 5|Indazole, 6|LZ1|NSC90357|BENZPYRAZOL|zlchem 598|ACMC-20aixv|Indazole, 98%|PubChem15665|4b2i|SCHEMBL6295|CHEMBL86795|SCHEMBL3056528|SCHEMBL5376344",118.140,C7H6N2,28.700,103.000,1.800,9,1,1,0,"InChI=1S/C7H6N2/c1-2-4-7-6(3-1)5-8-9-7/h1-5H,(H,8,9)",C1=CC=C2C(=C1)C=NN2,BAXOFTOLAUCFNW-UHFFFAOYSA-N,1H-indazole,Indazoles,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Biological Test Results: Active,10,155|157|161|165|167|175|200|330|2842|17269|23454|53454|366144|449906|551809|589266|589267|613143|613144|613145|613146|613147|613148|613149|613150|613151|613152|613153|613154|613155|613156|613157|613158|613159|613160|613161|613162|613163|613164|613165|613166|613167|613168|613169|613170|613171|613172|613173|613174|621858|977608|977611|1159387|1159607|1239772|1272365|1331793|1331794,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Anward|AOBChem USA|Apexmo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
10284,1-Hydroxyisoquinoline,"1-Hydroxyisoquinoline|491-30-5|Isoquinolin-1(2H)-one|2H-Isoquinolin-1-one|isoquinolin-1-ol|1-Isoquinolinol|Isocarbostyril|1(2H)-ISOQUINOLINONE|489453-23-8|Isoquinolin-1-one|1(2H)-Isoquinolone|1-hydroxyisoquinolin|isoquinolinol|1,2-dihydroisoquinolin-1-one|Isoquinolinone|Isoquinolone|87602-67-3|Isocarbostyril, 98%|MFCD00006899|UNII-95EG3HGG1P|1(2H)-ISOQUINILONE|95EG3HGG1P|CHEMBL339695|CHEBI:18350|1-isoquinolone|oxidoisoquinolinium|4YS|EINECS 207-732-1|NSC 27273|PubChem6257|1-hydroxy isoquinoline|1-(2H)-isoqu",145.160,C9H7NO,29.100,198.000,1.300,11,1,1,0,"InChI=1S/C9H7NO/c11-9-8-4-2-1-3-7(8)5-6-10-9/h1-6H,(H,10,11)",C1=CC=C2C(=C1)C=CNC2=O,VDBNYAPERZTOOF-UHFFFAOYSA-N,2H-isoquinolin-1-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,248|154621|162403|485350|485395|492548|493033|504770|540299|588519|720641|1201284|1308809|1347385,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambin",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11332,"(2,6-Dichlorophenoxy)acetic acid","2-(2,6-dichlorophenoxy)acetic acid|575-90-6|(2,6-Dichlorophenoxy)acetic acid|2,6-DICHLOROPHENOXYACETIC ACID|2,6-Dichlorophenoxyacetate|2,6-D|MLS000058815|SMR000069081|(2,6-Dichloro-phenoxy)-acetic acid|EINECS 209-395-6|NSC 409411|CBDivE_003504|cid_11332|2,6-D ACID|CHEMBL361845|SCHEMBL3729436|Acetic acid,6-dichlorophenoxy)-|BDBM32111|DTXSID30206114|HMS2409K09|ZINC123600|MFCD00272886|NSC409411|STK369640|AKOS001060594|DS-3325|MCULE-9934720851|NSC-409411|SDCCGMLS-0038975.P002|tert-butyl 3-(6-(3-methylisoxazol-5",221.030,C8H6Cl2O3,46.500,176.000,2.700,13,1,3,3,"InChI=1S/C8H6Cl2O3/c9-5-2-1-3-6(10)8(5)13-4-7(11)12/h1-3H,4H2,(H,11,12)",C1=CC(=C(C(=C1)Cl)OCC(=O)O)Cl,KHZWIIFEFQBNKL-UHFFFAOYSA-N,"2-(2,6-dichlorophenoxy)acetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,360|361|368|373|374|411|422|425|429|430|431|432|436|445|447|448|449|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|555|556|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|608|612|618|619|620|626|628|629|630|631|633|639|640|641|645|648|662|680|684|685|688|690|693|696|697|704|707|708|709|710|712|717|719|720|727|729|731|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|793|796|797|798|799|800|802|,20050326,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Activate Scientific|AKos Consulting & Solutions|Alichem|Ambeed|Angel Pharmatech Ltd.|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BindingDB|BLD Pharm|BOC Sciences|Burnham Center for Chemical Genomics|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemBridge|ChemDB|Chemenu Inc.|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|DiscoveryGate|DTP/NCI|Egon Willighagen (Dept. of B",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11970,2-Hydroxyphenylacetic acid,"2-Hydroxyphenylacetic acid|614-75-5|2-(2-hydroxyphenyl)acetic acid|(2-Hydroxyphenyl)acetic acid|Benzeneacetic acid, 2-hydroxy-|2-Hydroxybenzeneacetic acid|O-HYDROXYPHENYLACETIC ACID|2-Hydroxyphenylacetate|ortho-Hydroxyphenylacetic acid|Acetic acid, (o-hydroxyphenyl)-|(o-Hydroxyphenyl)acetic acid|UNII-UK3R9Q59AV|o-Hydroxy phenylacetic acid|MFCD00004323|UK3R9Q59AV|CHEMBL240714|CHEBI:28478|(2-HYDROXYPHENYL)-ACETIC ACID|(o-Hydroxyphenyl)acetate|2-Hydroxyphenylacetic acid, 99%|2-HPAA|2-hydroxy phenylacetic acid|",152.150,C8H8O3,57.500,144.000,0.900,11,2,3,2,"InChI=1S/C8H8O3/c9-7-4-2-1-3-6(7)5-8(10)11/h1-4,9H,5H2,(H,10,11)",C1=CC=C(C(=C1)CC(=O)O)O,CCVYRRGZDBSHFU-UHFFFAOYSA-N,2-(2-hydroxyphenyl)acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,10,155|157|161|165|167|175|309933|498706|1449688|1449696,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
12122,3-Hydroxyphenylacetic acid,"3-Hydroxyphenylacetic acid|621-37-4|2-(3-hydroxyphenyl)acetic acid|(3-Hydroxyphenyl)acetic acid|3-Hydroxybenzeneacetic acid|M-HYDROXYPHENYLACETIC ACID|(m-Hydroxyphenyl)acetic acid|Benzeneacetic acid, 3-hydroxy-|3-Hydroxyphenylacetate|Metahydroxy phenylacetic acid|Acetic acid, (m-hydroxyphenyl)-|MFCD00004337|(3-Hydroxy-phenyl)-acetic acid|UNII-K59Z6Z8REF|K59Z6Z8REF|CHEMBL190035|CHEBI:17445|Benzeneacetic acid, 3-hydroxy- (9CI)|Acetic acid, (m-hydroxyphenyl)- (8CI)|m-hydroxyphenylacetate|3-Hydroxyphenylacetic ",152.150,C8H8O3,57.500,144.000,0.900,11,2,3,2,"InChI=1S/C8H8O3/c9-7-3-1-2-6(4-7)5-8(10)11/h1-4,9H,5H2,(H,10,11)",C1=CC(=CC(=C1)O)CC(=O)O,FVMDYYGIDFPZAX-UHFFFAOYSA-N,2-(3-hydroxyphenyl)acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active,11,155|157|161|165|167|175|242222|243735|243773|977610|1070390,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
12947,Hydroxychloroquine sulfate,HYDROXYCHLOROQUINE SULFATE|747-36-4|Hydroxychloroquine sulphate|Ercoquin|2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol sulfate|TCMDC-123987|NSC 4375|Oxichlorochine Sulfate|C18H28ClN3O5S|2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid|NSC-4375|Quensyl|2-({4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino)ethan-1-ol; sulfuric acid|Plaquinol|Toremonil|2-((4-((7-chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethan-1-ol sulfate|DSSTox_CID_27788|DSSTox_RID_82563|DSSTo,434.000,C18H28ClN3O5S,131.000,413.000,NULL,28,4,8,9,"InChI=1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)",CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O,JCBIVZZPXRZKTI-UHFFFAOYSA-N,2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid,Hydroxychloroquine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,155|157|161|165|167|175|179|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1766|1768|1865|1948|2101|2107|2112|2147|2297|2302|2303|2304|2305|2306|2451|2472|2517|2528|2546|2549|2551|485281|485290|485350|493033|504327|504332|504770|504847|504865|540299|588519|588579|588834|602314|602332|624349|651631|651632|651633|651634|651645|651646|651696|651712|651713|652048|652051|686947|686950|68697,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|AN PharmaTech|Anward|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|AvaChem Scientific|Axon Medchem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
13021,"2-Amino-4,6-dimethylpyrimidine","2-AMINO-4,6-DIMETHYLPYRIMIDINE|767-15-7|4,6-dimethylpyrimidin-2-amine|Acetylacetoneguanidine|2-Pyrimidinamine, 4,6-dimethyl-|4,6-Dimethylpyrimidin-2-ylamine|4,6-Dimethyl-2-pyrimidinamine|4,6-dimethyl-2-aminopyrimidine|Pyrimidine, 2-amino-4,6-dimethyl-|UNII-4S48MI253M|4,6-Dimethyl-pyrimidin-2-ylamine|MFCD00006102|2-Amine-4,6-dimethylpyrimidine|CHEMBL4546836|2-amino-4,6-dimethyl pyrimidine|4S48MI253M|4,6-dimethylpyrimidine-2-ylamine|2-Amino-4,6-dimethylpyrimidine, 98%|NSC 3278|EINECS 212-181-5|AI3-08092|4llx|",123.160,C6H9N3,51.800,84.300,0.700,9,1,3,0,"InChI=1S/C6H9N3/c1-4-3-5(2)9-6(7)8-4/h3H,1-2H3,(H2,7,8,9)",CC1=CC(=NC(=N1)N)C,IDQNBVFPZMCDDN-UHFFFAOYSA-N,"4,6-dimethylpyrimidin-2-amine",NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,12,155|157|161|165|167|175|256|977610,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aromalake Chemical|AstaTech,",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
13401,3-Hydroxypicolinic acid,"3-HYDROXYPICOLINIC ACID|874-24-8|3-Hydroxypyridine-2-carboxylic acid|3-Hydroxy-2-pyridinecarboxylic acid|3-Hydroxypicolinicacid|MFCD00006294|2-Pyridinecarboxylic acid, 3-hydroxy-|CHEBI:64342|CHEMBL1234326|3-Hydroxypicolinate|3-Hydroxypicolinic acid, 98%|3-HPA|Pyridinecarboxylic acid, hydroxy-|EINECS 212-859-0|hydroxypicolinic acid|3-Hydroxypicolinic acid (3-Hydroxypyridine-2-carboxylic acid)|PubChem9286|ACMC-209qln|3-hydroxylpicolinic acid|3-hydroxy picolinic acid|3-Hydroxy-picolinic acid|NCIOpen2_001249|SC",139.110,C6H5NO3,70.400,137.000,1.300,10,2,4,1,"InChI=1S/C6H5NO3/c8-4-2-1-3-7-5(4)6(9)10/h1-3,8H,(H,9,10)",C1=CC(=C(N=C1)C(=O)O)O,BRARRAHGNDUELT-UHFFFAOYSA-N,3-hydroxypyridine-2-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing,9,566699|566700|566701|566702|566703|566704|566705|566706|566707|1247843|1247844,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|Angene Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
13770,Cyproheptadine hydrochloride,"cyproheptadine hydrochloride|969-33-5|Cyproheptadine Hcl|Periactin hydrochloride|Anarexol|Cipractin|Nuran|Antegan|Peritol|Periactin syrup|component of Dronactin|Cyproheptadine (hydrochloride)|Cyproheptadiene hydrochloride|41354-29-4|Cyproheptadine hydrochloride anhydrous|UNII-0S9323MCT0|Cyproheptadine hydrochloride sesquihydrate|Cyproheptadine Hydrochloride (anhydrous)|CPD000058431|MLS000028462|CHEBI:59695|0S9323MCT0|4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine hydrochloride|NSC-169911|SMR0000",323.900,C21H22ClN,3.200,423.000,NULL,23,1,1,0,"InChI=1S/C21H21N.ClH/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21;/h2-11H,12-15H2,1H3;1H",CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl,ZPMVNZLARAEGHB-UHFFFAOYSA-N,"1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride",Cyproheptadine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,192|248|357|361|364|368|371|373|374|375|377|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|453|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|547|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|677|678|680|684|686|687|694|701|708|709|719|731|732|746|750|751|757|758|759|760|761|764|770|771|772|,20050624,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|ApexBio Technology|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|AvaChem Scientific|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
13789,Canrenone,"CANRENONE|976-71-6|Aldadiene|UNII-78O20X9J0U|Spironolactone Related Compound A|78O20X9J0U|MFCD00071735|(1'S,2R,2'R,10'R,11'S,15'S)-2',15'-dimethylspiro[oxolane-2,14'-tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane]-6',8'-diene-5,5'-dione|Luvion|NSC 261713|SC-9376|DSSTox_CID_25930|DSSTox_RID_81231|Aldadiene (VAN)|DSSTox_GSID_45930|(8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione|Canrenonum|Canrenona|Canrenone [USAN:INN]|Canrenonu",340.500,C22H28O3,43.400,719.000,2.700,25,0,3,0,"InChI=1S/C22H28O3/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21)12-8-19(24)25-22/h3-4,13,16-18H,5-12H2,1-2H3/t16-,17+,18+,20+,21+,22-/m1/s1",C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C,UJVLDDZCTMKXJK-WNHSNXHDSA-N,"(8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione",Canrenone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1868|1875|1885|1903|1910|1961|1979|1984|1986|2006|2012|2013|2014|2016|2023|2025|2029|2052|2058|2066|2071|2073|2094|2097|2098|2099|2100|2101|2156|2216|2221|2227|2237|2239|2247|2288|2289|2314|2315|2326|2380|2391|2451|2462|2472|2517|2520|2521|2524|2528|2540|2544|2546|2550|2551|2553|2557|2563|2599|2629|2642|2648|2650|2661|26,20050808,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|Achemtek|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|ApexBio Technology|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|BePharm Ltd.|BioChemPartner|CCSbase|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
17472,Hexaethylene glycol,"HEXAETHYLENE GLYCOL|2615-15-8|3,6,9,12,15-Pentaoxaheptadecane-1,17-diol|Hexagol|Hexaoxyethylene glycol|PEG-6|HO-PEG6-OH|Polyethylene glycol 300|Polyoxyethylene (6)|Hexaethyleneglycol|2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol|NSC 201209|MFCD00002877|Ethanol, 2,2'-(oxybis(ethyleneoxyethyleneoxy))di-|CHEBI:49793|P6G|EINECS 220-045-1|BRN 1638281|AI3-01457|2-[2-(2-{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}ethoxy)ethoxy]ethan-1-ol|Hexa[ethylene glycol]|ACMC-1CIR4|Hexaethylene glycol, 97%|H(OCH",282.330,C12H26O7,86.600,141.000,-1.900,19,2,7,16,"InChI=1S/C12H26O7/c13-1-3-15-5-7-17-9-11-19-12-10-18-8-6-16-4-2-14/h13-14H,1-12H2",C(COCCOCCOCCOCCOCCO)O,IIRDTKBZINWQAW-UHFFFAOYSA-N,2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing,11,248|880|881|894|1030|1379|1452|1457|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1766|1768|1865|1948|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|485281|485290|504327|504332|504847|588579|602332|720532|720533,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|BePharm Ltd.|Biocore|Bios",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
18986,5-Methoxyindole-3-acetic acid,"5-Methoxyindole-3-acetic acid|3471-31-6|2-(5-methoxy-1H-indol-3-yl)acetic acid|5-Methoxyindoleacetic acid|5-Methoxy-3-indoleacetic acid|Methoxyindoleacetic acid|5-Methoxyindol-3-ylacetic acid|5-Methoxyindoleacetate|1H-Indole-3-acetic acid, 5-methoxy-|(5-Methoxy-1H-indol-3-yl)acetic acid|5-Methoxyindole-3-aceticacid|INDOLE-3-ACETIC ACID, 5-METHOXY-|MFCD00005638|2-(5-Methoxy-3-indolyl)acetic Acid|(5-Methoxy-1H-indol-3-yl)-acetic acid|5-Methoxy-1H-indole-3-acetic acid|2-(5-methoxyindol-3-yl)acetic acid|EINECS ",205.210,C11H11NO3,62.300,244.000,1.400,15,2,3,3,"InChI=1S/C11H11NO3/c1-15-8-2-3-10-9(5-8)7(6-12-10)4-11(13)14/h2-3,5-6,12H,4H2,1H3,(H,13,14)",COC1=CC2=C(C=C1)NC=C2CC(=O)O,COCNDHOPIHDTHK-UHFFFAOYSA-N,2-(5-methoxy-1H-indol-3-yl)acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active,11,485|631|731|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|878|880|894|898|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Angene Chemical|An",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
19188,Phenoxyacetic acid,"PHENOXYACETIC ACID|2-phenoxyacetic acid|122-59-8|Phenoxyethanoic acid|Acetic acid, phenoxy-|Phenoxy acetic acid|Glycolic acid phenyl ether|Glycol acid phenyl ether|o-Phenylglycolic acid|Glycollic acid phenyl ether|Acetic acid, 2-phenoxy-|Acide phenoxyacetique|Glycolic acid, phenyl ether|Phenoxyessigsaeure|Phenylglycolic acid, O-|Phenyl ether glycolic acid|Phenoxy-Acetic Acid|2-phenoxy-acetic acid|Acide phenoxyacetique [French]|POA|phenoxacetic acid|NSC 9810|MFCD00004296|UNII-YRC253429Q|CHEBI:8075|2-phenoxye",152.150,C8H8O3,46.500,127.000,1.300,11,1,3,3,"InChI=1S/C8H8O3/c9-8(10)6-11-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",C1=CC=C(C=C1)OCC(=O)O,LCPDWSOZIOUXRV-UHFFFAOYSA-N,2-phenoxyacetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,155|157|161|165|167|175|248|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1452|1457|1458|1469|1471|1476|1477|1478|1479|1487|1490|1688|1766|1768|1948|1987|2016|2023|2025|2029|2052|2057|2,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|BioCyc|Biologic",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
19266,4-Acetamidobenzoic acid,"4-Acetamidobenzoic acid|556-08-1|Acedoben|4-(Acetylamino)benzoic acid|p-Acetamidobenzoic acid|p-Acetylamino benzoic acid|4-Carboxyacetanilide|Benzoic acid, 4-(acetylamino)-|4-Acetylaminobenzoic acid|p-Acetoaminobenzoic acid|PAAB|N-Acetyl-p-aminobenzoic acid|p-Acetaminobenzoic acid|p-Acetylaminobenzoic acid|N-Acetyl-PABA|Para Acetamido Benzoic Acid|Acedobene|Acedobenum|4'-Carboxyacetanilide|Benzoic acid, p-acetamido-|NSC 4002|MFCD00002534|Acedoben-d4|UNII-04Z20NMK31|4-acetamido benzoic acid|CHEBI:46171|04Z20",179.170,C9H9NO3,66.400,207.000,1.300,13,2,3,2,"InChI=1S/C9H9NO3/c1-6(11)10-8-4-2-7(3-5-8)9(12)13/h2-5H,1H3,(H,10,11)(H,12,13)",CC(=O)NC1=CC=C(C=C1)C(=O)O,QCXJEYYXVJIFCE-UHFFFAOYSA-N,4-acetamidobenzoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,155|157|161|165|167|175|248|256|421|426|427|433|434|435|445|530|540|541|542|543|544|545|546|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|875|880|881|884|885|886|887|889|892|893|894|900|902|912|921|923|924|925|926|938|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1030|1452|1457|1458|1469|1471|1476|1477|1478|1479|1490|1688|1766|1768|1948|1996|2016|2023|2025|2029|2052|2066|21,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Advanced Technology & Industrial Co., Ltd.|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharma",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
20825,N-Phthaloylglycine,"N-Phthaloylglycine|4702-13-0|Phthalimidoacetic acid|N-Phthalylglycine|N-(Carboxymethyl)phthalimide|Phthaloylglycine|N,N-Phthaloylglycine|N-Phthalylglycin|2-(1,3-dioxoisoindolin-2-yl)acetic acid|(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid|1,3-Dioxo-2-isoindolineacetic acid|2H-Isoindole-2-acetic acid, 1,3-dihydro-1,3-dioxo-|UNII-6J5LY4N0CG|MFCD00005900|(1,3-dioxoisoindol-2-yl)acetic acid|2-ISOINDOLINEACETIC ACID, 1,3-DIOXO-|N-(Carboxymethyl)-phthalimide|2-(1,3-dioxoisoindol-2-yl)acetic acid|PHTHALOYL-",205.170,C10H7NO4,74.700,301.000,0.900,15,1,4,2,"InChI=1S/C10H7NO4/c12-8(13)5-11-9(14)6-3-1-2-4-7(6)10(11)15/h1-4H,5H2,(H,12,13)",C1=CC=C2C(=C1)C(=O)N(C2=O)CC(=O)O,WQINSVOOIJDOLJ-UHFFFAOYSA-N,"2-(1,3-dioxoisoindol-2-yl)acetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,9,155|157|161|165|167|175|248|485395|493033|504770|720641|771770|771771|771772|771773|771774|771777|771778|771779|771780|771781|1066235|1224905|1259310|1259370|1259374|1259422|1275624|1275625|1275626|1275627|1340929|1340930|1340931|1340932|1340933|1340934|1340947|1340948|1340949,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Angene Chemical|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
24139,2-Acetamido-2-deoxy-beta-D-glucopyranose,"acetylglucosamine|N-Acetyl-beta-D-glucosamine|N-acetylglucosamine|2-acetamido-2-deoxy-beta-D-glucopyranose|Beta-N-Acetylglucosamine|betaGlcNAc|CHEBI:28009|GlcNAc-beta|N-Acetyl Glucosamine|2-Acetamido-2-deoxy-beta-D-glucosamine|N-[(2R,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide|UNII-8P59336F68|2-Acetamido-2-deoxy-beta-D-glucose|8P59336F68|N-acetyl-D-glucosamine (complete stereochemistry)|NAcGlc|72-87-7|Cheon shim bo yun|n-acetyl-b-d-glucosamine|hydrolyzed chitin|pharmaceutical aid|ssGl",221.210,C8H15NO6,119.000,235.000,-1.700,15,5,6,2,"InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6-,7-,8-/m1/s1",CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O)CO)O)O,OVRNDRQMDRJTHS-FMDGEEDCSA-N,"N-[(2R,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide",Acetylglucosamine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active,11,940|1422|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|220916|220917|220918|220919|220920|220921|302089|302090|302091|362960|362961|362962|362963|362964|362965|362966|362967|362968|381592|381593|381594|381595|381596|381597|450447|450448|450449|450450|459221|485350|489738|489739|492967|493033|493162|493446|493447|501262|504770|540299|569255|569256|569258|569259|569260|569261|569262|588519|60,20050623,"A2B Chem|AA BLOCKS|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|AN PharmaTech|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|ChemBank|Chembase.cn|ChEMBL|chemical genetic matrix|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Chen Lab, School of Medicine, Emory University|Collaborative Drug Discovery, Inc.|DC Chemicals",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank, clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
29872,2-Amino-4-chlorobenzothiazole,"2-AMINO-4-CHLOROBENZOTHIAZOLE|19952-47-7|4-Chloro-1,3-benzothiazol-2-amine|4-chlorobenzo[d]thiazol-2-amine|2-Benzothiazolamine, 4-chloro-|4-Chlorobenzothiazol-2-ylamine|4-Chloro-2-benzothiazolamine|Benzothiazole, 2-amino-4-chloro-|MFCD00005791|4-Chloro-benzothiazol-2-ylamine|4-Chloro-2-aminobenzothiazole|2-Amino-4-chloro benzothiazole|CHEMBL1413383|2-Amino-4-chlorobenzothiazole, 97%|4-chlorobenzothiazole-2-ylamine|SMR000323910|EINECS 243-439-5|BRN 0136784|2D0|zlchem 166|PubChem21701|ACMC-1BSB6|DSSTox_CID_44",184.650,C7H5ClN2S,67.200,155.000,2.700,11,1,3,0,"InChI=1S/C7H5ClN2S/c8-4-2-1-3-5-6(4)10-7(9)11-5/h1-3H,(H2,9,10)",C1=CC2=C(C(=C1)Cl)N=C(S2)N,OEQQFQXMCPMEIH-UHFFFAOYSA-N,"4-chloro-1,3-benzothiazol-2-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,421|426|427|433|434|435|445|485|530|540|541|542|543|544|545|546|584|585|595|596|603|605|631|654|655|656|657|658|659|660|661|662|663|664|665|666|667|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|875|878|880|881|884|885|886|887|889|892|893|894|900|902|912|920|921|923|924|925|926|932|938|940|946|947|948|950|951|952|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1001|1006|1007|1008|1009|1012|1016|1018|,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|AstaTech",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
30165,Iodide ion,"Iodide|Iodide ion|trihydridoiodine|20461-54-5|Iodide(1-)|Iodide-127|iodinane|iodine anion|Iodide anion|Iodide Salt|lambda(3)-iodane|UNII-09G4I6V86Q|I-|09G4I6V86Q|Iodides|Colloidal iodine|Iodide oil|Iodine ion|Iodide ion(1-)|Iodine(1-)|Iodine, ion (I1-)|hydriodic acid, ion(1-)|CHEMBL185537|BDBM26981|CHEBI:16382|CHEBI:37181|DTXSID80912339|[IH5]|Iodide (6CI,7CI,8CI,9CI)|Ba 2796|DB12754|C00708|Q407654|Q27117062",126.904,I-,0.000,0.000,0.900,1,0,1,0,InChI=1S/HI/h1H/p-1,[I-],XMBWDFGMSWQBCA-UHFFFAOYSA-M,iodide,Iodides,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,238317|238327|238328|238513|238515|238542|238544|238546|238607|238687|238688|238715|238853|238896|265737|730518|730519|730874|730875|1249576|1249577|1249578|1249579|1249580|1249581|1262263|1262264|1262267|1278739|1278740|1278741|1278742|1306523|1306524|1306525|1306526|1306530|1306532,20040916,"ABI Chem|AK Scientific, Inc. (AKSCI)|Ambinter|BIND|BindingDB|BioCyc|BOC Sciences|ChEBI|ChemDB|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|EPA Substance Registry Services|FDA/SPL Indexing Data|Google Patents|Hairui Chemical|Human Metabolome Database (HMDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LeadScope|MuseChem|NCBI Structure",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
31239,Cetylpyridinium chloride,"cetylpyridinium chloride|123-03-5|1-hexadecylpyridin-1-ium chloride|hexadecylpyridinium chloride|Pristacin|1-Hexadecylpyridinium chloride|Cepacol|Cetamium|Dobendan|Pyrisept|Tserigel|Aktivex|Biosept|Ceprim|Ceepryn chloride|Cepacol chloride|Quaternario CPC|Acetoquat CPC|Intexsan CPC|Swabettes Hoechst|Ammonyx CPC|N-Hexadecylpyridinium chloride|Cetyl pyridinium chloride|N-Cetylpyridinium chloride|1-Cetylpyridinium chloride|Pyridinium, 1-hexadecyl-, chloride|hexadecyl pyridinium chloride|1-Palmitylpyridinium chl",340.000,C21H38ClN,3.900,208.000,NULL,23,0,1,15,"InChI=1S/C21H38N.ClH/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-19-22-20-17-15-18-21-22;/h15,17-18,20-21H,2-14,16,19H2,1H3;1H/q+1;/p-1",CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Cl-],YMKDRGPMQRFJGP-UHFFFAOYSA-M,1-hexadecylpyridin-1-ium;chloride,NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,17,875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1766|1768|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|40791|117245|117248|164291|164425|164434|164435|164441|164566|201391|201760|201761|201769|201770|2017,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Aceschem Inc|Achemo Scientific Limited|Achemtek|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|ApexBio Technology|Ark Pharm, Inc.|Aronis|Aurora Fine Chemicals LLC|Aurum Ph",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
33113,Phosphoaminophosphonic acid-adenylate ester,"AMP-PNP|ADENYLYL IMIDODIPHOSPHATE|gamma-Imino-ATP|AMPPNP|25612-73-1|Adenyl imidodiphosphate|phosphoaminophosphonic acid-adenylate ester|adenyl-5'-yl imidodiphosphate|CHEBI:47785|[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]amino]phosphonic acid|O(5')-(1,2-dihydroxy-2-phosphonoaminodiphosphoryl)adenosine|5'-O-(hydroxy{[hydroxy(phosphonoamino)phosphoryl]oxy}phosphoryl)adenosine|p(NH)Ppf|beta,gamma-Imido-ATP|beta,gamma-Imidoadenosine 5'-tripho",506.200,C10H17N6O12P3,282.000,801.000,-6.000,31,8,17,8,"InChI=1S/C10H17N6O12P3/c11-8-5-9(13-2-12-8)16(3-14-5)10-7(18)6(17)4(27-10)1-26-31(24,25)28-30(22,23)15-29(19,20)21/h2-4,6-7,10,17-18H,1H2,(H,24,25)(H2,11,12,13)(H4,15,19,20,21,22,23)/t4-,6-,7-,10-/m1/s1",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(NP(=O)(O)O)O)O)O)N,PVKSNHVPLWYQGJ-KQYNXXCUSA-N,"[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]amino]phosphonic acid",Adenylyl Imidodiphosphate,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active,7,1811|26386|75732|107588|107743|107772|107901|227584|523011|523023|523024|977610|977611|1120279|1199498|1199499|1199500|1199502|1199503|1199504|1199505|1199506|1199507|1199508|1199509|1199510|1199511|1199512|1199513|1199514|1199515|1199516|1199517|1272858|1272859|1272860|1272861|1272862|1272863|1272864|1346599|1413290|1424767|1424768,20050608,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|AbaChemScene|ABI Chem|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|BIND|BindingDB|BioCyc|BLD Pharm|BOC Sciences|Calbiochem|ChEBI|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EMD Millipore|eNovation Chemicals|EPA DSSTox|Google Patents|IBM|ISpharm|IUPHAR/BPS Guide",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
34037,5-Hydroxynicotinic acid,"5-Hydroxynicotinic acid|27828-71-3|5-hydroxypyridine-3-carboxylic acid|3-Pyridinecarboxylic acid, 5-hydroxy-|5-Hydroxy-nicotinic acid|5-Hydroxy-3-pyridinecarboxylic acid|5-hydroxy nicotinic acid|MFCD00129117|CHEMBL2146902|5-hydroxynicotinicacid|BRN 0115847|5HN|NICOTINIC ACID, 5-HYDROXY-|PubChem2415|ACMC-209gz9|Oprea1_058796|Oprea1_193943|5-22-05-00113 (Beilstein Handbook Reference)|SCHEMBL186161|5-Hydroxynicotinic acid, 97%|5-hydroxypyridinium-3-carboxylate|DTXSID50182143|CHEBI:169995|5-hydroxypyridine-3-ca",139.110,C6H5NO3,70.400,137.000,0.000,10,2,4,1,"InChI=1S/C6H5NO3/c8-5-1-4(6(9)10)2-7-3-5/h1-3,8H,(H,9,10)",C1=C(C=NC=C1O)C(=O)O,ATTDCVLRGFEHEO-UHFFFAOYSA-N,5-hydroxypyridine-3-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity,8,463173|485350|485395|493033|504770|540299|588519|602314|689539|689540|720641|720717|1224905|1247843|1247844|1347041|1347165,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Ampy",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
40632,Pirfenidone,"PIRFENIDONE|53179-13-8|5-methyl-1-phenylpyridin-2(1H)-one|Esbriet|Deskar|AMR-69|5-Methyl-1-phenyl-2-(1H)-pyridone|Pirfenidonum|Pirfenidona|Pirespa|2(1H)-Pyridinone, 5-methyl-1-phenyl-|AMR 69|5-methyl-1-phenyl-2(1H)-pyridinone|5-Methyl-1-phenyl-1H-pyridin-2-one|5-methyl-1-phenyl-2-pyridinone|5-Methyl-1-phenyl-2(1H)-pyridone|UNII-D7NLD2JX7U|MFCD00866047|D7NLD2JX7U|CHEBI:32016|NCGC00015806-03|DSSTox_CID_25183|DSSTox_RID_80731|DSSTox_GSID_45183|Pirfenidone [USAN:INN]|Pirfenidonum [INN-Latin]|Pirfenidona [INN-Sp",185.220,C12H11NO,20.300,285.000,1.900,14,0,1,1,"InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3",CC1=CN(C(=O)C=C1)C2=CC=CC=C2,ISWRGOKTTBVCFA-UHFFFAOYSA-N,5-methyl-1-phenylpyridin-2-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,357|410|411|422|429|436|444|445|446|447|448|450|451|526|530|547|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|694|732|875|879|880|881|883|884|885|886|887|889|891|892|893|894|895|899|900|901|902|912|914|915|917|918|923|924|925|926|927|928|938|940|943|944|945|954|957|958|959|992|995|997|998|1030|1376|1379|1385|1422|1452|1454|1457|1458|1459|1460|1461|1463|1465|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1511|1519|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1688|1705|1707|1708|,20050624,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Amb",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
40692,(-)-Mefloquine,"mefloquine|(-)-Mefloquine|(-)-(11S,2'R)-erythro-Mefloquine|53230-10-7|Racemic mefloquine|Mefloquin|CHEMBL172|(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol|CHEBI:63687|Ro 21-5998|51742-87-1|Mefloquinum|Mefloquina|(S)-(2,8-bis(trifluoromethyl)quinolin-4-yl)((R)-piperidin-2-yl)methanol|RTI1189-1-1|Mefloquinum [INN-Latin]|Mefloquina [INN-Spanish]|RO 13-7225|Mefloquine [USAN:INN:BAN]|MLS001332559|[(11S,2'R)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol|RTI1188-1-1|Ro 215",378.310,C17H16F6N2O,45.200,483.000,3.600,26,2,9,2,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2/t12-,15+/m1/s1",C1CCN[C@H](C1)[C@H](C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,XEEQGYMUWCZPDN-DOMZBBRYSA-N,"(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol",Mefloquine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,880|1469|1471|1479|1487|1490|1688|1766|1768|2528|2546|2551|2662|331674|331675|485290|492961|504327|504332|504339|504444|504648|504749|504832|504834|504845|504847|504848|504850|504865|504891|540267|540317|558029|588453|588456|588579|588590|588795|588855|588856|602310|602332|624030|624031|624032|624044|624170|624172|624173|624178|624202|624263|624296|624297|624414|643455|643456|643458|643459|651965|652106|664775|664776|664777|664797|664798|683685|683687|686978|686979|720579|720580|726919|726920|726921|728698|,20050801,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|ApexBio Technology|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|BePharm Ltd.|BerrChem|BIDD|BindingDB|BioCrick|Biosynth Carbosynth|BLD Pharm|Boerchem|Broad Institute|C. David Weaver Laborator",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrials, clinicaltrial]"
41055,5-Methoxybenzo[d]thiazol-2-amine,"54346-87-1|5-methoxybenzo[d]thiazol-2-amine|5-methoxy-1,3-benzothiazol-2-amine|2-Amino-5-methoxybenzothiazole|5-Methoxy-2-benzothiazolamine|5-Methoxy-benzothiazol-2-ylamine|2-Benzothiazolamine, 5-methoxy-|2-Amino-5-methoxy-1,3-benzothiazole|UNII-9H7992E7HJ|MFCD00464314|9H7992E7HJ|5-Methoxybenzothiazol-2-amine|5-methoxybenzothiazole-2-ylamine|BRN 0131022|5-Methoxy-2-aminobenzothiazole|EINECS 259-118-8|BENZOTHIAZOLE, 2-AMINO-5-METHOXY-|PubChem19102|BAS 01053454|Oprea1_028813|Oprea1_375563|SCHEMBL73908|4-27-00",180.230,C8H8N2OS,76.400,167.000,2.000,12,1,4,1,"InChI=1S/C8H8N2OS/c1-11-5-2-3-7-6(4-5)10-8(9)12-7/h2-4H,1H3,(H2,9,10)",COC1=CC2=C(C=C1)SC(=N2)N,OMIHQJBWAPWLBO-UHFFFAOYSA-N,"5-methoxy-1,3-benzothiazol-2-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity,8,940|1422|463173|485350|485395|493033|504770|540299|588519|602314|720641|720717|1224905,20050708,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aromsyn catalogue|ASINEX|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
62551,Pentaethylene glycol,"Pentaethylene glycol|4792-15-8|3,6,9,12-Tetraoxatetradecane-1,14-diol|HO-PEG5-OH|PENTAETHYLENEGLYCOL|Pentaglycol|HO[CH2CH2O]5H|MFCD00002878|2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethanol|Pentaethylene glycol, 98%|CHEBI:39631|DSSTox_CID_7579|DSSTox_RID_78510|DSSTox_GSID_27579|CAS-4792-15-8|PEG400|EINECS 225-341-4|BRN 1635593|2-(2-{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}ethoxy)ethan-1-ol|3,6,9,12-Tetraoxatetradocane-1,14-diol|C10H22O6|Pentaethylene glycol;|ACMC-1AOLP|SCHEMBL45272|4-01-00-02405 (Beilste",238.280,C10H22O6,77.400,108.000,-1.700,16,2,6,13,"InChI=1S/C10H22O6/c11-1-3-13-5-7-15-9-10-16-8-6-14-4-2-12/h11-12H,1-10H2",C(COCCOCCOCCOCCO)O,JLFNLZLINWHATN-UHFFFAOYSA-N,2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethanol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,1469|1479|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|651631|651632|651633|651634|651741|651743|651749|651751|651777|651778|651838|720516|720552|720634|720635|720636|720637|720653|720659|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|74307,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|BePharm Ltd.|Biocore|BioCyc|Biosynth Carbo",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
62882,Propranolol hydrochloride,Propranolol hydrochloride|318-98-9|Propranolol Hcl|Inderal|Anaprilin|Avlocardyl|Berkolol|Caridolol|Herzbase|Inderalici|Naprilin|Pronovan|Dociton|Ikopal|Kemi|Beta Neg|InnoPran XL|Propranolol chloride|Inderex|3506-09-0|propranolol (hydrochloride)|Propranolol.HCl|Propanolol hydrochloride|NSC-91523|1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride|DL-Propranolol hydrochloride|ICI 45520|AY 64043|1-(Isopropylamino)-3-(naphthalen-1-yloxy)propan-2-ol hydrochloride|MFCD00012558|PROPRANOLOL HYDROCHLORIDE ,295.800,C16H22ClNO2,41.500,257.000,NULL,20,3,3,6,"InChI=1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H",CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl,ZMRUPTIKESYGQW-UHFFFAOYSA-N,1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride,Propranolol,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,155|157|161|165|167|175|179|192|210|212|220|226|256|270|272|274|302|330|421|422|426|427|429|433|434|435|436|445|530|540|541|542|543|544|545|546|547|584|585|595|596|603|605|654|655|656|657|658|659|660|661|662|663|664|665|666|667|694|732|781|782|798|800|873|875|880|881|884|885|886|887|889|892|893|894|900|902|910|912|921|923|924|925|926|927|930|938|940|946|947|948|955|960|961|962|963|964|965|966|967|968|969|970|971|972|973|974|975|976|977|978|979|980|981|982|983|984|985|986|987|988|989|993|994|995|1021|1022|10,20050624,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alsachim|AN PharmaTech|Angene Chemical|Anward|Aronis|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BioChemPartner|BioCrick",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
64150,Amantadine hydrochloride,"Amantadine hydrochloride|665-66-7|1-Adamantanamine hydrochloride|Amantadine HCl|Symmetrel|1-Aminoadamantane hydrochloride|adamantan-1-amine hydrochloride|1-Adamantylamine hydrochloride|Adamantanamine hydrochloride|Amazolon|Midantan|Midantane|Mydantane|Influenol|Trivaline|Virofral|Amantan|Virasol|Viregyt|Virosol|Amantadine (hydrochloride)|1-Adamantanamine, hydrochloride|Adamantylamine hydrochloride|Aminoadamantane hydrochloride|Adamantine hydrochloride|1-Adamantanamine HCl|EXP 105-1|MFCD00074723|NSC 83653|Ma",187.710,C10H18ClN,26.000,144.000,NULL,12,2,1,0,"InChI=1S/C10H17N.ClH/c11-10-4-7-1-8(5-10)3-9(2-7)6-10;/h7-9H,1-6,11H2;1H",C1C2CC3CC1CC(C2)(C3)N.Cl,WOLHOYHSEKDWQH-UHFFFAOYSA-N,adamantan-1-amine;hydrochloride,Amantadine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,179|248|282|318|328|422|429|436|485|547|631|694|731|732|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|875|878|880|881|884|885|887|889|892|893|894|898|900|902|910|920|923|924|927|930|932|940|950|951|952|995|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|137,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambinter|AN PharmaTech|Angene Chemical|Anward|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pv",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
64689,beta-D-Glucose,"beta-D-glucose|beta-D-glucopyranose|492-61-5|glucoside|Curdlan|beta-glucose|beta-Dextrose|b-Glucose|b-d-glucose|UNII-J4R00M814D|.beta.-D-Glucopyranose|28905-12-6|CHEMBL1614854|(2R,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol|CHEBI:15903|J4R00M814D|(2R,3R,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol|54724-00-4|Glucosides|.beta.-D-Glucose|BGC|ZYMOSAN|Glucose, (beta-D)-Isomer|Callose|Curdlan gum|b-Dextrose|beta-D-Glucopyranose, anhydrous|beta-D-Glc|EINECS 207-756-2|beta-d-(+)-glucose|1,",180.160,C6H12O6,110.000,151.000,-2.600,12,5,6,1,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6-/m1/s1",C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O)O,WQZGKKKJIJFFOK-VFUOTHLCSA-N,"(2R,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,11,452766|452767|452768|452769|452770|452771|480616|768836|1479145|1479147|1479149|1479150,20040916,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|Angene Chemical|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|BioCrick|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemFaces|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
65052,4-Hydroxybenzamide,"4-Hydroxybenzamide|619-57-8|p-Hydroxybenzamide|4-Hydroxy-benzamide|Benzamide, 4-hydroxy-|UNII-9OU5YD093J|MFCD00007997|9OU5YD093J|CHEMBL123617|41911-58-4|4-oxidanylbenzamide|EINECS 210-602-7|NSC 524134|ACMC-1APVC|para-hydroxybenzoic amide|AI3-15540|para-hydroxy benzoic amide|4-Hydroxybenzamide, 98%|4-hydroxybenzene carboxamide|Oprea1_692786|SCHEMBL162830|SCHEMBL10792133|DTXSID10210931|ZINC157088|AMY16513|4-hydroxybenzamide 41911-58-4|4-HYDROXY-BENZOIC ACID,AMIDE|ANW-34012|BDBM50106201|NSC524134|SBB058350|AKO",137.140,C7H7NO2,63.300,128.000,0.300,10,2,2,1,"InChI=1S/C7H7NO2/c8-7(10)5-1-3-6(9)4-2-5/h1-4,9H,(H2,8,10)",C1=CC(=CC=C1C(=O)N)O,QXSAKPUBHTZHKW-UHFFFAOYSA-N,4-hydroxybenzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,8,155|157|161|165|167|175|248|154621|282833|282835|282838|282839|304534|304535|304536|1347041|1347165|1405639|1453183,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|Bi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
65999,Telmisartan,"Telmisartan|144701-48-4|Micardis|Pritor|BIBR 277|Kinzalmono|4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid|BIBR-277|BIBR 277SE|Telmisattan|Telmisartan [INN]|UNII-U5SYW473RQ|4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|BIBR-277SE|BIBR-277-SE|C33H30N4O2|MFCD00918125|CHEMBL1017|U5SYW473RQ|BIBR 277 SE|2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid|",514.600,C33H30N4O2,72.900,831.000,6.900,39,1,4,7,"InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)",CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,RMMXLENWKUUMAY-UHFFFAOYSA-N,2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid,Telmisartan,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|950|951|952|995|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1048|1049|1051|1066|1085|1135|1136|1195|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1379|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1452|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1469|1471|1476|1477|1478|1479|1481|1486|1487|1490|1496|1509|1510,20050624,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alinda Chemical|Alomone L",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
66644,Salicylhydroxamic acid,"Salicylhydroxamic acid|N,2-Dihydroxybenzamide|89-73-6|2-Hydroxybenzohydroxamic acid|Salicylohydroxamic acid|Benzamide, N,2-dihydroxy-|SHAM|Salicylohydroximic acid|2-Hydroxybenzhydroxamic acid|O-Hydroxybenzohydroxamic acid|C7H7NO3|2,N-Dihydroxy-benzamide|NSC 5088|SHA|NSC 193440|Saliaylhydroxamic acid|UNII-8Q07182D0T|2-hydroxybenzenecarbohydroxamic acid|Salicylic Hydroxamic Acid|MFCD00002110|Salicylhydroxamic acid, 99%|MLS000069410|CHEMBL309339|CHEBI:45615|NSC5088|8Q07182D0T|Benzamide,2-dihydroxy-|SMR00005909",153.140,C7H7NO3,69.600,149.000,0.900,11,3,3,1,"InChI=1S/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10)",C1=CC=C(C(=C1)C(=O)NO)O,HBROZNQEVUILML-UHFFFAOYSA-N,"N,2-dihydroxybenzamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,155|157|161|165|167|175|248|270|330|357|361|364|368|371|373|374|375|411|422|425|429|430|431|432|436|438|440|441|444|446|449|450|454|455|456|457|460|483|485|487|488|501|518|521|522|524|525|527|528|529|538|539|552|555|556|559|560|561|565|567|568|570|571|572|573|574|575|576|577|580|581|583|587|588|589|590|591|592|593|594|597|598|601|602|604|606|609|614|615|618|620|622|623|624|625|626|628|629|630|631|633|636|637|639|641|645|648|680|684|686|687|701|708|709|719|731|746|750|751|757|758|759|760|761|764|770|771|772|,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Ambeed|Ambinter|AN PharmaTech|Anward|Ark Pharm, Inc.|Aurum Pharmatech LLC|BePharm Ltd.|BerrChem|BindingDB|BioCyc|Biological Magnetic Resonance Dat",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
69696,4-Bromobenzenesulfonamide,"4-Bromobenzenesulfonamide|701-34-8|p-Bromobenzenesulfonamide|Benzenesulfonamide, p-bromo-|4-bromobenzene-1-sulfonamide|Benzenesulfonamide, 4-bromo-|4-Bromo-benzenesulfonamide|4-bromobenzene sulfonamide|MFCD00051977|NSC 31049|BRN 2691657|AI3-00699|p-Brombenzolsulfonamid|4-bromophenylsulfonamide|4-bromo-phenylsulfonamide|WLN: ZSWR DE|4-Bromobenzenesulphonamide|4-bromobenzene-sulfonamide|ACMC-209od3|4-bromo-1-benzenesulfonamide|3-11-00-00104 (Beilstein Handbook Reference)|SCHEMBL183959|CHEMBL178852|4-bromophen",236.090,C6H6BrNO2S,68.500,213.000,1.400,11,1,3,1,"InChI=1S/C6H6BrNO2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,(H2,8,9,10)",C1=CC(=CC=C1S(=O)(=O)N)Br,STYQHICBPYRHQK-UHFFFAOYSA-N,4-bromobenzenesulfonamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,11,248|237031|237422|237613|239922|239935|244692|415022|550080|669115|669116|669117|669119|669120|669121|669122|669123|1134599|1134600,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Achemica|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB|BioChemPartner|Biocore",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
70807,3[N-Morpholino]propane sulfonic acid,"MOPS|1132-61-2|4-Morpholinepropanesulfonic acid|3-(N-Morpholino)propanesulfonic acid|3-Morpholinopropanesulfonic acid|3-Morpholinopropane-1-sulfonic acid|Morpholinopropane sulfonic acid|3-morpholin-4-ylpropane-1-sulfonic acid|3[N-MORPHOLINO]PROPANE SULFONIC ACID|MFCD00006183|4-Morpholinepropane sulfonic acid|3-N-Morpholinopropanesulfonic acid|UNII-273BP63NV3|3-(morpholin-4-yl)propane-1-sulfonic acid|CHEBI:44115|273BP63NV3|Morpholinopropanesulfonic acid; WAS 15|MOPS, 99%, for biochemistry|4-Morpholinopropane",209.270,C7H15NO4S,75.200,227.000,-3.100,13,1,5,4,"InChI=1S/C7H15NO4S/c9-13(10,11)7-1-2-8-3-5-12-6-4-8/h1-7H2,(H,9,10,11)",C1COCCN1CCCS(=O)(=O)O,DVLFYONBTKHTER-UHFFFAOYSA-N,3-morpholin-4-ylpropane-1-sulfonic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Micromolar,12,651631|651632|651633|651634|720516|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743140|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|7,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Ark Pharm, Inc.|Assembly ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
72899,Indole-2-carboxylic acid,"Indole-2-carboxylic acid|1H-Indole-2-carboxylic acid|1477-50-5|2-Carboxyindole|2-Indolecarboxylic acid|MFCD00005611|Indol-2-Carboxylic Acid|1H-Indolecarboxylic acid|NSC 16598|1H-Indole-2-carboxylic|Indole-2-carboxylate|2-INDOLYLFORMIC ACID|CHEMBL278390|N-[4-(2-Pyridinyl)-2-thiazolyl]-2-pyridinamine|Indole-2-carboxylic acid, 99%|EINECS 216-030-4|carboxyindole|2-Indolecarboxylate|ICB|indolecarboxylic acid|indole carboxylic acid|PubChem1690|2-carboxy-1H-indole|2-indolcarboxylic acid|Spectrum_001485|2-indol car",161.160,C9H7NO2,53.100,193.000,2.300,12,2,2,1,"InChI=1S/C9H7NO2/c11-9(12)8-5-6-3-1-2-4-7(6)10-8/h1-5,10H,(H,11,12)",C1=CC=C2C(=C1)C=C(N2)C(=O)O,HCUARRIEZVDMPT-UHFFFAOYSA-N,1H-indole-2-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,155|157|161|165|167|175|248|608|875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1033|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1549|1552|1637|1648|1766|1768|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|142989|143472|143618|143765|143781|143790|146231|207450|207587|234200|408637|408638|447578|485281|485290|485350|488839|488862|488895|488896|488899|488965|488966|492953|492956|492972|493005|493008|493033|493087,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemis",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
73742,1-Aminoisoquinoline,"Isoquinolin-1-amine|1-Aminoisoquinoline|1532-84-9|1-ISOQUINOLINAMINE|isoquinolin-1-ylamine|1-amino-isoquinoline|UNII-QUG12T52WZ|MFCD00024137|QUG12T52WZ|isoquinolylamine|CHEMBL62083|Isoquinoline, 1-amino-|isoquinolinimine|aminoisoquinoline|2ohk|3kpw|1SQ|EINECS 216-243-2|1-amino isoquinoline|isoquinolin-1-yl-amine|PubChem18941|1-Aminoisoquinoline, 99%|SCHEMBL49220|BIDD:GT0381|SCHEMBL4797349|BDBM14320|DTXSID40165283|ZINC154817|BCP05774|ANW-59241|RW2954|SBB004129|AKOS006220712|CM10316|CS-W000494|MCULE-588578498",144.170,C9H8N2,38.900,136.000,1.900,11,1,2,0,"InChI=1S/C9H8N2/c10-9-8-4-2-1-3-7(8)5-6-11-9/h1-6H,(H2,10,11)",C1=CC=C2C(=C1)C=CN=C2N,OSILBMSORKFRTB-UHFFFAOYSA-N,isoquinolin-1-amine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,9,68131|92001|146109|155652|234083|234085|238162|239526|239887|405524|419413|977608|977611|1159386|1159387|1175065|1272394|1272395|1325941,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
76947,5-Methylisoxazole-3-carboxylic acid,"5-Methylisoxazole-3-carboxylic acid|3405-77-4|5-methyl-1,2-oxazole-3-carboxylic acid|3-ISOXAZOLECARBOXYLIC ACID, 5-METHYL-|5-methyl-isoxazole-3-carboxylic acid|MFCD01318162|UNII-YZP807C30G|YZP807C30G|3-CARBOXY-5-METHYLISOXAZOLE|5-methyl-3-isoxazolecarboxylic acid|5-methylisoxazole-3-carboxylicacid|1267623-84-6|EINECS 222-289-4|PubChem15552|ARONIS24549|SCHEMBL286771|5-methylisoxazol-3-carbonsaure|ACMC-209i51|AMOT0306|5-methylisoxazole carboxylic acid|DTXSID10878772|5-methyl-isoxazole-carboxylic acid|HMS1754B",127.100,C5H5NO3,63.300,125.000,0.700,9,1,4,1,"InChI=1S/C5H5NO3/c1-3-2-4(5(7)8)6-9-3/h2H,1H3,(H,7,8)",CC1=CC(=NO1)C(=O)O,BNMPIJWVMVNSRD-UHFFFAOYSA-N,"5-methyl-1,2-oxazole-3-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,485350|485395|493033|504770|540299|588519|720641|1347385,20050708,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Acemol|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Ange",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
78000,Oseltamivir phosphate,"Oseltamivir phosphate|204255-11-8|Tamiflu|Oseltamivir (phosphate)|UNII-4A3O49NGEZ|Ro 64-0796/002|GS 4104|4A3O49NGEZ|ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate|CHEBI:7799|Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (1:1)|(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate phosphate|Osteltamivir phosphate|(3R-(3alpha,4beta,5alpha))-Ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1",410.400,C16H31N2O8P,168.000,468.000,NULL,27,5,9,8,"InChI=1S/C16H28N2O4.H3O4P/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19;1-5(2,3)4/h9,12-15H,5-8,17H2,1-4H3,(H,18,19);(H3,1,2,3,4)/t13-,14+,15+;/m0./s1",CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O,PGZUMBJQJWIWGJ-ONAKXNSWSA-N,"ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate;phosphoric acid",Oseltamivir,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,524849|524852|524853|524857|524858|524859|524866|524867|525055|525056|525057|525058|525059|525063|525064|525065|525066|525067|525068|525079|525080|525082|525085|525086|525087|525088|525089|525090|525091|525092|531346|531347|531348|531349|531350|531351|531352|531353|531354|531355|531356|531357|531358|531359|531360|531361|531362|531363|531364|531365|531366|531367|531368|531369|531370|531371|531372|531373|531374|531375|531376|531377|531378|531379|648645|648646|648647|648648|648649|648650|722349|722350|722351|7,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Sci",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
78165,2-(N-Morpholino)ethanesulfonic acid,"4432-31-9|4-Morpholineethanesulfonic acid|2-Morpholinoethanesulfonic acid|2-(N-Morpholino)ethanesulfonic acid|MES|2-Morpholinoethanesulphonic acid|4-Morpholinethanesulfonic acid|2-morpholin-4-ylethanesulfonic acid|2-(4-Morpholinyl)ethanesulfonic acid|Morpholineethanesulfonic acid|MES (buffering agent)|2-(4-morpholinyl)-1-ethanesulfonic acid|Morpholino-N-ethylsulfonate|Ethanesulfonic acid, 2-morpholino-|2-(4-Morpholino)ethanesulfonic acid|2-(morpholin-4-yl)ethanesulfonic acid|UNII-2GNK67Q0C4|NSC 157116|2-(N-",195.240,C6H13NO4S,75.200,214.000,-3.500,12,1,5,3,"InChI=1S/C6H13NO4S/c8-12(9,10)6-3-7-1-4-11-5-2-7/h1-6H2,(H,8,9,10)",C1COCCN1CCS(=O)(=O)O,SXGZJKUKBWWHRA-UHFFFAOYSA-N,2-morpholin-4-ylethanesulfonic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,248|360|361|368|373|374|411|422|425|429|430|431|432|436|440|441|445|447|448|449|453|460|463|465|485|488|501|518|521|522|524|525|526|527|528|529|538|539|555|556|559|560|561|565|567|568|570|571|573|574|576|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|612|618|619|620|626|628|629|630|631|633|639|640|641|645|648|662|680|684|689|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|750|751|757|758|759|760|761|764|774|775|777|778|781|782|784|,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Ark P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
78569,1H-Benzimidazole-2-methanol,"1H-Benzimidazole-2-methanol|4856-97-7|(1H-Benzoimidazol-2-yl)methanol|1H-benzimidazol-2-ylmethanol|2-(Hydroxymethyl)benzimidazole|2-Benzimidazolemethanol|(1H-benzo[d]imidazol-2-yl)methanol|2-(Hydroxymethyl)-1H-benzimidazole|2-Hydroxymethylbenzimidazole|2-Hydroxymethyl-Benzoimidazole|(1H-Benzoimidazol-2-yl)-methanol|(1H-1,3-benzodiazol-2-yl)methanol|(1h-benzimidazol-2-yl)methanol|MFCD00014560|benzimidazol-2-ylmethan-1-ol|2xiy|1H-1,3-benzodiazol-2-ylmethanol|NSC18284|XIY|EINECS 225-451-2|PubChem7590|zlchem 11",148.160,C8H8N2O,48.900,140.000,0.900,11,2,2,1,"InChI=1S/C8H8N2O/c11-5-8-9-6-3-1-2-4-7(6)10-8/h1-4,11H,5H2,(H,9,10)",C1=CC=C2C(=C1)NC(=N2)CO,IAJLTMBBAVVMQO-UHFFFAOYSA-N,1H-benzimidazol-2-ylmethanol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,155|157|161|165|167|175|330|74488|485395|492967|493162|504770|588453|588456|588579|588590|588795|588855|588856|602310|602332|624178|624202|624263|624414|651965|652106|686978|686979|720579|720580|977608|1267460|1347041|1347075|1347076|1347165|1347385,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Amadis Chemical|Ambeed|AN PharmaTech|A",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
78607,4-Piperidinopiperidine,"4-Piperidinopiperidine|4897-50-1|1,4'-Bipiperidine|4-PIPERIDINO-PIPERIDINE|1,4'-Bipiperidyl|1,4-Bipiperidine|1-piperidin-4-ylpiperidine|4-(1-piperidinyl)piperidine|MFCD00006475|[1,4']BIPIPERIDINYL|4-(piperidin-1-yl)piperidine|4-Piperidino piperidine|4-piperidin-1-ylpiperidine|1-(piperidin-4-yl)piperidine|1-(4-PIPERIDYL)PIPERIDINE|N-(4-PIPERIDINO)PIPERIDINE|CHEMBL174391|CHEBI:40117|4-piperidylpiperidine|{1,4'}bipiperidinyl|4PN|4-Piperidinopiperidine, 95%, tech.|1,4'-Bipiperidinedihydrochloride|EINECS 225-522",168.280,C10H20N2,15.300,124.000,1.200,12,1,2,1,"InChI=1S/C10H20N2/c1-2-8-12(9-3-1)10-4-6-11-7-5-10/h10-11H,1-9H2",C1CCN(CC1)C2CCNCC2,QDVBKXJMLILLLB-UHFFFAOYSA-N,1-piperidin-4-ylpiperidine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,15290|15721|22299|25056|25063|143007|144196|309025|1347080|1508586,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Am",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
79874,"3,4-Dichlorophenylacetic acid","3,4-Dichlorophenylacetic acid|5807-30-7|2-(3,4-dichlorophenyl)acetic acid|(3,4-dichlorophenyl)acetic acid|3,4-Dichlorobenzene acetic acid|Benzeneacetic acid, 3,4-dichloro-|2-(3,4-dichlorophenyl)ethanoic acid|MFCD00004333|UNII-713NZ1A32D|3,4-dichlorophenyl acetic acid|CHEMBL3116309|713NZ1A32D|(3,4-dichloro-phenyl)-acetic acid|EINECS 227-368-7|NSC 132186|PubChem20195|ACMC-209m2g|3,4DichloroPhenylAceticAcid|3,4dichlorophenylacetic acid|SCHEMBL283587|3,4-dichlorophenyl-acetic acid|RARECHEM AL BO 0123|3,4-dichlo",205.030,C8H6Cl2O2,37.300,172.000,3.100,12,1,2,2,"InChI=1S/C8H6Cl2O2/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3H,4H2,(H,11,12)",C1=CC(=C(C=C1CC(=O)O)Cl)Cl,ZOUPGSMSNQLUNW-UHFFFAOYSA-N,"2-(3,4-dichlorophenyl)acetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,248|256|1068386|1392845|1453183,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aromsyn catalogue|Assembly Blocks Pvt. Ltd.|Aurora Fine ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
80971,Quinoline-3-carboxylic acid,"Quinoline-3-carboxylic acid|6480-68-8|3-Quinolinecarboxylic acid|3-Quinoline carboxylic acid|MFCD00006770|CHEMBL275098|3-Quinolinecarboxylic acid, 98%|Q3C|EINECS 229-337-3|PubChem7517|3,3-Di-indolylmethane|3-quinolylcarboxylic acid|ACMC-1BFC6|Oprea1_271938|SCHEMBL28048|DTXSID90215101|ZINC265642|BCP26872|ANW-34949|BBL100196|BDBM50518657|NSC403263|SBB028485|STL553707|AKOS000269791|CS-W007519|DS-0491|FS-2157|LS20865|MCULE-1429611341|NSC 403263|NSC-403263|VQ10002|AC-12219|SY004162|AB0012424|DB-054730|AM20070150",173.170,C10H7NO2,50.200,205.000,1.700,13,1,3,1,"InChI=1S/C10H7NO2/c12-10(13)8-5-7-3-1-2-4-9(7)11-6-8/h1-6H,(H,12,13)",C1=CC=C2C(=C1)C=C(C=N2)C(=O)O,DJXNJVFEFSWHLY-UHFFFAOYSA-N,quinoline-3-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,155|157|161|165|167|175|422|745|40666|272370|1123058|1123059|1127992|1127995|1127996|1254099|1259310|1259374|1259422,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|AOBChe",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
81058,"2,6-Dichlorophenylacetic acid","2,6-Dichlorophenylacetic acid|6575-24-2|2-(2,6-dichlorophenyl)acetic acid|(2,6-dichlorophenyl)acetic acid|Benzeneacetic acid, 2,6-dichloro-|2,6-Dichloro benzeneacetic acid|2,6-Dichlorophenylaceticacid|UNII-K8G025CX8W|2,6-DICHLOROPHENYL ACETIC ACID|EINECS 229-504-0|MFCD00004320|CHEMBL240293|K8G025CX8W|2,6-Dichlorobenzeneaceticacid|2CL|PubChem4323|ACMC-209ns0|SCHEMBL109215|2,6-dichlorobenzeneacetic acid|DTXSID1041633|BDBM16429|ZINC388514|(2,6-dichloro-phenyl)-acetic acid|2,6-DICHLOROPHENYLACIETICACID|ANW-3508",205.030,C8H6Cl2O2,37.300,162.000,2.600,12,1,2,2,"InChI=1S/C8H6Cl2O2/c9-6-2-1-3-7(10)5(6)4-8(11)12/h1-3H,4H2,(H,11,12)",C1=CC(=C(C(=C1)Cl)CC(=O)O)Cl,SFAILOOQFZNOAU-UHFFFAOYSA-N,"2-(2,6-dichlorophenyl)acetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,309933,20050709,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
81462,"2-[Bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol","bis-tris|6976-37-0|Bistris|2,2-Bis(hydroxymethyl)-2,2',2''-nitrilotriethanol|Bis(2-hydroxyethyl)aminotris(hydroxymethyl)methane|BIS-TRIS BUFFER|2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol|1,3-Propanediol, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-|UNII-Q1XC3631CP|MFCD00002853|Bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane|Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane|2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL|Q1XC3631CP|CHEBI:41250|2-(Bis(2-hydroxyethy",209.240,C8H19NO5,104.000,125.000,-3.300,14,5,6,8,"InChI=1S/C8H19NO5/c10-3-1-9(2-4-11)8(5-12,6-13)7-14/h10-14H,1-7H2",C(CO)N(CCO)C(CO)(CO)CO,OWMVSZAMULFTJU-UHFFFAOYSA-N,"2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,10,155|157|175|328|1259310|1259374|1259422,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|Angene Chemical|Anward|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
84029,Clarithromycin,"clarithromycin|81103-11-9|Biaxin|6-O-Methylerythromycin|Klaricid|6-O-Methylerythromycin a|Clarithromycine|Clathromycin|Abbott-56268|A-56268|Macladin|Clarith|Klacid|Kofron|Veclam|Clarithromycinum|Naxy|TE-031|Erythromycin, 6-O-methyl-|Biaxin XL|UNII-H1250JIK0A|Clarithromycin identity|C38H69NO13|TE031|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12,13-dihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyr",748.000,C38H69NO13,183.000,1190.000,3.200,52,4,14,8,"InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,AGOYDEPGAOXOCK-KCBOHYOISA-N,"(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione",Clarithromycin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,485|631|731|781|782|880|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1032|1040|1048|1049|1051|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1236|1251|1274|1304|1321|1325|1359|1362|1376|1385|1415|1416|1422|1423|1424|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1466|1467|1468|1469|1477|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1532|1533|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1662|16,20050624,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AmicBase - Antimicrobial Activities|Aurora Fine Chemicals LLC|Axon Medchem|BenchChem|BIDD|BindingDB|BioCrick|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
84759,Quinazolin-4-amine,"quinazolin-4-ylamine|quinazolin-4-amine|15018-66-3|4-Quinazolinamine|4-Aminoquinazoline|Quinazoline, 4-amino-|4-Quinazolineamine|MFCD00092016|quinazoline-4-ylamine|1LQ|4-amino quinazoline|4-amino-quinazoline|NSC288012|4-Quinazolinamine #|quinazolin-4(3h)-imine|Oprea1_618867|SCHEMBL142513|4-Quinazolinamine, AldrichCPR|CHEMBL266128|SCHEMBL9375368|DTXSID90164488|ZINC331945|4-Aminoquinazoline;NSC 288012|ALBB-005413|ANW-45325|BDBM50228495|SBB019476|STK001877|AKOS001104743|AB03303|AC-9148|CS-W008984|MCULE-3396256",145.160,C8H7N3,51.800,137.000,1.300,11,1,3,0,"InChI=1S/C8H7N3/c9-8-6-3-1-2-4-7(6)10-5-11-8/h1-5H,(H2,9,10,11)",C1=CC=C2C(=C1)C(=NC=N2)N,DRYRBWIFRVMRPV-UHFFFAOYSA-N,quinazolin-4-amine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,11,330|58164|134244|134245|155650|155653|551809|743344|743345|743346|743347|1145385|1159387|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259397|1259398|1259423|1296008|1296009|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347154|1347385|1347411,20050326,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharma S",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
89847,Methyl 4-sulfamoylbenzoate,"methyl 4-sulfamoylbenzoate|22808-73-7|Methyl 4-sulphamoylbenzoate|Methyl 4-(aminosulfonyl)benzoate|4-(Aminosulfonyl)benzoic acid methyl ester|Benzoic acid, 4-(aminosulfonyl)-, methyl ester|4-Sulfamoyl-benzoic acid methyl ester|UNII-0OTO8N4C4K|0OTO8N4C4K|Benzoic acid,4-(aminosulfonyl)-, methyl ester|Methyl p-sulfamylbenzoate|NSC 251214|4-Methoxycarbonylbenzenesulfonamide|RZG|EINECS 245-235-1|TimTec1_006275|CHEMBL148763|SCHEMBL1178941|DTXSID10177358|HMS1551N05|ZINC106888|4-methoxycarbonyl benzenesulfonamide|m",215.230,C8H9NO4S,94.800,298.000,0.600,14,1,5,3,"InChI=1S/C8H9NO4S/c1-13-8(10)6-2-4-7(5-3-6)14(9,11)12/h2-5H,1H3,(H2,9,11,12)",COC(=O)C1=CC=C(C=C1)S(=O)(=O)N,XLOVNJUCAFIANM-UHFFFAOYSA-N,methyl 4-sulfamoylbenzoate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,8,256|1949|50176|243139|243144|485395|492967|493162|504770|540299|588519|588778|602314|720641,20050326,"3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Ambeed|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemBlock|ChemBridge|ChemDB|ChemDiv|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|Chemotion|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug Dis",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
91650,Pyrimethanil,"Pyrimethanil|53112-28-0|4,6-dimethyl-N-phenyl-2-pyrimidinamine|4,6-dimethyl-N-phenylpyrimidin-2-amine|Pyrimethanil [ISO]|2-Pyrimidinamine, 4,6-dimethyl-N-phenyl-|2-Anilino-4,6-dimethylpyrimidine|UNII-6IA5HP6C8Z|6IA5HP6C8Z|CHEBI:8674|4,6-dimethyl-~{N}-phenyl-pyrimidin-2-amine|HSDB 6916|Dynmethanil|Mythos|Scala|Pyrimethanil||Pyrimethanil, BSI|MUK|BARIUMSELENATE|4,6-dimethyl-N-phenyl-pyrimidin-2-amine|Peakdale1_000145|DSSTox_CID_14877|DSSTox_RID_79216|DSSTox_GSID_34877|SCHEMBL20817|CHEMBL540677|DTXSID8034877|H",199.250,C12H13N3,37.800,179.000,2.900,15,1,3,2,"InChI=1S/C12H13N3/c1-9-8-10(2)14-12(13-9)15-11-6-4-3-5-7-11/h3-8H,1-2H3,(H,13,14,15)",CC1=CC(=NC(=N1)NC2=CC=CC=C2)C,ZLIBICFPKPWGIZ-UHFFFAOYSA-N,"4,6-dimethyl-N-phenylpyrimidin-2-amine",NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1469|1479|426461|492967|588513|588514|588515|588516|588526|588527|588532|588533|588534|588535|588536|588537|588541|588543|588544|588545|588546|588547|651631|651632|651633|651634|651741|651743|651749|651751|651777|651778|651838|720516|720552|720634|720635|720636|720637|720653|720659|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|74306,20050624,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|AN PharmaTech|Angene Chemical|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BerrChem|Bioco",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
94392,"2,6-Difluorophenol","2,6-Difluorophenol|28177-48-2|Phenol, 2,6-difluoro-|MFCD00002158|2.6-difluorophenol|2,6-difluoro phenol|2,6-Difluorophenol, 98%|2,6-Difluorophenol: 96.5%|2,6-Difluoro-phenol|EINECS 248-884-9|PubChem1495|SCHEMBL9271|ACMC-209h18|CHEMBL1232721|CKKOVFGIBXCEIJ-UHFFFAOYSA-|DTXSID00182456|ZINC388530|ACT00488|BCP26982|ANW-26346|CL9191|SBB085757|AKOS005259844|AC-3787|AS00191|CM11727|CS-W013440|LF10635|LS11403|PS-9147|BP-21484|S123|AB0018499|DB-023869|A1622|AM20040083|D2015|FT-0638766|F02870|Q-8930|177D482|W-107066|Q",130.090,C6H4F2O,20.200,87.100,2.000,9,1,3,0,"InChI=1S/C6H4F2O/c7-4-2-1-3-5(8)6(4)9/h1-3,9H",C1=CC(=C(C(=C1)F)O)F,CKKOVFGIBXCEIJ-UHFFFAOYSA-N,"2,6-difluorophenol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards,9,711584,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|AOBChe",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
95851,"Piperazine, 1,4-diacetyl-","1,1'-(Piperazine-1,4-diyl)diethanone|18940-57-3|Piperazine, 1,4-diacetyl-|1,4-Diacetylpiperazine|1-(4-acetylpiperazin-1-yl)ethanone|1,4-diacetyl-1,4-diazacyclohexane|Piperazine,4-diacetyl-|NSC 39650|BRN 0136055|AI3-28700|NSC39650|5-23-01-00045 (Beilstein Handbook Reference)|SCHEMBL860793|DTXSID00172352|AMY10038|NSC54822|ZINC1671491|9872AA|ANW-71298|NSC-39650|NSC-54822|AKOS003888568|Benzylpiperazine-M (piperazine), 2AC|DS-17612|Piperazine, 1,4-diacetyl- (6CI,8CI,9CI)",170.210,C8H14N2O2,40.600,173.000,-1.000,12,0,2,0,"InChI=1S/C8H14N2O2/c1-7(11)9-3-5-10(6-4-9)8(2)12/h3-6H2,1-2H3",CC(=O)N1CCN(CC1)C(=O)C,NBQBICYRKOTWRR-UHFFFAOYSA-N,1-(4-acetylpiperazin-1-yl)ethanone,NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Toxicity,7,NULL,20050326,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Achemo Scientific Limited|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|Biocore|BLD Pharm|Chem-Space.com Database|ChemDB|Chemenu Inc.|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Crystallography Open Database|Discov",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
96351,6-Methylnicotinamide,"6-Methylnicotinamide|6960-22-1|6-methylpyridine-3-carboxamide|3-Pyridinecarboxamide, 6-methyl-|MFCD00006342|6-methyl-3-pyridinecarboxamide|CHEMBL4204179|6-Methylnicotinamide, 97%|8EJ|6-methyl nicotinamide|Nicotinamide, 6-methyl-|Oprea1_578035|SCHEMBL351856|2-Methylpyridine-5-carboxamide|AMPD00206|ZINC39575|DTXSID00219877|NSC69797|AB2935|ANW-49408|BBL100086|BDBM50455086|NSC 69797|NSC-69797|RW3205|SBB028251|STL371213|6-Methylpyridine-3-carboxamide, 98%|AKOS005207287|MCULE-2376003868|QC-4169|VZ30825|SY023122|T",136.150,C7H8N2O,56.000,136.000,0.100,10,1,2,1,"InChI=1S/C7H8N2O/c1-5-2-3-6(4-9-5)7(8)10/h2-4H,1H3,(H2,8,10)",CC1=NC=C(C=C1)C(=O)N,IJXDURUAYOKSIS-UHFFFAOYSA-N,6-methylpyridine-3-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,248|1374430,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Acemol|Achemo Scientific Limited|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|Ampyridine Co.,Ltd|Angene Chemical|Anward|AOBChem USA|Apexmol|Ark Pharm, Inc.|Assembly Bloc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
96734,2-(5-Bromo-1H-indol-3-yl)acetic acid,"5-Bromoindole-3-acetic acid|40432-84-6|2-(5-bromo-1H-indol-3-yl)acetic acid|(5-Bromo-1H-indol-3-yl)-acetic acid|(5-bromo-1H-indol-3-yl)acetic acid|1h-indole-3-acetic acid, 5-bromo-|5-Bromo-3-indoleacetic acid|UNII-JC6F5DNA2X|MFCD00005637|JC6F5DNA2X|5-BR-IAA|CHEMBL82440|5-BROMO-1H-INDOLE-3-ACETIC ACID|2-(5-bromoindol-3-yl)acetic acid|5-Bromoindole-3-acetic acid, 99%|5-Bromoindole-3-aceticacid|4ojq|2SX|NSC88145|EINECS 254-917-8|PubChem15852|ACMC-1AO2Y|ethyl-2-chlorophenylacetate|5-bromo-3-indolylacetic acid|S",254.080,C10H8BrNO2,53.100,234.000,2.100,14,2,2,2,"InChI=1S/C10H8BrNO2/c11-7-1-2-9-8(4-7)6(5-12-9)3-10(13)14/h1-2,4-5,12H,3H2,(H,13,14)",C1=CC2=C(C=C1Br)C(=CN2)CC(=O)O,WTFGHMZUJMRWBK-UHFFFAOYSA-N,2-(5-bromo-1H-indol-3-yl)acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,155|157|161|165|167|175|90867|217022|275201|275202|275203|275204|275205|275206|296505|296506|493017|977608|1071653,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ar",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
98845,"2-Methyl-1,3-thiazole-5-carboxylic acid","40004-69-1|2-methyl-1,3-thiazole-5-carboxylic acid|2-methylthiazole-5-carboxylic acid|2-Methyl-5-thiazolecarboxylic acid|5-Thiazolecarboxylic acid, 2-methyl-|2-methyl-thiazole-5-carboxylic acid|MFCD01760300|CHEMBL247134|RU 21933|2-Methylthiazole-5-carboxylicacid|6V9|PubChem22287|ACMC-209j9u|SCHEMBL186167|DTXSID10193073|ALBB-024727|BCP05391|EBD50566|ZINC1688638|ANW-29248|BBL103846|BDBM50216552|NSC170606|RW3083|SBB053124|STL557656|AKOS005258857|CS-W002825|LS21069|MCULE-1715629651|NSC 170606|NSC-170606|PB12949",143.170,C5H5NO2S,78.400,128.000,1.200,9,1,4,1,"InChI=1S/C5H5NO2S/c1-3-6-2-4(9-3)5(7)8/h2H,1H3,(H,7,8)",CC1=NC=C(S1)C(=O)O,QCXCIYPOMMIBHO-UHFFFAOYSA-N,"2-methyl-1,3-thiazole-5-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,9,248|308653,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Ar",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
99223,3-Methylhippuric acid,"3-Methylhippuric acid|27115-49-7|m-Methylhippuric acid|N-(m-Toluoyl)glycine|m-Toluric acid|N-(3-Methylbenzoyl)glycine|3-Methylbenzoylglycine|Glycine, N-(3-methylbenzoyl)-|2-(3-Methylbenzamido)acetic acid|meta-Methylhippuric acid|Hippuric acid, m-methyl-|2-[(3-methylbenzoyl)amino]acetic acid|UNII-W60W59C1G5|CHEBI:68500|W60W59C1G5|MFCD00044399|N-(3-methylbenzene-1-carbonyl)glycine|2-[(3-methylphenyl)formamido]acetic acid|3-METHYLHIPPURICACID|2-[(3-methylphenyl)carbonylamino]acetic acid|3-methyl hippuric acid|",193.200,C10H11NO3,66.400,227.000,1.600,14,2,3,3,"InChI=1S/C10H11NO3/c1-7-3-2-4-8(5-7)10(14)11-6-9(12)13/h2-5H,6H2,1H3,(H,11,14)(H,12,13)",CC1=CC(=CC=C1)C(=O)NCC(=O)O,YKAKNMHEIJUKEX-UHFFFAOYSA-N,2-[(3-methylbenzoyl)amino]acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Identification|Literature|Names and Identifiers|Patents|Safety and Hazards,9,155|157|161|165|167|175|248|388272|388273|388274|492967|602314,20050326,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Achemica|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|Anward|Aurora Fine Chemicals LLC|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Combi-Bloc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
107706,Sivelestat,"Sivelestat|127373-66-4|Ono-5046|ONO5046|2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid|LY544349|Sivelestat (ONO-5046)|UNII-DWI62G0P59|C20H22N2O7S|EI546|N-(2-(4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid|CHEMBL76688|DWI62G0P59|EI546;LY544349;ONO5046|2-(2-(4-(pivaloyloxy)phenylsulfonamido)benzamido)acetic acid|2-[(2-{4-[(2,2-dimethylpropanoyl)oxy]benzenesulfonamido}phenyl)formamido]acetic acid|N-[2-(N'-(Carboxymethyl)-aminocarbonyl)-phenyl]-4-t-b",434.500,C20H22N2O7S,147.000,731.000,3.000,30,3,8,9,"InChI=1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24)",CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O,BTGNGJJLZOIYID-UHFFFAOYSA-N,"2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,66639|66643|66678|76713|76714|84880|578654|578657|578769|578772|609337|731570|731571|731572|731575|731576|731578|732625|732626|732627|732628|732629|743344|743345|743346|743347|1058695|1058696|1058699|1058703|1058704|1058705|1058706|1058707|1058708|1058709|1058710|1058711|1058712|1058713|1177395|1191721|1191722|1191723|1191724|1191725|1191726|1191727|1191728|1191729|1191730|1191731|1191732|1191733|1191734|1191735|1191737|1191740|1191741|1191742|1191744|1191745|1191746|1191747|1224824|1224825|1224857|1224859|,20050624,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Ark Pharm, Inc.|Assembl",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
120118,6-Phenylnicotinic acid,"6-Phenylnicotinic acid|29051-44-3|6-phenylpyridine-3-carboxylic acid|3-Pyridinecarboxylic acid, 6-phenyl-|CHEMBL2316892|2-phenyl-5-pyridinecarboxylic acid|2-Phenyl pyridine-5-carboxylic acid|6-Phenyl-nicotinic acid|6-PHENYLNICOTINICACID|6P3|EINECS 249-386-4|4i8x|6-phenyl nicotinic acid|ACMC-1CMXF|2-Phenyl-5-carboxypyridine|SCHEMBL505455|DTXSID80951647|6-phenyl-3-pyridinecarboxylic acid|6-Phenylnicotinic acid, AldrichCPR|ZINC2506130|6-phenyl-pyridine-3-carboxylic acid|ANW-26531|BDBM50425804|MFCD03086128|SBB0",199.200,C12H9NO2,50.200,224.000,2.000,15,1,3,2,"InChI=1S/C12H9NO2/c14-12(15)10-6-7-11(13-8-10)9-4-2-1-3-5-9/h1-8H,(H,14,15)",C1=CC=C(C=C1)C2=NC=C(C=C2)C(=O)O,DLFLQXUYRFIFOK-UHFFFAOYSA-N,6-phenylpyridine-3-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,724988|724995|977611,20050719,"3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A1 BioChem Labs|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|Biocore|Biosynth Carbosyn",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
121026,1-Phenyl-1H-pyrazole-4-carboxylic acid,"1-Phenyl-1H-pyrazole-4-carboxylic acid|1134-50-5|1-Phenylpyrazole-4-carboxylic acid|Pyrazole-4-carboxylic acid, 1-phenyl-|1H-Pyrazole-4-carboxylic acid, 1-phenyl-|MFCD00514518|1-phenylpyrazole-4-carboxylate|BRN 0139486|Pyrazole, 1|ZZA|1-Phenyl-1h-pyrazol-4-carboxylic acid|1-Phenyl-1H-pyrazole-4-carboxylicacid|ACMC-1C9E6|SCHEMBL70281|5-25-04-00056 (Beilstein Handbook Reference)|1-phenylpyrazole-4-carboxylic|CHEMBL406105|BDBM21615|DTXSID20150399|HMS1741L17|HMS3604M12|ACT07623|ALBB-000149|ZINC4218283|ANW-72862",188.180,C10H8N2O2,55.100,214.000,1.400,14,1,3,2,"InChI=1S/C10H8N2O2/c13-10(14)8-6-11-12(7-8)9-4-2-1-3-5-9/h1-7H,(H,13,14)",C1=CC=C(C=C1)N2C=C(C=N2)C(=O)O,ZROILLPDIUNLSE-UHFFFAOYSA-N,1-phenylpyrazole-4-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Toxicity,8,319190|485350|485395|493033|504770|540299|588519|720554|720641|1204703|1347080|1508586,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Alinda Chemical|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aromsyn ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
122146,CID 122146,chapso|82473-24-3|473C243|Q27452253,631.900,C32H59N2O8S+,173.000,1080.000,2.000,43,6,8,12,"InChI=1S/C32H58N2O8S/c1-20(7-10-29(39)33-13-6-14-34(4,5)18-23(36)19-43(40,41)42)24-8-9-25-30-26(17-28(38)32(24,25)3)31(2)12-11-22(35)15-21(31)16-27(30)37/h20-28,30,35-38H,6-19H2,1-5H3,(H-,33,39,40,41,42)/p+1/t20-,21+,22-,23?,24-,25+,26+,27-,28+,30+,31+,32-/m1/s1",C[C@H](CCC(=O)NCCC[N+](C)(C)CC(CS(=O)(=O)O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,GUQQBLRVXOUDTN-XOHPMCGNSA-O,"(2-hydroxy-3-sulfopropyl)-dimethyl-[3-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azanium",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050719,"A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|ChemExper Chemical Directory|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Combi-Blocks|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Glentham Life Sciences Ltd.|Google Patents|IBM|Japa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
123596,Imatinib mesylate,Imatinib mesylate|220127-57-1|Gleevec|Glivec|Imatinib mesilate|imatinib methanesulfonate|sti-571|Imatinib Mesylate (STI571)|Imatinib (mesylate)|CGP-57148B|imatinib monomesylate|CGP 57148B|220127-57-1 (mesylate)|4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate|STI 571|UNII-8A1O1M485B|N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate|CHEBI:31690|QTI-571|8A1O1M485,589.700,C30H35N7O4S,149.000,799.000,NULL,42,3,10,7,"InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)",CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,YLMAHDNUQAMNNX-UHFFFAOYSA-N,methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,Imatinib Mesylate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1892|1893|1894|1899|1903|1906|1910|1947|1950|1956|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2300|2380|2391|2435|2445|2462|2517|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|266584|266585|360729|360732|360938|396071|40430,20050326,"001Chemical|3A SpeedChemical Inc|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
125132,"2-[3-(2-Hydroxy-1,1-dihydroxymethyl-ethylamino)-propylamino]-2-hydroxymethyl-propane-1,3-diol","Bis-Tris propane|64431-96-5|1,3-Bis[tris(hydroxymethyl)methylamino]propane|2,2'-(Propane-1,3-diylbis(azanediyl))bis(2-(hydroxymethyl)propane-1,3-diol)|1,3-Bis(tris(hydroxymethyl)methylamino)propane|1,3-Propanediol, 2,2'-(1,3-propanediyldiimino)bis[2-(hydroxymethyl)-|2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL|UNII-N5YD0CS4DO|MFCD00004689|N5YD0CS4DO|2,2'-(propane-1,3-diyldiimino)bis[2-(hydroxymethyl)propane-1,3-diol]|CHEBI:40947|1,3-Bis(tris[hydroxymethyl]met",282.330,C11H26N2O6,145.000,183.000,-4.600,19,8,8,12,"InChI=1S/C11H26N2O6/c14-4-10(5-15,6-16)12-2-1-3-13-11(7-17,8-18)9-19/h12-19H,1-9H2",C(CNC(CO)(CO)CO)CNC(CO)(CO)CO,HHKZCCWKTZRCCL-UHFFFAOYSA-N,"2-[3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]propylamino]-2-(hydroxymethyl)propane-1,3-diol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,155|157|161|165|167|175|330|91439|91440|91575|1259310|1259374|1259422,20050326,"001Chemical|3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Acadechem|Achemtek|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Ambeed|AN PharmaTech|Angene Chemical|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|BePharm Ltd.|BerrChem|Biocore|BLD Pharm|BOC Sciences|BroadPharm|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Cheme",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
136069,"1,8-Naphthyridine","1,8-Naphthyridine|254-60-4|1,8-Diazanaphthalene|naphthyridine|1,8-Diazanapthalene|[1,8]Naphthyridine|napy|1,8-Pyridopyridine|UNII-043R04VL4M|Pyrido[2,3-b]pyridine|CHEBI:36628|043R04VL4M|MFCD00059751|naphthyridin|1,8-napthyridine|1,8 naphthyridine|PubChem16485|ACMC-209gk3|SCHEMBL8193|CHEMBL261758|SCHEMBL3713892|SCHEMBL9559247|DTXSID40180052|ACT10195|ZINC2527922|ANW-25729|AKOS005146157|AB02373|AC-9573|CS-W002277|GS-3533|VZ20774|SY021105|AB0023745|DB-005652|AM20070185|FT-0631893|N0464|W4877|6948-EP2270010A1|69",130.150,C8H6N2,25.800,102.000,1.500,10,0,2,0,InChI=1S/C8H6N2/c1-3-7-4-2-6-10-8(7)9-5-1/h1-6H,C1=CC2=C(N=C1)N=CC=C2,FLBAYUMRQUHISI-UHFFFAOYSA-N,"1,8-naphthyridine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,8,319840,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Angene Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
138363,4-Methoxyindole,"4-Methoxyindole|4837-90-5|4-Methoxy-1H-indole|1H-Indole, 4-methoxy-|4-Methoxylindole|1H-Indol-4-yl methyl ether|MFCD00009737|Indole, 4-methoxy-|4-methoxy-indole|zlchem 710|PubChem7433|ACMC-1AOXE|4-Methoxyindole, 98%|4-Methoxyindole, 99%|BIDD:GT0568|SCHEMBL321761|1H-Indol-4-yl methyl ether #|CHEMBL2018155|LUNOXNMCFPFPMO-UHFFFAOYSA-|DTXSID00197500|ZLD0162|HMS1632E13|ZINC407091|ACN-S002863|ACT02514|BCP26757|ANW-30657|BBL010878|SBB055969|STK648729|AKOS001476143|CS-W008893|EBD1615069|LS21192|MCULE-6459185191|PB1",147.170,C9H9NO,25.000,138.000,2.700,11,1,1,1,"InChI=1S/C9H9NO/c1-11-9-4-2-3-8-7(9)5-6-10-8/h2-6,10H,1H3",COC1=CC=CC2=C1C=CN2,LUNOXNMCFPFPMO-UHFFFAOYSA-N,4-methoxy-1H-indole,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,8,485350|485395|492967|493033|504770|540299|588519|656681|720641|720717|1224905,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A1 BioChem Labs|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
145742,Proline,"L-proline|proline|147-85-3|L-(-)-Proline|(S)-Pyrrolidine-2-carboxylic acid|H-Pro-OH|2-pyrrolidinecarboxylic acid|(2S)-pyrrolidine-2-carboxylic acid|(-)-Proline|(-)-(S)-Proline|(S)-2-Pyrrolidinecarboxylic acid|Prolinum|(-)-2-Pyrrolidinecarboxylic acid|L-Pyrrolidine-2-carboxylic acid|prolina|(S)-Proline|L-alpha-Pyrrolidinecarboxylic acid|L-Prolin|Prolinum [Latin]|Prolina [Spanish]|Proline, L-|Proline (VAN)|(S)-2-Carboxypyrrolidine|Proline [USAN:INN]|(L)-PROLINE|(S)-(-)-Proline|2-Pyrrolidinecarboxylic acid, (S",115.130,C5H9NO2,49.300,103.000,-2.500,8,2,3,1,"InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8)/t4-/m0/s1",C1C[C@H](NC1)C(=O)O,ONIBWKKTOPOVIA-BYPYZUCNSA-N,(2S)-pyrrolidine-2-carboxylic acid,Proline,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Micromolar,15,348|357|410|411|444|445|446|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|902|912|914|915|923|924|925|926|938|995|1030|1379|1452|1457|1458|1469|1471|1476|1478|1479|1487|1490|1688|1766|1768|1851|1948|2326|2528|2546|2551|2662|26797|49192|143614|227699|233318|284872|485290|492961|500825|504327|504332|504749|504832|504834|504847|504865|588579|602332|624030|624031|624032|624044|624170|624172|624173|624296|62,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|An",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
148192,Atazanavir,"Atazanavir|198904-31-3|Latazanavir|Zrivada|Reyataz|BMS-232632|CGP 73547|BMS 232632|Atazanavir Base|UNII-QZU4H47A3S|ATV|CGP-73547|Reyataz (TN)|CHEMBL1163|QZU4H47A3S|CHEBI:37924|NCGC00182552-01|Atazanavir [INN:BAN]|DSSTox_CID_28617|DSSTox_RID_82887|DSSTox_GSID_48691|(3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER|DR7|atazanavirum|methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxy",704.900,C38H52N6O7,171.000,1110.000,5.600,51,5,9,18,"InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1",CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,AXRYRYVKAWYZBR-GASGPIRDSA-N,"methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate",Atazanavir Sulfate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1811|20788|28083|81426|81427|81430|81431|81433|81615|81616|106906|106913|124202|124203|198568|238043|238682|239809|239810|239819|242866|242868|242869|242932|242933|246160|246193|246195|246225|246319|246965|248545|248546|248600|249499|263207|263208|263209|278953|278954|278955|278956|278957|278958|278959|278960|278961|278962|278963|278964|278965|278966|278967|278968|278969|278970|278971|278972|278973|278974|278975|278976|278977|278978|279165|279166|279167|279168|279169|279170|279171|279172|279173|279174|27917,20050624,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BenchChem|B",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
153241,Merimepodib,"Merimepodib|198821-22-6|VX-497|MMPD|UNII-2ZL2BA06FU|VX497|2ZL2BA06FU|VI-21497|CHEMBL304087|[(3S)-oxolan-3-yl] N-[[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]methyl]carbamate|(S)-tetrahydrofuran-3-yl 3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzylcarbamate|VI-21,497|MERIMEPODIB, VI-21497, VX-497|C23H24N4O6|Vx 497|Merimepodib [USAN:INN]|Merimebodib|Carbamic acid, ((3-((((3-methoxy-4-(5-oxazolyl)phenyl)amino)carbonyl)amino)phenyl)methyl)-, (3S)-tetrahydro-3-furanyl ester|carbamic acid, [",452.500,C23H24N4O6,124.000,652.000,2.100,33,3,7,8,"InChI=1S/C23H24N4O6/c1-30-20-10-17(5-6-19(20)21-12-24-14-32-21)27-22(28)26-16-4-2-3-15(9-16)11-25-23(29)33-18-7-8-31-13-18/h2-6,9-10,12,14,18H,7-8,11,13H2,1H3,(H,25,29)(H2,26,27,28)/t18-/m0/s1",COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)O[C@H]3CCOC3)C4=CN=CO4,JBPUGFODGPKTDW-SFHVURJKSA-N,"[(3S)-oxolan-3-yl] N-[[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]methyl]carbamate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,45812|46396|46583|92622|92740|92742|93053|155457|438025|1159387|1159388|1159389|1159390|1159394|1159395|1259416|1259421|1296008|1296009|1345084|1346986|1346987|1347055|1347159|1347160|1409598|1409614|1508605|1508606,20050801,"4C Pharma Scientific Inc|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|AK Scientific, Inc. (AKSCI)|Ambeed|Angene Chemical|ApexBio Technology|AstaTech, Inc.|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|BLD Pharm|Broad Institute|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Collaborative Drug Discovery, Inc.|Comparative Toxicogenomics Database (CTD)|CSNpharm|Davey Lab, Department of M",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
155815,Varespladib,"Varespladib|172732-68-2|LY315920|Varespladib (LY315920)|LY-315920|UNII-2Q3P98DATH|VAREPLADIB|S-5920|2Q3P98DATH|CHEMBL148674|2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetic acid|LY315920Varespladib|({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid|SMR004701444|Varespladib [USAN:INN]|VRD|2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid|PubChem22591|Varespladib (USAN/INN)|cc-80|S 5920|SCHEMBL26726|LY 315920, Varespladib|LY315920 (Varespladib)|LY315920 - Varesplad",380.400,C21H20N2O5,112.000,589.000,2.800,28,2,5,8,"InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25)",CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,BHLXTPHDSZUFHR-UHFFFAOYSA-N,2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,9,76650|158791|158796|158930|158931|159093|228956|228957|242401|242469|264364|264365|264366|264367|264368|264369|264370|264371|264372|264373|303770|303771|303772|303773|303774|303775|341237|341238|341239|341240|341241|341242|341243|341244|341245|341246|341247|341248|341249|341250|341251|341252|743344|743345|743346|743347|1159389|1159390|1159391|1159392|1169327|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259398|1259399|1259416|1259421|1259423|1282014|1296008|1296009|1345084|1345200|1346986,20050808,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Acesobio|Achemtek|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|Aurum Pharmatech LLC|BindingDB|BioChemPartner|Biocore|BioCrick|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institu",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
160456,3-Fluoro-4-hydroxybenzoic acid,"3-FLUORO-4-HYDROXYBENZOIC ACID|350-29-8|3-Fluoro-4-hydroxybenzoate|3-fluoro-4-hydroxy benzoic acid|Benzoic acid, 3-fluoro-4-hydroxy-|4-Carboxy-2-fluorophenol|3-Fluoro-4-hydroxy-benzoic acid|MFCD00143161|3-Fluoro-4-hydroxybenzoic acid, 95%|3pcf|FHB|PubChem2271|ACMC-1CO6Y|Oprea1_411304|SCHEMBL226720|4-hydroxy-3-fluorobenzoic acid|RARECHEM AL BO 0869|DTXSID60188530|ZINC404062|ACN-S003571|ACT00816|ANW-28048|SBB064411|STK082814|AKOS005392549|AB03853|AC-3960|AM82913|AS01857|CM12721|CS-W008917|FS-1317|MCULE-317271",156.110,C7H5FO3,57.500,160.000,1.600,11,2,4,1,"InChI=1S/C7H5FO3/c8-5-3-4(7(10)11)1-2-6(5)9/h1-3,9H,(H,10,11)",C1=CC(=C(C=C1C(=O)O)F)O,IUSDEKNMCOUBEE-UHFFFAOYSA-N,3-fluoro-4-hydroxybenzoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,977610,20050624,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Ambinter|AN Pha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
167250,Dimethylarsinate,"Dimethylarsinate|Cacodylate Ion|Cacodylate|Arsinic acid, dimethyl-, ion(1-)|15132-04-4|Bolate|Bolls|Dimethylarsonic Acid|rad-e-cat 25|Cacodylate ions|Cacodylic acid, free acid|Kakodylat|DMAV|Dimethylarsinic acidanion|Me2AsO2(-)|BDBM92451|CHEBI:16223|DTXSID60164758|[As(CH3)2O2](-)|Scotts Spot Grass and Weed Control|Scotts Stop Weeds After They Start|Q27098592",136.990,C2H6AsO2-,40.100,53.800,NULL,5,0,2,0,"InChI=1S/C2H7AsO2/c1-3(2,4)5/h1-2H3,(H,4,5)/p-1",C[As](=O)(C)[O-],OGGXGZAMXPVRFZ-UHFFFAOYSA-M,dimethylarsinate,Cacodylic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,1159607|1272365,20040916,"001Chemical|AAA Chemistry|ABI Chem|BindingDB|BioCyc|ChEBI|ChemDB|ChemIDplus|ChemSpider|ChemTik|EAWAG Biocatalysis/Biodegradation Database|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|Google Patents|Japan Chemical Substance Dictionary (Nikkaji)|LeadScope|MolCore BioPharmatech|NextBio|NextMove Software|NovoSeek|Protein Data Bank in Europe (PDBe)|SMID|ToxPlanet|UW Madison, Small Molecule Screening Facility|Wikidata|WikiPathways",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
170678,5-Bromo-6-methylpyridin-2-amine,"42753-71-9|2-Amino-5-bromo-6-methylpyridine|5-Bromo-6-methylpyridin-2-amine|6-Amino-3-bromo-2-methylpyridine|6-Amino-3-bromo-2-picoline|2-Pyridinamine, 5-bromo-6-methyl-|5-Bromo-6-methyl-2-pyridinamine|2-amino-5-bromo-6-picoline|MFCD00068230|5-bromo-6-methylpyridin-2-ylamine|5-bromo-6-methyl-2-pyridylamine|6-Amino-3-bromo-2-picoline, 98%|5-bromo-6-methyl-pyridin-2-amine|4JO|EINECS 255-927-5|5-bromo-6-methyl-pyridin-2-ylamine|6-Amino-3-bromo-2-picoline (6-Amino-3-bromo-2-methylpyridine)|PubChem1237|ACMC-1ARG",187.040,C6H7BrN2,38.900,97.100,1.600,9,1,2,0,"InChI=1S/C6H7BrN2/c1-4-5(7)2-3-6(8)9-4/h2-3H,1H3,(H2,8,9)",CC1=C(C=CC(=N1)N)Br,SEOZHXRTVJPQPZ-UHFFFAOYSA-N,5-bromo-6-methylpyridin-2-amine,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing,7,NULL,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|Ampyridine Co.,Ltd|AN PharmaTech|Anward|AOBChem USA",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
185698,alpha-D-Mannose,"alpha-D-Mannose|alpha-D-Mannopyranose|alpha-Mannose|7296-15-3|alpha-D-Man|CHEBI:28729|UNII-W3F28J9G0W|CHEMBL365590|W3F28J9G0W|(2S,3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol|3h-mannose|Manalpha1,|1rdl|1rin|alpha-aD-aMannopyranose|Epitope ID:130701|SCHEMBL76882|DTXSID001015858|ZINC3860903|alpha-D-mannose; D-mannose; mannose|BDBM50467903|29696-75-1|C00936|Q27103868|(2S,3S,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol",180.160,C6H12O6,110.000,151.000,-2.600,12,5,6,1,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6+/m1/s1",C([C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)O)O)O)O)O,WQZGKKKJIJFFOK-PQMKYFCFSA-N,"(2S,3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,1811|756902|756905|756909|756910|977610|977611|1422774,20040916,"A2B Chem|AA BLOCKS|AAA Chemistry|ABI Chem|Ambinter|Angene Chemical|BindingDB|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chembase.cn|ChEMBL|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|GlyTouCan Project|Google Patents|Hairui Chemical|IBM|Immune Epitope Database (IEDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MassBank of North America (MoNA)|Meta",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
208902,Ramelteon,"Ramelteon|196597-26-9|Rozerem|TAK-375|(S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide|UNII-901AS54I69|(S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propionamide|CHEMBL1218|TAK375|901AS54I69|N-{2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl}propanamide|N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide|N-[2-[(8S)-1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]propanamide|N-{2-[(8S)-1H,2H,6H,7H,8H-INDENO[5,4-B]FURAN-",259.339,C16H21NO2,38.300,331.000,2.700,19,1,2,4,"InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1",CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,"N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,940|1422|2240|2241|2275|2313|2322|2330|107723|107729|108025|108057|179962|232612|434959|485350|493033|504770|540299|567992|567993|567994|567995|567996|567997|568000|568001|568002|568003|568004|588519|602314|624137|624156|624260|624349|651548|651821|651957|651958|652010|652017|652039|652067|652126|652257|686940|686964|687014|687016|720508|720509|720543|720582|720596|720641|720648|720700|720702|720704|720717|743126|743269|743344|743345|743346|743347|743445|977599|977602|1053197|1117264|1138157|1159387|1159550,20050809,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Ambeed|AN",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
216210,Dabigatran,"Dabigatran|211914-51-1|BIBR 953|BIBR-953|CHEBI:70752|BIBR 953 (Dabigatran, Pradaxa)|3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid|UNII-I0VM4M70GC|I0VM4M70GC|BIBR 953 ZW|CHEMBL48361|3-[[2-[[(4-CARBAMIMIDOYLPHENYL)AMINO]METHYL]-1-METHYL-BENZOIMIDAZOLE-5-CARBONYL]-PYRIDIN-2-YL-AMINO]PROPANOIC ACID|N-[(2-{[(4-Carbamimidoylphenyl)amino]methyl}-1-Methyl-1h-Benzimidazol-5-Yl)carbonyl]-N-Pyridin-2-Yl-Beta-Alanine|3-(2-(((4-carbamimidoylphenyl)amino)methyl)",471.500,C25H25N7O3,150.000,757.000,1.700,35,4,7,9,"InChI=1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34)",CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,YBSJFWOBGCMAKL-UHFFFAOYSA-N,3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid,Dabigatran,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,30726|52166|89068|210579|225426|228064|228213|228436|645253|683501|719820|719821|719822|719823|719824|719834|719836|719838|719840|719841|719842|719843|719844|719845|719846|719847|719848|719849|721751|721752|721754|743344|743345|743346|743347|753175|753176|753177|753178|1057646|1057649|1057650|1057658|1057659|1159389|1195363|1202328|1224824|1224825|1224857|1224859|1224863|1254403|1259252|1259253|1259255|1259256|1266251|1296008|1296009|1299221|1299222|1315499|1315500|1332061|1345084|1345816|1346986|1346987|13,20050809,"3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
216326,Lenalidomide,"Lenalidomide|191732-72-6|Revlimid|Revimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CC-5013|Lenalidomide (CC-5013)|CDC 501|IMiD3|3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione|CC 5013|CDC-501|3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione|2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-|Revlimid (TN)|CHEBI:63791|C13H13N3O3|MFCD07772307|1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline|NCGC00167491-01|3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)",259.260,C13H13N3O3,92.500,437.000,-0.500,19,2,4,1,"InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)",C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,GOTYRUGSSMKFNF-UHFFFAOYSA-N,"3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione",Lenalidomide,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1471|1490|1688|1766|1768|2528|2546|2551|2662|159803|215443|215445|215453|257636|327396|327397|327398|327399|327400|327401|327402|327403|327404|327405|327406|327407|327408|327409|327410|327411|327412|327413|327414|327415|327416|327417|327418|327419|327420|327421|327422|327423|327424|327425|327426|327427|327428|327429|327430|327431|327432|327433|327434|327435|327436|327437|327438|327439|327440|327441|327442|327443|327444|327445|327446|327447|327448|327449|327450|327451|327452|327453|327454|327455|327456|32745,20050809,"001Chemical|3WAY PHARM INC|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alinda Chemical|Alsachim|Ambeed|AN PharmaTech|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fin",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
216327,Senicapoc,"Senicapoc|289656-45-7|2,2-bis(4-fluorophenyl)-2-phenylacetamide|ICA-17043|UNII-TS6G201A6Q|TS6G201A6Q|Benzeneacetamide, 4-fluoro-alpha-(4-fluorophenyl)-alpha-phenyl-|Senicapoc (USAN)|Bis(4-fluorophenyl)phenylacetamide|Senicapoc [USAN:INN]|ICA 17043|C20H15F2NO|2,2-BIS(4-FLUOROPHENYL)-2-PHENYL-ACETAMIDE|PubChem19381|4-Fluoro-alpha-(4-fluorophenyl)-alpha-phenylbenzeneacetamide|CHEMBL405821|GTPL2331|SCHEMBL1443805|AMY2744|DTXSID60276906|HMS3741E13|ACT06676|BCP14507|ZINC3816408|ANW-60823|BBL102413|BDBM50371391|MF",323.300,C20H15F2NO,43.100,397.000,4.100,24,1,3,4,"InChI=1S/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24)",C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N,SCTZUZTYRMOMKT-UHFFFAOYSA-N,"2,2-bis(4-fluorophenyl)-2-phenylacetamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,9,315276|315277|315278|315279|315280|315281|315282|315284|315292|315293|315294|315295|315296|315297|726257|726258|726259|726260|726261|726263|726285|726288|726289|726290|726291|726292|1159918|1259416|1259421|1346444|1409598,20050809,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|ACT Chemical|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BindingDB",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
227460,5-Amino-3-methyl-1H-pyrazole-4-carbonitrile,"5-amino-3-methyl-1H-pyrazole-4-carbonitrile|5453-07-6|3-Amino-5-methyl-1H-pyrazole-4-carbonitrile|3-Amino-4-cyano-5-methylpyrazole|5-Amino-4-cyano-3-methylpyrazole|1H-Pyrazole-4-carbonitrile, 3-amino-5-methyl-|NSC19055|NSC 19055|3-Imino-5-methyl-2,3-dihydro-1H-pyrazole-4-carbonitrile|1204294-67-6|ACMC-2097hs|SCHEMBL163701|RSCBB000034|AMY2082|DTXSID10202937|HMS1629J13|3-amino-4-cyano-5-methyl-pyrazole|ALBB-027427|ZINC4353708|ANW-13982|MFCD00128276|MFCD02020550|NSC-19055|STL560436|3-amino-4-cyano-5-methyl -py",122.130,C5H6N4,78.500,146.000,0.500,9,2,3,0,"InChI=1S/C5H6N4/c1-3-4(2-6)5(7)9-8-3/h1H3,(H3,7,8,9)",CC1=C(C(=NN1)N)C#N,CRRHJAMDQMQGKG-UHFFFAOYSA-N,3-amino-5-methyl-1H-pyrazole-4-carbonitrile,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,6,155|157|161|165|167|175|179|485350|485395|492967|493033|504770|540299|588519|720641|720717|1224905,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alinda Chemical|Ambeed|Angel Pharmatech Ltd.|Anward|Apexmol|Ark Pharm, Inc.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChemDB|ChemDiv|Chemenu Inc.|Chemhere|ChemIDplus|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
232487,(4-Methylpyridin-3-yl)methanol,(4-methylpyridin-3-yl)methanol|4664-27-1|3-HYDROXYMETHYL-4-METHYLPYRIDINE|NSC30040|SCHEMBL2642720|DTXSID00283134|(4-methyl-3-pyridyl)methan-1-ol|(4-methyl-pyridin-3-yl)-methanol|AMY38214|BCP27408|ZINC1656171|6388AB|ANW-60903|MFCD01444898|NSC-30040|SBB054781|(4-METHYL-3-PYRIDYL)METHANOL|AKOS004907410|MCULE-5512772750|PB21746|TS-01630|DB-070748|CS-0053194|FT-0651536|Q-1130|Z1431002713|WQ1,123.150,C7H9NO,33.100,85.000,0.300,9,1,2,1,"InChI=1S/C7H9NO/c1-6-2-3-8-4-7(6)5-9/h2-4,9H,5H2,1H3",CC1=C(C=NC=C1)CO,YZWSTKQAGIQVJK-UHFFFAOYSA-N,(4-methylpyridin-3-yl)methanol,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemo Scientific Limited|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aurum Pharmatech LLC|BePharm Ltd.|BioChemPartner|BLD Pharm|BOC Sciences|Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
250653,4-[(Methylsulfonyl)amino]benzoic acid,"4-(Methylsulfonamido)benzoic acid|7151-76-0|4-[(methylsulfonyl)amino]benzoic acid|4-(METHANESULFONYLAMINO)BENZOIC ACID|4-(methanesulfonamido)benzoic acid|4-methanesulfonamidobenzoic acid|Benzoic acid, 4-[(methylsulfonyl)amino]-|4-Methanesulfonylamino-benzoic acid|UNII-UHN43WS7FF|MFCD00025052|UHN43WS7FF|CHEMBL339996|NSC-70313|4-((Methylsulfonyl)amino)benzoic acid|p-(Methylsulfonamido)benzoic acid|2hds|4MB|NCIOpen2_003463|Oprea1_072870|Oprea1_337582|SCHEMBL118340|4-methylsulfonylaminobenzoic acid|4-methanesul",215.230,C8H9NO4S,91.800,298.000,0.700,14,2,5,3,"InChI=1S/C8H9NO4S/c1-14(12,13)9-7-4-2-6(3-5-7)8(10)11/h2-5,9H,1H3,(H,10,11)",CS(=O)(=O)NC1=CC=C(C=C1)C(=O)O,SROHFTOYGFCJAF-UHFFFAOYSA-N,4-(methanesulfonamido)benzoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,192|248|1811|147482|500280|977610|1259416|1347080|1508586,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alinda Chemical|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|Ark Pharm, Inc.|ASINEX|Assembly Blocks Pvt. Ltd.|Aurora Fine ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
252023,3-Hydroxy-2-methylbenzoic Acid,"3-Hydroxy-2-methylbenzoic Acid|603-80-5|3-Hydroxy-o-toluic Acid|3-Hydroxy-2-methyl benzoic acid|2-Methyl-3-hydroxybenzoic acid|Benzoic acid, 3-hydroxy-2-methyl-|MFCD00671541|3-Hydroxy-2-Methyl-Benzoic Acid|Kresolsaure|NSC73133|3,2-Cresotic acid|PubChem15694|ACMC-1B1JY|methyl 3-hydroxybenzoic acid|NCIOpen2_000440|SCHEMBL25755|2-Fluoro-4-biphenylboronicacid|DTXSID50291103|WT030|EBD36795|ZINC1698894|ANW-33488|NSC-73133|SBB063019|AKOS006230194|AC-2546|AM82925|CS-W019788|FS-3157|MCULE-6274989380|VZ26923|SY001962",152.150,C8H8O3,57.500,155.000,1.500,11,2,3,1,"InChI=1S/C8H8O3/c1-5-6(8(10)11)3-2-4-7(5)9/h2-4,9H,1H3,(H,10,11)",CC1=C(C=CC=C1O)C(=O)O,RIERSGULWXEJKL-UHFFFAOYSA-N,3-hydroxy-2-methylbenzoic acid,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|AN PharmaTech|Angene Chemical|Anward|AO",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
259188,5-Methyl-1H-indole-2-carboxylic acid,"5-Methyl-1H-indole-2-carboxylic acid|10241-97-1|5-Methylindole-2-carboxylic acid|5-Methyl-2-indolecarboxylic acid|MFCD00047166|CHEMBL23328|1H-Indole-2-carboxylic acid, 5-methyl-|4BY|NSC88873|ACMC-1BXAE|5-ME-ICA|Oprea1_147382|SCHEMBL704614|DAITVOCMWPNFTL-UHFFFAOYSA-|DTXSID20293351|5-methyl indole-2-carboxylic acid|AMY31808|ZINC2508153|ANW-48873|BBL022372|BDBM50009123|NSC-88873|SBB028490|STK158245|AKOS000198799|5-METHYLINDOLE-2-CARBOXYLICACID|AS06060|CM13617|CS-W007370|FS-3375|MCULE-5011941873|NCGC00338875-01",175.180,C10H9NO2,53.100,217.000,2.700,13,2,2,1,"InChI=1S/C10H9NO2/c1-6-2-3-8-7(4-6)5-9(11-8)10(12)13/h2-5,11H,1H3,(H,12,13)",CC1=CC2=C(C=C1)NC(=C2)C(=O)O,DAITVOCMWPNFTL-UHFFFAOYSA-N,5-methyl-1H-indole-2-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,155|157|161|165|167|175|142989|146231|453509|453510|453680|475504|475505|475508|1347041|1347165,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Ambeed|Ambinter|Anward|Apexmol|Ark Pharm, Inc.|Aromsyn catalogue|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmat",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
265635,"3-Hydroxythietane 1,1-dioxide","3-Hydroxythietane 1,1-dioxide|22524-35-2|3-Thietanol, 1,1-dioxide|3-Thietanol,1,1-dioxide|1,1-dioxothietan-3-ol|3-Hydroxy-thietane-1,1-dione|1,1-bis(oxidanylidene)thietan-3-ol|MFCD22741759|HV2|NSC101855|3-Thietanol,1-dioxide|3-Thietanol-1,1-dioxide|NCIOpen2_001821|SCHEMBL10654177|DTXSID60295430|ZINC1674463|1,1-Dioxo-1I>>6-thietan-3-ol|AKOS022171517|ACN-039409|DS-5600|NSC-101855|QC-10869|DB-014294|3-HYDROXY-1??-THIETANE-1,1-DIONE|CS-0051343|FT-0698046",122.150,C3H6O3S,62.800,140.000,-1.200,7,1,3,0,"InChI=1S/C3H6O3S/c4-3-1-7(5,6)2-3/h3-4H,1-2H2",C1C(CS1(=O)=O)O,CIUZABLJPXPIFC-UHFFFAOYSA-N,"1,1-dioxothietan-3-ol",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,8,248,20050326,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angene Chemical|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BLD Pharm|CEGChem|Chem-Space.com Database|ChemBank|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|ChemTik|Debye Scientifi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
265776,2-Methylaminopyrimidine,"2-Methylaminopyrimidine|931-61-3|n-methylpyrimidin-2-amine|N-Methyl-2-Pyrimidinamine|2-Pyrimidinamine, N-methyl-|Methyl-pyrimidin-2-yl-amine|MFCD00234126|2-(Methylamino)pyrimidine|methyl(pyrimidin-2-yl)amine|2-Pyrimidinamine, N-methyl- (9CI)|Pyrimidine, 2-(methylamino)-|Methylaminopyrimidin|JH4|NSC102272|methyl-2 pyrimidinylamine|methylpyrimidin-2-ylamine|methylpyrimidin-2-yl-amine|2-Pyrimidinamine,N-methyl-|NCIOpen2_001912|SCHEMBL676888|SCHEMBL22004207|DTXSID40295478|ZINC330858|ALBB-031685|ANW-57937|AKOS00",109.130,C5H7N3,37.800,58.700,0.500,8,1,3,1,"InChI=1S/C5H7N3/c1-6-5-7-3-2-4-8-5/h2-4H,1H3,(H,6,7,8)",CNC1=NC=CC=N1,BQNXHDSGGRTFNX-UHFFFAOYSA-N,N-methylpyrimidin-2-amine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,248,20050326,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Amatye|Ambeed|Angel Pharmatech Ltd.|Angene Chemical|Annker Organics|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharm",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
281137,5-Amino-2-methyloxazole-4-carbonitrile,"5-Amino-2-methyloxazole-4-carbonitrile|5098-16-8|5-amino-2-methyl-1,3-oxazole-4-carbonitrile|2-methyl-5-aminooxazole-4-carbonitrile|5-AMINO-2-METHYL-4-OXAZOLECARBONITRILE|4-Oxazolecarbonitrile, 5-amino-2-methyl-|NSC133684|5-amino-2-methyl-oxazole-4-carbonitrile|SCHEMBL2589650|6-NITROCHOLESTERYLACETATE|2-methyl-4-cyano-5-aminooxazole|DTXSID20299919|ZINC335545|7057AB|ANW-57952|MFCD02685652|AKOS006278040|MB02509|NSC-133684|2-methyl-5-amino-4-cyano-1,3-oxazole|AC-28399|DS-10763|AB0068084|FT-0619983|AM-807/25050",123.110,C5H5N3O,75.800,150.000,1.000,9,1,4,0,"InChI=1S/C5H5N3O/c1-3-8-4(2-6)5(7)9-3/h7H2,1H3",CC1=NC(=C(O1)N)C#N,OVIXKBXQNCJGDG-UHFFFAOYSA-N,"5-amino-2-methyl-1,3-oxazole-4-carbonitrile",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,248,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|AN PharmaTech|Anward|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|BePharm Ltd.|Biosynth Carbosynth|BLD Pharm|BOC Sciences|ChangChem|Chem-Space",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
302231,"6-Chlorotetrazolo[1,5-b]pyridazine","6-Chlorotetrazolo[1,5-b]pyridazine|21413-15-0|6-Chloro-[1,2,3,4]tetrazolo[1,5-b]pyridazine|Tetrazolo[1,5-b]pyridazine, 6-chloro-|6-Chlorotetrazolo[4,5-b]pyridazine|MFCD00462761|Tetrazolo[1,5-b]pyridazine,6-chloro-|NSC185169|6-Chloro-tetrazolo[1,5-b]pyridazine|ACMC-209fjv|Tetrazolo[1, 6-chloro-|SCHEMBL11783762|DTXSID00307001|ALBB-032486|WAA41315|ZINC1435441|6-Chlorotetrazolo[1.5--b]pyridazin|ANW-24425|BBL028654|STK042017|AKOS001275913|MCULE-5859342356|NSC-185169|6-Chlorotetraazolo[1,5-b]pyridazine #|Tetrazol",155.540,C4H2ClN5,56.000,131.000,0.800,10,0,4,0,InChI=1S/C4H2ClN5/c5-3-1-2-4-6-8-9-10(4)7-3/h1-2H,C1=CC(=NN2C1=NN=N2)Cl,RRBQGBYFXZPPAH-UHFFFAOYSA-N,"6-chlorotetrazolo[1,5-b]pyridazine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,155|157|161|165|167|175|200|206|212|220|248|256|264|274|296|328|422,20050326,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Achemica|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Ambinter|Angene Chemical|Anward|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chembase.cn|ChemBlock|ChemBridge|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|Combi-Blocks|Debye",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
304832,"1,3-Benzodioxole-4-carboxylic acid","1,3-benzodioxole-4-carboxylic acid|5768-39-8|benzo[d][1,3]dioxole-4-carboxylic acid|o-Piperonylic acid|2,3-methylenedioxybenzoic acid|benzo[1,3]dioxole-4-carboxylic acid|MFCD01076411|2H-1,3-benzodioxole-4-carboxylic acid|2,3-(Methylenedioxy)benzoic acid|Q6T|NSC201536|2-Methylenedioxybenzoic acid|SCHEMBL340702|1-carboxy-methylenedioxybenzene|DTXSID40308032|ZINC332540|ANW-57280|KM0136|SBB067368|STL512549|1,3-benzodioxole-4-carbonsäure|AKOS006222472|2,3-methylenedioxyphenylcarboxylic acid|CS-W022580|MCULE",166.130,C8H6O4,55.800,192.000,1.300,12,1,4,1,"InChI=1S/C8H6O4/c9-8(10)5-2-1-3-6-7(5)12-4-11-6/h1-3H,4H2,(H,9,10)",C1OC2=CC=CC(=C2O1)C(=O)O,DBUAYOWCIUQXQW-UHFFFAOYSA-N,"1,3-benzodioxole-4-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,5,155|157|161|165|167|175|248,20050326,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
319954,2-Amino-6-fluorobenzothiazole,"2-Amino-6-fluorobenzothiazole|348-40-3|6-fluorobenzo[d]thiazol-2-amine|6-Fluoro-1,3-benzothiazol-2-amine|2-Benzothiazolamine, 6-fluoro-|6-Fluoro-benzothiazol-2-ylamine|6-fluoro-2-benzothiazolamine|MFCD00013336|2-amino-6-fluoro benzothiazole|2-amino-6-fluoro-1,3-benzothiazole|2-amino-6-fluorobenzo-1,3-thiazole|2-Amino-6-fluorobenzothiazole, 99%|6-fluorobenzothiazole-2-ylamine|NSC266095|PubChem14467|Maybridge1_006546|ACMC-1AD1L|Oprea1_016706|Oprea1_694425|SCHEMBL78948|2-amino-6-flurobenzothiazole|6-Fluorobenz",168.190,C7H5FN2S,67.200,155.000,2.300,11,1,4,0,"InChI=1S/C7H5FN2S/c8-4-1-2-5-6(3-4)11-7(9)10-5/h1-3H,(H2,9,10)",C1=CC2=C(C=C1F)SC(=N2)N,CJLUXPZQUXVJNF-UHFFFAOYSA-N,"6-fluoro-1,3-benzothiazol-2-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,330|485|608|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1033|1040|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemical|Anward|Apexmol|Apollo Scientific|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
321710,Oxindole,"Oxindole|59-48-3|Indolin-2-one|2-Oxindole|2-Indolinone|1,3-Dihydro-2H-indol-2-one|1,3-Dihydroindol-2-one|Oxindol|2-Oxoindoline|Indol-2(3H)-one|2H-Indol-2-one, 1,3-dihydro-|2-Oxindoline|DICLOFENAC IMPURITY E|MFCD00005711|2-OXOINDOLE|1,3-dihydro-indol-2-one|2,3-dihydro-1H-indol-2-one|UNII-0S9338U62H|NSC 274863|dihydroindolone|CHEBI:31697|0S9338U62H|Oxindole, 97%, pure|Indoline-2-one|Dihydroindolon|2Oxindole|2-Ketoindoline|indolin 2-one|EINECS 200-429-5|1H-indol-2-one|3H-indol-2-one|INDOLINONE|zlchem 289|PubCh",133.150,C8H7NO,29.100,155.000,1.200,10,1,1,0,"InChI=1S/C8H7NO/c10-8-5-6-3-1-2-4-7(6)9-8/h1-4H,5H2,(H,9,10)",C1C2=CC=CC=C2NC1=O,JYGFTBXVXVMTGB-UHFFFAOYSA-N,"1,3-dihydroindol-2-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active,11,330|28956|28957|485350|485395|492967|493033|504770|540299|588519|720641|720717|748040|1062076|1062077|1062078|1062079|1062080|1062081|1062082|1062083|1062084|1062085|1092122|1092123|1092124|1092125|1092126|1121262|1224905|1259398|1259399|1259423,20040916,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
330448,1-Benzhydrylazetidin-3-ol,"1-Benzhydrylazetidin-3-ol|18621-17-5|1-Benzhydrylazetan-3-ol|1-(Diphenylmethyl)-3-hydroxyazetidine|1-(diphenylmethyl)azetidin-3-ol|1-benzhydryl-3-hydroxyazetidine|1-Benzhydryl-azetidin-3-ol|1-Benzhydryl-3-azetidinol|40432-51-7|n-benzhydrylazetidin-3-ol|1-diphenylmethyl-3-hydroxyazetidine|3-Azetidinol, 1-(diphenylmethyl)-|1-(Diphenylmethyl)-3-azetidinol|MFCD00205109|1-diphenylmethylazetidin-3-ol|CHEMBL3763552|n-(diphenylmethyl)azetidin-3-ol|300683-73-2|F2147-0186|N-Benzhydrylazetidin-3-ol hydrochloride|UXG|N",239.310,C16H17NO,23.500,232.000,2.600,18,1,2,3,"InChI=1S/C16H17NO/c18-15-11-17(12-15)16(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10,15-16,18H,11-12H2",C1C(CN1C(C2=CC=CC=C2)C3=CC=CC=C3)O,MMAJXKGUZYDTHV-UHFFFAOYSA-N,1-benzhydrylazetidin-3-ol,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,155|157|161|165|167|175|330|811|833|1044|1792|1823|2291|434982|492967|504770|602314|652031|720641|1159537|1159607|1224905|1259354|1259370|1259416|1276562|1347074,20050326,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Acemol|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
351685,"4-[(Dimethylamino)methyl]-1,3-thiazol-2-amine","4-[(dimethylamino)methyl]-1,3-thiazol-2-amine|116252-53-0|4-((dimethylamino)methyl)thiazol-2-amine|NSC522661|SCHEMBL5913878|ZINC1605296|MFCD11166509|STL472633|AKOS009304690|MCULE-8248111675|NSC-522661|4-((dimethylamino)methyl)thiazole-2-amine|4-thiazolemethanamine,2-amino-n,n-dimethyl-|4-Thiazolemethanamine,  2-amino-N,N-dimethyl-|4-[(dimethylamino)methyl]-1,3-thiazole-2-amine|Z2255110064|WUM",157.240,C6H11N3S,70.400,107.000,0.500,10,1,4,2,"InChI=1S/C6H11N3S/c1-9(2)3-5-4-10-6(7)8-5/h4H,3H2,1-2H3,(H2,7,8)",CN(C)CC1=CSC(=N1)N,HYQAPLLDHDEUSD-UHFFFAOYSA-N,"4-[(dimethylamino)methyl]-1,3-thiazol-2-amine",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,5,NULL,20050326,"A2B Chem|AA BLOCKS|ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChemDB|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|DTP/NCI|Enamine|Eximed Laboratory|Google Patents|IBM|Innovapharm|Mcule|MolPort|MuseChem|NCBI Structure|NextBio|NextMove Software|Norris Pharm|OtavaChemicals|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|SureChEMBL|THE BioTek|Thomson Pharma|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
439554,alpha-L-Fucose,"alpha-L-fucopyranose|ALPHA-L-FUCOSE|6696-41-9|alpha-L-Fucp|alpha-L-Fuc|6-Deoxy-a-L-galactopyranose|UNII-OF086I9H7W|6-deoxy-alpha-L-galactopyranose|OF086I9H7W|CHEBI:42548|(2R,3S,4R,5S,6S)-6-methyloxane-2,3,4,5-tetrol|(2R,3S,4R,5S,6S)-6-methyltetrahydro-2H-pyran-2,3,4,5-tetraol|alpha-L-Galactopyranose, 6-deoxy-|Epitope ID:136045|SCHEMBL348315|ZINC1532814|DB04473|BS-17317|A-8245|C20835|Q27095250|alpha-L-fucose; 6-deoxy-alpha-L-galactopyranose; L-fucose; fucose",164.160,C6H12O5,90.200,139.000,-2.100,11,4,5,0,"InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6+/m0/s1",C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O)O)O)O,SHZGCJCMOBCMKK-SXUWKVJYSA-N,"(2R,3S,4R,5S,6S)-6-methyloxane-2,3,4,5-tetrol",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20050624,"3B Scientific (Wuhan) Corp|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|ABI Chem|AEchem Scientific Corp., USA|Alichem|Ambeed|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Combi-Blocks|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Founder Pharma|GlyTouCan Project|Google",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
439680,beta-D-Mannose,"beta-D-Mannopyranose|beta-D-Mannose|7322-31-8|beta-Mannose|UNII-CUO87O37MT|(2R,3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol|CUO87O37MT|CHEBI:28563|Alpha-L-Gulopyranoside|beta-1,4-Mannan|beta-aD-aMannopyranose|Epitope ID:137485|(1->2)-beta-D-mannan|(1->4)-beta-D-mannan|SCHEMBL396651|(1->2)-beta-D-mannopyranan|CHEBI:27857|CHEBI:59573|CHEBI:80962|[2)-beta-D-Manp-(1->]n|DTXSID501015877|GUP|ZINC3830679|beta-D-mannose; D-mannose; mannose|NE16895|C02209|Q27103775|(2RS,3S,4S,5S,6R)-6-(Hydroxymethyl)tetrahydro",180.160,C6H12O6,110.000,151.000,-2.600,12,5,6,1,"InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5+,6-/m1/s1",C([C@@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)O)O)O)O)O,WQZGKKKJIJFFOK-RWOPYEJCSA-N,"(2R,3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20050623,"A2B Chem|AA BLOCKS|ABI Chem|Ambinter|Aurum Pharmatech LLC|BioCyc|BLD Pharm|ChEBI|Chembase.cn|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Crystallography Open Database|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|EPA DSSTox|FDA/SPL Indexing Data|GlyTouCan Project|Google Patents|IBM|Immune Epitope Database (IEDB)|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|LGC Standards|MetabolomicsWorkbench|MuseChem|NCBI Structure|NextBio|NextMove Softw",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
440982,3-Hydroxy-2-methylquinolin-4(1H)-one,"3-hydroxy-2-methylquinolin-4(1H)-one|34497-54-6|2-Methylquinoline-3,4-diol|3-Hydroxy-2-methyl-1H-quinolin-4-one|90924-17-7|4(1H)-Quinolinone, 3-hydroxy-2-methyl-|CHEBI:29216|3-hydroxy-2-methyl-1,4-dihydroquinolin-4-one|C06331|C11504|HQD|3,4-dioxyquinaldine|1h-3-hydroxy-4-oxoquinaldine|CHEBI:1215|SCHEMBL5114407|DTXSID70331550|BCP31694|4162AB|ANW-52917|c1271|MFCD15144272|ZINC16343276|2-methyl-3-hydroxy-4(1h)-quinolone|AKOS015999930|SB40434|AM806571|DS-17946|Q-9278|Q27461181|Z1814739411|2-Methylquinoline-3,4-d",175.180,C10H9NO2,49.300,270.000,1.800,13,2,3,0,"InChI=1S/C10H9NO2/c1-6-9(12)10(13)7-4-2-3-5-8(7)11-6/h2-5,12H,1H3,(H,11,13)",CC1=C(C(=O)C2=CC=CC=C2N1)O,FSCXZVPPDJYLDD-UHFFFAOYSA-N,3-hydroxy-2-methyl-1H-quinolin-4-one,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,6,NULL,20040916,"4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BioChemPartner|BioCyc|BLD Pharm|BOC Sciences|ChEBI|Chem-Space.com Database|Chembase.cn|ChemD",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
443445,Zinc gluconate,"ZINC GLUCONATE|4468-02-4|Zincgluconate|Gluconic Acid Zinc(II) Salt|Zinc gluconate hydrate|Zinc gluconate (USP)|UNII-U6WSN5SQ1Z|U6WSN5SQ1Z|Gluconic acid zinc|Zinc(II) Gluconate|Gluconic acid zinc complex|455.67 (anhydrous)|SCHEMBL21280|12H22O14Zn??xH2O|CHEMBL3833377|zinc (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate|CHEBI:29708|DTXSID20894125|AKOS015951235|DB11248|G0277|D02390|A826659|Q-201160|Q3822815|zinc (2R,3S,4R,5R)-2,3,4,5,6-pentakis(oxidanyl)hexanoate",455.700,C12H22O14Zn,283.000,165.000,NULL,27,10,14,8,"InChI=1S/2C6H12O7.Zn/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1",C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.C([C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O)O.[Zn+2],WHMDKBIGKVEYHS-IYEMJOQQSA-L,"zinc;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate",NULL,Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Food Additives and Ingredients|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,12,NULL,20050624,"ABBLIS Chemicals|ABI Chem|Acadechem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Biosynth Carbosynth|BLD Pharm|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemSpider|CSNpharm|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Hairui Chemical|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MolPort|NextBio|NextMove Software|NovoSeek|Sinfoo Biotech|SureChEMBL|TCI (Tokyo ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
444036,Fluticasone propionate,FLUTICASONE PROPIONATE|Flovent|Cutivate|80474-14-2|Flixotide|Flonase|Flixonase|Flovent HFA|Flunase|Flusonal|Fluspiral|Flutide|Flutivate|Asmatil|Axotide|Brethal|Fluinol|Flovent Diskus 50|Flixotide Disks|Flixotide Disk|Flovent Diskus|Flovent Diskus 100|Flovent Diskus 250|Flixotide Inhaler|Cultivate|Flixonase Nasal Spray|Fluticasonpropionat Allen|Fluticasone (propionate)|UNII-O2GMZ0LF5W|CCI 18781|CCI-18781|MFCD00866007|O2GMZ0LF5W|atemur|CHEBI:31441|Inalacor|Rinosone|Trialona|Ubizol|Zoflut|Fluticasone propionat,500.600,C25H31F3O5S,106.000,984.000,4.000,34,1,9,6,"InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1",CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,WMWTYOKRWGGJOA-CENSZEJFSA-N,"[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate",Fluticasone,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1332|1376|1385|1422|1465|1511|1529|1530|1531|1532|1554|1621|1626|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1956|1962|1974|1979|1987|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2240|2241|2247|2275|2280|2300|2313|2322|2330|2380|2382|2391|2435|2445|2462|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|74241|74247|78421|8890,20050624,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acorn PharmaTech Product List|AKos Consulting & Solutions|Alfa Chemistry|Angel Pharmatech Ltd.|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|AvaChem Scientific|BePharm Ltd.|BerrChem|BindingDB|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co.",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
444899,Arachidonic acid,"arachidonic acid|506-32-1|(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid|arachidonate|Immunocytophyte|(all-Z)-5,8,11,14-Eicosatetraenoic acid|cis-5,8,11,14-Eicosatetraenoic acid|5,8,11,14-Eicosatetraenoic acid, (all-Z)-|5Z,8Z,11Z,14Z-eicosatetraenoic acid|all-cis-5,8,11,14-eicosatetraenoic acid|UNII-27YG812J1I|CHEMBL15594|CHEBI:15843|5,8,11,14-Eicosatetraenoic acid|27YG812J1I|Icosa-5,8,11,14-tetraenoic acid|cis,cis,cis,cis-5,8,11,14-Eicosatetraenoic acid|MFCD00004417|5Z,8Z,11Z,14Z-icosatetraenoic acid|C20:",304.500,C20H32O2,37.300,362.000,6.300,22,1,2,14,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",CCCCC/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)O,YZXBAPSDXZZRGB-DOFZRALJSA-N,"(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid",Arachidonic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,875|880|881|884|885|887|889|892|893|894|900|901|902|910|923|924|927|930|995|1030|1379|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1766|1768|1811|1850|1863|1865|1899|1903|1906|1947|1948|1950|1962|1974|1987|2016|2023|2025|2029|2052|2057|2066|2101|2107|2112|2129|2130|2147|2174|2177|2234|2235|2240|2241|2275|2280|2300|2313|2322|2330|2391|2435|2445|2451|2462|2472|2501|2517|2528|2546|2549|2551|2557|2606|2629|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|32788|55271,20040916,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BenchChem|BindingDB|BioCyc|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|Calbiochem|CCSbase|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Databa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
445779,"2,5-Dimethylpyrimidin-4-amine","2,5-DIMETHYLPYRIMIDIN-4-AMINE|73-70-1|2,5-DIMETHYL-PYRIMIDIN-4-YLAMINE|CHEMBL1235533|PYD|4-Pyrimidinamine, 2,5-dimethyl- (9CI)|4-Pyrimidinamine,2,5-dimethyl-|ICP|UNII-J1SE9T8ANX|J1SE9T8ANX|SCHEMBL1586143|2,5-dimethyl-4-aminopyrimidine|2,5-Dimethyl-4-pyrimidineamine|DTXSID90332201|ZINC3591110|BDBM50016818|MFCD09909809|STL301945|AKOS006310877|2,5-DIMETHYL-4-PYRIMIDINAMINE|AB54986|DB02372|DS-5610|MCULE-3866178608|CS-0045882|Q27093382|Z2217033047",123.160,C6H9N3,51.800,94.300,0.600,9,1,3,0,"InChI=1S/C6H9N3/c1-4-3-8-5(2)9-6(4)7/h3H,1-2H3,(H2,7,8,9)",CC1=CN=C(N=C1N)C,UXKNAXNFIYFMIB-UHFFFAOYSA-N,"2,5-dimethylpyrimidin-4-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents,7,1147919|1147920|1147921|1147922|1147923,20050624,"001Chemical|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Achemo Scientific Limited|Activate Scientific|AKos Consulting & Solutions|Ambeed|Ambinter|Angene Chemical|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|BePharm Ltd.|BindingDB|Biocore|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemDB|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemShuttle|ChemSpider|Clearsynth|Combi-Blocks|DAOGE BIOPHARMA|DiscoveryGate|DrugBank|Egon Willighage",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
448209,Cytidine monophosphate N-acetylneuraminic acid,"CMP-Sialic acid|cytidine monophosphate N-acetylneuraminic acid|CMP-N-acetylneuraminate|CYTIDINE 5'-MONOPHOSPHO-N-|CMP-NeuNAc|Cmp-D-N-acetylneuraminic acid|3063-71-6|Cmp-nana|CHEBI:16556|CMP acetylneuraminic acid|CYTIDINE-5'-MONOPHOSPHATE-5-N-ACETYLNEURAMINIC ACID|CMP-Neu5Ac|CMP-N-acetyl-beta-neuraminate|(2R,4S,5R,6R)-2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxy",614.500,C20H31N4O16P,321.000,1120.000,-6.700,41,10,16,11,"InChI=1S/C20H31N4O16P/c1-7(26)22-12-8(27)4-20(18(32)33,39-16(12)13(29)9(28)5-25)40-41(35,36)37-6-10-14(30)15(31)17(38-10)24-3-2-11(21)23-19(24)34/h2-3,8-10,12-17,25,27-31H,4-6H2,1H3,(H,22,26)(H,32,33)(H,35,36)(H2,21,23,34)/t8-,9+,10+,12+,13+,14+,15+,16+,17+,20+/m0/s1",CC(=O)N[C@@H]1[C@H](C[C@](O[C@H]1[C@@H]([C@@H](CO)O)O)(C(=O)O)OP(=O)(O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC(=NC3=O)N)O)O)O,TXCIAUNLDRJGJZ-BILDWYJOSA-N,"(2R,4S,5R,6R)-5-acetamido-2-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid",Cytidine Monophosphate N-Acetylneuraminic Acid,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active,9,74253|74259,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AHH Chemical co.,ltd|BioCyc|CCSbase|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|Human Metabolome Database (HMDB)|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|KEGG|MedChemexpress MCE",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
451668,Decitabine,"Decitabine|5-Aza-2'-deoxycytidine|2353-33-5|Dacogen|5-Azadeoxycytidine|2'-Deoxy-5-azacytidine|AzadC|5-aza-CdR|5-aza-dC|Dezocitidine|NSC 127716|Dac|5-aza-2-deoxycytidine|4-amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,3,5-triazin-2(1H)-one|UNII-776B62CQ27|5A2dc|NSC-127716|4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-s-triazin-2(1H)-one|4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one|4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-tri",228.210,C8H12N4O4,121.000,356.000,-1.200,16,3,4,2,"InChI=1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1",C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O,XAUDJQYHKZQPEU-KVQBGUIXSA-N,"4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one",Decitabine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1041|1042|1043|1511|1554|1569|1662|1663|1672|1813|1814|1832|1850|1863|1875|1885|1899|1903|1906|1910|1947|1950|1962|1974|1979|1981|1985|1987|1999|2002|2003|2016|2023|2025|2029|2052|2057|2066|2094|2097|2098|2099|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2252|2253|2280|2300|2380|2384|2391|2401|2435|2445|2462|2517|2520|2521|2524|2540|2544|2550|2553|2557|2563|2599|2606|2629|2642|2648|2650|2661|2676|2685|2690|2716|2717|2718|2751|2796|2797|2805|2806|2825|98149|425652|425653|434955|43496,20050801,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Ambinter|Anward|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
459531,3-Aminoisonicotinic acid,"3-Aminoisonicotinic acid|7579-20-6|3-aminopyridine-4-carboxylic acid|3-Amino-4-pyridinecarboxylic acid|7529-20-6|3-Amino-isonicotinic acid|3-Amino-4-Pyridine Carboxylic Acid|4-Pyridinecarboxylic acid, 3-amino-|3-amino isonicotinic acid|MFCD00137840|CHEMBL1383671|3-Amino-4-pyridinecarboxylicacid|3-Aminoisonicotinic acid, 98%|3-Aminoisonicotinicacid|3-Amino-4-carboxypyridine|4SV|PubChem2420|3-Aminoisonicotinsaure|PubChem16665|3-aminoisonicotinoic acid|3-arninoisonicotinic acid|ACMC-1BHX3|EC-000.1274|Oprea1_71",138.120,C6H6N2O2,76.200,138.000,0.200,10,2,4,1,"InChI=1S/C6H6N2O2/c7-5-3-8-2-1-4(5)6(9)10/h1-3H,7H2,(H,9,10)",C1=CN=CC(=C1C(=O)O)N,FYEQKMAVRYRMBL-UHFFFAOYSA-N,3-aminopyridine-4-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,9,485|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1229|1230|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1458|1460|1461|1463|1465|1466|1467|1468|1469|1471|1477,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Alind",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
464205,Tenofovir,Tenofovir|147127-20-6|PMPA|(R)-9-(2-Phosphonomethoxypropyl)adenine|Truvada|(R)-PMPA|PMPA gel|Apropovir|tenofovir (anhydrous)|(R)-(((1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONIC ACID|(R)-9-[2-(Phosphonomethoxy)propyl]adenine|anhydrous tenofovir|tenofovir (anh.)|UNII-W4HFE001U5|GS-1275|CHEBI:63625|PMP-A|W4HFE001U5|[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid|(R)-(1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid|147127-20-6 (Tenofovir)|({[(2R)-1-(6-amino-9H-purin-9,287.210,C9H14N5O4P,136.000,354.000,-1.600,19,3,8,5,"InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1",C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid,Tenofovir,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1471|1490|1688|1766|1768|2528|2546|2551|2662|3059|10054|45994|47262|47263|47278|55965|72026|72409|72410|81263|82134|83112|83255|95008|98126|105555|105556|125503|142453|147626|211496|211497|275065|275077|275078|275079|275080|275081|275082|275083|275084|275085|275090|289141|289142|289143|289144|289145|289146|310043|310044|310047|313874|313875|317369|317370|317371|317372|317373|317374|320325|320326|320327|320328|320329|320330|322825|322826|322827|322828|322829|322830|322831|322832|322833|322834|322835|322836|3,20050801,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|AN PharmaTech|Angene Chemical|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
468595,Posaconazole,"Posaconazole|171228-49-2|Noxafil|Sch 56592|SCH56592|SCH-56592|Posaconazole SP|Schering 56592|UNII-6TK1G07BHZ|4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-TRIAZOL-1-YL)METHYL)-5-(2,4-DIFLUOROPHENYL)TETRAHYDROFURAN-3-YL)METHOXY)PHENYL)PIPERAZIN-1-YL)PHENYL)-1-((2S,3S)-2-HYDROXYPENTAN-3-YL)-1H-1,2,4-TRIAZOL-5(4H)-ONE|4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one|6TK1G07BHZ|CHEMBL1397|CHEBI:6435",700.800,C37H42F2N8O4,112.000,1170.000,4.600,51,1,11,12,"InChI=1S/C37H42F2N8O4/c1-3-35(26(2)48)47-36(49)46(25-42-47)31-7-5-29(6-8-31)43-14-16-44(17-15-43)30-9-11-32(12-10-30)50-20-27-19-37(51-21-27,22-45-24-40-23-41-45)33-13-4-28(38)18-34(33)39/h4-13,18,23-27,35,48H,3,14-17,19-22H2,1-2H3/t26-,27+,35-,37-/m0/s1",CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,RAGOYPUPXAKGKH-XAKZXMRKSA-N,"4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,258671|258672|259824|259825|259830|278433|278434|278435|278437|278438|278439|278440|278442|278445|278446|278449|278450|278453|278455|278457|278458|278461|278463|278465|278467|278469|278471|278473|278475|279038|279039|279040|279041|279042|279043|279044|279045|279046|279047|279048|279049|279050|279051|279052|279053|279054|279055|279056|279057|279058|279059|279060|279061|279062|279063|279064|279065|279066|279067|279068|279069|279070|279071|279072|279073|279074|279075|279076|279077|279194|279195|279196|279197|2,20050801,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acesobio|Achemo Scientific Limited|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Ambeed|Ambinter|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BindingDB|BioChemPartner|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerc",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
575777,"2,3-Dihydro-1H-indene-2-carboxylic acid","25177-85-9|2,3-dihydro-1H-indene-2-carboxylic acid|indane-2-carboxylic acid|2-Indancarboxylic Acid|Indan-2-carboxylic acid|2-Indanecarboxylic acid|1H-Indene-2-carboxylic acid, 2,3-dihydro-|MFCD00085095|CHEMBL81558|F2191-0018|Indan-2-carboxylic acid, 98%|2-carboxy-indan|2-carboxy-indane|6FZ|ACMC-209ghx|2-indane carboxylic acid|indane 2-carboxylic acid|Maybridge4_002460|2-Indanecarboxylic acid #|SCHEMBL289302|Indan-2-carboxylic acid, 97%|DTXSID30341796|HMS1527P18|ZINC337835|ALBB-025362|1980AB|ANW-25651|BBL015",162.180,C10H10O2,37.300,174.000,1.700,12,1,2,1,"InChI=1S/C10H10O2/c11-10(12)9-5-7-3-1-2-4-8(7)6-9/h1-4,9H,5-6H2,(H,11,12)",C1C(CC2=CC=CC=C21)C(=O)O,XUDCMQBOWOLYCF-UHFFFAOYSA-N,"2,3-dihydro-1H-indene-2-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,2240|2241|2275|2313|2316|2330|34499|434959|485350|492967|493033|493162|504770|540299|588519|602314|624156|720641|1159607|1224905,20050327,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemica|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LL",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
588246,"(2,6-Difluorophenyl)(pyrrolidin-1-yl)methanone","(2,6-difluorophenyl)(pyrrolidin-1-yl)methanone|84044-77-9|NX7|(2,6-difluorophenyl)-pyrrolidin-1-ylmethanone|Cambridge id 5844738|MLS000719318|CHEMBL1450678|SCHEMBL14103288|ZINC35148|HMS1702B21|HMS2685A19|1-(2,6-Difluorobenzoyl)pyrrolidine|MFCD02210599|STK764892|2,6-difluorophenyl pyrrolidinyl ketone|AKOS000596739|1-(2,6-Difluorobenzoyl)pyrrolidine #|MCULE-4725591376|SMR000287426|ST051260|(2,6-difluorophenyl)(1-pyrrolidinyl)methanone|Methanone, (2,6-difluorophenyl)(1-pyrrolidinyl)-|SR-01000533488|SR-01000533",211.210,C11H11F2NO,20.300,231.000,2.100,15,0,3,1,"InChI=1S/C11H11F2NO/c12-8-4-3-5-9(13)10(8)11(15)14-6-1-2-7-14/h3-5H,1-2,6-7H2",C1CCN(C1)C(=O)C2=C(C=CC=C2F)F,WKDBMZQECSVNDS-UHFFFAOYSA-N,"(2,6-difluorophenyl)-pyrrolidin-1-ylmethanone",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Patents|Biological Test Results: Active,5,485|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1251|1274|1276|1285|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1460|1461|1463|1465|1466|1467|1468|1469|1471|1477|1479|1481|1486|148,20050327,"abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambinter|ASINEX|Aurora Fine Chemicals LLC|BenchChem|Chem-Space.com Database|ChEMBL|ChemBlock|ChemBridge|ChemDB|ChemDiv|ChemSpider|Collaborative Drug Discovery, Inc.|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|Enamine|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|NIST Mass Spectrometry Data Center|Protein Data Bank in Europe (PDBe)|SureChEMBL|The Scripps Research Institute Molec",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
637517,Elaidic acid,"Elaidic acid|112-79-8|trans-Oleic acid|trans-9-Octadecenoic acid|(E)-octadec-9-enoic acid|9-octadecenoic acid|(E)-Oleic acid|9-Octadecenoic acid, (E)-|9-octadecenoic acid, (9E)-|trans-Octadec-9-enoic acid|(9E)-octadec-9-enoic acid|trans-Elaidic acid|Elaidinsaeure|Elaidinsaure|acide elaidique|9-elaidic acid|MFCD00063954|Octadec-9-enoic acid|9E-octadecenoic acid|UNII-4837010H8C|trans-.DELTA.9-Octadecenoic acid|(9E)-Octadecenoic acid|9-trans-Octadecenoic acid|D9-trans-Octadecenoic acid|trans-D9-Octadecenoic ac",282.500,C18H34O2,37.300,234.000,6.500,20,1,2,15,"InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9+",CCCCCCCC/C=C/CCCCCCCC(=O)O,ZQPPMHVWECSIRJ-MDZDMXLPSA-N,(E)-octadec-9-enoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,155|157|161|165|167|175|1811|32788|361445|977611|1159978|1259325|1259374|1347080|1479145|1479147|1479149|1479150,20040916,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Aceschem Inc|Achemtek|Acros Organics|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BindingDB|BioCyc|Biological Magnetic Resonance Data Bank (BMRB)|Biosynth Carbosynth|BLD Pharm|BOC Sciences|C. David Weaver Laboratory, Vanderbilt Univ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
673374,"Azepan-1-yl(1,3-benzodioxol-5-yl)methanone","azepan-1-yl(1,3-benzodioxol-5-yl)methanone|CHEMBL2203921|(azepan-1-yl)(2H-1,3-benzodioxol-5-yl)methanone|JGP|Oprea1_783471|SCHEMBL14140751|ZINC35394|BDBM50401980|STK417354|AKOS002557849|MCULE-7851867329|ST004923|SR-01000200660|SR-01000200660-1|2H-benzo[3,4-d]1,3-dioxolan-5-yl azaperhydroepinyl ketone|154235-79-7",247.290,C14H17NO3,38.800,299.000,2.400,18,0,3,1,"InChI=1S/C14H17NO3/c16-14(15-7-3-1-2-4-8-15)11-5-6-12-13(9-11)18-10-17-12/h5-6,9H,1-4,7-8,10H2",C1CCCN(CC1)C(=O)C2=CC3=C(C=C2)OCO3,ABPXISKFLMGPJG-UHFFFAOYSA-N,"azepan-1-yl(1,3-benzodioxol-5-yl)methanone",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Patents,4,1949|718838|718839|1259310|1259374|1259422,20050707,"ABI Chem|AKos Consulting & Solutions|BenchChem|BindingDB|Chem-Space.com Database|ChemBank|ChEMBL|ChemBridge|ChemDB|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|IBM|Mcule|MolPort|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Southern Research Institute|SureChEMBL|The Scripps Research Institute Molecular Screening Center|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
686921,"N-(1,3-Benzodioxol-5-ylmethyl)ethanesulfonamide","N-(1,3-benzodioxol-5-ylmethyl)ethanesulfonamide|Oprea1_061217|Oprea1_081260|ZINC54604|STK414847|AKOS000639356|MCULE-9281376907|ST066984|(2H-benzo[3,4-d]1,3-dioxolan-5-ylmethyl)(ethylsulfonyl)amine|332025-91-9",243.280,C10H13NO4S,73.000,324.000,1.200,16,1,5,4,"InChI=1S/C10H13NO4S/c1-2-16(12,13)11-6-8-3-4-9-10(5-8)15-7-14-9/h3-5,11H,2,6-7H2,1H3",CCS(=O)(=O)NCC1=CC2=C(C=C1)OCO2,UKPLBUIFSDRLEZ-UHFFFAOYSA-N,"N-(1,3-benzodioxol-5-ylmethyl)ethanesulfonamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways,2,1949,20050707,"ABI Chem|AKos Consulting & Solutions|BenchChem|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Mcule|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
735904,1-[4-(Methylsulfonyl)phenyl]piperazine,"1-[4-(methylsulfonyl)phenyl]piperazine|187669-60-9|1-(4-methylsulfonylphenyl)piperazine|1-(4-(methylsulfonyl)phenyl)piperazine|1-(4-methanesulfonylphenyl)piperazine|1-(4-methanesulfonyl-phenyl)-piperazine|1-[4-(methylsulphonyl)phenyl]piperazine|MixCom4_000241|Piperazine,1-[4-(methylsulfonyl)phenyl]-|Peakdale2_000513|Piperazine, 1-[4-(methylsulfonyl)phenyl]-|SCHEMBL532144|CHEMBL4543970|DTXSID20352876|ZINC154150|ALBB-005740|6306AD|MFCD03648601|STK501205|1-(4-(methylsulfonyl)phenyl)piperazin|AKOS003599584|FS-1",240.320,C11H16N2O2S,57.800,309.000,0.400,16,1,4,2,"InChI=1S/C11H16N2O2S/c1-16(14,15)11-4-2-10(3-5-11)13-8-6-12-7-9-13/h2-5,12H,6-9H2,1H3",CS(=O)(=O)C1=CC=C(C=C1)N2CCNCC2,KNQFDOLIXOOIGX-UHFFFAOYSA-N,1-(4-methylsulfonylphenyl)piperazine,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,6,1259310|1259374|1259422,20050708,"A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Ambeed|Angene Chemical|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BLD Pharm|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemDB|ChemDiv|Chemenu Inc.|ChemExper Chemical Directory|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|Combi-Blocks|Debye Scientific Co., Ltd|DiscoveryGate|eNovation Chemicals|EPA DSST",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
748256,3-(1H-Benzimidazol-1-yl)propanoic acid,"14840-18-7|3-Benzoimidazol-1-yl-propionic acid|3-(1H-benzimidazol-1-yl)propanoic acid|3-(1H-Benzo[d]imidazol-1-yl)propanoic acid|1H-Benzimidazole-1-propanoic acid|3-(benzimidazol-1-yl)propanoic acid|1-Benzimidazolepropionic acid|3-(1H-1,3-benzodiazol-1-yl)propanoic acid|3-(benzoimidazole-1-yl)-propionic acid|3-benzimidazolylpropanoic acid|3-BENZOIMIDAZOL-1-YL-PROPIONICACID|ACMC-1BS5D|EC-000.1976|SCHEMBL838860|CHEMBL3133889|DTXSID10353690|HMS1616M05|ZINC194295|ALBB-020841|3-benzoimidazol-1-yl-propanoic acid|",190.200,C10H10N2O2,55.100,220.000,0.900,14,1,3,3,"InChI=1S/C10H10N2O2/c13-10(14)5-6-12-7-11-8-3-1-2-4-9(8)12/h1-4,7H,5-6H2,(H,13,14)",C1=CC=C2C(=C1)N=CN2CCC(=O)O,XKGRXBQGCQJOHQ-UHFFFAOYSA-N,3-(benzimidazol-1-yl)propanoic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,10,485350|485395|492967|493033|504770|540299|588519|720641|720717|1077553|1077554|1077555|1077557|1077558|1077559|1077563|1077564|1077565|1077566|1077567|1077568|1077569|1224905,20050708,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Ambeed|Ambinter|Angene Chemical|Anward|Ark Pharm, Inc.|ASINEX|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|B",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
767567,3-Cyclopentyl-1-(piperazin-1-yl)propan-1-one,3-cyclopentyl-1-(piperazin-1-yl)propan-1-one|423153-33-7|1-(3-Cyclopentylpropanoyl) piperazine|RDV|3-cyclopentyl-1-piperazin-1-ylpropan-1-one|Cambridge id 5875278|Oprea1_451653|Oprea1_852716|CHEMBL4578549|ZINC245523|MFCD01829299|AKOS000141569|MCULE-1395724488|NE31797|3-cyclopentyl-1-piperazinylpropan-1-one|BB 0253799|ST50014056|EN300-31331|Z228586964,210.320,C12H22N2O,32.299,206.000,1.600,15,1,2,3,"InChI=1S/C12H22N2O/c15-12(14-9-7-13-8-10-14)6-5-11-3-1-2-4-11/h11,13H,1-10H2",C1CCC(C1)CCC(=O)N2CCNCC2,PUCYMVZANVWWKV-UHFFFAOYSA-N,3-cyclopentyl-1-piperazin-1-ylpropan-1-one,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Drug and Medication Information|Patents,4,1159537,20050708,"A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|AKos Consulting & Solutions|Ambeed|Ambinter|Angene Chemical|ASINEX|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChemBank|Chembase.cn|ChEMBL|ChemBridge|ChemDB|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|EDASA Scientific|Enamine|IBM|King Scientific|LabNetwork, a WuXi AppTec Company|Matrix Scientific|Mcule|MolPort|NCBI Structure|NextBio|Norris Pha",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
769265,"N~1~-Phenylpiperidine-1,4-dicarboxamide","N~1~-phenylpiperidine-1,4-dicarboxamide|401589-80-8|T0J|1-N-phenylpiperidine-1,4-dicarboxamide|SMR000071611|Cambridge id 7122779|MLS000088335|CHEMBL1569611|HMS2360G11|ZINC249866|STL200004|AKOS000599675|N1-phenylpiperidine-1,4-dicarboxamide|MCULE-5550953852|SDCCGMLS-0038840.P002|N~1~-phenyl-1,4-piperidinedicarboxamide|ST50276542|1-(N-phenylcarbamoyl)piperidine-4-carboxamide|Z33545544",247.290,C13H17N3O2,75.400,305.000,0.500,18,2,2,2,"InChI=1S/C13H17N3O2/c14-12(17)10-6-8-16(9-7-10)13(18)15-11-4-2-1-3-5-11/h1-5,10H,6-9H2,(H2,14,17)(H,15,18)",C1CN(CCC1C(=O)N)C(=O)NC2=CC=CC=C2,OSBGPHZLIBZPGJ-UHFFFAOYSA-N,"1-N-phenylpiperidine-1,4-dicarboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents|Biological Test Results: Micromolar,4,360|361|368|373|374|411|422|425|429|430|431|432|436|445|447|448|453|460|463|465|485|488|501|518|521|522|524|525|526|538|539|552|555|556|559|560|561|565|567|568|570|571|573|574|577|581|583|584|585|587|588|589|590|591|592|593|594|595|596|597|598|602|603|604|605|606|608|612|618|619|620|626|628|629|630|631|633|639|640|641|645|648|662|680|684|685|688|690|693|696|697|704|707|708|709|710|717|719|720|727|729|731|736|738|739|740|746|748|750|757|758|759|760|761|764|774|775|777|778|781|782|793|796|797|798|799|800|802|,20050708,"ABI Chem|AKos Consulting & Solutions|Ambinter|ASINEX|Aurora Fine Chemicals LLC|BenchChem|Burnham Center for Chemical Genomics|Chem-Space.com Database|ChEMBL|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|Enamine|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|TimTec|University of Kansas High Throughp",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
789635,N-[4-(Phenylamino)phenyl]acetamide,"N-(4-anilinophenyl)acetamide|N-[4-(phenylamino)phenyl]acetamide|B1A|4'-(Anilino)acetoanilide|4-acetamido-N-phenylaniline|Oprea1_324101|Oprea1_376523|MLS000711793|SCHEMBL9480198|CHEMBL1543600|HMS1678G05|HMS2752G04|ZINC289523|AKOS000507366|MCULE-1982978428|Acetamide, N-[4-(phenylamino)phenyl]-|SMR000281560|ST089498|SR-01000315100|SR-01000315100-1|38674-90-7",226.270,C14H14N2O,41.100,241.000,2.700,17,2,2,3,"InChI=1S/C14H14N2O/c1-11(17)15-13-7-9-14(10-8-13)16-12-5-3-2-4-6-12/h2-10,16H,1H3,(H,15,17)",CC(=O)NC1=CC=C(C=C1)NC2=CC=CC=C2,QAIADKFUCPEVKW-UHFFFAOYSA-N,N-(4-anilinophenyl)acetamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Names and Identifiers|Patents|Biological Test Results: Active,6,485|781|782|798|800|873|880|940|1021|1022|1046|1085|1230|1236|1242|1274|1304|1321|1359|1376|1377|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1460|1461|1463|1465|1467|1468|1469|1471|1477|1479|1481|1486|1490|1496|1509|1510|1511|1515|1527|1529|1530|1531|1533|1554|1556|1565|1566|1578|1619|1621|1625|1626|1628|1631|1634|1654|1656|1662|1663|1665|1672|1688|1700|1706|1721|1722|1766|1775|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1865|1868|,20050708,"ABI Chem|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|BenchChem|ChemBank|ChEMBL|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Japan Chemical Substance Dictionary (Nikkaji)|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|NextMove Software|NIST Mass Spectrometry Data Center|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|The Scripps Research Institute Molecular Screening Center|Thomson ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
817115,4-Bromo-2-hydroxypyridine,"4-BROMO-2-HYDROXYPYRIDINE|36953-37-4|4-bromopyridin-2-ol|4-Bromopyridin-2(1H)-one|4-bromo-1H-pyridin-2-one|4-BROMO-1,2-DIHYDROPYRIDIN-2-ONE|4-Bromo-2-pyridinol|4-BROMO-2(1H)-PYRIDINONE|4-Bromo-2-pyridone|4-Bromo-pyridin-2-ol|MFCD00234041|2(1H)-PYRIDINONE, 4-BROMO-|4-Bromo-2-hydroxy pyridine|2-HYDROXY-4-BROMOPYRIDINE|4-bromanyl-1~{H}-pyridin-2-one|4-Bromo-2-hydroxypyridine, 97%|4-Iodoopyridin-2(1H)-one|4-bromopyridone|4-bromo pyridone|HGQ|PubChem6560|4-Bromopyridine-2-ol|4-Bromo-2-hydroxyopyridine|4-bromo-1 ",174.000,C5H4BrNO,29.100,171.000,0.600,8,1,1,0,"InChI=1S/C5H4BrNO/c6-4-1-2-7-5(8)3-4/h1-3H,(H,7,8)",C1=CNC(=O)C=C1Br,SSLMGOKTIUIZLY-UHFFFAOYSA-N,4-bromo-1H-pyridin-2-one,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20050708,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|AAA Chemistry|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
882306,1-(4-Tosylpiperazin-1-yl)ethanone,1-(4-tosylpiperazin-1-yl)ethanone|1-acetyl-4-[(4-methylphenyl)sulfonyl]piperazine|3347-05-5|Oprea1_834908|1-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]ethanone|SCHEMBL14477863|ZINC453311|AKOS001296825|MCULE-7575438360|ST50808426|AG-690/12888001|SR-01000474134|SR-01000474134-1|F0867-0010,282.360,C13H18N2O3S,66.100,414.000,0.700,19,0,4,2,"InChI=1S/C13H18N2O3S/c1-11-3-5-13(6-4-11)19(17,18)15-9-7-14(8-10-15)12(2)16/h3-6H,7-10H2,1-2H3",CC1=CC=C(C=C1)S(=O)(=O)N2CCN(CC2)C(=O)C,RSIVSBAWSQRGLN-UHFFFAOYSA-N,1-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]ethanone,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,1159607|1259310|1259374|1259422|1272365,20050709,"ABI Chem|AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BenchChem|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|IBM|Life Chemicals|Mcule|MolPort|MuseChem|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|Specs|SureChEMBL|The Scripps Research Institute Molecular Screening Center|TimTec|UW Madison, Small Molecule Screening Facility|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
934518,N-(4-Fluorophenyl)-2-(1-pyrrolidinyl)acetamide,N-(4-fluorophenyl)-2-(1-pyrrolidinyl)acetamide|N-(4-fluorophenyl)-2-(pyrrolidin-1-yl)acetamide|397880-93-2|C12H15FN2O|F3316-0327|N-(4-fluorophenyl)-2-pyrrolidin-1-ylacetamide|EJQ|MLS000856742|CHEMBL1406979|HMS1686M22|HMS2645A18|ZINC527883|STK697300|AKOS000506872|MCULE-4455488321|SMR000278687|AP-124/43023481,222.260,C12H15FN2O,32.299,233.000,2.300,16,1,3,3,"InChI=1S/C12H15FN2O/c13-10-3-5-11(6-4-10)14-12(16)9-15-7-1-2-8-15/h3-6H,1-2,7-9H2,(H,14,16)",C1CCN(C1)CC(=O)NC2=CC=C(C=C2)F,XUHKVJOCQINJLO-UHFFFAOYSA-N,N-(4-fluorophenyl)-2-pyrrolidin-1-ylacetamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Biological Test Results: Active|Biological Test Results: Micromolar,4,485|631|731|757|758|759|760|761|764|781|782|797|798|800|861|862|868|871|873|878|880|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1246|1251|1273|1274|1276|1285|1296|1304|1321|1325|1326|1359|1362|1376|1377|1379|1381|1385|1415|1416|1422|1423|1424|1430|1434|1439|1440|1441|1443|1445|1446|1448|1454|1456|1457|1460|1461|1463|1465|1466|1467|1468|1469|1471,20050709,"ABI Chem|Acorn PharmaTech Product List|AKos Consulting & Solutions|Ambinter|ASINEX|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|ICCB-Longwood Screening Facility, Harvard Medical School|LabNetwork, a WuXi AppTec Company|Life Chemicals|Mcule|MLSMR|MolPort|MuseChem|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|Specs|UW Madison, Small Molecule Screening Facility|V",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
961974,N-Ethyl-4-[(methylsulfonyl)amino]benzamide,N-ethyl-4-[(methylsulfonyl)amino]benzamide|N-ethyl-4-(methanesulfonamido)benzamide|SCHEMBL11949250|HMS1596F17|ZINC571921|STL102382|AKOS000377493|MCULE-6357224460|824974-96-1|SR-01000283574|SR-01000283574-1|VWY,242.300,C10H14N2O3S,83.600,327.000,0.500,16,2,4,4,"InChI=1S/C10H14N2O3S/c1-3-11-10(13)8-4-6-9(7-5-8)12-16(2,14)15/h4-7,12H,3H2,1-2H3,(H,11,13)",CCNC(=O)C1=CC=C(C=C1)NS(=O)(=O)C,GWMALJVYSHCCNB-UHFFFAOYSA-N,N-ethyl-4-(methanesulfonamido)benzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Patents,3,1949|485350|485395|492967|493033|504770|540299|588519|602314|651828|720641|720717|1224905|1259310|1259374|1259422,20050709,"ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BenchChem|Chem-Space.com Database|ChemBridge|ChemDB|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|Google Patents|IBM|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MolPort|NCBI Structure|NextBio|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Southern Research Institute|SureChEMBL|The Scripps Research Institute Molecular Screening Center|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
971791,"N-(2-Methoxy-5-methylphenyl)-N'-4H-1,2,4-triazol-4-ylurea","N-(2-methoxy-5-methylphenyl)-N'-4H-1,2,4-triazol-4-ylurea|MLS000537682|VZS|CHEMBL1490395|1-(2-methoxy-5-methylphenyl)-3-(1,2,4-triazol-4-yl)urea|HMS2414B03|ZINC611720|STK461115|AKOS003349823|MCULE-6163740456|SMR000143874|ST50850206|SR-01000279036|SR-01000279036-1|1-(2-methoxy-5-methylphenyl)-3-(4H-1,2,4-triazol-4-yl)urea|N-(2-methoxy-5-methylphenyl)(1,2,4-triazol-4-ylamino)carboxamide|708236-68-4",247.250,C11H13N5O2,81.100,283.000,0.800,18,2,4,3,"InChI=1S/C11H13N5O2/c1-8-3-4-10(18-2)9(5-8)14-11(17)15-16-6-12-13-7-16/h3-7H,1-2H3,(H2,14,15,17)",CC1=CC(=C(C=C1)OC)NC(=O)NN2C=NN=C2,WMVVWYCMGLIOCC-UHFFFAOYSA-N,"1-(2-methoxy-5-methylphenyl)-3-(1,2,4-triazol-4-yl)urea",NULL,Biological Test Results|Biomolecular Interactions and Pathways,2,583|598|602|618|619|620|629|630|631|633|639|640|648|687|690|693|696|697|701|704|707|710|717|719|720|727|729|731|736|738|739|740|748|750|757|758|759|760|761|764|775|777|778|781|782|793|796|797|798|799|800|802|803|804|808|817|818|819|827|828|834|836|841|845|848|853|861|862|868|871|873|878|880|881|894|898|901|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1024|1025|1027|1030|1032|1040|1046|1049|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|,20050709,"ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|The Scripps Research Institute Molecular Screening Center|TimTec|UW Madison, Small Molecule Screening Facility|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1072430,2-Cyclohexyl-N-(3-pyridyl)acetamide,2-cyclohexyl-N-(3-pyridyl)acetamide|2-cyclohexyl-~{N}-pyridin-3-yl-ethanamide|2-cyclohexyl-N-pyridin-3-ylacetamide|Cambridge id 6752661|Oprea1_132259|HMS1691L22|ZINC780041|STK144980|AKOS003299206|MCULE-4312991087|2-cyclohexyl-N-(pyridin-3-yl)acetamide|ST062631|431907-04-9,218.290,C13H18N2O,42.000,224.000,3.100,16,1,2,3,"InChI=1S/C13H18N2O/c16-13(9-11-5-2-1-3-6-11)15-12-7-4-8-14-10-12/h4,7-8,10-11H,1-3,5-6,9H2,(H,15,16)",C1CCC(CC1)CC(=O)NC2=CN=CC=C2,SIURWXONEBYXJD-UHFFFAOYSA-N,2-cyclohexyl-N-pyridin-3-ylacetamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways,2,463173|485350|485395|493033|504770|540299|588519|602314|720641|720717|1159537|1224905|1259354,20050710,"ABI Chem|AKos Consulting & Solutions|ASINEX|Aurora Fine Chemicals LLC|BenchChem|Chem-Space.com Database|ChemBank|ChemBridge|ChemDB|ChemSpider|Collaborative Drug Discovery, Inc.|DiRusso Lab, Biochemistry Department, University of Nebraska|DiscoveryGate|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MolPort|NCBI Structure|NextBio|Paczesny and Yang Labs, IUPUI and University of Michigan|Protein Data Bank in Europe (PDBe)|TimTec|University of Kansas High Throughput Screening Laboratory|Vitas-M L",Chemical Vendors|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
1487531,N-[4-(2-Pyrimidinyloxy)phenyl]acetamide,N-[4-(2-pyrimidinyloxy)phenyl]acetamide|24550-10-5|N-[4-(pyrimidin-2-yloxy)phenyl]acetamide|N-{4-[(pyrimidin-2-yl)oxy]phenyl}acetamide|O0S|N-(4-pyrimidin-2-yloxyphenyl)acetamide|Oprea1_692558|MLS000540571|CHEMBL1588383|HMS2309E21|ZINC1401994|MFCD01443791|AKOS005103315|CCG-316477|MCULE-6363709677|SMR000125829|8N-008|Z54571979,229.230,C12H11N3O2,64.099,246.000,1.200,17,1,4,3,"InChI=1S/C12H11N3O2/c1-9(16)15-10-3-5-11(6-4-10)17-12-13-7-2-8-14-12/h2-8H,1H3,(H,15,16)",CC(=O)NC1=CC=C(C=C1)OC2=NC=CC=N2,DXVKZDBYLFVMFB-UHFFFAOYSA-N,N-(4-pyrimidin-2-yloxyphenyl)acetamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Biological Test Results: Micromolar,3,568|583|598|602|618|619|620|629|630|631|633|639|640|648|687|689|690|693|696|697|701|704|707|710|717|719|720|727|729|731|736|738|739|740|748|750|757|758|759|760|761|764|775|777|778|781|782|793|796|797|798|799|800|802|803|804|808|817|818|819|827|828|834|836|841|845|848|853|861|862|868|871|873|878|880|881|894|898|901|920|932|940|950|951|952|1001|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1024|1025|1027|1029|1030|1032|1040|1046|1049|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|12,20050711,"abcr GmbH|ABI Chem|AKos Consulting & Solutions|Ambinter|BenchChem|BLD Pharm|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChemBank|ChEMBL|ChemDB|Collaborative Drug Discovery, Inc.|DiscoveryGate|Enamine|ICCB-Longwood Screening Facility, Harvard Medical School|Key Organics/BIONET|King Scientific|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|UW Madison, Small Molecule Screening Facility|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2734675,2-Fluoro-4-hydroxybenzonitrile,"2-Fluoro-4-hydroxybenzonitrile|82380-18-5|4-Cyano-3-fluorophenol|3-fluoro-4-cyanophenol|2-fluoro-4-benzonitrile|BENZONITRILE, 2-FLUORO-4-HYDROXY-|4-Hydroxy-2-fluorobenzonitrile|MFCD00192177|2-fluoro-4-hydroxybenzenecarbonitrile|2-FLUORO-4-HYDROXYBENZONITRILE (4-CYANO-3-FLUOROPHENOL)|2-fluoro-4-hydroxy-benzonitrile|8H8|PubChem2610|PubChem3495|4wh7|ACMC-209pol|fluoro-4-hydroxybenzonitrile|2-fluoro4-hydroxybenzonitrile|SCHEMBL176946|4-hydroxy-2-fluoro-benzonitrile|6-fluoro-4-hydroxy benzonitrile|2-Fluoro-4-hyd",137.110,C7H4FNO,44.000,162.000,1.400,10,1,3,0,"InChI=1S/C7H4FNO/c8-7-3-6(10)2-1-5(7)4-9/h1-3,10H",C1=CC(=C(C=C1O)F)C#N,REIVHYDACHXPNH-UHFFFAOYSA-N,2-fluoro-4-hydroxybenzonitrile,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active,8,977608,20050719,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|AN PharmaTech|Angene Chemica",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2757014,5-Bromo-2-hydroxybenzonitrile,"5-Bromo-2-hydroxybenzonitrile|40530-18-5|2-Hydroxy-5-bromobenzonitrile|4-Bromo-2-cyanophenol|MFCD00143428|Benzonitrile, 5-bromo-2-hydroxy-|GNM9XBK3UN|UNII-GNM9XBK3UN|5-BROMOSALICYLONITRILE|5-bromo-2-hydroxy-benzonitrile|BUTTPARK 20\\02-76|5-bromo-2-hydroxybenzenecarbonitrile|UUJ|EINECS 254-958-1|5-bromosalicylnitrile|PubChem3782|ACMC-1APUZ|5-bromohydroxybenzonitrile|SCHEMBL247900|CHEMBL2323844|TIMTEC-BB SBB040157|Benzonitrile,5-bromo-2-hydroxy-|DTXSID60193563|ACT02945|EBD47831|ZINC2516785|AKOS BBS-00003099|A",198.020,C7H4BrNO,44.000,162.000,2.800,10,1,2,0,"InChI=1S/C7H4BrNO/c8-6-1-2-7(10)5(3-6)4-9/h1-3,10H",C1=CC(=C(C=C1Br)C#N)O,PVCONXMDUZOPJH-UHFFFAOYSA-N,5-bromo-2-hydroxybenzonitrile,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,728444|1259325|1272365,20050719,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Ar",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2777223,2-(Trifluoromethoxy)benzoic acid,"2-(Trifluoromethoxy)benzoic acid|1979-29-9|150436-84-3|o-trifluoromethoxybenzoic acid|MFCD00052325|alpha,alpha,alpha-Trifluoro-o-anisic Acid|RARECHEM AL BO 0449|K2P|PubChem4587|ACMC-209f2a|2-trifluoromethoxybenzoic acid|SCHEMBL219675|2-trifluoromethoxy benzoic acid|2-(trifluoromethoxy)-benzoic acid|ZINC167135|ACT12083|ANW-23792|Benzoic acid, 2-(trifluoromethoxy)-|SBB064323|STL195579|AKOS005254634|AC-4013|AS00955|AS01912|CM12886|CS-W015345|DS-1079|MCULE-3664743205|PS-8083|TF10377|VZ23338|2-(Trifluoromethoxy)",206.120,C8H5F3O3,46.500,214.000,2.800,14,1,6,2,"InChI=1S/C8H5F3O3/c9-8(10,11)14-6-4-2-1-3-5(6)7(12)13/h1-4H,(H,12,13)",C1=CC=C(C(=C1)C(=O)O)OC(F)(F)F,JMYSPFGUBNENSE-UHFFFAOYSA-N,2-(trifluoromethoxy)benzoic acid,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20050719,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemica|Achemo Scientific Limited|Achemtek|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Aromsyn catalogue|Assemb",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2779749,"1,2-Benzisoxazol-3-amine","1,2-Benzisoxazol-3-amine|36216-80-5|Benzo[d]isoxazol-3-amine|1,2-benzoxazol-3-amine|3-Amino-1,2-benzisoxazole|Benzo[d]isoxazol-3-ylamine|1,2-Benzoisoxazol-3-amine|benzo[d]isoxazole-3-ylamine|1,2-Benzisoxazol-3-amine, 97%|aminobenzisoxazole|amino-benzoisoxazole|zlchem 93|3-Aminobenzisoxazole|iminobenzisoxazolidine|PubChem14511|benzo[d]isoxazol-3-yl-amine|SCHEMBL52685|DTXSID30381536|ZLB0082|HMS1655N17|ZINC161908|ACT05775|ALBB-006860|ANW-52284|BBL005406|MFCD03407353|SBB040079|STK506282|AKOS000265417|1,2-benzis",134.140,C7H6N2O,52.000,129.000,1.400,10,1,3,0,"InChI=1S/C7H6N2O/c8-7-5-3-1-2-4-6(5)10-9-7/h1-4H,(H2,8,9)",C1=CC=C2C(=C1)C(=NO2)N,NLMVYUBGWZWUGB-UHFFFAOYSA-N,"1,2-benzoxazol-3-amine",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,608|1033|1549|1552|1637|1648|2842|485350|485395|493033|504770|540299|588519|651828|720641|720717|1159607|1224905|1259397|1259398|1259423|1272365,20050719,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
2815672,N-[(4-Cyanophenyl)methyl]morpholine-4-carboxamide,N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide|JGG|Maybridge2_000042|MLS001181977|CHEMBL1341300|HMS1303B20|HMS2885O21|ZINC158077|AKOS034415934|MCULE-6404504059|IDI1_001082|SMR000567662|SR-01000003491|SR-01000003491-1|720663-80-9,245.280,C13H15N3O2,65.400,322.000,0.400,18,1,3,2,"InChI=1S/C13H15N3O2/c14-9-11-1-3-12(4-2-11)10-15-13(17)16-5-7-18-8-6-16/h1-4H,5-8,10H2,(H,15,17)",C1COCCN1C(=O)NCC2=CC=C(C=C2)C#N,ZXWAHHRBFVCEAR-UHFFFAOYSA-N,N-[(4-cyanophenyl)methyl]morpholine-4-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Biological Test Results: Active|Biological Test Results: Micromolar,5,1490|1511|1527|1529|1530|1531|1554|1556|1565|1566|1578|1621|1654|1656|1662|1663|1672|1700|1706|1721|1722|1766|1768|1777|1778|1779|1789|1800|1813|1814|1817|1822|1825|1832|1845|1850|1861|1863|1868|1875|1885|1899|1903|1906|1910|1947|1950|1961|1962|1974|1979|1984|1986|1987|1996|2006|2012|2013|2014|2016|2023|2025|2029|2052|2057|2058|2066|2071|2073|2094|2097|2098|2099|2100|2101|2129|2130|2156|2174|2177|2216|2221|2227|2234|2235|2237|2239|2247|2280|2288|2289|2300|2314|2315|2326|2380|2391|2435|2445|2451|2462|2472|25,20050719,"ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BenchChem|ChemBank|ChEMBL|ChemDB|ChemExper Chemical Directory|ChemSpider|Collaborative Drug Discovery, Inc.|DiscoveryGate|ICCB-Longwood Screening Facility, Harvard Medical School|Mcule|MLSMR|MolPort|NCBI Structure|NextBio|Protein Data Bank in Europe (PDBe)|The Scripps Research Institute Molecular Screening Center|UW Madison, Small Molecule Screening Facility|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3002977,Maraviroc,"Maraviroc|376348-65-1|Selzentry|Celsentri|UK-427857|UK-427,857|UK 427857|UNII-MD6P741W8A|MD6P741W8A|CHEMBL256907|MVC|CHEMBL1201187|CHEBI:63608|4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide|NCGC00183109-02|4,4-difluoro-N-((1S)-3-((1R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexane-1-carboxamide|Celsentri(TM)|Selzentry(TM)|[3H]maraviroc|4,4-difluo",513.700,C29H41F2N5O,63.000,751.000,5.100,37,1,6,8,"InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1",CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,GSNHKUDZZFZSJB-HLMSNRGBSA-N,"4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide",Maraviroc,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,249028|250714|250740|270500|270503|270504|270506|320901|320902|320903|320904|320905|393050|393051|393052|393053|393054|393056|395483|395484|395485|395486|395488|395489|395490|395491|395492|397744|397746|449003|465010|465011|479402|479416|499095|499096|499097|499098|499099|499100|499101|499102|554055|554056|554058|554060|554132|554134|554135|554136|554137|554139|554140|554141|554142|554143|554144|554145|554146|554147|554148|554149|554150|554151|554152|554162|554163|579722|602332|624030|624170|624172|624173|6,20050801,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AbMole Bioscience|Achemtek|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Apexmol|AvaChem Scientific|BindingDB|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|CAPOT|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3033819,Azithromycin dihydrate,"AZITHROMYCIN DIHYDRATE|117772-70-0|Vinzam|Toraseptol|Azithromycin (hydrate)|Azitro|UNII-5FD1131I7S|XZ-450|5FD1131I7S|117772-70-0 (dihydrate)|Azitromax|Misultina|Tromix|CP-62,993|(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one dihydrate|Azadose|Ribotrex|Ultreon|Zenstav",785.000,C38H76N2O14,182.000,1150.000,NULL,54,7,16,7,"InChI=1S/C38H72N2O12.2H2O/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28;;/h20-33,35,41-43,45-46H,15-19H2,1-14H3;2*1H2/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-;;/m1../s1",CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O.O,SRMPHJKQVUDLQE-KUJJYQHYSA-N,"(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one;dihydrate",Azithromycin,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing,9,NULL,20050808,"AbaChemScene|ABI Chem|AbovChem LLC|Acorn PharmaTech Product List|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|ApexBio Technology|Aurora Fine Chemicals LLC|BioCrick|BLD Pharm|Boerchem|ChEBI|Chem-Space.com Database|Chembase.cn|Chemenu Inc.|ChemIDplus|ChemMol|ChemSpider|Combi-Blocks|CSNpharm|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Hangzhou APIChem Technology|iChemical Technology USA Inc|ISpha",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3033924,Levofloxacin Hemihydrate,"Levofloxacin Hemihydrate|138199-71-0|Levofloxacin hydrate|UNII-6GNT3Y5LMF|6GNT3Y5LMF|Levaquin (TN)|Dynaquin|(S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hemihydrate|RWJ 25213|MFCD07772024|C18H20FN3O4|Levofloxacin (USP)|Quixin (TN)|LVFX|Iquix (TN)|(s)-(-)-ofloxacine|(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hydrate (2:1)|Levofloxacin hydrate (JP17)|SCHEMB",740.700,C36H42F2N6O9,148.000,634.000,NULL,53,3,17,4,"InChI=1S/2C18H20FN3O4.H2O/c2*1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21;/h2*7-8,10H,3-6,9H2,1-2H3,(H,24,25);1H2/t2*10-;/m00./s1",C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.O,SUIQUYDRLGGZOL-RCWTXCDDSA-N,"(2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;hydrate",Levofloxacin,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,8,NULL,20050808,"3WAY PHARM INC|Aaron Chemicals LLC|abcr GmbH|ABI Chem|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Aurora Fine Chemicals LLC|BePharm Ltd.|BioCrick|BLD Pharm|Changzhou Highassay Chemical Co., Ltd|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|ChemTik|CSNpharm|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|ISphar",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3062316,Dasatinib,"Dasatinib|302962-49-8|Sprycel|BMS-354825|BMS 354825|BMS354825|Dasatinib anhydrous|Dasatinib (anhydrous)|N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE|Dasatinib (BMS-354825)|N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide|N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide|anh. dasatinib|UNII",488.000,C22H26ClN7O2S,135.000,642.000,3.600,33,3,9,7,"InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)",CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,"N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide",Dasatinib,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1433|1471|1490|1688|1766|1768|2528|2546|2551|2662|271945|271946|271947|271950|271951|271954|271967|271968|271970|271971|271972|271973|282221|282222|282223|282224|282225|282226|282227|282228|282229|282230|282231|282232|282233|282234|282235|282236|282237|282238|282239|282240|282241|282242|282243|282244|282245|282246|282247|282248|282249|282250|282251|282252|282253|282254|282255|282256|282257|282258|282259|282260|282261|282262|282263|282264|282265|282266|303305|303306|303307|303308|303309|329181|329182|329183|,20050809,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|Amb",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
3163396,6-Methyl-1H-indole-2-carboxylic acid,"6-Methyl-1H-indole-2-carboxylic acid|18474-59-4|6-Methylindole-2-carboxylic acid|1H-Indole-2-carboxylicacid, 6-methyl-|CHEMBL596007|4BL|SCHEMBL1144688|DTXSID70390349|HMS1630E02|ACT09171|ALBB-032679|AMY40742|ZINC2582714|ANW-48397|BBL020943|BDBM50305666|MFCD02664477|SBB010573|STK893649|AKOS000118128|FS-2410|MCULE-8264158205|SB15196|NCGC00337851-01|AB0001750|6-METHYL-1H-INDOLE-2-CARBOXYLICACID|BB 0216437|CS-0018975|FT-0677786|ST50294005|W3994|EN300-15104|S-5444|AB01329949-02|6-Methyl-1H-indole-2-carboxylic aci",175.180,C10H9NO2,53.100,217.000,2.700,13,2,2,1,"InChI=1S/C10H9NO2/c1-6-2-3-7-5-9(10(12)13)11-8(7)4-6/h2-5,11H,1H3,(H,12,13)",CC1=CC2=C(C=C1)C=C(N2)C(=O)O,ZKGSVVHFMZASJS-UHFFFAOYSA-N,6-methyl-1H-indole-2-carboxylic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,7,453509|453680|485350|485395|492967|493033|504770|540299|588519|720641|720717|1224905|1347041|1347165|1439857,20050810,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Achemtek|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Anward|Apexmol|Ark Pharm, Inc.|ASINEX|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharm",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3282410,1-[4-(2-Fluorophenyl)sulfonylpiperazin-1-yl]ethanone,Oprea1_040566|1-[4-(2-fluorophenyl)sulfonylpiperazin-1-yl]ethanone|SCHEMBL18711918|AKOS001386648|MCULE-5592491485|AB00028311-01|941208-22-6,286.320,C12H15FN2O3S,66.100,427.000,0.400,19,0,5,2,"InChI=1S/C12H15FN2O3S/c1-10(16)14-6-8-15(9-7-14)19(17,18)12-5-3-2-4-11(12)13/h2-5H,6-9H2,1H3",CC(=O)N1CCN(CC1)S(=O)(=O)C2=CC=CC=C2F,IMFVSIUUYBHKNQ-UHFFFAOYSA-N,1-[4-(2-fluorophenyl)sulfonylpiperazin-1-yl]ethanone,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20050906,ABI Chem|AKos Consulting & Solutions|Aurora Fine Chemicals LLC|BenchChem|ChemBank|ChemDB|ChemSpider|DiscoveryGate|Mcule|MolPort|NextBio|Protein Data Bank in Europe (PDBe)|Southern Research Institute|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
3777159,"2-Amino-2-hydroxymethyl-propane-1,3-diol","Htris|2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL|1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium|tris(hydroxymethyl)amino methane|3nm6|Ammoniotris(hydroxymethyl)methane|CHEBI:46097|(1,3-dihydroxy-2-hydroxymethyl-2-propyl)ammonium|Q27104562",122.140,C4H12NO3+,88.300,54.000,-2.900,8,4,3,3,"InChI=1S/C4H11NO3/c5-4(1-6,2-7)3-8/h6-8H,1-3,5H2/p+1",C(C(CO)(CO)[NH3+])O,LENZDBCJOHFCAS-UHFFFAOYSA-O,"[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azanium",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active,7,977611,20050911,"A&J Pharmtech CO., LTD.|ABI Chem|Ambinter|Aurora Fine Chemicals LLC|BioCyc|ChEBI|ChemDB|ChemSpider|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Google Patents|Innovapharm|Japan Chemical Substance Dictionary (Nikkaji)|MuseChem|NCBI Structure|NextBio|NextMove Software|NovoSeek|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Shanghai Institute of Organic Chemistry|SMID|Thomson Pharma|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
4369359,Sitagliptin,"Sitagliptin|486460-32-6|Januvia|Xelevia|MK-0431|(R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE|UNII-QFP0P1DV7Z|Tesavel|LEZ763|QFP0P1DV7Z|Sitagliptan|(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE|(3R)-3-AMINO-1-[3-(TRIFLUOROMETHYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE|(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7",407.310,C16H15F6N5O,77.000,566.000,0.700,28,1,10,4,"InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1",C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N,MFFMDFFZMYYVKS-SECBINFHSA-N,"(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one",Sitagliptin Phosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1811|2240|2241|2275|2313|2322|2330|273979|296027|296028|296029|296030|296031|296092|296093|296094|296095|296096|296097|296098|299379|299380|299381|299382|299383|309579|309583|309584|309585|309586|309587|309588|309589|309590|309591|309592|309593|309594|342284|342285|342289|342290|342291|343972|343973|343974|343975|349306|364560|393561|393562|393563|393564|393765|393769|418683|419062|419063|419064|419065|425652|425653|429380|434959|444050|444051|444052|444053|444054|444055|444056|444057|444058|484489|484490|4,20050624,"3A SpeedChemical Inc|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Phar",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5281040,Montelukast,"montelukast|158966-92-8|Singulair|UNII-MHM278SD3E|(R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|CHEMBL787|MHM278SD3E|CHEBI:50730|Cyclopropaneacetic acid, 1-((((1R)-1-(3-((1E)-2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)-|Montelukast [INN:BAN]|(R,E)-2-(1-(((1-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-(2-(2-hydroxypropan-2-yl)phenyl)propyl)thio)methyl)cyclopropy",586.200,C35H36ClNO3S,95.700,891.000,7.700,41,2,5,12,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,UCHDWCPVSPXUMX-TZIWLTJVSA-N,2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1195|16223|23846|55069|55076|55235|79335|79495|89083|102663|102664|102665|102799|117395|117828|205162|205163|311524|373867|425652|425653|428078|428079|428080|428143|444050|444051|444052|444053|444054|444055|444056|444057|444058|497575|497576|540209|540210|540211|540212|540213|588209|588210|588211|588212|588213|589043|624349|625144|625145|625146|625147|625148|625149|625150|625151|625152|625153|625154|625155|625156|625157|625158|625159|625160|625161|625162|625163|625164|625165|625166|625167|625168|625169|6251,20050624,"3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|Ambinter|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharma Scientific Limited|Arromax Pharmatech Co., Ltd|AstaTech, Inc.|Aurora Fine Chemicals LLC|AvaChem Scientific|Axon M",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5281605,Baicalein,"baicalein|491-67-8|5,6,7-Trihydroxyflavone|5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one|Noroxylin|5,6,7-trihydroxy-2-phenylchromen-4-one|BaiKalein|MFCD00017459|Baicelein|UNII-49QAH60606|NSC661431|CHEMBL8260|4H-1-Benzopyran-4-one, 5,6,7-trihydroxy-2-phenyl-|CHEBI:2979|49QAH60606|NSC-661431|5,7-Trihydroxyflavone|Biacalein|Sho-saiko-to|SMR000112462|SR-01000597499|NSC 661431|Baicalein, 8|Baicalein,(S)|3WL|Baicalein, 14|Baicalein, 98%|Spectrum_000427|Tocris-1761|SpecPlus_000758|5,6,7-trihydroxy-2-phenyl-chromen-4-",270.240,C15H10O5,87.000,413.000,1.700,20,3,5,1,"InChI=1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7,17-19H",C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O,FXNFHKRTJBSTCS-UHFFFAOYSA-N,"5,6,7-trihydroxy-2-phenylchromen-4-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,179|381|382|388|410|411|445|447|448|450|451|526|530|584|585|587|588|589|590|591|592|593|594|595|596|597|603|605|607|608|662|875|880|881|883|884|885|886|887|889|891|892|893|894|899|900|901|902|910|912|923|924|926|927|930|938|940|995|1030|1033|1204|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1490|1519|1549|1552|1637|1648|1766|1768|1851|1865|1948|2016|2023|2025|2029|2052|2066|2101|2107|2112|2147|2280|2380|2435|2445|2451|2472|2517|2520|2521|2524|2528|2540|2544|2546|2549|2551|,20040916,"001Chemical|3B Scientific (Wuhan) Corp|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
5282448,Fondaparinux,"Fondaparinux|Natural heparin pentasaccharide|104993-28-4|Arixtra|UNII-J177FOW5JL|CHEBI:61033|J177FOW5JL|TRISULFOAMINO HEPARIN PENTASACCHARIDE|a-D-Glucopyranoside, methylO-2-deoxy-6-O-sulfo-2-(sulfoamino)-a-D-glucopyranosyl-(14)-O-b-D-glucopyranuronosyl-(14)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-a-D-glucopyranosyl-(14)-O-2-O-sulfo-a-L-idopyranuronosyl-(14)-2-deoxy-2-(sulfoamino)-, 6-(hydrogen sulfate)|methyl 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1->4)-beta-D-glucopyranuronosyl-(1->4)-2-d",1508.300,C31H53N3O49S8,873.000,3450.000,-14.700,91,19,52,30,"InChI=1S/C31H53N3O49S8/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68)/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22-,23+",CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O,KANJSNBRCNMZMV-ABRZTLGGSA-N,"(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxyoxan-3-yl]oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid",Fondaparinux,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,13,1346098,20051011,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|BindingDB|BLD Pharm|BOC Sciences|Center for Chemical Genomics, University of Michigan|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Comparative Toxicogenomics Database (CTD)|CSNph",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5284360,Camostat mesylate,Camostat mesylate|camostat mesilate|59721-29-8|Camostat (mesylate)|Camostat Methanesulfonate|camostate|Foipan|FOY 305|Camostat methanesulfate|4-(2-(2-(dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate methanesulfonate|MFCD00941410|UNII-451M50A1EQ|Camostat mesilate;FOY305;FOY-S980|DSSTox_CID_238|DSSTox_RID_75452|DSSTox_GSID_20238|4-[[4-[(Aminoiminomethyl)amino]benzoyl]oxy]benzeneacetic Acid 2-(Dimethylamino)-2-oxoethyl Ester Methanesulfonate|C21H26N4O8S|CHEMBL85164|methanesulfonic acid 4-{2-[,494.500,C21H26N4O8S,200.000,695.000,NULL,34,3,9,9,"InChI=1S/C20H22N4O5.CH4O3S/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22;1-5(2,3)4/h3-10H,11-12H2,1-2H3,(H4,21,22,23);1H3,(H,2,3,4)",CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O,FSEKIHNIDBATFG-UHFFFAOYSA-N,[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate;methanesulfonic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,11,1189|1208|10927|48205|52321|66493|95186|95187|157534|158322|211753|215921|588834|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|7430,20051120,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Amadis Chemical|Ambeed|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Apexmol|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BioChemPartner|Biocore|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Burnham Center for Chemical Genomi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5303089,"(3-Methyl-2,4-dioxo-3,4-dihydroquinazolin-1(2H)-yl)acetic acid","(3-methyl-2,4-dioxo-3,4-dihydroquinazolin-1(2H)-yl)acetic acid|869947-94-4|2-(3-Methyl-2,4-dioxo-3,4-dihydroquinazolin-1(2H)-yl)acetic acid|2-(3-methyl-2,4-dioxo-1,3-dihydroquinazolinyl)acetic acid|2-(3-methyl-2,4-dioxoquinazolin-1-yl)acetic acid|ALBB-025272|ZINC4769777|MFCD07022104|SBB072251|STK664090|AKOS003395559|MCULE-2964241202|LS-08464|ST086822|R9515|1(2H)-quinazolineacetic acid, 3,4-dihydro-3-methyl-2,4-dioxo-|1-Quinazolineacetic acid, 1,2,3,4-tetrahydro-3-methyl-2,4-dioxo-|2-(3-methyl-2,4-dioxo-1,2,",234.210,C11H10N2O4,77.900,369.000,0.400,17,1,4,2,"InChI=1S/C11H10N2O4/c1-12-10(16)7-4-2-3-5-8(7)13(11(12)17)6-9(14)15/h2-5H,6H2,1H3,(H,14,15)",CN1C(=O)C2=CC=CC=C2N(C1=O)CC(=O)O,CUELILSJQNHUOS-UHFFFAOYSA-N,"2-(3-methyl-2,4-dioxoquinazolin-1-yl)acetic acid",NULL,Drug and Medication Information,1,NULL,20051130,"abcr GmbH|ABI Chem|AKos Consulting & Solutions|Alinda Chemical|Ambinter|Angene Chemical|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|ChemBlock|Chemenu Inc.|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|Combi-Blocks|DiscoveryGate|Key Organics/BIONET|Matrix Scientific|Mcule|MolPort|NextBio|NIST Mass Spectrometry Data Center|Oakwood Products|TimTec|Vitas-M Laboratory|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5311180,Nafamostat mesylate,Nafamostat mesylate|82956-11-4|Futhan|nafamostat mesilate|FUT-175|Nafamostat (mesylate)|6-amidino-2-naphthyl 4-guanidino-benzoate dimethanesulphonate|6-Carbamimidoylnaphthalen-2-yl 4-guanidinobenzoate dimethanesulfonate|Nafamstat|Nafamostat Mesylate(FUT-175)|UNII-1D2T74921W|6-[amino(imino)methyl]-2-naphthyl 4-{[amino(imino)methyl]amino}benzoate dimethanesulfonate|Nafamostat mesylate (USAN)|Nafamstat Mesilate|(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate;methanesulfonic acid|6-Amidino-,539.600,C21H25N5O8S2,266.000,645.000,NULL,36,6,10,5,"InChI=1S/C19H17N5O2.2CH4O3S/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23;2*1-5(2,3)4/h1-10H,(H3,20,21)(H4,22,23,24);2*1H3,(H,2,3,4)",CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,SRXKIZXIRHMPFW-UHFFFAOYSA-N,(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate;methanesulfonic acid,NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,1259318|1259389|1347080|1409594|1409598|1409599|1409600|1409601|1508586,20051220,"001Chemical|3B Scientific (Wuhan) Corp|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Angel Pharmatech Ltd.|Apexmol|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|AvaChem Scientific|BioChemPartner|Biocore|BioCrick|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5481350,Tenofovir disoproxil,Tenofovir disoproxil|201341-05-1|PMPA prodrug|Bis(POC)PMPA|Tenofovir (Disoproxil)|UNII-F4YU4LON7I|9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine|Tenofovir Disoproxil Fumarate|F4YU4LON7I|tenofovir bis(isopropyloxycarbonyloxymethyl) ester|CHEBI:63717|Tenofovirdisoproxil|(R)-(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl bis(carbonate)|bis({[(propan-2-yloxy)carbonyl]oxy}methyl) ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]o,519.400,C19H30N5O10P,185.000,698.000,1.600,35,1,14,17,"InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1",C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,JFVZFKDSXNQEJW-CQSZACIVSA-N,[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate,Tenofovir,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,392536|520604|520605|520606|749425|749428|749430|749432|749434|749435|749436|749438|749439|749440|749441|749442|749443|749444|749445|749446|749447|1259416|1259421|1409598,20050801,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|AN PharmaTech|AOBIOUS INC|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
5493444,Aliskiren,"Aliskiren|173334-57-1|Rasilez|Tekturna|SPP100|SPP 100|Aliskiren(CGP 60536)|Enviage|Riprazo|Sprimeo|UNII-502FWN4Q32|Aliskiren fumarate|CHEMBL1639|CHEBI:601027|502FWN4Q32|CGP 60536|(2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide|(2S,4S,5S,7S)-5-AMINO-N-(2-CARBAMOYL-2-METHYLPROPYL)-4-HYDROXY-2-ISOPROPYL-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-8-METHYLNONANAMIDE|Benzeneoctanamide, delta-amino-N-(3-amino-2,2-di",551.800,C30H53N3O6,146.000,717.000,3.500,39,4,7,19,"InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1",CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,UXOWGYHJODZGMF-QORCZRPOSA-N,"(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,350855|353146|371780|371781|371790|434000|434001|434151|434152|434153|452689|452690|452691|452692|452693|452694|452695|452696|452697|452706|452709|452710|452711|452712|452713|452714|452717|537695|537702|537703|537713|537726|537727|537728|551763|551764|601098|602332|608695|624030|624170|624172|624173|625279|625280|625281|625282|625283|625284|625285|625286|625287|625288|625289|625290|625291|625292|660349|660350|660351|690521|690524|743344|743345|743346|743347|1118627|1118628|1118629|1118630|1159580|1193304|11,20050809,"3WAY PHARM INC|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Alinda Chemical|Alsachim|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per WikiPathways]"
5702220,Bromhexine hydrochloride,"Bromhexine hydrochloride|611-75-6|Bromhexine HCl|Auxit|Bromohexine hydrochloride|Bromhexine (hydrochloride)|Broncokin|Viscolyt|2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrochloride|Bromhexine chloride|UNII-YC2ZOM3Z8V|Bromohexine monohydrochloride|MFCD00056626|NA 274|YC2ZOM3Z8V|C14H21Br2ClN2|CHEBI:31303|611-75-6 (HCl)|NCGC00095005-01|2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzylamine hydrochloride|2-Amino-N-cyclohexyl-3,5-dibromo-N-methylbenzylamine hydrochloride|N-(2-Amino-3,5-dibromobenzyl",412.590,C14H21Br2ClN2,29.300,256.000,NULL,19,2,2,3,"InChI=1S/C14H20Br2N2.ClH/c1-18(12-5-3-2-4-6-12)9-10-7-11(15)8-13(16)14(10)17;/h7-8,12H,2-6,9,17H2,1H3;1H",CN(CC1=C(C(=CC(=C1)Br)Br)N)C2CCCCC2.Cl,UCDKONUHZNTQPY-UHFFFAOYSA-N,"2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline;hydrochloride",Bromhexine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,13,875|880|881|884|885|887|889|892|893|894|900|902|910|923|924|927|930|940|995|1030|1379|1422|1452|1454|1457|1458|1460|1463|1467|1468|1469|1471|1476|1477|1478|1479|1487|1490|1519|1580|1581|1582|1583|1584|1585|1586|1587|1588|1589|1590|1593|1594|1595|1596|1597|1598|1599|1600|1601|1602|1603|1604|1605|1606|1607|1608|1609|1610|1612|1613|1614|1616|1688|1766|1768|1865|1948|2101|2107|2112|2147|2451|2472|2517|2528|2546|2549|2551|2662|485281|485290|485350|492961|493033|504327|504332|504749|504770|504832|504834|504847|50,20060307,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|Abe Lab, University of Texas MD Anderson Cancer Center|ABI Chem|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AN PharmaTech|Angene Chemical|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|BePharm Ltd.|BioCrick|Biosy",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6398764,Viread,"Tenofovir Disoproxil Fumarate|202138-50-9|Viread|Tenofovir DF|Tenofovir (Disoproxil Fumarate)|UNII-OTT9J7900I|OTT9J7900I|GS-4331-05|CHEBI:63718|GSK-548470|9-((R)-2-((bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate|9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine, fumarate|(R)-(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl dicarbonate fumarate|2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(",635.500,C23H34N5O14P,260.000,817.000,NULL,43,3,18,19,"InChI=1S/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t14-;/m1./s1",C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C(=C/C(=O)O)\\C(=O)O,VCMJCVGFSROFHV-WZGZYPNHSA-N,[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid,Tenofovir,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,289141|289143|289144|289145|310043|310044|310045|310047|325083|325084|325085|325086|325087|325088|325089|325090|325091|325092|325093|325094|325095|325096|325097|325098|325099|325100|325101|325102|325103|369218|416854|416855|416856|416858|416860|416861|416862|416863|541109|541129|541130|541131|541132|541133|541134|541135|541161|541162|541163|541164|541165|541166|541167|541168|541169|541170|541171|541172|541173|541174|541175|549081|549082|549083|549084|549085|549086|549087|549088|549089|572767|572768|572769|5,20060321,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|ABI Chem|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acesobio|Acorn PharmaTech Product List|Acros Organics|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|AOBIOUS INC|Apexmol|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|AvaChem Scientific|BioChemPartner|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Center for Chemical Geno",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6445562,Pelitinib,Pelitinib|257933-82-7|EKB-569|Pelitinib (EKB-569)|WAY-EKB 569|EKB 569|UNII-X5DWL380Z6|WAY-EKB-569|EKB569|(E)-N-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide|326894-84-2|(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide|C24H23ClFN5O2|X5DWL380Z6|(2E)-N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide|(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy,467.900,C24H23ClFN5O2,90.300,729.000,4.500,33,2,7,8,"InChI=1S/C24H23ClFN5O2/c1-4-33-22-12-20-17(11-21(22)30-23(32)6-5-9-31(2)3)24(15(13-27)14-28-20)29-16-7-8-19(26)18(25)10-16/h5-8,10-12,14H,4,9H2,1-3H3,(H,28,29)(H,30,32)/b6-5+",CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C,WVUNYSQLFKLYNI-AATRIKPKSA-N,(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,12,1433|7879|7892|66620|66621|69416|69431|69432|91107|164334|201868|202225|202680|202682|245771|245772|245773|245774|245775|245776|245777|247761|247801|247802|248903|248914|256559|256560|256561|256562|256563|256564|256565|256566|256567|256568|256569|256570|256571|256572|256573|256574|256575|256576|256577|256578|256579|256580|256581|256582|256583|256584|256585|256586|256587|256588|256589|256590|256591|256592|256593|256594|256595|256596|256597|256598|256599|256600|256601|256602|256603|256604|256605|256606|256607,20060429,"3WAY PHARM INC|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Ambit Biosciences|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|Bindin",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6452487,"2-(3,5-Dichlorophenyl)acetic acid","2-(3,5-dichlorophenyl)acetic acid|51719-65-4|3,5-DICHLOROPHENYLACETIC ACID|(3,5-dichlorophenyl)acetic acid|Benzeneacetic acid, 3,5-dichloro-|3,5-Dichlorobenzeneacetic acid|MFCD01764671|(3,5-Dichloro-phenyl)-acetic acid|3,5-dichlorophenylaceticacid|PubChem24116|3,5-dichlorphenylacetic acid|SCHEMBL868125|3,5-dichlorophenylacetic - acid|DTXSID20199667|Benzeneacetic acid,3,5-dichloro-|ACT09030|EBD26946|ANW-54068|CL8766|WT1618|WT1665|ZINC33986325|AKOS015848957|AB09922|CS-W004733|GS-4464|QC-7588|VZ25743|SY021382|",205.030,C8H6Cl2O2,37.300,162.000,2.600,12,1,2,2,"InChI=1S/C8H6Cl2O2/c9-6-1-5(3-8(11)12)2-7(10)4-6/h1-2,4H,3H2,(H,11,12)",C1=C(C=C(C=C1Cl)Cl)CC(=O)O,RERINLRFXYGZEE-UHFFFAOYSA-N,"2-(3,5-dichlorophenyl)acetic acid",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20060429,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alichem|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|Apexmol|Ark Pharm, Inc.|Assem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
6453528,Sulodexide,"Sulodexide|N(6),O(2)-Dimethyladenosine|57817-83-1|UNII-LEV25J2GTV|LEV25J2GTV|(2R,3R,4R,5R)-2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)purin-9-yl]oxolan-3-ol|Adenosine, N-methyl-2'-O-methyl-|Vessel|57821-29-1|zlchem 6|Glucuronylglucosamineglicane sulfate|N,2'-O-Dimethyladenosine|N6,O2'-Dimethyladenosine|n6,2'-O-dimethyladenosine|SCHEMBL665209|n6-methyl-2'-o-methyladenosine|DTXSID50206530|ZLA0007",295.290,C12H17N5O4,115.000,363.000,0.200,21,3,8,4,"InChI=1S/C12H17N5O4/c1-13-10-7-11(15-4-14-10)17(5-16-7)12-9(20-2)8(19)6(3-18)21-12/h4-6,8-9,12,18-19H,3H2,1-2H3,(H,13,14,15)/t6-,8-,9-,12-/m1/s1",CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)OC,GRYSXUXXBDSYRT-WOUKDFQISA-N,"(2R,3R,4R,5R)-2-(hydroxymethyl)-4-methoxy-5-[6-(methylamino)purin-9-yl]oxolan-3-ol",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry,7,NULL,20060429,ABI Chem|AX Molecules Inc|BLD Pharm|Chem-Space.com Database|ChemIDplus|ChemSpider|Comparative Toxicogenomics Database (CTD)|DiscoveryGate|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|MuseChem|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Smolecule|Springer Nature|SureChEMBL|THE BioTek|Thomson Pharma|ToxPlanet|Yick-Vic Chemicals & Pharmaceuticals (HK) Ltd.|zealing chemical,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918456,Prasugrel,"Prasugrel|150322-43-3|Effient|Efient|CS-747|Prasugrel (Effient)|5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate|LY640315|LY-640315|CS 747|Pcr 4099|CHEBI:87723|Prasugrel, 98%|2-[2-(Acetyloxy)-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]-1-cyclopropyl-2-(2-fluorophenyl)ethanone|5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate|5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-2-yl ",373.400,C20H20FNO3S,74.800,555.000,3.600,26,0,6,6,"InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3",CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,DTGLZDAWLRGWQN-UHFFFAOYSA-N,"[5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate",Prasugrel Hydrochloride,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,602332|624030|624170|624172|624173|651821|651957|651958|652010|652017|652039|652067|652126|652257|667513|686940|686964|687014|687016|705590|705606|705937|720508|720509|720543|720582|720596|720648|720700|720702|720704|743126|743269|743344|743345|743346|743347|743445|1053197|1117264|1117298|1117301|1117302|1117303|1117304|1117305|1117310|1117311|1117312|1117314|1117315|1117318|1159614|1179966|1179967|1186087|1215188|1215189|1215190|1215191|1215192|1215193|1215194|1224824|1224825|1224857|1224859|1224863|125925,20060728,"001Chemical|3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|ACT Chemical|Activate Scientific|Active Biopharma|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918540,Dalcetrapib,"Dalcetrapib|211513-37-0|JTT-705|Dalcetrapib (JTT-705, RO4607381)|JTT 705|RO4607381|RO-4607381|JTT705|UNII-3D050LIQ3H|S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate|3D050LIQ3H|CHEMBL313006|2-Methylpropanethioic acid S-[2-[1-(2-ethylbutyl)cyclohexylcarboxamido]phenyl] ester|S-2-(1-(2-ethylbutyl)cyclohexanecarboxamido)phenyl 2-methylpropanethioate|S-[2-({[1-(2-ethylbutyl)cyclohexyl]carbonyl}amino)phenyl] 2-methylpropanethioate|Thioisobutyric acid S-(2-{[1-(2-ethyl-butyl)-cycloh",389.600,C23H35NO2S,71.500,481.000,7.100,27,1,3,9,"InChI=1S/C23H35NO2S/c1-5-18(6-2)16-23(14-10-7-11-15-23)22(26)24-19-12-8-9-13-20(19)27-21(25)17(3)4/h8-9,12-13,17-18H,5-7,10-11,14-16H2,1-4H3,(H,24,26)",CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,YZQLWPMZQVHJED-UHFFFAOYSA-N,S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,51787|51791|51943|166506|166507|166645|166646|311047|657499|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1345084|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347080|1347159|1347160|1347162|1347411|1409598|1476688|1476690|1500886|1508586|1508598,20060728,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acesobio|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BindingDB|BioChemPartne",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918543,Almitrine mesylate,"Almitrine mesylate|Almitrine dimesylate|29608-49-9|Almitrine bismesylate|Almitrine dimethanesulfonate|Vectarion|UNII-6RY6V6XM8T|Almitrine mesylate [USAN]|6RY6V6XM8T|CHEBI:53779|6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine;methanesulfonic acid|N2,N4-Diallyl-6-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)-1,3,5-triazine-2,4-diamine dimethanesulfonate|Almitrine mesylate (USAN)|S-2620|(Diallylamino-4'-6'-triazinyl-2')-1-(bis p-fluorobenzydryl)-4 piperazine ",669.800,C28H37F2N7O6S2,195.000,694.000,NULL,45,4,15,10,"InChI=1S/C26H29F2N7.2CH4O3S/c1-3-13-29-24-31-25(30-14-4-2)33-26(32-24)35-17-15-34(16-18-35)23(19-5-9-21(27)10-6-19)20-7-11-22(28)12-8-20;2*1-5(2,3)4/h3-12,23H,1-2,13-18H2,(H2,29,30,31,32,33);2*1H3,(H,2,3,4)",CS(=O)(=O)O.CS(=O)(=O)O.C=CCNC1=NC(=NC(=N1)N2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C,MRDBGMJEPGXQHJ-UHFFFAOYSA-N,"6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine;methanesulfonic acid",Almitrine,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Biological Test Results: Active|Biological Test Results: Micromolar,10,743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|1117298|1117304|1117305|1117310|1117312|1117314|1117326|1117329|1117336|1117340|1117341|1117342|1117343|1117346|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|1159555|1159614|1224834|1224835|1224836|1224837|1224838|1224839|122,20060728,"3WAY PHARM INC|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|AvaChem Scientific|BLD Pharm|BOC Sciences|CAPOT|Changzhou Highassay Chemical Co., Ltd|ChEBI|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Clearsynth|Combi-Blocks|CSNpharm|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maa",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
6918848,(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide,AR-42|935881-37-1|OSU-HDAC42|AR 42|(S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide|(S)-HDAC-42|AR42|(S)-HDAC 42|UNII-E0GG29V0AQ|AR-42 (OSU-HDAC42)|E0GG29V0AQ|N-hydroxy-4-[[(2S)-3-methyl-2-phenylbutanoyl]amino]benzamide|N-hydroxy-4-{[(2S)-3-methyl-2-phenylbutanoyl]amino}benzamide|cc-20|MLS006011089|CHEMBL191482|OSU-42|SCHEMBL2348844|DTXSID4042678|AOB3995|N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide|AR-42 (HDAC-42)|AR-42 - HDAC-42|HMS3648K08|(S)-(+)-N-Hydroxy-4-(3-methyl-2-phenyl-butyrylami,312.400,C18H20N2O3,78.400,397.000,2.800,23,3,3,5,"InChI=1S/C18H20N2O3/c1-12(2)16(13-6-4-3-5-7-13)18(22)19-15-10-8-14(9-11-15)17(21)20-23/h3-12,16,23H,1-2H3,(H,19,22)(H,20,21)/t16-/m0/s1",CC(C)[C@@H](C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO,LAMIXXKAWNLXOC-INIZCTEOSA-N,N-hydroxy-4-[[(2S)-3-methyl-2-phenylbutanoyl]amino]benzamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,242794|248462|624476|624478|624479|651645|651646|651696|651712|651713|686947|686950|743244|743322|743323|743324|743344|743345|743346|743347|743364|743365|743366|1053194|1053195|1159510|1159511|1159512|1159513|1159530|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259325|1259357|1259358|1259359|1259360|1259361|1259362|1259374|1259389|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068,20060728,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABI Chem|AbMole Bioscience|Acesobio|Achemtek|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|Ambinter|Angene Chemical|Anward|AOBIOUS INC|ApexBio Technology|Aurum Pharmatech LLC|Axon Medchem|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|C. David Weaver Laboratory, Vanderbilt University|Center for Chemical Genomics, University of Michigan|Chan",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
9831415,Icosapent ethyl,"ethyl icosapentate|ICOSAPENT ETHYL|Eicosapentaenoic acid ethyl ester|ethyl eicosapentaenoate|Epadel|Vascepa|86227-47-6|EPA ethyl ester|Ethyl eicosapentaenoic acid|Timnodonic acid ethyl ester|cis-Eicosapentaenoic acid ethyl ester|AMR101|Ethyl icosapentate [JAN]|ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate|AMR 101|all cis-5,8,11,14,17-Eicosapentaenoic Acid Ethyl Ester|UNII-6GC8A4PAYH|Eicosapentaenoic acid, ethyl ester|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid ethyl ester|ethyl all-cis-5,8,11,14,1",330.500,C22H34O2,26.300,425.000,6.300,24,0,2,15,"InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-",CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCC(=O)OCC,SSQPWTVBQMWLSZ-AAQCHOMXSA-N,"ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing,10,624349|720641|720717|1159580|1224863|1259251|1259310|1259318|1259374|1259397|1259398|1259422|1259423|1347080|1508614,20061025,"3WAY PHARM INC|AbaChemScene|abcr GmbH|AbovChem LLC|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alsachim|Ambeed|Ambinter|AN PharmaTech|Aurora Fine Chemicals LLC|BLD Pharm|BOC Sciences|Broad Institute|Burnham Center for Chemical Genomics|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|chemical genetic matrix|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|Comparativ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9871419,Ticagrelor,"Ticagrelor|274693-27-5|Brilinta|Brilique|AZD6140|AZD-6140|AZD 6140|AR-C126532XX|UNII-GLH0314RVC|TICARGRELOR|[14C]-Ticagrelor|GLH0314RVC|C23H28F2N6O4S|CHEBI:68558|(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|(1S,2S,3R,5S)-3-[7",522.600,C23H28F2N6O4S,164.000,736.000,2.000,36,4,12,10,"InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1",CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F,OEKWJQXRCDYSHL-FNOIDJSQSA-N,"(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol",Ticagrelor,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,309606|309607|309608|309609|309610|309611|309612|309613|309614|309615|309616|661901|703441|703442|766345|766347|1061817|1061822|1061825|1061829|1061830|1061831|1061832|1061833|1061834|1061835|1061836|1061837|1061838|1061840|1061841|1186076|1186077|1186078|1186087|1222793|1296008|1296009|1298772|1314368|1345084|1345166|1346320|1346986|1346987|1347055|1347159|1347160|1409594|1409605|1462749|1462750|1479145|1479147|1479149|1479150|1508591|1508612,20061025,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acemol|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Ambeed|Ambinter|AN PharmaTech|Apexmol|Arromax Pharmatech Co., Ltd|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BePharm Ltd.|BindingDB|BioCr",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9875401,Rivaroxaban,"Rivaroxaban|366789-02-8|Xarelto|BAY 59-7939|(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide|UNII-9NDF7JZ4M3|BAY59-7939|9NDF7JZ4M3|C19H18ClN3O5S|5-Chloro-N-({(5s)-2-Oxo-3-[4-(3-Oxomorpholin-4-Yl)phenyl]-1,3-Oxazolidin-5-Yl}methyl)thiophene-2-Carboxamide|CHEBI:68579|Rivaroxaban, 98%|BAY-59-7939|5-chloro-N-{[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl}thiophene-2-carboxamide|Rivaroxaban (Xarelto)|2-Thiophenecarboxamide, 5-chloro-N-[",435.900,C19H18ClN3O5S,116.000,645.000,2.500,29,1,6,5,"InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1",C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl,KGFYHTZWPPHNLQ-AWEZNQCLSA-N,"5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide",Rivaroxaban,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,253570|253572|253589|253590|253616|253617|253691|253692|253820|253827|255023|255703|255704|256438|256439|351693|351695|527392|527393|527394|527398|527399|527407|527408|527409|527410|527412|527413|527418|527428|527433|527434|527436|527437|527438|527439|693261|693264|693265|693266|693267|693287|696047|696048|753175|753176|753177|753178|977610|1057598|1057602|1057646|1057648|1057649|1057650|1057658|1057659|1078023|1078024|1159390|1162318|1162328|1162329|1162332|1162335|1162337|1162340|1162342|1162345|1162346|1,20061025,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|AN PharmaTech|AOBIOUS INC|ApexBio Technology|Apexmol|Arromax Pharmatech Co., Ltd|Assembly Blocks Pvt. Ltd.|Ast",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9904746,Zinc Picolinate,Zinc Picolinate|17949-65-4|zinc;pyridine-2-carboxylate|UNII-ALO92O31SE|ZINCPICOLINATE|ALO92O31SE|Zinc Pyridine-2-carboxylate|zinc 2-pyridinecarboxylate|Dipicolinic acid zinc salt|C12H8N2O4Zn|SCHEMBL177833|DTXSID60170814|AKOS015918238|DB11175|H257|FT-0652546|A812451|J-011457|Q27273986,309.600,C12H8N2O4Zn,106.000,108.000,NULL,19,0,6,0,"InChI=1S/2C6H5NO2.Zn/c2*8-6(9)5-3-1-2-4-7-5;/h2*1-4H,(H,8,9);/q;;+2/p-2",C1=CC=NC(=C1)C(=O)[O-].C1=CC=NC(=C1)C(=O)[O-].[Zn+2],NHVUUBRKFZWXRN-UHFFFAOYSA-L,zinc;pyridine-2-carboxylate,NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,8,NULL,20061025,"Achemtek|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambeed|Angene Chemical|Biosynth Carbosynth|BLD Pharm|Chemenu Inc.|ChemIDplus|ChemSpider|ChemTik|Clearsynth|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Finetech Industry Limited|iChemical Technology USA Inc|ISpharm|Japan Chemical Substance Dictionary (Nikkaji)|Molepedia|MolPort|MuseChem|NextBio|NextMove Software|NORMAN Susp",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9926791,Tofacitinib,"Tofacitinib|Tasocitinib|477600-75-2|3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile|CP-690550|CP 690550|1259404-17-5|racemic-tofacitinib|rac-Tofacitinib|CP-690,550|UNII-87LA6FU830|Tofacitinib (CP-690550,Tasocitinib)|3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile|3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile|CHEMBL221959|CHEBI:71200|87L",312.370,C16H20N6O,88.900,488.000,1.500,23,1,5,3,"InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1",C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,UJLAWZDWDVHWOW-YPMHNXCESA-N,"3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1433|276239|276240|276241|276242|276243|276244|292818|292819|298726|298727|298728|298729|393824|393825|393826|393827|393828|393829|393830|393831|393832|393833|393834|393835|393836|393837|393838|393839|393840|393841|393842|393843|393997|393998|393999|394000|394001|394002|394003|394004|394005|394006|394007|394008|394009|394010|394011|394012|394013|394014|394015|394016|394017|394018|394019|394020|394021|394022|394023|394024|394025|394026|394027|394028|394029|394031|394032|394033|394034|394035|394036|394037|394,20061025,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Ambit Biosciences|Angene Chemical|Anward|AOBIOUS INC|ApexBio Technology|Apexmol|Assembly Blocks Pvt. ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
9966051,Vortioxetine,"VORTIOXETINE|508233-74-7|1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine|Brintellix|Lu AA21004|1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine|1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine|UNII-3O2K1S3WQV|Vortioxetine free base|3O2K1S3WQV|Piperazine, 1-[2-[(2,4-dimethylphenyl)thio]phenyl]-|CHEBI:76016|Trintellix|508233-74-7 (free base)|Brintellix (TN)|1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine|1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine|CHEMBL2204360|1-[2-[(2,4-Dimethylphenyl)th",298.400,C18H22N2S,40.600,316.000,4.200,21,1,3,3,"InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3",CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,YQNWZWMKLDQSAC-UHFFFAOYSA-N,"1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine",Vortioxetine,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,15,1259343|1259398|1259399|1259416|1259419|1259421|1259423|1345068|1345170|1345291|1345615|1346264|1346481|1346943|1347060|1347064|1347065|1347067|1347068|1347411|1368106|1368107|1368108|1368109|1368110|1368111|1403534|1403536|1403538|1403539|1403540|1403541|1409605|1479145|1479147|1479149|1479150,20061025,"001Chemical|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acadechem|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|Ambinter|Angel Pharmatech Ltd.|Ansion Pharma|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Block",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10000456,"1'-[2-[4-(Trifluoromethyl)phenyl]ethyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one","RS102895|RS-102895|RS 102895|1'-[2-[4-(trifluoromethyl)phenyl]ethyl]spiro[1~{H}-3,1-benzoxazine-4,4'-piperidine]-2-one|1'-[2-[4-(trifluoromethyl)phenyl]ethyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one|CID 10000456|GTPL779|SCHEMBL9972649|CHEMBL1593104|CHEBI:93458|BDBM442799|BCP05302|YWB02216|ZINC2563946|HY-18611A|CS-3487|NCGC00092306-02|RS102859|BRD-K83063356-003-01-7|Q27088628|1'-[2-[4-(Trifluoromethyl)phenyl]ethyl]-spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-one|1-(4-(Trifluoromethyl)phenethyl)spir",390.400,C21H21F3N2O2,41.600,552.000,4.300,28,1,6,3,"InChI=1S/C21H21F3N2O2/c22-21(23,24)16-7-5-15(6-8-16)9-12-26-13-10-20(11-14-26)17-3-1-2-4-18(17)25-19(27)28-20/h1-8H,9-14H2,(H,25,27)",C1CN(CCC12C3=CC=CC=C3NC(=O)O2)CCC4=CC=C(C=C4)C(F)(F)F,HIDWEYPGMLIQSN-UHFFFAOYSA-N,"1'-[2-[4-(trifluoromethyl)phenyl]ethyl]spiro[1H-3,1-benzoxazine-4,4'-piperidine]-2-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Biological Test Results: Active,7,1469|1477|1479|1490|1766|1768|2101|2107|2112|2314|2315|2451|2472|2517|2528|2546|2549|2551|485281|485290|504327|504847|588579|602332|720532|720533|1259397|1259398|1259416|1259421|1259423,20061025,"4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbovChem LLC|Acorn PharmaTech Product List|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|Angene Chemical|AOBIOUS INC|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|BindingDB|BioChemPartner|Biocore|BioCrick|Biosynth Carbosynth|BOC Sciences|Broad Institute|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemieliva P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
10074640,Masitinib,"Masitinib|790299-79-5|AB1010|Masatinib|Masitinib (AB1010)|AB-1010|Masivet|AB 1010|UNII-M59NC4E26P|Masitinib [INN]|4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide|M59NC4E26P|N-(4-Methyl-3-((4-(pyridin-3-yl)thiazol-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide|CHEMBL1908391|CHEBI:63450|Masitinib (INN)|MFCD09954132|4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)-1,3-thiazol-2-yl]amino}phenyl)benzamide|4-[(4-methylpiperaz",498.600,C28H30N6OS,102.000,696.000,4.300,36,2,7,7,"InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32)",CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,WJEOLQLKVOPQFV-UHFFFAOYSA-N,"4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,11,488908|488913|492960|624173|624392|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|624747|624748|624749|624750|624751|624752|624753|624754|624755|624756|624757|624758|624759|624760|624761|624762|624763|624764|624765|624766|6,20061025,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Accela ChemBio Inc.|Acesobio|Achemtek|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials, PDB, Protein Data Bank]"
10096344,Linagliptin,"Linagliptin|668270-12-0|Tradjenta|BI 1356|Ondero|BI-1356|Linagliptin (BI-1356)|UNII-3X29ZEJ4R2|BI-1356-BS|C25H28N8O2|ione|3X29ZEJ4R2|CHEMBL237500|CHEBI:68610|BS 1356 BS|(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione|(R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|8-[(3r)-3-Aminopiperidin-1-Yl]-7-But-2-Yn-1-Yl-3-Methyl-1-[(4-Methylquinazolin-2-Yl)methyl]-3,7-Dihydro-1h-Puri",472.500,C25H28N8O2,114.000,885.000,1.900,35,1,7,4,"InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1",CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,LTXREWYXXSTFRX-QGZVFWFLSA-N,"8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione",Linagliptin,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,304453|304454|304455|304456|304457|304458|304459|304460|304461|304462|304463|304464|304465|304466|304467|304468|304469|304470|304471|304472|304473|304474|304475|331175|614482|646406|646407|646408|646415|646420|646421|646542|646544|646546|688685|688686|688687|688688|688689|688690|688691|688693|743344|743345|743346|743347|748310|748311|748312|748313|748314|749996|1116427|1127773|1129901|1129902|1129903|1129904|1129905|1129906|1219110|1219111|1219112|1219113|1219114|1219117|1219118|1219119|1219120|1219121|1219,20061025,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2Z Chemical|AbaChemScene|ABBLIS Chemicals|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Apexmol|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynt",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10112191,"2-(2-Chloro-4-iodophenylamino)-3,4-difluorobenzoic acid","303175-44-2|2-(2-chloro-4-iodophenylamino)-3,4-difluorobenzoic acid|zapnometinib|UNII-4RZD8LK83V|4RZD8LK83V|2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic acid|PD-0184264|ATR-002|Benzoic acid, 2-[(2-chloro-4-iodophenyl)amino]-3,4-difluoro-|3,4-Difluoro-2-((2-chloro-4-iodophenyl)amino)benzoic acid|3,4-Difluoro-2-[(2-chloro-4-iodophenyl)amino]benzoic acid|Benzoic acid, 2-((2-chloro-4-iodophenyl)amino)-3,4-difluoro-|Zapnometinib [INN]|ATR002|CHEMBL481949|SCHEMBL1488782|GTPL11679|DTXSID80435811|2-((2-Chloro-4-i",409.550,C13H7ClF2INO2,49.300,363.000,5.000,20,2,5,3,"InChI=1S/C13H7ClF2INO2/c14-8-5-6(17)1-4-10(8)18-12-7(13(19)20)2-3-9(15)11(12)16/h1-5,18H,(H,19,20)",C1=CC(=C(C=C1I)Cl)NC2=C(C=CC(=C2F)F)C(=O)O,XCNBGWKQXRQKSA-UHFFFAOYSA-N,"2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic acid",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,410445,20061025,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambinter|Angene Chemical|BioChemPartner|Biocore|Biosynth Carbosynth|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemhere|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|eNovation Chemicals|EPA DSSTox|FDA/SPL Indexing Data|Finetech Industry Limited|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Japan Chemical Substance Dictionary (Nikkaji)|LabNetwork, a WuXi AppTec Company|MuseChem|Nature Chemistry|NextBio|NextMove Software|Nor",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10182969,Apixaban,"Apixaban|503612-47-3|Eliquis|BMS-562247-01|BMS-562247|BMS 562247-01|1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide|UNII-3Z9Y7UWC1J|1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide|3Z9Y7UWC1J|CHEMBL231779|1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide|CHEBI:72296|BMS562247-01|Apixaban-13C,D3|1-(4-methoxyph",459.500,C25H25N5O4,111.000,777.000,2.200,34,1,5,5,"InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)",COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,QNZCBYKSOIHPEH-UHFFFAOYSA-N,"1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Identification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,16,1811|299798|299799|302353|302354|302356|302357|302358|302359|302360|302361|302362|302364|302365|302366|302368|331785|331786|331788|331789|331790|331791|331807|351693|351695|396699|396700|396701|396705|396706|396707|396708|396709|396710|396712|458311|458312|458313|458314|527392|527393|527394|527398|527399|527407|527409|527410|527411|527419|527420|527421|527428|527430|527432|527433|527434|527435|527436|527437|527438|527439|527440|527441|527442|527443|527444|527445|743344|743345|743346|743347|977610|1180259|11,20061025,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Ansion Pharma|AOBIOUS INC|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
10324368,"(1r,2s,5s)-N-[(1s)-3-Amino-1-(Cyclobutylmethyl)-2,3-Dioxopropyl]-3-[(2s)-2-{[(Tert-Butylamino)carbonyl]amino}-3,3-Dimethylbutanoyl]-6,6-Dimethyl-3-Azabicyclo[3.1.0]hexane-2-Carboxamide","(1r,2s,5s)-N-[(1s)-3-Amino-1-(Cyclobutylmethyl)-2,3-Dioxopropyl]-3-[(2s)-2-{[(Tert-Butylamino)carbonyl]amino}-3,3-Dimethylbutanoyl]-6,6-Dimethyl-3-Azabicyclo[3.1.0]hexane-2-Carboxamide|394730-60-0|UNII-MQ2C9N3WCX|MQ2C9N3WCX|SCHEMBL583289|CHEMBL1233448|Sch 534128|Sch-534128|ZINC14210455|Q27461240|UNII-89BT58KELH component LHHCSNFAOIFYRV-ZYNAIFEFSA-N|(1R,2S,5S)-N-((1S)-3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-((2S)-2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-az",519.700,C27H45N5O5,151.000,959.000,3.100,37,4,5,10,"InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16-,17-,18-,20+/m0/s1",CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)N[C@@H](CC3CCC3)C(=O)C(=O)N)C,LHHCSNFAOIFYRV-ZYNAIFEFSA-N,"(1R,2S,5S)-N-[(2S)-4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl]-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",NULL,Biological Test Results|Chemical and Physical Properties|Classification|Drug and Medication Information|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active,11,1217440|1217441|1217442|1217496|1217497|1217498|1217499|1217500|1217501|1217502|1217503|1217504|1217505|1217506|1217507|1217533|1217534|1217550|1217551|1217552|1217554|1217555|1217556|1409598,20061025,"ApexBio Technology|ChEMBL|ChemIDplus|ChemSpider|Davey Lab, Department of Microbiology, NEIDL, Boston University|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|FDA/SPL Indexing Data|Google Patents|IBM|Japan Chemical Substance Dictionary (Nikkaji)|NextBio|NORMAN Suspect List Exchange|PATENTSCOPE (WIPO)|SCRIPDB|SureChEMBL|Thomson Pharma|Wikidata|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11338033,"4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide","AT7519|844442-38-2|AT-7519|AT 7519|4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide|UNII-X1BF92PW9T|N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide|AT7519 Hydrochloride|AT-7519 free base|4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide|X1BF92PW9T|4-[(2,6-dichlorobenzoyl)amino]-N-piperidin-4-yl-1H-pyrazole-5-carboxamide|4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide|844442-38-2 (free base),|1H-Py",382.200,C16H17Cl2N5O2,98.900,479.000,2.600,25,4,4,4,"InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)",C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl,OVPNQJVDAFNBDN-UHFFFAOYSA-N,"4-[(2,6-dichlorobenzoyl)amino]-N-piperidin-4-yl-1H-pyrazole-5-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,366144|366146|366147|366148|366149|366150|366151|366152|366153|366154|366158|366159|366161|366162|366163|366164|366165|366166|366167|366169|366170|366171|366419|366420|624392|624476|624478|624479|624702|624703|624704|624705|624706|624707|624708|624709|624710|624711|624712|624713|624714|624715|624716|624717|624718|624719|624720|624721|624722|624723|624724|624725|624726|624727|624728|624729|624730|624731|624732|624733|624734|624735|624736|624737|624738|624739|624740|624741|624742|624743|624744|624745|624746|6,20061026,"001Chemical|4C Pharma Scientific Inc|A2Z Chemical|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|BOC Sciences|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11528958,Verdiperstat,"Verdiperstat|890655-80-8|AZD3241|AZD 3241|AZD-3241|BHV-3421|UNII-TT3345YXVR|TT3345YXVR|BHV-3241|1-(2-Isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d]pyrimidin-4-one|1-[2-(propan-2-yloxy)ethyl]-2-sulfanylidene-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one|1-{2-[(propan-2-yl)oxy]ethyl}-2-sulfanylidene-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one|Verdiperstat [USAN]|Verdiperstat (USAN/INN)|Verdiperstat (AZD3241)|SCHEMBL1536607|CHEMBL4297594|SCHEMBL23225670|GTPL10052|BCP30847|EX-A3205|BD",253.320,C11H15N3O2S,89.400,322.000,1.000,17,2,3,4,"InChI=1S/C11H15N3O2S/c1-7(2)16-6-5-14-8-3-4-12-9(8)10(15)13-11(14)17/h3-4,7,12H,5-6H2,1-2H3,(H,13,15,17)",CC(C)OCCN1C2=C(C(=O)NC1=S)NC=C2,FVJCUZCRPIMVLB-UHFFFAOYSA-N,"1-(2-propan-2-yloxyethyl)-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Use and Manufacturing,8,NULL,20061026,"AbaChemScene|AKos Consulting & Solutions|Ark Pharm, Inc.|BindingDB|BioChemPartner|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemSpider|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|KEGG|Key Organics/BIONET|MedChemexpress MCE|MolPort|MuseChem|NCBI Structure|NextBio|NextM",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
11552706,Losmapimod,"Losmapimod|585543-15-3|GSK-AHAB|GW856553|GW856553X|GW-856553|UNII-F2DQF16BXE|Losmapimod (GW856553X)|F2DQF16BXE|6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide|GSK-AHAB;GW856553X;SB856553|6-(5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl)-N-neopentylnicotinamide|6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide.|Losmapimod [USAN:INN]|GSKAHAB|GW 856553X|SB 856553|Losmapimod (USAN/INN)|GTPL7835|SCHEMBL1070401|CH",383.500,C22H26FN3O2,71.100,573.000,3.800,28,2,4,6,"InChI=1S/C22H26FN3O2/c1-13-17(9-15(10-18(13)23)21(28)26-16-6-7-16)19-8-5-14(11-24-19)20(27)25-12-22(2,3)4/h5,8-11,16H,6-7,12H2,1-4H3,(H,25,27)(H,26,28)",CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C,KKYABQBFGDZVNQ-UHFFFAOYSA-N,"6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,476299|476300|476301|599580|599581|599582|599583|599584|599585|599586|599587|599588|599589|599590|599591|599592|599692|599693|599694|599695|599696|599698|599699|599700|599701|599702|599703|599704|599705|599706|599707|599708|599709|599710|599711|599712|599713|599714|599715|599716|599717|599718|599719|599797|599798|599799|599800|599801|599802|599803|599804|1159387|1159389|1159390|1159394|1159395|1159396|1159686|1259416|1259421|1296008|1296009|1345084|1345304|1346986|1346987|1347055|1347060|1347064|1347065|134,20061026,"001Chemical|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|Ark Pharma Scientific Limited|BenchChem|BindingDB|BioChemPartner|BioCrick|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|Center for Chemical Genomics, University of Michigan|ChEBI|Che",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11671467,Fostamatinib,"Fostamatinib|901119-35-5|Fostamatinib (R788)|R788|Tavalisse|UNII-SQ8A3S5101|Fostamatinib(R788)|R-788 Free acid|R 788|[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate|R788 FREE ACID|R-935788 Free acid|R-788|R935788 FREE ACID|SQ8A3S5101|R7935788|[6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-3-Oxo-2,3-Dihydro-4h-Pyrido[3,2-B][1,4]oxazin-4-Yl]methyl Dihydrogen Phosphate|2H-Pyrido(3,2-b)-",580.500,C23H26FN6O9P,187.000,904.000,1.600,40,4,15,10,"InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)",CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,GKDRMWXFWHEQQT-UHFFFAOYSA-N,"[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,737163|737175|737176|737177|737180|737181|737182|737183|737184|737185|737186|737187|737188|737189|743344|743345|743346|743347|1128155|1159721|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259398|1259399|1259416|1259421|1259423|1296008|1296009|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347080|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|13,20061026,"001Chemical|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
11977753,Dactolisib,"915019-65-7|dactolisib|NVP-BEZ235|BEZ235|NVP-BEZ 235|2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile|BEZ-235|NVPBEZ235|BEZ 235|NVP BEZ235|BEZ235 (NVP-BEZ235)|NVP-BEZ-235|UNII-RUJ6Z9Y0DT|RUJ6Z9Y0DT|BEZ235 (NVP-BEZ235, Dactolisib)|CHEBI:71952|BEZ235(NVP-BEZ235)|915019-65-7 (free base)|2-Methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile|2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-di",469.500,C30H23N5O,73.100,872.000,5.200,36,0,4,3,"InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3",CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,JOGKUKXHTYWRGZ-UHFFFAOYSA-N,"2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,488908|488913|492960|493040|588453|588456|588579|588590|588795|588855|588856|602310|602332|624173|624178|624202|624263|624392|624414|624476|624478|624479|626740|626744|648339|648340|648341|648342|648343|648344|648345|648346|648347|648348|648349|648350|648351|648352|648353|648354|648355|648356|648357|648358|648359|648360|648361|648362|648363|648364|648365|648366|648367|648368|648369|648498|648499|648500|648501|648502|648503|648504|648505|651645|651646|651696|651712|651713|651965|652106|652175|652180|652283|6,20070103,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|Abbott Labs|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acesobio|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Amadis Chemical|Ambinter|Angel Pharmatech Ltd.|Anward|AOBIOUS INC|ApexBio Technology|Apexmol|Ark ",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
12765065,2-(Benzo[b]thiophen-2-yl)acetic acid,2-(Benzo[b]thiophen-2-yl)acetic acid|75894-07-4|1-benzothien-2-ylacetic acid|2-(1-benzothiophen-2-yl)acetic acid|1-Benzothiophen-2-Ylacetic Acid|Benzo[b]thiophene-2-acetic acid|2FX|2-benzothienyl acetic acid|SCHEMBL631264|2-benzo[b]thienyl acetic acid|DTXSID50509336|benzo[b]thiophen-2-yl-acetic acid|(1-Benzothiophen-2-yl)acetic acid|1792AC|ANW-59104|MFCD09927470|ZINC39281982|AKOS006312877|DA-35175|DS-14817|AB0070311|FT-0716566|W-4279|Q27452970|Z2234185604,192.240,C10H8O2S,65.500,205.000,2.400,13,1,3,2,"InChI=1S/C10H8O2S/c11-10(12)6-8-5-7-3-1-2-4-9(7)13-8/h1-5H,6H2,(H,11,12)",C1=CC=C2C(=C1)C=C(S2)CC(=O)O,SAAWNQLNUJBOLW-UHFFFAOYSA-N,2-(1-benzothiophen-2-yl)acetic acid,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20070208,"001Chemical|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|Achemo Scientific Limited|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|Ambinter|Angel Pharmatech Ltd.|Anward|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|Biocore|BLD Pharm|BOC Sciences|Chem-Space.com Database|Chemenu Inc.|Chemical Synthesis",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
15951529,Enzalutamide,"Enzalutamide|915087-33-1|MDV3100|MDV-3100|4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide|MDV 3100|XTANDI|Enzalutamide (MDV3100)|MDV3100 (Enzalutamide)|UNII-93T0T9GKNU|MDV3100 Enzalutamide|93T0T9GKNU|CHEBI:68534|4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide|4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide",464.400,C21H16F4N4O2S,109.000,839.000,3.600,32,1,8,3,"InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)",CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,WXCXUHSOUPDCQV-UHFFFAOYSA-N,"4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,482793|482799|624476|624478|624479|651645|651646|651696|651712|651713|686947|686950|720861|743244|743322|743323|743324|743344|743345|743346|743347|754108|754109|754116|754117|754123|776885|776886|1053194|1053195|1159510|1159511|1159512|1159513|1159530|1183649|1183653|1187550|1187551|1187555|1187556|1187557|1187558|1187561|1187562|1187563|1199793|1199794|1199795|1199822|1224824|1224825|1224857|1224859|1233504|1233505|1233507|1259251|1259252|1259253|1259255|1259256|1259357|1259358|1259359|1259360|1259361|1259,20070307,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Anward|AOBIOUS INC|ApexBio Technolog",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16129704,Bivalirudin,"Bivalirudin|128270-60-0|Angiomax|BG-8967|Bivalirudin Trifluoroacetate|BG8967|Hirulog|UNII-TN9BEX005G|CHEBI:59173|TN9BEX005G|D-Phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl-L-leucine|L-Leucine, D-phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-gluta",2180.300,C98H138N24O33,902.000,4950.000,-7.100,155,28,35,67,InChI=1S/C98H138N24O33/c1-5-52(4)82(96(153)122-39-15-23-70(122)92(149)114-60(30-34-79(134)135)85(142)111-59(29-33-78(132)133)86(143)116-64(43-55-24-26-56(123)27-25-55)89(146)118-67(97(154)155)40-51(2)3)119-87(144)61(31-35-80(136)137)112-84(141)58(28-32-77(130)131)113-88(145)63(42-54-18-10-7-11-19-54)117-90(147)66(45-81(138)139)110-76(129)50-107-83(140)65(44-71(100)124)109-75(128)49-106-73(126)47-104-72(125)46-105-74(127)48-108-91(148)68-21-13-38-121(68)95(152)62(20-12-36-103-98(101)102)115-93(150)69-22-14-3,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](CC6=CC=CC=C6)N,OIRCOABEOLEUMC-GEJPAHFPSA-N,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[2-[[2-[[2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-car",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active,11,1345816|1473738|1473739|1473740|1473741|1474166|1474167,20070703,"3WAY PHARM INC|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|AbMole Bioscience|Achemtek|Acorn PharmaTech Product List|Active Biopharma|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambinter|AN PharmaTech|AvaChem Scientific|BindingDB|BioCrick|Biosynth Carbosynth|BOC Sciences|Boerchem|Broad Institute|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Clearsynth|Collaborative Drug Discovery, Inc.|Comparative",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16130571,Thymalfasin,Thymalfasin|62304-98-7|Zadaxin|Thymosin alpha 1|Thymosin alpha1|UNII-W0B22ISQ1C|Thymosin-alpha-1|W0B22ISQ1C|69440-99-9|N-Acetyl-L-seryl-L-alpha-aspartyl-L-alanyl-L-alanyl-L-valyl-L-alpha-aspartyl-L-threonyl-L-seryl-L-seryl-L-alpha-glutamyl-L-isoleucyl-L-threonyl-L-threonyl-L-lysyl-L-alpha-aspartyl-L-leucyl-L-lysyl-L-alpha-glutamyl-L-lysyl-L-lysyl-L-alpha-glutamyl-L-valyl-L-valyl-L-alpha-glutamyl-L-alpha-glutamyl-L-alanyl-L-alpha-glutamyl-L-asparagine|Thymosin alpha1 (ox)|Thymosin alpha1 (human)|Thymalfasin ,3108.300,C129H215N33O55,1460.000,7190.000,-24.000,217,49,59,111,InChI=1S/C129H215N33O55/c1-18-59(10)98(159-114(201)76(36-42-91(181)182)146-120(207)83(53-164)154-121(208)84(54-165)155-127(214)99(63(14)166)160-118(205)80(51-94(187)188)152-123(210)95(56(4)5)156-104(191)62(13)135-102(189)60(11)137-115(202)78(49-92(183)184)151-119(206)82(52-163)138-66(17)169)125(212)161-101(65(16)168)128(215)162-100(64(15)167)126(213)147-70(30-22-26-46-133)109(196)150-79(50-93(185)186)117(204)149-77(47-55(2)3)116(203)142-69(29-21-25-45-132)108(195)144-73(33-39-88(175)176)110(197)141-67(27-19,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C,NZVYCXVTEHPMHE-ZSUJOUNUSA-N,"(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylbutanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpenta",Thymalfasin,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,9,1259409,20070703,"A2Z Chemical|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acorn PharmaTech Product List|Active Biopharma|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|AN PharmaTech|Aurora Fine Chemicals LLC|AvaChem Scientific|BOC Sciences|ChEBI|Chembase.cn|ChEMBL|Chemenu Inc.|Chemical Carcinogenesis Research Information System (CCRIS)|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|ChemSpider|Clearsynth|Comparative Toxicogenomics Database (CTD)|CreativePeptides|Davey Lab, Department of Microbiology, NE",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16219160,CID 16219160,"potassium canrenoate|2181-04-6|SMR000875277|MLS001333149|MLS001333150|Canrenoic acid potassium salt, powder|181P046|potassium;3-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoate|Potassium;3-[(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoate",397.600,C22H30KO4,74.600,707.000,NULL,27,2,4,3,"InChI=1S/C22H30O4.K/c1-20-9-5-15(23)13-14(20)3-4-16-17(20)6-10-21(2)18(16)7-11-22(21,26)12-8-19(24)25;/h3-4,13,16-18,26H,5-12H2,1-2H3,(H,24,25);/t16-,17+,18+,20+,21+,22-;/m1./s1",C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(CCC(=O)O)O)C.[K],OCNCAPJTFQNUKP-RYVBEKKQSA-N,NULL,Canrenoic Acid,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Safety and Hazards,6,NULL,20070716,"A2B Chem|AA BLOCKS|Aurora Fine Chemicals LLC|Chembase.cn|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|MLSMR|NovoSeek|OChem|Pi Chemicals|Sigma-Aldrich|Smolecule",Chemical Vendors|Governmental Organizations|Legacy Depositors|NIH Initiatives|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
16220188,Pamapimod,"Pamapimod|449811-01-2|RO 4402257|Ro4402257|UNII-8S2C9V11K4|R1503|CHEMBL1090089|CHEBI:90685|8S2C9V11K4|Ro-4402257|Pamapimod (R-1503, Ro4402257)|6-(2,4-Difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one|6-(2,4-Difluorophenoxy)-2-{[3-Hydroxy-1-(2-Hydroxyethyl)propyl]amino}-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One|6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one|Pamapimod [USAN:INN]|6-(2,4-Difluorophenoxy)-2-((3-h",406.400,C19H20F2N4O4,108.000,591.000,2.400,29,3,9,8,"InChI=1S/C19H20F2N4O4/c1-25-17-11(10-22-19(24-17)23-13(4-6-26)5-7-27)8-16(18(25)28)29-15-3-2-12(20)9-14(15)21/h2-3,8-10,13,26-27H,4-7H2,1H3,(H,22,23,24)",CN1C2=NC(=NC=C2C=C(C1=O)OC3=C(C=C(C=C3)F)F)NC(CCO)CCO,JYYLVUFNAHSSFE-UHFFFAOYSA-N,"6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,9,476300|476301|476302|476303|476305|476307|476308|476309|476310|476311|476312|476313|476314|476315|476316|476317|476318|476319|592303|592305|592306|592307|592308|592309|592310|592311|592312|592313|592314|592315|592316|592317|592318|592319|592320|592321|592322|592323|592324|592325|592326|592374|592375|592376|592377|592378|592379|592380|592381|592382|592383|592384|592385|592386|592387|592388|592395|592403|592463|592464|592465|592466|592467|592468|592469|592470|592471|592472|592473|592474|592475|592476|592477|5,20070723,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Activate Scientific|Adooq BioScience|Ambinter|Ark Pharm, Inc.|BindingDB|BioChemPartner|BOC Sciences|Center for Chemical Genomics, University of Michigan|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|ChemSpider|Clearsynth|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DS",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
17024755,(4-Bromo-1H-pyrazol-1-yl)acetic acid,2-(4-bromo-1H-pyrazol-1-yl)acetic acid|82231-53-6|(4-bromo-1H-pyrazol-1-yl)acetic acid|2-(4-bromopyrazol-1-yl)acetic acid|2-(4-Bromo-1-pyrazolyl)acetic Acid|MFCD00159632|2-(4-bromopyrazolyl)acetic acid|AKOS B018507|(4-bromopyrazol-1-yl)acetic acid|SCHEMBL3888920|DTXSID90588680|ALBB-003765|CS-D0543|ZINC2531016|BBL008593|SBB021723|STK312913|AKOS000307377|MCULE-6860014603|RS-0396|ST086896|SY045887|AB0091201|DB-075827|FT-0758622|EN300-45525|C-1167|Z594413678|W3A,205.010,C5H5BrN2O2,55.100,142.000,0.600,10,1,3,2,"InChI=1S/C5H5BrN2O2/c6-4-1-7-8(2-4)3-5(9)10/h1-2H,3H2,(H,9,10)",C1=C(C=NN1CC(=O)O)Br,WRXIKBHQDRMYJJ-UHFFFAOYSA-N,2-(4-bromopyrazol-1-yl)acetic acid,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,5,NULL,20071113,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Activate Scientific|AEchem Scientific Corp., USA|AKos Consulting & Solutions|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|BLD Pharm|BOC Sciences|Chem-Space.com Data",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
18385211,6-Methyl-1H-indole-3-carboxylic acid,6-methyl-1H-indole-3-carboxylic acid|209920-43-4|6-METHYLINDOLE-3-CARBOXYLIC ACID|6-methyl-3-indolecarboxylic acid|MFCD06203633|6-methylindole-3-carboxylicacid|(R)-Ethyl D-lactate|SCHEMBL2659416|AMY2853|DTXSID80593329|ACT07057|BCP15604|ANW-49920|ZINC20269197|AKOS005362542|ACN-051231|CS-W022510|FS-3039|MCULE-7746839599|QC-9761|SB15153|SY058808|AB0023356|DB-003562|FT-0687189|W4392|EN300-53545|S-3895|J-518911|Z1172115955|WB1,175.180,C10H9NO2,53.100,217.000,2.400,13,2,2,1,"InChI=1S/C10H9NO2/c1-6-2-3-7-8(10(12)13)5-11-9(7)4-6/h2-5,11H,1H3,(H,12,13)",CC1=CC2=C(C=C1)C(=CN2)C(=O)O,PHHZCIOPSFQASN-UHFFFAOYSA-N,6-methyl-1H-indole-3-carboxylic acid,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20071204,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|ABI Chem|Acadechem|Accela ChemBio Inc.|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alichem|Ambeed|AN PharmaTech|Anward|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LL",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
21193114,4-(1H-Pyrazol-5-yl)piperidine,"4-(1H-Pyrazol-3-yl)piperidine|278798-08-6|4-(1H-pyrazol-5-yl)piperidine|Piperidine,4-(1H-pyrazol-3-yl)-|4-(1H-Pyrazol-5-yl)-piperidine|PIPERIDINE, 4-(1H-PYRAZOL-3-YL)-|MFCD10698548|4-(pyrazolyl)piperidine|4-1h-pyrazol-5-yl piperidine|SCHEMBL1586961|CHEMBL4522902|DTXSID50611286|4-(1H-pyrazol-3-yl)-piperidine|ANW-69398|ZINC19685960|AKOS005259405|AKOS015899996|AB62359|CCG-210060|BS-13526|DB-067842|BB 0261421|FT-0753500|EN300-62917|Y-6434|A819227|J-513224|W6S",151.210,C8H13N3,40.700,121.000,0.400,11,2,2,1,"InChI=1S/C8H13N3/c1-4-9-5-2-7(1)8-3-6-10-11-8/h3,6-7,9H,1-2,4-5H2,(H,10,11)",C1CNCCC1C2=CC=NN2,FCKYIGWJVZIPLK-UHFFFAOYSA-N,4-(1H-pyrazol-5-yl)piperidine,NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents|Safety and Hazards,6,NULL,20071205,"3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|Acadechem|Achemo Scientific Limited|Acorn PharmaTech Product List|AHH Chemical co.,ltd|AKos Consulting & Solutions|Alichem|Amadis Chemical|Ambeed|Ambinter|Angene Chemical|Anward|Ark Pharm, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BePharm Ltd.|Biocore|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
22992264,(5-Bromopyridin-3-yl)methanamine,"(5-Bromopyridin-3-yl)methanamine|135124-70-8|3-(Aminomethyl)-5-bromopyridine|(5-Bromo-3-pyridinyl)methylamine|5-Bromo-3-pyridinemethylamine|3-Aminomethyl-5-bromopyridine|3-Pyridinemethanamine, 5-bromo-|1-(5-BROMOPYRIDIN-3-YL)METHANAMINE|(5-bromo-3-pyridyl)methylamine|5-BROMO-3-PYRIDINEMETHANAMINE|MFCD06212876|ACMC-209bxx|5-aminomethyl-3-bromopyridine|SCHEMBL745600|3-Pyridinemethanamine,5-bromo-|DTXSID50629407|(5-bromopyridin-3-yl) methylamine|AMY27482|ANW-19747|SBB090527|ZINC12370809|AKOS005254701|c-(5-brom",187.040,C6H7BrN2,38.900,87.100,0.400,9,1,2,1,"InChI=1S/C6H7BrN2/c7-6-1-5(2-8)3-9-4-6/h1,3-4H,2,8H2",C1=C(C=NC=C1Br)CN,OQUHYNMITHDQLD-UHFFFAOYSA-N,(5-bromopyridin-3-yl)methanamine,NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,5,NULL,20071205,"001Chemical|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|Acadechem|Accela ChemBio Inc.|Achemica|Achemo Scientific Limited|Achemtek|Activate Scientific|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Amadis Chemical|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Anward|Apexmol|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BePharm Ltd.|B",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
23294017,"6,7-Dihydro-5H-pyrrolo[2,3-D]pyrimidine","6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDINE|5654-98-8|5,7-diazaindoline|WOY|SCHEMBL2449272|SCHEMBL22960001|ZINC39053702|AKOS006358652|AB68426|5,6-Dihydro-1H-pyrrolo[2,3-d]pyrimidine",121.140,C6H7N3,37.800,105.000,0.600,9,1,3,0,"InChI=1S/C6H7N3/c1-2-8-6-5(1)3-7-4-9-6/h3-4H,1-2H2,(H,7,8,9)",C1CNC2=NC=NC=C21,PANGDCFLXUDHDI-UHFFFAOYSA-N,"6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine",NULL,Biomolecular Interactions and Pathways|Literature|Names and Identifiers|Patents,4,NULL,20071205,"001Chemical|A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Alichem|Ambinter|Aurora Fine Chemicals LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chemenu Inc.|Chemhere|Chemieliva Pharmaceutical Co., Ltd|ChemSpider|ChemTik|DiscoveryGate|Enamine|eNovation Chemicals|Google Patents|IBM|MolCore BioPharmatech|MolPort|NCBI Structure|Norris Pharm|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SCRIPDB|Springer Nature|SureChEMBL|Synblock Inc|THE BioTek|Thieme Chemistry|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
23634441,Vadadustat,"Vadadustat|1000025-07-9|AKB-6548|PG-1016548|UNII-I60W9520VV|N-(5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl)glycine|B506|PG1016548|B-506|(5-(3-chlorophenyl)-3-hydroxypicolinoyl)glycine|I60W9520VV|Glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-|2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid|Glycine, N-((5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl)carbonyl)-|Glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-;Glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyri",306.700,C14H11ClN2O4,99.500,393.000,2.500,21,3,5,4,"InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)",C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,JGRXMPYUTJLTKT-UHFFFAOYSA-N,2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,12,1257682|1257683|1257684|1257947|1257948|1322829|1322831|1347060|1347064|1347065|1347067|1347068|1347411|1354491|1354535|1495355,20080107,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|Activate Scientific|Angel Pharmatech Ltd.|Apexmol|Ark Pharm, Inc.|Axon Medchem|BindingDB|BioChemPartner|BOC Sciences|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye Scientific Co., Ltd|DiscoveryGate|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Ch",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
23680530,Methylprednisolone sodium succinate,"METHYLPREDNISOLONE SODIUM SUCCINATE|2375-03-3|Solu-Medrol|Solumedrol|Urbason solubile|Solu-Medrone|Methylprednisolone succinate|UNII-LEC9GKY20K|LEC9GKY20K|6alpha-Methylprednisolone 21-hemisuccinate sodium salt|Methylprednisolone sodium hemisuccinate|Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21- (hydrogen succinate), monosodium salt|Asmacortone|Corticel|Metypresol|M-6-P|U 9088|Emmetipi|Metypred|Prednilem|Firmacort Fiale|Nirypan solubile|Sol Melcort|Lemod Solu|Metypred [inj.]|Medr",496.500,C26H33NaO8,141.000,988.000,NULL,35,2,8,7,"InChI=1S/C26H34O8.Na/c1-14-10-16-17-7-9-26(33,20(29)13-34-22(32)5-4-21(30)31)25(17,3)12-19(28)23(16)24(2)8-6-15(27)11-18(14)24;/h6,8,11,14,16-17,19,23,28,33H,4-5,7,9-10,12-13H2,1-3H3,(H,30,31);/q;+1/p-1/t14-,16-,17-,19-,23+,24-,25-,26-;/m0./s1",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)[O-])O.[Na+],FQISKWAFAHGMGT-SGJOWKDISA-M,"sodium;4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate",Methylprednisolone Hemisuccinate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,1195|130086|130844|130845|131976|135622|139247|180509|182836|651631|651632|651633|651634|652048|652051|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743063|743064|743065|743066|743067|743069|743074|743075|743077|743078|743079|743080|743081|743083|743084|743085|743086|743091|743094|743122|743139|743,20080205,"Aaron Chemicals LLC|AbaChemScene|Abe Lab, University of Texas MD Anderson Cancer Center|AbovChem LLC|AKos Consulting & Solutions|Alfa Chemistry|AN PharmaTech|ApexBio Technology|Aurora Fine Chemicals LLC|BioCrick|Biosynth Carbosynth|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|ChemIDplus|ChemMol|ChemSpider|Collaborative Drug Discovery, Inc.|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|FDA/SPL Inde",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
24748573,Silmitasertib,"Silmitasertib|1009820-21-6|CX-4945|5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid|CX4945|CX-4945 (Silmitasertib)|CX 4945|UNII-C6RWP0N0L2|5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid|5-[(3-chlorophenyl)amino]-Benzo[c]-2,6-naphthyridine-8-carboxylic acid|CX4945 (Silmitasertib)|C6RWP0N0L2|CHEMBL1230165|5-((3-Chlorophenyl)amino)benzo-[c][2,6]naphthyridine-8-carboxylic acid|5-[(3-chlorophenyl)amino]benzo[c]2,6-naphthyridine-8-carboxylic acid|5-[(3-Chlorophenyl)amino]",349.800,C19H12ClN3O2,75.100,491.000,4.400,25,2,5,3,"InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)",C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4,MUOKSQABCJCOPU-UHFFFAOYSA-N,"5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,566117|566120|566121|566122|566123|566124|566125|566126|566127|566128|566129|566130|566131|566132|566133|566134|566135|566136|566137|566138|566139|566140|566141|566142|566143|566144|566145|566146|566147|566148|566149|566150|566151|566152|566153|566154|566155|566156|566157|566158|566159|566160|566161|566162|566163|566164|566165|566166|566167|566168|566169|566170|566171|566172|566173|566174|566175|566176|566177|624392|624476|624478|624479|630587|630588|630589|637248|651645|651646|651696|651712|651713|684571|6,20080317,"001Chemical|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acadechem|Acesobio|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Anward|AOBIOUS INC|Apex",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
24821094,Ibrutinib,"Ibrutinib|936563-96-1|PCI-32765|IMBRUVICA|PCI 32765|Ibrutinib (PCI-32765)|PCI-32765 (Ibrutinib)|UNII-1X70OSD4VX|CRA-032765|Pc-32765|(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one|1X70OSD4VX|CHEBI:76612|PCI32765|1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one|1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one|1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)py",440.500,C25H24N6O2,99.200,678.000,3.600,33,1,6,5,"InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1",C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,XYFPWWZEPKGCCK-GOSISDBHSA-N,"1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,588453|588456|588579|588590|588795|588855|588856|602310|602332|624173|624178|624202|624263|624414|624476|624478|624479|629929|631100|631101|651645|651646|651696|651712|651713|651965|652106|671741|671742|671743|671744|686947|686948|686950|686978|686979|719893|720579|720580|743244|743322|743323|743324|743344|743345|743346|743347|1053194|1053195|1155508|1155511|1155512|1155519|1155520|1155521|1155522|1155533|1155535|1155538|1159389|1159394|1159510|1159511|1159512|1159513|1159530|1164540|1164541|1164542|1224824,20080630,"A&J Pharmtech CO., LTD.|A1 BioChem Labs|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|AOBIOUS INC|ApexBio Technology|Apexmol|Ark Pharma Scientific Limited|Arromax Pharmatech Co., Ltd|Assembly Blocks P",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
24828759,Fostamatinib disodium,"Fostamatinib disodium hexahydrate|914295-16-2|R788 disodium hexahydrate|UNII-86EEZ49YVB|86EEZ49YVB|R 788 sodium|Fostamatinib disodium [USAN]|R788 (disodium hexahydrate)|R 935788 sodium|R788 SODIUM|R935788 SODIUM|disodium;[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl phosphate;hexahydrate|Fostamatinib disodium (USAN)|R935788|R-788|R-935788|Tamatinib fosdium|Tavalisse (TN)|R-788 Sodium|R-935788 Sodium|R788 SODIUM HYDRATE|R-788 SODIUM HYDR",732.500,C23H36FN6Na2O15P,198.000,893.000,NULL,48,8,21,9,"InChI=1S/C23H26FN6O9P.2Na.6H2O/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4;;;;;;;;/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29);;;6*1H2/q;2*+1;;;;;;/p-2",CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)([O-])[O-])C.O.O.O.O.O.O.[Na+].[Na+],ZQGJCHHKJNSPMS-UHFFFAOYSA-L,"disodium;[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl phosphate;hexahydrate",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,710244|710245|710246|710247|710248,20080707,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|Activate Scientific|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|BioChemPartner|BioCrick|Chem-Space.com Database|ChEMBL|ChemIDplus|Clearsynth|Combi-Blocks|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|FDA/SPL Indexing Data|Finetech Industry Limited|KEGG|King Scientific|Lan Pharmatech|MolCore BioPharmatech|MolPort|MuseChem",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
25024769,Masitinib mesylate,"Masitinib mesylate|1048007-93-7|Masitinib (mesylate)|AB 1010 mesylate|AB-1010 mesylate|UNII-ZK89EG3A18|Masivet|ZK89EG3A18|AB 1010|4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-THIAZOL-2-YLAMINO)-PHENYL]-BENZAMIDE METHANESULFONATE|Kinavet|Masitinib mesilate|4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide Mesylate|928671-85-6|Masitinibmesylate|SCHEMBL1096348|C28H30N6OS.CH4O3S|DTXSID70146747|BCP30695|EX-A3996|YRB00793|3415AH|HY-10209A|",594.800,C29H34N6O4S2,164.000,788.000,NULL,41,3,10,7,"InChI=1S/C28H30N6OS.CH4O3S/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34;1-5(2,3)4/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32);1H3,(H,2,3,4)",CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5.CS(=O)(=O)O,TXCWBWKVIZGWEQ-UHFFFAOYSA-N,"methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20081117,"001Chemical|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbovChem LLC|Activate Scientific|Adooq BioScience|AK Scientific, Inc. (AKSCI)|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Ark Pharm, Inc.|Axon Medchem|BioChemPartner|BioCrick|Biosynth Carbosynth|BOC Sciences|Chem-Space.com Database|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemMol|Combi-Blocks|DC Chemicals|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharm",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
40694280,"1-Benzimidazoleacetamide,N-methyl-(6CI)","1-Benzimidazoleacetamide,N-methyl-(6CI)|103096-30-6|2-(1H-benzimidazol-1-yl)-N-methylacetamide|ZINC7454071|AKOS008907065|2-(benzimidazol-1-yl)-N-methylacetamide|WRM",189.210,C10H11N3O,46.900,219.000,0.900,14,1,2,2,"InChI=1S/C10H11N3O/c1-11-10(14)6-13-7-12-8-4-2-3-5-9(8)13/h2-5,7H,6H2,1H3,(H,11,14)",CNC(=O)CN1C=NC2=CC=CC=C21,FLYQCADZXXOQSG-UHFFFAOYSA-N,2-(benzimidazol-1-yl)-N-methylacetamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20090530,"A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambinter|BenchChem|Chem-Space.com Database|Chemieliva Pharmaceutical Co., Ltd|IBM|MolPort|MuseChem|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|ZINC",Chemical Vendors|Governmental Organizations|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
41031989,"2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetamide","2-(1,3,5-trimethyl-1H-pyrazol-4-yl)acetamide|1017502-16-7|CHEMBL4555896|ALBB-018013|ZINC9355845|7437AC|BBL015783|MFCD08685646|STK256647|AKOS005423771|MCULE-4771799502|LS-05950|2-(1,3,5-trimethylpyrazol-4-yl)acetamide|1H-pyrazole-4-acetamide, 1,3,5-trimethyl-|EN300-68911|Z287484230|2-(1,3,5-Trimethyl-1H-pyrazol-4-yl)acetamide, AldrichCPR|W1V",167.210,C8H13N3O,60.900,183.000,-0.200,12,1,2,2,"InChI=1S/C8H13N3O/c1-5-7(4-8(9)12)6(2)11(3)10-5/h4H2,1-3H3,(H2,9,12)",CC1=C(C(=NN1C)C)CC(=O)N,JQSGNNVZAVLVHV-UHFFFAOYSA-N,"2-(1,3,5-trimethylpyrazol-4-yl)acetamide",NULL,Biomolecular Interactions and Pathways|Classification|Safety and Hazards,3,NULL,20090530,"A2B Chem|AA BLOCKS|abcr GmbH|ABI Chem|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alinda Chemical|Angel Pharmatech Ltd.|Angene Chemical|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemieliva Pharmaceutical Co., Ltd|Combi-Blocks|DiscoveryGate|Enamine|Key Organics/BIONET|Matrix Scientific|Mcule|MolPort|NCBI Structure|Norris Pharm|Protein Data Bank in Europe (PDBe)|Sigma-Aldrich|Vitas-M Laboratory|ZINC",Chemical Vendors|Curation Efforts|Governmental Organizations|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
44137675,"2-[[(1R)-1-[7-Methyl-2-(4-morpholinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid","AZD6482|1173900-33-8|AZD-6482|AZD 6482|(R)-2-(1-(7-methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoic acid|2-[[(1R)-1-[7-Methyl-2-(4-morpholinyl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid|CHEMBL2165191|UNII-78G6MP5PZ5|78G6MP5PZ5|2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid|2-{[(1R)-1-[7-methyl-2-(morpholin-4-yl)-4-oxopyrido[1,2-a]pyrimidin-9-yl]ethyl]amino}benzoic acid|(R)-2-((1-(7-Methyl-2-morpholino-4-oxo-4H-py",408.400,C22H24N4O4,94.500,838.000,2.000,30,2,7,5,"InChI=1S/C22H24N4O4/c1-14-11-17(15(2)23-18-6-4-3-5-16(18)22(28)29)21-24-19(12-20(27)26(21)13-14)25-7-9-30-10-8-25/h3-6,11-13,15,23H,7-10H2,1-2H3,(H,28,29)/t15-/m1/s1",CC1=CN2C(=O)C=C(N=C2C(=C1)[C@@H](C)NC3=CC=CC=C3C(=O)O)N4CCOCC4,IRTDIKMSKMREGO-OAHLLOKOSA-N,"2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,9,624476|624478|624479|651645|651646|651696|651712|651713|686947|686950|699866|699873|699874|699895|741697|741698|741699|741700|741701|741702|741703|741704|741705|741706|741707|741708|741709|741710|741711|741712|741713|741714|741715|741716|741717|741718|741719|741720|741721|741722|741723|741724|741725|741726|741728|741729|741730|741731|741732|741733|741734|741735|741736|741737|741738|741739|741740|741741|741742|741744|741745|741746|741747|741748|741750|741751|741752|741753|741754|741755|741756|741757|741758|7,20090810,"A&J Pharmtech CO., LTD.|A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acadechem|Acesobio|Achemtek|ACT Chemical|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambeed|Ambinter|AOBIOUS INC|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|Boerchem|Broad Institute|CAPOT|Center for Chemical Genomics, Univers",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
44146842,Larazotide acetate,"Larazotide acetate|881851-50-9|AT-1001|Larazotide (acetate)|Larazotide acetate [USAN]|Larazotide acetate (USAN)|Glycine, glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-, monoacetate|UNII-FO8S2IW40N|FO8S2IW40N|CHEMBL2103815|DTXSID401007986|881851-50-9 (acetate)|CS-8047|HY-106268A|AT-1001 (LARAZOTIDE ACETATE)|A16916|D09352|Q25327025|Glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycine acetate|Acetic acid--N-[(1-{N-[14-amino-1,4,7,10,13-pentahydroxy-5-(2-methylpropyl)-2,8-di(propan-2",785.900,C34H59N9O12,339.000,1320.000,NULL,55,10,13,21,"InChI=1S/C32H55N9O10.C2H4O2/c1-16(2)12-20(38-30(49)26(17(3)4)39-24(44)14-35-23(43)13-33)28(47)40-27(18(5)6)31(50)37-19(9-10-22(34)42)32(51)41-11-7-8-21(41)29(48)36-15-25(45)46;1-2(3)4/h16-21,26-27H,7-15,33H2,1-6H3,(H2,34,42)(H,35,43)(H,36,48)(H,37,50)(H,38,49)(H,39,44)(H,40,47)(H,45,46);1H3,(H,3,4)/t19-,20-,21-,26-,27-;/m0./s1",CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CN.CC(=O)O,NYGCNONRVCGHAT-UFIKZEAMSA-N,acetic acid;2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid,NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,6,NULL,20090820,"A2B Chem|AA BLOCKS|AbaChemScene|AbMole Bioscience|Adooq BioScience|Ambeed|Chem-Space.com Database|ChEMBL|ChemIDplus|Comparative Toxicogenomics Database (CTD)|CSNpharm|DiscoveryGate|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|KEGG|MedChemexpress MCE|MolPort|MuseChem|NextMove Software|Springer Nature|TargetMol (Target Molecule Corp.)|THE BioTek|Therapeutic Target Database (TTD)|ToxPlanet|Wikidata",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
46192922,"1H-Pyrazolo[3,4-B]pyridin-5-amine","1H-PYRAZOLO[3,4-B]PYRIDIN-5-AMINE|942185-01-5|5-AMINO-1H-PYRAZOLO[3,4-B]PYRIDINE|1H-Pyrazolo[3,4-b]pyridin-5-ylamine|2H-pyrazolo[3,4-b]pyridin-5-amine|pyrazolo[5,4-b]pyridine-5-ylamine|SCHEMBL1496196|DTXSID20673053|CS-D0316|MFCD10699403|SBB073488|STL414928|ZINC18556296|AKOS005169606|GS-6692|MCULE-2669639183|PB20505|QC-2446|AB0038308|ST45255704|Y5668|C-8315|WQA",134.140,C6H6N4,67.600,127.000,0.100,10,2,3,0,"InChI=1S/C6H6N4/c7-5-1-4-2-9-10-6(4)8-3-5/h1-3H,7H2,(H,8,9,10)",C1=C2C=NNC2=NC=C1N,OVICNYHPCJRQEY-UHFFFAOYSA-N,"1H-pyrazolo[3,4-b]pyridin-5-amine",NULL,Biomolecular Interactions and Pathways|Classification|Names and Identifiers|Patents|Safety and Hazards,5,NULL,20100706,"001Chemical|3A SpeedChemical Inc|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Achemo Scientific Limited|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Alichem|Allbio Pharm Co., Ltd|Ambeed|Ambinter|Angel Pharmatech Ltd.|Angene Chemical|Apexmol|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Assembly Blocks Pvt. Ltd.|AstaTech, Inc.|Aurora Fi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
46861623,Alvelestat,"848141-11-7|Alvelestat|Alvelestat (AZD9668)|Alvelestat [INN]|Alvelestat; AZD 9668|avelestat-azd9668|AZD 9668|AZD-9668|AZD9668|AZD9668;AZD-9668;AZD 9668|UNII-6Y5629322X|Alvelestat (AZD9688)|CHEMBL3617964|Avelestat|6Y5629322X|6-methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-((5-(methylsulfonyl)pyridin-2-yl)methyl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide|6-methyl-5-(2-methylpyrazol-3-yl)-N-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide|N-((",545.500,C25H22F3N5O4S,123.000,1100.000,2.500,38,1,9,6,"InChI=1S/C25H22F3N5O4S/c1-15-20(22-9-10-31-32(22)2)12-21(23(34)30-13-17-7-8-19(14-29-17)38(3,36)37)24(35)33(15)18-6-4-5-16(11-18)25(26,27)28/h4-12,14H,13H2,1-3H3,(H,30,34)",CC1=C(C=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)NCC3=NC=C(C=C3)S(=O)(=O)C)C4=CC=NN4C,QNQZWEGMKJBHEM-UHFFFAOYSA-N,6-methyl-5-(2-methylpyrazol-3-yl)-N-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,1248077|1248080|1248081|1248083|1248084|1248085|1248086|1248087|1248088|1259416|1259421|1296008|1296009|1345084|1345798|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347159|1347160|1347411|1409598|1418665,20100907,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|Ambinter|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|BindingDB|BioChemPartner|BioCrick|BOC Sciences|Boerchem|Broad Institute|CEGChem|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Clearsynth|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Debye",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
46897844,N-[(1R)-2-(Tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide,"ML188|1417700-13-0|(R)-N-(4-(tert-Butyl)phenyl)-N-(2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl)furan-2-carboxamide|N-[(1R)-2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide|N-[(1r)-2-(Tert-Butylamino)-2-Oxo-1-(Pyridin-3-Yl)ethyl]-N-(4-Tert-Butylphenyl)furan-2-Carboxamide|0EN|3v3m|MLS003172139|CHEMBL2311740|CHEBI:93044|BDBM429329|BCP33267|MFCD32693920|ML-188|jm5b01461, Compound 146-(R)|ML-188; ML 188|NCGC00386917-01|SMR001876044|HY-136259|CS-0121057|VU0420363-1|Q27",433.500,C26H31N3O3,75.400,644.000,5.000,32,1,4,7,"InChI=1S/C26H31N3O3/c1-25(2,3)19-11-13-20(14-12-19)29(24(31)21-10-8-16-32-21)22(18-9-7-15-27-17-18)23(30)28-26(4,5)6/h7-17,22H,1-6H3,(H,28,30)/t22-/m1/s1",CC(C)(C)C1=CC=C(C=C1)N([C@H](C2=CN=CC=C2)C(=O)NC(C)(C)C)C(=O)C3=CC=CO3,JXGIYKRRPGCLFV-JOCHJYFZSA-N,N-[(1R)-2-(tert-butylamino)-2-oxo-1-pyridin-3-ylethyl]-N-(4-tert-butylphenyl)furan-2-carboxamide,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Biological Test Results: Active|Biological Test Results: Micromolar,7,488967|652067|652126|652257|686940|686964|687014|687016|720508|720509|720543|720582|720596|720648|720700|720702|720704|724827|724828|724830|725104|743126|743269|780255|780256|780257|780258|780259|780260|780261|780262|977608|1053197|1117264|1117267|1259318|1296008|1296009|1345084|1346378|1346986|1346987|1347055|1347120|1347159|1347160,20100927,"AbaChemScene|abcr GmbH|Ambeed|BenchChem|BindingDB|BioChemPartner|BLD Pharm|ChEBI|Chem-Space.com Database|ChEMBL|CSNpharm|DC Chemicals|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|Japan Chemical Substance Dictionary (Nikkaji)|Lan Pharmatech|MedChemexpress MCE|MLSMR|MolPort|National Center for Advancing Translational Sciences (NCATS)|NCBI Structure|Protein Data Bank in Europe (PDBe)|Shanghai Institute of Organic Chemistry|TargetMol (Target Molecule Corp.)|Thomson Pharma|Vanderbil",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
49787172,Emvododstat,"Emvododstat|PTC299|(4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate|UNII-053QD2I96A|053QD2I96A|1219951-09-3|1256565-36-2|SCHEMBL8509210|CHEMBL4650336|GTPL11421|PTC-299|HY-124593|CS-0087039|(S)-6-Chloro-1-(4-methoxy-phenyl)-1,3,4,9-tetrahydro-b-carboline-2-carboxylic acid 4-chloro-phenyl ester",467.300,C25H20Cl2N2O3,54.600,651.000,6.300,32,1,3,4,"InChI=1S/C25H20Cl2N2O3/c1-31-18-7-2-15(3-8-18)24-23-20(21-14-17(27)6-11-22(21)28-23)12-13-29(24)25(30)32-19-9-4-16(26)5-10-19/h2-11,14,24,28H,12-13H2,1H3/t24-/m0/s1",COC1=CC=C(C=C1)[C@H]2C3=C(CCN2C(=O)OC4=CC=C(C=C4)Cl)C5=C(N3)C=CC(=C5)Cl,SRSHBZRURUNOSM-DEOSSOPVSA-N,"(4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20101213,AbaChemScene|BenchChem|Chem-Space.com Database|ChEMBL|DiscoveryGate|eNovation Chemicals|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|SureChEMBL|TargetMol (Target Molecule Corp.)|THE BioTek|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
49867936,"4-(Carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid","1201902-80-8|MLN9708|MLN-9708|4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid|MLN 9708|133876-92-3|4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid|CHEMBL1813256|ixazomib citrate 1,3,2-dioxaborinane|4-(carboxymethyl)-2-[(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid|1,3,2-Dioxaborinane-4-",517.100,C20H23BCl2N2O9,168.000,815.000,NULL,34,4,9,10,"InChI=1S/C20H23BCl2N2O9/c1-10(2)5-14(21-33-17(29)8-20(34-21,19(31)32)7-16(27)28)25-15(26)9-24-18(30)12-6-11(22)3-4-13(12)23/h3-4,6,10,14H,5,7-9H2,1-2H3,(H,24,30)(H,25,26)(H,27,28)(H,31,32)/t14-,20?/m0/s1",B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,YTXSYWAKVMZICI-PVCZSOGJSA-N,"4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Biological Test Results: Active|Biological Test Results: Micromolar,10,611891|743344|743345|743346|743347|1128246|1224824|1224825|1224857|1224859|1259252|1259253|1259255|1259256|1259398|1259399|1259421|1259423|1296008|1296009|1346986|1346987|1347053|1347055|1347060|1347061|1347062|1347063|1347064|1347065|1347066|1347067|1347068|1347082|1347083|1347085|1347086|1347089|1347090|1347091|1347092|1347093|1347094|1347095|1347096|1347097|1347098|1347099|1347100|1347101|1347102|1347103|1347104|1347105|1347106|1347107|1347108|1347109|1347110|1347111|1347112|1347113|1347114|1347115|13471,20110217,"3A SpeedChemical Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|abcr GmbH|AbMole Bioscience|Aceschem Inc|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Ambinter|Angene Chemical|ApexBio Technology|Assembly Blocks Pvt. Ltd.|Aurora Fine Chemicals LLC|Aurum Pharmatech LLC|Axon Medchem|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|Broad Institute|Ca",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
51114235,N-(1-Ethyl-1H-pyrazol-4-yl)cyclobutanecarboxamide,N-(1-ethyl-1H-pyrazol-4-yl)cyclobutanecarboxamide|1259209-34-1|NUA|ZINC58393661|AKOS008122818|MCULE-9404884796|N-(1-ethylpyrazol-4-yl)cyclobutanecarboxamide|Z373768900,193.250,C10H15N3O,46.900,215.000,0.700,14,1,2,3,"InChI=1S/C10H15N3O/c1-2-13-7-9(6-11-13)12-10(14)8-4-3-5-8/h6-8H,2-5H2,1H3,(H,12,14)",CCN1C=C(C=N1)NC(=O)C2CCC2,UVTFDTBDFQZRHD-UHFFFAOYSA-N,N-(1-ethylpyrazol-4-yl)cyclobutanecarboxamide,NULL,Biomolecular Interactions and Pathways|Classification|Safety and Hazards,3,NULL,20110503,AKos Consulting & Solutions|Ambinter|BenchChem|Enamine|Mcule|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
52938427,Ozanimod,"Ozanimod|1306760-87-1|RPC1063|RPC-1063|Ozanimod (RPC1063)|(S)-5-(3-(1-((2-hydroxyethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile|UNII-Z80293URPV|Z80293URPV|5-[3-[(1~{S})-1-(2-hydroxyethylamino)-2,3-dihydro-1~{H}-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxy-benzenecarbonitrile|5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile|Benzonitrile, 5-(3-((1S)-2,3-dihydro-1-((2-hydroxyethyl)amino)-1H-inden-4-yl)",404.500,C23H24N4O3,104.000,609.000,3.100,30,2,7,7,"InChI=1S/C23H24N4O3/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3/t20-/m0/s1",CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N,XRVDGNKRPOAQTN-FQEVSTJZSA-N,"5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,1339916|1339920|1339921|1339922|1339923|1339924|1339926|1339927|1339928|1346162|1346170|1346205|1346236|1346242|1347060|1347064|1347065|1347067|1347068|1347411|1409598,20110613,"A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AKos Consulting & Solutions|Apexmol|BindingDB|BioChemPartner|BioCrick|BLD Pharm|Broad Institute|Center for Chemical Genomics, University of Michigan|Chem-Space.com Database|ChEMBL|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|Dr",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
53484825,(s)-1-(3-Chloro-4-fluorophenyl)ethanamine hydrochloride,(s)-1-(3-chloro-4-fluorophenyl)ethanamine hydrochloride|(S)-1-(3-CHLORO-4-FLUOROPHENYL)ETHANAMINE-HCl|2413817-93-1|(S)-1-(3-Chloro-4-fluorophenyl)ethanamine HCl|(S)-1-(3-Chloro-4-fluorophenyl)ethanamine xhydrochloride|(S)-1-(3-Chloro-4-fluorophenyl)ethan-1-amine hydrochloride|MFCD12758040|AKOS015923249|BS-18095|S-1226|(1S)-1-(3-chloro-4-fluorophenyl)ethanamine;hydrochloride,210.070,C8H10Cl2FN,26.000,131.000,NULL,12,2,2,1,"InChI=1S/C8H9ClFN.ClH/c1-5(11)6-2-3-8(10)7(9)4-6;/h2-5H,11H2,1H3;1H/t5-;/m0./s1",C[C@@H](C1=CC(=C(C=C1)F)Cl)N.Cl,PNZRFOSIIFHDFS-JEDNCBNOSA-N,(1S)-1-(3-chloro-4-fluorophenyl)ethanamine;hydrochloride,NULL,Classification|Drug and Medication Information|Names and Identifiers,3,NULL,20111116,abcr GmbH|Acorn PharmaTech Product List|Activate Scientific|AKos Consulting & Solutions|Ambeed|Ambinter|Aurum Pharmatech LLC|BenchChem|BLD Pharm|Chem-Space.com Database|Chembase.cn|ChemMol|Combi-Blocks|eNovation Chemicals|Key Organics/BIONET|King Scientific|Lan Pharmatech|MolPort|Norris Pharm|Syntree,Chemical Vendors|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
56844015,Ixazomib citrate,"Ixazomib citrate|1239908-20-3|Ixazomib citrate (Ester)|UNII-46CWK97Z3K|46CWK97Z3K|Ixazomib citrate [USAN]|1,3,2-Dioxaborolane-4,4-diacetic acid, 2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-5-oxo-|1,3,2-Dioxaborolane-4,4-diacetic acid, 2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-|Ninlaro (TN)|Ixazomib citrate (JAN/USAN)|SCHEMBL4427479|CHEMBL3545432|CHEBI:90939|DTXSID60924652|2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino",517.100,C20H23BCl2N2O9,168.000,797.000,NULL,34,4,9,11,"InChI=1S/C20H23BCl2N2O9/c1-10(2)5-14(21-33-19(32)20(34-21,7-16(27)28)8-17(29)30)25-15(26)9-24-18(31)12-6-11(22)3-4-13(12)23/h3-4,6,10,14H,5,7-9H2,1-2H3,(H,24,31)(H,25,26)(H,27,28)(H,29,30)/t14-/m0/s1",B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,MBOMYENWWXQSNW-AWEZNQCLSA-N,"2-[4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-5-oxo-1,3,2-dioxaborolan-4-yl]acetic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing|Biological Test Results: Active,11,1409598|1409605|1479145|1479147|1479149|1479150,20120321,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|AbovChem LLC|Activate Scientific|AKos Consulting & Solutions|Ambeed|BioChemPartner|Broad Institute|Cangzhou Enke Pharma Tech Co.,Ltd.|ChEBI|Chem-Space.com Database|ChEMBL|ChemFish Tokyo co.,ltd|ChemIDplus|Chemieliva Pharmaceutical Co., Ltd|ChemShuttle|Combi-Blocks|Davey Lab, Department of Microbiology, NEIDL, Boston University|DTP/NCI|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|EPA DSSTox|Excenen Pharmatec",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
60148207,Peridex,"Peridex|Periogard|18472-51-0|MFCD00083599|NSC753971|NSC-753971|1,1'-hexamethylene bis[5-(p-chlorophenyl) biguanide] di-D-gluconate",735.700,C28H44Cl2N10O7S,317.000,819.000,NULL,48,13,10,18,"InChI=1S/C22H30Cl2N10.C6H12O7.H2S/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18;7-1-2(8)3(9)4(10)5(11)6(12)13;/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34);2-5,7-11H,1H2,(H,12,13);1H2/t;2-,3-,4+,5-;/m.1./s1",C1=CC(=CC=C1N/C(=N/C(=NCCCCCCN=C(/N=C(/NC2=CC=C(C=C2)Cl)\\N)N)N)/N)Cl.C(O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O.S,YMZFNGGAVXWWHP-PVBYDLIKSA-N,"(1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid;sulfane",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry|Use and Manufacturing,6,NULL,20120831,Alfa Aesar|DTP/NCI|ToxPlanet,Chemical Vendors|Governmental Organizations|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
60172240,Unii-Q99G5ZE5U5,"APX-115|1395946-75-4|Ewha-18278|UNII-Q99G5ZE5U5|Isuzinaxib hydrochloride|Q99G5ZE5U5|3-Phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride|CHEMBL4650358|SCHEMBL15610231|EX-A4040A|VFC94675|HY-120801|CS-0079216|1-(Pyridin-2-yl)-3-phenyl-4-propyl-1H-pyrazol-5-ol hydrochloride|3-Phenyl-4-propyl-1-(2-pyridinyl)-1H-pyrazol-5-ol hydrochloride|5-phenyl-4-propyl-2-pyridin-2-yl-1H-pyrazol-3-one;hydrochloride|1H-Pyrazol-5-ol, 3-phenyl-4-propyl-1-(2-pyridinyl)-, hydrochloride (1:1)",315.800,C17H18ClN3O,45.200,412.000,NULL,22,2,3,4,"InChI=1S/C17H17N3O.ClH/c1-2-8-14-16(13-9-4-3-5-10-13)19-20(17(14)21)15-11-6-7-12-18-15;/h3-7,9-12,19H,2,8H2,1H3;1H",CCCC1=C(NN(C1=O)C2=CC=CC=N2)C3=CC=CC=C3.Cl,YEEIHSUMLNXRMI-UHFFFAOYSA-N,5-phenyl-4-propyl-2-pyridin-2-yl-1H-pyrazol-3-one;hydrochloride,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,5,NULL,20120924,A2B Chem|AA BLOCKS|AbaChemScene|Axon Medchem|BenchChem|Biosynth Carbosynth|BLD Pharm|Chem-Space.com Database|ChEMBL|ChemIDplus|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Lan Pharmatech|MedChemexpress MCE|MolPort|SureChEMBL|TargetMol (Target Molecule Corp.)|Thomson Pharma,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
66558664,Tazemetostat,"Tazemetostat|1403254-99-8|EPZ-6438|EPZ6438|N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide|E7438|UNII-Q40W93WPE1|EPZ 6438|E-7438|Q40W93WPE1|N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide|(1,1'-Biphenyl)-3-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4",572.700,C34H44N4O4,83.100,992.000,4.200,42,2,6,9,"InChI=1S/C34H44N4O4/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40)",CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,NSQSAUGJQHDYNO-UHFFFAOYSA-N,"N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,13,1199158|1199159|1199160|1199161|1199162|1199163|1199164|1199165|1199166|1199167|1199168|1199169|1199170|1199171|1199172|1199202|1240270|1240271|1240272|1240273|1240274|1240275|1240276|1240277|1240278|1240279|1240280|1259081|1259398|1259399|1259416|1259421|1259423|1281011|1281012|1281013|1281014|1281015|1296008|1296009|1331311|1331315|1331316|1344426|1345084|1345123|1346024|1346986|1346987|1347055|1347060|1347064|1347065|1347067|1347068|1347080|1347142|1347144|1347145|1347159|1347160|1347411|1350244|1350245|,20121112,"4C Pharma Scientific Inc|A2Z Chemical|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Ambeed|Ambinter|Angene Chemical|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|Ark Pharma Scientific Limited|Aurora Fine Chemicals LLC|Axon Medchem|BioChemPartner|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|Broad Institute|CEGChem|Center for Chemical Gen",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
68488178,Acebilustat,"Acebilustat|943764-99-6|EP-501|UNII-J64RI4D29U|J64RI4D29U|4-(((1S,4S)-5-(4-(4-(oxazol-2-yl)phenoxy)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)methyl)benzoic acid|CTX-4430|Acebilustat [INN]|Acebilustat(ZK322)|Acebilustat [WHO-DD]|SCHEMBL3036353|CHEMBL4297604|BCP19611|EX-A1277|MFCD30496703|AKOS030632028|CS-5999|DB15385|SB19003|HY-17625|Q27281250|4-[[(1S,4S)-2-[[4-[4-(1,3-oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-5-yl]methyl]benzoic acid|4-[[(1S,4S)-5-[[4-[4-(1,3-oxazol-2-yl)phenoxy]phen",481.500,C29H27N3O4,79.000,728.000,2.200,36,1,7,8,"InChI=1S/C29H27N3O4/c33-29(34)23-5-1-20(2-6-23)16-31-18-25-15-24(31)19-32(25)17-21-3-9-26(10-4-21)36-27-11-7-22(8-12-27)28-30-13-14-35-28/h1-14,24-25H,15-19H2,(H,33,34)/t24-,25-/m0/s1",C1[C@H]2CN([C@@H]1CN2CC3=CC=C(C=C3)OC4=CC=C(C=C4)C5=NC=CO5)CC6=CC=C(C=C6)C(=O)O,GERJIEKMNDGSCS-DQEYMECFSA-N,"4-[[(1S,4S)-5-[[4-[4-(1,3-oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]benzoic acid",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents,6,NULL,20121130,"A2B Chem|AA BLOCKS|AbaChemScene|abcr GmbH|AbMole Bioscience|AKos Consulting & Solutions|Angel Pharmatech Ltd.|BenchChem|BioChemPartner|Chem-Space.com Database|ChEMBL|ChemIDplus|ChemShuttle|Davey Lab, Department of Microbiology, NEIDL, Boston University|DC Chemicals|DrugBank|Egon Willighagen (Dept. of Bioinformatics - BiGCaT, Maastricht University)|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IBM|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|Novartis Institutes for BioMedi",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
68746916,CID 68746916,Dexamethasone phosphate disodium|DEXAMETHASONE SODIUM PHOSPHATE|SCHEMBL3694078|s5956|392D394,518.400,C22H30FNa2O8P,141.000,973.000,NULL,34,4,9,4,"InChI=1S/C22H30FO8P.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;/t12-,15+,16+,17+,19+,20+,21+,22+;;/m1../s1",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)(O)O)O)C)O)F)C.[Na].[Na],ODEOTKLZVXBMJD-FCJDYXGNSA-N,NULL,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Use and Manufacturing,8,NULL,20121130,"Chemieliva Pharmaceutical Co., Ltd|OChem|Selleck Chemicals|SureChEMBL",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
79838750,"5-(1,4-Oxazepan-4-YL)pyridine-2-carbonitrile","5-(1,4-OXAZEPAN-4-YL)PYRIDINE-2-CARBONITRILE|ZINC97227385|AKOS018397471|1556733-66-4",203.240,C11H13N3O,49.200,248.000,1.000,15,0,4,1,"InChI=1S/C11H13N3O/c12-8-10-2-3-11(9-13-10)14-4-1-6-15-7-5-14/h2-3,9H,1,4-7H2",C1CN(CCOC1)C2=CN=C(C=C2)C#N,QPJKHSFVBDONPD-UHFFFAOYSA-N,"5-(1,4-oxazepan-4-yl)pyridine-2-carbonitrile",NULL,Biomolecular Interactions and Pathways,1,NULL,20141019,AKos Consulting & Solutions|Ambinter|Aurora Fine Chemicals LLC|BenchChem|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
86291496,Zunsemetinib,"zunsemetinib|AX2VWG0ZCR|UNII-AX2VWG0ZCR|3-chloro-4-[(3,5-difluoropyridin-2-yl)methoxy]-1-[2-[2-(2-hydroxypropan-2-yl)pyrimidin-4-yl]-5-methylpyridin-4-yl]-6-methylpyridin-2-one|Zunsemetinib [INN]|ATI450|CDD450|CHEMBL3704901|SCHEMBL16279876|GTPL11681|ATI-450|CDD-450|BDBM175242|US9115089, 49|(1(2H),4'-Bipyridin)-2-one, 3-chloro-4-((3,5-difluoro-2-pyridinyl)methoxy)-2'-(2-(1-hydroxy-1-methylethyl)-4-pyrimidinyl)-5',6-dimethyl-, (-)-|(p)-3-Chloro-4-((3,5-difluoropyridin-2-yl)methoxy)-2'-(2-(2-hydroxypropan-2-yl",513.900,C25H22ClF2N5O3,101.000,888.000,2.500,36,1,9,6,"InChI=1S/C25H22ClF2N5O3/c1-13-10-30-18(17-5-6-29-24(32-17)25(3,4)35)9-20(13)33-14(2)7-21(22(26)23(33)34)36-12-19-16(28)8-15(27)11-31-19/h5-11,35H,12H2,1-4H3",CC1=CC(=C(C(=O)N1C2=CC(=NC=C2C)C3=NC(=NC=C3)C(C)(C)O)Cl)OCC4=C(C=C(C=N4)F)F,FQPQMJULRZINPV-UHFFFAOYSA-N,"3-chloro-4-[(3,5-difluoropyridin-2-yl)methoxy]-1-[2-[2-(2-hydroxypropan-2-yl)pyrimidin-4-yl]-5-methylpyridin-4-yl]-6-methylpyridin-2-one",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,1259195|1259196,20141222,BindingDB|ChEMBL|ChemIDplus|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|PATENTSCOPE (WIPO)|SureChEMBL|Thomson Pharma,Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
87071853,CID 87071853,147098-20-2|SCHEMBL150741|098R202,1003.200,C44H56CaF2N6O12S2,299.000,767.000,NULL,67,6,20,20,"InChI=1S/2C22H28FN3O6S.Ca/c2*1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32;/h2*5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30);/b2*10-9+;/t2*16-,17-;/m11./s1",CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.CC(C1=NC(=NC(=C1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)C2=CC=C(C=C2)F)N(S(=O)(=O)C)C)C.[Ca],GGPPBULYISSAKA-BGRFNVSISA-N,NULL,NULL,Literature|Patents,2,NULL,20150212,"Chemieliva Pharmaceutical Co., Ltd|OChem|SureChEMBL",Chemical Vendors|Curation Efforts|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
91886171,Dexamethasone 21-phosphate disodium salt hydrate,C22H28FO8P.2Na.H2O|2369AH|Dexamethasone 21-phosphate disodium salt hydrate,534.400,C22H30FNa2O9P,148.000,962.000,NULL,35,3,10,3,"InChI=1S/C22H30FO8P.2Na.H2O/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);;;1H2/q;2*+1;/p-2/t12-,15+,16+,17+,19+,20+,21+,22+;;;/m1.../s1",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.O.[Na+].[Na+],FPCPLJJFHIRQGP-PYHPNWRESA-L,"disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate;hydrate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Safety and Hazards|Use and Manufacturing,6,NULL,20151005,"AK Scientific, Inc. (AKSCI)",Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
93913810,"N-[(3R)-1,1-Dioxo-1lambda~6~-thiolan-3-yl]-N-methyl-N'-propan-2-ylurea","N-[(3R)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-N-methyl-N'-propan-2-ylurea|VZP|ZINC42838879",234.320,C9H18N2O3S,74.900,332.000,-0.100,15,1,3,2,"InChI=1S/C9H18N2O3S/c1-7(2)10-9(12)11(3)8-4-5-15(13,14)6-8/h7-8H,4-6H2,1-3H3,(H,10,12)/t8-/m1/s1",CC(C)NC(=O)N(C)[C@@H]1CCS(=O)(=O)C1,RMWFRPZNASSVCZ-MRVPVSSYSA-N,"1-[(3R)-1,1-dioxothiolan-3-yl]-1-methyl-3-propan-2-ylurea",NULL,Biomolecular Interactions and Pathways,1,NULL,20151210,NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
118323590,Danicopan,"Danicopan|1903768-17-1|ACH-4471|Danicopan free base|UNII-JM8C1SFX0U|JM8C1SFX0U|ACH-0144471|(2S,4R)-1-(2-(3-Acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide|Danicopan [USAN]|Danicopan (USAN/INN)|ACH-4471; Danicopan|CHEMBL4250860|SCHEMBL17024981|BDBM354268|EX-A3068|WHO 10610|1903768-17-1 (free base)|DB15401|US9796741, cmp No. 165|HY-117930|CS-0068562|D11641|(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- brom",580.400,C26H23BrFN7O3,123.000,891.000,3.300,38,1,8,6,"InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1",CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4C[C@@H](C[C@H]4C(=O)NC5=NC(=CC=C5)Br)F,PIBARDGJJAGJAJ-NQIIRXRSSA-N,"(2S,4R)-1-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,1393223|1393250|1393251|1393252,20160223,AbaChemScene|abcr GmbH|AbMole Bioscience|BenchChem|BindingDB|Chem-Space.com Database|ChEMBL|ChemIDplus|DrugBank|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IBM|KEGG|Lan Pharmatech|MedChemexpress MCE|MolPort|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|TargetMol (Target Molecule Corp.)|THE BioTek,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
118414016,"6-Isoquinolinecarboxamide, 1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxo-2-pyrrolidinyl)methoxy)-7-methoxy-","PF-06650833|1817626-54-2|PF06650833|UNII-S3F315JJXI|S3F315JJXI|1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide|1-[[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxo-2-pyrrolidinyl]methoxy]-7-methoxy-6-isoquinolinecarboxamide|1-{[(2s,3s,4s)-3-Ethyl-4-Fluoro-5-Oxopyrrolidin-2-Yl]methoxy}-7-Methoxyisoquinoline-6-Carboxamide|zimlovisertib|1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-methoxyisoquinoline-6-carboxamide|6-Isoquinolinecarboxamide, 1-(((2S,3S,4S)-3",361.400,C18H20FN3O4,104.000,535.000,2.000,26,2,6,6,"InChI=1S/C18H20FN3O4/c1-3-10-13(22-17(24)15(10)19)8-26-18-11-7-14(25-2)12(16(20)23)6-9(11)4-5-21-18/h4-7,10,13,15H,3,8H2,1-2H3,(H2,20,23)(H,22,24)/t10-,13+,15-/m0/s1",CC[C@H]1[C@H](NC(=O)[C@H]1F)COC2=NC=CC3=CC(=C(C=C32)OC)C(=O)N,JKDGKIBAOAFRPJ-ZBINZKHDSA-N,"1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-methoxyisoquinoline-6-carboxamide",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,11,1345640|1347060|1347064|1347065|1347067|1347068|1347411|1448128|1448131|1448132|1448133|1448134|1448141|1448142|1448143|1448144|1448145|1448149|1448150|1448151|1448152|1448153|1448154|1448155|1448156|1448157|1448158|1448159|1448160|1448161|1448162|1448163|1448164|1448165|1448166|1448167|1448168|1448169|1448170|1448171|1448172|1448173|1448174|1448175|1448178|1448179|1448180|1448181|1448182|1448183|1448184|1448185|1448186|1448187|1448188|1448189|1448190|1448191|1448192|1448193|1448194|1448195|1448196|1448197|,20160223,"A2B Chem|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|abcr GmbH|Activate Scientific|AKos Consulting & Solutions|Chem-Space.com Database|ChEMBL|Chemenu Inc.|ChemIDplus|ChemShuttle|Davey Lab, Department of Microbiology, NEIDL, Boston University|DrugBank|eNovation Chemicals|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|IBM|IUPHAR/BPS Guide to PHARMACOLOGY|Key Organics/BIONET|Lan Pharmatech|MedChemexpress MCE|MolPort|MuseChem|NCBI Structure|NIH/NCATS RNAi|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
121310009,Remdesivir nucleoside monophosphate,"Remdesivir nucleoside monophosphate|1911578-74-9|[(2~{R},3~{S},4~{R},5~{R})-5-(4-azanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate|D-Altrononitrile, 2-C-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-2,5-anhydro-, 6-(dihydrogen phosphate)|remdesivir monophosphate|RDV-MP|GS-441524 monophosphate|SCHEMBL17719237|CHEBI:150866|HY-44358|CS-0113740|[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosp",371.240,C12H14N5O7P,196.000,610.000,-3.100,25,5,11,4,"InChI=1S/C12H14N5O7P/c13-4-12(8-2-1-6-11(14)15-5-16-17(6)8)10(19)9(18)7(24-12)3-23-25(20,21)22/h1-2,5,7,9-10,18-19H,3H2,(H2,14,15,16)(H2,20,21,22)/t7-,9-,10-,12+/m1/s1",C1=C2C(=NC=NN2C(=C1)[C@]3([C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)C#N)N,ZBHOHJWLOOFLMW-LTGWCKQJSA-N,"[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Biomolecular Interactions and Pathways|Classification|Literature|Names and Identifiers|Patents,5,NULL,20160806,A2B Chem|AA BLOCKS|AbaChemScene|BenchChem|ChEBI|Google Patents|MedChemexpress MCE|MolPort|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
122164183,1-(2-Hydroxyethyl)-1H-pyrazole-4-carboxamide,1-(2-hydroxyethyl)-1H-pyrazole-4-carboxamide|1849283-80-2|SCHEMBL22048432|OCCN1N=CC(=C1)C(=O)N|AKOS033429389|ZINC306963371|1-(2-HYDROXYETHYL)PYRAZOLE-4-CARBOXAMIDE|Z1562205518|W17,155.150,C6H9N3O2,81.100,151.000,-1.600,11,2,3,3,"InChI=1S/C6H9N3O2/c7-6(11)5-3-8-9(4-5)1-2-10/h3-4,10H,1-2H2,(H2,7,11)",C1=C(C=NN1CCO)C(=O)N,LHYHSUSQLBMWFV-UHFFFAOYSA-N,1-(2-hydroxyethyl)pyrazole-4-carboxamide,NULL,Biomolecular Interactions and Pathways|Patents,2,NULL,20160927,A2B Chem|AA BLOCKS|AKos Consulting & Solutions|Ambeed|Ambinter|BenchChem|BLD Pharm|Chem-Space.com Database|Enamine|Google Patents|MolPort|NCBI Structure|PATENTSCOPE (WIPO)|Protein Data Bank in Europe (PDBe)|SureChEMBL|ZINC,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
123133940,Dexamethasone 21-phosphate disodium salt,Dexamethasone 21-phosphate disodium salt,548.500,C24H36FNa2O8P,141.000,973.000,NULL,36,4,9,4,"InChI=1S/C22H30FO8P.C2H6.2Na/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30;1-2;;/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30);1-2H3;;/t12-,15+,16+,17+,19+,20+,21+,22+;;;/m1.../s1",CC.C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)(O)O)O)C)O)F)C.[Na].[Na],UGUDWMSAJMYDFA-PYHPNWRESA-N,NULL,NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Safety and Hazards|Use and Manufacturing,6,NULL,20170119,Pi Chemicals,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
126782062,"2-Fluoro-N,3-dimethylbenzene-1-sulfonamide","2-fluoro-N,3-dimethylbenzene-1-sulfonamide|1864268-87-0|PK4|AKOS030710887|ZINC273215815|2-FLUORO-N,3-DIMETHYLBENZENESULFONAMIDE|Z1639162606",203.240,C8H10FNO2S,54.600,260.000,1.400,13,1,4,2,"InChI=1S/C8H10FNO2S/c1-6-4-3-5-7(8(6)9)13(11,12)10-2/h3-5,10H,1-2H3",CC1=C(C(=CC=C1)S(=O)(=O)NC)F,PXJRMCHXJXWNJG-UHFFFAOYSA-N,"2-fluoro-N,3-dimethylbenzenesulfonamide",NULL,Biomolecular Interactions and Pathways,1,NULL,20170425,AKos Consulting & Solutions|BenchChem|BLD Pharm|Chem-Space.com Database|Enamine|MolPort|NCBI Structure|Protein Data Bank in Europe (PDBe)|ZINC,Chemical Vendors|Governmental Organizations,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
129138801,Zotatifin,"Zotatifin|EFT226|EFT-226|2098191-53-6|UNII-2EWN8Z05CN|2EWN8Z05CN|Zotatifin [INN]|4-((5aR,6S,7S,8R,8aS)-7-((Dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5ah-cyclopenta(4,5)furo(3,2-C)pyridin-5a-yl)benzonitrile|4-((5aR,6S,7S,8R,8aS)-7-((Dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[4,5]furo[3,2-c]pyridin-5a-yl)benzonitrile|Zotatifin [USAN]|Zotatifin (USAN/INN)|CHEMBL4303782|SCHEMBL18864788|EX-A4623|BDBM50540861|NSC818001|NSC82",487.500,C28H29N3O5,108.000,819.000,2.400,36,2,8,6,"InChI=1S/C28H29N3O5/c1-31(2)16-20-23(18-8-6-5-7-9-18)28(19-12-10-17(15-29)11-13-19)27(33,25(20)32)24-21(36-28)14-22(34-3)30-26(24)35-4/h5-14,20,23,25,32-33H,16H2,1-4H3/t20-,23-,25-,27+,28+/m1/s1",CN(C)C[C@@H]1[C@H]([C@]2([C@@]([C@@H]1O)(C3=C(N=C(C=C3O2)OC)OC)O)C4=CC=C(C=C4)C#N)C5=CC=CC=C5,QYCXWOACFWMQFO-WZWZCULESA-N,"4-[(2S,3R,4S,5S,6R)-4-[(dimethylamino)methyl]-2,3-dihydroxy-10,12-dimethoxy-5-phenyl-7-oxa-11-azatricyclo[6.4.0.02,6]dodeca-1(12),8,10-trien-6-yl]benzonitrile",NULL,Biological Test Results|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Biological Test Results: Active|Biological Test Results: Micromolar,8,1409607|1409608|1409609|1409611|1409613|1409614|1409623,20170804,AbaChemScene|BindingDB|BLD Pharm|ChEMBL|Chemenu Inc.|ChemIDplus|DTP/NCI|Excenen Pharmatech|FDA/SPL Indexing Data|Google Patents|KEGG|MedChemexpress MCE|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|Thieme Chemistry,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
131632227,"(3S,3'S,4'S,5'S,6'R)-5-[(4-Ethylphenyl)methyl]-6'-(hydroxymethyl)spiro[1H-2-benzofuran-3,2'-oxane]-3',4',5'-triol",RT2,386.400,C22H26O6,99.400,521.000,1.500,28,4,6,4,"InChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21+,22+/m1/s1",CCC1=CC=C(C=C1)CC2=CC3=C(CO[C@@]34[C@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C2,VWVKUNOPTJGDOB-AANPDWTMSA-N,"(3S,3'S,4'S,5'S,6'R)-5-[(4-ethylphenyl)methyl]-6'-(hydroxymethyl)spiro[1H-2-benzofuran-3,2'-oxane]-3',4',5'-triol",NULL,Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,6,NULL,20171013,King Scientific|NCBI Structure|Protein Data Bank in Europe (PDBe),Chemical Vendors|Governmental Organizations|Legacy Depositors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
135398633,Guanosine-5'-triphosphate,GUANOSINE TRIPHOSPHATE|Guanosine-5'-triphosphate|GTP|guanosine 5'-triphosphate|86-01-1|5'-GTP|Guanosine 5'-triphosphoric acid|H4gtp|Guanosine 5'-(tetrahydrogen triphosphate)|UNII-01WV7J708X|CHEBI:15996|01WV7J708X|EINECS 201-647-3|BRN 1201437|56001-37-7|guanosintriphosphat|1jlr|1j2j|36051-31-7|Guanosine 5_-triphosphate|[3h]guanosine triphosphate|Guanosine 5'-triphosphorate|SCHEMBL44408|Guanosine triphosphate (6Cl)|GTPL1742|CHEMBL1233147|SCHEMBL15900104|DTXSID30235328|1e96|Guanosine 5'-triphosphate Disodium|Z,523.179,C10H16N5O14P3,295.000,927.000,-5.700,32,8,16,8,"InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/t3-,5-,6-,9-/m1/s1",C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N=C(NC2=O)N,XKMLYUALXHKNFT-UUOKFMHZSA-N,"[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",Guanosine Triphosphate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,12,880|1030|1457|1458|1460|1463|1468|1469|1471|1477|1479|1490|1811|1865|2101|2107|2112|2517|2549|125977|125978|126122|234406|269136|312071|312075|485281|485290|504327|504332|504845|504847|588579|602332|686978|686979|720532|720533|720579|720580|977611|1159524|1172275|1172276|1286110|1331368|1331369|1346293|1346348|1346625|1347082|1347083|1347085|1347086|1347131|1347154|1425594|1425595|1425596|1425607|1425632,20190115,"3B Scientific (Wuhan) Corp|3WAY PHARM INC|AAA Chemistry|AbaChemScene|abcr GmbH|ABI Chem|AbovChem LLC|Achemtek|Acros Organics|ACT Chemical|Activate Scientific|AEchem Scientific Corp., USA|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Chemistry|Ambeed|Ambinter|Apexmol|Aurora Fine Chemicals LLC|BIND|BindingDB|BioCyc|Biosynth Carbosynth|BLD Pharm|BOC Sciences|CCSbase|ChEBI|Chem-Space.com Database|Chembase.cn|ChEMBL|Chemenu Inc.|ChemExper Chemical Directory|ChemIDplus|Chemieli",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank, WikiPathways]"
135408753,4-Hydroxyquinazoline,"4-Hydroxyquinazoline|491-36-1|Quinazolin-4-ol|quinazolin-4(3H)-one|4-Quinazolinol|4(3H)-Quinazolinone|4-Quinazolone|4-Quinazolinone|4(1H)-Quinazolinone|4-HQN|4-Oxoquinazoline|3,4-Dihydroquinazolin-4-one|4(3H)-Quinazolone|1H-quinazolin-4-one|Quinazolin-4(1H)-one|MFCD00511302|132305-20-5|3-hydro-4-quinazolinone|quinazolin-4-one|UNII-84JOT4EY5X|NSC 5863|4-hydroxy quinazoline|3H-Quinazolin-4-one|QUINAZOLONE, 4-|17227-47-3|4-Hydroxyquinazoline, 98%|84JOT4EY5X|CHEMBL266540|134434-33-6|quinazolidin-4-one|CCRIS 680",146.150,C8H6N2O,41.500,200.000,0.700,11,1,2,0,"InChI=1S/C8H6N2O/c11-8-6-3-1-2-4-7(6)9-5-10-8/h1-5H,(H,9,10,11)",C1=CC=C2C(=C1)C(=O)NC=N2,QMNUDYFKZYBWQX-UHFFFAOYSA-N,3H-quinazolin-4-one,NULL,Agrochemical Information|Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,155|157|161|165|167|175|248|256|316|422|436|485|631|731|745|757|758|759|760|761|764|775|781|782|793|797|798|799|800|803|804|817|818|827|828|841|861|862|868|871|873|875|878|880|881|884|885|886|887|889|892|893|894|898|900|902|912|920|923|924|925|926|932|938|940|950|951|952|995|999|1001|1004|1006|1007|1008|1009|1012|1016|1018|1019|1020|1021|1022|1027|1030|1032|1040|1046|1048|1049|1051|1063|1066|1085|1135|1136|1203|1209|1214|1216|1217|1220|1222|1229|1230|1236|1239|1242|1251|1273|1274|1276|1285|1296|1304|1321|13,20190115,"001Chemical|3B Scientific (Wuhan) Corp|3WAY PHARM INC|A&J Pharmtech CO., LTD.|A2Z Chemical|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|Acadechem|Achemica|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Acros Organics|Activate Scientific|Adooq BioScience|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alfa Aesar|Alfa Chemistry|Alichem|Alinda Chemical|Allbio Pharm Co., Ltd|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angene Chemical|Anward|ApexBio Technology",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per PDB, Protein Data Bank]"
135413523,Sildenafil citrate,"Sildenafil citrate|171599-83-0|Revatio|VIAGRA|Caverta|Sildenafil (citrate)|Sildenafil citrate [USAN]|UNII-BW9B0ZE037|Sildenafil citrate salt|BW9B0ZE037|CHEBI:58987|5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 2-hydroxypropane-1,2,3-tricarboxylate|UK 92480-10|UK 92480|UK-92480-10|UK-92,480-10|DSSTox_CID_26076|DSSTox_RID_81321|DSSTox_GSID_46076|5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-",666.700,C28H38N6O11S,250.000,1070.000,NULL,46,5,15,12,"InChI=1S/C22H30N6O4S.C6H8O7/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28;7-3(8)1-6(13,5(11)12)2-4(9)10/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)",CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,DEIYFTQMQPDXOT-UHFFFAOYSA-N,"5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid",Sildenafil Citrate,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,2517|158099|225951|431557|431558|431559|431560|431561|431562|431563|431564|431565|431566|431567|431568|431569|431570|431571|431572|431573|588834|634183|651631|651632|651633|651634|651645|651646|651696|651712|651713|651828|652048|652051|686947|686950|686978|686979|720516|720532|720533|720552|720634|720635|720637|720674|720675|720678|720679|720680|720681|720682|720683|720684|720685|720686|720687|720691|720692|720693|720719|720725|743012|743014|743015|743033|743035|743036|743040|743041|743042|743053|743054|743,20190115,"3WAY PHARM INC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|ABI Chem|AbMole Bioscience|AbovChem LLC|Achemtek|Acorn PharmaTech Product List|Activate Scientific|AHH Chemical co.,ltd|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|ApexBio Technology|Apexmol|Ark Pharm, Inc.|Assembly Blocks Pvt. Ltd.|AvaChem Scientific|Axon Medchem|BePharm Ltd.|BindingDB|BioChemPartner|BioCrick|Biosynth Carbosynth|BLD Pharm|BOC Sciences|Boerchem|CCSbase|Center for Chemica",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135423438,Nintedanib,Nintedanib|Vargatef|656247-17-5|BIBF-1120|Intedanib|BIBF 1120|928326-83-4|BIBF1120|Nintedanib (BIBF 1120)|OFEV|(Z)-methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate|UNII-G6HRD2P839|Methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate|CID 9809715|G6HRD2P839|CHEBI:85164|1160294-26-7|(Z)-Methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)-phenylamino)(phenyl)methyle,539.600,C31H33N5O4,102.000,892.000,4.300,40,2,7,8,"InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,33,38H,15-18,20H2,1-3H3",CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,CPMDPSXJELVGJG-UHFFFAOYSA-N,methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate,NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar|Biological Test Results: Nanomolar,15,397037|397038|397039|397040|397041|397042|397043|397044|397045|397046|397047|397048|397049|397050|397051|397052|397053|397054|397055|397056|397059|397060|397061|397062|397063|397064|397065|397066|397067|397068|397069|397070|397071|397072|397073|397074|397075|397076|397077|397078|397079|397080|397081|397082|397083|397084|397085|397086|397087|397088|397089|397090|397091|397092|397241|397242|397243|397244|397245|397246|397247|397248|397249|397250|397251|397252|397253|397254|507185|507186|507187|507188|507189|5,20190115,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acadechem|Accela ChemBio Inc.|Aceschem Inc|Acesobio|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Ansion Pharma|AOBIOUS",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135449332,Eltrombopag,"Eltrombopag|496775-61-2|Promacta|Revolade|(Z)-3'-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid|SB497115|UNII-S56D65XJ9G|Eltrombopag free base|3'-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid|SB-497115|CHEMBL461101|S56D65XJ9G|CHEMBL3186485|CHEBI:85010|Eltrombopag (SB-497115-GR)|496775-61-2 (free base)|NCGC00274067-01|(Z)-3'-(2-(1-(3,4-Dimethy",442.500,C25H22N4O4,115.000,812.000,5.400,33,3,7,5,"InChI=1S/C25H22N4O4/c1-14-10-11-19(12-15(14)2)29-24(31)22(16(3)28-29)27-26-21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,28,30H,1-3H3,(H,32,33)",CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,SVOQIEJWJCQGDQ-UHFFFAOYSA-N,"3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Chemical and Physical Properties|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Safety and Hazards|Toxicity|Use and Manufacturing|Biological Test Results: Active|Biological Test Results: Micromolar,14,349040|349041|387558|387559|395496|625276|625293|743191|743194|743199|743202|743203|743209|743210|743211|743212|743213|743215|743217|743218|743219|743220|743221|743222|743223|743224|743225|743226|743227|743228|743239|743240|743241|743242|743344|743345|743346|743347|1117298|1117301|1117302|1117303|1117304|1117305|1117310|1117311|1117312|1117314|1117315|1117318|1159509|1159515|1159516|1159517|1159518|1159519|1159520|1159521|1159523|1159525|1159526|1159527|1159528|1159529|1159531|1159551|1159552|1159553|115955,20190115,"001Chemical|3WAY PHARM INC|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2B Chem|A2Z Chemical|AA BLOCKS|Aaron Chemicals LLC|AbaChemScene|ABBLIS Chemicals|abcr GmbH|AbMole Bioscience|AbovChem LLC|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Active Biopharma|Adooq BioScience|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|AlchemyPharm|Alfa Chemistry|Alsachim|Amadis Chemical|Ambeed|Ambinter|AN PharmaTech|Angel Pharmatech Ltd.|Angene Chemical|Anward|ApexBio Te",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135537060,Rintatolimod,"RINTATOLIMOD|Atvogen|Poly I:Poly C12U|POLYI-POLYC12U|Poly(I).poly(c12,U)|Mismatched double-stranded RNA|Poly I-Poly C (C12,U)|(rI(n).r(C(12)U)n)|DRG-0001|Poly(I)-Poly(C12U)|Rintatolimod [USAN:INN]|UNII-94325AJ25N|Poly(inosinic acid) poly(cytidylic(12), uridylic)acid|SCHEMBL27306|DTXSID50191952|94325AJ25N|5'-Inosinic acid, homopolymer, complex with 5'-cytidylic acid polymer with 5'-uridylic acid (1:1)",995.600,C28H40N9O25P3,517.000,1600.000,NULL,65,15,27,12,"InChI=1S/C10H13N4O8P.C9H14N3O8P.C9H13N2O9P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17;10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18;12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20);1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18);1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,10-;2*4-,6-,7-,8-/m111/s1",C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O.C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O,KNUXHTWUIVMBBY-JRJYXWDASA-N,"[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate;[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Pharmacology and Biochemistry|Use and Manufacturing,7,NULL,20190115,ABI Chem|ChemIDplus|ChemSpider|EPA DSSTox|LeadScope|NextBio|NovoSeek|PATENTSCOPE (WIPO)|Springer Nature|SureChEMBL|Thomson Pharma|ToxPlanet,Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
135564749,Apabetalone,"Apabetalone|1044870-39-4|RVX-208|2-(4-(2-Hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one|RVX-000222|RVX 208|2-[4-(2-Hydroxyethoxy)-3,5-Dimethylphenyl]-5,7-Dimethoxyquinazolin-4(3h)-One|RVX000222|UNII-8R4A7GDZ1D|RVX 000222|8R4A7GDZ1D|QC-216|2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-1H-quinazolin-4-one|Apabetalone [INN]|Apabetalone [USAN:INN]|RVX208|1K0|4j1p|4j3i|4mr4|4mr6|Apabetalone (USAN/INN)|SCHEMBL145019|GTPL7034|SCHEMBL17002023|AOB2133|DTXSID90146502|HMS3653C10|HMS374",370.400,C20H22N2O5,89.400,543.000,2.300,27,2,6,6,"InChI=1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24)",CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2,NETXMUIMUZJUTB-UHFFFAOYSA-N,"2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-3H-quinazolin-4-one",NULL,Biological Test Results|Biomolecular Interactions and Pathways|Classification|Drug and Medication Information|Literature|Names and Identifiers|Patents|Safety and Hazards|Biological Test Results: Active|Biological Test Results: Micromolar,10,752924|752925|752926|752927|752928|752929|752930|752931|752932|752933|752934|752935|752936|752937|752938|752939|752940|752941|752942|752943|752944|752945|752946|752947|752948|752949|752950|752951|752952|752953|752954|752955|752956|752957|752958|752959|752960|752961|752962|752963|752964|752965|752966|752967|752968|752969|752970|752971|752972|752973|752974|752975|752976|752977|752978|752979|752980|752981|752982|752983|752984|752985|752986|752987|752988|752989|752990|752991|752992|752993|752994|977608|977611|1,20190115,"001Chemical|4C Pharma Scientific Inc|A&J Pharmtech CO., LTD.|A2Z Chemical|AbaChemScene|abcr GmbH|AbMole Bioscience|AbovChem LLC|Acadechem|Aceschem Inc|Achemo Scientific Limited|Achemtek|Acorn PharmaTech Product List|Activate Scientific|Adooq BioScience|AEchem Scientific Corp., USA|AK Scientific, Inc. (AKSCI)|AKos Consulting & Solutions|Allbio Pharm Co., Ltd|Ambinter|Angel Pharmatech Ltd.|AOBIOUS INC|ApexBio Technology|Ark Pharm, Inc.|Ark Pharma Scientific Limited|AstaTech, Inc.|Aurora Fine Chemicals LLC|Aur",Chemical Vendors|Curation Efforts|Governmental Organizations|Journal Publishers|Legacy Depositors|NIH Initiatives|Research and Development|Subscription Services,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
137220375,"4-Acetamidobenzoic acid;9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one;1-(dimethylamino)propan-2-ol","Isoprinosine|36703-88-5|4-acetamidobenzoic acid;9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one;1-(dimethylamino)propan-2-ol|BCP21366|FT-0628301|Imunovir; Delimmun; Groprinosin;Inosine pranobex",1115.200,C52H78N10O17,399.000,658.000,NULL,79,13,22,14,"InChI=1S/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3",CC(CN(C)C)O.CC(CN(C)C)O.CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O,YLDCUKJMEKGGFI-UHFFFAOYSA-N,"4-acetamidobenzoic acid;9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one;1-(dimethylamino)propan-2-ol",Inosine Pranobex,Classification|Drug and Medication Information|Literature|Names and Identifiers|Pharmacology and Biochemistry,5,NULL,20190125,"Angel Pharmatech Ltd.|Ark Pharm, Inc.|BioChemPartner|Chem-Space.com Database|Clearsynth|Finetech Industry Limited|LEAPCHEM|Pi Chemicals|University of Kansas High Throughput Screening Laboratory",Chemical Vendors|Legacy Depositors|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
155903259,Unii-7R9A5P7H32,"PF-07321332|UNII-7R9A5P7H32|7R9A5P7H32|PF07321332|2628280-40-8|(1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-6,6-dimethyl-3-(3-methyl-N-(trifluoroacetyl)-L-valyl)-3-azabicyclo(3.1.0)hexane-2-carboxamide|(1R,2S,5S)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-6,6-dimethyl-3-[3-methyl-N-(trifluoroacetyl)-L-valyl]-3-azabicyclo[3.1.0]hexane-2-carboxamide|GTPL11503|CHEBI:170007|EX-A5024|PF 07321332|(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-(2,2,",499.500,C23H32F3N5O4,131.000,964.000,2.200,35,3,8,7,"InChI=1S/C23H32F3N5O4/c1-21(2,3)16(30-20(35)23(24,25)26)19(34)31-10-13-14(22(13,4)5)15(31)18(33)29-12(9-27)8-11-6-7-28-17(11)32/h11-16H,6-8,10H2,1-5H3,(H,28,32)(H,29,33)(H,30,35)/t11-,12-,13-,14-,15-,16+/m0/s1",CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)C(F)(F)F)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)C,LIENCHBZNNMNKG-OJFNHCPVSA-N,"(1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",NULL,Classification|Drug and Medication Information|Literature|Names and Identifiers,4,NULL,20210501,ChEBI|ChemIDplus|Excenen Pharmatech|FDA/SPL Indexing Data|IUPHAR/BPS Guide to PHARMACOLOGY,Chemical Vendors|Curation Efforts|Governmental Organizations|Research and Development,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
156592231,CID 156592231,114870-03-0,1531.300,C31H53N3NaO49S8,873.000,3450.000,NULL,92,19,52,30,"InChI=1S/C31H53N3O49S8.Na/c1-69-27-9(33-85(48,49)50)13(37)17(6(74-27)3-71-88(57,58)59)76-31-22(83-91(66,67)68)16(40)21(24(81-31)26(43)44)79-29-10(34-86(51,52)53)19(82-90(63,64)65)18(7(75-29)4-72-89(60,61)62)77-30-15(39)14(38)20(23(80-30)25(41)42)78-28-8(32-84(45,46)47)12(36)11(35)5(73-28)2-70-87(54,55)56;/h5-24,27-40H,2-4H2,1H3,(H,41,42)(H,43,44)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68);/t5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22",CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O.[Na],ZXIQEAFRRVQRSW-SKWQCJBYSA-N,NULL,NULL,Classification|Drug and Medication Information|Names and Identifiers|Safety and Hazards,4,NULL,20210908,A2B Chem|AA BLOCKS,Chemical Vendors,"COVID-19, COVID19, Coronavirus, Corona-virus, SARS, SARS2, SARS-CoV, SARS-CoV-2 [as per clinicaltrial, clinicaltrials, clinical trial, clinical trials]"
